PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Borucki, WJ; Koch, D; Basri, G; Batalha, N; Brown, T; Caldwell, D; Caldwell, J; Christensen-Dalsgaard, J; Cochran, WD; DeVore, E; Dunham, EW; Dupree, AK; Gautier, TN; Geary, JC; Gilliland, R; Gould, A; Howell, SB; Jenkins, JM; Kondo, Y; Latham, DW; Marcy, GW; Meibom, S; Kjeldsen, H; Lissauer, JJ; Monet, DG; Morrison, D; Sasselov, D; Tarter, J; Boss, A; Brownlee, D; Owen, T; Buzasi, D; Charbonneau, D; Doyle, L; Fortney, J; Ford, EB; Holman, MJ; Seager, S; Steffen, JH; Welsh, WF; Rowe, J; Anderson, H; Buchhave, L; Ciardi, D; Walkowicz, L; Sherry, W; Horch, E; Isaacson, H; Everett, ME; Fischer, D; Torres, G; Johnson, JA; Endl, M; MacQueen, P; Bryson, ST; Dotson, J; Haas, M; Kolodziejczak, J; Van Cleve, J; Chandrasekaran, H; Twicken, JD; Quintana, EV; Clarke, BD; Allen, C; Li, J; Wu, H; Tenenbaum, P; Verner, E; Bruhweiler, F; Barnes, J; Prsa, A				Borucki, William J.; Koch, David; Basri, Gibor; Batalha, Natalie; Brown, Timothy; Caldwell, Douglas; Caldwell, John; Christensen-Dalsgaard, Jorgen; Cochran, William D.; DeVore, Edna; Dunham, Edward W.; Dupree, Andrea K.; Gautier, Thomas N., III; Geary, John C.; Gilliland, Ronald; Gould, Alan; Howell, Steve B.; Jenkins, Jon M.; Kondo, Yoji; Latham, David W.; Marcy, Geoffrey W.; Meibom, Soren; Kjeldsen, Hans; Lissauer, Jack J.; Monet, David G.; Morrison, David; Sasselov, Dimitar; Tarter, Jill; Boss, Alan; Brownlee, Don; Owen, Toby; Buzasi, Derek; Charbonneau, David; Doyle, Laurance; Fortney, Jonathan; Ford, Eric B.; Holman, Matthew J.; Seager, Sara; Steffen, Jason H.; Welsh, William F.; Rowe, Jason; Anderson, Howard; Buchhave, Lars; Ciardi, David; Walkowicz, Lucianne; Sherry, William; Horch, Elliott; Isaacson, Howard; Everett, Mark E.; Fischer, Debra; Torres, Guillermo; Johnson, John Asher; Endl, Michael; MacQueen, Phillip; Bryson, Stephen T.; Dotson, Jessie; Haas, Michael; Kolodziejczak, Jeffrey; Van Cleve, Jeffrey; Chandrasekaran, Hema; Twicken, Joseph D.; Quintana, Elisa V.; Clarke, Bruce D.; Allen, Christopher; Li, Jie; Wu, Haley; Tenenbaum, Peter; Verner, Ekaterina; Bruhweiler, Frederick; Barnes, Jason; Prsa, Andrej			Kepler Planet-Detection Mission: Introduction and First Results	SCIENCE			English	Article							EXOPLANETS; EARTH	The Kepler mission was designed to determine the frequency of Earth-sized planets in and near the habitable zone of Sun-like stars. The habitable zone is the region where planetary temperatures are suitable for water to exist on a planet's surface. During the first 6 weeks of observations, Kepler monitored 156,000 stars, and five new exoplanets with sizes between 0.37 and 1.6 Jupiter radii and orbital periods from 3.2 to 4.9 days were discovered. The density of the Neptune-sized Kepler-4b is similar to that of Neptune and GJ 436b, even though the irradiation level is 800,000 times higher. Kepler-7b is one of the lowest-density planets (similar to 0.17 gram per cubic centimeter) yet detected. Kepler-5b, -6b, and -8b confirm the existence of planets with densities lower than those predicted for gas giant planets.	[Borucki, William J.; Koch, David; Lissauer, Jack J.; Morrison, David; Rowe, Jason; Bryson, Stephen T.; Dotson, Jessie; Haas, Michael] NASA, Ames Res Ctr, Moffett Field, CA 94035 USA; [Basri, Gibor; Marcy, Geoffrey W.; Anderson, Howard; Walkowicz, Lucianne; Isaacson, Howard] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Batalha, Natalie] San Jose State Univ, San Jose, CA 95192 USA; [Brown, Timothy] Las Cumbres Observ Global Telescope, Goleta, CA 93117 USA; [Caldwell, Douglas; DeVore, Edna; Jenkins, Jon M.; Tarter, Jill; Doyle, Laurance; Van Cleve, Jeffrey; Chandrasekaran, Hema; Twicken, Joseph D.; Quintana, Elisa V.; Clarke, Bruce D.; Li, Jie; Wu, Haley; Tenenbaum, Peter] SETI Inst, Mountain View, CA 94043 USA; [Christensen-Dalsgaard, Jorgen; Kjeldsen, Hans] Aarhus Univ, Aarhus, Denmark; [Cochran, William D.; Endl, Michael; MacQueen, Phillip] Univ Texas Austin, McDonald Observ, Austin, TX 78712 USA; [Dunham, Edward W.] Lowell Observ, Flagstaff, AZ 86001 USA; [Gautier, Thomas N., III] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Dupree, Andrea K.; Geary, John C.; Latham, David W.; Meibom, Soren; Sasselov, Dimitar; Charbonneau, David; Holman, Matthew J.; Buchhave, Lars; Torres, Guillermo] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Gilliland, Ronald] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Monet, David G.] US Naval Observ, Flagstaff, AZ 86001 USA; [Ford, Eric B.] Univ Florida, Gainesville, FL 32611 USA; [Everett, Mark E.] Planetary Sci Inst, Tucson, AZ 85719 USA; [Howell, Steve B.; Sherry, William] Natl Opt Astron Observ, Tucson, AZ 85719 USA; [Fischer, Debra] Yale Univ, New Haven, CT 06520 USA; [Caldwell, John] York Univ, N York, ON M3J 1P3, Canada; [Gould, Alan] Lawrence Hall Sci, Berkeley, CA 94720 USA; [Boss, Alan] Carnegie Inst Sci, Washington, DC 20015 USA; [Owen, Toby] Univ Hawaii, Hilo, HI 96720 USA; [Brownlee, Don] Univ Washington, Seattle, WA 98195 USA; [Buzasi, Derek] Eureka Sci, Oakland, CA 94602 USA; [Horch, Elliott] So Connecticut State Univ, New Haven, CT 06515 USA; [Fortney, Jonathan] Univ Calif Santa Cruz, Santa Cruz, CA 95064 USA; [Seager, Sara] MIT, Cambridge, MA 02139 USA; [Steffen, Jason H.] Fermilab Natl Accelerator Lab, Batavia, IL 60510 USA; [Welsh, William F.] San Diego State Univ, San Diego, CA 92182 USA; [Ciardi, David; Johnson, John Asher] CALTECH, Exoplanet Sci Inst, Pasadena, CA 91125 USA; [Kondo, Yoji] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20025 USA; [Kolodziejczak, Jeffrey] George C Marshall Space Flight Ctr, Huntsville, AL 35805 USA; [Allen, Christopher] Orbital Sci, Mountain View, CA 94043 USA; [Verner, Ekaterina; Bruhweiler, Frederick] Catholic Univ Amer, Washington, DC 20064 USA; [Barnes, Jason] Univ Idaho, Moscow, ID 83844 USA; [Prsa, Andrej] Villanova Univ, Villanova, PA 19085 USA	National Aeronautics & Space Administration (NASA); NASA Ames Research Center; University of California System; University of California Berkeley; California State University System; San Jose State University; Aarhus University; University of Texas System; University of Texas Austin; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; Space Telescope Science Institute; State University System of Florida; University of Florida; National Optical Astronomy Observatory; Yale University; York University - Canada; Carnegie Institution for Science; University of Hawaii System; University Hawaii Hilo; University of Washington; University of Washington Seattle; Eureka Scientific; Connecticut State University System; Southern Connecticut State University; University of California System; University of California Santa Cruz; Massachusetts Institute of Technology (MIT); United States Department of Energy (DOE); University of Chicago; Fermi National Accelerator Laboratory; California State University System; San Diego State University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; Catholic University of America; Idaho; University of Idaho; Villanova University	Borucki, WJ (corresponding author), NASA, Ames Res Ctr, Moffett Field, CA 94035 USA.	William.J.Borucki@nasa.gov	Ford, Eric B./AAB-5479-2019; Caldwell, Douglas A/L-7911-2014; rowe, james B/C-3661-2013; Barnes, Jason W/B-1284-2009; Fischer, Debra A/C-1639-2014; Cochran, William D/M-4421-2014; Buchhave, Lars A./ABF-2000-2020; Basri, Gibor B/Y-4048-2018; Welsh, William/AAS-3445-2021; Steffen, Jason H./A-4320-2013; Fortney, Jonathan/F-8813-2014	Ford, Eric B./0000-0001-6545-639X; Caldwell, Douglas A/0000-0003-1963-9616; rowe, james B/0000-0001-7216-8679; Barnes, Jason W/0000-0002-7755-3530; Fischer, Debra A/0000-0003-2221-0861; Cochran, William D/0000-0001-9662-3496; Buchhave, Lars A./0000-0003-1605-5666; Fortney, Jonathan/0000-0002-9843-4354; Rowe, Jason/0000-0002-5904-1865; Ciardi, David/0000-0002-5741-3047; Steffen, Jason/0000-0003-2202-3847; Batalha, Natalie/0000-0002-7030-9519; Chandrasekaran, Hema/0000-0002-9760-7735; Buzasi, Derek/0000-0002-1988-143X	NASA	NASA(National Aeronautics & Space Administration (NASA))	Kepler was competitively selected as the 10th Discovery mission. Funding for this mission is provided by NASA's Science Mission Directorate.	Adams ER, 2008, ASTROPHYS J, V673, P1160, DOI 10.1086/524925; BAKOS GA, ASTROPHYS J; Baraffe I, 2008, ASTRON ASTROPHYS, V482, P315, DOI 10.1051/0004-6361:20079321; BASRI G, ASTROPHYS J; BATALHA NM, ASTROPHYS J; BEDDING TR, ASTROPHYS J; Borucki W., 2008, P INT ASTRON UNION, V4, P289; Borucki WJ, 2009, SCIENCE, V325, P709, DOI 10.1126/science.1178312; BORUCKI WJ, ASTROPHYS J; CALDWELL DA, ASTROPHYS J; CHAPLIN WJ, ASTROPHYS J; CHRISTENSENDALS.J, ASTROPHYS J; DUNHAM E, ASTROPHYS J; Fortney JJ, 2008, ASTR SOC P, V398, P405; GILLILAND RL, ASTROPHYS J; GILLILAND RL, PUBL ASTRON SOC PACI; Gillon M, 2007, ASTRON ASTROPHYS, V472, pL13, DOI 10.1051/0004-6361:20077799; GRIGACHCENE A, ASTROPHYS J; HAAS MR, ASTROPHYS J; HEKKER S, ASTROPHYS J; JENKINS JM, ASTROPHYS J; KOCH DG, ASTROPHYS J; KOLENBERG K, ASTROPHYS J; LATHAM DW, ASTROPHYS J; O'Donovan FT, 2006, ASTROPHYS J, V651, pL61, DOI 10.1086/509123; Pal A, 2008, ASTROPHYS J, V680, P1450, DOI 10.1086/588010; Raymond SN, 2006, SCIENCE, V313, P1413, DOI 10.1126/science.1130461; ROWE JF, ASTROPHYS J; STELLO D, ASTROPHYS J; WELSH WF, ASTROPHYS J; WOLSZCZAN A, 1994, SCIENCE, V264, P538, DOI 10.1126/science.264.5158.538; WOLSZCZAN A, 1992, NATURE, V355, P145, DOI 10.1038/355145a0	33	2404	2421	9	403	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					977	980		10.1126/science.1185402	http://dx.doi.org/10.1126/science.1185402			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20056856				2022-12-28	WOS:000274625800034
J	Chan, YF; Marks, ME; Jones, FC; Villarreal, G; Shapiro, MD; Brady, SD; Southwick, AM; Absher, DM; Grimwood, J; Schmutz, J; Myers, RM; Petrov, D; Jonsson, B; Schluter, D; Bell, MA; Kingsley, DM				Chan, Yingguang Frank; Marks, Melissa E.; Jones, Felicity C.; Villarreal, Guadalupe, Jr.; Shapiro, Michael D.; Brady, Shannon D.; Southwick, Audrey M.; Absher, Devin M.; Grimwood, Jane; Schmutz, Jeremy; Myers, Richard M.; Petrov, Dmitri; Jonsson, Bjarni; Schluter, Dolph; Bell, Michael A.; Kingsley, David M.			Adaptive Evolution of Pelvic Reduction in Sticklebacks by Recurrent Deletion of a Pitx1 Enhancer	SCIENCE			English	Article							COMMON FRAGILE SITE; GASTEROSTEUS-ACULEATUS; THREESPINE STICKLEBACK; MORPHOLOGICAL EVOLUTION; PHENOTYPIC DIVERSITY; PARALLEL EVOLUTION; GENETIC THEORY; EVO-DEVO; ADAPTATION; EXPRESSION	The molecular mechanisms underlying major phenotypic changes that have evolved repeatedly in nature are generally unknown. Pelvic loss in different natural populations of threespine stickleback fish has occurred through regulatory mutations deleting a tissue-specific enhancer of the Pituitary homeobox transcription factor 1 (Pitx1) gene. The high prevalence of deletion mutations at Pitx1 may be influenced by inherent structural features of the locus. Although Pitx1 null mutations are lethal in laboratory animals, Pitx1 regulatory mutations show molecular signatures of positive selection in pelvic-reduced populations. These studies illustrate how major expression and morphological changes can arise from single mutational leaps in natural populations, producing new adaptive alleles via recurrent regulatory alterations in a key developmental control gene.	[Chan, Yingguang Frank; Marks, Melissa E.; Jones, Felicity C.; Villarreal, Guadalupe, Jr.; Shapiro, Michael D.; Brady, Shannon D.; Kingsley, David M.] Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA; [Chan, Yingguang Frank; Marks, Melissa E.; Jones, Felicity C.; Villarreal, Guadalupe, Jr.; Shapiro, Michael D.; Brady, Shannon D.; Kingsley, David M.] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Southwick, Audrey M.] Stanford Univ, Stanford Human Genome Ctr, Stanford, CA 94305 USA; [Absher, Devin M.; Grimwood, Jane; Schmutz, Jeremy; Myers, Richard M.] HudsonAlpha Inst, Huntsville, AL 35806 USA; [Petrov, Dmitri] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Jonsson, Bjarni] Inst Freshwater Fisheries, IS-550 Sauoarkrokur, Iceland; [Schluter, Dolph] Univ British Columbia, Dept Zool, Vancouver, BC V6T 1Z4, Canada; [Bell, Michael A.] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	Stanford University; Howard Hughes Medical Institute; Stanford University; Stanford University; HudsonAlpha Institute for Biotechnology; Stanford University; University of British Columbia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Kingsley, DM (corresponding author), Stanford Univ, Dept Dev Biol, Stanford, CA 94305 USA.	kingsley@stanford.edu	Chan, Yingguang Frank/ABG-9852-2020; Schmutz, Jeremy/N-3173-2013; Grimwood, Jane/ABD-5737-2021; Jones, Felicity C/AAY-3523-2021; Chan, Yingguang/A-7654-2011; Marks, Melissa/V-6587-2019	Chan, Yingguang Frank/0000-0001-6292-9681; Schmutz, Jeremy/0000-0001-8062-9172; Jones, Felicity C/0000-0002-5027-1031; Chan, Yingguang/0000-0001-6292-9681; Marks, Melissa/0000-0003-2625-6322; Schluter, Dolph/0000-0003-1683-7836	Stanford Affymetrix Bio-X Graduate Fellowship; Howard Hughes Medical Insititute (HHMI); Burroughs Wellcome Fund; NSF [DEB0211391, DEB0322818]; Natural Sciences and Engineering Research Council of Canada; Guggenheim Foundation; NIH [P50 HG02568]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002568] Funding Source: NIH RePORTER	Stanford Affymetrix Bio-X Graduate Fellowship; Howard Hughes Medical Insititute (HHMI)(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NSF(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Guggenheim Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank M. McLaughlin for fish husbandry, M. Nonet for the gift of the pBH-mcs-YFP vector, Broad Institute for the public gasAcu1 genome assembly, and many individuals for valuable fish samples (table S1). This work was supported by a Stanford Affymetrix Bio-X Graduate Fellowship (Y. F. C.); the Howard Hughes Medical Insititute (HHMI) Exceptional Research Opportunities Program (G. V.); the Burroughs Wellcome Fund (M. D. S.); NSF grants DEB0211391 and DEB0322818 (M. A. B.); a Canada Research Chair and grants from the Natural Sciences and Engineering Research Council of Canada and the Guggenheim Foundation (D. S.); NIH grant P50 HG02568 (R. M. M., D. P., and D. M. K.); and an HHMI investigatorship (D. M. K.). Sequences generated for this study are available in GenBank (accession GU130433-7).	BELL MA, 1987, BIOL J LINN SOC, V31, P347, DOI 10.1111/j.1095-8312.1987.tb01998.x; BELL MA, 1993, EVOLUTION, V47, P906, DOI 10.1111/j.1558-5646.1993.tb01243.x; Bell MA, 2007, J EXP ZOOL PART B, V308B, P189, DOI 10.1002/jez.b.21132; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cockram J, 2007, GENETICS, V177, P2535, DOI 10.1534/genetics.107.074765; Cole NJ, 2003, CURR BIOL, V13, pR951, DOI 10.1016/S0960-9822(03)00881-9; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Coyle SM, 2007, J HERED, V98, P581, DOI 10.1093/jhered/esm066; Cresko WA, 2004, P NATL ACAD SCI USA, V101, P6050, DOI 10.1073/pnas.0308479101; Durkin SG, 2008, P NATL ACAD SCI USA, V105, P246, DOI 10.1073/pnas.0708097105; Fay JC, 2000, GENETICS, V155, P1405; GILES N, 1983, J ZOOL, V199, P535; Glover TW, 2005, HUM MOL GENET, V14, pR197, DOI 10.1093/hmg/ddi265; Hinchliffe J. R., 1980, DEV VERTEBRATE LIMB; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hunt G, 2008, EVOLUTION, V62, P700, DOI 10.1111/j.1558-5646.2007.00310.x; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; KING MC, 1975, SCIENCE, V188, P107, DOI 10.1126/science.1090005; Kingsley David M., 2007, P41; Lanctot C, 1999, DEVELOPMENT, V126, P1805; Mayr E, 1970, POPULATIONS SPECIES; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Mishmar D, 1998, P NATL ACAD SCI USA, V95, P8141, DOI 10.1073/pnas.95.14.8141; Nagayoshi S, 2008, DEVELOPMENT, V135, P159, DOI 10.1242/dev.009050; Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420; Orr HA, 2005, NAT REV GENET, V6, P119, DOI 10.1038/nrg1523; REIMCHEN TE, 1980, CAN J ZOOL, V58, P1232, DOI 10.1139/z80-173; REIST JD, 1980, CAN J ZOOL, V58, P1253, DOI 10.1139/z80-175; Schwartz M, 2005, GENE DEV, V19, P2715, DOI 10.1101/gad.340905; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Stam LF, 1996, GENETICS, V144, P1559; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; SWARUP H, 1958, J EMBRYOL EXP MORPH, V6, P373; Zlotorynski E, 2003, MOL CELL BIOL, V23, P7143, DOI 10.1128/MCB.23.20.7143-7151.2003	34	694	698	8	297	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					302	305		10.1126/science.1182213	http://dx.doi.org/10.1126/science.1182213			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20007865	Green Accepted			2022-12-28	WOS:000273629700034
J	Coldea, R; Tennant, DA; Wheeler, EM; Wawrzynska, E; Prabhakaran, D; Telling, M; Habicht, K; Smeibidl, P; Kiefer, K				Coldea, R.; Tennant, D. A.; Wheeler, E. M.; Wawrzynska, E.; Prabhakaran, D.; Telling, M.; Habicht, K.; Smeibidl, P.; Kiefer, K.			Quantum Criticality in an Ising Chain: Experimental Evidence for Emergent E-8 Symmetry	SCIENCE			English	Article							MAGNETIC-FIELD; MODEL; CONB2O6	Quantum phase transitions take place between distinct phases of matter at zero temperature. Near the transition point, exotic quantum symmetries can emerge that govern the excitation spectrum of the system. A symmetry described by the E-8 Lie group with a spectrum of eight particles was long predicted to appear near the critical point of an Ising chain. We realize this system experimentally by using strong transverse magnetic fields to tune the quasi-one-dimensional Ising ferromagnet CoNb2O6 (cobalt niobate) through its critical point. Spin excitations are observed to change character from pairs of kinks in the ordered phase to spin-flips in the paramagnetic phase. Just below the critical field, the spin dynamics shows a fine structure with two sharp modes at low energies, in a ratio that approaches the golden mean predicted for the first two meson particles of the E-8 spectrum. Our results demonstrate the power of symmetry to describe complex quantum behaviors.	[Coldea, R.; Wheeler, E. M.; Prabhakaran, D.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Tennant, D. A.; Habicht, K.; Smeibidl, P.; Kiefer, K.] Helmholtz Zentrum Berlin Mat & Energie, D-14109 Berlin, Germany; [Wawrzynska, E.] Univ Bristol, HH Wills Phys Lab, Bristol BS8 1TL, Avon, England; [Telling, M.] Rutherford Appleton Lab, ISIS, Didcot OX11 0QX, Oxon, England	University of Oxford; Helmholtz Association; Helmholtz-Zentrum fuer Materialien und Energie GmbH (HZB); University of Bristol; UK Research & Innovation (UKRI); Science & Technology Facilities Council (STFC); STFC Rutherford Appleton Laboratory	Coldea, R (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England.	r.coldea@physics.ox.ac.uk	Tennant, David A/Q-2497-2015; Kiefer, Klaus/J-3544-2013; Telling, Mark/F-3294-2014; Habicht, Klaus/K-3636-2013	Tennant, David A/0000-0002-9575-3368; Kiefer, Klaus/0000-0002-5178-0495; Habicht, Klaus/0000-0002-9915-7221; Telling, Mark/0000-0002-7086-4897; Hetroy Wheeler, Elisa/0000-0002-2183-6435	Engineering and Physical Sciences Research Council (UK); European Commission [RII3-CT-2003-505925]; EPSRC [EP/H014934/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H014934/1] Funding Source: researchfish	Engineering and Physical Sciences Research Council (UK)(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank G. Mussardo, S. T. Carr, A. M. Tsvelik, M. Greiter, and in particular F. H. L. Essler and L. Balents for very useful discussions. Work at Oxford, Bristol, and ISIS was supported by the Engineering and Physical Sciences Research Council (UK) and at HZB by the European Commission under the 6th Framework Programme through the Key Action: Strengthening the European Research Area, Research Infrastructures, contract RII3-CT-2003-505925 (NMI3).	Bitko D, 1996, PHYS REV LETT, V77, P940, DOI 10.1103/PhysRevLett.77.940; Carr ST, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.177206; DELFINO G, 1995, NUCL PHYS B, V455, P724, DOI 10.1016/0550-3213(95)00464-4; Delfino G, 1996, NUCL PHYS B, V473, P469, DOI 10.1016/0550-3213(96)00265-9; GOGOLIN AO, 1998, BOSOMIZATION STRONGL; HEID C, 1995, J MAGN MAGN MATER, V151, P123, DOI 10.1016/0304-8853(95)00394-0; Kenzelmann M, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.017204; Kobayashi S, 1999, PHYS REV B, V60, P3331, DOI 10.1103/PhysRevB.60.3331; Lake B, 2000, PHYS REV LETT, V85, P832, DOI 10.1103/PhysRevLett.85.832; MCCOY BM, 1978, PHYS REV D, V18, P1259, DOI 10.1103/PhysRevD.18.1259; Prabhakaran D, 2003, J CRYST GROWTH, V250, P72, DOI 10.1016/S0022-0248(02)02229-7; Ronnow HM, 2005, SCIENCE, V308, P389, DOI 10.1126/science.1108317; Ruegg C, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.205701; Rutkevich SB, 2008, J STAT PHYS, V131, P917, DOI 10.1007/s10955-008-9495-1; SACDDEV S, 1999, QUANTUM PHASE TRANSI; Senthil T, 2004, SCIENCE, V303, P1490, DOI 10.1126/science.1091806; VOGAN D, 2007, NOTICES AMS, V54, P1022; ZAMOLODCHIKOV AB, 1989, INT J MOD PHYS A, V4, P4235, DOI 10.1142/S0217751X8900176X	20	456	461	4	142	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 8	2010	327	5962					177	180		10.1126/science.1180085	http://dx.doi.org/10.1126/science.1180085			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056884	Green Submitted			2022-12-28	WOS:000273394000027
J	Raihani, NJ; Grutter, AS; Bshary, R				Raihani, Nichola J.; Grutter, Alexandra S.; Bshary, Redouan			Punishers Benefit From Third-Party Punishment in Fish	SCIENCE			English	Article							ALTRUISTIC PUNISHMENT; PARTNER CONTROL		[Raihani, Nichola J.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Grutter, Alexandra S.] Univ Neuchatel, Inst Biol, CH-2009 Neuchatel, Switzerland; [Bshary, Redouan] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia	Zoological Society of London; University of Neuchatel; University of Queensland	Raihani, NJ (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	nichola.raihani@ioz.ac.uk	Raihani, Nichola J/C-2083-2015; Grutter, Alexandra S/J-2737-2013	Raihani, Nichola J/0000-0003-2339-9889; Grutter, Alexandra S/0000-0003-1688-2821; Bshary, Redouan/0000-0001-7198-8472				Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Bshary R, 2002, ANIM BEHAV, V63, P547, DOI 10.1006/anbe.2001.1937; Bshary R, 2008, NATURE, V455, P964, DOI 10.1038/nature07184; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; Jaffe K, 2004, ACTA BIOTHEOR, V52, P155, DOI 10.1023/B:ACBI.0000043440.36462.1a	7	93	98	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 8	2010	327	5962					171	171		10.1126/science.1183068	http://dx.doi.org/10.1126/science.1183068			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056883	Green Submitted			2022-12-28	WOS:000273394000025
J	Abboud, H; Henrich, WL				Abboud, Hanna; Henrich, William L.			Stage IV Chronic Kidney Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ANGIOTENSIN RECEPTOR BLOCKERS; CONVERTING ENZYME-INHIBITORS; DIABETES-MELLITUS; CARDIOVASCULAR EVENTS; CKD; PROTEINURIA; PROGRESSION; RISK; MORTALITY; OUTCOMES	A 54-year-old woman with an 11-year history of type 2 diabetes presents for care. She was first noted to have proteinuria 4 years earlier; her serum creatinine level then was 1.1 mg per deciliter (97 mu mol per liter). Her urinary protein excretion has progressively increased to 2.8 g per 24 hours, and her serum creatinine level to 3.1 mg per deciliter (274 mu mol per liter). The estimated glomerular filtration rate (GFR) is 26 ml per minute per 1.73 m(2) of body-surface area. Her blood pressure is 155/90 mm Hg, and the glycated hemoglobin level is 7.6 mg per deciliter. The medications she is currently taking include an oral hypoglycemic agent, an angiotensin-converting-enzyme (ACE) inhibitor, a statin, and a thiazide diuretic. How should her case be managed?	[Abboud, Hanna; Henrich, William L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol, San Antonio, TX 78229 USA	University of Texas System; University of Texas Health San Antonio	Henrich, WL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Med, Div Nephrol, 7703 Floyd Curl Dr, San Antonio, TX 78229 USA.	henrich@uthscsa.edu						[Anonymous], 2004, AM J KIDNEY DIS, V43, pS1; Bailie GR, 2005, NEPHROL DIAL TRANSPL, V20, P1110, DOI 10.1093/ndt/gfh771; Barnett AH, 2004, NEW ENGL J MED, V351, P1952, DOI 10.1056/NEJMoa042274; Barnett AH, 2005, NEW ENGL J MED, V352, P1731; Bomback AS, 2008, AM J KIDNEY DIS, V51, P199, DOI 10.1053/j.ajkd.2007.10.040; Brenner BM, 2001, NEW ENGL J MED, V345, P861, DOI 10.1056/NEJMoa011161; Collins AJ, 2003, AM J KIDNEY DIS, V41, pV, DOI 10.1016/S0272-6386(03)80001-X; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; de Brito-Ashurst I, 2009, J AM SOC NEPHROL, V20, P2075, DOI 10.1681/ASN.2008111205; Drueke TB, 2006, NEW ENGL J MED, V355, P2071, DOI 10.1056/NEJMoa062276; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; El-Achkar TM, 2005, KIDNEY INT, V67, P1483, DOI 10.1111/j.1523-1755.2005.00226.x; Esnault VLM, 2005, J AM SOC NEPHROL, V16, P474, DOI 10.1681/ASN.2004060505; Fellstrom BC, 2009, NEW ENGL J MED, V360, P1395, DOI 10.1056/NEJMoa0810177; Fox CS, 2004, JAMA-J AM MED ASSOC, V291, P844, DOI 10.1001/jama.291.7.844; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Gutierrez OM, 2008, NEW ENGL J MED, V359, P584, DOI 10.1056/NEJMoa0706130; Hou FF, 2006, NEW ENGL J MED, V354, P131, DOI 10.1056/NEJMoa053107; Hsu CC, 2005, JAMA-J AM MED ASSOC, V293, P2892, DOI 10.1001/jama.293.23.2892; Jafar TH, 2003, ANN INTERN MED, V139, P244, DOI 10.7326/0003-4819-139-4-200308190-00006; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kestenbaum B, 2005, J AM SOC NEPHROL, V16, P520, DOI 10.1681/ASN.2004070602; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Koren MJ, 2009, AM J KIDNEY DIS, V53, P741, DOI 10.1053/j.ajkd.2008.11.025; Kraut JA, 2005, AM J KIDNEY DIS, V45, P978, DOI 10.1053/j.ajkd.2005.03.003; Kunz R, 2008, ANN INTERN MED, V148, P30, DOI 10.7326/0003-4819-148-1-200801010-00190; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 2008, CAN MED ASSOC J, V179, P1154, DOI 10.1503/cmaj.080351; Levin A, 2007, AM J KIDNEY DIS, V50, P471; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Lewis EJ, 2001, NEW ENGL J MED, V345, P851, DOI 10.1056/NEJMoa011303; Maddirala S, 2008, AM J MED SCI, V336, P330, DOI 10.1097/MAJ.0b013e3181836ac7; Menon V, 2008, KIDNEY INT, V73, P1310, DOI 10.1038/ki.2008.67; MITCH WE, 1982, AM J MED, V72, P536, DOI 10.1016/0002-9343(82)90523-X; O'Hare AM, 2009, ANN INTERN MED, V150, P717, DOI 10.7326/0003-4819-150-10-200905190-00010; Parfrey PS, 2009, CLIN J AM SOC NEPHRO, V4, P755, DOI 10.2215/CJN.02730608; Pedrini MT, 1996, ANN INTERN MED, V124, P627, DOI 10.7326/0003-4819-124-7-199604010-00002; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Pun PH, 2009, KIDNEY INT, V76, P652, DOI 10.1038/ki.2009.219; Renal Data System, 2006, USRDS 2006 ANN DAT R; Rucker D, 2009, NAT REV NEPHROL, V5, P287, DOI 10.1038/nrneph.2009.42; Ruggenenti P, 2009, NAT REV NEPHROL, V5, P367, DOI 10.1038/nrneph.2009.77; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Siedlecki AM, 2009, KIDNEY INT, V75, P800, DOI 10.1038/ki.2008.690; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Solomon D, 2002, ARCH INTERN MED, V162, P2640, DOI 10.1001/archinte.162.17.2002; Stevens LA, 2009, KIDNEY INT, V75, P652, DOI 10.1038/ki.2008.638; Strippoli GFM, 2008, BMJ-BRIT MED J, V336, P645, DOI 10.1136/bmj.39472.580984.AE; TAGUMA Y, 1985, NEW ENGL J MED, V313, P1617, DOI 10.1056/NEJM198512263132601; Tseng CL, 2008, ARCH INTERN MED, V168, P55, DOI 10.1001/archinternmed.2007.9; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; van Domburg RT, 2008, J AM SOC NEPHROL, V19, P158, DOI 10.1681/ASN.2006101112; VANDIJK DJ, 2003, MANAGEMENT DIABETIC, P246; Wanner C, 2005, NEW ENGL J MED, V353, P238, DOI 10.1056/NEJMoa043545	54	96	104	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2010	362	1					56	65		10.1056/NEJMcp0906797	http://dx.doi.org/10.1056/NEJMcp0906797			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	540PA	20054047				2022-12-28	WOS:000273345500009
J	Ben-David, O; Rubinstein, SM; Fineberg, J				Ben-David, Oded; Rubinstein, Shmuel M.; Fineberg, Jay			Slip-stick and the evolution of frictional strength	NATURE			English	Article							RATE-DEPENDENT FRICTION; PHYSICAL ANALYSIS; DYNAMIC FRICTION; STATIC FRICTION; FAULTS; EARTHQUAKES; NUCLEATION; TRANSITION; RUPTURE; LAWS	The evolution of frictional strength has great fundamental and practical importance. Applications range from earthquake dynamics(1-4) to hard-drive read/write cycles(5). Frictional strength is governed by the resistance to shear of the large ensemble of discrete contacts that forms the interface that separates two sliding bodies. An interface's overall strength is determined by both the real contact area and the contacts' shear strength(6,7). Whereas the average motion of large, slowly sliding bodies is well-described by empirical friction laws(3,8-10), interface strength is a dynamic entity that is inherently related to both fast processes such as detachment/re-attachment(11-14) and the slow process of contact area rejuvenation(6,7,13,15,16). Here we show how frictional strength evolves from extremely short to long timescales, by continuous measurements of the concurrent local evolution of the real contact area and the corresponding interface motion (slip) from the first microseconds when contact detachment occurs to large (100-second) timescales. We identify four distinct and inter-related phases of evolution. First, all of the local contact area reduction occurs within a few microseconds, on the passage of a crack-like front. This is followed by the onset of rapid slip over a characteristic time, the value of which suggests a fracture-induced reduction of contact strength before any slip occurs. This rapid slip phase culminates with a sharp transition to slip at velocities an order of magnitude slower. At slip arrest, 'ageing' immediately commences as contact area increases on a characteristic timescale determined by the system's local memory of its effective contact time before slip arrest. We show how the singular logarithmic behaviour generally associated with ageing is cut off at short times(16). These results provide a comprehensive picture of how frictional strength evolves from the short times and rapid slip velocities at the onset of motion to ageing at the long times following slip arrest.	[Ben-David, Oded; Rubinstein, Shmuel M.; Fineberg, Jay] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel	Hebrew University of Jerusalem	Fineberg, J (corresponding author), Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel.	jay@vms.huji.ac.il		Fineberg, Jay/0000-0002-8381-6675	Israel Science Foundation [57/07]; US-Israel Binational Science Foundation [2006288]	Israel Science Foundation(Israel Science Foundation); US-Israel Binational Science Foundation(US-Israel Binational Science Foundation)	We acknowledge comments by J. R. Rice, M. O. Robbins, T. Baumberger and C. Caroli. This work, as part of the ESF EUROCORES programme FANAS, was supported by the Israel Science Foundation (grant 57/07). We also acknowledge support of the US-Israel Binational Science Foundation (grant 2006288).	Baumberger T, 1999, PHYS REV B, V60, P3928, DOI 10.1103/PhysRevB.60.3928; Beeler NM, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB004988; Ben-Zion Y, 2001, J MECH PHYS SOLIDS, V49, P2209, DOI 10.1016/S0022-5096(01)00036-9; Ben-Zion Y, 2008, REV GEOPHYS, V46, DOI 10.1029/2008RG000260; Berthoud P, 1999, PHYS REV B, V59, P14313, DOI 10.1103/PhysRevB.59.14313; Bowden F., 2001, FRICTION LUBRICATION; DIETERICH JH, 1979, J GEOPHYS RES, V84, P2161, DOI 10.1029/JB084iB05p02161; DIETERICH JH, 1992, TECTONOPHYSICS, V211, P115, DOI 10.1016/0040-1951(92)90055-B; DIETERICH JH, 1994, PURE APPL GEOPHYS, V143, P283, DOI 10.1007/BF00874332; DIETERICH JH, 1972, J GEOPHYS RES, V77, P3690, DOI 10.1029/JB077i020p03690; FULLER KNG, 1975, P ROY SOC LOND A MAT, V341, P537, DOI 10.1098/rspa.1975.0007; Kim HJ, 2007, TRIBOL LETT, V28, P299, DOI 10.1007/s11249-007-9273-2; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; Marone C, 1998, NATURE, V391, P69, DOI 10.1038/34157; Nakatani M, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004096; Nielsen S, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2007JB005122; OHNAKA M, 1990, TECTONOPHYSICS, V175, P197, DOI 10.1016/0040-1951(90)90138-X; OKUBO PG, 1984, J GEOPHYS RES, V89, P5817, DOI 10.1029/JB089iB07p05817; Rice JR, 2006, J GEOPHYS RES-SOL EA, V111, DOI 10.1029/2005JB004006; RICE JR, 1983, J APPL MECH-T ASME, V50, P343, DOI 10.1115/1.3167042; Rottler J, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.225504; Rubinstein SM, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.256103; Rubinstein SM, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.226103; Rubinstein SM, 2004, NATURE, V430, P1005, DOI 10.1038/nature02830; Scholz CH, 1998, NATURE, V391, P37, DOI 10.1038/34097; Urbakh M, 2004, NATURE, V430, P525, DOI 10.1038/nature02750; Xia KW, 2004, SCIENCE, V303, P1859, DOI 10.1126/science.1094022	27	177	189	8	133	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					76	79		10.1038/nature08676	http://dx.doi.org/10.1038/nature08676			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054393				2022-12-28	WOS:000273344900033
J	Davis, RE; Ngo, VN; Lenz, G; Tolar, P; Young, RM; Romesser, PB; Kohlhammer, H; Lamy, L; Zhao, H; Yang, YD; Xu, WH; Shaffer, AL; Wright, G; Xiao, WM; Powell, J; Jiang, JK; Thomas, CJ; Rosenwald, A; Ott, G; Muller-Hermelink, HK; Gascoyne, RD; Connors, JM; Johnson, NA; Rimsza, LM; Campo, E; Jaffe, ES; Wilson, WH; Delabie, J; Smeland, EB; Fisher, RI; Braziel, RM; Tubbs, RR; Cook, JR; Weisenburger, DD; Chan, WC; Pierce, SK; Staudt, LM				Davis, R. Eric; Ngo, Vu N.; Lenz, Georg; Tolar, Pavel; Young, Ryan M.; Romesser, Paul B.; Kohlhammer, Holger; Lamy, Laurence; Zhao, Hong; Yang, Yandan; Xu, Weihong; Shaffer, Arthur L.; Wright, George; Xiao, Wenming; Powell, John; Jiang, Jian-Kang; Thomas, Craig J.; Rosenwald, Andreas; Ott, German; Muller-Hermelink, Hans Konrad; Gascoyne, Randy D.; Connors, Joseph M.; Johnson, Nathalie A.; Rimsza, Lisa M.; Campo, Elias; Jaffe, Elaine S.; Wilson, Wyndham H.; Delabie, Jan; Smeland, Erlend B.; Fisher, Richard I.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, J. R.; Weisenburger, Dennis D.; Chan, Wing C.; Pierce, Susan K.; Staudt, Louis M.			Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma	NATURE			English	Article							ANTIGEN RECEPTOR; IG-ALPHA; TYROSINE KINASE; INTERNALIZATION; IMMUNOGLOBULIN; INHIBITORS; INITIATION; MOLECULE; SURVIVAL; TARGET	A role for B-cell-receptor (BCR) signalling in lymphomagenesis has been inferred by studying immunoglobulin genes in human lymphomas(1,2) and by engineering mouse models(3), but genetic and functional evidence for its oncogenic role in human lymphomas is needed. Here we describe a form of 'chronic active' BCR signalling that is required for cell survival in the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL). The signalling adaptor CARD11 is required for constitutive NF-kappa B pathway activity and survival in ABC DLBCL4. Roughly 10% of ABC DLBCLs have mutant CARD11 isoforms that activate NF-kappa B-5, but the mechanism that engages wild-type CARD11 in other ABC DLBCLs was unknown. An RNA interference genetic screen revealed that a BCR signalling component, Bruton's tyrosine kinase, is essential for the survival of ABC DLBCLs with wild-type CARD11. In addition, knockdown of proximal BCR subunits (IgM, Ig-kappa, CD79A and CD79B) killed ABC DLBCLs with wildtype CARD11 but not other lymphomas. The BCRs in these ABC DLBCLs formed prominent clusters in the plasma membrane with low diffusion, similarly to BCRs in antigen-stimulated normal B cells. Somatic mutations affecting the immunoreceptor tyrosine-based activation motif (ITAM) signalling modules(6) of CD79B and CD79A were detected frequently in ABC DLBCL biopsy samples but rarely in other DLBCLs and never in Burkitt's lymphoma or mucosa-associated lymphoid tissue lymphoma. In 18% of ABC DLBCLs, one functionally critical residue of CD79B, the first ITAM tyrosine, was mutated. These mutations increased surface BCR expression and attenuated Lyn kinase, a feedback inhibitor of BCR signalling. These findings establish chronic active BCR signalling as a new pathogenetic mechanism in ABC DLBCL, suggesting several therapeutic strategies.	[Davis, R. Eric; Ngo, Vu N.; Lenz, Georg; Young, Ryan M.; Romesser, Paul B.; Kohlhammer, Holger; Lamy, Laurence; Zhao, Hong; Yang, Yandan; Xu, Weihong; Shaffer, Arthur L.; Wilson, Wyndham H.; Staudt, Louis M.] NCI, Metab Branch, NIH, Bethesda, MD 20892 USA; [Jaffe, Elaine S.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Tolar, Pavel; Pierce, Susan K.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Romesser, Paul B.] NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20892 USA; [Wright, George] NCI, Biometr Res Branch, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA; [Xiao, Wenming; Powell, John] NIH, Bioinformat & Mol Anal Sect, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Jiang, Jian-Kang; Thomas, Craig J.] NHGRI, NIH, Chem Genom Ctr, Rockville, MD 20850 USA; [Rosenwald, Andreas; Muller-Hermelink, Hans Konrad] Univ Wurzburg, Dept Pathol, D-97080 Wurzburg, Germany; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, D-70376 Stuttgart, Germany; [Ott, German] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Gascoyne, Randy D.; Connors, Joseph M.; Johnson, Nathalie A.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Rimsza, Lisa M.; Fisher, Richard I.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, J. R.] SW Oncol Grp, Ann Arbor, MI 48106 USA; [Campo, Elias] Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain; [Delabie, Jan] Rikshosp Univ Hosp, Pathol Clin, N-0310 Oslo, Norway; [Smeland, Erlend B.] Univ Oslo, Rikshosp Univ Hosp, Inst Canc Res, N-0310 Oslo, Norway; [Smeland, Erlend B.] Univ Oslo, Ctr Canc Biomed, Fac Div, Norwegian Radium Hosp, N-0310 Oslo, Norway; [Fisher, Richard I.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Braziel, Rita M.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Tubbs, Raymond R.; Cook, J. R.] Cleveland Clin Pathol, Cleveland, OH 44195 USA; [Tubbs, Raymond R.; Cook, J. R.] Inst Lab Med, Cleveland, OH 44195 USA; [Weisenburger, Dennis D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE 68198 USA; [Weisenburger, Dennis D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Microbiol, Omaha, NE 68198 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI); University of Wurzburg; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; British Columbia Cancer Agency; University of Arizona; Southwest Oncology Group; University of Barcelona; Hospital Clinic de Barcelona; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Rochester; Oregon Health & Science University; Cleveland Clinic Foundation; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Staudt, LM (corresponding author), NCI, Metab Branch, NIH, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Jaffe, Elaine/G-8981-2014; Campo, Elias/AAC-5593-2019; Smeland, Erlend/AAO-3214-2020; Wright, George W/M-1660-2017; Connors, Joseph/AAF-5284-2019; Staudt, Louis/AAC-5324-2019; Lenz, Georg/I-6844-2012	Campo, Elias/0000-0001-9850-9793; Connors, Joseph/0000-0002-1361-7531; Tolar, Pavel/0000-0003-4693-7299; Thomas, Craig/0000-0001-9386-9001; Ngo, Vu/0000-0002-9501-6990; Romesser, Paul/0000-0001-8268-2903; Delabie, Jan/0000-0001-5023-0689	National Institutes of Health; National Cancer Institute; Center for Cancer Research; National Institute of Allergy and Infectious Disease; National Human Genome Research Institute; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC011008, ZIABC011070, ZIABC011007, ZIASC000550] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Honigberg for PCI-32765, L. Dang for IKK-beta inhibitors, S. Ansher for dasatinib, and S. Tohda for the TMD8 cell line. This research was supported by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute, the Center for Cancer Research, the National Institute of Allergy and Infectious Disease, and the National Human Genome Research Institute. P. B. R. was a Howard Hughes Medical Institute-National Institutes of Health Research Scholar.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; BAHLER DW, 1992, P NATL ACAD SCI USA, V89, P6770, DOI 10.1073/pnas.89.15.6770; Blethrow Justin, 2004, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1811s66; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Gauld SB, 2004, ONCOGENE, V23, P8001, DOI 10.1038/sj.onc.1208075; Gazumyan A, 2006, J EXP MED, V203, P1785, DOI 10.1084/jem.20060221; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Jiang S, 2007, ASSAY DRUG DEV TECHN, V5, P49, DOI 10.1089/adt.2006.032; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; KLEIN G, 1986, CANCER RES, V46, P3211; Kraus M, 1999, IMMUNITY, V11, P537, DOI 10.1016/S1074-7613(00)80129-6; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; Pan ZY, 2007, CHEMMEDCHEM, V2, P58, DOI 10.1002/cmdc.200600221; Refaeli Y, 2008, PLOS BIOL, V6, P1208, DOI 10.1371/journal.pbio.0060152; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Staudt LM, 2005, ADV IMMUNOL, V87, P163, DOI 10.1016/S0065-2776(05)87005-1; STEWART DM, 1995, HYBRIDOMA, V14, P243, DOI 10.1089/hyb.1995.14.243; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; Torres RM, 1999, IMMUNITY, V11, P527, DOI 10.1016/S1074-7613(00)80128-4	32	1114	1233	5	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					88	U97		10.1038/nature08638	http://dx.doi.org/10.1038/nature08638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054396	Green Accepted			2022-12-28	WOS:000273344900036
J	Gerritsma, R; Kirchmair, G; Zahringer, F; Solano, E; Blatt, R; Roos, CF				Gerritsma, R.; Kirchmair, G.; Zaehringer, F.; Solano, E.; Blatt, R.; Roos, C. F.			Quantum simulation of the Dirac equation	NATURE			English	Article							GRAPHENE	The Dirac equation(1) successfully merges quantum mechanics with special relativity. It provides a natural description of the electron spin, predicts the existence of antimatter(2) and is able to reproduce accurately the spectrum of the hydrogen atom. The realm of the Dirac equation-relativistic quantum mechanics-is considered to be the natural transition to quantum field theory. However, the Dirac equation also predicts some peculiar effects, such as Klein's paradox(3) and 'Zitterbewegung', an unexpected quivering motion of a free relativistic quantum particle(4). These and other predicted phenomena are key fundamental examples for understanding relativistic quantum effects, but are difficult to observe in real particles. In recent years, there has been increased interest in simulations of relativistic quantum effects using different physical set-ups(5-11), in which parameter tunability allows access to different physical regimes. Here we perform a proof-of-principle quantum simulation of the one-dimensional Dirac equation using a single trapped ion(7) set to behave as a free relativistic quantum particle. We measure the particle position as a function of time and study Zitterbewegung for different initial superpositions of positive- and negative-energy spinor states, as well as the crossover from relativistic to non-relativistic dynamics. The high level of control of trapped-ion experimental parameters makes it possible to simulate textbook examples of relativistic quantum physics.	[Gerritsma, R.; Kirchmair, G.; Zaehringer, F.; Blatt, R.; Roos, C. F.] Austrian Acad Sci, Inst Quantenopt & Quanteninformat, A-6020 Innsbruck, Austria; [Gerritsma, R.; Kirchmair, G.; Zaehringer, F.; Blatt, R.; Roos, C. F.] Univ Innsbruck, Inst Expt Phys, A-6020 Innsbruck, Austria; [Solano, E.] Univ Pais Vasco Euskal Herriko Unibertsitatea, Dept Quim Fis, Bilbao 48080, Spain; [Solano, E.] Basque Fdn Sci, IKERBASQUE, Bilbao 48011, Spain	Austrian Academy of Sciences; University of Innsbruck; University of Basque Country; Basque Foundation for Science	Roos, CF (corresponding author), Austrian Acad Sci, Inst Quantenopt & Quanteninformat, Otto Hittmair Pl 1, A-6020 Innsbruck, Austria.	christian.roos@uibk.ac.at	Kirchmair, Gerhard/J-5218-2013; Blatt, Rainer/H-9527-2014; Roos, Christian F/D-8475-2011	Kirchmair, Gerhard/0000-0003-4286-8839; Roos, Christian F/0000-0001-7121-8259; SOLANO VILLANUEVA, ENRIQUE LEONIDAS/0000-0002-8602-1181	Austrian Science Fund; European Commission; Institut fur Quanteninformation GmbH; Universidad del Pais Vasco - Euskal Herriko Unibertsitatea [GIU07/40]; European Union	Austrian Science Fund(Austrian Science Fund (FWF)); European Commission(European CommissionEuropean Commission Joint Research Centre); Institut fur Quanteninformation GmbH; Universidad del Pais Vasco - Euskal Herriko Unibertsitatea; European Union(European Commission)	We gratefully acknowledge support from the Austrian Science Fund, the European Commission (Marie-Curie programme) and the Institut fur Quanteninformation GmbH. E. S. acknowledges support of Universidad del Pais Vasco - Euskal Herriko Unibertsitatea grant GIU07/40 and European Union project EuroSQIP. This material is based upon work supported in part by Intelligence Advanced Research Projects Activity. We thank H. Haffner and M. Baranov for comments on the manuscript.	Anderson CD, 1933, PHYS REV, V43, P491, DOI 10.1103/PhysRev.43.491; Aspuru-Guzik A, 2005, SCIENCE, V309, P1704, DOI 10.1126/science.1113479; Bermudez A, 2007, PHYS REV A, V76, DOI 10.1103/PhysRevA.76.041801; Bermudez A, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.123602; Castro Neto AH, 2009, REV MOD PHYS, V81, P109, DOI 10.1103/RevModPhys.81.109; Cserti J, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.172305; FEYNMAN RP, 1982, INT J THEOR PHYS, V21, P467, DOI 10.1007/BF02650179; Friedenauer A, 2008, NAT PHYS, V4, P757, DOI 10.1038/nphys1032; Johanning M, 2009, J PHYS B-AT MOL OPT, V42, DOI 10.1088/0953-4075/42/15/154009; Katsnelson MI, 2006, NAT PHYS, V2, P620, DOI 10.1038/nphys384; Kirchmair G, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/2/023002; Klein O, 1929, Z PHYS, V53, P157, DOI 10.1007/BF01339716; Krekora P, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.043004; Lamata L, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.253005; Leibfried D, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.247901; Lougovski P, 2006, EUR PHYS J D, V38, P423, DOI 10.1140/epjd/e2006-00085-3; Otterbach J, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.063602; Porras D, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.207901; Rozmej P, 1999, J PHYS A-MATH GEN, V32, P5367, DOI 10.1088/0305-4470/32/28/314; Santos MF, 2007, PHYS REV LETT, V98, DOI 10.1103/PyhsRevLett.98.020401; Schliemann J, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.206801; Schrodinger Erwin, 1930, SITZ PREUSS AKAD WIS, V24, P418; THALLER B, 2004, VISUALIZING KINEMATI; Thaller B., 1992, DIRAC EQUATION; Vaishnav JY, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.153002; WALLENTOWITZ S, 1995, PHYS REV LETT, V75, P2932, DOI 10.1103/PhysRevLett.75.2932; Wang ZY, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.045402; Zhang XD, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.113903; Zhang XD, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.264303	30	521	524	1	163	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 7	2010	463	7277					68	U72		10.1038/nature08688	http://dx.doi.org/10.1038/nature08688			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054392	Green Submitted			2022-12-28	WOS:000273344900031
J	Sleiman, PMA; Flory, J; Imielinski, M; Bradfield, JP; Annaiah, K; Willis-Owen, SAG; Wang, K; Rafaels, NM; Michel, S; Bonnelykke, K; Zhang, HT; Kim, CE; Frackelton, EC; Glessner, JT; Hou, CP; Otieno, FG; Santa, E; Thomas, K; Smith, RM; Glaberson, WR; Garris, M; Chiavacci, RM; Beaty, TH; Ruczinski, I; Orange, JM; Allen, J; Spergel, JM; Grundmeier, R; Mathias, RA; Christie, JD; von Mutius, E; Cookson, WOC; Kabesch, M; Moffatt, MF; Grunstein, MM; Barnes, KC; Devoto, M; Magnusson, M; Li, HZ; Grant, SFA; Bisgaard, H; Hakonarson, H				Sleiman, Patrick M. A.; Flory, James; Imielinski, Marcin; Bradfield, Jonathan P.; Annaiah, Kiran; Willis-Owen, Saffron A. G.; Wang, Kai; Rafaels, Nicholas M.; Michel, Sven; Bonnelykke, Klaus; Zhang, Haitao; Kim, Cecilia E.; Frackelton, Edward C.; Glessner, Joseph T.; Hou, Cuiping; Otieno, F. George; Santa, Erin; Thomas, Kelly; Smith, Ryan M.; Glaberson, Wendy R.; Garris, Maria; Chiavacci, Rosetta M.; Beaty, Terri H.; Ruczinski, Ingo; Orange, Jordan M.; Allen, Julian; Spergel, Jonathan M.; Grundmeier, Robert; Mathias, Rasika A.; Christie, Jason D.; von Mutius, Erika; Cookson, William O. C.; Kabesch, Michael; Moffatt, Miriam F.; Grunstein, Michael M.; Barnes, Kathleen C.; Devoto, Marcella; Magnusson, Mark; Li, Hongzhe; Grant, Struan F. A.; Bisgaard, Hans; Hakonarson, Hakon			Variants of DENND1B Associated with Asthma in Children	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CHILDHOOD ASTHMA; SUSCEPTIBILITY GENES; ORMDL3 EXPRESSION; CELL SUBSETS; DROSOPHILA; DENN/MADD; PROTEIN	BACKGROUND Asthma is a complex disease that has genetic and environmental causes. The genetic factors associated with susceptibility to asthma remain largely unknown. METHODS We carried out a genomewide association study involving children with asthma. The sample included 793 North American children of European ancestry with persistent asthma who required daily inhaled glucocorticoid therapy and 1988 matched controls (the discovery set). We also tested for genomewide association in an independent cohort of 917 persons of European ancestry who had asthma and 1546 matched controls (the replication set). Finally, we tested for an association between 20 single-nucleotide polymorphisms (SNPs) at chromosome 1q31 and asthma in 1667 North American children of African ancestry who had asthma and 2045 ancestrally matched controls. RESULTS In our meta-analysis of all samples from persons of European ancestry, we observed an association, with genomewide significance, between asthma and SNPs at the previously reported locus on 17q21 and an additional eight SNPs at a novel locus on 1q31. The SNP most strongly associated with asthma was rs2786098 (P = 8.55 x 10(-9)). We observed replication of the association of asthma with SNP rs2786098 in the independent series of persons of European ancestry (combined P = 9.3 x 10(-11)). The alternative allele of each of the eight SNPs on chromosome 1q31 was strongly associated with asthma in the children of African ancestry (P = 1.6 x 10(-13) for the comparison across all samples). The 1q31 locus contains DENND1B, a gene that is expressed by natural killer cells and dendritic cells and that encodes a protein that interacts with the tumor necrosis factor a receptor. CONCLUSIONS We have identified a locus containing DENND1B on chromosome 1q31.3 that is associated with susceptibility to asthma.	[Sleiman, Patrick M. A.; Flory, James; Imielinski, Marcin; Bradfield, Jonathan P.; Annaiah, Kiran; Wang, Kai; Zhang, Haitao; Kim, Cecilia E.; Frackelton, Edward C.; Glessner, Joseph T.; Hou, Cuiping; Otieno, F. George; Santa, Erin; Thomas, Kelly; Smith, Ryan M.; Glaberson, Wendy R.; Garris, Maria; Chiavacci, Rosetta M.; Grant, Struan F. A.; Hakonarson, Hakon] Ctr Appl Gen, Philadelphia, PA 19104 USA; [Orange, Jordan M.; Spergel, Jonathan M.] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Allergy & Immunol, Philadelphia, PA 19104 USA; [Allen, Julian; Grunstein, Michael M.; Hakonarson, Hakon] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Pulm Med, Philadelphia, PA 19104 USA; [Devoto, Marcella; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Div Human Genet, Philadelphia, PA 19104 USA; [Grundmeier, Robert] Univ Penn, Childrens Hosp Philadelphia, Sch Med, Ctr Biomed Informat, Philadelphia, PA 19104 USA; [Christie, Jason D.] Univ Penn, Sch Med, Div Pulm Med, Philadelphia, PA 19104 USA; [Orange, Jordan M.; Spergel, Jonathan M.; Grundmeier, Robert; Grunstein, Michael M.; Magnusson, Mark; Grant, Struan F. A.; Hakonarson, Hakon] Univ Penn, Sch Med, Childrens Hosp Philadelphia, Dept Pediat, Philadelphia, PA 19104 USA; [Li, Hongzhe] Univ Penn, Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Willis-Owen, Saffron A. G.; Cookson, William O. C.; Moffatt, Miriam F.] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, London SW7 2AZ, England; [Rafaels, Nicholas M.; Beaty, Terri H.; Ruczinski, Ingo; Barnes, Kathleen C.] Johns Hopkins Univ, Baltimore, MD USA; [Mathias, Rasika A.] NHGRI, Genometr Sect, Inherited Dis Res Branch, NIH, Baltimore, MD USA; [von Mutius, Erika] Univ Munich, Munich, Germany; [Michel, Sven; Kabesch, Michael] Hannover Med Sch, Clin Paediat Pneumol & Neonatol, D-3000 Hannover, Germany; [Bonnelykke, Klaus; Bisgaard, Hans] Copenhagen Univ Hosp, Fac Hlth Sci, Copenhagen Prospect Studies Asthma Childhood, Gentofte, Denmark	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; University of Pennsylvania; Imperial College London; Johns Hopkins University; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); NIH National Institute on Aging (NIA); University of Munich; Hannover Medical School; University of Copenhagen	Hakonarson, H (corresponding author), Ctr Appl Gen, 1216E Abramson Res Ctr,3615 Civ Ctr Blvd, Philadelphia, PA 19104 USA.	hakonarson@email.chop.edu	Devoto, Marcella/AAP-7595-2021; Kronow, Joern/B-1054-2011; Kabesch, Michael/GZM-1583-2022; Bisgaard, Hans/N-4761-2016; Kabesch, Michael/AAB-5701-2020; Cookson, William/HHC-1790-2022	Bisgaard, Hans/0000-0003-4131-7592; orange, jordan/0000-0001-7117-7725; Spergel, Jonathan/0000-0002-4658-5353; Glessner, Joseph/0000-0001-5131-2811; DEVOTO, MARCELLA/0000-0002-4431-5114; von Mutius, Erika/0000-0002-8893-4515; Michel, Sven/0000-0003-3604-3187; Christie, Jason/0000-0003-0519-218X; Bonnelykke, Klaus/0000-0003-2003-1018; Grant, Struan/0000-0003-2025-5302; Willis-Owen, Saffron/0000-0003-2633-1150	Children's Hospital of Philadelphia; state of Pennsylvania [4100042728]; Cotswold Foundation; Lundbeck Foundation; National Human Genome Research Institute, National Institutes of Health; Mary Beryl Patch Turnbull Scholar program; MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0000934, G0801056B] Funding Source: researchfish	Children's Hospital of Philadelphia; state of Pennsylvania; Cotswold Foundation; Lundbeck Foundation(Lundbeckfonden); National Human Genome Research Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); Mary Beryl Patch Turnbull Scholar program; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by an Institute Development Award from Children's Hospital of Philadelphia (to Dr. Hakonarson), a grant from the state of Pennsylvania (4100042728, to Drs. Hakonarson and Grant), a Research Development Award from the Cotswold Foundation (to Drs. Hakonarson and Grant), and grants from the Lundbeck Foundation (to Dr. Sleiman) and the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health (to Dr. Mathias). Dr. Barnes was supported in part by the Mary Beryl Patch Turnbull Scholar program.	Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Del Villar K, 2004, P NATL ACAD SCI USA, V101, P4210, DOI 10.1073/pnas.0307349101; den Hollander AI, 1999, NAT GENET, V23, P217, DOI 10.1038/13848; den Hollander AI, 2001, HUM MOL GENET, V10, P2767, DOI 10.1093/hmg/10.24.2767; Expert Panel Report 3 (EPR-3), 2007, J ALLERGY CLIN IMMUN, V120, pS94; Expert Panel Report3(EPR-3), 2008, J ALLERGY CLIN IMMUN, V121, P1330; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Gosens I, 2008, EXP EYE RES, V86, P713, DOI 10.1016/j.exer.2008.02.005; Halapi E, 2004, CURR OPIN PULM MED, V10, P22, DOI 10.1097/00063198-200401000-00005; Lin PI, 2007, AM J HUM GENET, V80, P1002; Lin PI, 2007, AM J HUM GENET, V80, P531, DOI 10.1086/512133; Lindstedt M, 2005, J IMMUNOL, V175, P4839, DOI 10.4049/jimmunol.175.8.4839; Liu YJ, 2001, CELL, V106, P259, DOI 10.1016/S0092-8674(01)00456-1; Luca D, 2008, AM J HUM GENET, V82, P453, DOI 10.1016/j.ajhg.2007.11.003; MARTINEZ FD, 1995, NEW ENGL J MED, V332, P133, DOI 10.1056/NEJM199501193320301; Miyoshi J, 2004, TRENDS MOL MED, V10, P476, DOI 10.1016/j.molmed.2004.08.002; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Ober C, 2006, GENES IMMUN, V7, P95, DOI 10.1038/sj.gene.6364284; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Sleiman PMA, 2008, J ALLERGY CLIN IMMUN, V122, P1225, DOI 10.1016/j.jaci.2008.06.041; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Willinger T, 2005, J IMMUNOL, V175, P5895, DOI 10.4049/jimmunol.175.9.5895; Wills-Karp M, 2004, NAT REV GENET, V5, P376, DOI 10.1038/nrg1326	26	246	254	0	23	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2010	362	1					36	44		10.1056/NEJMoa0901867	http://dx.doi.org/10.1056/NEJMoa0901867			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	540PA	20032318				2022-12-28	WOS:000273345500007
J	Kang, S; Douglas, T				Kang, Sebyung; Douglas, Trevor			Some Enzymes Just Need a Space of Their Own	SCIENCE			English	Editorial Material							COMPLEXES		[Kang, Sebyung] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; Montana State Univ, Ctr Bioinspired Nanomat, Bozeman, MT 59717 USA	Montana State University System; Montana State University Bozeman; Montana State University System; Montana State University Bozeman	Kang, S (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	tdouglas@chemistry.montana.edu	Kang, Sebyung/E-6330-2010; Douglas, Trevor/GRS-0012-2022; Douglas, Trevor/F-2748-2011	Kang, Sebyung/0000-0001-7394-3550; Douglas, Trevor/0000-0002-7882-2704; 				Abe S, 2008, J AM CHEM SOC, V130, P10512, DOI 10.1021/ja802463a; Comellas-Aragones M, 2007, NAT NANOTECHNOL, V2, P635, DOI 10.1038/nnano.2007.299; Douglas T, 2006, SCIENCE, V312, P873, DOI 10.1126/science.1123223; Kang S, 2008, ANGEW CHEM INT EDIT, V47, P7845, DOI 10.1002/anie.200802481; RITSERT K, 1995, J MOL BIOL, V253, P151, DOI 10.1006/jmbi.1995.0542; Sutter M, 2008, NAT STRUCT MOL BIOL, V15, P939, DOI 10.1038/nsmb.1473; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2010, SCIENCE, V327, P81, DOI 10.1126/science.1179513; Zhou ZH, 2001, P NATL ACAD SCI USA, V98, P14802, DOI 10.1073/pnas.011597698	9	28	28	0	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 1	2010	327	5961					42	43		10.1126/science.1184318	http://dx.doi.org/10.1126/science.1184318			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044564				2022-12-28	WOS:000273395400022
J	Lingwood, D; Simons, K				Lingwood, Daniel; Simons, Kai			Lipid Rafts As a Membrane-Organizing Principle	SCIENCE			English	Review							GPI-ANCHORED PROTEINS; PLASMA-MEMBRANE; CELL-MEMBRANES; DETERGENT RESISTANCE; BILAYER THICKNESS; PHASE-SEPARATION; CROSS-LINKING; CHOLESTEROL; VESICLES; MODEL	Cell membranes display a tremendous complexity of lipids and proteins designed to perform the functions cells require. To coordinate these functions, the membrane is able to laterally segregate its constituents. This capability is based on dynamic liquid-liquid immiscibility and underlies the raft concept of membrane subcompartmentalization. Lipid rafts are fluctuating nanoscale assemblies of sphingolipid, cholesterol, and proteins that can be stabilized to coalesce, forming platforms that function in membrane signaling and trafficking. Here we review the evidence for how this principle combines the potential for sphingolipid-cholesterol self-assembly with protein specificity to selectively focus membrane bioactivity.	[Lingwood, Daniel; Simons, Kai] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	Max Planck Society	Simons, K (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	simons@mpi-cbg.de		Simons, Kai/0000-0002-9231-9996	European Union [LSHB-CT2007-037740]; Deutsche Forschungsgemeinschaft [1175]; Bundesministerium fur Bildung und Forschung BioChance Plus [0313827]	European Union(European Commission); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung BioChance Plus(Federal Ministry of Education & Research (BMBF))	We thank F. Julicher, G. Feigenson, J. Howard, P. Schwille, C. Brangwynne, H.-T. He, G. van Meer, and members of the Simons lab for critical reading of this paper. A special thank you goes to M. Surma, M. Gerl, and I. Levental for their construction of and contribution to the figures. This work was supported by European Union FP6 Lipid PRISM grant no. LSHB-CT2007-037740, Deutsche Forschungsgemeinschaft Schwerpunktprogramm 1175, and Bundesministerium fur Bildung und Forschung BioChance Plus grant no. 0313827.	Akimov SA, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.051901; Allende ML, 2002, CURR OPIN STRUC BIOL, V12, P587, DOI 10.1016/S0959-440X(02)00376-7; Anderson RGW, 2002, SCIENCE, V296, P1821, DOI 10.1126/science.1068886; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; BRETSCHER MS, 1993, SCIENCE, V261, P1280, DOI 10.1126/science.8362242; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Brugger B, 2000, J CELL BIOL, V151, P507, DOI 10.1083/jcb.151.3.507; Callaghan R, 1997, BBA-BIOMEMBRANES, V1328, P109, DOI 10.1016/S0005-2736(97)00079-5; Chakrabandhu K, 2007, EMBO J, V26, P209, DOI 10.1038/sj.emboj.7601456; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Drbal K, 2007, INT IMMUNOL, V19, P675, DOI 10.1093/intimm/dxm032; Eggeling C, 2009, NATURE, V457, P1159, DOI 10.1038/nature07596; Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Fantini J, 2003, CELL MOL LIFE SCI, V60, P1027, DOI 10.1007/s00018-003-3003-1; Feigenson GW, 2009, BBA-BIOMEMBRANES, V1788, P47, DOI 10.1016/j.bbamem.2008.08.014; Friedrichson T, 1998, NATURE, V394, P802, DOI 10.1038/29570; Garcia-Saez AJ, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M706162200; Ge MT, 2003, BIOPHYS J, V85, P1278, DOI 10.1016/S0006-3495(03)74563-9; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Gri G, 2004, IMMUNOL LETT, V94, P247, DOI 10.1016/j.imlet.2004.05.012; Hammond AT, 2005, P NATL ACAD SCI USA, V102, P6320, DOI 10.1073/pnas.0405654102; Hancock JF, 2006, NAT REV MOL CELL BIO, V7, P456, DOI 10.1038/nrm1925; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hess ST, 2007, P NATL ACAD SCI USA, V104, P17370, DOI 10.1073/pnas.0708066104; Huang JY, 1999, BIOPHYS J, V76, P2142, DOI 10.1016/S0006-3495(99)77369-8; IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162; Jacobson K, 2007, NAT CELL BIOL, V9, P7, DOI 10.1038/ncb0107-7; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kaizuka Y, 2009, J CELL BIOL, V185, P521, DOI 10.1083/jcb.200809136; Kalvodova L, 2005, J BIOL CHEM, V280, P36815, DOI 10.1074/jbc.M504484200; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kurzchalia TV, 2003, NAT CELL BIOL, V5, P684, DOI 10.1038/ncb0803-684; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Lee AG, 2003, BBA-BIOMEMBRANES, V1612, P1, DOI 10.1016/S0005-2736(03)00056-7; Lenne PF, 2006, EMBO J, V25, P3245, DOI 10.1038/sj.emboj.7601214; LENTZ BR, 1980, BIOCHEMISTRY-US, V19, P1943, DOI 10.1021/bi00550a034; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Lingwood D, 2007, NAT PROTOC, V2, P2159, DOI 10.1038/nprot.2007.294; Marsh D, 1998, BBA-REV BIOMEMBRANES, V1376, P267, DOI 10.1016/S0304-4157(98)00009-4; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McConnell HM, 2003, ANNU REV BIOPH BIOM, V32, P469, DOI 10.1146/annurev.biophys.32.110601.141704; Meder D, 2006, P NATL ACAD SCI USA, V103, P329, DOI 10.1073/pnas.0509885103; Mesmin B, 2009, BBA-MOL CELL BIOL L, V1791, P636, DOI 10.1016/j.bbalip.2009.03.002; Mitra K, 2004, P NATL ACAD SCI USA, V101, P4083, DOI 10.1073/pnas.0307332101; Mouritsen OG, 2004, LIPIDS, V39, P1101, DOI 10.1007/s11745-004-1336-x; MOURITSEN OG, 1993, ANNU REV BIOPH BIOM, V22, P145, DOI 10.1146/annurev.bb.22.060193.001045; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; MURATA M, 1995, P NATL ACAD SCI USA, V92, P10339, DOI 10.1073/pnas.92.22.10339; NEZIL FA, 1992, BIOPHYS J, V61, P1176, DOI 10.1016/S0006-3495(92)81926-4; Niemela PS, 2006, BIOPHYS J, V90, P851, DOI 10.1529/biophysj.105.067371; Pralle A, 2000, J CELL BIOL, V148, P997, DOI 10.1083/jcb.148.5.997; RORNER W, 2007, NATURE, V450, P670; SCHROEDER R, 1994, P NATL ACAD SCI USA, V91, P12130, DOI 10.1073/pnas.91.25.12130; Sengupta P, 2008, BBA-BIOMEMBRANES, V1778, P20, DOI 10.1016/j.bbamem.2007.08.028; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Sohn HW, 2008, J CELL BIOL, V182, P367, DOI 10.1083/jcb.200802007; Song KS, 1996, J BIOL CHEM, V271, P9690, DOI 10.1074/jbc.271.16.9690; Suzuki KGN, 2007, J CELL BIOL, V177, P717, DOI 10.1083/jcb.200609174; Swamy MJ, 2006, BIOPHYS J, V90, P4452, DOI 10.1529/biophysj.105.070839; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; van Zanten TS, 2009, P NATL ACAD SCI USA, V106, P18557, DOI 10.1073/pnas.0905217106; Veatch SL, 2008, ACS CHEM BIOL, V3, P287, DOI 10.1021/cb800012x; Veatch SL, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.148101; Viola A, 2007, NAT REV IMMUNOL, V7, P889, DOI 10.1038/nri2193; Yetukuri L, 2008, MOL BIOSYST, V4, P121, DOI 10.1039/b715468b; Zech T, 2009, EMBO J, V28, P466, DOI 10.1038/emboj.2009.6	68	3042	3093	25	1347	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					46	50		10.1126/science.1174621	http://dx.doi.org/10.1126/science.1174621			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044567				2022-12-28	WOS:000273395400025
J	Corn, BW				Corn, Benjamin W.			Ending End-of-Life Phobia - A Prescription for Enlightened Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Corn, Benjamin W.] Tel Aviv Med Ctr & Sch Med, Inst Radiotherapy, Tel Aviv, Israel; [Corn, Benjamin W.] Tel Aviv Univ, Sch Med, IL-69978 Tel Aviv, Israel; [Corn, Benjamin W.] Thomas Jefferson Univ, Jefferson Med Coll, Dept Radiat Oncol, Philadelphia, PA 19107 USA	Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv University; Jefferson University	Corn, BW (corresponding author), Tel Aviv Med Ctr & Sch Med, Inst Radiotherapy, Tel Aviv, Israel.							BLUMENAUER E, 2009, NY TIMES        1115; Burns JP, 2007, CHEST, V132, P1987, DOI 10.1378/chest.07-1441; Rosenbaum ME, 2005, J PALLIAT MED, V8, P1186, DOI 10.1089/jpm.2005.8.1186; Shanafelt T, 2003, J CLIN ONCOL, V21, P2616, DOI 10.1200/JCO.2003.06.075; Yalom I.D., 2008, STARING SUN OVERCOMI	5	13	13	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					E63	E63		10.1056/NEJMp0909740	http://dx.doi.org/10.1056/NEJMp0909740			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	538JV	20018960				2022-12-28	WOS:000273181300005
J	Bandell, M; Patapoutian, A				Bandell, Michael; Patapoutian, Ardem			Itching for Insight	CELL			English	Editorial Material							SENSORY NEURONS; PRURITUS; SUBSETS		[Bandell, Michael; Patapoutian, Ardem] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Patapoutian, Ardem] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Novartis; Scripps Research Institute	Patapoutian, A (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.	apatapoutian@gnf.org						Abila B, 1994, Afr J Med Med Sci, V23, P139; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; MNYIKA KS, 1991, J TROP MED HYG, V94, P27; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868	9	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 24	2009	139	7					1224	1226		10.1016/j.cell.2009.12.012	http://dx.doi.org/10.1016/j.cell.2009.12.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064368	Bronze			2022-12-28	WOS:000273048700010
J	Uyeki, TM; Sharma, A; Branda, JA				Uyeki, Timothy M.; Sharma, Amita; Branda, John A.			A Man with Fever and Respiratory Failure 2009 influenza A (H1N1) virus infection	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CRITICALLY-ILL PATIENTS; PNEUMONIC TULAREMIA; A(H1N1) INFECTION; UNITED-STATES; H5N1 VIRUS; SWINE; TESTS; OUTBREAK; TRANSMISSION; SENSITIVITY		[Uyeki, Timothy M.] Ctr Dis Control & Prevent, Epidemiol & Prevent Branch, Influenza Div, Atlanta, GA 30333 USA; [Sharma, Amita] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Branda, John A.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Sharma, Amita] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Branda, John A.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Centers for Disease Control & Prevention - USA; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Uyeki, TM (corresponding author), Ctr Dis Control & Prevent, Epidemiol & Prevent Branch, Influenza Div, Atlanta, GA 30333 USA.		Branda, John/ABD-5620-2020		Diasorin	Diasorin	Dr. Branda reports receiving grant support from Diasorin. No other potential conflict of interest relevant to this article was reported.; We thank Dr. Sandra Nelson for assistance in preparing the case presentation.	Anonymous, 2007, Morbidity and Mortality Weekly Report, V56, P1181; [Anonymous], 2009, PAND H1N1 2009 UPD 7; [Anonymous], UPD INT REC US ANT M; [Anonymous], 2009, GAZ BOSNIA HERZEGOVI, V43; Balish A., 2009, Morbidity and Mortality Weekly Report, V58, P826; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; Birnkrant D, 2009, NEW ENGL J MED, V361, P2204, DOI 10.1056/NEJMp0910479; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1029; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Chan KH, 2009, J CLIN VIROL, V45, P205, DOI 10.1016/j.jcv.2009.05.034; Childs RA, 2009, NAT BIOTECHNOL, V27, P797, DOI 10.1038/nbt0909-797; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Cunha BA, 2007, EUR J CLIN MICROBIOL, V26, P505, DOI 10.1007/s10096-007-0325-1; DEJONCHEERE CP, 2006, EJHP SCI, V12, P7; DEXLER JF, 2009, EMERG INFECT DIS, V15, P1662; Dodd JD, 2007, J THORAC IMAG, V22, P271, DOI 10.1097/RTI.0b013e3180546823; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; Englund J., 2009, Morbidity and Mortality Weekly Report, V58, P893; *ENZECMO INFL INV, 2009, JAMA-J AM MED ASSOC, V302, P1888; Faix DJ, 2009, NEW ENGL J MED, V361, P728, DOI 10.1056/NEJMc0904264; Feldman KA, 2001, NEW ENGL J MED, V345, P1601, DOI 10.1056/NEJMoa011374; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Ginocchio CC, 2009, J CLIN VIROL, V45, P191, DOI 10.1016/j.jcv.2009.06.005; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hageman JC, 2006, EMERG INFECT DIS, V12, P894, DOI 10.3201/eid1206.051141; HARDALO CJ, 1995, CLIN INFECT DIS, V21, P910, DOI 10.1093/clinids/21.4.910; Hurt AC, 2007, J CLIN VIROL, V39, P132, DOI 10.1016/j.jcv.2007.03.002; Hurt AC, 2009, INFLUENZA OTHER RESP, V3, P171, DOI 10.1111/j.1750-2659.2009.00086.x; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kaufman MA, 2009, MED J AUSTRALIA, V191, P154, DOI 10.5694/j.1326-5377.2009.tb02726.x; Kidd IM, 2009, LANCET, V374, P1036, DOI 10.1016/S0140-6736(09)61528-2; KIRSCH M, 1988, JAMA-J AM MED ASSOC, V259, P2737, DOI 10.1001/jama.259.18.2737; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Landry ML, 2008, J CLIN VIROL, V43, P148, DOI 10.1016/j.jcv.2008.06.006; Landry ML, 2004, J CLIN VIROL, V31, P113, DOI 10.1016/j.jcv.2004.04.005; Lewis PF, 2009, J INFECT DIS, V199, P1427, DOI 10.1086/598521; Louie J., 2009, Morbidity and Mortality Weekly Report, V58, P1071; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Matyas BI, 2007, ANN NY ACAD SCI, V1105, P351, DOI 10.1196/annals.1409.013; MILLER RR, 2009, CHEST           1120; Morishima T, 2002, CLIN INFECT DIS, V35, P512, DOI 10.1086/341407; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; *NOV SWIN OR INFL, 2009, NEW ENGL J MED, V361, P102; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Pollock NR, 2009, CLIN INFECT DIS, V49, pE66, DOI 10.1086/644502; Rello J, 2009, CRIT CARE, V13, DOI 10.1186/cc8044; Ruest A, 2003, J CLIN MICROBIOL, V41, P3487, DOI 10.1128/JCM.41.8.3487-3493.2003; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Steininger C, 2003, CLIN INFECT DIS, V36, P567, DOI 10.1086/367623; Tate JE, 2009, J INFECT DIS, V199, P1419, DOI 10.1086/598520; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; Thompson WW, 2004, JAMA-J AM MED ASSOC, V292, P1333, DOI 10.1001/jama.292.11.1333; Uyeki TM, 2009, CLIN INFECT DIS, V49, P279, DOI 10.1086/600035; Uyeki TM, 2009, CLIN INFECT DIS, V48, pE89, DOI 10.1086/597828; Uyeki TM, 2003, CLIN INFECT DIS, V36, P1095, DOI 10.1086/374053; Uyeki TM, 2003, PEDIATR INFECT DIS J, V22, P164; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; Wang H, 2008, LANCET, V371, P1427, DOI 10.1016/S0140-6736(08)60493-6; White NJ, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000091; WHO, 2009, WHO GUID PHARM MAN P; World Health Organization, 2009, CDC PROT REALT RTPCR; World Health Organization, 2009, CLIN MAN HUM INF PAN; Wormser GP, 2007, CLIN INFECT DIS, V45, P941, DOI 10.1086/522848	67	5	5	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2558	2569		10.1056/NEJMcpc0905545	http://dx.doi.org/10.1056/NEJMcpc0905545			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535WX	20032326	Bronze			2022-12-28	WOS:000273003700014
J	Honigman, B				Honigman, Benjamin			The Heart of the Matter	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												benjamin.honigman@ucdenver.edu						Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 23	2009	302	24					2638	2639		10.1001/jama.2009.1808	http://dx.doi.org/10.1001/jama.2009.1808			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535JU	20040544				2022-12-28	WOS:000272965300001
J	Bethell, T; Bergin, E				Bethell, Thomas; Bergin, Edwin			Formation and Survival of Water Vapor in the Terrestrial Planet-Forming Region	SCIENCE			English	Article							T-TAURI STARS; ORGANIC-MOLECULES; PROTOPLANETARY; PHOTODISSOCIATION; CHEMISTRY	Recent astronomical observations have revealed what may prove to be the ubiquity of water vapor during the early stages of planet formation. We present here a simple mechanism showing how water vapor forms in situ and is capable of shielding itself from molecule-destroying stellar radiation. The absorption of this radiation by water can control the thermodynamics of the terrestrial planet-forming zone. Similar to Earth's ozone layer, which shelters the chemistry of life, the water layer protects other water molecules and allows for a rich organic chemistry. The total abundance of water vapor in the natal habitable zone is equal to that of several thousand oceans.	[Bethell, Thomas; Bergin, Edwin] Univ Michigan, Dept Astron, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Bethell, T (corresponding author), Univ Michigan, Dept Astron, 830 Dennison Bldg,500 Church St, Ann Arbor, MI 48109 USA.	tbethell@astro.umich.edu			NASA [NN08 AH23G]	NASA(National Aeronautics & Space Administration (NASA))	We gratefully acknowledge funding by NASA under grant NN08 AH23G from the Astrophysics Theory and Fundamental Physics and Origins of Solar System programs.	Agundez M, 2008, ASTRON ASTROPHYS, V483, P831, DOI 10.1051/0004-6361:20077927; Baulch D.L., 1972, EVALUATED KINETIC DA; BERGIN EA, 2007, PROTOSTARS PLANETS, V5, pCH8; Chiang EI, 1997, ASTROPHYS J, V490, P368, DOI 10.1086/304869; Dullemond CP, 2005, ASTRON ASTROPHYS, V434, P971, DOI 10.1051/0004-6361:20042080; Furlan E, 2006, ASTROPHYS J SUPPL S, V165, P568, DOI 10.1086/505468; Glassgold AE, 2009, ASTROPHYS J, V701, P142, DOI 10.1088/0004-637X/701/1/142; Glassgold AE, 2004, ASTROPHYS J, V615, P972, DOI 10.1086/424509; Grevesse N, 2007, SPACE SCI REV, V130, P105, DOI 10.1007/s11214-007-9173-7; Hartmann L., 2001, ACCRETION PROCESSES; Ikoma M, 2006, ASTROPHYS J, V648, P696, DOI 10.1086/505780; Jonkheid B, 2007, ASTRON ASTROPHYS, V463, P203, DOI 10.1051/0004-6361:20065668; JOSEPH T, 1988, J CHEM PHYS, V88, P6982, DOI 10.1063/1.454396; MORDAUNT DH, 1994, J CHEM PHYS, V100, P7360, DOI 10.1063/1.466880; Reipurth B., 2007, PROTOSTARS PLANETS, VV, P507; Salyk C, 2008, ASTROPHYS J LETT, V676, pL49, DOI 10.1086/586894; Stimpfl M, 2006, J CRYST GROWTH, V294, P83, DOI 10.1016/j.jcrysgro.2006.05.057; Tappe A, 2008, ASTROPHYS J LETT, V680, pL117, DOI 10.1086/589998; VANDISHOECK EF, 1988, ASTROPHYS J, V334, P771, DOI 10.1086/166877; VANDISHOECK EF, 1984, ASTROPHYS J, V277, P576, DOI 10.1086/161729; Weidenschilling S.J., 1993, PROTOSTARS PLANETS, P1031; Yoshino K, 1996, CHEM PHYS, V211, P387, DOI 10.1016/0301-0104(96)00210-8	25	75	75	0	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1675	1677		10.1126/science.1176879	http://dx.doi.org/10.1126/science.1176879			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	20019283				2022-12-28	WOS:000272839000047
J	Charbonneau, D; Berta, ZK; Irwin, J; Burke, CJ; Nutzman, P; Buchhave, LA; Lovis, C; Bonfils, X; Latham, DW; Udry, S; Murray-Clay, RA; Holman, MJ; Falco, EE; Winn, JN; Queloz, D; Pepe, F; Mayor, M; Delfosse, X; Forveille, T				Charbonneau, David; Berta, Zachory K.; Irwin, Jonathan; Burke, Christopher J.; Nutzman, Philip; Buchhave, Lars A.; Lovis, Christophe; Bonfils, Xavier; Latham, David W.; Udry, Stephane; Murray-Clay, Ruth A.; Holman, Matthew J.; Falco, Emilio E.; Winn, Joshua N.; Queloz, Didier; Pepe, Francesco; Mayor, Michel; Delfosse, Xavier; Forveille, Thierry			A super-Earth transiting a nearby low-mass star	NATURE			English	Article							M-CIRCLE-PLUS; M-DWARFS; MAIN-SEQUENCE; PLANET; SEARCH; MODELS; SYSTEM; RADIUS; LIMIT; SUN	A decade ago, the detection of the first(1,2) transiting extrasolar planet provided a direct constraint on its composition and opened the door to spectroscopic investigations of extrasolar planetary atmospheres(3). Because such characterization studies are feasible only for transiting systems that are both nearby and for which the planet-to-star radius ratio is relatively large, nearby small stars have been surveyed intensively. Doppler studies(4-6) and microlensing(7) have uncovered a population of planets with minimum masses of 1.9-10 times the Earth's mass (M(circle plus)), called super-Earths. The first constraint on the bulk composition of this novel class of planets was afforded by CoRoT-7b (refs 8, 9), but the distance and size of its star preclude atmospheric studies in the foreseeable future. Here we report observations of the transiting planet GJ 1214b, which has a mass of 6.55M(circle plus) and a radius 2.68 times Earth's radius (R(circle plus)), indicating that it is intermediate in stature between Earth and the ice giants of the Solar System. We find that the planetary mass and radius are consistent with a composition of primarily water enshrouded by a hydrogen-helium envelope that is only 0.05% of the mass of the planet. The atmosphere is probably escaping hydrodynamically, indicating that it has undergone significant evolution during its history. The star is small and only 13 parsecs away, so the planetary atmosphere is amenable to study with current observatories.	[Charbonneau, David; Berta, Zachory K.; Irwin, Jonathan; Burke, Christopher J.; Nutzman, Philip; Buchhave, Lars A.; Latham, David W.; Murray-Clay, Ruth A.; Holman, Matthew J.; Falco, Emilio E.] Harvard Smithsonian Ctr Astrophys, Cambridge, MA 02138 USA; [Buchhave, Lars A.] Univ Copenhagen, Niels Bohr Inst, DK-2100 Copenhagen, Denmark; [Lovis, Christophe; Bonfils, Xavier; Udry, Stephane; Queloz, Didier; Pepe, Francesco; Mayor, Michel] Univ Geneva, Observ Geneva, CH-1290 Sauverny, Switzerland; [Bonfils, Xavier; Delfosse, Xavier; Forveille, Thierry] Univ Grenoble 1, CNRS, UMR 5571, Lab Astrophys Grenoble LAOG, F-38041 Grenoble 09, France; [Winn, Joshua N.] MIT, Dept Phys, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA	Harvard University; Smithsonian Astrophysical Observatory; Smithsonian Institution; University of Copenhagen; Niels Bohr Institute; University of Geneva; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); Massachusetts Institute of Technology (MIT)	Charbonneau, D (corresponding author), Harvard Smithsonian Ctr Astrophys, 60 Garden St, Cambridge, MA 02138 USA.	dcharbonneau@cfa.harvard.edu	Buchhave, Lars A./ABF-2000-2020	Buchhave, Lars A./0000-0003-1605-5666; Charbonneau, David/0000-0002-9003-484X; Berta-Thompson, Zachory/0000-0002-3321-4924; Burke, Christopher/0000-0001-7609-1146; Pepe, Francesco/0000-0002-9815-773X; Bonfils, Xavier/0000-0001-9003-8894; Burke, Christopher/0000-0002-7754-9486; udry, Stephane/0000-0001-7576-6236	David and Lucile Packard Foundation Fellowship for Science and Engineering; US National Science Foundation [AST-0807690]; NASA [NCC2-1390, NNX09AB33G]; European Southern Observatory Director's Discretionary [283.C-5022]	David and Lucile Packard Foundation Fellowship for Science and Engineering(The David & Lucile Packard Foundation); US National Science Foundation(National Science Foundation (NSF)); NASA(National Aeronautics & Space Administration (NASA)); European Southern Observatory Director's Discretionary	We thank M. Everett for gathering the FLWO 1.2-m observations, S. Seager for providing a digital version of the structural models, and D. Sasselov and S. Seager for comments on the manuscript. Support for this work was provided by the David and Lucile Packard Foundation Fellowship for Science and Engineering awarded to D. C., and by the US National Science Foundation under grant number AST-0807690. L. A. B. and D. W. L. acknowledge support from the NASA Kepler mission under cooperative agreement NCC2-1390. M. J. H. acknowledges support by NASA Origins Grant NNX09AB33G. The HARPS observations were gathered under the European Southern Observatory Director's Discretionary Program 283.C-5022 ( A). We thank the Smithsonian Astrophysical Observatory for supporting the MEarth Project at FLWO.	Baraffe I, 1998, ASTRON ASTROPHYS, V337, P403; Beaulieu JP, 2006, NATURE, V439, P437, DOI 10.1038/nature04441; Borucki WJ, 2009, SCIENCE, V325, P709, DOI 10.1126/science.1178312; Bouchy F, 2001, ASTRON ASTROPHYS, V374, P733, DOI 10.1051/0004-6361:20010730; Burke CJ, 2006, ASTRON J, V132, P210, DOI 10.1086/504468; Burrows A, 2003, ASTROPHYS J, V594, P545, DOI 10.1086/376897; Charbonneau D, 2000, ASTROPHYS J, V529, pL45, DOI 10.1086/312457; Delfosse X, 2000, ASTRON ASTROPHYS, V364, P217; Demory BO, 2009, ASTRON ASTROPHYS, V505, P205, DOI 10.1051/0004-6361/200911976; Henry GW, 2000, ASTROPHYS J, V529, pL41, DOI 10.1086/312458; Irwin J, 2009, ASTROPHYS J, V701, P1436, DOI 10.1088/0004-637X/701/2/1436; Kervella P, 2004, ASTRON ASTROPHYS, V426, P297, DOI 10.1051/0004-6361:20035930; Kovacs G, 2005, MON NOT R ASTRON SOC, V356, P557, DOI 10.1111/j.1365-2966.2004.08479.x; Leger A, 2009, ASTRON ASTROPHYS, V506, P287, DOI 10.1051/0004-6361/200911933; Leggett SK, 2000, ASTROPHYS J, V535, P965, DOI 10.1086/308887; Lepine S, 2005, ASTRON J, V130, P1680, DOI 10.1086/432792; Mandel K, 2002, ASTROPHYS J, V580, pL171, DOI 10.1086/345520; Mayor M, 2009, ASTRON ASTROPHYS, V507, P487, DOI 10.1051/0004-6361/200912172; Miller-Ricci E, 2009, ASTROPHYS J, V690, P1056, DOI 10.1088/0004-637X/690/2/1056; Murray-Clay RA, 2009, ASTROPHYS J, V693, P23, DOI 10.1088/0004-637X/693/1/23; Nutzman P, 2008, PUBL ASTRON SOC PAC, V120, P317, DOI 10.1086/533420; Queloz D, 2009, ASTRON ASTROPHYS, V506, P303, DOI 10.1051/0004-6361/200913096; REID IN, 1995, ASTRON J, V110, P1838, DOI 10.1086/117655; Rivera EJ, 2005, ASTROPHYS J, V634, P625, DOI 10.1086/491669; Seager S, 2007, ASTROPHYS J, V669, P1279, DOI 10.1086/521346; Torres G, 2007, ASTROPHYS J LETT, V671, pL65, DOI 10.1086/524886; Udry S, 2007, ASTRON ASTROPHYS, V469, pL43, DOI 10.1051/0004-6361:20077612; van Altena W.F., 1995, GEN CATALOGUE TRIGON, V4th edn.; Walkowicz LM, 2008, ASTROPHYS J, V677, P593, DOI 10.1086/526421	30	576	581	7	76	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 17	2009	462	7275					891	894		10.1038/nature08679	http://dx.doi.org/10.1038/nature08679			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016595	Green Submitted			2022-12-28	WOS:000272795400036
J	Galanty, Y; Belotserkovskaya, R; Coates, J; Polo, S; Miller, KM; Jackson, SP				Galanty, Yaron; Belotserkovskaya, Rimma; Coates, Julia; Polo, Sophie; Miller, Kyle M.; Jackson, Stephen P.			Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks	NATURE			English	Article							DAMAGE RESPONSE; UBIQUITIN; REPAIR; MDC1; UBIQUITYLATION; PROTEINS; DYNAMICS; ROLES; BINDS; ATM	DNA double-strand breaks (DSBs) are highly cytotoxic lesions that are generated by ionizing radiation and various DNA-damaging chemicals. Following DSB formation, cells activate the DNA-damage response (DDR) protein kinases ATM, ATR and DNA-PK (also known as PRKDC). These then trigger histone H2AX (also known as H2AFX) phosphorylation and the accumulation of proteins such as MDC1, 53BP1 (also known as TP53BP1), BRCA1, CtIP (also known as RBBP8), RNF8 and RNF168/RIDDLIN into ionizing radiation-induced foci (IRIF) that amplify DSB signalling and promote DSB repair(1,2). Attachment of small ubiquitin-related modifier (SUMO) to target proteins controls diverse cellular functions(3-6). Here, we show that SUMO1, SUMO2 and SUMO3 accumulate at DSB sites in mammalian cells, with SUMO1 and SUMO2/3 accrual requiring the E3 ligase enzymes PIAS4 and PIAS1. We also establish that PIAS1 and PIAS4 are recruited to damage sites via mechanisms requiring their SAP domains, and are needed for the productive association of 53BP1, BRCA1 and RNF168 with such regions. Furthermore, we show that PIAS1 and PIAS4 promote DSB repair and confer ionizing radiation resistance. Finally, we establish that PIAS1 and PIAS4 are required for effective ubiquitin-adduct formation mediated by RNF8, RNF168 and BRCA1 at sites of DNA damage(7-11). These findings thus identify PIAS1 and PIAS4 as components of the DDR and reveal how protein recruitment to DSB sites is controlled by coordinated SUMOylation and ubiquitylation.	[Galanty, Yaron; Belotserkovskaya, Rimma; Coates, Julia; Polo, Sophie; Miller, Kyle M.; Jackson, Stephen P.] Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Galanty, Yaron; Belotserkovskaya, Rimma; Coates, Julia; Polo, Sophie; Miller, Kyle M.; Jackson, Stephen P.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QN, England	University of Cambridge; University of Cambridge	Jackson, SP (corresponding author), Univ Cambridge, Wellcome Trust & Canc Res UK Gurdon Inst, Tennis Court Rd, Cambridge CB2 1QN, England.	s.jackson@gurdon.cam.ac.uk	Jackson, Stephen Philip/R-4548-2019; Dry, Kate/I-2328-2014	Jackson, Stephen Philip/0000-0001-9317-7937; Galanty, Yaron/0000-0001-7167-9004; Polo, Sophie/0000-0003-4821-9354; Miller, Kyle/0000-0002-4544-0013	Cancer Research UK; European Union [LSHG-CT-2005-512113, HEALTH-F2-2007-201630]	Cancer Research UK(Cancer Research UK); European Union(European Commission)	We thank S. P. J. lab members for support, in particular J. Harrigan, P. Huertas, S. Gravel, K. Dry and R. Chapman. We also thank C. Lukas for U2OS cells expressing GFP-BRCA1/Flag-BARD1, D. Durocher and G. Stewart for hTERT RIDDLE syndrome fibroblasts complemented with vector or HA-RNF168 and RNF168 antibody, T. Halazonetis for RNF8 antibody, R. Baer for the Flag-BARD1 construct, P. Harkin for the HA-BRCA1 construct, K. Iwabuchi for HA-tagged, full length, N, C, CDBRCT and BRCT 53BP1 constructs, R. Walker for help with FACS, and J. R. Morris for sharing results before publication. Research in the S. P. J. lab is supported by grants from Cancer Research UK and the European Union ( Integrated Project DNA repair, LSHG-CT-2005-512113, and Genomic Instability in Cancer and Precancer, HEALTH-F2-2007-201630).	Aravind L, 2000, TRENDS BIOCHEM SCI, V25, P112, DOI 10.1016/S0968-0004(99)01537-6; Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Downs JA, 2007, NATURE, V447, P951, DOI 10.1038/nature05980; Durant ST, 2005, CELL CYCLE, V4, P1216, DOI 10.4161/cc.4.9.2027; Evdokimov E, 2008, J CELL SCI, V121, P4106, DOI 10.1242/jcs.038570; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; LIMOLI CL, 1993, RADIAT RES, V134, P160, DOI 10.2307/3578455; Lou ZK, 2006, MOL CELL, V21, P187, DOI 10.1016/j.molcel.2005.11.025; Lukas C, 2003, NAT CELL BIOL, V5, P255, DOI 10.1038/ncb945; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Meulmeester E, 2008, NATURE, V452, P709, DOI 10.1038/452709a; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Pierce AJ, 2001, GENE DEV, V15, P3237, DOI 10.1101/gad.946401; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Sartori AA, 2007, NATURE, V450, P509, DOI 10.1038/nature06337; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Stewart GS, 2003, NATURE, V421, P961, DOI 10.1038/nature01446; Stuck M, 2004, DNA REPAIR, V3, P953, DOI 10.1016/j.dnarep.2004.03.007; Stucki M, 2005, CELL, V123, P1213, DOI 10.1016/j.cell.2005.09.038; Tahk S, 2007, P NATL ACAD SCI USA, V104, P11643, DOI 10.1073/pnas.0701877104; Xie AY, 2007, MOL CELL, V28, P1045, DOI 10.1016/j.molcel.2007.12.005	30	402	422	3	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					935	U132		10.1038/nature08657	http://dx.doi.org/10.1038/nature08657			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016603	Green Accepted			2022-12-28	WOS:000272795400046
J	Nesbitt, SJ; Smith, ND; Irmis, RB; Turner, AH; Downs, A; Norell, MA				Nesbitt, Sterling J.; Smith, Nathan D.; Irmis, Randall B.; Turner, Alan H.; Downs, Alex; Norell, Mark A.			A Complete Skeleton of a Late Triassic Saurischian and the Early Evolution of Dinosaurs	SCIENCE			English	Article							JURASSIC BOUNDARY; NEW-MEXICO; TERRESTRIAL; ARCHOSAURIA; EXTINCTION; ASSEMBLAGE; PHYLOGENY; DISPERSAL; THEROPODA; SKULL	Characterizing the evolutionary history of early dinosaurs is central to understanding their rise and diversification in the Late Triassic. However, fossils from basal lineages are rare. A new theropod dinosaur from New Mexico is a representative of the early North American diversification. Known from several nearly complete skeletons, it reveals a mosaic of plesiomorphic and derived features that clarify early saurischian dinosaur evolution and provide evidence for the antiquity of novel avian character systems including skeletal pneumaticity. The taxon further reveals latitudinal differences among saurischian assemblages during the Late Triassic, demonstrates that the theropod fauna from the Late Triassic of North America was not endemic, and suggests that intercontinental dispersal was prevalent during this time.	[Nesbitt, Sterling J.; Norell, Mark A.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Nesbitt, Sterling J.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Smith, Nathan D.] Univ Chicago, Comm Evolut Biol, Chicago, IL 60637 USA; [Smith, Nathan D.] Field Museum Nat Hist, Dept Geol, Chicago, IL 60605 USA; [Irmis, Randall B.] Utah Museum Nat Hist, Salt Lake City, UT 84112 USA; [Irmis, Randall B.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Turner, Alan H.] SUNY Stony Brook, Dept Anat Sci, Hlth Sci Ctr T8 040, Stony Brook, NY 11794 USA; [Downs, Alex] Ghost Ranch Conf Ctr, Ruth Hall Museum Paleontol, Abiquiu, NM 87510 USA	American Museum of Natural History (AMNH); Columbia University; University of Chicago; Field Museum of Natural History (Chicago); Utah System of Higher Education; University of Utah; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Nesbitt, SJ (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.	nesbitt@jsg.utexas.edu		Nesbitt, Sterling/0000-0002-7017-1652	National Geographic Society [8014-06]; David Clark Inc.; Jean Butz Memorial Fund; Theodore Roosevelt Memorial Fund; Jurassic Foundation; Explorers Club Exploration Grant; NSF; Samuel & Doris Welles Research Fund; Bryan Patterson Memorial Grant; University of California-Berkeley Department of Integrative Biology; University of Utah; Systematics Research Fund	National Geographic Society(National Geographic Society); David Clark Inc.; Jean Butz Memorial Fund; Theodore Roosevelt Memorial Fund; Jurassic Foundation; Explorers Club Exploration Grant; NSF(National Science Foundation (NSF)); Samuel & Doris Welles Research Fund; Bryan Patterson Memorial Grant; University of California-Berkeley Department of Integrative Biology; University of Utah; Systematics Research Fund	Fieldwork and research were funded by the National Geographic Society (grant no. 8014-06 to K. Padian), David Clark Inc., the Jean Butz Memorial Fund, the Theodore Roosevelt Memorial Fund (to R. B. I.), the Jurassic Foundation (to S. J. N.), an Explorers Club Exploration Grant (to S. J. N.), an NSF Graduate Fellowship (to S. J. N. and R. B. I.), the Samuel & Doris Welles Research Fund (to R. B. I. and K. Padian), a Bryan Patterson Memorial Grant (to R. B. I.), the University of California-Berkeley Department of Integrative Biology (to R. B. I.), the University of Utah (to R. B. I.), and the Systematics Research Fund (to N. D. S.). We thank the reviewers, R. Ree, and the Field Museum (Chicago) VertMorph discussion group; and the staff, volunteers, and paleontology seminar participants at Ghost Ranch for assistance with fieldwork. Ghost Ranch, the American Museum of Natural History, the Field Museum of Natural History, and the University of California Museum of Paleontology all facilitated the preparation of specimens.	Butler RJ, 2009, BIOL LETTERS, V5, P557, DOI 10.1098/rsbl.2009.0139; Clark JM, 2004, NATURE, V430, P1021, DOI 10.1038/nature02802; Ezcurra MD, 2006, GEODIVERSITAS, V28, P649; Fraser NC, 2002, PALAEONTOLOGY, V45, P79, DOI 10.1111/1475-4983.00228; Hesselbo SP, 2002, GEOLOGY, V30, P251, DOI 10.1130/0091-7613(2002)030<0251:TAMEAT>2.0.CO;2; Hopson JA, 2006, PALAEONTOL Z, V80, P124, DOI 10.1007/BF02988972; Irmis R, 2008, J VERTEBR PALEONTOL, V28, p95A; Irmis Randall B., 2007, Historical Biology, V19, P3, DOI 10.1080/08912960600719988; Irmis RB, 2007, SCIENCE, V317, P358, DOI 10.1126/science.1143325; Kundrat M, 2007, NATURWISSENSCHAFTEN, V94, P769, DOI 10.1007/s00114-007-0258-7; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Lloyd GT, 2008, P ROY SOC B-BIOL SCI, V275, P2483, DOI 10.1098/rspb.2008.0715; McElwain JC, 1999, SCIENCE, V285, P1386, DOI 10.1126/science.285.5432.1386; MUNDIL R, 2008, EOS, V89; Nesbitt S, 2007, B AM MUS NAT HIST, P1; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Novas FE, 1996, J VERTEBR PALEONTOL, V16, P723, DOI 10.1080/02724634.1996.10011361; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; Parker WG, 2007, J SYST PALAEONTOL, V5, P41, DOI 10.1017/S1477201906001994; Rauhut O.M.W., 2000, GAIA, V15, P75; Ree RH, 2008, SYSTEMATIC BIOL, V57, P4, DOI 10.1080/10635150701883881; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Sellwood BW, 2006, SEDIMENT GEOL, V190, P269, DOI 10.1016/j.sedgeo.2006.05.013; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1992, SCIENCE, V258, P1137, DOI 10.1126/science.258.5085.1137; Smith ND, 2007, ZOOL J LINN SOC-LOND, V151, P377, DOI 10.1111/j.1096-3642.2007.00325.x; Smith ND, 2005, SYST BIOL, V54, P166, DOI 10.1080/10635150590906000	28	165	170	1	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 11	2009	326	5959					1530	1533		10.1126/science.1180350	http://dx.doi.org/10.1126/science.1180350			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007898				2022-12-28	WOS:000272623600056
J	Salazar, JD; Saithong, T; Brown, PE; Foreman, J; Locke, JCW; Halliday, KJ; Carre, IA; Rand, DA; Millar, AJ				Salazar, Jose Domingo; Saithong, Treenut; Brown, Paul E.; Foreman, Julia; Locke, James C. W.; Halliday, Karen J.; Carre, Isabelle A.; Rand, David A.; Millar, Andrew J.			Prediction of Photoperiodic Regulators from Quantitative Gene Circuit Models	CELL			English	Article							ARABIDOPSIS-THALIANA; CIRCADIAN CLOCK; FLOWERING RESPONSE; MOLECULAR-BASIS; FLORAL INDUCTION; NETWORK MODEL; CONSTANS; TIME; EXPRESSION; PATHWAYS	Photoperiod sensors allow physiological adaptation to the changing seasons. The prevalent hypothesis is that day length perception is mediated through coupling of an endogenous rhythm with an external light signal. Sufficient molecular data are available to test this quantitatively in plants, though not yet in mammals. In Arabidopsis, the clock-regulated genes CONSTANS (CO) and FLAVIN, KELCH, F-BOX (FKF1) and their light-sensitive proteins are thought to form an external coincidence sensor. Here, we model the integration of light and timing information by CO, its target gene FLOWERING LOCUS T (FT), and the circadian clock. Among other predictions, our models show that FKF1 activates FT. We demonstrate experimentally that this effect is independent of the known activation of CO by FKF1, thus we locate a major, novel controller of photoperiodism. External coincidence is part of a complex photoperiod sensor: modeling makes this complexity explicit and may thus contribute to crop improvement.	[Saithong, Treenut; Brown, Paul E.; Foreman, Julia; Halliday, Karen J.; Millar, Andrew J.] Univ Edinburgh, Sch Biol Sci, Edinburgh EH9 3JH, Midlothian, Scotland; [Salazar, Jose Domingo; Locke, James C. W.; Carre, Isabelle A.] Univ Warwick, Dept Biol Sci, Coventry CV4 7AL, W Midlands, England; [Salazar, Jose Domingo; Rand, David A.] Univ Warwick, Math Inst, Coventry CV4 7AL, W Midlands, England; [Salazar, Jose Domingo; Brown, Paul E.; Locke, James C. W.; Rand, David A.] Univ Warwick, Interdisciplinary Programme Cellular Regulat, Coventry CV4 7AL, W Midlands, England; [Salazar, Jose Domingo; Brown, Paul E.; Locke, James C. W.; Rand, David A.] Univ Warwick, Warwick Syst Biol Ctr, Coventry CV4 7AL, W Midlands, England; [Locke, James C. W.] Univ Warwick, Dept Phys, Coventry CV4 7AL, W Midlands, England; [Millar, Andrew J.] Ctr Syst Biol Edinburgh, Edinburgh EH9 3JR, Midlothian, Scotland	University of Edinburgh; University of Warwick; University of Warwick; University of Warwick; University of Warwick; University of Warwick	Millar, AJ (corresponding author), Univ Edinburgh, Sch Biol Sci, Mayfield Rd, Edinburgh EH9 3JH, Midlothian, Scotland.	andrew.millar@ed.ac.uk	Rand, David A/J-9085-2012; CARRE, Isabelle A/D-8802-2011; Millar, Andrew J/G-2423-2012; Saithong, Treenut/L-1395-2019	Rand, David A/0000-0002-2217-3274; CARRE, Isabelle A/0000-0002-0548-7378; Millar, Andrew J/0000-0003-1756-3654; Saithong, Treenut/0000-0003-2888-6854; Locke, James/0000-0003-0670-1943; Halliday, Karen/0000-0003-0467-104X	BBSRC [BEP17427]; BBSRC/EPSRC SABR award [F0052371]; Gatsby Charitable Trust; Royal Thai Government; EU [005137]; EPSRC [D019621]; BBSRC [BB/D019621/1, BB/F005237/1] Funding Source: UKRI; EPSRC [EP/C544587/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [P19861/2, BB/F005237/1, BB/D019621/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/C544587/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC/EPSRC SABR award(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Gatsby Charitable Trust; Royal Thai Government; EU(European Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	A.J.M. gratefully acknowledges discussions with Carl Johnson, Steve Welch, and Peter Crawford; seed stocks provided by George Coupland; and the hospitality of Luis Serrano and the Centre de Regulacio Genomica, Barcelona during revision of the manuscript. J.D.S. and T.S. performed modeling studies; J.F. performed experimental work; P.E.B. and J.C.W.L. provided modeling tools; J.D.S., T.S., I.A.C., D.A.R. and A.J.M. designed modeling studies; K.J.H. and A.J.M. designed experimental work; A.J.M. wrote the paper with comments from all authors. This work was supported by BBSRC award BEP17427 to A.J.M., D.A.R. and I.A.C., and by BBSRC/EPSRC SABR award F0052371 to K.J.H., A.J.M., D.A.R. and others. J.C.W.L. was supported by a Sainsbury Postgraduate Scholarship from the Gatsby Charitable Trust. T.S. was supported by a Postgraduate Scholarship from the Royal Thai Government. D.A.R. holds an EPSRC Senior Fellowship and is supported by EU BioSim Network Contract 005137. The Centre for Systems Biology at Edinburgh is a Centre for Integrative Systems Biology supported by BBSRC and EPSRC award D019621.	Adams SR, 2001, J EXP BOT, V52, P655, DOI 10.1093/jexbot/52.357.655; An HL, 2004, DEVELOPMENT, V131, P3615, DOI 10.1242/dev.01231; Bohlenius H, 2006, SCIENCE, V312, P1040, DOI 10.1126/science.1126038; Borchert R, 2005, NATURE, V433, P627, DOI 10.1038/nature03259; Boss PK, 2004, PLANT CELL, V16, pS18, DOI 10.1105/tpc.015958; Bunning E., 1936, BER DEUT BOT GES, V54, P590, DOI DOI 10.1038/424033A; CARRE IA, 2006, ENDOGENOUS PLANT RHY, P167; Corbesier L, 1996, PLANT J, V9, P947, DOI 10.1046/j.1365-313X.1996.9060947.x; Corbesier L, 2007, SCIENCE, V316, P1030, DOI 10.1126/science.1141752; Dodd AN, 2005, SCIENCE, V309, P630, DOI 10.1126/science.1115581; El-Assal SED, 2001, NAT GENET, V29, P435, DOI 10.1038/ng767; ELLIOTT JA, 1974, PHOTOPERIODIC REGULA; Fornara F, 2009, DEV CELL, V17, P75, DOI 10.1016/j.devcel.2009.06.015; Fukamatsu Y, 2005, PLANT CELL PHYSIOL, V46, P1340, DOI 10.1093/pcp/pci144; Gould PD, 2006, PLANT CELL, V18, P1177, DOI 10.1105/tpc.105.039990; Guckenheimer J, 2013, APPL MATH SCI, V42; Hammer G, 2006, TRENDS PLANT SCI, V11, P587, DOI 10.1016/j.tplants.2006.10.006; HAMNER KC, 1964, AM NAT, V98, P295, DOI 10.1086/282328; Hayama R, 2004, PLANT PHYSIOL, V135, P677, DOI 10.1104/pp.104.042614; Hayama R, 2003, NATURE, V422, P719, DOI 10.1038/nature01549; Hayama R, 2007, PLANT CELL, V19, P2988, DOI 10.1105/tpc.107.052480; Hazlerigg D, 2008, CURR BIOL, V18, pR795, DOI 10.1016/j.cub.2008.07.040; Imaizumi T, 2005, SCIENCE, V309, P293, DOI 10.1126/science.1110586; Imaizumi T, 2003, NATURE, V426, P302, DOI 10.1038/nature02090; Imaizumi T, 2006, TRENDS PLANT SCI, V11, P550, DOI 10.1016/j.tplants.2006.09.004; Izawa T, 2007, INT REV CYTOL, V256, P191, DOI 10.1016/S0074-7696(07)56006-7; Jang S, 2008, EMBO J, V27, P1277, DOI 10.1038/emboj.2008.68; Kobayashi Y, 2007, GENE DEV, V21, P2371, DOI 10.1101/gad.1589007; Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092; Locke JCW, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100102; Locke JCW, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100018; Locke JCW, 2005, J THEOR BIOL, V234, P383, DOI 10.1016/j.jtbi.2004.11.038; Millar AJ, 1996, P NATL ACAD SCI USA, V93, P15491, DOI 10.1073/pnas.93.26.15491; Mizoguchi T, 2005, PLANT CELL, V17, P2255, DOI 10.1105/tpc.105.033464; Niwa Y, 2007, PLANT CELL PHYSIOL, V48, P925, DOI 10.1093/pcp/pcm067; OOSTEROM E, 2004, 4 INT CROP SCI C BRI; PITTENDRIGH CS, 1960, COLD SPRING HARB SYM, V25, P159, DOI 10.1101/SQB.1960.025.01.015; PITTENDRIGH CS, 1976, J COMP PHYSIOL, V106, P333, DOI 10.1007/BF01417860; Pouteau S, 2008, PLANT PHYSIOL, V148, P1465, DOI 10.1104/pp.108.127639; Roden LC, 2002, P NATL ACAD SCI USA, V99, P13313, DOI 10.1073/pnas.192365599; Sawa M, 2007, SCIENCE, V318, P261, DOI 10.1126/science.1146994; Suarez-Lopez P, 2001, NATURE, V410, P1116, DOI 10.1038/35074138; Thomas B., 1997, PHOTOPERIODISM PLANT; Turck F, 2008, ANNU REV PLANT BIOL, V59, P573, DOI 10.1146/annurev.arplant.59.032607.092755; Valverde F, 2004, SCIENCE, V303, P1003, DOI 10.1126/science.1091761; Welch SM, 2003, AGRON J, V95, P71, DOI 10.2134/agronj2003.0071; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Yanovsky MJ, 2002, NATURE, V419, P308, DOI 10.1038/nature00996	48	79	81	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1170	1179		10.1016/j.cell.2009.11.029	http://dx.doi.org/10.1016/j.cell.2009.11.029			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005809	Bronze, Green Submitted			2022-12-28	WOS:000272622800018
J	Christie-Johnston, CA; Connell, T; Mildenhall, T; Danchin, M				Christie-Johnston, C. A.; Connell, T.; Mildenhall, T.; Danchin, M.			Picture Quiz An 11 year old boy with chest pain and fever	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PRIMARY MENINGOCOCCAL PERICARDITIS; NEISSERIA-MENINGITIDIS; DISEASE; INFECTION; CHILDREN; COMPLICATIONS		[Christie-Johnston, C. A.; Connell, T.; Mildenhall, T.; Danchin, M.] Royal Childrens Hosp, Dept Gen Med, Melbourne, Vic 3052, Australia; [Connell, T.; Danchin, M.] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Connell, T.; Danchin, M.] Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia	Royal Children's Hospital Melbourne; University of Melbourne; Murdoch Children's Research Institute	Danchin, M (corresponding author), Royal Childrens Hosp, Dept Gen Med, Melbourne, Vic 3052, Australia.	margie.danchin@rch.org.au	Danchin, Margie/ABE-3391-2020					Baevsky RH, 1999, CLIN INFECT DIS, V29, P213, DOI 10.1086/520165; Beggs S, 2000, J PAEDIATR CHILD H, V36, P606, DOI 10.1046/j.1440-1754.2000.00523.x; Benes J, 2003, CLIN MICROBIOL INFEC, V9, P1062, DOI 10.1046/j.1469-0691.2003.00741.x; BLASER MJ, 1984, REV INFECT DIS, V6, P625; BOUCEK MM, 1984, J PEDIATR-US, V105, P538, DOI 10.1016/S0022-3476(84)80416-3; BRASIER AR, 1987, AM J MED, V82, P641, DOI 10.1016/0002-9343(87)90115-X; El Bashir H, 2004, PEDIATR INFECT DIS J, V23, P969, DOI 10.1097/01.inf.0000141731.98250.e3; Finkelstein Y, 1997, EUR J PEDIATR, V156, P585, DOI 10.1007/s004310050669; Goedvolk CA, 2003, ARCH DIS CHILD, V88, P927, DOI 10.1136/adc.88.10.927; GORE I, 1947, AM HEART J, V34, P827, DOI 10.1016/0002-8703(47)90147-6; Gupta S, 2007, PEDIATR EMERG CARE, V23, P163, DOI 10.1097/PEC.0b013e3180328c43; Jelfs J, 2002, PATHOLOGY, V34, P289, DOI 10.1080/00313020220131390; KANTER DM, 1956, AM J MED SCI, V232, P674, DOI 10.1097/00000441-195612000-00008; Kaplan SL, 2006, PEDIATRICS, V118, pE979, DOI 10.1542/peds.2006-0281; MARON BJ, 1972, JOHNS HOPKINS MED J, V131, P64; MORSE JR, 1971, ANN INTERN MED, V74, P212, DOI 10.7326/0003-4819-74-2-212; MOSS W, 1994, CLIN PEDIATR, V169, P171; Rosenstein NE, 2001, NEW ENGL J MED, V344, P1378, DOI 10.1056/NEJM200105033441807; Thompson MJ, 2006, LANCET, V367, P397, DOI 10.1016/S0140-6736(06)67932-4; van Deuren M, 2000, CLIN MICROBIOL REV, V13, P144, DOI 10.1128/CMR.13.1.144-166.2000; Vienne P, 2003, CLIN INFECT DIS, V37, P1639, DOI 10.1086/379719	21	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 9	2009	339								b4941	10.1136/bmj.b4941	http://dx.doi.org/10.1136/bmj.b4941			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531VG	20007220				2022-12-28	WOS:000272697500001
J	Nyweide, DJ; Weeks, WB; Gottlieb, DJ; Casalino, LP; Fisher, ES				Nyweide, David J.; Weeks, William B.; Gottlieb, Daniel J.; Casalino, Lawrence P.; Fisher, Elliott S.			Relationship of Primary Care Physicians' Patient Caseload With Measurement of Quality and Cost Performance	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HEALTH-CARE	Context Sufficient numbers of patients are necessary to generate statistically reliable measurements of physicians' quality and cost performance. Objective To determine whether primary care physicians in the same physician practice collectively see enough Medicare patients annually to detect meaningful differences between practices in ambulatory quality and cost measures. Design, Setting, and Patients Primary care physicians in the United States were linked to their physician practices using the Healthcare Organization Services database maintained by IMS Health. Patients who visited primary care physicians in the 2005 Medicare Part B 20% sample were used to estimate Medicare caseloads per practice. Caseloads necessary to detect 10% relative differences in costs and quality were calculated using national mean ambulatory Medicare spending, rates of mammography for women 66 to 69 years, and hemoglobin A(1c) testing for 66-to 75-year-olds with diabetes, preventable hospitalization rate, and 30-day readmission rate after discharge for congestive heart failure (CHF). Main Outcome Measures Percentage of primary care physician practices with a sufficient number of eligible patients to detect a 10% relative difference in each performance measure. Results Primary care physician practices had annual median caseloads of 260 Medicare patients (interquartile range [IQR], 135-500), 25 women eligible for mammography (IQR, 10-50), 30 patients with diabetes eligible for hemoglobin A1c testing (IQR, 15-55), and 0 patients hospitalized for CHF. For ambulatory costs, mammography rate, and hemoglobin A1c testing rate, the percentage of primary care physician practices with sufficient caseloads to detect 10% relative differences in performance ranged from less than 10% of practices with fewer than 11 primary care physicians to 100% of practices with more than 50 primary care physicians. None of the primary care physician practices had sufficient caseloads to detect 10% relative differences in preventable hospitalization or 30-day readmission after discharge for CHF. Conclusion Relatively few primary care physician practices are large enough to reliably measure 10% relative differences in common measures of quality and cost performance among fee-for-service Medicare patients. JAMA. 2009; 302(22): 2444-2450	[Nyweide, David J.] Ctr Medicare & Medicaid Serv, Off Res Dev & Informat, Baltimore, MD 21244 USA; [Weeks, William B.; Gottlieb, Daniel J.; Fisher, Elliott S.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Casalino, Lawrence P.] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY USA	Centers for Medicare & Medicaid Services; Dartmouth College; Cornell University	Nyweide, DJ (corresponding author), Ctr Medicare & Medicaid Serv, Off Res Dev & Informat, 7500 Secur Blvd,C3-21-28, Baltimore, MD 21244 USA.	david.nyweide@cms.hhs.gov	Casalino, Lawrence/ABE-1245-2020; Weeks, WB/G-7436-2014	Casalino, Lawrence/0000-0002-7927-7859; 	Commonwealth Fund [20070129]; National Institute on Aging [PO1 AG19783]; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	Commonwealth Fund; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was funded by grant 20070129 from The Commonwealth Fund and grant PO1 AG19783 from the National Institute on Aging; access to data were provided by the Healthcare Organization Services database from IMS Health; Dr Nyweide reports completion of this research with support from the National Institute on Aging prior to becoming an employee at the Centers for Medicare & Medicaid Services, and he reports receiving reimbursement from IMS Health for expenses associated with a research meeting in August 2008.	Bazzoli GJ, 2004, MED CARE RES REV, V61, P247, DOI 10.1177/1077558704266818; Berenson RA, 2008, HEALTH AFFAIR, V27, P1219, DOI 10.1377/hlthaff.27.5.1219; Center for Medicare & Medicaid Services, PHYS QUAL REP IN; *CTR MED MED SERV, 2008, ROADM IMPL VAL DRIV; *CTR MED MED SERV, MED PAY PERF P4P IN; Culler SD, 1998, MED CARE, V36, P804, DOI 10.1097/00005650-199806000-00004; ENTHOVEN AC, 2005, HLTH AFF MILLWOOD; EPSTEIN A, 1995, NEW ENGL J MED, V333, P57, DOI 10.1056/NEJM199507063330114; Fisher ES, 2007, HEALTH AFFAIR, V26, pW44, DOI 10.1377/hlthaff.26.1.w44; Gandhi TK, 2002, MED CARE, V40, P155, DOI 10.1097/00005650-200202000-00010; HING E, 2007, NATL CTR HLTH STAT P; Hofer TP, 1999, JAMA-J AM MED ASSOC, V281, P2098, DOI 10.1001/jama.281.22.2098; *IMS MARK IN, IMS HEALTHC ORG SERV; Jencks SF, 2003, JAMA-J AM MED ASSOC, V289, P305, DOI 10.1001/jama.289.3.305; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Krein SL, 2002, HEALTH SERV RES, V37, P1159, DOI 10.1111/1475-6773.01102; Landon BE, 2003, JAMA-J AM MED ASSOC, V290, P1183, DOI 10.1001/jama.290.9.1183; Lee TH, 2004, NEW ENGL J MED, V350, P2409, DOI 10.1056/NEJMsb041193; McCarthy D., 2007, AIMING HIGHER RESULT; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; National Committee for Quality Assurance, 2009, HEDIS 2009 SUMM TABL; PALMER RH, 1996, MED CARE S, V34, pS52; Parkerton PH, 2003, MED CARE, V41, P1034, DOI 10.1097/01.MLR.0000083745.83803.D6; Pope GC, 2004, HEALTH CARE FINANC R, V25, P119; Scholle SH, 2008, AM J MANAG CARE, V14, P829; Shortell SM, 2008, JAMA-J AM MED ASSOC, V300, P95, DOI 10.1001/jama.300.1.95; The Agency for Healthcare Research and Quality, 2007, GUID PREV QUAL IND H; Wennberg JE, 2008, TRACKING CARE PATIEN	28	48	48	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2444	2450		10.1001/jama.2009.1810	http://dx.doi.org/10.1001/jama.2009.1810			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	529MD	19996399	Green Accepted, Bronze			2022-12-28	WOS:000272520500023
J	Bruening, W; Fontanarosa, J; Tipton, K; Treadwell, JR; Launders, J; Schoelles, K				Bruening, Wendy; Fontanarosa, Joann; Tipton, Kelley; Treadwell, Jonathan R.; Launders, Jason; Schoelles, Karen			Systematic Review: Comparative Effectiveness of Core-Needle and Open Surgical Biopsy to Diagnose Breast Lesions	ANNALS OF INTERNAL MEDICINE			English	Review							TERM-FOLLOW-UP; ADD-ON DEVICE; VACUUM-ASSISTED DEVICE; GUIDED CORE; NONPALPABLE LESIONS; STEREOTACTIC BIOPSY; COST-EFFECTIVENESS; MAMMARY LESIONS; BENIGN LESIONS; ACCURACY	Background: Most women undergoing breast biopsy are found not to have cancer. Purpose: To compare the accuracy and harms of different breast biopsy methods in average-risk women suspected of having breast cancer. Data Sources: Databases, including MEDLINE and EMBASE, searched from 1990 to September 2009. Study Selection: Studies that compared core-needle biopsy diagnoses with open surgical diagnoses or clinical follow-up. Data Extraction: Data were abstracted by 1 of 3 researchers and verified by the primary investigator. Data Synthesis: 33 studies of stereotactic automated gun biopsy; 22 studies of stereotactic-guided, vacuum-assisted biopsy; 16 studies of ultrasonography-guided, automated gun biopsy; 7 studies of ultrasonography-guided, vacuum-assisted biopsy; and 5 studies of freehand automated gun biopsy met the inclusion criteria. Low-strength evidence showed that core-needle biopsies conducted under stereotactic guidance with vacuum assistance distinguished between malignant and benign lesions with an accuracy similar to that of open surgical biopsy. Ultrasonography-guided biopsies were also very accurate. The risk for severe complications is lower with core-needle biopsy than with open surgical procedures (<1% vs. 2% to 10%). Moderate-strength evidence showed that women in whom breast cancer was initially diagnosed by core-needle biopsy were more likely than women with cancer initially diagnosed by open surgical biopsy to be treated with a single surgical procedure (random-effects odds ratio, 13.7 [95% CI, 5.5 to 34.6]). Limitation: The strength of evidence was rated low for accuracy outcomes because the studies did not report important details required to assess the risk for bias. Conclusion: Stereotactic-and ultrasonography-guided core-needle biopsy procedures seem to be almost as accurate as open surgical biopsy, with lower complication rates.	[Bruening, Wendy; Fontanarosa, Joann; Tipton, Kelley; Treadwell, Jonathan R.; Launders, Jason; Schoelles, Karen] ECRI Inst, Evidence Based Practice Ctr, Plymouth Meeting, PA 19462 USA		Schoelles, K (corresponding author), ECRI Inst, Evidence Based Practice Ctr, 5200 Butler Pike, Plymouth Meeting, PA 19462 USA.	kschoelles@ecri.org	wang, edwin/G-5372-2010		ECRI Institute Evidence-based Practice Center, Plymouth Meeting, Pennsylvania; Agency for Healthcare Research and Quality [290-02-0019]; U.S. Department of Health and Human Services	ECRI Institute Evidence-based Practice Center, Plymouth Meeting, Pennsylvania; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); U.S. Department of Health and Human Services	This project was supported by the ECRI Institute Evidence-based Practice Center, Plymouth Meeting, Pennsylvania, with funding from the Agency for Healthcare Research and Quality under contract no. 290-02-0019, U.S. Department of Health and Human Services.	Abdsaleh S, 2003, ACTA RADIOL, V44, P47; Alonso-Bartolome P, 2004, ACTA RADIOL, V45, P390, DOI 10.1080/02841850410005633; Ambrogetti Daniela, 2003, Radiol Med, V106, P313; American Cancer Society, 2008, CANC FACTS FIG 2008; ANTLEY CM, 1998, BREAST J, V4, P3; Apesteguia L, 2002, EUR RADIOL, V12, P638, DOI 10.1007/s00330-001-1168-2; BARRETO V, 1991, EUR J SURG ONCOL, V17, P237; Bauer RL, 1997, ANN SURG ONCOL, V4, P316, DOI 10.1007/BF02303581; Beck R M, 2000, Swiss Surg, V6, P108, DOI 10.1024/1023-9332.6.3.108; Becker L, 2001, AM J ROENTGENOL, V177, P1451, DOI 10.2214/ajr.177.6.1771451; Bolivar AV, 2005, ACTA RADIOL, V46, P690, DOI 10.1080/02841850500225740; Bolivar AV, 1998, ACTA RADIOL, V39, P389; Brenner RJ, 2001, RADIOLOGY, V218, P866, DOI 10.1148/radiology.218.3.r01mr44866; Britton PD, 1997, CLIN RADIOL, V52, P764, DOI 10.1016/S0009-9260(97)80156-0; Bruening W., 2009, COMP EFFECTIVENESS C; BURBANK F, 1994, RADIOLOGY, V191, P165, DOI 10.1148/radiology.191.1.8134564; Cangiarella J, 2001, CANCER-AM CANCER SOC, V91, P173, DOI 10.1002/1097-0142(20010101)91:1<173::AID-CNCR22>3.0.CO;2-9; Caruso, 1998, Oncologist, V3, P45; Chapellier C, 2006, CLIN IMAG, V30, P99, DOI 10.1016/j.clinimag.2005.08.002; Ciatto S, 2007, BREAST CANCER RES TR, V101, P291, DOI 10.1007/s10549-006-9289-6; Cipolla C, 2006, BREAST, V15, P76, DOI 10.1016/j.breast.2005.01.007; CROSS MJ, 1995, ANN SURG ONCOL, V2, P195, DOI 10.1007/BF02307023; Crystal P, 2005, J CLIN ULTRASOUND, V33, P47, DOI 10.1002/jcu.20089; CUSICK JD, 1990, SURG GYNECOL OBSTET, V170, P407; Dahlstrom JE, 2001, PATHOLOGY, V33, P444, DOI 10.1080/00313020120083160; DEEKS J, 2004, COCHRANE COLLABORATI; Deeks JJ, 2005, J CLIN EPIDEMIOL, V58, P882, DOI 10.1016/j.jclinepi.2005.01.016; Delle Chiaie L, 2004, ULTRASOUND OBST GYN, V23, P393, DOI 10.1002/uog.1001; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhillon MS, 2006, CLIN RADIOL, V61, P276, DOI 10.1016/j.crad.2005.08.017; Dillon MF, 2005, ANN SURG, V242, P701, DOI 10.1097/01.sla.0000186186.05971.e0; Doyle AJ, 1999, AM J ROENTGENOL, V172, P688, DOI 10.2214/ajr.172.3.10063861; DOYLE AJ, 1995, AM J ROENTGENOL, V165, P281, DOI 10.2214/ajr.165.2.7618540; Dwamena B., 2007, MIDAS STATA MODULE M; Edney J, 2002, AM J SURG, V184, P554; ELVECROG EL, 1993, RADIOLOGY, V188, P453, DOI 10.1148/radiology.188.2.8327696; Fajardo LL, 2004, ACAD RADIOL, V11, P293, DOI 10.1016/S1076-6332(03)00510-5; Fishman JE, 2003, RADIOLOGY, V226, P779, DOI 10.1148/radiol.2263011622; Frazee RC, 1996, AM J SURG, V172, P491, DOI 10.1016/S0002-9610(97)89603-1; FRAZEE RC, 1996, AM J SURG, V172, P494; Fuhrman G, 1996, J La State Med Soc, V148, P167; Fuhrman GM, 1998, ANN SURG, V227, P932, DOI 10.1097/00000658-199806000-00017; Georgian-Smith D, 2002, AM J ROENTGENOL, V178, P1017, DOI 10.2214/ajr.178.4.1781017; GISVOLD JJ, 1994, AM J ROENTGENOL, V162, P815, DOI 10.2214/ajr.162.4.8140997; GRADY D, 1988, WESTERN J MED, V149, P226; Han BK, 2003, KOREAN J RADIOL, V4, P217, DOI 10.3348/kjr.2003.4.4.217; Harbord RM, 2007, BIOSTATISTICS, V8, P239, DOI 10.1093/biostatistics/kxl004; Head JF, 1996, AM SURGEON, V62, P1018; Helbich TH, 1997, RADIOLOGY, V203, P684, DOI 10.1148/radiology.203.3.9169689; Heywang-Kobrunner SH, 1998, EUR RADIOL, V8, P377, DOI 10.1007/s003300050398; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Ioffe OB, 1998, MODERN PATHOL, V11, P721; Jackman RJ, 1999, RADIOLOGY, V210, P799, DOI 10.1148/radiology.210.3.r99mr19799; Jackman RJ, 2002, RADIOLOGY, V222, P157, DOI 10.1148/radiol.2221010231; Jackman RJ, 2009, AM J ROENTGENOL, V192, P341, DOI 10.2214/AJR.08.1127; Johnson AT, 2002, AM J SURG, V184, P550, DOI 10.1016/S0002-9610(02)01099-1; KHATTAR SC, 1997, EUR J ULTRASOUND, V6, P1; Kirshenbaum KJ, 2003, AM J ROENTGENOL, V181, P527, DOI 10.2214/ajr.181.2.1810527; Kirwan SE, 2000, CLIN RADIOL, V55, P763, DOI 10.1053/crad.2000.0513; Koskela AK, 2005, RADIOLOGY, V236, P801, DOI 10.1148/radiol.2363040782; Kubota Kazunori, 2004, Breast Cancer, V11, P55, DOI 10.1007/BF02968003; Lacquement MA, 1999, J AM COLL SURGEONS, V189, P34, DOI 10.1016/S1072-7515(99)00080-0; Lai JTW, 2001, CAN ASSOC RADIOL J, V52, P223; Latosinsky S, 2000, BREAST CANCER RES TR, V60, P277, DOI 10.1023/A:1006449319179; Levin MF, 2001, CAN ASSOC RADIOL J, V52, P29; Liberman L, 1998, RADIOLOGY, V208, P717, DOI 10.1148/radiology.208.3.9722851; Liberman L, 1997, RADIOLOGY, V203, P151, DOI 10.1148/radiology.203.1.9122384; Liberman L, 2002, AM J ROENTGENOL, V179, DOI 10.2214/ajr.179.3.1790679; Liberman L, 2000, AM J ROENTGENOL, V175, P779, DOI 10.2214/ajr.175.3.1750779; Lijmer JG, 1999, JAMA-J AM MED ASSOC, V282, P1061, DOI 10.1001/jama.282.11.1061; Lomoschitz FM, 2004, RADIOLOGY, V232, P897, DOI 10.1148/radiol.2323031224; Mainiero MB, 1996, RADIOLOGY, V198, P665, DOI 10.1148/radiology.198.3.8628852; Makoske T, 2000, AM SURGEON, V66, P1104; March DE, 2003, RADIOLOGY, V227, P549, DOI 10.1148/radiol.2272020476; Margolin FR, 2001, AM J ROENTGENOL, V177, P559, DOI 10.2214/ajr.177.3.1770559; MCMAHON AJ, 1992, BRIT J SURG, V79, P1042, DOI 10.1002/bjs.1800791018; Meloni GB, 2002, ACTA RADIOL, V43, P575, DOI 10.1034/j.1600-0455.2002.430607.x; Meyer JE, 1996, AM J ROENTGENOL, V167, P179, DOI 10.2214/ajr.167.1.8659367; MEYER JE, 1981, SURG GYNECOL OBSTET, V153, P570; Meyer JE, 1999, JAMA-J AM MED ASSOC, V281, P1638, DOI 10.1001/jama.281.17.1638; Morris Elizabeth A, 2002, Breast J, V8, P187, DOI 10.1046/j.1524-4741.2002.08305.x; de Lucena CEM, 2007, J CLIN ULTRASOUND, V35, P363, DOI 10.1002/jcu.20380; Nguyen M, 1996, CANCER, V78, P2340; OWENS DK, 2009, J CLIN EPIDEMIOL; PARKER SH, 1993, RADIOLOGY, V187, P507, DOI 10.1148/radiology.187.2.8475299; PARKER SH, 1994, RADIOLOGY, V193, P359, DOI 10.1148/radiology.193.2.7972743; PARKER SH, 1990, RADIOLOGY, V176, P741, DOI 10.1148/radiology.176.3.2167501; PATCHEFSKY AS, 1973, AM J CLIN PATHOL, V60, P799; Perez-Fuentes JA, 2001, AM J ROENTGENOL, V177, P1459, DOI 10.2214/ajr.177.6.1771459; Peters N, 2008, INT J CANCER, V122, P468, DOI 10.1002/ijc.23078; Pettine S, 1996, AM J SURG, V171, P474, DOI 10.1016/S0002-9610(96)00007-4; Pfarl G, 2002, AM J ROENTGENOL, V179, P1503, DOI 10.2214/ajr.179.6.1791503; Pfleiderer SOR, 2003, J MAGN RESON IMAGING, V17, P493, DOI 10.1002/jmri.10282; Philpotts LE, 2003, AM J ROENTGENOL, V180, P347, DOI 10.2214/ajr.180.2.1800347; Pitre B, 1997, AM SURGEON, V63, P1124; Puglisi F, 1999, CANCER LETT, V146, P181, DOI 10.1016/S0304-3835(99)00262-1; Rakha EA, 2009, EUR J CANCER, V45, P1162, DOI 10.1016/j.ejca.2008.12.002; Reintgen DS, 2000, AM SURGEON, V66, P1108; Rosenblatt R, 1996, RADIOLOGY, V201, P67, DOI 10.1148/radiology.201.1.8816522; Sauer G, 2005, BRIT J CANCER, V92, P231, DOI 10.1038/sj.bjc.6602303; Schueller G, 2008, RADIOLOGY, V248, P406, DOI 10.1148/radiol.2482071994; Schulz-Wendtland R, 1998, ANTICANCER RES, V18, P2145; Scopa CD, 1996, CANCER DETECT PREV, V20, P620; Sim LSJ, 2008, J MED IMAG RADIAT ON, V52, P358, DOI 10.1111/j.1440-1673.2008.01968.x; Smith DN, 2001, J ULTRAS MED, V20, P43; Smyth A T, 1994, J La State Med Soc, V146, P499; Soo MS, 1999, CLIN IMAG, V23, P347, DOI 10.1016/S0899-7071(00)00164-9; Stolier AJ, 1997, J AM COLL SURGEONS, V185, P224, DOI 10.1016/S1072-7515(01)00919-X; Sutton S, 1997, Australas Radiol, V41, P103, DOI 10.1111/j.1440-1673.1997.tb00692.x; Tonegutti M, 2008, RADIOL MED, V113, P65, DOI 10.1007/s11547-008-0226-0; Treadwell Jonathan R, 2006, BMC Med Res Methodol, V6, P52, DOI 10.1186/1471-2288-6-52; Uematsu T, 2007, BREAST CANCER RES TR, V103, P269, DOI 10.1007/s10549-006-9373-y; Vag T, 2007, EUR RADIOL, V17, P3100, DOI 10.1007/s00330-007-0687-x; Verkooijen HM, 2002, INT J CANCER, V99, P853, DOI 10.1002/ijc.10419; Walker TM, 1997, BREAST, V6, P126, DOI 10.1016/S0960-9776(97)90552-X; Ward SE, 2000, CAN ASSOC RADIOL J, V51, P10; Weber WP, 2005, WORLD J SURG, V29, P495, DOI 10.1007/s00268-004-7635-6; Welle GJ, 2000, AM J ROENTGENOL, V175, P59, DOI 10.2214/ajr.175.1.1750059; White RR, 2001, ANN SURG, V233, P769, DOI 10.1097/00000658-200106000-00006; Whiting Penny, 2003, BMC Med Res Methodol, V3, P25, DOI 10.1186/1471-2288-3-25; Whitman GJ, 1998, AM J ROENTGENOL, V171, P67, DOI 10.2214/ajr.171.1.9648766; Wong T E, 2003, Med J Malaysia, V58, P399; WU YK, 2005, TZU CHI MED J, V17, P452; WU YK, 2005, TZU CHI MED J, V17, P405; Wunderbaldinger P, 2001, EUR RADIOL, V11, P2460, DOI 10.1007/s003300101010; Yeow KM, 2001, J VASC INTERV RADIOL, V12, P1313, DOI 10.1016/S1051-0443(07)61557-7; Youk JH, 2008, AM J ROENTGENOL, V190, P202, DOI 10.2214/AJR.07.2419; Zannis VJ, 1998, AM J SURG, V176, P525, DOI 10.1016/S0002-9610(98)00265-7	129	132	143	0	12	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2010	152	4					238	U75		10.7326/0003-4819-152-1-201001050-00190	http://dx.doi.org/10.7326/0003-4819-152-1-201001050-00190			19	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	560AF	20008742				2022-12-28	WOS:000274873300006
J	Volkman, HE; Pozos, TC; Zheng, J; Davis, JM; Rawls, JF; Ramakrishnan, L				Volkman, Hannah E.; Pozos, Tamara C.; Zheng, John; Davis, J. Muse; Rawls, John F.; Ramakrishnan, Lalita			Tuberculous Granuloma Induction via Interaction of a Bacterial Secreted Protein with Host Epithelium	SCIENCE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; IN-VIVO; CALMETTE-GUERIN; INFECTION; MATRIX-METALLOPROTEINASE-9; MACROPHAGES; EXPRESSION; ACTIVATION; ZEBRAFISH; RELEASE	Granulomas, organized aggregates of immune cells, are a hallmark of tuberculosis and have traditionally been thought to restrict mycobacterial growth. However, analysis of Mycobacterium marinum in zebrafish has shown that the early granuloma facilitates mycobacterial growth; uninfected macrophages are recruited to the granuloma where they are productively infected by M. marinum. Here, we identified the molecular mechanism by which mycobacteria induce granulomas: The bacterial secreted protein 6-kD early secreted antigenic target (ESAT-6), which has long been implicated in virulence, induced matrix metalloproteinase-9 (MMP9) in epithelial cells neighboring infected macrophages. MMP9 enhanced recruitment of macrophages, which contributed to nascent granuloma maturation and bacterial growth. Disruption of MMP9 function attenuated granuloma formation and bacterial growth. Thus, interception of epithelial MMP9 production could hold promise as a host-targeting tuberculosis therapy.	[Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98155 USA; [Volkman, Hannah E.] Univ Washington, Mol & Cellular Biol Grad Program, Seattle, WA 98155 USA; [Pozos, Tamara C.; Zheng, John] Univ Washington, Dept Pediat, Seattle, WA 98155 USA; [Davis, J. Muse] Emory Univ, Immunol & Mol Pathogenesis Grad Program, Atlanta, GA 30322 USA; [Rawls, John F.] Univ N Carolina, Dept Cell & Mol Physiol, Chapel Hill, NC 27599 USA; [Rawls, John F.] Univ N Carolina, Dept Microbiol & Immunol, Chapel Hill, NC 27599 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98155 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98155 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Emory University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Seattle, WA 98155 USA.	lalitar@u.washington.edu	Rawls, John F/C-9169-2009	Rawls, John F/0000-0002-5976-5206; Ramakrishnan, Lalita/0000-0003-0692-5533; Davis, J. Muse/0000-0001-9959-6921	Burroughs Wellcome Fund; Pew Scholars Program; NIH; American Heart Association; Pediatric Infectious Diseases Society; Children's Health Research Center; National Defense Science and Engineering; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054503, R01AI036396, R37AI054503] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [F32DK062675, K01DK073695, R01DK081426] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Pew Scholars Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); Pediatric Infectious Diseases Society; Children's Health Research Center; National Defense Science and Engineering; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank J. I. Gordon, W. Parks, D. Raible, D. Sherman, K. Urdahl, and P. Elkington for advice and discussion; D. Beery and R. Kim for help with microinjections; and J. Cameron, L. Swaim, and H. Wiedenhoft for fish facility maintenance. We also thank K. Winglee for developing FPC analysis methods, R. Burmeister for graphic design, and D. Tobin, B. Cormack, W. Parks, D. Stetson, R. Berg, and F. Chu for review of the manuscript. This work was supported by the Burroughs Wellcome Fund (L. R.), the Pew Scholars Program (J. F. R.), the NIH (L. R. and J. F. R.), an American Heart Association predoctoral fellowship (H. E. V.), a Pediatric Infectious Diseases Society postdoctoral award, the Children's Health Research Center new investigator award, an NIH diversity supplement (T. C. P.), and a National Defense Science and Engineering predoctoral fellowship (J. M. D.).	ADAMS DO, 1976, AM J PATHOL, V84, P164; Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x; Chang JC, 1996, THORAX, V51, P306, DOI 10.1136/thx.51.3.306; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; de Jonge MI, 2007, J BACTERIOL, V189, P6028, DOI 10.1128/JB.00469-07; Derrick SC, 2007, CELL MICROBIOL, V9, P1547, DOI 10.1111/j.1462-5822.2007.00892.x; Elkington PT, 2007, AM J RESP CELL MOL, V37, P431, DOI 10.1165/rcmb.2007-0011OC; Greenfield SP, 2007, UROLOGY, V69, P166, DOI 10.1016/j.urology.2006.10.018; Hagedorn M, 2009, SCIENCE, V323, P1729, DOI 10.1126/science.1169381; Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100; Koo IC, 2008, CELL MICROBIOL, V10, P1866, DOI 10.1111/j.1462-5822.2008.01177.x; Le Guellec D, 2004, INT J DEV BIOL, V48, P217, DOI 10.1387/ijdb.15272388; Park KJ, 2005, RESPIRATION, V72, P166, DOI 10.1159/000084048; Price NM, 2003, J IMMUNOL, V171, P5579, DOI 10.4049/jimmunol.171.10.5579; Price NM, 2001, J IMMUNOL, V166, P4223, DOI 10.4049/jimmunol.166.6.4223; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Sheen P, 2009, EUR RESPIR J, V33, P134, DOI 10.1183/09031936.00127807; Sherman DR, 2004, J INFECT DIS, V190, P123, DOI 10.1086/421472; Shi SAP, 2003, J EXP MED, V198, P987, DOI 10.1084/jem.20030603; Simeone R, 2009, CURR OPIN MICROBIOL, V12, P4, DOI 10.1016/j.mib.2008.11.003; Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072; Stanley SA, 2003, P NATL ACAD SCI USA, V100, P13001, DOI 10.1073/pnas.2235593100; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906; Van den Steen PE, 2002, CRIT REV BIOCHEM MOL, V37, P375, DOI 10.1080/10409230290771546; Volkman HE, 2004, PLOS BIOL, V2, P1946, DOI 10.1371/journal.pbio.0020367; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509; Zhu XW, 2007, J INFECT DIS, V196, P1076, DOI 10.1086/521030	30	338	349	4	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					466	469		10.1126/science.1179663	http://dx.doi.org/10.1126/science.1179663			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20007864	Green Accepted, Green Submitted			2022-12-28	WOS:000273783100038
J	Raines, KS; Salha, S; Sandberg, RL; Jiang, HD; Rodriguez, JA; Fahimian, BP; Kapteyn, HC; Du, JC; Miao, JW				Raines, Kevin S.; Salha, Sara; Sandberg, Richard L.; Jiang, Huaidong; Rodriguez, Jose A.; Fahimian, Benjamin P.; Kapteyn, Henry C.; Du, Jincheng; Miao, Jianwei			Three-dimensional structure determination from a single view	NATURE			English	Article							X-RAY-DIFFRACTION; RESOLUTION; MICROSCOPY	The ability to determine the structure of matter in three dimensions has profoundly advanced our understanding of nature. Traditionally, the most widely used schemes for three-dimensional (3D) structure determination of an object are implemented by acquiring multiple measurements over various sample orientations, as in the case of crystallography and tomography(1,2), or by scanning a series of thin sections through the sample, as in confocal microscopy(3). Here we present a 3D imaging modality, termed ankylography (derived from the Greek words ankylos meaning 'curved' and graphein meaning 'writing'), which under certain circumstances enables complete 3D structure determination from a single exposure using a monochromatic incident beam. We demonstrate that when the diffraction pattern of a finite object is sampled at a sufficiently fine scale on the Ewald sphere, the 3D structure of the object is in principle determined by the 2D spherical pattern. We confirm the theoretical analysis by performing 3D numerical reconstructions of a sodium silicate glass structure at 2 angstrom resolution, and a single poliovirus at 2-3nm resolution, from 2D spherical diffraction patterns alone. Using diffraction data from a soft X-ray laser, we also provide a preliminary demonstration that ankylography is experimentally feasible by obtaining a 3D image of a test object from a single 2D diffraction pattern. With further development, this approach of obtaining complete 3D structure information from a single view could find broad applications in the physical and life sciences.	[Raines, Kevin S.; Salha, Sara; Jiang, Huaidong; Fahimian, Benjamin P.; Miao, Jianwei] Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA; [Raines, Kevin S.; Salha, Sara; Jiang, Huaidong; Fahimian, Benjamin P.; Miao, Jianwei] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Rodriguez, Jose A.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA; [Sandberg, Richard L.; Kapteyn, Henry C.] Univ Colorado, Dept Phys, Boulder, CO 80309 USA; [Sandberg, Richard L.; Kapteyn, Henry C.] Univ Colorado, JILA, Boulder, CO 80309 USA; [Du, Jincheng] Univ N Texas, Dept Mat Sci & Engn, Denton, TX 76203 USA; [Du, Jincheng] Univ N Texas, Ctr Adv Sci Comp & Modeling, Denton, TX 76203 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Miao, JW (corresponding author), Univ Calif Los Angeles, Dept Phys & Astron, Los Angeles, CA 90095 USA.	miao@physics.ucla.edu	Du, Jincheng/A-8052-2011; Sandberg, Richard/F-8790-2011; Wang, Ge/AAH-8592-2020; Kapteyn, Henry C/H-6559-2011	Wang, Ge/0000-0002-2656-7705; Kapteyn, Henry C/0000-0001-8386-6317; Sandberg, Richard/0000-0001-9719-8188	US DOE, Office of Basic Energy Sciences; US NSF, Division of Materials Research and Engineering Research Center; UCLA MBI Whitcome; NSF Center in EUV Science and Technology	US DOE, Office of Basic Energy Sciences(United States Department of Energy (DOE)); US NSF, Division of Materials Research and Engineering Research Center(National Science Foundation (NSF)); UCLA MBI Whitcome; NSF Center in EUV Science and Technology	We thank P. Thibault for commenting on our manuscript, P. Thibault, M. M. Murnane, C.-C. Chen and R. Fung for discussions, C. Song for performing data analysis, Y. Mao for implementing an interpolation code, A. E. Sakdinawat for fabricating a test sample, P. Wachulak, M. Marconi, C. Menoni, J. J. Rocca and M. M. Murnane for help with data acquisition and T. Singh for parallelization of our phase retrieval codes. This work was supported by the US DOE, Office of Basic Energy Sciences, and the US NSF, Division of Materials Research and Engineering Research Center, an HHMI Gilliam fellowship for advanced studies and the UCLA MBI Whitcome fellowship. We used facilities supported by the NSF Center in EUV Science and Technology.	Abbey B, 2008, NAT PHYS, V4, P394, DOI 10.1038/nphys896; Barty A, 2008, NAT PHOTONICS, V2, P415, DOI 10.1038/nphoton.2008.128; Bubeck D, 2005, J VIROL, V79, P7745, DOI 10.1128/JVI.79.12.7745-7755.2005; Chapman HN, 2006, NAT PHYS, V2, P839, DOI 10.1038/nphys461; Chapman HN, 2006, J OPT SOC AM A, V23, P1179, DOI 10.1364/JOSAA.23.001179; Giacovazzo C., 2002, FUNDAMENTALS CRYSTAL; Jiang HD, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.038103; Kak A. C., 2001, PRINCIPLES COMPUTERI; Mancuso AP, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.035502; Miao J, 1998, J OPT SOC AM A, V15, P1662, DOI 10.1364/JOSAA.15.001662; Miao J., 2009, RESPONSE FEASIBILITY; Miao JW, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.215503; Miao JW, 1999, NATURE, V400, P342, DOI 10.1038/22498; Miao JW, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.088303; Miao JW, 2003, P NATL ACAD SCI USA, V100, P110, DOI 10.1073/pnas.232691299; Neutze R, 2000, NATURE, V406, P752, DOI 10.1038/35021099; Nishino Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.018101; Nugent KA, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.203902; Pawley J.B., 2006, HDB BIOL CONFOCAL MI, DOI [10.1007/978-0-387-45524-2_23, 10.1007/978-0-387-45524-2, DOI 10.1007/978-0-387-45524-2]; Pfeifer MA, 2006, NATURE, V442, P63, DOI 10.1038/nature04867; Robinson IK, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.195505; Sandberg RL, 2008, P NATL ACAD SCI USA, V105, P24, DOI 10.1073/pnas.0710761105; Sandberg RL, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.098103; Sayre D., 1980, LECT NOTE PHYS, V112, P229; Shapiro D, 2005, P NATL ACAD SCI USA, V102, P15343, DOI 10.1073/pnas.0503305102; Song CY, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.158101; Spence JCH, 2002, PHILOS T R SOC A, V360, P875, DOI 10.1098/rsta.2001.0972; Thibault P., 2009, FEASIBILITY 3D RECON; Thibault P, 2008, SCIENCE, V321, P379, DOI 10.1126/science.1158573; Williams GJ, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.025506; Zuo JM, 2003, SCIENCE, V300, P1419, DOI 10.1126/science.1083887	31	116	123	5	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					214	217		10.1038/nature08705	http://dx.doi.org/10.1038/nature08705			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20016484	Green Submitted			2022-12-28	WOS:000273582700032
J	Kaptoge, S; Di Angelantonio, E; Lowe, G; Pepys, MB; Thompson, SG; Collins, R; Danesh, J; Tipping, RW; Ford, CE; Pressel, SL; Walldius, G; Jungner, I; Folsom, AR; Chambless, L; Ballantyne, CM; Panagiotakos, D; Pitsavos, C; Chrysohoou, C; Stefanadis, C; Knuiman, MW; Goldbourt, U; Benderly, M; Tanne, D; Whincup, P; Wannamethee, SG; Morris, RW; Kiechl, S; Willeit, J; Mayr, A; Schett, G; Wald, N; Ebrahim, S; Lawlor, D; Yarnell, J; Gallacher, J; Casiglia, E; Tikhonoff, V; Nietert, PJ; Sutherland, SE; Bachman, DL; Keil, JE; Cushman, M; Psaty, BM; Tracy, R; Tybjaerg-Hansen, A; Nordestgaard, BG; Zacho, J; Frikke-Schmidt, R; Giampaoli, S; Palmieri, L; Panico, S; Vanuzzo, D; Pilotto, L; de la Camara, AG; Gerique, JAG; Simons, L; McCallum, J; Friedlander, Y; Fowkes, FGR; Lee, A; Taylor, J; Guralnik, JM; Phillips, CL; Wallace, RB; Blazer, DG; Khaw, KT; Brenner, H; Raum, E; Muller, H; Rothenbacher, D; Jansson, JH; Wennberg, P; Nissinen, A; Donfrancesco, C; Salomaa, V; Harald, K; Jousilahti, P; Vartiainen, E; Woodward, M; D'Agostino, RB; Wolf, PA; Vasan, RS; Benjamin, EJ; Bladbjerg, EM; Jorgensen, T; Moller, L; Jespersen, J; Dankner, R; Chetrit, A; Lubin, F; Rosengren, A; Wilhelmsen, L; Lappas, G; Eriksson, H; Bjorkelund, C; Lissner, L; Bengtsson, C; Cremer, P; Nagel, D; Tilvis, RS; Strandberg, TE; Kiyohara, Y; Arima, H; Doi, Y; Ninomiya, T; Rodriguez, B; Dekker, J; Nijpels, G; Stehouwer, CDA; Rimm, E; Pai, JK; Sato, S; Iso, H; Kitamura, A; Noda, H; Salonen, JT; Nyyssonen, K; Tuomainen, TP; Laukkanen, JA; Deeg, DJH; Bremmer, MA; Meade, TW; Cooper, JA; Hedblad, B; Berglund, G; Engstrom, G; Verschuren, WMM; Blokstra, A; Shea, S; Doring, A; Koenig, W; Meisinger, C; Bueno-De-Mesquita, HB; Kuller, LH; Grandits, G; Selmer, R; Tverdal, A; Nystad, W; Gillum, RF; Mussolino, M; Hankinson, S; Manson, JE; Knottenbelt, C; Bauer, KA; Davidson, K; Kirkland, S; Shaffer, J; Korin, MR; Naito, Y; Holme, I; Nakagawa, H; Miura, K; Ducimetiere, P; Jouven, X; Luc, G; Crespo, J; Garcia-Palmieri, MR; Amouyel, P; Arveiler, D; Evans, A; Ferrieres, J; Schulte, H; Assmann, G; Packard, CJ; Sattar, N; Westendorp, RG; Buckley, BM; Cantin, B; Lamarche, B; Despres, JP; Dagenais, GR; Barrett-Connor, E; Wingard, DL; Bettencourt, RR; Gudnason, V; Aspelund, T; Sigurdsson, G; Thorsson, B; Trevisan, M; Witteman, J; Kardys, I; Breteler, MMB; Hofman, A; Tunstall-Pedoe, H; Tavendale, R; Howard, BV; Zhang, Y; Bes, L; Umans, J; Ben-Shlomo, Y; Davey-Smith, G; Onat, A; Njostad, I; Mathiesen, EB; Lohen, ML; Wilsgaard, T; Ingelsson, E; Basu, S; Cederholm, T; Byberg, L; Gaziano, JM; Stampfer, M; Ridker, PM; Ulmer, H; Diem, G; Concin, H; Tosetto, A; Rodeghiero, F; Wassertheil-Smoller, S; Marmot, M; Clarke, R; Fletcher, A; Brunner, E; Shipley, M; Buring, J; Shepherd, J; Cobbe, S; Ford, I; Robertson, M; He, Y; Ibanez, AM; Feskens, EJM; Walker, M; Watson, S; Erqou, S; Kaptoge, S; Lewington, S; Pennells, L; Perry, PL; Ray, KK; Sarwar, N; Alexander, M; Thompson, A; White, IR; Wood, AM				Kaptoge, Stephen; Di Angelantonio, Emanuele; Lowe, Gordon; Pepys, Mark B.; Thompson, Simon G.; Collins, Rory; Danesh, John; Tipping, R. W.; Ford, C. E.; Pressel, S. L.; Walldius, G.; Jungner, I.; Folsom, A. R.; Chambless, L.; Ballantyne, C. M.; Panagiotakos, D.; Pitsavos, C.; Chrysohoou, C.; Stefanadis, C.; Knuiman, M. W.; Goldbourt, U.; Benderly, M.; Tanne, D.; Whincup, P.; Wannamethee, S. G.; Morris, R. W.; Kiechl, S.; Willeit, J.; Mayr, A.; Schett, G.; Wald, N.; Ebrahim, S.; Lawlor, D.; Yarnell, J.; Gallacher, J.; Casiglia, E.; Tikhonoff, V.; Nietert, P. J.; Sutherland, S. E.; Bachman, D. L.; Keil, J. E.; Cushman, M.; Psaty, B. M.; Tracy, R.; Tybjaerg-Hansen, A.; Nordestgaard, B. G.; Zacho, J.; Frikke-Schmidt, R.; Giampaoli, S.; Palmieri, L.; Panico, S.; Vanuzzo, D.; Pilotto, L.; de la Camara, A. Gomez; Gerique, J. A. Gomez; Simons, L.; McCallum, J.; Friedlander, Y.; Fowkes, F. G. R.; Lee, A.; Taylor, J.; Guralnik, J. M.; Phillips, C. L.; Wallace, R. B.; Blazer, D. G.; Khaw, K-T; Brenner, H.; Raum, E.; Mueller, H.; Rothenbacher, D.; Jansson, J-H; Wennberg, P.; Nissinen, A.; Donfrancesco, C.; Salomaa, V.; Harald, K.; Jousilahti, P.; Vartiainen, E.; Woodward, M.; D'Agostino, R. B.; Wolf, P. A.; Vasan, R. S.; Benjamin, E. J.; Bladbjerg, E-M; Jorgensen, T.; Moller, L.; Jespersen, J.; Dankner, R.; Chetrit, A.; Lubin, F.; Rosengren, A.; Wilhelmsen, L.; Lappas, G.; Eriksson, H.; Bjorkelund, C.; Lissner, L.; Bengtsson, C.; Cremer, P.; Nagel, D.; Tilvis, R. S.; Strandberg, T. E.; Kiyohara, Y.; Arima, H.; Doi, Y.; Ninomiya, T.; Rodriguez, B.; Dekker, J.; Nijpels, G.; Stehouwer, C. D. A.; Rimm, E.; Pai, J. K.; Sato, S.; Iso, H.; Kitamura, A.; Noda, H.; Salonen, J. T.; Nyyssonen, K.; Tuomainen, T-P; Laukkanen, J. A.; Deeg, D. J. H.; Bremmer, M. A.; Meade, T. W.; Cooper, J. A.; Hedblad, B.; Berglund, G.; Engstrom, G.; Verschuren, W. M. M.; Blokstra, A.; Shea, S.; Doring, A.; Koenig, W.; Meisinger, C.; Bueno-de-Mesquita, H. B.; Kuller, L. H.; Grandits, G.; Selmer, R.; Tverdal, A.; Nystad, W.; Gillum, R. F.; Mussolino, M.; Hankinson, S.; Manson, J. E.; Knottenbelt, C.; Bauer, K. A.; Davidson, K.; Kirkland, S.; Shaffer, J.; Korin, M. R.; Naito, Y.; Holme, I.; Nakagawa, H.; Miura, K.; Ducimetiere, P.; Jouven, X.; Luc, G.; Crespo, J.; Garcia-Palmieri, M. R.; Amouyel, P.; Arveiler, D.; Evans, A.; Ferrieres, J.; Schulte, H.; Assmann, G.; Packard, C. J.; Sattar, N.; Westendorp, R. G.; Buckley, B. M.; Cantin, B.; Lamarche, B.; Despres, J-P; Dagenais, G. R.; Barrett-Connor, E.; Wingard, D. L.; Bettencourt, R. R.; Gudnason, V.; Aspelund, T.; Sigurdsson, G.; Thorsson, B.; Trevisan, M.; Witteman, J.; Kardys, I.; Breteler, M. M. B.; Hofman, A.; Tunstall-Pedoe, H.; Tavendale, R.; Howard, B. V.; Zhang, Y.; Bes, L.; Umans, J.; Ben-Shlomo, Y.; Davey-Smith, G.; Onat, A.; Njostad, I.; Mathiesen, E. B.; Lohen, M-L; Wilsgaard, T.; Ingelsson, E.; Basu, S.; Cederholm, T.; Byberg, L.; Gaziano, J. M.; Stampfer, M.; Ridker, P. M.; Ulmer, H.; Diem, G.; Concin, H.; Tosetto, A.; Rodeghiero, F.; Wassertheil-Smoller, S.; Marmot, M.; Clarke, R.; Fletcher, A.; Brunner, E.; Shipley, M.; Buring, J.; Shepherd, J.; Cobbe, S.; Ford, I.; Robertson, M.; He, Y.; Ibanez, A. Marin; Feskens, E. J. M.; Walker, M.; Watson, S.; Erqou, S.; Kaptoge, S.; Lewington, S.; Pennells, L.; Perry, P. L.; Ray, K. K.; Sarwar, N.; Alexander, M.; Thompson, A.; White, I. R.; Wood, A. M.			C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis	LANCET			English	Article							LOW-DENSITY-LIPOPROTEIN; CARDIOVASCULAR-DISEASE; REGRESSION DILUTION; PLASMA-FIBRINOGEN; NONVASCULAR MORTALITY; INDEPENDENT PREDICTOR; INFLAMMATION; ASSOCIATIONS; MARKERS; WOMEN	Background Associations of C-reactive protein (CRP) concentration with risk of major diseases can best be assessed by long-term prospective follow-up of large numbers of people. We assessed the associations of CRP concentration with risk of vascular and non-vascular outcomes under different circumstances. Methods We meta-analysed individual records of 160 309 people without a history of vascular disease (ie, 1.31 million person-years at risk, 27769 fatal or non-fatal disease outcomes) from 54 long-term prospective studies. Within-study regression analyses were adjusted for within-person variation in risk factor levels. Results Log(c) CRP concentration was linearly associated with several conventional risk factors and inflammatory markers, and nearly log-linearly with the risk of ischaemic vascular disease and non-vascular mortality. Risk ratios (RRs) for coronary heart disease per 1-SD higher log, CRP concentration (three-fold higher) were 1.63 (95% CI 1.51-1.76) when initially adjusted for age and sex only, and 1.37 (1.27-1.48) when adjusted further for conventional risk factors; 1.44 (1.32-1.57) and 1.27 (1.15-1.40) for ischaemic stroke; 1.71 (1.53-1.91) and 1.55 (1.37-1.76) for vascular mortality; and 1.55 (1.41-1.69) and 1.54 (1.40-1.68) for non-vascular mortality RRs were largely unchanged after exclusion of smokers or initial follow-up. After further adjustment for fibrinogen, the corresponding RRs were 1.23 (1.07-1.42) for coronary heart disease; 1.32 (1.18-1.49) for ischaemic stroke; 1.34 (1.18-1.52) for vascular mortality; and 1.34 (1.20-1.50) for non-vascular mortality. Interpretation CRP concentration has continuous associations with the risk of coronary heart disease, ischaemic stroke, vascular mortality, and death from several cancers and lung disease that are each of broadly similar size. The relevance of CRP to such a range of disorders is unclear. Associations with ischaemic vascular disease depend considerably on conventional risk factors and other markers of inflammation. Funding British Heart Foundation, UK Medical Research Council, BUPA Foundation, and GlaxoSmithKline.	[Kaptoge, Stephen] Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Emerging Risk Factors Collaborat Coordinating Ctr, Cambridge CB1 4RN, England; [Lowe, Gordon] Univ Glasgow, Glasgow G12 8QQ, Lanark, Scotland; [Pepys, Mark B.] UCL, Sch Med, London WC1E 6BT, England; [Thompson, Simon G.] MRC, Biostat Unit, London W1N 4AL, England; [Collins, Rory] Univ Oxford, Oxford OX1 2JD, England	University of Cambridge; University of Glasgow; University of London; University College London; UCL Medical School; MRC Biostatistics Unit; University of Oxford	Kaptoge, S (corresponding author), Univ Cambridge, Strangeways Res Lab, Dept Publ Hlth & Primary Care, Emerging Risk Factors Collaborat Coordinating Ctr, Cambridge CB1 4RN, England.	erfc@phpc.cam.ac.uk	DiAngelantonio, Emanuele/ABE-6852-2020; Laukkanen, Jari A/I-4528-2017; Ulmer, Hanno/S-6615-2019; Tikhonoff, Valerie/AAC-3728-2019; Panagiotakos, Demosthenes/M-9167-2019; vhmpp, aks/F-9756-2012; PALMIERI, LUIGI/O-1845-2017; Aspelund, Thor/K-7022-2019; Thompson, Alexander/A-6109-2010; Ray, Kausik/Z-2055-2019; Collins, Rory/ABA-8487-2020; Jørgensen, Torben/Z-1335-2018; Tosetto, Alberto/AAM-3200-2020; Panagiotakos, Demosthenes/K-8294-2019; Laukkanen, Jari Antero/N-2196-2019; Woodward, Mark/L-6817-2017; White, Ian/AAE-1759-2021; Brenner, Hermann/B-4627-2017; Stehouwer, Coen/AAB-3435-2021; Wood, Angela/GZA-5762-2022; Panagiotakos, Demosthenes/C-9776-2013; Stefanadis, Christodoulos/ABH-2232-2020; Khaw, Kay-Tee/AAZ-3209-2021; Ramachandran, Vasan/Y-2527-2019; Marmot, M G/Y-3920-2019; Lennon, Lucy/ABB-9433-2020; Breteler, Monique M.B./J-5058-2014; Ford, Ian/ABE-6145-2020; Feskens, Edith/ABI-1446-2020; Brenner, Hermann/ABE-6383-2020; Brunner, Eric/H-2114-2011; Gudnason, Vilmundur/AAE-7126-2019; Gudnason, Vilmundur/K-6885-2015; Wald, Nicholas/AAY-8924-2021; Tanne, David/F-2560-2010; Wald, Nicholas/AAY-2814-2021; Meisinger, Christine/B-5358-2014; Tosetto, Alberto/AAB-9320-2022; Nordestgaard, Borge Gronne/ABF-1310-2020; Ballantyne, Christie/A-6599-2008; Davidson, Karina/GWC-0996-2022; Davidson, Karina/AAG-2388-2019; Benjamin, Emelia/E-7103-2011; Davey Smith, George/A-7407-2013; Lamarche, Benoit/ABA-4785-2021; Dankner, Rachel/Q-5245-2019; donfrancesco, chiara/K-1460-2016; Ferrieres, Jean/S-7993-2016	Laukkanen, Jari A/0000-0002-3738-1586; Ulmer, Hanno/0000-0001-5911-1002; Tikhonoff, Valerie/0000-0001-7846-0101; Panagiotakos, Demosthenes/0000-0001-8583-153X; PALMIERI, LUIGI/0000-0002-4298-2642; Aspelund, Thor/0000-0002-7998-5433; Tosetto, Alberto/0000-0002-0119-5204; Laukkanen, Jari Antero/0000-0002-3738-1586; Brenner, Hermann/0000-0002-6129-1572; Wood, Angela/0000-0002-7937-304X; Panagiotakos, Demosthenes/0000-0001-8583-153X; Stefanadis, Christodoulos/0000-0001-5974-6454; Ramachandran, Vasan/0000-0001-7357-5970; Marmot, M G/0000-0002-2431-6419; Lennon, Lucy/0000-0002-1738-1351; Breteler, Monique M.B./0000-0002-0626-9305; Feskens, Edith/0000-0001-5819-2488; Brenner, Hermann/0000-0002-6129-1572; Brunner, Eric/0000-0002-0595-4474; Gudnason, Vilmundur/0000-0001-5696-0084; Gudnason, Vilmundur/0000-0001-5696-0084; Tanne, David/0000-0002-6699-2220; Davidson, Karina/0000-0002-9162-477X; Davidson, Karina/0000-0002-9162-477X; Benjamin, Emelia/0000-0003-4076-2336; Davey Smith, George/0000-0002-1407-8314; Lamarche, Benoit/0000-0002-4443-5378; Dankner, Rachel/0000-0001-6454-6000; Nietert, Paul/0000-0002-3933-4986; Basu, Saonli/0000-0003-1200-4546; He, Yao/0000-0001-6205-7895; Lochen, Maja-Lisa/0000-0002-8532-6573; Woodward, Mark/0000-0001-9800-5296; Frikke-Schmidt, Ruth/0000-0003-4084-5027; Pennells, Lisa Anne/0000-0002-8594-3061; Korin, Maya/0000-0002-8010-7769; Stehouwer, Coen/0000-0001-8752-3223; Engstrom, Gunnar/0000-0002-8618-9152; donfrancesco, chiara/0000-0002-8040-5571; Rothenbacher, Dietrich/0000-0002-3563-2791; Bremmer, Marijke/0000-0002-0415-1127; Venkatasubramanian, Siddharth/0000-0002-5860-0768; Tverdal, Aage/0000-0002-2909-5678; Kirkland, Susan/0000-0002-8182-2369; Jespersen, Jorgen/0000-0002-3059-2356; Lawlor, Debbie A/0000-0002-6793-2262; Amouyel, Philippe/0000-0001-9088-234X; s, hema/0000-0002-3440-9475; Jorgensen, Torben/0000-0001-9453-2830; Whincup, Peter/0000-0002-5589-4107; Ferrieres, Jean/0000-0001-6144-1297; Ballantyne, Christie/0000-0002-6432-1730; Di Angelantonio, Emanuele/0000-0001-8776-6719; Nordestgaard, Borge/0000-0002-1954-7220; Lewington, Sarah/0000-0002-4496-4771; Bladbjerg, Else Marie/0000-0003-0912-2437; Morris, Richard/0000-0001-7240-4563; Koenig, Wolfgang/0000-0002-2064-9603	British Heart Foundation; UK Medical Research Council; BUPA Foundation; BUPA Foundation, and an unrestricted educational grant from GlaxoSmithKline; ESRC [ES/G007438/1] Funding Source: UKRI; MRC [G7900510, MC_U137686857, G0600705, MC_U105260792] Funding Source: UKRI; British Heart Foundation [PG/09/002/26056, RG/08/013/25942, RG/08/014/24067] Funding Source: researchfish; Economic and Social Research Council [ES/G007438/1] Funding Source: researchfish; Medical Research Council [G0600705, MC_U105260792, MC_U137686857, G0401527, G7900510] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR029882] Funding Source: NIH RePORTER	British Heart Foundation(British Heart Foundation); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); BUPA Foundation; BUPA Foundation, and an unrestricted educational grant from GlaxoSmithKline; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The ERFC Coordinating Centre is underpinned by a programme grant from the British Heart Foundation and supported by specific grants from the UK Medical Research Council and the BUPA Foundation, and an unrestricted educational grant from GlaxoSmithKline. A variety of sources have supported recruitment, follow-up, and laboratory measurements in the 116 cohorts contributing to the ERFC. Investigators of several of those studies have contributed to a list of some of these funding sources. We thank Juan-Pablo Casas, Aroon Hingorani, and Liam Smeeth for helpful comments. The writing committee accepts full responsibility for the content of this report.	Andersson J, 2009, CEREBROVASC DIS, V27, P544, DOI 10.1159/000214217; Andresdottir MB, 2003, AM J EPIDEMIOL, V158, P844, DOI 10.1093/aje/kwg222; [Anonymous], 2007, EUR J EPIDEMIOL, V22, P839, DOI 10.1007/s10654-007-9165-7; Bos MJ, 2006, CIRCULATION, V114, P1591, DOI 10.1161/CIRCULATIONAHA.106.619833; Casas JP, 2008, J INTERN MED, V264, P295, DOI 10.1111/j.1365-2796.2008.02015.x; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Clarke R, 1999, AM J EPIDEMIOL, V150, P341; Clarke R, 2008, EUR HEART J, V29, P800, DOI 10.1093/eurheartj/ehn049; Danesh J, 2005, JAMA-J AM MED ASSOC, V294, P1799, DOI 10.1001/jama.294.14.1799; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Danesh J, 2008, PLOS MED, V5, P600, DOI 10.1371/journal.pmed.0050078; Danesh J, 2007, EUR J EPIDEMIOL, V22, P129, DOI 10.1007/s10654-006-9096-8; DEBEER FC, 1982, J EXP MED, V156, P230, DOI 10.1084/jem.156.1.230; Di Angelantonio E, 2009, JAMA-J AM MED ASSOC, V302, P1993, DOI 10.1001/jama.2009.1619; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Emberson JR, 2004, EUR J CARDIOV PREV R, V11, P125, DOI 10.1097/01.hjr.0000114967.39211.e5; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Heikkila K, 2009, CANCER CAUSE CONTROL, V20, P15, DOI 10.1007/s10552-008-9212-z; Kaplan F, 2008, INFANT CHILD DEV, V17, P55, DOI 10.1002/icd.544; Kaptoge S, 2007, AM J EPIDEMIOL, V166, P867, DOI 10.1093/aje/kwm191; Kelley-Hedgepeth A, 2008, CLIN CHEM, V54, P1027, DOI 10.1373/clinchem.2007.098996; Kinlay S, 2007, J AM COLL CARDIOL, V49, P2003, DOI 10.1016/j.jacc.2007.01.083; Kuller LH, 1996, AM J EPIDEMIOL, V144, P537, DOI 10.1093/oxfordjournals.aje.a008963; Kundu JK, 2008, MUTAT RES-REV MUTAT, V659, P15, DOI 10.1016/j.mrrev.2008.03.002; Lange LA, 2006, JAMA-J AM MED ASSOC, V296, P2703, DOI 10.1001/jama.296.22.2703; Lawlor DA, 2005, THROMB HAEMOSTASIS, V93, P955, DOI 10.1160/TH04-12-0805; Packard CJ, 2009, CURR OPIN CARDIOL, V24, P358, DOI 10.1097/HCO.0b013e32832bcb22; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Pennells L, 2009, STAT MED, V28, P389; PEPYS MB, 1985, INT REV EXP PATHOL, V27, P83; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Ridker PM, 1997, NEW ENGL J MED, V336, P973, DOI 10.1056/NEJM199704033361401; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Scirica BM, 2006, CIRCULATION, V113, P2128, DOI 10.1161/CIRCULATIONAHA.105.611350; Shah T, 2009, INT J EPIDEMIOL, V38, P217, DOI 10.1093/ije/dyn217; Timpson NJ, 2005, LANCET, V366, P1954, DOI 10.1016/S0140-6736(05)67786-0; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Verma S, 2006, CIRCULATION, V113, P2135; Wood AM, 2009, STAT MED, V28, P1067, DOI 10.1002/sim.3530; Wood A, 2006, INT J EPIDEMIOL, V35, P1570, DOI 10.1093/ije/dyl233; Yudkin JS, 1999, ARTERIOSCL THROM VAS, V19, P972, DOI 10.1161/01.ATV.19.4.972; Zacho J, 2008, NEW ENGL J MED, V359, P1897, DOI 10.1056/NEJMoa0707402; Zhang YX, 1999, ATHEROSCLEROSIS, V145, P375, DOI 10.1016/S0021-9150(99)00105-7	50	1603	1654	2	199	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2010	375	9709					132	140		10.1016/S0140-6736(09)61717-7	http://dx.doi.org/10.1016/S0140-6736(09)61717-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544NM	20031199	Green Published, Bronze, Green Accepted			2022-12-28	WOS:000273664500030
J	Horvath, P; Barrangou, R				Horvath, Philippe; Barrangou, Rodolphe			CRISPR/Cas, the Immune System of Bacteria and Archaea	SCIENCE			English	Review							PROVIDES ACQUIRED-RESISTANCE; STREPTOCOCCUS-THERMOPHILUS; RNA-INTERFERENCE; PROKARYOTES; REPEATS; DEFENSE; DNA; ELEMENTS; VIRUSES; EVOLUTIONARY	Microbes rely on diverse defense mechanisms that allow them to withstand viral predation and exposure to invading nucleic acid. In many Bacteria and most Archaea, clustered regularly interspaced short palindromic repeats (CRISPR) form peculiar genetic loci, which provide acquired immunity against viruses and plasmids by targeting nucleic acid in a sequence-specific manner. These hypervariable loci take up genetic material from invasive elements and build up inheritable DNA-encoded immunity over time. Conversely, viruses have devised mutational escape strategies that allow them to circumvent the CRISPR/Cas system, albeit at a cost. CRISPR features may be exploited for typing purposes, epidemiological studies, host-virus ecological surveys, building specific immunity against undesirable genetic elements, and enhancing viral resistance in domesticated microbes.	[Horvath, Philippe] Danisco France SAS, F-86220 Dange St Romain, France; [Barrangou, Rodolphe] Danisco USA Inc, Madison, WI 53716 USA		Horvath, P (corresponding author), Danisco France SAS, BP10, F-86220 Dange St Romain, France.	philippe.horvath@danisco.com; rodolphe.barrangou@danisco.com	Barrangou, Rodolphe/I-2878-2014; HORVATH, Philippe/K-5266-2015; Ha, Dat Thinh/D-4995-2015	Barrangou, Rodolphe/0000-0002-0648-3504; HORVATH, Philippe/0000-0003-2015-8123; Ha, Dat Thinh/0000-0003-4260-4876; Santamaria Cuesta, David Lorenzo/0000-0002-8381-2471	Danisco A/S	Danisco A/S	We thank our colleagues P. Boyaval, C. Fremaux, D. Romero, and E. Bech Hansen for their support and scientific contributions, and S. Moineau, V. Siksnys, and J. Banfield for their insights and expertise. This work was supported by Danisco A/S. P. H. and R. B. have submitted patent applications relating to various uses of CRISPR.	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beloglazova N, 2008, J BIOL CHEM, V283, P20361, DOI 10.1074/jbc.M803225200; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Carte J, 2008, GENE DEV, V22, P3489, DOI 10.1101/gad.1742908; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Godde JS, 2006, J MOL EVOL, V62, P718, DOI 10.1007/s00239-005-0223-z; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; Hale CR, 2009, CELL, V139, P945, DOI 10.1016/j.cell.2009.07.040; Heidelberg JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004169; Held NL, 2009, ENVIRON MICROBIOL, V11, P457, DOI 10.1111/j.1462-2920.2008.01784.x; Horvath P, 2008, J BACTERIOL, V190, P1401, DOI 10.1128/JB.01415-07; Horvath P, 2009, INT J FOOD MICROBIOL, V131, P62, DOI 10.1016/j.ijfoodmicro.2008.05.030; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kunin V, 2008, GENOME RES, V18, P293, DOI 10.1101/gr.6835308; Kunin V, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-4-r61; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2002, NUCLEIC ACIDS RES, V30, P482, DOI 10.1093/nar/30.2.482; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; Semenova E, 2009, FEMS MICROBIOL LETT, V296, P110, DOI 10.1111/j.1574-6968.2009.01626.x; Shah SA, 2009, BIOCHEM SOC T, V37, P23, DOI 10.1042/BST0370023; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Tyson GW, 2008, ENVIRON MICROBIOL, V10, P200, DOI 10.1111/j.1462-2920.2007.01444.x; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; van der Ploeg JR, 2009, MICROBIOL-SGM, V155, P1966, DOI 10.1099/mic.0.027508-0; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019	36	1441	1776	25	1198	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 8	2010	327	5962					167	170		10.1126/science.1179555	http://dx.doi.org/10.1126/science.1179555			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056882				2022-12-28	WOS:000273394000024
J	Barr, CD; Dominici, F				Barr, Christopher D.; Dominici, Francesca			Cap and Trade Legislation for Greenhouse Gas Emissions Public Health Benefits From Air Pollution Mitigation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLIMATE-CHANGE		[Barr, Christopher D.; Dominici, Francesca] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Barr, CD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, 655 Huntington Ave,Bldg 2,Room 435A, Boston, MA 02115 USA.	cdbarr@gmail.com			NIEHS NIH HHS [R01 ES012054-08, R01 ES012054, R01 ES012054-07] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012054] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Arneth A, 2009, SCIENCE, V326, P672, DOI 10.1126/science.1181568; Bell ML, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-41; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; BRODER JM, 2009, NY TIMES        0630; Cifuentes L, 2001, SCIENCE, V293, P1257, DOI 10.1126/science.1063357; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Paltsev S, 2008, CLIM POLICY, V8, P395, DOI 10.3763/cpol.2007.0437; Streets DG, 2006, ENVIRON SCI TECHNOL, V40, P2099, DOI 10.1021/es051275n; 2009 US GREENHOUSE G	9	2	2	0	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2010	303	1					69	70		10.1001/jama.2009.1955	http://dx.doi.org/10.1001/jama.2009.1955			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539YS	20051573	Green Accepted			2022-12-28	WOS:000273296900023
J	Gardino, AK; Villali, J; Kivenson, A; Lei, M; Liu, CF; Steindel, P; Eisenmesser, EZ; Labeikovsky, W; Wolf-Watz, M; Clarkson, MW; Kern, D				Gardino, Alexandra K.; Villali, Janice; Kivenson, Aleksandr; Lei, Ming; Liu, Ce Feng; Steindel, Phillip; Eisenmesser, Elan Z.; Labeikovsky, Wladimir; Wolf-Watz, Magnus; Clarkson, Michael W.; Kern, Dorothee			Transient Non-native Hydrogen Bonds Promote Activation of a Signaling Protein	CELL			English	Article							FREE-ENERGY LANDSCAPES; MOLECULAR-DYNAMICS; CONFORMATIONAL-CHANGES; LIGAND-BINDING; STRING METHOD; TRANSITION; DOMAIN; SWITCH; PERSPECTIVE; SIMULATION	Phosphorylation is a common mechanism for activating proteins within signaling pathways. Yet, the molecular transitions between the inactive and active conformational states are poorly understood. Here we quantitatively characterize the free-energy landscape of activation of a signaling protein, nitrogen regulatory protein C (NtrC), by connecting functional protein dynamics of phosphorylation-dependent activation to protein folding and show that only a rarely populated, pre-existing active conformation is energetically stabilized by phosphorylation. Using nuclear magnetic resonance (NMR) dynamics, we test an atomic scale pathway for the complex conformational transition, inferred from molecular dynamics simulations (Lei et al., 2009). The data show that the loss of native stabilizing contacts during activation is compensated by non-native transient atomic interactions during the transition. The results unravel atomistic details of native-state protein energy landscapes by expanding the knowledge about ground states to transition landscapes.	[Gardino, Alexandra K.; Villali, Janice; Kivenson, Aleksandr; Lei, Ming; Liu, Ce Feng; Steindel, Phillip; Eisenmesser, Elan Z.; Labeikovsky, Wladimir; Wolf-Watz, Magnus; Clarkson, Michael W.; Kern, Dorothee] Brandeis Univ, Dept Biochem, Waltham, MA 02452 USA; [Gardino, Alexandra K.; Villali, Janice; Kivenson, Aleksandr; Lei, Ming; Liu, Ce Feng; Steindel, Phillip; Eisenmesser, Elan Z.; Labeikovsky, Wladimir; Wolf-Watz, Magnus; Clarkson, Michael W.; Kern, Dorothee] Brandeis Univ, Howard Hughes Med Inst, Waltham, MA 02452 USA	Brandeis University; Brandeis University; Howard Hughes Medical Institute	Kern, D (corresponding author), Brandeis Univ, Dept Biochem, Waltham, MA 02452 USA.	dkern@brandeis.edu	Labeikovsky, Wladimir/K-1648-2019	Labeikovsky, Wladimir/0000-0001-6074-3269; Clarkson, Michael W/0000-0002-4323-3424	Howard Hughes Medical Institute; NIH [GM62117, GM67963]; DOE (Office of Basic Energy Sciences) [DE-FG02-05ER15699]; NSF; Keck foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR006009, S10RR019090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB009419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007596, R01GM067963, R01GM062117] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE (Office of Basic Energy Sciences)(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Keck foundation(W.M. Keck Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Martin Karplus for a fruitful collaboration and helpful discussions in the computational studies that led to the predicted pathway, Dr. Chunyu Wang at Columbia University for providing us with a pulse sequence to measure R<INF>ex</INF> in large proteins and for helpful discussions, Dr. Lewis E. Kay at the University of Toronto for the R<INF>1</INF><SUP>HzNz</SUP> pulse sequence, and Dr. Jack Skalicky at the NHMFL at Florida with support from NSF for NMR time. This work was supported by the Howard Hughes Medical Institute, NIH grants to D. K. (GM62117 and GM67963), a DOE grant (Office of Basic Energy Sciences) to D. K (DE-FG02-05ER15699), and instrumentation grants by the NSF and the Keck foundation to D. K.	ANTHONY MAW, 2007, J CHEM PHYS, V126; AUSTIN RH, 1975, BIOCHEMISTRY-US, V14, P5355, DOI 10.1021/bi00695a021; Banavali NK, 2005, STRUCTURE, V13, P1715, DOI 10.1016/j.str.2005.09.005; Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258; Boehr DD, 2006, CHEM REV, V106, P3055, DOI 10.1021/cr050312q; Bolhuis PG, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2976011; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Buck M, 2001, SCIENCE, V291, P2329, DOI 10.1126/science.1060383; Christen M, 2008, J COMPUT CHEM, V29, P157, DOI 10.1002/jcc.20725; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dellago C, 2007, TOP CURR CHEM, V268, P291, DOI 10.1007/128_085; Dill KA, 1997, NAT STRUCT BIOL, V4, P10, DOI 10.1038/nsb0197-10; Dobson CM, 1998, ANGEW CHEM INT EDIT, V37, P868, DOI 10.1002/(SICI)1521-3773(19980420)37:7<868::AID-ANIE868>3.0.CO;2-H; Elber R, 2005, CURR OPIN STRUC BIOL, V15, P151, DOI 10.1016/j.sbi.2005.02.004; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fersht A., 1999, STRUCTURE MECH PROTE, DOI 10.1142/10574; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gardino AK, 2007, METHOD ENZYMOL, V423, P149, DOI 10.1016/S0076-6879(07)23006-X; Hastings CA, 2003, BIOCHEMISTRY-US, V42, P9081, DOI 10.1021/bi0273866; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410; Hu XH, 2006, J BIOMOL STRUCT DYN, V23, P509, DOI 10.1080/07391102.2006.10507075; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Isralewitz B, 2001, CURR OPIN STRUC BIOL, V11, P224, DOI 10.1016/S0959-440X(00)00194-9; Karplus M, 2005, PHILOS T R SOC A, V363, P331, DOI 10.1098/rsta.2004.1496; Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273; Khalili M, 2008, J PHYS CHEM B, V112, P2456, DOI 10.1021/jp076628e; Kubelka J, 2004, CURR OPIN STRUC BIOL, V14, P76, DOI 10.1016/j.sbi.2004.01.013; Kumar S, 2000, PROTEIN SCI, V9, P10; Latzer J, 2008, BIOCHEMISTRY-US, V47, P2110, DOI 10.1021/bi701350v; Lau AY, 2007, STRUCTURE, V15, P1203, DOI 10.1016/j.str.2007.07.015; Lei M, 2009, J MOL BIOL, V392, P823, DOI 10.1016/j.jmb.2009.06.065; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Loria JP, 1999, J AM CHEM SOC, V121, P2331, DOI 10.1021/ja983961a; Ma JP, 1997, P NATL ACAD SCI USA, V94, P11905, DOI 10.1073/pnas.94.22.11905; Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Maragliano L, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2212942; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Mulder FAA, 2001, NAT STRUCT BIOL, V8, P932, DOI 10.1038/nsb1101-932; Neudecker P, 2007, P NATL ACAD SCI USA, V104, P15717, DOI 10.1073/pnas.0705097104; Palmer AG, 2001, METHOD ENZYMOL, V339, P204, DOI 10.1016/S0076-6879(01)39315-1; Pan AC, 2008, J PHYS CHEM B, V112, P3432, DOI 10.1021/jp0777059; Price DJ, 2004, J CHEM PHYS, V121, P10096, DOI 10.1063/1.1808117; Ravindranathan KP, 2005, J MOL BIOL, V353, P196, DOI 10.1016/j.jmb.2005.08.009; Rogal J, 2008, J CHEM PHYS, V129, DOI 10.1063/1.3029696; SCHLITTER J, 1994, J MOL GRAPHICS, V12, P84, DOI 10.1016/0263-7855(94)80072-3; SCHUTKOWSKI M, 1994, EUR J BIOCHEM, V221, P455, DOI 10.1111/j.1432-1033.1994.tb18758.x; Silversmith RE, 1999, TRENDS MICROBIOL, V7, P16, DOI 10.1016/S0966-842X(98)01409-7; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Stock AM, 2006, J BACTERIOL, V188, P7328, DOI 10.1128/JB.01268-06; Tollinger M, 2001, J AM CHEM SOC, V123, P11341, DOI 10.1021/ja011300z; Tsai CJ, 2009, MOL BIOSYST, V5, P207, DOI 10.1039/b819720b; van der Vaart A, 2006, THEOR CHEM ACC, V116, P183, DOI 10.1007/s00214-005-0004-1; Vanden-Eijnden E, 2009, J CHEM PHYS, V130, DOI 10.1063/1.3130083; Vendruscolo M, 2005, PHILOS T R SOC A, V363, P433, DOI 10.1098/rsta.2004.1501; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429; Weikl TR, 2007, J MOL BIOL, V365, P1578, DOI 10.1016/j.jmb.2006.10.082; Wolynes PG, 2005, Q REV BIOPHYS, V38, P405, DOI 10.1017/S0033583505004075; Yang S, 2009, P NATL ACAD SCI USA, V106, P3776, DOI 10.1073/pnas.0808261106	60	94	95	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1109	1118		10.1016/j.cell.2009.11.022	http://dx.doi.org/10.1016/j.cell.2009.11.022			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005804	Green Accepted, Bronze			2022-12-28	WOS:000272622800013
J	Jimenez, JL; Canagaratna, MR; Donahue, NM; Prevot, ASH; Zhang, Q; Kroll, JH; DeCarlo, PF; Allan, JD; Coe, H; Ng, NL; Aiken, AC; Docherty, KS; Ulbrich, IM; Grieshop, AP; Robinson, AL; Duplissy, J; Smith, JD; Wilson, KR; Lanz, VA; Hueglin, C; Sun, YL; Tian, J; Laaksonen, A; Raatikainen, T; Rautiainen, J; Vaattovaara, P; Ehn, M; Kulmala, M; Tomlinson, JM; Collins, DR; Cubison, MJ; Dunlea, EJ; Huffman, JA; Onasch, TB; Alfarra, MR; Williams, PI; Bower, K; Kondo, Y; Schneider, J; Drewnick, F; Borrmann, S; Weimer, S; Demerjian, K; Salcedo, D; Cottrell, L; Griffin, R; Takami, A; Miyoshi, T; Hatakeyama, S; Shimono, A; Sun, JY; Zhang, YM; Dzepina, K; Kimmel, JR; Sueper, D; Jayne, JT; Herndon, SC; Trimborn, AM; Williams, LR; Wood, EC; Middlebrook, AM; Kolb, CE; Baltensperger, U; Worsnop, DR				Jimenez, J. L.; Canagaratna, M. R.; Donahue, N. M.; Prevot, A. S. H.; Zhang, Q.; Kroll, J. H.; DeCarlo, P. F.; Allan, J. D.; Coe, H.; Ng, N. L.; Aiken, A. C.; Docherty, K. S.; Ulbrich, I. M.; Grieshop, A. P.; Robinson, A. L.; Duplissy, J.; Smith, J. D.; Wilson, K. R.; Lanz, V. A.; Hueglin, C.; Sun, Y. L.; Tian, J.; Laaksonen, A.; Raatikainen, T.; Rautiainen, J.; Vaattovaara, P.; Ehn, M.; Kulmala, M.; Tomlinson, J. M.; Collins, D. R.; Cubison, M. J.; Dunlea, E. J.; Huffman, J. A.; Onasch, T. B.; Alfarra, M. R.; Williams, P. I.; Bower, K.; Kondo, Y.; Schneider, J.; Drewnick, F.; Borrmann, S.; Weimer, S.; Demerjian, K.; Salcedo, D.; Cottrell, L.; Griffin, R.; Takami, A.; Miyoshi, T.; Hatakeyama, S.; Shimono, A.; Sun, J. Y.; Zhang, Y. M.; Dzepina, K.; Kimmel, J. R.; Sueper, D.; Jayne, J. T.; Herndon, S. C.; Trimborn, A. M.; Williams, L. R.; Wood, E. C.; Middlebrook, A. M.; Kolb, C. E.; Baltensperger, U.; Worsnop, D. R.			Evolution of Organic Aerosols in the Atmosphere	SCIENCE			English	Article							SECONDARY; MASS; PITTSBURGH; CHEMISTRY; EMISSIONS; OXIDATION; GROWTH; MODEL	Organic aerosol (OA) particles affect climate forcing and human health, but their sources and evolution remain poorly characterized. We present a unifying model framework describing the atmospheric evolution of OA that is constrained by high-time-resolution measurements of its composition, volatility, and oxidation state. OA and OA precursor gases evolve by becoming increasingly oxidized, less volatile, and more hygroscopic, leading to the formation of oxygenated organic aerosol (OOA), with concentrations comparable to those of sulfate aerosol throughout the Northern Hemisphere. Our model framework captures the dynamic aging behavior observed in both the atmosphere and laboratory: It can serve as a basis for improving parameterizations in regional and global models.	[Jimenez, J. L.; DeCarlo, P. F.; Aiken, A. C.; Docherty, K. S.; Ulbrich, I. M.; Cubison, M. J.; Dunlea, E. J.; Huffman, J. A.; Dzepina, K.; Kimmel, J. R.; Sueper, D.] Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA; [Jimenez, J. L.; DeCarlo, P. F.; Aiken, A. C.; Docherty, K. S.; Ulbrich, I. M.; Cubison, M. J.; Dunlea, E. J.; Huffman, J. A.; Dzepina, K.; Kimmel, J. R.; Sueper, D.] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Canagaratna, M. R.; Kroll, J. H.; Ng, N. L.; Onasch, T. B.; Kimmel, J. R.; Sueper, D.; Jayne, J. T.; Herndon, S. C.; Trimborn, A. M.; Williams, L. R.; Wood, E. C.; Kolb, C. E.; Worsnop, D. R.] Aerodyne Res Inc, Billerica, MA 01821 USA; [Donahue, N. M.; Grieshop, A. P.; Robinson, A. L.] Carnegie Mellon Univ, Ctr Atmospher Particle Studies, Pittsburgh, PA 15213 USA; [Prevot, A. S. H.; DeCarlo, P. F.; Duplissy, J.; Lanz, V. A.; Alfarra, M. R.; Weimer, S.; Baltensperger, U.] Paul Scherrer Inst, Lab Atmospher Chem, Villigen, Switzerland; [Zhang, Q.; Sun, Y. L.; Tian, J.; Drewnick, F.; Weimer, S.; Demerjian, K.] SUNY Albany, Atmospher Sci Res Ctr, Albany, NY 12222 USA; [Zhang, Q.; Sun, Y. L.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Kroll, J. H.] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA; [Allan, J. D.; Alfarra, M. R.; Williams, P. I.; Bower, K.] Univ Manchester, Natl Ctr Atmospher Sci, Manchester, Lancs, England; [Smith, J. D.; Wilson, K. R.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Chem Sci, Berkeley, CA 94720 USA; [Lanz, V. A.; Hueglin, C.] Empa, Lab Air Pollut Environm Technol, Dubendorf, Switzerland; [Laaksonen, A.; Raatikainen, T.; Rautiainen, J.; Vaattovaara, P.; Worsnop, D. R.] Univ Kuopio, Dept Phys, FIN-70211 Kuopio, Finland; [Laaksonen, A.; Raatikainen, T.; Worsnop, D. R.] Finnish Meteorol Inst, FIN-00101 Helsinki, Finland; [Ehn, M.; Kulmala, M.; Worsnop, D. R.] Univ Helsinki, Dept Phys, Helsinki, Finland; [Kulmala, M.] Stockholm Univ, Dept Appl Environm Sci, S-10691 Stockholm, Sweden; [Tomlinson, J. M.; Collins, D. R.] Texas A&M Univ, Dept Atmospher Sci, College Stn, TX USA; [Kondo, Y.] Univ Tokyo, Adv Sci & Technol Res Ctr, Tokyo, Japan; [DeCarlo, P. F.] Univ Colorado, Dept Atmospher & Ocean Sci, Boulder, CO 80309 USA; [Allan, J. D.; Coe, H.; Alfarra, M. R.; Williams, P. I.; Bower, K.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester, Lancs, England; [Schneider, J.; Drewnick, F.; Borrmann, S.] Max Planck Inst Chem, Dept Particle Chem, D-55128 Mainz, Germany; [Borrmann, S.] Johannes Gutenberg Univ Mainz, Inst Atmospher Phys, Mainz, Germany; [Weimer, S.] Empa, Lab Internal Combust Engines, Dubendorf, Switzerland; [Salcedo, D.] Univ Autonoma Estado Morelos, Ctr Invest Quim, Cuernavaca, Morelos, Mexico; [Cottrell, L.; Griffin, R.] Univ New Hampshire, Climate Change Res Ctr, Durham, NH 03824 USA; [Griffin, R.] Rice Univ, Dept Civil & Environm Engn, Houston, TX USA; [Takami, A.; Miyoshi, T.; Hatakeyama, S.] Natl Inst Environm Studies, Asian Environm Res Grp, Tsukuba, Ibaraki, Japan; [Shimono, A.] Sanyu Plant Serv, Sagamihara, Kanagawa, Japan; [Sun, J. Y.; Zhang, Y. M.] Chinese Acad Meteorol Sci, Key Lab Atmospher Chem, Beijing, Peoples R China; [Dzepina, K.] Natl Ctr Atmospher Res, Div Atmospher Chem, Boulder, CO 80307 USA; [Kimmel, J. R.] Tofwerk, Thun, Switzerland; [Middlebrook, A. M.] NOAA, Earth Sci Res Lab, Boulder, CO USA	University of Colorado System; University of Colorado Boulder; University of Colorado System; University of Colorado Boulder; Aerodyne Research; Carnegie Mellon University; Swiss Federal Institutes of Technology Domain; Paul Scherrer Institute; State University of New York (SUNY) System; State University of New York (SUNY) Albany; University of California System; University of California Davis; Massachusetts Institute of Technology (MIT); UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC National Centre for Atmospheric Science; University of Manchester; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); University of Eastern Finland; Finnish Meteorological Institute; University of Helsinki; Stockholm University; Texas A&M University System; Texas A&M University College Station; University of Tokyo; University of Colorado System; University of Colorado Boulder; University of Manchester; Max Planck Society; Johannes Gutenberg University of Mainz; Swiss Federal Institutes of Technology Domain; Swiss Federal Laboratories for Materials Science & Technology (EMPA); Universidad Autonoma del Estado de Morelos; University System Of New Hampshire; University of New Hampshire; Rice University; National Institute for Environmental Studies - Japan; Chinese Academy of Meteorological Sciences (CAMS); National Center Atmospheric Research (NCAR) - USA; TOFWERK AG; National Oceanic Atmospheric Admin (NOAA) - USA	Jimenez, JL (corresponding author), Univ Colorado, Cooperat Inst Res Environm Sci, Boulder, CO 80309 USA.	jose.jimenez@colorado.edu; andre.prevot@psi.ch	Ulbrich, Ingrid/AAX-9228-2020; Aiken, Allison C/B-9659-2009; Huffman, J. Alex/A-7449-2010; Sun, Yele/F-1314-2010; Dzepina, Katja/A-1372-2014; Duplissy, Jonathan/A-1723-2010; Tomlinson, Jason M/C-6566-2009; Allan, James/B-1160-2010; Laaksonen, Ari/B-5094-2011; Williams, Paul I/C-2663-2013; Collins, Don R/F-9617-2012; Kolb, Charles E./A-8596-2009; Zhang, Qi/F-9653-2010; Robinson, Allen/I-5713-2012; Kondo, Yutaka/D-1459-2012; Raatikainen, Tomi/C-5410-2014; Onasch, Tim/AAY-4998-2020; Ehn, Mikael/N-2571-2016; Grieshop, Andrew P/C-9678-2012; Prevot, Andre S. H./C-6677-2008; Worsnop, Douglas R/D-2817-2009; Hatakeyama, Shiro/D-2001-2010; Donahue, Neil M/A-2329-2008; Drewnick, Frank/D-3978-2018; DeCarlo, Peter/B-2118-2008; Sun, Junying/AAU-6239-2020; Alfarra, M. Rami/K-2156-2012; Schneider, Johannes/A-2674-2010; Robinson, Allen L/M-3046-2014; DeCarlo, Peter F/AAA-8561-2019; Jimenez, Jose L/A-5294-2008; Salcedo, Dara/Z-5288-2019; Borrmann, Stephan/E-3868-2010; Kulmala, Markku T/I-7671-2016; Salcedo, Dara/B-7338-2008; Middlebrook, Ann M/E-4831-2011; Coe, Hugh/C-8733-2013; Grieshop, Andrew/AAL-1174-2020	Aiken, Allison C/0000-0001-5749-7626; Huffman, J. Alex/0000-0002-5363-9516; Sun, Yele/0000-0003-2354-0221; Dzepina, Katja/0000-0001-5312-0290; Duplissy, Jonathan/0000-0001-8819-0264; Tomlinson, Jason M/0000-0002-0734-3298; Allan, James/0000-0001-6492-4876; Laaksonen, Ari/0000-0002-1657-2383; Williams, Paul I/0000-0002-8973-4718; Collins, Don R/0000-0002-0010-290X; Robinson, Allen/0000-0003-1053-7090; Raatikainen, Tomi/0000-0002-2603-516X; Onasch, Tim/0000-0001-7796-7840; Ehn, Mikael/0000-0002-0215-4893; Grieshop, Andrew P/0000-0002-6470-9946; Prevot, Andre S. H./0000-0002-9243-8194; Worsnop, Douglas R/0000-0002-8928-8017; Hatakeyama, Shiro/0000-0002-9357-4091; Donahue, Neil M/0000-0003-3054-2364; DeCarlo, Peter/0000-0001-6385-7149; Schneider, Johannes/0000-0001-7169-3973; Robinson, Allen L/0000-0002-1819-083X; DeCarlo, Peter F/0000-0001-6385-7149; Jimenez, Jose L/0000-0001-6203-1847; Salcedo, Dara/0000-0002-6923-111X; Borrmann, Stephan/0000-0002-4774-9380; Kulmala, Markku T/0000-0003-3464-7825; Salcedo, Dara/0000-0002-6923-111X; Middlebrook, Ann M/0000-0002-2984-6304; Grieshop, Andrew/0000-0002-6470-9946; Alfarra, Rami/0000-0002-3925-3780; Griffin, Robert/0000-0001-7682-8769; Bower, Keith/0000-0002-9802-3264; Coe, Hugh/0000-0002-3264-1713	NSF; Environmental Protection Agency; Department of Energy; National Oceanic and Atmospheric Administration Office; Swiss NSF; EUROCHAMP; NERC [ncas10008, NE/D013690/1, ncas10006] Funding Source: UKRI; Natural Environment Research Council [ncas10006, NE/D013690/1, ncas10008] Funding Source: researchfish; Div Atmospheric & Geospace Sciences [0904292] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); Environmental Protection Agency(United States Environmental Protection Agency); Department of Energy(United States Department of Energy (DOE)); National Oceanic and Atmospheric Administration Office(National Oceanic Atmospheric Admin (NOAA) - USA); Swiss NSF(Swiss National Science Foundation (SNSF)); EUROCHAMP; NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by NSF's Atmospheric Chemistry Program, the Environmental Protection Agency's Science to Achieve Results program, the Department of Energy's Office of Biological and Environmental Research/Atmospheric Science Program, the National Oceanic and Atmospheric Administration Office of Global Programs, the Swiss NSF, EUROCHAMP, and other funding agencies listed in table S1.	Aiken AC, 2008, ENVIRON SCI TECHNOL, V42, P4478, DOI 10.1021/es703009q; Canagaratna MR, 2007, MASS SPECTROM REV, V26, P185, DOI 10.1002/mas.20115; de Gouw JA, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005623; DeCarlo PF, 2008, ATMOS CHEM PHYS, V8, P4027, DOI 10.5194/acp-8-4027-2008; Docherty KS, 2008, ENVIRON SCI TECHNOL, V42, P7655, DOI 10.1021/es8008166; Forster P, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P129; Fuzzi S, 2001, GEOPHYS RES LETT, V28, P4079, DOI 10.1029/2001GL013418; Goldstein AH, 2007, ENVIRON SCI TECHNOL, V41, P1514, DOI 10.1021/es072476p; Grieshop AP, 2009, ATMOS CHEM PHYS, V9, P2227, DOI 10.5194/acp-9-2227-2009; Hallquist M, 2009, ATMOS CHEM PHYS, V9, P5155, DOI 10.5194/acp-9-5155-2009; Heald CL, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023831; Herndon SC, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034058; Huffman JA, 2009, ATMOS CHEM PHYS, V9, P7161, DOI 10.5194/acp-9-7161-2009; Johnson D, 2006, ATMOS CHEM PHYS, V6, P403, DOI 10.5194/acp-6-403-2006; Kiehl JT, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL031383; Kroll JH, 2008, ATMOS ENVIRON, V42, P3593, DOI 10.1016/j.atmosenv.2008.01.003; Lanz VA, 2007, ATMOS CHEM PHYS, V7, P1503, DOI 10.5194/acp-7-1503-2007; Murphy DM, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2006JD007340; Nel A, 2005, SCIENCE, V308, P804, DOI 10.1126/science.1108752; Pankow JF, 2009, ATMOS ENVIRON, V43, P2829, DOI 10.1016/j.atmosenv.2008.12.050; PANKOW JF, 1994, ATMOS ENVIRON, V28, P189, DOI 10.1016/1352-2310(94)90094-9; Petters MD, 2007, ATMOS CHEM PHYS, V7, P1961, DOI 10.5194/acp-7-1961-2007; RADER DJ, 1986, J AEROSOL SCI, V17, P771, DOI 10.1016/0021-8502(86)90031-5; Robinson AL, 2007, SCIENCE, V315, P1259, DOI 10.1126/science.1133061; Subramanian R, 2006, ATMOS ENVIRON, V40, P8002, DOI 10.1016/j.atmosenv.2006.06.055; Ulbrich IM, 2009, ATMOS CHEM PHYS, V9, P2891, DOI 10.5194/acp-9-2891-2009; Volkamer R, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030752; Volkamer R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026899; Weitkamp EA, 2008, ENVIRON SCI TECHNOL, V42, P5177, DOI 10.1021/es800181b; Zhang Q, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029979; Zhang Q, 2005, ATMOS CHEM PHYS, V5, P3289, DOI 10.5194/acp-5-3289-2005	31	2547	2601	87	1849	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1525	1529		10.1126/science.1180353	http://dx.doi.org/10.1126/science.1180353			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007897				2022-12-28	WOS:000272623600055
J	Sekitani, T; Yokota, T; Zschieschang, U; Klauk, H; Bauer, S; Takeuchi, K; Takamiya, M; Sakurai, T; Someya, T				Sekitani, Tsuyoshi; Yokota, Tomoyuki; Zschieschang, Ute; Klauk, Hagen; Bauer, Siegfried; Takeuchi, Ken; Takamiya, Makoto; Sakurai, Takayasu; Someya, Takao			Organic Nonvolatile Memory Transistors for Flexible Sensor Arrays	SCIENCE			English	Article							FLASH MEMORY; NETWORKS; CIRCUITS	Using organic transistors with a floating gate embedded in hybrid dielectrics that comprise a 2-nanometer-thick molecular self-assembled monolayer and a 4-nanometer-thick plasma-grown metal oxide, we have realized nonvolatile memory arrays on flexible plastic substrates. The small thickness of the dielectrics allows very small program and erase voltages (<= 6 volts) to produce a large, nonvolatile, reversible threshold-voltage shift. The transistors endure more than 1000 program and erase cycles, which is within two orders of magnitude of silicon-based floating-gate transistors widely employed in flash memory. By integrating a flexible array of organic floating-gate transistors with a pressure-sensitive rubber sheet, we have realized a sensor matrix that detects the spatial distribution of applied mechanical pressure and stores the analog sensor input as a two-dimensional image over long periods of time.	[Sekitani, Tsuyoshi; Takeuchi, Ken; Someya, Takao] Univ Tokyo, Dept Elect & Elect Engn & Informat Syst, Bunkyo Ku, Tokyo 1138656, Japan; [Yokota, Tomoyuki; Someya, Takao] Univ Tokyo, Dept Appl Phys, Bunkyo Ku, Tokyo 1138656, Japan; [Zschieschang, Ute; Klauk, Hagen] Max Planck Inst Solid State Res, D-70569 Stuttgart, Germany; [Bauer, Siegfried] Johannes Kepler Univ Linz, A-4040 Linz, Austria; [Takamiya, Makoto; Sakurai, Takayasu] Univ Tokyo, Inst Ind Sci, Meguro Ku, Tokyo 1538505, Japan; [Someya, Takao] Univ Tokyo, INQIE, Meguro Ku, Tokyo 1538505, Japan	University of Tokyo; University of Tokyo; Max Planck Society; Johannes Kepler University Linz; University of Tokyo; University of Tokyo	Someya, T (corresponding author), Univ Tokyo, Dept Elect & Elect Engn & Informat Syst, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	Someya@ee.t.u-tokyo.ac.jp	Sekitani, Tsuyoshi/G-4599-2018; Bauer, Siegfried/A-2354-2009; Someya, Takao/H-3052-2015	Bauer, Siegfried/0000-0002-7770-9435; Someya, Takao/0000-0003-3051-1138	Core Research for Evolutional Science and Technology; Japan Science and Technology Agency (JST/CREST); Global Centers of Excellence (GCOE, Secure-Life Electronics, University of Tokyo); Special Coordination Funds for Promoting and Technology; Austrian Science Funds	Core Research for Evolutional Science and Technology(Core Research for Evolutional Science and Technology (CREST)); Japan Science and Technology Agency (JST/CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Global Centers of Excellence (GCOE, Secure-Life Electronics, University of Tokyo); Special Coordination Funds for Promoting and Technology; Austrian Science Funds(Austrian Science Fund (FWF))	This study was partially supported by Core Research for Evolutional Science and Technology, Japan Science and Technology Agency (JST/CREST), Global Centers of Excellence (GCOE, Secure-Life Electronics, University of Tokyo), and the Special Coordination Funds for Promoting and Technology. We thank H. Matsumoto and Y. Kuroda (Hitachi High-Technologies Corp.) for the process using FIB and imaging by TEM, H. Takagi (GENESIS Co., Ltd.) for designing the multichannel sensor driving system, and Daisankasei Co., Ltd. for high-purity parylene (diX-SR). We also thank T. Furukawa (Tokyo University of Science) and R. Koeppe (Johannes Kepler University Linz) for valuable discussion. S. B. thanks the Austrian Science Funds for financial support.	Baude PF, 2003, APPL PHYS LETT, V82, P3964, DOI 10.1063/1.1579554; Bez R, 2003, P IEEE, V91, P489, DOI 10.1109/JPROC.2003.811702; Chang MF, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3046115; Gebeyehu D, 2001, SYNTHETIC MET, V118, P1, DOI 10.1016/S0379-6779(00)00276-9; Gelinck GH, 2004, NAT MATER, V3, P106, DOI 10.1038/nmat1061; Klauk H, 2007, NATURE, V445, P745, DOI 10.1038/nature05533; Kliem H, 2005, J PHYS D APPL PHYS, V38, P1860, DOI 10.1088/0022-3727/38/12/002; Lee KH, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3089379; Liu ZC, 2006, IEEE T NANOTECHNOL, V5, P379, DOI 10.1109/TNANO.2006.876928; Ma H, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2857502; Naber RCG, 2005, NAT MATER, V4, P243, DOI 10.1038/nmat1329; Nguyen CA, 2008, ORG ELECTRON, V9, P1087, DOI 10.1016/j.orgel.2008.08.012; Schroeder R, 2004, ADV MATER, V16, P633, DOI 10.1002/adma.200306187; Sekitani T, 2008, P NATL ACAD SCI USA, V105, P4976, DOI 10.1073/pnas.0708340105; Sekitani T, 2007, NAT MATER, V6, P413, DOI 10.1038/nmat1903; Sekitani T, 2009, IEEE T ELECTRON DEV, V56, P1027, DOI 10.1109/TED.2009.2015169; Someya T, 2005, P NATL ACAD SCI USA, V102, P12321, DOI 10.1073/pnas.0502392102; Takeuchi K, 2009, IEEE J SOLID-ST CIRC, V44, P1227, DOI 10.1109/JSSC.2009.2014027; Wang W, 2009, IEEE T ELECTRON DEV, V56, P1036, DOI 10.1109/TED.2009.2016031; Wobkenberg PH, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.2954015; Zhen LJ, 2008, J PHYS D APPL PHYS, V41, DOI 10.1088/0022-3727/41/13/135111; Zhou LS, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2178213	22	816	841	14	642	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1516	1519		10.1126/science.1179963	http://dx.doi.org/10.1126/science.1179963			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007895				2022-12-28	WOS:000272623600052
J	Wang, H; Westin, L; Nong, Y; Birnbaum, S; Bendor, J; Brismar, H; Nestler, E; Aperia, A; Flajolet, M; Greengard, P				Wang, Hong; Westin, Linda; Nong, Yi; Birnbaum, Shari; Bendor, Jacob; Brismar, Hjalmar; Nestler, Eric; Aperia, Anita; Flajolet, Marc; Greengard, Paul			Norbin Is an Endogenous Regulator of Metabotropic Glutamate Receptor 5 Signaling	SCIENCE			English	Article							LONG-TERM POTENTIATION; PREPULSE INHIBITION; ALLOSTERIC MODULATORS; NEURITE-OUTGROWTH; MGLUR5 ANTAGONIST; PROTEIN; BRAIN; NMDA; MICE; PHOSPHORYLATION	Metabotropic glutamate receptor 5 (mGluR5) is highly expressed in the mammalian central nervous system (CNS). It is involved in multiple physiological functions and is a target for treatment of various CNS disorders, including schizophrenia. We report that Norbin, a neuron-specific protein, physically interacts with mGluR5 in vivo, increases the cell surface localization of the receptor, and positively regulates mGluR5 signaling. Genetic deletion of Norbin attenuates mGluR5-dependent stable changes in synaptic function measured as long-term depression or long-term potentiation of synaptic transmission in the hippocampus. As with mGluR5 knockout mice or mice treated with mGluR5-selective antagonists, Norbin knockout mice showed a behavioral phenotype associated with a rodent model of schizophrenia, as indexed by alterations both in sensorimotor gating and psychotomimetic-induced locomotor activity.	[Wang, Hong; Nong, Yi; Bendor, Jacob; Flajolet, Marc; Greengard, Paul] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA; [Westin, Linda; Brismar, Hjalmar; Aperia, Anita] Astrid Lindgren Childrens Hosp Q2 09, Karolinska Inst, Dept Woman & Child Hlth, S-17176 Stockholm, Sweden; [Birnbaum, Shari] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [Brismar, Hjalmar] Royal Inst Technol, Dept Appl Phys, S-10691 Stockholm, Sweden; [Nestler, Eric] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA	Rockefeller University; Karolinska Institutet; University of Texas System; University of Texas Southwestern Medical Center Dallas; Royal Institute of Technology; Icahn School of Medicine at Mount Sinai	Flajolet, M (corresponding author), Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10065 USA.	flajolm@rockefeller.edu	Brismar, Hjalmar/E-8524-2011	Brismar, Hjalmar/0000-0003-0578-4003; Greengard, Paul/0000-0002-4437-0893; Bendor, Jacob/0000-0003-1455-4891	NIH [MH074866, DA 10044, MH66172]; Swedish Research Council [03644-37-3]; Family Persson Foundation; USA Medical Research and Materiel Command [W81XWH-08-1-0111]; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH074866, P50MH066172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA010044] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swedish Research Council(Swedish Research CouncilEuropean Commission); Family Persson Foundation; USA Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank G. Schuetz, A. Nishi, and A. Schaefer for providing mouse lines used in this study; A. Nairn, L. Wennogle, W. Luo, M. Zhou, J. Warner-Schmidt, and K. Lee for helpful discussions; C. Brocia for technical assistance; and H. Zebroski III for peptide synthesis. This work was supported in part by grants from the NIH (MH074866, DA 10044) (P. G.) and MH66172 (E. N.), the Swedish Research Council (03644-37-3) (A. A.), and the Family Persson Foundation (A. A.), and by award W81XWH-08-1-0111 from The USA Medical Research and Materiel Command to P. G.	AIBA A, 1994, CELL, V79, P365, DOI 10.1016/0092-8674(94)90204-6; Bear MF, 2004, TRENDS NEUROSCI, V27, P370, DOI 10.1016/j.tins.2004.04.009; Brakeman PR, 1997, NATURE, V386, P284, DOI 10.1038/386284a0; Brody SA, 2004, MOL PSYCHIATR, V9, P35, DOI 10.1038/sj.mp.4001404; Casanova E, 2001, GENESIS, V31, P37, DOI 10.1002/gene.1078; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Conn PJ, 2009, TRENDS PHARMACOL SCI, V30, P25, DOI 10.1016/j.tips.2008.10.006; Conn PJ, 1997, ANNU REV PHARMACOL, V37, P205, DOI 10.1146/annurev.pharmtox.37.1.205; Coyle JT, 2003, ANN NY ACAD SCI, V1003, P318, DOI 10.1196/annals.1300.020; Flajolet M, 2003, P NATL ACAD SCI USA, V100, P16006, DOI 10.1073/pnas.2136600100; Henry SA, 2002, NEUROPHARMACOLOGY, V43, P1199, DOI 10.1016/S0028-3908(02)00332-5; Homayoun H, 2004, NEUROPSYCHOPHARMACOL, V29, P1259, DOI 10.1038/sj.npp.1300417; Huber KM, 2001, J NEUROPHYSIOL, V86, P321, DOI 10.1152/jn.2001.86.1.321; Ishizuka Y, 1999, BBA-MOL CELL RES, V1450, P92, DOI 10.1016/S0167-4889(99)00039-7; Jia ZP, 1998, LEARN MEMORY, V5, P331; Kawabata S, 1996, NATURE, V383, P89, DOI 10.1038/383089a0; Lu YM, 1997, J NEUROSCI, V17, P5196; Marino MJ, 2006, CURR OPIN PHARMACOL, V6, P98, DOI 10.1016/j.coph.2005.09.006; Minakami R, 1997, J BIOL CHEM, V272, P20291, DOI 10.1074/jbc.272.32.20291; Pietraszek M, 2004, J PHYSIOL PHARMACOL, V55, P587; Powell SB, 2009, BEHAV BRAIN RES, V204, P282, DOI 10.1016/j.bbr.2009.04.021; Shigemoto R, 2000, HAND CHEM N, V18, P63; Shinozaki K, 1999, MOL BRAIN RES, V71, P364, DOI 10.1016/S0169-328X(99)00181-3; Shinozaki K, 1997, BIOCHEM BIOPH RES CO, V240, P766, DOI 10.1006/bbrc.1997.7660; Swanson CJ, 2005, NAT REV DRUG DISCOV, V4, P131, DOI 10.1038/nrd1630	25	82	86	2	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1554	1557		10.1126/science.1178496	http://dx.doi.org/10.1126/science.1178496			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007903	Green Accepted			2022-12-28	WOS:000272623600062
J	Feudtner, C				Feudtner, Chris			The Breadth of Hopes.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Feudtner, C (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.		Feudtner, Chris/AAI-1126-2019	Feudtner, Chris/0000-0002-5879-0434				Feudtner C, 2005, J ALTERN COMPLEM MED, V11, pS23; Groopman J., 2004, ANATOMY HOPE PEOPLE; Quill TE, 2001, ANN INTERN MED, V135, P551, DOI 10.7326/0003-4819-135-7-200110020-00022; Snyder C.R., 2000, HDB HOPE THEORY MEAS; Whitney SN, 2008, CANCER, V113, P442, DOI 10.1002/cncr.23588	5	77	78	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2009	361	24					2306	2307		10.1056/NEJMp0906516	http://dx.doi.org/10.1056/NEJMp0906516			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529VS	20007559				2022-12-28	WOS:000272547600003
J	Shuster, S				Shuster, Sam			Christmas 2009: Anaesthesia Painless amputation: history of a discovery that wasn't made	BRITISH MEDICAL JOURNAL			English	Editorial Material							TOURNIQUET		Newcastle Univ, Newcastle Upon Tyne NE2 4, Tyne & Wear, England	Newcastle University - UK	Shuster, S (corresponding author), Newcastle Univ, Newcastle Upon Tyne NE2 4, Tyne & Wear, England.	sam@shuster.eclipse.co.uk						AITKINS J, 1742, NAVY SURG PRACTICAL; ALANSON E, 1779, PRACTICAL OBSERVATIO; BROCKLISS L, 2005, NELSONS SURG; Chiou-Tan FY, 2002, AM J PHYS MED REHAB, V81, P2, DOI 10.1097/00002060-200201000-00002; Clowes W., 1596, PROFITABLE NECESSARI; COOKE J, 1685, MARROW CHIRUGERIE S; DIONIS P, 1710, COURSE CHIRUGICAL OP; Edwards SA, 2000, J HAND SURG-BRIT EUR, V25B, P573, DOI 10.1054/jhsb.2000.0420; Estebe JP, 2000, ANAESTHESIA, V55, P21, DOI 10.1046/j.1365-2044.2000.01128.x; Galland RB, 2003, ANN ROY COLL SURG, V85, P393, DOI 10.1308/003588403322520753; GREAVES M, 1967, J PHYSL, V193, P256; HARRIS N, 1844, DISPATCHES LETT NELS; HUTCHINSON DT, 1993, J HAND SURG-AM, V18A, P206, DOI 10.1016/0363-5023(93)90347-6; IVES E, 1773, VOYAGE ENGLAND INDIA, P453; Kirkup J, 2007, HIST LIMB AMPUTATION, P1; LEGG S, 1966, TRAFALGAR EYE WITNES; Lewis T., 1927, BLOOD VESSELS HUMAN; LLOYD C, 1961, MED ROYAL NAVY, V3; MAGEE R, 1988, AUST NZ J SURG, V68, P675; Moore JC, 1784, METHOD PREVENTING DI; MOYLE J, 1693, SEA CHIRURG; NORTHCOTE W, 1770, MARINE PRACTICE PHYS; PETIT JL, 1719, HIST ACAD R SCI, P199; Robinson Kingsley, 2002, EVOLUTION ORTHOPAEDI, P175; Sachs M, 1999, WORLD J SURG, V23, P1088, DOI 10.1007/s002689900628; SHUSTER RR, 1996, HIST HERITAGE HLTH, P269; SHUSTER S, 1979, NEW SCI         1025, P68; Stanley P., 2003, FEAR PAIN BRIT SURG; WISEMAN R, 1676, SEVERAL CHIRUGICALL; WOODALL J, 1639, SURG MATE; Yonge James, 1679, CURRUS TRIUMPHALIS T	31	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 9	2009	339								b5202	10.1136/bmj.b5202	http://dx.doi.org/10.1136/bmj.b5202			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531VG	20007206				2022-12-28	WOS:000272697500004
J	Oswald, AJ; Wu, S				Oswald, Andrew J.; Wu, Stephen			Objective Confirmation of Subjective Measures of Human Well-Being: Evidence from the USA	SCIENCE			English	Article							QUALITY-OF-LIFE; HAPPINESS; SATISFACTION; HEALTH	A huge research literature, across the behavioral and social sciences, uses information on individuals' subjective well-being. These are responses to questions-asked by survey interviewers or medical personnel-such as, "How happy do you feel on a scale from 1 to 4?" Yet there is little scientific evidence that such data are meaningful. This study examines a 2005-2008 Behavioral Risk Factor Surveillance System random sample of 1.3 million U. S. citizens. Life satisfaction in each U. S. state is measured. Across America, people's answers trace out the same pattern of quality of life as previously estimated, from solely nonsubjective data, in one branch of economics (so-called "compensating differentials" neoclassical theory, originally from Adam Smith). There is a state-by-state match (r = 0.6, P < 0.001) between subjective and objective well-being. This result has some potential to help to unify disciplines.	[Oswald, Andrew J.] Univ Warwick, Dept Econ, Coventry CV4 7AL, W Midlands, England; [Wu, Stephen] Hamilton Coll, Dept Econ, Clinton, NY 13323 USA	University of Warwick; Hamilton College	Oswald, AJ (corresponding author), Univ Warwick, Dept Econ, Coventry CV4 7AL, W Midlands, England.	andrew.oswald@warwick.ac.uk	Oswald, Andrew/AAT-9888-2021	Wu, Stephen/0000-0003-4640-0221	U.K. Economic and Social Research; ESRC [ES/H021248/1, ES/D002877/1] Funding Source: UKRI; Economic and Social Research Council [ES/D002877/1, ES/H021248/1] Funding Source: researchfish	U.K. Economic and Social Research; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	For discussions and detailed points, we thank four referees and P. J. Hammond, M. Kimball, D. Krupka, E. Luttmer, J. Miles, E. Proto, and D. Sgroi. Valuable suggestions were made by D. Benjamin, D. Blanchflower, A. Clark, M. Clements, E. Diener, D. Dorling, D. Gilbert, A. Goodall, C. Graham, O. Heffetz, S. Luechinger, S. Mukherjee, R. Putnam, and J. Smith. The first author's work was supported by a U.K. Economic and Social Research research professorship. No conflicts of interest.	Barger SD, 2009, QUAL LIFE RES, V18, P179, DOI 10.1007/s11136-008-9426-2; Blanchflower DG, 2008, J HEALTH ECON, V27, P218, DOI 10.1016/j.jhealeco.2007.06.002; Cardozo BL, 2000, JAMA-J AM MED ASSOC, V284, P569, DOI 10.1001/jama.284.5.569; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; Diener E, 1999, PSYCHOL BULL, V125, P276, DOI 10.1037//0033-2909.125.2.276; Dunn EW, 2008, SCIENCE, V319, P1687, DOI 10.1126/science.1150952; Easterlin RA, 2003, P NATL ACAD SCI USA, V100, P11176, DOI 10.1073/pnas.1633144100; Fliessbach K, 2007, SCIENCE, V318, P1305, DOI 10.1126/science.1145876; Fowler JH, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2338; Gabriel SA, 2003, REG SCI URBAN ECON, V33, P619, DOI 10.1016/S0166-0462(02)00007-8; Gelman A, 2007, Q J POLIT SCI, V2, P345, DOI 10.1561/100.00006026; Gilbert D, 2006, STUMBLING HAPPINESS; GYOURKO J, 1991, J POLIT ECON, V99, P774, DOI 10.1086/261778; Hu YJ, 2007, PSYCHOL MED, V37, P1005, DOI 10.1017/S0033291707009993; Krueger AB, 2008, J PUBLIC ECON, V92, P1833, DOI 10.1016/j.jpubeco.2007.12.015; Luechinger S, 2009, ECON J, V119, P482, DOI 10.1111/j.1468-0297.2008.02241.x; Luttmer EFP, 2005, Q J ECON, V120, P963, DOI 10.1162/003355305774268255; Moro M, 2008, ECOL ECON, V65, P448, DOI 10.1016/j.ecolecon.2008.01.003; Oswald AJ, 1997, ECON J, V107, P1815, DOI 10.1111/1468-0297.00260; OSWALD AJ, 2009, I STUD LAB IZA UNPUB; Pittau MG, 2010, SOC INDIC RES, V96, P339, DOI 10.1007/s11205-009-9481-2; Radcliff B, 2001, AM POLIT SCI REV, V95, P939, DOI 10.1017/S0003055400400110; ROBACK J, 1982, J POLIT ECON, V90, P1257, DOI 10.1086/261120; SANDVIK E, 1993, J PERS, V61, P317, DOI 10.1111/j.1467-6494.1993.tb00283.x; Smith A., 1776, INQUIRY NATURE CAUSE; Steptoe A, 2005, NEUROBIOL AGING, V26, pS108, DOI 10.1016/j.neurobiolaging.2005.08.016; Stevenson B, 2008, J LEGAL STUD, V37, pS33, DOI 10.1086/592004; Stiglitz J., 2009, MEASUREMENT EC PERFO; Urry HL, 2004, PSYCHOL SCI, V15, P367, DOI 10.1111/j.0956-7976.2004.00686.x; Yang Y, 2008, AM SOCIOL REV, V73, P204, DOI 10.1177/000312240807300202	30	402	410	6	157	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					576	579		10.1126/science.1180606	http://dx.doi.org/10.1126/science.1180606			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	549CT	20019249	Green Submitted			2022-12-28	WOS:000274020500037
J	Baicker, K; Chandra, A				Baicker, Katherine; Chandra, Amitabh			Uncomfortable Arithmetic - Whom to Cover versus What to Cover	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							OREGON HEALTH PLAN; LESSONS; NATION		[Baicker, Katherine] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Chandra, Amitabh] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Baicker, K (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.							Bodenheimer T, 1997, NEW ENGL J MED, V337, P651, DOI 10.1056/NEJM199708283370923; Bodenheimer T, 1997, NEW ENGL J MED, V337, P720, DOI 10.1056/NEJM199709043371021; *CTR FIN ACC COST, 2008 MED EXP PAN SUR	3	8	8	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2					95	97		10.1056/NEJMp0911074	http://dx.doi.org/10.1056/NEJMp0911074			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	543FU	20018964				2022-12-28	WOS:000273558500002
J	Herring, B; Pauly, MV				Herring, Bradley; Pauly, Mark V.			"Play-or-Pay" Insurance Reforms for Employers - Confusion and Inequity	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Herring, Bradley] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21218 USA; [Pauly, Mark V.] Univ Penn, Wharton Sch, Hlth Care Syst Dept, Philadelphia, PA 19104 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Pennsylvania	Herring, B (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD 21218 USA.			Herring, Bradley/0000-0001-6845-1412				Congressional Budget Office, 2009, HIST EFF FED TAX RAT; Newhouse JP, 2000, HDB HLTH EC A, P645; PAULY M, 1997, HLTH BENEFITS WORK; PAULY MV, 1994, HEALTH AFFAIR, V13, P21, DOI 10.1377/hlthaff.13.2.21	4	2	2	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2					93	95		10.1056/NEJMp0911920	http://dx.doi.org/10.1056/NEJMp0911920			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	543FU	20042748				2022-12-28	WOS:000273558500001
J	Yeh, HC; Duncan, BB; Schmidt, MI; Wang, NY; Brancati, FL				Yeh, Hsin-Chieh; Duncan, Bruce B.; Schmidt, Maria Ines; Wang, Nae-Yuh; Brancati, Frederick L.			Smoking, Smoking Cessation, and Risk for Type 2 Diabetes Mellitus A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ATHEROSCLEROSIS RISK; WEIGHT-GAIN; INSULIN-RESISTANCE; COMMUNITIES; OBESITY; INFLAMMATION; EFFICIENCY	Background: Cigarette smoking is an established predictor of incident type 2 diabetes mellitus, but the effects of smoking cessation on diabetes risk are unknown. Objective: To test the hypothesis that smoking cessation increases diabetes risk in the short term, possibly owing to cessation-related weight gain. Design: Prospective cohort study. Setting: The ARIC (Atherosclerosis Risk in Communities) Study. Patients: 10 892 middle-aged adults who initially did not have diabetes in 1987 to 1989. Measurements: Smoking was assessed by interview at baseline and at subsequent follow-up. Incident diabetes was ascertained by fasting glucose assays through 1998 and self-report of physician diagnosis or use of diabetes medications through 2004. Results: During 9 years of follow-up, 1254 adults developed type 2 diabetes. Compared with adults who never smoked, the adjusted hazard ratio of incident diabetes in the highest tertile of pack-years was 1.42 (95% CI, 1.20 to 1.67). In the first 3 years of follow-up, 380 adults quit smoking. After adjustment for age, race, sex, education, adiposity, physical activity, lipid levels, blood pressure, and ARIC Study center, compared with adults who never smoked, the hazard ratios of diabetes among former smokers, new quitters, and continuing smokers were 1.22 (CI, 0.99 to 1.50), 1.73 (CI, 1.19 to 2.53), and 1.31 (CI, 1.04 to 1.65), respectively. Further adjustment for weight change and leukocyte count attenuated these risks substantially. In an analysis of long-term risk after quitting, the highest risk occurred in the first 3 years (hazard ratio, 1.91 [CI, 1.19 to 3.05]), then gradually decreased to 0 at 12 years. Limitation: Residual confounding is possible even with meticulous adjustment for established diabetes risk factors. Conclusion: Cigarette smoking predicts incident type 2 diabetes, but smoking cessation leads to higher short-term risk. For smokers at risk for diabetes, smoking cessation should be coupled with strategies for diabetes prevention and early detection.	[Yeh, Hsin-Chieh] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; Univ Fed Rio Grande do Sul, BR-90470280 Porto Alegre, RS, Brazil; Univ N Carolina, Chapel Hill, NC USA	Johns Hopkins University; Universidade Federal do Rio Grande do Sul; University of North Carolina; University of North Carolina Chapel Hill	Yeh, HC (corresponding author), Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-600, Baltimore, MD 21205 USA.	hyeh1@jhmi.edu	Schmidt, Maria/V-3196-2019; Schmidt, Maria Inês/AGT-5691-2022; Duncan, Bruce B/L-4140-2016; Schmidt, Maria Inês/AGP-6441-2022	Duncan, Bruce B/0000-0002-7491-2630; Schmidt, Maria Inês/0000-0002-3837-0731; Wang, Nae-Yuh/0000-0001-6513-9730	NHLBI [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; NIDDK [5R01-DK56918-03]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055021, N01HC055020, N01HC055015, N01HC055018, N01HC055016, N01HC055022, N01HC055019] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055018, R41HL055019, R42HL055018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, P60DK079637, R01DK056918] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The ARIC Study is supported by contracts from the NHLBI (N01-HC-55015, N01-HC-55016, N01-HC-55018, N01HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022) and a grant from the NIDDK (5R01-DK56918-03).	BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Balkau B, 2006, EUR J CARDIOV PREV R, V13, P334, DOI 10.1097/00149831-200606000-00007; Blaschke F, 2006, ARTERIOSCL THROM VAS, V26, P28, DOI 10.1161/01.ATV.0000191663.12164.77; Chinn S, 2005, LANCET, V365, P1629, DOI 10.1016/S0140-6736(05)66511-7; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Duncan BB, 2003, OBES RES, V11, P1339, DOI 10.1038/oby.2003.181; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; EFRON B, 1977, J AM STAT ASSOC, V72, P557, DOI 10.2307/2286217; Ferrara CM, 2001, INT J OBESITY, V25, P1322, DOI 10.1038/sj.ijo.0801716; Hur NW, 2007, EUR J CARDIOV PREV R, V14, P244, DOI 10.1097/01.hjr.0000239474.41379.79; Liu R, 2001, METABOLISM, V50, P79, DOI 10.1053/meta.2001.19436; Liu S, 2007, ARCH INTERN MED, V167, P1676, DOI 10.1001/archinte.167.15.1676; NAGELE U, 1984, J CLIN CHEM CLIN BIO, V22, P165; O'Hara P, 1998, AM J EPIDEMIOL, V148, P821, DOI 10.1093/oxfordjournals.aje.a009706; O'Malley SS, 2006, ARCH INTERN MED, V166, P667, DOI 10.1001/archinte.166.6.667; Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323; Rehani K, 2008, BBA-MOL CELL RES, V1783, P375, DOI 10.1016/j.bbamcr.2007.12.003; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; *U N CAR ARIC COOR, 1987, 2 U N CAR ARIC COORD; *U N CAR ARIC COOR, 1987, 11 U N CAR ARIC COOR; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; WARNICK GR, 1982, CLIN CHEM, V28, P1574; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wittebole X, 2007, CLIN EXP IMMUNOL, V147, P28, DOI 10.1111/j.1365-2249.2006.03248.x; Yeh HC, 2005, DIABETES CARE, V28, P1472, DOI 10.2337/diacare.28.6.1472	29	232	239	2	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2010	152	1					10	W3		10.7326/0003-4819-152-1-201001050-00005	http://dx.doi.org/10.7326/0003-4819-152-1-201001050-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543FJ	20048267	Green Accepted			2022-12-28	WOS:000273556600002
J	Raff, M				Raff, Martin			New Routes into the Human Brain	CELL			English	Editorial Material							RETT-SYNDROME; MOUSE MODEL; AUTISM; NEUROBIOLOGY; NEUROLIGINS; DISORDERS; MUTATIONS; REVERSAL; DISEASE; CELLS		UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England	University of London; University College London	Raff, M (corresponding author), UCL, MRC, Mol Cell Biol Lab, Mortimer St, London WC1E 6BT, England.	m.raff@ucl.ac.uk						Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hyman SE, 2008, NATURE, V455, P890, DOI 10.1038/nature07454; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; RAFF M, 2006, HIST NEUROSCIENCE AU, V5, P505; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034	15	6	6	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 24	2009	139	7					1209	1211		10.1016/j.cell.2009.12.010	http://dx.doi.org/10.1016/j.cell.2009.12.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064362	Bronze			2022-12-28	WOS:000273048700003
J	Shen, XH; Kim, WJ; Fujiwara, Y; Simon, MD; Liu, YC; Mysliwiec, MR; Yuan, GC; Lee, Y; Orkin, SH				Shen, Xiaohua; Kim, Woojin; Fujiwara, Yuko; Simon, Matthew D.; Liu, Yingchun; Mysliwiec, Matthew R.; Yuan, Guo-Cheng; Lee, Youngsook; Orkin, Stuart H.			Jumonji Modulates Polycomb Activity and Self-Renewal versus Differentiation of Stem Cells	CELL			English	Article							MODEL-BASED ANALYSIS; TRANSCRIPTIONAL REPRESSION; HISTONE METHYLATION; GENE; PROTEIN; DEMETHYLASE; NETWORK; PLURIPOTENCY; CHROMATIN; ROLES	Trimethylation on histone H3 lysine 27 (H3K27me3) by Polycomb repressive complex 2 (PRC2) regulates the balance between self-renewal and differentiation of embryonic stem cells (ESCs). The mechanisms controlling the activity and recruitment of PRC2 are largely unknown. Here we demonstrate that the founding member of the Jumonji family, JMJ (JUMONJI or JARID2), is associated with PRC2, colocalizes with PRC2 and H3K27me3 on chromatin, and modulates PRC2 function. In vitro JMJ inhibits PRC2 methyltransferase activity, consistent with increased H3K27me3 marks at PRC2 targets in Jmj(-/-) ESCs. Paradoxically, JMJ is required for efficient binding of PRC2, indicating that the interplay of PRC2 and JMJ fine-tunes deposition of the H3K27me3 mark. During differentiation, activation of genes marked by H3K27me3 and lineage commitments are delayed in Jmj(-/-) ESCs. Our results demonstrate that dynamic regulation of Polycomb complex activity orchestrated by JMJ balances self-renewal and differentiation, highlighting the involvement of chromatin dynamics in cell-fate transitions.	[Shen, Xiaohua; Kim, Woojin; Fujiwara, Yuko; Orkin, Stuart H.] Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Shen, Xiaohua; Kim, Woojin; Fujiwara, Yuko; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Orkin, Stuart H.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Liu, Yingchun; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, Yingchun; Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Simon, Matthew D.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Mysliwiec, Matthew R.; Lee, Youngsook] Univ Wisconsin, Sch Med & Publ Hlth, Dept Anat, Madison, WI 53706 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; University of Wisconsin System; University of Wisconsin Madison	Orkin, SH (corresponding author), Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	LIU, YING/GZL-7252-2022; Simon, Matthew/ABF-9127-2020; Hu, Ruogu/B-2203-2008; liu, ying/GXF-4294-2022	Simon, Matthew/0000-0001-7423-5265	Claudia Adams Barr Program in Cancer Research; National Institutes of Health [HL67050]; American Heart Association [0615633Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216] Funding Source: NIH RePORTER	Claudia Adams Barr Program in Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Magnuson, K. Helin, Q. Yan, K. H. Hansen, and R. Fang for reagents; K.H. Hansen, A. Kuo, and O. Gozani for advice on peptide- binding assays; R. Tomaino and S. Gygi for performing mass spec sequencing; DFCI Microarray Core for processing microarray samples; T. Liu and X.S. Liu for assistance with MAT; Q. Yan, B. Wilson, J. Xu, and J. Perry for criticism. X.S. and G.Y. are supported by the Claudia Adams Barr Program in Cancer Research. M.D.S. is a HHWF fellow. Y.L. is supported by the National Institutes of Health grant HL67050 and M. R. M. by American Heart Association grant 0615633Z. S.H.O. is an investigator of the HHMI.	Ambrosi DJ, 2007, STEM CELLS, V25, P1104, DOI 10.1634/stemcells.2006-0532; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken CP, 2008, CANCER RES, V68, P7621, DOI 10.1158/0008-5472.CAN-08-1217; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Gagneten S, 1997, NUCLEIC ACIDS RES, V25, P3326, DOI 10.1093/nar/25.16.3326; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim TG, 2003, J BIOL CHEM, V278, P42247, DOI 10.1074/jbc.M307386200; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Mysliwiec MR, 2006, GENESIS, V44, P407, DOI 10.1002/dvg.20221; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Sasai N, 2007, FEBS J, V274, P6139, DOI 10.1111/j.1742-4658.2007.06135.x; Savla U, 2008, DEVELOPMENT, V135, P813, DOI 10.1242/dev.016006; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Umlauf David, 2004, Methods Mol Biol, V287, P99; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Zarach JM, 2004, DEVELOPMENT, V131, P4189, DOI 10.1242/dev.01303; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	48	341	355	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1303	1314		10.1016/j.cell.2009.12.003	http://dx.doi.org/10.1016/j.cell.2009.12.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064376	Green Accepted, Bronze			2022-12-28	WOS:000273048700018
J	Dovidio, JF				Dovidio, John F.			Racial Bias, Unspoken But Heard	SCIENCE			English	Editorial Material							PREJUDICE		Yale Univ, Dept Psychol, New Haven, CT 06520 USA	Yale University	Dovidio, JF (corresponding author), Yale Univ, Dept Psychol, New Haven, CT 06520 USA.	john.dovidio@yale.edu						Ambady N, 2000, ADV EXP SOC PSYCHOL, V32, P201, DOI 10.1016/S0065-2601(00)80006-4; Chartrand TL., 2009, OXFORD HDB HUMAN ACT, P458; Dovidio JF, 2004, ADV EXP SOC PSYCHOL, V36, P1, DOI 10.1016/S0065-2601(04)36001-6; Dovidio JF, 1997, J EXP SOC PSYCHOL, V33, P510, DOI 10.1006/jesp.1997.1331; Gaertner SL, 2009, HDB PREJUDICE, P489; Henry PJ, 2008, PSYCHOL INQ, V19, P49, DOI 10.1080/10478400802049936; *NSF, BCS0613218 NSF; Richeson JA, 2005, J PERS SOC PSYCHOL, V88, P934, DOI 10.1037/0022-3514.88.6.934; Sinclair S, 2005, J PERS SOC PSYCHOL, V89, P583, DOI 10.1037/0022-3514.89.4.583; Weisbuch M, 2009, SCIENCE, V326, P1711, DOI 10.1126/science.1178358; 2009, GEN SOCIAL SURVEY	11	17	17	0	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 18	2009	326	5960					1641	1642		10.1126/science.1184231	http://dx.doi.org/10.1126/science.1184231			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533QJ	20019277				2022-12-28	WOS:000272839000040
J	Markowitz, SD; Bertagnolli, MM				Markowitz, Sanford D.; Bertagnolli, Monica M.			Molecular Origins of Cancer: Molecular Basis of Colorectal Cancer.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							GENOME-WIDE ASSOCIATION; ISLAND METHYLATOR PHENOTYPE; SPORADIC COLON-CANCER; FACTOR-BETA RECEPTOR; FECAL OCCULT BLOOD; P53 GENE-MUTATIONS; MICROSATELLITE-INSTABILITY; ADJUVANT CHEMOTHERAPY; GERMLINE MUTATIONS; 15-HYDROXYPROSTAGLANDIN DEHYDROGENASE		[Markowitz, Sanford D.] Case Western Reserve Univ, Sch Med, Dept Med, Div Hematol Oncol, Cleveland, OH 44106 USA; [Markowitz, Sanford D.] Case Western Reserve Univ, Sch Med, Ireland Canc Ctr, Cleveland, OH 44106 USA; [Markowitz, Sanford D.] Case Med Ctr, Cleveland, OH USA; [Markowitz, Sanford D.] Howard Hughes Med Inst, Chevy Chase, MD USA; [Bertagnolli, Monica M.] Brigham & Womens Hosp, Boston, MA 02115 USA	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Howard Hughes Medical Institute; Harvard University; Brigham & Women's Hospital	Markowitz, SD (corresponding author), Case Western Reserve Univ, Sch Med, Dept Med, Div Hematol Oncol, 10900 Euclid Ave, Cleveland, OH 44106 USA.	sxm10@cwru.edu; mbertagnolli@partners.org			Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA127306, R01 CA127306-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA127306] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		AALTONEN LA, 1993, SCIENCE, V260, P812, DOI 10.1126/science.8484121; Ahlquist DA, 2008, ANN INTERN MED, V149, P441, DOI 10.7326/0003-4819-149-7-200810070-00004; Al-Tassan N, 2002, NAT GENET, V30, P227, DOI 10.1038/ng828; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Arber N, 2006, NEW ENGL J MED, V355, P885, DOI 10.1056/NEJMoa061652; Backlund MG, 2005, J BIOL CHEM, V280, P3217, DOI 10.1074/jbc.M411221200; BAKER SJ, 1990, SCIENCE, V249, P912, DOI 10.1126/science.2144057; BAKER SJ, 1990, CANCER RES, V50, P7717; BAKER SJ, 1989, SCIENCE, V244, P217, DOI 10.1126/science.2649981; Barault L, 2008, CANCER RES, V68, P8541, DOI 10.1158/0008-5472.CAN-08-1171; Barber TD, 2008, P NATL ACAD SCI USA, V105, P3443, DOI 10.1073/pnas.0712384105; Baron JA, 2003, NEW ENGL J MED, V348, P891, DOI 10.1056/NEJMoa021735; Bertagnolli MM, 2006, NEW ENGL J MED, V355, P873, DOI 10.1056/NEJMoa061355; Bertagnolli MM, 2009, CLIN CANCER RES, V15, P2116, DOI 10.1158/1078-0432.CCR-08-2674; Bertagnolli MM, 2009, J CLIN ONCOL, V27, P1814, DOI 10.1200/JCO.2008.18.2071; Boland CR, 2008, FAM CANCER, V7, P41, DOI 10.1007/s10689-007-9145-9; Boman BM, 2008, J CLIN ONCOL, V26, P2828, DOI 10.1200/JCO.2008.17.6941; BOS JL, 1987, NATURE, V327, P293, DOI 10.1038/327293a0; Broderick P, 2007, NAT GENET, V39, P1315, DOI 10.1038/ng.2007.18; BRONNER CE, 1994, NATURE, V368, P258, DOI 10.1038/368258a0; CANNONALBRIGHT LA, 1988, NEW ENGL J MED, V319, P533, DOI 10.1056/NEJM198809013190902; Cha YI, 2007, ANNU REV MED, V58, P239, DOI 10.1146/annurev.med.57.121304.131253; Chan AT, 2007, NEW ENGL J MED, V356, P2131, DOI 10.1056/NEJMoa067208; Chen WD, 2005, JNCI-J NATL CANCER I, V97, P1124, DOI 10.1093/jnci/dji204; Cleary SP, 2009, GASTROENTEROLOGY, V136, P1251, DOI 10.1053/j.gastro.2008.12.050; Compton C, 2008, ABELOFFS CLIN ONCOLO, P1477; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Downward J, 1998, CURR OPIN GENET DEV, V8, P49, DOI 10.1016/S0959-437X(98)80061-0; Eppert K, 1996, CELL, V86, P543, DOI 10.1016/S0092-8674(00)80128-2; FEARON ER, 2008, DEVITA HELLMAN ROSEN, V1, P1218; FISHEL R, 1994, CELL, V77, P167; Goss KH, 2000, J CLIN ONCOL, V18, P1967, DOI 10.1200/JCO.2000.18.9.1967; Grady William M., 2008, P889; Grady WM, 1998, CANCER RES, V58, P3101; Grady WM, 1999, CANCER RES, V59, P320; GRADY WM, 2002, GASTROINTESTINAL ONC, P685; Hampel H, 2005, NEW ENGL J MED, V352, P1851, DOI 10.1056/NEJMoa043146; Hemminki K, 2001, MUTAT RES-FUND MOL M, V473, P11, DOI 10.1016/S0027-5107(00)00162-7; Herman JG, 1998, P NATL ACAD SCI USA, V95, P6870, DOI 10.1073/pnas.95.12.6870; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Howe JR, 1998, SCIENCE, V280, P1086, DOI 10.1126/science.280.5366.1086; Hundt S, 2009, ANN INTERN MED, V150, P162, DOI 10.7326/0003-4819-150-3-200902030-00005; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Imperiale TF, 2004, NEW ENGL J MED, V351, P2704, DOI 10.1056/NEJMoa033403; IONOV Y, 1993, NATURE, V363, P558, DOI 10.1038/363558a0; Issa JP, 2004, NAT REV CANCER, V4, P988, DOI 10.1038/nrc1507; Itzkowitz S, 2008, AM J GASTROENTEROL, V103, P2862, DOI 10.1111/j.1572-0241.2008.02088.x; Itzkowitz SH, 2007, CLIN GASTROENTEROL H, V5, P111, DOI 10.1016/j.cgh.2006.10.006; Jarvinen HJ, 2000, GASTROENTEROLOGY, V118, P829, DOI 10.1016/S0016-5085(00)70168-5; Jass JR, 2007, HISTOPATHOLOGY, V50, P113, DOI 10.1111/j.1365-2559.2006.02549.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jhawer M., 2008, CANCER RES, V68, P6859; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Jones S, 2002, HUM MOL GENET, V11, P2961, DOI 10.1093/hmg/11.23.2961; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kane MF, 1997, CANCER RES, V57, P808; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kastrinos F, 2007, SEMIN ONCOL, V34, P418, DOI 10.1053/j.seminoncol.2007.07.005; Kim GP, 2007, J CLIN ONCOL, V25, P767, DOI 10.1200/JCO.2006.05.8172; Kinzler K.W., 2002, GENETIC BASIS HUMAN, V2, P583; Kolodner RD, 1999, CANCER RES, V59, P5068; Kondo Y, 2004, CANCER METAST REV, V23, P29, DOI 10.1023/A:1025806911782; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; LEACH FS, 1993, CELL, V75, P1215, DOI 10.1016/0092-8674(93)90330-S; Leary RJ, 2008, P NATL ACAD SCI USA, V105, P16224, DOI 10.1073/pnas.0808041105; Lengauer C, 1997, NATURE, V386, P623, DOI 10.1038/386623a0; Levin B, 2008, CA-CANCER J CLIN, V58, P130, DOI 10.3322/CA.2007.0018; Li M, 2009, NAT BIOTECHNOL, V27, P858, DOI 10.1038/nbt.1559; Liaw D, 1997, NAT GENET, V16, P64, DOI 10.1038/ng0597-64; LIBUTTI SK, 2008, DEVITA HELLMAN ROSEN, V1, P1232; Lichtenstein P, 2000, NEW ENGL J MED, V343, P78, DOI 10.1056/NEJM200007133430201; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Lindor NM, 2005, JAMA-J AM MED ASSOC, V293, P1979, DOI 10.1001/jama.293.16.1979; Lynch HT, 2008, FAM CANCER, V7, P27, DOI 10.1007/s10689-007-9165-5; MALKIN D, 1993, SCIENCE, V259, P878, DOI 10.1126/science.8438145; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; Markowitz SD, 2007, NEW ENGL J MED, V356, P2195, DOI 10.1056/NEJMe078044; Markowitz SD, 2002, CANCER CELL, V1, P233, DOI 10.1016/S1535-6108(02)00053-3; Marsh DJ, 1997, NAT GENET, V16, P333, DOI 10.1038/ng0897-333; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Miyaki M, 1997, NAT GENET, V17, P271, DOI 10.1038/ng1197-271; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Myung SJ, 2006, P NATL ACAD SCI USA, V103, P12098, DOI 10.1073/pnas.0603235103; Neklason DW, 2008, CANCER RES, V68, P8993, DOI 10.1158/0008-5472.CAN-08-1376; Nosho K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003698; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; O'Brien MJ, 2007, GASTROENTEROL CLIN N, V36, P947, DOI 10.1016/j.gtc.2007.08.007; Ogino S, 2009, GUT, V58, P90, DOI 10.1136/gut.2008.155473; PAPADOPOULOS N, 1994, SCIENCE, V263, P1625, DOI 10.1126/science.8128251; Papaemmanuil E, 2008, EUR J HUM GENET, V16, P1477, DOI 10.1038/ejhg.2008.129; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parsons DW, 2005, NATURE, V436, P792, DOI 10.1038/436792a; PARSONS R, 1995, CANCER RES, V55, P5548; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; Rajagopalan H, 2004, NATURE, V428, P77, DOI 10.1038/nature02313; Ribic CM, 2003, NEW ENGL J MED, V349, P247, DOI 10.1056/NEJMoa022289; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Riggins GJ, 1996, NAT GENET, V13, P347, DOI 10.1038/ng0796-347; Saltz LB, 2004, J CLIN ONCOL, V22, P1201, DOI 10.1200/JCO.2004.10.182; Samowitz WS, 2001, CANCER EPIDEM BIOMAR, V10, P917; Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502; Sandler RS, 2003, NEW ENGL J MED, V348, P883, DOI 10.1056/NEJMoa021633; Sandler RS, 2003, NEW ENGL J MED, V348, P1939; Shen LL, 2007, P NATL ACAD SCI USA, V104, P18654, DOI 10.1073/pnas.0704652104; Siena S, 2009, JNCI-J NATL CANCER I, V101, P1308, DOI 10.1093/jnci/djp280; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Steinbach G, 2000, NEW ENGL J MED, V342, P1946, DOI 10.1056/NEJM200006293422603; Takagi Y, 1996, GASTROENTEROLOGY, V111, P1369, DOI 10.1053/gast.1996.v111.pm8898652; Tenesa A, 2008, NAT GENET, V40, P631, DOI 10.1038/ng.133; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; THIBODEAU SN, 1993, SCIENCE, V260, P816, DOI 10.1126/science.8484122; Tomlinson I, 2007, NAT GENET, V39, P984, DOI 10.1038/ng2085; Tomlinson IPM, 2008, NAT GENET, V40, P623, DOI 10.1038/ng.111; Toyota M, 1999, P NATL ACAD SCI USA, V96, P8681, DOI 10.1073/pnas.96.15.8681; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Vazquez A, 2008, NAT REV DRUG DISCOV, V7, P979, DOI 10.1038/nrd2656; Veigl ML, 1998, P NATL ACAD SCI USA, V95, P8698, DOI 10.1073/pnas.95.15.8698; Watanabe T, 2001, NEW ENGL J MED, V344, P1196, DOI 10.1056/NEJM200104193441603; Weisenberger DJ, 2006, NAT GENET, V38, P787, DOI 10.1038/ng1834; Wiesner GL, 2003, P NATL ACAD SCI USA, V100, P12961, DOI 10.1073/pnas.2132286100; Wong, 2009, J CLIN ONCOL, V27, P3070, DOI 10.1200/JCO.2009.23.6927; Wong R, 2008, J CLIN ONCOL, V26, P5668, DOI 10.1200/JCO.2008.19.5024; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yan M, 2004, P NATL ACAD SCI USA, V101, P17468, DOI 10.1073/pnas.0406142101; Yin Y, 2008, ONCOGENE, V27, P5443, DOI 10.1038/onc.2008.241; Zanke BW, 2007, NAT GENET, V39, P989, DOI 10.1038/ng2089; Zou HZ, 2007, CANCER EPIDEM BIOMAR, V16, P2686, DOI 10.1158/1055-9965.EPI-07-0518	132	1310	1374	5	197	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2009	361	25					2449	2460		10.1056/NEJMra0804588	http://dx.doi.org/10.1056/NEJMra0804588			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	533CE	20018966	Green Accepted			2022-12-28	WOS:000272798900009
J	Medrano, J; Malo, P; Uriarte, JJ; Lopez, AP				Medrano, Juan; Malo, Pablo; Uriarte, Jose J.; Lopez, Ana-Pia			Christmas 2009: Diagnosis Stigma and prejudice in Tintin	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MENTAL-ILLNESS		[Medrano, Juan; Lopez, Ana-Pia] Ctr Salud Mental Gasteiz Ctr, Vitoria 01002, Spain; [Malo, Pablo] Ctr Salud Mental Bombero Etxaniz, Bilbao 48010, Spain; [Uriarte, Jose J.] Hosp Zamudio, Zamudio 48170, Spain; [Medrano, Juan; Malo, Pablo; Uriarte, Jose J.] Txori Herri Med Assoc, Vitoria 01080, Spain		Medrano, J (corresponding author), Ctr Salud Mental Gasteiz Ctr, Vitoria 01002, Spain.	torridon@telefonica.net						Algoud A, 2004, INTEGRALE JURONS CAP; Apostolides J.-M., 2006, METAMORPHOSES TINTIN; ASSOULINE P, 1996, HERGE; Coverdale JH, 2006, ACAD PSYCHIATR, V30, P83, DOI 10.1176/appi.ap.30.1.83; PEETERS B, 2006, HERGE FILS TINTIN; Rose D, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-97; Sadoul Numa, 2000, TINTIN MOI ENTRETIEN; THOMPSON H, 1992, HERGE HIS CREATION; Tisseron S., 1993, TINTIN SECRETS FAMIL; TISSERON S, 1993, TINTIN SECRET HERGE; Wilson C, 2000, BRIT J PSYCHIAT, V176, P440, DOI 10.1192/bjp.176.5.440	11	6	6	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2009	339								b5308	10.1136/bmj.b5308	http://dx.doi.org/10.1136/bmj.b5308			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534XH	20015908				2022-12-28	WOS:000272930300015
J	Muller, F; Mutch, NJ; Schenk, WA; Smith, SA; Esterl, L; Spronk, HM; Schmidbauer, S; Gahl, WA; Morrissey, JH; Renne, T				Muller, Felicitas; Mutch, Nicola J.; Schenk, Wolfdieter A.; Smith, Stephanie A.; Esterl, Lucie; Spronk, Henri M.; Schmidbauer, Stefan; Gahl, William A.; Morrissey, James H.; Renne, Thomas			Platelet Polyphosphates Are Proinflammatory and Procoagulant Mediators In Vivo	CELL			English	Article							COAGULATION-FACTOR-XII; BLOOD-COAGULATION; CONTACT-PHASE; INORGANIC POLYPHOSPHATE; THROMBUS FORMATION; INTRINSIC PATHWAY; ACTIVATION; DEFICIENCY; DISEASE; SYSTEM	Platelets play a central role in thrombosis, hemostasis, and inflammation. We show that activated platelets release inorganic polyphosphate (polyP), a polymer of 60-100 phosphate residues that directly bound to and activated the plasma protease factor XII. PolyP-driven factor XII activation triggered release of the inflammatory mediator bradykinin by plasma kallikrein-mediated kininogen processing. PolyP increased vascular permeability and induced fluid extravasation in skin microvessels of mice. Mice deficient in factor XII or bradykinin receptors were resistant to polyP-induced leakage. PolyP initiated clotting of plasma via the contact pathway. Ablation of intrinsic coagulation pathway proteases factor XII and factor XI protected mice from polyP-triggered lethal pulmonary embolism. Targeting polyP with phosphatases interfered with procoagulant activity of activated platelets and blocked platelet-induced thrombosis in mice. Addition of polyP restored defective plasma clotting of Hermansky-Pudlak Syndrome patients, who lack platelet polyP. The data identify polyP as a new class of mediator having fundamental roles in platelet-driven proinflammatory and procoagulant disorders.	[Muller, Felicitas; Esterl, Lucie; Renne, Thomas] Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden; [Muller, Felicitas; Esterl, Lucie; Renne, Thomas] Karolinska Inst, Ctr Mol Med, S-17176 Stockholm, Sweden; [Mutch, Nicola J.] Univ Leeds, Fac Biol Sci, Dept Cardiovasc Med, Leeds LS2 9JT, W Yorkshire, England; [Schenk, Wolfdieter A.] Univ Wurzburg, Inst Inorgan Chem, D-97074 Wurzburg, Germany; [Smith, Stephanie A.; Morrissey, James H.] Univ Illinois, Coll Med, Urbana, IL 61801 USA; [Spronk, Henri M.] Maastricht Univ, Dept Internal Med, Lab Clin Thrombosis & Haemostasis, NL-6200 MD Maastricht, Netherlands; [Schmidbauer, Stefan] CSL Behring GmbH, D-35041 Marburg, Germany; [Gahl, William A.] NHGRI, Human Biochem Genet Sect, Bethesda, MD 20892 USA	Karolinska Institutet; Karolinska Institutet; University of Leeds; University of Wurzburg; University of Illinois System; University of Illinois Urbana-Champaign; Maastricht University; CSL; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Renne, T (corresponding author), Karolinska Inst, Dept Mol Med & Surg, S-17176 Stockholm, Sweden.	thomas@renne.net	Morrissey, James H./GLR-5645-2022; Morrissey, James H/H-4933-2011	Morrissey, James H/0000-0002-1570-1569; Renne, Thomas/0000-0003-4594-5975; Smith, Stephanie/0000-0003-4895-6215; Mutch, Nicola/0000-0002-7452-0813; Spronk, Henri/0000-0002-3858-334X	Deutsche Forschungsgemeinschaft [SFB 688]; EU; NIH [R01 HL47014]; National Human Genome Research Institute, NIH; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL047014] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG000215] Funding Source: NIH RePORTER; British Heart Foundation [PG/07/122/24195] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Human Genome Research Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); British Heart Foundation(British Heart Foundation)	This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (SFB 688) and the EU-funded ERARE program (T. R.); by NIH grant R01 HL47014 (J.H.M.); and by the Intramural Research Program of the National Human Genome Research Institute, NIH (W. A. G.). We thank Dr. T. Staffel (BK Giulini, Ludwigshafen, Germany) for donating synthetic polyP. We are grateful to Dr. David Gailani (Vanderbilt University, Nashville, TN, USA) for providing FXI null mice and Dr. Alan E. Mast (Blood Center of Wisconsin, Milwaukee, WI, USA) for anti-TFPI antibodies. We cordially thank Dr. Ulrich Walter (Julius-Maximilians-University Wurzburg, Wurzburg, Germany) for continuous mentoring and support. F. M. is supported by a Rudolf-Marx Grant of the Society for Thrombosis and Hemostasis Research (GTH). Three of the authors (N.J.M., S. A. S., and J.H.M.) are coinventors on pending patent applications on medical uses of polyP.	CASTALDI PA, 1965, NATURE, V207, P422, DOI 10.1038/207422a0; COLMAN RW, 2006, CONTACT ACTIVATION K, P107; del Conde I, 2005, J EXP MED, V201, P871, DOI 10.1084/jem.20041497; Endler G, 2007, J THROMB HAEMOST, V5, P1143, DOI 10.1111/j.1538-7836.2007.02530.x; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Gahl WA, 1998, NEW ENGL J MED, V338, P1258, DOI 10.1056/NEJM199804303381803; Gailani D, 2007, J THROMB HAEMOST, V5, P1106, DOI 10.1111/j.1538-7836.2007.02446.x; Gailani D, 2007, ARTERIOSCL THROM VAS, V27, P2507, DOI 10.1161/ATVBAHA.107.155952; GHEBREHIWET B, 1981, J EXP MED, V153, P665, DOI 10.1084/jem.153.3.665; Han ED, 2002, J CLIN INVEST, V109, P1057, DOI 10.1172/JCI200214211; Herwald H, 1998, NAT MED, V4, P298, DOI 10.1038/nm0398-298; Kannemeier C, 2007, P NATL ACAD SCI USA, V104, P6388, DOI 10.1073/pnas.0608647104; Kleinschnitz C, 2006, J EXP MED, V203, P513, DOI 10.1084/jem.20052458; KUMBLE KD, 1995, J BIOL CHEM, V270, P5818, DOI 10.1074/jbc.270.11.5818; Leeb-Lundberg LMF, 2005, PHARMACOL REV, V57, P27, DOI 10.1124/pr.57.1.2; Maas C, 2008, J CLIN INVEST, V118, P3208, DOI [10.1172/JC135424, 10.1172/JCI35424]; Mackman N, 2008, NATURE, V451, P914, DOI 10.1038/nature06797; MANGAL AK, 1980, LANCET, V315, P774; Muller F, 2008, CURR OPIN HEMATOL, V15, P516, DOI 10.1097/MOH.0b013e328309ec85; Pauer HU, 2004, THROMB HAEMOSTASIS, V92, P503, DOI 10.1160/TH04-04-0250; Ponczek MB, 2008, J THROMB HAEMOST, V6, P1876, DOI 10.1111/j.1538-7836.2008.03143.x; Rao NN, 2009, ANNU REV BIOCHEM, V78, P605, DOI 10.1146/annurev.biochem.77.083007.093039; RATNOFF OD, 1955, J CLIN INVEST, V34, P602, DOI 10.1172/JCI103109; RATNOFF OD, 1968, NEW ENGL J MED, V279, P760, DOI 10.1056/NEJM196810032791407; Renne T, 2005, J IMMUNOL, V175, P3377, DOI 10.4049/jimmunol.175.5.3377; Renne T, 2005, J EXP MED, V202, P271, DOI 10.1084/jem.20050664; Ruggeri ZM, 2002, NAT MED, V8, P1227, DOI 10.1038/nm1102-1227; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; Salomon O, 2008, BLOOD, V111, P4113, DOI 10.1182/blood-2007-10-120139; Schmaier AH, 2008, J CLIN INVEST, V118, P3006, DOI 10.1172/JCI36617; SCHMIDBAUER S, 2009, HAMOSTASEOLOGIE, V29, P22; Smith SA, 2008, J THROMB HAEMOST, V6, P1750, DOI 10.1111/j.1538-7836.2008.03104.x; Smith SA, 2006, P NATL ACAD SCI USA, V103, P903, DOI 10.1073/pnas.0507195103; Smith SA, 2008, BLOOD, V112, P2810, DOI 10.1182/blood-2008-03-145755; Smith SA, 2007, ELECTROPHORESIS, V28, P3461, DOI 10.1002/elps.200700041; Tucker EI, 2009, BLOOD, V113, P936, DOI 10.1182/blood-2008-06-163675; von Hundelshausen P, 2007, CIRC RES, V100, P27, DOI 10.1161/01.RES.0000252802.25497.b7; Wagner DD, 2008, BLOOD, V111, P5271, DOI 10.1182/blood-2008-01-078204; WALSH PN, 1981, BLOOD, V57, P106; Wang XK, 2006, J THROMB HAEMOST, V4, P1982, DOI 10.1111/j.1538-7836.2006.02093.x; Zuraw BL, 2008, NEW ENGL J MED, V359, P1027, DOI 10.1056/NEJMcp0803977	41	564	578	1	70	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1143	1156		10.1016/j.cell.2009.11.001	http://dx.doi.org/10.1016/j.cell.2009.11.001			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005807	Green Accepted, Bronze			2022-12-28	WOS:000272622800016
J	Andrea, G; Reuss, R				Andrea, G.; Reuss, Reinhard			Commentary: Patient's view	BRITISH MEDICAL JOURNAL			English	Editorial Material												reinhard.reuss@neuro.med.uni-giessen.de							0	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2009	339								b5178	10.1136/bmj.b5178	http://dx.doi.org/10.1136/bmj.b5178			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VH	20007658				2022-12-28	WOS:000272697600005
J	Firth, PG; Zheng, H; Biller, JA				Firth, P. G.; Zheng, H.; Biller, J. A.			CHRISTMAS: YEARS LIKE THIS Ingested foreign bodies and societal wealth: three year observational study of swallowed coins	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EURO	Objective To examine the relation between coins ingested by children and the Dow Jones Industrial Average. Design Observational study. Main outcome measures Total value of coins ingested and number of incidents of coins versus other objects swallowed, measured before and after the stock market crash of October 2008. Results Eighteen objects, including 11 coins, were ingested (NASDAQ ( numismatic and sundry detritus acquired) composite of 18). The total value of the 11 coins swallowed was $1.03 (FTSE 100 (fraction of the US$ or 100 cents) index of 103). The pecuniary extraction ratio ( PE ratio) was 0.57 (9/16). Comparing values for a period before and after October 2008, the mean monthly NASDAQ composite (0.41 (SD 0.67) v 0.5 (0.85), P=0.75), FTSE 100 index in cents (2.3 (6.8) v 3.1 (7.8), P=0.77), and PE ratio (0.54 (0.52) v 0.66 (0.29), P=0.50) did not change. The mean end-of-month closing value of the Dow Jones, however, decreased significantly (12537 (841.4) v 8388 (699.8), P<0.001) Conclusion There was no detectable difference in the total value of coins ingested, or ratio of coins to other objects swallowed, before or after a massive stock market crash.	[Firth, P. G.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Zheng, H.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Biostat, Boston, MA 02114 USA; [Biller, J. A.] Harvard Univ, Sch Med, Dept Gastroenterol, Waltham, MA 02451 USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Firth, PG (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Anesthesia Crit Care & Pain Med, 55 Fruit St, Boston, MA 02114 USA.	pfirth@partners.org		Firth, Paul/0000-0003-1909-5225				[Anonymous], DOW JONES IND AVERAG; Brynjolfsson E., 2010, WIRED INNOVATION IT; Cantu S, 2002, AM SURGEON, V68, P417; DORST JP, 1982, PEDIATRICS, V69, P224; Gill DG, 2004, ARCH DIS CHILD, V89, P795, DOI 10.1136/adc.2003.045419; Marlow Troy J., 1997, Journal of Emergency Medicine, V15, P487, DOI 10.1016/S0736-4679(97)00086-3; MORRISON JB, 1966, BRIT MED J, V2, P1052, DOI 10.1136/bmj.2.5521.1052; Papadopoulos FC, 2004, ARCH DIS CHILD, V89, P382, DOI 10.1136/adc.2003.033985; Philip J, 2004, PEDIATR ANESTH, V14, P1016, DOI 10.1111/j.1460-9592.2004.01510.x; REY M, 1966, C GEORGE GOES HOSP; Saxena AK, 2008, EUR J PEDIATR, V167, P243, DOI 10.1007/s00431-007-0449-4; Tsagkaropoulos S, 2009, EUR J CARDIO-THORAC, V36, P185, DOI 10.1016/j.ejcts.2009.02.053	12	0	0	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2009	339								b5066	10.1136/bmj.b5066	http://dx.doi.org/10.1136/bmj.b5066			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NU	19965938	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000272453700004
J	Grossman, SR; Shylakhter, I; Karlsson, EK; Byrne, EH; Morales, S; Frieden, G; Hostetter, E; Angelino, E; Garber, M; Zuk, O; Lander, ES; Schaffner, SF; Sabeti, PC				Grossman, Sharon R.; Shylakhter, Ilya; Karlsson, Elinor K.; Byrne, Elizabeth H.; Morales, Shannon; Frieden, Gabriel; Hostetter, Elizabeth; Angelino, Elaine; Garber, Manuel; Zuk, Or; Lander, Eric S.; Schaffner, Stephen F.; Sabeti, Pardis C.			A Composite of Multiple Signals Distinguishes Causal Variants in Regions of Positive Selection	SCIENCE			English	Article								The human genome contains hundreds of regions whose patterns of genetic variation indicate recent positive natural selection, yet for most the underlying gene and the advantageous mutation remain unknown. We developed a method, composite of multiple signals (CMS), that combines tests for multiple signals of selection and increases resolution by up to 100-fold. By applying CMS to candidate regions from the International Haplotype Map, we localized population-specific selective signals to 55 kilobases (median), identifying known and novel causal variants. CMS can not just identify individual loci but implicates precise variants selected by evolution.	[Grossman, Sharon R.; Shylakhter, Ilya; Karlsson, Elinor K.; Byrne, Elizabeth H.; Morales, Shannon; Frieden, Gabriel; Hostetter, Elizabeth; Angelino, Elaine; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA; [Grossman, Sharon R.; Shylakhter, Ilya; Karlsson, Elinor K.; Byrne, Elizabeth H.; Morales, Shannon; Hostetter, Elizabeth; Garber, Manuel; Zuk, Or; Lander, Eric S.; Schaffner, Stephen F.; Sabeti, Pardis C.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Grossman, Sharon R.; Shylakhter, Ilya; Karlsson, Elinor K.; Byrne, Elizabeth H.; Morales, Shannon; Hostetter, Elizabeth; Garber, Manuel; Zuk, Or; Lander, Eric S.; Schaffner, Stephen F.; Sabeti, Pardis C.] Harvard Univ, Cambridge, MA 02142 USA; [Morales, Shannon] Mt Sinai Sch Med, New York, NY 10029 USA; [Angelino, Elaine; Lander, Eric S.; Sabeti, Pardis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Grossman, SR (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA.	shari.grossman@post.harvard.edu; ilya_shl@alum.mit.edu; psabeti@oeb.harvard.edu	Sabeti, Pardis/GQH-8610-2022; Schaffner, Stephen F/D-1189-2011	Schaffner, Stephen/0000-0001-6699-3568; Karlsson, Elinor/0000-0002-4343-3776; Grossman, Sharon/0000-0001-6422-1134	Burroughs Wellcome Foundation; Packard Foundation; American Cancer Society	Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Packard Foundation(The David & Lucile Packard Foundation); American Cancer Society(American Cancer Society)	We thank K. Andersen, J. Lohmueller, B. Stranger, S. McCarroll, K. Lohmueller, K. Lindblad-Toh, M. Guttman, and J. Rinn for functional guidance, and E. Phelan, D. Altshuler, and the Sabeti Lab for helpful discussions throughout. P. C. S. is supported by the Burroughs Wellcome and Packard foundations. E. K. K. is supported by the American Cancer Society.	Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Park KS, 2006, J HUM GENET, V51, P85, DOI 10.1007/s10038-005-0327-8; Reiners J, 2005, HUM MOL GENET, V14, P3933, DOI 10.1093/hmg/ddi417; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090	17	347	360	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					883	886		10.1126/science.1183863	http://dx.doi.org/10.1126/science.1183863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20056855	Green Submitted			2022-12-28	WOS:000274408300067
J	Stiess, M; Maghelli, N; Kapitein, LC; Gomis-Ruth, S; Wilsch-Brauninger, M; Hoogenraad, CC; Tolic-Norrelykke, IM; Bradke, F				Stiess, Michael; Maghelli, Nicola; Kapitein, Lukas C.; Gomis-Rueth, Susana; Wilsch-Braeuninger, Michaela; Hoogenraad, Casper C.; Tolic-Norrelykke, Iva M.; Bradke, Frank			Axon Extension Occurs Independently of Centrosomal Microtubule Nucleation	SCIENCE			English	Article							GAMMA-TUBULIN; NEURONAL CENTROSOME; POLARIZATION; POLARITY; COMPLEX; CELL; CYTOSKELETON; PLASTICITY; DENDRITES; TRANSPORT	Microtubules are polymeric protein structures and components of the cytoskeleton. Their dynamic polymerization is important for diverse cellular functions. The centrosome is the classical site of microtubule nucleation and is thought to be essential for axon growth and neuronal differentiation-processes that require microtubule assembly. We found that the centrosome loses its function as a microtubule organizing center during development of rodent hippocampal neurons. Axons still extended and regenerated through acentrosomal microtubule nucleation, and axons continued to grow after laser ablation of the centrosome in early neuronal development. Thus, decentralized microtubule assembly enables axon extension and regeneration, and, after axon initiation, acentrosomal microtubule nucleation arranges the cytoskeleton, which is the source of the sophisticated morphology of neurons.	[Stiess, Michael; Gomis-Rueth, Susana; Bradke, Frank] Max Planck Inst Neurobiol, Independent Jr Res Grp Axonal Growth & Regenerat, D-82152 Martinsried, Germany; [Maghelli, Nicola; Wilsch-Braeuninger, Michaela; Tolic-Norrelykke, Iva M.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Kapitein, Lukas C.; Hoogenraad, Casper C.] Erasmus MC, Dept Neurosci, NL-3015 GE Rotterdam, Netherlands	Max Planck Society; Max Planck Society; Erasmus University Rotterdam; Erasmus MC	Bradke, F (corresponding author), Max Planck Inst Neurobiol, Independent Jr Res Grp Axonal Growth & Regenerat, Klopferspitz 18, D-82152 Martinsried, Germany.	fbradke@neuro.mpg.de	Hoogenraad, Casper/B-8866-2011; Kapitein, Lukas C/J-4776-2016; Tolić, Iva/F-1704-2014; Stiess, Michael/ABF-9835-2020	Hoogenraad, Casper/0000-0002-2666-0758; Kapitein, Lukas C/0000-0001-9418-6739; Tolić, Iva/0000-0003-1305-7922; Stiess, Michael/0000-0001-5363-0389; Maghelli, Nicola/0000-0001-8450-8271; Bradke, Frank/0000-0002-0345-3772	Erasmus Medical Center; Netherlands Organization for Scientific Research; Netherlands Organization for Health Research and Development; European Science Foundation (ESF-EURYI); Human Frontier Science Program; Max Planck Society; International Foundation for Research in Paraplegia; Deutsche Forschungsgemeinschaft	Erasmus Medical Center; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); European Science Foundation (ESF-EURYI)(European Science Foundation (ESF)); Human Frontier Science Program(Human Frontier Science Program); Max Planck Society(Max Planck Society); International Foundation for Research in Paraplegia; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank L. Meyn, N. Keijzer, and M. Kuijpers for preparing hippocampal neurons; M. Braun for electron microscopy; T. Gollisch and D. Neukirchen for critically reading the manuscript; W. B. Huttner for his support; P. Gordon-Weeks, R. Klein, J. Kleylein-Sohn, E. Nigg, O. Stemmann, and G. Tavosanis for discussions; and A. Khodjakov, M. Distel, R. Koster, E. Nigg, and J. Salisbury for sharing antibodies and plasmids. Supported by the Erasmus Medical Center and the Netherlands Organization for Scientific Research (L. C. K.), the Netherlands Organization for Health Research and Development, the European Science Foundation (ESF-EURYI) (C. C. H.), a Career Development Award from the Human Frontier Science Program (F. B. and C. C. H.), the Max Planck Society, the International Foundation for Research in Paraplegia, and the Deutsche Forschungsgemeinschaft (F. B.).	AHMAD FJ, 1994, NEURON, V12, P271, DOI 10.1016/0896-6273(94)90270-4; Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Baas PW, 2005, TRENDS CELL BIOL, V15, P518, DOI 10.1016/j.tcb.2005.08.004; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Gomis-Ruth S, 2008, CURR BIOL, V18, P992, DOI 10.1016/j.cub.2008.06.026; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Ma YT, 2004, CURR BIOL, V14, P725, DOI 10.1016/j.cub.2004.03.061; Maghelli N, 2008, J BIOPHOTONICS, V1, P299, DOI 10.1002/jbio.200810026; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Terada S, 2000, CELL, V103, P141, DOI 10.1016/S0092-8674(00)00094-5; Wang L, 2002, CURR BIOL, V12, P1496, DOI 10.1016/S0960-9822(02)01078-3; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; YU WQ, 1993, J CELL BIOL, V122, P349, DOI 10.1083/jcb.122.2.349; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B; Zolessi FR, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-2	30	191	193	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					704	707		10.1126/science.1182179	http://dx.doi.org/10.1126/science.1182179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20056854				2022-12-28	WOS:000274251800042
J	Blumenthal, D				Blumenthal, David			Launching HITECH	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ELECTRONIC HEALTH RECORDS		Off Natl Coordinator Hlth Informat Technol, Washington, DC USA		Blumenthal, D (corresponding author), Off Natl Coordinator Hlth Informat Technol, Washington, DC USA.		Hug, Balthasar L./G-1568-2010					Blumenthal D, 2009, NEW ENGL J MED, V360, P1477, DOI 10.1056/NEJMp0901592; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Jha AK, 2009, NEW ENGL J MED, V360, P1628, DOI 10.1056/NEJMsa0900592	3	565	569	0	24	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2010	362	5					382	385		10.1056/NEJMp0912825	http://dx.doi.org/10.1056/NEJMp0912825			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	551FV	20042745				2022-12-28	WOS:000274193300003
J	Spencer, JR; Denk, T				Spencer, John R.; Denk, Tilmann			Formation of Iapetus' Extreme Albedo Dichotomy by Exogenically Triggered Thermal Ice Migration	SCIENCE			English	Article							GALILEAN SATELLITES; DARK SIDE; HIGH-RESOLUTION; SATURN SYSTEM; LAPETUS; PHOEBE; HYPERION; ORIGIN; DIONE; RHEA	The extreme albedo asymmetry of Saturn's moon Iapetus, which is about 10 times as bright on its trailing hemisphere as on its leading hemisphere, has been an enigma for three centuries. Deposition of exogenic dark material on the leading side has been proposed as a cause, but this alone cannot explain the global shape, sharpness, and complexity of the transition between Iapetus' bright and dark terrain. We demonstrate that all these characteristics, and the asymmetry's large amplitude, can be plausibly explained by runaway global thermal migration of water ice, triggered by the deposition of dark material on the leading hemisphere. This mechanism is unique to Iapetus among the saturnian satellites because its slow rotation produces unusually high daytime temperatures and water ice sublimation rates for a given albedo.	[Spencer, John R.] SW Res Inst, Boulder, CO 80304 USA; [Denk, Tilmann] Free Univ Berlin, D-12249 Berlin, Germany	Free University of Berlin	Spencer, JR (corresponding author), SW Res Inst, 1050 Walnut St,Suite 300, Boulder, CO 80304 USA.	spencer@boulder.swri.edu		Denk, Tilmann/0000-0003-0764-3677	Cassini project; NASA [NNX07AU40G, NNG04GK67G]; German Aerospace Center	Cassini project; NASA(National Aeronautics & Space Administration (NASA)); German Aerospace Center(Helmholtz AssociationGerman Aerospace Centre (DLR))	We dedicate this paper to the late Steve Ostro, for his invaluable insights into the subsurface structure of Iapetus. We acknowledge the magnificent work by the Cassini project that made possible the observations presented here, and in particular the work of J. Pearl, M. Segura, and other members of the Cassini CIRS team. Supported by the Cassini project and by NASA grants NNX07AU40G and NNG04GK67G, and by the German Aerospace Center (DLR).	BELL JF, 1985, ICARUS, V61, P192, DOI 10.1016/0019-1035(85)90101-0; Black GJ, 2004, SCIENCE, V304, P553, DOI 10.1126/science.1096470; BRYSON CE, 1974, J CHEM ENG DATA, V19, P107, DOI 10.1021/je60061a021; BURATTI B, 1984, ICARUS, V58, P254, DOI 10.1016/0019-1035(84)90042-3; BURATTI BJ, 1995, ICARUS, V115, P219, DOI 10.1006/icar.1995.1093; BURATTI BJ, 1991, ICARUS, V90, P1, DOI 10.1016/0019-1035(91)90064-Z; Buratti BJ, 2002, ICARUS, V155, P375, DOI 10.1006/icar.2001.6730; Buratti BJ, 1998, ICARUS, V136, P223, DOI 10.1006/icar.1998.6026; Burns JA, 1996, ASTR SOC P, V104, P179; Cassini J.D., 1677, PHILOS T R SOC, V12, P831; COOK AF, 1970, ICARUS, V13, P282, DOI 10.1016/0019-1035(70)90057-6; Cruikshank DP, 2008, ICARUS, V193, P334, DOI 10.1016/j.icarus.2007.04.036; CRUIKSHANK DP, 1983, ICARUS, V53, P90, DOI 10.1016/0019-1035(83)90023-4; DENK T, 2009, SCIENCE, V10; DENK T, 2000, LUNAR PLANET SCI C, V31, P1660; Flasar FM, 2005, SCIENCE, V307, P1247, DOI 10.1126/science.1105806; Flasar FM, 2004, SPACE SCI REV, V115, P169, DOI 10.1007/s11214-004-1454-9; GAULT DE, 1974, P LUNAR PLANET SCI C, V3, P2365; Hendrix AR, 2008, ICARUS, V193, P344, DOI 10.1016/j.icarus.2007.07.025; Howett CJA, 2010, ICARUS, V206, P573, DOI 10.1016/j.icarus.2009.07.016; Marchi S, 2002, ASTRON ASTROPHYS, V381, P1059, DOI 10.1051/0004-6361:20011587; MATTHEWS RAJ, 1992, Q J ROY ASTRON SOC, V33, P253; Mendis DA, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2008JA013532; MENDIS DA, 1974, ANNU REV EARTH PL SC, V2, P419, DOI 10.1146/annurev.ea.02.050174.002223; Moore JM, 1999, ICARUS, V140, P294, DOI 10.1006/icar.1999.6132; Morrison D., 1977, PLANETARY SATELLITES, P363; Ostro SJ, 2006, ICARUS, V183, P479, DOI 10.1016/j.icarus.2006.02.019; Owen TC, 2001, ICARUS, V149, P160, DOI 10.1006/icar.2000.6521; PETERSON C, 1975, ICARUS, V24, P499, DOI 10.1016/0019-1035(75)90069-X; Porco CC, 2005, SCIENCE, V307, P1237, DOI 10.1126/science.1107981; Prockter LM, 1998, ICARUS, V135, P317, DOI 10.1006/icar.1998.5981; PURVES NG, 1980, ICARUS, V43, P51, DOI 10.1016/0019-1035(80)90086-X; SMITH BA, 1982, SCIENCE, V215, P504, DOI 10.1126/science.215.4532.504; SOTER S, 1974, IAU C CORN U ITH NY, V28; SPENCER JR, 1987, ICARUS, V69, P297, DOI 10.1016/0019-1035(87)90107-2; SPENCER JR, 1989, ICARUS, V78, P337, DOI 10.1016/0019-1035(89)90182-6; SQUYRES SW, 1983, NATURE, V303, P782, DOI 10.1038/303782a0; TABAK RG, 1989, EARTH MOON PLANETS, V44, P251, DOI 10.1007/BF00054241; Wilson PD, 1996, ICARUS, V122, P92, DOI 10.1006/icar.1996.0111; [No title captured]	40	58	58	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 22	2010	327	5964					432	435		10.1126/science.1177132	http://dx.doi.org/10.1126/science.1177132			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20007862				2022-12-28	WOS:000273783100028
J	Kedhi, E; Joesoef, KS; McFadden, E; Wassing, J; van Mieghem, C; Goedhart, D; Smits, PC				Kedhi, Elvin; Joesoef, Kaiyum Sheik; McFadden, Eugene; Wassing, Jochem; van Mieghem, Carlos; Goedhart, Dick; Smits, Pieter Cornelis			Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial	LANCET			English	Article							CORONARY-ARTERY-DISEASE; DIABETIC-PATIENTS; CLINICAL-TRIALS; REVASCULARIZATION; THROMBOSIS; REGISTRY	Background Everolimus-eluting and paclitaxel-eluting stents, compared with bare metal stents, reduced the risk of restenosis in clinical trials with strict inclusion and exclusion criteria. We compared the safety and efficacy of the second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice. Methods We randomly assigned 1800 consecutive patients (aged 18-85 years) undergoing percutaneous coronary intervention at one Centre to treatment with everolimus-eluting or paclitaxel-eluting stents. The primary endpoint was a composite of safety and efficacy (all-cause mortality, myocardial infarction, and target vessel revascularisation) within 12 months. Patients were not told which stent they had been allocated. Analysis was by intention to treat. The trial is registered with ClinicalTrials.gov, number NCT01016041. Findings Follow-up was completed in 1797 patients. The primary endpoint occurred in 56 (6%) of 897 patients in the everolimus-eluting stent group versus 82 (9%) of 903 in the paclitaxel-eluting stent group (relative risk 0.69 [95% Cl 0.50-0.95], p value for superiority=0.02). The difference was attributable to a lower rate of stent thrombosis (6 [<1%] vs 23 [3%], 0.26 [0.11-0.64], p=0.002), myocardial infarction (25 [3%] vs 48 [5%], 0.52 [0.33-0.84], p=0.007), and target vessel revascularisation (21 [2%] vs 54 [6%], 0.39 [0.24-0.64], p=0.0001). Cardiac death, non-fatal myocardial infarction, or target lesion revascularisation occurred in 44 [5%] patients in the everolimus-eluting stent group versus 74 [8%] patients in the paclitaxel-eluting stent group, p value for superiority was 0.005. Interpretation The everolimus-eluting stent is better than the second generation paclitaxel-eluting stent in unselected patients in terms of safety and efficacy. On the basis of our results, we suggest that paclitaxel-eluting stents should no longer be used in everyday clinical practice.	[Kedhi, Elvin; Joesoef, Kaiyum Sheik; McFadden, Eugene; Wassing, Jochem; van Mieghem, Carlos; Smits, Pieter Cornelis] Maasstad Ziekenhuis, Dept Cardiol, NL-3075 EA Rotterdam, Netherlands	Maasstad Hospital	Smits, PC (corresponding author), Maasstad Ziekenhuis, Dept Cardiol, Groene Hilledijk 315, NL-3075 EA Rotterdam, Netherlands.	smitsp@maasstadziekenhuis.nl	Kedhi, Elvin/GNW-5801-2022		Abbott Vascular; Boston Scientific	Abbott Vascular(Abbott Laboratories); Boston Scientific(Boston Scientific)	The Research Foundation received unrestricted research grants from Abbott Vascular and Boston Scientific. We gratefully acknowledge the help of the research nurses, technicians, and medical staff in Maasstad Ziekenhuis and referring hospitals whose cooperation made this study possible.	Billinger M, 2008, EUR HEART J, V29, P718, DOI 10.1093/eurheartj/ehn021; Cutlip DE, 2007, CIRCULATION, V115, P2344, DOI 10.1161/CIRCULATIONAHA.106.685313; Daemen J, 2007, LANCET, V369, P667, DOI 10.1016/S0140-6736(07)60314-6; Dibra A, 2005, NEW ENGL J MED, V353, P663, DOI 10.1056/NEJMoa044372; Joner M, 2008, J AM COLL CARDIOL, V52, P333, DOI 10.1016/j.jacc.2008.04.030; Mauri L, 2007, NEW ENGL J MED, V356, P1020, DOI 10.1056/NEJMoa067731; Morice M, 2002, NEW ENGL J MED, V346, P1773, DOI 10.1056/NEJMoa012843; Moses JW, 2003, NEW ENGL J MED, V349, P1315, DOI 10.1056/NEJMoa035071; Ong ATL, 2005, J AM COLL CARDIOL, V45, P1135, DOI 10.1016/j.jacc.2005.01.008; Onuma Y, 2009, J AM COLL CARDIOL, V54, P269, DOI 10.1016/j.jacc.2009.05.016; Pocock SJ, 2002, LANCET, V359, P1686, DOI 10.1016/S0140-6736(02)08594-X; Serruys Patrick W, 2006, EuroIntervention, V2, P286; Serruys PW, 2009, NEW ENGL J MED, V360, P961, DOI 10.1056/NEJMoa0804626; STOKES M, 1995, CATEGORICAL DATA ANA; Stone GW, 2008, JAMA-J AM MED ASSOC, V299, P1903, DOI 10.1001/jama.299.16.1903; Stone GW, 2004, NEW ENGL J MED, V350, P221, DOI 10.1056/NEJMoa032441; Turco MA, 2007, J AM COLL CARDIOL, V49, P1676, DOI 10.1016/j.jacc.2007.01.069; Windecker S, 2005, NEW ENGL J MED, V353, P653, DOI 10.1056/NEJMoa051175; 2000, EUR HEART J, V21, P1502	19	543	564	2	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					201	209		10.1016/S0140-6736(09)62127-9	http://dx.doi.org/10.1016/S0140-6736(09)62127-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20060578				2022-12-28	WOS:000273853800029
J	Keller, HU; Barbieri, C; Koschny, D; Lamy, P; Rickman, H; Rodrigo, R; Sierks, H; A'Hearn, MF; Angrilli, F; Barucci, MA; Bertaux, JL; Cremonese, G; Da Deppo, V; Davidsson, B; De Cecco, M; Debei, S; Fornasier, S; Fulle, M; Groussin, O; Gutierrez, PJ; Hviid, SF; Ip, WH; Jorda, L; Knollenberg, J; Kramm, JR; Kuhrt, E; Kuppers, M; Lara, LM; Lazzarin, M; Moreno, JL; Marzari, F; Michalik, H; Naletto, G; Sabau, L; Thomas, N; Wenzel, KP; Bertini, I; Besse, S; Ferri, F; Kaasalainen, M; Lowry, S; Marchi, S; Mottola, S; Sabolo, W; Schroder, SE; Spjuth, S; Vernazza, P				Keller, H. U.; Barbieri, C.; Koschny, D.; Lamy, P.; Rickman, H.; Rodrigo, R.; Sierks, H.; A'Hearn, M. F.; Angrilli, F.; Barucci, M. A.; Bertaux, J. -L.; Cremonese, G.; Da Deppo, V.; Davidsson, B.; De Cecco, M.; Debei, S.; Fornasier, S.; Fulle, M.; Groussin, O.; Gutierrez, P. J.; Hviid, S. F.; Ip, W. -H.; Jorda, L.; Knollenberg, J.; Kramm, J. R.; Kuehrt, E.; Kueppers, M.; Lara, L. -M.; Lazzarin, M.; Lopez Moreno, J.; Marzari, F.; Michalik, H.; Naletto, G.; Sabau, L.; Thomas, N.; Wenzel, K. -P.; Bertini, I.; Besse, S.; Ferri, F.; Kaasalainen, M.; Lowry, S.; Marchi, S.; Mottola, S.; Sabolo, W.; Schroeder, S. E.; Spjuth, S.; Vernazza, P.			E-Type Asteroid (2867) Steins as Imaged by OSIRIS on Board Rosetta	SCIENCE			English	Article							COLLISIONAL HISTORY; 1999 KW4; MISSION; TARGET; BELT; ASTEROID-2867-STEINS; 2867-STEINS; STRENGTH; CRATERS; SYSTEM	The European Space Agency's Rosetta mission encountered the main-belt asteroid (2867) Steins while on its way to rendezvous with comet 67P/Churyumov-Gerasimenko. Images taken with the OSIRIS (optical, spectroscopic, and infrared remote imaging system) cameras on board Rosetta show that Steins is an oblate body with an effective spherical diameter of 5.3 kilometers. Its surface does not show color variations. The morphology of Steins is dominated by linear faults and a large 2.1-kilometer-diameter crater near its south pole. Crater counts reveal a distinct lack of small craters. Steins is not solid rock but a rubble pile and has a conical appearance that is probably the result of reshaping due to Yarkovsky-O'Keefe-Radzievskii-Paddack (YORP) spin-up. The OSIRIS images constitute direct evidence for the YORP effect on a main-belt asteroid.	[Keller, H. U.; Sierks, H.; Hviid, S. F.; Kramm, J. R.; Schroeder, S. E.; Spjuth, S.] Max Planck Inst Solar Syst Res, Katlenburg Lindau, Germany; [Barbieri, C.; Angrilli, F.; Cremonese, G.; De Cecco, M.; Debei, S.; Lazzarin, M.; Marzari, F.; Naletto, G.; Ferri, F.; Marchi, S.] Univ Padua, Padua, Italy; [Koschny, D.; Wenzel, K. -P.; Vernazza, P.] European Space & Technol Ctr, Noordwijk, Netherlands; [Lamy, P.; Groussin, O.; Jorda, L.; Besse, S.] Univ Aix Marseille 1, Lab Astrophys Marseille, Marseille, France; [Rickman, H.] Inst Astron Rymdfys, Uppsala, Sweden; [Rodrigo, R.; Gutierrez, P. J.; Lara, L. -M.; Lopez Moreno, J.; Bertini, I.; Sabolo, W.] CSIC, Inst Astrofis Andalucia, Granada, Spain; [A'Hearn, M. F.] Univ Maryland, College Pk, MD 20742 USA; [Barucci, M. A.; Fornasier, S.] Observ Paris, Meudon, France; [Bertaux, J. -L.] CNRS, Serv Aeron, F-91371 Verrieres Le Buisson, France; [Davidsson, B.] Uppsala Univ, Dept Phys & Astron, Uppsala, Sweden; [Fulle, M.] Scuola Int Super Studi Avanzati, Trieste, Italy; [Ip, W. -H.] Natl Cent Univ, Jhongli, Taiwan; [Knollenberg, J.; Kuehrt, E.; Mottola, S.] German Aerosp Ctr, Berlin, Germany; [Kueppers, M.] ESAC, Madrid, Spain; [Michalik, H.] Inst Comp & Network Engn, Braunschweig, Germany; [Sabau, L.] Inst Nacl Tecn Aerospacial, Torrejon De Ardoz, Spain; [Thomas, N.] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland; [Kaasalainen, M.] Tampere Univ Technol, FIN-33101 Tampere, Finland; [Lowry, S.] Univ Kent, Canterbury, Kent, England; [Rickman, H.] Polish Acad Sci, Space Res Ctr, PL-01237 Warsaw, Poland; [Da Deppo, V.] CNR, Ist Nazl Fis Mat, Padua, Italy	Max Planck Society; University of Padua; European Space Agency; UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Astrofisica de Andalucia (IAA); University System of Maryland; University of Maryland College Park; UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Centre National de la Recherche Scientifique (CNRS); Uppsala University; International School for Advanced Studies (SISSA); National Central University; Helmholtz Association; German Aerospace Centre (DLR); European Space Agency; University of Bern; Tampere University; University of Kent; Centrum Badan Kosmicznych, Polish Academy of Sciences; Polish Academy of Sciences; Space Research Centre of the Polish Academy of Sciences; Consiglio Nazionale delle Ricerche (CNR); Istituto Nazionale per la Fisica della Materia (INFM-CNR); University of Padua	Keller, HU (corresponding author), Max Planck Inst Solar Syst Res, Katlenburg Lindau, Germany.	keller@linmpi.mpg.de	Da Deppo, Vania/D-2897-2012; Jorda, Laurent/AAA-1718-2021; Moreno, Jose Juan Lopez/M-5537-2019; Kaasalainen, Mikko/G-4236-2014; Lara, Luisa M/F-5614-2012; Marzari, Francesco/X-2440-2019; Gutiérrez, Pedro J/AAJ-6177-2020; Schröder, Stefan/D-9709-2013; Rickman, Hans/X-7631-2018; Naletto, Giampiero/S-6329-2016; Thomas, Nicolas/G-4693-2015	Da Deppo, Vania/0000-0001-6273-8738; Moreno, Jose Juan Lopez/0000-0002-7946-2624; Lara, Luisa M/0000-0002-7184-920X; Gutiérrez, Pedro J/0000-0002-7332-6269; Schröder, Stefan/0000-0003-0323-8324; Rickman, Hans/0000-0002-9603-6619; Naletto, Giampiero/0000-0003-2007-3138; Lowry, Stephen/0000-0002-5605-4329; Debei, Stefano/0000-0002-6757-6616; Ferri, Francesca/0000-0003-2395-5275; Bertini, Ivano/0000-0002-0616-2444; Thomas, Nicolas/0000-0002-0146-0071; De Cecco, Mariolino/0000-0003-1562-0328; Cremonese, Gabriele/0000-0001-9021-1140; Besse, Sebastien/0000-0002-1052-5439; JORDA, Laurent/0000-0001-8735-3308; fulle, marco/0000-0001-8435-5287	Agenzie Spaziale Italiana; Centre National d'Etudes Spatiales; Deutsches Zentrum fur Luft- und Raumfahrt [50 QP 9703/8]; Swedish National Space Board; Ministerio de Educacion y Ciencia; ESA	Agenzie Spaziale Italiana; Centre National d'Etudes Spatiales(Centre National D'etudes Spatiales); Deutsches Zentrum fur Luft- und Raumfahrt(Helmholtz AssociationGerman Aerospace Centre (DLR)); Swedish National Space Board; Ministerio de Educacion y Ciencia(Spanish Government); ESA(European Space Agency)	OSIRIS was built by a European consortium and is part of the Rosetta spacecraft, provided by the European Space Agency (ESA). We thank the Rosetta Science Operations Centre and the Rosetta Mission Operations Centre for their support. We acknowledge the funding of the national space agencies Agenzie Spaziale Italiana, Centre National d'Etudes Spatiales, Deutsches Zentrum fur Luft- und Raumfahrt (contract number 50 QP 9703/8), Swedish National Space Board, the Spanish Space Program (Ministerio de Educacion y Ciencia), and the ESA.	Asphaug E, 2008, METEORIT PLANET SCI, V43, P1075, DOI 10.1111/j.1945-5100.2008.tb00694.x; Barucci MA, 2005, ASTRON ASTROPHYS, V430, P313, DOI 10.1051/0004-6361:20041505; Benner LAM, 2008, ICARUS, V198, P294, DOI 10.1016/j.icarus.2008.06.010; Bottke WF, 2005, ICARUS, V179, P63, DOI 10.1016/j.icarus.2005.05.017; Bowell E., 1989, ASTEROIDS, VII, P524; Burbine TH, 2002, METEORIT PLANET SCI, V37, P1233, DOI 10.1111/j.1945-5100.2002.tb00892.x; Chapman C.R, 2002, ASTEROIDS, VIII, P315; Clark BC, 2004, J GEOPHYS RES-PLANET, V109, DOI 10.1029/2004JE002319; Clark BE, 2002, ICARUS, V155, P189, DOI 10.1006/icar.2001.6748; Fornasier S, 2008, ICARUS, V196, P119, DOI 10.1016/j.icarus.2008.02.015; Fornasier S, 2001, ICARUS, V152, P127, DOI 10.1006/icar.2001.6623; Fornasier SF, 2006, ASTRON ASTROPHYS, V449, pL9, DOI 10.1051/0004-6361:20064913; GAFFEY MJ, 1992, ICARUS, V100, P95, DOI 10.1016/0019-1035(92)90021-X; Hapke B, 2002, ICARUS, V157, P523, DOI 10.1006/icar.2002.6853; Hendrix AR, 2006, ASTRON J, V132, P1396, DOI 10.1086/506426; Holsapple KA, 2009, PLANET SPACE SCI, V57, P127, DOI 10.1016/j.pss.2008.05.015; Keller HU, 2007, SPACE SCI REV, V128, P433, DOI 10.1007/s11214-006-9128-4; Lamy PL, 2008, ASTRON ASTROPHYS, V487, P1187, DOI 10.1051/0004-6361:20078996; Lamy PL, 2008, ASTRON ASTROPHYS, V487, P1179, DOI 10.1051/0004-6361:20078995; Lazzarin M, 2006, ASTROPHYS J, V647, pL179, DOI 10.1086/507448; Marchi S, 2006, ASTRON J, V131, P1138, DOI 10.1086/498721; McCoy TJ, 1999, METEORIT PLANET SCI, V34, P735, DOI 10.1111/j.1945-5100.1999.tb01386.x; Michel P, 2009, ICARUS, V200, P503, DOI 10.1016/j.icarus.2008.04.002; Nolan MC, 1996, ICARUS, V124, P359, DOI 10.1006/icar.1996.0214; O'Brien DP, 2006, ICARUS, V183, P79, DOI 10.1016/j.icarus.2006.02.008; Ostro SJ, 2006, SCIENCE, V314, P1276, DOI 10.1126/science.1133622; RICHARDSON DC, 2002, ASTEROIDS, V3, P501; Richardson JE, 2005, ICARUS, V179, P325, DOI 10.1016/j.icarus.2005.07.005; Rubincam DP, 2000, ICARUS, V148, P2, DOI 10.1006/icar.2000.6485; Scheeres DJ, 2006, SCIENCE, V314, P1280, DOI 10.1126/science.1133599; Vokrouhlicky D, 2003, NATURE, V425, P147, DOI 10.1038/nature01948; Walsh KJ, 2008, NATURE, V454, P188, DOI 10.1038/nature07078	32	94	95	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					190	193		10.1126/science.1179559	http://dx.doi.org/10.1126/science.1179559			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056887	Green Published			2022-12-28	WOS:000273394000031
J	Chernew, ME; Sabik, L; Chandra, A; Newhouse, JP				Chernew, Michael E.; Sabik, Lindsay; Chandra, Amitabh; Newhouse, Joseph P.			Ensuring the Fiscal Sustainability of Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COST		[Chernew, Michael E.; Sabik, Lindsay; Newhouse, Joseph P.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Chandra, Amitabh] Harvard Univ, John F Kennedy Sch Govt, Cambridge, MA 02138 USA	Harvard University; Harvard Medical School; Harvard University	Chernew, ME (corresponding author), Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA.		Newhouse, Joseph/AAD-9763-2019; Newhouse, Joseph/AGJ-5632-2022	Sabik, Lindsay/0000-0002-0613-4929				Chernew ME, 2008, AM J MANAG CARE, V14, P412; Chernew ME, 2007, HEALTH AFFAIR, V26, pW195, DOI 10.1377/hlthaff.26.2.w195; Chernew ME, 2009, HEALTH AFFAIR, V28, P1253, DOI 10.1377/hlthaff.28.5.1253; Fisher ES, 2003, ANN INTERN MED, V138, P273, DOI 10.7326/0003-4819-138-4-200302180-00006; Sutherland JM, 2009, NEW ENGL J MED, V361, P1227, DOI 10.1056/NEJMp0907172	5	26	27	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2010	362	1					1	3		10.1056/NEJMp0910194	http://dx.doi.org/10.1056/NEJMp0910194			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	540PA	20007553				2022-12-28	WOS:000273345500001
J	Falconer, E; Chavez, EA; Henderson, A; Poon, SSS; McKinney, S; Brown, L; Huntsman, DG; Lansdorp, PM				Falconer, Ester; Chavez, Elizabeth A.; Henderson, Alexander; Poon, Steven S. S.; McKinney, Steven; Brown, Lindsay; Huntsman, David G.; Lansdorp, Peter M.			Identification of sister chromatids by DNA template strand sequences	NATURE			English	Article							ADENOMATOUS POLYPOSIS-COLI; IN-SITU HYBRIDIZATION; APC TUMOR-SUPPRESSOR; EMBRYONIC STEM-CELLS; SATELLITE DNA; SEGREGATION; CHROMOSOMES; CENTROSOME; PROTEIN; ORIENTATION	It is generally assumed that sister chromatids are genetically and functionally identical and that segregation to daughter cells is a random process. However, functional differences between sister chromatids regulate daughter cell fate in yeast(1) and sister chromatid segregation is not random in Escherichia coli(2). Differentiated sister chromatids, coupled with non-random segregation, have been proposed to regulate cell fate during the development of multicellular organisms(3). This hypothesis has not been tested because molecular features to reliably distinguish between sister chromatids are not obvious. Here we show that parental 'Watson' and 'Crick' DNA template strands can be identified in sister chromatids of murine metaphase chromosomes using CO-FISH(chromosome orientation fluorescence in situ hybridization(4)) with unidirectional probes specific for centromeric and telomeric repeats. All chromosomes were found to have a uniform orientation with the 5' end of the short arm on the same strand as T-rich major satellite repeats. The invariable orientation of repetitive DNA was used to differentially label sister chromatids and directly study mitotic segregation patterns in different cell types. Whereas sister chromatids appeared to be randomly distributed between daughter cells in cultured lung fibroblasts and embryonic stem cells, significant non-random sister chromatid segregation was observed in a subset of colon crypt epithelial cells, including cells outside positions reported for colon stem cells(5). Our results establish that DNA template sequences can be used to distinguish sister chromatids and follow their mitotic segregation in vivo.	[Falconer, Ester; Chavez, Elizabeth A.; Henderson, Alexander; Poon, Steven S. S.; Lansdorp, Peter M.] British Columbia Canc Agcy, Terry Fox Lab, Vancouver, BC V5Z 1L3, Canada; [Poon, Steven S. S.; McKinney, Steven] British Columbia Canc Agcy, Mol Oncol & Breast Canc Program, Vancouver, BC V5Z 1L3, Canada; [Brown, Lindsay; Huntsman, David G.] British Columbia Canc Agcy, Ctr Translat & Appl Genom, Vancouver, BC V6H 3Z6, Canada; [Lansdorp, Peter M.] Univ British Columbia, Dept Med, Div Hematol, Vancouver, BC V5Z 1L3, Canada	British Columbia Cancer Agency; British Columbia Cancer Agency; British Columbia Cancer Agency; University of British Columbia	Lansdorp, PM (corresponding author), British Columbia Canc Agcy, Terry Fox Lab, 601 W 10th Ave, Vancouver, BC V5Z 1L3, Canada.	plansdor@bccrc.ca	Huntsman, David/ABE-6082-2020	Lansdorp, Peter/0000-0001-7435-1071; Brown, Lindsay/0000-0002-2790-5112	Canadian Institutes of Health Research [RMF-92093]; Michael Smith Foundation for Health Research; Canadian Cancer Society Research Institute; Terry Fox Foundation; British Columbia Cancer Agency; Canada Foundation for Innovation; British Columbia Knowledge Development Fund; British Columbia Cancer Foundation; Blossom Fund of the University of British Columbia; Mahon family; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094146] Funding Source: NIH RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Canadian Cancer Society Research Institute(Canadian Cancer Society (CCS)); Terry Fox Foundation; British Columbia Cancer Agency; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); British Columbia Knowledge Development Fund; British Columbia Cancer Foundation; Blossom Fund of the University of British Columbia; Mahon family; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	K. Lisaingo helped acquire images for this study, J. Tan helped with image analysis and C. J. S. Smith assisted with in vivo studies. We thank S. Selig, T. de Lange and R. C. Wang for help with CO-FISH protocols. S. Aparicio, L. Lefebvre, L. F. Lansdorp, B. M. Lansdorp and members of the Lansdorp laboratory are thanked for discussions and for critically reading the manuscript. This study was funded in part by grants from the Canadian Institutes of Health Research (RMF-92093), the Michael Smith Foundation for Health Research, the Canadian Cancer Society Research Institute and the Terry Fox Foundation. We are grateful to the British Columbia Cancer Agency, the Canada Foundation for Innovation, the British Columbia Knowledge Development Fund, the British Columbia Cancer Foundation, the Blossom Fund of the University of British Columbia and the Mahon family for funding the infrastructure that enabled this work.	ALLEN JW, 1976, NATURE, V260, P449, DOI 10.1038/260449a0; ALVES P, 1978, J CELL SCI, V32, P185; Armakolas A, 2006, SCIENCE, V311, P1146, DOI 10.1126/science.1120519; Bailey SM, 2004, CYTOGENET GENOME RES, V107, P14, DOI 10.1159/000079565; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Bell CD, 2005, HISTOL HISTOPATHOL, V20, P1313, DOI 10.14670/HH-20.1313; Bouck DC, 2007, CURR BIOL, V17, P741, DOI 10.1016/j.cub.2007.03.033; Bouzinba-Segard H, 2006, P NATL ACAD SCI USA, V103, P8709, DOI 10.1073/pnas.0508006103; Ding H, 2004, CELL, V117, P873, DOI 10.1016/j.cell.2004.05.026; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Garagna S, 2001, P NATL ACAD SCI USA, V98, P171, DOI 10.1073/pnas.98.1.171; Gertsenstein M, 2002, Methods Mol Biol, V185, P285; Hanson CA, 2005, GENE, V361, P1, DOI 10.1016/j.gene.2005.07.024; HORZ W, 1981, NUCLEIC ACIDS RES, V9, P683, DOI 10.1093/nar/9.3.683; Jansen LET, 2007, J CELL BIOL, V176, P795, DOI 10.1083/jcb.200701066; JOHNSON GD, 1982, J IMMUNOL METHODS, V55, P231, DOI 10.1016/0022-1759(82)90035-7; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kaplan KB, 2001, NAT CELL BIOL, V3, P429, DOI 10.1038/35070123; Karpowicz P, 2009, EUR J CELL BIOL, V88, P397, DOI 10.1016/j.ejcb.2009.03.001; Kita K, 2006, MOL BIOL CELL, V17, P2331, DOI 10.1091/mbc.E05-06-0498; KLAR AJS, 1987, NATURE, V326, P466, DOI 10.1038/326466a0; Lansdorp PM, 2007, CELL, V129, P1244, DOI 10.1016/j.cell.2007.06.017; Lew DJ, 2008, CELL, V133, P21, DOI 10.1016/j.cell.2008.03.016; LIN MS, 1974, SCIENCE, V185, P1179, DOI 10.1126/science.185.4157.1179; Luo S, 2003, P NATL ACAD SCI USA, V100, P11133, DOI 10.1073/pnas.1831011100; Meyne J, 1994, Methods Mol Biol, V33, P141; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; POTTEN CS, 1978, CELL, V15, P899, DOI 10.1016/0092-8674(78)90274-X; RUDERT F, 1995, MAMM GENOME, V6, P76, DOI 10.1007/BF00303248; SCHNEIDER EL, 1977, P NATL ACAD SCI USA, V74, P2041, DOI 10.1073/pnas.74.5.2041; Thorpe PH, 2009, P NATL ACAD SCI USA, V106, P6673, DOI 10.1073/pnas.0811248106; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; White MA, 2008, NATURE, V455, P1248, DOI 10.1038/nature07282; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910	35	74	76	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					93	U103		10.1038/nature08644	http://dx.doi.org/10.1038/nature08644			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20016487	Green Accepted			2022-12-28	WOS:000273344900037
J	Haig, AJ; Tomkins, CC				Haig, Andrew J.; Tomkins, Christy C.			Diagnosis and Management of Lumbar Spinal Stenosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LOW-BACK-PAIN; CLINICAL-PRACTICE GUIDELINE; SYMPTOMS; SURGERY		[Haig, Andrew J.; Tomkins, Christy C.] Univ Michigan, Ann Arbor, MI 48108 USA	University of Michigan System; University of Michigan	Haig, AJ (corresponding author), Univ Michigan, 325 E Eisenhower, Ann Arbor, MI 48108 USA.	andyhaig@umich.edu	Tomkins-Lane, Christy/H-5367-2016; Haig, Andrew/B-5206-2013	Tomkins-Lane, Christy/0000-0002-0416-8965; 				Botwin Kenneth, 2007, Pain Physician, V10, P547; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Chou R, 2009, SPINE, V34, P1066, DOI 10.1097/BRS.0b013e3181a1390d; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; Drew B, 2000, J SPINAL DISORD, V13, P253, DOI 10.1097/00002517-200006000-00010; Haig AJ, 2006, ARCH PHYS MED REHAB, V87, P897, DOI 10.1016/j.apmr.2006.03.016; Haig AJ, 2007, J BONE JOINT SURG AM, V89A, P358, DOI 10.2106/JBJS.E.00704; Kalichman L, 2009, SPINE J, V9, P545, DOI 10.1016/j.spinee.2009.03.005; North American Spine Society, 2007, EV BAS CLIN GUID MUL; Yagci I, 2009, AM J PHYS MED REHAB, V88, P843, DOI 10.1097/PHM.0b013e3181b333a9	10	57	61	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2010	303	1					71	72		10.1001/jama.2009.1946	http://dx.doi.org/10.1001/jama.2009.1946			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539YS	20051574				2022-12-28	WOS:000273296900024
J	Chung, JH; Pipavath, SN				Chung, Jonathan H.; Pipavath, Sudhakar N.			Intrathoracic Rib	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Chung, Jonathan H.; Pipavath, Sudhakar N.] Univ Washington, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle	Chung, JH (corresponding author), Univ Washington, Seattle, WA 98195 USA.	jchung2@u.washington.edu							0	5	5	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2557	2557		10.1056/NEJMicm0810515	http://dx.doi.org/10.1056/NEJMicm0810515			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535WX	20032325				2022-12-28	WOS:000273003700012
J	Peng, JC; Valouev, A; Swigut, T; Zhang, JM; Zhao, YM; Sidow, A; Wysocka, J				Peng, Jamy C.; Valouev, Anton; Swigut, Tomek; Zhang, Junmei; Zhao, Yingming; Sidow, Arend; Wysocka, Joanna			Jarid2/Jumonji Coordinates Control of PRC2 Enzymatic Activity and Target Gene Occupancy in Pluripotent Cells	CELL			English	Article							EMBRYONIC STEM-CELLS; HISTONE METHYLTRANSFERASE ACTIVITY; POLYCOMB-REPRESSIVE COMPLEX-2; GENOME-WIDE ANALYSIS; DEVELOPMENTAL REGULATORS; MOUSE DEVELOPMENT; POLE BLASTOMERES; H3K4 DEMETHYLASE; XENOPUS-LAEVIS; EZH2	Polycomb Repressive Complex 2 (PRC2) regulates key developmental genes in embryonic stem (ES) cells and during development. Here we show that Jarid2/Jumonji, a protein enriched in pluripotent cells and a founding member of the Jumonji C (JmjC) domain protein family, is a PRC2 subunit in ES cells. Genome-wide ChIP-seq analyses of Jarid2, Ezh2, and Suz12 binding reveal that Jarid2 and PRC2 occupy the same genomic regions. We further show that Jarid2 promotes PRC2 recruitment to the target genes while inhibiting PRC2 histone methyltransferase activity, suggesting that it acts as a "molecular rheostat" that finely calibrates PRC2 functions at developmental genes. Using Xenopus laevis as a model we demonstrate that Jarid2 knockdown impairs the induction of gastrulation genes in blastula embryos and results in failure of differentiation. Our findings illuminate a mechanism of histone methylation regulation in pluripotent cells and during early cell-fate transitions.	[Peng, Jamy C.; Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Valouev, Anton; Sidow, Arend] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Sidow, Arend] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Zhang, Junmei] Univ Texas SW Med Ctr Dallas, Prot Chem Technol Ctr, Dallas, TX 75390 USA; [Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Chicago	Wysocka, J (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wysocka@stanford.edu	Peng, Jamy/N-1134-2018	Peng, Jamy/0000-0002-4043-8475; Swigut, Tomek/0000-0002-7649-6781	CIRM New Faculty [RN1005791]; W. M. Keck Distinguished Young Scholar, and Searle Scholar Awards; American Cancer Society Postdoctoral Fellowship [PF0816001DDC]; NIH [R01DK082664]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082664] Funding Source: NIH RePORTER	CIRM New Faculty; W. M. Keck Distinguished Young Scholar, and Searle Scholar Awards; American Cancer Society Postdoctoral Fellowship(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Authors thank E. Benevolenskaya for Jarid1a antibodies; G. Narlikar for nucleosomes; Y. Zhang and Y. Shi, for the PRC2 and Jarid1a expression constructs; A. Vonica for the Xbra cDNA; and E. Heard (LF2), T. Magnuson (Eed-/-), and B. Panning (E14) for ES cell lines. We thank Z. Weng, P. Lacroute, and Stanford Pathology/Genetics UHT Sequencing Initiative for sequencing ChIP libraries; A. Sun for help with Eed-FLAG line derivation; R. Bajpai and Z. Ma for advice on ES culture and HMT assay, respectively. We thank members of the Wysocka lab for discussions; and E. Duncan, E. Grow, Z. Ma, A. Ring, A. Rada, and A. Roos for comments on the manuscript. This work was supported by the CIRM New Faculty (RN1005791), W. M. Keck Distinguished Young Scholar, and Searle Scholar Awards for J.W., American Cancer Society Postdoctoral Fellowship (PF0816001DDC) for J.C.P., and NIH R01DK082664 for Y.Z.	Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davisson M, 2006, MAMM GENOME, V17, P363, DOI 10.1007/s00335-006-0001-2; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Faust C, 1998, DEVELOPMENT, V125, P4495; HEASMAN J, 1984, CELL, V37, P185, DOI 10.1016/0092-8674(84)90314-3; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim H, 2009, NUCLEIC ACIDS RES, V37, P2940, DOI 10.1093/nar/gkp149; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim T, 2004, MOL CELL BIOL, V24, P10151, DOI 10.1128/MCB.24.23.10151-10160.2004; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morin-Kensicki Elizabeth M., 2001, Genesis The Journal of Genetics and Development, V31, P142, DOI 10.1002/gene.10017; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Simon JA, 2009, NAT REV MOL CELL BIO; SNAPE A, 1987, DEV BIOL, V119, P503, DOI 10.1016/0012-1606(87)90053-4; Sun Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003406; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	47	414	430	1	34	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1290	1302		10.1016/j.cell.2009.12.002	http://dx.doi.org/10.1016/j.cell.2009.12.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064375	Bronze, Green Accepted			2022-12-28	WOS:000273048700017
J	Burstrom, B				Burstrom, Bo			Looking to Europe Will Swedish healthcare reforms affect equity?	BRITISH MEDICAL JOURNAL			English	Editorial Material							SOCIOECONOMIC INEQUALITIES; WESTERN-EUROPE; MORTALITY; SWEDEN; MORBIDITY; CHOICE; INCOME		Karolinska Inst, SE-17176 Stockholm, Sweden	Karolinska Institutet	Burstrom, B (corresponding author), Karolinska Inst, SE-17176 Stockholm, Sweden.	bo.burstrom@ki.se		Burstrom, Bo/0000-0001-5770-9422				Ahs AMH, 2006, HEALTH POLICY, V78, P178, DOI 10.1016/j.healthpol.2005.10.010; Anell A, 2005, HEALTH ECON, V14, pS237, DOI 10.1002/hec.1039; Barr DA, 2008, J MED ETHICS, V34, P271, DOI 10.1136/jme.2006.019570; Burstrom B, 2002, HEALTH POLICY, V62, P117, DOI 10.1016/S0168-8510(02)00016-7; Burstrom B, 2009, INT J HEALTH SERV, V39, P271, DOI 10.2190/HS.39.2.c; Burstrom K, 2005, HEALTH ECON, V14, P831, DOI 10.1002/hec.977; Dahlgren G, 2008, INT J HEALTH SERV, V38, P697, DOI 10.2190/HS.38.4.g; Elofsson S, 1998, SOC SCI MED, V46, P1375, DOI 10.1016/S0277-9536(98)00030-6; Fotaki M, 2008, J HEALTH SERV RES PO, V13, P178, DOI 10.1258/jhsrp.2008.007163; Government Offices of Sweden (Regeringskansliet), HLTH MED CAR SWED; Hanratty Barbara, 2007, J Health Serv Res Policy, V12, P90, DOI 10.1258/135581907780279585; Heath I, 2008, BRIT MED J, V336, P1215, DOI 10.1136/bmj.a170; Lakarforbundet, 2009, LAK VARDV; Lundberg O., 2008, NORDIC EXPERIENCE WE; LUNDGREN B, 2009, INT J HLTH SERVICES, V39, P401; Mackenbach JP, 1997, LANCET, V349, P1655, DOI 10.1016/S0140-6736(96)07226-1; Martinussen P.E., 2009, NORDIC HLTH CARE SYS, P21; *MIN HLTH SOC AFF, 2002, MAL FOLKH; Narlid M, 2008, LAKARTIDNINGEN, V105, P2831; *NAT BOARD HLTH WE, 1998, SJUKV SVER 1998; *NAT BOARD HLTH WE, 2009, HALS OCH SJUKV 2009; National Board of Health and Welfare, 2009, FOLKH 2009; Nolte E, 2003, BRIT MED J, V327, P1129, DOI 10.1136/bmj.327.7424.1129; REHNBERG C, 2009, UPPFOLJNING VARDVAL, P6; Reinhardt UE, 2002, HEALTH AFFAIR, V21, P169, DOI 10.1377/hlthaff.21.3.169; Saltman R.B., 2009, NORDIC HLTH CARE SYS, P126; Sjonell Goran, 2008, Lakartidningen, V105, P829; *STOCKH COUNT COUN, PAT 2009; *SWED AUTH LOC AUT, 2005, SWED HLTH CAR INT CO; *SWED NAT I PUBL H, 2006, MOR HLTH PROM HLTH S; Vagero D, 1997, LANCET, V350, P516, DOI 10.1016/S0140-6736(97)26033-2; van der Zee J, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-94; van Doorslaer E, 2006, CAN MED ASSOC J, V174, P177, DOI 10.1503/cmaj.050584; VARDFORETAGARNA	34	15	15	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2009	339								b4566	10.1136/bmj.b4566	http://dx.doi.org/10.1136/bmj.b4566			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	536ZJ	20028781				2022-12-28	WOS:000273082200014
J	Kong, A; Steinthorsdottir, V; Masson, G; Thorleifsson, G; Sulem, P; Besenbacher, S; Jonasdottir, A; Sigurdsson, A; Kristinsson, KT; Jonasdottir, A; Frigge, ML; Gylfason, A; Olason, PI; Gudjonsson, SA; Sverrisson, S; Stacey, SN; Sigurgeirsson, B; Benediktsdottir, KR; Sigurdsson, H; Jonsson, T; Benediktsson, R; Olafsson, JH; Johannsson, OT; Hreidarsson, AB; Sigurdsson, G; Ferguson-Smith, AC; Gudbjartsson, DF; Thorsteinsdottir, U; Stefansson, K				Kong, Augustine; Steinthorsdottir, Valgerdur; Masson, Gisli; Thorleifsson, Gudmar; Sulem, Patrick; Besenbacher, Soren; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Kristinsson, Kari Th.; Jonasdottir, Adalbjorg; Frigge, Michael L.; Gylfason, Arnaldur; Olason, Pall I.; Gudjonsson, Sigurjon A.; Sverrisson, Sverrir; Stacey, Simon N.; Sigurgeirsson, Bardur; Benediktsdottir, Kristrun R.; Sigurdsson, Helgi; Jonsson, Thorvaldur; Benediktsson, Rafn; Olafsson, Jon H.; Johannsson, Oskar Th.; Hreidarsson, Astradur B.; Sigurdsson, Gunnar; Ferguson-Smith, Anne C.; Gudbjartsson, Daniel F.; Thorsteinsdottir, Unnur; Stefansson, Kari		DIAGRAM Consortium	Parental origin of sequence variants associated with complex diseases	NATURE			English	Article							GENOME-WIDE ASSOCIATION; IMPRINTED GENES; SUSCEPTIBILITY; EXPRESSION; IMPUTATION; KCNQ1	Effects of susceptibility variants may depend on from which parent they are inherited. Although many associations between sequence variants and human traits have been discovered through genome-wide associations, the impact of parental origin has largely been ignored. Here we show that for 38,167 Icelanders genotyped using single nucleotide polymorphism ( SNP) chips, the parental origin of most alleles can be determined. For this we used a combination of genealogy and long-range phasing. We then focused on SNPs that associate with diseases and are within 500 kilobases of known imprinted genes. Seven independent SNP associations were examined. Five-one with breast cancer, one with basal-cell carcinoma and three with type 2 diabetes-have parental-origin-specific associations. These variants are located in two genomic regions, 11p15 and 7q32, each harbouring a cluster of imprinted genes. Furthermore, we observed a novel association between the SNP rs2334499 at 11p15 and type 2 diabetes. Here the allele that confers risk when paternally inherited is protective when maternally transmitted. We identified a differentially methylated CTCF-binding site at 11p15 and demonstrated correlation of rs2334499 with decreased methylation of that site.	[Kong, Augustine; Steinthorsdottir, Valgerdur; Masson, Gisli; Thorleifsson, Gudmar; Sulem, Patrick; Besenbacher, Soren; Jonasdottir, Aslaug; Sigurdsson, Asgeir; Jonasdottir, Adalbjorg; Frigge, Michael L.; Gylfason, Arnaldur; Olason, Pall I.; Gudjonsson, Sigurjon A.; Sverrisson, Sverrir; Stacey, Simon N.; Gudbjartsson, Daniel F.; Thorsteinsdottir, Unnur; Stefansson, Kari] deCODE Genet, IS-101 Reykjavik, Iceland; [Sigurgeirsson, Bardur; Olafsson, Jon H.] Landspitali Univ Hosp, Dept Dermatol, IS-101 Reykjavik, Iceland; [Benediktsdottir, Kristrun R.] Landspitali Univ Hosp, Dept Pathol, IS-101 Reykjavik, Iceland; [Sigurdsson, Helgi; Johannsson, Oskar Th.] Landspitali Univ Hosp, Dept Oncol, IS-101 Reykjavik, Iceland; [Jonsson, Thorvaldur] Landspitali Univ Hosp, Dept Surg, IS-101 Reykjavik, Iceland; [Benediktsson, Rafn; Hreidarsson, Astradur B.; Sigurdsson, Gunnar] Landspitali Univ Hosp, Dept Endocrinol & Metab, IS-101 Reykjavik, Iceland; [Ferguson-Smith, Anne C.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Thorsteinsdottir, Unnur; Stefansson, Kari] Univ Iceland, Fac Med, IS-101 Reykjavik, Iceland	Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; Landspitali National University Hospital; University of Cambridge; University of Iceland	Kong, A (corresponding author), deCODE Genet, Sturlugata 8, IS-101 Reykjavik, Iceland.	kong@decode.is; kstefans@decode.is	Abecasis, Goncalo R/B-7840-2010; Stefansson, Kari/AAE-7187-2019; Sigurgeirsson, Bárður/B-6130-2011; Altshuler, David M/A-4476-2009; Sijbrands, Eric/A-1065-2009; Boehm, Bernhard Otto/F-8750-2015; FROGUEL, Philippe/O-6799-2017; Hide, Winston/R-3815-2019; Rudan, Igor/I-1467-2012; Ferguson-Smith, Anne C/G-7534-2011; Sigurgeirsson, Bardur/AAP-7755-2020; Aulchenko, Yurii/M-8270-2013; Elliott, Amanda/G-5120-2012; Hide, Winston A/V-2727-2017; Hide, Winston Hide/C-7217-2009; Campbell, Harry/E-2959-2010; Langenberg, Claudia/ABG-9067-2021; Walters, G. Bragi/L-4215-2013; Benediktsson, Rafn/R-2457-2018; Meitinger, Thomas/O-1318-2015; Griffin, Simon/K-3106-2013; McCarthy, Mark/M-3763-2015	Altshuler, David M/0000-0002-7250-4107; Sijbrands, Eric/0000-0001-8857-7389; FROGUEL, Philippe/0000-0003-2972-0784; Hide, Winston/0000-0002-8621-3271; Rudan, Igor/0000-0001-6993-6884; Aulchenko, Yurii/0000-0002-7899-1575; Hide, Winston A/0000-0002-8621-3271; Hide, Winston Hide/0000-0002-8621-3271; Campbell, Harry/0000-0002-6169-6262; Langenberg, Claudia/0000-0002-5017-7344; Walters, G. Bragi/0000-0002-5415-6487; Benediktsson, Rafn/0000-0002-2954-9801; Sigurgeirsson, Bardur/0000-0002-9733-9742; Kong, Augustine/0000-0001-8193-5438; Weedon, Michael/0000-0002-6174-6135; Van Duijn, Cornelia/0000-0002-2374-9204; Griffin, Simon/0000-0002-2157-4797; Bergman, Richard/0000-0003-1539-4471; Gudbjartsson, Daniel/0000-0002-5222-9857; Zeggini, Eleftheria/0000-0003-4238-659X; Gloyn, Anna/0000-0003-1205-1844; Saxena, Richa/0000-0003-2233-1065; Hattersley, Andrew/0000-0001-5620-473X; bennett, amanda/0000-0003-2140-8710; Ferguson-Smith, Anne/0000-0002-7608-5894; Lindgren, Cecilia/0000-0002-4903-9374; Pramstaller, Peter P/0000-0002-9831-8302; Steinthorsdottir, Valgerdur/0000-0003-1846-6274; Besenbacher, Soren/0000-0003-1455-1738; McCarthy, Mark/0000-0002-4393-0510; Jorgensen, Torben/0000-0001-9453-2830; Meitinger, Thomas/0000-0002-8838-8403; Dina, Christian/0000-0002-7722-7348; Abecasis, Goncalo/0000-0003-1509-1825; Gudjonsson, Sigurjon A./0000-0001-9314-7412	FP7-MC-IAPP [218071]; Medical Research Council [MC_U106179471, MC_U127592696, G9723500, MC_U106179474] Funding Source: researchfish; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK029867] Funding Source: NIH RePORTER; MRC [MC_U106179474, G9723500, MC_U127592696] Funding Source: UKRI	FP7-MC-IAPP; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This project was funded in part by FP7-MC-IAPP Grant agreement no. 218071 (CancerGene) to deCODE genetics.	Authier F, 2002, J BIOL CHEM, V277, P9437, DOI 10.1074/jbc.M110188200; Bell AC, 2000, NATURE, V405, P482, DOI 10.1038/35013100; Cuddapah S, 2009, GENOME RES, V19, P24, DOI 10.1101/gr.082800.108; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Feinberg AP, 2007, NATURE, V447, P433, DOI 10.1038/nature05919; Georges M, 2003, TRENDS GENET, V19, P248, DOI 10.1016/S0168-9525(03)00082-9; Goldberg M, 2003, HUM GENET, V112, P334, DOI 10.1007/s00439-003-0907-7; Hindorff LA, 2009, CATALOG PUBLISHED GE; Ideraabdullah FY, 2008, MUTAT RES-FUND MOL M, V647, P77, DOI 10.1016/j.mrfmmm.2008.08.008; Kim TH, 2007, CELL, V128, P1231, DOI 10.1016/j.cell.2006.12.048; Kong A, 2008, NAT GENET, V40, P1068, DOI 10.1038/ng.216; Luedi PP, 2007, GENOME RES, V17, P1723, DOI 10.1101/gr.6584707; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Morison IM, 2001, NUCLEIC ACIDS RES, V29, P275, DOI 10.1093/nar/29.1.275; Parker-Katiraee L, 2007, PLOS GENET, V3, P665, DOI 10.1371/journal.pgen.0030065; Rampersaud E, 2008, CURR DIABETES REV, V4, P329, DOI 10.2174/157339908786241179; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Thomas G, 2009, NAT GENET, V41, P579, DOI 10.1038/ng.353; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207	24	412	424	1	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					868	U59		10.1038/nature08625	http://dx.doi.org/10.1038/nature08625			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016592	Green Accepted			2022-12-28	WOS:000272795400032
J	Routes, JM; Grossman, WJ; Verbsky, J; Laessig, RH; Hoffman, GL; Brokopp, CD; Baker, MW				Routes, John M.; Grossman, William J.; Verbsky, James; Laessig, Ronald H.; Hoffman, Gary L.; Brokopp, Charles D.; Baker, Mei W.			Statewide Newborn Screening for Severe T-Cell Lymphopenia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SEVERE COMBINED IMMUNODEFICIENCY; RAC2; MUTATION; GTPASE	Context A newborn blood screening (NBS) test that could identify infants with a profound deficiency of T cells may result in a reduction in mortality. Objective To determine if quantitating T-cell receptor excision circles (TRECs) using real-time quantitative polymerase chain reaction on DNA extracted from dried blood spots on NBS cards can detect infants with T-cell lymphopenia in a statewide program. Design, Setting, and Participants Between January 1 and December 31, 2008, the Wisconsin State Laboratory of Hygiene screened all infants born in Wisconsin for T-cell lymphopenia by quantitating the number of TRECs contained in a 3.2-mm punch (approximately 3 mu L of whole blood) of the NBS card. Flow cytometry to enumerate the number of T cells was performed on full-term infants and preterm infants when they reached the equivalent of at least 37 weeks' gestation with TREC values of less than 25/mu L. Infants with T-cell lymphopenia were evaluated by a clinical immunologist. Main Outcome Measures The number of infants with TREC values of less than 25/mu L with T-cell lymphopenia confirmed by flow cytometry. Results Exactly 71 000 infants were screened by the TREC assay. Seventeen infants aged at least 37 weeks' gestation had at least 1 abnormal TREC assay (TREC values <25/mu L), 11 of whom had samples analyzed by flow cytometry to enumerate T cells. Eight infants demonstrated T-cell lymphopenia. The causes of the T-cell lymphopenia included DiGeorge syndrome (n=2), idiopathic T-cell lymphopenia (n=2), extravascular extravasation of lymphocytes (n=3), and a Rac2 mutation (n=1). The infant with the Rac2 mutation underwent successful cord blood transplantation. Conclusion In a statewide screening program, use of the TREC assay performed on NBS cards was able to identify infants with T-cell lymphopenia. JAMA. 2009; 302(22): 2465-2470	[Routes, John M.; Grossman, William J.; Verbsky, James] Med Coll Wisconsin, Dept Pediat, Milwaukee, WI 53226 USA; [Routes, John M.; Grossman, William J.; Verbsky, James] Childrens Res Inst, Milwaukee, WI USA; [Laessig, Ronald H.; Hoffman, Gary L.; Brokopp, Charles D.; Baker, Mei W.] Univ Wisconsin, Sch Med & Publ Hlth, Wisconsin State Lab Hyg, Madison, WI 53706 USA; [Laessig, Ronald H.; Brokopp, Charles D.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Populat Hlth Sci, Madison, WI 53706 USA; [Baker, Mei W.] Univ Wisconsin, Sch Med & Publ Hlth, Dept Pediat, Madison, WI 53706 USA	Medical College of Wisconsin; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Routes, JM (corresponding author), Med Coll Wisconsin, Dept Pediat, 9000 W Wisconsin Ave, Milwaukee, WI 53226 USA.	jroutes@mcw.edu	Routes, john/AAA-4833-2021	Routes, john/0000-0001-8378-3773	Children's Hospital of Wisconsin; Jeffrey Modell Foundation; Wisconsin State Laboratory of Hygiene; Centers for Disease Control and Prevention [U01 EH000365]; NATIONAL CENTER FOR ENVIRONMENTAL HEALTH [U01EH000365] Funding Source: NIH RePORTER	Children's Hospital of Wisconsin; Jeffrey Modell Foundation; Wisconsin State Laboratory of Hygiene; Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR ENVIRONMENTAL HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was supported by funding from the Children's Hospital of Wisconsin, the Jeffrey Modell Foundation, the Wisconsin State Laboratory of Hygiene, and the Centers for Disease Control and Prevention (grant U01 EH000365).	Ambruso DR, 2000, P NATL ACAD SCI USA, V97, P4654, DOI 10.1073/pnas.080074897; [Anonymous], 2006, GENET MED S1, V8, p1S; Baker MW, 2009, J ALLERGY CLIN IMMUN, V124, P522, DOI 10.1016/j.jaci.2009.04.007; Chan K, 2005, J ALLERGY CLIN IMMUN, V115, P391, DOI 10.1016/j.jaci.2004.10.012; Douek DC, 2000, LANCET, V355, P1875, DOI 10.1016/S0140-6736(00)02293-5; Dumont C, 2009, BLOOD, V113, P3990, DOI 10.1182/blood-2008-09-181180; Gu Y, 2001, J BIOL CHEM, V276, P15929, DOI 10.1074/jbc.M010445200; McGhee SA, 2005, J PEDIATR-US, V147, P603, DOI 10.1016/j.jpeds.2005.06.001; Morinishi Y, 2009, J PEDIATR-US, V155, P829, DOI 10.1016/j.jpeds.2009.05.026; Puck JM, 2007, J ALLERGY CLIN IMMUN, V120, P760, DOI 10.1016/j.jaci.2007.08.043; Verschuren MCM, 1997, J IMMUNOL, V158, P1208; Werther RL, 2009, J ALLERGY CLIN IMMUN, V124, P600, DOI 10.1016/j.jaci.2009.07.005; Williams DA, 2000, BLOOD, V96, P1646	13	145	152	0	5	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2465	2470		10.1001/jama.2009.1806	http://dx.doi.org/10.1001/jama.2009.1806			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529MD	19996402	Bronze			2022-12-28	WOS:000272520500026
J	Tsai, TT; Maddox, TM; Roe, MT; Dai, D; Alexander, KP; Ho, PM; Messenger, JC; Nallamothu, BK; Peterson, ED; Rumsfeld, JS				Tsai, Thomas T.; Maddox, Thomas M.; Roe, Matthew T.; Dai, David; Alexander, Karen P.; Ho, P. Michael; Messenger, John C.; Nallamothu, Brahmajee K.; Peterson, Eric D.; Rumsfeld, John S.		Natl Cardiovasc Data Registry	Contraindicated Medication Use in Dialysis Patients Undergoing Percutaneous Coronary Intervention	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CHRONIC-HEMODIALYSIS PATIENTS; DRUG-RELATED PROBLEMS; RENAL-INSUFFICIENCY; ENOXAPARIN; ANTICOAGULATION; REGISTRY	Context The US Food and Drug Administration guides clinicians through drug labeling of medications that are contraindicated or not recommended for use in specific patient groups. Little is known about the use of such medications and their effects on outcomes in clinical practice. Objective To investigate the use of the contraindicated/not-recommended agents enoxaparin and eptifibatide among dialysis patients undergoing percutaneous coronary intervention (PCI) and their association with outcomes. Design, Setting, and Participants Data from 829 US hospitals on 22 778 dialysis patients who underwent PCI between January 1, 2004, and August 31, 2008. Main Outcome Measures In-hospital bleeding and death. Results Five thousand eighty-four patients (22.3%) received a contraindicated antithrombotic; of these patients, 2375 (46.7%) received enoxaparin, 3261 (64.1%) received eptifibatide, and 552 (10.9%) received both. Compared with patients who did not receive a contraindicated antithrombotic, patients who did had higher rates of in-hospital bleeding (5.6% vs 2.9%; odds ratio [OR], 1.93; 95% confidence interval [CI], 1.66-2.23) and death (6.5% vs 3.9%; OR, 1.68; 95% CI, 1.46-1.95). After multivariable adjustment, patients receiving contraindicated antithrombotics had significantly higher risks of in-hospital bleeding (OR, 1.66; 95% CI, 1.43-1.92) and death (OR, 1.24; 95% CI, 1.04-1.48). In 10 158 patients matched by propensity scores, receipt of contraindicated antithrombotics remained significantly associated with in-hospital bleeding (OR, 1.63; 95% CI, 1.35-1.98) but not in-hospital death (OR, 1.15; 95% CI, 0.97-1.36). Conclusions In a sample of dialysis patients undergoing PCI, 22.3% received a contraindicated antithrombotic medication. In propensity-matched analysis, receipt of these medications was significantly associated with an increased risk of in-hospital major bleeding. JAMA. 2009; 302(22): 2458-2464	[Tsai, Thomas T.] Denver VA Med Ctr, Cardiol Sect 111B, Denver, CO 80220 USA; [Tsai, Thomas T.; Maddox, Thomas M.; Ho, P. Michael; Messenger, John C.; Rumsfeld, John S.] Univ Colorado, Denver, CO USA; [Tsai, Thomas T.; Maddox, Thomas M.; Ho, P. Michael; Rumsfeld, John S.] Colorado Cardiovasc Outcomes Res Grp, Denver, CO USA; [Roe, Matthew T.; Dai, David; Alexander, Karen P.; Peterson, Eric D.] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA; [Nallamothu, Brahmajee K.] Univ Michigan Hosp, Ann Arbor VA Med Ctr, Ann Arbor, MI 48109 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Colorado System; University of Colorado Denver; Duke University; University of Michigan System; University of Michigan	Tsai, TT (corresponding author), Denver VA Med Ctr, Cardiol Sect 111B, 1055 Clermont St, Denver, CO 80220 USA.	thomas.tsai@va.gov	Peterson, Eric David/ABF-5033-2021		NCDR CathPCI Registry; VA Health Services Research and Development Service (HSR&D) Career Development Award	NCDR CathPCI Registry; VA Health Services Research and Development Service (HSR&D) Career Development Award	This analysis was funded by the NCDR CathPCI Registry, which oversees the collection and management of data in the registry. Dr Ho is supported by a VA Health Services Research and Development Service (HSR&D) Career Development Award.	ANDERSON RJ, 1982, ARCH INTERN MED, V142, P1305, DOI 10.1001/archinte.142.7.1305; BATES DW, 1995, JAMA-J AM MED ASSOC, V274, P29, DOI 10.1001/jama.274.1.29; Brindis R G, 2001, J Am Coll Cardiol, V37, P2240, DOI 10.1016/S0735-1097(01)01372-9; Busby LT, 2001, AM J HEMATOL, V67, P54, DOI 10.1002/ajh.1077; Ebbesen J, 2001, ARCH INTERN MED, V161, P2317, DOI 10.1001/archinte.161.19.2317; Gerlach AT, 2000, PHARMACOTHERAPY, V20, P771, DOI 10.1592/phco.20.9.771.35210; Gurm HS, 2008, J AM COLL CARDIOL, V51, P529, DOI 10.1016/j.jacc.2007.09.053; KAPLAN B, 1994, ANN PHARMACOTHER, V28, P320, DOI 10.1177/106002809402800304; KAPLAN B, 1994, ANN PHARMACOTHER, V28, P316, DOI 10.1177/106002809402800303; Kohn L.T., 2000, ERR IS HUMAN BUILDIN, VVolume 600; Long CL, 2004, ANN PHARMACOTHER, V38, P853, DOI 10.1345/aph.1D399; Lysaght MJ, 2002, J AM SOC NEPHROL, V13, pS37; Manley Harold J, 2003, BMC Nephrol, V4, P10, DOI 10.1186/1471-2369-4-10; Manley HJ, 2003, AM J KIDNEY DIS, V41, P386, DOI 10.1053/ajkd.2003.50048; Mehta SK, 2009, CIRC-CARDIOVASC INTE, V2, P222, DOI 10.1161/CIRCINTERVENTIONS.108.846741; Shaw RE, 2002, J AM COLL CARDIOL, V39, P1104, DOI 10.1016/S0735-1097(02)01731-X; Thorevska N, 2004, CHEST, V125, P856, DOI 10.1378/chest.125.3.856; Weintraub WS, 1997, J AM COLL CARDIOL, V29, P459	18	60	60	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2458	2464		10.1001/jama.2009.1800	http://dx.doi.org/10.1001/jama.2009.1800			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529MD	19996401	Bronze			2022-12-28	WOS:000272520500025
J	Larrabee, WF; Hilger, PA				Larrabee, W. F.; Hilger, P. A.			The First Composite Face and Maxilla Transplant	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material								Objective: To discuss the technical and anatomical analysis and design of an osteocutaneous allograft transplant incorporating the donor maxilla and the execution of the operative protocol during the transplant. Methods: The Cleveland Clinic reported the world's first successful combined face and maxilla transplant in December 2008. Unlike the 3 prior face transplants, this surgical procedure was done as a salvage operation in a patient who had undergone 23 major reconstructive procedures. The additional complexity due to significant postoperative scarring and recipient vessel depletion presented a unique challenge in this case. The extensive 3-dimensional losses of facial structures in multiple tissue planes required a Le Fort III osteomyocutaneous allotransplant incorporating the donor maxilla. Results: We report the first successful transfer of a complete bony framework and soft-tissue envelope. The allograft has shown excellent integration and no long-term rejection. The traditional conception based on anatomical studies suggested this transfer would require independent dissection of the internal maxillary vascular system. This was not required in our patient whose allograft was based solely on the facial arterial system and its arcades. Conclusions: Successful near-total face and maxilla allograft transplant can be accomplished based on the facial arterial system and its arcades. This presents a novel method for reconstructing massive facial injuries with significant involvement of the facial skeleton.	[Larrabee, W. F.; Hilger, P. A.] Univ Washington, Larrabee Ctr, Seattle, WA 98122 USA	University of Washington; University of Washington Seattle	Larrabee, WF (corresponding author), Univ Washington, Larrabee Ctr, 600 Broadway,Ste 280, Seattle, WA 98122 USA.	larrabee@u.washington.edu						Alam DS, 2009, ARCH FACIAL PLAST S, V11, P369, DOI 10.1001/archfacial.2009.80; ALAM DS, 2009, AM AC FAC PLAST REC; Cordeiro PG, 2008, J SURG ONCOL, V97, P669, DOI 10.1002/jso.21017; Darwin, 1872, EXPRESSION EMOTIONS, P364; Wiggins OP, 2004, AM J BIOETHICS, V4, P1, DOI 10.1080/15265160490496507; Yazici I, 2007, ANN PLAS SURG, V58, P338, DOI 10.1097/01.sap.0000237683.72676.12	6	2	2	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	NOV 25	2009	302	20					2250	2251		10.1001/jama.2009.1666	http://dx.doi.org/10.1001/jama.2009.1666			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	523NI	20050327				2022-12-28	WOS:000272080500030
J	Weinstein, MC; Skinner, JA				Weinstein, Milton C.; Skinner, Jonathan A.			Comparative Effectiveness and Health Care Spending - Implications for Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							ERLOTINIB PLUS GEMCITABINE; ADVANCED PANCREATIC-CANCER; COST-EFFECTIVENESS; REGIONAL-VARIATIONS; OUTCOMES; SURGERY; THERAPY; TRIAL		[Weinstein, Milton C.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Weinstein, Milton C.; Skinner, Jonathan A.] Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Skinner, Jonathan A.] Dartmouth Coll, Dept Econ, Hanover, NH 03755 USA	Harvard University; Harvard T.H. Chan School of Public Health; Dartmouth College; Dartmouth College	Weinstein, MC (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA.				NIA NIH HHS [P01 AG019783, P01 AG019783-08, P01-AG19783] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG019783] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		[Anonymous], 2008, AHRQ PUBL, V08-0034 (1-4), P1; Baicker K, 2004, HEALTH AFFAIR, V23, pW4184, DOI 10.1377/hlthaff.W4.184; CEA Registry, CTR EV VAL RISK HLTH; Chandra A, 2007, J POLIT ECON, V115, P103, DOI 10.1086/512249; Cohen JT, 2008, NEW ENGL J MED, V358, P661, DOI 10.1056/NEJMp0708558; Elkin EB, 2004, J CLIN ONCOL, V22, P854, DOI 10.1200/JCO.2004.04.158; FELDSTEIN M, 2009, WASHINGTON POST 0727; Fisher ES, 2003, ANN INTERN MED, V138, P288, DOI 10.7326/0003-4819-138-4-200302180-00007; Fuchs V. R., 1974, WHO SHALL LIVE HLTH; Garber AM, 2008, ANN INTERN MED, V148, P964, DOI 10.7326/0003-4819-148-12-200806170-00223; Jones RH, 2009, NEW ENGL J MED, V360, P1705, DOI 10.1056/NEJMoa0900559; Kim JJ, 2002, JAMA-J AM MED ASSOC, V287, P2382, DOI 10.1001/jama.287.18.2382; Kirkley A, 2008, NEW ENGL J MED, V359, P1097, DOI 10.1056/NEJMoa0708333; Kirschner N, 2008, ANN INTERN MED, V148, P956, DOI 10.7326/0003-4819-148-12-200806170-00222; Landrum MB, 2008, HEALTH AFFAIR, V27, P159, DOI 10.1377/hlthaff.27.1.159; Mahadevia PJ, 2003, JAMA-J AM MED ASSOC, V289, P313, DOI 10.1001/jama.289.3.313; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Miksad RA, 2007, J CLIN ONCOL, V25, P4506, DOI 10.1200/JCO.2007.13.0401; Moore MJ, 2007, J CLIN ONCOL, V25, P1960, DOI 10.1200/JCO.2006.07.9525; OCONNOR AM, 2004, HLTH AFF MILLWOOD S, pVAR63, DOI DOI 10.1377/HLTHAFF.VAR.63; Ong MK, 2009, CIRC-CARDIOVASC QUAL, V2, P548, DOI 10.1161/CIRCOUTCOMES.108.825612; Russell LB, 1996, JAMA-J AM MED ASSOC, V276, P1172, DOI 10.1001/jama.276.14.1172; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Skinner J, 2005, ANALYSES IN THE ECONOMICS OF AGING, P129; Skinner J, 2009, 14865 NAT BUR EC RES; Stukel TA, 2005, JAMA-J AM MED ASSOC, V293, P1329, DOI 10.1001/jama.293.11.1329; Thompson D, 2007, VALUE HEALTH, V10, P367, DOI 10.1111/j.1524-4733.2007.00190.x; Tosteson ANA, 2008, ANN INTERN MED, V149, P845, DOI 10.7326/0003-4819-149-12-200812160-00003; Walter LC, 2006, JAMA-J AM MED ASSOC, V296, P2336, DOI 10.1001/jama.296.19.2336; 2009, NY TIMES        0215, pA1	30	171	172	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 4	2010	362	5					460	465		10.1056/NEJMsb0911104	http://dx.doi.org/10.1056/NEJMsb0911104			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	551FV	20054039	Green Accepted			2022-12-28	WOS:000274193300014
J	Hirose, K				Hirose, Kei			Deep Mantle Properties	SCIENCE			English	Editorial Material							POST-PEROVSKITE PHASE; SPIN TRANSITION; EARTHS MANTLE; IRON		Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan	Tokyo Institute of Technology	Hirose, K (corresponding author), Tokyo Inst Technol, Dept Earth & Planetary Sci, Meguro Ku, Tokyo 1528551, Japan.	kei@geo.titech.ac.jp	Hirose, Kei/C-2165-2009	Hirose, Kei/0000-0003-4366-7721				Badro J, 2003, SCIENCE, V300, P789, DOI 10.1126/science.1081311; Badro J, 2004, SCIENCE, V305, P383, DOI 10.1126/science.1098840; Crowhurst JC, 2008, SCIENCE, V319, P451, DOI 10.1126/science.1149606; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Irifune T, 2010, SCIENCE, V327, P193, DOI 10.1126/science.1181443; Kellogg LH, 1999, SCIENCE, V283, P1881, DOI 10.1126/science.283.5409.1881; Li J, 2007, GEOPHYS MONOGR SER, V174, P47, DOI 10.1029/174GM06; Lin JF, 2007, SCIENCE, V317, P1740, DOI 10.1126/science.1144997; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; OHTA K, EARTH PLANE IN PRESS; Olsen N, 1999, GEOPHYS J INT, V138, P179, DOI 10.1046/j.1365-246x.1999.00854.x; Tsuchiya T, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.198501; van der Hilst RD, 1999, SCIENCE, V283, P1885, DOI 10.1126/science.283.5409.1885; Wentzcovitch RM, 2009, P NATL ACAD SCI USA, V106, P8447, DOI 10.1073/pnas.0812150106	15	6	8	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					151	152		10.1126/science.1184786	http://dx.doi.org/10.1126/science.1184786			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056878				2022-12-28	WOS:000273394000020
J	Sheu, YJ; Stillman, B				Sheu, Yi-Jun; Stillman, Bruce			The Dbf4-Cdc7 kinase promotes S phase by alleviating an inhibitory activity in Mcm4	NATURE			English	Article							EUKARYOTIC DNA-REPLICATION; CDK-DEPENDENT PHOSPHORYLATION; BUDDING YEAST; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; COMPLEX; CDC7-DBF4; INITIATION; CHECKPOINT; CHROMATIN	Eukaryotic DNA replication uses kinase regulatory pathways to facilitate coordination with other processes during cell division cycles and response to environmental cues. At least two cell cycle-regulated protein kinase systems, the S-phase-specific cyclin-dependent protein kinases (S-CDKs) and the Dbf4-Cdc7 kinase (DDK, Dbf4-dependent protein kinase) are essential activators for initiation of DNA replication(1-5). Although the essential mechanism of CDK activation of DNA replication in Saccharomyces cerevisiae has been established(6,7), exactly how DDK acts has been unclear. Here we show that the amino terminal serine/threonine-rich domain (NSD) of Mcm4 has both inhibitory and facilitating roles in DNA replication control and that the sole essential function of DDK is to relieve an inhibitory activity residing within the NSD. By combining an mcm4 mutant lacking the inhibitory activity with mutations that bypass the requirement for CDKs for initiation of DNA replication, we show that DNA synthesis can occur in G1 phase when CDKs and DDK are limited. However, DDK is still required for efficient S phase progression. In the absence of DDK, CDK phosphorylation at the distal part of the Mcm4 NSD becomes crucial. Moreover, DDK-null cells fail to activate the intra-S-phase checkpoint in the presence of hydroxyurea-induced DNA damage and are unable to survive this challenge. Our studies establish that the eukaryote-specific NSD of Mcm4 has evolved to integrate several protein kinase regulatory signals for progression through S phase.	[Sheu, Yi-Jun; Stillman, Bruce] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Stillman, B (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	stillman@cshl.edu		Sheu, Yi-Jun/0000-0003-1612-5708; Stillman, Bruce/0000-0002-9453-4091	US National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045436] Funding Source: NIH RePORTER	US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Acknowledgements We thank A. Stenlund and H.-G. Wendel for critical reading of the manuscript, J. Li, H. Araki and J. Diffley for plasmids and yeast strains. This work was supported by a grant from the US National Institute of General Medical Sciences.	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Devault A, 2008, MOL BIOL CELL, V19, P2267, DOI 10.1091/mbc.E07-06-0614; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; LASKEY RA, 1989, SCIENCE, V246, P609, DOI 10.1126/science.2683076; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Ogi H, 2008, GENE, V414, P32, DOI 10.1016/j.gene.2008.02.010; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; Sclafani RA, 2000, J CELL SCI, V113, P2111; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	28	215	219	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					113	U127		10.1038/nature08647	http://dx.doi.org/10.1038/nature08647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054399	Green Accepted			2022-12-28	WOS:000273344900041
J	de Perrot, M; Shargall, Y				de Perrot, Marc; Shargall, Yaron			Vanishing Mediastinal Mass	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[de Perrot, Marc] Toronto Gen Hosp, Toronto, ON, Canada; [Shargall, Yaron] St Joseph Hosp, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Saint Joseph's Health Centre, Toronto	de Perrot, M (corresponding author), Toronto Gen Hosp, Toronto, ON, Canada.		Shargall, Yaron/AAS-5073-2021	Shargall, Yaron/0000-0001-8585-0327					0	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2653	2653		10.1056/NEJMicm0809572	http://dx.doi.org/10.1056/NEJMicm0809572			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042757				2022-12-28	WOS:000273181300013
J	Racki, LR; Yang, JG; Naber, N; Partensky, PD; Acevedo, A; Purcell, TJ; Cooke, R; Cheng, YF; Narlikar, GJ				Racki, Lisa R.; Yang, Janet G.; Naber, Nariman; Partensky, Peretz D.; Acevedo, Ashley; Purcell, Thomas J.; Cooke, Roger; Cheng, Yifan; Narlikar, Geeta J.			The chromatin remodeller ACF acts as a dimeric motor to space nucleosomes	NATURE			English	Article							DNA TRANSLOCATION; ISWI; COMPLEX; PROTEIN; FAMILY; CHRAC; RECOGNITION; DISRUPTION; MECHANISM; HELICASES	Evenly spaced nucleosomes directly correlate with condensed chromatin and gene silencing. The ATP-dependent chromatin assembly factor (ACF) forms such structures in vitro and is required for silencing in vivo. ACF generates and maintains nucleosome spacing by constantly moving a nucleosome towards the longer flanking DNA faster than the shorter flanking DNA. How the enzyme rapidly moves back and forth between both sides of a nucleosome to accomplish bidirectional movement is unknown. Here we show that nucleosome movement depends cooperatively on two ACF molecules, indicating that ACF functions as a dimer of ATPases. Further, the nucleotide state determines whether the dimer closely engages one or both sides of the nucleosome. Three-dimensional reconstruction by single-particle electron microscopy of the ATPase-nucleosome complex in an activated ATP state reveals a dimer architecture in which the two ATPases face each other. Our results indicate a model in which the two ATPases work in a coordinated manner, taking turns to engage either side of a nucleosome, thereby allowing processive bidirectional movement. This novel dimeric motor mechanism differs from that of dimeric motors such as kinesin and dimeric helicases that processively translocate unidirectionally and reflects the unique challenges faced by motors that move nucleosomes.	[Cheng, Yifan; Narlikar, Geeta J.] Univ Calif San Francisco, Dept Biochem & Biophys, WM Keck Adv Microscopy Lab, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Narlikar, GJ (corresponding author), Univ Calif San Francisco, Dept Biochem & Biophys, WM Keck Adv Microscopy Lab, 600 16th St, San Francisco, CA 94158 USA.	ycheng@ucsf.edu; geeta.narlikar@ucsf.edu	Yang, Janet/P-2003-2015	Acevedo, Ashley/0000-0002-3002-9854; Cheng, Yifan/0000-0001-9535-0369	Sandler Family Supporting Foundation; UCSF Academic Senate Shared Equipment Grant; National Institutes of Health; Beckman Foundation; US National Science Foundation Graduate Research Fellowships; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073767] Funding Source: NIH RePORTER	Sandler Family Supporting Foundation; UCSF Academic Senate Shared Equipment Grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; US National Science Foundation Graduate Research Fellowships(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Widom for the 601 plasmid. We thank H. Madhani, M. D. Simon, and members of the Narlikar laboratory for helpful discussion and comments on the manuscript. We thank R. Howard for help with equilibrium analytical ultracentrifugation; W. Ross, J. Lin, S. Hota and B. Bartholomew for advice on footprinting, and C. Cunningham for assistance with nucleosome depiction. This work was supported by grants from the Sandler Family Supporting Foundation ( Sandler Opportunity Award and New Technology Award in Basic Science to Y. C., Program for Breakthrough Biomedical Research (PBBR) Award to G. J. N.), UCSF Academic Senate Shared Equipment Grant ( to Y. C.), grants from the National Institutes of Health ( to R. C. and G. J. N.) and by the Beckman Foundation ( to G. J. N.). P. D. P. and J. G. Y. were supported by US National Science Foundation Graduate Research Fellowships. G. J. N. is a Leukemia and Lymphoma Society Scholar. G. J. N. wishes to acknowledge D. Herschlag's generative mentorship.	Aalfs JD, 2001, J BIOL CHEM, V276, P34270, DOI 10.1074/jbc.M104163200; BLOSSER TR, NATURE IN PRESS, DOI DOI 10.1038/NATURE08627; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Chin J, 2004, METHOD ENZYMOL, V376, P3; Clapier CR, 2001, MOL CELL BIOL, V21, P875, DOI 10.1128/MCB.21.3.875-883.2001; Clapier CR, 2002, NUCLEIC ACIDS RES, V30, P649, DOI 10.1093/nar/30.3.649; Corona DFV, 2007, PLOS BIOL, V5, P2011, DOI 10.1371/journal.pbio.0050232; Corona DFV, 1999, MOL CELL, V3, P239, DOI 10.1016/S1097-2765(00)80314-7; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Dang WW, 2006, MOL CELL BIOL, V26, P7388, DOI 10.1128/MCB.01159-06; Deuring R, 2000, MOL CELL, V5, P355, DOI 10.1016/S1097-2765(00)80430-X; Durr H, 2006, NUCLEIC ACIDS RES, V34, P4160, DOI 10.1093/nar/gkl540; Durr H, 2005, CELL, V121, P363, DOI 10.1016/j.cell.2005.03.026; Eberharter A, 2001, EMBO J, V20, P3781, DOI 10.1093/emboj/20.14.3781; Enernark EJ, 2008, CURR OPIN STRUC BIOL, V18, P243, DOI 10.1016/j.sbi.2008.01.007; Fazzio TG, 2005, MOL CELL BIOL, V25, P9165, DOI 10.1128/MCB.25.21.9165-9174.2005; Ferreira H, 2007, J MOL BIOL, V374, P563, DOI 10.1016/j.jmb.2007.09.059; Fyodorov DV, 2004, GENE DEV, V18, P170, DOI 10.1101/gad.1139604; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Grune T, 2003, MOL CELL, V12, P449, DOI 10.1016/S1097-2765(03)00273-9; Hamiche A, 2001, P NATL ACAD SCI USA, V98, P14316, DOI 10.1073/pnas.251421398; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kagalwala MN, 2004, EMBO J, V23, P2092, DOI 10.1038/sj.emboj.7600220; Langst G, 2004, BBA-GENE STRUCT EXPR, V1677, P58, DOI 10.1016/j.bbaexp.2003.10.011; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; Lohman TM, 1998, CELL, V93, P9, DOI 10.1016/S0092-8674(00)81139-3; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Naber N, 2007, BIOPHYS J, V92, P172, DOI 10.1529/biophysj.106.090035; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Racki LR, 2008, CURR OPIN GENET DEV, V18, P137, DOI 10.1016/j.gde.2008.01.007; RADERMACHER M, 1994, J CELL BIOL, V127, P411, DOI 10.1083/jcb.127.2.411; Rice S, 1999, NATURE, V402, P778, DOI 10.1038/45483; Rice S, 2003, BIOPHYS J, V84, P1844, DOI 10.1016/S0006-3495(03)74992-3; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Shogren-Knaak M, 2006, SCIENCE, V311, P844, DOI 10.1126/science.1124000; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; Sun FL, 2001, MOL CELL BIOL, V21, P2867, DOI 10.1128/MCB.21.8.2867-2879.2001; Thoma NH, 2005, NAT STRUCT MOL BIOL, V12, P350, DOI 10.1038/nsmb919; VargaWeisz PD, 1997, NATURE, V388, P598, DOI 10.1038/41587; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	47	134	134	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1016	1021		10.1038/nature08621	http://dx.doi.org/10.1038/nature08621			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033039	Green Accepted, Green Submitted			2022-12-28	WOS:000272996000038
J	Snyder, SH				Snyder, Solomon H.			Molecules of Madness	CELL			English	Editorial Material							OPIATE RECEPTOR; SCHIZOPHRENIA; BRAIN		Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University	Snyder, SH (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	ssnyder@jhmi.edu			NIDA NIH HHS [DA00074, DA00266] Funding Source: Medline; NIMH NIH HHS [MH18501] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH018501, R01MH018501] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P50DA000266] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Apud JA, 2007, CNS DRUGS, V21, P535, DOI 10.2165/00023210-200721070-00002; Boehning D, 2003, ANNU REV NEUROSCI, V26, P105, DOI 10.1146/annurev.neuro.26.041002.131047; BREDT DS, 1994, ANNU REV BIOCHEM, V63, P175, DOI 10.1146/annurev.bi.63.070194.001135; Chubb JE, 2008, MOL PSYCHIATR, V13, P36, DOI 10.1038/sj.mp.4002106; Cichon S, 2009, AM J PSYCHIAT, V166, P540, DOI 10.1176/appi.ajp.2008.08091354; COYLE JT, 1969, SCIENCE, V166, P899, DOI 10.1126/science.166.3907.899; Huffaker SJ, 2009, NAT MED, V15, P509, DOI 10.1038/nm.1962; HUGHES J, 1975, NATURE, V258, P577, DOI 10.1038/258577a0; Kramer P. D., 1993, LISTENING PROZAC; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Patil ST, 2007, NAT MED, V13, P1102, DOI 10.1038/nm1632; PERT CB, 1973, SCIENCE, V179, P1011, DOI 10.1126/science.179.4077.1011; SNYDER SH, 1975, NATURE, V257, P185, DOI 10.1038/257185a0; Subramaniam S, 2009, SCIENCE, V324, P1327, DOI 10.1126/science.1172871; Yang GD, 2008, SCIENCE, V322, P587, DOI 10.1126/science.1162667	15	1	1	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 24	2009	139	7					1212	1215		10.1016/j.cell.2009.12.020	http://dx.doi.org/10.1016/j.cell.2009.12.020			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064363	Bronze			2022-12-28	WOS:000273048700004
J	Bohorquez, JC; Gourley, S; Dixon, AR; Spagat, M; Johnson, NF				Camilo Bohorquez, Juan; Gourley, Sean; Dixon, Alexander R.; Spagat, Michael; Johnson, Neil F.			Common ecology quantifies human insurgency	NATURE			English	Article							POWER-LAW DISTRIBUTIONS; DECISION-MAKING; BEHAVIOR	Many collective human activities, including violence, have been shown to exhibit universal patterns(1-19). The size distributions of casualties both in whole wars from 1816 to 1980 and terrorist attacks have separately been shown to follow approximate power-law distributions(6,7,9,10). However, the possibility of universal patterns ranging across wars in the size distribution or timing of within-conflict events has barely been explored. Here we show that the sizes and timing of violent events within different insurgent conflicts exhibit remarkable similarities. We propose a unified model of human insurgency that reproduces these commonalities, and explains conflict-specific variations quantitatively in terms of underlying rules of engagement. Our model treats each insurgent population as an ecology of dynamically evolving, self-organized groups following common decision-making processes. Our model is consistent with several recent hypotheses about modern insurgency(18-20), is robust to many generalizations(21), and establishes a quantitative connection between human insurgency, global terrorism(10) and ecology(13-17,22,23). Its similarity to financial market models(24-26) provides a surprising link between violent and non-violent forms of human behaviour.	[Gourley, Sean; Johnson, Neil F.] Univ Miami, Dept Phys, Complex Syst Grp, Miami, FL 33126 USA; [Camilo Bohorquez, Juan] Univ Los Andes, Dept Ind Engn, Bogota, Colombia; [Camilo Bohorquez, Juan] Univ Los Andes, CEIBA Complex Syst Res Ctr, Bogota, Colombia; [Dixon, Alexander R.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Spagat, Michael] Univ London, Royal Holloway Coll, Dept Econ, Egham TW20 0EX, Surrey, England	University of Miami; Universidad de los Andes (Colombia); CEIBA; Universidad de los Andes (Colombia); University of Cambridge; University of London; Royal Holloway University London	Johnson, NF (corresponding author), Univ Miami, Dept Phys, Complex Syst Grp, Miami, FL 33126 USA.	njohnson@physics.miami.edu	Bohorquez Pinzon, Juan Camilo/B-8008-2012	Dixon, Alexander/0000-0001-7628-4052				Adams ES, 2003, BEHAV ECOL, V14, P719, DOI 10.1093/beheco/arg061; Barabasi AL, 2005, NATURE, V435, P207, DOI 10.1038/nature03459; Cederman LE, 2003, AM POLIT SCI REV, V97, P135, DOI 10.1017/S0003055403000571; Clauset A, 2007, J CONFLICT RESOLUT, V51, P58, DOI 10.1177/0022002706296157; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Couzin ID, 2005, NATURE, V433, P513, DOI 10.1038/nature03236; DHULST R, 2000, INT J THEOR APPL FIN, V3, P609, DOI DOI 10.1142/S0219024900000784; Dussutour A, 2004, NATURE, V428, P70, DOI 10.1038/nature02345; Eguiluz VM, 2000, PHYS REV LETT, V85, P5659, DOI 10.1103/PhysRevLett.85.5659; Epstein JM., 1997, NONLINEAR DYNAMICS M; Flack J, 2008, NATURE, V453, P451, DOI 10.1038/453451a; Gabaix X, 2003, NATURE, V423, P267, DOI 10.1038/nature01624; Galam S, 2003, PHYSICA A, V323, P695, DOI 10.1016/S0378-4371(03)00006-2; Hammes Thomas X., 2004, SLING STONE WAR 21 C; Hicks MHR, 2009, NEW ENGL J MED, V360, P1585, DOI 10.1056/NEJMp0807240; Johnson DDP, 2008, NATURAL SECURITY: A DARWINIAN APPROACH TO A DANGEROUS WORLD, P159; Johnson N. F., 2003, FINANCIAL MARKET COM; Johnson NF, 2006, UNIVERSAL PATTERNS U; Lim M, 2007, SCIENCE, V317, P1540, DOI 10.1126/science.1142734; Lux T, 1999, NATURE, V397, P498, DOI 10.1038/17290; MANTEGNA RN, 1995, NATURE, V376, P46, DOI 10.1038/376046a0; May R., 2007, THEORETICAL ECOLOGY, V3rd; Packer George, 2006, NEW YORKER      1218; Palla G, 2007, NATURE, V446, P664, DOI 10.1038/nature05670; RICHARDSON LF, 1948, J AM STAT ASSOC, V43, P523, DOI 10.2307/2280704; Robb J, 2007, BRAVE NEW WAR NEXT S; Ruszczycki B, 2009, EUR PHYS J B, V72, P289, DOI 10.1140/epjb/e2009-00354-5; SPIRLING A, NEXT BIG THING SCALE; Wang W, 2009, P NATL ACAD SCI USA, V106, P8423, DOI 10.1073/pnas.0811782106; WRANGHAM RW, 1985, EMERGING SYNTHESIS S, P123	30	140	143	1	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					911	914		10.1038/nature08631	http://dx.doi.org/10.1038/nature08631			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016600				2022-12-28	WOS:000272795400041
J	Baker, WL; Coleman, CI; Kluger, J; Reinhart, KM; Talati, R; Quercia, R; Phung, OJ; White, CM				Baker, William L.; Coleman, Craig I.; Kluger, Jeffrey; Reinhart, Kurt M.; Talati, Ripple; Quercia, Robert; Phung, Olivia J.; White, C. Michael			Systematic Review: Comparative Effectiveness of Angiotensin-Converting Enzyme Inhibitors or Angiotensin II-Receptor Blockers for Ischemic Heart Disease	ANNALS OF INTERNAL MEDICINE			English	Review							CORONARY-ARTERY-DISEASE; VENTRICULAR SYSTOLIC DYSFUNCTION; HIGH-RISK PATIENTS; BASE-LINE CHARACTERISTICS; PLACEBO-CONTROLLED TRIAL; CARDIOVASCULAR EVENTS; MYOCARDIAL-INFARCTION; BLOOD-PRESSURE; ACE-INHIBITOR; SECONDARY PREVENTION	Background: Patients with ischemic heart disease and preserved ventricular function experience considerable morbidity and mortality despite standard medical therapy. Purpose: To compare benefits and harms of using angiotensin-converting enzyme (ACE) inhibitors, angiotensin II-receptor blockers (ARBs), or combination therapy in adults with stable ischemic heart disease and preserved ventricular function. Data Sources: MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Cochrane Database of Systematic Reviews (earliest date, July 2009) were searched without language restrictions. Study Selection: Two independent investigators screened citations for trials of at least 6 months' duration that compared ACE inhibitors, ARBs, or combination therapy with placebo or active control and reported any of several clinical outcomes. Data Extraction: Using standardized protocols, 2 independent investigators extracted information about study characteristics and rated the quality and strength of evidence. Disagreement was resolved by consensus. Data Synthesis: 41 studies met eligibility criteria. Moderate-to high-strength evidence (7 trials; 32 559 participants) showed that ACE inhibitors reduce the relative risk (RR) for total mortality (RR, 0.87 [95% CI, 0.81 to 0.94]) and nonfatal myocardial infarction (RR, 0.83 [CI, 0.73 to 0.94]) but increase the RR for syncope (RR, 1.24 [CI, 1.02 to 1.52]) and cough (RR, 1.67 [CI, 1.22 to 2.29]) compared with placebo. Low-strength evidence (1 trial; 5926 participants) suggested that ARBs reduce the RR for the composite end point of cardiovascular mortality, nonfatal myocardial infarction, or stroke (RR, 0.88 [CI, 0.77 to 1.00]) but not for the individual components. Moderate-strength evidence (1 trial; 25 620 participants) showed similar effects on total mortality (RR, 1.07 [CI, 0.98 to 1.16]) and myocardial infarction (RR, 1.08 [CI, 0.94 to 1.23]) but an increased risk for discontinuations because of hypotension (P < 0.001) and syncope (P = 0.035) with combination therapy compared with ACE inhibitors alone. Limitations: Many studies either did not assess or did not report harms in a systematic manner. Many studies did not adequately report benefits or harms by various patient subgroups. Conclusion: Adding an ACE inhibitor to standard medical therapy improves outcomes, including reduced risk for mortality and myocardial infarctions, in some patients with stable ischemic heart disease and preserved ventricular function. Less evidence supports a benefit of ARB therapy, and combination therapy seems no better than ACE inhibitor therapy alone and increases harms.	[Baker, William L.; Coleman, Craig I.; Kluger, Jeffrey; Reinhart, Kurt M.; Talati, Ripple; Quercia, Robert; Phung, Olivia J.; White, C. Michael] Univ Connecticut, Harefield Hosp, Evidence Based Practice Ctr, Hartford, CT 06102 USA	Royal Brompton & Harefield NHS Foundation Trust; Harefield Hospital; University of Connecticut	White, CM (corresponding author), Univ Connecticut, Harefield Hosp, Evidence Based Practice Ctr, 80 Seymour St, Hartford, CT 06102 USA.	cmwhite@harthosp.org	Baker, William L./H-7977-2016	Baker, William L./0000-0003-2172-0931; Coleman, Craig/0000-0003-4868-7158	University of Connecticut/Hartford Hospital Evidence-based Practice Center [290-2007-10067-I]; Agency for Healthcare Research and Quality [290-2007-10067-I]	University of Connecticut/Hartford Hospital Evidence-based Practice Center; Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	By the University of Connecticut/Hartford Hospital Evidence-based Practice Center (contract 290-2007-10067-I) with the Agency for Healthcare Research and Quality.	Al-Mallah MH, 2006, J AM COLL CARDIOL, V47, P1576, DOI 10.1016/j.jacc.2005.11.073; Bax L, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-40; Bertrand ME, 2007, INT J CARDIOL, V121, P57, DOI 10.1016/j.ijcard.2006.11.100; Bertrand ME, 2009, ARCH CARDIOVASC DIS, V102, P89, DOI 10.1016/j.acvd.2008.10.012; Borghi C, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.12.005; Bosch J, 2005, CIRCULATION, V112, P1339, DOI 10.1161/CIRCULATIONAHA.105.548461; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; Brugts JJ, 2007, J AM COLL CARDIOL, V50, P2148, DOI 10.1016/j.jacc.2007.08.029; Brunner-La Rocca HP, 2003, CHEST, V124, P1192, DOI 10.1378/chest.124.4.1192; Cohn JN, 2001, NEW ENGL J MED, V345, P1667, DOI 10.1056/NEJMoa010713; COLEMAN CI, 2009, COMP EFFECTIVENESS R; Dagenais GR, 2006, LANCET, V368, P581, DOI 10.1016/S0140-6736(06)69201-5; Dagenais GR, 2001, CIRCULATION, V104, P522, DOI 10.1161/hc3001.093502; Daly CA, 2005, EUR HEART J, V26, P1369, DOI 10.1093/eurheartj/ehi225; Danchin N, 2006, ARCH INTERN MED, V166, P787, DOI 10.1001/archinte.166.7.787; Deckers JW, 2006, EUR HEART J, V27, P796, DOI 10.1093/eurheartj/ehi809; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Dzau VJ, 2002, CARDIOVASC DRUG THER, V16, P149, DOI 10.1023/A:1015709617405; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fox KM, 2007, AM HEART J, V153, P629, DOI 10.1016/j.ahj.2007.01.032; Fox KM, 2003, LANCET, V362, P782; Fox KM, 1998, EUR HEART J, V19, pJ52; Fraker TD, 2007, J AM COLL CARDIOL, V50, P2264, DOI [10.1016/j.jacc.2007.08.002, 10.1161/CIRCULATIONAHA.107.187930]; GARG R, 1995, JAMA-J AM MED ASSOC, V273, P1450, DOI 10.1001/jama.273.18.1450; Gerstein HC, 1996, DIABETES CARE, V19, P1225, DOI 10.2337/diacare.19.11.1225; Gerstein HC, 2000, LANCET, V355, P253; Gianni M, 2007, EUR HEART J, V28, P1382, DOI 10.1093/eurheartj/ehm017; Gibbons RJ, 2003, CIRCULATION, V107, P149, DOI 10.1161/01.CIR.0000047041.66447.29; Gomma AH, 2001, CARDIOVASC DRUG THER, V15, P169, DOI 10.1023/A:1011131130922; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Kjoller-Hansen L, 1998, SCAND CARDIOVASC J, V32, P225, DOI 10.1080/14017439850140012; KOBER L, 1995, NEW ENGL J MED, V333, P1670, DOI 10.1056/NEJM199512213332503; Kondo J, 2003, AM HEART J, V146, DOI 10.1016/S0002-8703(03)00443-5; Lang Christopher D, 2008, J Cardiometab Syndr, V3, P45, DOI 10.1111/j.1559-4572.2008.07128.x; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; *LONG TERM EV SMIL, 1995, NEW ENGL J MED, V332, P80; Lonn EM, 2001, CIRCULATION, V103, P919; MacMahon S, 2000, J AM COLL CARDIOL, V36, P438, DOI 10.1016/S0735-1097(00)00736-1; Mancia Giuseppe, 2008, Medscape J Med, V10 Suppl, pS7; Mann JFE, 2005, CLIN NEPHROL, V63, P181; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; McMurray JJV, 2003, LANCET, V362, P767, DOI 10.1016/S0140-6736(03)14283-3; Mindlen F, 1996, CAN J CARDIOL, V12, P127; Morgan TO, 2000, AM J HYPERTENS, V13, P1161, DOI 10.1016/S0895-7061(00)01204-8; Nissen SE, 2004, JAMA-J AM MED ASSOC, V292, P2217, DOI 10.1001/jama.292.18.2217; Pavlicevic I, 2008, J POPUL THER CLIN PH, V15, pE372; Pfeffer MA, 2003, NEW ENGL J MED, V349, P1893, DOI 10.1056/NEJMoa032292; Pfeffer MA, 2003, LANCET, V362, P759, DOI 10.1016/S0140-6736(03)14282-1; Pfeffer MA, 1998, AM J CARDIOL, V82, p25H; Pilote L, 2004, ANN INTERN MED, V141, P102, DOI 10.7326/0003-4819-141-2-200407200-00008; Pitt B, 2000, LANCET, V355, P1582, DOI 10.1016/S0140-6736(00)02213-3; Remme WJ, 2007, CARDIOVASC DRUG THER, V21, P405, DOI 10.1007/s10557-007-6071-x; Remme WJ, 2009, CARDIOVASC DRUG THER, V23, P161, DOI 10.1007/s10557-008-6143-6; Rosendorff C, 2007, CIRCULATION, V115, P2761, DOI 10.1161/CIRCULATIONAHA.107.183885; Saha SA, 2008, DIABETES OBES METAB, V10, P41, DOI 10.1111/j.1463-1326.2006.00688.x; Saha SA, 2007, J CARDIOVASC PHARM T, V12, P192, DOI 10.1177/1074248407304791; Salehian O, 2007, AM HEART J, V154, P448, DOI 10.1016/j.ahj.2007.04.062; Schunemann H, 2008, GRADE HDB GRADING QU; Shah Apurva D, 2005, Clin Cardiol, V28, P551; Shea BJ, 2007, BMC MED RES METHODOL, V7, DOI 10.1186/1471-2288-7-10; Simoons ML, 1998, EUR HEART J, V19, pJ56; Solomon SD, 2006, CIRCULATION, V114, P26, DOI 10.1161/CIRCULATIONAHA.105.592733; Spaulding C, 1998, CIRCULATION, V98, P757, DOI 10.1161/01.CIR.98.8.757; Takahashi A, 2006, NEPHROL DIAL TRANSPL, V21, P2507, DOI 10.1093/ndt/gfl293; Teo KK, 1997, CAN J CARDIOL, V13, P591; Teo KK, 2000, CIRCULATION, V102, P1748; Teo KK, 2004, AM HEART J, V148, P52, DOI 10.1016/j.ahj.2004.03.020; Topouchian J, 2007, VASC HEALTH RISK MAN, V3, P381; TOWNEND JN, 1995, BRIT HEART J, V73, P434; Unger T, 2003, AM J CARDIOL, V91, p28G, DOI 10.1016/S0002-9149(03)00230-3; Wong SSL, 2006, J MED LIBR ASSOC, V94, P451; Yui Y, 2004, HYPERTENS RES, V27, P449, DOI 10.1291/hypres.27.449; Yui Y, 2004, HYPERTENS RES, V27, P181, DOI 10.1291/hypres.27.181; Yui Y, 2007, J HYPERTENS, V25, P2019, DOI 10.1097/HJH.0b013e32829c6908; Yusuf S, 2008, LANCET, V372, P1174, DOI 10.1016/S0140-6736(08)61242-8; Yusuf S, 2000, NEW ENGL J MED, V342, P145; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zannad F, 2006, KIDNEY INT, V70, P1318, DOI 10.1038/sj.ki.5001657; Zannad F, 2002, FUND CLIN PHARMACOL, V16, P353, DOI 10.1046/j.1472-8206.2002.00127.x	81	67	73	0	11	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2009	151	12					861	U6		10.7326/0000605-200912150-00162	http://dx.doi.org/10.7326/0000605-200912150-00162			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532ET	20008762				2022-12-28	WOS:000272728900004
J	Matute, DR; Butler, IA; Coyne, JA				Matute, Daniel R.; Butler, Ian A.; Coyne, Jerry A.			Little Effect of the tan Locus on Pigmentation in Female Hybrids between Drosophila santomea and D. melanogaster	CELL			English	Article							CIS-REGULATORY EVOLUTION; GENETIC-CONTROL; DIFFERENCE; PATTERNS; MUTATION; YELLOW; YAKUBA	Previous work on Drosophila santomea suggested that its absence of abdominal pigmentation, compared to the other darkly pigmented species, is based on mutations in the cis-regulatory region of tan, inactivating the expression of that gene in the abdomen of D. santomea males and females. Our discovery that D. santomea males can produce viable hybrids when mated to D. melanogaster females enables us to use the armamentarium of genetic tools in the latter species to study the genetic basis of this interspecific difference in pigmentation. Hybridization tests using D. melanogaster deficiencies that include tan show no evidence that this locus is involved in the lighter pigmentation of D. santomea females; rather, the pigmentation difference appears to involve at least four other loci in the region. Earlier results implicating tan may have been based on a type of transgenic analysis that can give misleading results about the genes involved in an evolutionary change.	[Matute, Daniel R.; Butler, Ian A.; Coyne, Jerry A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA	University of Chicago	Coyne, JA (corresponding author), Univ Chicago, Dept Ecol & Evolut, 1101 E 57 St, Chicago, IL 60637 USA.	j-coyne@uchicago.edu		Butler, Ian/0000-0002-1386-2430	National Institutes of Health [R01GM058260]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058260] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Jean Gladstone for technical assistance. This work was funded by National Institutes of Health grant R01GM058260 to J.A.C.	Carbone MA, 2005, GENETICS, V171, P211, DOI 10.1534/genetics.105.044412; Carroll SB, 2005, PLOS BIOL, V3, P1159, DOI 10.1371/journal.pbio.0030245; CARROLL SB, 2005, ENDLESS FORMS MOST B; Clark RM, 2006, NAT GENET, V38, P594, DOI 10.1038/ng1784; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Coyne JA, 2002, EVOLUTION, V56, P2424, DOI 10.1111/j.0014-3820.2002.tb00168.x; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Hoekstra HE, 2007, EVOLUTION, V61, P995, DOI 10.1111/j.1558-5646.2007.00105.x; Hyodo-Taguchi Y, 1997, MECH DEVELOP, V68, P27, DOI 10.1016/S0925-4773(97)00128-7; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Jeong S, 2006, CELL, V125, P1387, DOI 10.1016/j.cell.2006.04.043; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Lachaise D, 2000, P ROY SOC B-BIOL SCI, V267, P1487, DOI 10.1098/rspb.2000.1169; Lindsley D.L., 1992, GENOME DROSOPHILA ME, Veighth; Llopart A, 2002, EVOLUTION, V56, P2262; Llopart A, 2002, NATURE, V419, P360, DOI 10.1038/419360a; Matute DR, 2009, EVOLUTION, V63, P595, DOI 10.1111/j.1558-5646.2008.00588.x; Pinheiro J, 2001, MIXED EFFECTS MODELS; Ranz JM, 2007, PLOS BIOL, V5, P1366, DOI 10.1371/journal.pbio.0050152; Shapiro MD, 2006, P NATL ACAD SCI USA, V103, P13753, DOI 10.1073/pnas.0604706103; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Stern DL, 2000, EVOLUTION, V54, P1079, DOI 10.1554/0014-3820(2000)054[1079:PEDBAT]2.0.CO;2; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; Wittkopp PJ, 2003, TRENDS GENET, V19, P495, DOI 10.1016/S0168-9525(03)00194-X; Wittkopp PJ, 2003, P NATL ACAD SCI USA, V100, P1808, DOI 10.1073/pnas.0336368100; Wittkopp PJ, 2002, CURR BIOL, V12, P1547, DOI 10.1016/S0960-9822(02)01113-2; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	30	10	10	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1180	1188		10.1016/j.cell.2009.10.033	http://dx.doi.org/10.1016/j.cell.2009.10.033			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005810	Green Accepted, Bronze			2022-12-28	WOS:000272622800019
J	Neubauer, C; Gao, YG; Andersen, KR; Dunham, CM; Kelley, AC; Hentschel, J; Gerdes, K; Ramakrishnan, V; Brodersen, DE				Neubauer, Cajetan; Gao, Yong-Gui; Andersen, Kasper R.; Dunham, Christine M.; Kelley, Ann C.; Hentschel, Jendrik; Gerdes, Kenn; Ramakrishnan, V.; Brodersen, Ditlev E.			The Structural Basis for mRNA Recognition and Cleavage by the Ribosome-Dependent Endonuclease ReIE	CELL			English	Article							TOXIN-ANTITOXIN SYSTEM; AMINO-ACID STARVATION; ESCHERICHIA-COLI; A-SITE; TRANSLATION ELONGATION; CRYSTAL-STRUCTURE; MECHANISM; CODON; RELB; PURIFICATION	Translational control is widely used to adjust gene expression levels. During the stringent response in bacteria, mRNA is degraded on the ribosome by the ribosome-dependent endonuclease, ReIE. The molecular basis for recognition of the ribosome and mRNA by ReIE and the mechanism of cleavage are unknown. Here, we present crystal structures of E. coli ReIE in isolation (2.5 angstrom) and bound to programmed Thermus thermophilus 70S ribosomes before (3.3 angstrom) and after (3.6 angstrom) cleavage. ReIE occupies the A site and causes cleavage of mRNA after the second nucleotide of the codon by reorienting and activating the mRNA for 2'-OH-induced hydrolysis. Stacking of A site codon bases with conserved residues in ReIE and 16S rRNA explains the requirement for the ribosome in catalysis and the subtle sequence specificity of the reaction. These structures provide detailed insight into the translational regulation on the bacterial ribosome by mRNA cleavage.	[Neubauer, Cajetan; Gao, Yong-Gui; Dunham, Christine M.; Kelley, Ann C.; Hentschel, Jendrik; Ramakrishnan, V.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Andersen, Kasper R.; Brodersen, Ditlev E.] Aarhus Univ, Dept Mol Biol, DK-8000 Aarhus C, Denmark; [Gerdes, Kenn] Univ Newcastle, Sch Med, Inst Cell & Mol Biosci, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	MRC Laboratory Molecular Biology; Aarhus University; Newcastle University - UK	Ramakrishnan, V (corresponding author), MRC, Mol Biol Lab, Cambridge CB2 0QH, England.	ramak@mrc-lmb.cam.ac.uk; deb@mb.au.dk	Gerdes, Kenn/AAS-5548-2021; Gerdes, Kenn/M-2420-2014; Gao, Yonggui/A-9473-2015; Brodersen, Ditlev E./AAQ-5241-2020; Gao, Yong Gui/A-2187-2011; Neubauer, Cajetan/B-8935-2016	Gerdes, Kenn/0000-0002-7462-4612; Gerdes, Kenn/0000-0002-7462-4612; Gao, Yonggui/0000-0001-7298-0835; Neubauer, Cajetan/0000-0002-5348-5609; Brodersen, Ditlev/0000-0002-5413-4667; Andersen, Kasper Rojkjaer/0000-0002-4415-8067; Ramakrishnan, V/0000-0002-4699-2194	Medical Research Council (UK); Wellcome Trust; Agouron Institute; Louis-Jeantet Foundation; Boehringer-Ingelheim Fonds fellowship; Lundbeck and Novo Nordisk Foundations; Medical Research Council [MC_U105184332] Funding Source: researchfish; MRC [MC_U105184332] Funding Source: UKRI	Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Agouron Institute(Pfizer); Louis-Jeantet Foundation; Boehringer-Ingelheim Fonds fellowship(Boehringer Ingelheim); Lundbeck and Novo Nordisk Foundations(Novo Nordisk Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	V. R. was supported by the Medical Research Council (UK), the Wellcome Trust, the Agouron Institute, and the Louis-Jeantet Foundation. C.N. was supported by a Boehringer-Ingelheim Fonds fellowship, D. E. B. received support from the Lundbeck and Novo Nordisk Foundations, and D. E. B. and K. G. were part of the Danish National Research Foundation Centre for mRNP Biogenesis and Metabolism. We thank beamline staff at Deutsches Elektronen-Synchrotron, Sandor Brockhauser at the ESRF, Clemens Schulze-Briese at Swiss Light Source, and Leong Ng for help with screening and data collection, as well as Martin Overgaard at Syddansk Universitet, Odense, Denmark for ReIE expression plasmids, Sew-Yeu Peak-Chew for help with MALDI mass spectrometry, and Kathrin Lang, Kurt Gothelf, and Sebastian Eustermann for useful discussions. V. R. is on the Scientific Advisory Board of Rib-X Pharmaceuticals, a company dedicated to making new antibiotics that target the ribosome.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andreev D, 2008, RNA, V14, P233, DOI 10.1261/rna.693208; Bauerova-Hlinkova V, 2009, FEBS J, V276, P4156, DOI 10.1111/j.1742-4658.2009.07125.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Christensen SK, 2003, MOL MICROBIOL, V48, P1389, DOI 10.1046/j.1365-2958.2003.03512.x; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Christensen-Dalsgaard M, 2008, NUCLEIC ACIDS RES, V36, P6472, DOI 10.1093/nar/gkn667; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Christensen-Dalsgaard M, 2008, METHOD ENZYMOL, V447, P521, DOI 10.1016/S0076-6879(08)02225-8; Cochrane JC, 2008, ACCOUNTS CHEM RES, V41, P1027, DOI 10.1021/ar800050c; Cruz-Reyes J, 1998, BIOCHEMISTRY-US, V37, P6059, DOI 10.1021/bi972868g; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Galvani C, 2001, J BACTERIOL, V183, P2700, DOI 10.1128/JB.183.8.2700-2703.2001; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Garza-Sanchez F, 2008, J MOL BIOL, V378, P505, DOI 10.1016/j.jmb.2008.02.065; Garza-Sanchez F, 2009, MOL MICROBIOL, V73, P882, DOI 10.1111/j.1365-2958.2009.06813.x; Gotfredsen M, 1998, MOL MICROBIOL, V29, P1065, DOI 10.1046/j.1365-2958.1998.00993.x; Grady R, 2003, MOL MICROBIOL, V47, P1419, DOI 10.1046/j.1365-2958.2003.03387.x; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; HEINEMANN U, 1983, J BIOMOL STRUCT DYN, V1, P523, DOI 10.1080/07391102.1983.10507459; JELENC PC, 1979, P NATL ACAD SCI USA, V76, P3174, DOI 10.1073/pnas.76.7.3174; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kamada K, 2005, MOL CELL, V19, P497, DOI 10.1016/j.molcel.2005.07.004; Laurberg M, 2008, NATURE, V454, P852, DOI 10.1038/nature07115; Li GY, 2009, J BIOL CHEM, V284, P14628, DOI 10.1074/jbc.M809656200; MURGOLA EJ, 1988, P NATL ACAD SCI USA, V85, P4162, DOI 10.1073/pnas.85.12.4162; Odaert B, 2007, J BIOL CHEM, V282, P2019, DOI 10.1074/jbc.M608271200; Ogle JM, 2001, SCIENCE, V292, P897, DOI 10.1126/science.1060612; Overgaard M, 2008, MOL MICROBIOL, V69, P841, DOI 10.1111/j.1365-2958.2008.06313.x; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; PRESCOTT C, 1991, NUCLEIC ACIDS RES, V19, P5281, DOI 10.1093/nar/19.19.5281; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; Schmidt O, 2007, J MOL BIOL, V372, P894, DOI 10.1016/j.jmb.2007.07.016; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Sorensen MA, 2001, J MOL BIOL, V307, P785, DOI 10.1006/jmbi.2001.4525; Spottke B, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh089; Sunohara T, 2004, J BIOL CHEM, V279, P15368, DOI 10.1074/jbc.M312805200; Takagi H, 2005, NAT STRUCT MOL BIOL, V12, P327, DOI 10.1038/nsmb911; Voorhees RM, 2009, NAT STRUCT MOL BIOL, V16, P528, DOI 10.1038/nsmb.1577; Weixlbaumer A, 2008, SCIENCE, V322, P953, DOI 10.1126/science.1164840; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; Yusupova G, 2006, NATURE, V444, P391, DOI 10.1038/nature05281; ZEGERS I, 1994, J BIOL CHEM, V269, P127	45	161	163	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1084	1095		10.1016/j.cell.2009.11.015	http://dx.doi.org/10.1016/j.cell.2009.11.015			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005802	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000272622800011
J	Martin, R; Williams, C; O'Neill, D				Martin, Ruth; Williams, Caroline; O'Neill, Desmond			Christmas 2009: Young and Old Retrospective analysis of attitudes to ageing in the Economist: apocalyptic demography for opinion formers	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							POPULATION		[Martin, Ruth; Williams, Caroline; O'Neill, Desmond] Univ Dublin Trinity Coll, Ctr Ageing Neurosci & Humanities, Dublin 2, Ireland	Trinity College Dublin	O'Neill, D (corresponding author), Univ Dublin Trinity Coll, Ctr Ageing Neurosci & Humanities, Dublin 2, Ireland.	doneill@tcd.ie	O'Neill, Desmond/D-1486-2013	O'Neill, Desmond/0000-0002-5542-9897				[Anonymous], 2000, OVERSELLING POPULATI; [Anonymous], 2000, IMAGINARY TIME BOMB; BARER ML, 1987, SOC SCI MED, V24, P851, DOI 10.1016/0277-9536(87)90186-9; Bartley M, 2009, J STROKE CEREBROVASC, V18, P259, DOI 10.1016/j.jstrokecerebrovasdis.2008.11.006; BELL J, 1992, GERONTOLOGIST, V32, P305, DOI 10.1093/geront/32.3.305; BUTLER R, 2006, AGEISM AM; BUTLER RN, 1969, GERONTOLOGIST, V9, P243, DOI 10.1093/geront/9.4_Part_1.243; Cohen HL, 2002, EDUC GERONTOL, V28, P599, DOI 10.1080/03601270290099796; Coleman R, 2003, J MASS COMMUN Q, V80, P295, DOI 10.1177/107769900308000205; Denton FT, 1998, CAN J AGING, V17, P83, DOI 10.1017/S0714980800010369; Donlon MM, 2005, J SOC ISSUES, V61, P307, DOI 10.1111/j.1540-4560.2005.00407.x; Dudley Edwards R., 1993, PURSUIT REASON EC 18; Gee EM, 2002, INT J EPIDEMIOL, V31, P750, DOI 10.1093/ije/31.4.750; GERBNER G, 1980, AM BEHAV SCI, V23, P705, DOI 10.1177/000276428002300506; Goffman E., 1963, BEHAV PUBLIC PLACES, P3; KENNELLY S, 2004, IR J MED SCI S2, V173, pP40; Martin A., 2005, BMJ CLIN RES ED, V330, P368, DOI DOI 10.1136/BMJ.330.7487.368-A; MCHUGH K, 2003, RECENT ADV RES UPDAT, V6, P275; Murphy KM, 2006, J POLIT ECON, V114, P871, DOI 10.1086/508033; MYERS K, 2004, LILLIPUT, P259; *NAT AC AG SOC, 1999, DEM IS NOT DEST; O'Hanlon A., 2005, HLTH SOCIAL SERVICES; PALMORE EB, 2005, ENCY AGEISM, P194; Ramasubramanian S, 2007, J MASS COMMUN Q, V84, P249, DOI 10.1177/107769900708400204; Reinhart VR, 1999, ECON LETT, V62, P339, DOI 10.1016/S0165-1765(98)00250-X; Richards T, 2007, BRIT MED J, V335, P698, DOI 10.1136/bmj.39356.408102.59; Robertson A, 1997, AGEING SOC, V17, P425, DOI 10.1017/S0144686X97006521; ROSA A, 2004, EC B, V9, P1; Rozanova J., 2006, INT J AGEING LATER L, V1, P111, DOI DOI 10.3384/IJAL.1652-8670.0612111; Sontag S., 1978, ILLNESS METAPHOR; *UN, 1999, WORLD DEV REP	31	40	40	3	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2009	339								b4914	10.1136/bmj.b4914	http://dx.doi.org/10.1136/bmj.b4914			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VE	19995819	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000272697300003
J	Eisenegger, C; Naef, M; Snozzi, R; Heinrichs, M; Fehr, E				Eisenegger, C.; Naef, M.; Snozzi, R.; Heinrichs, M.; Fehr, E.			Prejudice and truth about the effect of testosterone on human bargaining behaviour	NATURE			English	Article							HEALTHY-YOUNG WOMEN; PRISON-INMATES; MEN; DOMINANCE; RESPONSES; FAIRNESS	Both biosociological and psychological models, as well as animal research, suggest that testosterone has a key role in social interactions(1-7). Evidence from animal studies in rodents shows that testosterone causes aggressive behaviour towards conspecifics(7). Folk wisdom generalizes and adapts these findings to humans, suggesting that testosterone induces antisocial, egoistic, or even aggressive human behaviours. However, many researchers have questioned this folk hypothesis(1-6), arguing that testosterone is primarily involved in status-related behaviours in challenging social interactions, but causal evidence that discriminates between these views is sparse. Here we show that the sublingual administration of a single dose of testosterone in women causes a substantial increase in fair bargaining behaviour, thereby reducing bargaining conflicts and increasing the efficiency of social interactions. However, subjects who believed that they received testosterone-regardless of whether they actually received it or not-behaved much more unfairly than those who believed that they were treated with placebo. Thus, the folk hypothesis seems to generate a strong negative association between subjects' beliefs and the fairness of their offers, even though testosterone administration actually causes a substantial increase in the frequency of fair bargaining offers in our experiment.	[Eisenegger, C.; Naef, M.; Snozzi, R.; Fehr, E.] Univ Zurich, Inst Empir Res Econ, Lab Social & Neural Syst Res, CH-8006 Zurich, Switzerland; [Naef, M.] Univ London, Dept Econ, Egham TW20 0EX, Surrey, England; [Heinrichs, M.] Univ Freiburg, Dept Psychol, Lab Biol & Personal Psychol, D-79104 Freiburg, Germany	University of Zurich; University of London; Royal Holloway University London; University of Freiburg	Eisenegger, C (corresponding author), Univ Zurich, Inst Empir Res Econ, Lab Social & Neural Syst Res, CH-8006 Zurich, Switzerland.	eisenegger@iew.uzh.ch; efehr@iew.uzh.ch	Naef, Michael/B-2257-2009	Naef, Michael/0000-0002-0810-2912; Snozzi, Romana/0000-0001-8655-6904	National Center of Competence in Affective Sciences; Neurochoice Project of SystemsX; Swiss National Science Foundation	National Center of Competence in Affective Sciences; Neurochoice Project of SystemsX; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This paper is part of the Research Priority Program 'Foundations of Human Social Behaviour-Altruism versus Egoism' at the University of Zurich. We also acknowledge support by the National Center of Competence in Affective Sciences, the Neurochoice Project of SystemsX, and the Swiss National Science Foundation. We thank F. Heusi for her research assistance during the conduct of the experiments.	Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; BJORKQVIST K, 1994, AGGRESSIVE BEHAV, V20, P17, DOI 10.1002/1098-2337(1994)20:1<17::AID-AB2480200104>3.0.CO;2-U; Burnham TC, 2007, P ROY SOC B-BIOL SCI, V274, P2327, DOI 10.1098/rspb.2007.0546; Camerer C.F., 2011, BEHAV GAME THEORY EX, DOI 10.1257/jep.9.2.209; CASHDAN E, 1995, HORM BEHAV, V29, P354, DOI 10.1006/hbeh.1995.1025; Christie R, 1970, STUDIES MACHIAVELLIS; Coates JM, 2008, P NATL ACAD SCI USA, V105, P6167, DOI 10.1073/pnas.0704025105; Crockett MJ, 2008, SCIENCE, V320, P1739, DOI 10.1126/science.1155577; Dabbs JM, 1997, PSYCHOSOM MED, V59, P477, DOI 10.1097/00006842-199709000-00003; DABBS JM, 1995, PERS INDIV DIFFER, V18, P627, DOI 10.1016/0191-8869(94)00177-T; DABBS JM, 1988, PERS INDIV DIFFER, V9, P269, DOI 10.1016/0191-8869(88)90088-8; DEROGATIS LR, 1977, SCL90R J HOPK U SCH; EDWARDS DA, 1969, PHYSIOL BEHAV, V4, P333, DOI 10.1016/0031-9384(69)90185-1; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Fischbacher U, 2007, EXP ECON, V10, P171, DOI 10.1007/s10683-006-9159-4; FORSYTHE R, 1994, GAME ECON BEHAV, V6, P347, DOI 10.1006/game.1994.1021; Goldberg LR, 2006, J RES PERS, V40, P84, DOI 10.1016/j.jrp.2005.08.007; GUTH W, 1982, J ECON BEHAV ORGAN, V3, P367, DOI 10.1016/0167-2681(82)90011-7; Henrich J, 2001, AM ECON REV, V91, P73, DOI 10.1257/aer.91.2.73; Josephs RA, 2003, PSYCHOL SCI, V14, P158, DOI 10.1111/1467-9280.t01-1-01435; Josephs RA, 2006, J PERS SOC PSYCHOL, V90, P999, DOI 10.1037/0022-3514.90.6.999; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Kosfeld M, 2005, NATURE, V435, P673, DOI 10.1038/nature03701; Laux L., 1981, STATE TRAIT ANGSTINV; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; Mazur A., 2005, BIOSOCIOLOGY DOMINAN; POPE HG, 1990, J CLIN PSYCHIAT, V51, P28; PURIFOY FE, 1979, SOC BIOL, V26, P179, DOI 10.1080/19485565.1979.9988376; ROTH AE, 1991, AM ECON REV, V81, P1068; Schultheiss OC, 1999, HORM BEHAV, V36, P234, DOI 10.1006/hbeh.1999.1542; SCHWENKMEZGER P, 1992, STATE TRAIT AERGERAU; Steyer, 1997, MEHRDIMENSIONALE BEF; STUENKEL CA, 1991, J CLIN ENDOCR METAB, V72, P1054, DOI 10.1210/jcem-72-5-1054; Tuiten A, 2000, ARCH GEN PSYCHIAT, V57, P149, DOI 10.1001/archpsyc.57.2.149; van Honk J, 2005, BIOL PSYCHIAT, V58, P218, DOI 10.1016/j.biopsych.2005.04.003; van Honk J, 2004, PSYCHONEUROENDOCRINO, V29, P937, DOI 10.1016/j.psyneuen.2003.08.007; van Honk J, 2001, BEHAV NEUROSCI, V115, P238, DOI 10.1037//0735-7044.115.1.238; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104; Zethraeus N, 2009, P NATL ACAD SCI USA, V106, P6535, DOI 10.1073/pnas.0812757106	39	258	269	0	95	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 21	2010	463	7279					356	U104		10.1038/nature08711	http://dx.doi.org/10.1038/nature08711			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	545PM	19997098				2022-12-28	WOS:000273748100044
J	Rosser, WW; Colwill, JM; Kasperski, J; Wilson, L				Rosser, Walter W.; Colwill, Jack M.; Kasperski, Jan; Wilson, Lynn			Patient-Centered Medical Homes in Ontario	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CARE		[Rosser, Walter W.] Queens Univ, Dept Family Med, Kingston, ON, Canada; [Colwill, Jack M.] Univ Missouri, Sch Med, Dept Family & Community Med, Columbia, MO 65211 USA; [Kasperski, Jan] Ontario Coll Family Phys, Toronto, ON, Canada; [Wilson, Lynn] Univ Toronto, Dept Family & Community Med, Toronto, ON M5S 1A1, Canada	Queens University - Canada; University of Missouri System; University of Missouri Columbia; University of Toronto	Rosser, WW (corresponding author), Queens Univ, Dept Family Med, Kingston, ON, Canada.		Greiver, Michelle/N-8764-2015	Greiver, Michelle/0000-0001-8957-0285				FORSTER J, 1994, CAN FAM PHYSICIAN, V40, P1523; Rosser W W, 1999, Healthc Pap, V1, P5; The Robert Graham Center, 2007, PAT CTR MED HOM HIST; Tu K, 2009, CAN FAM PHYSICIAN, V55, P719; Valderas JM, 2009, ANN FAM MED, V7, P104, DOI 10.1370/afm.949	5	49	49	1	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3								10.1056/NEJMp0911519	http://dx.doi.org/10.1056/NEJMp0911519			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	545NE	20054034				2022-12-28	WOS:000273738400004
J	Pleasance, ED; Cheetham, RK; Stephens, PJ; McBride, DJ; Humphray, SJ; Greenman, CD; Varela, I; Lin, ML; Ordonez, GR; Bignell, GR; Ye, K; Alipaz, J; Bauer, MJ; Beare, D; Butler, A; Carter, RJ; Chen, LN; Cox, AJ; Edkins, S; Kokko-Gonzales, PI; Gormley, NA; Grocock, RJ; Haudenschild, CD; Hims, MM; James, T; Jia, MM; Kingsbury, Z; Leroy, C; Marshall, J; Menzies, A; Mudie, LJ; Ning, ZM; Royce, T; Schulz-Trieglaff, OB; Spiridou, A; Stebbings, LA; Szajkowski, L; Teague, J; Williamson, D; Chin, L; Ross, MT; Campbell, PJ; Bentley, DR; Futreal, PA; Stratton, MR				Pleasance, Erin D.; Cheetham, R. Keira; Stephens, Philip J.; McBride, David J.; Humphray, Sean J.; Greenman, Chris D.; Varela, Ignacio; Lin, Meng-Lay; Ordonez, Gonzalo R.; Bignell, Graham R.; Ye, Kai; Alipaz, Julie; Bauer, Markus J.; Beare, David; Butler, Adam; Carter, Richard J.; Chen, Lina; Cox, Anthony J.; Edkins, Sarah; Kokko-Gonzales, Paula I.; Gormley, Niall A.; Grocock, Russell J.; Haudenschild, Christian D.; Hims, Matthew M.; James, Terena; Jia, Mingming; Kingsbury, Zoya; Leroy, Catherine; Marshall, John; Menzies, Andrew; Mudie, Laura J.; Ning, Zemin; Royce, Tom; Schulz-Trieglaff, Ole B.; Spiridou, Anastassia; Stebbings, Lucy A.; Szajkowski, Lukasz; Teague, Jon; Williamson, David; Chin, Lynda; Ross, Mark T.; Campbell, Peter J.; Bentley, David R.; Futreal, P. Andrew; Stratton, Michael R.			A comprehensive catalogue of somatic mutations from a human cancer genome	NATURE			English	Article							NUCLEOTIDE EXCISION-REPAIR; ETS TRANSCRIPTION FACTOR; CARCINOGENESIS; EPIDEMIOLOGY; MECHANISMS; PATHWAYS; RECEPTOR; BREAST	All cancers carry somatic mutations. A subset of these somatic alterations, termed driver mutations, confer selective growth advantage and are implicated in cancer development, whereas the remainder are passengers. Here we have sequenced the genomes of a malignant melanoma and a lymphoblastoid cell line from the same person, providing the first comprehensive catalogue of somatic mutations from an individual cancer. The catalogue provides remarkable insights into the forces that have shaped this cancer genome. The dominant mutational signature reflects DNA damage due to ultraviolet light exposure, a known risk factor for malignant melanoma, whereas the uneven distribution of mutations across the genome, with a lower prevalence in gene footprints, indicates that DNA repair has been preferentially deployed towards transcribed regions. The results illustrate the power of a cancer genome sequence to reveal traces of the DNA damage, repair, mutation and selection processes that were operative years before the cancer became symptomatic.	[Pleasance, Erin D.; Stephens, Philip J.; McBride, David J.; Greenman, Chris D.; Varela, Ignacio; Lin, Meng-Lay; Ordonez, Gonzalo R.; Bignell, Graham R.; Beare, David; Butler, Adam; Chen, Lina; Edkins, Sarah; Jia, Mingming; Leroy, Catherine; Marshall, John; Menzies, Andrew; Mudie, Laura J.; Ning, Zemin; Stebbings, Lucy A.; Teague, Jon; Campbell, Peter J.; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [Cheetham, R. Keira; Humphray, Sean J.; Bauer, Markus J.; Carter, Richard J.; Cox, Anthony J.; Kokko-Gonzales, Paula I.; Gormley, Niall A.; Grocock, Russell J.; Hims, Matthew M.; James, Terena; Kingsbury, Zoya; Schulz-Trieglaff, Ole B.; Spiridou, Anastassia; Szajkowski, Lukasz; Ross, Mark T.; Bentley, David R.] Illumina Cambridge Ltd, Saffron Walden CB10 1XL, Essex, England; [Ye, Kai] Leiden Univ, Med Ctr, Dept Mol Epidemiol, NL-2333 ZC Leiden, Netherlands; [Ye, Kai] Leiden Univ, Med Ctr, Dept Med Stat & Bioinformat, NL-2333 ZC Leiden, Netherlands; [Alipaz, Julie; Royce, Tom] Illumina Inc, Corp Headquarters, San Diego, CA 92121 USA; [Haudenschild, Christian D.; Williamson, David] Illumina Hayward, Hayward, CA 94545 USA; [Chin, Lynda] Dana Farber Canc Inst, Boston, MA 02115 USA; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England	Wellcome Trust Sanger Institute; Illumina; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Illumina; Illumina; Harvard University; Dana-Farber Cancer Institute; University of London; Institute of Cancer Research - UK	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	paf@sanger.ac.uk; mrs@sanger.ac.uk	Ye, Kai/GSD-9856-2022; Varela, Ignacio/AAA-7680-2021; Ning, Zemin/D-2411-2013; Weinstock, George M/C-6314-2013; Ye, Kai/B-3640-2012; Varela, Ignacio/G-1699-2016	Ye, Kai/0000-0002-2851-6741; Varela, Ignacio/0000-0002-0969-506X; Weinstock, George M/0000-0002-2997-4592; Varela, Ignacio/0000-0002-0969-506X; Cox, Anthony/0000-0002-6534-749X; Ning, Zemin/0000-0003-4359-776X; Marshall, John/0000-0002-1216-5457; Edkins, Sarah/0000-0003-0717-1972	Wellcome Trust [077012/Z/05/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	The authors acknowledge the support of C. Henry, S. Kahn, D. Evers, G. Smith, K. Hall and the technical and administrative support staff at Illumina. I. V. is supported by the Human Frontiers Science Program and P.J.C. by the Kay Kendall Leukaemia Fund. We would like to acknowledge the Wellcome Trust for support under grant reference 077012/Z/05/Z.	Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Daya-Grosjean L, 2005, MUTAT RES-FUND MOL M, V571, P43, DOI 10.1016/j.mrfmmm.2004.11.013; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Fousteri M, 2008, CELL RES, V18, P73, DOI 10.1038/cr.2008.6; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Futreal PA, 2001, NATURE, V409, P850, DOI 10.1038/35057046; Ghadersohi A, 2008, INT J CANCER, V123, P1376, DOI 10.1002/ijc.23667; Giglia-Mari G, 2003, HUM MUTAT, V21, P217, DOI 10.1002/humu.10179; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kawanishi S, 2001, MUTAT RES-REV MUTAT, V488, P65, DOI 10.1016/S1383-5742(00)00059-4; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Leiter U, 2008, ADV EXP MED BIOL, V624, P89, DOI 10.1007/978-0-387-77574-6_8; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; MORSE HG, 1993, CANCER GENET CYTOGEN, V69, P108, DOI 10.1016/0165-4608(93)90083-X; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; Oettgen P, 2000, J BIOL CHEM, V275, P1216, DOI 10.1074/jbc.275.2.1216; Palavalli LH, 2009, NAT GENET, V41, P518, DOI 10.1038/ng.340; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Pfeifer GP, 2009, HUM GENET, V125, P493, DOI 10.1007/s00439-009-0657-2; Pfeifer GP, 2005, MUTAT RES-FUND MOL M, V571, P19, DOI 10.1016/j.mrfmmm.2004.06.057; Scaglioni PP, 2007, CURR TOP MICROBIOL, V313, P85; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Sood AK, 2007, HUM PATHOL, V38, P1628, DOI 10.1016/j.humpath.2007.03.010; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; TEITZ T, 1990, GENE, V87, P295, DOI 10.1016/0378-1119(90)90316-J; Winkler GS, 2006, EMBO J, V25, P3089, DOI 10.1038/sj.emboj.7601194; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	41	1190	1245	1	147	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					191	U73		10.1038/nature08658	http://dx.doi.org/10.1038/nature08658			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20016485	Green Accepted, hybrid			2022-12-28	WOS:000273582700027
J	Phillips, A; van Oosterhout, J				Phillips, Andrew; van Oosterhout, Joep			DART points the way for HIV treatment programmes	LANCET			English	Editorial Material							ANTIRETROVIRAL THERAPY		[Phillips, Andrew] UCL, Dept Infect & Populat Hlth, London NW3 2PF, England; [van Oosterhout, Joep] Univ Malawi, Coll Med, Dept Med, Blantyre, Malawi	University of London; University College London; University of Malawi	Phillips, A (corresponding author), UCL, Dept Infect & Populat Hlth, London NW3 2PF, England.	a.phillips@pcps.ucl.ac.uk	Phillips, Andrew N/B-4427-2008	Phillips, Andrew N/0000-0003-2384-4807				COUTINHO A, 2008, 15 C RETR OPP INF BO, P125; Mugyenyi P, 2010, LANCET, V375, P123, DOI 10.1016/S0140-6736(09)62067-5; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; Shumbusho F, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000163; UNAIDS & World Bank, 2009, GLOB EC CRIS HIV PRE; van Oosterhout JJG, 2009, TROP MED INT HEALTH, V14, P856, DOI 10.1111/j.1365-3156.2009.02309.x; World Health Organization, 2009, RAP ADV ANT THER HIV; World Health Organization, 2006, ANT THER HIV INF AD	8	6	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2010	375	9709					96	98		10.1016/S0140-6736(09)62103-6	http://dx.doi.org/10.1016/S0140-6736(09)62103-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	544NM	20004465				2022-12-28	WOS:000273664500005
J	Baker, CJ; Pickering, LK; Chilton, L; Cieslak, P; Ehresmann, KR; Englund, J; Friedman, C; Judson, FN; Keitel, WA; Lett, SM; Marcy, MS; Meissner, CH; Neuzil, K; Sawyer, MH; Sumaya, CV; Temte, J				Baker, Carol J.; Pickering, Larry K.; Chilton, Lance; Cieslak, Paul; Ehresmann, Kristen R.; Englund, Janet; Friedman, Carol; Judson, Franklyn N.; Keitel, Wendy A.; Lett, Susan M.; Marcy, Michael S.; Meissner, Cody H.; Neuzil, Kathleen; Sawyer, Mark H.; Sumaya, Ciro Valent; Temte, Jonathan		Advisory Comm Immunization Practic	Recommended Adult Immunization Schedule: United States, 2010	ANNALS OF INTERNAL MEDICINE			English	Article									[Friedman, Carol] Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, Atlanta, GA 30333 USA; [Baker, Carol J.; Keitel, Wendy A.] Baylor Coll Med, Houston, TX 77030 USA; [Chilton, Lance] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA; [Cieslak, Paul] Oregon Publ Hlth Div, Portland, OR USA; [Ehresmann, Kristen R.] Minnesota Dept Hlth, St Paul, MN USA; [Englund, Janet] Childrens Hosp, Seattle, WA USA; [Englund, Janet] Reg Med Ctr, Seattle, WA USA; [Judson, Franklyn N.] Univ Colorado, Hlth Sci Ctr, Denver, CO USA; [Lett, Susan M.] Massachusetts Dept Publ Hlth, Jamaica Plain, MA USA; [Marcy, Michael S.] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Meissner, Cody H.] Tufts Med Ctr, Boston, MA USA; [Meissner, Cody H.] Tufts Med Ctr, Boston, GA USA; [Neuzil, Kathleen] Univ Washington, Seattle, WA 98195 USA; [Sawyer, Mark H.] Univ Calif San Diego, Sch Med, San Diego, CA USA; [Sawyer, Mark H.] Rady Childrens Hosp San Diego, San Diego, CA USA; [Sumaya, Ciro Valent] Texas A&M Hlth Sci Ctr, College Stn, TX USA; [Temte, Jonathan] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI USA	Centers for Disease Control & Prevention - USA; Baylor College of Medicine; University of New Mexico; Minnesota Department of Health (MHD); Seattle Children's Hospital; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Massachusetts Department of Public Health; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Tufts Medical Center; Tufts Medical Center; University of Washington; University of Washington Seattle; University of California System; University of California San Diego; Rady Childrens Hospital San Diego; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University of Wisconsin System; University of Wisconsin Madison	Friedman, C (corresponding author), Ctr Dis Control & Prevent, Immunizat Serv Div, Natl Ctr Immunizat & Resp Dis, 1600 Clifton Rd NE,Mailstop E52, Atlanta, GA 30333 USA.	cxf7@cdc.gov.gov	Plain, Jérôme/P-4843-2019	Plain, Jérôme/0000-0001-5806-9965					0	47	50	0	0	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2010	152	1					36	W8		10.7326/0003-4819-152-1-201001050-00008	http://dx.doi.org/10.7326/0003-4819-152-1-201001050-00008			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543FJ	20048270				2022-12-28	WOS:000273556600005
J	Sequist, TD; Fitzmaurice, GM; Marshall, R; Shaykevich, S; Marston, A; Safran, DG; Ayanian, JZ				Sequist, Thomas D.; Fitzmaurice, Garrett M.; Marshall, Richard; Shaykevich, Shimon; Marston, Amy; Safran, Dana Gelb; Ayanian, John Z.			Cultural Competency Training and Performance Reports to Improve Diabetes Care for Black Patients A Cluster Randomized, Controlled Trial	ANNALS OF INTERNAL MEDICINE			English	Article							QUALITY-OF-CARE; ETHNIC DISPARITIES; RACIAL DISPARITIES; HEALTH DISPARITIES; MANAGED CARE; RACE; ADULTS; RECOMMENDATIONS; PERSPECTIVES; PERCEPTIONS	Background: Increasing clinician awareness of racial disparities and improving communication may enhance diabetes care among black patients. Objective: To evaluate the effect of cultural competency training and performance feedback for primary care clinicians on diabetes care for black patients. Design: Cluster randomized, controlled trial conducted between June 2007 and May 2008. (ClinicalTrials.gov registration number: NCT00436176) Setting: 8 ambulatory health centers in eastern Massachusetts. Participants: 124 primary care clinicians caring for 2699 (36%) black and 4858 (64%) white diabetic patients. Intervention: Intervention clinicians received cultural competency training and monthly race-stratified performance reports that highlighted racial differences in control of hemoglobin A(1c) (HbA(1c)) and low-density lipoprotein (LDL) cholesterol levels and blood pressure. Measurements: Clinician awareness of racial differences in diabetes care and rates of achieving clinical control targets among black patients at 12 months. Results: White and black patients differed significantly in baseline rates of achieving an HbA(1c) level less than 7% (46% vs. 40%), an LDL cholesterol level less than 2.59 mmol/L (<100 mg/dL) (55% vs. 43%), and blood pressure less than 130/80 mm Hg (32% vs. 24%) (all P < 0.050). At study completion, intervention clinicians were significantly more likely than control clinicians to acknowledge the presence of racial disparities in the 8 health centers as a whole (82% vs. 59%; P = 0.003), within their local health center (70% vs. 51%; P = 0.020), and among their own patients (63% vs. 43%; P = 0.037). Black patients of clinicians in the intervention and control groups did not differ at 12 months in rates of controlling HbA(1c) level (48% vs. 45%; P = 0.24), LDL cholesterol level (48% vs. 49%; P = 0.40), or blood pressure (23% vs. 25%; P = 0.47). Limitation: 11% of primary care teams did not attend cultural competency training sessions. Conclusion: The combination of cultural competency training and race-stratified performance reports increased clinician awareness of racial disparities in diabetes care but did not improve clinical outcomes among black patients.	[Sequist, Thomas D.] Harvard Univ, Div Gen Med, Sch Med, Tufts Med Ctr, Boston, MA 02120 USA; Blue Cross & Blue Shield Massachusetts, Boston, MA 02215 USA	Harvard University; Harvard Medical School; Tufts Medical Center	Sequist, TD (corresponding author), Harvard Univ, Div Gen Med, Sch Med, Tufts Med Ctr, 1620 Tremont St, Boston, MA 02120 USA.	tsequist@partners.org			Robert Wood Johnson Foundation	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF))	By the Robert Wood Johnson Foundation.	Beach MC, 2006, BMC PUBLIC HEALTH, V6, DOI 10.1186/1471-2458-6-104; Beach MC, 2005, MED CARE, V43, P356, DOI 10.1097/01.mlr.0000156861.58905.96; Betancourt JR, 2003, PUBLIC HEALTH REP, V118, P293, DOI 10.1093/phr/118.4.293; Brown AF, 2005, DIABETES CARE, V28, P2864, DOI 10.2337/diacare.28.12.2864; Chin MH, 2007, MED CARE RES REV, V64, p7S, DOI 10.1177/1077558707305413; Cooper LA, 2006, J GEN INTERN MED, V21, pS21, DOI 10.1111/j.1525-1497.2006.00305.x; Harris MI, 1999, DIABETES CARE, V22, P403, DOI 10.2337/diacare.22.3.403; *HARV PILGR HEALTH, 2009, CULT INSIGHT TRAIN C; Johnson RL, 2004, J GEN INTERN MED, V19, P101, DOI 10.1111/j.1525-1497.2004.30262.x; Kiefe CI, 2001, JAMA-J AM MED ASSOC, V285, P2871, DOI 10.1001/jama.285.22.2871; Kimura J, 2008, DIS MANAGE, V11, P13, DOI 10.1089/dis.2008.111718; Kirk JK, 2006, DIABETES CARE, V29, P2130, DOI 10.2337/dc05-1973; Lurie N, 2005, NEW ENGL J MED, V353, P727, DOI 10.1056/NEJMe058143; Lurie N, 2005, CIRCULATION, V111, P1264, DOI 10.1161/01.CIR.0000157738.12783.71; McBean AM, 2003, DIABETES CARE, V26, P3250, DOI 10.2337/diacare.26.12.3250; McWilliams JM, 2009, ANN INTERN MED, V150, P505, DOI 10.7326/0003-4819-150-8-200904210-00005; *NAT COMM QUAL ASS, 2009, HEDIS QUAL MEASU; Paez KA, 2009, J GEN INTERN MED, V24, P495, DOI 10.1007/s11606-009-0919-7; Peek ME, 2007, MED CARE RES REV, V64, p101S, DOI 10.1177/1077558707305409; Price EG, 2005, ACAD MED, V80, P578, DOI 10.1097/00001888-200506000-00013; Rothman AA, 2003, ANN INTERN MED, V138, P256, DOI 10.7326/0003-4819-138-3-200302040-00034; Schulman KA, 1999, NEW ENGL J MED, V340, P618, DOI 10.1056/NEJM199902253400806; Sequist TD, 2006, ARCH INTERN MED, V166, P675, DOI 10.1001/archinte.166.6.675; Sequist TD, 2008, ARCH INTERN MED, V168, P1145, DOI 10.1001/archinte.168.11.1145; Sequist TD, 2008, J GEN INTERN MED, V23, P678, DOI 10.1007/s11606-008-0510-7; Smith WR, 2007, ANN INTERN MED, V147, P654, DOI 10.7326/0003-4819-147-9-200711060-00010; Stevens LA, 2006, NEW ENGL J MED, V354, P2473, DOI 10.1056/NEJMra054415; Taylor SL, 2006, ANN THORAC SURG, V81, P531, DOI 10.1016/j.athoracsur.2005.08.004; Thom DH., 2006, BMC MED EDUC, V6, P38, DOI DOI 10.1186/1472-6920-6-38; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Woolf SH, 2009, JAMA-J AM MED ASSOC, V301, P1166, DOI 10.1001/jama.2009.320	31	75	76	0	13	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2010	152	1					40	W10		10.7326/0003-4819-152-1-201001050-00009	http://dx.doi.org/10.7326/0003-4819-152-1-201001050-00009			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	543FJ	20048271				2022-12-28	WOS:000273556600006
J	Zhang, FR; Huang, W; Chen, SM; Sun, LD; Liu, H; Li, Y; Cui, Y; Yan, XX; Yang, HT; Yang, RD; Chu, TS; Zhang, C; Zhang, L; Han, JW; Yu, GQ; Quan, C; Yu, YX; Zhang, Z; Shi, BQ; Zhang, LH; Cheng, H; Wang, CY; Lin, Y; Zheng, HF; Fu, XA; Zuo, XB; Wang, Q; Long, H; Sun, YP; Cheng, YL; Tian, HQ; Zhou, FS; Liu, HX; Lu, WS; He, SM; Du, WL; Shen, M; Jin, QY; Wang, Y; Low, HQ; Erwin, T; Yang, NH; Li, JY; Zhao, X; Jiao, YL; Mao, LG; Yin, G; Jiang, ZX; Wang, XD; Yu, JP; Hu, ZH; Gong, CH; Liu, YQ; Liu, RY; Wang, DM; Wei, D; Liu, JX; Cao, WK; Cao, HZ; Li, YP; Yan, WG; Wei, SY; Wang, KJ; Hibberd, ML; Yang, S; Zhang, XJ; Liu, JJ				Zhang, Fu-Ren; Huang, Wei; Chen, Shu-Min; Sun, Liang-Dan; Liu, Hong; Li, Yi; Cui, Yong; Yan, Xiao-Xiao; Yang, Hai-Tao; Yang, Rong-De; Chu, Tong-Sheng; Zhang, Chi; Zhang, Lin; Han, Jian-Wen; Yu, Gong-Qi; Quan, Cheng; Yu, Yong-Xiang; Zhang, Zheng; Shi, Ben-Qing; Zhang, Lian-Hua; Cheng, Hui; Wang, Chang-Yuan; Lin, Yan; Zheng, Hou-Feng; Fu, Xi-An; Zuo, Xian-Bo; Wang, Qiang; Long, Heng; Sun, Yi-Ping; Cheng, Yi-Lin; Tian, Hong-Qing; Zhou, Fu-Sheng; Liu, Hua-Xu; Lu, Wen-Sheng; He, Su-Min; Du, Wen-Li; Shen, Min; Jin, Qi-Yi; Wang, Ying; Low, Hui-Qi; Erwin, Tantoso; Yang, Ning-Han; Li, Jin-Yong; Zhao, Xin; Jiao, Yue-Lin; Mao, Li-Guo; Yin, Gang; Jiang, Zhen-Xia; Wang, Xiao-Dong; Yu, Jing-Ping; Hu, Zong-Hou; Gong, Cui-Hua; Liu, Yu-Qiang; Liu, Rui-Yu; Wang, De-Min; Wei, Dong; Liu, Jin-Xian; Cao, Wei-Kun; Cao, Hong-Zhong; Li, Yong-Ping; Yan, Wei-Guo; Wei, Shi-Yu; Wang, Kui-Jun; Hibberd, Martin L.; Yang, Sen; Zhang, Xue-Jun; Liu, Jian-Jun			Genomewide Association Study of Leprosy	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INFLAMMATORY-BOWEL-DISEASE; CROHNS-DISEASE; SUSCEPTIBILITY; IMMUNITY; MYCOBACTERIA; GENETICS; GENES; HLA	BACKGROUND The narrow host range of Mycobacterium leprae and the fact that it is refractory to growth in culture has limited research on and the biologic understanding of leprosy. Host genetic factors are thought to influence susceptibility to infection as well as disease progression. METHODS We performed a two-stage genomewide association study by genotyping 706 patients and 1225 controls using the Human610-Quad BeadChip (Illumina). We then tested three independent replication sets for an association between the presence of leprosy and 93 single-nucleotide polymorphisms (SNPs) that were most strongly associated with the disease in the genomewide association study. Together, these replication sets comprised 3254 patients and 5955 controls. We also carried out tests of heterogeneity of the associations (or lack thereof) between these 93 SNPs and disease, stratified according to clinical subtype (multibacillary vs. paucibacillary). RESULTS We observed a significant association (P<1.00x10(-10)) between SNPs in the genes CCDC122, C13orf31, NOD2, TNFSF15, HLA-DR, and RIPK2 and a trend toward an association (P = 5.10x10(-5)) with a SNP in LRRK2. The associations between the SNPs in C13orf31, LRRK2, NOD2, and RIPK2 and multibacillary leprosy were stronger than the associations between these SNPs and paucibacillary leprosy. CONCLUSIONS Variants of genes in the NOD2-mediated signaling pathway ( which regulates the innate immune response) are associated with susceptibility to infection with M. leprae.	[Zhang, Fu-Ren] Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, Jinan 250022, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; University of Jinan	Zhang, FR (corresponding author), Shandong Acad Med Sci, Shandong Prov Inst Dermatol & Venereol, 57 Jiyan Lu, Jinan 250022, Shandong, Peoples R China.	zhangfuren@hotmail.com; ayzxj@vip.sina.com; liuj3@gis.a-star.edu.sg	Liu, Jianjun/AAK-4989-2020; Wang, Demin/AAX-4449-2020; Zheng, Houfeng/K-4424-2012; Hibberd, Martin L/D-5050-2009; van der Meer, Jos W.M./C-8521-2013; Netea, Mihai/N-5155-2014; Chen, Gang/G-2722-2010; Kullberg, BJ/C-8520-2013	Liu, Jianjun/0000-0002-3255-3019; Wang, Demin/0000-0001-5549-3795; Zheng, Houfeng/0000-0001-5681-8598; van der Meer, Jos W.M./0000-0001-5120-3690; Kullberg, BJ/0000-0002-6813-8167; Hibberd, Martin/0000-0001-8587-1849	Research Foundation of Shandong Provincial Institute of Dermatology and Venereology; Research Foundation of Shandong Academy of Medical Science; Shandong Provincial Leprosy Control Special Financial Support; Shandong Provincial Research Fund of Science and Technology [2006GG2302029]; Shandong Provincial Health System; Shandong Provincial Taishan Scholar Construction Project; National Natural Science Foundation [30771943/C030116]; Anhui Provincial Special Scientific Program; Agency for Science, Technology, and Research of Singapore	Research Foundation of Shandong Provincial Institute of Dermatology and Venereology; Research Foundation of Shandong Academy of Medical Science; Shandong Provincial Leprosy Control Special Financial Support; Shandong Provincial Research Fund of Science and Technology; Shandong Provincial Health System; Shandong Provincial Taishan Scholar Construction Project; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Anhui Provincial Special Scientific Program; Agency for Science, Technology, and Research of Singapore(Agency for Science Technology & Research (A*STAR))	Supported by grants from the Research Foundation of Shandong Provincial Institute of Dermatology and Venereology (2008-7), the Research Foundation of Shandong Academy of Medical Science ( 2005), the Shandong Provincial Leprosy Control Special Financial Support ( 2007), the Shandong Provincial Research Fund of Science and Technology (2006GG2302029), the Outstanding Scholarship 1020 Project of Shandong Provincial Health System ( 2008), the Shandong Provincial Taishan Scholar Construction Project ( 2009), the National Natural Science Foundation (30771943/C030116), the Anhui Provincial Special Scientific Program (2007-7), and the Agency for Science, Technology, and Research of Singapore.	ABEL L, 1988, AM J HUM GENET, V42, P256; ABEL L, 1995, GENET EPIDEMIOL, V12, P63, DOI 10.1002/gepi.1370120107; Alcais A, 2007, NAT GENET, V39, P517, DOI 10.1038/ng2000; [Anonymous], 1982, World Health Organ Tech Rep Ser, V675, P1; Behr MA, 2006, INFLAMM BOWEL DIS, V12, P1000, DOI 10.1097/01.mib.0000228183.70197.dd; Britton WJ, 2004, LANCET, V363, P1209, DOI 10.1016/S0140-6736(04)15952-7; Casanova JL, 2002, ANNU REV IMMUNOL, V20, P581, DOI 10.1146/annurev.immunol.20.081501.125851; CHAKRAVARTTI MR, 1973, TOPICS HUMAN GENETIC, V1; Cho JH, 2008, NAT REV IMMUNOL, V8, P458, DOI 10.1038/nri2340; Croft M, 2009, NAT REV IMMUNOL, V9, P271, DOI 10.1038/nri2526; Divangahi M, 2008, J IMMUNOL, V181, P7157, DOI 10.4049/jimmunol.181.10.7157; FINE PEM, 1983, INT J LEPROSY, V51, P553; Franchi L, 2009, IMMUNOL REV, V227, P106, DOI 10.1111/j.1600-065X.2008.00734.x; Geluk A, 2006, HUM IMMUNOL, V67, P439, DOI 10.1016/j.humimm.2006.03.009; Hasegawa M, 2008, EMBO J, V27, P373, DOI 10.1038/sj.emboj.7601962; Hastings RC, 1994, LEPROSY, P291; Hitotsumatsu O, 2008, IMMUNITY, V28, P381, DOI 10.1016/j.immuni.2008.02.002; Meylan F, 2008, IMMUNITY, V29, P79, DOI 10.1016/j.immuni.2008.04.021; Mira MT, 2004, NATURE, V427, P636, DOI 10.1038/nature02326; MODLIN RL, 1994, J INVEST DERMATOL, V102, P828, DOI 10.1111/1523-1747.ep12381958; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Moraes MO, 2006, LEPROSY REV, V77, P189; Moreira LO, 2008, CELL MICROBIOL, V10, P2067, DOI 10.1111/j.1462-5822.2008.01189.x; Murphy KM, 2002, NAT REV IMMUNOL, V2, P933, DOI 10.1038/nri954; Noguchi E, 2009, NAT IMMUNOL, V10, P471, DOI 10.1038/ni.1722; Ottenhoff THM, 2005, TUBERCULOSIS, V85, P53, DOI 10.1016/j.tube.2004.09.011; OTTENHOFF THM, 1987, INT J LEPROSY, V55, P521; Pierce ES, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000234; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quintana-Murci L, 2007, NAT IMMUNOL, V8, P1165, DOI 10.1038/ni1535; Ridley D S, 1966, Int J Lepr Other Mycobact Dis, V34, P255; Schurr E, 2006, SEMIN IMMUNOL, V18, P404, DOI 10.1016/j.smim.2006.07.005; SHIELDS ED, 1987, J CLIN INVEST, V79, P1139, DOI 10.1172/JCI112930; Shimada K, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000379; Siddiqui MR, 2001, NAT GENET, V27, P439, DOI 10.1038/86958; Smith WW, 2005, P NATL ACAD SCI USA, V102, P18676, DOI 10.1073/pnas.0508052102; Thiebaut R, 2009, AM J GASTROENTEROL, V104, P384, DOI 10.1038/ajg.2008.36; TODD JR, 1990, REV INFECT DIS, V12, P63	38	522	539	2	93	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2609	2618		10.1056/NEJMoa0903753	http://dx.doi.org/10.1056/NEJMoa0903753			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20018961	Green Accepted			2022-12-28	WOS:000273181300008
J	Dhruva, SS; Bero, LA; Redberg, RF				Dhruva, Sanket S.; Bero, Lisa A.; Redberg, Rita F.			Strength of Study Evidence Examined by the FDA in Premarket Approval of Cardiovascular Devices	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							HEALTH-CARE COSTS; MEDICAL DEVICES; TRIALS; SAFETY	Context Medical devices are common in clinical practice and have important effects on morbidity and mortality, yet there has not been a systematic examination of evidence used by the US Food and Drug Administration (FDA) for device approval. Objectives To study premarket approval (PMA)-the most stringent FDA review process-of cardiovascular devices and to characterize the type and strength of evidence on which it is based. Data Sources and Study Selection Systematic review of 123 summaries of safety and effectiveness data for 78 PMAs for high-risk cardiovascular devices that received PMA between January 2000 and December 2007. Data Extraction Examination of the methodological characteristics considered essential to minimize confounding and bias, as well as the primary end points of the 123 studies supporting the PMAs. Results Thirty-three of 123 studies (27%) used to support recent FDA approval of cardiovascular devices were randomized and 17 of 123 (14%) were blinded. Fifty-one of 78 PMAs (65%) were based on a single study. One hundred eleven of 213 primary end points (52%) were compared with controls and 34 of 111 controls (31%) were retrospective. One hundred eighty-seven of 213 primary end points (88%) were surrogate measures and 122 of 157 (78%) had a discrepancy between the number of patients enrolled in the study and the number analyzed. Conclusion Premarket approval of cardiovascular devices by the FDA is often based on studies that lack adequate strength and may be prone to bias. JAMA. 2009;302(24):2679-2685 www.jama.com	[Redberg, Rita F.] Univ Calif San Francisco, Dept Med, Div Cardiol, San Francisco, CA 94143 USA; [Bero, Lisa A.] Univ Calif San Francisco, Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA; [Bero, Lisa A.] Univ Calif San Francisco, Sch Med, Inst Hlth Policy Studies, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Redberg, RF (corresponding author), Univ Calif San Francisco, Dept Med, Div Cardiol, 505 Parnassus Ave,SteM 1180, San Francisco, CA 94143 USA.	redberg@medicine.ucsf.edu		Bero, Lisa/0000-0003-1893-6651	NIH/NCRR [UL1 RR024131]	NIH/NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Mark Pletcher, MD, Department of Epidemiology and Biostatistics, UCSF, provided statistical assistance, which was supported by NIH/NCRR grant UL1 RR024131 to the UCSF Clinical and Translational Science Institute. Jeffrey Tice, MD, and Steven Schroeder, MD, Department of Medicine, UCSF, provided helpful comments, and Deborah Airo, BA, Department of Epidemiology and Biostatistics, UCSF, provided editorial assistance. The UCSF Pathway to Discovery in Health and Society also provided assistance. None received compensation for their contribution.	Alexander GC, 2009, JAMA-J AM MED ASSOC, V301, P2488, DOI 10.1001/jama.2009.851; [Anonymous], NAT HLTH EXP 2020 HI; [Anonymous], PREM APPR; Boden WE, 2008, NEW ENGL J MED, V358, P2197, DOI 10.1056/NEJMp0801433; Congressional Budget Office, 2008, TECHN CHANG GROWTH H; Curfman GD, 2009, NEW ENGL J MED, V360, P1550, DOI 10.1056/NEJMe0902377; Douglas PS, 2009, J AM COLL CARDIOL, V53, P1629, DOI 10.1016/j.jacc.2009.03.005; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P2789, DOI 10.1001/jama.299.23.2789; Feigal DW, 2003, NEW ENGL J MED, V348, P191, DOI 10.1056/NEJMp020170; Feldmon MD, 2008, J GEN INTERN MED, V23, P57, DOI 10.1007/s11606-007-0275-4; Fleming TR, 1996, ANN INTERN MED, V125, P605, DOI 10.7326/0003-4819-125-7-199610010-00011; Furlan AJ, 2005, STROKE, V36, P398, DOI 10.1161/01.STR.0000153057.07181.94; Glickman SW, 2009, NEW ENGL J MED, V360, P816, DOI 10.1056/NEJMsb0803929; Gostin LO, 2008, JAMA-J AM MED ASSOC, V299, P2313, DOI 10.1001/jama.299.19.2313; Higgins JPT, COCHRANE HDB SYSTEMA, P4; Iglehart JK, 2009, NEW ENGL J MED, V361, P325, DOI 10.1056/NEJMp0904133; Lim E, 2008, ANN INTERN MED, V149, P612, DOI 10.7326/0003-4819-149-9-200811040-00004; Maisel WH, 2005, JAMA-J AM MED ASSOC, V294, P955, DOI 10.1001/jama.294.8.955; Maisel WH, 2004, ANN INTERN MED, V140, P296, DOI 10.7326/0003-4819-140-4-200402170-00012; Maisel WH, 2008, NEW ENGL J MED, V358, P985, DOI 10.1056/NEJMp0800495; MEIER B, 2005, NY TIMES        0524, P1; Mitka M, 2008, JAMA-J AM MED ASSOC, V300, P1985, DOI 10.1001/jama.2008.528; Mongan JJ, 2008, NEW ENGL J MED, V358, P1509, DOI 10.1056/NEJMsb0707912; MUNI NI, 2007, CARDIOVASCULAR THERA; O'Connor AB, 2009, JAMA-J AM MED ASSOC, V302, P191, DOI 10.1001/jama.2009.973; Orszag PR, 2007, NEW ENGL J MED, V357, P1885, DOI 10.1056/NEJMp078191; *PMA, 020045 PMA; *PMA, 040036 PMA; Rising K, 2008, PLOS MED, V5, P1561, DOI 10.1371/journal.pmed.0050217; *US FDA, PREM APPR DEV ADV OV; *US FDA, MEDTR REC SPRINT FID; *US FDA, MED DEV US FREE MOD; *US FDA, DEV CLASS GEN SPEC C; *US FDA, PMA APPL CONT SUMM S; Yock Cynthia A, 2004, Am Heart Hosp J, V2, P21, DOI 10.1111/j.1541-9215.2004.03320.x; Zhang B, 2007, BIOSENS BIOELECTRON, V23, P19, DOI 10.1016/j.bios.2007.03.007; 2009, LANCET, V373, P694	37	141	145	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 23	2009	302	24					2679	2685		10.1001/jama.2009.1899	http://dx.doi.org/10.1001/jama.2009.1899			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535JU	20040556				2022-12-28	WOS:000272965300024
J	Chong, JL; Wenzel, PL; Saenz-Robles, MT; Nair, V; Ferrey, A; Hagan, JP; Gomez, YM; Sharma, N; Chen, HZ; Ouseph, M; Wang, SH; Trikha, P; Culp, B; Mezache, L; Winton, DJ; Sansom, OJ; Chen, DN; Bremner, R; Cantalupo, PG; Robinson, ML; Pipas, JM; Leone, G				Chong, Jean-Leon; Wenzel, Pamela L.; Saenz-Robles, M. Teresa; Nair, Vivek; Ferrey, Antoney; Hagan, John P.; Gomez, Yorman M.; Sharma, Nidhi; Chen, Hui-Zi; Ouseph, Madhu; Wang, Shu-Huei; Trikha, Prashant; Culp, Brian; Mezache, Louise; Winton, Douglas J.; Sansom, Owen J.; Chen, Danian; Bremner, Rod; Cantalupo, Paul G.; Robinson, Michael L.; Pipas, James M.; Leone, Gustavo			E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells	NATURE			English	Article							INTESTINAL EPITHELIUM; CELLULAR PROLIFERATION; TRANSCRIPTION FACTORS; BINDING PROTEIN; S-PHASE; EXPRESSION; E2F3; CYCLE; ROLES; MICE	In the established model of mammalian cell cycle control, the retinoblastoma protein (Rb) functions to restrict cells from entering S phase by binding and sequestering E2f activators (E2f1, E2f2 and E2f3), which are invariably portrayed as the ultimate effectors of a transcriptional program that commit cells to enter and progress through S phase(1,2). Using a panel of tissue-specific cre-transgenic mice and conditional E2f alleles we examined the effects of E2f1, E2f2 and E2f3 triple deficiency in murine embryonic stem cells, embryos and small intestines. We show that in normal dividing progenitor cells E2f1-3 function as transcriptional activators, but contrary to the current view, are dispensable for cell division and instead are necessary for cell survival. In differentiating cells E2f1-3 function in a complex with Rb as repressors to silence E2f targets and facilitate exit from the cell cycle. The inactivation of Rb in differentiating cells resulted in a switch of E2f1-3 from repressors to activators, leading to the superactivation of E2f responsive targets and ectopic cell divisions. Loss of E2f1-3 completely suppressed these phenotypes caused by Rb deficiency. This work contextualizes the activator versus repressor functions of E2f1-3 in vivo, revealing distinct roles in dividing versus differentiating cells and in normal versus cancer-like cell cycles.	[Chong, Jean-Leon; Wenzel, Pamela L.; Nair, Vivek; Ferrey, Antoney; Hagan, John P.; Gomez, Yorman M.; Sharma, Nidhi; Chen, Hui-Zi; Ouseph, Madhu; Wang, Shu-Huei; Trikha, Prashant; Culp, Brian; Mezache, Louise; Leone, Gustavo] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Chong, Jean-Leon; Wenzel, Pamela L.; Nair, Vivek; Ferrey, Antoney; Gomez, Yorman M.; Sharma, Nidhi; Chen, Hui-Zi; Ouseph, Madhu; Wang, Shu-Huei; Trikha, Prashant; Culp, Brian; Mezache, Louise; Leone, Gustavo] Ohio State Univ, Coll Biol Sci, Dept Mol Genet, Columbus, OH 43210 USA; [Chong, Jean-Leon; Wenzel, Pamela L.; Nair, Vivek; Ferrey, Antoney; Hagan, John P.; Gomez, Yorman M.; Sharma, Nidhi; Chen, Hui-Zi; Ouseph, Madhu; Wang, Shu-Huei; Trikha, Prashant; Culp, Brian; Mezache, Louise; Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Saenz-Robles, M. Teresa; Cantalupo, Paul G.; Pipas, James M.] Univ Pittsburgh, Dept Biol Sci, Pittsburgh, PA 15260 USA; [Winton, Douglas J.] Li Ka Shing Ctr, Cambridge Res Inst, Cambridge CB2 0RE, England; [Sansom, Owen J.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Chen, Danian; Bremner, Rod] Univ Toronto, Toronto Western Res Inst, Univ Hlth Network, Dept Ophthalmol & Visual Sci, Toronto, ON M5T 2S8, Canada; [Chen, Danian; Bremner, Rod] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5T 2S8, Canada; [Robinson, Michael L.] Miami Univ, Dept Zool, Oxford, OH 45056 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; CRUK Cambridge Institute; University of Cambridge; Beatson Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University System of Ohio; Miami University	Leone, G (corresponding author), Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA.	Gustavo.Leone@osumc.edu	Ouseph, Madhu/B-8940-2009; Wenzel, Pamela/A-2992-2010; Trikha, Prashant/B-5897-2012; Wenzel, Pamela/AAJ-1944-2021; Bremner, Rod/I-6490-2012; Chen, Danian/GXV-7996-2022	Ouseph, Madhu/0000-0002-3422-1675; Wenzel, Pamela/0000-0002-4530-015X; Bremner, Rod/0000-0001-9184-7212; Chen, Danian/0000-0002-6916-2978; Sansom, Owen J./0000-0001-9540-3010; Hagan, John/0000-0003-0295-4898	NIH [R01CA85619, R01CA82259, R01HD04470, P01CA097189, CA098956, 5 T32 CA106196-04]; DoD award [BC061730]; NATIONAL CANCER INSTITUTE [R01CA085619, T32CA106196, P01CA097189, R01CA098956, R01CA082259] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DoD award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. Rawahneh, J. Moffitt and R. Rajmohan for technical assistance with histology. We also thank A. de Bruin and S. Naidu for assistance in analysing histological slides. We are thankful to J. Groden, A. Simcox and D. Guttridge for their critical comments. This work was funded by NIH grants to G. L. (R01CA85619, R01CA82259, R01HD04470, P01CA097189) and NIH grant to J. M. P. ( CA098956); J.- L. C. is the recipient of a DoD award ( BC061730). P. L. W. was supported by NIH training grant 5 T32 CA106196-04.	Chong JL, 2009, MOL CELL BIOL, V29, P414, DOI 10.1128/MCB.01161-08; Cloud JE, 2002, MOL CELL BIOL, V22, P2663, DOI 10.1128/MCB.22.8.2663-2672.2002; Coopersmith CM, 1997, ONCOGENE, V15, P131, DOI 10.1038/sj.onc.1201176; DeGregori J, 1997, P NATL ACAD SCI USA, V94, P7245, DOI 10.1073/pnas.94.14.7245; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Haigis K, 2006, J BIOL CHEM, V281, P638, DOI 10.1074/jbc.M509053200; HELIN K, 1992, CELL, V70, P337, DOI 10.1016/0092-8674(92)90107-N; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Iglesias A, 2004, J CLIN INVEST, V113, P1398, DOI 10.1172/JCI200418879; Ireland H, 2004, GASTROENTEROLOGY, V126, P1236, DOI 10.1053/j.gastro.2004.03.020; JOHNSON DG, 1993, NATURE, V365, P349, DOI 10.1038/365349a0; KAELIN WG, 1992, CELL, V70, P351, DOI 10.1016/0092-8674(92)90108-O; Kong LJ, 2007, ONCOGENE, V26, P321, DOI 10.1038/sj.onc.1209817; Leone G, 1998, GENE DEV, V12, P2120, DOI 10.1101/gad.12.14.2120; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Malumbres M, 2004, CELL, V118, P493, DOI 10.1016/j.cell.2004.08.002; Malumbres M, 2005, TRENDS BIOCHEM SCI, V30, P630, DOI 10.1016/j.tibs.2005.09.005; Martin A, 2005, CANCER CELL, V7, P591, DOI 10.1016/j.ccr.2005.05.006; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Murga M, 2001, IMMUNITY, V15, P959, DOI 10.1016/S1074-7613(01)00254-0; NEVINS JR, 1992, NATURE, V358, P375, DOI 10.1038/358375a0; Rowland BD, 2006, CELL, V127, P871, DOI 10.1016/j.cell.2006.11.019; RUSSELL P, 1986, CELL, V45, P781, DOI 10.1016/0092-8674(86)90550-7; Saenz-Robles MT, 2007, J VIROL, V81, P13191, DOI 10.1128/JVI.01658-07; Sharma N, 2006, J BIOL CHEM, V281, P36124, DOI 10.1074/jbc.M604152200; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507	30	180	185	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					930	934		10.1038/nature08677	http://dx.doi.org/10.1038/nature08677			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016602	Green Accepted, Green Submitted			2022-12-28	WOS:000272795400045
J	O'Gara, PT; Shepard, JO; Yared, K; Sohani, AR; Butcher, BW; Rosenberg, ES; Newton-Cheh, C; Abramson, JS				O'Gara, Patrick T.; Shepard, Jo-Anne O.; Yared, Kibar; Sohani, Aliyah R.; Butcher, Brad W.; Rosenberg, Eric S.; Newton-Cheh, Christopher; Abramson, Jeremy S.			Case 39-2009: A 28-Year-Old Pregnant Woman with Acute Cardiac Failure.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article; Proceedings Paper	Air Medical Transport Conference	SEP, 2008	Tampa, FL				LARGE-CELL LYMPHOMA; RISK		[O'Gara, Patrick T.] Brigham & Womens Hosp, Div Cardiovasc Med, Boston, MA 02115 USA; [Shepard, Jo-Anne O.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Yared, Kibar] Massachusetts Gen Hosp, Dept Cardiol, Boston, MA 02114 USA; [Sohani, Aliyah R.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [O'Gara, Patrick T.; Yared, Kibar] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Shepard, Jo-Anne O.] Harvard Univ, Sch Med, Dept Radiol, Boston, MA 02115 USA; [Sohani, Aliyah R.] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	O'Gara, PT (corresponding author), Brigham & Womens Hosp, Div Cardiovasc Med, 75 Francis St, Boston, MA 02115 USA.		Butcher, Brad/AAH-7707-2020; Abramson, Jeremy/N-5178-2019					ADDIS BJ, 1986, HISTOPATHOLOGY, V10, P379, DOI 10.1111/j.1365-2559.1986.tb02491.x; Bates SM, 2008, CHEST, V133, p844S, DOI 10.1378/chest.08-0761; Bishop PC, 1999, J CLIN ONCOL, V17, P2479, DOI 10.1200/JCO.1999.17.8.2479; Martelli M, 2008, CRIT REV ONCOL HEMAT, V68, P256, DOI 10.1016/j.critrevonc.2008.07.020; MAYNARD SE, 2008, BRENNER RECTORS KIDN, P1567; OGARA PT, 2006, VASCULAR MED COMPANI, P503; Rodig SJ, 2007, AM J SURG PATHOL, V31, P106, DOI 10.1097/01.pas.0000213334.40358.0e; Rosenwald A, 2003, J EXP MED, V198, P851, DOI 10.1084/jem.20031074; Savage KJ, 2003, BLOOD, V102, P3871, DOI 10.1182/blood-2003-06-1841; Sherif HMF, 2008, ANN THORAC SURG, V85, P1793, DOI 10.1016/j.athoracsur.2007.11.018; Sliwa K, 2006, LANCET, V368, P687, DOI 10.1016/S0140-6736(06)69253-2; Stone JH, 1998, JAMA-J AM MED ASSOC, V280, P559, DOI 10.1001/jama.280.6.559; Swerdlow SH, 2008, WHO CLASSIFICATION T, V5, P250; Vikse BE, 2008, NEW ENGL J MED, V359, P800, DOI 10.1056/NEJMoa0706790; Warnes CA, 2008, BRAUNWALDS HEART DIS, V8th, P1967; Warnes CA, 2008, J AM COLL CARDIOL, V52, pE1, DOI 10.1016/j.jacc.2008.10.001; Wilson BJ, 2003, BRIT MED J, V326, P845, DOI 10.1136/bmj.326.7394.845; 2008, N ENGL J MED, V358, P513	18	5	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2009	361	25					2462	2473		10.1056/NEJMcpc0907803	http://dx.doi.org/10.1056/NEJMcpc0907803			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine	533CE	20018968				2022-12-28	WOS:000272798900013
J	Williamson, JR				Williamson, James R.			The Ribosome at Atomic Resolution	CELL			English	Editorial Material							ESCHERICHIA-COLI RIBOSOME; ANGSTROM RESOLUTION; SUBUNIT; RNA; PROTEINS; RECONSTITUTION; MICROSCOPY; PARTICLES; MODEL	The 2009 Nobel Prize in Chemistry has been awarded to Venki Ramakrishnan, Tom Steitz, and Ada Yonath for crystallographic studies of the ribosome. The atomic resolution structures of the ribosomal subunits provide an extraordinary context for understanding one of the most fundamental aspects of cellular function: protein synthesis.	[Williamson, James R.] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA; [Williamson, James R.] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Williamson, JR (corresponding author), Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA.	jrwill@scripps.edu	Williamson, James R/B-2891-2009; Williamson, James/AAL-2104-2021	Williamson, James R/0000-0002-8772-468X; Williamson, James/0000-0002-8772-468X				Ban N, 2000, SCIENCE, V289, P905, DOI 10.1126/science.289.5481.905; CAPEL MS, 1987, SCIENCE, V238, P1403, DOI 10.1126/science.3317832; FRANK J, 1995, NATURE, V376, P441, DOI 10.1038/376441a0; LAKE JA, 1976, J MOL BIOL, V105, P131, DOI 10.1016/0022-2836(76)90200-X; NIERHAUS KH, 1974, P NATL ACAD SCI USA, V71, P4713, DOI 10.1073/pnas.71.12.4713; NOLLER HF, 1992, SCIENCE, V256, P1416, DOI 10.1126/science.1604315; NOLLER HF, 1972, P NATL ACAD SCI USA, V69, P3115, DOI 10.1073/pnas.69.11.3115; Schluenzen F, 2000, CELL, V102, P615, DOI 10.1016/S0092-8674(00)00084-2; STARK H, 1995, STRUCTURE, V3, P815, DOI 10.1016/S0969-2126(01)00216-7; STERN S, 1988, J MOL BIOL, V204, P447, DOI 10.1016/0022-2836(88)90588-8; TISSIERES A, 1958, NATURE, V182, P778, DOI 10.1038/182778b0; TRAUB P, 1968, P NATL ACAD SCI USA, V59, P777, DOI 10.1073/pnas.59.3.777; Wimberly BT, 2000, NATURE, V407, P327, DOI 10.1038/35030006; YONATH AE, 1980, BIOCHEM INT, V1, P428; Yusupov MM, 2001, SCIENCE, V292, P883, DOI 10.1126/science.1060089	15	9	9	0	17	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1041	1043		10.1016/j.cell.2009.11.028	http://dx.doi.org/10.1016/j.cell.2009.11.028			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005796	Bronze			2022-12-28	WOS:000272622800004
J	Meyer, CH; Holz, FG				Meyer, Carsten H.; Holz, Frank G.			Blurred Vision after Cardiac Catheterization.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Meyer, Carsten H.; Holz, Frank G.] Univ Bonn, D-5300 Bonn, Germany	University of Bonn	Meyer, CH (corresponding author), Univ Bonn, D-5300 Bonn, Germany.	meyer_eye@yahoo.com	Meyer, Carsten/A-3981-2017	Meyer, Carsten/0000-0002-0530-5298					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2009	361	24					2366	2366		10.1056/NEJMicm0808384	http://dx.doi.org/10.1056/NEJMicm0808384			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529VS	20007562				2022-12-28	WOS:000272547600010
J	Kumagi, T; Hiasa, Y; Hirschfield, GM				Kumagi, T.; Hiasa, Y.; Hirschfield, G. M.			Hepatocellular carcinoma for the non-specialist	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RANDOMIZED CONTROLLED-TRIAL; HEPATITIS-B; ETHANOL INJECTION; NATURAL-HISTORY; MANAGEMENT; CHEMOEMBOLIZATION; DIAGNOSIS; ABLATION; DESIGN		[Hirschfield, G. M.] Toronto Western Hosp, Ctr Liver, Toronto, ON M5T 2S8, Canada; [Kumagi, T.; Hiasa, Y.] Ehime Univ, Sch Med, Matsuyama, Ehime 7910295, Japan	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Ehime University	Hirschfield, GM (corresponding author), Toronto Western Hosp, Ctr Liver, Toronto, ON M5T 2S8, Canada.	gideon.hirschfield@uhn.on.ca	Hirschfield, Gideon M/M-2143-2015; Kumagi, Teru/AAS-7427-2021; Hiasa, Yoichi/ABD-2759-2021	Hirschfield, Gideon M/0000-0002-6736-2255; Kumagi, Teru/0000-0002-2292-7750; Hiasa, Yoichi/0000-0003-4117-339X				BEASLEY RP, 1981, LANCET, V2, P1129; Bruix J, 2005, HEPATOLOGY, V42, P1208, DOI 10.1002/hep.20933; Bruix J, 2001, J HEPATOL, V35, P421, DOI 10.1016/S0168-8278(01)00130-1; Chang MH, 1997, NEW ENGL J MED, V336, P1855, DOI 10.1056/NEJM199706263362602; Chen W, 2009, J PHYCOL, V45, P9; Cho YK, 2009, HEPATOLOGY, V49, P453, DOI 10.1002/hep.22648; Forner A, 2008, HEPATOLOGY, V47, P97, DOI 10.1002/hep.21966; Hussain K, 2009, Minerva Gastroenterol Dietol, V55, P123; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lin SM, 2005, GUT, V54, P1151, DOI 10.1136/gut.2004.045203; Llovet JM, 1999, HEPATOLOGY, V29, P62, DOI 10.1002/hep.510290145; Llovet JM, 2003, HEPATOLOGY, V37, P429, DOI 10.1053/jhep.2003.50047; Llovet JM, 2002, LANCET, V359, P1734, DOI 10.1016/S0140-6736(02)08649-X; Llovet JM, 2008, NEW ENGL J MED, V359, P378, DOI 10.1056/NEJMoa0708857; Llovet JM, 2008, JNCI-J NATL CANCER I, V100, P698, DOI 10.1093/jnci/djn134; Llovet JM, 2008, J HEPATOL, V48, pS20, DOI 10.1016/j.jhep.2008.01.022; Lo CM, 2002, HEPATOLOGY, V35, P1164, DOI 10.1053/jhep.2002.33156; Lok AS, 2009, GASTROENTEROLOGY, V136, P138, DOI 10.1053/j.gastro.2008.09.014; Lopez PM, 2006, ALIMENT PHARM THER, V23, P1535, DOI 10.1111/j.1365-2036.2006.02932.x; Makuuchi M, 2008, HEPATOL RES, V38, P37, DOI 10.1111/j.1872-034X.2007.00216.x; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Sangiovanni A, 2004, GASTROENTEROLOGY, V126, P1005, DOI 10.1053/j.gastro.2003.12.049; SHEU JC, 1985, GASTROENTEROLOGY, V89, P259, DOI 10.1016/0016-5085(85)90324-5; Shiina S, 2005, GASTROENTEROLOGY, V129, P122, DOI 10.1053/j.gastro.2005.04.009; Singal A, 2009, ALIMENT PHARM THER, V30, P37, DOI 10.1111/j.1365-2036.2009.04014.x; SINGAL AK, 2009, CLIN GASTROENTEROL H; Trevisani F, 2001, J HEPATOL, V34, P570, DOI 10.1016/S0168-8278(00)00053-2; Villa E, 2000, HEPATOLOGY, V32, P233, DOI 10.1053/jhep.2000.9603; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	30	16	16	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 4	2009	339								b5039	10.1136/bmj.b5039	http://dx.doi.org/10.1136/bmj.b5039			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NU	19965932				2022-12-28	WOS:000272453700003
J	Carro, MS; Lim, WK; Alvarez, MJ; Bollo, RJ; Zhao, XD; Snyder, EY; Sulman, EP; Anne, SL; Doetsch, F; Colman, H; Lasorella, A; Aldape, K; Califano, A; Iavarone, A				Carro, Maria Stella; Lim, Wei Keat; Alvarez, Mariano Javier; Bollo, Robert J.; Zhao, Xudong; Snyder, Evan Y.; Sulman, Erik P.; Anne, Sandrine L.; Doetsch, Fiona; Colman, Howard; Lasorella, Anna; Aldape, Ken; Califano, Andrea; Iavarone, Antonio			The transcriptional network for mesenchymal transformation of brain tumours	NATURE			English	Article							GROWTH-FACTOR RECEPTOR; NEURAL STEM-CELL; C-MYC; EXPRESSION; DIFFERENTIATION; MECHANISMS; BINDING; SURVIVAL; PROLIFERATION; GLIOGENESIS	The inference of transcriptional networks that regulate transitions into physiological or pathological cellular states remains a central challenge in systems biology. A mesenchymal phenotype is the hallmark of tumour aggressiveness in human malignant glioma, but the regulatory programs responsible for implementing the associated molecular signature are largely unknown. Here we show that reverse-engineering and an unbiased interrogation of a glioma-specific regulatory network reveal the transcriptional module that activates expression of mesenchymal genes in malignant glioma. Two transcription factors (C/EBP beta and STAT3) emerge as synergistic initiators and master regulators of mesenchymal transformation. Ectopic co-expression of C/EBP beta and STAT3 reprograms neural stem cells along the aberrant mesenchymal lineage, whereas elimination of the two factors in glioma cells leads to collapse of the mesenchymal signature and reduces tumour aggressiveness. In human glioma, expression of C/EBP beta and STAT3 correlates with mesenchymal differentiation and predicts poor clinical outcome. These results show that the activation of a small regulatory module is necessary and sufficient to initiate and maintain an aberrant phenotypic state in cancer cells.	[Carro, Maria Stella; Zhao, Xudong; Anne, Sandrine L.; Lasorella, Anna; Califano, Andrea; Iavarone, Antonio] Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA; [Lim, Wei Keat; Califano, Andrea] Columbia Univ, Med Ctr, Dept Biomed Informat, New York, NY 10032 USA; [Lim, Wei Keat; Alvarez, Mariano Javier; Califano, Andrea] Columbia Univ, Med Ctr, Ctr Computat Biol & Bioinformat, New York, NY 10032 USA; [Alvarez, Mariano Javier; Califano, Andrea] Columbia Univ, Med Ctr, Joint Ctr Syst Biol, New York, NY 10032 USA; [Doetsch, Fiona; Lasorella, Anna; Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Pathol, New York, NY 10032 USA; [Lasorella, Anna] Columbia Univ, Med Ctr, Dept Pediat, New York, NY 10032 USA; [Iavarone, Antonio] Columbia Univ, Med Ctr, Dept Neurol, New York, NY 10032 USA; [Bollo, Robert J.] NYU, Sch Med, Dept Neurosurg, New York, NY 10016 USA; [Bollo, Robert J.] NYU, Langone Med Ctr, New York, NY 10016 USA; [Snyder, Evan Y.] Burnham Inst Med Res, La Jolla, CA 92037 USA; [Sulman, Erik P.] Univ Texas MD Anderson Canc Ctr, Div Radiat Oncol, Houston, TX 77030 USA; [Colman, Howard] Univ Texas MD Anderson Canc Ctr, Dept Neurooncol, Houston, TX 77030 USA; [Aldape, Ken] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA	Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; Columbia University; New York University; New York University; NYU Langone Medical Center; Sanford Burnham Prebys Medical Discovery Institute; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center	Califano, A (corresponding author), Columbia Univ, Med Ctr, Inst Canc Genet, New York, NY 10032 USA.	califano@c2b2.columbia.edu; ai2102@columbia.edu	Stella, Maria Stella/GVS-1585-2022; Colman, Howard/L-5433-2019	Carro, Maria Stella/0000-0002-8570-7691; Sulman, Erik/0000-0003-4933-9120; Iavarone, Antonio/0000-0002-0683-4634; zhao, zhao xu dong/0000-0001-9126-7365; Califano, Andrea/0000-0003-4742-3679	National Institute of Health [R01CA109755, R01CA101644, R01CA085628, R01NS061776]; NCI Grand Opportunities TDDN Network [1RC2CA148308-01]; In Silico Research Centre of Excellence [NCI-caBIG 29XS192]; National Centers for Biomedical Computing NIH Roadmap Initiative [U54CA121852]; National Institute of General Medical Sciences [P20GM075059]; Italian Ministry of Welfare/Provincia di Benevento; Fondation de Recherche Medicale; NATIONAL CANCER INSTITUTE [U54CA121852, R01CA101644, R01CA127643, R01CA190891, R01CA109755, R01CA085628, RC2CA148308, U01CA168426] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066116] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM075059] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS061776] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI Grand Opportunities TDDN Network; In Silico Research Centre of Excellence; National Centers for Biomedical Computing NIH Roadmap Initiative; National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Italian Ministry of Welfare/Provincia di Benevento; Fondation de Recherche Medicale; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institute of Health grants R01CA109755 (A. C.), R01CA101644 (A. L.), R01CA085628 and R01NS061776 (A. I.), NCI Grand Opportunities TDDN Network 1RC2CA148308-01 (A. C.), In Silico Research Centre of Excellence NCI-caBIG 29XS192 (A. C.), National Centers for Biomedical Computing NIH Roadmap Initiative U54CA121852 (A. C.) and National Institute of General Medical Sciences grant P20GM075059 (E.Y.S.). M. S. C. is supported by a fellowship from the Italian Ministry of Welfare/Provincia di Benevento and S. L. A. by a fellowship from Fondation de Recherche Medicale. We thank N. Ramirez-Martinez for technical assistance with mouse husbandry and in vivo procedures.	Aoki K, 1998, J BIOL CHEM, V273, P26698, DOI 10.1074/jbc.273.41.26698; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bachoo RM, 2002, CANCER CELL, V1, P269, DOI 10.1016/S1535-6108(02)00046-6; Barnabe-Heider F, 2005, NEURON, V48, P253, DOI 10.1016/j.neuron.2005.08.037; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonni A, 1997, SCIENCE, V278, P477, DOI 10.1126/science.278.5337.477; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bussemaker HJ, 2001, NAT GENET, V27, P167, DOI 10.1038/84792; Butte A J, 2000, Pac Symp Biocomput, P418; Chen YQ, 2008, NATURE, V452, P429, DOI 10.1038/nature06757; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Demuth T, 2004, J NEURO-ONCOL, V70, P217, DOI 10.1007/s11060-004-2751-6; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Frank SR, 2001, GENE DEV, V15, P2069, DOI 10.1101/gad.906601; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Fuks F, 2001, EMBO J, V20, P2536, DOI 10.1093/emboj/20.10.2536; Hanauer DA, 2007, CURR MOL MED, V7, P133, DOI 10.2174/156652407779940431; Kargiotis O, 2006, J NEURO-ONCOL, V78, P281, DOI 10.1007/s11060-005-9097-6; Lander AD, 2004, PLOS BIOL, V2, P712, DOI 10.1371/journal.pbio.0020164; Lee JP, 2007, NAT MED, V13, P439, DOI 10.1038/nm1548; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Lim WK, 2009, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2009, P504; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mani KM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.2; Margolin AA, 2006, NAT PROTOC, V1, P663, DOI 10.1038/nprot.2006.106; Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595; Menard C, 2002, NEURON, V36, P597, DOI 10.1016/S0896-6273(02)01026-7; Nadeau S, 2005, MOL CELL NEUROSCI, V29, P525, DOI 10.1016/j.mcn.2005.04.004; Nakashima K, 1999, SCIENCE, V284, P479, DOI 10.1126/science.284.5413.479; Nigro JM, 2005, CANCER RES, V65, P1678, DOI 10.1158/0008-5472.CAN-04-2921; Ohgaki H, 2005, J NEUROPATH EXP NEUR, V64, P479, DOI 10.1093/jnen/64.6.479; Palomero T, 2006, P NATL ACAD SCI USA, V103, P18261, DOI 10.1073/pnas.0606108103; Paquin A, 2005, J NEUROSCI, V25, P10747, DOI 10.1523/JNEUROSCI.2662-05.2005; Park KI, 2006, EXP NEUROL, V199, P156, DOI 10.1016/j.expneurol.2006.04.002; Parker MA, 2005, EXP NEUROL, V194, P320, DOI 10.1016/j.expneurol.2005.04.018; Pelloski CE, 2005, CLIN CANCER RES, V11, P3326, DOI 10.1158/1078-0432.CCR-04-1765; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Ramji DP, 2002, BIOCHEM J, V365, P561, DOI 10.1042/bj20020508; Rhodes DR, 2005, NAT GENET, V37, pS31, DOI 10.1038/ng1570; Rothschild G, 2006, MOL CELL BIOL, V26, P4351, DOI 10.1128/MCB.01743-05; Simmons ML, 2001, CANCER RES, V61, P1122; Sterneck E, 1998, J NEUROCHEM, V70, P2424; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takashima Y, 2007, CELL, V129, P1377, DOI 10.1016/j.cell.2007.04.028; Taylor RC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000166; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Tso CL, 2006, MOL CANCER RES, V4, P607, DOI 10.1158/1541-7786.MCR-06-0005; Wurmser AE, 2004, NATURE, V430, P350, DOI 10.1038/nature02604; Zhao CH, 2009, CONTROL ENG PRACT, V17, P221, DOI 10.1016/j.conengprac.2008.07.001; Zhao XD, 2008, NAT CELL BIOL, V10, P643, DOI 10.1038/ncb1727	52	877	905	3	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					318	U68		10.1038/nature08712	http://dx.doi.org/10.1038/nature08712			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20032975	Green Accepted			2022-12-28	WOS:000273748100036
J	Machida, Y; Nakatsuji, S; Onoda, S; Tayama, T; Sakakibara, T				Machida, Yo; Nakatsuji, Satoru; Onoda, Shigeki; Tayama, Takashi; Sakakibara, Toshiro			Time-reversal symmetry breaking and spontaneous Hall effect without magnetic dipole order	NATURE			English	Article							BERRY-PHASE; SPIN CHIRALITY; SUPERCONDUCTIVITY; LATTICE	Spin liquids are magnetically frustrated systems, in which spins are prevented from ordering or freezing, owing to quantum or thermal fluctuations among degenerate states induced by the frustration. Chiral spin liquids are a hypothetical class of spin liquids in which the time-reversal symmetry is macroscopically broken in the absence of an applied magnetic field or any magnetic dipole long-range order. Even though such chiral spin-liquid states were proposed more than two decades ago(1-3), an experimental realization and observation of such states has remained a challenge. One of the characteristic order parameters in such systems is a macroscopic average of the scalar spin chirality, a solid angle subtended by three nearby spins. In previous experimental reports, however, the spin chirality was only parasitic to the non-coplanar spin structure associated with a magnetic dipole long-range order or induced by the applied magnetic field(4-10), and thus the chiral spin-liquid state has never been found. Here, we report empirical evidence that the time-reversal symmetry can be broken spontaneously on a macroscopic scale in the absence of magnetic dipole long-range order. In particular, we employ the anomalous Hall effect(4,11) to directly probe the broken time-reversal symmetry for the metallic frustrated magnet Pr2Ir2O7. An onset of the Hall effect is observed at zero field in the absence of uniform magnetization, within the experimental accuracy, suggesting an emergence of a chiral spin liquid. The origin of this spontaneous Hall effect is ascribed to chiral spin textures(4,5,12,13), which are inferred from the magnetic measurements indicating the spin ice-rule formation(14,15).	[Machida, Yo; Nakatsuji, Satoru; Tayama, Takashi; Sakakibara, Toshiro] Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan; [Onoda, Shigeki] RIKEN, Condensed Matter Theory Lab, Wako, Saitama 3510198, Japan	University of Tokyo; RIKEN	Nakatsuji, S (corresponding author), Univ Tokyo, Inst Solid State Phys, Kashiwa, Chiba 2778581, Japan.	satoru@issp.u-tokyo.ac.jp	Onoda, Shigeki/B-4322-2013	Onoda, Shigeki/0000-0001-6063-3166; Nakatsuji, Satoru/0000-0001-9134-659X	Japanese Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science and Technology, Japan; Kurata Grant	Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kurata Grant	We thank L. Balicas, H. Kawamura, Y. Maeno, Y. Matsumoto, N. Nagaosa, Y. Ohta and T. Taniguchi for their support and discussions. This work is partially supported by Grants-in-Aid from the Japanese Society for the Promotion of Science, by Grants-in-Aid for Scientific Research on Priority Areas and Scientific Research on Innovative Areas from the Ministry of Education, Culture, Sports, Science and Technology, Japan, and by the Kurata Grant. Y. M. is supported by JSPS research fellowships. The calculations were performed in part by using the RIKEN Super Combined Cluster (RSCC).	[Anonymous], 1880, P PHYS SOC LOND; BASKARAN G, 1988, PHYS REV B, V37, P580, DOI 10.1103/PhysRevB.37.580; BERRY MV, 1984, PROC R SOC LON SER-A, V392, P45, DOI 10.1098/rspa.1984.0023; Bramwell ST, 2001, SCIENCE, V294, P1495, DOI 10.1126/science.1064761; Gardner JS, 1999, PHYS REV LETT, V82, P1012, DOI 10.1103/PhysRevLett.82.1012; Grohol D, 2005, NAT MATER, V4, P323, DOI 10.1038/nmat1353; Ikeda A, 2008, J PHYS SOC JPN, V77, DOI 10.1143/JPSJ.77.073707; Kawamura H, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.047202; Landau LD., 1984, ELECTRODYNAMICS CONT; LAUGHLIN RB, 1988, SCIENCE, V242, P525, DOI 10.1126/science.242.4878.525; Lee M, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.186601; Machida Y, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.057203; MacLaughlin DE, 2009, PHYSICA B, V404, P667, DOI 10.1016/j.physb.2008.11.167; Metalidis G, 2006, PHYS REV B, V74, DOI 10.1103/PhysRevB.74.045327; Moessner R, 2006, PHYS TODAY, V59, P24, DOI 10.1063/1.2186278; Molavian HR, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.157204; NAGAOSA N, 2009, ANOMALOUS HALL EFFEC; Nakatsuji S, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.087204; Neubauer A, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.186602; ONODA S, 2009, QUANTUM MELTING SPIN; Pureur P, 2004, EUROPHYS LETT, V67, P123, DOI [10.1209/epl/i2004-10042-8, 10.1209/epl/i2003-10042-8]; Sakakibara T, 2003, PHYS REV LETT, V90, DOI 10.1103/PhysRevLett.90.207205; Siddharthan R, 2001, PHYS REV B, V63, DOI 10.1103/PhysRevB.63.184412; Sundaram G, 1999, PHYS REV B, V59, P14915, DOI 10.1103/PhysRevB.59.14915; Taguchi Y, 2001, SCIENCE, V291, P2573, DOI 10.1126/science.1058161; Taniguchi T, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.246605; THOULESS DJ, 1982, PHYS REV LETT, V49, P405, DOI 10.1103/PhysRevLett.49.405; WADA K, 1980, PROG THEOR PHYS, V64, P327, DOI 10.1143/PTP.64.327; WEN XG, 1989, PHYS REV B, V39, P11413, DOI 10.1103/PhysRevB.39.11413; Ye JW, 1999, PHYS REV LETT, V83, P3737, DOI 10.1103/PhysRevLett.83.3737	30	300	301	5	160	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					210	213		10.1038/nature08680	http://dx.doi.org/10.1038/nature08680			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20010605				2022-12-28	WOS:000273582700031
J	Boettcher, SW; Spurgeon, JM; Putnam, MC; Warren, EL; Turner-Evans, DB; Kelzenberg, MD; Maiolo, JR; Atwater, HA; Lewis, NS				Boettcher, Shannon W.; Spurgeon, Joshua M.; Putnam, Morgan C.; Warren, Emily L.; Turner-Evans, Daniel B.; Kelzenberg, Michael D.; Maiolo, James R.; Atwater, Harry A.; Lewis, Nathan S.			Energy-Conversion Properties of Vapor-Liquid-Solid-Grown Silicon Wire-Array Photocathodes	SCIENCE			English	Article							P-TYPE SILICON	Silicon wire arrays, though attractive materials for use in photovoltaics and as photocathodes for hydrogen generation, have to date exhibited poor performance. Using a copper-catalyzed, vapor-liquid-solid-growth process, SiCl4 and BCl3 were used to grow ordered arrays of crystalline p-type silicon (p-Si) microwires on p(+)-Si(111) substrates. When these wire arrays were used as photocathodes in contact with an aqueous methyl viologen(2+/+) electrolyte, energy-conversion efficiencies of up to 3% were observed for monochromatic 808-nanometer light at fluxes comparable to solar illumination, despite an external quantum yield at short circuit of only 0.2. Internal quantum yields were at least 0.7, demonstrating that the measured photocurrents were limited by light absorption in the wire arrays, which filled only 4% of the incident optical plane in our test devices. The inherent performance of these wires thus conceptually allows the development of efficient photovoltaic and photoelectrochemical energy-conversion devices based on a radial junction platform.	[Atwater, Harry A.] CALTECH, Kavli Nanosci Inst, Pasadena, CA 91125 USA; CALTECH, Beckman Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology	Atwater, HA (corresponding author), CALTECH, Kavli Nanosci Inst, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	haa@caltech.edu; nslewis@caltech.edu	Turner-Evans, Daniel/J-4488-2016; Atwater, Harry A/H-2823-2014; Warren, Emily/F-6536-2012; Spurgeon, Josh/AAF-9551-2021; Boettcher, Shannon/G-3053-2010	Turner-Evans, Daniel/0000-0002-8020-0170; Atwater, Harry A/0000-0001-9435-0201; Warren, Emily/0000-0001-8568-7881; Boettcher, Shannon/0000-0001-8971-9123	Stanford Global Climate and Energy Project; U.S. Department of Energy [DE-FG02-05ER15754]	Stanford Global Climate and Energy Project; U.S. Department of Energy(United States Department of Energy (DOE))	We acknowledge the Stanford Global Climate and Energy Project and the U.S. Department of Energy (grant DE-FG02-05ER15754) for financial support. S. W. B. thanks the Kavli Nanoscience Institute for a postdoctoral fellowship. L. O'Leary is thanked for her contributions. The authors have filed U.S. patent applications (20090020150 and 20090020853) related to this work.	BOOKBINDER DC, 1979, J AM CHEM SOC, V101, P7721, DOI 10.1021/ja00520a019; Colombo C, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3125435; DAVIS JR, 1980, IEEE T ELECTRON DEV, V27, P677, DOI 10.1109/T-ED.1980.19922; DOMINEY RN, 1982, J AM CHEM SOC, V104, P467, DOI 10.1021/ja00366a016; Garnett EC, 2008, J AM CHEM SOC, V130, P9224, DOI 10.1021/ja8032907; GIBBONS JF, 1984, APPL PHYS LETT, V45, P1095, DOI 10.1063/1.95028; Goodey AP, 2007, J AM CHEM SOC, V129, P12344, DOI 10.1021/ja073125d; Gratzel M, 2001, NATURE, V414, P338, DOI 10.1038/35104607; Hamann TW, 2005, J AM CHEM SOC, V127, P7815, DOI 10.1021/ja0436188; Istratov AA, 2002, J ELECTROCHEM SOC, V149, pG21, DOI 10.1149/1.1421348; Kayes BM, 2005, J APPL PHYS, V97, DOI 10.1063/1.1901835; Kayes BM, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2779236; Kelzenberg MD, 2008, NANO LETT, V8, P710, DOI 10.1021/nl072622p; LEWIS NS, 1984, J ELECTROCHEM SOC, V131, P2496, DOI 10.1149/1.2115347; Maiolo JR, 2007, J AM CHEM SOC, V129, P12346, DOI 10.1021/ja074897c; Muskens OL, 2008, NANO LETT, V8, P2638, DOI 10.1021/nl0808076; Peng KQ, 2005, SMALL, V1, P1062, DOI 10.1002/smll.200500137; Putnam MC, 2008, NANO LETT, V8, P3109, DOI 10.1021/nl801234y; Schmidt V, 2009, ADV MATER, V21, P2681, DOI 10.1002/adma.200803754; Spurgeon JM, 2008, J PHYS CHEM C, V112, P6186, DOI 10.1021/jp077481u; STARGARDT JF, 1983, ANAL CHIM ACTA, V146, P1, DOI 10.1016/S0003-2670(00)80586-3; Stelzner T, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/29/295203; Tian B, 2009, CHEM SOC REV, V38, P16, DOI 10.1039/b718703n; Tsakalakos L, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2821113; WAGNER RS, 1964, APPL PHYS LETT, V4, P89, DOI 10.1063/1.1753975	25	469	480	3	331	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					185	187		10.1126/science.1180783	http://dx.doi.org/10.1126/science.1180783			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056886				2022-12-28	WOS:000273394000029
J	Norvig, P; Relman, DA; Goldstein, DB; Kammen, DM; Weinberger, DR; Aiello, LC; Church, G; Hennessy, JL; Sachs, J; Burrows, A; Pisano, GP; Goldstein, JR; Anastas, P; Klausner, R; Baltimore, D; Montgomery, DR; Baer, TM; Bigelow, NP; Holt, RD; Nicholson, JK				Norvig, Peter; Relman, David A.; Goldstein, David B.; Kammen, Daniel M.; Weinberger, Daniel R.; Aiello, Leslie C.; Church, George; Hennessy, John L.; Sachs, Jeffrey; Burrows, Adam; Pisano, Gary P.; Goldstein, Joshua R.; Anastas, Paul; Klausner, Richard; Baltimore, David; Montgomery, David R.; Baer, Thomas M.; Bigelow, Nicholas P.; Holt, Robert D.; Nicholson, Jeremy K.			2020 visions	NATURE			English	Editorial Material									[Relman, David A.] Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; [Goldstein, David B.] Duke Univ, Durham, NC 27706 USA; [Kammen, Daniel M.] Univ Calif Berkeley, Renewable & Appropriate Energy Lab, Berkeley, CA 94720 USA; [Church, George] Harvard Univ, Sch Med, Cambridge, MA 02138 USA; [Hennessy, John L.] Stanford Univ, Stanford, CA 94305 USA; [Pisano, Gary P.] Harvard Univ, Sch Business, Cambridge, MA 02138 USA; [Anastas, Paul] Yale Univ, Ctr Green Chem & Green Engn, New Haven, CT 06520 USA; [Baltimore, David] CALTECH, Pasadena, CA 91125 USA; [Montgomery, David R.] Univ Washington, Seattle, WA 98195 USA; [Baer, Thomas M.] Stanford Photon Res Ctr, Stanford, CA USA; [Bigelow, Nicholas P.] Univ Rochester, Dept Phys & Astron, Rochester, NY 14627 USA; [Holt, Robert D.] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Nicholson, Jeremy K.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, London SW7 2AZ, England	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Duke University; University of California System; University of California Berkeley; Harvard University; Stanford University; Harvard University; Yale University; California Institute of Technology; University of Washington; University of Washington Seattle; University of Rochester; State University System of Florida; University of Florida; Imperial College London			Norvig, Peter/ABF-7770-2021; Goldstein, David/AAY-8125-2020; Anastas, Paul/L-3258-2013; Nicholson, Jeremy K/B-3395-2012	Anastas, Paul/0000-0003-4777-5172; Nicholson, Jeremy K/0000-0002-8123-8349; Relman, David A./0000-0001-8331-1354					0	60	65	5	65	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 7	2010	463	7277					26	32		10.1038/463026a	http://dx.doi.org/10.1038/463026a			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	540OV	20054379				2022-12-28	WOS:000273344900016
J	Sarewitz, D				Sarewitz, Daniel			Tomorrow never knows	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA.	dsarewitz@gmail.com						PIELKE RA, 1999, APPL BEHAV SCI REV, V7, P83, DOI DOI 10.1016/S1068-8595(00)80012-4; 2008, NATURE, V453, P268	2	7	7	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 7	2010	463	7277					24	24		10.1038/463024a	http://dx.doi.org/10.1038/463024a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	540OV	20054374	Bronze			2022-12-28	WOS:000273344900011
J	Ferraro, FR; Beccari, G; Dalessandro, E; Lanzoni, B; Sills, A; Rood, RT; Pecci, FF; Karakas, AI; Miocchi, P; Bovinelli, S				Ferraro, F. R.; Beccari, G.; Dalessandro, E.; Lanzoni, B.; Sills, A.; Rood, R. T.; Pecci, F. Fusi; Karakas, A. I.; Miocchi, P.; Bovinelli, S.			Two distinct sequences of blue straggler stars in the globular cluster M 30	NATURE			English	Article							STELLAR COLLISIONS; DYNAMICAL MODELS; MAIN-SEQUENCE; MASS-TRANSFER; PARAMETERS; CATALOG; ORIGIN	Stars in globular clusters are generally believed to have all formed at the same time, early in the Galaxy's history(1). 'Blue stragglers' are stars massive enough(2) that they should have evolved into white dwarfs long ago. Two possible mechanisms have been proposed for their formation: mass transfer between binary companions(3) and stellar mergers resulting from direct collisions between two stars(4). Recently the binary explanation was claimed to be dominant(5). Here we report that there are two distinct parallel sequences of blue stragglers in M 30. This globular cluster is thought to have undergone 'core collapse', during which both the collision rate and the mass transfer activity in binary systems would have been enhanced(6). We suggest that the two observed sequences are a consequence of cluster core collapse, with the bluer population arising from direct stellar collisions and the redder one arising from the evolution of close binaries that are probably still experiencing an active phase of mass transfer.	[Ferraro, F. R.; Dalessandro, E.; Lanzoni, B.; Miocchi, P.; Bovinelli, S.] Univ Bologna, Dept Astron, I-40127 Bologna, Italy; [Beccari, G.] European Space Agcy, Dept Space Sci, NL-2200 AG Noordwijk, Netherlands; [Sills, A.] McMaster Univ, Dept Phys & Astron, Hamilton, ON L8S 4M1, Canada; [Rood, R. T.] Univ Virginia, Dept Astron, Charlottesville, VA 22904 USA; [Pecci, F. Fusi] Osservatorio Astron Bologna, INAF, I-40127 Bologna, Italy; [Karakas, A. I.] Mt Stromlo & Siding Spring Observ, Res Sch Astron & Astrophys, Weston, ACT 2611, Australia	University of Bologna; European Space Agency; McMaster University; University of Virginia; Istituto Nazionale Astrofisica (INAF); Australian National University	Ferraro, FR (corresponding author), Univ Bologna, Dept Astron, Via Ranzani 1, I-40127 Bologna, Italy.	francesco.ferraro3@unibo.it	Buzzoni, Alberto/ABC-5997-2021; Miocchi, Paolo/U-6428-2017	Buzzoni, Alberto/0000-0002-6514-1870; Beccari, Giacomo/0000-0002-3865-9906; Dalessandro, Emanuele/0000-0003-4237-4601; Miocchi, Paolo/0000-0002-8400-2139; Karakas, Amanda/0000-0002-3625-6951; Sills, Alison/0000-0003-3551-5090	Istituto Nazionale di Astrofisica; Agenzia Spaziale Italiana; Ministero dell'Istruzione, dell'Universita e della Ricerca; European Space Research and Technology Centre Faculty Visiting Scientist Programme; Space Telescope Science Institute	Istituto Nazionale di Astrofisica(Istituto Nazionale Astrofisica (INAF)); Agenzia Spaziale Italiana(Agenzia Spaziale Italiana (ASI)); Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); European Space Research and Technology Centre Faculty Visiting Scientist Programme; Space Telescope Science Institute(Space Telescope Science Institute)	This research was supported by Progetti di Ricerca di Interesse Nazionale 2008, granted by the Istituto Nazionale di Astrofisica. We acknowledge the financial support of the Agenzia Spaziale Italiana and the Ministero dell'Istruzione, dell'Universita e della Ricerca. F. R. F., B. L., E. D. and A. S. thank the Formation and Evolution of Globular Clusters programme and the Kavli Institute for Theoretical Physics in Santa Barbara ( California, USA) for hospitality during their stay, when the motivations of this project were discussed and the work planned. We acknowledge support from the European Space Research and Technology Centre Faculty Visiting Scientist Programme. R. T. R. is partly supported by a Space Telescope Science Institute grant. This research has made use of the ESO/ST-ECF Science Archive facility, which is a joint collaboration of the European Southern Observatory (ESO) and the Space Telescope European Coordinating Facility (ST-ECF).	BAILYN CD, 1992, ASTROPHYS J, V392, P519, DOI 10.1086/171452; Cariulo P, 2004, ASTRON ASTROPHYS, V421, P1121, DOI 10.1051/0004-6361:20040145; Davies MB, 2004, MON NOT R ASTRON SOC, V349, P129, DOI 10.1111/j.1365-2966.2004.07474.x; DJORGOVSKI S, 1993, ASTR SOC P, V50, P373; Ferraro FR, 2006, ASTROPHYS J, V647, pL53, DOI 10.1086/507327; Ferraro F. R., 2008, P IAU S, V246, P281; Ferraro FR, 1999, ASTRON J, V118, P1738, DOI 10.1086/301029; Ferraro FR, 2003, ASTROPHYS J, V588, P464, DOI 10.1086/374042; Harris WE, 1996, ASTRON J, V112, P1487, DOI 10.1086/118116; Hartigan P. M., 1985, APPL STAT-J ROY ST C, V34, P320; HILLS JG, 1976, ASTROPHYS LETT COMM, V17, P87; Hurley JR, 2008, ASTRON J, V135, P2129, DOI 10.1088/0004-6256/135/6/2129; KING IR, 1966, ASTRON J, V71, P64, DOI 10.1086/109857; Knigge C, 2009, NATURE, V457, P288, DOI 10.1038/nature07635; LEONARD PJT, 1989, ASTRON J, V98, P217, DOI 10.1086/115138; Mapelli M, 2006, MON NOT R ASTRON SOC, V373, P361, DOI 10.1111/j.1365-2966.2006.11038.x; Marin-Franch A, 2009, ASTROPHYS J, V694, P1498, DOI 10.1088/0004-637X/694/2/1498; MCCREA WH, 1964, MON NOT R ASTRON SOC, V128, P147, DOI 10.1093/mnras/128.2.147; MCMILLAN S, 1990, ASTROPHYS J, V362, P522, DOI 10.1086/169289; Meylan G, 1997, ASTRON ASTROPHYS REV, V8, P1, DOI 10.1007/s001590050008; Noyola E, 2006, ASTRON J, V132, P447, DOI 10.1086/505390; Pietrukowicz P, 2004, ACTA ASTRONOM, V54, P19; Sharma BS, 1997, SURG NEUROL, V47, P489, DOI 10.1016/S0090-3019(96)00209-1; Sills A, 2009, ASTROPHYS J, V692, P1411, DOI 10.1088/0004-637X/692/2/1411; STETSON PB, 1994, PUBL ASTRON SOC PAC, V106, P250, DOI 10.1086/133378; Tian B, 2006, ASTRON ASTROPHYS, V455, P247, DOI 10.1051/0004-6361:20064879; TRAGER SC, 1993, ASTR SOC P, V50, P347; VILHU O, 1982, ASTRON ASTROPHYS, V109, P17	29	131	131	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 24	2009	462	7276					1028	1031		10.1038/nature08607	http://dx.doi.org/10.1038/nature08607			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033041	Green Submitted, Green Published			2022-12-28	WOS:000272996000040
J	Sharma, P				Sharma, Prateek			Barrett's Esophagus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HIGH-GRADE DYSPLASIA; PUMP INHIBITOR THERAPY; GASTROESOPHAGEAL-REFLUX; PHOTODYNAMIC THERAPY; RISK-FACTORS; ADENOCARCINOMA; CANCER; ENDOSCOPY; DIAGNOSIS; TRIAL	A 56-year-old obese man with long-standing gastroesophageal reflux who recently received a diagnosis of Barrett's esophagus presents for a follow-up visit. He has been taking omeprazole at a dose of 20 mg twice daily and currently has no symptoms of reflux. He has no dysphagia or weight loss. Endoscopic and histopathological examinations show a 4-cm segment of Barrett's esophagus without dysplasia. How should Barrett's esophagus be managed?	[Sharma, Prateek] Univ Kansas, Sch Med, Div Gastroenterol & Hepatol, Kansas City, KS USA; [Sharma, Prateek] Vet Affairs Med Ctr, Kansas City, MO USA	University of Kansas; University of Kansas Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Sharma, P (corresponding author), 4801 E Linwood Blvd, Kansas City, MO 64129 USA.	psharma@kumc.edu			Given Imaging; Barrx Medical; Olympus; Cogentus; Mauna Kea Technologies; Takeda	Given Imaging; Barrx Medical; Olympus; Cogentus; Mauna Kea Technologies; Takeda(Takeda Pharmaceutical Company Ltd)	Dr. Sharma reports receiving consulting fees from AstraZeneca, Santarus, and Takeda and grant support from Given Imaging, Barrx Medical, Olympus, Cogentus, Mauna Kea Technologies, and Takeda. No other potential conflict of interest relevant to this article was reported.	Abela JE, 2008, AM J GASTROENTEROL, V103, P2402, DOI 10.1111/j.1572-0241.2007.01746.x; Attwood SE, 2008, J GASTROINTEST SURG, V12, P1646, DOI 10.1007/s11605-008-0645-1; Boyer J, 2007, ENDOSCOPY, V39, P840, DOI 10.1055/s-2007-966653; Cooper GS, 2009, AM J GASTROENTEROL, V104, P1356, DOI 10.1038/ajg.2009.159; Corey KE, 2003, AM J GASTROENTEROL, V98, P2390, DOI 10.1016/j.amjgastroenterol.2003.08.008; Corley DA, 2002, GASTROENTEROLOGY, V122, P633, DOI 10.1053/gast.2002.31879; Corley DA, 2003, GASTROENTEROLOGY, V124, P47, DOI 10.1053/gast.2003.50008; Das D, 2009, RECENT RES CANCER, V181, P161; El-Serag HB, 2004, AM J GASTROENTEROL, V99, P1877, DOI 10.1111/j.1572-0241.2004.30228.x; Fitzgerald RC, 2005, CLIN GASTROENTEROL H, V3, P529, DOI 10.1016/S1542-3565(05)00248-X; Heitmiller RF, 1996, ANN SURG, V224, P66, DOI 10.1097/00000658-199607000-00010; Hillman LC, 2004, MED J AUSTRALIA, V180, P387, DOI 10.5694/j.1326-5377.2004.tb05991.x; Hirota WK, 2006, GASTROINTEST ENDOSC, V63, P570, DOI 10.1016/j.gie.2006.02.004; Hulscher JBF, 2002, NEW ENGL J MED, V347, P1662, DOI 10.1056/NEJMoa022343; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Kahrilas PJ, 2008, NEW ENGL J MED, V359, P1700, DOI 10.1056/NEJMcp0804684; Kiesslich R, 2006, CLIN GASTROENTEROL H, V4, P979, DOI 10.1016/j.cgh.2006.05.010; Konda VJA, 2008, CLIN GASTROENTEROL H, V6, P159, DOI 10.1016/j.cgh.2007.09.013; Kubo A, 2009, GASTROENTEROLOGY, V136, P806, DOI 10.1053/j.gastro.2008.11.042; Lagergren J, 1999, NEW ENGL J MED, V340, P825, DOI 10.1056/NEJM199903183401101; Larghi A, 2005, GASTROINTEST ENDOSC, V62, P16, DOI 10.1016/S0016-5107(05)00319-6; Montgomery E, 2001, HUM PATHOL, V32, P368, DOI 10.1053/hupa.2001.23510; Oberg S, 2002, ANN SURG, V235, P338; Overholt BF, 2007, GASTROINTEST ENDOSC, V66, P460, DOI 10.1016/j.gie.2006.12.037; Overholt BF, 2005, GASTROINTEST ENDOSC, V62, P488, DOI 10.1016/j.gie.2005.06.047; Pechz O, 2008, GUT, V57, P1200, DOI 10.1136/gut.2007.142539; Pohl H, 2005, J NATL CANCER I, V97, P142, DOI 10.1093/jnci/dji024; Rabinovitch PS, 2001, AM J GASTROENTEROL, V96, P3071, DOI 10.1111/j.1572-0241.2001.05261.x; Rastogi A, 2008, GASTROINTEST ENDOSC, V67, P394, DOI 10.1016/j.gie.2007.07.019; Reid BJ, 2000, AM J GASTROENTEROL, V95, P1669, DOI 10.1111/j.1572-0241.2000.02196.x; Rex DK, 2003, GASTROENTEROLOGY, V125, P1670, DOI 10.1053/j.gastro.2003.09.030; Ronkainen J, 2005, GASTROENTEROLOGY, V129, P1825, DOI 10.1053/j.gastro.2005.08.053; Shaheen NJ, 2009, NEW ENGL J MED, V360, P2277, DOI 10.1056/NEJMoa0808145; Sharma P, 2004, GASTROENTEROLOGY, V127, P310, DOI 10.1053/j.gastro.2004.04.010; Sharma P, 1997, AM J GASTROENTEROL, V92, P582; Sharma P, 2006, GASTROENTEROLOGY, V131, P1392, DOI 10.1053/j.gastro.2006.08.032; Sharma P, 2006, CLIN GASTROENTEROL H, V4, P566, DOI 10.1016/j.cgh.2006.03.001; Sharma P, 2009, GASTROINTEST ENDOSC, V69, pAB135, DOI 10.1016/j.gie.2009.03.181; Skacel M, 2000, AM J GASTROENTEROL, V95, P3383; *SOC SURG AL TRACT, 2007, J GASTROINTEST SURG, V11, P1213; Wang KK, 2008, AM J GASTROENTEROL, V103, P788, DOI 10.1111/j.1572-0241.2008.01835.x; WANI S, 2009, GASTROINTEST EN 1029; Wani S, 2009, CLIN GASTROENTEROL H, V7, P27, DOI 10.1016/j.cgh.2008.08.014; Wani SB, 2009, GASTROENTEROLOGY, V136, pA592; Watson AHR, 2005, GUIDELINES DIAGNOSIS; Wolfsen HC, 2008, GASTROENTEROLOGY, V135, P24, DOI 10.1053/j.gastro.2008.03.019; Wong A, 2005, CLIN GASTROENTEROL H, V3, P1, DOI 10.1016/S1542-3565(04)00602-0	47	182	202	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2548	2556		10.1056/NEJMcp0902173	http://dx.doi.org/10.1056/NEJMcp0902173			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535WX	20032324				2022-12-28	WOS:000273003700010
J	Youk, H; van Oudenaarden, A				Youk, Hyun; van Oudenaarden, Alexander			Growth landscape formed by perception and import of glucose in yeast	NATURE			English	Article							INDIVIDUAL HEXOSE TRANSPORTERS; SACCHAROMYCES-CEREVISIAE; SYSTEMS BIOLOGY; METABOLIC PATHWAYS; NETWORK; PHENOTYPES; PROTEIN; GENES; EXPRESSION; MODELS	An important challenge in systems biology is to quantitatively describe microbial growth using a few measurable parameters that capture the essence of this complex phenomenon. Two key events at the cell membrane-extracellular glucose sensing and uptake-initiate the budding yeast's growth on glucose. However, conventional growth models focus almost exclusively on glucose uptake. Here we present results from growth-rate experiments that cannot be explained by focusing on glucose uptake alone. By imposing a glucose uptake rate independent of the sensed extracellular glucose level, we show that despite increasing both the sensed glucose concentration and uptake rate, the cell's growth rate can decrease or even approach zero. We resolve this puzzle by showing that the interaction between glucose perception and import, not their individual actions, determines the central features of growth, and characterize this interaction using a quantitative model. Disrupting this interaction by knocking out two key glucose sensors significantly changes the cell's growth rate, yet uptake rates are unchanged. This is due to a decrease in burden that glucose perception places on the cells. Our work shows that glucose perception and import are separate and pivotal modules of yeast growth, the interaction of which can be precisely tuned and measured.	[Youk, Hyun; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	Youk, Hyun/E-2661-2016; van Oudenaarden, Alexander/AAA-1705-2019	Youk, Hyun/0000-0003-1687-5760; 	National Institutes of Health (NIH); National Science Foundation (NSF); Natural Sciences and Engineering Research Council of Canada's (NSERC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation (NSF)(National Science Foundation (NSF)); Natural Sciences and Engineering Research Council of Canada's (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank E. Boles for the kind gift of strains. We also thank D. Botstein, D. Muzzey, J. Gore and S. Rifkin for critical reading of our manuscript and useful discussions. This work was funded by a National Institutes of Health (NIH) Director's Pioneer awarded to A. v. O., and grants from the NIH and National Science Foundation (NSF). H. Y. was supported by the Natural Sciences and Engineering Research Council of Canada's (NSERC) Graduate Fellowship.	Airoldi EM, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000257; Alon U, 2007, NATURE, V446, P497, DOI 10.1038/446497a; Bennett MR, 2008, NATURE, V454, P1119, DOI 10.1038/nature07211; BILU Y, PLOS COMP BIOL, V2, pE106; BISSON LF, 1993, CRIT REV BIOCHEM MOL, V28, P259, DOI 10.3109/10409239309078437; Boer VM, 2008, P NATL ACAD SCI USA, V105, P6930, DOI 10.1073/pnas.0802601105; Boles E, 1997, FEMS MICROBIOL REV, V21, P85, DOI 10.1016/S0168-6445(97)00052-1; Castrillo Juan I, 2007, J Biol, V6, P4, DOI 10.1186/jbiol54; Daran-Lapujade P, 2007, P NATL ACAD SCI USA, V104, P15753, DOI 10.1073/pnas.0707476104; Dekel E, 2005, NATURE, V436, P588, DOI 10.1038/nature03842; Dickinson J.R., 2004, METABOLISM MOL PHYSL; Duarte NC, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-63; Famili I, 2003, P NATL ACAD SCI USA, V100, P13134, DOI 10.1073/pnas.2235812100; Fell D., 1997, UNDERSTANDING CONTRO; Gancedo JM, 2008, FEMS MICROBIOL REV, V32, P673, DOI 10.1111/j.1574-6976.2008.00117.x; Goyal S, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.138105; Ihmels J, 2005, SCIENCE, V309, P938, DOI 10.1126/science.1113833; Ihmels J, 2004, NAT BIOTECHNOL, V22, P86, DOI 10.1038/nbt918; Jiang Y, 1998, EMBO J, V17, P6942, DOI 10.1093/emboj/17.23.6942; Kaniak A, 2004, EUKARYOT CELL, V3, P221, DOI 10.1128/EC.3.1.221-231.2004; Kell DB, 2004, CURR OPIN MICROBIOL, V7, P296, DOI 10.1016/j.mib.2004.04.012; Kim JH, 2006, J BIOL CHEM, V281, P26144, DOI 10.1074/jbc.M603636200; Kim JH, 2003, MOL CELL BIOL, V23, P5208, DOI 10.1128/MCB.23.15.5208-5216.2003; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P20245, DOI 10.1073/pnas.0804953105; Krishna S, 2007, P NATL ACAD SCI USA, V104, P20815, DOI 10.1073/pnas.0706231105; Levine E, 2007, P NATL ACAD SCI USA, V104, P9224, DOI 10.1073/pnas.0610987104; Levy S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000250; Lorenz DR, 2009, P NATL ACAD SCI USA, V106, P1145, DOI 10.1073/pnas.0812551106; Maier A, 2002, FEMS YEAST RES, V2, P539, DOI 10.1016/S1567-1356(02)00140-X; Mallavarapu A, 2009, J R SOC INTERFACE, V6, P257, DOI 10.1098/rsif.2008.0205; Monod J., 1942, ACTUALITES SCI IND; Moriya H, 2004, P NATL ACAD SCI USA, V101, P1572, DOI 10.1073/pnas.0305901101; NIELSEN J, 2003, BIOREACTION ENG PRIN, P235; Ostergaard S, 2000, MICROBIOL MOL BIOL R, V64, P34, DOI 10.1128/MMBR.64.1.34-50.2000; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Pao SS, 1998, MICROBIOL MOL BIOL R, V62, P1; REIFENBERGER E, 1995, MOL MICROBIOL, V16, P157, DOI 10.1111/j.1365-2958.1995.tb02400.x; Reifenberger E, 1997, EUR J BIOCHEM, V245, P324, DOI 10.1111/j.1432-1033.1997.00324.x; Reijenga KA, 2001, BIOPHYS J, V80, P626, DOI 10.1016/S0006-3495(01)76043-2; Santangelo GM, 2006, MICROBIOL MOL BIOL R, V70, P253, DOI 10.1128/MMBR.70.1.253-282.2006; Savageau M, 1976, BIOCH SYSTEMS ANAL S; Savageau MA, 2009, P NATL ACAD SCI USA, V106, P6435, DOI 10.1073/pnas.0809869106; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Stelling J, 2004, CURR OPIN MICROBIOL, V7, P513, DOI 10.1016/j.mib.2004.08.004; Stephanopoulos G, 2007, SCIENCE, V315, P801, DOI 10.1126/science.1139612; Van Hoek P, 1998, APPL ENVIRON MICROB, V64, P4226; WALSH MC, 1996, J BACTERIOL, V170, P2593; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Yin ZK, 2003, MOL MICROBIOL, V48, P713, DOI 10.1046/j.1365-2958.2003.03478.x; Zaslaver A, 2004, NAT GENET, V36, P486, DOI 10.1038/ng1348	50	59	61	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					875	U65		10.1038/nature08653	http://dx.doi.org/10.1038/nature08653			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016593	Green Accepted, Green Submitted			2022-12-28	WOS:000272795400033
J	Robinson, D				Robinson, David			Christmas 2009: Afterlife From flower graves to breast clinics	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, London SE1 3QD, England	University of London; King's College London	Robinson, D (corresponding author), Kings Coll London, London SE1 3QD, England.	dave.robinson@kcl.ac.uk						BOSELEY S, 2009, GUARDIAN        0322; CAO XQ, 1986, STORY STONE CHINESE; DEBRUXELLES S, 2005, TIMES           1027; Tsao Hsueh-Chin, 1978, DREAM RED MANSIONS; Twine C, 2006, BREAST, V15, P667, DOI 10.1016/j.breast.2006.03.006; 2007, TODAY MORNING E 0519	6	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2009	339								b4932	10.1136/bmj.b4932	http://dx.doi.org/10.1136/bmj.b4932			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534XF	20008440				2022-12-28	WOS:000272930100001
J	Andreae, MO				Andreae, Meinrat O.			A New Look at Aging Aerosols	SCIENCE			English	Editorial Material							CCN ACTIVITY; CARBON; WATER		Max Planck Inst Chem, D-55020 Mainz, Germany	Max Planck Society	Andreae, MO (corresponding author), Max Planck Inst Chem, D-55020 Mainz, Germany.	m.andreae@mpic.de	Andreae, Meinrat O./B-1068-2008	Andreae, Meinrat O./0000-0003-1968-7925				Andreae MO, 2008, EARTH-SCI REV, V89, P13, DOI 10.1016/j.earscirev.2008.03.001; Andreae MO, 2006, ATMOS CHEM PHYS, V6, P3131, DOI 10.5194/acp-6-3131-2006; Canagaratna MR, 2007, MASS SPECTROM REV, V26, P185, DOI 10.1002/mas.20115; Donahue NM, 2006, ENVIRON SCI TECHNOL, V40, P2635, DOI 10.1021/es052297c; Fuzzi S, 2001, GEOPHYS RES LETT, V28, P4079, DOI 10.1029/2001GL013418; Gelencser A, 2003, J ATMOS CHEM, V45, P25, DOI 10.1023/A:1024060428172; Gunthe SS, 2009, ATMOS CHEM PHYS, V9, P7551, DOI 10.5194/acp-9-7551-2009; Jimenez JL, 2009, SCIENCE, V326, P1525, DOI 10.1126/science.1180353; Robinson AL, 2007, SCIENCE, V315, P1259, DOI 10.1126/science.1133061; Shinozuka Y, 2009, ATMOS CHEM PHYS, V9, P6727, DOI 10.5194/acp-9-6727-2009; Simoneit BRT, 2004, J GEOPHYS RES-ATMOS, V109, DOI 10.1029/2004JD004598; Takahama S, 2007, ATMOS ENVIRON, V41, P9435, DOI 10.1016/j.atmosenv.2007.08.051; Zhang Q, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029979; Zorn SR, 2008, ATMOS CHEM PHYS, V8, P4711, DOI 10.5194/acp-8-4711-2008	14	50	50	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1493	1494		10.1126/science.1183158	http://dx.doi.org/10.1126/science.1183158			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007891				2022-12-28	WOS:000272623600045
J	Boehr, DD				Boehr, David D.			During Transitions Proteins Make Fleeting Bonds	CELL			English	Editorial Material							SIGNALING PROTEIN; DYNAMICS	How do proteins efficiently and precisely shift from one conformation to another? Gardino et al. (2009) show that transient hydrogen bonds are critical to the conformational transition of the nitrogen regulatory protein NtrC between its native state and its active state.	Penn State Univ, Dept Chem, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Boehr, DD (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	ddb12@psu.edu	Boehr, David/A-2068-2010					Baldwin AJ, 2009, NAT CHEM BIOL, V5, P808, DOI 10.1038/nchembio.238; Boehr DD, 2009, NAT CHEM BIOL, V5, P789, DOI 10.1038/nchembio.232; DILL KA, 1997, NAT STRUCT BIOL, V4, P19, DOI DOI 10.1038/NSB0197-10; Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105; FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933; Gardino AK, 2007, METHOD ENZYMOL, V423, P149, DOI 10.1016/S0076-6879(07)23006-X; Lei M, 2009, J MOL BIOL, V392, P823, DOI 10.1016/j.jmb.2009.06.065; Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881; Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429	9	10	11	0	3	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1049	1051		10.1016/j.cell.2009.11.031	http://dx.doi.org/10.1016/j.cell.2009.11.031			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005798	Bronze			2022-12-28	WOS:000272622800006
J	Sinclair, A; Smith, C				Sinclair, Andrew; Smith, Craig			Females Battle to Suppress Their Inner Male	CELL			English	Editorial Material							SEX DETERMINATION; FOXL2; GENE	Conventional wisdom holds that the ovary and testis are terminally differentiated organs in adult mammals. However, Uhlenhaut et al. (2009) now report that deletion of a single gene, Foxl2, is sufficient to induce transdifferentiation of ovary into testis in adult mice, suggesting that testicular development is actively repressed throughout the life of females.	[Sinclair, Andrew; Smith, Craig] Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia; [Sinclair, Andrew; Smith, Craig] Univ Melbourne, Dept Pediat, Melbourne, Vic 3052, Australia	Murdoch Children's Research Institute; University of Melbourne	Sinclair, A (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic 3052, Australia.	andrew.sinclair@mcri.edu.au	Sinclair, Andrew H/A-3598-2010	Sinclair, Andrew H/0000-0003-2741-7992; Smith, Craig/0000-0002-1670-5545				Garcia-Ortiz JE, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-36; Liu CF, 2009, HUM MOL GENET, V18, P405, DOI 10.1093/hmg/ddn362; NEF S, 2008, J BIOL, V74; NEF S, 2008, J BIOL, V8; Ottolenghi C, 2005, HUM MOL GENET, V14, P2053, DOI 10.1093/hmg/ddi210; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298	9	13	14	0	9	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 11	2009	139	6					1051	1053		10.1016/j.cell.2009.11.036	http://dx.doi.org/10.1016/j.cell.2009.11.036			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005799	Bronze			2022-12-28	WOS:000272622800007
J	Williams, AH; Valdez, G; Moresi, V; Qi, XX; McAnally, J; Elliott, JL; Bassel-Duby, R; Sanes, JR; Olson, EN				Williams, Andrew H.; Valdez, Gregorio; Moresi, Viviana; Qi, Xiaoxia; McAnally, John; Elliott, Jeffrey L.; Bassel-Duby, Rhonda; Sanes, Joshua R.; Olson, Eric N.			MicroRNA-206 Delays ALS Progression and Promotes Regeneration of Neuromuscular Synapses in Mice	SCIENCE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MOTOR-NEURON DEGENERATION; SKELETAL-MUSCLE; RNA; EXPRESSION; MUTATIONS; DISEASE; TARGETS; PROTEIN; TDP-43	Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease characterized by loss of motor neurons, denervation of target muscles, muscle atrophy, and paralysis. Understanding ALS pathogenesis may require a fuller understanding of the bidirectional signaling between motor neurons and skeletal muscle fibers at neuromuscular synapses. Here, we show that a key regulator of this signaling is miR-206, a skeletal muscle-specific microRNA that is dramatically induced in a mouse model of ALS. Mice that are genetically deficient in miR-206 form normal neuromuscular synapses during development, but deficiency of miR-206 in the ALS mouse model accelerates disease progression. miR-206 is required for efficient regeneration of neuromuscular synapses after acute nerve injury, which probably accounts for its salutary effects in ALS. miR-206 mediates these effects at least in part through histone deacetylase 4 and fibroblast growth factor signaling pathways. Thus, miR-206 slows ALS progression by sensing motor neuron injury and promoting the compensatory regeneration of neuromuscular synapses.	[Williams, Andrew H.; Moresi, Viviana; Qi, Xiaoxia; McAnally, John; Bassel-Duby, Rhonda; Olson, Eric N.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA; [Valdez, Gregorio; Sanes, Joshua R.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Valdez, Gregorio; Sanes, Joshua R.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA; [Elliott, Jeffrey L.] Univ Texas SW Med Ctr Dallas, Dept Neurol, Dallas, TX 75390 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Harvard University; University of Texas System; University of Texas Southwestern Medical Center Dallas	Olson, EN (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA.	eric.olson@utsouthwestern.edu	Moresi, Viviana/N-7977-2013	Moresi, viviana/0000-0003-1912-0339	National Cancer Institute [U24 CA126608]; Simmons Cancer Center; Department of Radiology; National Heart, Lung, and Blood Institute [T32HL007360]; National Institute of Neurological Disorders and Stroke (NINDS) [1F32NS061464-01A1]; National Institute on Aging; NIH; Donald W. Reynolds Center for Clinical Cardiovascular Research; Leducq Foundation; Robert A. Welch Foundation; NATIONAL CANCER INSTITUTE [U24CA126608] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007360, R01HL093039] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F32NS061464] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Simmons Cancer Center; Department of Radiology; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of Neurological Disorders and Stroke (NINDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Donald W. Reynolds Center for Clinical Cardiovascular Research; Leducq Foundation(Leducq Foundation); Robert A. Welch Foundation(The Welch Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank N. Liu, E. van Rooij, M. Arnold, G. Huang, Z. Paroo, and M. Potthoff for scientific discussions; J. Cabrera for graphics; J. Backs for HDAC4 conditional mice; M. Lewis for assistance with x-rays; and J. Richardson and J. Shelton for help with histology. Imaging was facilitated by the University of Texas Southwestern Small Animal Imaging Resource, which is supported in part by the National Cancer Institute U24 CA126608, the Simmons Cancer Center, and Department of Radiology at University of Texas Southwestern. A. H. W is supported by National Heart, Lung, and Blood Institute grant T32HL007360. G. V is supported by National Institute of Neurological Disorders and Stroke (NINDS) grant 1F32NS061464-01A1. J. R. S. is supported by grants from the National Institute on Aging and NINDS. E. N. O. is supported by grants from NIH, the Donald W. Reynolds Center for Clinical Cardiovascular Research, the Leducq Foundation, and the Robert A. Welch Foundation. E. N. O. is a cofounder of miRagen Therapeutics and holds equity in the company. A. H. W. and E. N. O. have filed a patent relating to this work. E. N. O. and J. R. S. dedicate this paper to their friend the late John Merlie, whose discovery of 7H4 (12) led directly to our work.	Beer HD, 2005, ONCOGENE, V24, P5269, DOI 10.1038/sj.onc.1208560; BENNETT MR, 1975, COLD SPRING HARB SYM, V40, P409, DOI 10.1101/SQB.1976.040.01.039; Bruijn LI, 2004, ANNU REV NEUROSCI, V27, P723, DOI 10.1146/annurev.neuro.27.070203.144244; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Cohen TJ, 2007, J BIOL CHEM, V282, P33752, DOI 10.1074/jbc.M706268200; Dunckley T, 2007, NEW ENGL J MED, V357, P775, DOI 10.1056/NEJMoa070174; EFTIMIE R, 1991, P NATL ACAD SCI USA, V88, P1349, DOI 10.1073/pnas.88.4.1349; Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035; FRANK E, 1975, COLD SPRING HARB SYM, V40, P275, DOI 10.1101/SQB.1976.040.01.028; FRANK E, 1975, J PHYSIOL-LONDON, V247, P725, DOI 10.1113/jphysiol.1975.sp010954; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066; Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; LOHOF AM, 1993, NATURE, V363, P350, DOI 10.1038/363350a0; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; SANES JR, 1985, TRENDS NEUROSCI, V8, P523, DOI 10.1016/0166-2236(85)90188-2; Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389; Schaefer AM, 2005, J COMP NEUROL, V490, P209, DOI 10.1002/cne.20620; Schaeffer L, 2001, NEURON, V31, P15, DOI 10.1016/S0896-6273(01)00353-1; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Simon DJ, 2008, CELL, V133, P903, DOI 10.1016/j.cell.2008.04.035; Son M, 2007, P NATL ACAD SCI USA, V104, P6072, DOI 10.1073/pnas.0610923104; Tang HB, 2009, MOL BIOL CELL, V20, P1120, DOI 10.1091/mbc.E08-07-0759; Umemori H, 2008, J BIOL CHEM, V283, P34053, DOI 10.1074/jbc.M805729200; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942; VELLECA MA, 1994, MOL CELL BIOL, V14, P7095, DOI 10.1128/MCB.14.11.7095; WOHLFART G, 1957, NEUROLOGY, V7, P124, DOI 10.1212/WNL.7.2.124	34	537	572	0	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1549	1554		10.1126/science.1181046	http://dx.doi.org/10.1126/science.1181046			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007902	Green Accepted			2022-12-28	WOS:000272623600061
J	Zarzeczny, A; Scott, C; Hyun, I; Bennett, J; Chandler, J; Charge, S; Heine, H; Isasi, R; Kato, K; Lovell-Badge, R; McNagny, K; Pei, DQ; Rossant, J; Surani, A; Taylor, PL; Ogbogu, U; Caulfield, T				Zarzeczny, Amy; Scott, Christopher; Hyun, Insoo; Bennett, Jami; Chandler, Jennifer; Charge, Sophie; Heine, Heather; Isasi, Rosario; Kato, Kazuto; Lovell-Badge, Robin; McNagny, Kelly; Pei, Duanqing; Rossant, Janet; Surani, Azim; Taylor, Patrick L.; Ogbogu, Ubaka; Caulfield, Timothy			iPS Cells: Mapping the Policy Issues	CELL			English	Editorial Material							STEM-CELLS; INTELLECTUAL PROPERTY; INFORMED-CONSENT; ETHICS	Given the explosion of research on induced pluripotent stem (iPS) cells, it is timely to consider the various ethical, legal, and social issues engaged by this fast-moving field. Here, we review issues associated with the procurement, basic research, and clinical translation of iPS cells.	[Caulfield, Timothy] Univ Alberta, Fac Law, Edmonton, AB T6G 2H5, Canada; [Caulfield, Timothy] Univ Alberta, Sch Publ Hlth, Hlth Law Inst, Edmonton, AB T6G 2H5, Canada; [Scott, Christopher] Stanford Univ, Ctr Biomed Eth, Stanford, CA 94305 USA; [Hyun, Insoo] Case Western Reserve Univ, Sch Med, Dept Bioeth, Cleveland, OH 44106 USA; [Bennett, Jami; McNagny, Kelly] Univ British Columbia, Biomed Res Ctr, Vancouver, BC V6T 1Z3, Canada; [Chandler, Jennifer] Univ Ottawa, Fac Law, Ottawa, ON K1N 6N5, Canada; [Charge, Sophie] Stem Cell Network, Ottawa, ON K1H 8L6, Canada; [Isasi, Rosario] McGill Univ, Ctr Genom & Policy, Montreal, PQ H3A 1A4, Canada; [Kato, Kazuto] Kyoto Univ, Inst Res Humanities, Grad Sch Biostudies, Inst Integrated Cell Mat Sci, Kyoto 6068501, Japan; [Lovell-Badge, Robin] Natl Inst Med Res, London NW7 1AA, England; [Pei, Duanqing] Guangzhou Inst Biomed, Guangzhou 510663, Guangdong, Peoples R China; [Pei, Duanqing] Guangzhou Inst Hlth, Guangzhou 510663, Guangdong, Peoples R China; [Rossant, Janet] Hosp Sick Children, Toronto, ON M5G 2L3, Canada; [Surani, Azim] Univ Cambridge, Gurdon Inst, Cambridge CB2 1QN, England; [Taylor, Patrick L.] Childrens Hosp Boston, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Ogbogu, Ubaka] Univ Toronto, Fac Law, Toronto, ON M5S 2C5, Canada	University of Alberta; University of Alberta; Stanford University; Case Western Reserve University; University of British Columbia; University of Ottawa; McGill University; Kyoto University; MRC National Institute for Medical Research; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Cambridge; Harvard University; Boston Children's Hospital; University of Toronto	Caulfield, T (corresponding author), Univ Alberta, Fac Law, Edmonton, AB T6G 2H5, Canada.	tcaulfld@law.ualberta.ca	McNagny, Kelly/P-5239-2014	McNagny, Kelly/0000-0003-4737-3499; Ogbogu, Ubaka/0000-0001-7764-6799; Surani, Azim/0000-0002-8640-4318; Kato, Kazuto/0000-0001-9006-9551; Lovell-Badge, Robin/0000-0001-9364-4179	MRC [G0800784, MC_U117562207] Funding Source: UKRI; Medical Research Council [G0800784, MC_U117562207] Funding Source: Medline; Medical Research Council [G0800784B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Aalto-Setala K, 2009, PLOS BIOL, V7, P204, DOI 10.1371/journal.pbio.1000042; Bergman K, 2007, NAT BIOTECHNOL, V25, P419, DOI 10.1038/nbt0407-419; Caulfield T, 2008, REGEN MED, V3, P483, DOI 10.2217/17460751.3.4.483; Caulfield T, 2007, CAN MED ASSOC J, V176, P1722, DOI 10.1503/cmaj.061675; Hansson MG, 2006, LANCET ONCOL, V7, P266, DOI 10.1016/S1470-2045(06)70618-0; Isasi RM, 2006, EUR J HEALTH LAW, V13, P9, DOI 10.1163/157180906777036328; Kee K, 2009, NATURE, V462, P222, DOI 10.1038/nature08562; Loring JF, 2006, SCIENCE, V311, P1716, DOI 10.1126/science.1120953; Lowrance WW, 2007, SCIENCE, V317, P600, DOI 10.1126/science.1147699; Mascalzoni D, 2008, PLOS MED, V5, P1302, DOI 10.1371/journal.pmed.0050192; Nayernia K, 2006, DEV CELL, V11, P125, DOI 10.1016/j.devcel.2006.05.010; Sugarman J, 2008, CELL STEM CELL, V2, P529, DOI 10.1016/j.stem.2008.05.005; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Vrtovec KT, 2008, NAT BIOTECHNOL, V26, P393, DOI 10.1038/nbt0408-393; Wilson JM, 2009, SCIENCE, V324, P727, DOI 10.1126/science.1174935	15	56	57	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1032	1037		10.1016/j.cell.2009.11.039	http://dx.doi.org/10.1016/j.cell.2009.11.039			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005794	Bronze, Green Published			2022-12-28	WOS:000272622800002
J	Barkman, T; Zhang, JZ				Barkman, Todd; Zhang, Jianzhi			Evidence for escape from adaptive conflict?	NATURE			English	Letter							GENE DUPLICATION; EVOLUTION		[Zhang, Jianzhi] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Barkman, Todd] Western Michigan Univ, Dept Biol Sci, Kalamazoo, MI 49008 USA	University of Michigan System; University of Michigan; Western Michigan University	Zhang, JZ (corresponding author), Univ Michigan, Dept Ecol & Evolutionary Biol, 1075 Nat Sci Bldg,830 N Univ Ave, Ann Arbor, MI 48109 USA.	jianzhi@umich.edu						Des Marais DL, 2008, NATURE, V454, P762, DOI 10.1038/nature07092; Force A, 1999, GENETICS, V151, P1531; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; HUGHES AL, 1994, P ROY SOC B-BIOL SCI, V256, P119, DOI 10.1098/rspb.1994.0058; Ohno S., 1970, EVOLUTION GENE DUPLI; Shimada N, 2005, J EXP BOT, V56, P2573, DOI 10.1093/jxb/eri251; Terpe K, 2006, APPL MICROBIOL BIOT, V72, P211, DOI 10.1007/s00253-006-0465-8; Thomson JM, 2005, NAT GENET, V37, P630, DOI 10.1038/ng1553; Zhang JZ, 2006, NAT GENET, V38, P819, DOI 10.1038/ng1812; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	10	19	19	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					E1	E2		10.1038/nature08663	http://dx.doi.org/10.1038/nature08663			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010636	Bronze			2022-12-28	WOS:000272559900045
J	Wright, L; Silva, DS				Wright, Linda; Silva, Diego S.			Incentives for organ donation: Israel's novel approach	LANCET			English	Editorial Material									[Wright, Linda] Univ Hlth Network, Toronto, ON M5G 2N2, Canada; [Wright, Linda] Univ Toronto, Fac Med, Dept Surg, Toronto, ON M5S 1A1, Canada; [Silva, Diego S.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON M5S 1A1, Canada; [Wright, Linda; Silva, Diego S.] Univ Toronto, Joint Ctr Bioeth, Toronto, ON M5S 1A1, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University of Toronto; University of Toronto	Wright, L (corresponding author), Univ Hlth Network, Toronto, ON M5G 2N2, Canada.	Linda.wright@uhn.on.ca	Silva, Diego/GRF-5446-2022; Silva, Diego/ABE-7560-2020	Silva, Diego/0000-0002-8195-6404				Abouna GM, 2008, TRANSPL P, V40, P34, DOI 10.1016/j.transproceed.2007.11.067; *CAN I HLTH INF, 2008, 2008 CAN ORG REPL RE; Hippen B, 2009, CURR OPIN ORGAN TRAN, V14, P140, DOI 10.1097/MOT.0b013e3283295e0d; Lavee J, 2010, LANCET, V375, P1131, DOI 10.1016/S0140-6736(09)61795-5; MOR E., TRANSPLANT TOURISM I; Simpkin AL, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b991; Tuttle-Newhall JE, 2009, AM J TRANSPLANT, V9, P879, DOI 10.1111/j.1600-6143.2009.02565.x; United Network for Organ Sharing, ALL DEC KIDN	8	14	14	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2010	375	9722					1233	1234		10.1016/S0140-6736(09)61520-8	http://dx.doi.org/10.1016/S0140-6736(09)61520-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	585VN	20022098				2022-12-28	WOS:000276858400008
J	Murray, CJL; Frenk, J				Murray, Christopher J. L.; Frenk, Julio			Ranking 37th-Measuring the Performance the US Health Care System	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Murray, Christopher J. L.] Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA; [Frenk, Julio] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA	Institute for Health Metrics & Evaluation; University of Washington; University of Washington Seattle; Harvard University; Harvard T.H. Chan School of Public Health	Murray, CJL (corresponding author), Univ Washington, Inst Hlth Metr & Evaluat, Seattle, WA 98195 USA.							Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Doe J, 2009, WHO STAT INFORM SYST; Murray CJL, 2000, B WORLD HEALTH ORGAN, V78, P717; Wilper AP, 2009, AM J PUBLIC HEALTH, V99, P2289, DOI 10.2105/AJPH.2008.157685; World Health Organization, 2000, WORLD HLTH REP 2000	5	85	87	0	14	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2					98	99		10.1056/NEJMp0910064	http://dx.doi.org/10.1056/NEJMp0910064			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	543FU	20054038				2022-12-28	WOS:000273558500003
J	Chuang, TM; Allan, MP; Lee, J; Xie, Y; Ni, N; Bud'ko, SL; Boebinger, GS; Canfield, PC; Davis, JC				Chuang, T. -M.; Allan, M. P.; Lee, Jinho; Xie, Yang; Ni, Ni; Bud'ko, S. L.; Boebinger, G. S.; Canfield, P. C.; Davis, J. C.			Nematic Electronic Structure in the "Parent" State of the Iron-Based Superconductor Ca(Fe1-xCox)(2)As-2	SCIENCE			English	Article							PHASES	The mechanism of high-temperature superconductivity in the newly discovered iron-based superconductors is unresolved. We use spectroscopic imaging-scanning tunneling microscopy to study the electronic structure of a representative compound CaFe1.94Co0.06As2 in the "parent" state from which this superconductivity emerges. Static, unidirectional electronic nanostructures of dimension eight times the inter-iron-atom distance a(Fe-Fe) and aligned along the crystal a axis are observed. In contrast, the delocalized electronic states detectable by quasiparticle interference imaging are dispersive along the b axis only and are consistent with a nematic alpha(2) band with an apparent band folding having wave vector (q) over right arrow congruent to +/- 2 pi/8a(Fe-Fe) along the a axis. All these effects rotate through 90 degrees at orthorhombic twin boundaries, indicating that they are bulk properties. As none of these phenomena are expected merely due to crystal symmetry, underdoped ferropnictides may exhibit a more complex electronic nematic state than originally expected.	[Chuang, T. -M.; Allan, M. P.; Lee, Jinho; Xie, Yang; Davis, J. C.] Cornell Univ, Atom & Solid State Phys Lab, Dept Phys, Ithaca, NY 14853 USA; [Chuang, T. -M.; Boebinger, G. S.] Florida State Univ, Dept Phys, Natl High Magnet Field Lab, Tallahassee, FL 32310 USA; [Allan, M. P.; Davis, J. C.] Univ St Andrews, Sch Phys & Astron, St Andrews KY16 9SS, Fife, Scotland; [Lee, Jinho; Davis, J. C.] Brookhaven Natl Lab, Condensed Matter Phys & Mat Sci Dept, Upton, NY 11973 USA; [Ni, Ni; Bud'ko, S. L.; Canfield, P. C.] Iowa State Univ, US DOE, Ames Lab, Ames, IA 50011 USA; [Ni, Ni; Bud'ko, S. L.; Canfield, P. C.] Iowa State Univ, Dept Phys & Astron, Ames, IA 50011 USA; [Davis, J. C.] Univ British Columbia, Dept Phys & Astron, Vancouver, BC V5Z 1M9, Canada	Cornell University; State University System of Florida; Florida State University; University of St Andrews; United States Department of Energy (DOE); Brookhaven National Laboratory; Iowa State University; United States Department of Energy (DOE); Ames National Laboratory; Iowa State University; University of British Columbia	Davis, JC (corresponding author), Cornell Univ, Atom & Solid State Phys Lab, Dept Phys, Ithaca, NY 14853 USA.	jcdavis@ccmr.cornell.edu	Chuang, Tien-Ming/AAP-3917-2021; Canfield, Paul/H-2698-2014; Allan, Milan Peter/D-7763-2012	Chuang, Tien-Ming/0000-0002-4524-1380; Allan, Milan Peter/0000-0002-5437-1945; Ni, Ni/0000-0003-4602-3999	DOE, Basic Energy Sciences [DE-AC02-07CH11358]; Cornell Center for Materials Research [NSF/DMR-0520404]; U. K. Engineering and Physical Sciences Research Council; Scottish Funding Council;  [NSF/DMR-0654118]	DOE, Basic Energy Sciences(United States Department of Energy (DOE)); Cornell Center for Materials Research; U. K. Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Scottish Funding Council; 	We thank F. Baumberger, P. J. Hirschfeld, J. E. Hoffman, A. Kaminski, D.-H. Lee, G. Luke, E.-A. Kim, M. Lawler, A. P. Mackenzie, I. I. Mazin, M. Norman, S. Pan, G. Sawatzky, and S. Uchida for helpful discussions and communications. These studies are supported by the Center for Emergent Superconductivity, a DOE Energy Frontier Research Center headquartered at Brookhaven National Laboratory. Work at the Ames Laboratory was supported by the DOE, Basic Energy Sciences under Contract no. DE-AC02-07CH11358. Support for this work was provided by NSF/DMR-0654118 through the National High Magnetic Field Lab (to T.-M. C.); the Cornell Center for Materials Research under NSF/DMR-0520404 (to Y.X.); and the U. K. Engineering and Physical Sciences Research Council and the Scottish Funding Council (to M. P. A.). J. C. D. acknowledges gratefully the hospitality and support of the Physics and Astronomy Department at the University of British Columbia, Vancouver, BC, Canada.	Baek SH, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.052504; Chen XH, 2008, NATURE, V453, P761, DOI 10.1038/nature07045; Diallo SO, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.187206; Fang C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.224509; Goldman AI, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.100506; Hosono H, 2009, PHYSICA C, V469, P314, DOI 10.1016/j.physc.2009.03.014; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Kemper AF, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.104511; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kohsaka Y, 2008, NATURE, V454, P1072, DOI 10.1038/nature07243; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Lee WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.176101; Massee F, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.220517; Mazin II, 2009, NAT PHYS, V5, P141, DOI 10.1038/NPHYS1160; Nascimento VB, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.076104; Ni N, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.014523; Rotter M, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.107006; Sefat AS, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.117004; Si QM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.076401; Wang C, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/67006; Xu CK, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134507; Yildirim T, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.057010; Yin Y, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.097002; ZAANEN J, 1989, PHYS REV B, V40, P7391, DOI 10.1103/PhysRevB.40.7391; Zhai H, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.064517; Zhao J, 2009, NAT PHYS, V5, P555, DOI 10.1038/NPHYS1336	29	409	409	2	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					181	184		10.1126/science.1181083	http://dx.doi.org/10.1126/science.1181083			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056885				2022-12-28	WOS:000273394000028
J	Javerzat, JP				Javerzat, Jean-Paul			Directing the Centromere Guardian	SCIENCE			English	Editorial Material							SISTER-CHROMATID COHESION; PROTEIN PHOSPHATASE 2A; MEIOSIS-I; CHROMOSOME SEGREGATION; SHUGOSHIN; BUB1; MITOSIS; LOCALIZATION; KINETOCHORES; MEI-S332		Univ Bordeaux 2, Inst Biochim & Genet Cellulaires, CNRS, UMR5095, F-33077 Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Javerzat, JP (corresponding author), Univ Bordeaux 2, Inst Biochim & Genet Cellulaires, CNRS, UMR5095, F-33077 Bordeaux, France.	Jpaul.Javerzat@ibgc.u-bordeaux2.fr						Bernard P, 2001, NAT CELL BIOL, V3, P522, DOI 10.1038/35074598; Boyarchuk Y, 2007, J CELL BIOL, V176, P919, DOI 10.1083/jcb.200609044; Katis VL, 2004, CURR BIOL, V14, P560, DOI 10.1016/j.cub.2004.03.001; Kawashima SA, 2007, GENE DEV, V21, P420, DOI 10.1101/gad.1497307; Kawashima SA, 2010, SCIENCE, V327, P172, DOI 10.1126/science.1180189; Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663; Kitajima TS, 2005, CURR BIOL, V15, P353, DOI 10.1016/j.cub.2004.12.044; Kitajima TS, 2004, NATURE, V427, P510, DOI 10.1038/nature02312; Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220; McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086; Rabitsch KP, 2004, CURR BIOL, V14, P287, DOI 10.1016/j.cub.2004.01.051; Riedel CG, 2006, NATURE, V441, P53, DOI 10.1038/nature04664; Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016; Santaguida S, 2009, EMBO J, V28, P2511, DOI 10.1038/emboj.2009.173; Tang ZY, 2004, P NATL ACAD SCI USA, V101, P18012, DOI 10.1073/pnas.0408600102; Vanoosthuyse V, 2007, MOL BIOL CELL, V18, P1657, DOI 10.1091/mbc.E06-10-0890; Yamagishi Y, 2008, NATURE, V455, P251, DOI 10.1038/nature07217	17	4	4	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 8	2010	327	5962					150	151		10.1126/science.1184770	http://dx.doi.org/10.1126/science.1184770			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056877				2022-12-28	WOS:000273394000019
J	Gaskell, CM				Gaskell, C. Martin			Close supermassive binary black holes	NATURE			English	Letter							ACTIVE GALACTIC NUCLEI; BROAD-LINE REGION; PEAKED EMISSION-LINES; 3C 390.3; STEPS; SIZE		Univ Texas Austin, Dept Astron, Austin, TX 78712 USA	University of Texas System; University of Texas Austin	Gaskell, CM (corresponding author), Univ Texas Austin, Dept Astron, RLM 15308, Austin, TX 78712 USA.	gaskell@astro.as.utexas.edu		Gaskell, C/0000-0003-4888-2009	Direct For Mathematical & Physical Scien [0803883] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		BEGELMAN MC, 1980, NATURE, V287, P307, DOI 10.1038/287307a0; Boroson TA, 2009, NATURE, V458, P53, DOI 10.1038/nature07779; CHORNOCK R, 2009, ASTRON TELEGR, V1955; CHORNOCK R, 2009, QUASAR SDSS J1536 04; Dietrich M, 1998, ASTROPHYS J SUPPL S, V115, P185, DOI 10.1086/313085; Eracleous M, 2003, ASTROPHYS J, V599, P886, DOI 10.1086/379540; Eracleous M, 1997, ASTROPHYS J, V490, P216, DOI 10.1086/304859; Gaskell C.M., 1983, LIEGE INT ASTROPHYSI, V24, P473; Gaskell C.M., 1988, ACTIVE GALACTIC NUCL, P61, DOI [10.1007/3-540-19492-4_168, DOI 10.1007/3-540-19492-4_168]; Gaskell CM, 1996, ASTROPHYS J, V464, pL107, DOI 10.1086/310119; Gaskell CM, 1996, LECT NOTES PHYS, V471, P165; Gaskell CM, 1999, ASTR SOC P, V175, P157; Lauer TR, 2009, ASTROPHYS J, V703, P930, DOI 10.1088/0004-637X/703/1/930; O'Brien PT, 1998, ASTROPHYS J, V509, P163, DOI 10.1086/306464; Sergeev SG, 2000, ASTRON ASTROPHYS, V356, P41	15	37	37	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 7	2010	463	7277					E1	E2		10.1038/nature08665	http://dx.doi.org/10.1038/nature08665			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054358	Bronze, Green Submitted			2022-12-28	WOS:000273344900024
J	Rocheleau, T; Ndukum, T; Macklin, C; Hertzberg, JB; Clerk, AA; Schwab, KC				Rocheleau, T.; Ndukum, T.; Macklin, C.; Hertzberg, J. B.; Clerk, A. A.; Schwab, K. C.			Preparation and detection of a mechanical resonator near the ground state of motion	NATURE			English	Article							RESOLVED-SIDE-BAND; PARAMETRIC TRANSDUCER; OSCILLATOR; CAVITY	Cold, macroscopic mechanical systems are expected to behave contrary to our usual classical understanding of reality; the most striking and counterintuitive predictions involve the existence of states in which the mechanical system is located in two places simultaneously. Various schemes have been proposed to generate and detect such states(1,2), and all require starting from mechanical states that are close to the lowest energy eigenstate, the mechanical ground state. Here we report the cooling of the motion of a radio-frequency nanomechanical resonator by parametric coupling to a driven, microwave-frequency superconducting resonator. Starting from a thermal occupation of 480 quanta, we have observed occupation factors as low as 3.8 +/- 1.3 and expect the mechanical resonator to be found with probability 0.21 in the quantum ground state of motion. Further cooling is limited by random excitation of the microwave resonator and heating of the dissipative mechanical bath. This level of cooling is expected to make possible a series of fundamental quantum mechanical observations including direct measurement of the Heisenberg uncertainty principle and quantum entanglement with qubits.	[Schwab, K. C.] CALTECH, Pasadena, CA 91125 USA; [Clerk, A. A.] McGill Univ, Dept Phys, Montreal, PQ H3A 2T8, Canada; [Hertzberg, J. B.] Univ Maryland, Dept Phys, College Pk, MD 20742 USA; [Rocheleau, T.; Ndukum, T.; Macklin, C.] Cornell Univ, Dept Phys, Ithaca, NY 14853 USA	California Institute of Technology; McGill University; University System of Maryland; University of Maryland College Park; Cornell University	Schwab, KC (corresponding author), CALTECH, Pasadena, CA 91125 USA.	schwab@caltech.edu	Naing, Thura Lin/GNP-0731-2022; Clerk, Aashish/A-4008-2008	Clerk, Aashish/0000-0001-7297-9068	Fundamental Questions Institute [RFP2-08-27]; US National Science Foundation (NSF) [DMR-0804567, ECS-0335765]	Fundamental Questions Institute; US National Science Foundation (NSF)(National Science Foundation (NSF))	We acknowledge conversations with M. Blencowe, M. Aspelmeyer, R. Ilic, M. Skvarla, M. Metzler and M. Shaw and assistance from M. Savva, S. Rosenthal and M. Corbett. This work has been supported by the Fundamental Questions Institute (http://fqxi.org) (RFP2-08-27) and the US National Science Foundation (NSF) (DMR-0804567). Device fabrication was performed at the Cornell Nanoscale Facility, a member of the US National Nanotechnology Infrastructure Network (NSF grant ECS-0335765).	Armour AD, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.148301; BLAIR DG, 1995, PHYS REV LETT, V74, P1908, DOI 10.1103/PhysRevLett.74.1908; Blencowe MP, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.014511; Castellanos-Beltran MA, 2008, NAT PHYS, V4, P929, DOI 10.1038/nphys1090; Cleland AN, 1998, NATURE, V392, P160, DOI 10.1038/32373; Courty JM, 2001, EUR PHYS J D, V17, P399, DOI 10.1007/s100530170014; DIEDRICH F, 1989, PHYS REV LETT, V62, P403, DOI 10.1103/PhysRevLett.62.403; Dobrindt JM, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.263602; Dykman M. I., 1978, Soviet Physics - Solid State, V20, P1306; Grajcar M, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.035406; Groblacher S, 2009, NAT PHYS, V5, P485, DOI 10.1038/NPHYS1301; LINTHORNE NP, 1990, J PHYS D APPL PHYS, V23, P1, DOI 10.1088/0022-3727/23/1/001; Marquardt F, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093902; Marshall W, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.130401; Martin I, 2004, PHYS REV B, V69, DOI 10.1103/PhysRevB.69.125339; Naik A, 2006, NATURE, V443, P193, DOI 10.1038/nature05027; Park YS, 2009, NAT PHYS, V5, P489, DOI 10.1038/NPHYS1303; Poggio M, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.017201; Regal CA, 2008, NAT PHYS, V4, P555, DOI 10.1038/nphys974; Schliesser A, 2009, NAT PHYS, V5, P509, DOI 10.1038/NPHYS1304; Segev E, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/9/096206; Shytov AV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.228303; Stipe BC, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.096801; Teufel JD, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/9/095002; Teufel JD, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.197203; Verbridge SS, 2008, APPL PHYS LETT, V92, DOI 10.1063/1.2822406; Utami D, 2008, PHYS REV A, V78, DOI 10.1103/PhysRevA.78.042323; Wilson-Rae I, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.093901; Xue F, 2007, PHYS REV B, V76, DOI 10.1103/PhysRevB.76.205302	30	386	387	2	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					72	75		10.1038/nature08681	http://dx.doi.org/10.1038/nature08681			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20010604	Green Accepted, Green Submitted			2022-12-28	WOS:000273344900032
J	Cole-Hamilton, DJ				Cole-Hamilton, David J.			Janus Catalysts Direct Nanoparticle Reactivity	SCIENCE			English	Editorial Material									Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland	University of St Andrews	Cole-Hamilton, DJ (corresponding author), Univ St Andrews, Sch Chem, St Andrews KY16 9ST, Fife, Scotland.	djc@st-and.ac.uk						Cole-Hamilton DJ, 2003, SCIENCE, V299, P1702, DOI 10.1126/science.1081881; Crossley S, 2010, SCIENCE, V327, P68, DOI 10.1126/science.1180769; Desset SL, 2009, GREEN CHEM, V11, P630, DOI 10.1039/b822139a; Machut C, 2007, ANGEW CHEM INT EDIT, V46, P3040, DOI 10.1002/anie.200605166; Shen M, 2009, LANGMUIR, V25, P10843, DOI 10.1021/la901380b; Wiebus E, 2006, CATAL MET C, V30, P105, DOI 10.1007/1-4020-4087-3_5	6	68	70	3	138	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					41	42		10.1126/science.1184556	http://dx.doi.org/10.1126/science.1184556			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044563				2022-12-28	WOS:000273395400021
J	Jha, AK; Orav, EJ; Epstein, AM				Jha, Ashish K.; Orav, E. John; Epstein, Arnold M.			Public Reporting of Discharge Planning and Rates of Readmissions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; QUALITY-OF-CARE; MEDICARE BENEFICIARIES; RANDOMIZED-TRIALS; MORTALITY-RATES; UNITED-STATES; PERFORMANCE; SYSTEM	BACKGROUND A reduction in hospital readmissions may improve quality and reduce costs. The Centers for Medicare and Medicaid Services has initiated a national effort to measure and publicly report on the conduct of discharge planning. We know little about how U. S. hospitals perform on the current discharge metrics, the factors that underlie better performance, and whether better performance is related to lower readmission rates. METHODS We examined hospital performance on the basis of two measures of discharge planning: the adequacy of documentation in the chart that discharge instructions were provided to patients with congestive heart failure, and patient-reported experiences with discharge planning. We examined the association between performance on these measures and rates of readmission for congestive heart failure and pneumonia. RESULTS We found a weak correlation in performance between the two discharge measures (r = 0.05, P<0.001). Although larger hospitals performed better on the chart-based measure, smaller hospitals and those with higher nurse-staffing levels performed better on the patient-reported measure. We found no association between performance on the chart-based measure and readmission rates among patients with congestive heart failure ( readmission rates among hospitals performing in the highest quartile vs. the lowest quartile, 23.7% vs. 23.5%; P = 0.54) and only a very modest association between performance on the patient-reported measure and readmission rates for congestive heart failure ( readmission rates among hospitals performing in the highest quartile vs. the lowest quartile, 22.4% vs. 24.7%; P<0.001) and pneumonia (17.5% vs. 19.5%, P<0.001). CONCLUSIONS Our findings suggest that current efforts to collect and publicly report data on discharge planning are unlikely to yield large reductions in unnecessary readmissions.	[Jha, Ashish K.; Orav, E. John; Epstein, Arnold M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Jha, Ashish K.; Orav, E. John; Epstein, Arnold M.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu			Commonwealth Fund	Commonwealth Fund	Supported by the Commonwealth Fund.	[Anonymous], 2007, MPA COMMITTEE REPORT; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Epstein AM, 2009, NEW ENGL J MED, V360, P1457, DOI 10.1056/NEJMe0901006; FISHER ES, 1994, NEW ENGL J MED, V331, P989, DOI 10.1056/NEJM199410133311506; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; *QUALITYNET, 2009, SPEC MAN NAT HOSP IN; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Schoen C, 2006, HEALTH AFFAIR, V25, pW457, DOI 10.1377/hlthaff.25.w457; Wennberg JE, 1998, DARTMOUTH ATLAS HLTH	19	185	186	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2637	2645		10.1056/NEJMsa0904859	http://dx.doi.org/10.1056/NEJMsa0904859			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042755	Bronze			2022-12-28	WOS:000273181300011
J	Klumpp, S; Zhang, ZG; Hwa, T				Klumpp, Stefan; Zhang, Zhongge; Hwa, Terence			Growth Rate-Dependent Global Effects on Gene Expression in Bacteria	CELL			English	Article							ESCHERICHIA-COLI K-12; MESSENGER-RNA; TRANSCRIPTIONAL REGULATION; TOGGLE SWITCH; LAC OPERON; REPLICATION; DNA; PERSISTER; TOLERANCE; PROMOTER	Bacterial gene expression depends not only on specific regulatory mechanisms, but also on bacterial growth, because important global parameters such as the abundance of RNA polymerases and ribosomes are all growth-rate dependent. Understanding of these global effects is necessary for a quantitative understanding of gene regulation and for the design of synthetic genetic circuits. We find that the observed growth-rate dependence of constitutive gene expression can be explained by a simple model using the measured growth-rate dependence of the relevant cellular parameters. More complex growth dependencies for genetic circuits involving activators, repressors, and feedback control were analyzed and verified experimentally with synthetic circuits. Additional results suggest a feedback mechanism mediated by general growth-dependent effects that does not require explicit gene regulation if the expressed protein affects cell growth. This mechanism can lead to growth bistability and promote the acquisition of important physiological functions such as antibiotic resistance and tolerance (persistence).	[Klumpp, Stefan; Hwa, Terence] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Klumpp, Stefan; Hwa, Terence] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Zhang, Zhongge; Hwa, Terence] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Klumpp, Stefan] Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Max Planck Society	Klumpp, S (corresponding author), Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA.	klumpp@ctbp.ucsd.edu; hwa@ucsd.edu	Klumpp, Stefan/AAC-3936-2019; Hwa, Terry/GOJ-9904-2022; Hwa, Terence/J-4012-2013; Klumpp, Stefan/C-2966-2008	Klumpp, Stefan/0000-0003-0584-2146; Hwa, Terence/0000-0003-1837-6842; Klumpp, Stefan/0000-0003-0584-2146	National Science Foundation through the Center for Theoretical Biological Physics [PHY-0822283]; National Institutes of Health [RO1GM77298]; Deutsche Forschungsgemeinschaft [KL818/1-1, 1-2];  [MCB0746581]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077298] Funding Source: NIH RePORTER	National Science Foundation through the Center for Theoretical Biological Physics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Hans Bremer, Patrick Dennis, Mans Ehrenberg, Peter Geiduschek, Richard Gourse, Carl Gunderson, Po-han Lee, Eduard Mateescu, Atul Narang, Moselio Schaechter, Matthew Scott, Arbel Tadmor, and Lingchong You for discussions during the course of this work. This work was supported by the National Science Foundation through the Center for Theoretical Biological Physics (grant PHY-0822283) and through grant MCB0746581, by the National Institutes of Health through grant RO1GM77298, and by a fellowship from Deutsche Forschungsgemeinschaft (grants KL818/1-1 and 1-2, to S.K.).	Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bremer H, 1996, ESCHERICHIA COLI SAL; Cayley S, 2004, J MOL RECOGNIT, V17, P488, DOI 10.1002/jmr.695; CHIARAMELLO AE, 1989, J BACTERIOL, V171, P4272, DOI 10.1128/JB.171.8.4272-4280.1989; COFFMAN RL, 1971, J MOL BIOL, V60, P1, DOI 10.1016/0022-2836(71)90442-6; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Donachie W. D., 1987, ESCHERICHIA COLI SAL, P1578; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; ENGBERG B, 1975, J BACTERIOL, V123, P179, DOI 10.1128/JB.123.1.179-186.1975; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; HARVEY RJ, 1980, ANTIMICROB AGENTS CH, V18, P323, DOI 10.1128/AAC.18.2.323; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Husnain SI, 2008, J BACTERIOL, V190, P2450, DOI 10.1128/JB.01732-07; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Jain C, 2002, MOL MICROBIOL, V43, P1053, DOI 10.1046/j.1365-2958.2002.02808.x; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Keener J, 1996, ESCHERICHIA COLI SAL, V2, P1417; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P20245, DOI 10.1073/pnas.0804953105; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Liang ST, 1999, J MOL BIOL, V288, P521, DOI 10.1006/jmbi.1999.2710; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; Liang ST, 2000, J BACTERIOL, V182, P3037, DOI 10.1128/JB.182.11.3037-3044.2000; LINCHAO S, 1986, MOL GEN GENET, V203, P143, DOI 10.1007/BF00330395; Lou CB, 2008, J THEOR BIOL, V255, P205, DOI 10.1016/j.jtbi.2008.07.035; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Maaloe O., 1979, BIOL REGUL DEV, V1, P487; Miller J.H., 1972, EXPT MOL GENETICS; Nanninga N, 1985, MOL CYTOLOGY ESCHERI, P259; Narang A, 2008, B MATH BIOL, V70, P1032, DOI 10.1007/s11538-007-9289-7; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Neidhardt FC, 1990, PHYSL BACTERIAL CELL; NILSSON G, 1984, NATURE, V312, P75, DOI 10.1038/312075a0; PATO ML, 1970, COLD SPRING HARB SYM, V35, P497, DOI 10.1101/SQB.1970.035.01.065; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; PerezMartin J, 1996, J MOL BIOL, V258, P575, DOI 10.1006/jmbi.1996.0270; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; SOMPAYRAC L, 1973, NATURE-NEW BIOL, V241, P133, DOI 10.1038/newbio241133a0; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; WANNER BL, 1977, J BACTERIOL, V130, P212, DOI 10.1128/JB.130.1.212-222.1977; WILLUMSEN BM, 1975, THESIS U COPENHAGEN	54	399	404	4	90	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 24	2009	139	7					1366	1375		10.1016/j.cell.2009.12.001	http://dx.doi.org/10.1016/j.cell.2009.12.001			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064380	Green Accepted, Bronze			2022-12-28	WOS:000273048700023
J	Reuben, DB				Reuben, David B.			Medical Care for the Final Years of Life "When You're 83, It's Not Going to Be 20 Years"	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OLDER PERSONS; COLLABORATIVE CARE; MOBILITY PROBLEMS; HEARING-LOSS; VITAMIN-D; QUALITY; FALLS; PREVENTION; INTERVENTION; MANAGEMENT	The case of an 83-year-old man who has had a fall-related injury and continues to be the sole caregiver for his wife who has dementia exemplifies a common situation that clinicians face-planning for the final years of an elderly individual's life. To appropriately focus on the patient's most pressing issues, the approach should begin with an assessment of life expectancy and incorporation of evidence-based care whenever possible. Short-term issues are focused on efforts to restore the patient to his previous state of health. Mid-range issues address providing preventive care, identifying geriatric syndromes, and helping him cope with the psychosocial needs of being a caregiver. Long-term issues relate to planning for his eventual decline and meeting his goals for the end of life. Unfortunately, the workload and inefficiencies of primary care practice present barriers to providing optimal care for older patients. Systematic approaches, including team care, are needed to adequately manage chronic diseases and coordinate care. JAMA. 2009;302(24):2686-2694 www.jama.com	Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Geriatr, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Reuben, DB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Geriatr, 10945 Conte Ave,Ste 2339, Los Angeles, CA 90095 USA.	dreuben@mednet.ucla.edu			Archstone Foundation; UniHealth Foundation; National Institutes of Health/National Institute on Aging [NIH/NIA] [P30-AG028748]; NATIONAL INSTITUTE ON AGING [P30AG028748] Funding Source: NIH RePORTER	Archstone Foundation; UniHealth Foundation; National Institutes of Health/National Institute on Aging [NIH/NIA](United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Dr Reuben reports receiving support from the Archstone Foundation, the UniHealth Foundation, and the UCLA Older Americans Independence Center ( National Institutes of Health/National Institute on Aging [NIH/NIA] grant P30-AG028748).	*AAFP ACP AOA, 2007, JOINT PRINC PAT CENT; [Anonymous], 2008, MMWR; [Anonymous], 2008, AHRQ PUBL, V08-0034 (1-4), P1; ARIAS E, 2007, NATL VITAL STAT REPO, V9; Avenell A, 2005, BMJ-BRIT MED J, V331, P324, DOI 10.1136/bmj.331.7512.324; Baron RJ, 2009, JAMA-J AM MED ASSOC, V301, P1922, DOI 10.1001/jama.2009.558; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Bischoff-Ferrari HA, 2004, JAMA-J AM MED ASSOC, V291, P1999, DOI 10.1001/jama.291.16.1999; Bischoff-Ferrari HA, 2007, AM J CLIN NUTR, V86, P1780; Bischoff-Ferrari HA, 2009, ARCH INTERN MED, V169, P551, DOI 10.1001/archinternmed.2008.600; Borghi L, 2002, NEW ENGL J MED, V346, P77, DOI 10.1056/NEJMoa010369; Boult C, 2008, J GERONTOL A-BIOL, V63, P321, DOI 10.1093/gerona/63.3.321; Callahan CM, 2006, JAMA-J AM MED ASSOC, V295, P2148, DOI 10.1001/jama.295.18.2148; Chang JT, 2007, J AM GERIATR SOC, V55, pS327, DOI 10.1111/j.1532-5415.2007.01339.x; *DEP HLTH HUM SERV, HOM SAF CHECKL; Department of Health and Human Services, US PREV SERV TASK FO; DesRoches CM, 2008, NEW ENGL J MED, V359, P50, DOI 10.1056/NEJMsa0802005; Ganz DA, 2008, J GEN INTERN MED, V23, P2018, DOI 10.1007/s11606-008-0808-5; Gill TM, 1998, ANN INTERN MED, V128, P96, DOI 10.7326/0003-4819-128-2-199801150-00004; Gillespie Lesley D, 2012, Cochrane Database Syst Rev, pCD007146, DOI 10.1002/14651858.CD007146.pub3; Heaney RP, 2008, J AM COLL NUTR, V27, P519, DOI 10.1080/07315724.2008.10719734; Hickman SE, 2008, J LAW MED ETHICS, V36, P119, DOI 10.1111/j.1748-720X.2008.00242.x; Holmboe ES, 2008, ARCH INTERN MED, V168, P1396, DOI 10.1001/archinte.168.13.1396; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lessig MC, 2008, INT PSYCHOGERIATR, V20, P459, DOI 10.1017/S1041610207006035; LIPS P, 2009, CLIN ENDOCRINOL OXF, DOI DOI 10.1111/J.0300-0664.2009.03701.X; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; Moore AA, 1996, AM J MED, V100, P438, DOI 10.1016/S0002-9343(97)89520-4; *NAT ASS AR AG AG, ANSW AG; Neuhouser ML, 2009, ARCH INTERN MED, V169, P294, DOI 10.1001/archinternmed.2008.540; Nikolaus T, 2003, J AM GERIATR SOC, V51, P300, DOI 10.1046/j.1532-5415.2003.51102.x; Nutting PA, 2009, ANN FAM MED, V7, P254, DOI 10.1370/afm.1002; Penninx BWJH, 2001, ARCH INTERN MED, V161, P2309, DOI 10.1001/archinte.161.19.2309; *PHYS ORD LIF SUST, WER HER HELP HON TRE; Reuben DB, 2004, J GERONTOL A-BIOL, V59, P1056; Reuben DB, 2003, J AM GERIATR SOC, V51, P1787, DOI 10.1046/j.1532-5415.2003.51565.x; Reuben DB, 1998, J AM GERIATR SOC, V46, P1008, DOI 10.1111/j.1532-5415.1998.tb02758.x; Reuben DB, 2009, HAZZARDS GERIATRIC M, P141; REUBEN DB, 2009, AGS ANN M APR 30 CHI; Schousboe JT, 2007, JAMA-J AM MED ASSOC, V298, P629, DOI 10.1001/jama.298.6.629; SIU AL, 1991, ANN INTERN MED, V115, P122, DOI 10.7326/0003-4819-115-2-122; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Tsai AC, 2005, AM J MANAG CARE, V11, P478; *UCLA, 20 MIN MED EX OFF FO; Unutzer J, 2002, JAMA-J AM MED ASSOC, V288, P2836, DOI 10.1001/jama.288.22.2836; *US DEP HHS, PNEUM POL VACC 10 6; *US SOC SEC ADM, 2005, PER LIF TABL; Vickrey BG, 2006, ANN INTERN MED, V145, P713, DOI 10.7326/0003-4819-145-10-200611210-00004; Voukelatos A, 2007, J AM GERIATR SOC, V55, P1185, DOI 10.1111/j.1532-5415.2007.01244.x; Wagner E H, 1998, Eff Clin Pract, V1, P2; WALLACE JI, 1995, J AM GERIATR SOC, V43, P329, DOI 10.1111/j.1532-5415.1995.tb05803.x; Wenger NS, 2009, J AM GERIATR SOC, V57, P547, DOI 10.1111/j.1532-5415.2008.02128.x; Willis SL, 2006, JAMA-J AM MED ASSOC, V296, P2805, DOI 10.1001/jama.296.23.2805; Yueh B, 2003, JAMA-J AM MED ASSOC, V289, P1976, DOI 10.1001/jama.289.15.1976	54	82	83	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 23	2009	302	24					2686	2694		10.1001/jama.2009.1871	http://dx.doi.org/10.1001/jama.2009.1871			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	535JU	20040557	Green Accepted			2022-12-28	WOS:000272965300025
J	Collerton, J; Davies, K; Jagger, C; Kingston, A; Bond, J; Eccles, MP; Robinson, LA; Martin-Ruiz, C; von Zglinicki, T; James, OFW; Kirkwood, TBL				Collerton, Joanna; Davies, Karen; Jagger, Carol; Kingston, Andrew; Bond, John; Eccles, Martin P.; Robinson, Louise A.; Martin-Ruiz, Carmen; von Zglinicki, Thomas; James, Oliver F. W.; Kirkwood, Thomas B. L.			Health and disease in 85 year olds: baseline findings from the Newcastle 85+cohort study	BRITISH MEDICAL JOURNAL			English	Article							CHRONIC KIDNEY-DISEASE; GLOMERULAR-FILTRATION-RATE; PEOPLE; POPULATION; PREVALENCE; ACCURACY; DEMENTIA; LIFE; AGE	Objectives The Newcastle 85+ Study aims to systematically study the clinical, biological, and psychosocial attributes of an unselected cohort of 85 year olds and to examine subsequent health trajectories as the cohort ages; health at baseline is reported. Design Cross sectional analysis of baseline data from a cohort study. Setting Newcastle upon Tyne and North Tyneside primary care trusts, United Kingdom. Participants 1042 people born in 1921 and registered with the participating general practices. Main outcome measures Detailed health assessment and review of general practice records (disease, medication, and use of general practice services); participants could decline elements of the protocol. Results Of the 1453 eligible people, 851 (58.6%) were recruited to health assessment plus record review, 188 (12.9%) to record review only, and 3 (0.2%) to health assessment only. Data from record review are reported on a maximum of 1030 and from health assessment on a maximum of 853; individual denominators differ owing to withdrawal and missing values. Of the health assessment sample (n=853), 62.1% (n=530) were women and 10.4% (n=89) were in institutional care. The most prevalent diseases were hypertension (57.5%, 592/1030) and osteoarthritis (51.8%, 534/1030). Moderate or severe cognitive impairment was present in 11.7% (96/824) of participants, severe or profound urinary incontinence in 21.3% (173/813), hearing impairment in 59.6% (505/848), and visual impairment in 37.2% (309/831). Health assessment identified participants with possible disease but without a previous diagnosis in their medical record for hypertension (25.1%, 206/821), ischaemic heart disease (12.6%, 99/788), depression (6.9%, 53/772), dementia (6.7%, 56/840), and atrial fibrillation (3.8%, 30/788). Undiagnosed diabetes mellitus and thyroid disease were rare (1%, 7/717 and 6/762, respectively). A median of 3 (interquartile range 1-8) activities of daily living were undertaken with difficulty. Overall, 77.6% (646/832) of participants rated their health compared with others of the same age as good, very good, or excellent. High contact rates in the previous year with general practitioners (93.8%, 960/1024) were recorded. Women had significantly higher disease counts (medians: women 5, men 4; P=0.033) and disability scores (medians: women 4, men 2; P=0.0006) than men, but were less likely to have attended outpatient clinics in the previous three months (women 29% (150/524), men 37% (118/320), odds ratio 0.7, 95% confidence interval 0.5 to 0.9). Conclusions This large cohort of 85 year olds showed good levels of both self rated health and functional ability despite significant levels of disease and impairment. Hypertension, ischaemic heart disease, atrial fibrillation, depression, and dementia may be underdiagnosed. Notable differences were found between the sexes: women outnumbered men and had more disease and disability.	[Davies, Karen; Jagger, Carol; Kingston, Andrew; Bond, John; Eccles, Martin P.; Robinson, Louise A.; Martin-Ruiz, Carmen; von Zglinicki, Thomas; Kirkwood, Thomas B. L.] Univ Newcastle, Inst Ageing & Hlth, Newcastle Upon Tyne NE4 5PL, Tyne & Wear, England; [Jagger, Carol] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Bond, John; Eccles, Martin P.; Robinson, Louise A.] Univ Newcastle, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; University of Leicester; Newcastle University - UK		j.c.collerton@ncl.ac.uk	Eccles, Martin P/AAD-4029-2020	von Zglinicki, Thomas/0000-0002-5939-0248; Jagger, Carol/0000-0002-6377-9926; Davies, Karen/0000-0002-2820-9397; Robinson, Louise/0000-0003-0209-2503; Kingston, Andrew/0000-0003-4211-7007; Martin-Ruiz, Carmen/0000-0002-3361-6974	Medical Research Council and Biotechnology and Biological Sciences Research Council [G0500997]; Newcastle Healthcare Charity; Medical Research Council [G0601333, G0500997, G0700718, G0700718B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10260] Funding Source: researchfish; MRC [G0700718, G0601333, G0500997] Funding Source: UKRI	Medical Research Council and Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Newcastle Healthcare Charity; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The baseline phase of the Newcastle 85+ Study was supported by a combined grant from the Medical Research Council and Biotechnology and Biological Sciences Research Council (grant No G0500997) and a grant from the Newcastle Healthcare Charity. The funders had no role in the study design; in the collection, analysis, and interpretation of data; in the writing of the paper; and in the decision to submit the paper for publication.	Bamford C, 2007, FAM PRACT, V24, P108, DOI 10.1093/fampra/cml068; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; BOWLING AP, 1989, J ROY COLL GEN PRACT, V39, P52; Brayne C, 1998, PSYCHOL MED, V28, P319; *BRIT MED ASS ROYA, 2009, 58 BMA RPS; CHOBANIAN AV, 2003, 7 US DEP HLTH HUM SE; Christensen K, 2009, LANCET, V374, P1196, DOI 10.1016/S0140-6736(09)61460-4; Collerton Joanna, 2007, BMC Geriatr, V7, P14, DOI 10.1186/1471-2318-7-14; *DEP EP PUBL HLTH, 2005, HLTH SURV ENGL 2005; DUNN G, 1992, DESIGN ANAL RELIABIL, P145; Fletcher AE, 2004, LANCET, V364, P1667, DOI 10.1016/S0140-6736(04)17353-4; Gold CH, 2002, J GERONTOL B-PSYCHOL, V57, pS168, DOI 10.1093/geronb/57.3.S168; *GOV ACT DEP, 2007, INT LIF TABL 2005 20; *GOV ACT DEP, 2006, GOV ACT DEP POP PROJ; JOOSTEN E, 1992, GERONTOLOGY, V38, P111, DOI 10.1159/000213315; Kriegsman DMW, 1996, J CLIN EPIDEMIOL, V49, P1407, DOI 10.1016/S0895-4356(96)00274-0; Lippi G, 2008, AGE AGEING, V37, P722, DOI 10.1093/ageing/afn201; Manjunath G, 2001, CURR OPIN NEPHROL HY, V10, P785, DOI 10.1097/00041552-200111000-00009; Marmot M, 2003, HLTH WEALTH LIFESTYL; Molloy D W, 1997, Int Psychogeriatr, V9 Suppl 1, P87, DOI 10.1017/S1041610297004754; National Institute for Health and Clinical Excellence, 2006, MAN HYP AD PRIM CAR; *NHS INF CTR HLTH, 2007, QUAL OUTC FRAM QOF 2; Nybo H, 2001, J AM GERIATR SOC, V49, P601, DOI 10.1046/j.1532-5415.2001.49121.x; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Office of the Deputy Prime Minister, 2004, ENGL IND DEPR 2004 S; Pitkala KH, 2001, J AM GERIATR SOC, V49, P596, DOI 10.1046/j.1532-5415.2001.49120.x; Roberts G, 1999, J GERONTOL B-PSYCHOL, V54, pS24, DOI 10.1093/geronb/54B.1.S24; Roderick PJ, 2008, AGE AGEING, V37, P179, DOI 10.1093/ageing/afm180; Rule AD, 2004, ANN INTERN MED, V141, P929, DOI 10.7326/0003-4819-141-12-200412210-00009; Seematter-Bagnoud Laurence, 2006, Eur J Ageing, V3, P41, DOI 10.1007/s10433-006-0022-4; Sheikh JA, 1986, CLIN GERONTOLOGY GUI; Simpson CF, 2004, J AM GERIATR SOC, V52, P123, DOI 10.1111/j.1532-5415.2004.52021.x; Tinker A, 2001, 85 NOT OUT STUDY PEO; United Nations Department of Economic and Social Affairs, 2002, WORLD POP AG 1950 20; von Faber M, 2001, ARCH INTERN MED, V161, P2694, DOI 10.1001/archinte.161.22.2694; Wanless D, 2001, SECURING OUR FUTURE; WILLIAMSON J, 1964, LANCET, V1, P1117	37	247	253	0	17	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 22	2009	339								b4904	10.1136/bmj.b4904	http://dx.doi.org/10.1136/bmj.b4904			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	536ZJ	20028777	hybrid, Green Published, Green Submitted			2022-12-28	WOS:000273082200004
J	Mank, JE				Mank, Judith E.			Sexual Selection and Darwin's Mystery of Mysteries	SCIENCE			English	Editorial Material							SPECIATION; DIVERSITY		Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	University of Oxford	Mank, JE (corresponding author), Univ Oxford, Dept Zool, Edward Grey Inst, S Parks Rd, Oxford OX1 3PS, England.	judith.mank@zoo.ox.ac.uk	Mank, Judith E/C-6859-2009	Mank, Judith/0000-0002-2450-513X				Andersson M, 2006, TRENDS ECOL EVOL, V21, P296, DOI 10.1016/j.tree.2006.03.015; BARRACLOUGH TG, 1995, P ROY SOC B-BIOL SCI, V259, P211, DOI 10.1098/rspb.1995.0031; Coyne J.A., 2004, SPECIATION; DARWIN C, 1859, SPECIES MEANS NATURA; Dobzhansky T, 1970, GENETICS EVOLUTIONAR; KNOWLTON N, 1993, SCIENCE, V260, P1629, DOI 10.1126/science.8503007; LANDE R, 1981, P NATL ACAD SCI-BIOL, V78, P3721, DOI 10.1073/pnas.78.6.3721; MAYNARD SMITH J., 1966, AMER NATUR, V100, P637; Mayr E., 1963, ANIMAL SPECIES EVOLU; Sato A, 2001, MOL BIOL EVOL, V18, P299, DOI 10.1093/oxfordjournals.molbev.a003806; Savolainen V, 2006, NATURE, V441, P210, DOI 10.1038/nature04566; Seehausen O, 1997, SCIENCE, V277, P1808, DOI 10.1126/science.277.5333.1808; van Doorn GS, 2009, SCIENCE, V326, P1704, DOI 10.1126/science.1181661	13	2	3	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 18	2009	326	5960					1639	1640		10.1126/science.1184680	http://dx.doi.org/10.1126/science.1184680			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	20019275				2022-12-28	WOS:000272839000038
J	Rupert, TJ; Gianola, DS; Gan, Y; Hemker, KJ				Rupert, T. J.; Gianola, D. S.; Gan, Y.; Hemker, K. J.			Experimental Observations of Stress-Driven Grain Boundary Migration	SCIENCE			English	Article							GROWTH; DEFORMATION; MOTION; AL; MECHANISMS; MODEL	In crystalline materials, plastic deformation occurs by the motion of dislocations, and the regions between individual crystallites, called grain boundaries, act as obstacles to dislocation motion. Grain boundaries are widely envisaged to be mechanically static structures, but this report outlines an experimental investigation of stress-driven grain boundary migration manifested as grain growth in nanocrystalline aluminum thin films. Specimens fabricated with specially designed stress and strain concentrators are used to uncover the relative importance of these parameters on grain growth. In contrast to traditional descriptions of grain boundaries as stationary obstacles to dislocation-based plasticity, the results of this study indicate that shear stresses drive grain boundaries to move in a manner consistent with recent molecular dynamics simulations and theoretical predictions of coupled grain boundary migration.	[Rupert, T. J.; Gianola, D. S.; Hemker, K. J.] Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA; [Rupert, T. J.] MIT, Dept Mat Sci & Engn, Cambridge, MA 02139 USA; [Gianola, D. S.] Univ Penn, Dept Mat Sci & Engn, Philadelphia, PA 19104 USA; [Gan, Y.] Karlsruhe Inst Technol, Inst Mat Res 2, D-76131 Karlsruhe, Germany	Johns Hopkins University; Massachusetts Institute of Technology (MIT); University of Pennsylvania; Helmholtz Association; Karlsruhe Institute of Technology	Hemker, KJ (corresponding author), Johns Hopkins Univ, Dept Mech Engn, Baltimore, MD 21218 USA.	hemker@jhu.edu	Hemker, Kevin J/A-3315-2010; Gan, Yixiang/B-1551-2008; Rupert, Timothy/A-2508-2009	Gan, Yixiang/0000-0002-9621-0277; Gianola, Daniel/0000-0003-4660-0805; Rupert, Timothy/0000-0002-7378-7807	U. S. Department of Energy, Office of Basic Energy Science; NSF [DMR-0210215]; Alexander von Humboldt postdoctoral fellowship	U. S. Department of Energy, Office of Basic Energy Science(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); Alexander von Humboldt postdoctoral fellowship(Alexander von Humboldt Foundation)	This work was supported by the U. S. Department of Energy, Office of Basic Energy Science and the NSF Nanoscale Interdisciplinary Research Team program (grant no. DMR-0210215). The authors are grateful for illuminating discussions with J. D. Embury and C. Eberl regarding the development of complex stress states in patterned thin films. D. S. G. acknowledges support from an Alexander von Humboldt postdoctoral fellowship.	ASHBY MF, 1973, ACTA METALL MATER, V21, P149, DOI 10.1016/0001-6160(73)90057-6; BAINBRIDGE DW, 1954, ACTA METALL MATER, V2, P322, DOI 10.1016/0001-6160(54)90175-3; Bernstein N, 2008, ACTA MATER, V56, P1106, DOI 10.1016/j.actamat.2007.11.002; Brandstetter S, 2008, SCRIPTA MATER, V58, P61, DOI 10.1016/j.scriptamat.2007.08.042; Cahn JW, 2006, ACTA MATER, V54, P4953, DOI 10.1016/j.actamat.2006.08.004; Cahn JW, 2004, ACTA MATER, V52, P4887, DOI 10.1016/j.actamat.2004.02.048; Caillard D, 2009, ACTA MATER, V57, P2390, DOI 10.1016/j.actamat.2009.01.023; COBLE RL, 1963, J APPL PHYS, V34, P1679, DOI 10.1063/1.1702656; Fan GJ, 2006, ACTA MATER, V54, P4781, DOI 10.1016/j.actamat.2006.06.016; GERTSMAN VY, 1994, SCRIPTA METALL MATER, V30, P577, DOI 10.1016/0956-716X(94)90432-4; Gianola DS, 2006, SCRIPTA MATER, V55, P649, DOI 10.1016/j.scriptamat.2006.06.002; Gianola DS, 2006, ACTA MATER, V54, P2253, DOI 10.1016/j.actamat.2006.01.023; Gianola DS, 2008, ADV MATER, V20, P303, DOI 10.1002/adma.200701607; GRIFFITHS JR, 1971, J MECH PHYS SOLIDS, V19, P419, DOI 10.1016/0022-5096(71)90009-3; HALL EO, 1951, P PHYS SOC LOND B, V64, P747, DOI 10.1088/0370-1301/64/9/303; Ivanov VA, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.064106; Jin M, 2007, THIN SOLID FILMS, V515, P3202, DOI 10.1016/j.tsf.2006.01.052; Jin M, 2004, ACTA MATER, V52, P5381, DOI 10.1016/j.actamat.2004.07.044; LI CH, 1953, ACTA METALL MATER, V1, P223, DOI 10.1016/0001-6160(53)90062-5; Molodov DA, 2007, ACTA MATER, V55, P1843, DOI 10.1016/j.actamat.2006.10.045; Mompiou F, 2009, ACTA MATER, V57, P2198, DOI 10.1016/j.actamat.2009.01.014; Nalla RK, 2003, NAT MATER, V2, P164, DOI 10.1038/nmat832; Olmsted DL, 2009, ACTA MATER, V57, P3694, DOI 10.1016/j.actamat.2009.04.007; Pan D, 2007, NANO LETT, V7, P2108, DOI 10.1021/nl071093m; PETCH NJ, 1953, J IRON STEEL I, V174, P25; RAE CMF, 1980, PHILOS MAG A, V41, P477, DOI 10.1080/01418618008239327; RITCHIE RO, 1973, J MECH PHYS SOLIDS, V21, P395, DOI 10.1016/0022-5096(73)90008-2; SHERBY OD, 1989, PROG MATER SCI, V33, P169, DOI 10.1016/0079-6425(89)90004-2; Shvindlerman L. S., 1999, CRC MAT SCI TECHNOL; Winning M, 2002, ACTA MATER, V50, P353, DOI 10.1016/S1359-6454(01)00343-3; Winning M, 2001, ACTA MATER, V49, P211, DOI 10.1016/S1359-6454(00)00321-9; Zhang H, 2008, PHILOS MAG, V88, P243, DOI 10.1080/14786430701810764; Zhang K, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2008377	33	475	480	13	462	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1686	1690		10.1126/science.1178226	http://dx.doi.org/10.1126/science.1178226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	20019286				2022-12-28	WOS:000272839000051
J	Kubanek, A; Koch, M; Sames, C; Ourjoumtsev, A; Pinkse, PWH; Murr, K; Rempe, G				Kubanek, A.; Koch, M.; Sames, C.; Ourjoumtsev, A.; Pinkse, P. W. H.; Murr, K.; Rempe, G.			Photon-by-photon feedback control of a single-atom trajectory	NATURE			English	Article								Feedback is one of the most powerful techniques for the control of classical systems. An extension into the quantum domain is desirable as it could allow the production of non-trivial quantum states(1-4) and protection against decoherence(5,6). The difficulties associated with quantum, as opposed to classical, feedback arise from the quantum measurement process-in particular the quantum projection noise and the limited measurement rate-as well as from quantum fluctuations perturbing the evolution in a driven open system. Here we demonstrate real-time feedback control(7-12) of the motion of a single atom trapped in an optical cavity. Individual probe photons carrying information about the atomic position(13,14) activate a dipole laser that steers the atom on timescales 70 times shorter than the atom's oscillation period in the trap. Depending on the specific implementation, the trapping time is increased by a factor of more than four owing to feedback cooling, which can remove almost all the kinetic energy of the atom in a quarter of an oscillation period(12). Our results show that the detected photon flux reflects the atomic motion, and thus mark a step towards the exploration of the quantum trajectory(15,16) of a single atom at the standard quantum limit.	[Kubanek, A.; Koch, M.; Sames, C.; Ourjoumtsev, A.; Pinkse, P. W. H.; Murr, K.; Rempe, G.] Max Planck Inst Quantum Opt, D-85748 Garching, Germany	Max Planck Society	Kubanek, A (corresponding author), Max Planck Inst Quantum Opt, Hans Kopfermann Str 1, D-85748 Garching, Germany.	alexander.kubanek@mpq.mpg.de; gerhard.rempe@mpq.mpg.de	Kubanek, Alexander/AAT-9287-2020; Sames, Christian/A-3015-2013	Kubanek, Alexander/0000-0002-2417-1985; Ourjoumtsev, Alexei/0000-0003-4166-0518	Bavarian PhD programme of excellence QCCC; Deutsche Forschungsgemeinschaft [635]; European Union project SCALA	Bavarian PhD programme of excellence QCCC; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Union project SCALA	Partial support by the Bavarian PhD programme of excellence QCCC, the Deutsche Forschungsgemeinschaft research unit 635 and the European Union project SCALA are gratefully acknowledged.	ASHKIN A, 1977, APPL PHYS LETT, V30, P202, DOI 10.1063/1.89335; Braginsky V. B., 1992, QUANTUM MEASUREMENT; Bushev P, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.043003; Carmichael H, 1993, OPEN SYSTEMS APPROAC; Combes J, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.160503; Fischer T, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.163002; Hood CJ, 2000, SCIENCE, V287, P1447, DOI 10.1126/science.287.5457.1447; Jacobs K, 2003, PHYS REV A, V67, DOI 10.1103/PhysRevA.67.030301; Khudaverdyan M, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.123006; Kubanek A, 2008, PHYS REV LETT, V101, DOI 10.1103/PhysRevLett.101.203602; LYNN TW, 2005, J OPT B-QUANTUM S O, V7, P215; Maunz P, 2004, NATURE, V428, P50, DOI 10.1038/nature02387; MOLMER K, 1993, J OPT SOC AM B, V10, P524, DOI 10.1364/JOSAB.10.000524; Morrow NV, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.093003; Pinkse PWH, 2000, NATURE, V404, P365, DOI 10.1038/35006006; Puppe T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.013002; SHAPIRO JH, 1987, J OPT SOC AM B, V4, P1604, DOI 10.1364/JOSAB.4.001604; Steck DA, 2006, PHYS REV A, V74, DOI 10.1103/PhysRevA.74.012322; Viola L, 2004, J MOD OPTIC, V51, P2357, DOI 10.1080/09500340412331284902; Viola L, 1999, PHYS REV LETT, V82, P2417, DOI 10.1103/PhysRevLett.82.2417; WISEMAN HM, 1994, PHYS REV A, V49, P2133, DOI 10.1103/PhysRevA.49.2133	21	62	63	2	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 17	2009	462	7275					898	901		10.1038/nature08563	http://dx.doi.org/10.1038/nature08563			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016597				2022-12-28	WOS:000272795400038
J	Saj, A; Arzy, S; Vuilleumier, P				Saj, Arnaud; Arzy, Shahar; Vuilleumier, Patrik			Functional Brain Imaging in a Woman With Spatial Neglect Due to Conversion Disorder	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter							PARALYSIS; PARIETAL		[Saj, Arnaud] Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland; [Arzy, Shahar] Hadassah Hebrew Univ Hosp, Dept Neurol, Jerusalem, Israel; [Vuilleumier, Patrik] Univ Geneva, Fac Med, Dept Neurosci, CH-1211 Geneva 4, Switzerland	University of Geneva; Hebrew University of Jerusalem; Hadassah University Medical Center; University of Geneva	Saj, A (corresponding author), Univ Hosp Geneva, Dept Neurol, Geneva, Switzerland.	patrik.vuilleumier@unige.ch	Vuilleumier, Patrik/AAJ-1839-2021	Vuilleumier, Patrik/0000-0002-8198-9214; Arzy, Shahar/0000-0001-6500-8095				Aybek S, 2008, CURR OPIN PSYCHIATR, V21, P275, DOI 10.1097/YCO.0b013e3282f94242; Fink GR, 2000, NEUROLOGY, V54, P1324, DOI 10.1212/WNL.54.6.1324; Halligan PW, 2000, LANCET, V355, P986, DOI 10.1016/S0140-6736(00)99019-6; Marshall JC, 1997, COGNITION, V64, pB1, DOI 10.1016/S0010-0277(97)00020-6; Mesulam MM, 1999, PHILOS T R SOC B, V354, P1325, DOI 10.1098/rstb.1999.0482; Vuilleumier P, 2005, PROG BRAIN RES, V150, P309, DOI 10.1016/S0079-6123(05)50023-2	6	15	15	0	2	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60654-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	2009	302	23					2552	2554		10.1001/jama.2009.1834	http://dx.doi.org/10.1001/jama.2009.1834			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532HK	20009053	Bronze			2022-12-28	WOS:000272737200021
J	Rawlins, L; Woollard, M; Williams, J; Hallam, P				Rawlins, L.; Woollard, M.; Williams, J.; Hallam, P.			CHRISTMAS 2009: MUSIC Effect of listening to Nellie the Elephant during CPR training on performance of chest compressions by lay people: randomised crossover trial	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HOSPITAL CARDIAC-ARREST; CARDIOPULMONARY-RESUSCITATION; SKILLS; RETENTION; RATES	Objectives To determine whether listening to music during cardiopulmonary resuscitation (CPR) training increases the proportion of lay people delivering chest compressions of 100 per minute. Design Prospective randomised crossover trial. Setting Large UK university. Participants 130 volunteers (81 men) recruited on an opportunistic basis. Exclusion criteria included age under 18, trained health professionals, and cardiopulmonary resuscitation (CPR) training within the past three months. Interventions Volunteers performed three sequences of one minute of continuous chest compressions on a skill meter resuscitation manikin accompanied by no music, repeated choruses of Nellie the Elephant (Nellie), and That's the Way (I like it) (TTW) according to a pre-randomised order. Main outcome measures Rate of chest compressions delivered (primary outcome), depth of compressions, proportion of incorrect compressions, and type of error. Results Median (interquartile range) compression rates were 110 (93-119) with no music, 105 (98-107) with Nellie, and 109 (103-110) with TTW. There were significant differences within groups between Nellie v no music and Nellie v TTW (P<0.001) but not no music v TTW (P=0.055). A compression rate of between 95 and 105 was achieved with no music, Nellie, and TTW for 15/130 (12%), 42/130 (32%), and 12/130 (9%) attempts, respectively. Differences in proportions were significant for Nellie v no music and Nellie v TTW (P<0.001) but not for no music v TTW (P=0.55). Relative risk for a compression rate between 95 and 105 was 2.8 (95% confidence interval 1.66 to 4.80) for Nellie v no music, 0.8 (0.40 to 1.62) for TTW v no music, and 3.5 (1.97 to 6.33) for Nellie v TTW. The number needed to treat for listening to Nellie v no music was 5 (4 to 10)-that is, the number of cardiac arrests required during which lay responders listen to Nellie to facilitate one patient receiving compressions at the correct rate (v no music) would be between four and 10. A greater proportion of compressions were too shallow when participants listened to Nellie v no music (56% v 47%, P=0.022). Conclusions Listening to Nellie the Elephant significantly increased the proportion of lay people delivering compression rates at close to 100 per minute. Unfortunately it also increased the proportion of compressions delivered at an inadequate depth. As current resuscitation guidelines give equal emphasis to correct rate and depth, listening to Nellie the Elephant as a learning aid during CPR training should be discontinued. Further research is required to identify music that, when played during CPR training, increases the proportion of lay responders providing chest compressions at both the correct rate and depth.	[Woollard, M.] Coventry Univ, Prehosp Emergency & Cardiovasc Care Appl Res Grp, Coventry CV1 5FB, W Midlands, England; [Rawlins, L.] Univ Birmingham, Sch Med, Birmingham B15 2TT, W Midlands, England; [Williams, J.] Univ Hertfordshire, Sch Hlth & Emergency Profess, Hatfield AL10 9AB, Herts, England; [Hallam, P.] W Midlands Ambulance Serv NHS Trust, Brierley Hill DY5 1LX, W Midlands, England	Coventry University; University of Birmingham; University of Hertfordshire	Woollard, M (corresponding author), Coventry Univ, Prehosp Emergency & Cardiovasc Care Appl Res Grp, Coventry CV1 5FB, W Midlands, England.	Malcolm.woollard@coventry.ac.uk	Williams, Julia/AAQ-8655-2021	Williams, Julia/0000-0003-0796-5465				BERDEN HJJM, 1994, ANN EMERG MED, V23, P1003, DOI 10.1016/S0196-0644(94)70094-X; Christenson J, 2007, RESUSCITATION, V74, P52, DOI 10.1016/j.resuscitation.2006.11.005; CUMMINS RO, 1985, JAMA-J AM MED ASSOC, V253, P2408, DOI 10.1001/jama.253.16.2408; Eftestol T, 2002, CIRCULATION, V105, P2270, DOI 10.1161/01.CIR.0000016362.42586.FE; Handley JA, 1998, RESUSCITATION, V36, P3, DOI 10.1016/S0300-9572(97)00095-6; Int Liaison Comm Resuscitation, 2005, RESUSCITATION, V67, P181, DOI 10.1016/j.resuscitation.2005.09.010; LARSEN MP, 1993, ANN EMERG MED, V22, P1652, DOI 10.1016/S0196-0644(05)81302-2; Matlock D, 2008, ANN EMERG MED, V52, pS67, DOI 10.1016/j.annemergmed.2008.06.149; Mellor Ric, 2010, Int Emerg Nurs, V18, P61, DOI 10.1016/j.ienj.2009.08.003; MOSER DK, 1992, HEART LUNG, V21, P372; Norris RM, 2005, HEART, V91, P1537, DOI 10.1136/hrt.2004.057018; Resuscitation Council (UK), 2005, AD BAS LIF SUPP GUID; Sayre MR, 2008, CIRCULATION, V117, P2162, DOI 10.1161/CIRCULATIONAHA.107.189380; THOMPSON RG, 1979, ANN INTERN MED, V90, P737, DOI 10.7326/0003-4819-90-5-737; Vaillancourt C, 2008, CAN J EMERG MED, V10, P51, DOI 10.1017/S1481803500010010; WILSON E, 1983, ANN EMERG MED, V12, P482, DOI 10.1016/S0196-0644(83)80643-X; Woollard M, 2004, RESUSCITATION, V60, P17, DOI 10.1016/j.resuscitation.2003.09.006; Woollard M, 2003, RESUSCITATION, V59, P123, DOI 10.1016/S0300-9572(03)00174-6; Woollard M, 2003, AMBULANCE UK, V18, P263	19	31	33	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 13	2009	339								b4707	10.1136/bmj.b4707	http://dx.doi.org/10.1136/bmj.b4707			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531VJ	20008376	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000272697900001
J	Gerardot, BD; Ohberg, P				Gerardot, Brian D.; Oehberg, Patrik			A Strongly Driven Spin	SCIENCE			English	Editorial Material							QUANTUM-DOT		[Gerardot, Brian D.; Oehberg, Patrik] Heriot Watt Univ, Dept Phys, Scottish Univ Phys Alliance, Edinburgh EH14 4AS, Midlothian, Scotland	Heriot Watt University; University of Edinburgh	Gerardot, BD (corresponding author), Heriot Watt Univ, Dept Phys, Scottish Univ Phys Alliance, Edinburgh EH14 4AS, Midlothian, Scotland.	b.d.gerardot@hw.ac.uk; p.ohberg@hw.ac.uk	Gerardot, Brian D./AHB-1102-2022; Gerardot, Brian D/D-2418-2009; Öhberg, Patrik/C-8926-2013	Gerardot, Brian D/0000-0002-0279-898X; Öhberg, Patrik/0000-0002-8780-4233	Engineering and Physical Sciences Research Council [EP/G02216X/1] Funding Source: researchfish; EPSRC [EP/G02216X/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Balasubramanian G, 2009, NAT MATER, V8, P383, DOI [10.1038/nmat2420, 10.1038/NMAT2420]; FEYNMAN RP, 1957, J APPL PHYS, V28, P49, DOI 10.1063/1.1722572; Jelezko F, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.076401; Khaneja N, 2001, PHYS REV A, V63, DOI 10.1103/PhysRevA.63.032308; Koppens FHL, 2006, NATURE, V442, P766, DOI 10.1038/nature05065; Press D, 2008, NATURE, V456, P218, DOI 10.1038/nature07530	7	3	3	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1489	1490		10.1126/science.1183659	http://dx.doi.org/10.1126/science.1183659			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007888				2022-12-28	WOS:000272623600042
J	Seaman, MNJ				Seaman, Matthew N. J.			Enhanced SnapShot: Endosome-to-Golgi Retrieval	CELL			English	Editorial Material							RETROGRADE TRANSPORT; COMPLEX; RECRUITMENT; RECOGNITION; NETWORK; YEAST; RAB7		Cambridge Inst Med Res, Cambridge CB2 0XY, England	University of Cambridge	Seaman, MNJ (corresponding author), Cambridge Inst Med Res, Cambridge CB2 0XY, England.				MRC [G0700750] Funding Source: UKRI; Medical Research Council [G0700750] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Hayes GL, 2009, MOL BIOL CELL, V20, P209, DOI 10.1091/mbc.E08-07-0740; Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353; Perez-Victoria FJ, 2008, MOL BIOL CELL, V19, P2350, DOI 10.1091/mbc.E07-11-1189; Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048; Seaman MNJ, 2007, J CELL SCI, V120, P2378, DOI 10.1242/jcs.009654; Seaman MNJ, 2009, J CELL SCI, V122, P2371, DOI 10.1242/jcs.048686; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016	10	4	4	1	2	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 11	2009	139	6							1198.e1	10.1016/j.cell.2009.11.040	http://dx.doi.org/10.1016/j.cell.2009.11.040			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005812	Bronze			2022-12-28	WOS:000272622800021
J	Mugyenyi, P; Walker, AS; Hakim, J; Munderi, P; Gibb, DM; Kityo, C; Reid, A; Grosskurth, H; Darbyshire, JH; Ssali, F; Bray, D; Katabira, E; Babiker, AG; Gilks, CF; Grosskurth, H; Munderi, P; Kabuye, G; Nsibambi, D; Kasirye, R; Zalwango, E; Nakazibwe, M; Kikaire, B; Nassuna, G; Massa, R; Fadhiru, K; Namyalo, M; Zalwango, A; Generous, L; Khauka, P; Rutikarayo, N; Nakahima, W; Mugisha, A; Todd, J; Levin, J; Muyingo, S; Ruberantwari, A; Kaleebu, P; Yirrell, D; Ndembi, N; Lvagoba, F; Hughes, P; Aber, M; Lara, AM; Foster, S; Amurwon, J; Wakholi, BN; Whitworth, J; Wangati, K; Amuron, B; Kajungu, D; Nakiyingi, J; Omony, W; Fadhiru, K; Nsibambi, D; Khauka, P; Mugyenyi, P; Kityo, C; Ssali, F; Tumukunde, D; Otim, T; Kabanda, J; Musana, H; Akao, J; Kyomugisha, H; Byamukama, A; Sabiiti, J; Komugyena, J; Wavamunno, P; Mukiibi, S; Drasiku, A; Byaruhanga, R; Labeja, O; Katundu, P; Tugume, S; Awio, P; Namazzi, A; Bakeinyaga, GT; Katabira, H; Abaine, D; Tukamushaba, J; Anywar, W; Ojiambo, W; Angweng, E; Murungi, S; Haguma, W; Atwiine, S; Kigozi, J; Namale, L; Mukose, A; Mulindwa, G; Atwiine, D; Muhwezi, A; Nimwesiga, E; Barungi, G; Takubwa, J; Murungi, S; Mwebesa, D; Kagina, G; Mulindwa, M; Ahimbisibwe, F; Mwesigwa, P; Akuma, S; Zawedde, C; Nyiraguhirwa, D; Tumusiime, C; Bagaya, L; Namara, W; Kigozi, J; Karungi, J; Kankunda, R; Enzama, R; Latif, A; Hakim, J; Robertson, V; Reid, A; Chidziva, E; Bulaya-Tembo, R; Musoro, G; Taziwa, F; Chimbetete, C; Chakonza, L; Mawora, A; Muvirimi, C; Tinago, G; Svovanapasis, P; Simango, M; Chirema, O; Machingura, J; Mutsai, S; Phiri, M; Bafana, T; Chirara, M; Muchabaiwa, L; Muzambi, M; Mutowo, J; Chivhunga, T; Chigwedere, E; Pascoe, M; Warambwa, C; Zengeza, E; Mapinge, F; Makota, S; Jamu, A; Ngorima, N; Chirairo, H; Chitsungo, S; Chimanzi, J; Maweni, C; Warara, R; Matongo, M; Mudzingwa, S; Jangano, M; Moyo, K; Vere, L; Mdege, N; Machingura, I; Katabira, E; Ronald, A; Kambungu, A; Lutwama, F; Mambule, I; Nanfuka, A; Walusimbi, J; Nabankema, E; Nalumenya, R; Namuli, T; Kulume, R; Namata, I; Nyachwo, L; Florence, A; Kusiima, A; Lubwama, E; Nairuba, R; Oketta, F; Buluma, E; Waita, R; Ojiambo, H; Sadik, F; Wanyama, J; Nabongo, P; Oyugi, J; Sematala, F; Muganzi, A; Twijukye, C; Byakwaga, H; Ochai, R; Muhweezi, D; Coutinho, A; Etukoit, B; Gilks, C; Boocock, K; Puddephatt, C; Grundy, C; Bohannon, J; Winogron, D; Gibb, DM; Burke, A; Bray, D; Babiker, A; Walker, AS; Wilkes, H; Rauchenberger, M; Sheehan, S; Spencer-Drake, C; Taylor, K; Spyer, M; Ferrier, A; Naidoo, B; Dunn, D; Goodall, R; Darbyshire, JH; Peto, L; Nanfuka, R; Mufuka-Kapuya, C; Kaleebu, P; Pillay, D; Robertson, V; Yirrell, D; Tugume, S; Chirara, M; Katundu, P; Ndembi, N; Lyagoba, F; Dunn, D; Goodall, R; McCormick, A; Lara, AM; Foster, S; Amurwon, J; Wakholi, BN; Kigozi, J; Muchabaiwa, L; Muzambi, M				Mugyenyi, P.; Walker, A. S.; Hakim, J.; Munderi, P.; Gibb, D. M.; Kityo, C.; Reid, A.; Grosskurth, H.; Darbyshire, J. H.; Ssali, F.; Bray, D.; Katabira, E.; Babiker, A. G.; Gilks, C. F.; Grosskurth, H.; Munderi, P.; Kabuye, G.; Nsibambi, D.; Kasirye, R.; Zalwango, E.; Nakazibwe, M.; Kikaire, B.; Nassuna, G.; Massa, R.; Fadhiru, K.; Namyalo, M.; Zalwango, A.; Generous, L.; Khauka, P.; Rutikarayo, N.; Nakahima, W.; Mugisha, A.; Todd, J.; Levin, J.; Muyingo, S.; Ruberantwari, A.; Kaleebu, P.; Yirrell, D.; Ndembi, N.; Lvagoba, F.; Hughes, P.; Aber, M.; Lara, A. Medina; Foster, S.; Amurwon, J.; Wakholi, B. Nyanzi; Whitworth, J.; Wangati, K.; Amuron, B.; Kajungu, D.; Nakiyingi, J.; Omony, W.; Fadhiru, K.; Nsibambi, D.; Khauka, P.; Mugyenyi, P.; Kityo, C.; Ssali, F.; Tumukunde, D.; Otim, T.; Kabanda, J.; Musana, H.; Akao, J.; Kyomugisha, H.; Byamukama, A.; Sabiiti, J.; Komugyena, J.; Wavamunno, P.; Mukiibi, S.; Drasiku, A.; Byaruhanga, R.; Labeja, O.; Katundu, P.; Tugume, S.; Awio, P.; Namazzi, A.; Bakeinyaga, G. T.; Katabira, H.; Abaine, D.; Tukamushaba, J.; Anywar, W.; Ojiambo, W.; Angweng, E.; Murungi, S.; Haguma, W.; Atwiine, S.; Kigozi, J.; Namale, L.; Mukose, A.; Mulindwa, G.; Atwiine, D.; Muhwezi, A.; Nimwesiga, E.; Barungi, G.; Takubwa, J.; Murungi, S.; Mwebesa, D.; Kagina, G.; Mulindwa, M.; Ahimbisibwe, F.; Mwesigwa, P.; Akuma, S.; Zawedde, C.; Nyiraguhirwa, D.; Tumusiime, C.; Bagaya, L.; Namara, W.; Kigozi, J.; Karungi, J.; Kankunda, R.; Enzama, R.; Latif, A.; Hakim, J.; Robertson, V.; Reid, A.; Chidziva, E.; Bulaya-Tembo, R.; Musoro, G.; Taziwa, F.; Chimbetete, C.; Chakonza, L.; Mawora, A.; Muvirimi, C.; Tinago, G.; Svovanapasis, P.; Simango, M.; Chirema, O.; Machingura, J.; Mutsai, S.; Phiri, M.; Bafana, T.; Chirara, M.; Muchabaiwa, L.; Muzambi, M.; Mutowo, J.; Chivhunga, T.; Chigwedere, E.; Pascoe, M.; Warambwa, C.; Zengeza, E.; Mapinge, F.; Makota, S.; Jamu, A.; Ngorima, N.; Chirairo, H.; Chitsungo, S.; Chimanzi, J.; Maweni, C.; Warara, R.; Matongo, M.; Mudzingwa, S.; Jangano, M.; Moyo, K.; Vere, L.; Mdege, N.; Machingura, I.; Katabira, E.; Ronald, A.; Kambungu, A.; Lutwama, F.; Mambule, I.; Nanfuka, A.; Walusimbi, J.; Nabankema, E.; Nalumenya, R.; Namuli, T.; Kulume, R.; Namata, I.; Nyachwo, L.; Florence, A.; Kusiima, A.; Lubwama, E.; Nairuba, R.; Oketta, F.; Buluma, E.; Waita, R.; Ojiambo, H.; Sadik, F.; Wanyama, J.; Nabongo, P.; Oyugi, J.; Sematala, F.; Muganzi, A.; Twijukye, C.; Byakwaga, H.; Ochai, R.; Muhweezi, D.; Coutinho, A.; Etukoit, B.; Gilks, C.; Boocock, K.; Puddephatt, C.; Grundy, C.; Bohannon, J.; Winogron, D.; Gibb, D. M.; Burke, A.; Bray, D.; Babiker, A.; Walker, A. S.; Wilkes, H.; Rauchenberger, M.; Sheehan, S.; Spencer-Drake, C.; Taylor, K.; Spyer, M.; Ferrier, A.; Naidoo, B.; Dunn, D.; Goodall, R.; Darbyshire, J. H.; Peto, L.; Nanfuka, R.; Mufuka-Kapuya, C.; Kaleebu, P.; Pillay, D.; Robertson, V.; Yirrell, D.; Tugume, S.; Chirara, M.; Katundu, P.; Ndembi, N.; Lyagoba, F.; Dunn, D.; Goodall, R.; McCormick, A.; Lara, A. Medina; Foster, S.; Amurwon, J.; Wakholi, B. Nyanzi; Kigozi, J.; Muchabaiwa, L.; Muzambi, M.		DART Trail Grp	Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial	LANCET			English	Article							PUBLIC-HEALTH APPROACH; 5-YEAR OUTCOMES	Background HIV antiretroviral therapy (ART) is often managed without routine laboratory monitoring in Africa; however, the effect of this approach is unknown. This trial investigated whether routine toxicity and efficacy monitoring of HIV-infected patients receiving ART had an important long-term effect on clinical outcomes in Africa. Methods In this open, non-inferiority trial in three centres in Uganda and one in Zimbabwe, 3321 symptomatic, ART-naive, HIV-infected adults with CD4 counts less than 200 cells per mu L starting ART were randomly assigned to laboratory and clinical monitoring (LCM; n=1659) or clinically driven monitoring (CDM; n=1662) by a computer-generated list. Haematology, biochemistry, and CD4-cell counts were done every 12 weeks. In the LCM group, results were available to clinicians; in the CDM group, results (apart from CD4-cell count) could be requested if clinically indicated and grade 4 toxicities were available. Participants switched to second-line ART after new or recurrent WHO stage 4 events in both groups, or CD4 count less than 100 cells per mu L (LCM only). Co-primary endpoints were new WHO stage 4 HIV events or death, and serious adverse events. Non-inferiority was defined as the upper 95% confidence limit for the hazard ratio (HR) for new WHO stage 4 events or death being no greater than 1.18. Analyses were by intention to treat. This study is registered, number ISRCTN13968779. Findings Two participants assigned to CDM and three to LCM were excluded from analyses. 5-year survival was 87% (95% CI 85-88) in the CDM group and 90% (88-91) in the LCM group, and 122 (7%) and 112 (7%) participants, respectively, were lost to follow-up over median 4.9 years' follow-up. 459 (28%) participants receiving CDM versus 356 (21%) LCM had a new WHO stage 4 event or died (6.94 [95% CI 6.33-7.60] vs 5.24 [4.72-5.81] per 100 person-years; absolute difference 1.70 per 100 person-years [0.87-2.54]; HR 1.31 [1.14-1.51]; p=0.0001). Differences in disease progression occurred from the third year on ART, whereas higher rates of switch to second-line treatment occurred in LCM from the second year. 283 (17%) participants receiving CDM versus 260 (16%) LCM had a new serious adverse event (HR 1.12 [0.94-1.32]; p=0.19), with anaemia the most common (76 vs 61 cases). Interpretation ART can be delivered safely without routine laboratory monitoring for toxic effects, but differences in disease progression suggest a role for monitoring of CD4-cell count from the second year of ART to guide the switch to second-line treatment. Funding UK Medical Research Council, the UK Department for International Development, the Rockefeller Foundation, GlaxoSmithKline, Gilead Sciences, Boehringer-Ingelheim, and Abbott Laboratories.	[Walker, A. S.; Gibb, D. M.; Darbyshire, J. H.; Bray, D.; Burke, A.; Babiker, A.; Wilkes, H.; Rauchenberger, M.; Sheehan, S.; Spencer-Drake, C.; Taylor, K.; Spyer, M.; Ferrier, A.; Naidoo, B.; Dunn, D.; Goodall, R.; Peto, L.] MRC, Clin Trials Unit, London NW1 2DA, England; [Munderi, P.; Grosskurth, H.; Kabuye, G.; Nsibambi, D.; Kasirye, R.; Zalwango, E.; Nakazibwe, M.; Kikaire, B.; Nassuna, G.; Massa, R.; Fadhiru, K.; Namyalo, M.; Zalwango, A.; Generous, L.; Khauka, P.; Rutikarayo, N.; Nakahima, W.; Kaleebu, P.; Yirrell, D.; Ndembi, N.; Hughes, P.; Aber, M.; Lara, A. Medina; Foster, S.; Amurwon, J.; Wakholi, B. Nyanzi; Whitworth, J.; Wangati, K.; Amuron, B.; Kajungu, D.; Nakiyingi, J.; Omony, W.; Lyagoba, F.] MRC UVRI Uganda Res Unit AIDS, Entebbe, Uganda; [Mugyenyi, P.; Kityo, C.; Ssali, F.; Tumukunde, D.; Otim, T.; Kabanda, J.; Musana, H.; Akao, J.; Kyomugisha, H.; Byamukama, A.; Sabiiti, J.; Komugyena, J.; Wavamunno, P.; Mukiibi, S.; Drasiku, A.; Byaruhanga, R.; Labeja, O.; Katundu, P.; Tugume, S.; Awio, P.; Namazzi, A.; Bakeinyaga, G. T.; Katabira, H.; Abaine, D.; Tukamushaba, J.; Anywar, W.; Ojiambo, W.; Angweng, E.; Murungi, S.; Haguma, W.; Atwiine, S.; Kigozi, J.; Namale, L.; Mukose, A.; Mulindwa, G.; Atwiine, D.; Muhwezi, A.; Nimwesiga, E.; Barungi, G.; Takubwa, J.; Mwebesa, D.; Kagina, G.; Mulindwa, M.; Ahimbisibwe, F.; Mwesigwa, P.; Akuma, S.; Zawedde, C.; Nyiraguhirwa, D.; Tumusiime, C.; Bagaya, L.; Namara, W.; Karungi, J.; Kankunda, R.; Enzama, R.] Joint Clin Res Ctr, Kampala, Uganda; [Hakim, J.; Reid, A.; Latif, A.; Robertson, V.; Chidziva, E.; Bulaya-Tembo, R.; Musoro, G.; Taziwa, F.; Chimbetete, C.; Chakonza, L.; Mawora, A.; Muvirimi, C.; Tinago, G.; Svovanapasis, P.; Simango, M.; Chirema, O.; Machingura, J.; Mutsai, S.; Phiri, M.; Bafana, T.; Chirara, M.; Muchabaiwa, L.; Muzambi, M.; Mutowo, J.; Chivhunga, T.; Chigwedere, E.; Pascoe, M.; Warambwa, C.; Zengeza, E.; Mapinge, F.; Makota, S.; Jamu, A.; Ngorima, N.; Chirairo, H.; Chitsungo, S.; Chimanzi, J.; Maweni, C.; Warara, R.; Matongo, M.; Mudzingwa, S.; Jangano, M.; Moyo, K.; Vere, L.; Mdege, N.; Machingura, I.] Univ Zimbabwe, Harare, Zimbabwe; [Katabira, E.; Ronald, A.; Kambungu, A.; Lutwama, F.; Mambule, I.; Nanfuka, A.; Walusimbi, J.; Nabankema, E.; Nalumenya, R.; Namuli, T.; Kulume, R.; Namata, I.; Nyachwo, L.; Florence, A.; Kusiima, A.; Lubwama, E.; Nairuba, R.; Oketta, F.; Buluma, E.; Waita, R.; Ojiambo, H.; Sadik, F.; Wanyama, J.; Nabongo, P.; Oyugi, J.; Sematala, F.; Muganzi, A.; Twijukye, C.; Byakwaga, H.] Makerere Univ, Mulago, Uganda; [Gilks, C.; Boocock, K.; Puddephatt, C.; Grundy, C.; Bohannon, J.; Winogron, D.] Univ London Imperial Coll Sci Technol & Med, London, England	Medical Research Council Clinical Trials Unit; Joint Clinic Research Center - United Arab Emirates; University of Zimbabwe; Makerere University; Imperial College London	Walker, AS (corresponding author), MRC, Clin Trials Unit, 222 Euston Rd, London NW1 2DA, England.	asw@ctu.mrc.ac.uk	Gilks, Charles/B-4184-2012; kasirye, ronnie/AAW-7818-2021; NDEMBI, Nicaise/AAE-4383-2020; Kajungu, Dan/AAY-8527-2020; Franzeck, Fabian C/B-5055-2011; Walker, Sarah/HDM-8717-2022; Unemo, Magnus/ABD-6653-2021	Gilks, Charles/0000-0002-8953-3123; Kajungu, Dan/0000-0002-3363-7062; Todd, Jim/0000-0001-5918-4914; Kasirye, Ronnie/0000-0002-5200-464X; Gibb, Diana/0000-0002-9738-5490; Muchabaiwa, Lazarus/0000-0003-3504-4559; Grosskurth, Heiner/0000-0001-9960-7280	UK Medical Research Council; UK Department for International Development (DFID); Rockefeller Foundation; GlaxoSmith Kline; Gilead Sciences; Boehringer-Ingelheim; Abbott Laboratories; Medical Research Council [MC_U950080931, MC_U122886352, G0600344] Funding Source: researchfish; MRC [MC_U950080931, G0600344, MC_U122886352] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Department for International Development (DFID); Rockefeller Foundation; GlaxoSmith Kline(GlaxoSmithKline); Gilead Sciences(Gilead Sciences); Boehringer-Ingelheim(Boehringer Ingelheim); Abbott Laboratories(Abbott Laboratories); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank all the patients and staff from all the centres participating in the DART trial. DART was funded by the UK Medical Research Council, the UK Department for International Development (DFID), and the Rockefeller Foundation. GlaxoSmith Kline, Gilead Sciences, and Boehringer-Ingelheim donated first-line drugs for DART, and Abbott Laboratories provided LPV/r (Kaletra/Aluvia) as part of the second-line regimen for DART.; Funding UK Medical Research Council, the UK Department for International Development, the Rockefeller Foundation, GlaxoSmithKline, Gilead Sciences, Boehringer-ingelheim, and Abbott Laboratories.	[Anonymous], 1990, Wkly Epidemiol Rec, V65, P221; [Anonymous], 1994, INT C HARM TECHN REQ; Boulle A, 2008, B WORLD HEALTH ORGAN, V86, P678, DOI 10.2471/BLT.07.045294; Bussmann H, 2008, AIDS, V22, P2303, DOI 10.1097/QAD.0b013e3283129db0; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Coutinho A, 2008, 15 C RETR OPP INF BO; Division of AIDS, 1992, DIV AIDS GRAD SEV AD; Gilks CF, 2006, LANCET, V368, P505, DOI 10.1016/S0140-6736(06)69158-7; Hosseinipour MC, 2009, AIDS, V23, P1127, DOI 10.1097/QAD.0b013e32832ac34e; Kaleebu P, 2006, AIDS, V20, P1391, DOI 10.1097/01.aids.0000233572.59522.45; Kantor R, 2009, CLIN INFECT DIS, V49, P454, DOI 10.1086/600396; LARA AM, 2009, 5 IAS C HIV PATH TRE; Lawn SD, 2009, AIDS, V23, P335, DOI 10.1097/QAD.0b013e328321823f; Leger P, 2009, NEW ENGL J MED, V361, P828, DOI 10.1056/NEJMc0809485; Munderi P, 2008, TROP MED INT HEALTH, V13, P6, DOI 10.1111/j.1365-3156.2007.01973.x; Munderi P, 2006, 16 INT AIDS C TOR CA; PETO R, 1976, BRIT J CANCER, V34, P585, DOI 10.1038/bjc.1976.220; Phillips AN, 2008, LANCET, V371, P1443, DOI 10.1016/S0140-6736(08)60624-8; UNAIDS & World Bank, 2009, GLOB EC CRIS HIV PRE; Walker AS, 2008, AIDS, V22, P237, DOI 10.1097/QAD.0b013e3282f2d760; *WHO, UN ACC SCAL PRIOR HI; World Bank, 2009, AV HUM CRIS GLOB DOW; World Health Organization, 2006, ANT THER HIV INF AD; Zhang FJ, 2009, ANN INTERN MED, V151, P241, DOI 10.7326/0003-4819-151-4-200908180-00006	24	233	236	0	16	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2010	375	9709					123	131		10.1016/S0140-6736(09)62067-5	http://dx.doi.org/10.1016/S0140-6736(09)62067-5			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544NM	20004464	Green Published, Green Accepted			2022-12-28	WOS:000273664500029
J	Bode, LGM; Kluytmans, JAJW; Wertheim, HFL; Bogaers, D; Vandenbroucke-Grauls, CMJE; Roosendaal, R; Troelstra, A; Box, ATA; Voss, A; van der Tweel, I; van Belkum, A; Verbrugh, HA; Vos, MC				Bode, Lonneke G. M.; Kluytmans, Jan A. J. W.; Wertheim, Heiman F. L.; Bogaers, Diana; Vandenbroucke-Grauls, Christina M. J. E.; Roosendaal, Robert; Troelstra, Annet; Box, Adrienne T. A.; Voss, Andreas; van der Tweel, Ingeborg; van Belkum, Alex; Verbrugh, Henri A.; Vos, Margreet C.			Preventing Surgical-Site Infections in Nasal Carriers of Staphylococcus aureus	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTRANASAL MUPIROCIN; PERITONEAL-DIALYSIS; HEMODIALYSIS-PATIENTS; DOUBLE-BLIND; CARRIAGE; SURGERY; RISK; COLONIZATION; PROPHYLAXIS; ELIMINATION	BACKGROUND Nasal carriers of Staphylococcus aureus are at increased risk for health care-associated infections with this organism. Decolonization of nasal and extranasal sites on hospital admission may reduce this risk. METHODS In a randomized, double-blind, placebo-controlled, multicenter trial, we assessed whether rapid identification of S. aureus nasal carriers by means of a real-time polymerase-chain-reaction (PCR) assay, followed by treatment with mupirocin nasal ointment and chlorhexidine soap, reduces the risk of hospital-associated S. aureus infection. RESULTS From October 2005 through June 2007, a total of 6771 patients were screened on admission. A total of 1270 nasal swabs from 1251 patients were positive for S. aureus. We enrolled 917 of these patients in the intention-to-treat analysis, of whom 808 (88.1%) underwent a surgical procedure. All the S. aureus strains identified on PCR assay were susceptible to methicillin and mupirocin. The rate of S. aureus infection was 3.4% (17 of 504 patients) in the mupirocin-chlorhexidine group, as compared with 7.7% (32 of 413 patients) in the placebo group (relative risk of infection, 0.42; 95% confidence interval [CI], 0.23 to 0.75). The effect of mupirocin-chlorhexidine treatment was most pronounced for deep surgical-site infections (relative risk, 0.21; 95% CI, 0.07 to 0.62). There was no significant difference in all-cause in-hospital mortality between the two groups. The time to the onset of nosocomial infection was shorter in the placebo group than in the mupirocin-chlorhexidine group (P = 0.005). CONCLUSIONS The number of surgical-site S. aureus infections acquired in the hospital can be reduced by rapid screening and decolonizing of nasal carriers of S. aureus on admission. (Current Controlled Trials number, ISRCTN56186788.)	[Bode, Lonneke G. M.; Wertheim, Heiman F. L.; van Belkum, Alex; Verbrugh, Henri A.; Vos, Margreet C.] Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, NL-3015 CE Rotterdam, Netherlands; [Kluytmans, Jan A. J. W.; Bogaers, Diana] Amphia Hosp, Lab Microbiol & Infect Control, Breda, Netherlands; [Kluytmans, Jan A. J. W.; Vandenbroucke-Grauls, Christina M. J. E.; Roosendaal, Robert] Vrije Univ Amsterdam Med Ctr, Dept Med Microbiol & Infect Control, Amsterdam, Netherlands; [Troelstra, Annet; Box, Adrienne T. A.] Univ Med Ctr, Dept Med Microbiol, Utrecht, Netherlands; [van der Tweel, Ingeborg] Univ Med Ctr, Julius Ctr Hlth Sci & Primary Care, Utrecht, Netherlands; [Voss, Andreas] Canisius Wilhelmina Hosp, Dept Med Microbiol & Infect Dis, Nijmegen, Netherlands; [Voss, Andreas] Sint Maartenskliniek, Ctr Orthoped Surg, Nijmegen, Netherlands; [Wertheim, Heiman F. L.] Univ Oxford, Clin Res Unit, Hanoi, Vietnam	Erasmus University Rotterdam; Erasmus MC; Amphia Hospital; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Canisius-Wilhelmina Hospital; Sint Maartens Clinic; University of Oxford	Bode, LGM (corresponding author), Erasmus Univ, Med Ctr, Dept Med Microbiol & Infect Dis, S Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	l.bode@erasmusmc.nl	Wertheim, Heiman FL/F-3338-2016; Vandenbroucke-Grauls, Christina/AAO-7953-2020; Voss, A./H-8111-2014	Wertheim, Heiman FL/0000-0002-5003-5565; Vandenbroucke-Grauls, Christina/0000-0003-2074-1597; 	ZonMw [62000009]; Molnlycke Health Care; GlaxoSmithKline; Roche; bioMerieux; 3M	ZonMw(Netherlands Organization for Health Research and Development); Molnlycke Health Care; GlaxoSmithKline(GlaxoSmithKline); Roche(Roche Holding); bioMerieux; 3M(3M)	Supported by grants from ZonMw (62000009), Molnlycke Health Care (formerly Regent Medical), GlaxoSmithKline, Roche, bioMerieux, and 3M.	Bending M, 1996, J AM SOC NEPHROL, V7, P2403; BOELAERT JR, 1993, NEPHROL DIAL TRANSPL, V8, P235; Choudhurry RSR, 2006, J MICROBIOL METH, V65, P354, DOI 10.1016/j.mimet.2005.08.009; Deshpande LM, 2002, DIAGN MICR INFEC DIS, V42, P283, DOI 10.1016/S0732-8893(01)00328-5; DOERN GV, 1994, J CLIN MICROBIOL, V32, P1757, DOI 10.1128/JCM.32.7.1757-1762.1994; Hacek DM, 2008, CLIN ORTHOP RELAT R, V466, P1349, DOI 10.1007/s11999-008-0210-y; HORAN TC, 2004, HOSP EPIDEMIOLOGY IN, P1659; KAISER AB, 1988, ANN THORAC SURG, V45, P35, DOI 10.1016/S0003-4975(10)62391-0; Kalmeijer MD, 2002, CLIN INFECT DIS, V35, P353, DOI 10.1086/341025; Kluytmans JAJW, 1996, INFECT CONT HOSP EP, V17, P793; Kluytmans JAJW, 1996, INFECT CONT HOSP EP, V17, P780; KLUYTMANS JAJW, 1995, J INFECT DIS, V171, P216, DOI 10.1093/infdis/171.1.216; Laupland KB, 2003, CLIN INFECT DIS, V37, P933, DOI 10.1086/377735; LUZAR MA, 1990, NEW ENGL J MED, V322, P505, DOI 10.1056/NEJM199002223220804; Mertz D, 2009, ARCH INTERN MED, V169, P172, DOI 10.1001/archinternmed.2008.536; Miller LG, 2008, CLIN INFECT DIS, V46, P752, DOI 10.1086/526773; Nouwen J, 2006, J CLIN MICROBIOL, V44, P2233, DOI 10.1128/JCM.02083-05; Paule SM, 2004, J MOL DIAGN, V6, P191, DOI 10.1016/S1525-1578(10)60509-0; Perl TM, 2002, NEW ENGL J MED, V346, P1871, DOI 10.1056/NEJMoa003069; Solberg C O, 1965, Acta Med Scand Suppl, V436, P1; TENOVER FC, 1995, J CLIN MICROBIOL, V33, P2233, DOI 10.1128/JCM.33.9.2233-2239.1995; van Rijen MML, 2008, J ANTIMICROB CHEMOTH, V61, P254, DOI 10.1093/jac/dkm480; VANRIJEN M, 2008, COCHRANE DB SYST REV, V4, DOI DOI 10.1002/14651858.CD006216.PUB2; von Eiff C, 2001, NEW ENGL J MED, V344, P11, DOI 10.1056/NEJM200101043440102; WEINSTEIN HJ, 1959, NEW ENGL J MED, V260, P1303, DOI 10.1056/NEJM195906252602601; Wendt C, 2007, INFECT CONT HOSP EP, V28, P1036, DOI 10.1086/519929; Wertheim HFL, 2005, LANCET INFECT DIS, V5, P751, DOI 10.1016/S1473-3099(05)70295-4; Wertheim HFL, 2004, LANCET, V364, P703, DOI 10.1016/S0140-6736(04)16897-9; Wertheim HFL, 2004, J HOSP INFECT, V56, P321, DOI 10.1016/j.jhin.2004.01.026; Wertheim HFL, 2004, ANN INTERN MED, V140, P419, DOI 10.7326/0003-4819-140-6-200403160-00007; WILLIAMS RE, 1963, BACTERIOL REV, V27, P56, DOI 10.1128/MMBR.27.1.56-71.1963	31	763	777	2	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2010	362	1					9	17		10.1056/NEJMoa0808939	http://dx.doi.org/10.1056/NEJMoa0808939			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	540PA	20054045	Green Published			2022-12-28	WOS:000273345500004
J	Sokol, DK				Sokol, Daniel K.			Ethics Man Searching for medical Rumpoles	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Sokol, DK (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	daniel.sokol@talk21.com						Andre J., 2002, BIOETHICS PRACTICE; Ashcroft R, 1998, J MED ETHICS, V24, P188; Holm S, 2010, J MED ETHICS, V36, P65, DOI 10.1136/jme.2009.035188; Mattick K, 2006, J MED ETHICS, V32, P181, DOI 10.1136/jme.2005.014597; Stirrat GM, 2010, J MED ETHICS, V36, P55, DOI 10.1136/jme.2009.034660	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2010	340								c42	10.1136/bmj.c42	http://dx.doi.org/10.1136/bmj.c42			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	542IE	20053833				2022-12-28	WOS:000273485500009
J	Schwarzkopf, DS; Rees, G				Schwarzkopf, D. Sam; Rees, Geraint			Brain Activity to Rely On?	SCIENCE			English	Editorial Material							CORTEX; CONNECTIVITY; HUMANS		[Schwarzkopf, D. Sam] UCL, Inst Cognit Neurosci, London WC1N 3AR, England; [Rees, Geraint] UCL, Wellcome Trust Ctr Neuroimaging, London WC1N 3BG, England	University of London; University College London; University of London; University College London	Schwarzkopf, DS (corresponding author), UCL, Inst Cognit Neurosci, 17 Queen Sq, London WC1N 3AR, England.	g.rees@ucl.ac.uk	Rees, Geraint/C-1493-2008; Schwarzkopf, D. Sam/F-5285-2012	Rees, Geraint/0000-0002-9623-7007; Schwarzkopf, D. Sam/0000-0003-3686-1622				BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Frith C, 1999, TRENDS COGN SCI, V3, P105, DOI 10.1016/S1364-6613(99)01281-4; Haynes JD, 2005, NATURE, V438, P496, DOI 10.1038/nature04169; Haynes JD, 2005, NEURON, V46, P811, DOI 10.1016/j.neuron.2005.05.012; Haynes JD, 2006, NAT REV NEUROSCI, V7, P523, DOI 10.1038/nrn1931; Kenet T, 2003, NATURE, V425, P954, DOI 10.1038/nature02078; Lamme VAF, 2006, TRENDS COGN SCI, V10, P494, DOI 10.1016/j.tics.2006.09.001; Moutoussis K, 2002, P NATL ACAD SCI USA, V99, P9527, DOI 10.1073/pnas.142305699; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P221, DOI 10.1152/jn.1986.56.1.221; Rees G, 2007, PHILOS T R SOC B, V362, P877, DOI 10.1098/rstb.2007.2094; Schurger A, 2010, SCIENCE, V327, P97, DOI 10.1126/science.1180029; Sterzer P, 2009, TRENDS COGN SCI, V13, P310, DOI 10.1016/j.tics.2009.04.006	12	4	4	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 1	2010	327	5961					43	44		10.1126/science.1184242	http://dx.doi.org/10.1126/science.1184242			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044565				2022-12-28	WOS:000273395400023
J	Stephens, PJ; McBride, DJ; Lin, ML; Varela, I; Pleasance, ED; Simpson, JT; Stebbings, LA; Leroy, C; Edkins, S; Mudie, LJ; Greenman, CD; Jia, MM; Latimer, C; Teague, JW; Lau, KW; Burton, J; Quail, MA; Swerdlow, H; Churcher, C; Natrajan, R; Sieuwerts, AM; Martens, JWM; Silver, DP; Langerod, A; Russnes, HEG; Foekens, JA; Reis-Filho, JS; van't Veer, L; Richardson, AL; Borresen-Dale, AL; Campbell, PJ; Futreal, PA; Stratton, MR				Stephens, Philip J.; McBride, David J.; Lin, Meng-Lay; Varela, Ignacio; Pleasance, Erin D.; Simpson, Jared T.; Stebbings, Lucy A.; Leroy, Catherine; Edkins, Sarah; Mudie, Laura J.; Greenman, Chris D.; Jia, Mingming; Latimer, Calli; Teague, Jon W.; Lau, King Wai; Burton, John; Quail, Michael A.; Swerdlow, Harold; Churcher, Carol; Natrajan, Rachael; Sieuwerts, Anieta M.; Martens, John W. M.; Silver, Daniel P.; Langerod, Anita; Russnes, Hege E. G.; Foekens, John A.; Reis-Filho, Jorge S.; van't Veer, Laura; Richardson, Andrea L.; Borresen-Dale, Anne-Lise; Campbell, Peter J.; Futreal, P. Andrew; Stratton, Michael R.			Complex landscapes of somatic rearrangement in human breast cancer genomes	NATURE			English	Article							TANDEM DUPLICATION; MYELOID-LEUKEMIA; COPY NUMBER; FUSION GENE; PATTERNS; TRANSLOCATIONS; IDENTIFICATION; ABERRATIONS; ETV6-NTRK3; MUTATION	Multiple somatic rearrangements are often found in cancer genomes; however, the underlying processes of rearrangement and their contribution to cancer development are poorly characterized. Here we use a paired-end sequencing strategy to identify somatic rearrangements in breast cancer genomes. There are more rearrangements in some breast cancers than previously appreciated. Rearrangements are more frequent over gene footprints and most are intrachromosomal. Multiple rearrangement architectures are present, but tandem duplications are particularly common in some cancers, perhaps reflecting a specific defect in DNA maintenance. Short overlapping sequences at most rearrangement junctions indicate that these have been mediated by non-homologous end-joining DNA repair, although varying sequence patterns indicate that multiple processes of this type are operative. Several expressed in-frame fusion genes were identified but none was recurrent. The study provides a new perspective on cancer genomes, highlighting the diversity of somatic rearrangements and their potential contribution to cancer development.	[Stephens, Philip J.; McBride, David J.; Lin, Meng-Lay; Varela, Ignacio; Pleasance, Erin D.; Simpson, Jared T.; Stebbings, Lucy A.; Leroy, Catherine; Edkins, Sarah; Mudie, Laura J.; Greenman, Chris D.; Jia, Mingming; Latimer, Calli; Teague, Jon W.; Lau, King Wai; Burton, John; Quail, Michael A.; Swerdlow, Harold; Churcher, Carol; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Natrajan, Rachael; Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, Mol Pathol Lab, London SW3 6JB, England; [Sieuwerts, Anieta M.; Martens, John W. M.; Foekens, John A.] Erasmus Univ, Med Ctr, Josephine Nefkens Inst, Dept Med Oncol, NL-3000 CA Rotterdam, Netherlands; [Silver, Daniel P.; Richardson, Andrea L.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Langerod, Anita; Russnes, Hege E. G.; Borresen-Dale, Anne-Lise] Oslo Univ Hosp, Norwegian Radium Hosp, Dept Genet, N-0310 Oslo, Norway; [van't Veer, Laura] Netherlands Canc Inst, NL-1066 CX Amsterdam, Netherlands; [Richardson, Andrea L.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Borresen-Dale, Anne-Lise] Oslo Univ Hosp Radiumhosp, Inst Canc Res, Dept Genet, N-0310 Oslo, Norway; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England	Wellcome Trust Sanger Institute; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Erasmus University Rotterdam; Erasmus MC; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; University of Oslo; Netherlands Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School; University of Oslo; University of London; Institute of Cancer Research - UK	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	paf@sanger.ac.uk; mrs@sanger.ac.uk	Russnes, Hege Elisabeth Giercksky/N-6170-2015; Quail, michael/ABE-6131-2020; Varela, Ignacio/AAA-7680-2021; Varela, Ignacio/G-1699-2016; Silver, Daniel/P-3443-2019	Russnes, Hege Elisabeth Giercksky/0000-0001-8724-1891; Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Swerdlow, Harold/0000-0002-9510-160X; Natrajan, Rachael/0000-0002-9987-2946; Edsall, Lee Elizabeth/0000-0002-0326-2829; Edkins, Sarah/0000-0003-0717-1972	Kay Kendall Leukaemia Fund [KKL282]; Human Frontiers [LT000561/2009-L]; NCI [CA089393]; Breakthrough Breast Cancer; Research Council of Norway [155218, 175240]; Wellcome Trust [077012/Z/05/Z]; NATIONAL CANCER INSTITUTE [P50CA089393] Funding Source: NIH RePORTER	Kay Kendall Leukaemia Fund; Human Frontiers; NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Breakthrough Breast Cancer; Research Council of Norway(Research Council of Norway); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to M. Lambros, F. Geyer and R. Vatcheva for their assistance in the FISH experiments. We would like to acknowledge the support of the Kay Kendall Leukaemia Fund under Grant KKL282, Human Frontiers Award reference LT000561/2009-L, the Dana-Farber/Harvard SPORE in breast cancer under NCI grant reference CA089393, Breakthrough Breast Cancer, the Research Council of Norway Grants no. 155218 and 175240, and the Wellcome Trust under grant reference 077012/Z/05/Z.	Abeysinghe SS, 2003, HUM MUTAT, V22, P229, DOI 10.1002/humu.10254; Basecke J, 2006, BRIT J HAEMATOL, V135, P438, DOI 10.1111/j.1365-2141.2006.06301.x; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Bignell GR, 2007, GENOME RES, V17, P1296, DOI 10.1101/gr.6522707; Blow JJ, 2008, NAT REV CANCER, V8, P799, DOI 10.1038/nrc2500; Bohlander SK, 2005, SEMIN CANCER BIOL, V15, P162, DOI 10.1016/j.semcancer.2005.01.008; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Hefferin ML, 2005, DNA REPAIR, V4, P639, DOI 10.1016/j.dnarep.2004.12.005; Hoglund M, 2002, CANCER GENET CYTOGEN, V135, P103, DOI 10.1016/S0165-4608(01)00645-8; Jones DTW, 2008, CANCER RES, V68, P8673, DOI 10.1158/0008-5472.CAN-08-2097; Kaye FJ, 2009, MOL CANCER THER, V8, P1399, DOI 10.1158/1535-7163.MCT-09-0135; Knezevich SR, 1998, NAT GENET, V18, P184, DOI 10.1038/ng0298-184; Lambros MBK, 2006, LAB INVEST, V86, P398, DOI 10.1038/labinvest.3700390; Lannon CL, 2005, SEMIN CANCER BIOL, V15, P215, DOI 10.1016/j.semcancer.2005.01.003; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Mitelman F, 2004, NAT GENET, V36, P331, DOI 10.1038/ng1335; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Ruan YJ, 2007, GENOME RES, V17, P828, DOI 10.1101/gr.6018607; Sawyers CL, 1999, NEW ENGL J MED, V340, P1330, DOI 10.1056/NEJM199904293401706; SCHOLZ FW, 1987, J AM STAT ASSOC, V82, P918, DOI 10.2307/2288805; Soda M, 2007, NATURE, V448, P561, DOI 10.1038/nature05945; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679; van Gent DC, 2007, ONCOGENE, V26, P7731, DOI 10.1038/sj.onc.1210871; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Volik S, 2003, P NATL ACAD SCI USA, V100, P7696, DOI 10.1073/pnas.1232418100; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Weterings E, 2008, CELL RES, V18, P114, DOI 10.1038/cr.2008.3; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020	37	629	651	0	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1005	U60		10.1038/nature08645	http://dx.doi.org/10.1038/nature08645			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033038	Green Accepted, Green Submitted			2022-12-28	WOS:000272996000036
J	Zhou, WJ; Ercan, D; Chen, L; Yun, CH; Li, DN; Capelletti, M; Cortot, AB; Chirieac, L; Iacob, RE; Padera, R; Engen, JR; Wong, KK; Eck, MJ; Gray, NS; Janne, PA				Zhou, Wenjun; Ercan, Dalia; Chen, Liang; Yun, Cai-Hong; Li, Danan; Capelletti, Marzia; Cortot, Alexis B.; Chirieac, Lucian; Iacob, Roxana E.; Padera, Robert; Engen, John R.; Wong, Kwok-Kin; Eck, Michael J.; Gray, Nathanael S.; Jaenne, Pasi A.			Novel mutant-selective EGFR kinase inhibitors against EGFR T790M	NATURE			English	Article							PAN-ERBB INHIBITOR; CELL LUNG-CANCER; TYROSINE KINASE; RESISTANCE; MUTATION; GEFITINIB; SENSITIVITY; NILOTINIB; IMATINIB; HKI-272	The clinical efficacy of epidermal growth factor receptor ( EGFR) kinase inhibitors in EGFR-mutant non-small-cell lung cancer (NSCLC) is limited by the development of drug-resistance mutations, including the gatekeeper T790M mutation(1-3). Strategies targeting EGFR T790M with irreversible inhibitors have had limited success and are associated with toxicity due to concurrent inhibition of wild-type EGFR(4,5). All current EGFR inhibitors possess a structurally related quinazoline-based core scaffold and were identified as ATP-competitive inhibitors of wild-type EGFR. Here we identify a covalent pyrimidine EGFR inhibitor by screening an irreversible kinase inhibitor library specifically against EGFR T790M. These agents are 30- to 100-fold more potent against EGFR T790M, and up to 100-fold less potent against wildtype EGFR, than quinazoline-based EGFR inhibitors in vitro. They are also effective in murine models of lung cancer driven by EGFR T790M. Co-crystallization studies reveal a structural basis for the increased potency and mutant selectivity of these agents. These mutant-selective irreversible EGFR kinase inhibitors may be clinically more effective and better tolerated than quinazoline-based inhibitors. Our findings demonstrate that functional pharmacological screens against clinically important mutant kinases represent a powerful strategy to identify new classes of mutant-selective kinase inhibitors.	[Zhou, Wenjun; Yun, Cai-Hong; Eck, Michael J.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Zhou, Wenjun; Yun, Cai-Hong; Eck, Michael J.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ercan, Dalia; Chen, Liang; Li, Danan; Capelletti, Marzia; Cortot, Alexis B.; Wong, Kwok-Kin; Jaenne, Pasi A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Ercan, Dalia; Chen, Liang; Li, Danan; Capelletti, Marzia; Cortot, Alexis B.; Wong, Kwok-Kin; Jaenne, Pasi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chirieac, Lucian; Padera, Robert] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Iacob, Roxana E.; Engen, John R.] Northeastern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA; [Iacob, Roxana E.; Engen, John R.] Northeastern Univ, Dept Chem & Biol Chem, Boston, MA 02115 USA; [Wong, Kwok-Kin; Jaenne, Pasi A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Wong, Kwok-Kin; Jaenne, Pasi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Wong, Kwok-Kin; Jaenne, Pasi A.] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Northeastern University; Northeastern University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Gray, NS (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	Nathanael_Gray@dfci.harvard.edu; pjanne@partners.org	云, 彩红/E-1437-2018; Cortot, Alexis B/F-7006-2019; Chirieac, Lucian R./AAD-2030-2019; Capelletti, Marzia/L-6317-2016	Cortot, Alexis B/0000-0003-0098-2238; wong, kwok kin/0000-0001-6323-235X; Engen, John R./0000-0002-6918-9476; Capelletti, Marzia/0000-0001-5095-7060; Chen, Liang/0000-0001-7300-6604	National Institutes of Health [RO1CA11446, R01CA135257, R01CA080942, R01CA130876-02, R01CA116020, R01AG2400401, R01 CA122794, R01GM070590]; National Cancer Institute Lung SPORE [P50CA090578]; Cecily and Robert Harris Foundation; Uniting Against Lung Cancer; Flight Attendant Medical Research Institute; Hazel and Samuel Bellin Research Fund; Damon Runyon Foundation Cancer Innovation Award; NATIONAL CANCER INSTITUTE [R01CA130876, R01CA135257, R01CA122794, P50CA090578, R01CA080942, R01CA116020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Lung SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cecily and Robert Harris Foundation; Uniting Against Lung Cancer; Flight Attendant Medical Research Institute; Hazel and Samuel Bellin Research Fund; Damon Runyon Foundation Cancer Innovation Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by grants from the National Institutes of Health RO1CA11446 ( P. A. J.), R01CA135257 ( P. A. J.), R01CA080942 ( M. J. E.), R01CA130876-02 ( N. S. G.), R01CA116020 ( M. J. E.), R01AG2400401 (K.-K.W.), R01 CA122794 ( K.- K. W.), R01GM070590 ( J. R. E.), National Cancer Institute Lung SPORE P50CA090578 ( P. A. J. and K.- K. W.), the Cecily and Robert Harris Foundation ( K.- K. W.), Uniting Against Lung Cancer ( K.- K. W.), the Flight Attendant Medical Research Institute ( K.- K. W.)., the Hazel and Samuel Bellin Research Fund ( P. A. J.) and the Damon Runyon Foundation Cancer Innovation Award ( N. S. G.). This work is contribution 948 from the Barnett Institute. The authors thank Sai Advantium Pharma for performing the pharmacokinetic studies.	Alam M, 2007, BIOORG MED CHEM LETT, V17, P3463, DOI 10.1016/j.bmcl.2007.03.078; Besse B, 2008, EJC SUPPL, V6, P64, DOI 10.1016/S1359-6349(08)72135-9; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Breault GA, 2003, BIOORG MED CHEM LETT, V13, P2961, DOI 10.1016/S0960-894X(03)00203-8; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Godin-Heymann N, 2008, MOL CANCER THER, V7, P874, DOI 10.1158/1535-7163.MCT-07-2387; Gontarewicz A, 2008, LEUKEMIA RES, V32, P1857, DOI 10.1016/j.leukres.2008.04.012; Hur W, 2008, BIOORG MED CHEM LETT, V18, P5916, DOI 10.1016/j.bmcl.2008.07.062; Janne PA, 2007, J CLIN ONCOL, V25, P3936, DOI 10.1200/JCO.2007.11.1336; Janne PA, 2008, J CLIN ONCOL, V26; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Lietha D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003800; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; O'Hare T, 2008, P NATL ACAD SCI USA, V105, P5507, DOI 10.1073/pnas.0800587105; Ogino A, 2007, CANCER RES, V67, P7807, DOI 10.1158/0008-5472.CAN-07-0681; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Yonesaka K, 2008, CLIN CANCER RES, V14, P6963, DOI 10.1158/1078-0432.CCR-08-0957; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Yuza Y, 2007, CANCER BIOL THER, V6, P661, DOI 10.4161/cbt.6.5.4003	28	758	874	8	182	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1070	1074		10.1038/nature08622	http://dx.doi.org/10.1038/nature08622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	535UB	20033049	Green Accepted			2022-12-28	WOS:000272996000050
J	Ezra, DG; Rose, G; Coombes, A; Plant, G				Ezra, Daniel G.; Rose, Geoff; Coombes, Andrew; Plant, Gordon			Christmas 2009: Diagnosis Animated ophthalmology	BRITISH MEDICAL JOURNAL			English	Editorial Material							EYE		[Ezra, Daniel G.] Moorfields Eye Hosp, Natl Inst Hlth Res, Biomed Res Ctr Ophthalmol, London, England; [Ezra, Daniel G.] UCL Inst Ophthalmol, Dept Cell Biol, London EC1V 9EL, England; [Ezra, Daniel G.; Rose, Geoff; Plant, Gordon] Moorfields Eye Hosp NHS Trust, London EC1V 2PD, England; [Coombes, Andrew] St Bartholomews & Royal London NHS Trust, London E1 1BB, England; [Plant, Gordon] Natl Hosp Neurol & Neurosurg, London, England	University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; University of London; University College London; Moorfields Eye Hospital NHS Foundation Trust; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Ezra, DG (corresponding author), Moorfields Eye Hosp, Natl Inst Hlth Res, Biomed Res Ctr Ophthalmol, London, England.	d.ezra@ucl.ac.uk						Darzi A., 2008, HIGH QUALITY CARE AL; Ertan A, 2006, J CATARACT REFR SURG, V32, P2039, DOI 10.1016/j.jcrs.2006.08.032; Ezra DG, 2008, ORBIT, V27, P55, DOI 10.1080/01676830601174593; Francis BA, 2008, AM J OPHTHALMOL, V146, P741, DOI 10.1016/j.ajo.2008.05.048; Haymes SA, 2009, OPHTHAL EPIDEMIOL, V16, P163, DOI 10.1080/09286580902738167; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Meda N, 2001, J FR OPHTALMOL, V24, P463; Whitnall SE, 1921, ANATOMY HUMAN ORBIT; Yip JLY, 2008, BRIT J OPHTHALMOL, V92, P30, DOI 10.1136/bjo.2007.123471	9	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2009	339								b4948	10.1136/bmj.b4948	http://dx.doi.org/10.1136/bmj.b4948			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534XF	20008441				2022-12-28	WOS:000272930100002
J	Swiezewski, S; Liu, FQ; Magusin, A; Dean, C				Swiezewski, Szymon; Liu, Fuquan; Magusin, Andreas; Dean, Caroline			Cold-induced silencing by long antisense transcripts of an Arabidopsis Polycomb target	NATURE			English	Article							NONCODING RNAS; FLOWERING TIME; FLC; VERNALIZATION; PROTEIN; FCA; NORMALIZATION; METHYLATION; CEREVISIAE; EXPRESSION	Transcription in eukaryotic genomes generates an extensive array of non-protein-coding RNA, the functional significance of which is mostly unknown(1). We are investigating the link between non-coding RNA and chromatin regulation through analysis of FLC - a regulator of flowering time in Arabidopsis and a target of several chromatin pathways. Here we use an unbiased strategy to characterize non-coding transcripts of FLC and show that sense/antisense transcript levels correlate in a range of mutants and treatments, but change independently in cold-treated plants. Prolonged cold epigenetically silences FLC in a Polycomb-mediated process called vernalization(2). Our data indicate that upregulation of long non-coding antisense transcripts covering the entire FLC locus may be part of the cold-sensing mechanism. Induction of these antisense transcripts occurs earlier than, and is independent of, other vernalization markers(3) and coincides with a reduction in sense transcription. We show that addition of the FLC antisense promoter sequences to a reporter gene is sufficient to confer cold-induced silencing of the reporter. Our data indicate that cold-induced FLC antisense transcripts have an early role in the epigenetic silencing of FLC, acting to silence FLC transcription transiently. Recruitment of the Polycomb machinery then confers the epigenetic memory. Antisense transcription events originating from 3' ends of genes might be a general mechanism to regulate the corresponding sense transcription in a condition/stage-dependent manner.	[Swiezewski, Szymon; Liu, Fuquan; Magusin, Andreas; Dean, Caroline] John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Dean, C (corresponding author), John Innes Ctr Plant Sci Res, Norwich NR4 7UH, Norfolk, England.	caroline.dean@bbsrc.ac.uk	Liu, Fuquan/AGD-6751-2022	Swiezewski, Szymon/0000-0002-2007-2779; Dean, Caroline/0000-0002-6555-3525	BBSRC [BB/D010799/1]; NERC [NE/C507629]; EU SIROCCO [LSHG-CT-2006-037900]; BBSRC [BBS/E/J/000CA305] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/J/000CA305, BB/D010799/1] Funding Source: researchfish; Natural Environment Research Council [NE/C507629/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); EU SIROCCO; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank all members of the Dean laboratory for discussions, J. Ecker and B. Gregory (Salk Institute) for help with the RiboMinus technique, C. Lister for help with cloning steps, M. Lenhard and H. Breuninger for seeds of LUC control plants. This research was supported by the BBSRC Core Strategic Grant to the John Innes Centre and BBSRC BB/D010799/1, NERC NE/C507629 and EU SIROCCO LSHG-CT-2006-037900 grants to C. D.	Bastow R, 2004, NATURE, V427, P164, DOI 10.1038/nature02269; BECHTOLD N, 1993, CR ACAD SCI III-VIE, V316, P1194; Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014; Camblong J, 2009, GENE DEV, V23, P1534, DOI 10.1101/gad.522509; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; De Lucia F, 2008, P NATL ACAD SCI USA, V105, P16831, DOI 10.1073/pnas.0808687105; Greb T, 2007, CURR BIOL, V17, P73, DOI 10.1016/j.cub.2006.11.052; HAJDUKIEWICZ P, 1994, PLANT MOL BIOL, V25, P989, DOI 10.1007/BF00014672; He YP, 2008, SCIENCE, V322, P1855, DOI 10.1126/science.1163853; Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009; LEE I, 1994, PLANT J, V6, P903, DOI 10.1046/j.1365-313X.1994.6060903.x; Liu FQ, 2007, MOL CELL, V28, P398, DOI 10.1016/j.molcel.2007.10.018; Macknight R, 1997, CELL, V89, P737, DOI 10.1016/S0092-8674(00)80256-1; Mylne JS, 2006, P NATL ACAD SCI USA, V103, P5012, DOI 10.1073/pnas.0507427103; Oeder S, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-200; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pandey RR, 2008, MOL CELL, V32, P232, DOI 10.1016/j.molcel.2008.08.022; Pelz CR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-520; Petruk S, 2006, CELL, V127, P1209, DOI 10.1016/j.cell.2006.10.039; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Quesada V, 2003, EMBO J, V22, P3142, DOI 10.1093/emboj/cdg305; R Development Core Team, 2006, R LANG ENV STAT COMP; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Sheldon CC, 2009, PLANT J, V59, P488, DOI 10.1111/j.1365-313X.2009.03883.x; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Sung SB, 2004, NATURE, V427, P159, DOI 10.1038/nature02195; Sung SB, 2006, GENE DEV, V20, P3244, DOI 10.1101/gad.1493306; Swiezewski S, 2007, P NATL ACAD SCI USA, V104, P3633, DOI 10.1073/pnas.0611459104; Volker A, 2001, J CELL SCI, V114, P3001; Yamamoto YY, 2003, PLANT J, V35, P273, DOI 10.1046/j.1365-313X.2003.01797.x	32	584	633	8	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					799	U122		10.1038/nature08618	http://dx.doi.org/10.1038/nature08618			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010688				2022-12-28	WOS:000272559900041
J	Parvanov, ED; Petkov, PM; Paigen, K				Parvanov, Emil D.; Petkov, Petko M.; Paigen, Kenneth			Prdm9 Controls Activation of Mammalian Recombination Hotspots	SCIENCE			English	Article							HISTONE H3 METHYLTRANSFERASE; MEIOTIC RECOMBINATION; MOUSE		[Parvanov, Emil D.; Petkov, Petko M.; Paigen, Kenneth] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Petkov, PM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Petko.Petkov@jax.org; Ken.Paigen@jax.org		Parvanov, Emil/0000-0001-6744-0949; Petkov, Petko/0000-0002-6694-9150	NIH [GM 078643, GM 083408, GM 078452, GM 076468, CA 34196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078452, R01GM083408, R01GM078643, P50GM076468] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are indebted to E. Sargent, T. Billings, and G. Gilbert for technical assistance. The work was supported in part by NIH grants GM 078643, 083408, 078452, and 076468 and CA 34196.	Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Neumann R, 2006, HUM MOL GENET, V15, P1401, DOI 10.1093/hmg/ddl063; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Parvanov ED, 2009, PLOS BIOL, V7, P340, DOI 10.1371/journal.pbio.1000036; SHIROISHI T, 1991, EMBO J, V10, P681, DOI 10.1002/j.1460-2075.1991.tb07997.x	9	388	394	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					835	835		10.1126/science.1181495	http://dx.doi.org/10.1126/science.1181495			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20044538	Green Accepted			2022-12-28	WOS:000274408300052
J	Brennecka, GA; Weyer, S; Wadhwa, M; Janney, PE; Zipfel, J; Anbar, AD				Brennecka, G. A.; Weyer, S.; Wadhwa, M.; Janney, P. E.; Zipfel, J.; Anbar, A. D.			U-238/U-235 Variations in Meteorites: Extant Cm-247 and Implications for Pb-Pb Dating	SCIENCE			English	Article							EARLY SOLAR-SYSTEM; ISOTOPIC COMPOSITION; LIVE CM-247; FRACTIONATION; CONDENSATION; AGE; INCLUSIONS; URANIUM; SEARCH; NEBULA	The U-238/U-235 isotope ratio has long been considered invariant in meteoritic materials (equal to 137.88). This assumption is a cornerstone of the high-precision lead-lead dates that define the absolute age of the solar system. Calcium-aluminum-rich inclusions (CAIs) of the Allende meteorite display variable U-238/U-235 ratios, ranging between 137.409 +/- 0.039 and 137.885 +/- 0.009. This range implies substantial uncertainties in the ages that were previously determined by lead-lead dating of CAIs, which may be overestimated by several million years. The correlation of uranium isotope ratios with proxies for curium/uranium (that is, thorium/uranium and neodymium/uranium) provides strong evidence that the observed variations of U-238/U-235 in CAIs were produced by the decay of extant curium-247 to uranium-235 in the early solar system, with an initial Cm-247/U-235 ratio of approximately 1.1 x 10(-4) to 2.4 x 10(-4).	[Brennecka, G. A.; Wadhwa, M.; Janney, P. E.; Anbar, A. D.] Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA; [Weyer, S.] Goethe Univ Frankfurt, Inst Geowissensch, Frankfurt, Germany; [Zipfel, J.] Senckenberg Forsch Inst, Frankfurt, Germany; [Anbar, A. D.] Arizona State Univ, Dept Chem & Biochem, Tempe, AZ 85287 USA; [Zipfel, J.] Natl Museum, Frankfurt, Germany	Arizona State University; Arizona State University-Tempe; Goethe University Frankfurt; Senckenberg Gesellschaft fur Naturforschung (SGN); Arizona State University; Arizona State University-Tempe	Brennecka, GA (corresponding author), Arizona State Univ, Sch Earth & Space Explorat, Tempe, AZ 85287 USA.	brennecka@asu.edu	Janney, Philip/K-2733-2013; Weyer, Stefan/AAA-8827-2020	Janney, Philip/0000-0001-5740-4266; Brennecka, Gregory/0000-0002-0852-5595	NASA Origins of Solar Systems [NNX07AF49G]; NASA Astrobiology Institute [NNA09DA79A]; NASA Exobiology Program [NNX07AU15G]	NASA Origins of Solar Systems(National Aeronautics & Space Administration (NASA)); NASA Astrobiology Institute; NASA Exobiology Program(National Aeronautics & Space Administration (NASA))	We thank the Center for Meteorite Studies at Arizona State University and the Senckenberg Museum in Frankfurt for providing the samples. We thank the W. M. Keck Laboratory for Environmental Biogeochemistry and R. Hines for technical assistance. We are grateful to H. Palme for helpful discussions and to R. Williams and L. Borg for assistance with the double spike. We also thank G. Wasserburg, S. Galer, and an anonymous reviewer for thoughtful comments that greatly improved the manuscript. This work was partially supported by NASA Origins of Solar Systems grant NNX07AF49G to M. W., as well as NASA Astrobiology Institute grant NNA09DA79A and NASA Exobiology Program grant NNX07AU15G to A. D. A.	Amelin Y, 2002, SCIENCE, V297, P1678, DOI 10.1126/science.1073950; ARDEN JW, 1977, NATURE, V269, P788, DOI 10.1038/269788a0; BLAKE JB, 1973, NATURE-PHYS SCI, V243, P138, DOI 10.1038/physci243138a0; Bouvier A, 2007, GEOCHIM COSMOCHIM AC, V71, P1583, DOI 10.1016/j.gca.2006.12.005; BOYNTON WV, 1978, EARTH PLANET SC LETT, V40, P63, DOI 10.1016/0012-821X(78)90074-2; BOYNTON WV, 1975, GEOCHIM COSMOCHIM AC, V39, P569, DOI 10.1016/0016-7037(75)90003-4; Burkhardt C, 2008, GEOCHIM COSMOCHIM AC, V72, P6177, DOI 10.1016/j.gca.2008.10.023; CHEN JH, 1981, EARTH PLANET SC LETT, V52, P1, DOI 10.1016/0012-821X(81)90202-8; CHEN JH, 1980, GEOPHYS RES LETT, V7, P275, DOI 10.1029/GL007i004p00275; DAVIS AM, 1979, GEOCHIM COSMOCHIM AC, V43, P1611, DOI 10.1016/0016-7037(79)90181-9; GRAY CM, 1973, ICARUS, V20, P213, DOI 10.1016/0019-1035(73)90052-3; Jacobsen B, 2008, EARTH PLANET SC LETT, V272, P353, DOI 10.1016/j.epsl.2008.05.003; Lugmair GW, 1998, GEOCHIM COSMOCHIM AC, V62, P2863, DOI 10.1016/S0016-7037(98)00189-6; LUGMAIR GW, 1992, GEOCHIM COSMOCHIM AC, V56, P1673, DOI 10.1016/0016-7037(92)90234-A; MacPherson GJ, 2005, TREATISE GEOCHEM, V1, P201; MASON B, 1982, CONTRIBUTIONS EARTH, V25; NITTLER LR, 2006, METEORITES EARLY SOL, V2, P127; PATTERSON C, 1956, GEOCHIM COSMOCHIM AC, V10, P230, DOI 10.1016/0016-7037(56)90036-9; SHIMAMURA T, 1981, LUNAR PLANET SCI, V12, P976; Stirling CH, 2005, GEOCHIM COSMOCHIM AC, V69, P1059, DOI 10.1016/j.gca.2004.06.034; Stirling CH, 2007, EARTH PLANET SC LETT, V264, P208, DOI 10.1016/j.epsl.2007.09.019; TATSUMOTO M, 1980, NATURE, V286, P118, DOI 10.1038/286118a0; Wasserburg GJ, 2006, NUCL PHYS A, V777, P5, DOI 10.1016/j.nuclphysa.2005.07.015; Weyer S, 2008, GEOCHIM COSMOCHIM AC, V72, P345, DOI 10.1016/j.gca.2007.11.012	25	129	131	1	56	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					449	451		10.1126/science.1180871	http://dx.doi.org/10.1126/science.1180871			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20044543				2022-12-28	WOS:000273783100033
J	David, CJ; Chen, M; Assanah, M; Canoll, P; Manley, JL				David, Charles J.; Chen, Mo; Assanah, Marcela; Canoll, Peter; Manley, James L.			HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer	NATURE			English	Article							TRACT-BINDING-PROTEIN; EXPRESSION; GROWTH; A1; CELLS; GENE; PTB; DIFFERENTIATION; SPECIFICITY; REPRESSION	When oxygen is abundant, quiescent cells efficiently extract energy from glucose primarily by oxidative phosphorylation, whereas under the same conditions tumour cells consume glucose more avidly, converting it to lactate. This long-observed phenomenon is known as aerobic glycolysis(1), and is important for cell growth(2,3). Because aerobic glycolysis is only useful to growing cells, it is tightly regulated in a proliferation-linked manner(4). In mammals, this is partly achieved through control of pyruvate kinase isoform expression. The embryonic pyruvate kinase isoform, PKM2, is almost universally re-expressed in cancer(2), and promotes aerobic glycolysis, whereas the adult isoform, PKM1, promotes oxidative phosphorylation(2). These two isoforms result from mutually exclusive alternative splicing of the PKM pre-mRNA, reflecting inclusion of either exon 9 (PKM1) or exon 10 (PKM2). Here we show that three heterogeneous nuclear ribonucleoprotein (hnRNP) proteins, polypyrimidine tract binding protein (PTB, also known as hnRNPI), hnRNPA1 and hnRNPA2, bind repressively to sequences flanking exon 9, resulting in exon 10 inclusion. We also demonstrate that the oncogenic transcription factor c-Myc upregulates transcription of PTB, hnRNPA1 and hnRNPA2, ensuring a high PKM2/PKM1 ratio. Establishing a relevance to cancer, we show that human gliomas overexpress c-Myc, PTB, hnRNPA1 and hnRNPA2 in a manner that correlates with PKM2 expression. Our results thus define a pathway that regulates an alternative splicing event required for tumour cell proliferation.	[David, Charles J.; Chen, Mo; Manley, James L.] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Assanah, Marcela; Canoll, Peter] Columbia Univ, Dept Pathol & Cell Biol, New York, NY 10032 USA	Columbia University; Columbia University	Manley, JL (corresponding author), Columbia Univ, Dept Biol Sci, New York, NY 10027 USA.	jlm2@columbia.edu		Chen, Mo/0000-0002-6647-8483; Manley, James/0000-0002-8341-1459	Avon Foundation; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM048259] Funding Source: NIH RePORTER	Avon Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Black for BB7 antibody; T. Kashima for hnRNP A1/A2 siRNA; R. Prywes and E. Henckles for C2C12 cells; M. Sheetz and X. Zhang for NIH-3T3 cells; C. Prives, T. Barsotti and L. Biderman for MCF-7 cells, Rb and E2F1 siRNA; R. Dalla-Favera and Q. Shen for anti-c-Myc antibodies and c-Myc expression vector; R. Eisenman for N-Myc antibody; and members of the Manley laboratory for discussions. This work was supported by grants from the Avon Foundation and the NIH.	BIAMONTI G, 1993, J MOL BIOL, V230, P77, DOI 10.1006/jmbi.1993.1127; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Boutz PL, 2007, GENE DEV, V21, P71, DOI 10.1101/gad.1500707; BURD CG, 1994, EMBO J, V13, P1197, DOI 10.1002/j.1460-2075.1994.tb06369.x; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667; Del Gatto-Konczak F, 1999, MOL CELL BIOL, V19, P251; Eilers M, 2008, GENE DEV, V22, P2755, DOI 10.1101/gad.1712408; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Hanamura A, 1998, RNA, V4, P430; HARADA Y, 1995, J BIOCHEM-TOKYO, V118, P780, DOI 10.1093/oxfordjournals.jbchem.a124980; He X, 2007, ONCOGENE, V26, P4961, DOI 10.1038/sj.onc.1210307; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jin W, 2000, CANCER RES, V60, P1221; Kashima T, 2007, HUM MOL GENET, V16, P3149, DOI 10.1093/hmg/ddm276; KRAINER AR, 1984, CELL, V36, P993, DOI 10.1016/0092-8674(84)90049-7; Krummel DAP, 2009, NATURE, V458, P475, DOI 10.1038/nature07851; Martinez-Contreras R, 2006, PLOS BIOL, V4, P172, DOI 10.1371/journal.pbio.0040021; Sauliere J, 2006, MOL CELL BIOL, V26, P8755, DOI 10.1128/MCB.00893-06; Schlosser I, 2005, ONCOGENE, V24, P520, DOI 10.1038/sj.onc.1208198; Shiio Y, 2002, EMBO J, V21, P5088, DOI 10.1093/emboj/cdf525; Spellman R, 2006, TRENDS BIOCHEM SCI, V31, P73, DOI 10.1016/j.tibs.2005.12.003; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Takenaka M, 1996, EUR J BIOCHEM, V235, P366, DOI 10.1111/j.1432-1033.1996.00366.x; WANG T, 1976, NATURE, V261, P702, DOI 10.1038/261702a0; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wu KJ, 2002, ONCOGENE, V21, P7872, DOI 10.1038/sj.onc.1205986; Zerbe LK, 2004, MOL CARCINOGEN, V41, P187, DOI 10.1002/mc.20053; Zheng HW, 2008, NATURE, V455, P1129, DOI 10.1038/nature07443; Zhou J, 2001, BREAST CANCER RES TR, V66, P217, DOI 10.1023/A:1010631915831	31	741	776	5	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					364	U114		10.1038/nature08697	http://dx.doi.org/10.1038/nature08697			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20010808	Green Accepted			2022-12-28	WOS:000273748100046
J	Iglehart, JK				Iglehart, John K.			Nearing Negotiations - Reconciling Key Differences between House and Senate Reform Measures	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3								10.1056/NEJMp0912964	http://dx.doi.org/10.1056/NEJMp0912964			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	545NE	20054036				2022-12-28	WOS:000273738400005
J	Li, RQ; Fan, W; Tian, G; Zhu, HM; He, L; Cai, J; Huang, QF; Cai, QL; Li, B; Bai, YQ; Zhang, ZH; Zhang, YP; Wang, W; Li, J; Wei, FW; Li, H; Jian, M; Li, JW; Zhang, ZL; Nielsen, R; Li, DW; Gu, WJ; Yang, ZT; Xuan, ZL; Ryder, OA; Leung, FCC; Zhou, Y; Cao, JJ; Sun, X; Fu, YG; Fang, XD; Guo, XS; Wang, B; Hou, R; Shen, FJ; Mu, B; Ni, PX; Lin, RM; Qian, WB; Wang, GD; Yu, C; Nie, WH; Wang, JH; Wu, ZG; Liang, HQ; Min, JM; Wu, Q; Cheng, SF; Ruan, J; Wang, MW; Shi, ZB; Wen, M; Liu, BH; Ren, XL; Zheng, HS; Dong, D; Cook, K; Shan, G; Zhang, H; Kosiol, C; Xie, XY; Lu, ZH; Zheng, HC; Li, YR; Steiner, CC; Lam, TTY; Lin, SY; Zhang, QH; Li, GQ; Tian, J; Gong, TM; Liu, HD; Zhang, DJ; Fang, L; Ye, C; Zhang, JB; Hu, WB; Xu, AL; Ren, YY; Zhang, GJ; Bruford, MW; Li, QB; Ma, LJ; Guo, YR; An, N; Hu, YJ; Zheng, Y; Shi, YY; Li, ZQ; Liu, Q; Chen, YL; Zhao, J; Qu, N; Zhao, SC; Tian, F; Wang, XL; Wang, HY; Xu, LZ; Liu, X; Vinar, T; Wang, YJ; Lam, TW; Yiu, SM; Liu, SP; Zhang, HM; Li, DS; Huang, Y; Wang, X; Yang, GH; Jiang, Z; Wang, JY; Qin, N; Li, L; Li, JX; Bolund, L; Kristiansen, K; Wong, GKS; Olson, M; Zhang, XQ; Li, SG; Yang, HM; Wang, J; Wang, J				Li, Ruiqiang; Fan, Wei; Tian, Geng; Zhu, Hongmei; He, Lin; Cai, Jing; Huang, Quanfei; Cai, Qingle; Li, Bo; Bai, Yinqi; Zhang, Zhihe; Zhang, Yaping; Wang, Wen; Li, Jun; Wei, Fuwen; Li, Heng; Jian, Min; Li, Jianwen; Zhang, Zhaolei; Nielsen, Rasmus; Li, Dawei; Gu, Wanjun; Yang, Zhentao; Xuan, Zhaoling; Ryder, Oliver A.; Leung, Frederick Chi-Ching; Zhou, Yan; Cao, Jianjun; Sun, Xiao; Fu, Yonggui; Fang, Xiaodong; Guo, Xiaosen; Wang, Bo; Hou, Rong; Shen, Fujun; Mu, Bo; Ni, Peixiang; Lin, Runmao; Qian, Wubin; Wang, Guodong; Yu, Chang; Nie, Wenhui; Wang, Jinhuan; Wu, Zhigang; Liang, Huiqing; Min, Jiumeng; Wu, Qi; Cheng, Shifeng; Ruan, Jue; Wang, Mingwei; Shi, Zhongbin; Wen, Ming; Liu, Binghang; Ren, Xiaoli; Zheng, Huisong; Dong, Dong; Cook, Kathleen; Shan, Gao; Zhang, Hao; Kosiol, Carolin; Xie, Xueying; Lu, Zuhong; Zheng, Hancheng; Li, Yingrui; Steiner, Cynthia C.; Lam, Tommy Tsan-Yuk; Lin, Siyuan; Zhang, Qinghui; Li, Guoqing; Tian, Jing; Gong, Timing; Liu, Hongde; Zhang, Dejin; Fang, Lin; Ye, Chen; Zhang, Juanbin; Hu, Wenbo; Xu, Anlong; Ren, Yuanyuan; Zhang, Guojie; Bruford, Michael W.; Li, Qibin; Ma, Lijia; Guo, Yiran; An, Na; Hu, Yujie; Zheng, Yang; Shi, Yongyong; Li, Zhiqiang; Liu, Qing; Chen, Yanling; Zhao, Jing; Qu, Ning; Zhao, Shancen; Tian, Feng; Wang, Xiaoling; Wang, Haiyin; Xu, Lizhi; Liu, Xiao; Vinar, Tomas; Wang, Yajun; Lam, Tak-Wah; Yiu, Siu-Ming; Liu, Shiping; Zhang, Hemin; Li, Desheng; Huang, Yan; Wang, Xia; Yang, Guohua; Jiang, Zhi; Wang, Junyi; Qin, Nan; Li, Li; Li, Jingxiang; Bolund, Lars; Kristiansen, Karsten; Wong, Gane Ka-Shu; Olson, Maynard; Zhang, Xiuqing; Li, Songgang; Yang, Huanming; Wang, Jian; Wang, Jun			The sequence and de novo assembly of the giant panda genome	NATURE			English	Article							TASTE RECEPTOR; EVOLUTION; FAMILIES; DNA	Using next-generation sequencing technology alone, we have successfully generated and assembled a draft sequence of the giant panda genome. The assembled contigs (2.25 gigabases (Gb)) cover approximately 94% of the whole genome, and the remaining gaps (0.05 Gb) seem to contain carnivore-specific repeats and tandem repeats. Comparisons with the dog and human showed that the panda genome has a lower divergence rate. The assessment of panda genes potentially underlying some of its unique traits indicated that its bamboo diet might be more dependent on its gut microbiome than its own genetic composition. We also identified more than 2.7 million heterozygous single nucleotide polymorphisms in the diploid genome. Our data and analyses provide a foundation for promoting mammalian genetic research, and demonstrate the feasibility for using next-generation sequencing technologies for accurate, cost-effective and rapid de novo assembly of large eukaryotic genomes.	[Li, Ruiqiang; Fan, Wei; Tian, Geng; Zhu, Hongmei; Huang, Quanfei; Cai, Qingle; Li, Bo; Bai, Yinqi; Li, Jun; Jian, Min; Li, Jianwen; Li, Dawei; Yang, Zhentao; Xuan, Zhaoling; Zhou, Yan; Cao, Jianjun; Fang, Xiaodong; Guo, Xiaosen; Wang, Bo; Mu, Bo; Ni, Peixiang; Lin, Runmao; Qian, Wubin; Yu, Chang; Wu, Zhigang; Liang, Huiqing; Min, Jiumeng; Cheng, Shifeng; Ruan, Jue; Wang, Mingwei; Shi, Zhongbin; Wen, Ming; Liu, Binghang; Ren, Xiaoli; Zheng, Huisong; Shan, Gao; Zhang, Hao; Zheng, Hancheng; Li, Yingrui; Lin, Siyuan; Zhang, Qinghui; Li, Guoqing; Tian, Jing; Gong, Timing; Fang, Lin; Ye, Chen; Zhang, Juanbin; Ren, Yuanyuan; Zhang, Guojie; Li, Qibin; Ma, Lijia; Guo, Yiran; An, Na; Hu, Yujie; Zheng, Yang; Liu, Qing; Chen, Yanling; Zhao, Jing; Qu, Ning; Zhao, Shancen; Tian, Feng; Wang, Xiaoling; Wang, Haiyin; Xu, Lizhi; Liu, Xiao; Wang, Xia; Yang, Guohua; Jiang, Zhi; Wang, Junyi; Qin, Nan; Li, Li; Li, Jingxiang; Bolund, Lars; Kristiansen, Karsten; Wong, Gane Ka-Shu; Zhang, Xiuqing; Li, Songgang; Yang, Huanming; Wang, Jian; Wang, Jun] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Li, Ruiqiang; Kristiansen, Karsten; Wang, Jun] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Tian, Geng; Cai, Jing; Wang, Guodong; Ruan, Jue; Li, Yingrui; Zhang, Guojie; Li, Qibin; Ma, Lijia; Guo, Yiran; Hu, Yujie; Zheng, Yang] Chinese Acad Sci, Grad Univ, Beijing 100062, Peoples R China; [He, Lin] Fudan Univ, Inst Biomed Sci, Shanghai 200032, Peoples R China; [He, Lin; Shi, Yongyong; Li, Zhiqiang] Shanghai Jiao Tong Univ, Minist Educ, Key Lab Genet Dev & Neuropsychiat Disorders, BioX Ctr, Shanghai 200030, Peoples R China; [Cai, Jing; Zhang, Yaping; Wang, Wen; Wang, Guodong; Nie, Wenhui; Wang, Jinhuan; Zhang, Guojie] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Peoples R China; [Cai, Qingle; Min, Jiumeng; Cheng, Shifeng; Qu, Ning] Shenzhen Univ, Sch Med, Genome Res Inst, Shenzhen 518000, Peoples R China; [Zhang, Zhihe; Hou, Rong; Shen, Fujun] Chengdu Res Base Giant Panda Breeding, Chengdu 610081, Peoples R China; [Wei, Fuwen; Wu, Qi] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing 100101, Peoples R China; [Li, Heng] Wellcome Trust Genome Campus, Cambridge CB10 1SA, England; [Zhang, Zhaolei; Dong, Dong; Cook, Kathleen] Univ Toronto, Dept Mol Genet, Banting & Best Dept Med Res, Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Nielsen, Rasmus] Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA; [Gu, Wanjun; Xie, Xueying; Lu, Zuhong] Southeast Univ, Minist Educ, Key Lab Child Dev & Learning Sci, Nanjing 210096, Peoples R China; [Ryder, Oliver A.; Steiner, Cynthia C.] San Diego Zoos Inst Conservat Res, Escondido, CA 92027 USA; [Leung, Frederick Chi-Ching; Lam, Tommy Tsan-Yuk] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Sun, Xiao; Liu, Hongde; Zhang, Dejin] Southeast Univ, State Key Lab Bioelect, Nanjing 210096, Peoples R China; [Fu, Yonggui; Hu, Wenbo; Xu, Anlong] Sun Yat Sen Univ, Coll Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Kosiol, Carolin] Vet Med Univ Wien, Inst Populat Genet, A-1210 Vienna, Austria; [Bruford, Michael W.] Cardiff Univ, Cardiff Sch Biosci, Biodivers & Ecol Proc Grp, Cardiff CF10 3AX, Wales; [Vinar, Tomas] Comenius Univ, Dept Appl Informat, Fac Math Phys & Informat, Bratislava 84248, Slovakia; [Wang, Yajun] Sichuan Univ, Sch Life Sci, Chengdu 610064, Peoples R China; [Lam, Tak-Wah; Yiu, Siu-Ming] Univ Hong Kong, Dept Comp Sci, Hong Kong, Hong Kong, Peoples R China; [Liu, Shiping] S China Univ Technol, Guangzhou 510641, Peoples R China; [Zhang, Hemin; Li, Desheng; Huang, Yan] China Conservat & Res Ctr Giant Panda, Wolong Nat Reserve 623006, Peoples R China; [Wong, Gane Ka-Shu] Univ Alberta, Dept Med, Edmonton, AB T6G 2E9, Canada; [Wong, Gane Ka-Shu] Univ Alberta, Dept Biol Sci, Edmonton, AB T6G 2E9, Canada; [Olson, Maynard] Univ Washington, Genome Ctr, Seattle, WA USA	Beijing Genomics Institute (BGI); University of Copenhagen; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Fudan University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Kunming Institute of Zoology; Shenzhen University; Chinese Academy of Sciences; Institute of Zoology, CAS; Wellcome Trust Sanger Institute; University of Toronto; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Southeast University - China; Zoological Society of San Diego; University of Hong Kong; Southeast University - China; Sun Yat Sen University; University of Veterinary Medicine Vienna; Cardiff University; Comenius University Bratislava; Sichuan University; University of Hong Kong; South China University of Technology; University of Alberta; University of Alberta; University of Washington; University of Washington Seattle	Wang, J (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.	wangjian@genomics.org.cn; wangj@genomics.org.cn	WONG, Gane Ka-Shu/G-5784-2013; Li, Yingrui/K-1064-2015; Vinar, Tomas/I-3695-2014; wang, junyi/GYA-3213-2022; Shi, Yongyong/GSO-1627-2022; Gu, Wanjun/P-5389-2019; Lu, Zuhong/A-5448-2013; Yu, Chang/AAE-8538-2019; Gu, Wanjun/B-3998-2010; Guo, Yiran/H-4120-2011; Li, Heng/D-9344-2011; Fang, Xiaodong/K-6743-2018; Bruford, Michael W/D-3750-2009; Li, Zhiqiang/AAI-4003-2021; Lin, Runmao/I-5049-2014; Bruford, Michael/Y-7463-2019; Zhang, Guojie/B-6188-2014; chen, yanling/GRE-8287-2022; Yiu, Siu Ming/C-1843-2009; Liu, Xiao/P-2732-2015; Kristiansen, Karsten/J-5148-2014; Nielsen, Rasmus/D-4405-2009; Zhang, Guojie/J-7273-2019; Lam, Tsan Yuk/D-4837-2012; Wang, Jun/C-8434-2016; Wang, Jun/B-9503-2016	WONG, Gane Ka-Shu/0000-0001-6108-5560; Vinar, Tomas/0000-0003-3898-3447; Shi, Yongyong/0000-0003-1710-1505; Gu, Wanjun/0000-0003-4501-0539; Li, Heng/0000-0003-4874-2874; Fang, Xiaodong/0000-0001-7061-3337; Bruford, Michael W/0000-0001-6357-6080; Li, Zhiqiang/0000-0002-0174-9254; Lin, Runmao/0000-0003-1999-0035; Bruford, Michael/0000-0001-6357-6080; Zhang, Guojie/0000-0001-6860-1521; Yiu, Siu Ming/0000-0002-3975-8500; Liu, Xiao/0000-0002-8073-0534; Kristiansen, Karsten/0000-0002-6024-0917; Nielsen, Rasmus/0000-0003-0513-6591; Zhang, Guojie/0000-0001-6860-1521; Cai, Jing/0000-0002-2496-4731; Cook, Kate/0000-0002-0174-1113; Fan, Wei/0000-0001-5036-8733; Lam, Tsan Yuk/0000-0002-9769-1527; Ruan, Jue/0000-0003-3713-3192; Wang, Jun/0000-0002-8540-8931; Lam, Tak-Wah/0000-0003-4676-8587; liu, bh/0000-0002-4948-2835; Wang, Jun/0000-0002-2113-5874; Lu, Zuhong/0000-0003-3332-2615; Li, Jun/0000-0001-7218-429X; LIU, Shiping/0000-0003-0019-619X	Shenzhen Municipal Government; Yantian District local government of Shenzhen; National Natural Science Foundation of China [30725008]; Danish Natural Science Research Council; Solexa project [272-07-0196]; Danish Strategic Research Council [2106-07-0021]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003229] Funding Source: NIH RePORTER	Shenzhen Municipal Government; Yantian District local government of Shenzhen; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Danish Natural Science Research Council(Danish Natural Science Research Council); Solexa project; Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We are indebted to the faculty and staff of Beijing Genomics Institute at Shenzhen, whose names were not included in the author list, but who contributed to this team work. This project is funded by the Shenzhen Municipal Government and the Yantian District local government of Shenzhen. This project is supported by the National Natural Science Foundation of China (30725008), Ole Romer grant from the Danish Natural Science Research Council, the Solexa project (272-07-0196), and Danish Strategic Research Council (2106-07-0021). We thank C. Wang, X. Huang and L. Luo for their assistance in collecting the blood sample. We thank D. D. Pollock for repeat content estimation. We thank M. Shi, Y. Wang and M. Ting Wong for analysis of the reproduction related genes. We also thank L. Goodman for editing the manuscript.	Alexeyenko A, 2006, BIOINFORMATICS, V22, pE9, DOI 10.1093/bioinformatics/btl213; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chandrashekar J, 2000, CELL, V100, P703, DOI 10.1016/S0092-8674(00)80706-0; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Donnelly P, 1995, ANNU REV GENET, V29, P401, DOI 10.1146/annurev.ge.29.120195.002153; Go Y, 2006, MOL BIOL EVOL, V23, P964, DOI 10.1093/molbev/msj106; Jurka J, 2005, CYTOGENET GENOME RES, V110, P462, DOI 10.1159/000084979; Kapitonov VV, 2008, NAT REV GENET, V9, DOI 10.1038/nrg2165-c1; Kosiol C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000144; Krause J, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-220; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Li RQ, 2009, GENOME RES, V19, P1124, DOI 10.1101/gr.088013.108; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Nash WG, 1998, CYTOGENET CELL GENET, V83, P182, DOI 10.1159/000015176; Nei M, 2005, ANNU REV GENET, V39, P121, DOI 10.1146/annurev.genet.39.073003.112240; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Nicholas TJ, 2009, GENOME RES, V19, P491, DOI 10.1101/gr.084715.108; Nielsen R, 2005, PLOS BIOL, V3, P976, DOI 10.1371/journal.pbio.0030170; Pevzner PA, 2001, P NATL ACAD SCI USA, V98, P9748, DOI 10.1073/pnas.171285098; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Stanke M, 2003, BIOINFORMATICS, V19, pII215, DOI 10.1093/bioinformatics/btg1080; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957; Yasuo T, 2008, BIOL PHARM BULL, V31, P1833, DOI 10.1248/bpb.31.1833; Yu J, 2005, PLOS BIOL, V3, P266, DOI 10.1371/journal.pbio.0030038; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042; Zhang BW, 2007, MOL BIOL EVOL, V24, P1801, DOI 10.1093/molbev/msm099; Zheng Y, 2010, SCI CHINA LIFE SCI, V53, P107, DOI 10.1007/s11427-010-0001-z	30	796	919	12	549	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					311	317		10.1038/nature08696	http://dx.doi.org/10.1038/nature08696			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20010809	Green Accepted, hybrid			2022-12-28	WOS:000273748100035
J	Shizuka, D; Lyon, BE				Shizuka, Daizaburo; Lyon, Bruce E.			Coots use hatch order to learn to recognize and reject conspecific brood parasitic chicks	NATURE			English	Article							AVIAN EGG-RECOGNITION; AMERICAN COOTS; HOST-DEFENSE; ARMS-RACE; MODEL; EVOLUTION; DISCRIMINATION; COEVOLUTION; MECHANISMS; NESTLINGS	Avian brood parasites and their hosts provide model systems for investigating links between recognition, learning, and their fitness consequences(1-4). One major evolutionary puzzle has continued to capture the attention of naturalists for centuries: why do hosts of brood parasites generally fail to recognize parasitic offspring after they have hatched from the egg(5-9), even when the host and parasitic chicks differ to almost comic degrees(7)? One prominent theory to explain this pattern proposes that the costs of mistakenly learning to recognize the wrong offspring make recognition maladaptive(10). Here we show that American coots, Fulica americana, can recognize and reject parasitic chicks in their brood by using learned cues, despite the fact that the hosts and the brood parasites are of the same species. A series of chick cross-fostering experiments confirm that coots use first-hatched chicks in a brood as referents to learn to recognize their own chicks and then discriminate against later-hatched parasitic chicks in the same brood. When experimentally provided with the wrong reference chicks, coots can be induced to discriminate against their own offspring, confirming that the learning errors proposed by theory can exist(10). However, learning based on hatching order is reliable in naturally parasitized coot nests because host eggs hatch predictably ahead of parasite eggs. Conversely, a lack of reliable information may help to explain why the evolution of chick recognition is not more common in hosts of most interspecific brood parasites.	[Shizuka, Daizaburo; Lyon, Bruce E.] Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA	University of California System; University of California Santa Cruz	Shizuka, D (corresponding author), Univ Calif Santa Cruz, Dept Ecol & Evolutionary Biol, Santa Cruz, CA 95064 USA.	shizuka@biology.ucsc.edu	Lyon, Bruce E/E-8491-2011		National Geographic Society; National Science Foundation [DDIG IOS-0808579, IOS 0443807]; Chapman Fund; Sigma Xi Society	National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); Chapman Fund; Sigma Xi Society	We thank J. Herrick and W. Messner for access to their property; B. Bair, L. Cargill, E. Clancey, J. Clark, J. Click, R. Drobek, S. Everding, K. Funk, J. Garcia, L. Hamilton, D. Hansen, E. Hoosier, M. Magrath, J. Melhaff, C. Morrill, C. Nelson, A. O'Brien, L. Orr, G. Peters, G. Taylor, K. Tjernell and J. Sapp for assistance in the field; B. Sinervo for advice on the study design; J. Eadie, A. Lotem, D. Mock, R. Montgomerie, R. Mulder, K. Wasson and A. Zink for helpful comments on the paper; and P. Raimondi and R. Montgomerie for statistical advice. Funding was provided by the National Geographic Society, the National Science Foundation (DDIG IOS-0808579 to D. S., and IOS 0443807 to B. E. L.), the Chapman Fund and the Sigma Xi Society. Fieldwork was conducted under permits from the Canadian Wildlife Service and the University of California, Santa Cruz, Institutional Animal Care and Use Committee.	Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; BRISKIE JV, 1990, AUK, V107, P789, DOI 10.2307/4088016; Britton NF, 2007, B MATH BIOL, V69, P957, DOI 10.1007/s11538-006-9178-5; Davies N. B, 2000, COWBIRDS OTHER CHEAT; DAVIES NB, 1988, ANIM BEHAV, V36, P262, DOI 10.1016/S0003-3472(88)80269-0; Davies NB, 2009, SCIENCE, V324, P1318, DOI 10.1126/science.1172227; DAWKINS R, 1979, PROC R SOC SER B-BIO, V205, P489, DOI 10.1098/rspb.1979.0081; Foley D. D., 1956, NY FISH GAME J, V3, P240; Grim T, 2006, EVOL ECOL RES, V8, P785; GULLION GORDON W., 1950, CONDOR, V52, P272; HORSFALL JA, 1984, ANIM BEHAV, V32, P216, DOI 10.1016/S0003-3472(84)80340-1; Jenner E, 1788, PHILOS T ROY SOC LON, V78, P219, DOI DOI 10.1098/RSTL.1788.0016; Langmore NE, 2009, BEHAV ECOL, V20, P978, DOI 10.1093/beheco/arp086; Langmore NE, 2003, NATURE, V422, P157, DOI 10.1038/nature01460; Lawes MJ, 2003, BEHAV ECOL, V14, P757, DOI 10.1093/beheco/arg068; LOTEM A, 1995, ANIM BEHAV, V49, P1185, DOI 10.1006/anbe.1995.0152; LOTEM A, 1993, NATURE, V362, P743, DOI 10.1038/362743a0; LYON BE, 1994, NATURE, V371, P240, DOI 10.1038/371240a0; LYON BE, 1993, ANIM BEHAV, V46, P911, DOI 10.1006/anbe.1993.1273; Lyon BE, 2002, EVOLUTION, V56, P1253, DOI 10.1111/j.0014-3820.2002.tb01436.x; Lyon BE, 2003, NATURE, V422, P495, DOI 10.1038/nature01505; LYON BE, 1993, BEHAV ECOL SOCIOBIOL, V33, P87; Lyon BE, 2008, ANNU REV ECOL EVOL S, V39, P343, DOI 10.1146/annurev.ecolsys.39.110707.173354; R Core Team, 2020, R LANG ENV STAT COMP; Reed WL, 2009, AM NAT, V174, P685, DOI 10.1086/605962; Rodriguez-Girones MA, 1999, AM NAT, V153, P633, DOI 10.1086/303198; ROTHSTEIN SI, 1982, AM ZOOL, V22, P547; ROTHSTEIN SI, 1990, ANNU REV ECOL SYST, V21, P481, DOI 10.1146/annurev.es.21.110190.002405; ROTHSTEIN SI, 1978, ANIM BEHAV, V26, P671, DOI 10.1016/0003-3472(78)90133-1; ROTHSTEIN SI, 1975, CONDOR, V77, P250, DOI 10.2307/1366221; ROTHSTEIN SI, 1974, AUK, V91, P796, DOI 10.2307/4084731; Sato NJ, 2010, BIOL LETTERS, V6, P67, DOI 10.1098/rsbl.2009.0540; Soler M, 2009, J AVIAN BIOL, V40, P237, DOI 10.1111/j.1600-048X.2009.04676.x; Strausberger BM, 2009, BEHAV ECOL, V20, P691, DOI 10.1093/beheco/arp042	34	62	65	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 14	2010	463	7278					223	U108		10.1038/nature08655	http://dx.doi.org/10.1038/nature08655			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20016486	Green Published			2022-12-28	WOS:000273582700034
J	Chow, BY; Han, X; Dobry, AS; Qian, XF; Chuong, AS; Li, MJ; Henninger, MA; Belfort, GM; Lin, YX; Monahan, PE; Boyden, ES				Chow, Brian Y.; Han, Xue; Dobry, Allison S.; Qian, Xiaofeng; Chuong, Amy S.; Li, Mingjie; Henninger, Michael A.; Belfort, Gabriel M.; Lin, Yingxi; Monahan, Patrick E.; Boyden, Edward S.			High-performance genetically targetable optical neural silencing by light-driven proton pumps	NATURE			English	Article							IN-VIVO; MILLISECOND-TIMESCALE; CLAMP ANALYSIS; PH-DEPENDENCE; BACTERIORHODOPSIN; NEURONS; HALORHODOPSIN; RHODOPSINS; BRAIN; ARCHAERHODOPSIN	The ability to silence the activity of genetically specified neurons in a temporally precise fashion would provide the opportunity to investigate the causal role of specific cell classes in neural computations, behaviours and pathologies. Here we show that members of the class of light-driven outward proton pumps can mediate powerful, safe, multiple-colour silencing of neural activity. The gene archaerhodopsin-3 (Arch)(1) from Halorubrum sodomense enables near-100% silencing of neurons in the awake brain when virally expressed in the mouse cortex and illuminated with yellow light. Arch mediates currents of several hundred picoamps at low light powers, and supports neural silencing currents approaching 900 pA at light powers easily achievable in vivo. Furthermore, Arch spontaneously recovers from light-dependent inactivation, unlike light-driven chloride pumps that enter long-lasting inactive states in response to light. These properties of Arch are appropriate to mediate the optical silencing of significant brain volumes over behaviourally relevant timescales. Arch function in neurons is well tolerated because pH excursions created by Arch illumination are minimized by self-limiting mechanisms to levels comparable to those mediated by channelrhodopsins(2,3) or natural spike firing. To highlight how proton pump ecological and genomic diversity may support new innovation, we show that the blue-green light-drivable proton pump from the fungus Leptosphaeria maculans(4) (Mac) can, when expressed in neurons, enable neural silencing by blue light, thus enabling alongside other developed reagents the potential for independent silencing of two neural populations by blue versus red light. Light-driven proton pumps thus represent a high-performance and extremely versatile class of 'optogenetic' voltage and ion modulator, which will broadly enable new neuro-scientific, biological, neurological and psychiatric investigations.	[Chow, Brian Y.; Han, Xue; Dobry, Allison S.; Qian, Xiaofeng; Chuong, Amy S.; Li, Mingjie; Henninger, Michael A.; Monahan, Patrick E.; Boyden, Edward S.] MIT, Media Lab, Synthet Neurobiol Grp, Cambridge, MA 02139 USA; [Chow, Brian Y.; Han, Xue; Dobry, Allison S.; Qian, Xiaofeng; Chuong, Amy S.; Li, Mingjie; Henninger, Michael A.; Monahan, Patrick E.; Boyden, Edward S.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chow, Brian Y.; Han, Xue; Dobry, Allison S.; Qian, Xiaofeng; Chuong, Amy S.; Li, Mingjie; Henninger, Michael A.; Belfort, Gabriel M.; Lin, Yingxi; Monahan, Patrick E.; Boyden, Edward S.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Chow, Brian Y.; Han, Xue; Dobry, Allison S.; Qian, Xiaofeng; Chuong, Amy S.; Li, Mingjie; Henninger, Michael A.; Belfort, Gabriel M.; Lin, Yingxi; Monahan, Patrick E.; Boyden, Edward S.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Boyden, ES (corresponding author), MIT, Media Lab, Synthet Neurobiol Grp, Cambridge, MA 02139 USA.	esb@media.mit.edu		/0000-0002-7002-1275; Li, Mingjie/0000-0001-5337-4901	NIH [DP2 OD002002-01, 1K99MH085944]; NSF [0835878, 0848804]; McGovern Institute Neurotechnology; Department of Defense, NARSAD; Alfred P. Sloan Foundation, Jerry and Marge Burnett; SFN Research Award for Innovation in Neuroscience; MIT Media Lab; Benesse Foundation; Wallace H. Coulter Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH085944] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002002] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); McGovern Institute Neurotechnology; Department of Defense, NARSAD(NARSADUnited States Department of Defense); Alfred P. Sloan Foundation, Jerry and Marge Burnett(Alfred P. Sloan Foundation); SFN Research Award for Innovation in Neuroscience; MIT Media Lab; Benesse Foundation; Wallace H. Coulter Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	E. S. B. acknowledges funding by the NIH Director's New Innovator Award (DP2 OD002002-01), as well as the NSF (0835878 and 0848804), the McGovern Institute Neurotechnology Award Program, the Department of Defense, NARSAD, the Alfred P. Sloan Foundation, Jerry and Marge Burnett, the SFN Research Award for Innovation in Neuroscience, the MIT Media Lab, the Benesse Foundation, and the Wallace H. Coulter Foundation. X. H. acknowledges the Helen Hay Whitney Foundation and NIH 1K99MH085944. The authors thank E. Klinman for help with transfections, R. Desimone for advice, J. Lin for technical aid on intracellular pH measurements, K. Ihara for discussions about archaerhodopsins, and M. Hemann and N. Gershenfeld and the Center for Bits and Atoms for use of their respective laboratory facilities.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; BAMBERG E, 1993, P NATL ACAD SCI USA, V90, P639, DOI 10.1073/pnas.90.2.639; BERNSTEIN JG, 2008, P SOC PHOTOOPT INSTR, V6854; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Bevensee MO, 1996, J PHYSIOL-LONDON, V494, P315, DOI 10.1113/jphysiol.1996.sp021494; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Enamil N, 2006, J MOL BIOL, V358, P675, DOI 10.1016/j.jmb.2006.02.032; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; Klare Johann P., 2008, V45, P73, DOI 10.1007/400_2007_041; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; LUKASHEV EP, 1994, PHOTOCHEM PHOTOBIOL, V60, P69, DOI 10.1111/j.1751-1097.1994.tb03945.x; Meyer TM, 2000, NEUROREPORT, V11, P33, DOI 10.1097/00001756-200001170-00007; Ming M, 2006, BIOPHYS J, V90, P3322, DOI 10.1529/biophysj.105.076547; MOGI T, 1989, J BIOL CHEM, V264, P14197; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Narikawa K, 2000, J NEUROPHYSIOL, V84, P2171, DOI 10.1152/jn.2000.84.4.2171; Richter DW, 1996, J NEUROSCI METH, V67, P121, DOI 10.1016/0165-0270(96)00042-8; TATENO M, 1994, ARCH BIOCHEM BIOPHYS, V315, P127, DOI 10.1006/abbi.1994.1480; Trapp S, 1996, J PHYSIOL-LONDON, V496, P695, DOI 10.1113/jphysiol.1996.sp021720; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	30	807	877	4	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					98	102		10.1038/nature08652	http://dx.doi.org/10.1038/nature08652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054397	Green Accepted, Green Submitted			2022-12-28	WOS:000273344900038
J	Schwickart, M; Huang, XD; Lill, JR; Liu, JF; Ferrando, R; French, DM; Maecker, H; O'Rourke, K; Bazan, F; Eastham-Anderson, J; Yue, P; Dornan, D; Huang, DCS; Dixit, VM				Schwickart, Martin; Huang, XiaoDong; Lill, Jennie R.; Liu, Jinfeng; Ferrando, Ronald; French, Dorothy M.; Maecker, Heather; O'Rourke, Karen; Bazan, Fernando; Eastham-Anderson, Jeffrey; Yue, Peng; Dornan, David; Huang, David C. S.; Dixit, Vishva M.			Deubiquitinase USP9X stabilizes MCL1 and promotes tumour cell survival	NATURE			English	Article							MULTIPLE-MYELOMA; BCL-2 FAMILY; UBIQUITIN LIGASE; BREAST-CANCER; IN-VITRO; APOPTOSIS; EXPRESSION; PROTEINS; PATHWAY; ACTIVATION	MCL1 is essential for the survival of stem and progenitor cells of multiple lineages(1,2), and is unique among pro-survival BCL2 family members in that it is rapidly turned over through the action of ubiquitin ligases(3-6). B-and mantle-cell lymphomas, chronic myeloid leukaemia, and multiple myeloma(7-9), however, express abnormally high levels of MCL1, contributing to chemoresistance and disease relapse. The mechanism of MCL1 overexpression in cancer is not well understood. Here we show that the deubiquitinase USP9X stabilizes MCL1 and thereby promotes cell survival. USP9X binds MCL1 and removes the Lys 48-linked polyubiquitin chains that normally mark MCL1 for proteasomal degradation. Increased USP9X expression correlates with increased MCL1 protein in human follicular lymphomas and diffuse large B-cell lymphomas. Moreover, patients with multiple myeloma overexpressing USP9X have a poor prognosis. Knockdown of USP9X increases MCL1 polyubiquitination, which enhances MCL1 turnover and cell killing by the BH3 mimetic ABT-737. These results identify USP9X as a prognostic and therapeutic target, and they show that deubiquitinases may stabilize labile oncoproteins in human malignancies.	[Schwickart, Martin; Huang, XiaoDong; O'Rourke, Karen; Dixit, Vishva M.] Genentech Inc, Dept Physiol Chem, San Francisco, CA 94080 USA; [Lill, Jennie R.] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Liu, Jinfeng; Yue, Peng] Genentech Inc, Dept Bioinformat, San Francisco, CA 94080 USA; [Ferrando, Ronald; French, Dorothy M.; Eastham-Anderson, Jeffrey] Genentech Inc, Dept Pathol, San Francisco, CA 94080 USA; [Bazan, Fernando] Genentech Inc, Dept Prot Engn, San Francisco, CA 94080 USA; [Maecker, Heather] Genentech Inc, Dept Translat Oncol, San Francisco, CA 94080 USA; [Dornan, David] Genentech Inc, Dept Res Oncol Diagnost, San Francisco, CA 94080 USA; [Huang, David C. S.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia	Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Roche Holding; Genentech; Royal Melbourne Hospital; Walter & Eliza Hall Institute	Dixit, VM (corresponding author), Genentech Inc, Dept Physiol Chem, 1 DNA Way, San Francisco, CA 94080 USA.	dixit@gene.com	Huang, David C. S./C-7586-2013; dixit, vishva m/A-4496-2012; Bazan, J. Fernando/B-4562-2010	Huang, David C. S./0000-0002-3101-4873; dixit, vishva m/0000-0001-6983-0326; Maecker, Heather/0000-0002-5378-1141; Liu, Jinfeng/0000-0002-0343-8222				Austin M, 2005, J BIOL CHEM, V280, P33280, DOI 10.1074/jbc.M508187200; Brey EM, 2003, J HISTOCHEM CYTOCHEM, V51, P575, DOI 10.1177/002215540305100503; Carrasco DR, 2006, CANCER CELL, V9, P313, DOI 10.1016/j.ccr.2006.03.019; Cuconati A, 2003, GENE DEV, V17, P2922, DOI 10.1101/gad.1156903; Ding QQ, 2008, CANCER RES, V68, P6109, DOI 10.1158/0008-5472.CAN-08-0579; Ding QQ, 2007, CANCER RES, V67, P4564, DOI 10.1158/0008-5472.CAN-06-1788; Domina AM, 2004, ONCOGENE, V23, P5301, DOI 10.1038/sj.onc.1207692; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang DCS, 1997, ONCOGENE, V14, P405, DOI 10.1038/sj.onc.1200848; Hummel M, 2006, NEW ENGL J MED, V354, P2419, DOI 10.1056/NEJMoa055351; Jourdan M, 2003, ONCOGENE, V22, P2950, DOI 10.1038/sj.onc.1206423; Kaufmann SH, 1998, BLOOD, V91, P991, DOI 10.1182/blood.V91.3.991.991_991_1000; Kitada S, 1998, BLOOD, V91, P3379, DOI 10.1182/blood.V91.9.3379; Maurer U, 2006, MOL CELL, V21, P749, DOI 10.1016/j.molcel.2006.02.009; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Nijhawan D, 2003, GENE DEV, V17, P1475, DOI 10.1101/gad.1093903; Oda E, 2000, SCIENCE, V288, P1053, DOI 10.1126/science.288.5468.1053; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Opferman JT, 2003, NATURE, V426, P671, DOI 10.1038/nature02067; Opferman JT, 2005, SCIENCE, V307, P1101, DOI 10.1126/science.1106114; Tahir SK, 2007, CANCER RES, V67, P1176, DOI 10.1158/0008-5472.CAN-06-2203; van Delft MF, 2006, CANCER CELL, V10, P389, DOI 10.1016/j.ccr.2006.08.027; Wang JM, 2003, MOL CELL BIOL, V23, P1896, DOI 10.1128/MCB.23.6.1896-1909.2003; Warr MR, 2008, CURR MOL MED, V8, P138; Wood SA, 1997, MECH DEVELOP, V63, P29, DOI 10.1016/S0925-4773(97)00672-2; Wuilleme-Toumi S, 2005, LEUKEMIA, V19, P1248, DOI 10.1038/sj.leu.2403784; Zhan F, 2006, BLOOD, V108, P2020, DOI 10.1182/blood-2005-11-013458; Zhao Y, 2007, MOL CELL BIOL, V27, P4328, DOI 10.1128/MCB.00153-07; Zhong Q, 2005, CELL, V121, P1085, DOI 10.1016/j.cell.2005.06.009	31	475	493	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					103	U114		10.1038/nature08646	http://dx.doi.org/10.1038/nature08646			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20023629				2022-12-28	WOS:000273344900039
J	Katan, MB; Ludwig, DS				Katan, Martijn B.; Ludwig, David S.			Extra Calories Cause Weight Gain-But How Much?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Katan, Martijn B.] Vrije Univ Amsterdam, Inst Hlth Sci, NL-1081 HV Amsterdam, Netherlands; [Ludwig, David S.] Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA	Vrije Universiteit Amsterdam; Harvard University; Boston Children's Hospital	Katan, MB (corresponding author), Vrije Univ Amsterdam, Inst Hlth Sci, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	katan99@falw.vu.nl	Katan, Martijn/ABB-6613-2021	Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Goldsmith R, 2010, AM J PHYSIOL-REG I, V298, pR79, DOI 10.1152/ajpregu.00053.2009; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; Hall KD, 2008, AM J CLIN NUTR, V88, P1495, DOI 10.3945/ajcn.2008.26333; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; Mc Dowell MA, 2005, ADV DATA, V361, P1; OGDEN CL, 2004, ADV DATA, V347, P1, DOI DOI 10.1377/HLTHAFF.28.5.W822; Shils ME, 2006, MODERN NUTR HLTH DIS, P982; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Wang YC, 2006, PEDIATRICS, V118, pE1721, DOI 10.1542/peds.2006-0682; WEINSIER RL, 1993, INT J OBESITY, V17, P693	10	67	68	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2010	303	1					65	66		10.1001/jama.2009.1912	http://dx.doi.org/10.1001/jama.2009.1912			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539YS	20051571	Green Published			2022-12-28	WOS:000273296900021
J	Nachega, JB; Leisegang, R; Bishai, D; Nguyen, H; Hislop, M; Cleary, S; Regensberg, L; Maartens, G				Nachega, Jean B.; Leisegang, Rory; Bishai, David; Nguyen, Hoang; Hislop, Michael; Cleary, Susan; Regensberg, Leon; Maartens, Gary			Association of Antiretroviral Therapy Adherence and Health Care Costs	ANNALS OF INTERNAL MEDICINE			English	Article							RESOURCE-LIMITED SETTINGS; HIV-INFECTED PATIENTS; PHARMACY RECORDS; VIRAL LOAD; BASE-LINE; 1ST YEAR; RESISTANCE; MORTALITY; SURVIVAL; OUTCOMES	Background: Antiretroviral therapy (ART) adherence predicts HIV disease progression and survival, but its effect on direct health care costs is unclear. Objective: To determine the effect of ART adherence on direct health care costs among adults in a resource-limited setting. Design: Cohort study. Setting: Aid for AIDS, a private-sector disease management program in South Africa. Patients: 6833 HIV-infected adults who started ART between 6 August 2000 and 30 April 2006. Measurements: Monthly direct health care costs authorized by Aid for AIDS were averaged over all months. Pharmacy claim adherence, expressed as a percentage, was categorized into quartiles, from 1 (lowest) to 4 (highest). Effects of covariates on monthly total costs were assessed with a 2-step model with logit for probability of nonzero costs and a generalized linear model (GLM). Results: Total mean monthly costs were $370 (SD, $644). Mean monthly costs of ART were $32 (SD, $18); hospitalizations, $151 (SD, $436); consultations, $76 (SD, $66); investigations, $37 (SD, $50); and non-ART medications, $53 (SD, $180). Total mean monthly costs ranged from $313 (SD, $598) for quartile 4 to $376 (SD, $657) for quartile 1. Hospitalization costs increased from 29% to 51% of total costs as adherence decreased. In the GLM 2-step model, moving from adherence quartile 1 to quartile 2, 3, or 4 increased the probability of having nonzero total monthly costs by 0.078, 0.15, and 0.21 percentage point, respectively (P < 0.001). For patients with nonzero costs, increasing adherence from quartile 1 to quartile 2, 3, or 4 decreased total monthly costs by $70, $133, and $192, respectively (P < 0.001). Moving from adherence quartiles 1 to 4 had the highest decrease in net overall median monthly health care costs (-$85 [interquartile range,-$116 to-$41]). Limitations: Indirect health care costs were not included. Experience may not reflect that of public HIV/AIDS programs. Conclusion: High ART adherence was associated with lower mean monthly direct health care costs, particularly reduced hospitalization costs, in this South African HIV cohort.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Groote Schuur Hosp, Cape Town, South Africa; Univ Cape Town, ZA-7925 Cape Town, South Africa	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town; University of Cape Town	Nachega, JB (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, 651 Huntington Ave,SPH 2 Bldg,Room 437C, Boston, MA 02115 USA.	jnachega@hsph.harvard.edu	Maartens, Gary/S-2788-2019; , David Bishai/GRO-4211-2022; Maartens, Gary/F-3836-2014; Cleary, Susan/AHE-7259-2022	Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Cleary, Susan/0000-0002-9071-7958; Bishai, David/0000-0003-0714-9062; Nachega, Jean/0000-0002-2862-4443	Division of AIDS, National Institute of Allergy and Infectious Diseases, U. S. National Institutes of Health [R01 AI 5535901, R01 AI 016137]; Mentored Patient-Oriented Research Career Award [K23 AI068582-01]; European Developing Countries Clinical Trial Partnership Senior Fellowship Award [TA-08-40200-021]; Center for Biostatistics in AIDS Research, Harvard School of Public of Health; Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055359, R01AI016137, K23AI068582] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergy and Infectious Diseases, U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Mentored Patient-Oriented Research Career Award; European Developing Countries Clinical Trial Partnership Senior Fellowship Award; Center for Biostatistics in AIDS Research, Harvard School of Public of Health; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	By the Division of AIDS, National Institute of Allergy and Infectious Diseases, U. S. National Institutes of Health, grants R01 AI 5535901 and R01 AI 016137 (Drs. Nachega and Maartens) and Mentored Patient-Oriented Research Career Award K23 AI068582-01 (Dr. Nachega); the European Developing Countries Clinical Trial Partnership Senior Fellowship Award, TA-08-40200-021 (Dr. Nachega); the 2009 John McGoldrick Senior Fellowship Award, Center for Biostatistics in AIDS Research, Harvard School of Public of Health (Dr. Nachega); and the Doris Duke Charitable Foundation Operations Research on AIDS Care and Treatment in Africa Award (Dr. Maartens).	Bangsberg DR, 2008, J INFECT DIS, V197, pS272, DOI 10.1086/533415; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bishai D, 2007, AIDS, V21, P1333, DOI 10.1097/QAD.0b013e328137709e; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Blough DK, 1999, J HEALTH ECON, V18, P153, DOI 10.1016/S0167-6296(98)00032-0; Bodri M, 2006, ANTIVIR THER, V11, P63; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Chesney MA, 2006, JAIDS-J ACQ IMM DEF, V43, pS149, DOI 10.1097/01.qai.0000243112.91293.26; Choo PW, 1999, MED CARE, V37, P846, DOI 10.1097/00005650-199909000-00002; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Acurcio FDA, 2006, REV ESP SALUD PUBLIC, V80, P41, DOI [10.1590/S1135-57272006000100005, 10.1590/s1135-57272006000100005]; Egger M., 2007, C RETR OPP INF CROI; Fewell Z, 2004, STATA J, V4, P402, DOI 10.1177/1536867X0400400403; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Freedberg KA, 2006, JAIDS-J ACQ IMM DEF, V43, pS113, DOI 10.1097/01.qai.0000248334.52072.25; Gardner EM, 2008, APPL HEALTH ECON HEA, V6, P145, DOI 10.2165/00148365-200806020-00006; Gross R, 2008, HIV CLIN TRIALS, V9, P202, DOI 10.1310/hct0903-202; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hirsch JD, 2009, J MANAGE CARE PHARM, V15, P32, DOI 10.18553/jmcp.2009.15.1.32; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Huber P.J., 1967, P 5 BERKELEY S MATH, V1, P221; Jones A, 2000, HDB HLTH EC, P265; Kilian Reinhold, 2002, J Ment Health Policy Econ, V5, P21; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P360; Manning WG, 1998, J HEALTH ECON, V17, P283, DOI 10.1016/S0167-6296(98)00025-3; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; Mills E, 2007, LANCET, V370, P1885, DOI 10.1016/S0140-6736(07)61790-5; Mullahy J, 1998, J HEALTH ECON, V17, P247, DOI 10.1016/S0167-6296(98)00030-7; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; *OAND CORP, 2009, FXCONVERTER CURR CON; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Purdum AG, 2004, AIDS CARE, V16, P767, DOI 10.1080/09540120412331269602; REGENSBERG L, 2009, AFA CLIN GUIDELINES; *STAT S AFR, 2009, CONS PRIC IND IND; STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wood E, 2006, AIDS, V20, P1117, DOI 10.1097/01.aids.0000226951.49353.ed	48	49	50	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2010	152	1					18	W5		10.7326/0003-4819-152-1-201001050-00006	http://dx.doi.org/10.7326/0003-4819-152-1-201001050-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	543FJ	20048268				2022-12-28	WOS:000273556600003
J	Boomsma, JJ; Pamilo, P				Boomsma, Jacobus J.; Pamilo, Pekka			Rossiter H. Crozier (1943-2009)	SCIENCE			English	Biographical-Item									[Boomsma, Jacobus J.] Univ Copenhagen, Dept Biol, DK-2100 Copenhagen, Denmark; Univ Helsinki, Dept Biosci, FIN-00014 Helsinki, Finland	University of Copenhagen; University of Helsinki	Boomsma, JJ (corresponding author), Univ Copenhagen, Dept Biol, Univ Pk 15, DK-2100 Copenhagen, Denmark.	jjboomsma@bio.ku.dk; pekka.pamilo@helsinki.fi	Pamilo, Pekka/C-6907-2011; Boomsma, Jacobus J/M-2785-2014	Boomsma, Jacobus J/0000-0002-3598-1609					0	1	1	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 1	2010	327	5961					45	45		10.1126/science.1185061	http://dx.doi.org/10.1126/science.1185061			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044566				2022-12-28	WOS:000273395400024
J	Kapahi, P; Vijg, J				Kapahi, Pankaj; Vijg, Jan			Aging - Lost in Translation?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EXTENDS LIFE-SPAN; MICE		[Kapahi, Pankaj] Buck Inst Age Res, Novato, CA USA; [Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA	Buck Institute for Research on Aging; Yeshiva University; Albert Einstein College of Medicine	Kapahi, P (corresponding author), Buck Inst Age Res, Novato, CA USA.				NATIONAL INSTITUTE ON AGING [R01AG031337] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG031337] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216	4	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2669	2670		10.1056/NEJMcibr0909815	http://dx.doi.org/10.1056/NEJMcibr0909815			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042759				2022-12-28	WOS:000273181300018
J	Faasse, K; Cundy, T; Petrie, KJ				Faasse, Kate; Cundy, Tim; Petrie, Keith J.			Medicine and the Media Thyroxine: anatomy of a health scare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Faasse, Kate; Petrie, Keith J.] Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand; [Cundy, Tim] Univ Auckland, Dept Med, Auckland, New Zealand	University of Auckland; University of Auckland	Petrie, KJ (corresponding author), Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand.	kj.petrie@auckland.ac.nz		Cundy, Timothy/0000-0003-4890-9400; Faasse, Kate/0000-0003-3073-3718				Page LA, 2006, J PSYCHOSOM RES, V60, P413, DOI 10.1016/j.jpsychores.2005.11.008; Petrie KJ, 2004, BRIT J HEALTH PSYCH, V9, P101, DOI 10.1348/135910704322778759; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x	3	43	43	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2009	339								b5613	10.1136/bmj.b5613	http://dx.doi.org/10.1136/bmj.b5613			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	539JA	20040484				2022-12-28	WOS:000273249000013
J	Brass, AL; Huang, IC; Benita, Y; John, SP; Krishnan, MN; Feeley, EM; Ryan, BJ; Weyer, JL; van der Weyden, L; Fikrig, E; Adams, DJ; Xavier, RJ; Farzan, M; Elledge, SJ				Brass, Abraham L.; Huang, I-Chueh; Benita, Yair; John, Sinu P.; Krishnan, Manoj N.; Feeley, Eric M.; Ryan, Bethany J.; Weyer, Jessica L.; van der Weyden, Louise; Fikrig, Erol; Adams, David J.; Xavier, Ramnik J.; Farzan, Michael; Elledge, Stephen J.			The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; RNA INTERFERENCE; GENE FAMILY; CELLS; ENDOCYTOSIS; EXPRESSION; SCREEN; TRANSCRIPTION; COMPLEXES; INFECTION	Influenza viruses exploit host cell machinery to replicate, resulting in epidemics of respiratory illness. In turn, the host expresses antiviral restriction factors to defend against infection. To find host cell modifiers of influenza A H1N1 viral infection, we used a functional genomic screen and identified over 120 influenza A virus-dependency factors with roles in endosomal acidification, vesicular trafficking, mitochondrial metabolism, and RNA splicing. We discovered that the interferon-inducible transmembrane proteins IFITM1, 2, and 3 restrict an early step in influenza A viral replication. The IFITM proteins confer basal resistance to influenza A virus but are also inducible by interferons type I and II and are critical for interferon's virustatic actions. Further characterization revealed that the IFITM proteins inhibit the early replication of flaviviruses, including dengue virus and West Nile virus. Collectively this work identifies a family of antiviral restriction factors that mediate cellular innate immunity to at least three major human pathogens.	[Brass, Abraham L.; John, Sinu P.; Feeley, Eric M.; Ryan, Bethany J.] Massachusetts Gen Hosp, MIT, Ragon Inst, Charlestown, MA 02129 USA; [Brass, Abraham L.; John, Sinu P.; Feeley, Eric M.; Ryan, Bethany J.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Brass, Abraham L.; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Benita, Yair; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Brass, Abraham L.; Elledge, Stephen J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst,Dept Genet,Div Genet, Boston, MA 02115 USA; [Huang, I-Chueh; Weyer, Jessica L.; Farzan, Michael] Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA; [Krishnan, Manoj N.; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; [Fikrig, Erol] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [van der Weyden, Louise; Adams, David J.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Yale University; Howard Hughes Medical Institute; Yale University; Wellcome Trust Sanger Institute	Brass, AL (corresponding author), Massachusetts Gen Hosp, MIT, Ragon Inst, Charlestown, MA 02129 USA.	abrass@partners.org; farzan@hms.harvard.edu; selledge@genetics.med.harvard.edu	Benita, Yair/E-3094-2012; van der Weyden, Louise/AAV-5711-2021; John, Sinu/AAS-2054-2020	van der Weyden, Louise/0000-0002-0645-1879; Farzan, Michael/0000-0002-2990-5319; Adams, David/0000-0001-9490-0306; Feeley, Eric/0000-0003-0910-8758	NIH [AI 50031, AI070343, AI062773, DK060049, DK043351, U54 AI057159]; Cancer Research UK and the Wellcome Trust; Kay Kendall Leukaemia Foundation; New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, N01AI050031, R01AI062773, U01AI070343] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, R01DK060049, P30DK040561] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK and the Wellcome Trust; Kay Kendall Leukaemia Foundation; New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the ICCB-Longwood; C. Shamu, S. Chang, S. Rudnicki, S. Johnston, K. Rudnicki, D. Wrobel, M. Ocana, and Z. Cooper; Ragon Institute; L. Whiteman, K. Hartman, A. Piechocka-Trocha, J. Proudfoot, and T. Diefenbach. We thank J. Philips, A. Mehle, M. Franti, F. Diaz-Griffero, J. Mabry (CDC), and J. Chou for helpful discussions. Funding support: A. L. B. wishes to express his gratitude to the Phillip T. and Susan M. Ragon Foundation for their generous support. A.L.B. (MGH GI Unit, Harvard Center for AIDS Research); M.N.K. and E.F. (NIH grants AI 50031 and AI070343); Y. B. and R.J.X. (CSIBD, CCIB, Genetics and Genomics Core, and NIH grants AI062773, DK060049, and DK043351); I.C.H. and M.F. (NERCE U54 AI057159). D.J.A. is supported by Cancer Research UK and the Wellcome Trust. L.v.d.W. is supported by a fellowship from the Kay Kendall Leukaemia Foundation. This study was supported by the New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NIH grant U54 AI057159 to D. Kasper). S. J. E. and E. F. are Investigators with the Howard Hughes Medical Institute.	Alber D, 1996, J INTERF CYTOK RES, V16, P375, DOI 10.1089/jir.1996.16.375; [Anonymous], ORTHOMYXOVIRIDAE VIR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; BOULOY M, 1978, P NATL ACAD SCI USA, V75, P4886, DOI 10.1073/pnas.75.10.4886; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Chen C, 2008, P NATL ACAD SCI USA, V105, P11790, DOI 10.1073/pnas.0803711105; EVANS SS, 1993, J IMMUNOL, V150, P736; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hoffhines AJ, 2006, J BIOL CHEM, V281, P37877, DOI 10.1074/jbc.M609398200; Holler O, 2009, REV SCI TECH OIE, V28, P219, DOI 10.20506/rst.28.1.1867; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; IMAI T, 1993, J IMMUNOL, V151, P6470; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Martin CSS, 2009, TRENDS MICROBIOL, V17, P514, DOI 10.1016/j.tim.2009.08.002; Massenet S, 1999, MOL CELL BIOL, V19, P2142; Mitchell Joyce A, 2003, AMIA Annu Symp Proc, P460; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Monto AS, 2009, CLIN INFECT DIS, V48, pS20, DOI 10.1086/591853; Morriswood B, 2007, J CELL SCI, V120, P2574, DOI 10.1242/jcs.007005; Nagy A., 2003, MANIPULATING MOUSE E; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; SKEHEL JJ, 1995, AM J RESP CRIT CARE, V152, pS13, DOI 10.1164/ajrccm/152.4_Pt_2.S13; Smith RA, 2006, GENES IMMUN, V7, P113, DOI 10.1038/sj.gene.6364278; Stevens SW, 2001, RNA, V7, P1543; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062; Yoshii K, 2009, ARCH VIROL, V154, P573, DOI 10.1007/s00705-009-0345-5	46	918	956	2	91	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1243	1254		10.1016/j.cell.2009.12.017	http://dx.doi.org/10.1016/j.cell.2009.12.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064371	Green Accepted, Bronze			2022-12-28	WOS:000273048700013
J	Husale, S; Persson, HHJ; Sahin, O				Husale, Sudhir; Persson, Henrik H. J.; Sahin, Ozgur			DNA nanomechanics allows direct digital detection of complementary DNA and microRNA targets	NATURE			English	Article							LABEL-FREE DETECTION; GENE-EXPRESSION; ELECTRICAL DETECTION; HYBRIDIZATION; NANOPARTICLES; PCR	Techniques to detect and quantify DNA and RNA molecules in biological samples have had a central role in genomics research(1-3). Over the past decade, several techniques have been developed to improve detection performance and reduce the cost of genetic analysis(4-10). In particular, significant advances in label-free methods have been reported(11-17). Yet detection of DNA molecules at concentrations below the femtomolar level requires amplified detection schemes(1,8). Here we report a unique nanomechanical response of hybridized DNA and RNA molecules that serves as an intrinsic molecular label. Nanomechanical measurements on a microarray surface have sufficient background signal rejection to allow direct detection and counting of hybridized molecules. The digital response of the sensor provides a large dynamic range that is critical for gene expression profiling. We have measured differential expressions of microRNAs in tumour samples; such measurements have been shown to help discriminate between the tissue origins of metastatic tumours(18). Two hundred picograms of total RNA is found to be sufficient for this analysis. In addition, the limit of detection in pure samples is found to be one attomolar. These results suggest that nanomechanical read-out of microarrays promises attomolar-level sensitivity and large dynamic range for the analysis of gene expression, while eliminating biochemical manipulations, amplification and labelling.	[Husale, Sudhir; Sahin, Ozgur] Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02142 USA; [Persson, Henrik H. J.] Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA	Harvard University; Stanford University	Sahin, O (corresponding author), Harvard Univ, Rowland Inst Harvard, Cambridge, MA 02142 USA.	sahin@rowland.harvard.edu	Sahin, Ozgur/A-7988-2013	Sahin, Ozgur/0000-0003-2766-2816	Rowland Junior Fellows Program; US National Institutes of Health [HG000205]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P01HG000205] Funding Source: NIH RePORTER	Rowland Junior Fellows Program; US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This research is supported by the Rowland Junior Fellows Program. H. H. J. P. was supported in part by US National Institutes of Health grant HG000205. We thank R. W. Davis for discussions.	Burg TP, 2007, NATURE, V446, P1066, DOI 10.1038/nature05741; Cao YWC, 2002, SCIENCE, V297, P1536, DOI 10.1126/science.297.5586.1536; Chen CF, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni178; Cheng MMC, 2006, CURR OPIN CHEM BIOL, V10, P11, DOI 10.1016/j.cbpa.2006.01.006; Clack NG, 2008, NAT BIOTECHNOL, V26, P825, DOI 10.1038/nbt1416; Demers LM, 2002, SCIENCE, V296, P1836, DOI 10.1126/science.1071480; Fang SP, 2006, J AM CHEM SOC, V128, P14044, DOI 10.1021/ja065223p; Fritz J, 2002, P NATL ACAD SCI USA, V99, P14142, DOI 10.1073/pnas.232276699; Fritz J, 2000, SCIENCE, V288, P316, DOI 10.1126/science.288.5464.316; Geiss GK, 2008, NAT BIOTECHNOL, V26, P317, DOI 10.1038/nbt1385; Hahm J, 2004, NANO LETT, V4, P51, DOI 10.1021/nl034853b; HE L, 2004, NAT REV GENET, V5, P522; Herne TM, 1997, J AM CHEM SOC, V119, P8916, DOI 10.1021/ja9719586; HIGUCHI R, 1992, BIO-TECHNOL, V10, P413, DOI 10.1038/nbt0492-413; Ilic B, 2005, NANO LETT, V5, P925, DOI 10.1021/nl050456k; Ke YG, 2008, SCIENCE, V319, P180, DOI 10.1126/science.1150082; Lockhart DJ, 2000, NATURE, V405, P827, DOI 10.1038/35015701; Mertens J, 2008, NAT NANOTECHNOL, V3, P301, DOI 10.1038/nnano.2008.91; Mirmomtaz E, 2008, NANO LETT, V8, P4134, DOI 10.1021/nl802722k; Nam JM, 2004, J AM CHEM SOC, V126, P5932, DOI 10.1021/ja049384+; Park SJ, 2002, SCIENCE, V295, P1503, DOI 10.1126/science.1067003; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Sahin O, 2007, NAT NANOTECHNOL, V2, P507, DOI 10.1038/nnano.2007.226; Sahin O, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/44/445717; Sahin O, 2007, REV SCI INSTRUM, V78, DOI 10.1063/1.2801009; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Sinensky AK, 2007, NAT NANOTECHNOL, V2, P653, DOI 10.1038/nnano.2007.293; Taton TA, 2000, SCIENCE, V289, P1757, DOI 10.1126/science.289.5485.1757; Yu AA, 2005, NANO LETT, V5, P1061, DOI 10.1021/nl050495w; Zhang J, 2006, NAT NANOTECHNOL, V1, P214, DOI 10.1038/nnano.2006.134; Zhou DJ, 2003, ANGEW CHEM INT EDIT, V42, P4934, DOI 10.1002/anie.200352178	31	117	119	2	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1075	U138		10.1038/nature08626	http://dx.doi.org/10.1038/nature08626			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20010806	Green Accepted			2022-12-28	WOS:000272996000051
J	Moreira, LA; Iturbe-Ormaetxe, I; Jeffery, JA; Lu, GJ; Pyke, AT; Hedges, LM; Rocha, BC; Hall-Mendelin, S; Day, A; Riegler, M; Hugo, LE; Johnson, KN; Kay, BH; McGraw, EA; van den Hurk, AF; Ryan, PA; O'Neill, SL				Moreira, Luciano A.; Iturbe-Ormaetxe, Inaki; Jeffery, Jason A.; Lu, Guangjin; Pyke, Alyssa T.; Hedges, Lauren M.; Rocha, Bruno C.; Hall-Mendelin, Sonja; Day, Andrew; Riegler, Markus; Hugo, Leon E.; Johnson, Karyn N.; Kay, Brian H.; McGraw, Elizabeth A.; van den Hurk, Andrew F.; Ryan, Peter A.; O'Neill, Scott L.			A Wolbachia Symbiont in Aedes aegypti Limits Infection with Dengue, Chikungunya, and Plasmodium	CELL			English	Article							MONOCLONAL-ANTIBODIES; STATISTICAL-ANALYSIS; VIRULENT WOLBACHIA; MOSQUITO; CHOLESTEROL; EXPRESSION; DROSOPHILA; PROTEIN; FEVER; PCR	Wolbachia are maternally inherited intracellular bacterial symbionts that are estimated to infect more than 60% of all insect species. While Wolbachia is commonly found in many mosquitoes it is absent from the species that are considered to be of major importance for the transmission of human pathogens. The successful introduction of a life-shortening strain of Wolbachia into the dengue vector Aedes aegypti that halves adult lifespan has recently been reported. Here we show that this same Wolbachia infection also directly inhibits the ability of a range of pathogens to infect this mosquito species. The effect is Wolbachia strain specific and relates to Wolbachia priming of the mosquito innate immune system and potentially competition for limiting cellular resources required for pathogen replication. We suggest that this Wolbachia-mediated pathogen interference may work synergistically with the life-shortening strategy proposed previously to provide a powerful approach for the control of insect transmitted diseases.	[Moreira, Luciano A.; Iturbe-Ormaetxe, Inaki; Hedges, Lauren M.; Riegler, Markus; Johnson, Karyn N.; McGraw, Elizabeth A.; O'Neill, Scott L.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Moreira, Luciano A.; Rocha, Bruno C.] Fiocruz MS, Rene Rachou Res Inst, Belo Horizonte, MG, Brazil; [Jeffery, Jason A.; Lu, Guangjin; Hugo, Leon E.; Kay, Brian H.; Ryan, Peter A.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Pyke, Alyssa T.; van den Hurk, Andrew F.] Queensland Hlth Forens Serv, Coopers Plains, Qld 4108, Australia; [Pyke, Alyssa T.; van den Hurk, Andrew F.] Queensland Hlth Sci Serv, Coopers Plains, Qld 4108, Australia; [Hall-Mendelin, Sonja; Day, Andrew; van den Hurk, Andrew F.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland; Fundacao Oswaldo Cruz; QIMR Berghofer Medical Research Institute; Queensland Health; Queensland Health; University of Queensland	O'Neill, SL (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia.	scott.oneill@uq.edu.au	Johnson, Karyn N/B-7980-2008; van den Hurk, Andrew/X-9831-2019; Hugo, R. Leon E/O-3013-2018; McGraw, Elizabeth/GRF-0434-2022; O'Neill, Scott L/B-3568-2009; McGraw, Elizabeth A/A-6658-2012; Rocha, Bruno C/M-6397-2015; van den Hurk, Andrew F/G-7992-2012; O'Neill, Scott/R-9560-2019	Johnson, Karyn N/0000-0001-8647-8985; van den Hurk, Andrew/0000-0001-6262-831X; Hugo, R. Leon E/0000-0002-6767-9850; O'Neill, Scott L/0000-0002-4131-3615; McGraw, Elizabeth A/0000-0001-7973-088X; Rocha, Bruno C/0000-0003-0118-3913; O'Neill, Scott/0000-0002-4131-3615; Ryan, Peter/0000-0003-0674-4441; Riegler, Markus/0000-0001-7363-431X; Pyke, Alyssa/0000-0003-3512-4321	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Health and Medical Research Council, Australia	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	We are grateful to Nichola Kenny and Wai Yuen Cheah for technical support and Paul Addison and Amy Fong for help with mosquito histology. We are also thankful to Roy Hall and Natalie Prow for providing the anti-dengue and B10 antibodies, Antoniana Krettli for the anti- CSP antibody, and Jose Ribeiro for useful discussions on saliva collection. We are particularly thankful for wild caught mosquito material supplied by Petrina Johnson and Scott Ritchie. We would like to thank FIOCRUZ - Brazil for the support on the malaria experiments. We thank members of the O'Neill and McGraw laboratories for critical reading of the manuscript. This research was supported by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation and the National Health and Medical Research Council, Australia.	Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763; Atella GC, 2009, ACTA TROP, V109, P159, DOI 10.1016/j.actatropica.2008.10.004; Barclay E, 2008, LANCET, V371, P973, DOI 10.1016/S0140-6736(08)60435-3; Blitzer EJ, 2005, INSECT MOL BIOL, V14, P301, DOI 10.1111/j.1365-2583.2005.00560.x; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Broom AK, 1998, PATHOLOGY, V30, P286, DOI 10.1080/00313029800169456; Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368; Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X; Clark DC, 2007, J GEN VIROL, V88, P1175, DOI 10.1099/vir.0.82609-0; COOK PE, 2008, TRANSGENESIS MANAGEM; Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103; DECAMARGO MT, 1978, J PARASITOL, V64, P924, DOI 10.2307/3279533; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x; GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jin CY, 2009, APPL ENVIRON MICROB, V75, P3373, DOI 10.1128/AEM.00207-09; Joehanes R, 2008, BIOINFORMATICS, V24, P2788, DOI 10.1093/bioinformatics/btn523; Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6; Knox TB, 2003, J MED ENTOMOL, V40, P950, DOI 10.1603/0022-2585-40.6.950; Kremer N, 2009, HEREDITY, V103, P248, DOI 10.1038/hdy.2009.63; KRETTLI AU, 1988, PARASITE IMMUNOL, V10, P523, DOI 10.1111/j.1365-3024.1988.tb00240.x; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Miller WJ, 2006, APPL ENVIRON MICROB, V72, P826, DOI 10.1128/AEM.72.1.826-835.2006; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Ng LFP, 2009, MICROBES INFECT, V11, P1163, DOI 10.1016/j.micinf.2009.09.001; ONeill SL, 1997, INFLUENTIAL PASSENGE; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Pachauri R.K, 2007, CLIMATE CHANGE 2007, P104; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rasgon JL, 2003, J MED ENTOMOL, V40, P125, DOI 10.1603/0022-2585-40.2.125; Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132; Rodrigues FG, 2008, INSECT MOL BIOL, V17, P175, DOI 10.1111/j.1365-2583.2008.00791.x; RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407; Schneider D, 2000, SCIENCE, V288, P2376, DOI 10.1126/science.288.5475.2376; Sinkins SP, 2000, INSECT TRANSGENESIS, P271; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; TURELL MJ, 1988, AM J TROP MED HYG, V39, P597, DOI 10.4269/ajtmh.1988.39.597; VANDENHURK AF, 2009, VECTOR BORNE ZOONOTI; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Woodring Jennifer L., 1996, P51; World Health Organization, 2009, FACT SHEET; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	56	1060	1103	6	310	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1268	1278		10.1016/j.cell.2009.11.042	http://dx.doi.org/10.1016/j.cell.2009.11.042			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064373	Green Published, Bronze			2022-12-28	WOS:000273048700015
J	Morris, L; Taitsman, JK				Morris, Lewis; Taitsman, Julie K.			The Agenda for Continuing Medical Education -- Limiting Industry's Influence.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Morris, Lewis; Taitsman, Julie K.] US Dept HHS, Off Inspector Gen, Washington, DC 20201 USA		Morris, L (corresponding author), US Dept HHS, Off Inspector Gen, Washington, DC 20201 USA.							*ACCR COUNC CONT M, 2008, ACCR CME IS ED MATT; Accreditation Council for Continuing Medical Education, 2007, ACCME STAND COMM SUP; [Anonymous], 2008, ACCME ANN REP DAT 20; Bureau of Labor Statistics U. S. Department of Labor, OCC OUTL HDB PHYS SU; *COLL FAM PHYS CAN, 2008, MAINPR MAINPR M1 MAI; Institute of Medicine, 2009, CONFL INT MED RES ED; *PFIZ MED ED GROUP, 2008, NEW PFIZ CME GRANT C; PORUCZNIK MA, 2009, BOARD MEMBERS NAMED; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; Rothman DJ, 2009, JAMA-J AM MED ASSOC, V301, P1367, DOI 10.1001/jama.2009.407; *SEN COMM FIN, 2007, US ED GRANTS PHARM M	11	26	26	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2009	361	25					2478	2482		10.1056/NEJMsb0905411	http://dx.doi.org/10.1056/NEJMsb0905411			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	533CE	20018969				2022-12-28	WOS:000272798900015
J	Jefferson, T; Ferroni, E				Jefferson, Tom; Ferroni, Eliana			Christmas 2009: Years like this The Spanish influenza pandemic seen through the BMJ's eyes: observations and unanswered questions	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Jefferson, Tom; Ferroni, Eliana] Cochrane Collaborat, Acute Resp Infect Grp, Rome, Italy		Jefferson, T (corresponding author), Cochrane Collaborat, Acute Resp Infect Grp, Rome, Italy.	jefferson.tom@gmail.com	FERRONI, ELIANA/ABB-3304-2021	FERRONI, ELIANA/0000-0003-4803-2004				ALCABES P, 2009, FEARS FANTASY HAVE F; BALL EJ, 1919, BMJ-BRIT MED J, V1, P358; Benjafield JD, 1919, BRIT MED J, V1919, P167, DOI 10.1136/bmj.2.3058.167; Brundage JF, 2006, LANCET INFECT DIS, V6, P303, DOI 10.1016/S1473-3099(06)70466-2; Garvie A, 1919, Br Med J, V2, P519; Glezen WP, 1996, EPIDEMIOL REV, V18, P64, DOI 10.1093/oxfordjournals.epirev.a017917; Greenwood M, 1918, BRIT MED J, V1918, P563, DOI 10.1136/bmj.2.3021.563; Gregor A, 1919, BRIT MED J, V1919, P242, DOI 10.1136/bmj.1.3035.242; Honigsbaum M., 2008, LIVING ENZA FORGOTTE; Horder T, 1919, Br Med J, V2, P695; *IPCS INCHEM, MUST GAS; Leishman WB, 1920, BRIT MED J, V1920, P214, DOI 10.1136/bmj.1.3085.214; Macklin AH, 1920, BRIT MED J, V1920, P465, DOI 10.1136/bmj.1.3092.465; Rose Bradford J, 1919, BMJ-BRIT MED J, V1, P127; SHOPE RE, 1958, PUBLIC HEALTH REP, V73, P165, DOI 10.2307/4590072; Shufflebotham F, 1919, BRIT MED J, V1919, P478, DOI 10.1136/bmj.1.3042.478; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Watson AM, 1919, BRIT MED J, V1919, P40, DOI 10.1136/bmj.1.3028.40-a; 1919, BMJ, V2, P499	19	4	4	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2009	339								b5313	10.1136/bmj.b5313	http://dx.doi.org/10.1136/bmj.b5313			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534XH	20015909				2022-12-28	WOS:000272930300017
J	Mulrooney, DA; Yeazel, MW; Kawashima, T; Mertens, AC; Mitby, P; Stovall, M; Donaldson, SS; Green, DM; Sklar, CA; Robison, LL; Leisenring, WM				Mulrooney, Daniel A.; Yeazel, Mark W.; Kawashima, Toana; Mertens, Ann C.; Mitby, Pauline; Stovall, Marilyn; Donaldson, Sarah S.; Green, Daniel M.; Sklar, Charles A.; Robison, Leslie L.; Leisenring, Wendy M.			Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article							LONG-TERM SURVIVORS; CORONARY-ARTERY-DISEASE; CLINICAL HEART-FAILURE; HODGKINS-DISEASE; DOXORUBICIN THERAPY; CARDIOVASCULAR-DISEASE; 5-YEAR SURVIVORS; RISK-FACTORS; CARDIOTOXICITY; CHILDREN	Objectives To assess the incidence of and risks for congestive heart failure, myocardial infarction, pericardial disease, and valvular abnormalities among adult survivors of childhood and adolescent cancers. Design Retrospective cohort study. Setting 26 institutions that participated in the Childhood Cancer Survivor Study. Participants 14 358 five year survivors of cancer diagnosed under the age of 21 with leukaemia, brain cancer, Hodgkin's lymphoma, non-Hodgkin's lymphoma, kidney cancer, neuroblastoma, soft tissue sarcoma, or bone cancer between 1970 and 1986. Comparison group included 3899 siblings of cancer survivors. Main outcome measures Participants or their parents (in participants aged less than 18 years) completed a questionnaire collecting information on demographic characteristics, height, weight, health habits, medical conditions, and surgical procedures occurring since diagnosis. The main outcome measures were the incidence of and risk factors for congestive heart failure, myocardial infarction, pericardial disease, and valvular abnormalities in survivors of cancer compared with siblings. Results Survivors of cancer were significantly more likely than siblings to report congestive heart failure (hazard ratio (HR) 5.9, 95% confidence interval 3.4 to 9.6; P<0.001), myocardial infarction (HR 5.0, 95% CI 2.3 to 10.4; P<0.001), pericardial disease (HR 6.3, 95% CI 3.3 to 11.9; P<0.001), or valvular abnormalities (HR 4.8, 95% CI 3.0 to 7.6; P<0.001). Exposure to 250 mg/m(2) or more of anthracyclines increased the relative hazard of congestive heart failure, pericardial disease, and valvular abnormalities by two to five times compared with survivors who had not been exposed to anthracyclines. Cardiac radiation exposure of 1500 centigray or more increased the relative hazard of congestive heart failure, myocardial infarction, pericardial disease, and valvular abnormalities by twofold to sixfold compared to non-irradiated survivors. The cumulative incidence of adverse cardiac outcomes in cancer survivors continued to increase up to 30 years after diagnosis. Conclusion Survivors of childhood and adolescent cancer are at substantial risk for cardiovascular disease. Healthcare professionals must be aware of these risks when caring for this growing population.	[Mulrooney, Daniel A.; Yeazel, Mark W.] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Mulrooney, Daniel A.; Yeazel, Mark W.] Masonic Canc Ctr, Minneapolis, MN 55455 USA; [Kawashima, Toana] Fred Hutchinson Canc Res Ctr, Canc Prevent Program Publ Hlth Sci, Seattle, WA 98109 USA; [Mertens, Ann C.] Emory Univ, Amer Family Life Assurance Co Canc Ctr, Atlanta, GA 30322 USA; [Mertens, Ann C.] Emory Univ, Blood Disorders Serv, Atlanta, GA 30322 USA; [Mitby, Pauline] Childrens Hosp & Clin Minnesota, Minneapolis, MN 55404 USA; [Stovall, Marilyn] Univ Texas MD Anderson Canc Ctr, Dept Radiat Phys, Houston, TX 77030 USA; [Donaldson, Sarah S.] Stanford Univ, Med Ctr, Dept Radiat Oncol, Stanford, CA 94305 USA; [Sklar, Charles A.] Mem Sloan Kettering Canc Ctr, New York, NY 10065 USA	University of Minnesota System; University of Minnesota Twin Cities; Fred Hutchinson Cancer Center; Emory University; Emory University; Children's Hospitals & Clinics of Minnesota; University of Texas System; UTMD Anderson Cancer Center; Stanford University; Memorial Sloan Kettering Cancer Center	Mulrooney, DA (corresponding author), Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA.	mulro006@umn.edu	Robison, Leslie/N-8122-2018	Donaldson, Sarah/0000-0001-7125-3118	National Cancer Institute, Bethesda, MD [U24 CA 55727]; American Lebanese Syrian Associated Charities, Memphis, TN. USA; National Institute of Health, Bethesda, MD [1K12RR023247]; Children's Cancer Research Fund, Minneapolis, MN, USA; NATIONAL CANCER INSTITUTE [U24CA055727] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K12RR023247] Funding Source: NIH RePORTER	National Cancer Institute, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); American Lebanese Syrian Associated Charities, Memphis, TN. USA(American Lebanese Syrian Associated Charities (ALSAC)); National Institute of Health, Bethesda, MD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Cancer Research Fund, Minneapolis, MN, USA; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	LLR, andWML principal investigator, supported by grant U24 CA 55727 from the National Cancer Institute, Bethesda, MD, and the American Lebanese Syrian Associated Charities, Memphis, TN. USA. DAM was supported by grant 1K12RR023247 from the National Institute of Health, Bethesda, MD, and the Children's Cancer Research Fund, Minneapolis, MN, USA. The funding agencies were not involved in data collection, analysis, interpretation, or writing of this manuscript.	Adams MJ, 2005, PEDIATR BLOOD CANCER, V44, P600, DOI 10.1002/pbc.20352; Adams MJ, 2004, J CLIN ONCOL, V22, P3139, DOI 10.1200/JCO.2004.09.109; Aleman BMP, 2007, BLOOD, V109, P1878, DOI 10.1182/blood-2006-07-034405; ALI MK, 1994, CANCER-AM CANCER SOC, V74, P182, DOI 10.1002/1097-0142(19940701)74:1<182::AID-CNCR2820740129>3.0.CO;2-2; CARLSON RG, 1991, CHEST, V99, P538, DOI 10.1378/chest.99.3.538; Floyd JD, 2005, J CLIN ONCOL, V23, P7685, DOI 10.1200/JCO.2005.08.789; Gaya AM, 2005, CLIN ONCOL-UK, V17, P153, DOI 10.1016/j.clon.2004.09.016; Green DM, 2001, J CLIN ONCOL, V19, P1926, DOI 10.1200/JCO.2001.19.7.1926; Gurney JG, 2003, J CLIN ENDOCR METAB, V88, P4731, DOI 10.1210/jc.2003-030784; Gurney JG, 2003, CANCER-AM CANCER SOC, V97, P663, DOI 10.1002/cncr.11095; HANCOCK SL, 1993, J CLIN ONCOL, V11, P1208, DOI 10.1200/JCO.1993.11.7.1208; Heidenreich PA, 2003, J AM COLL CARDIOL, V42, P743, DOI 10.1016/S0735-1097(03)00759-9; Huddart RA, 2003, J CLIN ONCOL, V21, P1513, DOI 10.1200/JCO.2003.04.173; Hudson MM, 2007, J CLIN ONCOL, V25, P3635, DOI 10.1200/JCO.2006.09.7451; Hull MC, 2003, JAMA-J AM MED ASSOC, V290, P2831, DOI 10.1001/jama.290.21.2831; Kadan-Lottick NS, 2002, JAMA-J AM MED ASSOC, V287, P1832, DOI 10.1001/jama.287.14.1832; Katz A, 1997, AM J MED SCI, V314, P399, DOI 10.1097/00000441-199712000-00007; King V, 1996, INT J RADIAT ONCOL, V36, P881, DOI 10.1016/S0360-3016(96)00295-7; Kremer LCM, 2002, ANN ONCOL, V13, P819, DOI 10.1093/annonc/mdf167; Kremer LCM, 2001, J CLIN ONCOL, V19, P191, DOI 10.1200/JCO.2001.19.1.191; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Laverdiere C, 2005, PEDIATR BLOOD CANCER, V45, P324, DOI 10.1002/pbc.20331; Leisenring WM, 2009, J CLIN ONCOL, V27, P2319, DOI 10.1200/JCO.2008.21.1813; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lipshultz SE, 2005, J CLIN ONCOL, V23, P2629, DOI 10.1200/JCO.2005.12.121; LIPSHULTZ SE, 1991, NEW ENGL J MED, V324, P808, DOI 10.1056/NEJM199103213241205; Lipshultz SE, 2004, J CLIN ONCOL, V22, P769, DOI 10.1200/JCO.2004.12.937; Lipshultz SE, 1996, J CLIN ONCOL, V14, P328, DOI 10.1200/JCO.1996.14.2.328; LIPSHULTZ SE, 1995, NEW ENGL J MED, V332, P1738, DOI 10.1056/NEJM199506293322602; Louie AD, 2000, BONE MARROW TRANSPL, V25, P1191, DOI 10.1038/sj.bmt.1702419; Mant J, 2006, J CLIN EPIDEMIOL, V59, P862, DOI 10.1016/j.jclinepi.2005.11.021; MARTIN RG, 1975, AM J CARDIOL, V35, P216, DOI 10.1016/0002-9149(75)90004-1; Meinardi MT, 2000, CANCER TREAT REV, V26, P429, DOI 10.1053/ctrv.2000.0175; Mertens AC, 2004, J CLIN EPIDEMIOL, V57, P933, DOI 10.1016/j.jclinepi.2004.01.005; Mertens AC, 2008, JNCI-J NATL CANCER I, V100, P1368, DOI 10.1093/jnci/djn310; Mulrooney DA, 2008, CURR TREAT OPTION ON, V9, P51, DOI 10.1007/s11864-008-0054-4; Nathan PC, 2008, J CLIN ONCOL, V26, P4401, DOI 10.1200/JCO.2008.16.9607; Neglia JP, 2001, J NATL CANCER I, V93, P618, DOI 10.1093/jnci/93.8.618; Pai VB, 2000, DRUG SAFETY, V22, P263, DOI 10.2165/00002018-200022040-00002; Pein F, 2004, BRIT J CANCER, V91, P37, DOI 10.1038/sj.bjc.6601904; POHJOLASINTONEN S, 1987, CANCER-AM CANCER SOC, V60, P31, DOI 10.1002/1097-0142(19870701)60:1<31::AID-CNCR2820600107>3.0.CO;2-D; Postma A, 2002, MED PEDIATR ONCOL, V39, P86, DOI 10.1002/mpo.10074; Reinders JG, 1999, RADIOTHER ONCOL, V51, P35, DOI 10.1016/S0167-8140(99)00026-2; Robison LL, 2002, MED PEDIATR ONCOL, V38, P229, DOI 10.1002/mpo.1316; Rubin D.B., 1987, MULTIPLE IMPUTATION, DOI DOI 10.1002/9780470316696.FMATTER; Sehdev AES, 2001, ARCH INTERN MED, V161, P277, DOI 10.1001/archinte.161.2.277; Simone J.V., 2003, CHILDHOOD CANC SURVI; Sklar C, 2000, J CLIN ENDOCR METAB, V85, P3227, DOI 10.1210/jc.85.9.3227; STEINHERZ LJ, 1991, JAMA-J AM MED ASSOC, V266, P1672, DOI 10.1001/jama.266.12.1672; Stovall M, 2006, RADIAT RES, V166, P141, DOI 10.1667/RR3525.1; TAYLOR JMG, 1990, STAT MED, V9, P505, DOI 10.1002/sim.4780090504; Therneau TM, 2000, MODELING SURVIVAL DA; van Dalen EC, 2006, EUR J CANCER, V42, P3191, DOI 10.1016/j.ejca.2006.08.005; van der Pal HJH, 2005, CANCER TREAT REV, V31, P173, DOI 10.1016/j.ctrv.2005.03.008; Velensek V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-141; WATTS RG, 1991, AM J HEMATOL, V36, P217, DOI 10.1002/ajh.2830360314; Yasui Y, 2003, AM J EPIDEMIOL, V158, P1108, DOI 10.1093/aje/kwg278	57	649	662	0	15	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2009	339								b4606	10.1136/bmj.b4606	http://dx.doi.org/10.1136/bmj.b4606			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531VE	19996459	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000272697300001
J	Bruzzone, P				Bruzzone, Paolo			New Israeli law about organ transplantation	LANCET			English	Editorial Material									Univ Roma La Sapienza, Umberto Policlin Roma I, Paride Stefanini Dept Surg Surg Sci & Transplanta, I-001661 Rome, Italy	Sapienza University Rome; University Hospital Sapienza Rome	Bruzzone, P (corresponding author), Univ Roma La Sapienza, Umberto Policlin Roma I, Paride Stefanini Dept Surg Surg Sci & Transplanta, I-001661 Rome, Italy.	paolo.bruzzone@fastwebnet.it	Bruzzone, Paolo/M-2089-2016	Bruzzone, Paolo/0000-0002-7124-1245				Bramstedt Katrina A, 2006, Prog Transplant, V16, P170; Bruzzone P, 2008, ORGAN TRANSPLANTATION: ETHICAL, LEGAL AND PSYCHOSOCIAL ASPECTS - TOWARDS A COMMON EUROPEAN POLICY, P327; Delaney J, 2009, AM J BIOETHICS, V9, P3, DOI 10.1080/15265160902985019; EPSTEIN RA, 2008, ALTRUISM IS NOT ENOU, P79; Kolber AJ, 2003, RUTGERS LAW REV, V55, P671; Kranenburg L, 2008, NEPHROL DIAL TRANSPL, V23, P1039, DOI 10.1093/ndt/gfm643; Lavee J, 2010, LANCET, V375, P1131, DOI 10.1016/S0140-6736(09)61795-5; Matesanz R., 2007, TRANSPLANT REV-ORLAN, V21, P177, DOI [10.1016/J.TRRE.2007.07.005, DOI 10.1016/J.TRRE.2007.07.005, 10.1016/j.trre.2007.07.005]; Steinberg D, 2004, AM J BIOETHICS, V4, P4, DOI 10.1080/15265160490518557; TABARROK A, 2009, LIFE SAVING INCENTIV; Trotter Griffin, 2008, Transplant Rev (Orlando), V22, P158, DOI 10.1016/j.trre.2008.04.001; Veatch RM, 2004, AM J BIOETHICS, V4, P1, DOI 10.1080/15265160490906709	12	8	8	0	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 10	2010	375	9722					1235	1236		10.1016/S0140-6736(09)61665-2	http://dx.doi.org/10.1016/S0140-6736(09)61665-2			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	585VN	20022101				2022-12-28	WOS:000276858400009
J	Unger, EF; Thompson, AM; Blank, MJ; Temple, R				Unger, Ellis F.; Thompson, Aliza M.; Blank, Melanie J.; Temple, Robert			Erythropoiesis-Stimulating Agents - Time for a Reevaluation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHRONIC KIDNEY-DISEASE; EPOETIN; ALPHA		[Unger, Ellis F.; Thompson, Aliza M.; Blank, Melanie J.; Temple, Robert] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Unger, EF (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; *FOOD DRUG ADM, 2007, FDA BRIEF INF JOINT; *FOOD DRUG ADM CTR, 2001, MED OFF CLIN REV DAR; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485	5	196	204	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3					189	192		10.1056/NEJMp0912328	http://dx.doi.org/10.1056/NEJMp0912328			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545NE	20054037				2022-12-28	WOS:000273738400001
J	Weeks, AD; Alia, G; Vernon, G; Namayanja, A; Gosakan, R; Majeed, T; Hart, A; Jafri, H; Nardin, J; Carroli, G; Fairlie, F; Raashid, Y; Mirembe, F; Alfirevic, Z				Weeks, Andrew D.; Alia, Godfrey; Vernon, Gillian; Namayanja, Annette; Gosakan, Radhika; Majeed, Tayyaba; Hart, Anna; Jafri, Hussain; Nardin, Juan; Carroli, Guillermo; Fairlie, Fiona; Raashid, Yasmin; Mirembe, Florence; Alfirevic, Zarko			Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial	LANCET			English	Article							MANAGEMENT; INJECTION	Background Retained placenta is associated with post-partum haemorrhage. Meta-analysis has suggested that umbilical injection of oxytocin could increase placental expulsion without the need for a surgeon or anaesthetic. We assessed the effect of high-dose umbilical vein oxytocin as a treatment for retained placenta. Methods In this double-blind, placebo-controlled trial, haemodynamically stable women with a retained placenta for more than 30 min were recruited from 13 sites in the UK, Uganda, and Pakistan. 577 women were randomly assigned by a computer-generated randomisation list stratified by Centre to 30 mL saline containing either 50 IU oxytocin (n=292) or 5 mL water (n=285), which was injected into the placenta through an umbilical vein catheter. All trial participants, study workers, and data handlers were masked to individual allocations. The primary outcome was the need for manual removal of the placenta. Analysis was by intention to treat. This study is registered, number ISRCTN 13204258. Findings The primary outcome was recorded for all participants. We detected no difference between the groups in the need for manual removal of placenta (oxytocin 179/292 [61.3%] vs placebo 177/285 [62.1%]; relative risk 0.98, 95% CI 0.87-1.12; p=0.84). The need for manual removal was higher in the UK (overall 250/361 [69%]) than in Uganda (90/190 [47%]) or Pakistan (16/26 [62%]). Adverse events did not differ between the two groups. Interpretation Umbilical oxytocin has no clinically significant effect on the need for manual removal for women with retained placenta. Funding WHO, WellBeing of Women, Pakistan Higher Education Commission.	[Weeks, Andrew D.] Univ Liverpool, Liverpool Womens Hosp, Sch Reprod & Dev Med, Liverpool L8 7SS, Merseyside, England; [Alia, Godfrey; Namayanja, Annette; Mirembe, Florence] Makerere Univ, Dept Obstet & Gynaecol, Kampala, Uganda; [Gosakan, Radhika; Fairlie, Fiona] Royal Hallamshire Hosp, Sheffield S10 2JF, S Yorkshire, England; [Majeed, Tayyaba; Jafri, Hussain; Raashid, Yasmin] Lady Willingdon Hosp, Dept Obstet & Gynaecol, Lahore, Pakistan; [Hart, Anna] Univ Cent Lancashire, Fac Hlth & Social Care, Preston PR1 2HE, Lancs, England; [Nardin, Juan; Carroli, Guillermo] CREP, Rosario, Santa Fe, Argentina	University of Liverpool; Makerere University; University of Sheffield; University of Central Lancashire	Weeks, AD (corresponding author), Univ Liverpool, Liverpool Womens Hosp, Sch Reprod & Dev Med, Crown St, Liverpool L8 7SS, Merseyside, England.	aweeks@liv.ac.uk			WHO [35026]; Well Being of Women [W1/03]; Pakistan Higher Education Commission [20-688/RD/06/1738]	WHO(World Health Organization); Well Being of Women(Wellbeing of Women (WoW)); Pakistan Higher Education Commission(Higher Education Commission of Pakistan)	Funding for this trial was provided by WHO (HRP project A 35026). Well Being of Women (W1/03), and Pakistan Higher Education Commission (20-688/R&D/06/1738). We thank all the midwives who recruited to the Release Study throughout the world and the participants who agreed to take part in the study; people who sat on the multiple review committees who helped to refine the study protocol, especially Gill Gyte, Elizabeth Key, and Tina Lavender who Worked with us over the complex consent issues; and Alliance Pharmaceuticals who donated and prepared the oxytocin and placebo vials for the trial.	[Anonymous], 2009, WHO GUID MAN POSTP H; *ASS IMPR MAT SERV, 1997, CHART ETH RES MAT CA; Calderale L, 1994, G ITAL OSTET GINECOL, V16, P283; Carroli G, 1998, BRIT J OBSTET GYNAEC, V105, P179, DOI 10.1111/j.1471-0528.1998.tb10049.x; Carroli G., 2001, COCHRANE DB SYST REV, V4; FRAPPELL JM, 1988, J OBSTET GYNAECOL, V8, P322, DOI 10.3109/01443618809008808; Gazvani MR, 1998, OBSTET GYNECOL, V91, P203, DOI 10.1016/S0029-7844(97)00622-4; HANSEN P, 1987, Ugeskrift for Laeger, V149, P3318; HERMAN A, 1993, AM J OBSTET GYNECOL, V168, P1496, DOI 10.1016/S0002-9378(11)90788-1; HUBER MGP, 1991, AM J OBSTET GYNECOL, V164, P1216, DOI 10.1016/0002-9378(91)90685-K; KRISTIANSEN FV, 1987, AM J OBSTET GYNECOL, V156, P979, DOI 10.1016/0002-9378(87)90372-3; Malek A, 1996, J Matern Fetal Med, V5, P245, DOI 10.1002/(SICI)1520-6661(199609/10)5:5<245::AID-MFM3>3.3.CO;2-L; PIPINGAS A, 1993, AM J OBSTET GYNECOL, V168, P793, DOI 10.1016/S0002-9378(12)90821-2; Rogers MS, 2007, ACTA OBSTET GYN SCAN, V86, P48, DOI 10.1080/00016340601088570; SELINGER M, 1986, J OBSTET GYNAECOL, V7, P115, DOI 10.3109/01443618609112286; Sivalingam N, 2001, Med J Malaysia, V56, P451; Vernon G, 2006, TRIALS, V7, DOI 10.1186/1745-6215-7-13; Weeks A, 2005, BJOG-INT J OBSTET GY, V112, P1458, DOI 10.1111/j.1471-0528.2005.00681.x; Weeks AD, 2002, EUR J OBSTET GYN R B, V102, P109, DOI 10.1016/S0301-2115(01)00592-9; Weeks AD, 2008, BEST PRACT RES CL OB, V22, P1103, DOI 10.1016/j.bpobgyn.2008.07.005; WILKENJENSEN C, 1989, AM J OBSTET GYNECOL, V161, P155, DOI 10.1016/0002-9378(89)90254-8; Yamahara N, 2000, LIFE SCI, V66, P1401, DOI 10.1016/S0024-3205(00)00451-3	22	29	29	0	5	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 9	2010	375	9709					141	147		10.1016/S0140-6736(09)61752-9	http://dx.doi.org/10.1016/S0140-6736(09)61752-9			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544NM	20004013				2022-12-28	WOS:000273664500031
J	Crocker, RM; Jones, DI; Melia, F; Ott, J; Protheroe, RJ				Crocker, Roland M.; Jones, David I.; Melia, Fulvio; Ott, Juergen; Protheroe, Raymond J.			A lower limit of 50 microgauss for the magnetic field near the Galactic Centre	NATURE			English	Article							RADIO-CONTINUUM SURVEY; INTERSTELLAR GAS; IRON LINE; EMISSION; PLANE; GALAXIES; ORIGIN; RIDGE; GHZ; ARC	The amplitude of the magnetic field near the Galactic Centre has been uncertain by two orders of magnitude for several decades. On a scale of similar to 100 parsecs (pc), fields of similar to 1,000 microgauss (mu G; refs 1-3) have been reported, implying a magnetic energy density more than 10,000 times stronger than typical for the Galaxy. Alternatively, the assumption of pressure equilibrium between the various phases of the Galactic Centre interstellar medium (including turbulent molecular gas, the contested(4) 'very hot' plasma, and the magnetic field) suggests fields of similar to 100 mu G over similar to 400 pc size scales(5). Finally, assuming equipartition, fields of only similar to 6 mu G have been inferred from radio observations(6) for 400 pc scales. Here we report a compilation of previous data that reveals a downward break in the region's non-thermal radio spectrum (attributable to a transition from bremsstrahlung to synchrotron cooling of the in situ cosmic-ray electron population). We show that the spectral break requires that the Galactic Centre field be at least similar to 50 mu G on 400 pc scales, lest the synchrotron-emitting electrons produce too much gamma-ray emission, given other existing constraints(7). Other considerations support a field of 100 mu G, implying that over 10% of the Galaxy's magnetic energy is contained in only less than or similar to 0.05% of its volume.	[Crocker, Roland M.] Monash Univ, Sch Phys, Clayton, Vic 3110, Australia; [Crocker, Roland M.; Jones, David I.] Max Planck Inst Kernphys, D-69117 Heidelberg, Germany; [Jones, David I.; Protheroe, Raymond J.] Univ Adelaide, Sch Phys & Chem, Dept Phys, Adelaide, SA 5005, Australia; [Jones, David I.] Australia Telescope Natl Facil, Marsfield, NSW 2122, Australia; [Melia, Fulvio] Univ Arizona, Dept Phys, Program Appl Math, Tucson, AZ 85721 USA; [Melia, Fulvio] Univ Arizona, Steward Observ, Tucson, AZ 85721 USA; [Ott, Juergen] Natl Radio Astron Observ, Socorro, NM 87801 USA; [Ott, Juergen] CALTECH, Pasadena, CA 91125 USA	Monash University; Max Planck Society; University of Adelaide; Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Arizona; University of Arizona; National Radio Astronomy Observatory (NRAO); California Institute of Technology	Crocker, RM (corresponding author), Monash Univ, Sch Phys, Clayton, Vic 3110, Australia.	Roland.Crocker@mpi-hd.mpg.de	Melia, Fulvio/V-4197-2018	Melia, Fulvio/0000-0002-8014-0593; Ott, Juergen/0000-0001-8224-1956; Crocker, Roland/0000-0002-2036-2426				Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; Crocker RM, 2007, ASTROPHYS J, V666, P934, DOI 10.1086/518243; DUNCAN AR, 1995, MON NOT R ASTRON SOC, V277, P36; Ferriere K, 2007, ASTRON ASTROPHYS, V467, P611, DOI 10.1051/0004-6361:20066992; Fukui Y, 2006, SCIENCE, V314, P106, DOI 10.1126/science.1130425; Gusten R, 2004, SPRINGER PROC PHYS, V91, P253; HANDA T, 1987, PUBL ASTRON SOC JPN, V39, P709; Hunter SD, 1997, ASTROPHYS J, V481, P205, DOI 10.1086/304012; KOYAMA K, 1989, NATURE, V339, P603, DOI 10.1038/339603a0; LaRosa TN, 2005, ASTROPHYS J, V626, pL23, DOI 10.1086/431647; MORRIS M, 1989, ASTROPHYS J, V343, P703, DOI 10.1086/167742; MORRIS M, 2007, GALACTIC CTR MAGNETO; Paglione TAD, 1998, ASTROPHYS J, V493, P680, DOI 10.1086/305136; PARKER EN, 1966, ASTROPHYS J, V145, P811, DOI 10.1086/148828; Porter TA, 2006, ASTROPHYS J, V648, pL29, DOI 10.1086/507770; REICH W, 1990, ASTRON ASTROPHYS SUP, V83, P539; Reich W., 1984, Astronomy & Astrophysics Supplement Series, V58, P197; Revnivtsev M, 2009, NATURE, V458, P1142, DOI 10.1038/nature07946; SPERGEL DN, 1992, NATURE, V357, P665, DOI 10.1038/357665a0; Thompson TA, 2006, ASTROPHYS J, V645, P186, DOI 10.1086/504035; Voelk H. J., 1989, ASTRON ASTROPHYS, V218, P67; Wommer E, 2008, MON NOT R ASTRON SOC, V387, P987, DOI 10.1111/j.1365-2966.2008.13308.x; YAMAUCHI S, 1990, ASTROPHYS J, V365, P532, DOI 10.1086/169507; Yun MS, 2001, ASTROPHYS J, V554, P803, DOI 10.1086/323145; YUSEFZADEH F, 1987, ASTRON J, V94, P1178, DOI 10.1086/114555; 2006, NATURE, V439, P695	26	123	123	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 7	2010	463	7277					65	67		10.1038/nature08635	http://dx.doi.org/10.1038/nature08635			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054391	Green Submitted			2022-12-28	WOS:000273344900030
J	Lang, KR				Lang, Kenneth R.			Serendipitous Astronomy	SCIENCE			English	Editorial Material									Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA	Tufts University	Lang, KR (corresponding author), Tufts Univ, Dept Phys & Astron, Medford, MA 02155 USA.	ken.lang@tufts.edu						Galilei G., 1610, SIDEREUS NUNCIUS; Herschel W., 1781, PHIL T R SOC, V71; KLEBESADEL RW, 1973, ASTROPHYS J, V182, pL85, DOI 10.1086/181225; Lang K. R., 2006, PARTING COSMIC VEIL; LANG KR, 1979, SOURCE BOOK ASTRONOM; Piazzi G., 1801, RISULTATI RISULTATI; TAYLOR JH, 1982, ASTROPHYS J, V253, P908, DOI 10.1086/159690; VANHELDEN A, 1989, SIDEREAL MESSENGER; 2009, JOINT INT ASTR UN IN	9	3	3	0	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 1	2010	327	5961					39	40		10.1126/science.1183653	http://dx.doi.org/10.1126/science.1183653			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044562				2022-12-28	WOS:000273395400020
J	Cao, B; Li, XW; Mao, Y; Wang, J; Lu, HZ; Chen, YS; Liang, ZA; Liang, LR; Zhang, SJ; Zhang, B; Gu, L; Lu, LH; Wang, DY; Wang, C				Cao, Bin; Li, Xing-Wang; Mao, Yu; Wang, Jian; Lu, Hong-Zhou; Chen, Yu-Sheng; Liang, Zong-An; Liang, Lirong; Zhang, Su-Juan; Zhang, Bin; Gu, Li; Lu, Lian-He; Wang, Da-Yan; Wang, Chen		Natl Influenza Pandemic H1N1 2009	Clinical Features of the Initial Cases of 2009 Pandemic Influenza A (H1N1) Virus Infection in China	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HOSPITALIZED-PATIENTS; CALIFORNIA; OUTCOMES	BACKGROUND The first case of 2009 pandemic influenza A (H1N1) virus infection in China was documented on May 10. Subsequently, persons with suspected cases of infection and contacts of those with suspected infection were tested. Persons in whom infection was confirmed were hospitalized and quarantined, and some of them were closely observed for the purpose of investigating the nature and duration of the disease. METHODS During May and June 2009, we observed 426 persons infected with the 2009 pandemic influenza A (H1N1) virus who were quarantined in 61 hospitals in 20 provinces. Real-time reverse-transcriptase-polymerase-chain-reaction (RT-PCR) testing was used to confirm infection, the clinical features of the disease were closely monitored, and 254 patients were treated with oseltamivir within 48 hours after the onset of disease. RESULTS The mean age of the 426 patients was 23.4 years, and 53.8% were male. The diagnosis was made at ports of entry (in 32.9% of the patients), during quarantine (20.2%), and in the hospital (46.9%). The median incubation period of the virus was 2 days (range, 1 to 7). The most common symptoms were fever (in 67.4% of the patients) and cough (69.5%). The incidence of diarrhea was 2.8%, and the incidence of nausea and vomiting was 1.9%. Lymphopenia, which was common in both adults (68.1%) and children (92.3%), typically occurred on day 2 (range, 1 to 3) and resolved by day 7 (range, 6 to 9). Hypokalemia was observed in 25.4% of the patients. Duration of fever was typically 3 days (range, 1 to 11). The median length of time during which patients had positive real-time RT-PCR test results was 6 days (range, 1 to 17). Independent risk factors for prolonged real-time RT-PCR positivity included an age of less than 14 years, male sex, and a delay from the onset of symptoms to treatment with oseltamivir of more than 48 hours. CONCLUSIONS Surveillance of the 2009 H1N1 virus in China shows that the majority of those infected have a mild illness. The typical period during which the virus can be detected with the use of real-time RT-PCR is 6 days (whether or not fever is present). The duration of infection may be shortened if oseltamivir is administered.	[Li, Xing-Wang; Mao, Yu; Zhang, Su-Juan; Zhang, Bin; Lu, Lian-He] Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, Beijing 100015, Peoples R China; [Cao, Bin; Liang, Lirong; Gu, Li; Wang, Chen] Capital Med Univ, Beijing Inst Resp Med, Beijing Chao Yang Hosp, Beijing 100020, Peoples R China; [Wang, Jian] Eighth Hosp Guangdong, Guangzhou, Guangdong, Peoples R China; [Lu, Hong-Zhou] Shanghai Publ Hlth Clin Ctr, Shanghai, Peoples R China; [Chen, Yu-Sheng] Fujian Prov Peoples Hosp, Fuzhou, Peoples R China; [Liang, Zong-An] Sichuan Univ, W China Med Sch, W China Hosp, Chengdu 610064, Peoples R China; [Wang, Da-Yan] Chinese Ctr Dis Control & Prevent, Chinese Natl Influenza Ctr, Beijing, Peoples R China	Capital Medical University; Capital Medical University; Sichuan University; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention	Li, XW (corresponding author), Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, 8 Jingshun E St, Beijing 100015, Peoples R China.	ditanlxw@yahoo.com.cn; cyh-birm@263.net	zhang, weidong/N-1070-2014; wang, chen/GWM-9481-2022	zhang, weidong/0000-0002-8079-1185; 	Chinese Ministry of Science and Technology; Beijing Science and Technology Project [Z08050700020801]; Beijing Nova Program [2007A037]; Important National Science and Technology-Specific Projects [2009ZX10004-016]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); Beijing Science and Technology Project; Beijing Nova Program(Beijing Municipal Science & Technology Commission); Important National Science and Technology-Specific Projects	Supported by grants from the Chinese Ministry of Science and Technology, the Beijing Science and Technology Project (Z08050700020801), the Beijing Nova Program (2007A037), and Important National Science and Technology-Specific Projects (2009ZX10004-016).	[Anonymous], 2009, Wkly Epidemiol Rec, V84, P237; Boivin G, 2003, J INFECT DIS, V188, P578, DOI 10.1086/377046; Booth CM, 2003, JAMA-J AM MED ASSOC, V289, P2801, DOI 10.1001/jama.289.21.JOC30885; Cao B, 2009, EMERG INFECT DIS, V15, P1418, DOI 10.3201/eid1509.090794; CDC, 2009, CDC PROT REALT RTPCR; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P467; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Choi KW, 2003, ANN INTERN MED, V139, P715, DOI 10.7326/0003-4819-139-9-200311040-00005; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Jordan H. T., 2009, Morbidity and Mortality Weekly Report, V58, P470; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Naffakh N, 2009, MICROBES INFECT, V11, P725, DOI 10.1016/j.micinf.2009.05.002; Nichols JE, 2001, J VIROL, V75, P5921, DOI 10.1128/JVI.73.13.5921-5929.2001; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Trifonov V, 2009, EURO SURVEILL, V14; WHO, 2009, WKLY EPIDEMIOL REC, V84, P185; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; *WHO, 2009, INFL A H1N1 UPD 14 G; WHO, 2009, WHO GUID PHARM MAN P; 2009, MMWR MORB MORTAL WKL, V58, P431	22	444	530	2	82	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2507	2517		10.1056/NEJMoa0906612	http://dx.doi.org/10.1056/NEJMoa0906612			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535WX	20007555	Bronze			2022-12-28	WOS:000273003700006
J	Shapira, SD; Gat-Viks, I; Shum, BOV; Dricot, A; de Grace, MM; Wu, LG; Gupta, PB; Hao, T; Silver, SJ; Root, DE; Hill, DE; Regev, A; Hacohen, N				Shapira, Sagi D.; Gat-Viks, Irit; Shum, Bennett O. V.; Dricot, Amelie; de Grace, Marciela M.; Wu, Liguo; Gupta, Piyush B.; Hao, Tong; Silver, Serena J.; Root, David E.; Hill, David E.; Regev, Aviv; Hacohen, Nir			A Physical and Regulatory Map of Host-Influenza Interactions Reveals Pathways in H1N1 Infection	CELL			English	Article							DOUBLE-STRANDED-RNA; VIRUS-INFECTION; NS1 PROTEIN; ANTIVIRAL RESPONSES; GENE-EXPRESSION; RIG-I; REPLICATION; BINDING; SCREEN; ACTIVATION	During the course of a viral infection, viral proteins interact with an array of host proteins and pathways. Here, we present a systematic strategy to elucidate the dynamic interactions between H1N1 influenza and its human host. A combination of yeast two-hybrid analysis and genome-wide expression profiling implicated hundreds of human factors in mediating viral-host interactions. These factors were then examined functionally through depletion analyses in primary lung cells. The resulting data point to potential roles for some unanticipated host and viral proteins in viral infection and the host response, including a network of RNA-binding proteins, components of WNT signaling, and viral polymerase subunits. This multilayered approach provides a comprehensive and unbiased physical and regulatory model of influenza-host interactions and demonstrates a general strategy for uncovering complex host-pathogen relationships.	[Shapira, Sagi D.; Gat-Viks, Irit; Shum, Bennett O. V.; de Grace, Marciela M.; Wu, Liguo; Gupta, Piyush B.; Silver, Serena J.; Root, David E.; Regev, Aviv; Hacohen, Nir] MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Shapira, Sagi D.; de Grace, Marciela M.; Wu, Liguo; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Shapira, Sagi D.; Wu, Liguo; Hacohen, Nir] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Dricot, Amelie; Hao, Tong; Hill, David E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [de Grace, Marciela M.] Harvard Univ, Sch Med, Program Virol, Boston, MA 02115 USA; [Dricot, Amelie; Hao, Tong; Hill, David E.] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Dricot, Amelie; Hao, Tong; Hill, David E.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Regev, A (corresponding author), MIT & Harvard, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	aregev@broad.mit.edu; nhacohen@partners.org	Hill, David E/B-6617-2011	Shapira, Sagi/0000-0002-5425-3682; Shum, Bennett/0000-0001-6150-7233	National Institutes of Health (NIH) [U01 AI074575, R01 HG001715, P50 HG004233]; NIH New Innovator Award; Ford Foundation Predoctoral Fellowship; EMBO Postdoctoral Fellowship; The Ellison Foundation; Howard Hughes Medical Institute; Burroughs Wellcome Fund; NIH Pioneer Award; Sloan Foundation;  [U54 AI057159]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004233, R01HG001715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074575, U54AI057159] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002230, DP1OD003958] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ford Foundation Predoctoral Fellowship; EMBO Postdoctoral Fellowship(European Molecular Biology Organization (EMBO)); The Ellison Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation(Alfred P. Sloan Foundation); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Lieber and K. Maciag for discussions and help with data analysis. We thank C. Shamu and S. Chiang at ICCB (HMS) for the siRNA library and expert advice, S. Gupta and the Broad's Genetic Analysis Platform for microarray processing, H. Le, A. Derr, B. Wong, and the staff at the Broad RNAi Platform for assistance with RNAi studies and analysis, L. Wu for the vRNA reporter plasmid, R. Cadagan and A. Garcia-Sastre for Delta NS1 virus, E. Fodor for PR8 plasmids, R. Lamb for Udorn plasmids, and S. Hart for assistance with artwork. This work was supported by National Institutes of Health (NIH) grant U01 AI074575 (N.H., D.R., and D.H.); U54 AI057159 and the NIH New Innovator Award (N.H.); Ford Foundation Predoctoral Fellowship (M.G.); EMBO Postdoctoral Fellowship (I.G.V.); The Ellison Foundation and NIH grants R01 HG001715 and P50 HG004233 (D.H.); and the Howard Hughes Medical Institute, a Career Award at the Scientific Interface from the Burroughs Wellcome Fund, the NIH Pioneer Award, and the Sloan Foundation (A.R.).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailer SM, 2009, CURR OPIN MICROBIOL, V12, P453, DOI 10.1016/j.mib.2009.06.004; Brander C, 2000, CURR OPIN MICROBIOL, V3, P379, DOI 10.1016/S1369-5274(00)00108-9; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; GARCIA JA, 1992, P NATL ACAD SCI USA, V89, P9372, DOI 10.1073/pnas.89.20.9372; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hayward S Diane, 2006, Sci STKE, V2006, pre4; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Luftig M, 2004, P NATL ACAD SCI USA, V101, P141, DOI 10.1073/pnas.2237183100; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Patel RC, 1999, J BIOL CHEM, V274, P20432, DOI 10.1074/jbc.274.29.20432; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Reichman TW, 2003, J MOL BIOL, V332, P85, DOI 10.1016/S0022-2836(03)00885-4; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wressnigg N, 2009, J GEN VIROL, V90, P366, DOI 10.1099/vir.0.006122-0	34	490	514	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1255	1267		10.1016/j.cell.2009.12.018	http://dx.doi.org/10.1016/j.cell.2009.12.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064372	Green Accepted, Bronze, Green Submitted			2022-12-28	WOS:000273048700014
J	Song, H; Kim, Y; Jang, YH; Jeong, H; Reed, MA; Lee, T				Song, Hyunwook; Kim, Youngsang; Jang, Yun Hee; Jeong, Heejun; Reed, Mark A.; Lee, Takhee			Observation of molecular orbital gating	NATURE			English	Article							ELECTRON-TUNNELING SPECTROSCOPY; SINGLE; CONDUCTANCE; TRANSISTOR; TRANSPORT; JUNCTIONS	The control of charge transport in an active electronic device depends intimately on the modulation of the internal charge density by an external node(1). For example, a field-effect transistor relies on the gated electrostatic modulation of the channel charge produced by changing the relative position of the conduction and valence bands with respect to the electrodes. In molecular-scale devices(2-10), a longstanding challenge has been to create a true three-terminal device that operates in this manner (that is, by modifying orbital energy). Here we report the observation of such a solid-state molecular device, in which transport current is directly modulated by an external gate voltage. Resonance-enhanced coupling to the nearest molecular orbital is revealed by electron tunnelling spectroscopy, demonstrating direct molecular orbital gating in an electronic device. Our findings demonstrate that true molecular transistors can be created, and so enhance the prospects for molecularly engineered electronic devices.	[Song, Hyunwook; Lee, Takhee] Gwangju Inst Sci & Technol, Dept Nanobio Mat & Elect, Kwangju 500712, South Korea; [Song, Hyunwook; Jang, Yun Hee; Lee, Takhee] Gwangju Inst Sci & Technol, Dept Mat Sci & Engn, Kwangju 500712, South Korea; [Kim, Youngsang; Jeong, Heejun] Hanyang Univ, Dept Appl Phys, Ansan 426791, South Korea; [Reed, Mark A.] Yale Univ, Dept Elect Engn, New Haven, CT 06520 USA; [Reed, Mark A.] Yale Univ, Dept Appl Phys, New Haven, CT 06520 USA	Gwangju Institute of Science & Technology (GIST); Gwangju Institute of Science & Technology (GIST); Hanyang University; Yale University; Yale University	Lee, T (corresponding author), Gwangju Inst Sci & Technol, Dept Nanobio Mat & Elect, Kwangju 500712, South Korea.	mark.reed@yale.edu; tlee@gist.ac.kr	Lee, Takhee/AAR-9632-2021; Kim, Youngsang/G-3964-2014; Kim, Youngsang/AAP-2256-2020; Reed, Mark/A-9970-2011	Lee, Takhee/0000-0001-5988-5219; Kim, Youngsang/0000-0002-8994-4897; Kim, Youngsang/0000-0002-8994-4897; Reed, Mark/0000-0001-6479-7256; Kim, Youngsang/0000-0001-6320-3380; Song, Hyunwook/0000-0002-7311-2463	Korean National Research Laboratory programme; Korean National Core Research Center; World Class University programme of the Korean Ministry of Education, Science and Technology; Program for Integrated Molecular System at the Gwangju Institute of Science and Technology; SystemIC2010 project of the Korean Ministry of Knowledge Economy; US Army Research Office [W911NF-08-1-0365]; Canadian Institute for Advanced Research	Korean National Research Laboratory programme; Korean National Core Research Center; World Class University programme of the Korean Ministry of Education, Science and Technology; Program for Integrated Molecular System at the Gwangju Institute of Science and Technology; SystemIC2010 project of the Korean Ministry of Knowledge Economy; US Army Research Office; Canadian Institute for Advanced Research(Canadian Institute for Advanced Research (CIFAR))	This work was supported by the Korean National Research Laboratory programme; a Korean National Core Research Center grant; the World Class University programme of the Korean Ministry of Education, Science and Technology; the Program for Integrated Molecular System at the Gwangju Institute of Science and Technology; the SystemIC2010 project of the Korean Ministry of Knowledge Economy; the US Army Research Office (W911NF-08-1-0365); and the Canadian Institute for Advanced Research.	Ahn CH, 2006, REV MOD PHYS, V78, P1185, DOI 10.1103/RevModPhys.78.1185; Andrews DQ, 2008, J AM CHEM SOC, V130, P17309, DOI 10.1021/ja804399q; AVIRAM A, 1974, CHEM PHYS LETT, V29, P277, DOI 10.1016/0009-2614(74)85031-1; Beebe JM, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.026801; Datta SS, 2009, PHYS REV B, V79, DOI 10.1103/PhysRevB.79.205404; Galperin M, 2004, J CHEM PHYS, V121, P11965, DOI 10.1063/1.1814076; GALPERIN M, 2004, NANO LETT, V4, P1605; Galperin M, 2008, SCIENCE, V319, P1056, DOI 10.1126/science.1146556; Ghosh AW, 2004, NANO LETT, V4, P565, DOI 10.1021/nl035109u; Ghosh S, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2140470; JAKLEVIC RC, 1966, PHYS REV LETT, V17, P1139, DOI 10.1103/PhysRevLett.17.1139; Joachim C, 2000, NATURE, V408, P541, DOI 10.1038/35046000; Komeda T, 2005, PROG SURF SCI, V78, P41, DOI 10.1016/j.progsurf.2005.05.001; Kubatkin S, 2003, NATURE, V425, P698, DOI 10.1038/nature02010; Kushmerick JG, 2004, NANO LETT, V4, P639, DOI 10.1021/nl049871n; Liang WJ, 2002, NATURE, V417, P725, DOI 10.1038/nature00790; Park J, 2002, NATURE, V417, P722, DOI 10.1038/nature00791; PERSSON BNJ, 1987, PHYS REV LETT, V59, P339, DOI 10.1103/PhysRevLett.59.339; Piva PG, 2005, NATURE, V435, P658, DOI 10.1038/nature03563; Reed MA, 1997, SCIENCE, V278, P252, DOI 10.1126/science.278.5336.252; Shimazaki T, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.115428; Stipe BC, 1998, SCIENCE, V280, P1732, DOI 10.1126/science.280.5370.1732; Troisi A, 2003, J CHEM PHYS, V118, P6072, DOI 10.1063/1.1556854; Troisi A, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2390698; Venkataraman L, 2006, NATURE, V442, P904, DOI 10.1038/nature05037; Wang WY, 2004, NANO LETT, V4, P643, DOI 10.1021/nl049870v; Wang WY, 2003, PHYS REV B, V68, DOI [10.1103/PhysRevB.68.035416, 10.1103/PhysRevB.68.184105]; Xu BQ, 2005, J AM CHEM SOC, V127, P2386, DOI 10.1021/ja042385h; Xu BQ, 2003, SCIENCE, V301, P1221, DOI 10.1126/science.1087481; Yu LH, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.206803	30	625	630	7	253	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1039	1043		10.1038/nature08639	http://dx.doi.org/10.1038/nature08639			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033044				2022-12-28	WOS:000272996000043
J	Thomas, EJ; Lucke, JF; Wueste, L; Weavind, L; Patel, B				Thomas, Eric J.; Lucke, Joseph F.; Wueste, Laura; Weavind, Lisa; Patel, Bela			Association of Telemedicine for Remote Monitoring of Intensive Care Patients With Mortality, Complications, and Length of Stay	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CRITICALLY ILL; OUTCOMES	Context Telemedicine technology, which can enable intensivists to simultaneously monitor several intensive care units (ICUs) from an off-site location, is increasingly common, but there is little evidence to support its use. Objective To assess the association of remote monitoring of ICU patients (ICU tele-medicine [tele-ICU]) with mortality, complications, and length of stay (LOS). Design, Setting, and Patients Observational study conducted in 6 ICUs of 5 hospitals in a large US health care system to assess the use of tele-ICU. The study included 2034 patients in the preintervention period (January 2003 to August 2005) and 2108 patients in the postintervention period (July 2004 to July 2006). Main Outcome Measures Hospital and ICU mortality, complications, and hospital and ICU survivors' LOS, with outcomes adjusted for severity of illness. Results Local physicians delegated full treatment authority to the tele-ICU for 655 patients (31.1%) and authority to intervene only in life-threatening events for the remainder. Observed hospital mortality rates were 12.0% (95% confidence interval [CI], 10.6% to 13.5%) in the preintervention period and 9.9% (95% CI, 8.6% to 11.2%) in the postintervention period (preintervention to postintervention decrease, 2.1%; 95% CI, 0.2% to 4.1%; P=.03); observed ICU mortality rates were 9.2% (95% CI, 8.0% to 10.5%) in the preintervention period and 7.8% (95% CI, 6.7% to 9.0%) in the postintervention period (preintervention to postintervention decrease, 1.4%; 95% CI, -0.3% to 3.2%; P=.12). After adjustment for severity of illness, there were no significant differences associated with the telemedicine intervention for hospital mortality ( relative risk, 0.85; 95% CI, 0.71 to 1.03) or for ICU mortality (relative risk, 0.88; 95% CI, 0.71 to 1.08). There was a significant interaction between the tele-ICU intervention and severity of illness (P<.001), in which tele-ICU was associated with improved survival in sicker patients but with no improvement or worse outcomes in less sick patients. There were no significant differences between the preintervention and postintervention periods for hospital or ICU LOS. Conclusion Remote monitoring of ICU patients was not associated with an overall improvement in mortality or LOS. JAMA. 2009;302(24):2671-2678 www.jama.com	[Thomas, Eric J.; Wueste, Laura; Weavind, Lisa; Patel, Bela] Univ Texas Hlth Sci Ctr Houston, Dept Internal Med, Houston, TX USA; [Lucke, Joseph F.] Univ Texas Hlth Sci Ctr Houston, Sch Med, Dept Pediat, Houston, TX USA; [Thomas, Eric J.; Wueste, Laura] Univ Texas Houston, Mem Hermann Ctr Healthcare Qual & Safety, Houston, TX USA	University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston	Thomas, EJ (corresponding author), Univ Texas Med Sch Houston, 6410 Fannin UPB 1100-45, Houston, TX 77030 USA.	eric.thomas@uth.tmc.edu			Agency for Healthcare Research and Quality [R01 HS015234-01]; National Center for Research Resources, National Institutes of Health [UL1 RR024148 01]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R01HS015234] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024148] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Center for Research Resources, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This study was funded by grant R01 HS015234-01 from the Agency for Healthcare Research and Quality and by grant UL1 RR024148 01 from the National Center for Research Resources, National Institutes of Health ( Clinical and Translational Sciences Award).	Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Bates D.M., 2009, LME4 LINEAR MIXED EF, VR package Ver. 0.999375-28; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Breslow MJ, 2004, CRIT CARE MED, V32, P31, DOI 10.1097/01.CCM.0000104204.61296.41; CHALFIN DB, 1995, INTENS CARE MED, V21, P952, DOI 10.1007/BF01712339; Gelman A., 2007, DATA ANAL USING REGR; Hoenig JM, 2001, AM STAT, V55, P19, DOI 10.1198/000313001300339897; JAMES D, 2008, CHRON CHRONOLOGICAL; Jung SH, 2001, STAT MED, V20, P1971, DOI 10.1002/sim.846.abs; KOLLEF MH, 1993, JAMA-J AM MED ASSOC, V270, P1965, DOI 10.1001/jama.270.16.1965; LAPSLEY M, 2008, RODBC ODBC DATABASE; LEGALL JR, 1993, JAMA-J AM MED ASSOC, V270, P2957, DOI 10.1001/jama.270.24.2957; Leisch F, 2002, COMPSTAT 2002: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P575; Little R.J.A., 2002, STAT ANAL MISSING DA; Loader C., 1999, LOCAL REGRESSION LIK; *NEW ENGL HEALTHC, 2007, TEL REM MAN INT CAR; Pronovost P J, 2001, Curr Opin Crit Care, V7, P297, DOI 10.1097/00075198-200108000-00014; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Pronovost PJ, 2002, JAMA-J AM MED ASSOC, V288, P2151, DOI 10.1001/jama.288.17.2151; Tang Z, 2007, CRIT CARE MED, V35, P2057, DOI 10.1097/01.CCM.0000281516.84767.96; Team RC., 2022, LANG ENV STAT COMP; Venables WN., 2002, MODERN APPL STAT S; Young M P, 2000, Eff Clin Pract, V3, P284	23	150	153	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 23	2009	302	24					2671	2678		10.1001/jama.2009.1902	http://dx.doi.org/10.1001/jama.2009.1902			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535JU	20040555	Bronze			2022-12-28	WOS:000272965300023
J	Weissman, MM; Olfson, M				Weissman, Myrna M.; Olfson, Mark			Translating Intergenerational Research on Depression Into Clinical Practice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							MATERNAL DEPRESSION; CARE; PSYCHOTHERAPY; PSYCHIATRY; HEALTH		[Olfson, Mark] Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, New York, NY 10032 USA	Columbia University; New York State Psychiatry Institute	Olfson, M (corresponding author), Columbia Univ Coll Phys & Surg, New York State Psychiat Inst, Dept Psychiat, 1051 Riverside Dr, New York, NY 10032 USA.	mo49@columbia.edu	Olfson, Mark/AAA-8547-2021	Weissman, Myrna/0000-0003-3490-3075	AHRQ HHS [U18 HS016097, HS016097] Funding Source: Medline; NIMH NIH HHS [R01 MH036197, P30 MH071478, R01 MH063852, MH036197, R01 MH082255, R01 MH036197-24A1, MH082255, MH071478, MH063852] Funding Source: Medline; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [U18HS016097] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH036197, R01MH082255, R01MH063852, P30MH071478] Funding Source: NIH RePORTER	AHRQ HHS(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		CUNNINGHAM PJ, 2009, HEALTH AFFAIR, V28, P490, DOI DOI 10.1377/HLTHAFF.28.3.W490; Garber J, 2009, JAMA-J AM MED ASSOC, V301, P2215, DOI 10.1001/jama.2009.788; Gilbody S, 2006, ARCH INTERN MED, V166, P2314, DOI 10.1001/archinte.166.21.2314; Kahn RS, 1999, PEDIATRICS, V103, P576, DOI 10.1542/peds.103.3.576; Leigh H, 2006, GEN HOSP PSYCHIAT, V28, P189, DOI 10.1016/j.genhosppsych.2005.10.003; Olson AL, 2002, PEDIATRICS, V110, P1169, DOI 10.1542/peds.110.6.1169; Swartz HA, 2008, AM J PSYCHIAT, V165, P1155, DOI 10.1176/appi.ajp.2008.07081339; Weissman MM, 2006, AM J PSYCHIAT, V163, P1001, DOI 10.1176/appi.ajp.163.6.1001; Weissman MM, 2006, JAMA-J AM MED ASSOC, V295, P1389, DOI 10.1001/jama.295.12.1389; Weissman MM, 2006, ARCH GEN PSYCHIAT, V63, P925, DOI 10.1001/archpsyc.63.8.925	10	19	20	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 23	2009	302	24					2695	2696		10.1001/jama.2009.1919	http://dx.doi.org/10.1001/jama.2009.1919			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535JU	20040558	Green Accepted			2022-12-28	WOS:000272965300026
J	Catalli, K; Shim, SH; Prakapenka, V				Catalli, Krystle; Shim, Sang-Heon; Prakapenka, Vitali			Thickness and Clapeyron slope of the post-perovskite boundary	NATURE			English	Article							EARTHS LOWER MANTLE; PHASE-TRANSITION; LOWERMOST-MANTLE; D''-LAYER; MGSIO3; POSTPEROVSKITE; DISCONTINUITY	The thicknesses and Clapeyron slopes of mantle phase boundaries strongly influence the seismic detectability of the boundaries and convection in the mantle. The unusually large positive Clapeyron slope found for the boundary between perovskite (Pv) and post-perovskite (pPv)(1-3) ( the 'pPv boundary') would destabilize high-temperature anomalies in the lowermost mantle(4), in disagreement with the seismic observations(5). Here we report the thickness of the pPv boundary in (Mg0.91Fe0.092+)SiO3 and (Mg0.9Fe0.13+)(Al0.1Si0.9)O-3 as determined in a laser-heated diamond-anvil cell under in situ high-pressure (up to 145 GPa), high-temperature ( up to 3,000 K) conditions. The measured Clapeyron slope is consistent with the D '' discontinuity(6). In both systems, however, the pPv boundary thickness increases to 400-600 +/- 100 km, which is substantially greater than the thickness of the D '' discontinuity (< 30 km)(7). Although the Fe2+ buffering effect of ferropericlase(8-10) could decrease the pPv boundary thickness, the boundary may remain thick in a pyrolitic composition because of the effects of Al and the rapid temperature increase in the D '' layer. The pPv boundary would be particularly thick in regions with an elevated Al content and/or a low Mg/Si ratio, reducing the effects of the large positive Clapeyron slope on the buoyancy of thermal anomalies and stabilizing compositional heterogeneities in the lowermost mantle. If the pPv transition is the source of the D '' discontinuity, regions with sharp discontinuities may require distinct compositions, such as a higher Mg/Si ratio or a lower Al content.	[Catalli, Krystle; Shim, Sang-Heon] MIT, Cambridge, MA 02139 USA; [Prakapenka, Vitali] Univ Chicago, GeoSoilEnviroCARS, Chicago, IL 60637 USA	Massachusetts Institute of Technology (MIT); University of Chicago	Shim, SH (corresponding author), MIT, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	sangshim@mit.edu		Shim, Sang-Heon/0000-0001-5203-6038	US National Science Foundation (NSF) [EAR0738655]; US Department of Energy ( DOE) National Nuclear Security Administration Stewardship Science Graduate Fellowship	US National Science Foundation (NSF)(National Science Foundation (NSF)); US Department of Energy ( DOE) National Nuclear Security Administration Stewardship Science Graduate Fellowship(United States Department of Energy (DOE))	This work is supported by the US National Science Foundation (NSF) grant EAR0738655 (S.-H. S.) and a US Department of Energy ( DOE) National Nuclear Security Administration Stewardship Science Graduate Fellowship ( K. C.). A. Kubo and B. Grocholski assisted in X-ray measurements. Discussion with T. L. Grove and R. D. van der Hilst improved the paper. This work was performed in the GeoSoilEnviroCARS sector of the Advanced Light Source (APS), Argonne National Laboratory. GeoSoilEnviroCARS is supported by the NSF and the DOE. Use of the APS is supported by the DOE.	Auzende AL, 2008, EARTH PLANET SC LETT, V269, P164, DOI 10.1016/j.epsl.2008.02.001; Garnero EJ, 2007, GEOL SOC AM SPEC PAP, V430, P79, DOI 10.1130/2007.2430(05); Garnero EJ, 2000, ANNU REV EARTH PL SC, V28, P509, DOI 10.1146/annurev.earth.28.1.509; Hammersley AP, 1997, FIT2D INTRO OVERVIEW; Hirose K, 1999, NATURE, V397, P53, DOI 10.1038/16225; Hirose K, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL024468; Hutko AR, 2008, SCIENCE, V320, P1070, DOI 10.1126/science.1155822; Jeanloz R, 1984, J PHYS C SOLID STATE, VC8, P83; Kobayashi Y, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023257; Lay T, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032465; Lay T, 1998, NATURE, V392, P461, DOI 10.1038/33083; Lay T, 2006, SCIENCE, V314, P1272, DOI 10.1126/science.1133280; Mao WL, 2004, P NATL ACAD SCI USA, V101, P15867, DOI 10.1073/pnas.0407135101; McCammon C, 1997, NATURE, V387, P694, DOI 10.1038/42685; Murakami M, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021956; Murakami M, 2004, SCIENCE, V304, P855, DOI 10.1126/science.1095932; Nakagawa T, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020648; Ni SD, 2002, SCIENCE, V296, P1850, DOI 10.1126/science.1070698; Nishio-Hamane D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029991; Oganov AR, 2004, NATURE, V430, P445, DOI 10.1038/nature02701; Ono S, 2005, EARTH PLANET SC LETT, V236, P914, DOI 10.1016/j.epsl.2005.06.001; Shim SH, 2008, P NATL ACAD SCI USA, V105, P7382, DOI 10.1073/pnas.0711174105; Shim SH, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019639; Sidorin I, 1999, SCIENCE, V286, P1326, DOI 10.1126/science.286.5443.1326; Sinmyo R, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL025858; Sinmyo R, 2008, J GEOPHYS RES-SOL EA, V113, DOI 10.1029/2008JB005730; Stixrude L, 1997, J GEOPHYS RES-SOL EA, V102, P14835, DOI 10.1029/97JB00550; Tangeman JA, 2001, GEOPHYS RES LETT, V28, P2517, DOI 10.1029/2000GL012222; Tateno S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL023309; Tateno S, 2009, EARTH PLANET SC LETT, V277, P130, DOI 10.1016/j.epsl.2008.10.004; Tsuchiya T, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2003JB002446; Tsuchiya T, 2004, EARTH PLANET SC LETT, V224, P241, DOI 10.1016/j.epsl.2004.05.017; van der Hilst RD, 2007, SCIENCE, V315, P1813, DOI 10.1126/science.1137867; Wookey J, 2005, NATURE, V438, P1004, DOI 10.1038/nature04345	34	88	90	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					782	U101		10.1038/nature08598	http://dx.doi.org/10.1038/nature08598			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010685				2022-12-28	WOS:000272559900037
J	Grundy, C; Steinbach, R; Edwards, P; Green, J; Armstrong, B; Wilkinson, P				Grundy, Chris; Steinbach, Rebecca; Edwards, Phil; Green, Judith; Armstrong, Ben; Wilkinson, Paul			Effect of 20 mph traffic speed zones on road injuries in London, 1986-2006: controlled interrupted time series analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DISEASE; SAFETY; BURDEN; RISK	Objective To quantify the effect of the introduction of 20 mph ( 32 km an hour) traffic speed zones on road collisions, injuries, and fatalities in London. Design Observational study based on analysis of geographically coded police data on road casualties, 1986-2006. Analyses were made of longitudinal changes in counts of road injuries within each of 119 029 road segments with at least one casualty with conditional fixed effects Poisson models. Estimates of the effect of introducing 20 mph zones on casualties within those zones and in adjacent areas were adjusted for the underlying downward trend in traffic casualties. Setting London. Main outcome measures All casualties from road collisions; those killed and seriously injured (KSI). Results The introduction of 20 mph zones was associated with a 41.9% (95% confidence interval 36.0% to 47.8%) reduction in road casualties, after adjustment for underlying time trends. The percentage reduction was greatest in younger children and greater for the category of killed or seriously injured casualties than for minor injuries. There was no evidence of casualty migration to areas adjacent to 20 mph zones, where casualties also fell slightly by an average of 8.0% (4.4% to 11.5%). Conclusions 20 mph zones are effective measures for reducing road injuries and deaths.	[Grundy, Chris; Green, Judith; Armstrong, Ben; Wilkinson, Paul] Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England; [Edwards, Phil] Univ London London Sch Hyg & Trop Med, Dept Epidemiol & Populat Hlth, London WC1E 7HT, England	University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine	Grundy, C (corresponding author), Univ London London Sch Hyg & Trop Med, Dept Publ Hlth & Policy, London WC1E 7HT, England.	chris.grundy@lshtm.ac.uk		Green, Judith/0000-0002-2315-5326; Edwards, Phil/0000-0003-4431-8822; Steinbach, Rebecca/0000-0002-5674-2455; armstrong, benedict/0000-0003-4407-0409; Wilkinson, Paul/0000-0001-7456-259X	Transport for London [TfL2218]	Transport for London	This study was funded by Transport for London ( contract No TfL2218). The views expressed in the publication are those of the authors and not necessarily those of Transport for London.	Aarts L, 2006, ACCIDENT ANAL PREV, V38, P215, DOI 10.1016/j.aap.2005.07.004; BANNISTER D, 2005, ROLE TRANSPORT SUPPO; Bunn F, 2003, INJURY PREV, V9, P200, DOI 10.1136/ip.9.3.200; Bunn F., 2003, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD003110, DOI 10.1002/14651858.CD003110]; Cook C., 2005, ASSESSING IMPACT TRA; Department for Transport, 2007, ROAD CAS GREAT BRIT; Department for Transport, 2000, TOM ROADS SAF EV; Elvik R, 2001, ACCIDENT ANAL PREV, V33, P327, DOI 10.1016/S0001-4575(00)00046-4; Grundy C., 2008, 20 MPH ZONES ROAD SA; Hyder AA, 2003, LANCET, V362, P2034, DOI 10.1016/S0140-6736(03)15145-8; Hyder Adnan A, 2004, J Coll Physicians Surg Pak, V14, P742; Lopez AD, 2006, LANCET, V367, P1747, DOI 10.1016/S0140-6736(06)68770-9; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Persaud B, 2007, ACCIDENT ANAL PREV, V39, P546, DOI 10.1016/j.aap.2006.09.009; Ward H, 2006, 69 DEP TRANSP; WEBSTER D, 2003, PPR243	16	114	116	1	32	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2009	339								b4469	10.1136/bmj.b4469	http://dx.doi.org/10.1136/bmj.b4469			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VH	20007666	Green Accepted, Green Submitted, Green Published, hybrid			2022-12-28	WOS:000272697600002
J	Shu, XO; Zheng, Y; Cai, H; Gu, K; Chen, Z; Zheng, W; Lu, W				Shu, Xiao Ou; Zheng, Ying; Cai, Hui; Gu, Kai; Chen, Zhi; Zheng, Wei; Lu, Wei			Soy Food Intake and Breast Cancer Survival	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RISK; TAMOXIFEN; GENISTEIN; ISOFLAVONES; SUPPLEMENTATION; PHYTOESTROGENS; DIET; CONSUMPTION; PROGNOSIS; WOMEN	Context Soy foods are rich in isoflavones, a major group of phytoestrogens that have been hypothesized to reduce the risk of breast cancer. However, the estrogen-like effect of isoflavones and the potential interaction between isoflavones and tamoxifen have led to concern about soy food consumption among breast cancer patients. Objective To evaluate the association of soy food intake after diagnosis of breast cancer with total mortality and cancer recurrence. Design, Setting, and Participants The Shanghai Breast Cancer Survival Study, a large, population-based cohort study of 5042 female breast cancer survivors in China. Women aged 20 to 75 years with diagnoses between March 2002 and April 2006 were recruited and followed up through June 2009. Information on cancer diagnosis and treatment, lifestyle exposures after cancer diagnosis, and disease progression was collected at approximately 6 months after cancer diagnosis and was reassessed at 3 follow-up interviews conducted at 18, 36, and 60 months after diagnosis. Annual record linkage with the Shanghai Vital Statistics Registry database was carried out to obtain survival information for participants who were lost to follow-up. Medical charts were reviewed to verify disease and treatment information. Main Outcome Measures Total mortality and breast cancer recurrence or breast cancer-related deaths. Cox regression analysis was carried out with adjustment for known clinical predictors and other lifestyle factors. Soy food intake was treated as a time-dependent variable. Results During the median follow-up of 3.9 years (range, 0.5-6.2 years), 444 deaths and 534 recurrences or breast cancer-related deaths were documented in 5033 surgically treated breast cancer patients. Soy food intake, as measured by either soy protein or soy isoflavone intake, was inversely associated with mortality and recurrence. The hazard ratio associated with the highest quartile of soy protein intake was 0.71 (95% confidence interval [CI], 0.54-0.92) for total mortality and 0.68 (95% CI, 0.54-0.87) for recurrence compared with the lowest quartile of intake. The multivariate-adjusted 4-year mortality rates were 10.3% and 7.4%, and the 4-year recurrence rates were 11.2% and 8.0%, respectively, for women in the lowest and highest quartiles of soy protein intake. The inverse association was evident among women with either estrogen receptor-positive or-negative breast cancer and was present in both users and nonusers of tamoxifen. Conclusion Among women with breast cancer, soy food consumption was significantly associated with decreased risk of death and recurrence. JAMA. 2009; 302(22): 2437-2443	[Shu, Xiao Ou; Cai, Hui; Chen, Zhi; Zheng, Wei] Vanderbilt Univ, Med Ctr, Dept Med, Vanderbilt Epidemiol Ctr,Div Epidemiol, Nashville, TN 37203 USA; [Shu, Xiao Ou; Cai, Hui; Chen, Zhi; Zheng, Wei] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN 37203 USA; [Zheng, Ying; Gu, Kai; Lu, Wei] Shanghai Inst Prevent Med, Shanghai, Peoples R China	Vanderbilt University; Vanderbilt University	Shu, XO (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Vanderbilt Epidemiol Ctr,Div Epidemiol, 2525 W End Ave,Ste 600, Nashville, TN 37203 USA.	xiao-ou.shu@vanderbilt.edu	Zheng, Wei/O-3351-2013; Lu, Wei/AAE-2921-2022; zhang, weihua/GXV-1334-2022	Zheng, Wei/0000-0003-1226-070X; Lu, Wei/0000-0002-4150-8674; 	US Department of Defense [DAMD17-02-1-0607]; National Cancer Institute [R01 CA118229]; NATIONAL CANCER INSTITUTE [R01CA118229] Funding Source: NIH RePORTER	US Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by grants from the US Department of Defense Breast Cancer Research Program (grant DAMD17-02-1-0607) and the National Cancer Institute (grant R01 CA118229).	Adlercreutz H, 1997, ANN MED, V29, P95, DOI 10.3109/07853899709113696; Albertazzi P, 1998, OBSTET GYNECOL, V91, P6, DOI 10.1016/S0029-7844(97)00597-8; [Anonymous], 1998, INT CLASSIFICATION D; CASSIDY A, 1994, AM J CLIN NUTR, V60, P333, DOI 10.1093/ajcn/60.3.333; Cassidy Aedin, 2006, J Br Menopause Soc, V12, P49, DOI 10.1258/136218006777525776; Clarkson TB, 2002, J NUTR, V132, p566S, DOI 10.1093/jn/132.3.566S; Constantinou AI, 2005, EUR J CANCER, V41, P647, DOI 10.1016/j.ejca.2004.12.005; Duncan AM, 1999, J CLIN ENDOCR METAB, V84, P192, DOI 10.1210/jc.84.1.192; Grunau GL, 2006, J CLIN EPIDEMIOL, V59, P274, DOI 10.1016/j.jclinepi.2005.08.007; Guha N, 2009, BREAST CANCER RES TR, V118, P395, DOI 10.1007/s10549-009-0321-5; Harrell F.E., 2015, REGRESSION MODELING, DOI [10.1007/978-3-319-19425-7, DOI 10.1007/978-3-319-19425-7, 10.1007/978-1-4757-3462-1]; Helferich W. G., 2008, Inflammopharmacology, V16, P219, DOI 10.1007/s10787-008-8020-0; Horn-Ross PL, 2003, J NATL CANCER I, V95, P1158, DOI 10.1093/jnci/djg015; Hosmer D. W., 1999, APPL SURVIVAL ANAL; Ishimi Y, 2009, FORUM NUTR, V61, P104, DOI 10.1159/000212743; Ju YH, 2002, CANCER RES, V62, P2474; Lee SA, 2009, AM J CLIN NUTR, V89, P1920, DOI 10.3945/ajcn.2008.27361; Lu LJW, 1996, CANCER EPIDEM BIOMAR, V5, P63; Messina MJ, 2008, NUTR J, V7, DOI 10.1186/1475-2891-7-17; Mouridsen HT, 2003, BREAST, V12, pS2, DOI 10.1016/S0960-9776(03)80158-3; MURKIES AL, 1995, MATURITAS, V21, P189, DOI 10.1016/0378-5122(95)00899-V; Nagata C, 1998, JNCI-J NATL CANCER I, V90, P1830, DOI 10.1093/jnci/90.23.1830; Pierce JP, 2007, J CLIN ONCOL, V25, P2345, DOI 10.1200/JCO.2006.08.6819; Pierce JP, 2007, JAMA-J AM MED ASSOC, V298, P289, DOI 10.1001/jama.298.3.289; Pierce JP, 2009, CURR OPIN OBSTET GYN, V21, P86, DOI 10.1097/GCO.0b013e32831da7f2; Quella SK, 2000, J CLIN ONCOL, V18, P1068, DOI 10.1200/JCO.2000.18.5.1068; Schwartz JA, 1998, BIOCHEM BIOPH RES CO, V253, P38, DOI 10.1006/bbrc.1998.9751; Shen F, 1999, ANTICANCER RES, V19, P1657; Shu XO, 2004, EUR J CLIN NUTR, V58, P17, DOI 10.1038/sj.ejcn.1601738; Tanos V, 2002, EUR J OBSTET GYN R B, V102, P188, DOI 10.1016/S0301-2115(01)00582-6; Taylor CK, 2009, NUTR REV, V67, P398, DOI 10.1111/j.1753-4887.2009.00213.x; Trock BJ, 2006, JNCI-J NATL CANCER I, V98, P459, DOI 10.1093/jnci/djj102; *UN SOYB BOARD, NAT REP CONS ATT NUT; Velentzis LS, 2008, EUR J CANCER, V44, P1799, DOI 10.1016/j.ejca.2008.05.019; Washburn S, 1999, MENOPAUSE, V6, P7; Wu AH, 2008, BRIT J CANCER, V98, P9, DOI 10.1038/sj.bjc.6604145; Yang Y, 2002, CHINESE FOOD COMPOSI	37	276	289	2	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2437	2443		10.1001/jama.2009.1783	http://dx.doi.org/10.1001/jama.2009.1783			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529MD	19996398	Green Accepted, Bronze			2022-12-28	WOS:000272520500022
J	Hulleman, CS; Harackiewicz, JM				Hulleman, Chris S.; Harackiewicz, Judith M.			Promoting Interest and Performance in High School Science Classes	SCIENCE			English	Article							ACHIEVEMENT GOALS; PIPELINE; VALUES	We tested whether classroom activities that encourage students to connect course materials to their lives will increase student motivation and learning. We hypothesized that this effect will be stronger for students who have low expectations of success. In a randomized field experiment with high school students, we found that a relevance intervention, which encouraged students to make connections between their lives and what they were learning in their science courses, increased interest in science and course grades for students with low success expectations. The results have implications for the development of science curricula and theories of motivation.	[Hulleman, Chris S.] James Madison Univ, Dept Grad Psychol, Harrisonburg, VA 22807 USA; [Harackiewicz, Judith M.] Univ Wisconsin, Dept Psychol, Madison, WI 53706 USA	James Madison University; University of Wisconsin System; University of Wisconsin Madison	Hulleman, CS (corresponding author), James Madison Univ, Dept Grad Psychol, Harrisonburg, VA 22807 USA.	hullemcs@jmu.edu			Department of Psychology and the Institute for Education Sciences; U. S. Department of Education [R305C050055, R305B050029]	Department of Psychology and the Institute for Education Sciences; U. S. Department of Education(US Department of Education)	This article is based on a doctoral dissertation submitted by C. S. H. to the University of Wisconsin-Madison under the supervision of J. M. H. Thanks are extended to M. Alibali, G. Borman, P. Devine, and A. Gamoran for their service on the dissertation committee; to the Madison Metropolitan School District for their assistance with data collection; and to J. Hyde, S. McFadyen- Ketchum, C. Thurber, and T. Hulleman for their comments on earlier versions of this manuscript. This research was supported in part by grants from the Department of Psychology and the Institute for Education Sciences, U. S. Department of Education, through award no. R305C050055 to the University of Wisconsin-Madison and award no. R305B050029 to Vanderbilt University.	Cohen GL, 2006, SCIENCE, V313, P1307, DOI 10.1126/science.1128317; Denofrio LA, 2007, SCIENCE, V318, P1872, DOI 10.1126/science.1150788; Eccles (Parsons) J. S., 1983, ACHIEVEMENT ACHIEVEM, P75, DOI DOI 10.1007/S11251-015-9352-Y; Fortenberry NL, 2007, SCIENCE, V317, P1175, DOI 10.1126/science.1143834; Hanauer DI, 2006, SCIENCE, V314, P1880, DOI 10.1126/science.1136796; Harackiewicz JM, 2002, J EDUC PSYCHOL, V94, P562, DOI 10.1037//0022-0663.94.3.562; *HELP AM YOUTH, 2008, CAR AC; HIDI S, 1990, REV EDUC RES, V60, P549, DOI 10.3102/00346543060004549; Hidi S, 2000, REV EDUC RES, V70, P151, DOI 10.2307/1170660; Hidi S, 2006, EDUC PSYCHOL-US, V41, P111, DOI 10.1207/s15326985ep4102_4; Hulleman CS, 2008, J EDUC PSYCHOL, V100, P398, DOI 10.1037/0022-0663.100.2.398; HULLEMAN CS, J ED PSYCHO IN PRESS; Jacobs JE, 2002, CHILD DEV, V73, P509, DOI 10.1111/1467-8624.00421; Kwiek NC, 2007, SCIENCE, V317, P1871, DOI 10.1126/science.1146811; Lepper M.R., 2000, INTRINSIC EXTRINSIC, P257, DOI [10.1016/B978-012619070-0/50032-5, DOI 10.1016/B978-012619070-0/50032-5]; Linn MC, 2006, SCIENCE, V313, P1049, DOI 10.1126/science.1131408; *METR NASHV PUBL S, 2008, METR NASHV PUBL SCH; Mitchell K., 2005, RIGOR RELEVANCE RESU; National Research Council, 2000, PEOPLE LEARN BRAIN M; National Research Council & the Institute of Medicine, 2004, ENG SCH FOST HIGH SC; NEWBY TJ, 1991, J EDUC PSYCHOL, V83, P195, DOI 10.1037/0022-0663.83.2.195; Newmann F. M., 2001, AUTHENTIC INTELLECTU; Newmann FM, 1996, AM J EDUC, V104, P280, DOI 10.1086/444136; Pintrich PR., 2002, MOTIVATION ED THEORY; Russell SH, 2007, SCIENCE, V316, P548, DOI 10.1126/science.1140384; Tucker SA, 2008, SCIENCE, V319, P1621, DOI 10.1126/science.1153261; Updegraff KA, 1996, LEARN INDIVID DIFFER, V8, P239, DOI 10.1016/S1041-6080(96)90016-3	27	519	529	9	111	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1410	1412		10.1126/science.1177067	http://dx.doi.org/10.1126/science.1177067			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	527EX	19965759				2022-12-28	WOS:000272351100045
J	Rewitz, KF; Yamanaka, N; Gilbert, LI; O'Connor, MB				Rewitz, Kim F.; Yamanaka, Naoki; Gilbert, Lawrence I.; O'Connor, Michael B.			The Insect Neuropeptide PTTH Activates Receptor Tyrosine Kinase Torso to Initiate Metamorphosis	SCIENCE			English	Article							PROTHORACICOTROPIC HORMONE; BOMBYX-MORI; BODY-SIZE; DROSOPHILA; SIGNAL; ERK; ECDYSONE; PATHWAY; MECHANISMS	Holometabolous insects undergo complete metamorphosis to become sexually mature adults. Metamorphosis is initiated by brain-derived prothoracicotropic hormone ( PTTH), which stimulates the production of the molting hormone ecdysone via an incompletely defined signaling pathway. Here we demonstrate that Torso, a receptor tyrosine kinase that regulates embryonic terminal cell fate in Drosophila, is the PTTH receptor. Trunk, the embryonic Torso ligand, is related to PTTH, and ectopic expression of PTTH in the embryo partially rescues trunk mutants. In larvae, torso is expressed specifically in the prothoracic gland ( PG), and its loss phenocopies the removal of PTTH. The activation of Torso by PTTH stimulates extracellular signal-regulated kinase (ERK) phosphorylation, and the loss of ERK in the PG phenocopies the loss of PTTH and Torso. We conclude that PTTH initiates metamorphosis by activation of the Torso/ERK pathway.	[Rewitz, Kim F.; Yamanaka, Naoki; O'Connor, Michael B.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Yamanaka, Naoki; O'Connor, Michael B.] Univ Minnesota, Howard Hughes Med Inst, Minneapolis, MN 55455 USA; [Gilbert, Lawrence I.] Univ N Carolina, Dept Biol, Chapel Hill, NC 27599 USA	University of Minnesota System; University of Minnesota Twin Cities; Howard Hughes Medical Institute; University of Minnesota System; University of Minnesota Twin Cities; University of North Carolina; University of North Carolina Chapel Hill	O'Connor, MB (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	moconnor@umn.edu	O'Connor, Michael B/C-9977-2014; Yamanaka, Naoki/F-1358-2010; Rewitz, Kim F/M-6012-2014	O'Connor, Michael B/0000-0002-3067-5506; Yamanaka, Naoki/0000-0002-6244-2686; Rewitz, Kim F/0000-0002-4409-9941	Danish Natural Science Research Council [272-07-0340]; Howard Hughes Medical Institute	Danish Natural Science Research Council(Danish Natural Science Research Council); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	K. F. R. was supported by a postdoctoral fellowship from the Danish Natural Science Research Council ( grant no. 272-07-0340). M. B. O. is an investigator with the Howard Hughes Medical Institute. We are grateful to our collaborators J. T. Warren and R. Rybczynski and to reviewers for helpful comments. We also thank H. Kataoka for Bombyx PTTH. The GenBank accession number for Bombyx Torso is GQ477743.	Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Casali A, 2001, DEVELOPMENT, V128, P1709; CASANOVA J, 1989, GENE DEV, V3, P2025, DOI 10.1101/gad.3.12b.2025; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Gilbert LI, 2002, ANNU REV ENTOMOL, V47, P883, DOI 10.1146/annurev.ento.47.091201.145302; KAWAKAMI A, 1990, SCIENCE, V247, P1333, DOI 10.1126/science.2315701; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Li WX, 2005, DEV DYNAM, V232, P656, DOI 10.1002/dvdy.20295; Lin JL, 2007, J INSECT PHYSIOL, V53, P622, DOI 10.1016/j.jinsphys.2007.03.004; McBrayer Z, 2007, DEV CELL, V13, P857, DOI 10.1016/j.devcel.2007.11.003; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Mishra S, 2005, CURR BIOL, V15, P366, DOI 10.1016/j.cub.2005.02.022; NOGUTI T, 1995, FEBS LETT, V376, P251, DOI 10.1016/0014-5793(95)01296-8; Ono H, 2006, DEV BIOL, V298, P555, DOI 10.1016/j.ydbio.2006.07.023; Popa SM, 2008, ANNU REV PHYSIOL, V70, P213, DOI 10.1146/annurev.physiol.70.113006.100540; Rewitz KF, 2009, INSECT BIOCHEM MOLEC, V39, P475, DOI 10.1016/j.ibmb.2009.04.005; Rybczynski R, 2003, MOL CELL ENDOCRINOL, V205, P159, DOI 10.1016/S0303-7207(03)00090-X; Rybczynski R, 2001, MOL CELL ENDOCRINOL, V184, P1, DOI 10.1016/S0303-7207(01)00664-5; RYBCZYNSKI R, 2005, COMPREHENSIVE MOL IN, V3, P61; SPRENGER F, 1989, NATURE, V338, P478, DOI 10.1038/338478a0	20	213	234	3	83	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1403	1405		10.1126/science.1176450	http://dx.doi.org/10.1126/science.1176450			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965758				2022-12-28	WOS:000272351100043
J	Lee, PV; Berenson, RA; Tooker, J				Lee, Peter V.; Berenson, Robert A.; Tooker, John			Payment Reform - The Need to Harmonize Approaches in Medicare and the Private Sector	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Lee, Peter V.] Pacific Business Grp Hlth, San Francisco, CA USA; [Berenson, Robert A.] Urban Inst, Washington, DC 20037 USA; [Tooker, John] Amer Coll Physicians, Philadelphia, PA USA	Urban Institute; American College of Physicians	Lee, PV (corresponding author), Pacific Business Grp Hlth, San Francisco, CA USA.							Centers for Medicare & Medicaid Services, NAT HLTH EXP FACT SH; Fisher ES, 2007, HEALTH AFFAIR, V26, pW44, DOI 10.1377/hlthaff.26.1.w44; GINSBURG PB, 2005, HLTH AFF MILLWOOD S; *MED PAYM ADV COMM, 2008, REF DEL SYST	4	10	10	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2010	362	1					3	5		10.1056/NEJMp0910459	http://dx.doi.org/10.1056/NEJMp0910459			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	540PA	20007550				2022-12-28	WOS:000273345500002
J	Muller, PAJ; Caswell, PT; Doyle, B; Iwanicki, MP; Tan, EH; Karim, S; Lukashchuk, N; Gillespie, DA; Ludwig, RL; Gosselin, P; Cromer, A; Brugge, JS; Sansom, OJ; Norman, JC; Vousden, KH				Muller, Patricia A. J.; Caswell, Patrick T.; Doyle, Brendan; Iwanicki, Marcin P.; Tan, Ee H.; Karim, Saadia; Lukashchuk, Natalia; Gillespie, David A.; Ludwig, Robert L.; Gosselin, Pauline; Cromer, Anne; Brugge, Joan S.; Sansom, Owen J.; Norman, Jim C.; Vousden, Karen H.			Mutant p53 Drives Invasion by Promoting Integrin Recycling	CELL			English	Article							LI-FRAUMENI-SYNDROME; TUMOR-SUPPRESSOR; CELL-MIGRATION; IN-VIVO; ALPHA-5-BETA-1 INTEGRIN; 3D MICROENVIRONMENTS; EPITHELIAL-CELLS; BREAST-CANCER; MOUSE MODELS; GAIN	p53 is a tumor suppressor protein whose function is frequently lost in cancers through missense mutations within the Tp53 gene. This results in the expression of point-mutated p53 proteins that have both lost wild-type tumor suppressor activity and show gain of functions that contribute to transformation and metastasis. Here, we show that mutant p53 expression can promote invasion, loss of directionality of migration, and metastatic behavior. These activities of p53 reflect enhanced integrin and epidermal growth factor receptor (EGFR) trafficking, which depends on Rab-coupling protein (RCP) and results in constitutive activation of EGFR/integrin signaling. We provide evidence that mutant p53 promotes cell invasion via the inhibition of TAp63, and simultaneous loss of p53 and TAp63 recapitulates the phenotype of mutant p53 in cells. These findings open the possibility that blocking alpha5/beta1-integrin and/or the EGF receptor will have therapeutic benefit in mutant p53-expressing cancers.	[Muller, Patricia A. J.; Caswell, Patrick T.; Doyle, Brendan; Tan, Ee H.; Karim, Saadia; Lukashchuk, Natalia; Gillespie, David A.; Ludwig, Robert L.; Sansom, Owen J.; Norman, Jim C.; Vousden, Karen H.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Iwanicki, Marcin P.; Gosselin, Pauline; Cromer, Anne; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Beatson Institute; Harvard University; Harvard Medical School	Norman, JC (corresponding author), Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	j.norman@beatson.gla.ac.uk; k.vousden@beatson.gla.ac.uk	Caswell, Patrick/N-3063-2015; Gillespie, David/R-4771-2019; Muller, Patricia AJ/AAH-1888-2019	Caswell, Patrick/0000-0002-2633-2324; Gillespie, David/0000-0002-6338-0544; Muller, Patricia AJ/0000-0002-0926-1499; Tan, Ee Hong/0000-0002-5971-6455; NORMAN, Jim/0000-0002-0098-3014; Sansom, Owen J./0000-0001-9540-3010	Cancer Research UK; BCRF [GM064346]; NIGMS [GM064346]; Netherlands Organisation for Scientific Research	Cancer Research UK(Cancer Research UK); BCRF; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work in K.H.V.'s, J.C.N.'s, and O.J.S.'s laboratories is supported by Cancer Research UK, and the work in J.S.B.'s laboratory by BCRF and NIGMS (GM064346). P.A.J.M. is a recipient of a Rubicon Fellowship from the Netherlands Organisation for Scientific Research. The p53R172H mice were obtained from the MMHRC and the p53 flox mice kindly provided by Anton Berns. We would like to thank Derek Miller for assistance and advice with the in vivo studies and Sam Lawn and Lyne McGarry for help with the Matrigel invasion assay. We are also grateful to Gerry Melino for the p63-responsive reporter construct.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Attardi LD, 1999, CELL MOL LIFE SCI, V55, P48, DOI 10.1007/s000180050269; Blagosklonny MV, 2000, FASEB J, V14, P1901, DOI 10.1096/fj.99-1078rev; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Brockbank EC, 2005, BRIT J CANCER, V92, P102, DOI 10.1038/sj.bjc.6602255; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Cantor JP, 2007, INT J CANCER, V120, P24, DOI 10.1002/ijc.22073; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Epstein CB, 1998, ONCOGENE, V16, P2115, DOI 10.1038/sj.onc.1201734; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; LANE DP, 1994, BRIT MED BULL, V50, P582, DOI 10.1093/oxfordjournals.bmb.a072911; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; LIN JY, 1995, ONCOGENE, V10, P2387; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; Matas D, 2001, EMBO J, V20, P4163, DOI 10.1093/emboj/20.15.4163; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Sigal A, 2000, CANCER RES, V60, P6788; Soussi T, 2000, ANN NY ACAD SCI, V910, P121; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622	38	580	592	6	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1327	1341		10.1016/j.cell.2009.11.026	http://dx.doi.org/10.1016/j.cell.2009.11.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064378	Bronze			2022-12-28	WOS:000273048700020
J	Fu, AC; Raizen, SA; Shavelson, RJ				Fu, Alice C.; Raizen, Senta A.; Shavelson, Richard J.			The Nation's Report Card: A Vision of Large-Scale Science Assessment	SCIENCE			English	Editorial Material							PERFORMANCE ASSESSMENTS		[Fu, Alice C.; Shavelson, Richard J.] Stanford Univ, Sch Educ, Stanford, CA 94305 USA; [Raizen, Senta A.] Natl Ctr Improving Sci Educ WestEd, Washington, DC 20036 USA	Stanford University	Fu, AC (corresponding author), Stanford Univ, Sch Educ, Stanford, CA 94305 USA.	alicefu@stanford.edu						American Association for the Advancement of Science. (AAAS), 1993, 2061 AAAS; Baxter G., 1998, ED MEASUREMENT ISSUE, V17, P37; Bransford J. D, 1999, PEOPLE LEARN BRAIN M; CLEMENT J, 1982, AM J PHYS, V50, P66, DOI 10.1119/1.12989; GRIGG WS, 2006, 2006466 NAT CTR ED S; Hestenes D., 1992, PHYS TEACH, V30, P141, DOI [DOI 10.1119/1.2343497, https://doi.org/10.1119/1.2343497]; McClure JR, 1999, J RES SCI TEACH, V36, P475, DOI 10.1002/(SICI)1098-2736(199904)36:4<475::AID-TEA5>3.0.CO;2-O; MINSTRELL J, 2004, DIAGNOSER TOOLS; NAGB, 2008, SCI FRAM 2009 NAT AS; *NAGB, 2007, SCI ASS IT SPEC 2009; National Research Council, 2001, KNOWING WHAT STUDENT; National Research Council (NRC), 1996, NAT SCI ED STAND; Quellmalz ES, 2009, SCIENCE, V323, P75, DOI 10.1126/science.1168046; RuizPrimo MA, 1996, J RES SCI TEACH, V33, P1045, DOI 10.1002/(SICI)1098-2736(199612)33:10<1045::AID-TEA1>3.0.CO;2-S; RuizPrimo MA, 1996, J RES SCI TEACH, V33, P569, DOI 10.1002/(SICI)1098-2736(199608)33:6<569::AID-TEA1>3.0.CO;2-M; Shavelson RJ, 1999, J EDUC MEAS, V36, P61, DOI 10.1111/j.1745-3984.1999.tb00546.x; SHAVELSON RJ, 1991, APPLIED MEASUREMENT, V4, P347, DOI DOI 10.1207/S15324818AME0404_7; Steedle JT, 2009, J RES SCI TEACH, V46, P699, DOI 10.1002/tea.20308; White R., 1992, PROBING UNDERSTANDIN; Yin Y, 2005, J RES SCI TEACH, V42, P166, DOI 10.1002/tea.20049; Yin Y, 2008, APPL MEAS EDUC, V21, P335, DOI 10.1080/08957340802347845	21	9	9	2	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1637	1638		10.1126/science.1177780	http://dx.doi.org/10.1126/science.1177780			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533QJ	20019274				2022-12-28	WOS:000272839000037
J	Donaldson, LJ; Rutter, PD; Ellis, BM; Greaves, FEC; Mytton, OT; Pebody, RG; Yardley, IE				Donaldson, Liam J.; Rutter, Paul D.; Ellis, Benjamin M.; Greaves, Felix E. C.; Mytton, Oliver T.; Pebody, Richard G.; Yardley, Iain E.			Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							CRITICALLY-ILL PATIENTS; A(H1N1) INFECTION; A H1N1; DEATH	Objective To establish mortality from pandemic A/H1N1 2009 influenza up to 8 November 2009. Design Investigation of all reported deaths related to pandemic A/H1N1 in England. Setting Mandatory reporting systems established in acute hospitals and primary care. Participants Physicians responsible for the patient. Main outcome measures Numbers of deaths from influenza combined with mid-range estimates of numbers of cases of influenza to calculate age specific case fatality rates. Underlying conditions, time course of illness, and antiviral treatment. Results With the official mid-range estimate for incidence of pandemic A/H1N1, the overall estimated case fatality rate was 26 ( range 11-66) per 100 000. It was lowest for children aged 5-14 (11 (range 3-36) per 100 000) and highest for those aged 65 ( 980 ( range 300-3200) per 100 000). In the 138 people in whom the confirmed cause of death was pandemic A/H1N1, the median age was 39 (interquartile range 17-57). Two thirds of patients who died (92, 67%) would now be eligible for the first phase of vaccination in England. Fifty (36%) had no, or only mild, pre-existing illness. Most patients (108, 78%) had been prescribed antiviral drugs, but of these, 82 (76%) did not receive them within the first 48 hours of illness. Conclusions Viewed statistically, mortality in this pandemic compares favourably with 20th century influenza pandemics. A lower population impact than previous pandemics, however, is not a justification for public health inaction. Our data support the priority vaccination of high risk groups. We observed delayed antiviral use in most fatal cases, which suggests an opportunity to reduce deaths by making timely antiviral treatment available, although the lack of a control group limits the ability to extrapolate from this observation. Given that a substantial minority of deaths occur in previously healthy people, there is a case for extending the vaccination programme and for continuing to make early antiviral treatment widely available.	[Donaldson, Liam J.; Rutter, Paul D.; Ellis, Benjamin M.; Greaves, Felix E. C.; Mytton, Oliver T.; Yardley, Iain E.] Dept Hlth, London SW1A 2NS, England; [Pebody, Richard G.] Hlth Protect Agcy, London, England	Health Protection Agency	Donaldson, LJ (corresponding author), Dept Hlth, Richmond House, London SW1A 2NS, England.	liam.donaldson@dh.gsi.gov.uk	Greaves, Felix/AAL-5891-2021; Greaves, Felix/A-1324-2012	Greaves, Felix/0000-0001-9393-3122; Greaves, Felix/0000-0001-9393-3122; Ellis, Benjamin/0000-0002-0269-8436; Mytton, Oliver/0000-0003-3218-9912; Pebody, Richard/0000-0002-9069-2885				Baker M, 2009, EUROSURVEILLANCE, V14, P1; Battegay M, 2020, SWISS MED WKLY, V150, DOI [10.4414/smw.w20203, 10.4414/smw.2020.20203]; BLACK A, 2006, FUTURE ACUTE CARE; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chan M., 2009, WORLD NOW START 2009; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; de Silva UC, 2009, EUROSURVEILLANCE, V14, P11; Dominguez-Cherit G, 2009, JAMA-J AM MED ASSOC, V302, P1880, DOI 10.1001/jama.2009.1536; DONALDSON L, 2009, H1N1 SWINE FLU VACCI; ECHEVARRIAZUNO S, 2009, LANCET          1111; *ESWI, 2009, PAND 20 CENT; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Garske T, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b2840; Health Protection Agency, 2009, SUSP CAS SCOTL TEST; *HLTH PROT AG, 2009, UPD CONF SWIN FLU CA; *HLTH PROT AG, QSURVEILLANCE NAT SU; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Luk J, 2001, CLIN INFECT DIS, V33, P1375, DOI 10.1086/322662; Mathers CD, 2005, B WORLD HEALTH ORGAN, V83, P171; Maudsley G, 1996, J PUBLIC HEALTH MED, V18, P59, DOI 10.1093/oxfordjournals.pubmed.a024463; MOOK P, 2007, SURVEILLANCE INFLUEN; *NHS INF CTR, 2009, SEAS INFL READ COD; Noble G.R., 1982, BASIC APPL INFLUENZA, P41; Office for National Statistics, 2009, MORT STAT DEATHS REG; Office for National Statistics, POP EST UK ENGL WAL; PAYNE AMM, 1958, P ROY SOC MED, V51, P1009; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Saklad M., 1941, ANESTHESIOLOGY, V2, P281, DOI DOI 10.1097/00000542-194105000-00004; SERFLING RE, 1963, PUBLIC HEALTH REP, V78, P494, DOI 10.2307/4591848; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; The ANZIC Influenza investigators, 2009, NEW ENGL J MED, V361, P1991; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; Wilson N, 2009, EUROSURVEILLANCE, V14; WOODALL J, 1958, BRIT MED J, V2, P1316, DOI 10.1136/bmj.2.5108.1316; World Health Organization, 1992, INT CLASS DIS REL HL; [No title captured]	40	291	301	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2009	339								b5213	10.1136/bmj.b5213	http://dx.doi.org/10.1136/bmj.b5213			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531VH	20007665	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000272697600008
J	Hsieh, MM; Kang, EM; Fitzhugh, CD; Link, MB; Bolan, CD; Kurlander, R; Childs, RW; Rodgers, GP; Powell, JD; Tisdale, JF				Hsieh, Matthew M.; Kang, Elizabeth M.; Fitzhugh, Courtney D.; Link, M. Beth; Bolan, Charles D.; Kurlander, Roger; Childs, Richard W.; Rodgers, Griffin P.; Powell, Jonathan D.; Tisdale, John F.			Allogeneic Hematopoietic Stem-Cell Transplantation for Sickle Cell Disease.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							VERSUS-HOST-DISEASE; BONE-MARROW TRANSPLANTATION; PULMONARY-HYPERTENSION; IN-VITRO; T-CELLS; ANEMIA; CHIMERISM; RAPAMYCIN; CAMPATH-1H; SIROLIMUS	Background: Myeloablative allogeneic hematopoietic stem-cell transplantation is curative in children with sickle cell disease, but in adults the procedure is unduly toxic. Graft rejection and graft-versus-host disease (GVHD) are additional barriers to its success. We performed nonmyeloablative stem-cell transplantation in adults with sickle cell disease. Methods: Ten adults (age range, 16 to 45 years) with severe sickle cell disease underwent nonmyeloablative transplantation with CD34+ peripheral-blood stem cells, mobilized by granulocyte colony-stimulating factor (G-CSF), which were obtained from HLA-matched siblings. The patients received 300 cGy of total-body irradiation plus alemtuzumab before transplantation, and sirolimus was administered afterward. Results: All 10 patients were alive at a median follow-up of 30 months after transplantation (range, 15 to 54). Nine patients had long-term, stable donor lymphohematopoietic engraftment at levels that sufficed to reverse the sickle cell disease phenotype. Mean (+/-SE) donor-recipient chimerism for T cells (CD3+) and myeloid cells (CD14+15+) was 53.3+/-8.6% and 83.3+/-10.3%, respectively, in the nine patients whose grafts were successful. Hemoglobin values before transplantation and at the last follow-up assessment were 9.0+/-0.3 and 12.6+/-0.5 g per deciliter, respectively. Serious adverse events included the narcotic-withdrawal syndrome and sirolimus-associated pneumonitis and arthralgia. Neither acute nor chronic GVHD developed in any patient. Conclusions: A protocol for nonmyeloablative allogeneic hematopoietic stem-cell transplantation that includes total-body irradiation and treatment with alemtuzumab and sirolimus can achieve stable, mixed donor-recipient chimerism and reverse the sickle cell phenotype. (ClinicalTrials.gov number, NCT00061568.) N Engl J Med 2009;361:2309-17.	[Hsieh, Matthew M.; Fitzhugh, Courtney D.; Link, M. Beth; Rodgers, Griffin P.; Tisdale, John F.] NIDDKD, Mol & Clin Hematol Branch, Bethesda, MD 20892 USA; [Bolan, Charles D.; Childs, Richard W.] NHLBI, Hematol Branch, Bethesda, MD 20892 USA; [Kang, Elizabeth M.] NIAID, Host Def Lab, Bethesda, MD 20892 USA; [Kurlander, Roger] Ctr Clin, Dept Lab Med, Bethesda, MD USA; [Powell, Jonathan D.] Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Johns Hopkins University; Johns Hopkins Medicine	Tisdale, JF (corresponding author), 9000 Rockville Pike,Bldg 10,Rm 9N 116, Bethesda, MD 20892 USA.	johntis@mail.nih.gov			NATIONAL CANCER INSTITUTE [P30CA006973] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL002345, ZIAHL006007, ZIAHL006090] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000989, R01AI077610] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [P30 CA006973] Funding Source: Medline; NIAID NIH HHS [R01 AI077610] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Anthi A, 2007, AM J RESP CRIT CARE, V175, P1272, DOI 10.1164/rccm.200610-1498OC; Battaglia M, 2006, J IMMUNOL, V177, P8338, DOI 10.4049/jimmunol.177.12.8338; Bernaudin F, 2007, BLOOD, V110, P2749, DOI 10.1182/blood-2007-03-079665; Bolan CD, 2001, BLOOD, V98, P1687, DOI 10.1182/blood.V98.6.1687; Childs R, 2000, NEW ENGL J MED, V343, P750, DOI 10.1056/NEJM200009143431101; Coenen JJA, 2007, BONE MARROW TRANSPL, V39, P537, DOI 10.1038/sj.bmt.1705628; Cutler C, 2007, BLOOD, V109, P3108, DOI 10.1182/blood-2006-09-046219; Fraser CJ, 2006, BLOOD, V108, P2867, DOI 10.1182/blood-2006-02-003954; GILLEECE MH, 1993, BLOOD, V82, P807; Gladwin MT, 2004, NEW ENGL J MED, V350, P886, DOI 10.1056/NEJMoa035477; Griffith LM, 2005, BRIT J HAEMATOL, V128, P668, DOI 10.1111/j.1365-2141.2005.05364.x; Hsieh MM, 2008, BIOL BLOOD MARROW TR, V14, P256, DOI 10.1016/j.bbmt.2007.11.001; Iannone R, 2003, BIOL BLOOD MARROW TR, V9, P519, DOI 10.1016/S1083-8791(03)00192-7; INGRAM VM, 1957, NATURE, V180, P326, DOI 10.1038/180326a0; Kang EM, 2002, BLOOD, V99, P850, DOI 10.1182/blood.V99.3.850; Kottaridis PD, 2000, BLOOD, V96, P2419; Kuypers DRJ, 2005, DRUG SAFETY, V28, P153, DOI 10.2165/00002018-200528020-00006; Morris EC, 2003, BLOOD, V102, P404, DOI 10.1182/blood-2002-09-2687; Nollet F, 2001, BONE MARROW TRANSPL, V28, P511, DOI 10.1038/sj.bmt.1703162; PAULING L, 1949, SCIENCE, V110, P543, DOI 10.1126/science.110.2865.543; POWARS DR, 1991, ANN INTERN MED, V115, P614, DOI 10.7326/0003-4819-115-8-614; Powars DR, 2005, MEDICINE, V84, P363, DOI 10.1097/01.md.0000189089.45003.52; Powell JD, 2005, TRANSPLANTATION, V80, P1541, DOI 10.1097/01.tp.0000185299.72295.90; Powell JD, 1999, J IMMUNOL, V162, P2775; Powell JD, 2006, CURR OPIN INVESTIG D, V7, P1002; Quinn CT, 2004, BLOOD, V103, P4023, DOI 10.1182/blood-2003-11-3758; Rebello P, 2001, CYTOTHERAPY, V3, P261, DOI 10.1080/146532401317070899; Siegal D, 2008, BONE MARROW TRANSPL, V42, P51, DOI 10.1038/bmt.2008.88; Srinivasan R, 2006, BRIT J HAEMATOL, V133, P305, DOI 10.1111/j.1365-2141.2006.06019.x; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V290, P756; Steinberg MH, 2003, JAMA-J AM MED ASSOC, V289, P1645, DOI 10.1001/jama.289.13.1645; Stewart BL, 2004, BLOOD, V104, P3501, DOI 10.1182/blood-2004-01-0200; Vermylen C, 1998, BONE MARROW TRANSPL, V22, P1, DOI 10.1038/sj.bmt.1701291; Walters MC, 2001, BIOL BLOOD MARROW TR, V7, P665, DOI 10.1053/bbmt.2001.v7.pm11787529; Walters MC, 1996, NEW ENGL J MED, V335, P369, DOI 10.1056/NEJM199608083350601; Wierenga KJJ, 2001, LANCET, V357, P680, DOI 10.1016/S0140-6736(00)04132-5	36	287	295	0	21	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2009	361	24					2309	2317		10.1056/NEJMoa0904971	http://dx.doi.org/10.1056/NEJMoa0904971			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529VS	20007560	Green Accepted			2022-12-28	WOS:000272547600005
J	Ludwig, DS				Ludwig, David S.			Artificially Sweetened Beverages Cause for Concern	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR-DISEASE; FOOD-INTAKE; MECHANISMS; SUCROSE; OBESITY; WEIGHT; HUMANS; TASTE		Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital	Ludwig, DS (corresponding author), Childrens Hosp, Dept Med, Optimal Weight Life Program, 300 Longwood Ave, Boston, MA 02115 USA.	david.ludwig@childrens.harvard.edu		Ludwig, David/0000-0003-3307-8544	NIDDK NIH HHS [K24DK082730] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Fowler SP, 2008, OBESITY, V16, P1894, DOI 10.1038/oby.2008.284; Lenoir M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000698; Li XD, 2002, P NATL ACAD SCI USA, V99, P4692, DOI 10.1073/pnas.072090199; Ludwig DS, 2002, JAMA-J AM MED ASSOC, V287, P2414, DOI 10.1001/jama.287.18.2414; Mann J, 2007, EUR J CLIN NUTR, V61, pS100, DOI 10.1038/sj.ejcn.1602940; Mattes RD, 2009, AM J CLIN NUTR, V89, P1, DOI 10.3945/ajcn.2008.26792; Nettleton JA, 2009, DIABETES CARE, V32, P688, DOI 10.2337/dc08-1799; Raben A, 2002, AM J CLIN NUTR, V76, P721, DOI 10.1093/ajcn/76.4.721; Sorensen LB, 2005, AM J CLIN NUTR, V82, P421, DOI 10.1093/ajcn/82.2.421; Swithers SE, 2008, BEHAV NEUROSCI, V122, P161, DOI 10.1037/0735-7044.122.1.161	10	50	55	0	18	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2477	2478		10.1001/jama.2009.1822	http://dx.doi.org/10.1001/jama.2009.1822			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529MD	19996404				2022-12-28	WOS:000272520500028
J	Melton, C; Judson, RL; Blelloch, R				Melton, Collin; Judson, Robert L.; Blelloch, Robert			Opposing microRNA families regulate self-renewal in mouse embryonic stem cells	NATURE			English	Article							TRANSCRIPTIONAL NETWORK; DNA METHYLATION; C-MYC; PLURIPOTENCY; RNA; DIFFERENTIATION; EXPRESSION; LIN-28; NANOG; URIDYLATION	When embryonic stem cells (ESCs) differentiate, they must both silence the ESC self-renewal program and activate new tissue-specific programs. In the absence of DGCR8 (Dgcr8(-/-)), a protein required for microRNA (miRNA) biogenesis, mouse ESCs are unable to silence self-renewal. Here we show that the introduction of let-7 miRNAs-a family of miRNAs highly expressed in somatic cells-can suppress self-renewal in Dgcr8(-/-) but not wild-type ESCs. Introduction of ESC cell cycle regulating (ESCC) miRNAs into the Dgcr8(-/-) ESCs blocks the capacity of let-7 to suppress self-renewal. Profiling and bioinformatic analyses show that let-7 inhibits whereas ESCC miRNAs indirectly activate numerous self-renewal genes. Furthermore, inhibition of the let-7 family promotes de-differentiation of somatic cells to induced pluripotent stem cells. Together, these findings show how the ESCC and let-7 miRNAs act through common pathways to alternatively stabilize the self-renewing versus differentiated cell fates.	[Melton, Collin; Judson, Robert L.; Blelloch, Robert] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Program Biomed Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Melton, Collin; Judson, Robert L.; Blelloch, Robert] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blelloch, R (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Program Biomed Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA.	blellochr@stemcell.ucsf.edu			National Institutes of Health (NIH) [K08 NS48118, R01 NS057221]; California Institute of Regenerative Medicine (CIRM) [RS1-00161, RN2-00906]; American Health Assistance Foundation; Pew Charitable Trust; National Science Foundation (NSF); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS057221, K08NS048118] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); American Health Assistance Foundation(BrightFocus Foundation); Pew Charitable Trust; National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank M. Ramalho-Santos, S. Fisher, M. Conti and members of the Blelloch laboratory for critical reading of the manuscript. We would like to thank A. Amiet for let-7 and control inhibitors, M. Bishop for c-Myc floxed mice and A. Shenoy for ESC-derived neural progenitor cells cultures. Furthermore, we would like to acknowledge A. Olshen and R. Roy for their helpful advice concerning our statistical methods. This work was supported by funds to R. B. from the National Institutes of Health (NIH; K08 NS48118 and R01 NS057221), California Institute of Regenerative Medicine (CIRM; Seed Grant RS1-00161, New Faculty Award RN2-00906), the American Health Assistance Foundation (formerly Stem Cell Research Foundation), and the Pew Charitable Trust. C. M. and R.L.J. are supported by the National Science Foundation (NSF) graduate research fellowships.	Babiarz J. E., 2009, STEMBOOK, P1, DOI [10.3824/stembook.1.47.1, DOI 10.3824/STEMBOOK.1.47.1]; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	49	520	558	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					621	U45		10.1038/nature08725	http://dx.doi.org/10.1038/nature08725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20054295	Green Submitted, Green Accepted			2022-12-28	WOS:000274193900027
J	Dalgliesh, GL; Furge, K; Greenman, C; Chen, LN; Bignell, G; Butler, A; Davies, H; Edkins, S; Hardy, C; Latimer, C; Teague, J; Andrews, J; Barthorpe, S; Beare, D; Buck, G; Campbell, PJ; Forbes, S; Jia, MM; Jones, D; Knott, H; Kok, CY; Lau, KW; Leroy, C; Lin, ML; McBride, DJ; Maddison, M; Maguire, S; McLay, K; Menzies, A; Mironenko, T; Mulderrig, L; Mudie, L; O'Meara, S; Pleasance, E; Rajasingham, A; Shepherd, R; Smith, R; Stebbings, L; Stephens, P; Tang, G; Tarpey, PS; Turrell, K; Dykema, KJ; Khoo, SK; Petillo, D; Wondergem, B; Anema, J; Kahnoski, RJ; Teh, B; Stratton, MR; Futreal, PA				Dalgliesh, Gillian L.; Furge, Kyle; Greenman, Chris; Chen, Lina; Bignell, Graham; Butler, Adam; Davies, Helen; Edkins, Sarah; Hardy, Claire; Latimer, Calli; Teague, Jon; Andrews, Jenny; Barthorpe, Syd; Beare, Dave; Buck, Gemma; Campbell, Peter J.; Forbes, Simon; Jia, Mingming; Jones, David; Knott, Henry; Kok, Chai Yin; Lau, King Wai; Leroy, Catherine; Lin, Meng-Lay; McBride, David J.; Maddison, Mark; Maguire, Simon; McLay, Kirsten; Menzies, Andrew; Mironenko, Tatiana; Mulderrig, Lee; Mudie, Laura; O'Meara, Sarah; Pleasance, Erin; Rajasingham, Arjunan; Shepherd, Rebecca; Smith, Raffaella; Stebbings, Lucy; Stephens, Philip; Tang, Gurpreet; Tarpey, Patrick S.; Turrell, Kelly; Dykema, Karl J.; Khoo, Sok Kean; Petillo, David; Wondergem, Bill; Anema, John; Kahnoski, Richard J.; Teh, Bin Tean; Stratton, Michael R.; Futreal, P. Andrew			Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes	NATURE			English	Article							CELL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; SOMATIC MUTATIONS; CANCER GENOMES; P600	Clear cell renal cell carcinoma (ccRCC) is the most common form of adult kidney cancer, characterized by the presence of inactivating mutations in the VHL gene in most cases(1,2), and by infrequent somatic mutations in known cancer genes. To determine further the genetics of ccRCC, we have sequenced 101 cases through 3,544 protein-coding genes. Here we report the identification of inactivating mutations in two genes encoding enzymes involved in histone modification-SETD2, a histone H3 lysine 36 methyltransferase, and JARID1C (also known as KDM5C), a histone H3 lysine 4 demethylase-as well as mutations in the histone H3 lysine 27 demethylase, UTX (KMD6A), that we recently reported(3). The results highlight the role of mutations in components of the chromatin modification machinery in human cancer. Furthermore, NF2 mutations were found in non-VHL mutated ccRCC, and several other probable cancer genes were identified. These results indicate that substantial genetic heterogeneity exists in a cancer type dominated by mutations in a single gene, and that systematic screens will be key to fully determining the somatic genetic architecture of cancer.	[Khoo, Sok Kean; Petillo, David; Teh, Bin Tean] Van Andel Res Inst, Lab Canc Genert, Grand Rapids, MI 49503 USA; [Anema, John; Kahnoski, Richard J.] Spectrum Hlth Hosp, Dept Urol, Grand Rapids, MI 49503 USA; [Teh, Bin Tean] Natl Canc Ctr, NCCS VARI Translat Canc Res Lab, Singapore 169610, Singapore; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Furge, Kyle; Dykema, Karl J.; Wondergem, Bill] Van Andel Res Inst, Lab Computat Biol, Grand Rapids, MI 49503 USA; [Dalgliesh, Gillian L.; Greenman, Chris; Chen, Lina; Bignell, Graham; Butler, Adam; Davies, Helen; Edkins, Sarah; Hardy, Claire; Latimer, Calli; Teague, Jon; Andrews, Jenny; Barthorpe, Syd; Beare, Dave; Buck, Gemma; Campbell, Peter J.; Forbes, Simon; Jia, Mingming; Jones, David; Knott, Henry; Kok, Chai Yin; Lau, King Wai; Leroy, Catherine; Lin, Meng-Lay; McBride, David J.; Maddison, Mark; Maguire, Simon; McLay, Kirsten; Menzies, Andrew; Mironenko, Tatiana; Mulderrig, Lee; Mudie, Laura; O'Meara, Sarah; Pleasance, Erin; Rajasingham, Arjunan; Shepherd, Rebecca; Smith, Raffaella; Stebbings, Lucy; Stephens, Philip; Tang, Gurpreet; Tarpey, Patrick S.; Turrell, Kelly; Stratton, Michael R.; Futreal, P. Andrew] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England	Van Andel Institute; National Cancer Centre Singapore (NCCS); University of London; Institute of Cancer Research - UK; Van Andel Institute; Wellcome Trust Sanger Institute	Teh, B (corresponding author), Van Andel Res Inst, Lab Canc Genert, Grand Rapids, MI 49503 USA.	Bin.Teh@vai.org; mrs@sanger.ac.uk; paf@sanger.ac.uk	Dalgliesh, Gillian/B-7799-2008	Dalgliesh, Gillian/0000-0001-8526-5064; Teh, Bin Tean/0000-0003-1514-1124; Edkins, Sarah/0000-0003-0717-1972; Buck, Gemma/0000-0001-5289-1050	Wellcome Trust [077012/Z/05/Z]; Hauenstein and Gerber Foundations	Wellcome Trust(Wellcome TrustEuropean Commission); Hauenstein and Gerber Foundations	We would like to acknowledge the Wellcome Trust for support under grant reference 077012/Z/05/Z and the Hauenstein and Gerber Foundations for support for the microarray expression work. We also thank S. Martin, W. McLaughlin and S. Noyes for administrative support and F. Brasseur for providing the matched-pair ccRCC cell lines.	Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Bommi-Reddy A, 2008, P NATL ACAD SCI USA, V105, P16484, DOI 10.1073/pnas.0806574105; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; DeMasi J, 2005, P NATL ACAD SCI USA, V102, P11486, DOI 10.1073/pnas.0505322102; Demuth I, 2007, ONCOGENE, V26, P7792, DOI 10.1038/sj.onc.1210876; Dicks E, 2007, BIOINFORMATICS, V23, P1689, DOI 10.1093/bioinformatics/btm152; Eble JN, 2004, PATHOLOGY GENETICS T; Edge SB, 2009, AJCC CANC STAGING MA, V7; Ferner RE, 2007, LANCET NEUROL, V6, P340, DOI 10.1016/S1474-4422(07)70075-3; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	27	874	905	0	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					360	363		10.1038/nature08672	http://dx.doi.org/10.1038/nature08672			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20054297	Green Accepted			2022-12-28	WOS:000273748100045
J	Venditti, C; Meade, A; Pagel, M				Venditti, Chris; Meade, Andrew; Pagel, Mark			Phylogenies reveal new interpretation of speciation and the Red Queen	NATURE			English	Article							EVOLUTION; MODELS; EXTINCTION; DIVERGENCE; RATES	The Red Queen(1) describes a view of nature in which species continually evolve but do not become better adapted. It is one of the more distinctive metaphors of evolutionary biology, but no test of its claim that speciation occurs at a constant rate(2) has ever been made against competing models that can predict virtually identical outcomes, nor has any mechanism been proposed that could cause the constant-rate phenomenon. Here we use 101 phylogenies of animal, plant and fungal taxa to test the constant-rate claim against four competing models. Phylogenetic branch lengths record the amount of time or evolutionary change between successive events of speciation. The models predict the distribution of these lengths by specifying how factors combine to bring about speciation, or by describing how rates of speciation vary throughout a tree. We find that the hypotheses that speciation follows the accumulation of many small events that act either multiplicatively or additively found support in 8% and none of the trees, respectively. A further 8% of trees hinted that the probability of speciation changes according to the amount of divergence from the ancestral species, and 6% suggested speciation rates vary among taxa. By comparison, 78% of the trees fit the simplest model in which new species emerge from single events, each rare but individually sufficient to cause speciation. This model predicts a constant rate of speciation, and provides a new interpretation of the Red Queen: the metaphor of species losing a race against a deteriorating environment is replaced by a view linking speciation to rare stochastic events that cause reproductive isolation. Attempts to understand species-radiations(3) or why some groups have more or fewer species should look to the size of the catalogue of potential causes of speciation shared by a group of closely related organisms rather than to how those causes combine.	[Venditti, Chris; Meade, Andrew; Pagel, Mark] Univ Reading, Sch Biol Sci, Reading RG6 6BX, Berks, England; [Pagel, Mark] Santa Fe Inst, Santa Fe, NM 87501 USA	University of Reading; The Santa Fe Institute	Pagel, M (corresponding author), Univ Reading, Sch Biol Sci, Reading RG6 6BX, Berks, England.	m.pagel@reading.ac.uk			Natural Environment Research Council (NERC), UK; Leverhulme Trust; Natural Environment Research Council [NE/C51992X/1] Funding Source: researchfish	Natural Environment Research Council (NERC), UK(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Leverhulme Trust(Leverhulme Trust); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank the Centre for Advanced Computing and Emerging Technologies (ACET) at the University of Reading for the use of the ThamesBlue supercomputer. We thank M. Turelli for calling our attention to Gillespie's Poisson process model and for comments on earlier drafts of the paper. M. Steel pointed out the geometric distribution proof given in the Supplementary Information. This research was supported by grants to M. P. from the Natural Environment Research Council (NERC), UK, and the Leverhulme Trust.	Benton M.J., 1990, P119; Cameron SA, 2007, BIOL J LINN SOC, V91, P161, DOI 10.1111/j.1095-8312.2007.00784.x; Castoe TA, 2006, MOL PHYLOGENET EVOL, V39, P91, DOI 10.1016/j.ympev.2005.12.014; Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420; Fritsch PW, 2006, SYST BOT, V31, P181, DOI 10.1600/036364406775971877; GILLESPIE JH, 1984, P NATL ACAD SCI-BIOL, V81, P8009, DOI 10.1073/pnas.81.24.8009; Green PJ, 1995, BIOMETRIKA, V82, P711, DOI 10.1093/biomet/82.4.711; Mallet J, 2007, NATURE, V446, P279, DOI 10.1038/nature05706; Mitsainas GP, 2009, BIOL J LINN SOC, V96, P685, DOI 10.1111/j.1095-8312.2008.01161.x; Navarro A, 2003, SCIENCE, V300, P321, DOI 10.1126/science.1080600; NEE S, 1992, P NATL ACAD SCI USA, V89, P8322, DOI 10.1073/pnas.89.17.8322; Nee S, 2006, ANNU REV ECOL EVOL S, V37, P1, DOI 10.1146/annurev.ecolsys.37.091305.110035; Orr HA, 2001, EVOLUTION, V55, P1085; Pagel M, 2004, SYST BIOL, V53, P571, DOI 10.1080/10635150490468675; Pagel M, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S1-S16; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pagel M, 2006, SCIENCE, V314, P119, DOI 10.1126/science.1129647; PEARSON PN, 1992, PALEOBIOLOGY, V18, P115, DOI 10.1017/S0094837300013920; Rabosky DL, 2008, EVOLUTION, V62, P1866, DOI 10.1111/j.1558-5646.2008.00409.x; Seehausen O, 2008, NATURE, V455, P620, DOI 10.1038/nature07285; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; Van Valen L., 1973, EVOL THEORY REV, V1, P1, DOI DOI 10.1038/344864A0; Venditti C, 2008, SYST BIOL, V57, P286, DOI 10.1080/10635150802044045; Venditti C, 2006, SYST BIOL, V55, P637, DOI 10.1080/10635150600865567; Yule GU, 1925, PHILOS T R SOC LON B, V213, P21, DOI 10.1098/rstb.1925.0002; [No title captured]; [No title captured]; [No title captured]; [No title captured]	30	111	112	0	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					349	352		10.1038/nature08630	http://dx.doi.org/10.1038/nature08630			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20010607				2022-12-28	WOS:000273748100042
J	Schmidt, H; Voigt, K; Wikler, D				Schmidt, Harald; Voigt, Kristin; Wikler, Daniel			Carrots, Sticks, and Health Care Reform - Problems with Wellness Incentives	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Schmidt, Harald] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; Harvard Univ, Program Eth & Hlth, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University	Schmidt, H (corresponding author), Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA.			Voigt, Kristin/0000-0002-6452-7712				*BENICOMP ADV, 2009, DET OV; Bishop G, 2006, NEW ENGL J MED, V355, P756, DOI 10.1056/NEJMp068170; BURD SA, 2009, WALL STREET J   0612; Mello MM, 2008, NEW ENGL J MED, V359, P192, DOI 10.1056/NEJMhle0801929; Schmidt H, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3504	5	74	74	0	8	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2								10.1056/NEJMp0911552	http://dx.doi.org/10.1056/NEJMp0911552			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	543FU	20042747				2022-12-28	WOS:000273558500005
J	Maze, I; Covington, HE; Dietz, DM; LaPlant, Q; Renthal, W; Russo, SJ; Mechanic, M; Mouzon, E; Neve, RL; Haggarty, SJ; Ren, YH; Sampath, SC; Hurd, YL; Greengard, P; Tarakhovsky, A; Schaefer, A; Nestler, EJ				Maze, Ian; Covington, Herbert E., III; Dietz, David M.; LaPlant, Quincey; Renthal, William; Russo, Scott J.; Mechanic, Max; Mouzon, Ezekiell; Neve, Rachael L.; Haggarty, Stephen J.; Ren, Yanhua; Sampath, Srihari C.; Hurd, Yasmin L.; Greengard, Paul; Tarakhovsky, Alexander; Schaefer, Anne; Nestler, Eric J.			Essential Role of the Histone Methyltransferase G9a in Cocaine-Induced Plasticity	SCIENCE			English	Article							NUCLEUS-ACCUMBENS; DELTA-FOSB; GENE-EXPRESSION; EXPOSURE; PROTEIN; NEURONS; REWARD; AMPHETAMINE; MECHANISMS; ADDICTION	Cocaine-induced alterations in gene expression cause changes in neuronal morphology and behavior that may underlie cocaine addiction. In mice, we identified an essential role for histone 3 lysine 9 (H3K9) dimethylation and the lysine dimethyltransferase G9a in cocaine-induced structural and behavioral plasticity. Repeated cocaine administration reduced global levels of H3K9 dimethylation in the nucleus accumbens. This reduction in histone methylation was mediated through the repression of G9a in this brain region, which was regulated by the cocaine-induced transcription factor Delta FosB. Using conditional mutagenesis and viral-mediated gene transfer, we found that G9a down-regulation increased the dendritic spine plasticity of nucleus accumbens neurons and enhanced the preference for cocaine, thereby establishing a crucial role for histone methylation in the long-term actions of cocaine.	[Maze, Ian; Covington, Herbert E., III; Dietz, David M.; LaPlant, Quincey; Russo, Scott J.; Mouzon, Ezekiell; Ren, Yanhua; Hurd, Yasmin L.; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [LaPlant, Quincey; Renthal, William; Mechanic, Max] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [LaPlant, Quincey; Renthal, William; Mechanic, Max] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Haggarty, Stephen J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Haggarty, Stephen J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA; [Haggarty, Stephen J.] Harvard & Massachusetts Inst Technol, Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Sampath, Srihari C.; Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA; [Greengard, Paul; Schaefer, Anne] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rockefeller University; Rockefeller University	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu	Dietz, David/AAW-4574-2021; Dietz, David/J-9458-2015; Haggarty, Stephen J/M-9495-2016; Maze, Ian/P-8077-2018; Russo, Scott/R-7107-2019	Dietz, David/0000-0002-6927-9236; Dietz, David/0000-0002-6927-9236; Haggarty, Stephen J/0000-0002-7872-168X; Russo, Scott/0000-0002-6470-1805; Maze, Ian/0000-0003-1490-7781; Renthal, William/0000-0003-0206-2101	National Institute on Drug Abuse [P01 DA08227, R01 DA07359, P0110044]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014133, P01DA008227, P01DA010044, R01DA007359] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Drug Abuse: P01 DA08227 and R01 DA07359 (E. J. N.) and P0110044 (P. G.). E. J. N. certifies that none of the materials included in the manuscript have been previously published or are under consideration elsewhere, including on the Internet. All work involving the use of animals was conducted in accordance with institutional and Institutional Animal Care and Use Committee guidelines at both the University of Texas Southwestern Medical Center and Mount Sinai School of Medicine.	Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Brami-Cherrier K, 2009, J NEUROCHEM, V108, P1323, DOI 10.1111/j.1471-4159.2009.05879.x; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Renthal W, 2008, J NEUROSCI, V28, P7344, DOI 10.1523/JNEUROSCI.1043-08.2008; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Robinson TE, 1997, J NEUROSCI, V17, P8491; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Thomas MJ, 2003, PHILOS T ROY SOC B, V358, P815, DOI 10.1098/rstb.2002.1236; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Ujike H, 2002, ANN NY ACAD SCI, V965, P55; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077	27	474	492	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					213	216		10.1126/science.1179438	http://dx.doi.org/10.1126/science.1179438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056891	Green Accepted			2022-12-28	WOS:000273394000038
J	Bokoch, MP; Zou, YZ; Rasmussen, SGF; Liu, CW; Nygaard, R; Rosenbaum, DM; Fung, JJ; Choi, HJ; Thian, FS; Kobilka, TS; Puglisi, JD; Weis, WI; Pardo, L; Prosser, RS; Mueller, L; Kobilka, BK				Bokoch, Michael P.; Zou, Yaozhong; Rasmussen, Soren G. F.; Liu, Corey W.; Nygaard, Rie; Rosenbaum, Daniel M.; Fung, Juan Jose; Choi, Hee-Jung; Thian, Foon Sun; Kobilka, Tong Sun; Puglisi, Joseph D.; Weis, William I.; Pardo, Leonardo; Prosser, R. Scott; Mueller, Luciano; Kobilka, Brian K.			Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor	NATURE			English	Article							TOGGLE SWITCH MODEL; CRYSTAL-STRUCTURE; BINDING-SITE; BETA(2)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; LYSINE RESIDUES; HELIX MOVEMENT; ACTIVATION; RHODOPSIN; RECOGNITION	G-protein-coupled receptors (GPCRs) are seven-transmembrane proteins that mediate most cellular responses to hormones and neurotransmitters. They are the largest group of therapeutic targets for a broad spectrum of diseases. Recent crystal structures of GPCRs(1-5) have revealed structural conservation extending from the orthosteric ligand-binding site in the transmembrane core to the cytoplasmic G-protein-coupling domains. In contrast, the extracellular surface (ECS) of GPCRs is remarkably diverse and is therefore an ideal target for the discovery of subtype-selective drugs. However, little is known about the functional role of the ECS in receptor activation, or about conformational coupling of this surface to the native ligand-binding pocket. Here we use NMR spectroscopy to investigate ligand-specific conformational changes around a central structural feature in the ECS of the beta(2) adrenergic receptor: a salt bridge linking extracellular loops 2 and 3. Small-molecule drugs that bind within the transmembrane core and exhibit different efficacies towards G-protein activation (agonist, neutral antagonist and inverse agonist) also stabilize distinct conformations of the ECS. We thereby demonstrate conformational coupling between the ECS and the orthosteric binding site, showing that drugs targeting this diverse surface could function as allosteric modulators with high subtype selectivity. Moreover, these studies provide a new insight into the dynamic behaviour of GPCRs not addressable by static, inactive-state crystal structures.	[Bokoch, Michael P.; Zou, Yaozhong; Rasmussen, Soren G. F.; Nygaard, Rie; Rosenbaum, Daniel M.; Fung, Juan Jose; Choi, Hee-Jung; Thian, Foon Sun; Kobilka, Tong Sun; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Liu, Corey W.; Puglisi, Joseph D.] Stanford Univ, Stanford Magnet Resonance Lab, Sch Med, Stanford, CA 94305 USA; [Choi, Hee-Jung; Puglisi, Joseph D.; Weis, William I.] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; [Pardo, Leonardo] Univ Autonoma Barcelona, Lab Med Computac, Unitat Bioestadist, E-08193 Barcelona, Spain; [Prosser, R. Scott] Univ Toronto, UTM, Dept Chem, Mississauga, ON L5L 1C6, Canada; [Mueller, Luciano] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA	Stanford University; Stanford University; Stanford University; Autonomous University of Barcelona; University of Toronto; University Toronto Mississauga; Bristol-Myers Squibb	Kobilka, BK (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA.	kobilka@stanford.edu	Bokoch, Michael P./J-2637-2019; FUNG, John Julian/A-2679-2012; Weis, William I/G-1437-2011; Nygaard, Rie/B-7351-2013	Bokoch, Michael P./0000-0003-1387-9547; FUNG, John Julian/0000-0002-3038-0441; Weis, William I/0000-0002-5583-6150; Pardo, Leonardo/0000-0003-1778-7420; Rasmussen, Soren/0000-0002-1853-1841; Choi, Hee-Jung/0000-0002-1167-1526; Kobilka, Brian/0000-0001-5958-3990	National Institutes of Health [NS028471, GM56169]; Stanford Medical Scientist Training Program; Lundbeck Foundation; University of Copenhagen and 7TM Pharma; Instituto de Salud Carlos III; Lundbeck Foundation [R19-2008-2113, R37-2009-3457] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH082313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028471, R37NS028471] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Medical Scientist Training Program; Lundbeck Foundation(Lundbeckfonden); University of Copenhagen and 7TM Pharma; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We acknowledge support from National Institutes of Health, grants NS028471 (B. K. K.) and GM56169 (W. I. W.), the Stanford Medical Scientist Training Program (M. P. B.), the Lundbeck Foundation (S. G. F. R.), the University of Copenhagen and 7TM Pharma (R.N.), and the Instituto de Salud Carlos III (L. P.).	Abraham SJ, 2008, J BIOMOL NMR, V42, P143, DOI 10.1007/s10858-008-9274-y; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI [10.1016/S1043-9471(05)80049-7, DOI 10.1016/S1043-9471(05)80049-7]; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; GERKEN TA, 1982, J BIOL CHEM, V257, P2894; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; JENTOFT JE, 1979, J BIOL CHEM, V254, P4366; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; SHERRY AD, 1983, J BIOL CHEM, V258, P8663; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; TOTA MR, 1990, J BIOL CHEM, V265, P16891; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; ZHANG MJ, 1993, J BIOL CHEM, V268, P22420	37	388	401	2	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					108	U121		10.1038/nature08650	http://dx.doi.org/10.1038/nature08650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054398	Green Accepted			2022-12-28	WOS:000273344900040
J	Liu, HT; He, J; Tang, JY; Liu, H; Pang, P; Cao, D; Krstic, P; Joseph, S; Lindsay, S; Nuckolls, C				Liu, Haitao; He, Jin; Tang, Jinyao; Liu, Hao; Pang, Pei; Cao, Di; Krstic, Predrag; Joseph, Sony; Lindsay, Stuart; Nuckolls, Colin			Translocation of Single-Stranded DNA Through Single-Walled Carbon Nanotubes	SCIENCE			English	Article							SOLID-STATE NANOPORES; TRANSPORT; MOLECULES; CHANNEL; FABRICATION; MEMBRANES; ACID	We report the fabrication of devices in which one single-walled carbon nanotube spans a barrier between two fluid reservoirs, enabling direct electrical measurement of ion transport through the tube. A fraction of the tubes pass anomalously high ionic currents. Electrophoretic transport of small single-stranded DNA oligomers through these tubes is marked by large transient increases in ion current and was confirmed by polymerase chain reaction analysis. Each current pulse contains about 10(7) charges, an enormous amplification of the translocated charge. Carbon nanotubes simplify the construction of nanopores, permit new types of electrical measurements, and may open avenues for control of DNA translocation.	[He, Jin; Liu, Hao; Pang, Pei; Cao, Di; Lindsay, Stuart] Biodesign Inst, Tempe, AZ 85287 USA; [Liu, Haitao; Tang, Jinyao; Nuckolls, Colin] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Liu, Hao; Lindsay, Stuart] Dept Chem & Biochem, Tempe, AZ 85287 USA; [Pang, Pei; Cao, Di; Lindsay, Stuart] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Krstic, Predrag; Joseph, Sony] Oak Ridge Natl Lab, Div Phys, Oak Ridge, TN 37831 USA	Columbia University; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Oak Ridge National Laboratory	Lindsay, S (corresponding author), Biodesign Inst, Tempe, AZ 85287 USA.	Stuart.Lindsay@asu.edu; cn37@columbia.edu	he, jin/AAV-8045-2021; he, jin/C-6256-2009; Tang, Jinyao/I-3851-2012	he, jin/0000-0002-2633-9809; 	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004770] Funding Source: NIH RePORTER; NHGRI NIH HHS [R21 HG004770-01, R21 HG004770] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Chang H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2179131; Chow KF, 2008, J AM CHEM SOC, V130, P7544, DOI 10.1021/ja802013q; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Fan R, 2005, NANO LETT, V5, P1633, DOI 10.1021/nl0509677; Guo XF, 2006, SCIENCE, V311, P356, DOI 10.1126/science.1120986; Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Ito T, 2003, CHEM COMMUN, P1482, DOI 10.1039/b302511j; Jin XZ, 2007, LANGMUIR, V23, P13209, DOI 10.1021/la702326v; Joseph S, 2003, NANO LETT, V3, P1399, DOI 10.1021/nl0346326; Joseph S, 2008, NANO LETT, V8, P452, DOI 10.1021/nl072385q; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Kasianowicz JJ, 2001, ANAL CHEM, V73, P2268, DOI 10.1021/ac000958c; Kim MJ, 2006, ADV MATER, V18, P3149, DOI 10.1002/adma.200601191; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Liang XG, 2008, NANO LETT, V8, P1472, DOI 10.1021/nl080473k; Meller A, 2002, ELECTROPHORESIS, V23, P2583, DOI 10.1002/1522-2683(200208)23:16<2583::AID-ELPS2583>3.0.CO;2-H; Rhee M, 2007, TRENDS BIOTECHNOL, V25, P174, DOI 10.1016/j.tibtech.2007.02.008; Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901; Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941; Tu XM, 2009, NATURE, V460, P250, DOI 10.1038/nature08116; Warakulwit C, 2008, NANO LETT, V8, P500, DOI 10.1021/nl072652s; Xie YH, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799989; Yeh IC, 2004, P NATL ACAD SCI USA, V101, P12177, DOI 10.1073/pnas.0402699101	26	256	270	6	205	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					64	67		10.1126/science.1181799	http://dx.doi.org/10.1126/science.1181799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044570	Green Accepted			2022-12-28	WOS:000273395400030
J	Roberts, NL; Piotrowski, AM; McManus, JF; Keigwin, LD				Roberts, Natalie L.; Piotrowski, Alexander M.; McManus, Jerry F.; Keigwin, Lloyd D.			Synchronous Deglacial Overturning and Water Mass Source Changes	SCIENCE			English	Article							WESTERN NORTH-ATLANTIC; RARE-EARTH ELEMENTS; THERMOHALINE CIRCULATION; ISOTOPIC COMPOSITION; NEODYMIUM ISOTOPES; CORE RECORD; DEEP-WATER; OCEAN; FORAMINIFERA; CLIMATE	Understanding changes in ocean circulation during the last deglaciation is crucial to unraveling the dynamics of glacial-interglacial and millennial climate shifts. We used neodymium isotope measurements on postdepositional iron-manganese oxide coatings precipitated on planktonic foraminifera to reconstruct changes in the bottom water source of the deep western North Atlantic at the Bermuda Rise. Comparison of our deep water source record with overturning strength proxies shows that both the deep water mass source and the overturning rate shifted rapidly and synchronously during the last deglacial transition. In contrast, any freshwater perturbation caused by Heinrich event 1 could have only affected shallow overturning. These findings show how changes in upper-ocean overturning associated with millennial-scale events differ from those associated with whole-ocean deglacial climate events.	[Roberts, Natalie L.; Piotrowski, Alexander M.] Univ Cambridge, Dept Earth Sci, Godwin Lab Palaeoclimate Res, Cambridge CB2 3EQ, England; [McManus, Jerry F.] Columbia Univ, Lamont Doherty Earth Observ, Dept Earth & Environm Sci, Palisades, NY 10964 USA; [Keigwin, Lloyd D.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA	University of Cambridge; Columbia University; Woods Hole Oceanographic Institution	Roberts, NL (corresponding author), Univ Cambridge, Dept Earth Sci, Godwin Lab Palaeoclimate Res, Cambridge CB2 3EQ, England.	nr297@cam.ac.uk			Natural Environment Research Council [NE/F006047/1] Funding Source: researchfish; Directorate For Geosciences [0937221] Funding Source: National Science Foundation	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))		BOYLE EA, 1987, NATURE, V330, P35, DOI 10.1038/330035a0; BROECKER WS, 1989, GEOCHIM COSMOCHIM AC, V53, P2465, DOI 10.1016/0016-7037(89)90123-3; Chase Z, 2002, EARTH PLANET SC LETT, V204, P215, DOI 10.1016/S0012-821X(02)00984-6; Curry WB, 2005, PALEOCEANOGRAPHY, V20, DOI 10.1029/2004PA001021; DANSGAARD W, 1993, NATURE, V364, P218, DOI 10.1038/364218a0; ELDERFIELD H, 1982, NATURE, V296, P214, DOI 10.1038/296214a0; Evans HK, 2008, GEOCHEM GEOPHY GEOSY, V9, DOI 10.1029/2007GC001771; Ganopolski A, 2001, NATURE, V409, P153, DOI 10.1038/35051500; Gherardi JM, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001696; Gil IM, 2009, PALEOCEANOGRAPHY, V24, DOI 10.1029/2008PA001729; Goldstein S.L., 2003, TREATISE GEOCHEMISTR, P453, DOI [10.1016/B0-08-043751-6/06179-X, DOI 10.1016/B0-08-043751-6/06179-X]; Hillaire-Marcel C, 2001, NATURE, V410, P1073, DOI 10.1038/35074059; KEIGWIN LD, 1991, J GEOPHYS RES-OCEANS, V96, P16811, DOI 10.1029/91JC01624; KEIGWIN LD, 1989, DEEP-SEA RES, V36, P845, DOI 10.1016/0198-0149(89)90032-0; Keigwin LD, 2008, PALEOCEANOGRAPHY, V23, DOI 10.1029/2007PA001500; Klevenz V, 2008, EARTH PLANET SC LETT, V265, P571, DOI 10.1016/j.epsl.2007.10.053; Lacan F, 2005, EARTH PLANET SC LETT, V232, P245, DOI 10.1016/j.epsl.2005.01.004; Martin EE, 2000, GEOCHIM COSMOCHIM AC, V64, P835, DOI 10.1016/S0016-7037(99)00376-2; McCave IN, 2002, SCIENCE, V298, P1186, DOI 10.1126/science.1076960; McManus JF, 2004, NATURE, V428, P834, DOI 10.1038/nature02494; PALMER MR, 1985, EARTH PLANET SC LETT, V73, P285, DOI 10.1016/0012-821X(85)90077-9; PALMER MR, 1985, EARTH PLANET SC LETT, V73, P299, DOI 10.1016/0012-821X(85)90078-0; PIEPGRAS DJ, 1982, SCIENCE, V217, P207, DOI 10.1126/science.217.4556.207; PIEPGRAS DJ, 1987, GEOCHIM COSMOCHIM AC, V51, P1257, DOI 10.1016/0016-7037(87)90217-1; Piotrowski AM, 2005, SCIENCE, V307, P1933, DOI 10.1126/science.1104883; Pomies C, 2002, EARTH PLANET SC LETT, V203, P1031, DOI 10.1016/S0012-821X(02)00924-X; Praetorius SK, 2008, NAT GEOSCI, V1, P449, DOI 10.1038/ngeo227; Robinson LF, 2009, GEOLOGY, V37, P195, DOI 10.1130/G25363A.1; Robinson LF, 2005, SCIENCE, V310, P1469, DOI 10.1126/science.1114832; Tachikawa K, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/1999JC000285; Wunsch C, 2003, QUATERNARY SCI REV, V22, P371, DOI 10.1016/S0277-3791(02)00177-4; Yu EF, 1996, NATURE, V379, P689, DOI 10.1038/379689a0	32	186	187	3	70	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					75	78		10.1126/science.1178068	http://dx.doi.org/10.1126/science.1178068			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044573	Green Published			2022-12-28	WOS:000273395400033
J	Hemingway, H; Riley, RD; Altman, DG				Hemingway, Harry; Riley, Richard D.; Altman, Douglas G.			Ten steps towards improving prognosis research	BRITISH MEDICAL JOURNAL			English	Article							CORONARY-HEART-DISEASE; CLINICAL-PRACTICE; BLADDER-CANCER; METAANALYSIS; MARKERS; ASSOCIATION; OUTCOMES; INFORMATION; DEPRESSION; PREDICTION		[Hemingway, Harry] UCL, London WC1 6BT, England; [Riley, Richard D.] Univ Birmingham, Dept Publ Hlth Epidemiol & Biostat, Birmingham B15 2TT, W Midlands, England; [Altman, Douglas G.] Ctr Stat Med, Oxford, England	University of London; University College London; University of Birmingham; University of Oxford	Hemingway, H (corresponding author), UCL, London WC1 6BT, England.	h.hemingway@ucl.ac.uk	Hemingway, Harry/C-1219-2009; Riley, Richard/G-2406-2011; Altman, Douglas G/A-9714-2012; Riley, Richard David/ABE-5877-2020	Hemingway, Harry/0000-0003-2279-0624; Riley, Richard David/0000-0001-8699-0735	National Institute for Health Research [RP-PG-0407-10314] Funding Source: researchfish; MRC [G0800808] Funding Source: UKRI; Medical Research Council [G0800808] Funding Source: Medline; Department of Health [RP-PG-0407-10314] Funding Source: Medline	National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health		Altman DG, 2000, STAT MED, V19, P453, DOI 10.1002/(SICI)1097-0258(20000229)19:4<453::AID-SIM350>3.0.CO;2-5; Claxton K, 2004, HEALTH TECHNOL ASSES, V8, P1, DOI 10.3310/hta8310; Corrao G, 2000, ADDICTION, V95, P1505, DOI 10.1046/j.1360-0443.2000.951015056.x; Council for International Organizations of Medical Sciences WHO, 2002, INT ETH GUID BIOM RE; Fenwick E, 2008, MED DECIS MAKING, V28, P21, DOI 10.1177/0272989X07308751; Guyatt G., 2008, USERS GUIDES MEDICAL; Hayden JA, 2008, J CLIN EPIDEMIOL, V61, P552, DOI 10.1016/j.jclinepi.2007.08.005; Hayden JA, 2009, J CLIN EPIDEMIOL, V62, P781, DOI 10.1016/j.jclinepi.2008.09.004; Hayden JA, 2006, ANN INTERN MED, V144, P427, DOI 10.7326/0003-4819-144-6-200603210-00010; HEMINGWAY H, HLTH TECHNO IN PRESS; Hemingway H, 2006, J CLIN EPIDEMIOL, V59, P1229, DOI 10.1016/j.jclinepi.2006.02.005; HENRIKSSON M, BMJ IN PRESS; Hlatky Mark A, 2009, Circulation, V119, P2408, DOI 10.1161/CIRCULATIONAHA.109.192278; Kuper H, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4265; Kyzas PA, 2005, JNCI-J NATL CANCER I, V97, P1043, DOI 10.1093/jnci/dji184; Kyzas PA, 2007, EUR J CANCER, V43, P2559, DOI 10.1016/j.ejca.2007.08.030; Kyzas PA, 2007, JNCI-J NATL CANCER I, V99, P236, DOI 10.1093/jnci/djk032; Look MP, 2002, JNCI-J NATL CANCER I, V94, P116, DOI 10.1093/jnci/94.2.116; Malats W, 2005, LANCET ONCOL, V6, P678; McShane LM, 2005, JNCI-J NATL CANCER I, V97, P1180, DOI 10.1093/jnci/dji237; Moons KGM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b375; Muntwyler J, 1998, LANCET, V352, P1882, DOI 10.1016/S0140-6736(98)06351-X; NEASE RF, 1995, JAMA-J AM MED ASSOC, V273, P1185, DOI 10.1001/jama.273.15.1185; Nicholson A, 2006, EUR HEART J, V27, P2763, DOI 10.1093/eurheartj/ehl338; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Pengel LHM, 2003, BMJ-BRIT MED J, V327, P323, DOI 10.1136/bmj.327.7410.323; Perel Pablo, 2006, BMC Med Inform Decis Mak, V6, P38, DOI 10.1186/1472-6947-6-38; Reilly BM, 2006, ANN INTERN MED, V144, P201, DOI 10.7326/0003-4819-144-3-200602070-00009; Rifai N, 2008, CLIN CHEM, V54, P1101, DOI 10.1373/clinchem.2008.108993; Riley R D, 2003, Health Technol Assess, V7, P1; Riley RD, 2009, BRIT J CANCER, V100, P1219, DOI 10.1038/sj.bjc.6604999; Riley RD, 2003, BRIT J CANCER, V88, P1191, DOI 10.1038/sj.bjc.6600886; Riley RD, 2007, J CLIN EPIDEMIOL, V60, P863, DOI 10.1016/j.jclinepi.2007.02.004; Romero-Corral A, 2006, LANCET, V368, P666, DOI 10.1016/S0140-6736(06)69251-9; Rothberg BEG, 2009, JNCI-J NATL CANCER I, V101, P452, DOI 10.1093/jnci/djp038; Schmitz-Drager BJ, 2000, EUR UROL, V38, P691, DOI 10.1159/000020364; Sutcliffe P, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13050; Thakkinstian A, 2008, NEPHROL DIAL TRANSPL, V23, P3017, DOI 10.1093/ndt/gfn185; Whiteley W, 2009, STROKE, V40, pE380, DOI 10.1161/STROKEAHA.108.528752; Williams MD, 2009, CLIN ENDOCRINOL, V70, P484, DOI 10.1111/j.1365-2265.2008.03352.x; World Medical Association, 2008, DECL HELS; Yousef F, 2008, AM J EPIDEMIOL, V168, P237, DOI 10.1093/aje/kwn121; Zandbergen EGJ, 2001, INTENS CARE MED, V27, P1661, DOI 10.1007/s001340101076	43	101	100	1	24	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 30	2009	339								b4184	10.1136/bmj.b4184	http://dx.doi.org/10.1136/bmj.b4184			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539JB	20042483				2022-12-28	WOS:000273249100001
J	Selivanova, G; Ivaska, J				Selivanova, Galina; Ivaska, Johanna			Integrins and Mutant p53 on the Road to Metastasis	CELL			English	Editorial Material									[Ivaska, Johanna] Univ Turku, Turku Ctr Biotechnol, FIN-20500 Turku, Finland; [Ivaska, Johanna] Univ Turku, Dept Biochem & Food Chem, FIN-20500 Turku, Finland; [Ivaska, Johanna] VTT Tech Res Ctr Finland, FIN-20500 Turku, Finland; [Selivanova, Galina] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden	University of Turku; University of Turku; VTT Technical Research Center Finland; Karolinska Institutet	Ivaska, J (corresponding author), Univ Turku, Turku Ctr Biotechnol, FIN-20500 Turku, Finland.	johanna.ivaska@vtt.fi		Selivanova, Galina/0000-0002-8698-4332; Ivaska, Johanna/0000-0002-6295-6556				Bon G, 2009, CANCER RES, V69, P5978, DOI 10.1158/0008-5472.CAN-09-0244; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Kaur S, 2009, AM J PATHOL, V175, P2184, DOI 10.2353/ajpath.2009.090028; Selivanova G, 2007, ONCOGENE, V26, P2243, DOI 10.1038/sj.onc.1210295	7	19	22	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 24	2009	139	7					1220	1222		10.1016/j.cell.2009.12.016	http://dx.doi.org/10.1016/j.cell.2009.12.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064366	Bronze			2022-12-28	WOS:000273048700008
J	Kopp, RE; Simons, FJ; Mitrovica, JX; Maloof, AC; Oppenheimer, M				Kopp, Robert E.; Simons, Frederik J.; Mitrovica, Jerry X.; Maloof, Adam C.; Oppenheimer, Michael			Probabilistic assessment of sea level during the last interglacial stage	NATURE			English	Article							ABROLHOS ISLANDS; CLIMATE; RISE; AGE; WARMTH; PERIOD; MODEL; EARTH	With polar temperatures, similar to 3-5 degrees C warmer than today, the last interglacial stage (similar to 125 kyr ago) serves as a partial analogue for 1-2 degrees C global warming scenarios. Geological records from several sites indicate that local sea levels during the last interglacial were higher than today, but because local sea levels differ from global sea level, accurately reconstructing past global sea level requires an integrated analysis of globally distributed data sets. Here we present an extensive compilation of local sea level indicators and a statistical approach for estimating global sea level, local sea levels, ice sheet volumes and their associated uncertainties. We find a 95% probability that global sea level peaked at least 6.6 m higher than today during the last interglacial; it is likely (67% probability) to have exceeded 8.0 m but is unlikely (33% probability) to have exceeded 9.4 m. When global sea level was close to its current level (>=-10 m), the millennial average rate of global sea level rise is very likely to have exceeded 5.6 m kyr(-1) but is unlikely to have exceeded 9.2 m kyr(-1). Our analysis extends previous last interglacial sea level studies by integrating literature observations within a probabilistic framework that accounts for the physics of sea level change. The results highlight the long-term vulnerability of ice sheets to even relatively low levels of sustained global warming.	[Kopp, Robert E.; Simons, Frederik J.; Maloof, Adam C.; Oppenheimer, Michael] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA; [Kopp, Robert E.; Oppenheimer, Michael] Princeton Univ, Woodrow Wilson Sch Publ & Int Affairs, Princeton, NJ 08544 USA; [Mitrovica, Jerry X.] Harvard Univ, Dept Earth & Planetary Sci, Cambridge, MA 02138 USA	Princeton University; Princeton University; Harvard University	Kopp, RE (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	rkopp@alumni.caltech.edu	Kopp, Robert E/B-8822-2008; Simons, Frederik J/A-3427-2008	Simons, Frederik J/0000-0003-2021-6645; Kopp, Robert/0000-0003-4016-9428; Oppenheimer, Michael/0000-0002-9708-5914	Princeton Institute for Computational Science and Engineering; Princeton University Office of Information Technology; Science, Technology, and Environmental Policy	Princeton Institute for Computational Science and Engineering; Princeton University Office of Information Technology(Princeton University); Science, Technology, and Environmental Policy	We thank J. R. Stroud, L. D. Brown and B. McShane for statistical guidance, and M. Bender, B. Horton, D. Nychka and D. Peltier for comments. We also thank G. Spada for providing his SELEN sea level code, which we used for preliminary calculations incorporated in a previous version of the statistical model. Computing resources were substantially provided by the TIGRESS high performance computer centre at Princeton University, which is jointly supported by the Princeton Institute for Computational Science and Engineering and the Princeton University Office of Information Technology. R. E. K. was supported by a postdoctoral fellowship in the programme on Science, Technology, and Environmental Policy at the Woodrow Wilson School of Princeton University.	Banerjee S, 2003, HIERARCHICAL MODELIN; BERGER A, 1991, QUATERNARY SCI REV, V10, P297, DOI 10.1016/0277-3791(91)90033-Q; Camoin GF, 2001, PALAEOGEOGR PALAEOCL, V175, P325, DOI 10.1016/S0031-0182(01)00378-9; Carlson AE, 2008, NAT GEOSCI, V1, P620, DOI 10.1038/ngeo285; CROWLEY TJ, 1994, SCIENCE, V265, P1566, DOI 10.1126/science.265.5178.1566; Cuffey KM, 2000, NATURE, V404, P591, DOI 10.1038/35007053; DZIEWONSKI AM, 1981, PHYS EARTH PLANET IN, V25, P297, DOI 10.1016/0031-9201(81)90046-7; Eisenhauer A, 1996, GEOL RUNDSCH, V85, P606, DOI 10.1007/BF02369014; Esat TM, 1999, SCIENCE, V283, P197, DOI 10.1126/science.283.5399.197; FARRELL WE, 1976, GEOPHYS J ROY ASTR S, V46, P647, DOI 10.1111/j.1365-246X.1976.tb01252.x; Grinsted A, 2010, CLIM DYNAM, V34, P461, DOI 10.1007/s00382-008-0507-2; HASTINGS WK, 1970, BIOMETRIKA, V57, P97, DOI 10.1093/biomet/57.1.97; Jansen E, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P433; Kaspar F, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022456; KATS VE, 2004, ALTAISKOE CHUISKOE, P99; Kendall RA, 2005, GEOPHYS J INT, V161, P679, DOI 10.1111/j.1365-246X.2005.02553.x; LAMBECK K, 1992, NATURE, V357, P125, DOI 10.1038/357125a0; Lea DW, 2004, J CLIMATE, V17, P2170, DOI 10.1175/1520-0442(2004)017<2170:TYCITS>2.0.CO;2; Lighty R.G., 1982, Coral Reefs, V1, P125, DOI 10.1007/BF00301694; LISIECKI LE, 2005, PALEOCEANOGRAPHY, V0020; Meehl GA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P747; MITROVICA JX, 1991, J GEOPHYS RES-SOL EA, V96, P20053, DOI 10.1029/91JB01284; Mitrovica JX, 2005, GEOPHYS J INT, V161, P491, DOI 10.1111/j.1365-246X.2005.02609.x; Mitrovica JX, 2003, GEOPHYS J INT, V154, P253, DOI 10.1046/j.1365-246X.2003.01942.x; Mitrovica JX, 2002, QUATERNARY SCI REV, V21, P2179, DOI 10.1016/S0277-3791(02)00080-X; Muhs DR, 2002, QUATERNARY SCI REV, V21, P1355, DOI 10.1016/S0277-3791(01)00114-7; Otto-Bliesner BL, 2006, SCIENCE, V311, P1751, DOI 10.1126/science.1120808; Overpeck JT, 2006, SCIENCE, V311, P1747, DOI 10.1126/science.1115159; Peltier WR, 2004, ANNU REV EARTH PL SC, V32, P111, DOI 10.1146/annurev.earth.32.082503.144359; PELTIER WR, 1974, REV GEOPHYS, V12, P649, DOI 10.1029/RG012i004p00649; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Rahmstorf S, 2007, SCIENCE, V315, P368, DOI 10.1126/science.1135456; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Rohling EJ, 2008, NAT GEOSCI, V1, P38, DOI 10.1038/ngeo.2007.28; Schellmann G, 2004, EARTH-SCI REV, V64, P157, DOI 10.1016/S0012-8252(03)00043-6; Tamisiea ME, 2007, SCIENCE, V316, P881, DOI 10.1126/science.1137157; Thomas AL, 2009, SCIENCE, V324, P1186, DOI 10.1126/science.1168754; Thompson WG, 2005, SCIENCE, V308, P401, DOI 10.1126/science.1104035; Weldeab S, 2007, SCIENCE, V316, P1303, DOI 10.1126/science.1140461; Wu P., 1978, THESIS U TORONTO; Yin JJ, 2009, NAT GEOSCI, V2, P262, DOI 10.1038/NGEO462; ZAGWIJN WH, 1983, GEOL MIJNBOUW, V62, P437; ZHU ZR, 1993, EARTH PLANET SC LETT, V118, P281, DOI 10.1016/0012-821X(93)90173-7	43	461	467	3	114	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					863	U51		10.1038/nature08686	http://dx.doi.org/10.1038/nature08686			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016591	Green Submitted			2022-12-28	WOS:000272795400031
J	Lin, SC; Hsu, J; Fan, VY				Lin, Steven C.; Hsu, Julia; Fan, Victoria Y.			Christmas 2009: Afterlife "Silent virtuous teachers": anatomical dissection in Taiwan	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hsu, Julia] Tzu Chi Coll Med, Dept Med Humanities, Hualien, Taiwan; [Lin, Steven C.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Hsu, Julia] Buddhist Tzu Chi Gen Hosp, Hualien, Taiwan; [Fan, Victoria Y.] Harvard Univ, Sch Publ Hlth, Dept Global Hlth & Populat, Boston, MA 02115 USA	Tzu Chi University; Boston University; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Lin, SC (corresponding author), Tzu Chi Coll Med, Dept Med Humanities, Hualien, Taiwan.	juliah@mail.tcu.edu.tw	Fan, Victoria/AGG-4359-2022	Fan, Victoria/0000-0001-7755-9425				Chen G., 2008, CHINA MEDIA RES, V4, P56; Dyer GSM, 2000, ACAD MED, V75, P969, DOI 10.1097/00001888-200010000-00008; Granger Noelle A, 2004, Anat Rec B New Anat, V281, P6; NNODIM JO, 1996, CLIN ANAT, V9, P76; Rizzolo Lawrence J., 2002, Anatomical Record, V269, P242, DOI 10.1002/ar.10188; Winkelmann A, 2004, BRIT MED J, V329, P1455, DOI 10.1136/bmj.329.7480.1455; ZHANG JP, 1999, YEAR 85 86 SILENT VI, P192; Zhang LJ, 1999, J THORAC IMAG, V14, P85, DOI 10.1097/00005382-199904000-00003	8	51	51	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2009	339								b5001	10.1136/bmj.b5001	http://dx.doi.org/10.1136/bmj.b5001			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534XH	20015895				2022-12-28	WOS:000272930300010
J	Williams, DJ; Potokar, TS				Williams, David J.; Potokar, Tom S.			Django's Hand	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Williams, David J.] Morrison Hosp, Dept Burns & Plast Surg, Swansea SA6 6NL, W Glam, Wales; [Potokar, Tom S.] Swansea Univ, Sch Med, Swansea SA2 8PP, W Glam, Wales	Morriston Hospital; Swansea University	Williams, DJ (corresponding author), Morrison Hosp, Dept Burns & Plast Surg, Swansea SA6 6NL, W Glam, Wales.	davidj.williams@swansea-tr.wales.nhs.uk	Puiu, Maria/F-3138-2016	Potokar, Tom/0000-0001-9282-8128				ALEXANDRE P, 2003, PLAN SELMERMACCAFERR; ALEXANDRE P, 2001, PLAN GUITARE SELMER, V807; ANTONIETTO A, 1947, RODEO CLUB; BALMER P, 2002, S GRAPPELLI LIFE JAZ; BALMER P, 2003, S GRAPPELLI DJANGO; BAXTER R, 2008, COMMUNICATION; CHARLE F, 1999, STORY S MACCAFERRI G; CRABB DJM, 1980, HAND, V12, P200, DOI 10.1016/S0072-968X(80)80016-7; Delaunay Charles, 1961, D REINHARDT; DERRIEN H, 1951, DJANGO CLUB ST GERMA; DESCAMPS M, 1949, DJANGO BOURGET GYPSY; DIAMANTBERGER H, 1932, CLAIR LUNE; Dregni Michael, 2006, DJANGO LIFE MUSIC GY; GARRETT JW, 1971, HUM FACTORS, V13, P117, DOI 10.1177/001872087101300204; GEHRIG P, 1978, D REINHARDT LEGENDE; Greiner, 1991, HAND ANTHROPOMETRY U, P426; JEREMY J, 1990, LEGACY D REINHARDT; Kastner Jamie, 2005, DJANGOMANIA; LABRO M, 1952, ROUTE BONHEUR; LEVY JD, 1982, ILLUSTRATED HERBAL H; MARTY P, 2005, DJANGO RESSUSCITE; MEEKER D, 2006, SWING GUITAR GENIUS, pM46; MIRKEN M, 1983, FRETS, V5, P36; MIRKEN M, 1983, FRETS, V5, P39; NORRIS R, 1993, INT C SYMPH OP MUS I; PAVIOT P, 1957, D REINHARDT; PERCIVALL J, 2006, D REINHARDT SURVIVED; PETSCH HK, DJANGO JAZZ TRIBUTE; PETULENGRO G, 1979, ROMANY HERBAL REMEDI; WHILLOCK I, 2000, HAND PROPORTION MADE; WILLIAMS P, 1998, DJANGO; Winspur I, 1998, MUSICIANS HAND CLIN; 1944, DJANGO BAL TABARIN	33	0	0	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 16	2009	339								b5348	10.1136/bmj.b5348	http://dx.doi.org/10.1136/bmj.b5348			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534XH	20015898				2022-12-28	WOS:000272930300018
J	Rebeiz, M; Ramos-Womack, M; Jeong, S; Andolfatto, P; Werner, T; True, J; Stern, DL; Carroll, SB				Rebeiz, Mark; Ramos-Womack, Margarita; Jeong, Sangyun; Andolfatto, Peter; Werner, Thomas; True, John; Stern, David L.; Carroll, Sean B.			Evolution of the tan Locus Contributed to Pigment Loss in Drosophila santomea: A Response to Matute et al.	CELL			English	Article							QUANTITATIVE TRAIT LOCI; MORPHOLOGICAL DIFFERENCES; PCR	We have shown previously that the loss of abdominal pigmentation in D. santomea relative to its sister species D. yakuba resulted, in part, from cis-regulatory mutations at the tan locus. Matute et al. claim, based solely upon extrapolation from genetic crosses of D. santomea and D. melanogaster, a much more divergent species, that at least four X chromosome regions but not tan are responsible for pigmentation differences. Here, we provide additional evidence from introgressions of D. yakuba genes into D. santomea that support a causative role for tan in the loss of pigmentation and present analyses that contradict Matute et al.'s claims. We discuss how the choice of parental species and other factors affect the ability to identify loci responsible for species divergence, and we affirm that all of our previously reported results and conclusions stand.	[Rebeiz, Mark; Jeong, Sangyun; Werner, Thomas; Carroll, Sean B.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Rebeiz, Mark; Jeong, Sangyun; Werner, Thomas; Carroll, Sean B.] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Ramos-Womack, Margarita; Stern, David L.] Princeton Univ, Howard Hughes Med Inst, Princeton, NJ 08544 USA; [Ramos-Womack, Margarita; Andolfatto, Peter; Stern, David L.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Andolfatto, Peter] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Howard Hughes Medical Institute; Princeton University; Princeton University; Princeton University	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, 1525 Linden Dr, Madison, WI 53706 USA.	sbcarrol@wisc.edu		Stern, David/0000-0002-1847-6483; True, John/0000-0001-5124-5495; Andolfatto, Peter/0000-0003-3393-4574; Rebeiz, Mark/0000-0001-5731-5570	National Institutes of Health (NIH) [F32-GM78972, GM063622-06A1]; Balzan Foundation; National Science Foundation (NSF) [IOS-0640339]; Harold W. Dodds Honorific Fellowship; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078972, R01GM063622] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Balzan Foundation; National Science Foundation (NSF)(National Science Foundation (NSF)); Harold W. Dodds Honorific Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health (NIH) Postdoctoral Fellowship F32-GM78972 (M.R.); the Balzan Foundation, a National Science Foundation (NSF) Doctoral Dissertation Improvement Grant (M.R.-W.), and Harold W. Dodds Honorific Fellowship 2008-2009 (M.R.-W.); NIH grant GM063622-06A1 and NSF grant IOS-0640339 (D.L.S,); and the Howard Hughes Medical Institute (S.B.C. and D.L.S.).	Abiola O, 2003, NAT REV GENET, V4, P911, DOI 10.1038/nrg1206; BEADLE GW, 1980, SCI AM, V242, P112, DOI 10.1038/scientificamerican0180-112; DOEBLEY J, 1993, GENETICS, V134, P559; Gloor G. B., 1992, DROSOPHILA INFORMATI, V71, P148; Gupta M, 2005, ANAL BIOCHEM, V344, P292, DOI 10.1016/j.ab.2005.05.018; Hawley RS, 2006, GENETICS, V174, P5, DOI 10.1534/genetics.106.064550; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Kopp A, 2000, NATURE, V408, P553, DOI 10.1038/35046017; Landry CR, 2007, HEREDITY, V99, P483, DOI 10.1038/sj.hdy.6801045; Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544; Matute DR, 2009, CELL, V139, P1180, DOI 10.1016/j.cell.2009.10.033; Papp AC, 2003, BIOTECHNIQUES, V34, P1068, DOI 10.2144/03345dd03; SERVICE PM, 2004, SCI AGING KNOWLEDGE, V12, pPE13; Stern DL, 1998, NATURE, V396, P463, DOI 10.1038/24863; Sucena E, 2000, P NATL ACAD SCI USA, V97, P4530, DOI 10.1073/pnas.97.9.4530; True JR, 2005, PLOS GENET, V1, P551, DOI 10.1371/journal.pgen.0010063; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052	17	22	22	0	6	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1189	1196		10.1016/j.cell.2009.11.004	http://dx.doi.org/10.1016/j.cell.2009.11.004			8	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005811	Bronze			2022-12-28	WOS:000272622800020
J	Watson, AJ; Schuster, U; Bakker, DCE; Bates, NR; Corbiere, A; Gonzalez-Davila, M; Friedrich, T; Hauck, J; Heinze, C; Johannessen, T; Kortzinger, A; Metzl, N; Olafsson, J; Olsen, A; Oschlies, A; Padin, XA; Pfeil, B; Santana-Casiano, JM; Steinhoff, T; Telszewski, M; Rios, AF; Wallace, DWR; Wanninkhof, R				Watson, Andrew J.; Schuster, Ute; Bakker, Dorothee C. E.; Bates, Nicholas R.; Corbiere, Antoine; Gonzalez-Davila, Melchor; Friedrich, Tobias; Hauck, Judith; Heinze, Christoph; Johannessen, Truls; Koertzinger, Arne; Metzl, Nicolas; Olafsson, Jon; Olsen, Are; Oschlies, Andreas; Antonio Padin, X.; Pfeil, Benjamin; Magdalena Santana-Casiano, J.; Steinhoff, Tobias; Telszewski, Maciej; Rios, Aida F.; Wallace, Douglas W. R.; Wanninkhof, Rik			Tracking the Variable North Atlantic Sink for Atmospheric CO2	SCIENCE			English	Article							IN-SITU; OCEAN; VARIABILITY; EXCHANGE; TRENDS; LAND; FLUX	The oceans are a major sink for atmospheric carbon dioxide (CO2). Historically, observations have been too sparse to allow accurate tracking of changes in rates of CO2 uptake over ocean basins, so little is known about how these vary. Here, we show observations indicating substantial variability in the CO2 uptake by the North Atlantic on time scales of a few years. Further, we use measurements from a coordinated network of instrumented commercial ships to define the annual flux into the North Atlantic, for the year 2005, to a precision of about 10%. This approach offers the prospect of accurately monitoring the changing ocean CO2 sink for those ocean basins that are well covered by shipping routes.	[Watson, Andrew J.; Schuster, Ute; Bakker, Dorothee C. E.; Hauck, Judith; Telszewski, Maciej] Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England; [Bates, Nicholas R.] Bermuda Biol Stn Res, Ferry Reach, Bermuda; [Corbiere, Antoine; Metzl, Nicolas] Univ Paris 06, CNRS, Lab Oceanog & Climat, Experimentat & Approches Numer Inst Pierre Simon, F-75252 Paris, France; [Gonzalez-Davila, Melchor; Magdalena Santana-Casiano, J.] Univ Las Palmas Gran Canaria, Fac Marine Sci, Dept Chem, Las Palmas Gran Canaria, Gran Canaria, Spain; [Friedrich, Tobias; Koertzinger, Arne; Oschlies, Andreas; Steinhoff, Tobias; Wallace, Douglas W. R.] Leibniz Inst Meereswissensch, D-24105 Kiel, Germany; [Heinze, Christoph; Johannessen, Truls; Olsen, Are; Pfeil, Benjamin] Univ Bergen, Inst Geophys, N-5007 Bergen, Norway; [Heinze, Christoph; Johannessen, Truls; Olsen, Are; Pfeil, Benjamin] Univ Bergen, Bjerknes Ctr Climate Res, N-5007 Bergen, Norway; [Olafsson, Jon] Marine Res Inst, IS-121 Reykjavik, Iceland; [Olafsson, Jon] Univ Iceland, Reykjavik, Iceland; [Olsen, Are] Univ Gothenburg, Dept Chem, S-41296 Gothenburg, Sweden; [Antonio Padin, X.; Rios, Aida F.] CSIC, Inst Invest Marinas, Vigo 36208, Spain; [Wanninkhof, Rik] Natl Ocean & Atmospher Adm, Atlantic Oceanog & Meteorol Lab, Miami, FL 33149 USA	University of East Anglia; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Sorbonne Universite; Universidad de Las Palmas de Gran Canaria; Helmholtz Association; GEOMAR Helmholtz Center for Ocean Research Kiel; University of Bergen; Bjerknes Centre for Climate Research; University of Bergen; Marine & Freshwater Research Institute (MFRI); University of Iceland; University of Gothenburg; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); National Oceanic Atmospheric Admin (NOAA) - USA; Atlantic Oceanographic & Meteorological Laboratory (AOML)	Watson, AJ (corresponding author), Univ E Anglia, Sch Environm Sci, Norwich NR4 7TJ, Norfolk, England.	a.watson@uea.ac.uk	CASIANO, JUANA MAGDALENA SANTANA/K-5058-2014; Friedrich, Tobias/D-1053-2013; Hauck, Judith/AAC-3967-2019; Körtzinger, Arne/A-4141-2014; Padin, X.A./AAA-1305-2019; Oschlies, Andreas/F-9749-2012; DAVILA, MELCHOR GONZALEZ/K-4958-2014; Olsen, Are/A-1511-2011; Bakker, Dorothee C E/E-4951-2015	CASIANO, JUANA MAGDALENA SANTANA/0000-0002-7930-7683; Friedrich, Tobias/0000-0001-7324-4100; Hauck, Judith/0000-0003-4723-9652; Körtzinger, Arne/0000-0002-8181-3593; Oschlies, Andreas/0000-0002-8295-4013; DAVILA, MELCHOR GONZALEZ/0000-0003-3230-8985; Olsen, Are/0000-0003-1696-9142; Bakker, Dorothee C E/0000-0001-9234-5337; Steinhoff, Tobias/0000-0002-2298-1298; metzl, nicolas/0000-0002-1165-1074; PADIN, XOSE ANTONIO/0000-0002-4277-3410; Watson, Andrew/0000-0002-9654-8147	European Commission under CarboOcean [511176]; Intercambio de Carbono entre Canarias y Barcelona [CTM2005-03893/MAR, CTM2006-27116-E/MAR]; Natural Environment Research Council's Centre for Observation of Air-Sea Interactions and Fluxes and the National Centre for Earth Observation in the United Kingdom; Institut National des Sciences de l'Univers and Institut Paul Emile Victor in France; Natural Environment Research Council [earth010003] Funding Source: researchfish; NERC [earth010003] Funding Source: UKRI	European Commission under CarboOcean; Intercambio de Carbono entre Canarias y Barcelona; Natural Environment Research Council's Centre for Observation of Air-Sea Interactions and Fluxes and the National Centre for Earth Observation in the United Kingdom; Institut National des Sciences de l'Univers and Institut Paul Emile Victor in France; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank Seatrade Reefer Chartering, Belgium; Geest Line Ltd, UK; Royal Arctic Line, Denmark; Royal Caribbean International, USA; Atlantic Container Lines Inc., USA; Eimskip Company, Iceland; and Wallenius Lines, Sweden, as well as the captains, officers, and crew of all ships for support of our projects. We acknowledge funding from the European Commission under CarboOcean [project 511176 (GOCE)]; Intercambio de Carbono entre Canarias y Barcelona CTM2005-03893/MAR and CTM2006-27116-E/MAR in Spain; the Natural Environment Research Council's Centre for Observation of Air-Sea Interactions and Fluxes and the National Centre for Earth Observation in the United Kingdom; and Institut National des Sciences de l'Univers and Institut Paul Emile Victor in France.	Bousquet P, 2000, SCIENCE, V290, P1342, DOI 10.1126/science.290.5495.1342; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Corbiere A, 2007, TELLUS B, V59, P168, DOI [10.1111/j.1600-0889.2006.00232.x, 10.1111/j.l600-0889.2006.00232.x]; Eden C, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002521; Friedrich T, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2007JC004646; Gruber N, 2009, NATURE, V458, P155, DOI 10.1038/458155a; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; KING AW, 2008, N AM CARBON BUDGET I; Kohonen T., 1995, SERIES INFORM SCI, V30; Le Quere C, 2003, TELLUS B, V55, P649, DOI 10.1034/j.1600-0889.2003.00043.x; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Luger H, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003101; Luger H, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002200; Manning AC, 2006, TELLUS B, V58, P95, DOI 10.1111/j.1600-0889.2006.00175.x; Muller SA, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003065; Naegler T, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025408; Nightingale PD, 2000, GLOBAL BIOGEOCHEM CY, V14, P373, DOI 10.1029/1999GB900091; Olsen A, 2004, REMOTE SENS ENVIRON, V89, P309, DOI 10.1016/j.rse.2003.10.011; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; Patra PK, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002257; Peters W, 2007, P NATL ACAD SCI USA, V104, P18925, DOI 10.1073/pnas.0708986104; Schuster U, 2009, DEEP-SEA RES PT II, V56, P620, DOI 10.1016/j.dsr2.2008.12.011; Schuster U, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003941; Sweeney C, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002784; Takahashi T, 2002, DEEP-SEA RES PT II, V49, P1601, DOI 10.1016/S0967-0645(02)00003-6; Takahashi T, 2009, DEEP-SEA RES PT II, V56, P554, DOI 10.1016/j.dsr2.2008.12.009; Thomas H, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003167; Webster R., 2001, GEOSTATISTICS ENV SC	28	128	129	2	52	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1391	1393		10.1126/science.1177394	http://dx.doi.org/10.1126/science.1177394			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965756				2022-12-28	WOS:000272351100039
J	Bochukova, EG; Huang, N; Keogh, J; Henning, E; Purmann, C; Blaszczyk, K; Saeed, S; Hamilton-Shield, J; Clayton-Smith, J; O'Rahilly, S; Hurles, ME; Farooqi, IS				Bochukova, Elena G.; Huang, Ni; Keogh, Julia; Henning, Elana; Purmann, Carolin; Blaszczyk, Kasia; Saeed, Sadia; Hamilton-Shield, Julian; Clayton-Smith, Jill; O'Rahilly, Stephen; Hurles, Matthew E.; Farooqi, I. Sadaf			Large, rare chromosomal deletions associated with severe early-onset obesity	NATURE			English	Article							CLINICAL SPECTRUM; ADULT OBESITY; AUTISM; MICRODELETION; RECEPTOR; 16P11.2; GENE; REARRANGEMENTS; SENSITIVITY; CHILDHOOD	Obesity is a highly heritable and genetically heterogeneous disorder(1). Here we investigated the contribution of copy number variation to obesity in 300 Caucasian patients with severe early-onset obesity, 143 of whom also had developmental delay. Large (>500 kilobases), rare (<1%) deletions were significantly enriched in patients compared to 7,366 controls (P<0.001). We identified several rare copy number variants that were recurrent in patients but absent or at much lower prevalence in controls. We identified five patients with overlapping deletions on chromosome 16p11.2 that were found in 2 out of 7,366 controls (P<5 x 10(-5)). In three patients the deletion co-segregated with severe obesity. Two patients harboured a larger de novo 16p11.2 deletion, extending through a 593-kilobase region previously associated with autism(2-4) and mental retardation(5); both of these patients had mild developmental delay in addition to severe obesity. In an independent sample of 1,062 patients with severe obesity alone, the smaller 16p11.2 deletion was found in an additional two patients. All 16p11.2 deletions encompass several genes but include SH2B1, which is known to be involved in leptin and insulin signalling(6). Deletion carriers exhibited hyperphagia and severe insulin resistance disproportionate for the degree of obesity. We show that copy number variation contributes significantly to the genetic architecture of human obesity.	[Bochukova, Elena G.; Keogh, Julia; Henning, Elana; Purmann, Carolin; Blaszczyk, Kasia; Saeed, Sadia; O'Rahilly, Stephen; Farooqi, I. Sadaf] Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 0QQ, England; [Huang, Ni; Hurles, Matthew E.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Hamilton-Shield, Julian] Bristol Childrens Hosp, Bristol BS2 8BG, Avon, England; [Clayton-Smith, Jill] St Marys Hosp, Manchester M13 9WL, Lancs, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Wellcome Trust Sanger Institute; Bristol Royal Hospital For Children; University of Manchester	Farooqi, IS (corresponding author), Univ Cambridge, Addenbrookes Hosp, Metab Res Labs, Inst Metab Sci, Cambridge CB2 0QQ, England.	meh@sanger.ac.uk; isf20@cam.ac.uk	Shield, Julian PH/D-6297-2014; Farooqi, Ismaa Sadaf/AAZ-3046-2020; O'Rahilly, Stephen/ABF-6509-2020	Shield, Julian PH/0000-0003-2601-7575; O'Rahilly, Stephen/0000-0003-2199-4449; Bochukova, Elena/0000-0003-0275-1548; Saeed, Sadia/0000-0003-3144-7772; Farooqi, Sadaf/0000-0001-7609-3504	Wellcome Trust [077014/Z/05/0Z, 082390/Z/07/Z, 085475]; MRC Centre for Obesity and Related Disorders; NIHR Cambridge Biomedical Research Centre; NIH; MRC [G0900554] Funding Source: UKRI; Medical Research Council [G0900554] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); MRC Centre for Obesity and Related Disorders(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR Cambridge Biomedical Research Centre(National Institute for Health Research (NIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the patients, their families and all the Physicians who have referred patients to the Genetics of Obesity Study (GOOS). E. G. B., N.H., M. E. H. (grant no. 077014/Z/05/0Z) and I. S. F. (grant no. 082390/Z/07/Z) were funded by the Wellcome Trust. I. S. F. and S.O.R. are funded by the MRC Centre for Obesity and Related Disorders and NIHR Cambridge Biomedical Research Centre. We would like to thank L. Mavrogiannis for advice on MLPA analysis and V. Trowse for help with clinical studies. This study makes use of control data provided by the Genetic Association Information Network (GAIN) and the Wellcome Trust Case Control Consortium 2 (WTCCC2), through work funded by NIH and the Wellcome Trust (under award 085475). The GAIN General Research Use data sets used for the analyses described in this manuscript were obtained from the database of Genotype and Phenotype (dbGaP; http://www.ncbi.nlm.nih.gov/gap, dbGaP accession numbers phs000017 and phs000021). A full list of the investigators who contributed to the generation of the WTCCC2 data is available from http://www.wtccc.org.uk/ccc2.	Bijlsma EK, 2009, EUR J MED GENET, V52, P77, DOI 10.1016/j.ejmg.2009.03.006; Dina C, 2007, NAT GENET, V39, P724, DOI 10.1038/ng2048; Farooqi IS, 2007, NEW ENGL J MED, V356, P237, DOI 10.1056/NEJMoa063988; Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Hirschhorn JN, 2002, J CLIN ENDOCR METAB, V87, P4438, DOI 10.1210/jc.2002-021329; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Lee JA, 2006, NEURON, V52, P103, DOI 10.1016/j.neuron.2006.09.027; Loos RJF, 2008, NAT GENET, V40, P768, DOI 10.1038/ng.140; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; Morris DL, 2009, DIABETES, V58, P2039, DOI 10.2337/db08-1388; Poot M, 2010, EUR J HUM GENET, V18, P39, DOI 10.1038/ejhg.2009.120; Ren DC, 2005, CELL METAB, V2, P95, DOI 10.1016/j.cmet.2005.07.004; Ren DC, 2007, J CLIN INVEST, V117, P397, DOI 10.1172/JCI29417; Sebat J, 2007, SCIENCE, V316, P445, DOI 10.1126/science.1138659; Sharp AJ, 2008, NAT GENET, V40, P322, DOI 10.1038/ng.93; Stefansson H, 2008, NATURE, V455, P232, DOI 10.1038/nature07229; Thorleifsson G, 2009, NAT GENET, V41, P18, DOI 10.1038/ng.274; van Bon BWM, 2009, J MED GENET, V46, P511, DOI 10.1136/jmg.2008.063412; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287	25	364	392	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					666	670		10.1038/nature08689	http://dx.doi.org/10.1038/nature08689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	19966786	Green Accepted			2022-12-28	WOS:000274193900037
J	Bailor, MH; Sun, XY; Al-Hashimi, HM				Bailor, Maximillian H.; Sun, Xiaoyan; Al-Hashimi, Hashim M.			Topology Links RNA Secondary Structure with Global Conformation, Dynamics, and Adaptation	SCIENCE			English	Article							DIMERIZATION INITIATION SITE; CRYSTAL-STRUCTURE; DECODING SITE; NUCLEIC-ACIDS; BINDING; RECOGNITION; PREDICTION; NMR; AMINOGLYCOSIDES; JUNCTIONS	Thermodynamic rules that link RNA sequences to secondary structure are well established, but the link between secondary structure and three-dimensional global conformation remains poorly understood. We constructed comprehensive three-dimensional maps depicting the orientation of A-form helices across RNA junctions in the Protein Data Bank and rationalized our findings with modeling and nuclear magnetic resonance spectroscopy. We show that the secondary structures of junctions encode readily computable topological constraints that accurately predict the three-dimensional orientation of helices across all two-way junctions. Our results suggest that RNA global conformation is largely defined by topological constraints encoded at the secondary structural level and that tertiary contacts and intermolecular interactions serve to stabilize specific conformers within the topologically allowed ensemble.	[Bailor, Maximillian H.; Sun, Xiaoyan; Al-Hashimi, Hashim M.] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Al-Hashimi, HM (corresponding author), Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA.	hashimi@umich.edu			NIH [R01 AI066975-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066975] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Brooks for stimulating discussions and A. Kurochkin for NMR expertise. We acknowledge the Michigan Economic Development Cooperation and the Michigan Technology Tri-Corridor for the support of the purchase of a 600-MHz spectrometer and the W. F. Keck Foundation, NSF, and NIH for funds for the purchase of a 800-MHz spectrometer. Supported by NIH grant R01 AI066975-01.	Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bindewald E, 2008, NUCLEIC ACIDS RES, V36, pD392, DOI 10.1093/nar/gkm842; Blount KF, 2003, NUCLEIC ACIDS RES, V31, P5490, DOI 10.1093/nar/gkg755; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Ennifar E, 2006, NUCLEIC ACIDS RES, V34, P2328, DOI 10.1093/nar/gkl317; Francois B, 2004, ANGEW CHEM INT EDIT, V43, P6735, DOI 10.1002/anie.200462092; Francois B, 2005, NUCLEIC ACIDS RES, V33, P5677, DOI 10.1093/nar/gki862; Frank AT, 2009, NUCLEIC ACIDS RES, V37, P3670, DOI 10.1093/nar/gkp156; Freisz S, 2008, ANGEW CHEM INT EDIT, V47, P4110, DOI 10.1002/anie.200800726; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Kondo J, 2007, CHEMMEDCHEM, V2, P1631, DOI 10.1002/cmdc.200700113; Kondo J, 2006, BIOCHIMIE, V88, P1027, DOI 10.1016/j.biochi.2006.05.017; Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590; LILLEY DMJ, 1995, NUCLEIC ACIDS RES, V23, P3363, DOI 10.1093/nar/23.17.3363; Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010; Musselman C, 2006, J BIOMOL NMR, V36, P235, DOI 10.1007/s10858-006-9087-9; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; PUGLISI JD, 1992, SCIENCE, V257, P76, DOI 10.1126/science.1621097; Schwalbe H, 2007, ANGEW CHEM INT EDIT, V46, P1212, DOI 10.1002/anie.200604163; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Shapiro BA, 2007, CURR OPIN STRUC BIOL, V17, P157, DOI 10.1016/j.sbi.2007.03.001; Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Vicens Q, 2001, STRUCTURE, V9, P647, DOI 10.1016/S0969-2126(01)00629-3; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	30	150	152	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					202	206		10.1126/science.1181085	http://dx.doi.org/10.1126/science.1181085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056889				2022-12-28	WOS:000273394000035
J	Sonksen, P; Hillier, S				Sonksen, Peter; Hillier, Stephen			A Patient's Journey Spinal cord injury	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hillier, Stephen] The Surgery, Bishops Waltham SO32 1GR, Hants, England			phsonksen@aol.com; stephenhillier@doctors.org.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 7	2010	340								b5204	10.1136/bmj.b5204	http://dx.doi.org/10.1136/bmj.b5204			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542IG	20056693				2022-12-28	WOS:000273485700007
J	Kim, MY; Oskarsson, T; Acharyya, S; Nguyen, DX; Zhang, XHF; Norton, L; Massague, J				Kim, Mi-Young; Oskarsson, Thordur; Acharyya, Swarnali; Nguyen, Don X.; Zhang, Xiang H. -F.; Norton, Larry; Massague, Joan			Tumor Self-Seeding by Circulating Cancer Cells	CELL			English	Article							BREAST-CANCER; LUNG METASTASIS; INTERLEUKIN-6; MELANOMA; IL-6; INFLAMMATION; FASCIN; GENES; DISSEMINATION; ANGIOGENESIS	Cancer cells that leave the primary tumor can seed metastases in distant organs, and it is thought that this is a unidirectional process. Here we show that circulating tumor cells (CTCs) can also colonize their tumors of origin, in a process that we call "tumor self-seeding." Self-seeding of breast cancer, colon cancer, and melanoma tumors in mice is preferentially mediated by aggressive CTCs, including those with bone, lung, or brain-metastatic tropism. We find that the tumor-derived cytokines IL-6 and IL-8 act as CTC attractants whereas MMP1/collagenase-1 and the actin cytoskeleton component fascin-1 are mediators of CTC infiltration into mammary tumors. We show that self-seeding can accelerate tumor growth, angiogenesis, and stromal recruitment through seed-derived factors including the chemokine CXCL1. Tumor self-seeding could explain the relationships between anaplasia, tumor size, vascularity and prognosis, and local recurrence seeded by disseminated cells following ostensibly complete tumor excision.	[Kim, Mi-Young; Oskarsson, Thordur; Acharyya, Swarnali; Nguyen, Don X.; Zhang, Xiang H. -F.; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Norton, Larry] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Massague, Joan] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA.	massaguj@mskcc.org	Oskarsson, Thordur/HBP-9601-2022; Kim, Mi Young/C-1829-2011	Oskarsson, Thordur/0000-0002-0983-6969; Zhang, Xiang/0000-0002-5674-8670; Massague, Joan/0000-0001-9324-8408; Norton, Larry/0000-0003-3701-9250	National Institutes of Health [CA94060]; Hearst Foundation; Alan and Sandra Gerry Metastasis Research Initiative; Department of Defense Era of Hope postdoctoral fellowship; NATIONAL CANCER INSTITUTE [P01CA094060, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hearst Foundation; Alan and Sandra Gerry Metastasis Research Initiative; Department of Defense Era of Hope postdoctoral fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank F. Miller for cell lines, T. Shree for MMTV-PyMT mice, P. Bos and S. Tavazoie for critical discussions, W. Shu for technical support, and D. Padua, G. Gupta, and A. Insinga for contributions during the initiation of this work. This work was funded by grants from the National Institutes of Health (CA94060), the Hearst Foundation, and the Alan and Sandra Gerry Metastasis Research Initiative. M.Y.K. is supported by a Department of Defense Era of Hope postdoctoral fellowship. J.M. is an Investigator of the Howard Hughes Medical Institute.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Arihiro K, 2000, Breast Cancer, V7, P221, DOI 10.1007/BF02967464; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CHARBONNEAU H, 1988, P NATL ACAD SCI USA, V85, P7182, DOI 10.1073/pnas.85.19.7182; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Dupre SA, 2007, INT J EXP PATHOL, V88, P351, DOI 10.1111/j.1365-2613.2007.00539.x; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Esfandi F, 2006, CANCER LETT, V244, P76, DOI 10.1016/j.canlet.2005.12.003; Galkina E, 2007, CURR DRUG TARGETS, V8, P1239, DOI 10.2174/138945007783220650; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Rafii S, 2003, CANCER CELL, V4, P331, DOI 10.1016/S1535-6108(03)00278-2; Rutka JT, 2008, NEOPLASIA, V10, P149, DOI 10.1593/neo.07909; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Scheel C, 2007, CANCER RES, V67, P11476, DOI 10.1158/0008-5472.CAN-07-1653; SCHEIBENBOGEN C, 1995, MELANOMA RES, V5, P179, DOI 10.1097/00008390-199506000-00006; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Ugurel S, 2001, J CLIN ONCOL, V19, P577, DOI 10.1200/JCO.2001.19.2.577; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; WANG JM, 1990, BIOCHEM BIOPH RES CO, V169, P165, DOI 10.1016/0006-291X(90)91449-3; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843	47	948	989	7	241	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1315	1326		10.1016/j.cell.2009.11.025	http://dx.doi.org/10.1016/j.cell.2009.11.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064377	Green Accepted, Bronze			2022-12-28	WOS:000273048700019
J	Davidoff, F				Davidoff, Frank			Heterogeneity Is Not Always Noise Lessons From Improvement	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MEDICAL EMERGENCY TEAM; RAPID RESPONSE TEAM; PATIENT SAFETY RESEARCH; CRITICAL-CARE OUTREACH; QUALITY IMPROVEMENT; CLINICAL-TRIALS; HEALTH-CARE; CODE RATES; MORTALITY; IMPLEMENTATION	Rigorous experimental methods suppress differences among study participants (noise) to detect true intervention effects (signals). But suppressing participants' heterogeneity obscures an essential dimension of biological and clinical knowledge. Medicine is therefore ambivalent about the influence of heterogeneity on outcomes and struggles to find ways to take it properly into account in both clinical practice and research. This analysis explores the roots of that ambivalence. Drawing on the evaluation of 2 health care improvement initiatives, this article examines the unique features of improvement that help to understand heterogeneity's influence on study methods, and suggests a variety of ways to assess the effect of heterogeneity on study outcome measures. JAMA. 2009; 302(23):2580-2586 www.jama.com	[Davidoff, Frank] Annals Internal Med, Philadelphia, PA USA; [Davidoff, Frank] Inst Healthcare Improvement, Cambridge, MA USA	Institute for Healthcare Improvement	Davidoff, F (corresponding author), 143 Garden St, Wethersfield, CT 06109 USA.	fdavidoff@cox.net						Auerbach AD, 2007, NEW ENGL J MED, V357, P608, DOI 10.1056/NEJMsb070738; Batalden P, 2007, JAMA-J AM MED ASSOC, V298, P1059, DOI 10.1001/jama.298.9.1059; Bellomo R, 2004, CRIT CARE MED, V32, P916, DOI 10.1097/01.CCM.0000119428.02968.9E; Bosk CL, 2009, LANCET, V374, P444, DOI 10.1016/S0140-6736(09)61440-9; Bravata DM, 2005, ANN INTERN MED, V142, P1056, DOI 10.7326/0003-4819-142-12_Part_2-200506211-00005; Brilli RJ, 2007, PEDIATR CRIT CARE ME, V8, P236, DOI 10.1097/01.PCC.0000262947.72442.EA; Brown C, 2008, QUAL SAF HEALTH CARE, V17, P163, DOI 10.1136/qshc.2007.023648; Brown C, 2008, QUAL SAF HEALTH CARE, V17, P178, DOI 10.1136/qshc.2007.023663; CAMPBELL DT, 1963, EXPT QUASIEXPERIMENT, P17; Campbell NC, 2007, BMJ-BRIT MED J, V334, P455, DOI 10.1136/bmj.39108.379965.BE; Chan PS, 2008, JAMA-J AM MED ASSOC, V300, P2506, DOI 10.1001/jama.2008.715; CHEN J, CONDITIONALITY METS; Chen J, 2009, CRIT CARE MED, V37, P148, DOI 10.1097/CCM.0b013e3181928ce3; Cook TD, 2002, EXPT QUASIEXPERIMENT, P1, DOI 10.1198/jasa.2005.s22; Cretikos Michelle A, 2007, Crit Care Resusc, V9, P205; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; DeVita MA, 2006, CRIT CARE MED, V34, P2463, DOI 10.1097/01.CCM.0000235743.38172.6E; Dixon-Woods M, 2010, J HEALTH SERV RES PO, V15, P11, DOI 10.1258/jhsrp.2009.009041; Egger M., 2001, SYSTEMATIC REV HLTH, P3; Esmonde L, 2006, INTENS CARE MED, V32, P1713, DOI 10.1007/s00134-006-0380-6; Flyvbjerg Bent, 2001, MAKING SOCIAL SCI MA; Greenhalgh T, 2004, MILBANK Q, V82, P581, DOI 10.1111/j.0887-378X.2004.00325.x; Greenhalgh T, 2009, MILBANK Q, V87, P391, DOI 10.1111/j.1468-0009.2009.00562.x; Grol RPTM, 2007, MILBANK Q, V85, P93, DOI 10.1111/j.1468-0009.2007.00478.x; Hawe P, 2004, J EPIDEMIOL COMMUN H, V58, P788, DOI 10.1136/jech.2003.014415; Heng HHQ, 2008, JAMA-J AM MED ASSOC, V300, P1580, DOI 10.1001/jama.300.13.1580; Heng HHQ, 2009, J CELL PHYSIOL, V220, P538, DOI 10.1002/jcp.21799; Hillman K, 2005, LANCET, V365, P2091; Jones D, 2005, CRIT CARE, V9, pR808, DOI 10.1186/cc3906; Jones D, 2007, CRIT CARE, V11, DOI 10.1186/cc5673; Jones D, 2007, RESUSCITATION, V74, P235, DOI 10.1016/j.resuscitation.2006.12.007; Katz MH, 1999, MULTIVARIABLE ANAL P; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; King E, 2006, J HOSP MED, V1, P296, DOI 10.1002/jhm.114; Kravitz RL, 2004, MILBANK Q, V82, P661, DOI 10.1111/j.0887-378X.2004.00327.x; Lau J, 1998, LANCET, V351, P123, DOI 10.1016/S0140-6736(97)08468-7; LIGHT RJ, 1984, SUMMING SCI REV RES, P9; MEINERT CL, 1966, CLIN TRIALS DICT TER, P83; Naeem N, 2005, RESUSCITATION, V67, P13, DOI 10.1016/j.resuscitation.2005.04.016; Pawson R., 1997, REALISTIC EVALUATION; Priestley G, 2004, INTENS CARE MED, V30, P1398, DOI 10.1007/s00134-004-2268-7; Pronovost P, 2005, QUAL SAF HEALTH CARE, V14, P231, DOI 10.1136/qshc.2005.015180; Pronovost P, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1714; Pronovost P, 2006, NEW ENGL J MED, V355, P2725, DOI 10.1056/NEJMoa061115; Saint S, 2009, JT COMM J QUAL PATIE, V35, P239, DOI 10.1016/S1553-7250(09)35032-1; Schmid-Mazzoccoli A, 2008, QUAL SAF HEALTH CARE, V17, P377, DOI 10.1136/qshc.2006.020438; Schouten LMT, 2008, BMJ-BRIT MED J, V336, P1491, DOI 10.1136/bmj.39570.749884.BE; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Scott Ian A, 2007, ACP J Club, V146, pA8; Sebat F, 2005, CHEST, V127, P1729, DOI 10.1378/chest.127.5.1729; Sharek PJ, 2007, JAMA-J AM MED ASSOC, V298, P2267, DOI 10.1001/jama.298.19.2267; Sharp S.J., 2001, SYSTEMATIC REV HLTH, P176; Shojania KG, 2005, HEALTH AFFAIR, V24, P138, DOI 10.1377/hlthaff.24.1.138; Speroff Theodore, 2004, Qual Manag Health Care, V13, P17; Swales J, 2000, J ROY SOC MED, V93, P402, DOI 10.1177/014107680009300804; Thompson S.G., 2001, SYSTEMATIC REV HLTH, P157; Tibballs J, 2005, ARCH DIS CHILD, V90, P1148, DOI 10.1136/adc.2004.069401; Tilley N, 2009, CRIMINOL CRIM JUSTIC, V9, P135, DOI 10.1177/1748895809102549; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Vandenbroucke JP, 2008, PLOS MED, V5, P339, DOI 10.1371/journal.pmed.0050067; Vlopp KG, 2009, NEW ENGL J MED, V361, P331, DOI 10.1056/NEJMp0903496; Walshe K, 2007, INT J QUAL HEALTH C, V19, P57, DOI 10.1093/intqhc/mzm004; Wang R, 2007, NEW ENGL J MED, V357, P2189, DOI 10.1056/NEJMsr077003; Winters BD, 2006, JAMA-J AM MED ASSOC, V296, P1645, DOI 10.1001/jama.296.13.1645; Winters BD, 2007, CRIT CARE MED, V35, P1238, DOI 10.1097/01.CCM.0000262388.85669.68; Zenker P, 2007, JT COMM J QUAL PATIE, V33, P418, DOI 10.1016/S1553-7250(07)33048-1; Zwarenstein M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2390	67	85	85	0	13	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	2009	302	23					2580	2586		10.1001/jama.2009.1845	http://dx.doi.org/10.1001/jama.2009.1845			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532HK	20009058				2022-12-28	WOS:000272737200026
J	Lieb, W; Beiser, AS; Vasan, RS; Tan, ZS; Au, R; Harris, TB; Roubenoff, R; Auerbach, S; DeCarli, C; Wolf, PA; Seshadri, S				Lieb, Wolfgang; Beiser, Alexa S.; Vasan, Ramachandran S.; Tan, Zaldy S.; Au, Rhoda; Harris, Tamara B.; Roubenoff, Ronenn; Auerbach, Sanford; DeCarli, Charles; Wolf, Philip A.; Seshadri, Sudha			Association of Plasma Leptin Levels With Incident Alzheimer Disease and MRI Measures of Brain Aging	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							HIPPOCAMPAL SYNAPTIC PLASTICITY; CENTRAL-NERVOUS-SYSTEM; COGNITIVE FUNCTION; CENTRAL OBESITY; HEART-DISEASE; RISK; DEMENTIA; NEUROPATHOLOGY; MORTALITY; NEURONS	Context The adipokine leptin facilitates long-term potentiation and synaptic plasticity in the hippocampus, promotes beta-amyloid clearance, and improves memory function in animal models of aging and Alzheimer disease (AD). Objective To relate baseline circulating leptin concentrations in a community-based sample of individuals without dementia to incident dementia and AD during follow-up and magnetic resonance imaging (MRI) measures of brain aging in survivors. Design, Setting, and Participants Prospective study of plasma leptin concentrations measured in 785 persons without dementia (mean [SD] age, 79 [5] years; 62% female), who were in the Framingham original cohort at the 22nd examination cycle (1990-1994). A subsample of 198 dementia-free survivors underwent volumetric brain MRI between 1999 and 2005, approximately 7.7 years after leptin was assayed. Two measures of brain aging, total cerebral brain volume and temporal horn volume (which is inversely related to hippocampal volume) were assessed. Main Outcome Measure Incidence of dementia and AD during follow-up until December 31, 2007. Results During a median follow-up of 8.3 years (range, 0-15.5 years), 111 participants developed incident dementia; 89 had AD. Higher leptin levels were associated with a lower risk of incident dementia and AD in multivariable models (hazard ratio per 1-SD increment in log leptin was 0.68 [95% confidence interval, 0.54-0.87] for all-cause dementia and 0.60 [95% confidence interval, 0.46-0.79] for AD). This corresponds to an absolute AD risk over a 12-year follow-up of 25% for persons in the lowest quartile (first quartile) vs 6% for persons in the fourth quartile of sex-specific leptin levels. In addition, a 1-SD elevation in plasma leptin level was associated with higher total cerebral brain volume and lower temporal horn volume, although the association of leptin level with temporal horn volume did not reach statistical significance. Conclusion Circulating leptin was associated with a reduced incidence of dementia and AD and with cerebral brain volume in asymptomatic older adults. JAMA. 2009;302(23):2565-2572	[Beiser, Alexa S.; Au, Rhoda; Auerbach, Sanford; Wolf, Philip A.; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Lieb, Wolfgang; Beiser, Alexa S.; Vasan, Ramachandran S.; Wolf, Philip A.; Seshadri, Sudha] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Beiser, Alexa S.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02118 USA; [Vasan, Ramachandran S.] Boston Univ, Sch Med, Dept Epidemiol & Prevent Med, Boston, MA 02118 USA; [Tan, Zaldy S.] Brigham & Womens Hosp, Boston VA Healthcare Syst, Boston, MA 02115 USA; [Tan, Zaldy S.] Brigham & Womens Hosp, Div Aging, Boston, MA 02115 USA; [Harris, Tamara B.] NIA, Intramural Res Program, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Roubenoff, Ronenn] Tufts Univ, Friedman Sch Nutr Sci & Policy, Boston, MA 02111 USA; [DeCarli, Charles] Univ Calif Davis, Dept Neurol, Sacramento, CA 95817 USA; [DeCarli, Charles] Univ Calif Davis, Ctr Neurosci, Sacramento, CA 95817 USA	Boston University; Framingham Heart Study; Boston University; Boston University; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Boston Healthcare System; Harvard University; Brigham & Women's Hospital; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Tufts University; University of California System; University of California Davis; University of California System; University of California Davis	Seshadri, S (corresponding author), Boston Univ, Sch Med, Dept Neurol, 72 E Concord St,B602, Boston, MA 02118 USA.	suseshad@bu.edu	Kennedy, Kristen M/B-4699-2008; Ramachandran, Vasan/Y-2527-2019; DeCarli, Charles/B-5541-2009; Lieb, Wolfgang/AAC-7650-2022	Kennedy, Kristen M/0000-0001-5373-9026; Ramachandran, Vasan/0000-0001-7357-5970; Roubenoff, Ronenn/0000-0002-3959-3179; Auerbach, Sanford/0000-0003-2962-6405; Seshadri, Sudha/0000-0001-6135-2622; Beiser, Alexa/0000-0001-8551-7778; Au, Rhoda/0000-0001-7742-4491; Wolf, Philip/0000-0002-3628-301X	National Institutes of Health [N01-HC-25195, N01HV28178, RO1DK080739, 2K24HL04334]; National Heart, Lung, and Blood Institute; National Institute on Aging [R01 AG16495, AG08122, AG033193, AG031287]; National Institute of Neurological Disorders and Stroke [R01 NS17950]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC025195] Funding Source: NIH RePORTER; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028178] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL028178, K24HL004334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK080739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS017950] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG010129, R01AG031287, R01AG008122, R01AG016495, R01AG033193] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by contracts N01-HC-25195, N01HV28178, RO1DK080739, and 2K24HL04334 (awarded to Dr Vasan) from the National Institutes of Health and the National Heart, Lung, and Blood Institute; grants R01 AG16495, AG08122, AG033193, and AG031287 from the National Institute on Aging; and grant R01 NS17950 from the National Institute of Neurological Disorders and Stroke.	Ahima RS, 1999, ENDOCRINOLOGY, V140, P2755, DOI 10.1210/en.140.6.2755; Akomolafe A, 2006, ARCH NEUROL-CHICAGO, V63, P1551, DOI 10.1001/archneur.63.11.1551; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barrett-Connor E, 1998, J Nutr Health Aging, V2, P113; Bouret SG, 2004, SCIENCE, V304, P108, DOI 10.1126/science.1095004; Cooke SF, 2006, BRAIN, V129, P1659, DOI 10.1093/brain/awl082; DAVIS PC, 1995, NEUROLOGY, V45, P178, DOI 10.1212/WNL.45.1.178; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; DeCarli C, 2005, NEUROBIOL AGING, V26, P491, DOI 10.1016/j.neurobiolaging.2004.05.004; Doherty GH, 2008, NEUROSCIENCE, V154, P1297, DOI 10.1016/j.neuroscience.2008.04.052; Elmquist JK, 1998, NAT NEUROSCI, V1, P445, DOI 10.1038/2164; Fewlass DC, 2004, FASEB J, V18, P1870, DOI 10.1096/fj.04-2572com; Frisoni GB, 2002, AM J NEURORADIOL, V23, P35; Geerlings SW, 2002, PSYCHOL MED, V32, P609, DOI 10.1017/S0033291702005585; Giesel FL, 2008, EUR J RADIOL, V66, P268, DOI 10.1016/j.ejrad.2007.06.009; Gosche KM, 2002, NEUROLOGY, V58, P1476, DOI 10.1212/WNL.58.10.1476; Greco SJ, 2008, BIOCHEM BIOPH RES CO, V376, P536, DOI 10.1016/j.bbrc.2008.09.026; Harvey J, 2005, BIOCHEM SOC T, V33, P1029, DOI 10.1042/BST0331029; Harvey J, 2006, PROG LIPID RES, V45, P369, DOI 10.1016/j.plipres.2006.03.001; Jack CR, 1998, NEUROLOGY, V51, P993, DOI 10.1212/WNL.51.4.993; Lee SA, 2007, CANCER EPIDEM BIOMAR, V16, P2464, DOI 10.1158/1055-9965.EPI-07-0374; Li XL, 2002, NEUROSCIENCE, V113, P607, DOI 10.1016/S0306-4522(02)00162-8; Linkov F, 2009, EUR CYTOKINE NETW, V20, P21, DOI 10.1684/ecn.2009.0146; Ma ZM, 1996, CLIN CHEM, V42, P942; Maslow K, 2008, ALZHEIMERS DEMENT, V4, P110, DOI 10.1016/j.jalz.2008.02.005; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Nam SY, 2001, J CLIN ENDOCR METAB, V86, P4849, DOI 10.1210/jc.86.10.4849; Narita K, 2009, BIOL PSYCHIAT, V65, P992, DOI 10.1016/j.biopsych.2008.10.006; Peila R, 2002, DIABETES, V51, P1256, DOI 10.2337/diabetes.51.4.1256; Peltz G, 2007, ARCH MED RES, V38, P563, DOI 10.1016/j.arcmed.2006.12.009; Power DA, 2001, DEMENT GERIATR COGN, V12, P167, DOI 10.1159/000051252; Ridha BH, 2006, LANCET NEUROL, V5, P828, DOI 10.1016/S1474-4422(06)70550-6; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Saad MF, 1997, J CLIN ENDOCR METAB, V82, P579, DOI 10.1210/jc.82.2.579; Seshadri S, 2004, NEUROLOGY, V63, P1591, DOI 10.1212/01.WNL.0000142968.22691.70; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Stattin P, 2004, INT J CANCER, V109, P149, DOI 10.1002/ijc.11668; Tan ZS, 2007, NEUROLOGY, V68, P1902, DOI 10.1212/01.wnl.0000263217.36439.da; Tang BL, 2008, BIOCHEM BIOPH RES CO, V368, P181, DOI 10.1016/j.bbrc.2008.01.063; Tezapsidis N, 2009, NEUROLOGY, V72, P1030; Tezapsidis N, 2009, J ALZHEIMERS DIS, V16, P731, DOI 10.3233/JAD-2009-1021; Whitmer RA, 2008, NEUROLOGY, V71, P1057, DOI 10.1212/01.wnl.0000306313.89165.ef; Whitmer RA, 2005, BMJ-BRIT MED J, V330, P1360, DOI 10.1136/bmj.38446.466238.E0; Wolf PA, 2007, CURR ALZHEIMER RES, V4, P111, DOI 10.2174/156720507780362263; Wulsin LR, 2005, PSYCHOSOM MED, V67, P697, DOI 10.1097/01.psy.0000181274.56785.28	45	294	299	0	23	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	2009	302	23					2565	2572		10.1001/jama.2009.1836	http://dx.doi.org/10.1001/jama.2009.1836			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532HK	20009056	Green Accepted, Bronze			2022-12-28	WOS:000272737200024
J	Williamson, I; Benge, S; Barton, S; Petrou, S; Letley, L; Fasey, N; Haggard, M; Little, P				Williamson, Ian; Benge, Sarah; Barton, Sheila; Petrou, Stavros; Letley, Louise; Fasey, Nicky; Haggard, Mark; Little, Paul			Topical intranasal corticosteroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care: double blind randomised placebo controlled trial	BMJ-BRITISH MEDICAL JOURNAL			English	Article							EAR; TYMPANOMETRY; STEROIDS	Objective To determine the clinical effectiveness of topical intranasal corticosteroids in children with bilateral otitis media with effusion. Design Double blind randomised placebo controlled trial. Setting 76 Medical Research Council General Practice Research Framework practices throughout the United Kingdom, between 2004 and 2007. Participants 217 children aged 4-11 years who had at least one practice recorded episode of otitis media or a related ear problem in the previous 12 months, and with bilateral otitis media with effusion confirmed by a research nurse using otoscopy plus micro-tympanometry (B/B or B/C2, modified Jerger types). Intervention Mometasone furoate 50 mu g or placebo spray given once daily into each nostril for three months. Main outcome measures Proportions of children cured of bilateral otitis media with effusion assessed with tympanometry (C1 or A type) at one month (primary end point), three months, and nine months; adverse events; three month diary symptoms. Results 41% (39/96) of the topical steroid group and 45% (44/98) of the placebo group were cured in one or both ears at one month (difference favouring placebo 4.3% (95% confidence interval -9.3% to 18.1%). Poisson regression was done with adjustment for four pre-specified covariates (clinical severity, P=0.003; atopy, P=0.67; age, P=0.92; season, P=0.71). The adjusted relative risk at one month was 0.97 (95% confidence interval 0.74 to 1.26). At three months, 58% of the topical steroid group and 52% of the placebo group were cured (relative risk 1.23, 0.84 to 1.80). Diary symptoms did not differ between the two groups, and no significant harms were reported. Conclusions Topical steroids are unlikely to be an effective treatment for otitis media with effusion in general practice. High rates of natural resolution occurred by 1-3 months. Trial registration Current Controlled Trials ISRCTN38988331; National Research Register NO575123823; MREC 03/11/073.	[Williamson, Ian; Little, Paul] Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England; [Barton, Sheila] Univ Southampton, Clin Trials Unit, Southampton Gen Hosp, Southampton SO9 5NH, Hants, England; [Petrou, Stavros] Univ Oxford, Hlth Econ Res Ctr, Dept Publ Hlth, Oxford OX1 2JD, England; [Petrou, Stavros] Univ Oxford, Natl Perinatal Epidemiol Unit, Oxford OX1 2JD, England; [Letley, Louise; Fasey, Nicky] Gen Practice Res Framework, London, England; [Haggard, Mark] Dept Expt Psychol, MRC Otitis Media Grp, Cambridge, England	University of Southampton; University of Southampton; University of Oxford; University of Oxford; University of Cambridge	Williamson, I (corresponding author), Univ Southampton, Aldermoor Hlth Ctr, Southampton SO16 5ST, Hants, England.	igw@soton.ac.uk	Petrou, Stavros/ABD-8323-2021	Petrou, Stavros/0000-0003-3121-6050; Barton, Sheila/0000-0003-4963-4242; Little, Paul/0000-0003-3664-1873	Health Technology Assessment Programme; MRC [MC_U122797165, G0501681, MC_U122785828] Funding Source: UKRI; Medical Research Council [U1475000004, G0501681, MC_U122785828, MC_U122797165] Funding Source: researchfish	Health Technology Assessment Programme(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Health Technology Assessment Programme. The views herein expressed are those of the authors and not necessarily those of the Department of Health.	BAREK PJ, 1999, COCHRANE DB SYST REV; Bisset A, 1997, LANCET, V349, P134, DOI 10.1016/S0140-6736(05)60918-X; Browning GG, 2001, CLIN OTOLARYNGOL, V26, P263; Cengel S, 2006, INT J PEDIATR OTORHI, V70, P639, DOI 10.1016/j.ijporl.2005.08.013; DEMPSTER JH, 1991, CLIN OTOLARYNGOL, V16, P157, DOI 10.1111/j.1365-2273.1991.tb01967.x; Department of Health, 2007, TRENDS CHILDR SURG 1; FIELLAUNIKOLAJSEN M, 1983, ANN OTO RHINOL LARYN, V92, P172, DOI 10.1177/000348948309200215; Fokkens WJ, 2004, PEDIAT ALLERG IMM-UK, V15, P261, DOI 10.1111/j.1399-3038.2004.00135.x; HAGGARD M, 2008, 8 ESPO INT C BUD JUN; HAGGARD MP, 1999, EVIDENCE BASED OTITI, P375; Hogan SC, 1997, BRIT MED J, V314, P350, DOI 10.1136/bmj.314.7077.350; JERGER J, 1970, ARCHIV OTOLARYNGOL, V92, P311; LEAL MM, 2008, 8 ESPO INT C BUD JUN; Little P, 2001, BMJ-BRIT MED J, V322, P336, DOI 10.1136/bmj.322.7282.336; Lous J, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001801.pub2; MAW AR, 1992, BRIT MED J, V304, P67, DOI 10.1136/bmj.304.6819.67; National Institute for Health and Clinical Excellence, 2008, SURG MAN OT MED EFF; Nondahl DM, 1998, AUDIOLOGY, V37, P295; Perera R, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006285; ROSENFELD RM, 1991, ARCH OTOLARYNGOL, V117, P984; Schenkel EJ, 2000, PEDIATRICS, V105, DOI 10.1542/peds.105.2.e22; STOOL SE, 1994, OTITIS MEDIA EFFUSIO; Thomas CL, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001935.pub2; Tracy JM, 1998, ANN ALLERG ASTHMA IM, V80, P198, DOI 10.1016/S1081-1206(10)62956-0; vanBalen FAM, 1996, LANCET, V348, P713, DOI 10.1016/S0140-6736(96)02511-1; Williamson I, 2006, BRIT J GEN PRACT, V56, P170; Williamson I, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13370; WILLIAMSON I, 2006, CLIN EVID, V15, P814; Williamson IG, 2007, JAMA-J AM MED ASSOC, V298, P2487, DOI 10.1001/jama.298.21.2487; WILLIAMSON IG, 1994, J LARYNGOL OTOL, V108, P930, DOI 10.1017/S0022215100128567; Yaman H, 2008, J LARYNGOL OTOL, V122, P25, DOI 10.1017/S0022215107007724; ZIELHUIS GA, 1989, LANCET, V1, P311; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	33	30	30	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2009	339								b4984	10.1136/bmj.b4984	http://dx.doi.org/10.1136/bmj.b4984			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534XH	20015903	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000272930300009
J	Khazeni, N; Hutton, DW; Garber, AM; Hupert, N; Owens, DK				Khazeni, Nayer; Hutton, David W.; Garber, Alan M.; Hupert, Nathaniel; Owens, Douglas K.			Effectiveness and Cost-Effectiveness of Vaccination Against Pandemic Influenza (H1N1) 2009	ANNALS OF INTERNAL MEDICINE			English	Article							CROSS-REACTIVE IMMUNITY; HEALTH-CARE WORKERS; A H5N1 INFECTION; AVIAN INFLUENZA; ANTI-H5 ANTIBODY; SIMPLE-MODELS; HONG-KONG; TRANSMISSION; VIRUS; RISK	Background: Decisions on the timing and extent of vaccination against pandemic (H1N1) 2009 virus are complex. Objective: To estimate the effectiveness and cost-effectiveness of pandemic influenza (H1N1) vaccination under different scenarios in October or November 2009. Design: Compartmental epidemic model in conjunction with a Markov model of disease progression. Data Sources: Literature and expert opinion. Target Population: Residents of a major U. S. metropolitan city with a population of 8.3 million. Time Horizon: Lifetime. Perspective: Societal. Interventions: Vaccination in mid-October or mid-November 2009. Outcome Measures: Infections and deaths averted, costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness. Results of Base-Case Analysis: Assuming each primary infection causes 1.5 secondary infections, vaccinating 40% of the population in October or November would be cost-saving. Vaccination in October would avert 2051 deaths, gain 69 679 QALYs, and save $469 million compared with no vaccination; vaccination in November would avert 1468 deaths, gain 49 422 QALYs, and save $302 million. Results of Sensitivity Analysis: Vaccination is even more cost-saving if longer incubation periods, lower rates of infectiousness, or increased implementation of nonpharmaceutical interventions delay time to the peak of the pandemic. Vaccination saves fewer lives and is less cost-effective if the epidemic peaks earlier than mid-October. Limitations: The model assumed homogenous mixing of case-patients and contacts; heterogeneous mixing would result in faster initial spread, followed by slower spread. Additional costs and savings not included in the model would make vaccination more cost-saving. Conclusion: Earlier vaccination against pandemic (H1N1) 2009 prevents more deaths and is more cost-saving. Complete population coverage is not necessary to reduce the viral reproductive rate sufficiently to help shorten the pandemic.	[Khazeni, Nayer] Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA; Cornell Univ, Weill Med Coll, New York, NY 10065 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System; Cornell University	Khazeni, N (corresponding author), Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, 300 Pasteur Dr,H3143, Stanford, CA 94305 USA.		Garber, Alan M/F-1476-2010		Agency for Healthcare Research and Quality [1 F32 HS018003-01A1]; National Institute on Drug Abuse [2 R01 DA15612-016]; Stanford Graduate Fellowship; Department of Veterans Affairs; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS018003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Stanford Graduate Fellowship(Stanford University); Department of Veterans Affairs(US Department of Veterans Affairs); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	By the Agency for Healthcare Research and Quality (1 F32 HS018003-01A1; Dr. Khazeni), the National Institute on Drug Abuse (2 R01 DA15612-016; Dr. Owens), a Stanford Graduate Fellowship (Mr. Hutton), and the Department of Veterans Affairs (Drs. Owens and Garber).	ANDERSON RM, 1990, LANCET, V335, P641, DOI 10.1016/0140-6736(90)90420-A; Apisarnthanarak A, 2005, CLIN INFECT DIS, V40, pE16, DOI 10.1086/427034; Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Bridges CB, 2000, J INFECT DIS, V181, P344, DOI 10.1086/315213; Bridges CB, 2002, J INFECT DIS, V185, P1005, DOI 10.1086/340044; *BUR VIT STAT, 2007, SUMM VIT STAT 2007; *CDCP, SEAS INFL FLU DIS; *CDCP, QUEST ANSW MON INFL; *CDCP, 2009, INT CDC GUID NONPH C; *CDCP, SEAS INFL FLU KEY FA; *CDCP, BRIEF PUBL HLTH INV; *CDCP, 2002, SMALLP VACC CLIN GUI; *CDCP, 2006, FLUSURGE VERS 2 0; Centers for Disease Control and Prevention, 2009, 2008 2009 INFL SEAS; Centers for Disease Control and Prevention, 2009 H1N1 FLU SWIN F; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chio A, 2003, NEUROLOGY, V60, P1146, DOI 10.1212/01.WNL.0000055091.96905.D0; CLARK TW, 2009, N ENGL J MED; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Davey VJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002606; DAVIES JR, 1984, J HYG-CAMBRIDGE, V92, P125, DOI 10.1017/S002217240006410X; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; DENOON DJ, 2009, SWINE FLU VACCINE TI; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Ghani AC, 2005, AM J EPIDEMIOL, V162, P479, DOI 10.1093/aje/kwi230; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; GREENBERG ME, 2009, N ENGL J MED; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; LANDAU E, 2009, CDC US MAY NEED 600; Larson RC, 2007, OPER RES, V55, P399, DOI 10.1287/opre.1070.0399; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Leroux-Roels I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001665; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Liem NT, 2005, EMERG INFECT DIS, V11, P210, DOI 10.3201/eid1102.041075; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; MCKAY B, 2009, PREGNANT WOMEN KIDS; McKibbin WJ, 2006, GLOBAL MACROECONOMIC; MENDEL JR, 2001, DIAGNOSIS MANAGEMENT, P145; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Neustadt RE, 1978, SWINE FLU AFFAIR DEC, DOI [10.17226/12660, DOI 10.17226/12660]; *NY CIT DEP HLTH M, PREV INFL GET VACC; *NY CIT DEP HLTH M, 2009, HLTH AL 22 PAND H1N1; *NY CITY DEP HLTH, 2009, 27 NY CITY DEP HLTH; *NY CITY DEP HLTH, 2009, 21 NY CITY DEP HLTH; *NY CITY DEP HLTH, 2009, 19 NY CITY DEP HLTH; *NY CITY DEP HLTH, 2009, 17 NY CITY DEP HLTH; PINE AE, 2005, VACCINATION VENTURES; Pourbohloul B, 2009, INFLUENZA OTHER RESP, V3, P215, DOI 10.1111/j.1750-2659.2009.00100.x; ROOS R, 2009, HHS ADVISORS URGE FU; ROOS R, 2009, MORE RESULTS POINT 1; SCHNIRRING L, 2009, OFFICIALS LOWER EXPE; SCHNIRRING L, 2009, FDA CLEARS CSS VACC; Smith CB, 2002, J INFECT DIS, V185, P980, DOI 10.1086/339416; SONOGUCHI T, 1986, J INFECT DIS, V153, P33, DOI 10.1093/infdis/153.1.33; Talbird SE, 2009, AM J HEALTH-SYST PH, V66, P469, DOI 10.2146/ajhp080296; Thorpe LE, 2004, EMERG INFECT DIS, V10, P917; Thorson A, 2006, ARCH INTERN MED, V166, P119, DOI 10.1001/archinte.166.1.119; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Turner DA, 2006, VACCINE, V24, P1035, DOI 10.1016/j.vaccine.2004.12.033; U. S. Bureau of theCensus, 2009, STAT ABSTR US; U.S. Department of Health and Human Services, PAND INFL PLAN; *US DEP HHS, 2006, HHS BUYS ADD VACC PO; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; WHO, 2009, PAND INFL VACC MAN P; *WHO, 2009, GLOB AL RESP GAR PAN; *WHO, 2009, SUMM WHO VIRT CONS S; World Health Organization, 2009, PAND H1N1 2009; World Health Organization, 2009, WORLD NOW START 2009; World Health Organization, 2009, SAF PAND VACC; Yang Y, 2009, SCIENCE; 2007, SAN JOSE MERCUR 0617; 2006, METLIFE SURVEY NURSI; 2009, NY1 NEWS        0701	85	77	77	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2009	151	12					829	U2		10.7326/0000605-200912150-00157	http://dx.doi.org/10.7326/0000605-200912150-00157			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532ET	20008759				2022-12-28	WOS:000272728900001
J	Holland, G; Cassidy, M; Ballentine, CJ				Holland, Greg; Cassidy, Martin; Ballentine, Chris J.			Meteorite Kr in Earth's Mantle Suggests a Late Accretionary Source for the Atmosphere	SCIENCE			English	Article							RARE-GAS SYSTEMATICS; NOBLE-GASES; TERRESTRIAL PLANETS; GIANT IMPACTS; WELL GASES; WATER ICE; ORIGIN; EVOLUTION; NEON; ISOTOPES	Noble gas isotopes are key tracers of both the origin of volatiles found within planets and the processes that control their eventual distribution between planetary interiors and atmospheres. Here, we report the discovery of primordial Kr in samples derived from Earth's mantle and show it to be consistent with a meteorite or fractionated solar nebula source. The high-precision Kr and Xe isotope data together suggest that Earth's interior acquired its volatiles from accretionary material similar to average carbonaceous chondrites and that the noble gases in Earth's atmosphere and oceans are dominantly derived from later volatile capture rather than impact degassing or outgassing of the solid Earth during its main accretionary stage.	[Holland, Greg; Ballentine, Chris J.] Univ Manchester, Sch Earth Atmospher & Environm Sci, Manchester M13 9PL, Lancs, England; [Cassidy, Martin] Univ Houston, Dept Earth & Atmospher Sci, Houston, TX 77204 USA	University of Manchester; University of Houston System; University of Houston	Holland, G (corresponding author), Univ Manchester, Sch Earth Atmospher & Environm Sci, Oxford Rd, Manchester M13 9PL, Lancs, England.	g.holland@manchester.ac.uk		Ballentine, Chris/0000-0001-9382-070X	UK Natural Environment Research Council; NERC [NE/D004292/1] Funding Source: UKRI; STFC [ST/G003068/1] Funding Source: UKRI; Natural Environment Research Council [NE/D004292/1] Funding Source: researchfish; Science and Technology Facilities Council [ST/G003068/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	We thank Oxy and Amerada Hess corporations for permission to sample the Bravo Dome Field. We thank D. Blagburn and B. Clementson for laboratory support and R. Pepin for discussions on the manuscript. This work was funded by UK Natural Environment Research Council.	AHRENS TJ, 1993, ANNU REV EARTH PL SC, V21, P525, DOI 10.1146/annurev.ea.21.050193.002521; ALLEGRE CJ, 1987, EARTH PLANET SC LETT, V81, P127, DOI 10.1016/0012-821X(87)90151-8; Ballentine CJ, 2008, PHILOS T R SOC A, V366, P4183, DOI 10.1098/rsta.2008.0150; Ballentine CJ, 2005, NATURE, V433, P33, DOI 10.1038/nature03182; BARNUN A, 1988, PHYS REV B, V38, P7749, DOI 10.1103/PhysRevB.38.7749; Caffee MW, 1999, SCIENCE, V285, P2115, DOI 10.1126/science.285.5436.2115; Chambers JE, 2004, EARTH PLANET SC LETT, V223, P241, DOI 10.1016/j.epsl.2004.04.031; DONAHUE TM, 1986, ICARUS, V66, P195, DOI 10.1016/0019-1035(86)90151-X; Harper CL, 1996, SCIENCE, V273, P1814, DOI 10.1126/science.273.5283.1814; Holland G, 2006, NATURE, V441, P186, DOI 10.1038/nature04761; Marty B, 2008, SCIENCE, V319, P75, DOI 10.1126/science.1148001; MIZUNO H, 1980, EARTH PLANET SC LETT, V50, P202, DOI 10.1016/0012-821X(80)90131-4; Moreira M, 1998, SCIENCE, V279, P1178, DOI 10.1126/science.279.5354.1178; Notesco G, 1999, ICARUS, V142, P298, DOI 10.1006/icar.1999.6202; OWEN T, 1992, NATURE, V358, P43, DOI 10.1038/358043a0; Pepin RO, 2003, SPACE SCI REV, V106, P211, DOI 10.1023/A:1024693822280; PEPIN RO, 1991, ICARUS, V92, P2, DOI 10.1016/0019-1035(91)90036-S; Pepin RO, 2006, EARTH PLANET SC LETT, V252, P1, DOI 10.1016/j.epsl.2006.09.014; Pepin RO, 2006, EARTH PLANET SC LETT, V250, P470, DOI 10.1016/j.epsl.2006.08.014; PODOSEK FA, 1994, METEORITICS, V29, P6, DOI 10.1111/j.1945-5100.1994.tb00649.x; PORCELLI D, 1995, GEOCHIM COSMOCHIM AC, V59, P4921, DOI 10.1016/0016-7037(95)00336-3; SASAKI S, 1991, ICARUS, V91, P29, DOI 10.1016/0019-1035(91)90123-B; SIGNER P, 1963, EARTH SCI METEORITIC; STAUDACHER T, 1987, NATURE, V325, P605, DOI 10.1038/325605a0; Touboul M, 2007, NATURE, V450, P1206, DOI 10.1038/nature06428; Trieloff M, 2002, EARTH PLANET SC LETT, V200, P297, DOI 10.1016/S0012-821X(02)00639-8; WETHERILL GW, 1985, SCIENCE, V228, P877, DOI 10.1126/science.228.4701.877; YORK D, 1969, EARTH PLANET SC LETT, V5, P320	31	74	74	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 11	2009	326	5959					1522	1525		10.1126/science.1179518	http://dx.doi.org/10.1126/science.1179518			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007896				2022-12-28	WOS:000272623600054
J	Freemantle, N; Calvert, M				Freemantle, Nick; Calvert, Mel			What can we learn from observational studies of oseltamivir to treat influenza in healthy adults?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							H1N1 INFLUENZA; CARE SERVICES; COMPLICATIONS; RISK; CHILDREN; HOSPITALIZATION; INFECTION; PNEUMONIA; OUTCOMES; ONTARIO		[Freemantle, Nick; Calvert, Mel] Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England	University of Birmingham	Freemantle, N (corresponding author), Univ Birmingham, Sch Hlth & Populat Sci, Birmingham B15 2TT, W Midlands, England.	N.Freemantle@bham.ac.uk	Calvert, Melanie/F-7055-2011	Calvert, Melanie/0000-0002-1856-837X; Freemantle, Nick/0000-0001-5807-5740				Abdel-Ghafar AN, 2008, NEW ENGL J MED, V358, P261, DOI 10.1056/NEJMra0707279; Barr CE, 2007, CURR MED RES OPIN, V23, P523, DOI 10.1185/030079906X167499; Blumentals WA, 2007, CURR MED RES OPIN, V23, P2961, DOI 10.1185/030079907X242520; Bowles SK, 2002, J AM GERIATR SOC, V50, P608, DOI 10.1046/j.1532-5415.2002.50153.x; Casscells SW, 2009, CIRC-CARDIOVASC QUAL, V2, P108, DOI 10.1161/CIRCOUTCOMES.108.820357; Chemaly RF, 2007, CLIN INFECT DIS, V44, P964, DOI 10.1086/512374; Enger C, 2004, PHARMACOEPIDEM DR S, V13, P227, DOI 10.1002/pds.845; Freemantle N, 2008, BMJ-BRIT MED J, V336, P627, DOI 10.1136/bmj.39491.493252.80; Gums JG, 2008, EXPERT OPIN PHARMACO, V9, P151, DOI 10.1517/14656566.9.2.151 ; Hanshaoworakul W, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006051; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3675; Madjid M, 2009, CARDIOLOGY, V113, P98, DOI 10.1159/000172796; McGeer A, 2007, CLIN INFECT DIS, V45, P1568, DOI 10.1086/523584; Nordstrom BL, 2005, CURR MED RES OPIN, V21, P761, DOI 10.1185/030079905X46214; Orzeck EA, 2007, CLIN THER, V29, P2246, DOI 10.1016/j.clinthera.2007.10.001; Peters Patrick H, 2008, Medscape J Med, V10, P131; Piedra PA, 2009, PEDIATRICS, V124, P170, DOI 10.1542/peds.2008-0977; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481	20	12	12	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2009	339								b5248	10.1136/bmj.b5248	http://dx.doi.org/10.1136/bmj.b5248			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531VE	19995814				2022-12-28	WOS:000272697300007
J	Li, JL; Browning, S; Mahal, SP; Oelschlegel, AM; Weissmann, C				Li, Jiali; Browning, Shawn; Mahal, Sukhvir P.; Oelschlegel, Anja M.; Weissmann, Charles			Darwinian Evolution of Prions in Cell Culture	SCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; MOUSE SCRAPIE; PROTEIN; STRAINS; ASSAY; CONFORMATION; HAMSTERS; AGENT	Prions are infectious proteins consisting mainly of PrPSc, a beta sheet-rich conformer of the normal host protein PrPC, and occur in different strains. Strain identity is thought to be encoded by PrPSc conformation. We found that biologically cloned prion populations gradually became heterogeneous by accumulating "mutants," and selective pressures resulted in the emergence of different mutants as major constituents of the evolving population. Thus, when transferred from brain to cultured cells, "cell-adapted" prions outcompeted their "brain-adapted" counterparts, and the opposite occurred when prions were returned from cells to brain. Similarly, the inhibitor swainsonine selected for a resistant substrain, whereas, in its absence, the susceptible substrain outgrew its resistant counterpart. Prions, albeit devoid of a nucleic acid genome, are thus subject to mutation and selective amplification.	[Li, Jiali; Browning, Shawn; Mahal, Sukhvir P.; Oelschlegel, Anja M.; Weissmann, Charles] Scripps Florida, Dept Infectol, Jupiter, FL 33458 USA	State University System of Florida; University of Florida	Weissmann, C (corresponding author), Scripps Florida, Dept Infectol, 130 Scripps Way, Jupiter, FL 33458 USA.	charlesw@scripps.edu	li, jiali/C-8811-2011		NIH [NSO59543]; Alafi Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS059543, R01NS067214] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alafi Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. A. Demczyk for assistance with cell culture, E. Smith for assistance with the SSCA, I. Suponitsky-Kroyter for the proteolytic digestion analyses, and A. Sherman for histochemistry and animal work. We thank T. Bartfai, G. Joyce, and C. Lasmezas for critical reading of the manuscript and valuable suggestions. The project was supported by an R01 grant (# NSO59543) from the NIH and by a generous donation from the Alafi Family Foundation to C.	Arima K, 2005, J VIROL, V79, P7104, DOI 10.1128/JVI.79.11.7104-7112.2005; Arjona A, 2004, P NATL ACAD SCI USA, V101, P8768, DOI 10.1073/pnas.0400158101; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BRUCE ME, 1992, E H S NEURO, P497; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Caughey B, 1999, MOL BIOTECHNOL, V13, P45, DOI 10.1385/MB:13:1:45; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Eigen M, 1996, TRENDS MICROBIOL, V4, P216, DOI 10.1016/0966-842X(96)20011-3; EPSTEIN IR, 1979, BIOPHYS CHEM, V10, P153, DOI 10.1016/0301-4622(79)85035-8; FRASER H, 1992, PRION DIS HUMANS ANI, P59; Ghaemmaghami S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000673; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kellershohn N, 1998, BIOCHEM J, V334, P539, DOI 10.1042/bj3340539; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kuczius T, 1999, MOL MED, V5, P406, DOI 10.1007/BF03402129; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; MCCONNELL I, COMMUNICATION; Owen JP, 2007, J VIROL, V81, P10532, DOI 10.1128/JVI.00640-07; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; TULSIANI DRP, 1983, J BIOL CHEM, V258, P7578; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4	31	300	305	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					869	872		10.1126/science.1183218	http://dx.doi.org/10.1126/science.1183218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20044542	Green Accepted			2022-12-28	WOS:000274408300063
J	Kelly, H; Barr, I				Kelly, Heath; Barr, Ian			Large trials confirm immunogenicity of H1N1 vaccines	LANCET			English	Editorial Material							RESPONSES; ANTIBODY		[Kelly, Heath] Victorian Infect Dis Reference Lab, Epidemiol Unit, Melbourne, Vic 3051, Australia; [Barr, Ian] WHO Collaborating Ctr Reference & Res Influenza, Melbourne, Vic, Australia	Victorian Infectious Diseases Reference Laboratory; World Health Organization	Kelly, H (corresponding author), Victorian Infect Dis Reference Lab, Epidemiol Unit, Melbourne, Vic 3051, Australia.	heath.kelly@mh.org.au		Barr, Ian/0000-0002-7351-418X				ALKHAYATT R, 1984, J HYG-CAMBRIDGE, V93, P301, DOI 10.1017/S0022172400064834; Baker MG, 2009, EUROSURVEILLANCE, V14, P2; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; *EUR MED AG, 2007, GUID INFL VACC PREP; Greenbaum JA, 2009, P NATL ACAD SCI USA, V106, P20365, DOI 10.1073/pnas.0911580106; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Kelly HA, 2009, MED J AUSTRALIA, V191, P146, DOI 10.5694/j.1326-5377.2009.tb02723.x; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; Nauta JJP, 2009, BIOLOGICALS, V37, P216, DOI 10.1016/j.biologicals.2009.02.002; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Stephenson I, 2009, EMERG INFECT DIS, V15, P1250, DOI 10.3201/eid1508.081754; US Food and Drug Administration, 2007, GUID IND CLIN DAT NE; Vajo Z, 2010, LANCET, V375, P49, DOI 10.1016/S0140-6736(09)62039-0; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481	16	21	21	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2010	375	9708					6	9		10.1016/S0140-6736(09)62132-2	http://dx.doi.org/10.1016/S0140-6736(09)62132-2			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539BZ	20018366				2022-12-28	WOS:000273229700006
J	Murchison, EP; Tovar, C; Hsu, A; Bender, HS; Kheradpour, P; Rebbeck, CA; Obendorf, D; Conlan, C; Bahlo, M; Blizzard, CA; Pyecroft, S; Kreiss, A; Kellis, M; Stark, A; Harkins, TT; Graves, JAM; Woods, GM; Hannon, GJ; Papenfuss, AT				Murchison, Elizabeth P.; Tovar, Cesar; Hsu, Arthur; Bender, Hannah S.; Kheradpour, Pouya; Rebbeck, Clare A.; Obendorf, David; Conlan, Carly; Bahlo, Melanie; Blizzard, Catherine A.; Pyecroft, Stephen; Kreiss, Alexandre; Kellis, Manolis; Stark, Alexander; Harkins, Timothy T.; Graves, Jennifer A. Marshall; Woods, Gregory M.; Hannon, Gregory J.; Papenfuss, Anthony T.			The Tasmanian Devil Transcriptome Reveals Schwann Cell Origins of a Clonally Transmissible Cancer	SCIENCE			English	Article							FACIAL-TUMOR DISEASE; SARCOPHILUS-HARRISII; IMMUNOHISTOCHEMICAL CHARACTERIZATION; VENEREAL TUMOR; MICRORNAS; DIVERSITY; NEOPLASMS; EVOLUTION; PROTEIN; SYSTEM	The Tasmanian devil, a marsupial carnivore, is endangered because of the emergence of a transmissible cancer known as devil facial tumor disease (DFTD). This fatal cancer is clonally derived and is an allograft transmitted between devils by biting. We performed a large-scale genetic analysis of DFTD with microsatellite genotyping, a mitochondrial genome analysis, and deep sequencing of the DFTD transcriptome and microRNAs. These studies confirm that DFTD is a monophyletic clonally transmissible tumor and suggest that the disease is of Schwann cell origin. On the basis of these results, we have generated a diagnostic marker for DFTD and identify a suite of genes relevant to DFTD pathology and transmission. We provide a genomic data set for the Tasmanian devil that is applicable to cancer diagnosis, disease evolution, and conservation biology.	[Murchison, Elizabeth P.; Bender, Hannah S.; Rebbeck, Clare A.; Conlan, Carly; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Murchison, Elizabeth P.; Bender, Hannah S.; Graves, Jennifer A. Marshall] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Murchison, Elizabeth P.; Bender, Hannah S.; Graves, Jennifer A. Marshall] Australian Natl Univ, ARC Ctr Excellence Kangaroo Genom, Canberra, ACT 0200, Australia; [Tovar, Cesar; Obendorf, David; Blizzard, Catherine A.; Kreiss, Alexandre; Woods, Gregory M.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Hsu, Arthur; Bahlo, Melanie; Papenfuss, Anthony T.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3052, Australia; [Kheradpour, Pouya; Kellis, Manolis; Stark, Alexander] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Pyecroft, Stephen] Dept Primary Ind & Water, Mt Pleasant Anim Hlth Labs, Kings Meadows, Tas 7249, Australia; [Kellis, Manolis; Stark, Alexander] MIT, Broad Inst, Cambridge, MA 02141 USA; [Kellis, Manolis; Stark, Alexander] Harvard Univ, Cambridge, MA 02141 USA; [Harkins, Timothy T.] Roche Appl Sci, Indianapolis, IN 46250 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Australian National University; Australian National University; University of Tasmania; Menzies Institute for Medical Research; Walter & Eliza Hall Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Roche Holding	Murchison, EP (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England.	elizabeth.murchison@sanger.ac.uk	Papenfuss, Anthony T/C-6297-2008; Hannon, Gregory/AAB-3568-2019; Woods, Greg/J-7533-2014; Kellis, Manolis/ABE-7385-2020; Stark, Alexander/D-1473-2012	Papenfuss, Anthony T/0000-0002-1102-8506; Woods, Greg/0000-0001-8421-7917; Kellis, Manolis/0000-0001-7113-9630; Stark, Alexander/0000-0003-2611-0841; rebbeck, clare/0000-0002-2502-9622; Tovar Lopez, Cesar Dario/0000-0001-9555-2489; Blizzard, Catherine/0000-0002-8683-2937; Hsu, Arthur/0000-0001-8308-1106; Bender, Hannah/0000-0001-9458-4964; Murchison, Elizabeth Proby/0000-0001-7462-8907; Graves, Jennifer/0000-0001-6480-7856	Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA013106, P01 CA013106-38] Funding Source: Medline; NHGRI NIH HHS [R01 HG004037] Funding Source: Medline; NIGMS NIH HHS [R01 GM062534, R01 GM062534-10] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062534] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CANFIELD PJ, 1993, J ZOO WILDLIFE MED, V24, P158; CLARK HB, 1985, AM J PATHOL, V121, P96; COOPER HL, 1964, J NATL CANCER I, V33, P691; Dahlin LB, 2008, SCAND J SURG, V97, P310, DOI 10.1177/145749690809700407; Gold R, 1999, BRAIN PATHOL, V9, P343; GRECO D, 1997, TXB VET PHYSL; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; GRINER LA, 1979, J NATL CANCER I, V62, P589, DOI 10.1093/jnci/62.3.589; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Jones ME, 2004, MOL ECOL, V13, P2197, DOI 10.1111/j.1365-294X.2004.02239.x; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Loh R, 2006, VET PATHOL, V43, P896, DOI 10.1354/vp.43-6-896; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; Marchal T, 1997, VET IMMUNOL IMMUNOP, V57, P1, DOI 10.1016/S0165-2427(96)05757-1; McCallum H, 2008, TRENDS ECOL EVOL, V23, P631, DOI 10.1016/j.tree.2008.07.001; McCallum H, 2007, ECOHEALTH, V4, P318, DOI 10.1007/s10393-007-0118-0; Mozos E, 1996, VET PATHOL, V33, P257, DOI 10.1177/030098589603300301; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Rebbeck CA, 2009, EVOLUTION, V63, P2340, DOI 10.1111/j.1558-5646.2009.00724.x; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Ueda R, 2009, P NATL ACAD SCI USA, V106, P10746, DOI 10.1073/pnas.0811817106; Verrier JD, 2009, GLIA, V57, P1265, DOI 10.1002/glia.20846	25	156	225	1	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 1	2010	327	5961					84	87		10.1126/science.1180616	http://dx.doi.org/10.1126/science.1180616			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044575	Green Submitted, Green Accepted			2022-12-28	WOS:000273395400036
J	Simon, J; Protasenko, V; Lian, CX; Xing, HL; Jena, D				Simon, John; Protasenko, Vladimir; Lian, Chuanxin; Xing, Huili; Jena, Debdeep			Polarization-Induced Hole Doping in Wide-Band-Gap Uniaxial Semiconductor Heterostructures	SCIENCE			English	Article							LIGHT-EMITTING-DIODES	Impurity-based p-type doping in wide-band-gap semiconductors is inefficient at room temperature for applications such as lasers because the positive-charge carriers (holes) have a large thermal activation energy. We demonstrate high-efficiency p-type doping by ionizing acceptor dopants using the built-in electronic polarization in bulk uniaxial semiconductor crystals. Because the mobile hole gases are field-ionized, they are robust to thermal freezeout effects and lead to major improvements in p-type electrical conductivity. The new doping technique results in improved optical emission efficiency in prototype ultraviolet light-emitting-diode structures. Polarization-induced doping provides an attractive solution to both p-and n-type doping problems in wide-band-gap semiconductors and offers an unconventional path for the development of solid-state deep-ultraviolet optoelectronic devices and wide-band-gap bipolar electronic devices of the future.	[Simon, John; Protasenko, Vladimir; Lian, Chuanxin; Xing, Huili; Jena, Debdeep] Univ Notre Dame, Dept Elect Engn, Notre Dame, IN 46556 USA	University of Notre Dame	Jena, D (corresponding author), Univ Notre Dame, Dept Elect Engn, 275 Fitzpatrick Hall, Notre Dame, IN 46556 USA.	djena@nd.edu		Simon, John/0000-0003-2987-3641; Xing, Huili/0000-0002-2709-3839	Direct For Mathematical & Physical Scien [0907583] Funding Source: National Science Foundation	Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))		Bernardini F, 1997, PHYS REV B, V56, P10024, DOI 10.1103/PhysRevB.56.R10024; Brandt O, 2006, NAT MATER, V5, P769, DOI 10.1038/nmat1728; Calle F, 1998, MRS INTERNET J N S R, V3, part. no., DOI 10.1557/S109257830000096X; Cao Y, 2007, APPL PHYS LETT, V90, DOI 10.1063/1.2736207; Eiting CJ, 1997, ELECTRON LETT, V33, P1987, DOI 10.1049/el:19971257; Goepfert ID, 1999, ELECTRON LETT, V35, P1109, DOI 10.1049/el:19990758; Gotz W, 1996, APPL PHYS LETT, V68, P667, DOI 10.1063/1.116503; Han SH, 2009, APPL PHYS LETT, V94, DOI 10.1063/1.3153508; Jena D, 2003, PHYS REV B, V67, DOI 10.1103/PhysRevB.67.153306; Khan A, 2008, NAT PHOTONICS, V2, P77, DOI 10.1038/nphoton.2007.293; Kozodoy P, 1999, APPL PHYS LETT, V74, P3681, DOI 10.1063/1.123220; Kozodoy P, 2000, J APPL PHYS, V87, P1832, DOI 10.1063/1.372098; Rajan S, 2004, APPL PHYS LETT, V84, P1591, DOI 10.1063/1.1652254; Rajan S, 2007, J APPL PHYS, V102, DOI 10.1063/1.2769950; Simon J, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2168253; Steigerwald DA, 2002, IEEE J SEL TOP QUANT, V8, P310, DOI 10.1109/2944.999186; Taniyasu Y, 2006, NATURE, V441, P325, DOI 10.1038/nature04760; Tu RC, 2003, IEEE PHOTONIC TECH L, V15, P1342, DOI 10.1109/LPT.2003.818240; Wood C., 2007, POLARIZATION EFFECTS; Wu YF, 2004, IEEE ELECTR DEVICE L, V25, P117, DOI 10.1109/LED.2003.822667	20	559	575	35	400	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					60	64		10.1126/science.1183226	http://dx.doi.org/10.1126/science.1183226			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044569				2022-12-28	WOS:000273395400029
J	Loarie, SR; Duffy, PB; Hamilton, H; Asner, GP; Field, CB; Ackerly, DD				Loarie, Scott R.; Duffy, Philip B.; Hamilton, Healy; Asner, Gregory P.; Field, Christopher B.; Ackerly, David D.			The velocity of climate change	NATURE			English	Article							MIGRATION CAPACITY; PROTECTED AREAS; CHANGE IMPACTS; DISPERSAL; MOUNTAIN; SYSTEMS; FOREST; SHIFTS; BIRDS; USA	The ranges of plants and animals are moving in response to recent changes in climate(1). As temperatures rise, ecosystems with 'nowhere to go', such as mountains, are considered to be more threatened(2,3). However, species survival may depend as much on keeping pace with moving climates as the climate's ultimate persistence(4,5). Here we present a new index of the velocity of temperature change (km yr(-1)), derived from spatial gradients (degrees C km(-1)) and multimodel ensemble forecasts of rates of temperature increase (degrees C yr(-1)) in the twenty-first century. This index represents the instantaneous local velocity along Earth's surface needed to maintain constant temperatures, and has a global mean of 0.42 km yr(-1) (A1B emission scenario). Owing to topographic effects, the velocity of temperature change is lowest in mountainous biomes such as tropical and subtropical coniferous forests (0.08 km yr(-1)), temperate coniferous forest, and montane grasslands. Velocities are highest in flooded grasslands (1.26 km yr(-1)), mangroves and deserts. High velocities suggest that the climates of only 8% of global protected areas have residence times exceeding 100 years. Small protected areas exacerbate the problem in Mediterranean-type and temperate coniferous forest biomes. Large protected areas may mitigate the problem in desert biomes. These results indicate management strategies for minimizing biodiversity loss from climate change. Montane landscapes may effectively shelter many species into the next century. Elsewhere, reduced emissions, a much expanded network of protected areas(6), or efforts to increase species movement may be necessary(7).	[Loarie, Scott R.; Duffy, Philip B.; Asner, Gregory P.; Field, Christopher B.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Duffy, Philip B.] Climate Cent Inc, Palo Alto, CA 94301 USA; [Hamilton, Healy] Calif Acad Sci, Ctr Appl Biodivers Informat, San Francisco, CA 94118 USA; [Ackerly, David D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Carnegie Institution for Science; California Academy of Sciences; University of California System; University of California Berkeley	Loarie, SR (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	loarie@stanford.edu	Ackerly, David/A-1247-2009; Asner, Gregory/G-9268-2013	Ackerly, David/0000-0002-1847-7398; Asner, Gregory/0000-0001-7893-6421	Gordon and Betty Moore Foundation; Stanford University Global Climate and Energy Project	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Stanford University Global Climate and Energy Project	This work was made possible through the support of the Gordon and Betty Moore Foundation and the Stanford University Global Climate and Energy Project.	Beckage B, 2008, P NATL ACAD SCI USA, V105, P4197, DOI 10.1073/pnas.0708921105; Burrough PA., 1998, PRINCIPLES GEOGRAPHI, P190; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Hannah L, 2008, ANN NY ACAD SCI, V1134, P201, DOI 10.1196/annals.1439.009; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Malcolm JR, 2002, J BIOGEOGR, V29, P835, DOI 10.1046/j.1365-2699.2002.00702.x; Maurer EP, 2009, HYDROL EARTH SYST SC, V13, P183, DOI 10.5194/hess-13-183-2009; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; Peterson DL, 1997, GLOBAL ECOL BIOGEOGR, V6, P7, DOI 10.2307/2997523; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Trivedi MR, 2008, GLOBAL CHANGE BIOL, V14, P1089, DOI 10.1111/j.1365-2486.2008.01553.x; Van Houtan KS, 2007, ECOL LETT, V10, P219, DOI 10.1111/j.1461-0248.2007.01004.x; WEISS SB, 1988, ECOLOGY, V69, P1486, DOI 10.2307/1941646; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	31	1450	1499	39	1300	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 24	2009	462	7276					1052	U111		10.1038/nature08649	http://dx.doi.org/10.1038/nature08649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033047				2022-12-28	WOS:000272996000046
J	Garcia-Castellanos, D; Estrada, F; Jimenez-Munt, I; Gorini, C; Fernandez, M; Verges, J; De Vicente, R				Garcia-Castellanos, D.; Estrada, F.; Jimenez-Munt, I.; Gorini, C.; Fernandez, M.; Verges, J.; De Vicente, R.			Catastrophic flood of the Mediterranean after the Messinian salinity crisis	NATURE			English	Article							ALBORAN SEA; GIBRALTAR STRAIT; LATE MIOCENE; INCISION; BASIN; DESICCATION; EVOLUTION; BOUNDARY; CHANNEL; ORIGIN	The Mediterranean Sea became disconnected from the world's oceans and mostly desiccated by evaporation about 5.6 million years ago during the Messinian salinity crisis(1-3). The Atlantic waters found a way through the present Gibraltar Strait and rapidly refilled the Mediterranean 5.33 million years ago in an event known as the Zanclean flood(4). The nature, abruptness and evolution of this flood remain poorly constrained(4-6). Borehole and seismic data show incisions over 250 m deep on both sides of the Gibraltar Strait that have previously been attributed to fluvial erosion during the desiccation(4,7). Here we show the continuity of this 200-km-long channel across the strait and explain its morphology as the result of erosion by the flooding waters, adopting an incision model validated in mountain rivers. This model in turn allows us to estimate the duration of the flood. Although the available data are limited, our findings suggest that the feedback between water flow and incision in the early stages of flooding imply discharges of about 10(8) m(3) s(-1) (three orders of magnitude larger than the present Amazon River) and incision rates above 0.4 m per day. Although the flood started at low water discharges that may have lasted for up to several thousand years, our results suggest that 90 per cent of the water was transferred in a short period ranging from a few months to two years. This extremely abrupt flood may have involved peak rates of sea level rise in the Mediterranean of more than ten metres per day.	[Garcia-Castellanos, D.; Jimenez-Munt, I.; Fernandez, M.; Verges, J.; De Vicente, R.] CSIC, Inst Ciencies Terra Jaume Almera, Barcelona, Spain; [Estrada, F.] CSIC, Inst Ciencies Mar, Barcelona, Spain; [Gorini, C.] Univ Paris 06, F-75005 Paris, France; [Gorini, C.] CNRS, ISTEP, UMR 7193, F-75005 Paris, France	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Geociencias Barcelona (GEO3BCN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; Sorbonne Universite	Garcia-Castellanos, D (corresponding author), CSIC, Inst Ciencies Terra Jaume Almera, Sole & Sabaris S-N, Barcelona, Spain.	danielgc@ictja.csic.es	Estrada, Ferran/G-8255-2015; Vergés, Jaume/AAH-9519-2019; Jimenez-Munt, Ivone/B-7073-2009; Garcia-Castellanos, Daniel/B-1203-2008; Fernandez, Manel/A-1628-2012; Jiménez-Munt, Ivone/AAA-8214-2021; Vergés, Jaume/D-3070-2011	Vergés, Jaume/0000-0002-4467-5291; Jimenez-Munt, Ivone/0000-0003-4178-3585; Garcia-Castellanos, Daniel/0000-0001-8454-8572; Fernandez, Manel/0000-0002-4487-2359; Vergés, Jaume/0000-0002-4467-5291; Estrada, Ferran/0000-0001-5536-0183	Spanish Government [CGL2006-05493]	Spanish Government(Spanish GovernmentEuropean Commission)	We thank P. Meijer for providing the reconstructed Messinian hypsometry of the Mediterranean. Thoughtful and constructive reviews by P. Carling and P. Gibbard, and critical comments from I. Cacho, P. Meijer, A. Camerlenghi, R. Carbonell and D. Brown helped in improving earlier versions of the manuscript. This is a Group of Dynamics of the Lithosphere contribution funded by the Spanish Government through the projects 'topoAtlas' (CGL2006-05493), 'TopoMed' and 'Conturiber'.	[Anonymous], 1996, P ODP INIT REPORTS O, DOI DOI 10.2973/ODP.PROC.IR.161.1996; Attal M, 2008, J GEOPHYS RES-EARTH, V113, DOI 10.1029/2007JF000893; BARBER PM, 1981, MAR GEOL, V44, P253, DOI 10.1016/0025-3227(81)90053-0; Blanc PL, 2006, PALAEOGEOGR PALAEOCL, V238, P349, DOI 10.1016/j.palaeo.2006.03.033; Blanc PL, 2002, GEODIN ACTA, V15, P303, DOI 10.1016/S0985-3111(02)01095-1; Broecker WS, 2006, SCIENCE, V312, P1146, DOI 10.1126/science.1123253; CAMPILLO AC, 1992, GEO-MAR LETT, V12, P165, DOI 10.1007/BF02084928; Clauzon G, 1996, GEOLOGY, V24, P363, DOI 10.1130/0091-7613(1996)024<0363:AIOTMS>2.3.CO;2; CLAUZON G, 1978, MAR GEOL, V27, P231, DOI 10.1016/0025-3227(78)90033-6; COVEY C, 1994, GLOBAL PLANET CHANGE, V9, P263, DOI 10.1016/0921-8181(94)90020-5; DOCHERTY C, 1995, TERTIARY BASINS SPAI, P392; Duggen S, 2003, NATURE, V422, P602, DOI 10.1038/nature01553; Elliot W.J., 1989, 3 NSERL USDA OH STAT; Esteras M., 2000, REV SOC GEOL ESPAN, V13, P539; Garcia-Castellanos D, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2002JB002073; Govers R, 2009, GEOLOGY, V37, P167, DOI 10.1130/G25141A.1; Gupta S, 2007, NATURE, V448, P342, DOI 10.1038/nature06018; HSU KJ, 1973, NATURE, V242, P240, DOI 10.1038/242240a0; Hsua K.J., 1973, INITIAL REPORTS DEEP, V42, P1203, DOI DOI 10.2973/DSDP.PROC.13.1973; Iaccarino Silvia M., 1999, Proceedings of the Ocean Drilling Program Scientific Results, V161, P529; Iribarren L, 2007, MAR GEOL, V243, P97, DOI 10.1016/j.margeo.2007.05.011; Krijgsman W, 1999, NATURE, V400, P652, DOI 10.1038/23231; Lave J, 2001, J GEOPHYS RES-SOL EA, V106, P26561, DOI 10.1029/2001JB000359; Loget N, 2006, SEDIMENT GEOL, V188, P341, DOI 10.1016/j.sedgeo.2006.03.012; Meijer PT, 2004, PALEOCEANOGRAPHY, V19, DOI 10.1029/2003PA000956; Meijer PT, 2005, EARTH PLANET SC LETT, V240, P510, DOI 10.1016/j.epsl.2005.09.029; OCONNOR JE, 1992, GEOL SOC AM BULL, V104, P267, DOI 10.1130/0016-7606(1992)104<0267:MAIOPD>2.3.CO;2; OCONNOR JE, 1993, 274190 GSA; Pierre C, 2006, SEDIMENT GEOL, V188, P319, DOI 10.1016/j.sedgeo.2006.03.011; Pliego JM, 2005, TUNN UNDERGR SP TECH, V20, P558, DOI 10.1016/j.tust.2005.08.008; Rouchy JM, 2006, SEDIMENT GEOL, V188, P35, DOI 10.1016/j.sedgeo.2006.02.005; Tandon K, 1998, MAR GEOL, V144, P275, DOI 10.1016/S0025-3227(97)00105-9; Watts A.B., 1993, BASIN RES, V5, P153, DOI DOI 10.1111/J.1365-2117.1993.TB00063.X; Whipple KX, 1999, J GEOPHYS RES-SOL EA, V104, P17661, DOI 10.1029/1999JB900120; Whittaker AC, 2007, GEOLOGY, V35, P103, DOI 10.1130/G23106A.1; Wobus C, 2005, NATURE, V434, P1008, DOI 10.1038/nature03499	36	303	311	4	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					778	U96		10.1038/nature08555	http://dx.doi.org/10.1038/nature08555			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010684				2022-12-28	WOS:000272559900036
J	Laurance, J				Laurance, Jeremy			Medicine in the News Health stories of the decade	BRITISH MEDICAL JOURNAL			English	Editorial Material												J.Laurance@independent.co.uk							0	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 10	2009	339								b5281	10.1136/bmj.b5281	http://dx.doi.org/10.1136/bmj.b5281			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531VH	20007663				2022-12-28	WOS:000272697600010
J	Reuss, R; Rommer, PS; Bruck, W; Paul, F; Bolz, M; Jarius, S; Boettcher, T; Grossmann, A; Bock, A; Zipp, F; Benecke, R; Zettl, UK				Reuss, Reinhard; Rommer, Paulus S.; Brueck, Wolfgang; Paul, Friedemann; Bolz, Michael; Jarius, Sven; Boettcher, Tobias; Grossmann, Annette; Bock, Alexander; Zipp, Frauke; Benecke, Reiner; Zettl, Uwe K.			Interactive Case Report A woman with acute myelopathy in pregnancy: case outcome	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							AQUAPORIN-4		[Reuss, Reinhard; Rommer, Paulus S.; Benecke, Reiner; Zettl, Uwe K.] Univ Rostock, Dept Neurol, D-18147 Rostock, Germany; [Brueck, Wolfgang] Univ Med Ctr Gottingen, Inst Neuropathol, Gottingen, Germany; [Paul, Friedemann] Charite, NeuroCure Clin Res Ctr, D-13353 Berlin, Germany; [Bolz, Michael] Univ Rostock, Dept Gynaecol, D-18147 Rostock, Germany; [Jarius, Sven] Heidelberg Univ, Dept Neurol, Div Mol Neuroimmunol, Heidelberg, Germany; [Boettcher, Tobias] Dietrich Bonhoeffer Klinikum Neubrandenburg, Div Neurol, Neubrandenburg, Germany; [Grossmann, Annette] Univ Rostock, Dept Radiol, D-18147 Rostock, Germany; [Paul, Friedemann; Zipp, Frauke] Charite, Cecilie Vogt Clin Neurol, D-13353 Berlin, Germany	University of Rostock; University of Gottingen; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Rostock; Ruprecht Karls University Heidelberg; University of Rostock; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Reuss, R (corresponding author), Univ Rostock, Dept Neurol, D-18147 Rostock, Germany.	reinhard.reuss@neuro.med.uni-giessen.de	Paul, Friedemann/ABF-9415-2020; Zipp, Frauke/C-9968-2015	Zipp, Frauke/0000-0002-1231-1928; paul, friedemann/0000-0002-6378-0070				Cree BAC, 2005, NEUROLOGY, V64, P1270, DOI 10.1212/01.WNL.0000159399.81861.D5; De Falco M, 2007, IN VIVO, V21, P813; Jarius S, 2008, NAT CLIN PRACT NEURO, V4, P202, DOI 10.1038/ncpneuro0764; Quick AM, 2005, FASEB J, V19, P170, DOI 10.1096/fj.04-1901hyp; Weinshenker BG, 2006, ANN NEUROL, V59, P566, DOI 10.1002/ana.20770	5	20	22	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2009	339								b4026	10.1136/bmj.b4026	http://dx.doi.org/10.1136/bmj.b4026			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531VH	20007656	Green Accepted			2022-12-28	WOS:000272697600001
J	Cohen, AS; Burns, B; Goadsby, PJ				Cohen, Anna S.; Burns, Brian; Goadsby, Peter J.			High-Flow Oxygen for Treatment of Cluster Headache A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							DOUBLE-BLIND; ZOLMITRIPTAN; SUMATRIPTAN	Context Cluster headache is an excruciatingly painful primary headache syndrome, with attacks of unilateral pain and cranial autonomic symptoms. The current licensed treatment for acute attacks is subcutaneous sumatriptan. Objective To ascertain whether high-flow inhaled oxygen was superior to placebo in the acute treatment of cluster headache. Design, Setting, and Patients A double-blind, randomized, placebo-controlled crossover trial of 109 adults (aged 18-70 years) with cluster headache as defined by the International Headache Society. Patients treated 4 headache episodes with high-flow inhaled oxygen or placebo, alternately. Patients were randomized to the order in which they received the active treatment or placebo. Patients were recruited and followed up between 2002 and 2007 at the National Hospital for Neurology and Neurosurgery, London, England. Intervention Inhaled oxygen at 100%, 12 L/min, delivered by face mask, for 15 minutes at the start of an attack of cluster headache or high-flow air placebo delivered alternately for 4 attacks. Main Outcome Measures The primary end point was to render the patient pain free, or in the absence of a diary to have adequate relief, at 15 minutes. Secondary end points included rendering the patient pain free at 30 minutes, reduction in pain up to 60 minutes, need for rescue medication 15 minutes after treatment, overall response to the treatment and overall functional disability, and effect on associated symptoms. Results Fifty-seven patients with episodic cluster headache and 19 with chronic cluster headache were available for the analysis. For the primary end point the difference between oxygen, 78% (95% confidence interval, 71%-85% for 150 attacks) and air, 20% (95% confidence interval, 14%-26%; for 148 attacks) was significant (Wald test, chi(2)(5)=66.7, P<.001). There were no important adverse events. Conclusion Treatment of patients with cluster headache at symptom onset using inhaled high-flow oxygen compared with placebo was more likely to result in being pain-free at 15 minutes. Trial Registration isrctn.org Identifier: ISRCTN94092997 JAMA. 2009; 302(22): 2451-2457	[Goadsby, Peter J.] Univ Calif San Francisco, Dept Neurol, Headache Grp, San Francisco, CA 94115 USA; [Cohen, Anna S.; Burns, Brian; Goadsby, Peter J.] Natl Hosp Neurol & Neurosurg, Inst Neurol, Headache Grp, Queen Sq London, England	University of California System; University of California San Francisco; University of London; University College London; UCL Medical School; University College London Hospitals NHS Foundation Trust	Goadsby, PJ (corresponding author), Univ Calif San Francisco, Dept Neurol, Headache Grp, 1701 Div St, San Francisco, CA 94115 USA.	pgoadsby@headache.ucsf.edu	Goadsby, Peter J/Z-1970-2019	Goadsby, Peter J/0000-0003-3260-5904	University College London	University College London(General Electric)	The trial was jointly sponsored by University College London and BOC Limited (now Linde Gases, Priestley Road, Guildford, Surrey, UK), who supplied the cylinders and the masks.	Akerman S, 2009, HEADACHE, V49, P1131, DOI 10.1111/j.1526-4610.2009.01501.x; Bahra A, 2002, NEUROLOGY, V58, P354, DOI 10.1212/WNL.58.3.354; Bahra A, 2000, NEUROLOGY, V54, P1832, DOI 10.1212/WNL.54.9.1832; Cittadini E, 2006, ARCH NEUROL-CHICAGO, V63, P1537, DOI 10.1001/archneur.63.11.nct60002; Cohen AS, 2007, CEPHALALGIA, V27, P1188; DEXTER JD, 1970, NEUROLOGY, V20, P513, DOI 10.1212/WNL.20.5.513; Dodick D, 2004, HEADACHE, V44, P414, DOI 10.1111/j.1526-4610.2004.04078.x; EKBOM K, 1992, CEPHALALGIA, V12, P254, DOI 10.1046/j.1468-2982.1992.1204254.x; EKBOM K, 1993, ACTA NEUROL SCAND, V88, P63; EKBOM K, 1991, NEW ENGL J MED, V325, P322, DOI 10.1056/nejm199108013250505; FOGAN L, 1985, ARCH NEUROL-CHICAGO, V42, P362, DOI 10.1001/archneur.1985.04060040072015; Goadsby PJ, 2007, CURR NEUROL NEUROSCI, V7, P117, DOI 10.1007/s11910-007-0006-6; KUDROW L, 1981, HEADACHE, V21, P1, DOI 10.1111/j.1526-4610.1981.hed2101001.x; Matharu MS, 2004, ANN NEUROL, V56, P488, DOI 10.1002/ana.20210; May A, 2006, EUR J NEUROL, V13, P1066, DOI 10.1111/j.1468-1331.2006.01566.x; OLESEN J, 1999, FRONTIERS HEADACHE R, V9; Paemeleire K, 2006, NEUROLOGY, V67, P109, DOI 10.1212/01.wnl.0000223332.35936.6e; Rapoport AM, 2007, NEUROLOGY, V69, P821, DOI 10.1212/01.wnl.0000267886.85210.37; Silberstein SD, 2004, CEPHALALGIA, V24, P2, DOI 10.1111/j.1468-2982.2004.00892.x; Sjaastad O, 2003, CEPHALALGIA, V23, P528, DOI 10.1046/j.1468-2982.2003.00585.x; Snijders T.A., 1999, INTRO BASIC ADV MULT; SORGE F, 1988, CEPHALALGIA, V8, P1, DOI 10.1046/j.1468-2982.1988.0801001.x; van Vliet JA, 2003, NEUROLOGY, V60, P630, DOI 10.1212/01.WNL.0000046589.45855.30; Yang M, 2000, J ROY STAT SOC A STA, V163, P49, DOI 10.1111/1467-985X.00156	24	195	199	0	11	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2451	2457		10.1001/jama.2009.1855	http://dx.doi.org/10.1001/jama.2009.1855			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529MD	19996400				2022-12-28	WOS:000272520500024
J	Edwards, MJ; Flatman, RH; Mitchenall, LA; Stevenson, CEM; Le, TBK; Clarke, TA; McKay, AR; Fiedler, HP; Buttner, MJ; Lawson, DM; Maxwell, A				Edwards, Marcus J.; Flatman, Ruth H.; Mitchenall, Lesley A.; Stevenson, Clare E. M.; Le, Tung B. K.; Clarke, Thomas A.; McKay, Adam R.; Fiedler, Hans-Peter; Buttner, Mark J.; Lawson, David M.; Maxwell, Anthony			A Crystal Structure of the Bifunctional Antibiotic Simocyclinone D8, Bound to DNA Gyrase	SCIENCE			English	Article							RESISTANCE-DETERMINING REGION; BIOSYNTHETIC GENE-CLUSTER; STREPTOMYCES-ANTIBIOTICUS; II TOPOISOMERASES; INHIBITORS; BINDING; ENERGY	Simocyclinones are bifunctional antibiotics that inhibit bacterial DNA gyrase by preventing DNA binding to the enzyme. We report the crystal structure of the complex formed between the N-terminal domain of the Escherichia coli gyrase A subunit and simocyclinone D8, revealing two binding pockets that separately accommodate the aminocoumarin and polyketide moieties of the antibiotic. These are close to, but distinct from, the quinolone-binding site, consistent with our observations that several mutations in this region confer resistance to both agents. Biochemical studies show that the individual moieties of simocyclinone D8 are comparatively weak inhibitors of gyrase relative to the parent compound, but their combination generates a more potent inhibitor. Our results should facilitate the design of drug molecules that target these unexploited binding pockets.	[Edwards, Marcus J.; Flatman, Ruth H.; Mitchenall, Lesley A.; Stevenson, Clare E. M.; Lawson, David M.; Maxwell, Anthony] John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England; [Le, Tung B. K.; Buttner, Mark J.] John Innes Ctr, Dept Mol Microbiol, Norwich NR4 7UH, Norfolk, England; [Clarke, Thomas A.] Univ E Anglia, Sch Biol Sci, Norwich NR4 7TJ, Norfolk, England; [McKay, Adam R.] UCL, Dept Chem, London WC1H 0AJ, England; [Fiedler, Hans-Peter] Univ Tubingen, Inst Mikrobiol, D-72076 Tubingen, Germany	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of East Anglia; University of London; University College London; Eberhard Karls University of Tubingen	Maxwell, A (corresponding author), John Innes Ctr, Dept Biol Chem, Norwich NR4 7UH, Norfolk, England.	tony.maxwell@bbsrc.ac.uk	Lawson, David M/D-1810-2009; clarke, tom/D-1837-2009	clarke, tom/0000-0002-6234-1914; Mitchenall, Lesley/0000-0002-0063-1991; Maxwell, Anthony/0000-0002-5756-6430; Edwards, Marcus/0000-0002-0243-3788; Le, Tung BK/0000-0003-4764-8851; Buttner, Mark/0000-0002-3505-2981	UK Biotechnology and Biological Sciences Research Council (BBSRC); European Commission [LSHB-CT-2004-503466]; Plant Bioscience Limited; John Innes Centre Rotation studentship; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000201] Funding Source: researchfish	UK Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Plant Bioscience Limited; John Innes Centre Rotation studentship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by UK Biotechnology and Biological Sciences Research Council (BBSRC) and the European Commission (CombiGyrase LSHB-CT-2004-503466); M.J.E. was supported by a CASE studentship funded by BBSRC and Plant Bioscience Limited, and T. B. K. L. was supported by a John Innes Centre Rotation studentship. We thank A. Zeeck ( University of Guttingen) for providing us with a sample of MGD8N2A; P. Johnson for assistance with CD experiments; R. Field, L. Heide, and D. Hopwood for helpful discussions; and N. Ruiz and T. Silhavy for their advice and for the E. coli imp4213 mutant. Atomic coordinates and structure factors have been deposited in the Protein Data Bank with accession code 2WL2. We dedicate this paper to the memory of Chris Lamb, director of the John Innes Centre from 1999 to 2009.	Anderle C, 2008, ANTIMICROB AGENTS CH, V52, P1982, DOI 10.1128/AAC.01235-07; Bates A. D., 2005, DNA TOPOLOGY; Bates AD, 2007, BIOCHEMISTRY-US, V46, P7929, DOI 10.1021/bi700789g; Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294; Flatman RH, 2006, ANTIMICROB AGENTS CH, V50, P1136, DOI 10.1128/AAC.50.4.1136-1142.2006; Flatman RH, 2005, ANTIMICROB AGENTS CH, V49, P1093, DOI 10.1128/AAC.49.3.1093-1100.2005; Galm U, 2002, ARCH MICROBIOL, V178, P102, DOI 10.1007/s00203-002-0429-z; Holdgate GA, 1997, BIOCHEMISTRY-US, V36, P9663, DOI 10.1021/bi970294+; HOOPER DC, 1993, QUINOLONE ANTIMICROB, P485; Lamour V, 2002, J BIOL CHEM, V277, P18947, DOI 10.1074/jbc.M111740200; Laponogov I, 2009, NAT STRUCT MOL BIOL, V16, P667, DOI 10.1038/nsmb.1604; Lewis RJ, 1996, EMBO J, V15, P1412, DOI 10.1002/j.1460-2075.1996.tb00483.x; Li SM, 2005, CURR MED CHEM, V12, P419, DOI 10.2174/0929867053363063; Livermore D, 2007, J ANTIMICROB CHEMOTH, V60, pI59, DOI 10.1093/jac/dkm160; Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8; Maxwell A, 2003, CURR TOP MED CHEM, V3, P283, DOI 10.2174/1568026033452500; Oliphant CM, 2002, AM FAM PHYSICIAN, V65, P455; Oppegard LM, 2009, ANTIMICROB AGENTS CH, V53, P2110, DOI 10.1128/AAC.01440-08; Ruiz N, 2005, CELL, V121, P307, DOI 10.1016/j.cell.2005.02.014; Schimana J, 2000, J ANTIBIOT, V53, P779, DOI 10.7164/antibiotics.53.779; Schoeffler AJ, 2008, Q REV BIOPHYS, V41, P41, DOI 10.1017/S003358350800468X; Theobald U, 2000, ANTON LEEUW INT J G, V78, P307, DOI 10.1023/A:1010282818272; Trefzer A, 2002, ANTIMICROB AGENTS CH, V46, P1174, DOI 10.1128/AAC.46.5.1174-1182.2002; Tsai FTF, 1997, PROTEINS, V28, P41; YOSHIDA H, 1990, ANTIMICROB AGENTS CH, V34, P1271, DOI 10.1128/AAC.34.6.1271; YOSHIDA H, 1991, ANTIMICROB AGENTS CH, V35, P1647, DOI 10.1128/AAC.35.8.1647	26	72	77	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1415	1418		10.1126/science.1179123	http://dx.doi.org/10.1126/science.1179123			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965760				2022-12-28	WOS:000272351100047
J	Bhutani, N; Brady, JJ; Damian, M; Sacco, A; Corbel, SY; Blau, HM				Bhutani, Nidhi; Brady, Jennifer J.; Damian, Mara; Sacco, Alessandra; Corbel, Stephane Y.; Blau, Helen M.			Reprogramming towards pluripotency requires AID-dependent DNA demethylation	NATURE			English	Article							CLASS SWITCH RECOMBINATION; STEM-CELLS; GENE-EXPRESSION; SOMATIC-CELLS; ACTIVATION; DIFFERENTIATION; FIBROBLASTS; HETEROKARYONS; GENERATION; DEAMINASE	Reprogramming of somatic cell nuclei to yield induced pluripotent stem (iPS) cells makes possible derivation of patient-specific stem cells for regenerative medicine. However, iPS cell generation is asynchronous and slow (2-3 weeks), the frequency is low (<0.1%), and DNA demethylation constitutes a bottleneck. To determine regulatory mechanisms involved in reprogramming, we generated interspecies heterokaryons ( fused mouse embryonic stem (ES) cells and human fibroblasts) that induce reprogramming synchronously, frequently and fast. Here we show that reprogramming towards pluripotency in single heterokaryons is initiated without cell division or DNA replication, rapidly ( 1 day) and efficiently (70%). Short interfering RNA (siRNA)-mediated knockdown showed that activation-induced cytidine deaminase ( AID, also known as AICDA) is required for promoter demethylation and induction of OCT4 (also known as POU5F1) and NANOG gene expression. AID protein bound silent methylated OCT4 and NANOG promoters in fibroblasts, but not active demethylated promoters in ES cells. These data provide the first evidence that mammalian AID is required for active DNA demethylation and initiation of nuclear reprogramming towards pluripotency in human somatic cells.	[Bhutani, Nidhi; Brady, Jennifer J.; Damian, Mara; Sacco, Alessandra; Corbel, Stephane Y.; Blau, Helen M.] Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Inst Stem Cell Biol & Regenerat Med,Sch Med, Stanford, CA 94305 USA; [Damian, Mara] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	Stanford University; Stanford University	Blau, HM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Baxter Lab Stem Cell Biol, Inst Stem Cell Biol & Regenerat Med,Sch Med, Stanford, CA 94305 USA.	hblau@stanford.edu			National Science Foundation; National Institutes of Health (NIH) [AI007328, AG009521, AG024987]; Baxter Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007328] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG009521, R01AG009521, R01AG024987] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Baxter Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank O. Alkan for generating retroviral constructs for GFP and DsRed expression; R. Doyonnas for helping to standardize FACS isolation of heterokaryons; Y. Liao for performing the initial experiments showing demethylation in heterokaryons; M. Pajcini for technical assistance with the BrdU experiments; D. Schatz and S. Unniraman for providing the human AID construct; F. Alt for his generous provision of antibody to AID; J. A. Dahl for discussions about chromatin immunoprecipitation assays; H. Chang for use of the Bioruptor sonicator; and M. Wernig, G. Sen, C.-Z. Chen and J. Pomerantz for comments on the manuscript. This work was supported by a National Science Foundation Graduate Research Fellowship awarded to J. J. B., National Institutes of Health (NIH) training grant AI007328 to M. D., and NIH grants AG009521, AG024987 and support from the Baxter Foundation to H. M. B.	Aasen T, 2008, NAT BIOTECHNOL, V26, P1276, DOI 10.1038/nbt.1503; Aoi T, 2008, SCIENCE, V321, P699, DOI 10.1126/science.1154884; BARON MH, 1986, CELL, V46, P591, DOI 10.1016/0092-8674(86)90885-8; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhattacharya B, 2004, BLOOD, V103, P2956, DOI 10.1182/blood-2003-09-3314; BLAU HM, 1991, J CELL BIOL, V112, P781, DOI 10.1083/jcb.112.5.781; BLAU HM, 1983, CELL, V32, P1171, DOI 10.1016/0092-8674(83)90300-8; BLAU HM, 1992, ANNU REV BIOCHEM, V61, P1213, DOI 10.1146/annurev.bi.61.070192.010025; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; CHIU CP, 1985, CELL, V40, P417, DOI 10.1016/0092-8674(85)90155-2; CHIU CP, 1984, CELL, V37, P879, DOI 10.1016/0092-8674(84)90423-9; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Conticello Silvestro G, 2007, Adv Immunol, V94, P37, DOI 10.1016/S0065-2776(06)94002-4; Cortazar D, 2007, DNA REPAIR, V6, P489, DOI 10.1016/j.dnarep.2006.10.013; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; Dahl JA, 2008, NAT PROTOC, V3, P1032, DOI 10.1038/nprot.2008.68; Deb K, 2006, SCIENCE, V311, P992, DOI 10.1126/science.1120925; Eminli S, 2009, NAT GENET, V41, P968, DOI 10.1038/ng.428; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; GURDON JB, 1962, DEV BIOL, V4, P256, DOI 10.1016/0012-1606(62)90043-X; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Millar CB, 2002, SCIENCE, V297, P403, DOI 10.1126/science.1073354; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Okazaki IM, 2002, NATURE, V416, P340, DOI 10.1038/nature727; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Palermo A, 2009, FASEB J, V23, P1431, DOI 10.1096/fj.08-122903; Park IH, 2008, NATURE, V451, P141, DOI [10.1038/nature06534, 10.1038/natureO6534]; PAVLATH GK, 1986, J CELL BIOL, V102, P124, DOI 10.1083/jcb.102.1.124; Pereira CF, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000170; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Simonsson S, 2004, NAT CELL BIOL, V6, P984, DOI 10.1038/ncb1176; SPEAR BT, 1990, MOL CELL BIOL, V10, P5047, DOI 10.1128/MCB.10.10.5047; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Vuong BQ, 2009, NAT IMMUNOL, V10, P420, DOI 10.1038/ni.1708; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; WRIGHT WE, 1984, EXP CELL RES, V151, P55, DOI 10.1016/0014-4827(84)90355-0; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang F, 2007, P NATL ACAD SCI USA, V104, P4395, DOI 10.1073/pnas.0700181104	49	529	557	2	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1042	U57		10.1038/nature08752	http://dx.doi.org/10.1038/nature08752			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20027182	Green Accepted			2022-12-28	WOS:000275108400028
J	Mushlin, AI; Ghomrawi, H				Mushlin, Alvin I.; Ghomrawi, Hassan			Health Care Reform and the Need for Comparative-Effectiveness Research	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COST-EFFECTIVENESS		[Mushlin, Alvin I.; Ghomrawi, Hassan] Weill Cornell Med Coll, Dept Publ Hlth, New York, NY USA	Cornell University	Mushlin, AI (corresponding author), Weill Cornell Med Coll, Dept Publ Hlth, New York, NY USA.			Ghomrawi, Hassan/0000-0003-1291-5278				Chalkidou K, 2009, COMP EFFECTIVENESS R; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Davis K, 2009, STARTING PATH HIGH P; Mushlin AI, 1998, CIRCULATION, V97, P2129, DOI 10.1161/01.CIR.97.21.2129; Pollack A., 2008, NY TIMES        1127, pB1	5	40	43	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3								10.1056/NEJMp0912651	http://dx.doi.org/10.1056/NEJMp0912651			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	545NE	20054035				2022-12-28	WOS:000273738400003
J	Humbard, MA; Miranda, HV; Lim, JM; Krause, DJ; Pritz, JR; Zhou, GY; Chen, SX; Wells, L; Maupin-Furlow, JA				Humbard, Matthew A.; Miranda, Hugo V.; Lim, Jae-Min; Krause, David J.; Pritz, Jonathan R.; Zhou, Guangyin; Chen, Sixue; Wells, Lance; Maupin-Furlow, Julie A.			Ubiquitin-like small archaeal modifier proteins (SAMPs) in Haloferax volcanii	NATURE			English	Article							PROTEASOME-ACTIVATING NUCLEOTIDASE; RHODANESE-LIKE PROTEIN; MOLYBDENUM COFACTOR; DEPENDENT DEGRADATION; SULFUR CARRIER; SYSTEM; CHAINS; PUP; DEUBIQUITINATION; METALLOPROTEASE	Archaea, one of three major evolutionary lineages of life, encode proteasomes highly related to those of eukaryotes. In contrast, archaeal ubiquitin-like proteins are less conserved and not known to function in protein conjugation. This has complicated our understanding of the origins of ubiquitination and its connection to proteasomes. Here we report two small archaeal modifier proteins, SAMP1 and SAMP2, with a beta-grasp fold and carboxy-terminal diglycine motif similar to ubiquitin, that form protein conjugates in the archaeon Haloferax volcanii. The levels of SAMP-conjugates were altered by nitrogen-limitation and proteasomal gene knockout and spanned various functions including components of the Urm1 pathway. LC-MS/MS-based collision-induced dissociation demonstrated isopeptide bonds between the C-terminal glycine of SAMP2 and the epsilon-amino group of lysines from a number of protein targets and Lys58 of SAMP2 itself, revealing poly-SAMP chains. The widespread distribution and diversity of pathways modified by SAMPylation suggest that this type of protein conjugation is central to the archaeal lineage.	[Humbard, Matthew A.; Miranda, Hugo V.; Krause, David J.; Pritz, Jonathan R.; Zhou, Guangyin; Maupin-Furlow, Julie A.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Chen, Sixue] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Chen, Sixue] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32611 USA; [Lim, Jae-Min; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University System of Georgia; University of Georgia	Maupin-Furlow, JA (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	jmaupin@ufl.edu	Maupin-Furlow, Julie/AAW-4035-2020; Wells, Lance/H-3118-2013; CHEN, SI/GZL-4800-2022	Maupin-Furlow, Julie/0000-0001-6105-0923; Wells, Lance/0000-0003-4956-5363	NIH [1S10 RR025418-01, NCRR P41 RR018502, R01 GM057498]; DOE [DE-FG02-05ER15650]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025418, P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057498] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at UF ICBR including C. Diaz and R. Zheng for MS and S. Shanker for DNA sequencing. Thanks to M. Terns and F. Aydemir for advice on purification of SAMP conjugates from anti-Flag agarose, N. Furlow for plasmid DNA preparations and J. Foster for other advice. We thank also T. Allers, M. Mevarech, M. Dyall-Smith and M. Danson labs for H. volcanii strains and plasmids. This work was funded in part by NIH 1S10 RR025418-01 to SC, Integrated Technology Resource for Biomedical Glycomics at UGA (supported by NIH/NCRR P41 RR018502, L. W. senior investigator) and NIH R01 GM057498 and DOE DE-FG02-05ER15650 to J.A.M.-F.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Burroughs AM, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-4; Burroughs AM, 2009, PROTEINS, V75, P895, DOI 10.1002/prot.22298; Chen X, 2009, J MOL BIOL, V392, P208, DOI 10.1016/j.jmb.2009.07.018; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Colnaghi R, 2001, FEBS LETT, V500, P153, DOI 10.1016/S0014-5793(01)02610-2; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Dyall-Smith M., 2008, HALOHANDBOOK PROTOCO; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; Gonen H, 1996, ADV EXP MED BIOL, V389, P209; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Humbard MA, 2006, J BACTERIOL, V188, P7521, DOI 10.1128/JB.00943-06; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Kaczowka SJ, 2003, J BACTERIOL, V185, P165, DOI 10.1128/JB.185.1.165-174.2003; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Kirkland PA, 2008, J BACTERIOL, V190, P193, DOI 10.1128/JB.01196-07; Kirkland PA, 2007, MICROBIOL-SGM, V153, P2271, DOI 10.1099/mic.0.2007/005769-0; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Leimkuhler S, 2003, J BIOL CHEM, V278, P26127, DOI 10.1074/jbc.M303092200; Liao SH, 2009, BIOCHEM J, V422, P207, DOI 10.1042/BJ20090738; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Maupin-Furlow JA, 2000, FRONT BIOSCI-LANDMRK, V5, pD837, DOI 10.2741/furlow; McLuskey K, 2003, J BIOL CHEM, V278, P23706, DOI 10.1074/jbc.M301485200; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Reuter CJ, 2004, J BACTERIOL, V186, P7763, DOI 10.1128/JB.186.22.7763-7772.2004; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Spallarossa A, 2004, J MOL BIOL, V335, P583, DOI 10.1016/j.jmb.2003.10.072; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Tarasov VY, 2008, MOL MICROBIOL, V67, P772, DOI 10.1111/j.1365-2958.2007.06081.x; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zhou GY, 2008, J BACTERIOL, V190, P8096, DOI 10.1128/JB.01180-08	44	142	157	2	32	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					54	U60		10.1038/nature08659	http://dx.doi.org/10.1038/nature08659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054389	Green Accepted			2022-12-28	WOS:000273344900028
J	Liu, Q; Tang, ZX; Surdenikova, L; Kim, S; Patel, KN; Kim, A; Ru, F; Guan, Y; Weng, HJ; Geng, YX; Undem, BJ; Kollarik, M; Chen, ZF; Anderson, DJ; Dong, XZ				Liu, Qin; Tang, Zongxiang; Surdenikova, Lenka; Kim, Seungil; Patel, Kush N.; Kim, Andrew; Ru, Fei; Guan, Yun; Weng, Hao-Jui; Geng, Yixun; Undem, Bradley J.; Kollarik, Marian; Chen, Zhou-Feng; Anderson, David J.; Dong, Xinzhong			Sensory Neuron-Specific GPCR Mrgprs Are Itch Receptors Mediating Chloroquine-Induced Pruritus	CELL			English	Article							MAST-CELLS; SCRATCHING BEHAVIOR; ADAPTIVE EVOLUTION; HUMAN SKIN; HISTAMINE; FAMILY; GENE; SENSATION; MALARIA; PATHWAY	The cellular and molecular mechanisms mediating histamine-independent itch in primary sensory neurons are largely unknown. Itch induced by chloroquine (CQ) is a common side effect of this widely used antimalarial drug. Here, we show that Mrgprs, a family of G protein-coupled receptors expressed exclusively in peripheral sensory neurons, function as itch receptors. Mice lacking a cluster of Mrgpr genes display significant deficits in itch induced by CQ but not histamine. CQ directly excites sensory neurons in an Mrgpr-dependent manner. CQ specifically activates mouse MrgprA3 and human MrgprX1. Loss- and gain-of-function studies demonstrate that MrgprA3 is required for CQ responsiveness in mice. Furthermore, MrgprA3-expressing neurons respond to histamine and coexpress gastrin-releasing peptide, a peptide involved in itch sensation, and MrgprC11. Activation of these neurons with the MrgprC11-specific agonist BAM8-22 induces itch in wild-type but not mutant mice. Therefore, Mrgprs may provide molecular access to itch-selective neurons and constitute novel targets for itch therapeutics.	[Liu, Qin; Tang, Zongxiang; Patel, Kush N.; Kim, Andrew; Weng, Hao-Jui; Geng, Yixun; Dong, Xinzhong] Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Surdenikova, Lenka; Ru, Fei; Undem, Bradley J.; Kollarik, Marian] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA; [Guan, Yun] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Baltimore, MD 21205 USA; [Surdenikova, Lenka] Jessenius Med Sch, Dept Pathophysiol, Martin 03753, Slovakia; [Kim, Seungil; Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Anesthesiol, St Louis, MO 63110 USA; [Kim, Seungil; Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Psychiat, St Louis, MO 63110 USA; [Kim, Seungil; Chen, Zhou-Feng] Washington Univ, Sch Med, Pain Ctr, Dept Dev Biol, St Louis, MO 63110 USA; [Anderson, David J.] CALTECH, Div Biol, Pasadena, CA 91125 USA; [Anderson, David J.; Dong, Xinzhong] Howard Hughes Med Inst, Chevy Chase, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins University; Comenius University Bratislava; Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); California Institute of Technology; Howard Hughes Medical Institute	Dong, XZ (corresponding author), Johns Hopkins Univ, Sch Med, Ctr Sensory Biol, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	xdong2@jhmi.edu		Weng, Hao-Jui/0000-0002-7006-7599	Alfred P. Sloan Neuroscience; Whitehall Foundation; Blaustein Pain Research Fund award; National Institutes of Health [NS054791, HL038095, DK074480, AR056318, NS048499]; VEGA [1/0018/08]; NATIONAL EYE INSTITUTE [T32EY017203] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL038095, R29HL038095] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056318] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074480] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS048499, R01NS054791] Funding Source: NIH RePORTER	Alfred P. Sloan Neuroscience; Whitehall Foundation; Blaustein Pain Research Fund award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VEGA(Vedecka grantova agentura MSVVaS SR a SAV (VEGA)European Commission); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Shirley Pease and the staff of the Caltech transgenic mouse facility for assistance with embryonic stem cell manipulation. We also thank M. Ring-kamp and R. Meyer for helpful comments on the manuscript. The work was supported by an Alfred P. Sloan Neuroscience grant, a Whitehall Foundation grant, a Blaustein Pain Research Fund award, and grants from the National Institutes of Health to X.D. (NS054791), B.J.U. (HL038095), M.K. (DK074480), Z.F.C. (AR056318), and D.J.A. (NS048499). L.S. is supported by VEGA 1/0018/08. D.J.A and X.D. are an Investigator and an Early Career Scientist of the Howard Hughes Medical Institute, respectively.	Abila B, 1994, Afr J Med Med Sci, V23, P139; Adam M. E., 2004, Saudi Pharmaceutical Journal, V12, P130; Ademowo O, 1998, MALARIA INFECT DIS A, V8, P14; AJAYI AA, 1989, EUR J CLIN PHARMACOL, V37, P539, DOI 10.1007/BF00558141; ALVING K, 1991, CELL TISSUE RES, V264, P529, DOI 10.1007/BF00319042; Batanero E, 2002, ALLERGY, V57, P65, DOI 10.1034/j.1398-9995.2002.13368.x; Caterina MJ, 1999, CURR OPIN NEUROBIOL, V9, P525, DOI 10.1016/S0959-4388(99)00009-4; Choi SS, 2003, GENOME RES, V13, P2252, DOI 10.1101/gr.1431603; Chuang HH, 2001, NATURE, V411, P957, DOI 10.1038/35082088; Davidson S, 2007, J NEUROSCI, V27, P10007, DOI 10.1523/JNEUROSCI.2862-07.2007; DENCKER L, 1975, TOXICOLOGY, V5, P255, DOI 10.1016/0300-483X(75)90122-5; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Evans JA, 2005, QJM-INT J MED, V98, P789, DOI 10.1093/qjmed/hci121; EZEAMUZIE CI, 1990, J TROP MED HYG, V93, P423; Fujita F, 2007, BRIT J PHARMACOL, V151, P134, DOI 10.1038/sj.bjp.0707219; Green AD, 2006, PAIN, V124, P50, DOI 10.1016/j.pain.2006.03.023; GREEN K B, 1989, Skin Pharmacology, V2, P77; Han SK, 2006, NEURON, V52, P691, DOI 10.1016/j.neuron.2006.09.036; Han SK, 2002, P NATL ACAD SCI USA, V99, P14740, DOI 10.1073/pnas.192565799; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Johanek LM, 2008, J NEUROSCI, V28, P7659, DOI 10.1523/JNEUROSCI.1760-08.2008; Johanek LM, 2007, J NEUROSCI, V27, P7490, DOI 10.1523/JNEUROSCI.1249-07.2007; Kanny Gisele, 2003, Eur J Intern Med, V14, P395, DOI 10.1016/S0953-6205(03)90011-2; Kim BM, 2004, NEUROSCI LETT, V361, P159, DOI 10.1016/j.neulet.2004.01.019; KURAISHI Y, 1995, EUR J PHARMACOL, V275, P229, DOI 10.1016/0014-2999(94)00780-B; Kwong K, 2008, AM J PHYSIOL-LUNG C, V295, pL858, DOI 10.1152/ajplung.90360.2008; Lembo PMC, 2002, NAT NEUROSCI, V5, P201, DOI 10.1038/nn815; Liu Y, 2008, J NEUROSCI, V28, P125, DOI 10.1523/JNEUROSCI.4472-07.2008; MNYIKA KS, 1991, J TROP MED HYG, V94, P27; Nakayama Y, 2002, METHOD FIND EXP CLIN, V24, P267, DOI 10.1358/mf.2002.24.5.802303; Nicolson TA, 2002, NEUROSCIENCE, V110, P329, DOI 10.1016/S0306-4522(01)00561-9; NOSAL R, 1991, AGENTS ACTIONS, V33, P37, DOI 10.1007/BF01993121; OLATUNDE A, 1977, AFR J MED MED SCI, V6, P27; OLATUNDE IA, 1971, BRIT J PHARMACOL, V43, P335; Onyeji CO, 2001, EUR J PHARM SCI, V13, P195, DOI 10.1016/S0928-0987(01)00108-7; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; SAMS WM, 1965, J INVEST DERMATOL, V45, P482, DOI 10.1038/jid.1965.162; Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002; Schmelz M, 1997, J NEUROSCI, V17, P8003; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shim WS, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-29; Sowunmi A, 2000, ANN TROP MED PARASIT, V94, P209, DOI 10.1080/00034980050006375; Steinhoff M, 2003, J NEUROSCI, V23, P6176; Sun YG, 2007, NATURE, V448, P700, DOI 10.1038/nature06029; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868; Tanaka M, 2004, J PHARM PHARMACOL, V56, P977, DOI 10.1211/0022357043932; YAMAZAKI M, 1994, BLOOD, V83, P3509; Yang S, 2005, GENE, V352, P30, DOI 10.1016/j.gene.2005.03.001; Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100	49	523	552	3	60	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1353	1365		10.1016/j.cell.2009.11.034	http://dx.doi.org/10.1016/j.cell.2009.11.034			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20004959	Bronze, Green Accepted			2022-12-28	WOS:000273048700022
J	Santos-Lleo, M; Schartel, N; Tananbaum, H; Tucker, W; Weisskopf, MC				Santos-Lleo, Maria; Schartel, Norbert; Tananbaum, Harvey; Tucker, Wallace; Weisskopf, Martin C.			The first decade of science with Chandra and XMM-Newton	NATURE			English	Review							X-RAY-EMISSION; ACTIVE GALACTIC NUCLEI; DARK-MATTER PROFILE; BLACK-HOLE; SUPERNOVA-REMNANT; GASEOUS ATMOSPHERE; GALAXY CLUSTERS; HIGH-RESOLUTION; LINE EMISSION; SNR 1987A	NASA's Chandra X-ray Observatory and the ESA's X-ray Multi-Mirror Mission (XMM-Newton) made their first observations ten years ago. The complementary capabilities of these observatories allow us to make high-resolution images and precisely measure the energy of cosmic X-rays. Less than 50 years after the first detection of an extrasolar X-ray source, these observatories have achieved an increase in sensitivity comparable to going from naked-eye observations to the most powerful optical telescopes over the past 400 years. We highlight some of the many discoveries made by Chandra and XMM-Newton that have transformed twenty-first century astronomy.	[Weisskopf, Martin C.] NASA, George C Marshall Space Flight Ctr, Space Sci Off, Huntsville, AL 35812 USA; [Santos-Lleo, Maria; Schartel, Norbert] European Space Agcy, XMM Newton Sci Operat Ctr, Madrid 28691, Spain; [Tananbaum, Harvey; Tucker, Wallace] Smithsonian Astrophys Observ, Chandra Xray Ctr, Cambridge, MA 02138 USA	National Aeronautics & Space Administration (NASA); NASA Marshall Space Flight Center; European Space Agency; Harvard University; Smithsonian Institution	Weisskopf, MC (corresponding author), NASA, George C Marshall Space Flight Ctr, Space Sci Off, Huntsville, AL 35812 USA.	martin.c.weisskopf@nasa.gov	Santos-Lleo, Maria/GSN-1727-2022	Santos-Lleo, Maria/0000-0001-5948-8360; Schartel, Norbert/0000-0001-5039-0519				Abubekerov MK, 2009, ASTRON REP+, V53, P232, DOI 10.1134/S1063772909030056; Alexander R, 2008, NEW ASTRON REV, V52, P60, DOI 10.1016/j.newar.2008.04.004; Allen SW, 2008, MON NOT R ASTRON SOC, V383, P879, DOI 10.1111/j.1365-2966.2007.12610.x; Anderson ME, 2009, ASTROPHYS J, V698, P317, DOI 10.1088/0004-637X/698/1/317; Baganoff FK, 2001, NATURE, V413, P45, DOI 10.1038/35092510; Bhardwaj A, 2005, ASTROPHYS J, V627, pL73, DOI 10.1086/431933; Bhardwaj A, 2005, ASTROPHYS J, V624, pL121, DOI 10.1086/430521; Bhardwaj A, 2007, PLANET SPACE SCI, V55, P1135, DOI 10.1016/j.pss.2006.11.009; Bhardwaj A, 2007, J ATMOS SOL-TERR PHY, V69, P179, DOI 10.1016/j.jastp.2006.07.011; Bodewits D, 2007, ASTRON ASTROPHYS, V469, P1183, DOI 10.1051/0004-6361:20077410; BOHRINGER H, 1993, MON NOT R ASTRON SOC, V264, pL25; Boyarsky A, 2006, PHYS REV D, V74, DOI 10.1103/PhysRevD.74.103506; Brandt WN, 2005, ANNU REV ASTRON ASTR, V43, P827, DOI 10.1146/annurev.astro.43.051804.102213; Branduardi-Raymont G, 2008, J GEOPHYS RES-SPACE, V113, DOI 10.1029/2007JA012600; Branduardi-Raymont G, 2007, PLANET SPACE SCI, V55, P1126, DOI 10.1016/j.pss.2006.11.017; Brunner H, 2008, ASTRON ASTROPHYS, V479, P283, DOI 10.1051/0004-6361:20077687; Brusa M, 2009, ASTROPHYS J, V693, P8, DOI 10.1088/0004-637X/693/1/8; Butt Y, 2009, NATURE, V460, P701, DOI 10.1038/nature08127; CASTOR J, 1975, ASTROPHYS J, V200, pL107, DOI 10.1086/181908; Cattaneo A, 2009, NATURE, V460, P213, DOI 10.1038/nature08135; Clowe D, 2006, ASTROPHYS J, V648, pL109, DOI 10.1086/508162; de Plaa J, 2007, ASTRON ASTROPHYS, V465, P345, DOI 10.1051/0004-6361:20066382; Dennerl K, 2008, PLANET SPACE SCI, V56, P1414, DOI 10.1016/j.pss.2008.03.008; Dennerl K, 2006, SPACE SCI REV, V126, P403, DOI 10.1007/s11214-006-9028-7; Elsner RF, 2005, ICARUS, V178, P417, DOI 10.1016/j.icarus.2005.06.006; Fabian AC, 2009, NATURE, V459, P540, DOI 10.1038/nature08007; Fabian AC, 2003, MON NOT R ASTRON SOC, V344, pL43, DOI 10.1046/j.1365-8711.2003.06902.x; Favata F, 2005, ASTROPHYS J SUPPL S, V160, P469, DOI 10.1086/432542; Feigelson ED, 2005, ASTROPHYS J SUPPL S, V160, P379, DOI 10.1086/432512; Fiore F, 2009, ASTROPHYS J, V693, P447, DOI 10.1088/0004-637X/693/1/447; Forman W, 2007, ASTROPHYS J, V665, P1057, DOI 10.1086/519480; Gaensler BM, 2006, ANNU REV ASTRON ASTR, V44, P17, DOI 10.1146/annurev.astro.44.051905.092528; Getman KV, 2005, ASTROPHYS J SUPPL S, V160, P319, DOI 10.1086/432092; Gudel M, 2007, ASTRON ASTROPHYS, V468, P353, DOI 10.1051/0004-6361:20065724; Gudel M, 2007, ASTRON ASTROPHYS, V474, pL25, DOI 10.1051/0004-6361:20078143; Gudel M, 2008, SCIENCE, V319, P309, DOI 10.1126/science.1149926; Gudel M, 2009, ASTRON ASTROPHYS REV, V17, P309, DOI 10.1007/s00159-009-0022-4; Harris DE, 2006, ANNU REV ASTRON ASTR, V44, P463, DOI 10.1146/annurev.astro.44.051905.092446; Hasinger G, 2007, ASTROPHYS J SUPPL S, V172, P29, DOI 10.1086/516576; Hasinger G, 2005, ASTRON ASTROPHYS, V441, P417, DOI 10.1051/0004-6361:20042134; Ho WCG, 2009, NATURE, V462, P71, DOI 10.1038/nature08525; Hopkins PF, 2009, ASTROPHYS J, V694, P599, DOI 10.1088/0004-637X/694/1/599; Iwasawa K, 2004, MON NOT R ASTRON SOC, V355, P1073, DOI 10.1111/j.1365-2966.2004.08392.x; Jaasen F, 2001, ASTRON ASTROPHYS, V365, pL1, DOI 10.1051/0004-6361:20000036; Kinkhabwala A, 2002, ASTROPHYS J, V575, P732, DOI 10.1086/341482; Komatsu E, 2009, ASTROPHYS J SUPPL S, V180, P330, DOI 10.1088/0067-0049/180/2/330; Komossa S, 2004, ASTROPHYS J, V603, pL17, DOI 10.1086/382046; Komossa S, 2003, ASTROPHYS J, V582, pL15, DOI 10.1086/346145; Koutroumpa D, 2009, SPACE SCI REV, V143, P217, DOI 10.1007/s11214-008-9381-9; Laming JM, 2006, ASTROPHYS J, V644, P260, DOI 10.1086/503553; Lewis AD, 2003, ASTROPHYS J, V586, P135, DOI 10.1086/367556; Liu JF, 2008, ASTROPHYS J LETT, V679, pL37, DOI 10.1086/588840; Lopez LA, 2009, ASTROPHYS J, V691, P875, DOI 10.1088/0004-637X/691/1/875; Massey R, 2007, NATURE, V445, P286, DOI 10.1038/nature05497; McNamara BR, 2007, ANNU REV ASTRON ASTR, V45, P117, DOI 10.1146/annurev.astro.45.051806.110625; Miller JM, 2007, ANNU REV ASTRON ASTR, V45, P441, DOI 10.1146/annurev.astro.45.051806.110555; Miller JM, 2009, ASTROPHYS J, V697, P900, DOI 10.1088/0004-637X/697/1/900; Ness JU, 2004, ASTRON ASTROPHYS, V418, P337, DOI 10.1051/0004-6361:20035736; Ness JU, 2004, ASTRON ASTROPHYS, V414, pL49, DOI 10.1051/0004-6361:20031761; Peterson JR, 2006, PHYS REP, V427, P1, DOI 10.1016/j.physrep.2005.12.007; Pointecouteau E, 2005, ASTRON ASTROPHYS, V435, P1, DOI 10.1051/0004-6361:20042569; Porquet D, 2003, ASTRON ASTROPHYS, V407, pL17, DOI 10.1051/0004-6361:20030983; Racusin JL, 2009, ASTROPHYS J, V703, P1752, DOI 10.1088/0004-637X/703/2/1752; Ranalli P, 2008, MON NOT R ASTRON SOC, V386, P1464, DOI 10.1111/j.1365-2966.2008.13128.x; Revnivtsev M, 2009, NATURE, V458, P1142, DOI 10.1038/nature07946; Reynolds SP, 2008, ANNU REV ASTRON ASTR, V46, P89, DOI 10.1146/annurev.astro.46.060407.145237; Reynolds SP, 2007, ASTROPHYS J, V668, pL135, DOI 10.1086/522830; Schulz R, 2006, ASTRON ASTROPHYS, V448, pL53, DOI 10.1051/0004-6361:200600003; SHAKESPEARE W, 1914, TEMPEST ACT 2 SCENE; Silverman JD, 2008, ASTROPHYS J, V679, P118, DOI 10.1086/529572; Simionescu A, 2007, ASTRON ASTROPHYS, V465, P749, DOI 10.1051/0004-6361:20066650; Snowden SL, 2009, ASTROPHYS J, V691, P372, DOI 10.1088/0004-637X/691/1/372; Snowden SL, 2004, ASTROPHYS J, V610, P1182, DOI 10.1086/421841; Tsujimoto M, 2005, ASTROPHYS J SUPPL S, V160, P503, DOI 10.1086/432093; Turner TJ, 2009, ASTRON ASTROPHYS REV, V17, P47, DOI [10.1007/s00159-009-0017-1, 10.1007/s00159-009-0017-l]; Vikhlinin A, 2006, ASTROPHYS J, V640, P691, DOI 10.1086/500288; Vikhlinin A, 2009, ASTROPHYS J, V692, P1060, DOI 10.1088/0004-637X/692/2/1060; Vink J, 2006, ESA SPEC PUBL, V604, P319; Wargelin BJ, 2004, ASTROPHYS J, V607, P596, DOI 10.1086/383410; Weisskopf MC, 2006, SPRINGER-PRAX BOOKS, P55, DOI 10.1007/3-540-30313-8_3; Weisskopf MC, 2002, PUBL ASTRON SOC PAC, V114, P1, DOI 10.1086/338108; Weisskopf MC, 2000, ASTROPHYS J, V536, pL81, DOI 10.1086/312733; Wolk SJ, 2005, ASTROPHYS J SUPPL S, V160, P423, DOI 10.1086/432099; Worrall DM, 2009, ASTRON ASTROPHYS REV, V17, P1, DOI 10.1007/s00159-008-0016-7; Yencho B, 2009, ASTROPHYS J, V698, P380, DOI 10.1088/0004-637X/698/1/380; Zappacosta L, 2006, ASTROPHYS J, V650, P777, DOI 10.1086/505739; Zhekov SA, 2006, ASTROPHYS J, V645, P293, DOI 10.1086/504285; Zhekov SA, 2009, ASTROPHYS J, V692, P1190, DOI 10.1088/0004-637X/692/2/1190	90	21	21	2	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					997	1004		10.1038/nature08690	http://dx.doi.org/10.1038/nature08690			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033037	Green Submitted			2022-12-28	WOS:000272996000035
J	Thomas, AM; Nadeau, RM; Burgmann, R				Thomas, Amanda M.; Nadeau, Robert M.; Buergmann, Roland			Tremor-tide correlations and near-lithostatic pore pressure on the deep San Andreas fault	NATURE			English	Article							NON-VOLCANIC TREMOR; EARTH TIDES; NONVOLCANIC TREMOR; EPISODIC TREMOR; SLIP; PARKFIELD; SUBDUCTION	Since its initial discovery nearly a decade ago(1), non-volcanic tremor has provided information about a region of the Earth that was previously thought incapable of generating seismic radiation. A thorough explanation of the geologic process responsible for tremor generation has, however, yet to be determined. Owing to their location at the plate interface, temporal correlation with geodetically measured slow-slip events and dominant shear wave energy, tremor observations in southwest Japan have been interpreted as a superposition of many low-frequency earthquakes that represent slip on a fault surface(2,3). Fluids may also be fundamental to the failure process in subduction zone environments, as teleseismic and tidal modulation of tremor in Cascadia and Japan and high Poisson ratios in both source regions are indicative of pressurized pore fluids(3-7). Here we identify a robust correlation between extremely small, tidally induced shear stress parallel to the San Andreas fault and non-volcanic tremor activity near Parkfield, California. We suggest that this tremor represents shear failure on a critically stressed fault in the presence of near-lithostatic pore pressure. There are a number of similarities between tremor in subduction zone environments, such as Cascadia and Japan, and tremor on the deep San Andreas transform(3-12), suggesting that the results presented here may also be applicable in other tectonic settings.	[Thomas, Amanda M.; Nadeau, Robert M.; Buergmann, Roland] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley Seismol Lab, Berkeley, CA 94720 USA	University of California System; University of California Berkeley	Thomas, AM (corresponding author), Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley Seismol Lab, 307 McCone Hall, Berkeley, CA 94720 USA.	amthomas@berkeley.edu	Burgmann, Roland/AAE-5138-2022; Nadeau, Robert/G-1884-2017	Nadeau, Robert/0000-0003-1255-0643; Burgmann, Roland/0000-0002-3560-044X	National Science Foundation [EAR-0537641, EAR-0544730]; US Geological Survey [06HQGR0167, 07HQAG0014, 08HQGR0100]	National Science Foundation(National Science Foundation (NSF)); US Geological Survey(United States Geological Survey)	We thank D. Agnew, N. Beeler, G. Beroza, F. Bonetto, J. Gomberg, A. Guilhem, R. Nakata, Z. Peng, E. Roeloffs and D. Shelly for discussion and comments that improved the manuscript. Funding was provided in part by the National Science Foundation through a Graduate Research Fellowship and awards EAR-0537641 and EAR-0544730, and by the US Geological Survey through awards 06HQGR0167, 07HQAG0014 and 08HQGR0100. Data used in this study were obtained from the Northern California Earthquake Data Center (NCEDC). This is Berkeley Seismological Laboratory contribution # 10-23.	Agnew DC, 1997, J GEOPHYS RES-SOL EA, V102, P5109, DOI 10.1029/96JB03458; AGNEW DC, 1996, SPOTL SOME PROGRAMS; Audet P, 2009, NATURE, V457, P76, DOI 10.1038/nature07650; Becken M, 2008, GEOPHYS J INT, V173, P718, DOI 10.1111/j.1365-246X.2008.03754.x; Beeler NM, 2003, J GEOPHYS RES-SOL EA, V108, DOI 10.1029/2001JB001518; BLANPIED ML, 1995, J GEOPHYS RES-SOL EA, V100, P13045, DOI 10.1029/95JB00862; Brenguier F, 2008, SCIENCE, V321, P1478, DOI 10.1126/science.1160943; Cochran ES, 2004, SCIENCE, V306, P1164, DOI 10.1126/science.1103961; DEVORE JL, 2004, PROBABILITY STAT ENG, pCH14; DIETERICH JH, 1987, TECTONOPHYSICS, V144, P127, DOI 10.1016/0040-1951(87)90012-6; Gomberg J, 2008, SCIENCE, V319, P173, DOI 10.1126/science.1149164; Hart RHG, 1996, J GEOPHYS RES-SOL EA, V101, P25553, DOI 10.1029/96JB02273; Ide S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028890; Lambert A, 2009, J GEOPHYS RES-SOL EA, V114, DOI 10.1029/2008JB006038; Lockner DA, 1999, J GEOPHYS RES-SOL EA, V104, P20133, DOI 10.1029/1999JB900205; Nadeau RM, 2005, SCIENCE, V307, P389, DOI 10.1126/science.1107142; Nadeau RM, 2004, SCIENCE, V303, P220, DOI 10.1126/science.1090353; Nadeau RM, 2009, SCIENCE, V325, P191, DOI 10.1126/science.1174155; Nakata R, 2008, NAT GEOSCI, V1, P676, DOI 10.1038/ngeo288; Obara K, 2002, SCIENCE, V296, P1679, DOI 10.1126/science.1070378; Rogers G, 2003, SCIENCE, V300, P1942, DOI 10.1126/science.1084783; Rubinstein JL, 2008, SCIENCE, V319, P186, DOI 10.1126/science.1150558; Rubinstein JL, 2007, NATURE, V448, P579, DOI 10.1038/nature06017; Shelly DR, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2007GC001640; Shelly DR, 2007, NATURE, V446, P305, DOI 10.1038/nature05666; Shelly DR, 2006, NATURE, V442, P188, DOI 10.1038/nature04931; Shelly DR, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036367; Vidale JE, 1998, J GEOPHYS RES-SOL EA, V103, P24567, DOI 10.1029/98JB00594	28	165	166	3	39	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1048	U105		10.1038/nature08654	http://dx.doi.org/10.1038/nature08654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033046				2022-12-28	WOS:000272996000045
J	Mitchell, TM				Mitchell, Tom M.			Mining Our Reality	SCIENCE			English	Editorial Material									Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA	Carnegie Mellon University	Mitchell, TM (corresponding author), Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA.	tom.mitchell@cs.cmu.edu						Aggarwal CC, 2008, ADV DATABASE SYST, V34, P1, DOI 10.1007/978-0-387-70992-5; Ginsberg J, 2009, NATURE, V457, P1012, DOI 10.1038/nature07634; Lazer D, 2009, SCIENCE, V323, P721, DOI 10.1126/science.1167742; Leskovec J, 2007, KDD-2007 PROCEEDINGS OF THE THIRTEENTH ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P420; Lindell Y., 2008, J PRIVACY CONFIDENT, V2008, P197, DOI DOI 10.29012/JPC.V1I1.566; Pentland A, 2008, MIT SLOAN MANAGE REV, V50, P70; Schmidt M, 2009, SCIENCE, V324, P81, DOI 10.1126/science.1165893; Vespignani A, 2009, SCIENCE, V325, P425, DOI 10.1126/science.1171990; Waltz D, 2009, SCIENCE, V324, P43, DOI 10.1126/science.1172781	9	46	52	2	31	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1644	1645		10.1126/science.1174459	http://dx.doi.org/10.1126/science.1174459			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	20019279				2022-12-28	WOS:000272839000042
J	Castellani, C; Picci, L; Tamanini, A; Girardi, P; Rizzotti, P; Assael, BM				Castellani, Carlo; Picci, Luigi; Tamanini, Anna; Girardi, Paolo; Rizzotti, Paolo; Assael, Baroukh Maurice			Association Between Carrier Screening and Incidence of Cystic Fibrosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							REPRODUCTIVE-BEHAVIOR; DIAGNOSIS; CONSENSUS; POPULATION; COHORT; MODEL; GENE	Context A downward trend in cystic fibrosis (CF) birth incidence has been reported in some areas. Objective To evaluate the association between carrier screening and CF birth incidence. Design, Setting, and Participants In northeastern Italy, CF birth incidence is monitored by means of a long-standing neonatal screening program. In the same area, 2 sections using different carrier detection approaches were identified-the western region, in which CF carrier tests are offered only to relatives of patients or to couples planning in vitro fertilization; and the eastern region, in which carrier testing is offered to relatives and carrier screening to infertile couples and to couples of reproductive age. A total of 779 631 newborns underwent CF neonatal screening between January 1993 and December 2007, of whom 195 had CF detected. Main Outcome Measure Cystic fibrosis birth incidence in the 2 regions. Results A time-related decrease in birth incidence was found, with a mean annual percentage decrease of 0.16 per 10 000 neonates (P < .001). In the western region, 2559 carrier tests were performed, 314 carriers were identified, and 9 carrier couples were detected. In the eastern region, 87 025 carrier tests were performed, 3650 carriers were identified, and 82 carrier couples were detected. The birth rate decrease was greater in the eastern region (decrease rate, 0.24; 95% confidence interval [CI], 0.12-0.36) than in the western region (decrease rate, 0.04; 95% CI, -0.16 to 0.08; P = .01). The increase in the number of screened carriers over time was significantly correlated with the decrease in CF birth incidence (correlation coefficient=-0.53; 95% CI, -0.20 to -0.74; P = .003). Conclusion In northeastern Italy, carrier screening was associated with a decrease in the incidence of CF. JAMA. 2009;302(23):2573-2579	[Castellani, Carlo; Assael, Baroukh Maurice] Verona Hosp, Cyst Fibrosis Ctr, I-37126 Verona, Italy; [Tamanini, Anna; Rizzotti, Paolo] Verona Hosp, Clin Chem & Hematol Lab, I-37126 Verona, Italy; [Picci, Luigi] Univ Padua, Dept Pediat, Padua, Italy; [Girardi, Paolo] Univ Verona, Dept Med & Publ Hlth, Unit Epidemiol & Med Stat, I-37100 Verona, Italy	University of Padua; University of Verona	Castellani, C (corresponding author), Verona Hosp, Cyst Fibrosis Ctr, Piazzale Stefani 1, I-37126 Verona, Italy.	carlo.castellani@azosp.vr.it	Tamanini, Anna/AAC-3510-2022; Castellani, Carlo/AAB-3847-2019	Tamanini, Anna/0000-0002-7427-0981; girardi, Paolo/0000-0001-8330-9414				Berwouts S, 2008, HUM MUTAT, V29, P1063, DOI 10.1002/humu.20764; BORGO G, 1992, PRENATAL DIAG, V12, P821, DOI 10.1002/pd.1970121008; Borgo G, 1999, Community Genet, V2, P82, DOI 10.1159/000016191; Cao A, 2002, OBSTET GYN CLIN N AM, V29, P305, DOI 10.1016/S0889-8545(01)00006-7; Castellani C, 1997, ACTA PAEDIATR, V86, P497, DOI 10.1111/j.1651-2227.1997.tb08920.x; Castellani C, 2008, J CYST FIBROS, V7, P179, DOI 10.1016/j.jcf.2008.03.009; Castellani C, 2009, J CYST FIBROS, V8, P153, DOI 10.1016/j.jcf.2009.01.004; Cunningham S, 1998, ARCH DIS CHILD, V78, P345, DOI 10.1136/adc.78.4.345; Dudding T, 2000, ARCH DIS CHILD-FETAL, V82, pF124, DOI 10.1136/fn.82.2.F124; Dupuis A, 2005, J PEDIATR-US, V147, P312, DOI 10.1016/j.jpeds.2005.06.043; Farrell PM, 2008, J PEDIATR-US, V153, pS4, DOI 10.1016/j.jpeds.2008.05.005; GREEN MR, 1993, ARCH DIS CHILD, V68, P464, DOI 10.1136/adc.68.4.464; Grody WW, 2001, GENET MED, V3, P87, DOI 10.1097/00125817-200103000-00001; Hale JE, 2008, NEW ENGL J MED, V358, P973, DOI 10.1056/NEJMc0707530; HEELEY ME, 1991, PEDIATR PULM, P72; Howell RR, 1999, ARCH INTERN MED, V159, P1529; Kaback MM, 2000, EUR J PEDIATR, V159, pS192, DOI 10.1007/PL00014401; Mayell SJ, 2009, J CYST FIBROS, V8, P71, DOI 10.1016/j.jcf.2008.09.005; MENNIE ME, 1992, LANCET, V340, P214, DOI 10.1016/0140-6736(92)90476-J; Mischler EH, 1998, PEDIATRICS, V102, P44, DOI 10.1542/peds.102.1.44; Morea A, 2005, MOL HUM REPROD, V11, P607, DOI 10.1093/molehr/gah214; Polnay JC, 2002, ARCH DIS CHILD, V87, P284, DOI 10.1136/adc.87.4.284; RIORDAN JR, 1989, SCIENCE, V245, P1066; Scotet V, 2008, J PEDIATR, V152, P25, DOI 10.1016/j.jpeds.2007.07.046; Slieker MG, 2005, CHEST, V128, P2309, DOI 10.1378/chest.128.4.2309; SONTAG MK, 2008, PED PULMONOL S, V31, P272; Southern KW, 2007, J CYST FIBROS, V6, P57, DOI 10.1016/j.jcf.2006.05.008; Watson Michael S, 2004, Genet Med, V6, P387, DOI 10.1097/01.GIM.0000139506.11694.7C	28	63	65	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	2009	302	23					2573	2579		10.1001/jama.2009.1758	http://dx.doi.org/10.1001/jama.2009.1758			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532HK	20009057	Green Published			2022-12-28	WOS:000272737200025
J	Greenfield, S; Billimek, J; Pellegrini, F; Franciosi, M; De Berardis, G; Nicolucci, A; Kaplan, SH				Greenfield, Sheldon; Billimek, John; Pellegrini, Fabio; Franciosi, Monica; De Berardis, Giorgia; Nicolucci, Antonio; Kaplan, Sherrie H.			Comorbidity Affects the Relationship Between Glycemic Control and Cardiovascular Outcomes in Diabetes A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							INTENSIVE GLUCOSE CONTROL; ILLNESS BURDEN INDEX; QUED STUDY-GROUP; METABOLIC CONTROL; AMERICAN-COLLEGE; TYPE-2; DISEASE; QUALITY; STATEMENT; MELLITUS	Background: Recent studies have shown mixed results regarding the effectiveness of intensive glucose-lowering therapy in reducing risk for cardiovascular events. Objective: To determine whether attaining hemoglobin A(1c) (HbA(1c)) targets of 6.5% or less or 7.0% or less for glycemic control at baseline provides differential benefits for patients with high versus low-to-moderate levels of comorbidity. Design: 5-year longitudinal observational study of patients with type 2 diabetes. Patients were categorized into high and low-to-moderate comorbidity subgroups by using the Total Illness Burden Index (TIBI), a validated patient-reported measure of comorbidity. Setting: 101 diabetes outpatient clinics and 103 general practitioners' clinics in Italy. Patients: 2613 (83%) of 3074 patients with type 2 diabetes, sampled randomly from diabetes outpatient clinic rosters and recruited consecutively from general practitioners' clinics, who completed the baseline questionnaire. Measurements: TIBI score, total mortality, and incident cardiovascular events. Hazard ratios (HRs) were adjusted for age and sex. Results: Attaining an HbA(1c) level of 6.5% or less at baseline was associated with lower 5-year incidence of cardiovascular events in the low-to-moderate comorbidity subgroup (adjusted HR, 0.60 [95% CI, 0.42 to 0.85]; P = 0.005) but not in the high comorbidity subgroup (adjusted HR, 0.92 [CI, 0.68 to 1.25]; P = 0.61; P for subgroup by HbA(1c) interaction = 0.048). Similarly, attaining a baseline HbA(1c) level of 7.0% predicted fewer cardiovascular events in the low-to-moderate comorbidity subgroup (adjusted HR, 0.61 (CI, 0.44 to 0.83; P = 0.001) but not in the high comorbidity subgroup (adjusted HR, 0.88 [CI, 0.66 to 1.17]; P = 0.38; P for subgroup by HbA(1c) interaction = 0.093). Limitations: The observational nature of the study does not allow causal inference. The length of the data collection period was limited. Information on clinical management was not available. Conclusion: Patients with the high levels of comorbidity common in type 2 diabetes may receive diminished cardiovascular benefit from intensive blood glucose control. Comorbidity should be considered when tailoring glucose-lowering therapy in patients with type 2 diabetes.	Univ Calif Irvine, Irvine, CA USA; Ist Ric Farmacol Mario Negri, Consorzio Mario Negri Sud, I-66030 Santa Maria Imbaro, Italy	University of California System; University of California Irvine; Consorzio Mario Negri Sud; Istituto di Ricerche Farmacologiche Mario Negri IRCCS	Greenfield, S (corresponding author), Hlth Policy Res Inst, 100 Theory,Suite 110, Irvine, CA 92697 USA.	sgreenfi@uci.edu		Kaplan, Sherrie/0000-0002-8644-5849; Greenfield, Sheldon/0000-0003-4628-1998	Pfizer of Italy	Pfizer of Italy	Primary Funding Source: Pfizer of Italy.	Amer Diabet Assoc, 2008, DIABETES CARE, V31, pS12, DOI 10.2337/dc08-S012; Belfiglio M, 2001, DIABETES CARE, V24, P423, DOI 10.2337/diacare.24.3.423; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Corser W, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-85; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Franciosi M, 2001, DIABETES CARE, V24, P1870, DOI 10.2337/diacare.24.11.1870; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; GREENFIELD S, 1995, MED CARE, V33, pAS47; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Huang ES, 2008, ANN INTERN MED, V149, P11, DOI 10.7326/0003-4819-149-1-200807010-00005; Kelly TN, 2009, ANN INTERN MED, V151, P394, DOI 10.7326/0003-4819-151-6-200909150-00137; Lee TA, 2008, ANN INTERN MED, V149, P380, DOI 10.7326/0003-4819-149-6-200809160-00004; Litwin MS, 2007, CANCER-AM CANCER SOC, V109, P1777, DOI 10.1002/cncr.22615; Montori VM, 2009, ANN INTERN MED, V150, P803, DOI 10.7326/0003-4819-150-11-200906020-00008; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Pellegrini F, 2003, ARCH INTERN MED, V163, P473, DOI 10.1001/archinte.163.4.473; Qaseern A, 2007, ANN INTERN MED, V147, P417, DOI 10.7326/0003-4819-147-6-200709180-00012; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; Singh S, 2008, JAMA-J AM MED ASSOC, V300, P1439, DOI 10.1001/jama.300.12.1439; Skyler JS, 2009, DIABETES CARE, V32, P187, DOI 10.2337/dc08-9026; Stier DM, 1999, UROLOGY, V54, P424, DOI 10.1016/S0090-4295(99)00203-4; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6	22	124	132	0	9	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2009	151	12					854	U4		10.7326/0003-4819-151-12-200912150-00005	http://dx.doi.org/10.7326/0003-4819-151-12-200912150-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532ET	20008761				2022-12-28	WOS:000272728900003
J	Louicharoen, C; Patin, E; Paul, R; Nuchprayoon, I; Witoonpanich, B; Peerapittayamongkol, C; Casademont, I; Sura, T; Laird, NM; Singhasivanon, P; Quintana-Murci, L; Sakuntabhai, A				Louicharoen, Chalisa; Patin, Etienne; Paul, Richard; Nuchprayoon, Issarang; Witoonpanich, Bhee; Peerapittayamongkol, Chayanon; Casademont, Isabelle; Sura, Thanyachai; Laird, Nan M.; Singhasivanon, Pratap; Quintana-Murci, Lluis; Sakuntabhai, Anavaj			Positively Selected G6PD-Mahidol Mutation Reduces Plasmodium vivax Density in Southeast Asians	SCIENCE			English	Article							HUMAN-POPULATIONS; KAREN POPULATION; HUMAN GENOME; MALARIA; FALCIPARUM; DEFICIENCY; RESISTANCE; THAILAND; ORIGIN; G6PD	Glucose-6-phosphate dehydrogenase (G6PD) deficiency-the most common known enzymopathy-is associated with neonatal jaundice and hemolytic anemia usually after exposure to certain infections, foods, or medications. Although G6PD-deficient alleles appear to confer a protective effect against malaria, the link with clinical protection from Plasmodium infection remains unclear. We investigated the effect of a common G6PD deficiency variant in Southeast Asia-the G6PD-Mahidol(487A) variant-on human survival related to vivax and falciparum malaria. Our results show that strong and recent positive selection has targeted the Mahidol variant over the past 1500 years. We found that the G6PD-Mahidol(487A) variant reduces vivax, but not falciparum, parasite density in humans, which indicates that Plasmodium vivax has been a driving force behind the strong selective advantage conferred by this mutation.	[Patin, Etienne; Quintana-Murci, Lluis] Inst Pasteur, CNRS, URA3012, Human Evolutionary Genet Unit, F-75015 Paris, France; [Louicharoen, Chalisa; Paul, Richard; Witoonpanich, Bhee; Peerapittayamongkol, Chayanon; Casademont, Isabelle; Sakuntabhai, Anavaj] Inst Pasteur, Lab Genet Reponse Infect Chez Homme, F-75724 Paris, France; [Louicharoen, Chalisa] Chulalongkorn Univ, Fac Grad Sch, Interdept Program Biomed Sci, Bangkok, Thailand; [Nuchprayoon, Issarang] Chulalongkorn Univ, Fac Med, Dept Pediat, Bangkok 10330, Thailand; [Sura, Thanyachai; Sakuntabhai, Anavaj] Mahidol Univ, Ramathibodi Hosp, Fac Med, Dept Med, Bangkok 10400, Thailand; [Laird, Nan M.] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Singhasivanon, Pratap] Mahidol Univ, Fac Trop Med, Dept Trop Hyg, Bangkok, Thailand	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Chulalongkorn University; Chulalongkorn University; Mahidol University; Harvard University; Harvard T.H. Chan School of Public Health; Mahidol University	Quintana-Murci, L (corresponding author), Inst Pasteur, CNRS, URA3012, Human Evolutionary Genet Unit, F-75015 Paris, France.	lluis.quintana-murci@pasteur.fr; anavaj.sakuntabhai@pasteur.fr	Peerapittayamongkol, Chayanon/B-4920-2010; Patin, Etienne/G-6768-2012; Quintana-Murci, Lluis/AAB-7468-2022; Peerapittayamongkol, Chayanon/K-7965-2019	Quintana-Murci, Lluis/0000-0003-2429-6320; Paul, Richard/0000-0002-0665-5089; Patin, Etienne/0000-0002-9911-4459; Singhasivanon, Pratap/0000-0002-9759-1702; Nuchprayoon, Issarang/0000-0002-4014-5082	BIOTEC [BT-B06-MG-14-4507]; Thailand Research Fund [BRG/16/2544]; Mahidol University [OR-9123]; Institut Pasteur program [PTR202]; CNRS; Agence Nationale de la Recherche (ANR) [ANR-05-JCJC-0124-01]; Gates Grand Challenge program; Wellcome Trust; U. K. Medical Research Council; Royal Golden Jubilee Program; French Embassy in Thailand; French Medical Research Foundation (FRM); Medical Scholar Program; Mahidol University	BIOTEC; Thailand Research Fund(Thailand Research Fund (TRF)); Mahidol University; Institut Pasteur program; CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche (ANR)(French National Research Agency (ANR)); Gates Grand Challenge program; Wellcome Trust(Wellcome Trust); U. K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Golden Jubilee Program; French Embassy in Thailand; French Medical Research Foundation (FRM)(Fondation pour la Recherche Medicale); Medical Scholar Program; Mahidol University	We thank all study participants and their families, and the staff of the Rajanagarindra Tropical Diseases International Center, Faculty of Tropical Medicine, Bangkok, who helped in data collection. We also thank O. Mercereau-Puijalon and L. Abel for critical comments on the manuscript, and P. Sabeti and I. Schlyakhter for providing a command-line version of Sweep. This work was funded in part by Thailand's biotechnology funding agency BIOTEC (BT-B06-MG-14-4507), the Thailand Research Fund (BRG/16/2544), and Mahidol University (OR-9123) to A. S.; by the Institut Pasteur program PTR202 to L. Q.-M. and A. S.; and by the CNRS and an Agence Nationale de la Recherche (ANR) grant (ANR-05-JCJC-0124-01) to L. Q.-M. This work is part of the MalariaGEN Consortium supported by the Gates Grand Challenge program, the Wellcome Trust, and the U. K. Medical Research Council. C. L. was supported by the Royal Golden Jubilee Program, the Thailand Research Fund, and the French Embassy in Thailand; E. P. by the French Medical Research Foundation (FRM); and B. W. by the Medical Scholar Program, Mahidol University, and the French Embassy in Thailand.	ALLISON AC, 1956, ANN HUM GENET, V21, P67, DOI 10.1111/j.1469-1809.1971.tb00266.x; Austerlitz F, 2003, GENETICS, V165, P1579; Besaggio D, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S12; BEUTLER E, 1994, BLOOD, V84, P3613, DOI 10.1182/blood.V84.11.3613.bloodjournal84113613; Carter R, 2003, TRENDS PARASITOL, V19, P214, DOI 10.1016/S1471-4922(03)00070-9; Carter R, 2002, CLIN MICROBIOL REV, V15, P564, DOI 10.1128/CMR.15.4.564-594.2002; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Enattah NS, 2008, AM J HUM GENET, V82, P57, DOI 10.1016/j.ajhg.2007.09.012; Escalante AA, 2005, P NATL ACAD SCI USA, V102, P1980, DOI 10.1073/pnas.0409652102; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Garnham PCC., 1966, MALARIA PARASITES OT; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; Huang YX, 2008, MOL GENET METAB, V93, P44, DOI 10.1016/j.ymgme.2007.08.122; Hume JCC, 2003, TRENDS PARASITOL, V19, P144, DOI 10.1016/S1471-4922(03)00008-4; Joy DA, 2003, SCIENCE, V300, P318, DOI 10.1126/science.1081449; Kwiatkowski DP, 2005, AM J HUM GENET, V77, P171, DOI 10.1086/432519; MARTIN SK, 1979, LANCET, V1, P524; Nosten F, 1999, LANCET, V354, P546, DOI 10.1016/S0140-6736(98)09247-2; Nuchprayoon I, 2008, J HUM GENET, V53, P48, DOI 10.1007/s10038-007-0217-3; PANICH V, 1972, Journal of the Medical Association of Thailand, V55, P576; Phimpraphi W, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-99; Phimpraphi W, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003887; POWELL RD, 1965, AM J TROP MED HYG, V14, P358, DOI 10.4269/ajtmh.1965.14.358; Prchal Josef T, 2005, Hematology Am Soc Hematol Educ Program, P19, DOI 10.1182/asheducation-2005.1.19; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Saunders MA, 2002, GENETICS, V162, P1849; Schliekelman P, 2001, NATURE, V411, P545, DOI 10.1038/35079176; Slatkin M, 2008, GENET RES, V90, P129, DOI 10.1017/S0016672307008944; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; Williams TN, 1997, QJM-INT J MED, V90, P751; Wood ET, 2005, AM J HUM GENET, V77, P637, DOI 10.1086/491748	32	128	131	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1546	1549		10.1126/science.1178849	http://dx.doi.org/10.1126/science.1178849			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007901				2022-12-28	WOS:000272623600060
J	Schmitt, HD; Jahn, R				Schmitt, Hans Dieter; Jahn, Reinhard			A Tethering Complex Recruits SNAREs and Grabs Vesicles	CELL			English	Editorial Material							MEMBRANE; ARCHITECTURE	Protein tethers can bridge gaps between membranes. Ren et al. (2009) now provide evidence that the yeast Dsl1 complex tethers vesicles to the endoplasmic reticulum (ER) by binding ER SNARE proteins at its base and capturing vesicles using a loop region that extends 20 nm from the ER membrane.	[Schmitt, Hans Dieter; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany	Max Planck Society	Jahn, R (corresponding author), Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.	rjahn@gwdg.de		Jahn, Reinhard/0000-0003-1542-3498				Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Cai YY, 2008, CELL, V133, P1202, DOI 10.1016/j.cell.2008.04.049; Famulski JK, 2008, J CELL BIOL, V180, P507, DOI 10.1083/jcb.200708021; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Hirose H, 2004, EMBO J, V23, P1267, DOI 10.1038/sj.emboj.7600135; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Levine T, 2006, CURR OPIN CELL BIOL, V18, P371, DOI 10.1016/j.ceb.2006.06.011; Sacher M, 2008, TRAFFIC, V9, P2032, DOI 10.1111/j.1600-0854.2008.00833.x; Zink S, 2009, DEV CELL, V17, P403, DOI 10.1016/j.devcel.2009.07.012	9	6	6	0	4	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1053	1055		10.1016/j.cell.2009.11.041	http://dx.doi.org/10.1016/j.cell.2009.11.041			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005800	Bronze, Green Published			2022-12-28	WOS:000272622800008
J	Cohen, D				Cohen, Deborah			Complications: tracking down the data on oseltamivir	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL; HEALTHY-ADULTS; NEURAMINIDASE INHIBITORS; ACUTE INFLUENZA; METAANALYSIS; EFFICACY; SAFETY; ROCHE					dcohen@bmj.com						*DEP HLTH, US ANT DRUGS INFL PA; DONALDSON L, 2006, J ROY SOC MED, V99; Freemantle N, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5248; Graf C, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b4330; Hama R., 2005, SESS JAP SOC PED INF; Hayden Frederick G, 2004, Pediatr Infect Dis J, V23, pS262, DOI 10.1097/01.inf.0000144680.39895.ce; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jefferson T, 2006, LANCET, V367, P303, DOI 10.1016/S0140-6736(06)67970-1; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; Kashiwagi S, 2000, Kansenshogaku Zasshi, V74, P1044; Li LY, 2003, CHINESE MED J-PEKING, V116, P44; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; Shun-Shin M, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3172; Smith J, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5364; Smith J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b5374; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Treanor JohnJ., 2000, 38 ANN M INF DIS SOC; 2008, HOFFMAN LA ROCHE PRO	19	37	38	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2009	339								b5387	10.1136/bmj.b5387	http://dx.doi.org/10.1136/bmj.b5387			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531VE	19995818				2022-12-28	WOS:000272697300014
J	Gnant, M; Steger, GG				Gnant, Michael; Steger, Guenther G.			Fighting overtreatment in adjuvant breast cancer therapy	LANCET			English	Editorial Material									[Gnant, Michael; Steger, Guenther G.] Med Univ Vienna, A-1090 Vienna, Austria	Medical University of Vienna	Gnant, M (corresponding author), Med Univ Vienna, A-1090 Vienna, Austria.	michael.gnant@meduniwien.ac.at	Gnant, Michael/AAN-7054-2020	Gnant, Michael/0000-0003-1002-2118				Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Albain KS, 2009, LANCET, V374, P2055, DOI 10.1016/S0140-6736(09)61523-3; Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; Coleman Robert, 2009, Curr Opin Support Palliat Care, V3, P213, DOI 10.1097/SPC.0b013e32832f4149; Del Mastro L, 2008, ANN ONCOL, V19, P299, DOI 10.1093/annonc/mdm475; Dodwell D, 2009, LANCET ONCOL, V10, P738, DOI 10.1016/S1470-2045(09)70203-7; Gnant M, 2009, NEW ENGL J MED, V360, P679, DOI 10.1056/NEJMoa0806285; Goldhirsch A, 2009, ANN ONCOL, V20, P1319, DOI 10.1093/annonc/mdp322; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289	9	29	29	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2029	2030		10.1016/S0140-6736(09)62097-3	http://dx.doi.org/10.1016/S0140-6736(09)62097-3			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	537OO	20004965				2022-12-28	WOS:000273122900004
J	Abdo, AA; Ackermann, M; Ajello, M; Baldini, L; Ballet, J; Barbiellini, G; Baring, MG; Bastieri, D; Baughman, BM; Bechtol, K; Bellazzini, R; Berenji, B; Blandford, RD; Bloom, ED; Bonamente, E; Borgland, AW; Bregeon, J; Brez, A; Brigida, M; Bruel, P; Burnett, TH; Buson, S; Caliandro, GA; Cameron, RA; Caraveo, PA; Casandjian, JM; Cecchi, C; Celik, O; Chekhtman, A; Cheung, CC; Chiang, J; Ciprini, S; Claus, R; Cognard, I; Cohen-Tanugi, J; Cominsky, LR; Conrad, J; Cutini, S; Dermer, CD; de Angelis, A; de Palma, F; Digel, SW; Silva, EDE; Drell, PS; Dubois, R; Dumora, D; Espinoza, C; Farnier, C; Favuzzi, C; Fegan, SJ; Focke, WB; Fortin, P; Frailis, M; Fukazawa, Y; Funk, S; Fusco, P; Gargano, F; Gasparrini, D; Gehrels, N; Germani, S; Giavitto, G; Giebels, B; Giglietto, N; Giordano, F; Glanzman, T; Godfrey, G; Grenier, IA; Grondin, MH; Grove, JE; Guillemot, L; Guiriec, S; Hanabata, Y; Harding, AK; Hayashida, M; Hays, E; Hughes, RE; Jackson, MS; Johannesson, G; Johnson, AS; Johnson, TJ; Johnson, WN; Kamae, T; Katagiri, H; Kataoka, J; Katsuta, J; Kawai, N; Kerr, M; Knodlseder, J; Kocian, ML; Kramer, M; Kuss, M; Lande, J; Latronico, L; Lemoine-Goumard, M; Longo, F; Loparco, F; Lott, B; Lovellette, MN; Lubrano, P; Lyne, AG; Madejski, GM; Makeev, A; Mazziotta, MN; McEnery, JE; Meurer, C; Michelson, PF; Mitthumsiri, W; Mizuno, T; Monte, C; Monzani, ME; Morselli, A; Moskalenko, IV; Murgia, S; Nakamori, T; Nolan, PL; Norris, JP; Noutsos, A; Nuss, E; Ohsugi, T; Omodei, N; Orlando, E; Ormes, JF; Paneque, D; Parent, D; Pelassa, V; Pepe, M; Pesce-Rollins, M; Piron, F; Porter, TA; Raino, S; Rando, R; Razzano, M; Reimer, A; Reimer, O; Reposeur, T; Rochester, LS; Rodriguez, AY; Romani, RW; Roth, M; Ryde, F; Sadrozinski, HFW; Sanchez, D; Sander, A; Parkinson, PMS; Scargle, JD; Sgro, C; Siskind, EJ; Smith, DA; Smith, PD; Spandre, G; Spinelli, P; Stappers, BW; Stecker, FW; Strickman, MS; Suson, DJ; Tajima, H; Takahashi, H; Takahashi, T; Tanaka, T; Thayer, JB; Thayer, JG; Theureau, G; Thompson, DJ; Tibaldo, L; Tibolla, O; Torres, DF; Tosti, G; Tramacere, A; Uchiyama, Y; Usher, TL; Vasileiou, V; Venter, C; Vilchez, N; Vitale, V; Waite, AP; Wang, P; Winer, BL; Wood, KS; Yamazaki, R; Ylinen, T; Ziegler, M				Abdo, A. A.; Ackermann, M.; Ajello, M.; Baldini, L.; Ballet, J.; Barbiellini, G.; Baring, M. G.; Bastieri, D.; Baughman, B. M.; Bechtol, K.; Bellazzini, R.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Bonamente, E.; Borgland, A. W.; Bregeon, J.; Brez, A.; Brigida, M.; Bruel, P.; Burnett, T. H.; Buson, S.; Caliandro, G. A.; Cameron, R. A.; Caraveo, P. A.; Casandjian, J. M.; Cecchi, C.; Celik, Oe.; Chekhtman, A.; Cheung, C. C.; Chiang, J.; Ciprini, S.; Claus, R.; Cognard, I.; Cohen-Tanugi, J.; Cominsky, L. R.; Conrad, J.; Cutini, S.; Dermer, C. D.; de Angelis, A.; de Palma, F.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Dumora, D.; Espinoza, C.; Farnier, C.; Favuzzi, C.; Fegan, S. J.; Focke, W. B.; Fortin, P.; Frailis, M.; Fukazawa, Y.; Funk, S.; Fusco, P.; Gargano, F.; Gasparrini, D.; Gehrels, N.; Germani, S.; Giavitto, G.; Giebels, B.; Giglietto, N.; Giordano, F.; Glanzman, T.; Godfrey, G.; Grenier, I. A.; Grondin, M. -H.; Grove, J. E.; Guillemot, L.; Guiriec, S.; Hanabata, Y.; Harding, A. K.; Hayashida, M.; Hays, E.; Hughes, R. E.; Jackson, M. S.; Johannesson, G.; Johnson, A. S.; Johnson, T. J.; Johnson, W. N.; Kamae, T.; Katagiri, H.; Kataoka, J.; Katsuta, J.; Kawai, N.; Kerr, M.; Knoedlseder, J.; Kocian, M. L.; Kramer, M.; Kuss, M.; Lande, J.; Latronico, L.; Lemoine-Goumard, M.; Longo, F.; Loparco, F.; Lott, B.; Lovellette, M. N.; Lubrano, P.; Lyne, A. G.; Madejski, G. M.; Makeev, A.; Mazziotta, M. N.; McEnery, J. E.; Meurer, C.; Michelson, P. F.; Mitthumsiri, W.; Mizuno, T.; Monte, C.; Monzani, M. E.; Morselli, A.; Moskalenko, I. V.; Murgia, S.; Nakamori, T.; Nolan, P. L.; Norris, J. P.; Noutsos, A.; Nuss, E.; Ohsugi, T.; Omodei, N.; Orlando, E.; Ormes, J. F.; Paneque, D.; Parent, D.; Pelassa, V.; Pepe, M.; Pesce-Rollins, M.; Piron, F.; Porter, T. A.; Raino, S.; Rando, R.; Razzano, M.; Reimer, A.; Reimer, O.; Reposeur, T.; Rochester, L. S.; Rodriguez, A. Y.; Romani, R. W.; Roth, M.; Ryde, F.; Sadrozinski, H. F. -W.; Sanchez, D.; Sander, A.; Parkinson, P. M. Saz; Scargle, J. D.; Sgro, C.; Siskind, E. J.; Smith, D. A.; Smith, P. D.; Spandre, G.; Spinelli, P.; Stappers, B. W.; Stecker, F. W.; Strickman, M. S.; Suson, D. J.; Tajima, H.; Takahashi, H.; Takahashi, T.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Theureau, G.; Thompson, D. J.; Tibaldo, L.; Tibolla, O.; Torres, D. F.; Tosti, G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Vasileiou, V.; Venter, C.; Vilchez, N.; Vitale, V.; Waite, A. P.; Wang, P.; Winer, B. L.; Wood, K. S.; Yamazaki, R.; Ylinen, T.; Ziegler, M.			Gamma-Ray Emission from the Shell of Supernova Remnant W44 Revealed by the Fermi LAT	SCIENCE			English	Article							SHOCKED MOLECULAR GAS; PULSAR WIND NEBULA; VERY-HIGH-ENERGY; PARTICLE-ACCELERATION; STREAMING INSTABILITY; WAVE DISSIPATION; RX J1713.7-3946; AREA TELESCOPE; GALACTIC PLANE; COSMIC-RAYS	Recent observations of supernova remnants (SNRs) hint that they accelerate cosmic rays to energies close to similar to 10(15) electron volts. However, the nature of the particles that produce the emission remains ambiguous. We report observations of SNR W44 with the Fermi Large Area Telescope at energies between 2 x 10(8) electron volts and 3 x 10(11) electron volts. The detection of a source with a morphology corresponding to the SNR shell implies that the emission is produced by particles accelerated there. The gamma-ray spectrum is well modeled with emission from protons and nuclei. Its steepening above similar to 10(9) electron volts provides a probe with which to study how particle acceleration responds to environmental effects such as shock propagation in dense clouds and how accelerated particles are released into interstellar space.	[Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Cameron, R. A.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kocian, M. L.; Lande, J.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Murgia, S.; Nolan, P. L.; Reimer, A.; Reimer, O.; Rochester, L. S.; Romani, R. W.; Tajima, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Waite, A. P.; Wang, P.] Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA; [Abdo, A. A.; Chekhtman, A.; Dermer, C. D.; Grove, J. E.; Johnson, W. N.; Lovellette, M. N.; Makeev, A.; Strickman, M. S.; Wood, K. S.] USN, Res Lab, Div Space Sci, Washington, DC 20375 USA; [Ackermann, M.; Ajello, M.; Bechtol, K.; Berenji, B.; Blandford, R. D.; Bloom, E. D.; Borgland, A. W.; Cameron, R. A.; Chiang, J.; Claus, R.; Digel, S. W.; do Couto e Silva, E.; Drell, P. S.; Dubois, R.; Focke, W. B.; Funk, S.; Glanzman, T.; Godfrey, G.; Hayashida, M.; Johannesson, G.; Johnson, A. S.; Kamae, T.; Kocian, M. L.; Lande, J.; Madejski, G. M.; Michelson, P. F.; Mitthumsiri, W.; Monzani, M. E.; Murgia, S.; Nolan, P. L.; Reimer, A.; Reimer, O.; Rochester, L. S.; Romani, R. W.; Tajima, H.; Tanaka, T.; Thayer, J. B.; Thayer, J. G.; Tramacere, A.; Uchiyama, Y.; Usher, T. L.; Waite, A. P.; Wang, P.] Stanford Univ, SLAC Natl Accelerator Lab, Stanford, CA 94305 USA; [Baldini, L.; Bellazzini, R.; Bregeon, J.; Brez, A.; Kuss, M.; Latronico, L.; Omodei, N.; Pesce-Rollins, M.; Razzano, M.; Sgro, C.; Spandre, G.] Ist Nazl Fis Nucl, Sez Pisa, I-56127 Pisa, Italy; [Ballet, J.; Casandjian, J. M.; Grenier, I. A.; Tibaldo, L.] Univ Paris Diderot, CEA Saclay, Inst Rech Lois Fondament Univers,Serv Astrophys, Lab Astrophys Instrumentat Modelisat,CNRS, F-91191 Gif Sur Yvette, France; [Barbiellini, G.; Longo, F.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Barbiellini, G.; Longo, F.] Univ Trieste, Dipartimento Fis, I-34127 Trieste, Italy; [Baring, M. G.] Rice Univ, Dept Phys & Astron, Houston, TX 77251 USA; [Bastieri, D.; Rando, R.; Tibaldo, L.] Ist Nazl Fis Nucl, Sez Padova, I-35131 Padua, Italy; [Bastieri, D.; Buson, S.; Rando, R.; Tibaldo, L.] Univ Padua, Dipartimento Fis G Galilei, I-35131 Padua, Italy; [Baughman, B. M.; Hughes, R. E.; Sander, A.; Smith, P. D.; Winer, B. L.] Ohio State Univ, Dept Phys, Ctr Cosmol & Astroparticle Phys, Columbus, OH 43210 USA; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Ist Nazl Fis Nucl, Sez Perugia, I-06123 Perugia, Italy; [Bonamente, E.; Cecchi, C.; Ciprini, S.; Germani, S.; Lubrano, P.; Pepe, M.; Tosti, G.] Univ Perugia, Dipartimento Fis, I-06123 Perugia, Italy; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Univ Bari, Dipartimento Fis M Merlin, I-70126 Bari, Italy; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Favuzzi, C.; Fusco, P.; Giglietto, N.; Giordano, F.; Loparco, F.; Monte, C.; Raino, S.; Spinelli, P.] Politecn Bari, I-70126 Bari, Italy; [Brigida, M.; Caliandro, G. A.; de Palma, F.; Favuzzi, C.; Fusco, P.; Gargano, F.; Giglietto, N.; Giordano, F.; Loparco, F.; Mazziotta, M. N.; Monte, C.; Raino, S.; Spinelli, P.] Ist Nazl Fis Nucl, Sez Bari, I-70126 Bari, Italy; [Bruel, P.; Fegan, S. J.; Fortin, P.; Giebels, B.; Sanchez, D.] Ecole Polytech, CNRS, IN2P3, Lab Leprince Ringuet, F-91128 Palaiseau, France; [Burnett, T. H.; Kerr, M.; Roth, M.] Univ Washington, Dept Phys, Seattle, WA 98195 USA; [Caraveo, P. A.] Ist Nazl Astrofis, Ist Astrofis Spaziale & Fis Cosm, I-20133 Milan, Italy; [Celik, Oe.; Cheung, C. C.; Gehrels, N.; Harding, A. K.; Hays, E.; Johnson, T. J.; McEnery, J. E.; Stecker, F. W.; Thompson, D. J.; Vasileiou, V.; Venter, C.] NASA, Goddard Space Flight Ctr, CRESST, Greenbelt, MD 20771 USA; [Celik, Oe.; Vasileiou, V.] Univ Maryland Baltimore Cty, Baltimore, MD 21250 USA; [Chekhtman, A.; Makeev, A.] George Mason Univ, Fairfax, VA 22030 USA; [Cognard, I.; Theureau, G.] CNRS, UMR 6115, LPCE, F-45071 Orleans 02, France; [Cognard, I.; Theureau, G.] INSU, CNRS, Observ Paris, Stn Radioastron Nancay, F-18330 Nancay, France; [Cohen-Tanugi, J.; Farnier, C.; Nuss, E.; Pelassa, V.; Piron, F.] Univ Montpellier 2, CNRS, IN2P3, Lab Phys Theor & Astroparticules, Montpellier, France; [Cominsky, L. R.; Meurer, C.] Sonoma State Univ, Dept Phys & Astron, Rohnert Pk, CA 94928 USA; [Conrad, J.; Jackson, M. S.; Meurer, C.] Stockholm Univ, Dept Phys, SE-10691 Stockholm, Sweden; [Conrad, J.; Jackson, M. S.; Ryde, F.; Ylinen, T.] Oskar Klein Ctr Cosmoparticle Phys, SE-10691 Stockholm, Sweden; [Cutini, S.; Gasparrini, D.] ASI, Sci Data Ctr, I-00044 Frascati, Roma, Italy; [de Angelis, A.; Frailis, M.] Univ Udine, Dipartimento Fis, I-33100 Udine, Italy; [de Angelis, A.; Frailis, M.] Ist Nazl Fis Nucl, Sez Trieste, Grp Coll Udine, I-33100 Udine, Italy; [Dumora, D.; Grondin, M. -H.; Guillemot, L.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] Univ Bordeaux, CEN Bordeaux Gradignan, UMR 5797, F-33175 Gradignan, France; [Dumora, D.; Grondin, M. -H.; Guillemot, L.; Lemoine-Goumard, M.; Lott, B.; Parent, D.; Reposeur, T.; Smith, D. A.] CEN Bordeaux Gradignan, CNRS, UMR 5797, IN2P3, F-33175 Gradignan, France; [Espinoza, C.; Kramer, M.; Lyne, A. G.; Noutsos, A.; Stappers, B. W.] Univ Manchester, Sch Phys & Astron, Jodrell Bank, Ctr Astrophys, Manchester M13 9PL, Lancs, England; [Fukazawa, Y.; Hanabata, Y.; Katagiri, H.; Mizuno, T.; Ohsugi, T.; Takahashi, H.; Yamazaki, R.] Hiroshima Univ, Dept Phys Sci, Hiroshima 7398526, Japan; [Gehrels, N.; Johnson, T. J.] Univ Maryland, College Pk, MD 20742 USA; [Giavitto, G.] Ist Nazl Fis Nucl, Sez Trieste, I-34127 Trieste, Italy; [Guiriec, S.] Univ Alabama, Huntsville, AL 35899 USA; [Jackson, M. S.; Ryde, F.; Ylinen, T.] Royal Inst Technol KTH, Dept Phys, SE-10691 Stockholm, Sweden; [Kataoka, J.; Kawai, N.; Nakamori, T.] Tokyo Inst Technol, Dept Phys, Meguro, Tokyo 1528551, Japan; [Kataoka, J.] Waseda Univ, Shinjuku Ku, Tokyo 1698050, Japan; [Katsuta, J.; Takahashi, T.] Japan Aerosp Explorat Agcy, Inst Space & Astronaut Sci, Sagamihara, Kanagawa 2298510, Japan; [Katsuta, J.] Univ Tokyo, Grad Sch Sci, Dept Phys, Bunkyo Ku, Tokyo 1130033, Japan; [Kawai, N.] RIKEN, Inst Phys & Chem Res, Cosm Radiat Lab, Wako, Saitama 3510198, Japan; [Knoedlseder, J.; Vilchez, N.] Univ Toulouse 3, CNRS, Ctr Etud Spatiale Rayonnements, F-31028 Toulouse 4, France; [Kramer, M.] Max Planck Inst Radioastron, D-53121 Bonn, Germany; [Morselli, A.; Vitale, V.] Ist Nazl Fis Nucl, Sez Roma Tor Vergata, I-00133 Rome, Italy; [Norris, J. P.; Ormes, J. F.] Univ Denver, Dept Phys & Astron, Denver, CO 80208 USA; [Orlando, E.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany; [Porter, T. A.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Ziegler, M.] Univ Calif Santa Cruz, Dept Phys, Santa Cruz Inst Particle Phys, Santa Cruz, CA 95064 USA; [Porter, T. A.; Sadrozinski, H. F. -W.; Parkinson, P. M. Saz; Ziegler, M.] Univ Calif Santa Cruz, Dept Astron & Astrophys, Santa Cruz, CA 95064 USA; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Astro & Teilchenphys, A-6020 Innsbruck, Austria; [Reimer, A.; Reimer, O.] Leopold Franzens Univ Innsbruck, Inst Theoret Phys, A-6020 Innsbruck, Austria; [Rodriguez, A. Y.; Torres, D. F.] CSIC, IEEC, Inst Ciencies Espai, Barcelona 08193, Spain; [Scargle, J. D.] NASA, Ames Res Ctr, Div Space Sci, Moffett Field, CA 94035 USA; [Siskind, E. J.] NYCB Real Time Comp Inc, Lattingtown, NY 11560 USA; [Suson, D. J.] Purdue Univ Calumet, Dept Chem & Phys, Hammond, IN 46323 USA; [Tibolla, O.] Max Planck Inst Kernphys, D-69029 Heidelberg, Germany; [Torres, D. F.] ICREA, Barcelona 08010, Spain; [Tramacere, A.] CIFS, I-10133 Turin, Italy; [Venter, C.] North West Univ, ZA-2520 Potchefstroom, South Africa; [Vitale, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Ylinen, T.] Univ Kalmar, Sch Pure & Appl Nat Sci, SE-39182 Kalmar, Sweden	Stanford University; United States Department of Defense; United States Navy; Naval Research Laboratory; Stanford University; United States Department of Energy (DOE); SLAC National Accelerator Laboratory; Istituto Nazionale di Fisica Nucleare (INFN); UDICE-French Research Universities; Universite Paris Cite; CEA; Centre National de la Recherche Scientifique (CNRS); Universite Paris Saclay; Istituto Nazionale di Fisica Nucleare (INFN); University of Trieste; Rice University; Istituto Nazionale di Fisica Nucleare (INFN); University of Padua; University System of Ohio; Ohio State University; Istituto Nazionale di Fisica Nucleare (INFN); University of Perugia; Universita degli Studi di Bari Aldo Moro; Politecnico di Bari; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Institut Polytechnique de Paris; University of Washington; University of Washington Seattle; Istituto Nazionale Astrofisica (INAF); National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; University System of Maryland; University of Maryland Baltimore County; George Mason University; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); UDICE-French Research Universities; PSL Research University Paris; Observatoire de Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Universite de Montpellier; California State University System; Sonoma State University; Stockholm University; Oskar Klein Centre; Agenzia Spaziale Italiana (ASI); University of Udine; Istituto Nazionale di Fisica Nucleare (INFN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); UDICE-French Research Universities; Universite de Bordeaux; University of Manchester; Jodrell Bank Centre for Astrophysics; Hiroshima University; University System of Maryland; University of Maryland College Park; Istituto Nazionale di Fisica Nucleare (INFN); University of Alabama System; University of Alabama Huntsville; Royal Institute of Technology; Tokyo Institute of Technology; Waseda University; Japan Aerospace Exploration Agency (JAXA); Institute of Space & Astronautical Science (ISAS); University of Tokyo; RIKEN; Centre National de la Recherche Scientifique (CNRS); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Max Planck Society; Istituto Nazionale di Fisica Nucleare (INFN); University of Denver; Max Planck Society; University of California System; University of California Santa Cruz; University of California System; University of California Santa Cruz; University of Innsbruck; University of Innsbruck; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias del Espacio (ICE); Institut d'Estudis Espacials de Catalunya (IEEC); University of Barcelona; National Aeronautics & Space Administration (NASA); NASA Ames Research Center; Purdue University System; Purdue University; Max Planck Society; ICREA; North West University - South Africa; University of Rome Tor Vergata; Linnaeus University; University of Kalmar	Tajima, H (corresponding author), Stanford Univ, Dept Phys, Kavli Inst Particle Astrophys & Cosmol, WW Hansen Expt Phys Lab, Stanford, CA 94305 USA.	htajima@slac.stanford.edu; ttanaka@slac.stanford.edu; uchiyama@slac.stanford.edu	McEnery, Julie E/D-6612-2012; lubrano, pasquale/F-7269-2012; Torres, Diego F./AAF-7931-2019; Fukazawa, Yasushi/G-2081-2017; Rando, Riccardo/O-1302-2019; Baldini, Luca/E-5396-2012; Parkinson, Pablo Miguel Saz/I-7980-2013; Gehrels, Neil/D-2971-2012; Rando, Riccardo/M-7179-2013; Harding, Alice K/D-3160-2012; Cutini, Sara/ABB-1787-2020; Jóhannesson, Guðlaugur/O-8741-2015; Loparco, Francesco/O-8847-2015; Torres, Diego F/ABD-7940-2020; Tajima, Hiroyasu/I-6228-2014; Tosti, Gino/E-9976-2013; Caraveo, Patrizia/AAL-5708-2020; tramacere, andrea/B-9424-2012; Funk, Stefan/B-7629-2015; Reimer, Anita/K-5822-2015; Gargano, Fabio/AAD-5121-2021; Funk, Stefan/AAI-1568-2021; Bastieri, Denis/AAC-5917-2020; Moskalenko, Igor V/A-1301-2007; Johnson, Neil/G-3309-2014; Mazziotta, Mario N/O-8867-2015; Jóhannesson, Guðlaugur/ABC-7216-2020; Morselli, Aldo/G-6769-2011; cohen-tanugi, Johann/ABB-1481-2021; Stecker, Floyd W/D-3169-2012; Kuss, Michael W/H-8959-2012; giglietto, nicola/I-8951-2012; Giglietto, Nicola/Y-2425-2019; Torres, Diego F./O-9422-2016; Gargano, Fabio/O-8934-2015; Thompson, David J/D-2939-2012; Sgrò, Carmelo/K-3395-2016; Espinoza, Cristóbal/U-4428-2017; Nolan, Patrick L/A-5582-2009; Venter, Christo/E-6884-2011; Reimer, Olaf/A-3117-2013; Gasparrini, Dario/X-6699-2019; Hays, Elizabeth/D-3257-2012; Takahashi, Hiromitsu H/T-2713-2017; Orlando, Elena/R-5594-2016	lubrano, pasquale/0000-0003-0221-4806; Torres, Diego F./0000-0002-1522-9065; Fukazawa, Yasushi/0000-0002-0921-8837; Rando, Riccardo/0000-0001-6992-818X; Cutini, Sara/0000-0002-1271-2924; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Loparco, Francesco/0000-0002-1173-5673; Tajima, Hiroyasu/0000-0002-1721-7252; Caraveo, Patrizia/0000-0003-2478-8018; tramacere, andrea/0000-0002-8186-3793; Funk, Stefan/0000-0002-2012-0080; Reimer, Anita/0000-0001-8604-7077; Gargano, Fabio/0000-0002-5055-6395; Funk, Stefan/0000-0002-2012-0080; Bastieri, Denis/0000-0002-6954-8862; Moskalenko, Igor V/0000-0001-6141-458X; Mazziotta, Mario N/0000-0001-9325-4672; Jóhannesson, Guðlaugur/0000-0003-1458-7036; Morselli, Aldo/0000-0002-7704-9553; cohen-tanugi, Johann/0000-0001-9022-4232; giglietto, nicola/0000-0002-9021-2888; Giglietto, Nicola/0000-0002-9021-2888; Torres, Diego F./0000-0002-1522-9065; Gargano, Fabio/0000-0002-5055-6395; Thompson, David J/0000-0001-5217-9135; Espinoza, Cristóbal/0000-0003-2481-2348; Venter, Christo/0000-0002-2666-4812; Reimer, Olaf/0000-0001-6953-1385; Gasparrini, Dario/0000-0002-5064-9495; Takahashi, Hiromitsu H/0000-0001-6314-5897; Pepe, Monica/0000-0001-5624-4010; Grenier, Isabelle/0000-0003-3274-674X; de Palma, Francesco/0000-0001-5898-2834; Omodei, Nicola/0000-0002-5448-7577; Cecchi, Claudia/0000-0002-2192-8233; Giavitto, Gianluca/0000-0002-7629-6499; Cheung, Chi (Teddy)/0000-0002-4377-0174; SANCHEZ, David/0000-0002-7210-4496; Monzani, Maria Elena/0000-0002-8254-5308; Cameron, Robert/0000-0003-0942-2747; Casandjian, Jean-Marc/0000-0003-1404-0524; De Angelis, Alessandro/0000-0002-3288-2517; Johnson, Tyrel/0000-0002-2771-472X; Sgro', Carmelo/0000-0001-5676-6214; RAZZANO, MASSIMILIANO/0000-0003-4825-1629; Frailis, Marco/0000-0002-7400-2135; Porter, Troy/0000-0002-2621-4440; Baldini, Luca/0000-0002-9785-7726; Murgia, Simona/0000-0003-0516-9422; Cognard, Ismael/0000-0002-1775-9692; Fusco, Piergiorgio/0000-0002-9383-2425; Noutsos, Aristeidis/0000-0002-4151-3860; Tanaka, Takaaki/0000-0002-4383-0368; Orlando, Elena/0000-0001-6406-9910; SPINELLI, Paolo/0000-0001-6688-8864; Buson, Sara/0000-0002-3308-324X; Sadrozinski, Hartmut/0000-0003-0019-5410; Tibaldo, Luigi/0000-0001-7523-570X; Kramer, Michael/0000-0002-4175-2271; Pesce-Rollins, Melissa/0000-0003-1790-8018; Kerr, Matthew/0000-0002-0893-4073; Katagiri, Hideaki/0000-0003-2347-8819; Tibolla, Omar/0000-0002-9074-0584; Berenji, Bijan/0000-0002-4551-772X; Ciprini, Stefano/0000-0002-0712-2479; Ackermann, Markus/0000-0001-8952-588X; Spandre, Gloria/0000-0003-0802-3453	NASA; Department of Energy in the United States; CEA/Irfu; IN2P3/CNRS; Centre National d'Etudes Spatiales in France; ASI; INFN; INAF in Italy; Ministry of Education, Culture, Sports, Science, and Technology, High Energy Accelerator Research Organization (KEK); JAXA in Japan; K. A. Wallenberg Foundation; Swedish Research Council; National Space Board in Sweden; ICREA Funding Source: Custom; STFC [ST/G002487/1] Funding Source: UKRI; Grants-in-Aid for Scientific Research [21740184] Funding Source: KAKEN; Science and Technology Facilities Council [ST/G002487/1] Funding Source: researchfish	NASA(National Aeronautics & Space Administration (NASA)); Department of Energy in the United States(United States Department of Energy (DOE)); CEA/Irfu(French Atomic Energy Commission); IN2P3/CNRS(Centre National de la Recherche Scientifique (CNRS)); Centre National d'Etudes Spatiales in France(Centre National D'etudes Spatiales); ASI(Agenzia Spaziale Italiana (ASI)); INFN(Istituto Nazionale di Fisica Nucleare (INFN)); INAF in Italy(Istituto Nazionale Astrofisica (INAF)); Ministry of Education, Culture, Sports, Science, and Technology, High Energy Accelerator Research Organization (KEK)(High Energy Accelerator Research Organization (KEK)); JAXA in Japan; K. A. Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); National Space Board in Sweden; ICREA(ICREA); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The Fermi LAT Collaboration acknowledges support from a number of agencies and institutes for both development and the operation of the LAT as well as scientific data analysis. These include NASA and Department of Energy in the United States; CEA/Irfu, IN2P3/CNRS, and Centre National d'Etudes Spatiales in France; ASI, INFN, and INAF in Italy; Ministry of Education, Culture, Sports, Science, and Technology, High Energy Accelerator Research Organization (KEK) and JAXA in Japan; and the K. A. Wallenberg Foundation, the Swedish Research Council, and the National Space Board in Sweden.	Abdo AA, 2009, ASTROPHYS J SUPPL S, V183, P46, DOI 10.1088/0067-0049/183/1/46; Abdo AA, 2009, ASTROPHYS J LETT, V700, pL127, DOI 10.1088/0004-637X/700/2/L127; ABDO AA, 1 FERMI LARGE AREA T; Aharonian F, 2007, ASTROPHYS J, V661, P236, DOI 10.1086/512603; Aharonian F, 2007, ASTRON ASTROPHYS, V464, P235, DOI 10.1051/0004-6361:20066381; AHARONIAN FA, 1994, ASTRON ASTROPHYS, V285, P645; Aharonian FA, 2004, NATURE, V432, P75, DOI 10.1038/nature02960; Aharonian FA, 2002, ASTRON ASTROPHYS, V395, P803, DOI 10.1051/0004-6361:20021347; Atwood WB, 2009, ASTROPHYS J, V697, P1071, DOI 10.1088/0004-637X/697/2/1071; Bell AR, 2001, MON NOT R ASTRON SOC, V321, P433, DOI 10.1046/j.1365-8711.2001.04063.x; Berezhko EG, 2008, ASTRON ASTROPHYS, V492, P695, DOI 10.1051/0004-6361:200810444; BLANDFORD R, 1987, PHYS REP, V154, P1, DOI 10.1016/0370-1573(87)90134-7; Bykov AM, 2000, ASTROPHYS J, V538, P203, DOI 10.1086/309103; Castelletti G, 2007, ASTRON ASTROPHYS, V471, P537, DOI 10.1051/0004-6361:20077062; deJager OC, 1997, ASTROPHYS J, V482, P874, DOI 10.1086/304177; DRURY LO, 1994, ASTRON ASTROPHYS, V287, P959; Esposito JA, 1996, ASTROPHYS J, V461, P820, DOI 10.1086/177104; Frail DA, 1996, ASTROPHYS J, V464, pL165, DOI 10.1086/310103; Gabici S, 2007, ASTROPHYS J, V665, pL131, DOI 10.1086/521047; Helfand DJ, 2006, ASTRON J, V131, P2525, DOI 10.1086/503253; Hoffman IM, 2005, ASTROPHYS J, V627, P803, DOI 10.1086/430419; Malkov MA, 2001, REP PROG PHYS, V64, P429, DOI 10.1088/0034-4885/64/4/201; Petre R, 2002, ASTROPHYS J, V579, P404, DOI 10.1086/342672; Porter TA, 2006, ASTROPHYS J, V648, pL29, DOI 10.1086/507770; Ptuskin VS, 2005, ASTRON ASTROPHYS, V429, P755, DOI 10.1051/0004-6361:20041517; Ptuskin VS, 2003, ASTRON ASTROPHYS, V403, P1, DOI 10.1051/0004-6361:20030323; Reach WT, 2006, ASTRON J, V131, P1479, DOI 10.1086/499306; Reach WT, 2005, ASTROPHYS J, V618, P297, DOI 10.1086/425855; Reynolds SP, 2008, ANNU REV ASTRON ASTR, V46, P89, DOI 10.1146/annurev.astro.46.060407.145237; Seta M, 2004, ASTRON J, V127, P1098, DOI 10.1086/381058; WOLSZCZAN A, 1991, ASTROPHYS J, V372, pL99, DOI 10.1086/186033	31	212	214	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1103	1106		10.1126/science.1182787	http://dx.doi.org/10.1126/science.1182787			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20056857				2022-12-28	WOS:000274901100028
J	Tanaka, S; Sawaya, MR; Yeates, TO				Tanaka, Shiho; Sawaya, Michael R.; Yeates, Todd O.			Structure and Mechanisms of a Protein-Based Organelle in Escherichia coli	SCIENCE			English	Article							SALMONELLA-TYPHIMURIUM LT2; CARBOXYSOME SHELL; THIOBACILLUS-NEAPOLITANUS; CRYSTAL-STRUCTURE; ETHANOLAMINE; MICROCOMPARTMENTS; 1,2-PROPANEDIOL; PROKARYOTES; PROPIONATE; INSIGHTS	Many bacterial cells contain proteinaceous microcompartments that act as simple organelles by sequestering specific metabolic processes involving volatile or toxic metabolites. Here we report the three-dimensional (3D) crystal structures, with resolutions between 1.65 and 2.5 angstroms, of the four homologous proteins (EutS, EutL, EutK, and EutM) that are thought to be the major shell constituents of a functionally complex ethanolamine utilization (Eut) microcompartment. The Eut microcompartment is used to sequester the metabolism of ethanolamine in bacteria such as Escherichia coli and Salmonella enterica. The four Eut shell proteins share an overall similar 3D fold, but they have distinguishing structural features that help explain the specific roles they play in the microcompartment. For example, EutL undergoes a conformational change that is probably involved in gating molecular transport through shell protein pores, whereas structural evidence suggests that EutK might bind a nucleic acid component. Together these structures give mechanistic insight into bacterial microcompartments.	[Tanaka, Shiho; Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sawaya, Michael R.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Sawaya, Michael R.; Yeates, Todd O.] Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Yeates, Todd O.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yeates, TO (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles Young Dr E, Los Angeles, CA 90095 USA.	yeates@mbi.ucla.edu		Yeates, Todd/0000-0001-5709-9839	Howard Hughes Medical Institute Funding Source: Medline; Direct For Biological Sciences [0843065] Funding Source: National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; CHEN P, 1994, J BACTERIOL, V176, P5474, DOI 10.1128/JB.176.17.5474-5482.1994; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Crowley CS, 2008, STRUCTURE, V16, P1324, DOI 10.1016/j.str.2008.05.013; ENGLISH RS, 1994, MOL MICROBIOL, V12, P647, DOI 10.1111/j.1365-2958.1994.tb01052.x; Havemann GD, 2002, J BACTERIOL, V184, P1253, DOI 10.1128/JB.184.5.1253-1261.2002; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Klein MG, 2009, J MOL BIOL, V392, P319, DOI 10.1016/j.jmb.2009.03.056; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; RONDON MR, 1995, J BACTERIOL, V177, P7119, DOI 10.1128/JB.177.24.7119-7124.1995; RONDON MR, 1995, J BACTERIOL, V177, P5434, DOI 10.1128/jb.177.19.5434-5439.1995; Sagermann M, 2009, P NATL ACAD SCI USA, V106, P8883, DOI 10.1073/pnas.0902324106; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; SHIVELY JM, 1973, SCIENCE, V182, P584, DOI 10.1126/science.182.4112.584; SHIVELY JM, 1988, INT REV CYTOL, V113, P35; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zhang RG, 2002, J BIOL CHEM, V277, P19183, DOI 10.1074/jbc.M112171200	26	168	174	3	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					81	84		10.1126/science.1179513	http://dx.doi.org/10.1126/science.1179513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044574				2022-12-28	WOS:000273395400035
J	Yoshida-Moriguchi, T; Yu, LP; Stalnaker, SH; Davis, S; Kunz, S; Madson, M; Oldstone, MBA; Schachter, H; Wells, L; Campbell, KP				Yoshida-Moriguchi, Takako; Yu, Liping; Stalnaker, Stephanie H.; Davis, Sarah; Kunz, Stefan; Madson, Michael; Oldstone, Michael B. A.; Schachter, Harry; Wells, Lance; Campbell, Kevin P.			O-Mannosyl Phosphorylation of Alpha-Dystroglycan Is Required for Laminin Binding	SCIENCE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; LASSA FEVER VIRUS; ABNORMAL GLYCOSYLATION; RECEPTOR; MUTATIONS; GLYCOSYLTRANSFERASE; GLYCOPROTEINS; GLYCANS; FORM	Alpha-dystroglycan (alpha-DG) is a cell-surface glycoprotein that acts as a receptor for both extracellular matrix proteins containing laminin-G domains and certain arenaviruses. Receptor binding is thought to be mediated by a posttranslational modification, and defective binding with laminin underlies a subclass of congenital muscular dystrophy. Using mass spectrometry- and nuclear magnetic resonance (NMR)-based structural analyses, we identified a phosphorylated O-mannosyl glycan on the mucin-like domain of recombinant alpha-DG, which was required for laminin binding. We demonstrated that patients with muscle-eye-brain disease and Fukuyama congenital muscular dystrophy, as well as mice with myodystrophy, commonly have defects in a postphosphoryl modification of this phosphorylated O-linked mannose, and that this modification is mediated by the like-acetylglucosaminyltransferase (LARGE) protein. These findings expand our understanding of the mechanisms that underlie congenital muscular dystrophy.	[Yoshida-Moriguchi, Takako; Davis, Sarah; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Yoshida-Moriguchi, Takako; Davis, Sarah; Campbell, Kevin P.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Yoshida-Moriguchi, Takako; Davis, Sarah; Campbell, Kevin P.] Univ Iowa, Dept Neurol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Yoshida-Moriguchi, Takako; Davis, Sarah; Campbell, Kevin P.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Yu, Liping] Univ Iowa, Med Nucl Magnet Resonance Facil, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Stalnaker, Stephanie H.; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Kunz, Stefan] Univ Lausanne, Lausanne, Switzerland; [Kunz, Stefan] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Madson, Michael] Bio Logist, Clear Lake, IA 50428 USA; [Oldstone, Michael B. A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Schachter, Harry] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University System of Georgia; University of Georgia; University of Lausanne; Scripps Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, 4283 Carver Biomed Res Bldg,285 Newton Rd, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Wells, Lance/H-3118-2013; Kishore, Gade/C-6943-2011; Kunz, Stefan/K-5840-2017	Kishore, Gade/0000-0003-0911-4381; Yu, Liping/0000-0003-3536-6427; Wells, Lance/0000-0003-4956-5363; Kunz, Stefan/0000-0001-6030-9550; Campbell, Kevin/0000-0003-2066-5889	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055540, R21AI055540, R01AI009484, R01AI045927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [P41 RR018502] Funding Source: Medline; NIAID NIH HHS [R01 AI045927, AI55540, R01 AI055540, R01 AI045927-09, R01 AI045927-10, R01 AI009484, R01 AI045927-08, R01 AI009484-40, R21 AI055540, R01 AI009484-41] Funding Source: Medline; NIDDK NIH HHS [P30 DK054759, P30 DK 54759] Funding Source: Medline; NINDS NIH HHS [U54 NS053672, 1U54NS053672] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Chiba A, 1997, J BIOL CHEM, V272, P2156; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; GANDER JE, 1974, ANNU REV MICROBIOL, V28, P103, DOI 10.1146/annurev.mi.28.100174.000535; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; ILG T, 1994, J BIOL CHEM, V269, P24073; Ilg T, 1996, J BIOL CHEM, V271, P21583, DOI 10.1074/jbc.271.35.21583; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Kunz S, 2005, J VIROL, V79, P5979, DOI 10.1128/JVI.79.10.5979-5987.2005; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manzini MC, 2008, HUM MUTAT, V29, pE231, DOI 10.1002/humu.20844; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Sasaki T, 1998, BBA-GEN SUBJECTS, V1425, P599, DOI 10.1016/S0304-4165(98)00114-7; Spiropoulou CF, 2002, J VIROL, V76, P5140, DOI 10.1128/JVI.76.10.5140-5146.2002; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3	25	244	251	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					88	92		10.1126/science.1180512	http://dx.doi.org/10.1126/science.1180512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044576	Green Accepted, Green Submitted			2022-12-28	WOS:000273395400037
J	Cauchemez, S; Donnelly, CA; Reed, C; Ghani, AC; Fraser, C; Kent, CK; Finelli, L; Ferguson, NM				Cauchemez, Simon; Donnelly, Christl A.; Reed, Carrie; Ghani, Azra C.; Fraser, Christophe; Kent, Charlotte K.; Finelli, Lyn; Ferguson, Neil M.			Household Transmission of 2009 Pandemic Influenza A (H1N1) Virus in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASIAN INFLUENZA; OSELTAMIVIR; CONTACTS; PATTERNS; STRAIN; MODEL	BACKGROUND As of June 11, 2009, a total of 17,855 probable or confirmed cases of 2009 pandemic influenza A (H1N1) had been reported in the United States. Risk factors for transmission remain largely uncharacterized. We characterize the risk factors and describe the transmission of the virus within households. METHODS Probable and confirmed cases of infection with the 2009 H1N1 virus in the United States were reported to the Centers for Disease Control and Prevention with the use of a standardized case form. We investigated transmission of infection in 216 households - including 216 index patients and their 600 household contacts - in which the index patient was the first case patient and complete information on symptoms and age was available for all household members. RESULTS An acute respiratory illness developed in 78 of 600 household contacts (13%). In 156 households (72% of the 216 households), an acute respiratory illness developed in none of the household contacts; in 46 households (21%), illness developed in one contact; and in 14 households (6%), illness developed in more than one contact. The proportion of household contacts in whom acute respiratory illness developed decreased with the size of the household, from 28% in two-member households to 9% in six-member households. Household contacts 18 years of age or younger were twice as susceptible as those 19 to 50 years of age ( relative susceptibility, 1.96; Bayesian 95% credible interval, 1.05 to 3.78; P = 0.005), and household contacts older than 50 years of age were less susceptible than those who were 19 to 50 years of age ( relative susceptibility, 0.17; 95% credible interval, 0.02 to 0.92; P = 0.03). Infectivity did not vary with age. The mean time between the onset of symptoms in a case patient and the onset of symptoms in the household contacts infected by that patient was 2.6 days ( 95% credible interval, 2.2 to 3.5). CONCLUSIONS The transmissibility of the 2009 H1N1 influenza virus in households is lower than that seen in past pandemics. Most transmissions occur soon before or after the onset of symptoms in a case patient.	[Cauchemez, Simon; Donnelly, Christl A.; Ghani, Azra C.; Fraser, Christophe; Ferguson, Neil M.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling, London W2 1PG, England; [Reed, Carrie; Kent, Charlotte K.; Finelli, Lyn] Ctr Dis Control & Prevent, Atlanta, GA USA	Imperial College London; Centers for Disease Control & Prevention - USA	Cauchemez, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling, Norfolk Pl, London W2 1PG, England.	s.cauchemez@imperial.ac.uk	Fraser, Christophe/A-8109-2008; Finelli, Lyn/AAK-2360-2020; Ferguson, Neil/B-8578-2008; Ghani, Azra/B-8560-2009	Fraser, Christophe/0000-0003-2399-9657; Ferguson, Neil/0000-0002-1154-8093; Donnelly, Christl/0000-0002-0195-2463; Ghani, Azra/0000-0002-0007-4910	Medical Research Council; Bill and Melinda Gates Foundation; European Union; Models of Infectious Disease Agent Study initiative of the National Institute of General Medical Sciences; Royal Society; Research Councils U. K.; Medical Research Council [G0600719B] Funding Source: researchfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); European Union(European Commission); Models of Infectious Disease Agent Study initiative of the National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Royal Society(Royal Society of London); Research Councils U. K.(UK Research & Innovation (UKRI)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the Medical Research Council, the Bill and Melinda Gates Foundation, the European Union Framework 7 program (FluModCont), and the Models of Infectious Disease Agent Study initiative of the National Institute of General Medical Sciences ( all for the work at Imperial College), the Royal Society ( to Dr. Fraser), and Research Councils U. K. ( to Dr. Cauchemez).	Carrat F, 2002, ARCH INTERN MED, V162, P1842, DOI 10.1001/archinte.162.16.1842; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; *CDCP, 2009 H1N1 FLU SIT UP; *CDCP, H1N1 FLU CLIN PUBL H; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Centers for Disease Control and Prevention (CDC), 2009, CDC REC AM TIM PERS; CHIN TDY, 1960, PUBLIC HEALTH REP, V75, P149, DOI 10.2307/4590751; DAVIS LE, 1970, AM J EPIDEMIOL, V92, P240, DOI 10.1093/oxfordjournals.aje.a121203; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; FRANK AL, 1981, J INFECT DIS, V144, P433, DOI 10.1093/infdis/144.5.433; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; HALL CB, 1979, J INFECT DIS, V140, P610, DOI 10.1093/infdis/140.4.610; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; *NOV SWIN OR INFL, 2009, NEW ENGL J MED, V361, P102; RAMPEY AH, 1992, BIOMETRICS, V48, P117, DOI 10.2307/2532743; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; WOODALL J, 1958, BRIT MED J, V2, P1316, DOI 10.1136/bmj.2.5108.1316	23	357	366	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2619	2627		10.1056/NEJMoa0905498	http://dx.doi.org/10.1056/NEJMoa0905498			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042753	Green Accepted			2022-12-28	WOS:000273181300009
J	Dente, K				Dente, Karen			Overhaul or Overload for French Science?	CELL			English	Editorial Material																			0	0	0	0	0	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 24	2009	139	7					1206	1208		10.1016/j.cell.2009.12.004	http://dx.doi.org/10.1016/j.cell.2009.12.004			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064361	Bronze			2022-12-28	WOS:000273048700002
J	Mathieu, RD; Geller, AM				Mathieu, Robert D.; Geller, Aaron M.			A binary star fraction of 76 per cent and unusual orbit parameters for the blue stragglers of NGC 188	NATURE			English	Article							WIYN OPEN CLUSTER; SOLAR-TYPE STARS; SPECTROSCOPIC BINARIES; TIDAL CIRCULARIZATION; M67; NGC-188; TRIPLE; POPULATIONS; EVOLUTION; SYSTEMS	Blue straggler stars lie on or near the main sequences of star clusters (all members of which formed around the same time), but typically are more luminous than the turn-off stars and therefore long ago should have evolved off the main sequence to become giants and white dwarfs. They are thought to derive from normal main-sequence stars that have undergone a recent increase in mass. Statistical evidence indicates that in globular star clusters the blue stragglers probably form from binary stars(1). The specific formation processes, such as mass transfer, mergers or stellar collisions during dynamical encounters of binary stars, remain unresolved. Here we report that 16 of the 21 blue stragglers ( 76 per cent) in the old (7-Gyr; ref. 2) open cluster NGC188 are currently in binary systems, a frequency three times that found among normal solar-type main-sequence stars. These blue straggler binaries have a remarkable period-eccentricity distribution, with all but three having orbital periods of similar to 1,000 days. Moreover, these stars are rotating faster than normal main-sequence stars of the same surface temperatures. These data show that most, and possibly all, blue stragglers derive from multiple-star systems, and indicate that the several formation processes operate simultaneously. We suggest that rapid rotation of blue stragglers may place upper limits on their ages.	[Mathieu, Robert D.; Geller, Aaron M.] Univ Wisconsin, Dept Astron, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison	Mathieu, RD (corresponding author), Univ Wisconsin, Dept Astron, 475 N Charter St, Madison, WI 53706 USA.	mathieu@astro.wisc.edu			US National Science Foundation [AST-0406615]; Wisconsin Space Grant Consortium	US National Science Foundation(National Science Foundation (NSF)); Wisconsin Space Grant Consortium	We thank the staff of the WIYN Observatory and the many graduate and undergraduate students who have assisted in observing NGC188. The WIYN Observatory is a joint facility of the University of Wisconsin-Madison, Indiana University, Yale University and the US National Optical Astronomy Observatories. We thank D. Fabrycky, J. Hurley, N. Leigh, H. Perets and A. Sills for their comments. This work was funded by the US National Science Foundation grant AST-0406615 and the Wisconsin Space Grant Consortium.	Carney BW, 2001, ASTRON J, V122, P3419, DOI 10.1086/324233; DUQUENNOY A, 1991, ASTRON ASTROPHYS, V248, P485; Geller AM, 2008, ASTRON J, V135, P2264, DOI 10.1088/0004-6256/135/6/2264; Geller AM, 2009, ASTRON J, V137, P3743, DOI 10.1088/0004-6256/137/4/3743; Girardi L, 2002, ASTRON ASTROPHYS, V391, P195, DOI 10.1051/0004-6361:20020612; Hurley JR, 2005, MON NOT R ASTRON SOC, V363, P293, DOI 10.1111/j.1365-2966.2005.09448.x; Hurley JR, 2002, MON NOT R ASTRON SOC, V329, P897, DOI 10.1046/j.1365-8711.2002.05038.x; Knigge C, 2009, NATURE, V457, P288, DOI 10.1038/nature07635; KRAFT RP, 1967, ASTROPHYS J, V150, P551, DOI 10.1086/149359; Latham D. W, 2007, HIGHLIGHTS ASTRON, V14, P444; MATHIEU RD, 1990, ASTRON J, V100, P1859, DOI 10.1086/115643; Mathieu RD, 2004, ASTROPHYS J, V602, pL121, DOI 10.1086/382686; Mathieu RD, 2000, ASTR SOC P, V198, P517; MAZEH T, 1990, ASTRON J, V99, P675, DOI 10.1086/115362; Meibom S, 2005, ASTROPHYS J, V620, P970, DOI 10.1086/427082; MEIBOM S, 2009, P IAU S, V258, P357; MERMILLIOD JC, 1992, BINARIES AS TRACERS OF STELLAR FORMATION, P183; MILONE AAE, 1992, IAU S, V151, P475; Perets HB, 2009, ASTROPHYS J, V697, P1048, DOI 10.1088/0004-637X/697/2/1048; Platais I, 2003, ASTRON J, V126, P2922, DOI 10.1086/379677; Sandquist EL, 2003, ASTRON J, V125, P810, DOI 10.1086/346087; Sarajedini A, 1999, ASTRON J, V118, P2894, DOI 10.1086/301149; Sills A, 2005, MON NOT R ASTRON SOC, V358, P716, DOI 10.1111/j.1365-2966.2005.08809.x; SKUMANICH A, 1972, ASTROPHYS J, V171, P565, DOI 10.1086/151310; van den Berg M, 2001, ASTRON ASTROPHYS, V375, P375, DOI 10.1051/0004-6361:20010589; Zwart SFP, 1997, ASTRON ASTROPHYS, V328, P143	26	100	100	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 24	2009	462	7276					1032	1035		10.1038/nature08568	http://dx.doi.org/10.1038/nature08568			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033042				2022-12-28	WOS:000272996000041
J	Hawkes, N				Hawkes, Nigel			Body Politic A spanner in the herbal works	BRITISH MEDICAL JOURNAL			English	Editorial Material												nigel.hawkes1@btinternet.com						2006, BRIT MED J, V333, P935	1	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 21	2009	339								b5441	10.1136/bmj.b5441	http://dx.doi.org/10.1136/bmj.b5441			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	536ZH	20026505				2022-12-28	WOS:000273082000001
J	Nugus, P; Bridges, J; Braithwaite, J				Nugus, Peter; Bridges, Jackie; Braithwaite, Jeffrey			Christmas 2009: Professional Matters Selling patients	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Braithwaite, Jeffrey] Univ New S Wales, Fac Med, Australian Inst Hlth Innovat, Ctr Clin Governance Res, Sydney, NSW 2052, Australia	University of New South Wales Sydney		p.nugus@unsw.edu.au	Braithwaite, Jeffrey/AAN-1467-2020	Braithwaite, Jeffrey/0000-0003-0296-4957; Bridges, Jackie/0000-0001-6776-736X				BLOOR M, 1976, SOCIOLOGY, V10, P43, DOI 10.1177/003803857601000103; Eisenberg EM, 2005, COMMUN MONOGR, V72, P390, DOI 10.1080/03637750500322602; EMERSON RM, 1991, SOC PROBL, V38, P198, DOI 10.1525/sp.1991.38.2.03a00060; HAMMERSLEY M, 1990, SOCIOLOGY, V24, P597, DOI 10.1177/0038038590024004003; Hammersley M., 1995, ETHNOGRAPHY PRINCIPL; Hartswood M., 2003, Computer Supported Cooperative Work: The Journal of Collaborative Computing, V12, P241, DOI 10.1023/A:1025055829026; Hewett DG, 2009, SOC SCI MED, V69, P1732, DOI 10.1016/j.socscimed.2009.09.048; Hughes Geoffrey, 2004, Emerg Med Australas, V16, P387, DOI 10.1111/j.1742-6723.2004.00641.x; Innes G, 2000, CJEM, V2, P47; Jean YA, 2004, SOCIOL HEALTH ILL, V26, P385, DOI 10.1111/j.0141-9889.2004.00396.x; Merton Robert K., 1957, STUDENT PHYS INTRO S; Nugus P, 2010, SOC SCI MED, V70, P511, DOI 10.1016/j.socscimed.2009.11.001; Ragin C., 1994, CONSTRUCTING SOCIAL; Salhan D, 2009, SOC SCI MED, V68, P1221, DOI 10.1016/j.socscimed.2009.01.041; Shem Samuel, 1978, HOUSE GOD; Strauss AL., 1985, SOCIAL ORG MED WORK; Sudnow D., 1967, PASSING SOCIAL ORG D; Tesch R., 1990, QUALITATIVE RES ANAL; WHALEN MR, 1990, LANG SOC, V19, P465, DOI 10.1017/S0047404500014779	19	14	14	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 14	2009	339								b5201	10.1136/bmj.b5201	http://dx.doi.org/10.1136/bmj.b5201			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	534XF	20008442				2022-12-28	WOS:000272930100003
J	Lager, A; Bremberg, S; Vagero, D				Lager, A.; Bremberg, S.; Vagero, D.			The association of early IQ and education with mortality: 65 year longitudinal study in Malmo, Sweden	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							CORONARY-HEART-DISEASE; COGNITIVE PERFORMANCE; OCCUPATIONAL CLASS; EARLY ADULTHOOD; CHILDHOOD IQ; SOCIAL-CLASS; MIDDLE-AGE; RISK; COHORT; INEQUALITIES	Objectives To establish whether differences in early IQ explain why people with longer education live longer, or whether differences in father's or own educational attainment explain why people with higher early IQ live longer. Design Population based longitudinal study. Mortality risks were estimated with Cox proportional hazards regressions. Setting Malmo, Sweden. Participants 1530 children who took IQ tests at age 10 and were followed up until age 75. Results Own educational attainment was negatively associated with all cause mortality in both sexes, even when early IQ and father's education were adjusted for (hazard ratio (HR) for each additional year in school 0.91 (95% CI 0.85 to 0.97) for men and HR 0.88 (95% CI 0.78 to 0.98) for women). Higher early IQ was linked with a reduced mortality risk in men, even when own educational attainment and father's education were adjusted for (HR for one standard deviation increase in IQ 0.85 (95% CI 0.75 to 0.96)). In contrast, there was no crude effect of early IQ for women, and women with above average IQ had an increased mortality risk when own educational attainment was adjusted for, but only after the age of 60 (HR 1.60 ( 95% CI 1.06 to 2.42)). Adding measures of social career over and above educational attainment to the model (for example, occupational status at age 36 and number of children) only marginally affected the hazard ratio for women with above average IQ (<5%). Conclusions Mortality differences by own educational attainment were not explained by early IQ. Childhood IQ was independently linked, albeit differently, to male adult mortality and to female adult mortality even when father's education and own educational attainment was adjusted for, thus social background and own social career seem unlikely to be responsible for mortality differences by childhood IQ. The clear difference in the effect of IQ between men and women suggests that the link between IQ and mortality involves the social and physical environment rather than simply being a marker of a healthy body to begin with. Cognitive skills should, therefore, be addressed in our efforts to create childhood environments that promote health.	[Lager, A.; Vagero, D.] Stockholm Univ, Karolinska Inst, Ctr Hlth Equity Studies CHESS, Stockholm, Sweden; [Lager, A.; Bremberg, S.] Karolinska Inst, Dept Publ Hlth Sci, Stockholm, Sweden; [Lager, A.; Bremberg, S.] Swedish Natl Inst Publ Hlth, Ostersund, Sweden	Karolinska Institutet; Stockholm University; Karolinska Institutet	Lager, A (corresponding author), Stockholm Univ, Karolinska Inst, Ctr Hlth Equity Studies CHESS, Stockholm, Sweden.	anton.lager@chess.su.se	Lager, Anton/AAD-1124-2020	Vagero, Denny/0000-0002-1854-2292	Swedish National Institute of Public Health	Swedish National Institute of Public Health	The Swedish Council for Working Life and Social Research financed the updating of the Malmo Longitudinal Study database. AL and SB were funded by the Swedish National Institute of Public Health. The funders had no role in the collection, analysis, and interpretation of the data; the writing of the article; or the decision to submit the article for publication.	ANDERBERG R, 1944, EXPT INTELLIGENSUNDE; Batty GD, 2007, ANN EPIDEMIOL, V17, P278, DOI 10.1016/j.annepidem.2006.07.010; Batty GD, 2009, EUR HEART J, V30, P1903, DOI 10.1093/eurheartj/ehp254; Batty GD, 2008, BRIT J PSYCHIAT, V193, P461, DOI 10.1192/bjp.bp.107.037424; Batty GD, 2006, BMJ-BRIT MED J, V332, P580, DOI 10.1136/bmj.38723.660637.AE; CASSEL J, 1976, AM J EPIDEMIOL, V104, P107, DOI 10.1093/oxfordjournals.aje.a112281; Deary I, 2008, NATURE, V456, P175, DOI 10.1038/456175a; Erikson R, 2008, EUR J PUBLIC HEALTH, V18, P473, DOI 10.1093/eurpub/ckn053; Geyer S, 2006, J EPIDEMIOL COMMUN H, V60, P804, DOI 10.1136/jech.2005.041319; Gottfredson LS, 2004, J PERS SOC PSYCHOL, V86, P174, DOI 10.1037/0022-3514.86.1.174; Hallgren S., 1939, THESIS; Hart CL, 2004, SOC SCI MED, V59, P2131, DOI 10.1016/j.socscimed.2004.03.016; Hemmingsson T, 2007, SOC SCI MED, V65, P1410, DOI 10.1016/j.socscimed.2007.05.006; Hugosson K., 2003, WORKING LIFE SUSTAIN; Huisman M, 2005, LANCET, V365, P493, DOI 10.1016/S0140-6736(05)17867-2; HUSEN T, 1969, TALENT OPPORTUNITY C; HUSEN T, 1950, TESTRESULTATENS PROG; Kuh D, 2004, INT J EPIDEMIOL, V33, P408, DOI 10.1093/ije/dyh043; Kunst AE, 1998, BMJ-BRIT MED J, V316, P1636, DOI 10.1136/bmj.316.7145.1636; KUO HHD, 2001, GENDER EARLY LIFE CI; Lawlor DA, 2008, EUR J EPIDEMIOL, V23, P695, DOI 10.1007/s10654-008-9281-z; Lynch J, 2006, J EPIDEMIOL COMMUN H, V60, P436, DOI 10.1136/jech.2005.041350; Marmot M., 2004, STATUS SYNDROME, DOI 10.1111/J.1740-9713.2004.00058.X; Martin LT, 2005, AM J EPIDEMIOL, V162, P887, DOI 10.1093/aje/kwi300; Martin LT, 2004, J EPIDEMIOL COMMUN H, V58, P674, DOI 10.1136/jech.2003.016444; Neisser U, 1996, AM PSYCHOL, V51, P77, DOI 10.1037/0003-066X.51.2.77; NORDLUND A, 1998, SMOKING CANC SWEDISH; Osler M, 2007, INT J EPIDEMIOL, V36, P212, DOI 10.1093/ije/dyl261; Schaap MM, 2009, SOC SCI MED, V68, P1271, DOI 10.1016/j.socscimed.2009.01.007; Snowdon D. A., 1999, PARADOXES LONGEVITY; Steenland K, 2004, AM J PUBLIC HEALTH, V94, P1037, DOI 10.2105/AJPH.94.6.1037; STERN LW, 1920, INTELLIGENZ KINDER J; Whalley LJ, 2001, BRIT MED J, V322, P819, DOI 10.1136/bmj.322.7290.819	33	34	36	1	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 11	2009	339								b5282	10.1136/bmj.b5282	http://dx.doi.org/10.1136/bmj.b5282			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VI	20008007	Green Published, hybrid, Green Submitted			2022-12-28	WOS:000272697800004
J	Peile, E				Peile, Ed			Commentary: Learning out of your depth	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Warwick, Warwick Med Sch, Med Teaching Ctr, Coventry CV4 7AL, W Midlands, England	University of Warwick	Peile, E (corresponding author), Univ Warwick, Warwick Med Sch, Med Teaching Ctr, Coventry CV4 7AL, W Midlands, England.	ed.peile@warwick.ac.uk						Gopnik A., 2009, PHILOS BABY; OVERTON WF, 1981, INT J BEHAV DEV, V4, P99, DOI 10.1177/016502548100400107; Reuss R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3862; Slotnick HB, 1999, ACAD MED, V74, P1106, DOI 10.1097/00001888-199910000-00014; van Lohuizen MT, 2009, MED TEACH, V31, pE494, DOI 10.3109/01421590902744894	5	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2009	339								b5180	10.1136/bmj.b5180	http://dx.doi.org/10.1136/bmj.b5180			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VH	20007660				2022-12-28	WOS:000272697600007
J	Schulman, S; Kearon, C; Kakkar, AK; Mismetti, P; Schellong, S; Eriksson, H; Baanstra, D; Schnee, J; Goldhaber, SZ				Schulman, Sam; Kearon, Clive; Kakkar, Ajay K.; Mismetti, Patrick; Schellong, Sebastian; Eriksson, Henry; Baanstra, David; Schnee, Janet; Goldhaber, Samuel Z.		RE-COVER Study Grp	Dabigatran versus Warfarin in the Treatment of Acute Venous Thromboembolism.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							DEEP-VEIN THROMBOSIS; ORAL ANTICOAGULANT-THERAPY; RANDOMIZED-TRIAL; ATRIAL-FIBRILLATION; PREVENTION; ETEXILATE; HEPARIN; XIMELAGATRAN; REPLACEMENT; ENOXAPARIN	Background: The direct oral thrombin inhibitor dabigatran has a predictable anticoagulant effect and may be an alternative therapy to warfarin for patients who have acute venous thromboembolism. Methods: In a randomized, double-blind, noninferiority trial involving patients with acute venous thromboembolism who were initially given parenteral anticoagulation therapy for a median of 9 days (interquartile range, 8 to 11), we compared oral dabigatran, administered at a dose of 150 mg twice daily, with warfarin that was dose-adjusted to achieve an international normalized ratio of 2.0 to 3.0. The primary outcome was the 6-month incidence of recurrent symptomatic, objectively confirmed venous thromboembolism and related deaths. Safety end points included bleeding events, acute coronary syndromes, other adverse events, and results of liver-function tests. Results: A total of 30 of the 1274 patients randomly assigned to receive dabigatran (2.4%), as compared with 27 of the 1265 patients randomly assigned to warfarin (2.1%), had recurrent venous thromboembolism; the difference in risk was 0.4 percentage points (95% confidence interval [CI], -0.8 to 1.5; P<0.001 for the prespecified noninferiority margin). The hazard ratio with dabigatran was 1.10 (95% CI, 0.65 to 1.84). Major bleeding episodes occurred in 20 patients assigned to dabigatran (1.6%) and in 24 patients assigned to warfarin (1.9%) (hazard ratio with dabigatran, 0.82; 95% CI, 0.45 to 1.48), and episodes of any bleeding were observed in 205 patients assigned to dabigatran (16.1%) and 277 patients assigned to warfarin (21.9%; hazard ratio with dabigatran, 0.71; 95% CI, 0.59 to 0.85). The numbers of deaths, acute coronary syndromes, and abnormal liver-function tests were similar in the two groups. Adverse events leading to discontinuation of the study drug occurred in 9.0% of patients assigned to dabigatran and in 6.8% of patients assigned to warfarin (P=0.05). Conclusions: For the treatment of acute venous thromboembolism, a fixed dose of dabigatran is as effective as warfarin, has a safety profile that is similar to that of warfarin, and does not require laboratory monitoring. (ClinicalTrials.gov number, NCT00291330.) N Engl J Med 2009;361:2342-52.	[Schulman, Sam; Kearon, Clive] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Schulman, Sam; Kearon, Clive] Henderson Res Ctr, Hamilton, ON, Canada; [Schulman, Sam] Karolinska Univ Hosp, Dept Hematol, Stockholm, Sweden; [Kakkar, Ajay K.] Thrombosis Res Inst, London, England; [Kakkar, Ajay K.] Queen Mary Univ London, London, England; [Mismetti, Patrick] Bellevue Hosp, Dept Vasc Pathol, St Etienne, France; [Schellong, Sebastian] Municipal Hosp Friedrichstadt, Med Div 2, Dresden, Germany; [Eriksson, Henry] Sahlgrens Univ Hosp, Dept Med, Gothenburg, Sweden; [Baanstra, David] Boehringer Ingelheim GmbH & Co KG, Clin Res, Alkmaar, Netherlands; [Schnee, Janet] Boehringer Ingelheim GmbH & Co KG, Ridgefield, CT USA; [Goldhaber, Samuel Z.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Boston, MA 02115 USA	McMaster University; Karolinska Institutet; Karolinska University Hospital; Thrombosis Research Institute; University of London; Queen Mary University London; CHU de St Etienne; Sahlgrenska University Hospital; Boehringer Ingelheim; Boehringer Ingelheim; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Schulman, S (corresponding author), HHS Gen Hosp, Thrombosis Serv, 237 Barton St E, Hamilton, ON L8L 2X2, Canada.	schulms@mcmaster.ca	Kaynar, Leylagul/F-6991-2013; GUNEY, MEHMET RASIT/GSJ-2147-2022; Kovacs, Michael/G-3315-2011; PUECH-LEAO, PEDRO/AAW-8801-2020; Quere, Isabelle/AAB-8519-2020; Waage, Anders/D-7705-2013; Puech-Leao, Pedro/A-1715-2015; Biesma, Douwe H./AAV-6343-2020; Schulman, Sam/I-7559-2019	Kaynar, Leylagul/0000-0002-2035-9462; GUNEY, MEHMET RASIT/0000-0002-7795-6022; PUECH-LEAO, PEDRO/0000-0002-6974-9509; Quere, Isabelle/0000-0002-1492-9764; Biesma, Douwe H./0000-0001-8334-3057; Schulman, Sam/0000-0002-8512-9043; Chen, Lu/0000-0002-9580-8576; Gadisseur, Alain/0000-0001-9419-8772; Mateo, Jose/0000-0002-4227-3256; Farkas, Katalin/0000-0001-5577-6808; Dees, Adriaan/0000-0001-9164-4538				Ansell J, 2008, CHEST, V133, p160S, DOI 10.1378/chest.08-0670; Baetz BE, 2008, PHARMACOTHERAPY, V28, P1354, DOI 10.1592/phco.28.11.1354; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Eriksson BI, 2007, J THROMB HAEMOST, V5, P2178, DOI 10.1111/j.1538-7836.2007.02748.x; Eriksson BI, 2007, LANCET, V370, P949, DOI 10.1016/S0140-6736(07)61445-7; Ezekowitz MD, 2007, AM J CARDIOL, V100, P1419, DOI 10.1016/j.amjcard.2007.06.034; Fiessinger JN, 2005, JAMA-J AM MED ASSOC, V293, P681, DOI 10.1001/jama.293.6.681; GALLUS A, 1986, LANCET, V2, P1293; Gould MK, 1999, ANN INTERN MED, V130, P789, DOI 10.7326/0003-4819-130-10-199905180-00002; Gross PL, 2009, CLIN PHARMACOL THER, V86, P139, DOI 10.1038/clpt.2009.98; HOLMGREN KAJ, 1985, ACTA MED SCAND, V218, P279; HULL RD, 1990, NEW ENGL J MED, V322, P1260, DOI 10.1056/NEJM199005033221802; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; LANCASTER TR, 1991, ARCH INTERN MED, V151, P1944, DOI 10.1001/archinte.151.10.1944; LEVINE MN, 1995, THROMB HAEMOSTASIS, V74, P606; Oger E, 2000, THROMB HAEMOSTASIS, V83, P657; Rose AJ, 2008, J THROMB HAEMOST, V6, P1647, DOI 10.1111/j.1538-7836.2008.03075.x; SCHULMAN S, 1985, ACTA MED SCAND, V217, P547; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Schulman S, 2003, NEW ENGL J MED, V349, P1713, DOI 10.1056/NEJMoa030104; SCHULMAN S, 1995, NEW ENGL J MED, V332, P1661, DOI 10.1056/NEJM199506223322501; Spencer FA, 2006, J GEN INTERN MED, V21, P722, DOI 10.1111/j.1525-1497.2006.00458.x	22	1807	1895	1	97	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2009	361	24					2342	2352		10.1056/NEJMoa0906598	http://dx.doi.org/10.1056/NEJMoa0906598			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529VS	19966341	Green Published			2022-12-28	WOS:000272547600008
J	Whitfield, JD; Mostafa, G				Whitfield, John D.; Mostafa, Gamal			Ileocecal Intussusception.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Whitfield, John D.; Mostafa, Gamal] Carolinas Med Ctr, Charlotte, NC 28203 USA	Carolinas Medical Center	Whitfield, JD (corresponding author), Carolinas Med Ctr, Charlotte, NC 28203 USA.	gamal.mostafa@carolinashealthcare.org	mostafa, gamal/AAX-4458-2021						0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2009	361	24					E55	E55		10.1056/NEJMicm0808287	http://dx.doi.org/10.1056/NEJMicm0808287			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529VS	20007558				2022-12-28	WOS:000272547600011
J	Albain, KS; Barlow, WE; Ravdin, PM; Farrar, WB; Burton, GV; Ketchel, SJ; Cobau, CD; Levine, EG; Ingle, JN; Pritchard, KI; Lichter, AS; Schneider, DJ; Abeloff, MD; Henderson, IC; Muss, HB; Green, SJ; Lew, D; Livingston, RB; Martino, S; Osborne, CK				Albain, Kathy S.; Barlow, William E.; Ravdin, Peter M.; Farrar, William B.; Burton, Gary V.; Ketchel, Steven J.; Cobau, Charles D.; Levine, Ellis G.; Ingle, James N.; Pritchard, Kathleen I.; Lichter, Allen S.; Schneider, Daniel J.; Abeloff, Martin D.; Henderson, I. Craig; Muss, Hyman B.; Green, Stephanie J.; Lew, Danika; Livingston, Robert B.; Martino, Silvana; Osborne, C. Kent		Breast Canc Intergrp N America	Adjuvant chemotherapy and timing of tamoxifen in postmenopausal patients with endocrine-responsive, node-positive breast cancer: a phase 3, open-label, randomised controlled trial	LANCET			English	Article							FLUOROURACIL CHEMOTHERAPY; METHOTREXATE; CYCLOPHOSPHAMIDE; CELLS; ANTAGONISM; CARCINOMA; THERAPY; WOMEN	Background Tamoxifien is standard adjuvant treatment for postmenopausal women with hormone-receptor-positive breast cancer. We assessed the benefit of adding chemotherapy to adjuvant tamoxifen and whether tamoxifen should be given concurrently or after chemotherapy. Methods We undertook a phase 3, parallel, randomised trial (SWOG-8814, INT-0100) in postmenopausal women with hormone-receptor-positive, node-positive breast cancer to test two major objectives: whether the primary outcome, disease-free survival, was longer with cyclophosphamide, doxorubicin, and fluorouracil (CAF) given every 4 weeks for six cycles plus 5 years of daily tamoxifen than with tamoxifen alone; and whether disease-free survival was longer with CAF followed by tamoxifen (CAF-T) than with CAF plus concurrent tamoxifen (CAFT). Overall survival and toxicity were predefined, important secondary outcomes for each objective. Patients in this open-label trial were randomly assigned by a computer algorithm in a 2:33 ratio (tamoxifen:CAF-T:CAFT) and analysis was by intention to treat of eligible patients. Groups were compared by stratified log-rank tests, followed by Cox regression analyses adjusted for significant prognostic factors. This trial is registered with ClinicalTrials.gov, number NCT00929591. Findings Of 1558 randomised women, 1477 (95%) were eligible for inclusion in the analysis. After a maximum of 13 years of follow-up (median 8.94 years), 637 women had a disease-free survival event (tamoxifen, 179 events in 361 patients; CAF-T, 216 events in 566 patients; CAFT, 242 events in 550 patients). For the first objective, therapy with the CAF plus tamoxifen groups combined (CAFT or CAF-T) was superior to tamoxifen alone for the primary endpoint of disease-free survival (adjusted Cox regression hazard ratio [HR] 0.76, 95% CI 0.64-0.91; p=0.002) but only marginally for the secondary endpoint of overall survival (HR 0.83, 0.68-1.01; p=0.057). For the second objective, the adjusted HRs favoured CAF-T over CAFT but did not reach significance for disease-free survival (HR 0.84, 0.70-1.01; p=0.061) or overall survival (HR 0.90, 0.73-1.10; p=0.30). Neutropenia, stomatitis, thromboembolism, congestive heart failure, and leukaemia were more frequent in the combined CAF plus tamoxifen groups than in the tamoxifen-alone group. Interpretation Chemotherapy with CAF plus tamoxifen given sequentially is more effective adjuvant therapy for postmenopausal patients with endocrine-responsive, node-positive breast cancer than is tamoxifen alone. However, it might be possible to identify some subgroups that do not benefit from anthracycline-based chemotherapy despite positive nodes.	[Albain, Kathy S.] Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Stritch Sch Med, 2160 S 1st Ave, Maywood, IL 60153 USA; [Barlow, William E.; Green, Stephanie J.; Lew, Danika] SW Oncol Grp Stat Ctr, Seattle, WA USA; [Ravdin, Peter M.] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Farrar, William B.] Ohio State Univ, Ctr Hlth, Columbus, OH 43210 USA; [Burton, Gary V.] Louisiana State Univ Hlth Sci Ctr, Shreveport, LA 71105 USA; [Ketchel, Steven J.; Livingston, Robert B.] Univ Arizona, Ctr Canc, Tucson, AZ USA; [Levine, Ellis G.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA; [Cobau, Charles D.] Flower Mem Hosp, Sylvania, OH USA; [Ingle, James N.] Mayo Clin, Rochester, MN USA; [Lichter, Allen S.] Univ Michigan, Ann Arbor, MI 48109 USA; [Abeloff, Martin D.] Johns Hopkins Med Ctr, Baltimore, MD USA; [Henderson, I. Craig] Univ Calif San Francisco, San Francisco, CA 94143 USA; [Muss, Hyman B.] Univ Vermont, Burlington, VT USA; [Muss, Hyman B.] Vermont Canc Ctr, Burlington, VT USA; [Martino, Silvana] Angeles Clin & Res Inst, Santa Monica, CA USA; [Osborne, C. Kent] Baylor Coll Med, Houston, TX 77030 USA	Loyola University Chicago; Fred Hutchinson Cancer Center; University of Texas System; University of Texas Health San Antonio; University System of Ohio; Ohio State University; Louisiana State University System; Louisiana State University Health Sciences Center at Shreveport; University of Arizona; Roswell Park Cancer Institute; Mayo Clinic; University of Michigan System; University of Michigan; Johns Hopkins University; Johns Hopkins Medicine; University of California System; University of California San Francisco; University of Vermont; Angeles Clinic & Research Institute; Baylor College of Medicine	Albain, KS (corresponding author), Loyola Univ, Med Ctr, Cardinal Bernardin Canc Ctr, Stritch Sch Med, 2160 S 1st Ave, Maywood, IL 60153 USA.	kalbain@lumc.edu	Pritchard, Kathleen I/I-2184-2014	Pritchard, Kathleen I/0000-0003-0758-9666	National Cancer Institute, Department of Health and Human Services [CA38926, CA32102, CA21115, CA02599, CA60138, CA25224, CA77202-06, CA04920, CA58658, CA13612, CA37981, CA76447, CA22433, CA58416, CA20319, CA58686, CA04919, CA46441, CA58861, CA27057, CA32734, CA35281, CA12644, CA16385, CA45560, CA58882, CA14028, CA35176, CA46282, CA46113, CA52650]; NATIONAL CANCER INSTITUTE [U10CA035119, U10CA045377, U10CA077202, U10CA012644, U10CA052650, U10CA014028, U10CA076447, U10CA022433, U10CA037981, U10CA002599, U10CA058415, U10CA060138, U10CA035192, U10CA016385, U10CA045560, U10CA028862, U10CA076429, U10CA035128, U10CA058882, U10CA027057, U10CA035281, U10CA025224, U10CA032734, U10CA058686, U10CA013612, U10CA038926, U10CA042777, U10CA058861, U10CA052623, U10CA020319, U10CA063844, U10CA046113, U10CA035200, U10CA046441, U10CA004919, U10CA052772, U10CA021115, U10CA058658, U10CA058348, U10CA067663, U10CA012213, U10CA045461, U10CA035090, U10CA045807, U10CA035431, U10CA035283, U10CA058723, U10CA035084, U10CA004920, U10CA045450, U10CA046282, U10CA035117, U10CA052654, U10CA035176, U10CA046368, U10CA032102, U10CA058416, U10CA003096, U10CA046136, U10CA052757, U10CA045466, U10CA035178, U10CA035261] Funding Source: NIH RePORTER	National Cancer Institute, Department of Health and Human Services(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was solely supported by the National Cancer Institute as a High Priority Trial and was undertaken by the Southwest Oncology Group (SWOG) for The Breast Cancer Intergroup of North America. The investigation was supported in part by the following PHS Cooperative Agreement grant numbers awarded by the National Cancer Institute, Department of Health and Human Services: CA38926, CA32102, CA21115, CA02599, CA60138, CA25224. CA77202-06, CA04920, CA58658, CA13612, CA37981, CA76447, CA22433, CA58416, CA20319, CA58686, CA04919, CA46441, CA58861, CA27057, CA32734, CA35281, CA12644, CA16385, CA45560, CA58882, CA14028, CA35176, CA46282, CA46113, CA52650, CA03096, CA28862, CA35090, CA58723, CA35283, CA45807, CA35200, CA35119, CA45450, CA46136, CA42777, CA35261, CA45466, CA35117, CA46368, CA59348, CA12213, CA52654, CA35128, CA58415, CA52623, CA35192, CA45377, CA35996, CA52757, CA76132, CA35431, CA76462, CA45461, CA35084, CA76429, CA35178, CA67663, CA63844, CA52772. We thank The Breast Cancer Intergroup of North America discipline leaders for their advice or assistance during the design or conduct of this study. We thank the membership of the Breast Committees of SWOG, ECOG, NCCTG, CALGB, and NCIC for their support of this study over the long accrual period. We also thank the survivors of breast cancer who were treated and followed-tip on this protocol.	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; *AJCC, 1988, STAG MAN; ALBAIN K, 1997 ASCO ANN M; ALBAIN K, 2001, 2001 ASCO ANN M SAN; Albain KS, 2010, LANCET ONCOL, V11, P55, DOI 10.1016/S1470-2045(09)70314-6; ALBAIN KS, 2002, P ASCO, V21, P143; [Anonymous], 1988, NEW ENGL J MED, V319, P1681; BULL JM, 1978, CANCER, V41, P1649, DOI 10.1002/1097-0142(197805)41:5<1649::AID-CNCR2820410501>3.0.CO;2-J; BUZDAR AU, 1986, NATL CANCER I MONOGR, V1, P81; CASTIGLIONEGERT.M, 2002, JNCI-J NATL CANCER I, V994, P1054; Clarke M, 1998, LANCET, V351, P1451; Crivellari D, 2000, J CLIN ONCOL, V18, P1412, DOI 10.1200/JCO.2000.18.7.1412; CUMMINGS FJ, 1985, J CLIN ONCOL, V3, P932, DOI 10.1200/JCO.1985.3.7.932; Eifel P, 2001, JNCI-J NATL CANCER I, V93, P979; FISHER B, 1990, J CLIN ONCOL, V8, P1005, DOI 10.1200/JCO.1990.8.6.1005; FISHER B, 1989, J CLIN ONCOL, V7, P572, DOI 10.1200/JCO.1989.7.5.572; FLEMING TR, 1984, CONTROL CLIN TRIALS, V5, P348, DOI 10.1016/S0197-2456(84)80014-8; GOLDENBERG GJ, 1985, BIOCHEM PHARMACOL, V34, P763, DOI 10.1016/0006-2952(85)90755-5; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; HUG V, 1985, J CLIN ONCOL, V3, P1672, DOI 10.1200/JCO.1985.3.12.1672; Levine MN, 1998, J CLIN ONCOL, V16, P2651, DOI 10.1200/JCO.1998.16.8.2651; MANTEL NATHAN, 1966, CANCERCHEMOTHERAP REP, V50, P163; Namer M, 2004, BREAST CANCER RES TR, V88, pS59; Osborne C K, 1981, Breast Cancer Res Treat, V1, P121, DOI 10.1007/BF01805864; OSBORNE CK, 1989, J CLIN ONCOL, V7, P710, DOI 10.1200/JCO.1989.7.6.710; Perloff M, 1996, J CLIN ONCOL, V14, P1589, DOI 10.1200/JCO.1996.14.5.1589; PICO C, 2002, 2002 ASCO ANN M ORL; Pritchard KI, 1997, J CLIN ONCOL, V15, P2302, DOI 10.1200/JCO.1997.15.6.2302; RIVKIN SE, 1994, J CLIN ONCOL, V12, P2078, DOI 10.1200/JCO.1994.12.10.2078; SERTOLI MR, 2002, ASCO ANN M ORL FL US; SUTHERLAND RL, 1983, EUR J CANCER CLIN ON, V19, P615, DOI 10.1016/0277-5379(83)90177-3	31	171	179	1	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC-JAN	2009	374	9707					2055	2063		10.1016/S0140-6736(09)61523-3	http://dx.doi.org/10.1016/S0140-6736(09)61523-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	537OO	20004966	Green Accepted, Bronze			2022-12-28	WOS:000273122900028
J	Winikoff, B; Dabash, R; Durocher, J; Darwish, E; Ngoc, NTN; Leon, W; Raghavan, S; Medhat, I; Chi, HTK; Barrera, G; Blum, J				Winikoff, Beverly; Dabash, Rasha; Durocher, Jill; Darwish, Emad; Ngoc, Nguyen Thi Nhu; Leon, Wilfrido; Raghavan, Sheila; Medhat, Ibrahim; Chi, Huynh Thi Kim; Barrera, Gustavo; Blum, Jennifer			Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women not exposed to oxytocin during labour: a double-blind, randomised, non-inferiority trial	LANCET			English	Article							RECTALLY ADMINISTERED MISOPROSTOL; INTRAUTERINE MISOPROSTOL; MANAGEMENT	Background Oxytocin, the standard of care for treatment of post-partum haemorrhage, is not available in all settings because of refrigeration requirements and the need for intravenous administration. Misoprostol, an effective uterotonic agent with several advantages for resource-poor settings, has been investigated as an alternative. This trial established whether sublingual misoprostol was similarly efficacious to intravenous oxytocin for treatment of post-partum haemorrhage in women not exposed to oxytocin during labour. Methods In this double-blind, non-inferiority trial, 9348 women not exposed to prophylactic oxytocin bad blood loss measured after vaginal delivery at four hospitals in Ecuador, Egypt, and Vietnam (one secondary-level and three tertiary-level facilities). 978 (10%) women were diagnosed with primary post-partum haemorrhage and were randomly assigned to receive 800 mu g misoprostol (n=488) or 40 IU intravenous oxytocin (n=490). Providers and women were masked to treatment assignment. Primary endpoints were cessation of active bleeding within 20 min and additional blood loss of 300 mL or more after treatment. Clinical equivalence of misoprostol would be accepted if the upper bound of the 97.5% CI fell below the predefined non-inferiority margin of 6%. All outcomes were assessed from the time of initial treatment. This study is registered with ClinicalTrials.gov, number NCT00116350. Findings All randomly assigned participants were analysed. Active bleeding was controlled within 20 min with study treatment alone for 440 (90%) women given misoprostol and 468 (96%) given oxytocin (relative risk [RR] 0.94, 95% CI 0.91-0.98; crude difference 5.3%, 95% Cl 2.6-8.6). Additional blood loss of 300 mL or greater after treatment occurred for 147 (30%) of women receiving misoprostol and 83 (17%) receiving oxytocin (RR 1.78, 95% CI 1.40-2.26). Shivering (229 [47%] vs 82 [17%]; RR 2.80, 95% CI 2.25-3.49) and fever (217 [44%] vs 27 [6%]; 8.07, 5.52-11.8) were significantly more common with misoprostol than with oxytocin. No women had hysterectomies or died. Interpretation In settings in which use of oxytocin is not feasible, misoprostol might be a suitable first-line treatment alternative for post-partum haemorrhage.	[Winikoff, Beverly; Dabash, Rasha; Durocher, Jill; Raghavan, Sheila; Blum, Jennifer] Gynu Hlth Projects, New York, NY 10010 USA; [Darwish, Emad; Medhat, Ibrahim] Univ Alexandria, Shatby Matern Hosp, Alexandria, Egypt; [Ngoc, Nguyen Thi Nhu] Ctr Res & Consultancy Reprod Hlth, Ho Chi Minh City, Vietnam; [Leon, Wilfrido; Barrera, Gustavo] Hosp Gineco Obstet Isidro Ayora, Quito, Ecuador	Egyptian Knowledge Bank (EKB); Alexandria University	Dabash, R (corresponding author), Gynu Hlth Projects, 15 E 26th St,Suite 801, New York, NY 10010 USA.	rdabash@gynuity.org		Durocher, Jill/0000-0002-5572-8133	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We thank the women who participated in this study and the hospital staff who attended to them in addition to collecting necessary data for this study; members of our Post-Partum Haemorrhage Advisory Committee: Paul Blumenthal, Jose Guilherme Cecatti, Nancy Sloan, Friday Okonofua, Swaraj Rajbhandari, Jeff Spieler, and Gijs Walraven; the Data Safety and Monitoring Board Members: Jose Guilherme Cecatti, Thomas Easterling, and Anne Paxton for their time and contributions; Tamer Abdel Daeim, Ayisha Diop, Ilana Dzuba, Nevine Hassanein, Yasser El Kassar, Nguyen thi Ngoc Phuong, Melanie Pena, Ernesto Pinto, and Pham Viet Thanh for their contributions and support; and our partners at Family Care International. This research was funded by a grant from the Bill & Melinda Gates Foundation.	Abdel-Aleem H, 2001, INT J GYNECOL OBSTET, V72, P75, DOI 10.1016/S0020-7292(00)00321-0; AbouZahr C, 2003, BRIT MED BULL, V67, P1, DOI 10.1093/bmb/ldg015; Adekanmi OA, 2001, BRIT J OBSTET GYNAEC, V108, P541, DOI 10.1111/j.1471-0528.2001.00110.x; Alfirevic Z, 2007, INT J GYNECOL OBSTET, V99, pS198, DOI 10.1016/j.ijgo.2007.09.012; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; Blum J, 2007, INT J GYNECOL OBSTET, V99, pS202, DOI 10.1016/j.ijgo.2007.09.013; Blum J, 2010, LANCET, V375, P217, DOI 10.1016/S0140-6736(09)61923-1; *DEP REPR HLTH RES, 1996, CAR NORM BIRTH PRACT; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; Gulmezoglu AM, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000494.pub3; Gulmezoglu AM, 2001, LANCET, V358, P689, DOI 10.1016/S0140-6736(01)05835-4; Hofmeyr GJ, 2008, BEST PRACT RES CL OB, V22, P1025, DOI 10.1016/j.bpobgyn.2008.08.005; Hofmeyr GJ, 2005, BJOG-INT J OBSTET GY, V112, P547, DOI 10.1111/j.1471-0528.2004.00512.x; HOFMEYR GJ, 2004, BJOG, V111, P1014; Khan KS, 2006, LANCET, V367, P1066, DOI 10.1016/S0140-6736(06)68397-9; Lokugamage AU, 2001, ACTA OBSTET GYN SCAN, V80, P835, DOI 10.1034/j.1600-0412.2001.080009835.x; Mousa HA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003249.pub2; O'Brien P, 1998, OBSTET GYNECOL, V92, P212, DOI 10.1016/S0029-7844(98)00161-6; Oboro VO, 2003, INT J GYNECOL OBSTET, V80, P67, DOI 10.1016/S0020-7292(02)00301-6; Ozan H., 2000, Clinical and Experimental Obstetrics and Gynecology, V27, P221; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Prata N, 2005, INT J GYNECOL OBSTET, V90, P51, DOI 10.1016/j.ijgo.2005.03.007; Ramanathan G, 2006, J OBSTET GYNAECOL CA, V28, P967, DOI 10.1016/S1701-2163(16)32308-8; Royal College of Obstetricians and Gynaecologists, 2009, RCOG GREEN TOP GUID, V52; Shojai R, 2004, Gynecol Obstet Fertil, V32, P703, DOI 10.1016/j.gyobfe.2004.05.015; SHOJAI R, 2001, EUR J OBSTET GYN R B, V30, P572; Tang OS, 2007, INT J GYNECOL OBSTET, V99, pS160, DOI 10.1016/j.ijgo.2007.09.004; Tsu VD, 2004, INT J GYNECOL OBSTET, V85, pS83, DOI 10.1016/j.ijgo.2004.02.011; Walraven G, 2004, BJOG-INT J OBSTET GY, V111, P1014, DOI 10.1111/j.1471-0528.2004.00217.x; WHO United Nations Population Fund Unicef World Bank, 2003, MAN COMPL PREGN CHIL; Zuberi Nadeem F, 2008, BMC Pregnancy Childbirth, V8, P40, DOI 10.1186/1471-2393-8-40	31	92	101	0	11	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					210	216		10.1016/S0140-6736(09)61924-3	http://dx.doi.org/10.1016/S0140-6736(09)61924-3			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20060161				2022-12-28	WOS:000273853800030
J	Sugano, SS; Shimada, T; Imai, Y; Okawa, K; Tamai, A; Mori, M; Hara-Nishimura, I				Sugano, Shigeo S.; Shimada, Tomoo; Imai, Yu; Okawa, Katsuya; Tamai, Atsushi; Mori, Masashi; Hara-Nishimura, Ikuko			Stomagen positively regulates stomatal density in Arabidopsis	NATURE			English	Article							SECRETORY PEPTIDE; CELL-DIVISION; DIFFERENTIATION; MOUTHS; TOO	Stomata in the epidermal tissues of leaves are valves through which passes CO2, and as such they influence the global carbon cycle(1). The two-dimensional pattern and density of stomata in the leaf epidermis are genetically and environmentally regulated to optimize gas exchange(2). Two putative intercellular signalling factors, EPF1 and EPF2, function as negative regulators of stomatal development in Arabidopsis, possibly by interacting with the receptor-like protein TMM3-6. One or more positive intercellular signalling factors are assumed to be involved in stomatal development, but their identities are unknown(7). Here we show that a novel secretory peptide, which we designate as stomagen, is a positive intercellular signalling factor that is conserved among vascular plants. Stomagen is a 45-amino-acid, cysteine-rich peptide that is generated from a 102-amino-acid precursor protein designated as STOMAGEN. Both an in planta analysis and a semi-in-vitro analysis with recombinant and chemically synthesized stomagen peptides showed that stomagen has stomata-inducing activity in a dose-dependent manner. A genetic analysis showed that TMM is epistatic to STOMAGEN (At4g12970), suggesting that stomatal development is finely regulated by competitive binding of positive and negative regulators to the same receptor. Notably, STOMAGEN is expressed in inner tissues (the mesophyll) of immature leaves but not in the epidermal tissues where stomata develop. This study provides evidence of a mesophyll-derived positive regulator of stomatal density. Our findings provide a conceptual advancement in understanding stomatal development: inner photosynthetic tissues optimize their function by regulating stomatal density in the epidermis for efficient uptake of CO2.	[Sugano, Shigeo S.; Shimada, Tomoo; Imai, Yu; Hara-Nishimura, Ikuko] Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan; [Okawa, Katsuya] Kyowa Hakko Kirin Co Ltd, Innovat Drug Res Labs, Taksasaki 3701295, Japan; [Tamai, Atsushi; Mori, Masashi] Ishikawa Prefectural Univ, Res Inst Bioresources & Biotechnol, Nonoichi, Ishikawa 9218836, Japan	Kyoto University; Kyowa Kirin Ltd; Ishikawa Prefecture University	Hara-Nishimura, I (corresponding author), Kyoto Univ, Grad Sch Sci, Sakyo Ku, Kyoto 6068502, Japan.	ihnishi@gr.bot.kyoto-u.ac.jp			Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan [16085203, 17107002]; Japan Science and Technology Agency (JST)	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	We thank T. Nakagawa for donating the TMM:: GFP seeds; K. Yamada for his technical support of quantitative PCR; and Y. Nakata for her technical support of in situ hybridization. We thank J. Raymond for reading and editing the manuscript. We thank the ABRC for providing seeds of Arabidopsis T-DNA insertion lines. This work was supported by Grants-in-Aid for Scientific Research (no. 16085203 and 17107002) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, by the Global Center of Excellence Program 'Formation of a Strategic Base for Biodiversity and Evolutionary Research: from Genome to Ecosystem' of MEXT, and by Japan Science and Technology Agency (JST).	Berger D, 2000, GENE DEV, V14, P1119; Bergmann DC, 2004, CURR OPIN PLANT BIOL, V7, P26, DOI 10.1016/j.pbi.2003.10.001; Dohi K, 2008, ARCH VIROL, V153, P1667, DOI 10.1007/s00705-008-0165-z; Geisler M, 1998, PLANTA, V205, P522, DOI 10.1007/s004250050351; Geisler M, 2000, PLANT CELL, V12, P2075, DOI 10.1105/tpc.12.11.2075; Hara K, 2007, GENE DEV, V21, P1720, DOI 10.1101/gad.1550707; Hara K, 2009, PLANT CELL PHYSIOL, V50, P1019, DOI 10.1093/pcp/pcp068; HARAHISHIMURA I, 1993, PLANT J, V4, P793, DOI 10.1046/j.1365-313X.1993.04050793.x; Hetherington AM, 2003, NATURE, V424, P901, DOI 10.1038/nature01843; Hunt L, 2009, CURR BIOL, V19, P864, DOI 10.1016/j.cub.2009.03.069; Jensen ON, 1996, RAPID COMMUN MASS SP, V10, P1371, DOI 10.1002/(SICI)1097-0231(199608)10:11<1371::AID-RCM682>3.0.CO;2-5; Kinoshita T, 1999, PLANT J, V19, P43, DOI 10.1046/j.1365-313X.1999.00497.x; Kono A, 2007, PLANT CELL, V19, P1265, DOI 10.1105/tpc.106.046763; Kunieda T, 2008, PLANT CELL, V20, P2631, DOI 10.1105/tpc.108.060160; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacAlister CA, 2007, NATURE, V445, P537, DOI 10.1038/nature05491; Nadeau JA, 2002, SCIENCE, V296, P1697, DOI 10.1126/science.1069596; Nadeau Jeanette A, 2002, Arabidopsis Book, V1, pe0066, DOI 10.1199/tab.0066; Nadeau JA, 2009, CURR OPIN PLANT BIOL, V12, P29, DOI 10.1016/j.pbi.2008.10.006; Obayashi T, 2009, NUCLEIC ACIDS RES, V37, pD987, DOI 10.1093/nar/gkn807; Pillitteri LJ, 2007, NATURE, V445, P501, DOI 10.1038/nature05467; SACHS T, 1987, CLONAL BASIS DEV, P161; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Serna L, 2002, NEW PHYTOL, V153, P399, DOI 10.1046/j.0028-646X.2001.00343.x; Shimada T, 2006, PLANT CELL PHYSIOL, V47, P1187, DOI 10.1093/pcp/pcj103; Shpak ED, 2005, SCIENCE, V309, P290, DOI 10.1126/science.1109710; von Groll U, 2002, PLANT CELL, V14, P1527, DOI 10.1105/tpc.001016	27	298	329	8	370	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					241	U130		10.1038/nature08682	http://dx.doi.org/10.1038/nature08682			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20010603	Green Published			2022-12-28	WOS:000273582700038
J	Nolan, T; McVernon, J; Skeljo, M; Richmond, P; Wadia, U; Lambert, S; Nissen, M; Marshall, H; Booy, R; Heron, L; Hartel, G; Lai, M; Basser, R; Gittleson, C; Greenberg, M				Nolan, Terry; McVernon, Jodie; Skeljo, Maryanne; Richmond, Peter; Wadia, Ushma; Lambert, Stephen; Nissen, Michael; Marshall, Helen; Booy, Robert; Heron, Leon; Hartel, Gunter; Lai, Michael; Basser, Russell; Gittleson, Charmaine; Greenberg, Michael			Immunogenicity of a Monovalent 2009 Influenza A(H1N1) Vaccine in Infants and Children A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							H1N1 INFLUENZA; SCHOOLCHILDREN; SAFETY	Context In the ongoing influenza pandemic, a safe and effective vaccine against 2009 influenza A(H1N1) is needed for infants and children. Objective To assess the immunogenicity and safety of a 2009 influenza A(H1N1) vaccine in children. Design, Setting, and Participants Randomized, observer-blind, age-stratified, parallel group study assessing 2 doses of an inactivated, split-virus 2009 influenza A(H1N1) vaccine in 370 healthy infants and children aged 6 months to less than 9 years living in Australia. Intervention Intramuscular injection of 15 mu g or 30 mu g of hemagglutinin antigen dose of monovalent, unadjuvanted 2009 influenza A(H1N1) vaccine in a 2-dose regimen, administered 21 days apart. Main Outcome Measures Hemagglutination inhibition assay to estimate the proportion of participants with antibody titers of 1:40 or greater, seroconversion, or a significant antibody titer increase, and factor increase in geometric mean titer. Assessments of solicited adverse events during 7 days and unsolicited adverse events for 21 days after each vaccination. Results Following the first dose of vaccine, antibody titers of 1: 40 or greater were observed in 161 of 174 infants and children in the 15-mu g group (92.5%; 95% confidence interval [CI], 87.6%-95.6%) and in 168 of 172 infants and children in the 30-mu g group (97.7%; 95% CI, 94.2%-99.1%). Corresponding seroconversion rates were 86.8%(95% CI, 80.9%-91.0%) and 94.2% (95% CI, 89.6%-96.8%), and factor increases in geometric mean titer were 13.6 (95% CI, 11.8-15.6) and 18.3 (95% CI, 15.7-21.4). All participants demonstrated antibody titers of 1: 40 or greater after the second vaccine dose. Immune responses were robust regardless of age, baseline serostatus, or seasonal influenza vaccination status. The majority of adverse events were mild to moderate in severity. Conclusion One 15-mu g dose of vaccine was immunogenic in infants and children starting at 6 months of age and vaccine-associated reactions were mild to moderate in severity. Trial Registration clinicaltrials.gov Identifier: NCT00940108 JAMA. 2010; 303(1): 37-46	[Nolan, Terry] Univ Melbourne, Melbourne Sch Populat Hlth, Sch Populat Hlth, Vaccine & Immunizat Res Grp, Carlton, Vic 3010, Australia; [Nolan, Terry; McVernon, Jodie; Skeljo, Maryanne] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Richmond, Peter; Wadia, Ushma] Univ Western Australia, Sch Pediat & Child Hlth, Subiaco, WA, Australia; [Richmond, Peter; Wadia, Ushma] Telethon Inst Child Hlth Res, Subiaco, WA, Australia; [Lambert, Stephen; Nissen, Michael] Royal Childrens Hosp, Queensland Pediat Infect Dis Lab, Herston, Qld, Australia; [Marshall, Helen] Univ Adelaide, Dept Pediat, Adelaide, SA, Australia; [Marshall, Helen] Womens & Childrens Hosp, Adelaide, SA, Australia; [Booy, Robert; Heron, Leon] Univ Sydney, Natl Ctr Immunizat Res & Surveillance Vaccine Pre, Sydney, NSW 2006, Australia; [Booy, Robert; Heron, Leon] Childrens Hosp Westmead, Westmead, NSW, Australia; [Hartel, Gunter; Lai, Michael; Basser, Russell; Gittleson, Charmaine; Greenberg, Michael] CSL Ltd, Clin Res & Dev, Parkville, Vic, Australia	University of Melbourne; Murdoch Children's Research Institute; University of Western Australia; Telethon Kids Institute; University of Western Australia; Royal Children's Hospital Brisbane; University of Adelaide; Womens & Childrens Hospital Australia; University of Sydney; University of Sydney; CSL	Nolan, T (corresponding author), Univ Melbourne, Melbourne Sch Populat Hlth, Sch Populat Hlth, Vaccine & Immunizat Res Grp, L5-207 Bouverie St, Carlton, Vic 3010, Australia.	t.nolan@unimelb.edu.au	Richmond, Peter C/G-3379-2012; Nissen, Michael D/M-6823-2013; Lambert, Stephen B/B-8348-2008; Booy, Robert/D-4188-2011; Greenberg, Michael E/AGZ-9651-2022; Lambert, Stephen/N-7819-2019; Marshall, Helen/G-3603-2013; Hartel, Gunter/J-7790-2017; Nolan, Terry/A-2236-2008	Richmond, Peter C/0000-0001-7562-7228; Nissen, Michael D/0000-0003-1686-3313; Lambert, Stephen B/0000-0002-2709-193X; Lambert, Stephen/0000-0002-2709-193X; Hartel, Gunter/0000-0002-5454-6450; Nolan, Terry/0000-0001-6018-3863; Wadia, Ushma/0000-0002-8097-5072; McVernon, Jodie/0000-0001-9774-1961; Marshall, Helen/0000-0003-2521-5166; Greenberg, Michael/0000-0002-4085-4348; Lai, Michael/0000-0003-4983-7146				Anonymous, 2009, Morbidity and Mortality Weekly Report, V58, P1100; *AUSTR GOV DEP HLT, 19 AUSTR GOV DEP HLT; Basta NE, 2009, AM J EPIDEMIOL, V170, P679, DOI 10.1093/aje/kwp237; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; *COMM PROPR MED PR, 1996, NOT GUID HARM REQ IN; Eichelberger M, 2008, VACCINE, V26, P4299, DOI 10.1016/j.vaccine.2008.06.012; Garcia-Garcia L, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3928; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; *HLTH PROT AG HLTH, 2009, EURO SURVEILL, V14; Jordan R, 2006, VACCINE, V24, P1047, DOI 10.1016/j.vaccine.2005.09.017; Kelly H, 2009, EUROSURVEILLANCE, V14, P33; MCBRYDE E, 2009, EARLY TRANSMISSION C; Medlock J, 2009, SCIENCE, V325, P1705, DOI 10.1126/science.1175570; Nguyen-Van-Tam JS, 2006, ARCH DIS CHILD, V91, P5, DOI 10.1136/adc.2005.079087; Nichol KL, 2008, VACCINE, V26, pD17, DOI 10.1016/j.vaccine.2008.07.048; Nishiura H, 2009, EUROSURVEILLANCE, V14; Nolan T, 2008, VACCINE, V26, P6383, DOI 10.1016/j.vaccine.2008.08.046; Nolan T, 2009, INFLUENZA OTHER RESP, V3, P315, DOI 10.1111/j.1750-2659.2009.00108.x; Poehling KA, 2009, VACCINE, V27, P2695, DOI 10.1016/j.vaccine.2009.02.043; Public Health Agency of Canada, STAT SEAS TRIV IN IN; Reichert TA, 2001, NEW ENGL J MED, V344, P889, DOI 10.1056/NEJM200103223441204; Stone R, 2009, SCIENCE, V325, P1482, DOI 10.1126/science.325_1482; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Wise J, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3969; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535; [No title captured]	29	157	162	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2010	303	1					37	46		10.1001/jama.2009.1911	http://dx.doi.org/10.1001/jama.2009.1911			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539YS	20026597	Bronze			2022-12-28	WOS:000273296900017
J	Pfeifer, D; Alfonso, C; Wood, D				Pfeifer, Dina; Alfonso, Claudia; Wood, David			Defining the safety profile of pandemic influenza vaccines	LANCET			English	Editorial Material									[Pfeifer, Dina; Alfonso, Claudia; Wood, David] WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland	World Health Organization	Pfeifer, D (corresponding author), WHO, Dept Immunizat Vaccines & Biol, CH-1211 Geneva, Switzerland.	pfeiferd@who.int						Black S, 2009, LANCET, V374, P2115, DOI 10.1016/S0140-6736(09)61877-8; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; *EUR MED AG, 2009, PAND INFL A H1N1 V V; *EUR MED AG, 2009, 2 PAND PHARM WEEKL U; *GLOB ADV COMM VAC, 2009, WKLY E IN PRESS 1203; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Liang XF, 2010, LANCET, V375, P56, DOI 10.1016/S0140-6736(09)62003-1; *MIN HLTH PEOPL RE, 2009, 21 MIN HLTH PEOPL RE; Plennevaux E, 2010, LANCET, V375, P41, DOI 10.1016/S0140-6736(09)62026-2; Vajo Z, 2010, LANCET, V375, P49, DOI 10.1016/S0140-6736(09)62039-0; *WHO, 2007, REG PREP HUM PAND IN; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	12	7	7	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2010	375	9708					9	11		10.1016/S0140-6736(09)62133-4	http://dx.doi.org/10.1016/S0140-6736(09)62133-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	539BZ	20018368				2022-12-28	WOS:000273229700007
J	Miras, HN; Cooper, GJT; Long, DL; Bogge, H; Muller, A; Streb, C; Cronin, L				Miras, Haralampos N.; Cooper, Geoffrey J. T.; Long, De-Liang; Boegge, Hartmut; Mueller, Achim; Streb, Carsten; Cronin, Leroy			Unveiling the Transient Template in the Self-Assembly of a Molecular Oxide Nanowheel	SCIENCE			English	Article							MOLYBDENUM-BLUE; BUILDING-BLOCKS	Self-assembly has proven a powerful means of preparing structurally intricate nanomaterials, but the mechanism is often masked by the common one-pot mixing procedure. We employed a flow system to study the steps underlying assembly of a previously characterized molybdenum oxide wheel 3.6 nanometers in diameter. We observed crystallization of an intermediate structure in which a central {Mo-36} cluster appears to template the assembly of the surrounding {Mo-150} wheel. The transient nature of the template is demonstrated by its ejection after the wheel is reduced to its final electronic state. The template's role in the self-assembly mechanism is further confirmed by the deliberate addition of the template to the reaction mixture, which greatly accelerates the assembly time of the {Mo-150} wheel and increases the yield.	[Miras, Haralampos N.; Cooper, Geoffrey J. T.; Long, De-Liang; Streb, Carsten; Cronin, Leroy] Univ Glasgow, Dept Chem, WestCHEM, Glasgow G12 8QQ, Lanark, Scotland; [Boegge, Hartmut; Mueller, Achim] Univ Bielefeld, Fak Chem, D-33501 Bielefeld, Germany	University of Glasgow; University of Bielefeld	Cronin, L (corresponding author), Univ Glasgow, Dept Chem, WestCHEM, Glasgow G12 8QQ, Lanark, Scotland.	L.Cronin@chem.gla.ac.uk	Miras, Haralampos/C-1691-2008; Cronin, Leroy/AAW-8067-2020; Cronin, Leroy/B-7752-2008; Long, Deliang/C-3500-2011; Streb, Carsten/A-7326-2009; Miras, Haralampos N./C-6345-2014	Miras, Haralampos/0000-0002-0086-5173; Cronin, Leroy/0000-0001-8035-5757; Cronin, Leroy/0000-0001-8035-5757; Streb, Carsten/0000-0002-5846-1905; Miras, Haralampos N./0000-0002-0086-5173; Muller, Achim/0000-0003-0117-4021	EPSRC [EP/H024107/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/H024107/1] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))		Badjic JD, 2004, SCIENCE, V303, P1845, DOI 10.1126/science.1094791; Baxter P. N. W., 1996, COMPREHENSIVE SUPRAM, V9, P165; Chae HK, 2004, NATURE, V427, P523, DOI 10.1038/nature02311; CRAM DJ, 1992, NATURE, V356, P29, DOI 10.1038/356029a0; Holliday BJ, 2001, ANGEW CHEM INT EDIT, V40, P2022, DOI 10.1002/1521-3773(20010601)40:11<2022::AID-ANIE2022>3.3.CO;2-4; LEHN JM, 1985, SCIENCE, V227, P849, DOI 10.1126/science.227.4689.849; Long DL, 2007, CHEM SOC REV, V36, P105, DOI 10.1039/b502666k; Mal P, 2009, SCIENCE, V324, P1697, DOI 10.1126/science.1175313; Matsuda R, 2005, NATURE, V436, P238, DOI 10.1038/nature03852; Mulfort KL, 2009, J AM CHEM SOC, V131, P3866, DOI 10.1021/ja809954r; Muller A, 2003, COORDIN CHEM REV, V245, P153, DOI 10.1016/S0010-8545(03)00110-3; Muller A, 1997, ANGEW CHEM INT EDIT, V36, P484, DOI 10.1002/anie.199704841; Muller A, 2000, ACCOUNTS CHEM RES, V33, P2, DOI 10.1021/ar9601510; Muller A, 1999, Z ANORG ALLG CHEM, V625, P1187, DOI 10.1002/(SICI)1521-3749(199907)625:7<1187::AID-ZAAC1187>3.0.CO;2-#; MULLER A, 1995, ANGEW CHEM INT EDIT, V34, P2122, DOI 10.1002/anie.199521221; Muller A, 1999, CHEM-EUR J, V5, P1496, DOI 10.1002/(SICI)1521-3765(19990503)5:5<1496::AID-CHEM1496>3.0.CO;2-D; Sato S, 2006, SCIENCE, V313, P1273, DOI 10.1126/science.1129830; Shishido S, 2008, J AM CHEM SOC, V130, P10588, DOI 10.1021/ja800784a	18	205	208	4	113	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					72	74		10.1126/science.1181735	http://dx.doi.org/10.1126/science.1181735			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044572				2022-12-28	WOS:000273395400032
J	Tran, TS; Rubio, ME; Clem, RL; Johnson, D; Case, L; Tessier-Lavigne, M; Huganir, RL; Ginty, DD; Kolodkin, AL				Tran, Tracy S.; Rubio, Maria E.; Clem, Roger L.; Johnson, Dontais; Case, Lauren; Tessier-Lavigne, Marc; Huganir, Richard L.; Ginty, David D.; Kolodkin, Alex L.			Secreted semaphorins control spine distribution and morphogenesis in the postnatal CNS	NATURE			English	Article							DENDRITIC SPINES; PYRAMIDAL NEURONS; MORPHOLOGY; PLEXIN-A3; CORTEX	The majority of excitatory synapses in the mammalian CNS (central nervous system) are formed on dendritic spines(1), and spine morphology and distribution are critical for synaptic transmission(2-6), synaptic integration and plasticity(7). Here, we show that a secreted semaphorin, Sema3F, is a negative regulator of spine development and synaptic structure. Mice with null mutations in genes encoding Sema3F, and its holoreceptor components neuropilin-2 (Npn-2, also known as Nrp2) and plexin A3 (PlexA3, also known as Plxna3), exhibit increased dentate gyrus (DG) granule cell (GC) and cortical layer V pyramidal neuron spine number and size, and also aberrant spine distribution. Moreover, Sema3F promotes loss of spines and excitatory synapses in dissociated neurons in vitro, and in Npn-2(-/-) brain slices cortical layer V and DG GCs exhibit increased mEPSC (miniature excitatory postsynaptic current) frequency. In contrast, a distinct Sema3A-Npn-1/PlexA4 signalling cascade controls basal dendritic arborization in layer V cortical neurons, but does not influence spine morphogenesis or distribution. These disparate effects of secreted semaphorins are reflected in the restricted dendritic localization of Npn-2 to apical dendrites and of Npn-1 (also known as Nrp1) to all dendrites of cortical pyramidal neurons. Therefore, Sema3F signalling controls spine distribution along select dendritic processes, and distinct secreted semaphorin signalling events orchestrate CNS connectivity through the differential control of spine morphogenesis, synapse formation, and the elaboration of dendritic morphology.	[Tran, Tracy S.; Clem, Roger L.; Johnson, Dontais; Huganir, Richard L.; Ginty, David D.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA; [Tran, Tracy S.; Clem, Roger L.; Johnson, Dontais; Huganir, Richard L.; Ginty, David D.; Kolodkin, Alex L.] Johns Hopkins Univ, Sch Med, Howard Hughes Med Inst, Baltimore, MD 21205 USA; [Rubio, Maria E.] Univ Connecticut, Dept Physiol, Storrs, CT 06269 USA; [Rubio, Maria E.] Univ Connecticut, Dept Neurobiol, Storrs, CT 06269 USA; [Case, Lauren; Tessier-Lavigne, Marc] Stanford Univ, Grad Program Neurosci, Stanford, CA 94305 USA; [Tessier-Lavigne, Marc] Genentech Inc, Div Res, San Francisco, CA 94080 USA	Johns Hopkins University; Howard Hughes Medical Institute; Johns Hopkins University; University of Connecticut; University of Connecticut; Stanford University; Roche Holding; Genentech	Ginty, DD (corresponding author), Johns Hopkins Univ, Sch Med, Solomon H Snyder Dept Neurosci, Baltimore, MD 21205 USA.	dginty@jhmi.edu; kolodkin@jhmi.edu	Tran, Tracy/M-2173-2019	Tran, Tracy/0000-0002-2179-5725	NRSA [F32 NS051003, R01 DC-006881]; NSF [DB1-0420580, P50 MH06883];  [R01 MH59199]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH059199, F32MH087037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS050274, F32NS051003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC006881] Funding Source: NIH RePORTER	NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Delannoy and the Johns Hopkins University School of Medicine Microscope Facility for assistance with EM analysis; M. Pucak and the NINDS Multi-photon Core Facility at JHMI; D. Bergles and D. Linden for comments on the manuscript; R. Yuste for helpful discussions; K. Chak and members of the Kolodkin and Ginty laboratories for assistance throughout the course of this project. This work was supported by R01 MH59199 to D. D. G. and A. L. K.; NRSA F32 NS051003 to T. S. T.; R01 DC-006881 and NSF DB1-0420580 to M. E. R.; and P50 MH06883 to R. L. H. and D. D. G. D. D. G., R. L. H. and A. L. K. are investigators of the Howard Hughes Medical Institute.	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Ballesteros-Yanez I, 2006, NEUROSCIENCE, V138, P403, DOI 10.1016/j.neuroscience.2005.11.038; Bouzioukh F, 2006, EUR J NEUROSCI, V23, P2247, DOI 10.1111/j.1460-9568.2006.04783.x; Cheng HJ, 2001, NEURON, V32, P249, DOI 10.1016/S0896-6273(01)00478-0; Elston GN, 2002, PROG BRAIN RES, V136, P109; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Fishell G, 2008, NEURON, V57, P333, DOI 10.1016/j.neuron.2008.01.018; Gao WJ, 2004, J COMP NEUROL, V476, P174, DOI 10.1002/cne.20224; Gu CH, 2003, DEV CELL, V5, P45, DOI 10.1016/S1534-5807(03)00169-2; Hayashi Y, 2005, NEURON, V46, P529, DOI 10.1016/j.neuron.2005.05.006; Inoue T, 2005, NAT METHODS, V2, P415, DOI 10.1038/NMETH763; McAllister AM, 2007, ANNU REV NEUROSCI, V30, P425, DOI 10.1146/annurev.neuro.29.051605.112830; Nimchinsky EA, 2002, ANNU REV PHYSIOL, V64, P313, DOI 10.1146/annurev.physiol.64.081501.160008; Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4; Pasterkamp RJ, 2009, CURR OPIN NEUROBIOL, V19, P263, DOI 10.1016/j.conb.2009.06.001; Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291; Sahay A, 2005, J NEUROSCI, V25, P3613, DOI 10.1523/JNEUROSCI.5255-04.2005; Saito T, 2006, NAT PROTOC, V1, P1552, DOI 10.1038/nprot.2006.276; Spruston N, 2008, NAT REV NEUROSCI, V9, P206, DOI 10.1038/nrn2286; Suto F, 2005, J NEUROSCI, V25, P3628, DOI 10.1523/JNEUROSCI.4480-04.2005; Yamashita N, 2007, J NEUROSCI, V27, P12546, DOI 10.1523/JNEUROSCI.3463-07.2007; Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013; Yuste R, 2004, NAT REV NEUROSCI, V5, P24, DOI 10.1038/nrn1300; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	24	180	184	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1065	U128		10.1038/nature08628	http://dx.doi.org/10.1038/nature08628			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20010807	Green Accepted			2022-12-28	WOS:000272996000049
J	Wang, F; Yang, W				Wang, Feng; Yang, Wei			Structural Insight into Translesion Synthesis by DNA Pol II	CELL			English	Article							POLYMERASE-II; ESCHERICHIA-COLI; SPONTANEOUS MUTAGENESIS; ABASIC LESION; Y-FAMILY; ZETA; REPLICATION; MECHANISM; FIDELITY; SNAPSHOTS	E. coli DNA Pol II and eukaryotic Rev3 are B-family polymerases that can extend primers past a damaged or mismatched site when the high-fidelity replicative polymerases in the same family are ineffective. We report here the biochemical and structural properties of DNA Pol II that facilitate this translesion synthesis. DNA Pol II can extend primers past lesions either directly or by template skipping, in which small protein cavities outside of the active site accommodate looped-out template nucleotides 1 or 2 bp upstream. Because of multiple looping-out alternatives, mutation spectra of bypass synthesis are complicated. Moreover, translesion synthesis is enhanced by altered partitioning of DNA substrate between the polymerase active site and the proofreading exonuclease site. Compared to the replicative B family polymerases, DNA Pol II has subtle amino acid changes remote from the active site that allow it to replicate normal DNA with high efficiency yet conduct translesion synthesis when needed.	[Wang, Feng; Yang, Wei] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Yang, W (corresponding author), NIDDK, Mol Biol Lab, NIH, 9000 Rockville Pike,Bldg 5,Room B1-03, Bethesda, MD 20892 USA.	wei.yang@nih.gov	Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195	National Institute of Diabetes and Digestive and Kidney Diseases intramural research program at National Institutes of Health	National Institute of Diabetes and Digestive and Kidney Diseases intramural research program at National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Doublie for purified gp43 protein and the gp43-beta- clone, W. Konigsberg for the gp43 exo- clone, our labmates for technical support, D. Leahy and R. Craigie for critical reading of the manuscript, and F. Dyda for maintaining the X-ray equipment. The research is funded by the National Institute of Diabetes and Digestive and Kidney Diseases intramural research program at National Institutes of Health.	Abdulovic AL, 2008, NUCLEIC ACIDS RES, V36, P2082, DOI 10.1093/nar/gkn054; Al Mamun AAM, 2006, MUTAT RES-FUND MOL M, V593, P164, DOI 10.1016/j.mrfmmm.2005.07.016; Al Mamun AAM, 2007, MUTAT RES-FUND MOL M, V625, P29, DOI 10.1016/j.mrfmmm.2007.05.002; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; ANDERSON WF, 1994, J MOL BIOL, V238, P120, DOI 10.1006/jmbi.1994.1765; Arana ME, 2007, DNA REPAIR, V6, P213, DOI 10.1016/j.dnarep.2006.09.012; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beard WA, 2002, J BIOL CHEM, V277, P47393, DOI 10.1074/jbc.M210036200; Bebenek A, 2001, J BIOL CHEM, V276, P10387, DOI 10.1074/jbc.M007707200; Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137; Becherel OJ, 2001, P NATL ACAD SCI USA, V98, P8566, DOI 10.1073/pnas.141113398; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; BONNER CA, 1990, P NATL ACAD SCI USA, V87, P7663, DOI 10.1073/pnas.87.19.7663; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAI H, 1995, J BIOL CHEM, V270, P15327, DOI 10.1074/jbc.270.25.15327; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Curti E, 2009, MOL MICROBIOL, V71, P315, DOI 10.1111/j.1365-2958.2008.06526.x; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster PL, 2005, MUTAT RES-FUND MOL M, V569, P3, DOI 10.1016/j.mrfmmm.2004.07.017; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Fuchs RP, 2007, DNA REPAIR, V6, P1032, DOI 10.1016/j.dnarep.2007.02.021; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Garcia-Diaz M, 2006, CELL, V124, P331, DOI [10.1016/j.cell.2005.10.039, 10.1016/j.cel.2005.10.039]; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Hogg M, 2007, J BIOL CHEM, V282, P1432, DOI 10.1074/jbc.M605675200; IWASAKI H, 1991, MOL GEN GENET, V226, P24, DOI 10.1007/BF00273583; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kroeger KM, 2004, BIOCHEMISTRY-US, V43, P6723, DOI 10.1021/bi049813g; Lawrence CW, 2001, PHILOS T R SOC B, V356, P41, DOI 10.1098/rstb.2000.0001; Lee HR, 2009, BIOCHEMISTRY-US, V48, P2087, DOI 10.1021/bi8016284; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; McKenzie GJ, 2001, CURR OPIN MICROBIOL, V4, P586, DOI 10.1016/S1369-5274(00)00255-1; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Neeley WL, 2007, J BIOL CHEM, V282, P12741, DOI 10.1074/jbc.M700575200; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PazElizur T, 1996, J BIOL CHEM, V271, P24662, DOI 10.1074/jbc.271.40.24662; REHAKRANTZ LJ, 2009, BIOCH IN PRESS 0621; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; Schenten D, 2009, J EXP MED, V206, P477, DOI 10.1084/jem.20080669; Sharief FS, 1999, GENOMICS, V59, P90, DOI 10.1006/geno.1999.5843; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; STRAUSS BS, 1985, CANCER SURV, V4, P493; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Wagner J, 2002, DNA REPAIR, V1, P159, DOI 10.1016/S1568-7864(01)00012-X; Wilson RC, 2008, MOL CELL, V29, P767, DOI 10.1016/j.molcel.2008.01.014; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yeiser B, 2002, P NATL ACAD SCI USA, V99, P8737, DOI 10.1073/pnas.092269199; Zeng G, 1998, BIOTECHNIQUES, V25, P206, DOI 10.2144/98252bm05; Zhong XJ, 2006, NUCLEIC ACIDS RES, V34, P4731, DOI 10.1093/nar/gkl465	56	82	83	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1279	1289		10.1016/j.cell.2009.11.043	http://dx.doi.org/10.1016/j.cell.2009.11.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064374	Green Accepted, Bronze			2022-12-28	WOS:000273048700016
J	Lo, B; Grady, D				Lo, Bernard; Grady, Deborah			Strengthening Institutional Review Board Review of Highly Innovative Interventions in Clinical Trials	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lo, Bernard] Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA; [Lo, Bernard; Grady, Deborah] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Lo, Bernard] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lo, B (corresponding author), Univ Calif San Francisco, Program Med Eth, 521 Parnassus Ave,Room C126, San Francisco, CA 94143 USA.	bernie@medicine.ucsf.edu			NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR024131-04, UL1 RR024131, 1 UL1 RR024131-04] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Amariglio N, 2009, PLOS MED, V6, P221, DOI 10.1371/journal.pmed.1000029; *CIT RESP CAR RES, POL TRIAL A; Ertl H, 2009, MOL THER, V17, P397, DOI 10.1038/mt.2009.19; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Kahn JO, 2000, JAMA-J AM MED ASSOC, V284, P2193, DOI 10.1001/jama.284.17.2193; Lo B, 2009, CONFLICT INTEREST ME, P4; Scharschmidt T, 2006, HUM GENE THER, V17, P448, DOI 10.1089/hum.2006.17.448; Schneider CK, 2006, NAT BIOTECHNOL, V24, P493, DOI 10.1038/nbt0506-493	8	10	10	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 23	2009	302	24					2697	2698		10.1001/jama.2009.1917	http://dx.doi.org/10.1001/jama.2009.1917			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535JU	20040559	Green Accepted			2022-12-28	WOS:000272965300027
J	Mercader, J				Mercader, Julio			Mozambican Grass Seed Consumption During the Middle Stone Age	SCIENCE			English	Article							SORGHUM; STARCH; GRAIN	The role of starchy plants in early hominin diets and when the culinary processing of starches began have been difficult to track archaeologically. Seed collecting is conventionally perceived to have been an irrelevant activity among the Pleistocene foragers of southern Africa, on the grounds of both technological difficulty in the processing of grains and the belief that roots, fruits, and nuts, not cereals, were the basis for subsistence for the past 100,000 years and further back in time. A large assemblage of starch granules has been retrieved from the surfaces of Middle Stone Age stone tools from Mozambique, showing that early Homo sapiens relied on grass seeds starting at least 105,000 years ago, including those of sorghum grasses.	Univ Calgary, Dept Archaeol, Calgary, AB T2N 1N4, Canada	University of Calgary	Mercader, J (corresponding author), Univ Calgary, Dept Archaeol, Calgary, AB T2N 1N4, Canada.		Mercader, Julio/G-5182-2010		Canada Research Chairs program; Canada Foundation for Innovation; Social Sciences and Humanities Research Council of Canada [10-2007-0697]; Faculty of Social Sciences/Department of Archeology at the University of Calgary; National Geographic Society	Canada Research Chairs program(Canada Research Chairs); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC)); Faculty of Social Sciences/Department of Archeology at the University of Calgary; National Geographic Society(National Geographic Society)	This work was supported by the Canada Research Chairs program, Canada Foundation for Innovation, Social Sciences and Humanities Research Council of Canada ( file no. 10-2007-0697; CID: 148244), Faculty of Social Sciences/Department of Archeology at the University of Calgary, and the National Geographic Society.	CAGAMPANG GB, 1985, STARKE, V37, P253, DOI 10.1002/star.19850370802; CARANSA A, 1987, STARCH-STARKE, V39, P381, DOI 10.1002/star.19870391104; de Beaune SA, 2004, CURR ANTHROPOL, V45, P139, DOI 10.1086/381045; de Wet JMJ, 1976, ORIGINS AFRICAN PLAN, P453, DOI DOI 10.1515/9783110806373.453; Deacon H.J., 1993, S AFR ARCHAEOL B, V48, P86, DOI [10.2307/3888947, DOI 10.2307/3888947]; DEWET JMJ, 1978, AM J BOT, V65, P477, DOI 10.2307/2442706; Duodu KG, 2002, J CEREAL SCI, V35, P161, DOI 10.1006/jcrs.2001.0411; HARBERS LH, 1975, J ANIM SCI, V41, P1496, DOI 10.2527/jas1975.4151496x; Lachelt S., 2004, GEOLOGY MINERAL RESO; Lombard M, 2007, J HUM EVOL, V53, P406, DOI 10.1016/j.jhevol.2007.05.004; Mercader J, 2008, QUATERNARY RES, V70, P283, DOI 10.1016/j.yqres.2008.04.010; Mercader J, 2009, J HUM EVOL, V57, P63, DOI 10.1016/j.jhevol.2009.03.005; National Research Council, 1996, LOST CROPS AFR, VI; Sujka M, 2007, INT AGROPHYS, V21, P107; Van Peer P, 2003, J HUM EVOL, V45, P187, DOI 10.1016/S0047-2484(03)00103-9; Wadley L, 2007, J ARCHAEOL SCI, V34, P1001, DOI 10.1016/j.jas.2006.09.016	16	74	81	2	22	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 18	2009	326	5960					1680	1683		10.1126/science.1173966	http://dx.doi.org/10.1126/science.1173966			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533QJ	20019285				2022-12-28	WOS:000272839000049
J	Modugno, G				Modugno, Giovanni			Universal Few-Body Binding	SCIENCE			English	Editorial Material							ATOMS; SYSTEM		[Modugno, Giovanni] Univ Florence, LENS, I-50019 Florence, Italy; [Modugno, Giovanni] Univ Florence, Dept Phys, I-50019 Florence, Italy	University of Florence; University of Florence	Modugno, G (corresponding author), Univ Florence, LENS, Via Nello Carrara 1, I-50019 Florence, Italy.	modugno@lens.unifi.it	Modugno, Giovanni/C-3179-2009; Modugno, Giovanni/AAT-9718-2021	Modugno, Giovanni/0000-0002-4394-8593; Modugno, Giovanni/0000-0002-4394-8593				Braaten E, 2007, ANN PHYS-NEW YORK, V322, P120, DOI 10.1016/j.aop.2006.10.011; Buchler HP, 2007, NAT PHYS, V3, P726, DOI 10.1038/nphys678; Daley AJ, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.040402; EFIMOV V, 1970, PHYS LETT B, VB 33, P563, DOI 10.1016/0370-2693(70)90349-7; Esry BD, 1999, PHYS REV LETT, V83, P1751, DOI 10.1103/PhysRevLett.83.1751; Ferlaino F, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.140401; Gross N, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.163202; Kraemer T, 2006, NATURE, V440, P315, DOI 10.1038/nature04626; Pollack SE, 2009, SCIENCE, V326, P1683, DOI 10.1126/science.1182840; TIESINGA E, 1993, PHYS REV A, V47, P4114, DOI 10.1103/PhysRevA.47.4114; von Stecher J, 2009, NAT PHYS, V5, P417, DOI 10.1038/NPHYS1253; Zaccanti M, 2009, NAT PHYS, V5, P586, DOI 10.1038/NPHYS1334	12	4	4	0	0	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 18	2009	326	5960					1640	1641		10.1126/science.1184235	http://dx.doi.org/10.1126/science.1184235			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	20019276				2022-12-28	WOS:000272839000039
J	Collettini, C; Niemeijer, A; Viti, C; Marone, C				Collettini, Cristiano; Niemeijer, Andre; Viti, Cecilia; Marone, Chris			Fault zone fabric and fault weakness	NATURE			English	Article							SAN-ANDREAS FAULT; FRICTIONAL BEHAVIOR; SLIP; STRESS; GOUGE; STRENGTH; SYSTEM; ROCKS; CORES; CLAY	Geological and geophysical evidence suggests that some crustal faults are weak(1-6) compared to laboratory measurements of frictional strength(7). Explanations for fault weakness include the presence of weak minerals(4), high fluid pressures within the fault core(8,9) and dynamic processes such as normal stress reduction(10), acoustic fluidization(11) or extreme weakening at high slip velocity(12-14). Dynamic weakening mechanisms can explain some observations; however, creep and aseismic slip are thought to occur on weak faults, and quasi-static weakening mechanisms are required to initiate frictional slip on mis-oriented faults, at high angles to the tectonic stress field. Moreover, the maintenance of high fluid pressures requires specialized conditions(15) and weak mineral phases are not present in sufficient abundance to satisfy weak fault models(16), so weak faults remain largely unexplained. Here we provide laboratory evidence for a brittle, frictional weakening mechanism based on common fault zone fabrics. We report on the frictional strength of intact fault rocks sheared in their in situ geometry. Samples with well-developed foliation are extremely weak compared to their powdered equivalents. Micro- and nanostructural studies show that frictional sliding occurs along very fine-grained foliations composed of phyllosilicates ( talc and smectite). When the same rocks are powdered, frictional strength is high, consistent with cataclastic processes. Our data show that fault weakness can occur in cases where weak mineral phases constitute only a small percentage of the total fault rock and that low friction results from slip on a network of weak phyllosilicate-rich surfaces that define the rock fabric. The widespread documentation of foliated fault rocks along mature faults in different tectonic settings and from many different protoliths(4,17- 19) suggests that this mechanism could be a viable explanation for fault weakening in the brittle crust.	[Collettini, Cristiano] Univ Perugia, Dipartimento Sci Terra, I-06100 Perugia, Italy; [Niemeijer, Andre; Marone, Chris] Penn State Univ, Dept Geosci, University Pk, PA 16802 USA; [Niemeijer, Andre; Marone, Chris] Penn State Univ, Energy Inst, Ctr Geomech Geofluids & Geohazards, University Pk, PA 16802 USA; [Viti, Cecilia] Univ Siena, Dipartimento Sci Terra, I-53100 Siena, Italy	University of Perugia; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Siena	Collettini, C (corresponding author), Univ Perugia, Dipartimento Sci Terra, I-06100 Perugia, Italy.	colle@unipg.it	Niemeijer, Andre/AHE-5571-2022; Niemeijer, Andre/W-5388-2019	Niemeijer, Andre/0000-0003-3983-9308; collettini, cristiano/0000-0002-4828-2516	NSF [OCE-0196462, EAR-0510182, INGV-DPC S5]; ERC [205175]; Directorate For Geosciences [0911569] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); ERC(European Research Council (ERC)European Commission); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank I. Faoro for cutting the samples and J. P. Ampuero, D. Faulkner, R. Holdsworth and S. Smith for discussions. This research was motivated in part by stimulating discussions with P. Montone, M. Barchi and M. Cocco. We gratefully acknowledge funding by NSF grants OCE-0196462 EAR-0510182 and an INGV-DPC S5 M. Barchi grant. A.N. was supported in part by the ERC St. G. Nr. 205175 USEMS project.	Ampuero JP, 2008, GEOPHYS J INT, V173, P674, DOI 10.1111/J.1365-246X.2008.03736.X; Beeler NM, 1996, J GEOPHYS RES-SOL EA, V101, P8697, DOI 10.1029/96JB00411; Bos B, 2000, TECTONOPHYSICS, V327, P173, DOI 10.1016/S0040-1951(00)00168-2; Boutareaud S, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032554; BRUNE JN, 1969, J GEOPHYS RES, V74, P3821, DOI 10.1029/JB074i015p03821; BYERLEE J, 1978, PURE APPL GEOPHYS, V116, P615, DOI 10.1007/BF00876528; Carpenter BM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036660; Chiaraluce L, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB005015; Collettini C, 2001, GEOLOGY, V29, P927, DOI 10.1130/0091-7613(2001)029<0927:NFNF>2.0.CO;2; Collettini C, 2009, GEOLOGY, V37, P567, DOI 10.1130/G25645A.1; Di Toro G, 2006, SCIENCE, V311, P647, DOI 10.1126/science.1121012; EVANS JP, 1995, J GEOPHYS RES-SOL EA, V100, P13007, DOI 10.1029/94JB02625; Faulkner DR, 2006, NATURE, V444, P922, DOI 10.1038/nature05353; Faulkner DR, 2003, TECTONOPHYSICS, V367, P235, DOI 10.1016/S0040-1951(03)00134-3; Holdsworth RE, 2004, SCIENCE, V303, P181, DOI 10.1126/science.1092491; Imber J, 2008, GEOL SOC SPEC PUBL, V299, P151, DOI 10.1144/SP299.10; Jefferies SP, 2006, J STRUCT GEOL, V28, P220, DOI 10.1016/j.jsg.2005.10.008; Marone C, 1998, ANNU REV EARTH PL SC, V26, P643, DOI 10.1146/annurev.earth.26.1.643; Melosh HJ, 1996, NATURE, V379, P601, DOI 10.1038/379601a0; Moore DE, 2007, NATURE, V448, P795, DOI 10.1038/nature06064; Niemeijer AR, 2007, J GEOPHYS RES-SOL EA, V112, DOI 10.1029/2007JB005008; Niemeijer AR, 2006, TECTONOPHYSICS, V427, P231, DOI 10.1016/j.tecto.2006.03.048; Noda Hiroyuki, 2009, Journal of Geophysical Research - Part B - Solid Earth, V114, DOI 10.1029/2008JB006143; Rice J., 1992, FAULT MECH TRANSPORT, P475, DOI DOI 10.1016/S0074-6142(08)62835-1; Saffer DM, 2001, GEOPHYS RES LETT, V28, P2297, DOI 10.1029/2001GL012869; Scholz CH, 2000, GEOLOGY, V28, P163, DOI 10.1130/0091-7613(2000)28<163:EFASSA>2.0.CO;2; Schore A.N., 2002, PRIMITIVE MENTAL STA, V2, P1; SHEA WT, 1993, J STRUCT GEOL, V15, P1097, DOI 10.1016/0191-8141(93)90158-7; Townend J, 2000, GEOLOGY, V28, P399, DOI 10.1130/0091-7613(2000)28<399:HFKTCS>2.0.CO;2; Vrolijk P, 1999, J STRUCT GEOL, V21, P1039, DOI 10.1016/S0191-8141(99)00103-0; Wibberley CAJ, 2005, NATURE, V436, P689, DOI 10.1038/nature03901; WINTSCH RP, 1995, J GEOPHYS RES-SOL EA, V100, P13021, DOI 10.1029/94JB02622; ZOBACK MD, 1987, SCIENCE, V238, P1105, DOI 10.1126/science.238.4830.1105	33	380	391	6	117	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					907	U98		10.1038/nature08585	http://dx.doi.org/10.1038/nature08585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016599				2022-12-28	WOS:000272795400040
J	Kuper, A				Kuper, Adam			Claude Levi-Strauss (1908-2009) OBITUARY	NATURE			English	Biographical-Item									Yale Univ, Dept Anthropol, New Haven, CT 06520 USA	Yale University	Kuper, A (corresponding author), Yale Univ, Dept Anthropol, New Haven, CT 06520 USA.	adam.kuper@googlemail.com						LEVISTRAUSS CG, PUBLICATION LIST	1	0	0	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 17	2009	462	7275					862	862		10.1038/462862a	http://dx.doi.org/10.1038/462862a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	533AX	20016590				2022-12-28	WOS:000272795400030
J	Khazeni, N; Hutton, DW; Garber, AM; Owens, DK				Khazeni, Nayer; Hutton, David W.; Garber, Alan M.; Owens, Douglas K.			Effectiveness and Cost-Effectiveness of Expanded Antiviral Prophylaxis and Adjuvanted Vaccination Strategies for an Influenza A (H5N1) Pandemic	ANNALS OF INTERNAL MEDICINE			English	Article							CROSS-REACTIVE IMMUNITY; GUILLAIN-BARRE-SYNDROME; HEALTH-CARE WORKERS; AVIAN INFLUENZA; CLINICAL-TRIAL; OSELTAMIVIR-RESISTANCE; INFECTIOUS-DISEASES; CYTOKINE RESPONSES; ANTI-H5 ANTIBODY; RANDOMIZED-TRIAL	Background: The pandemic potential of influenza A (H5N1) virus is a prominent public health concern of the 21st century. Objective: To estimate the effectiveness and cost-effectiveness of alternative pandemic (H5N1) mitigation and response strategies. Design: Compartmental epidemic model in conjunction with a Markov model of disease progression. Data Sources: Literature and expert opinion. Target Population: Residents of a U. S. metropolitan city with a population of 8.3 million. Time Horizon: Lifetime. Perspective: Societal. Interventions: 3 scenarios: 1) vaccination and antiviral pharmacotherapy in quantities similar to those currently available in the U. S. stockpile (stockpiled strategy), 2) stockpiled strategy but with expanded distribution of antiviral agents (expanded prophylaxis strategy), and 3) stockpiled strategy but with adjuvanted vaccine (expanded vaccination strategy). All scenarios assumed standard nonpharmaceutical interventions. Outcome Measures: Infections and deaths averted, costs, quality-adjusted life-years (QALYs), and incremental cost-effectiveness. Results of Base-Case Analysis: Expanded vaccination was the most effective and cost-effective of the 3 strategies, averting 68% of infections and deaths and gaining 404 030 QALYs at $10 844 per QALY gained relative to the stockpiled strategy. Results of Sensitivity Analysis: Expanded vaccination remained incrementally cost-effective over a wide range of assumptions. Limitations: The model assumed homogenous mixing of cases and contacts; heterogeneous mixing would result in faster initial spread, followed by slower spread. We did not model interventions for children or older adults; the model is not designed to target interventions to specific groups. Conclusion: Expanded adjuvanted vaccination is an effective and cost-effective mitigation strategy for an influenza A (H5N1) pandemic. Expanded antiviral prophylaxis can help delay the pandemic while additional strategies are implemented.	[Khazeni, Nayer] Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khazeni, N (corresponding author), Stanford Univ, Med Ctr, Div Pulm & Crit Care Med, 300 Pasteur Dr,H3143, Stanford, CA 94305 USA.		Garber, Alan M/F-1476-2010		National Institutes of Health; Agency for Healthcare Research and Quality; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [F32HS018003] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007948] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA015612, R37DA015612] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	National Institutes of Health and Agency for Healthcare Research and Quality.	Apisarnthanarak A, 2005, CLIN INFECT DIS, V40, pE16, DOI 10.1086/427034; Arino J, 2006, J R SOC INTERFACE, V3, P453, DOI 10.1098/rsif.2006.0112; Atkinson MP, 2008, B MATH BIOL, V70, P820, DOI 10.1007/s11538-007-9281-2; Banzhoff A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004384; Baras B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001401; Bernstein DI, 2008, J INFECT DIS, V197, P667, DOI 10.1086/527489; Binder S, 1999, SCIENCE, V284, P1311, DOI 10.1126/science.284.5418.1311; Bootsma MCJ, 2007, P NATL ACAD SCI USA, V104, P7588, DOI 10.1073/pnas.0611071104; Brahmbhatt M, 2006, 1 INT C AV INFL HUM; Bravata DM, 2006, BIOSECUR BIOTERROR, V4, P244, DOI 10.1089/bsp.2006.4.244; Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; Bridges CB, 2000, J INFECT DIS, V181, P344, DOI 10.1086/315213; *BUR VIT STAT, 2007, SUMM VIT STAT 2007 C; *CDCP, SEAS INFL DIS; *CDCP, 2006, FLUSURGE VERS 2 0; Centers for Disease Control and Prevention, KEY FACTS SEAS FLU V; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P433; CHENG M, 2009, UKS ATTEMPTS STOP SW; Chio A, 2003, NEUROLOGY, V60, P1146, DOI 10.1212/01.WNL.0000055091.96905.D0; Chotpitayasunondh T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004028; Chutinimitkul S, 2007, J VIROL METHODS, V139, P44, DOI 10.1016/j.jviromet.2006.09.007; *CIDRAP, 2006, NEWS HHS ADDS REL ST; CLARK TW, 2009, N ENGL J MED; Cowling BJ, 2009, ANN INTERN MED, V151, P437, DOI 10.7326/0003-4819-151-7-200910060-00142; Dasta JF, 2005, CRIT CARE MED, V33, P1266, DOI 10.1097/01.CCM.0000164543.14619.00; Davey VJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002606; DAVIES JR, 1984, J HYG-CAMBRIDGE, V92, P125, DOI 10.1017/S002217240006410X; de Jong MD, 2005, NEW ENGL J MED, V353, P2667, DOI 10.1056/NEJMoa054512; Dinh PN, 2006, EMERG INFECT DIS, V12, P1841; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; Evans D, 2009, J INFECT DIS, V200, P321, DOI 10.1086/603560; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; FRYBACK DG, 1993, MED DECIS MAKING, V13, P89, DOI 10.1177/0272989X9301300202; Galli G, 2009, P NATL ACAD SCI USA, V106, P7962, DOI 10.1073/pnas.0903181106; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Glass RJ, 2006, EMERG INFECT DIS, V12, P1671, DOI 10.3201/eid1211.060255; *GLAXOSMITHKLINE P, 2008, REL PACK INS; Goji NA, 2008, J INFECT DIS, V198, P635, DOI 10.1086/590916; Hayden FG, 1998, J CLIN INVEST, V101, P643, DOI 10.1172/JCI1355; Hayden F, 2009, CLIN INFECT DIS, V48, pS3, DOI 10.1086/591851; Kandun IN, 2006, NEW ENGL J MED, V355, P2186, DOI 10.1056/NEJMoa060930; Katz JM, 1999, J INFECT DIS, V180, P1763, DOI 10.1086/315137; Keitel WA, 2008, J INFECT DIS, V198, P1309, DOI 10.1086/592172; Khazeni N, 2009, ANN INTERN MED, V151, P464, DOI 10.7326/0003-4819-151-7-200910060-00143; KISSEL JT, 2001, DIAGNOSIS MANAGEMENT; Kobasa D, 2004, NATURE, V431, P703, DOI 10.1038/nature02951; KUNG H, 2005, NATL VITAL STAT REPO, V56; Larson RC, 2007, OPER RES, V55, P399, DOI 10.1287/opre.1070.0399; Leekha S, 2007, INFECT CONT HOSP EP, V28, P1071, DOI 10.1086/520101; Leroux-Roels I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001665; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Levie K, 2008, J INFECT DIS, V198, P642, DOI 10.1086/590913; Liem NT, 2005, EMERG INFECT DIS, V11, P210, DOI 10.3201/eid1102.041075; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Mangili A, 2005, LANCET, V365, P989, DOI 10.1016/S0140-6736(05)71089-8; Massarella JW, 2000, J CLIN PHARMACOL, V40, P836, DOI 10.1177/00912700022009567; Matassov D, 2007, VIRAL IMMUNOL, V20, P441, DOI 10.1089/vim.2007.0027; McKibbin WJ, 2006, GLOBAL MACROECONOMIC; MONTO AS, 1970, J INFECT DIS, V122, P16, DOI 10.1093/infdis/122.1-2.16; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Neustadt RE, 1978, SWINE FLU AFFAIR DEC, DOI [10.17226/12660, DOI 10.17226/12660]; Nichol KL, 2006, J INFECT DIS, V194, pS111, DOI 10.1086/507544; Nolan T, 2008, VACCINE, V26, P6383, DOI 10.1016/j.vaccine.2008.08.046; *ROCH PHARM, 2008, TAM PACK INS; Rumke HC, 2008, VACCINE, V26, P2378, DOI 10.1016/j.vaccine.2008.02.068; Sangrujee N, 2004, B WORLD HEALTH ORGAN, V82, P9; Sencer DJ, 2006, EMERG INFECT DIS, V12, P29; Seo SH, 2002, NAT MED, V8, P950, DOI 10.1038/nm757; Smith CB, 2002, J INFECT DIS, V185, P980, DOI 10.1086/339416; SONOGUCHI T, 1986, J INFECT DIS, V153, P33, DOI 10.1093/infdis/153.1.33; Stephenson I, 2003, VACCINE, V21, P1687, DOI 10.1016/S0264-410X(02)00632-1; Stephenson I, 2008, NEW ENGL J MED, V359, P1631, DOI 10.1056/NEJMc0805274; Talbird SE, 2009, AM J HEALTH-SYST PH, V66, P469, DOI 10.2146/ajhp080296; Taubenberger JK, 2005, ARCH VIROL, P101; Taubenberger JK, 2006, EMERG INFECT DIS, V12, P15, DOI 10.3201/eid1209.05-0979; Thorpe LE, 2004, EMERG INFECT DIS, V10, P917; Treanor JJ, 2006, NEW ENGL J MED, V354, P1343, DOI 10.1056/NEJMoa055778; Tumpey TM, 2002, P NATL ACAD SCI USA, V99, P13849, DOI 10.1073/pnas.212519699; Turner DA, 2006, VACCINE, V24, P1035, DOI 10.1016/j.vaccine.2004.12.033; U.S. Department of Health and Human Services, PAND INFL PLAN; Ungchusak K, 2005, NEW ENGL J MED, V352, P333, DOI 10.1056/NEJMoa044021; *US BUR CENS, 2009 STAT ABSTR US; *US DEP HHS, PAND FLU PLAN; *US DEP HHS, COMM STRAT PAND INFL; *US DEP HHS, PAND PLANN UPD 6; *US DEP HHS, PAND PAND SCAR 20 CE; Vong S, 2006, EMERG INFECT DIS, V12, P1542, DOI 10.3201/eid1210.060424; Wang M, 2006, EMERG INFECT DIS, V12, P1773, DOI 10.3201/eid1211.060675; Webster RG, 2006, NEW ENGL J MED, V355, P2174, DOI 10.1056/NEJMp068205; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; *WHO, 2009, GLOB AL RESP GAR; *WHO, 2009, SUMM WHO VIRT CONS S; *WHO, GLOB AL RESP GAR VAC; WHO (World Health Organization), 2011, GLOB AL RESP GAR INF; World Health Organization, GLOB AL RESP GAR AV; Wright PF, 2008, NEW ENGL J MED, V358, P2540, DOI 10.1056/NEJMp0803650; Zurcher T, 2006, J ANTIMICROB CHEMOTH, V58, P723, DOI 10.1093/jac/dkl321; Zverev V. V., 2007, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, P10; 2006, METLIFE SURVEY NURS; 2007, SAN JOSE MERCUR 0617	103	30	30	0	10	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	DEC 15	2009	151	12					840	U3		10.7326/0000605-200912150-00156	http://dx.doi.org/10.7326/0000605-200912150-00156			15	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532ET	20008760				2022-12-28	WOS:000272728900002
J	Pathirage, LPMM; Kularatne, SAM; Wijesinghe, S; Ratnatunga, NVI; Gawarammana, IB				Pathirage, L. P. Manoji Muditha; Kularatne, Senanyake A. M.; Wijesinghe, Sulochana; Ratnatunga, Neelakanthi V. I.; Gawarammana, Indika B.			Fulminant colitis and toxic myocarditis: a unifying cause?	LANCET			English	Editorial Material									[Pathirage, L. P. Manoji Muditha; Kularatne, Senanyake A. M.; Gawarammana, Indika B.] Univ Peradeniya, Dept Med, Peradeniya 20000, Sri Lanka; [Wijesinghe, Sulochana; Ratnatunga, Neelakanthi V. I.] Univ Peradeniya, Dept Pathol, Peradeniya 20000, Sri Lanka	University of Peradeniya; University of Peradeniya	Pathirage, LPMM (corresponding author), Univ Peradeniya, Dept Med, Peradeniya 20000, Sri Lanka.	manojipathi@yahoo.com						[Anonymous], 1997, B WORLD HEALTH ORGAN, V75, P291; *DEP HLTH, 2003, ANN HLTH B, P93; DUMA RJ, 1969, NEW ENGL J MED, V281, P1315, DOI 10.1056/NEJM196912112812401; GUIMARAE.AC, 1974, AM J CARDIOL, V34, P103, DOI 10.1016/0002-9149(74)90100-3; MARKOWITZ SM, 1974, AM J CLIN PATHOL, V62, P619	5	2	2	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					2026	2026		10.1016/S0140-6736(09)61491-4	http://dx.doi.org/10.1016/S0140-6736(09)61491-4			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532EA	20006131				2022-12-28	WOS:000272727000026
J	Sinsabaugh, RL; Hill, BH; Shah, JJF				Sinsabaugh, Robert L.; Hill, Brian H.; Shah, Jennifer J. Follstad			Ecoenzymatic stoichiometry of microbial organic nutrient acquisition in soil and sediment	NATURE			English	Article							ECOLOGICAL STOICHIOMETRY; THEORETICAL-MODEL; METABOLIC THEORY; ENZYME-ACTIVITY; CARBON BUDGET; GLOBAL-SCALE; TEMPERATURE; TERRESTRIAL; LIMITATION; PHOSPHORUS	Biota can be described in terms of elemental composition, expressed as an atomic ratio of carbon: nitrogen: phosphorus (refs 1-3). The elemental stoichiometry of microoorganisms is fundamental for understanding the production dynamics and biogeochemical cycles of ecosystems because microbial biomass is the trophic base of detrital food webs(4-6). Here we show that heterotrophic microbial communities of diverse composition from terrestrial soils and freshwater sediments share a common functional stoichiometry in relation to organic nutrient acquisition. The activities of four enzymes that catalyse the hydrolysis of assimilable products from the principal environmental sources of C, N and P show similar scaling relationships over several orders of magnitude, with a mean ratio for C: N: P activities near 1:1:1 in all habitats. We suggest that these ecoenzymatic ratios reflect the equilibria between the elemental composition of microbial biomass and detrital organic matter and the efficiencies of microbial nutrient assimilation and growth. Because ecoenzymatic activities intersect the stoichiometric and metabolic theories of ecology(7-9), they provide a functional measure of the threshold at which control of community metabolism shifts from nutrient to energy flow.	[Sinsabaugh, Robert L.] Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA; [Hill, Brian H.] US EPA, Natl Hlth & Environm Effects Lab, Duluth, MN 55804 USA; [Shah, Jennifer J. Follstad] Duke Univ, Dept Biol, Durham, NC 27708 USA	University of New Mexico; United States Environmental Protection Agency; Duke University	Sinsabaugh, RL (corresponding author), Univ New Mexico, Dept Biol, Albuquerque, NM 87131 USA.	rlsinsab@unm.edu			National Science Foundation [DBI-0630558]	National Science Foundation(National Science Foundation (NSF))	J.J.F.S. was supported by the National Science Foundation (DBI-0630558).	Allen AP, 2009, ECOL LETT, V12, P369, DOI 10.1111/j.1461-0248.2009.01302.x; Allison SD, 2007, MANUAL OF ENVIRONMENTAL MICROBIOLOGY, 3RD ED, P704; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Burns R. G., 2002, ENZYMES ENV ACTIVITY; Cleveland CC, 2007, BIOGEOCHEMISTRY, V85, P235, DOI 10.1007/s10533-007-9132-0; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; Cross WF, 2005, FRESHWATER BIOL, V50, P1895, DOI 10.1111/j.1365-2427.2005.01458.x; Elser JJ, 2000, NATURE, V408, P578, DOI 10.1038/35046058; Frost PC, 2006, ECOL LETT, V9, P774, DOI 10.1111/j.1461-0248.2006.00919.x; Gillooly JF, 2005, P NATL ACAD SCI USA, V102, P11923, DOI 10.1073/pnas.0504756102; Herron PM, 2009, SOIL BIOL BIOCHEM, V41, P1262, DOI 10.1016/j.soilbio.2009.03.010; Hill BH, 2006, FRESHWATER BIOL, V51, P1670, DOI 10.1111/j.1365-2427.2006.01606.x; Hill BH, 2010, BIOGEOCHEMISTRY, V97, P195, DOI 10.1007/s10533-009-9366-0; Houghton RA, 2007, ANNU REV EARTH PL SC, V35, P313, DOI 10.1146/annurev.earth.35.031306.140057; Kerkhoff AJ, 2005, GLOBAL ECOL BIOGEOGR, V14, P585, DOI 10.1111/j.1466-822x.2005.00187.x; Manzoni S, 2008, SCIENCE, V321, P684, DOI 10.1126/science.1159792; Moorhead DL, 2006, ECOL MONOGR, V76, P151, DOI 10.1890/0012-9615(2006)076[0151:ATMOLD]2.0.CO;2; Olander LP, 2000, BIOGEOCHEMISTRY, V49, P175, DOI 10.1023/A:1006316117817; Parton W, 2007, SCIENCE, V315, P361, DOI 10.1126/science.1134853; REDFIELD AC, 1958, AM SCI, V46, P205; Reich PB, 2004, P NATL ACAD SCI USA, V101, P11001, DOI 10.1073/pnas.0403588101; Sand-Jensen K, 2007, FRESHWATER BIOL, V52, P2340, DOI 10.1111/j.1365-2427.2007.01852.x; Schimel JP, 2003, SOIL BIOL BIOCHEM, V35, P549, DOI 10.1016/S0038-0717(03)00015-4; Sinsabaugh RL, 2005, BIOGEOCHEMISTRY, V75, P201, DOI 10.1007/s10533-004-7112-1; Sinsabaugh RL, 2002, BIOGEOCHEMISTRY, V60, P1, DOI 10.1023/A:1016541114786; SINSABAUGH RL, ECOL MONOGR IN PRESS; Sinsabaugh RL, 2008, ECOL LETT, V11, P1252, DOI 10.1111/j.1461-0248.2008.01245.x; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Warton DI, 2006, BIOL REV, V81, P259, DOI 10.1017/S1464793106007007; [No title captured]	30	692	805	131	1120	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					795	U117		10.1038/nature08632	http://dx.doi.org/10.1038/nature08632			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010687				2022-12-28	WOS:000272559900040
J	Brown, RE				Brown, Raeford E., Jr.			Don't Touch Me	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rbrow1@email.uky.edu		Brown, Raeford/0000-0002-2295-2657					0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2409	2410		10.1001/jama.2009.1675	http://dx.doi.org/10.1001/jama.2009.1675			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529MD	19996391				2022-12-28	WOS:000272520500001
J	Zempsky, WT				Zempsky, William T.			Treatment of Sickle Cell Pain Fostering Trust and Justice	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							HOSPITAL-CARE; DISEASE; HEALTH		Univ Connecticut, Sch Med, Pain Relief Program, Connecticut Childrens Med Ctr, Hartford, CT 06106 USA	Connecticut Children's Medical Center; University of Connecticut	Zempsky, WT (corresponding author), Univ Connecticut, Sch Med, Pain Relief Program, Connecticut Childrens Med Ctr, 282 Washington St, Hartford, CT 06106 USA.	wzempsk@ccmckids.org			NHLBI NIH HHS [1 K23 HL090832-01A1] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K23HL090832] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Brousseau DC, 2009, PEDIATR BLOOD CANCER, V53, P174, DOI 10.1002/pbc.22039; Jackson B, 2006, REV GEN PSYCHOL, V10, P21, DOI 10.1037/1089-2680.10.1.21; Kirsh KL, 2002, CLIN J PAIN, V18, pS52, DOI 10.1097/00002508-200207001-00006; Maxwell K, 1999, BRIT MED J, V318, P1585, DOI 10.1136/bmj.318.7198.1585; Shapiro BS, 1997, J PAIN SYMPTOM MANAG, V14, P168, DOI 10.1016/S0885-3924(97)00019-5; Solomon LR, 2008, BLOOD, V111, P997, DOI 10.1182/blood-2007-07-089144; Substance Abuse and Mental Health Services Administration, 2007, NSDUH SER H, VSMA 06-4194; Tanabe P, 2007, ACAD EMERG MED, V14, P419, DOI 10.1197/j.aem.2006.11.033; Todd KH, 2006, J PAIN, V7, P453, DOI 10.1016/j.jpain.2006.05.004; Williams DR, 2009, J BEHAV MED, V32, P20, DOI 10.1007/s10865-008-9185-0	10	48	48	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2479	2480		10.1001/jama.2009.1811	http://dx.doi.org/10.1001/jama.2009.1811			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529MD	19996405				2022-12-28	WOS:000272520500029
J	Teh, J; Berendt, T; Lipsky, BA				Teh, James; Berendt, Tony; Lipsky, Benjamin A.			Rational Imaging Investigating suspected bone infection in the diabetic foot	BRITISH MEDICAL JOURNAL			English	Editorial Material							DIAGNOSTIC-ACCURACY; COST-EFFECTIVENESS; OSTEOMYELITIS; METAANALYSIS		[Teh, James] Nuffield Orthopaed Ctr, Dept Radiol, Oxford OX3 7LD, England; [Berendt, Tony] Nuffield Orthopaed Ctr, Bone Infect Unit, Oxford OX3 7LD, England; [Lipsky, Benjamin A.] VA Puget Sound Hlth Care Syst, Seattle, WA 98416 USA; [Lipsky, Benjamin A.] Univ Washington, Seattle, WA 98416 USA	Nuffield Orthopaedic Centre; Nuffield Orthopaedic Centre; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Washington; University of Washington Seattle	Teh, J (corresponding author), Nuffield Orthopaed Ctr, Dept Radiol, Oxford OX3 7LD, England.	james.teh@tiscali.co.uk		Lipsky, Benjamin A./0000-0001-9886-5114; Teh, James/0000-0002-6111-4269				Basu S, 2009, SEMIN NUCL MED, V39, P36, DOI 10.1053/j.semnuclmed.2008.08.004; Berendt AR, 2008, DIABETES-METAB RES, V24, pS190, DOI 10.1002/dmrr.853; Berendt AR, 2008, DIABETES-METAB RES, V24, pS145, DOI 10.1002/dmrr.836; Butalia S, 2008, JAMA-J AM MED ASSOC, V299, P806, DOI 10.1001/jama.299.7.806; Capriotti G, 2006, NUCL MED COMMUN, V27, P757, DOI 10.1097/01.mnm.0000230065.85705.b3; Dinh MT, 2008, CLIN INFECT DIS, V47, P519, DOI 10.1086/590011; ECKMAN MH, 1995, JAMA-J AM MED ASSOC, V273, P712, DOI 10.1001/jama.273.9.712; Fleischer AE, 2009, J FOOT ANKLE SURG, V48, P39, DOI 10.1053/j.jfas.2008.09.003; Kapoor A, 2007, ARCH INTERN MED, V167, P125, DOI 10.1001/archinte.167.2.125; Keidar Z, 2005, J NUCL MED, V46, P444; Lavery LA, 2003, DIABETES CARE, V26, P1435, DOI 10.2337/diacare.26.5.1435; Lavery LA, 2009, DIABETES RES CLIN PR, V83, P347, DOI 10.1016/j.diabres.2008.11.030; Lipsky BA, 2004, CLIN INFECT DIS, V39, P885, DOI 10.1086/383271; Lipsky BA, 1997, CLIN INFECT DIS, V25, P1318, DOI 10.1086/516148; Morrison WB, 1998, RADIOLOGY, V207, P625, DOI 10.1148/radiology.207.3.9609883; MORRISON WB, 1995, RADIOLOGY, V196, P557, DOI 10.1148/radiology.196.2.7617877; Tan PL, 2007, BRIT J RADIOL, V80, P939, DOI 10.1259/bjr/30036666	17	17	17	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 4	2009	339								b4690	10.1136/bmj.b4690	http://dx.doi.org/10.1136/bmj.b4690			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NU	19965936				2022-12-28	WOS:000272453700001
J	Venter, O; Laurance, WF; Iwamura, T; Wilson, KA; Fuller, RA; Possingham, HP				Venter, Oscar; Laurance, William F.; Iwamura, Takuya; Wilson, Kerrie A.; Fuller, Richard A.; Possingham, Hugh P.			Harnessing Carbon Payments to Protect Biodiversity	SCIENCE			English	Article									[Venter, Oscar; Iwamura, Takuya; Wilson, Kerrie A.; Fuller, Richard A.; Possingham, Hugh P.] Univ Queensland, Ctr Ecol, Brisbane, Qld 4072, Australia; [Laurance, William F.] James Cook Univ, Sch Marine & Trop Biol, Cairns, Qld 4870, Australia; [Laurance, William F.] Smithsonian Trop Res Inst, Balboa, Ancon, Panama	University of Queensland; James Cook University; Smithsonian Institution; Smithsonian Tropical Research Institute	Venter, O (corresponding author), Univ Queensland, Ctr Ecol, Brisbane, Qld 4072, Australia.	oventer@uq.edu.au	Possingham, Hugh/B-1337-2008; Venter, Oscar/G-6893-2011; Fuller, Richard/B-7971-2008; Wilson, Kerrie/W-4181-2019; Wilson, Kerrie A/C-8058-2009; Laurance, William F/B-2709-2012; POSSINGHAM, HUGH/R-8310-2019; Venter, Oscar/ABE-1477-2021; Iwamura, Takuya/D-1125-2018	Possingham, Hugh/0000-0001-7755-996X; Fuller, Richard/0000-0001-9468-9678; Wilson, Kerrie/0000-0002-0092-935X; Wilson, Kerrie A/0000-0002-0092-935X; Laurance, William F/0000-0003-4430-9408; POSSINGHAM, HUGH/0000-0001-7755-996X; Iwamura, Takuya/0000-0002-3740-7758				Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Laurance WF, 2008, BIOSCIENCE, V58, P286, DOI 10.1641/B580402; Miles L, 2008, SCIENCE, V320, P1454, DOI 10.1126/science.1155358; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Venter O, 2009, CONSERV LETT, V2, P123, DOI 10.1111/j.1755-263X.2009.00059.x; Wilson KA, 2006, NATURE, V440, P337, DOI 10.1038/nature04366	6	167	172	8	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1368	1368		10.1126/science.1180289	http://dx.doi.org/10.1126/science.1180289			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965752				2022-12-28	WOS:000272351100032
J	Wolfe, CJ; Solomon, SC; Laske, G; Collins, JA; Detrick, RS; Orcutt, JA; Bercovici, D; Hauri, EH				Wolfe, Cecily J.; Solomon, Sean C.; Laske, Gabi; Collins, John A.; Detrick, Robert S.; Orcutt, John A.; Bercovici, David; Hauri, Erik H.			Mantle Shear-Wave Velocity Structure Beneath the Hawaiian Hot Spot	SCIENCE			English	Article							PLUMES; TOMOGRAPHY; CONVECTION; HOTSPOTS; KERNELS; TIMES; FLOW	Defining the mantle structure that lies beneath hot spots is important for revealing their depth of origin. Three-dimensional images of shear-wave velocity beneath the Hawaiian Islands, obtained from a network of sea-floor and land seismometers, show an upper-mantle low-velocity anomaly that is elongated in the direction of the island chain and surrounded by a parabola-shaped high-velocity anomaly. Low velocities continue downward to the mantle transition zone between 410 and 660 kilometers depth, a result that is in agreement with prior observations of transition-zone thinning. The inclusion of SKS observations extends the resolution downward to a depth of 1500 kilometers and reveals a several-hundred-kilometer-wide region of low velocities beneath and southeast of Hawaii. These images suggest that the Hawaiian hot spot is the result of an upwelling high-temperature plume from the lower mantle.	[Wolfe, Cecily J.] Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA; [Solomon, Sean C.; Hauri, Erik H.] Carnegie Inst Sci, Dept Terr Magnetism, Washington, DC 20015 USA; [Laske, Gabi; Orcutt, John A.] Scripps Inst Oceanog, Cecil H & Ida M Green Inst Geophys & Planetary Ph, San Diego, CA 92093 USA; [Collins, John A.; Detrick, Robert S.] Woods Hole Oceanog Inst, Woods Hole, MA 02543 USA; [Bercovici, David] Yale Univ, Dept Geol & Geophys, New Haven, CT 06520 USA	University of Hawaii System; University of Hawaii Manoa; Carnegie Institution for Science; University of California System; University of California San Diego; Scripps Institution of Oceanography; Woods Hole Oceanographic Institution; Yale University	Wolfe, CJ (corresponding author), Univ Hawaii Manoa, Hawaii Inst Geophys & Planetol, Honolulu, HI 96822 USA.	cecily@soest.hawaii.edu	Wolfe, Cecily/E-7874-2011	Bercovici, David/0000-0003-1993-0016; Wolfe, Cecily/0000-0003-3144-5697; Orcutt, John/0000-0001-5508-0050	NSF	NSF(National Science Foundation (NSF))	We are grateful to NSF for its support of this project. We thank G. Ito and M. Ballmer for helpful discussions, G. Nolet for input regarding methodology, and S. Grand for a copy of his global model. We also acknowledge the crews of the research vessels Melville, Ka'imikai-O-Kanaloa, and Kilo Moana; the Jason remotely operated vehicle team; the Ocean Bottom Seismograph Instrument Pool; the Carnegie Institution's portable seismology laboratory; and the hosts of temporary stations on the Hawaiian Islands. We thank L. Boschi and three anonymous reviewers for comments on earlier versions of this paper.	Boschi L, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025063; Collins JA, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2001GL013302; Courtillot V, 2003, EARTH PLANET SC LETT, V205, P295, DOI 10.1016/S0012-821X(02)01048-8; Dahlen FA, 2000, GEOPHYS J INT, V141, P157, DOI 10.1046/j.1365-246X.2000.00070.x; DAVIES GF, 1988, J GEOPHYS RES-SOLID, V93, P10467, DOI 10.1029/JB093iB09p10467; Duncan RA, 2004, GEOCHEM GEOPHY GEOSY, V5, DOI 10.1029/2004GC000704; Garnero EJ, 2007, GEOL SOC AM SPEC PAP, V430, P79, DOI 10.1130/2007.2430(05); Hauri EH, 1996, NATURE, V382, P415, DOI 10.1038/382415a0; Herzberg C, 2007, GEOCHEM GEOPHY GEOSY, V8, DOI 10.1029/2006GC001390; Ito G., 2007, TREATISE GEOPHYS, P371, DOI [DOI 10.1016/13978-044452748-6.00123-1, DOI 10.1016/B978-044452748-6/00123-1]; Katzman R, 1998, J GEOPHYS RES-SOL EA, V103, P17933, DOI 10.1029/98JB00504; KURZ MD, 1983, EARTH PLANET SC LETT, V66, P388, DOI 10.1016/0012-821X(83)90154-1; Laske G, 2007, GEOL SOC AM SPEC PAP, V430, P209, DOI 10.1130/2007.2430(11); Li C., 2008, GEOCHEM GEOPHY GEOSY, V9, P5, DOI [10.1029/2007GC001806, DOI 10.1029/2007GC001806]; Li X, 2000, NATURE, V405, P938, DOI 10.1038/35016054; Montelli R, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2006GC001248; Montelli R, 2004, SCIENCE, V303, P338, DOI 10.1126/science.1092485; Moore WB, 1998, SCIENCE, V279, P1008, DOI 10.1126/science.279.5353.1008; MORGAN WJ, 1971, NATURE, V230, P42, DOI 10.1038/230042a0; RIBE NM, 1994, J GEOPHYS RES-SOL EA, V99, P669, DOI 10.1029/93JB02386; RICHARDS MA, 1988, GEOPHYS J INT, V94, P367, DOI 10.1111/j.1365-246X.1988.tb02260.x; Shen Y, 2003, EARTH PLANET SC LETT, V214, P143, DOI 10.1016/S0012-821X(03)00349-2; SLEEP NH, 1990, J GEOPHYS RES-SOLID, V95, P6715, DOI 10.1029/JB095iB05p06715; Smith WHF, 1997, SCIENCE, V277, P1956, DOI 10.1126/science.277.5334.1956; Sobolev AV, 2005, NATURE, V434, P590, DOI 10.1038/nature03411; van der Hilst RD, 2005, GEOPHYS J INT, V163, P956, DOI 10.1111/j.1365-246X.2005.02817.x; VANKEKEN PE, 1995, J GEOPHYS RES, V100, P7137; WILSON JT, 1963, CAN J PHYS, V41, P863, DOI 10.1139/p63-094; Wolfe CJ, 2002, EARTH PLANET SC LETT, V198, P129, DOI 10.1016/S0012-821X(02)00493-4	29	158	167	5	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1388	1390		10.1126/science.1180165	http://dx.doi.org/10.1126/science.1180165			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965755				2022-12-28	WOS:000272351100038
J	Fradkin, E; Kivelson, SA				Fradkin, Eduardo; Kivelson, Steven A.			Electron Nematic Phases Proliferate	SCIENCE			English	Editorial Material							HIGH-TEMPERATURE SUPERCONDUCTORS		[Fradkin, Eduardo] Univ Illinois, Dept Phys, Urbana, IL 61801 USA; [Kivelson, Steven A.] Stanford Univ, Dept Phys, Stanford, CA 94305 USA	University of Illinois System; University of Illinois Urbana-Champaign; Stanford University	Fradkin, E (corresponding author), Univ Illinois, Dept Phys, 1110 W Green St, Urbana, IL 61801 USA.	efradkin@illinois.edu	Fradkin, Eduardo H/B-5612-2013	Fradkin, Eduardo/0000-0001-6837-463X; Kivelson, Steven/0000-0001-9149-9502				Ando Y, 2002, PHYS REV LETT, V88, DOI 10.1103/PhysRevLett.88.137005; Borzi RA, 2007, SCIENCE, V315, P214, DOI 10.1126/science.1134796; Cooper KB, 2002, PHYS REV B, V65, DOI 10.1103/PhysRevB.65.241313; Fang C, 2008, PHYS REV B, V77, DOI 10.1103/PhysRevB.77.224509; Halboth CJ, 2000, PHYS REV LETT, V85, P5162, DOI 10.1103/PhysRevLett.85.5162; Hinkov V, 2008, SCIENCE, V319, P597, DOI 10.1126/science.1152309; Howald C, 2003, P NATL ACAD SCI USA, V100, P9705, DOI 10.1073/pnas.1233768100; Kamihara Y, 2008, J AM CHEM SOC, V130, P3296, DOI 10.1021/ja800073m; Kee HY, 2003, PHYS REV B, V68, DOI 10.1103/PhysRevB.68.245109; Kivelson SA, 1998, NATURE, V393, P550, DOI 10.1038/31177; Kohsaka Y, 2007, SCIENCE, V315, P1380, DOI 10.1126/science.1138584; Lee WC, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.176101; Oganesyan V, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.195109; Sun K, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.085124; Xu CK, 2008, PHYS REV B, V78, DOI 10.1103/PhysRevB.78.134507; Zhai H, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.064517; Zhao J, 2009, NAT PHYS, V5, P555, DOI 10.1038/NPHYS1336	20	30	30	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 8	2010	327	5962					155	156		10.1126/science.1183464	http://dx.doi.org/10.1126/science.1183464			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056881				2022-12-28	WOS:000273394000023
J	Willis, J; Jones, R; Nwokolo, N; Levy, J				Willis, Joanna; Jones, Rachael; Nwokolo, Nneka; Levy, Jeremy			Lesson of the Week Protein and creatine supplements and misdiagnosis of kidney disease	BMJ-BRITISH MEDICAL JOURNAL			English	Article							PREDICTION		[Willis, Joanna; Levy, Jeremy] Imperial Coll Healthcare NHS Trust, Imperial Coll Kidney, London W12 0HS, England; [Willis, Joanna; Levy, Jeremy] Imperial Coll Healthcare NHS Trust, Transplant Inst, London W12 0HS, England; [Jones, Rachael; Nwokolo, Nneka] Chelsea & Westminster Hosp NHS Fdn Trust, London SW10 9NH, England	Imperial College London; Imperial College London; Imperial College London	Levy, J (corresponding author), Imperial Coll Healthcare NHS Trust, Imperial Coll Kidney, London W12 0HS, England.	j.levy@imperial.ac.uk		Willis, Joanna/0000-0003-3260-4311				Bemben MG, 2005, SPORTS MED, V35, P107, DOI 10.2165/00007256-200535020-00002; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Demant TW, 1999, SPORTS MED, V28, P49, DOI 10.2165/00007256-199928010-00005; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Hespel P, 2001, J PHYSIOL-LONDON, V536, P625, DOI 10.1111/j.1469-7793.2001.0625c.xd; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; National Collaborating Centre for Chronic Conditions, 2008, CHRON KIDN DIS NAT C	7	12	12	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2010	340								b5027	10.1136/bmj.b5027	http://dx.doi.org/10.1136/bmj.b5027			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542II	20061359				2022-12-28	WOS:000273486100006
J	Ebaugh, JL; Raffetto, JD				Ebaugh, James L.; Raffetto, Joseph D.			Giant Abdominal Aortic Aneurysm	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ebaugh, James L.; Raffetto, Joseph D.] Vet Affairs Boston Healthcare Syst, W Roxbury, MA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Ebaugh, JL (corresponding author), Vet Affairs Boston Healthcare Syst, W Roxbury, MA USA.	james.ebaugh2@med.va.gov							0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2010	362	1					66	66		10.1056/NEJMicm0808225	http://dx.doi.org/10.1056/NEJMicm0808225			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	540PA	20054048				2022-12-28	WOS:000273345500010
J	McGevna, L; Tavakkol, Z				McGevna, Laura; Tavakkol, Zarry			Necrolytic Migratory Erythema	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[McGevna, Laura] Univ Vermont, Burlington, VT 05405 USA; [Tavakkol, Zarry] Univ Washington, Seattle, WA 98195 USA	University of Vermont; University of Washington; University of Washington Seattle	McGevna, L (corresponding author), Univ Vermont, Burlington, VT 05405 USA.								0	7	7	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2010	362	1					e1	e1		10.1056/NEJMicm0810147	http://dx.doi.org/10.1056/NEJMicm0810147			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	540PA	20054043				2022-12-28	WOS:000273345500011
J	Pakmor, R; Kromer, M; Ropke, FK; Sim, SA; Ruiter, AJ; Hillebrandt, W				Pakmor, Ruediger; Kromer, Markus; Roepke, Friedrich K.; Sim, Stuart A.; Ruiter, Ashley J.; Hillebrandt, Wolfgang			Sub-luminous type Ia supernovae from the mergers of equal-mass white dwarfs with mass similar to 0.9M(circle dot)	NATURE			English	Article							STAR; NUCLEOSYNTHESIS; EVOLUTION; MODELS; RATES; DETONATIONS; EXPLOSIONS; BINARIES; OBJECTS; CODE	Type Ia supernovae are thought to result from thermonuclear explosions of carbon-oxygen white dwarf stars(1). Existing models(2) generally explain the observed properties, with the exception of the sub-luminous 1991bg-like supernovae(3). It has long been suspected that the merger of two white dwarfs could give rise to a type Ia event(4,5), but hitherto simulations have failed to produce an explosion(6,7). Here we report a simulation of the merger of two equal-mass white dwarfs that leads to a sub-luminous explosion, although at the expense of requiring a single common-envelope phase, and component masses of similar to 0.9M(circle dot). The light curve is too broad, but the synthesized spectra, red colour and low expansion velocities are all close to what is observed for sub-luminous 1991bg-like events. Although the mass ratios can be slightly less than one and still produce a sub-luminous event, the masses have to be in the range 0.83M(circle dot) to 0.9M(circle dot).	[Pakmor, Ruediger; Kromer, Markus; Roepke, Friedrich K.; Sim, Stuart A.; Ruiter, Ashley J.; Hillebrandt, Wolfgang] Max Planck Inst Astrophys, D-85748 Garching, Germany	Max Planck Society	Pakmor, R (corresponding author), Max Planck Inst Astrophys, Karl Schwarzschild Str 1, D-85748 Garching, Germany.	rpakmor@mpa-garching.mpg.de		Kromer, Markus/0000-0003-4380-7536; Sim, Stuart/0000-0002-9774-1192	German Research Foundation; Excellence Cluster "Origin and Structure of the Universe''	German Research Foundation(German Research Foundation (DFG)); Excellence Cluster "Origin and Structure of the Universe''	We thank K. Belczynski for supporting the population synthesis analysis and S. Taubenberger and S. Hachinger for discussions. This work was supported by the Transregional Research Centre "The Dark Universe'' of the German Research Foundation and by the Excellence Cluster "Origin and Structure of the Universe''. The work of F. K. R. is supported through the Emmy Noether Program of the German Research Foundation. We are grateful for computer time provided by the Computer Centre of the Max Planck Society in Garching, where all simulations were performed.	Belczynski K, 2002, ASTROPHYS J, V572, P407, DOI 10.1086/340304; Belczynski K, 2008, ASTROPHYS J SUPPL S, V174, P223, DOI 10.1086/521026; BENZ W, 1990, ASTROPHYS J, V348, P647, DOI 10.1086/168273; Fink M, 2007, ASTRON ASTROPHYS, V476, P1133, DOI 10.1051/0004-6361:20078438; Hachinger S, 2009, MON NOT R ASTRON SOC, V399, P1238, DOI 10.1111/j.1365-2966.2009.15403.x; Hicken M, 2007, ASTROPHYS J, V669, pL17, DOI 10.1086/523301; Howell DA, 2006, NATURE, V443, P308, DOI 10.1038/nature05103; Howell DA, 2001, ASTROPHYS J, V556, P302, DOI 10.1086/321584; HOYLE F, 1960, ASTROPHYS J, V132, P565, DOI 10.1086/146963; IBEN I, 1984, ASTROPHYS J SUPPL S, V54, P335, DOI 10.1086/190932; Kasen D, 2009, NATURE, V460, P869, DOI 10.1038/nature08256; Krisciunas K, 2003, ASTRON J, V125, P166, DOI 10.1086/345571; Kromer M, 2009, MON NOT R ASTRON SOC, V398, P1809, DOI 10.1111/j.1365-2966.2009.15256.x; LEIBUNDGUT B, 1993, ASTRON J, V105, P301, DOI 10.1086/116427; Mazzali PA, 2007, SCIENCE, V315, P825, DOI 10.1126/science.1136259; NOMOTO K, 1984, ASTROPHYS J, V286, P644, DOI 10.1086/162639; Pastorello A, 2007, MON NOT R ASTRON SOC, V377, P1531, DOI 10.1111/j.1365-2966.2007.11700.x; Pastorello A, 2007, MON NOT R ASTRON SOC, V376, P1301, DOI 10.1111/j.1365-2966.2007.11527.x; Ropke FK, 2007, ASTRON ASTROPHYS, V464, P683, DOI 10.1051/0004-6361:20066585; Ruiter AJ, 2009, ASTROPHYS J, V699, P2026, DOI 10.1088/0004-637X/699/2/2026; SAIO H, 1985, ASTRON ASTROPHYS, V150, pL21; Seitenzahl IR, 2009, ASTROPHYS J, V696, P515, DOI 10.1088/0004-637X/696/1/515; Springel V, 2005, MON NOT R ASTRON SOC, V364, P1105, DOI 10.1111/j.1365-2966.2005.09655.x; Stritzinger M, 2006, ASTRON ASTROPHYS, V450, P241, DOI 10.1051/0004-6361:20053652; Taubenberger S, 2008, MON NOT R ASTRON SOC, V385, P75, DOI 10.1111/j.1365-2966.2008.12843.x; THIELEMANN FK, 1986, ASTRON ASTROPHYS, V158, P17; Travaglio C, 2004, ASTRON ASTROPHYS, V425, P1029, DOI 10.1051/0004-6361:20041108; WEBBINK RF, 1984, ASTROPHYS J, V277, P355, DOI 10.1086/161701	29	257	258	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 7	2010	463	7277					61	64		10.1038/nature08642	http://dx.doi.org/10.1038/nature08642			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054390	Green Submitted			2022-12-28	WOS:000273344900029
J	Plennevaux, E; Sheldon, E; Blatter, M; Reeves-Hoche, MK; Denis, M				Plennevaux, Eric; Sheldon, Eric; Blatter, Mark; Reeves-Hoche, Mary-Kate; Denis, Martine			Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials	LANCET			English	Article							IMMUNOGENICITY; TRANSMISSION; PATHOGENESIS; VIRUS	Background Data are needed from large clinical trials of paediatric, adult, and elderly people to find the appropriate antigen dose and vaccination schedule for the 2009 pandemic influenza A H1N1. We therefore report preliminary safety and immunogenicity results after one injection of a licensed monovalent pandemic H1N1 vaccine in the USA. Methods We randomly assigned healthy children (aged 6-35 months and 3-9 years) and adults (18-64 years and >= 65 years) to vaccine containing per dose 7.5 mu g (children and adults), 15 mu g (children and adults), or 30 mu g (adults only) haemagglutinin in two placebo-controlled, observer-masked, multicentre phase 2 studies done in the USA. Participants were allocated with an interactive voice-response system or computer-generated randomisation lists with opaque scratchable patches. Primary outcome was haemagglutination inhibition antibody response 21 days after the first of two planned vaccinations (interim analysis of studies in progress). Analyses were by full-analysis set. The trials are registered with ClinicalTrials.gov as NCT00953524 and NCT00952419. Findings 410 of 423 children and 724 of 750 adults given an active vaccine, and 50 of 51 children and 95 of 99 adults given placebo were assessed for immunogenicity on day 21. After active vaccination, 45 of 101 (45%; 95% CI 35-55) to 47 of 94 (50%; 40-61) infants aged 6-35 months, 75 of 109 (69%; 59-77) to 80 of 106 (75%; 66-83) 3-9-year-old children, 134 of 141 (95%; 90-98) to 144 of 144 (100%; 98-100) of 18-64-year-old adults, and 93 of 100 (93%; 86-96) to 93 of 98 (95%; 89-98) elderly adults were seroprotected (proportion with titres 2:1:40). No vaccine-related serious adverse events occurred. Injection-site and systemic reactions were reported by up to about 50% of every age and vaccine group, with no noticeable differences between vaccine and placebo groups. Interpretation One dose of vaccine was highly immunogenic in adults, suggesting that it afforded sufficient protection against this pandemic influenza A H1N1 virus. Two doses of vaccine will probably be needed in children younger than 9 years. Safety and reactogenicity of the vaccine were acceptable and similar to those of seasonal vaccine. Funding Office of the Assistant Secretary for Preparedness and Response, and Biomedical Advanced Research and Development Authority.	[Plennevaux, Eric] Sanofi Pasteur, Clin Dev Dept, Lyon, France; [Sheldon, Eric] Miami Res Associates, Miami, FL USA; [Blatter, Mark] Primary Phys Res, Pittsburgh, PA USA; [Reeves-Hoche, Mary-Kate] Sanofi Pasteur, Dept Res & Dev, Swiftwater, PA USA	Sanofi-Aventis; Sanofi France; Sanofi-Aventis	Denis, M (corresponding author), 1541 Ave Marcel Merieux, F-69280 Marcy Letoile, France.	martine.denis@sanofipasteur.com		Sheldon, Eric/0000-0002-8212-3607	Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Activity [HHSO100200900121]	Office of the Assistant Secretary for Preparedness and Response; Biomedical Advanced Research and Development Activity	This project has been wholly funded with federal funds from the Office of the Assistant Secretary for Preparedness and Response, and Biomedical Advanced Research and Development Activity under contract number HHSO100200900121. We thank the clinical and project team members at Sanofi-Pasteur, particularly D Kirby and A Shedd; J Hoffiter, K Heard, B Levron, S Singer, A O'Ned, M Wali, J Lathey, J Kramer, D Francis, A Strickland, Y Rodriguez, K Fries, B Hu, J Haines, A Rosas, Y Kazachkov, K McKinney, and E Yau (statistician); the principal investigators of the two studies and their teams-W Andrews, M Baron, R Biedenbender, L Chu, M Cornish, C Cunha, W Daly, M Davis, D DeSantis, W Harper, D Herrington, M Hollingsworth, R Jeanfireau, C Johnson, T Legg, A Moskow, A Pragalos, D Riff, E Riffer, J Rosen, W Seger, W Smith, C Strout, and B Wittmer. This report was prepared with the assistance of G Marsh at Sanofi-Pasteur. The views expressed in written conference materials or publications and by speakers and moderators at Department of Health and Human Services-sponsored conferences do not necessarily reflect the official policies ofthe Department of Health and Human Services; mention of trade names, commercial practices, or organisations does not imply endorsement by the US Government.	Brouwers L, 2009, EUROSURVEILLANCE, V14, P5; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P1009; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P941; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; *CPMP, 1997, CPMPBWP21496 EMEA; Falsey AR, 2009, J INFECT DIS, V200, P172, DOI 10.1086/599790; *FOOD DRUG ADM CTR, 2009, REG CONS REG US NOV; Frey S, 2003, VACCINE, V21, P4234, DOI 10.1016/S0264-410X(03)00456-0; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Itoh Y, 2009, NATURE, V460, P1021, DOI 10.1038/nature08260; Kelly HA, 2009, MED J AUSTRALIA, V191, P146, DOI 10.5694/j.1326-5377.2009.tb02723.x; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Munster VJ, 2009, SCIENCE, V325, P481, DOI 10.1126/science.1177127; Ruben FL, 2004, CLIN INFECT DIS, V38, P678, DOI 10.1086/382883; Vaillant L, 2009, EUROSURVEILLANCE, V14, P2; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; World Health Organization, 2002, WHO MAN AN INFL DIAG; World Health Organization, 2009, CHAR EM INFL A H1N1; Yang Y, 2009, SCIENCE, V326, P729, DOI 10.1126/science.1177373	21	219	225	2	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2010	375	9708					41	48		10.1016/S0140-6736(09)62026-2	http://dx.doi.org/10.1016/S0140-6736(09)62026-2			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539BZ	20018365				2022-12-28	WOS:000273229700030
J	Blosser, TR; Yang, JG; Stone, MD; Narlikar, GJ; Zhuang, XW				Blosser, Timothy R.; Yang, Janet G.; Stone, Michael D.; Narlikar, Geeta J.; Zhuang, Xiaowei			Dynamics of nucleosome remodelling by individual ACF complexes	NATURE			English	Article							DNA TRANSLOCATION; SINGLE-MOLECULE; HISTONE OCTAMER; ENERGY-TRANSFER; CORE PARTICLE; CHROMATIN; ISWI; SWI/SNF; MECHANISM; CATALYSIS	The ATP-dependent chromatin assembly and remodelling factor (ACF) functions to generate regularly spaced nucleosomes, which are required for heritable gene silencing. The mechanism by which ACF mobilizes nucleosomes remains poorly understood. Here we report a single-molecule FRET study that monitors the remodelling of individual nucleosomes by ACF in real time, revealing previously unknown remodelling intermediates and dynamics. In the presence of ACF and ATP, the nucleosomes exhibit gradual translocation along DNA interrupted by well-defined kinetic pauses that occurred after approximately seven or three to four base pairs of translocation. The binding of ACF, translocation of DNA and exiting of translocation pauses are all ATP-dependent, revealing three distinct functional roles of ATP during remodelling. At equilibrium, a continuously bound ACF complex can move the nucleosome back-and-forth many times before dissociation, indicating that ACF is a highly processive and bidirectional nucleosome translocase.	[Blosser, Timothy R.; Stone, Michael D.; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Blosser, Timothy R.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Yang, Janet G.; Narlikar, Geeta J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94107 USA; [Stone, Michael D.; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; University of California System; University of California San Francisco; Harvard University; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	geeta.narlikar@ucsf.edu; zhuang@chemistry.harvard.edu	Yang, Janet/P-2003-2015		Howard Hughes Medical Institute; National Institutes of Health [GM073767]; Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073767] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Widom for providing the plasmid containing the 601 positioning sequence and R. E. Kingston for the plasmids containing the SNF2h and Acf1 genes. We also thank L. Racki and E. Abbondanzieri for helpful discussions, and W. Huang and B. Harada for help with some experiments. This work is supported in part by Howard Hughes Medical Institute ( to X. Z.) and the National Institutes of Health (GM073767) and the Beckman Foundation ( to G. J. N). X. Z. is a Howard Hughes Medical Institute investigator. M. D. S. was a NIH Ruth L. Kirschstein NSRA Fellow, G. J. N is a Leukemia and Lymphoma Society Scholar.	Aalfs JD, 2001, J BIOL CHEM, V276, P34270, DOI 10.1074/jbc.M104163200; Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Fitzgerald DJ, 2004, EMBO J, V23, P3836, DOI 10.1038/sj.emboj.7600364; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kassabov SR, 2002, MOL CELL BIOL, V22, P7524, DOI 10.1128/MCB.22.21.7524-7534.2002; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; LeRoy G, 2000, J BIOL CHEM, V275, P14787, DOI 10.1074/jbc.C000093200; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Partensky PD, 2009, J MOL BIOL, V391, P12, DOI 10.1016/j.jmb.2009.04.085; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	41	141	143	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1022	U79		10.1038/nature08627	http://dx.doi.org/10.1038/nature08627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033040	Green Submitted, Green Accepted			2022-12-28	WOS:000272996000039
J	Leung, CT; Brugge, JS				Leung, Cheuk T.; Brugge, Joan S.			Tumor Self-Seeding: Bidirectional Flow of Tumor Cells	CELL			English	Editorial Material							BREAST-CANCER METASTASIS; STEM-CELLS; GROWTH		[Leung, Cheuk T.; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	joan_brugge@hms.harvard.edu		Leung, Cheuk/0000-0002-5838-5535				Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Dittma T, 2008, CLIN EXP METASTAS, V25, P11, DOI 10.1007/s10585-007-9095-5; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237	9	33	37	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 24	2009	139	7					1226	1228		10.1016/j.cell.2009.12.013	http://dx.doi.org/10.1016/j.cell.2009.12.013			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064369	Bronze			2022-12-28	WOS:000273048700011
J	Snitz, BE; O'Meara, ES; Carlson, MC; Arnold, AM; Ives, DG; Rapp, SR; Saxton, J; Lopez, OL; Dunn, LO; Sink, KM; DeKosky, ST				Snitz, Beth E.; O'Meara, Ellen S.; Carlson, Michelle C.; Arnold, Alice M.; Ives, Diane G.; Rapp, Stephen R.; Saxton, Judith; Lopez, Oscar L.; Dunn, Leslie O.; Sink, Kaycee M.; DeKosky, Steven T.		GEM Study Investigators	Ginkgo biloba for Preventing Cognitive Decline in Older Adults A Randomized Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							EXTRACT EGB-761; BASE-LINE; MEMORY; IMPAIRMENT; DEMENTIA	Context The herbal product Ginkgo biloba is taken frequently with the intention of improving cognitive health in aging. However, evidence from adequately powered clinical trials is lacking regarding its effect on long-term cognitive functioning. Objective To determine whether G biloba slows the rates of global or domain-specific cognitive decline in older adults. Design, Setting, and Participants The Ginkgo Evaluation of Memory ( GEM) study, a randomized, double-blind, placebo-controlled clinical trial of 3069 community-dwelling participants aged 72 to 96 years, conducted in 6 academic medical centers in the United States between 2000 and 2008, with a median follow-up of 6.1 years. Intervention Twice-daily dose of 120-mg extract of G biloba (n=1545) or identical-appearing placebo (n=1524). Main Outcome Measures Rates of change over time in the Modified Mini-Mental State Examination (3MSE), in the cognitive subscale of the Alzheimer Disease Assessment Scale (ADAS-Cog), and in neuropsychological domains of memory, attention, visual-spatial construction, language, and executive functions, based on sums of z scores of individual tests. Results Annual rates of decline in z scores did not differ between G biloba and placebo groups in any domains, including memory (0.043; 95% confidence interval [CI], 0.034-0.051 vs 0.041; 95% CI, 0.032-0.050), attention ( 0.043; 95% CI, 0.037-0.050 vs 0.048; 95% CI, 0.041-0.054), visuospatial abilities (0.107; 95% CI, 0.097-0.117 vs 0.118; 95% CI, 0.108-0.128), language (0.045; 95% CI, 0.037-0.054 vs 0.041; 95% CI, 0.033-0.048), and executive functions (0.092; 95% CI, 0.086-0.099 vs 0.089; 95% CI, 0.082-0.096). For the 3MSE and ADAS-Cog, rates of change varied by baseline cognitive status ( mild cognitive impairment), but there were no differences in rates of change between treatment groups ( for 3MSE, P=.71; for ADAS-Cog, P=.97). There was no significant effect modification of treatment on rate of decline by age, sex, race, education, APOE*E4 allele, or baseline mild cognitive impairment (P>.05). Conclusion Compared with placebo, the use of G biloba, 120 mg twice daily, did not result in less cognitive decline in older adults with normal cognition or with mild cognitive impairment. Trial Registration clinicaltrials.gov Identifier: NCT00010803 JAMA. 2009;302(24):2663-2670 www.jama.com	[DeKosky, Steven T.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Snitz, Beth E.; Saxton, Judith; Lopez, Oscar L.; Dunn, Leslie O.; DeKosky, Steven T.] Univ Pittsburgh, Dept Neurol, Pittsburgh, PA 15260 USA; [Ives, Diane G.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15260 USA; [O'Meara, Ellen S.; Arnold, Alice M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Carlson, Michelle C.] Johns Hopkins Med Inst, Dept Mental Hlth, Baltimore, MD 21205 USA; [Rapp, Stephen R.] Wake Forest Univ, Dept Psychiat & Behav Med, Winston Salem, NC 27109 USA; [Sink, Kaycee M.] Wake Forest Univ, Dept Internal Med Geriatr Gerontol, Sch Med, Winston Salem, NC 27109 USA	University of Virginia; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins Medicine; Wake Forest University; Wake Forest University	DeKosky, ST (corresponding author), Univ Virginia, Sch Med, POB 800793, Charlottesville, VA 22908 USA.	dekosky@virginia.edu	Sink, Kaycee/AAY-5920-2020	Nahin, Richard/0000-0002-3682-4816; Sink, Kaycee/0000-0001-9608-3856; DeKosky, Steven/0000-0003-3743-2758	NCCAM [U01 AT000162]; the National Institute on Aging; National Heart, Lung, and Blood Institute; University of Pittsburgh; Alzheimer's Disease Research Center [P50AG05133]; Roena Kulynych Center for Memory and Cognition Research; National Institute of Neurological Disorders and Stroke; NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE [U01AT000162] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U19AG010483, P50AG005133] Funding Source: NIH RePORTER	NCCAM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); the National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of Pittsburgh(University of Pittsburgh); Alzheimer's Disease Research Center; Roena Kulynych Center for Memory and Cognition Research; National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CENTER FOR COMPLEMENTARY &ALTERNATIVE MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Complementary & Alternative Medicine); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was funded by grant U01 AT000162 from the NCCAM and the Office of Dietary Supplements and by support from the National Institute on Aging, National Heart, Lung, and Blood Institute, University of Pittsburgh Alzheimer's Disease Research Center (grant P50AG05133), Roena Kulynych Center for Memory and Cognition Research, and National Institute of Neurological Disorders and Stroke. We gratefully acknowledge Schwabe Pharmaceuticals, Karlsruhe, Germany, for donation of G biloba tablets and identical placebos.	ALLAIN H, 1993, CLIN THER, V15, P549; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Barnes P. M., 2008, NATL HLTH STAT REPOR; BECKER JT, 1987, CORTEX, V23, P59, DOI 10.1016/S0010-9452(87)80019-9; Bernick C, 2005, NEUROLOGY, V65, P1388, DOI 10.1212/01.wnl.0000182897.18229.ec; Birks J, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003120.pub3; Brandt J., 1988, NEUROPSY NEUROPSY BE, V1, P111; Chen X, 1997, CLIN EXP PHARMACOL P, V24, P958, DOI 10.1111/j.1440-1681.1997.tb02727.x; DeKosky ST, 2008, JAMA-J AM MED ASSOC, V300, P2253, DOI 10.1001/jama.2008.683; DeKosky ST, 2006, CONTEMP CLIN TRIALS, V27, P238, DOI 10.1016/j.cct.2006.02.007; Delis DC., 2000, CALIFORNIA VERBAL LE; Dodge HH, 2008, NEUROLOGY, V70, P1809, DOI 10.1212/01.wnl.0000303814.13509.db; Fitzpatrick AL, 2006, CONTEMP CLIN TRIALS, V27, P541, DOI 10.1016/j.cct.2006.06.007; Hadjiivanova CI, 2002, PHYTOTHER RES, V16, P488, DOI 10.1002/ptr.933; HINDMARCH I, 1986, PRESSE MED, V15, P1592; Huang SY, 2004, CLIN NUTR, V23, P615, DOI 10.1016/j.clnu.2003.10.010; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; HUGUET F, 1992, J PHARM PHARMACOL, V44, P24, DOI 10.1111/j.2042-7158.1992.tb14357.x; Kaschel R, 2009, HUM PSYCHOPHARM CLIN, V24, P345, DOI 10.1002/hup.1037; Kennedy DO, 2000, PSYCHOPHARMACOLOGY, V151, P416, DOI 10.1007/s002130000501; Lopez OL, 2006, J NEUROL NEUROSUR PS, V77, P159, DOI 10.1136/jnnp.2004.045567; Luo Y, 2002, P NATL ACAD SCI USA, V99, P12197, DOI 10.1073/pnas.182425199; Mohs R C, 1996, Int Psychogeriatr, V8, P195, DOI 10.1017/S1041610296002578; Pietri S, 1997, J MOL CELL CARDIOL, V29, P733, DOI 10.1006/jmcc.1996.0316; Rapp SR, 2003, JAMA-J AM MED ASSOC, V289, P2663, DOI 10.1001/jama.289.20.2663; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Saxton J, 2000, CLIN NEUROPSYCHOL, V14, P526, DOI 10.1076/clin.14.4.526.7204; Schwartz BS, 2004, ENVIRON HEALTH PERSP, V112, P314, DOI 10.1289/ehp.6727; Snitz BE, 2009, AGING MENT HEALTH, V13, P171, DOI 10.1080/13607860802380656; Solomon PR, 2002, JAMA-J AM MED ASSOC, V288, P835, DOI 10.1001/jama.288.7.835; Spreen O, 1998, COMPENDIUM NEUROPSYC; TENG EL, 1987, J CLIN PSYCHIAT, V48, P314; Trenerry MR., 1989, STROOP NEUROPSYCHOLO; van Dongen M, 2003, J CLIN EPIDEMIOL, V56, P367, DOI 10.1016/S0895-4356(03)00003-9; Wesnes KA, 2000, PSYCHOPHARMACOLOGY, V152, P353, DOI 10.1007/s002130000533; Winblad B, 2004, J INTERN MED, V256, P240, DOI 10.1111/j.1365-2796.2004.01380.x	36	214	224	1	36	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 23	2009	302	24					2663	2670		10.1001/jama.2009.1913	http://dx.doi.org/10.1001/jama.2009.1913			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535JU	20040554	Green Accepted, Bronze			2022-12-28	WOS:000272965300022
J	Tao, X; Avalos, JL; Chen, JY; MacKinnon, R				Tao, Xiao; Avalos, Jose L.; Chen, Jiayun; MacKinnon, Roderick			Crystal Structure of the Eukaryotic Strong Inward-Rectifier K+ Channel Kir2.2 at 3.1 angstrom Resolution	SCIENCE			English	Article							POTASSIUM CHANNEL; INTRACELLULAR SPERMINE; VENTRICULAR CELLS; CYTOPLASMIC PORE; ION SELECTIVITY; DISULFIDE BOND; INNER PORE; RECTIFICATION; BLOCK; POLYAMINES	Inward-rectifier potassium (K+) channels conduct K+ ions most efficiently in one direction, into the cell. Kir2 channels control the resting membrane voltage in many electrically excitable cells, and heritable mutations cause periodic paralysis and cardiac arrhythmia. We present the crystal structure of Kir2.2 from chicken, which, excluding the unstructured amino and carboxyl termini, is 90% identical to human Kir2.2. Crystals containing rubidium (Rb+), strontium (Sr2+), and europium (Eu3+) reveal binding sites along the ion conduction pathway that are both conductive and inhibitory. The sites correlate with extensive electrophysiological data and provide a structural basis for understanding rectification. The channel's extracellular surface, with large structured turrets and an unusual selectivity filter entryway, might explain the relative insensitivity of eukaryotic inward rectifiers to toxins. These same surface features also suggest a possible approach to the development of inhibitory agents specific to each member of the inward-rectifier K+ channel family.	[Tao, Xiao; Avalos, Jose L.; Chen, Jiayun; MacKinnon, Roderick] Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, New York, NY 10065 USA	Howard Hughes Medical Institute; Rockefeller University	MacKinnon, R (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab Mol Neurobiol & Biophys, 1230 York Ave, New York, NY 10065 USA.	mackinn@rockefeller.edu		Avalos, Jose L./0000-0002-7209-4208	Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043949] Funding Source: NIH RePORTER	Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank P. Hoff and members of D. Gadsby's laboratory (Rockefeller University) for assistance with oocyte preparation; R. Molday ( University of British Columbia) for providing the anti-1D4 tag cell line; K. R. Rajashankar and K. Perry at beamline 24ID-C (Advanced Photon Source, Argonne National Laboratory) and H. Robinson at beamline X29 (National Synchrotron Light Source, Brookhaven National Laboratory) for assistance at the synchrotron; members of the MacKinnon laboratory for assistance; and A. Banerjee, J. Butterwick, M. Whorton, and J. Chen (Purdue University) for comments on the manuscript. J. L. A. was a fellow of the Damon Runyon Cancer Research Foundation. R. M. is an investigator in the Howard Hughes Medical Institute. The x-ray crystallographic coordinates and structure factor files have been deposited in the Protein Data Bank with accession ID 3JYC.	Cho HC, 2000, BIOCHEMISTRY-US, V39, P4649, DOI 10.1021/bi992469g; Cotton A. F., 1988, ADV INORGANIC CHEM; Dibb KM, 2003, J BIOL CHEM, V278, P49537, DOI 10.1074/jbc.M307723200; FAKLER B, 1994, NEURON, V13, P1413, DOI 10.1016/0896-6273(94)90426-X; FAKLER B, 1994, FEBS LETT, V356, P199, DOI 10.1016/0014-5793(94)01258-X; FAKLER B, 1995, CELL, V80, P149, DOI 10.1016/0092-8674(95)90459-X; Fan Z, 1997, J BIOL CHEM, V272, P5388, DOI 10.1074/jbc.272.9.5388; Felix JP, 2006, BIOCHEMISTRY-US, V45, P10129, DOI 10.1021/bi060509s; Fujiwara Y, 2006, J GEN PHYSIOL, V127, P401, DOI 10.1085/jgp.200509434; Garcia M L, 1999, Methods Enzymol, V294, P624; Guo DL, 2000, J GEN PHYSIOL, V115, P799, DOI 10.1085/jgp.115.6.799; Guo DL, 2003, J GEN PHYSIOL, V122, P485, DOI 10.1085/jgp.200308890; Guo DL, 2003, J GEN PHYSIOL, V121, P261, DOI 10.1085/jgp.200208771; Guo DL, 2001, J GEN PHYSIOL, V117, P395, DOI 10.1085/jgp.117.5.395; HAGIWARA S, 1979, J PHYSIOL-LONDON, V292, P251, DOI 10.1113/jphysiol.1979.sp012849; Harvey AL, 2004, CURR MED CHEM, V11, P3065, DOI 10.2174/0929867043363820; Henry P, 1996, J PHYSIOL-LONDON, V495, P681, DOI 10.1113/jphysiol.1996.sp021625; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HODGKIN AL, 1949, ARCH SCI PHYSIOL, V3, P129; HODGKIN AL, 1959, J PHYSIOL-LONDON, V148, P127, DOI 10.1113/jphysiol.1959.sp006278; HORIE M, 1987, J PHYSIOL-LONDON, V387, P251, DOI 10.1113/jphysiol.1987.sp016572; Huang CL, 1998, NATURE, V391, P803, DOI 10.1038/35882; Imredy JP, 1998, BIOCHEMISTRY-US, V37, P14867, DOI 10.1021/bi980929k; Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a; Jin WL, 1998, BIOCHEMISTRY-US, V37, P13291, DOI 10.1021/bi981178p; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14294, DOI 10.1021/bi991206j; KATZ B, 1949, ARCH SCI PHYSIOL, V3, P285; Kubo Y, 2001, J PHYSIOL-LONDON, V531, P645, DOI 10.1111/j.1469-7793.2001.0645h.x; Kuo AL, 2003, SCIENCE, V300, P1922, DOI 10.1126/science.1085028; Kurata HT, 2007, J GEN PHYSIOL, V130, P145, DOI 10.1085/jgp.200709742; LEECH CA, 1981, J PHYSIOL-LONDON, V319, P295, DOI 10.1113/jphysiol.1981.sp013909; Leyland ML, 1999, PFLUG ARCH EUR J PHY, V438, P778, DOI 10.1007/s004240051106; Liu GX, 2001, J PHYSIOL-LONDON, V532, P115, DOI 10.1111/j.1469-7793.2001.0115g.x; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; LOPATIN AN, 1994, NATURE, V372, P366, DOI 10.1038/372366a0; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lu Z, 2004, ANNU REV PHYSIOL, V66, P103, DOI 10.1146/annurev.physiol.66.032102.150822; LU Z, 1994, NATURE, V371, P243, DOI 10.1038/371243a0; Lu Z, 1997, BIOCHEMISTRY-US, V36, P6936, DOI 10.1021/bi9702849; MATSUDA H, 1987, NATURE, V325, P156, DOI 10.1038/325156a0; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; NOBLE D, 1968, J PHYSIOL-LONDON, V195, P185, DOI 10.1113/jphysiol.1968.sp008454; Oliver D, 1998, BIOPHYS J, V74, P2318, DOI 10.1016/S0006-3495(98)77941-X; Pearson WL, 1998, J GEN PHYSIOL, V112, P351, DOI 10.1085/jgp.112.3.351; Pegan S, 2005, NAT NEUROSCI, V8, P279, DOI 10.1038/nn1411; Pegan S, 2006, BIOCHEMISTRY-US, V45, P8599, DOI 10.1021/bi060653d; Ramu Y, 2004, BIOCHEMISTRY-US, V43, P10701, DOI 10.1021/bi049125x; Schulze D, 2003, J BIOL CHEM, V278, P10500, DOI 10.1074/jbc.M208413200; Shin HG, 2005, J GEN PHYSIOL, V126, P123, DOI 10.1085/jgp.200509296; Shyng SL, 2000, J GEN PHYSIOL, V116, P599, DOI 10.1085/jgp.116.5.599; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; Spassova MA, 1998, J GEN PHYSIOL, V112, P211, DOI 10.1085/jgp.112.2.211; Stanfield PR, 2002, REV PHYSIOL BIOCH P, V145, P47, DOI 10.1007/BFb0116431; SWARTZ KJ, 1995, NEURON, V15, P941, DOI 10.1016/0896-6273(95)90184-1; TAGLIALATELA M, 1995, EMBO J, V14, P5532, DOI 10.1002/j.1460-2075.1995.tb00240.x; TAKAHASHI N, 1994, J BIOL CHEM, V269, P23274; VANDENBERG CA, 1987, P NATL ACAD SCI USA, V84, P2560, DOI 10.1073/pnas.84.8.2560; WIBLE BA, 1994, NATURE, V371, P246, DOI 10.1038/371246a0; YANG J, 1995, NEURON, V14, P1047, DOI 10.1016/0896-6273(95)90343-7; Yang J, 1997, P NATL ACAD SCI USA, V94, P1568, DOI 10.1073/pnas.94.4.1568; Zeng WZ, 2002, AM J PHYSIOL-RENAL, V282, pF826, DOI 10.1152/ajprenal.00300.2001; Zhang HL, 1999, NAT CELL BIOL, V1, P183, DOI 10.1038/11103; Zhou Y, 2004, BIOCHEMISTRY-US, V43, P4978, DOI 10.1021/bi049876z; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	66	252	257	1	49	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 18	2009	326	5960					1668	1674		10.1126/science.1180310	http://dx.doi.org/10.1126/science.1180310			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	20019282	Green Accepted			2022-12-28	WOS:000272839000046
J	Schlichting, HE; Ofek, EO; Wenz, M; Sari, R; Gal-Yam, A; Livio, M; Nelan, E; Zucker, S				Schlichting, H. E.; Ofek, E. O.; Wenz, M.; Sari, R.; Gal-Yam, A.; Livio, M.; Nelan, E.; Zucker, S.			A single sub-kilometre Kuiper belt object from a stellar occultation in archival data	NATURE			English	Article							TRANS-NEPTUNIAN OBJECTS; SIZE DISTRIBUTION; MILLISECOND DIPS; SCORPIUS X-1; SCO X-1; SEARCH; BODIES; STARS	The Kuiper belt is a remnant of the primordial Solar System. Measurements of its size distribution constrain its accretion and collisional history, and the importance of material strength of Kuiper belt objects(1-4). Small, sub-kilometre-sized, Kuiper belt objects elude direct detection, but the signature of their occultations of background stars should be detectable(5-9). Observations at both optical(10) and X-ray(11) wavelengths claim to have detected such occultations, but their implied abundances are inconsistent with each other and far exceed theoretical expectations. Here we report an analysis of archival data that reveals an occultation by a body with an approximately 500-metre radius at a distance of 45 astronomical units. The probability of this event arising from random statistical fluctuations within our data set is about two per cent. Our survey yields a surface density of Kuiper belt objects with radii exceeding 250 metres of 2.1(-1.7)(+4.8) x 10(7) deg(-2), ruling out inferred surface densities from previous claimed detections by more than 5 sigma. The detection of only one event reveals a deficit of sub-kilometre-sized Kuiper belt objects compared to a population extrapolated from objects with radii exceeding 50 kilometres. This implies that sub-kilometre-sized objects are undergoing collisional erosion, just like debris disks observed around other stars.	[Schlichting, H. E.; Ofek, E. O.; Sari, R.] CALTECH, Dept Astron, Pasadena, CA 91125 USA; [Schlichting, H. E.] Univ Toronto, CITA, Toronto, ON M5S 3H8, Canada; [Wenz, M.] NASA, Goddard Space Flight Ctr, Greenbelt, MD 20771 USA; [Sari, R.] Hebrew Univ Jerusalem, Racah Inst Phys, IL-91904 Jerusalem, Israel; [Gal-Yam, A.] Weizmann Inst Sci, Fac Phys, IL-76100 Rehovot, Israel; [Livio, M.; Nelan, E.] Space Telescope Sci Inst, Baltimore, MD 21218 USA; [Zucker, S.] Tel Aviv Univ, Dept Geophys & Planetary Sci, IL-69978 Tel Aviv, Israel	California Institute of Technology; University of Toronto; National Aeronautics & Space Administration (NASA); NASA Goddard Space Flight Center; Hebrew University of Jerusalem; Weizmann Institute of Science; Space Telescope Science Institute; Tel Aviv University	Schlichting, HE (corresponding author), CALTECH, Dept Astron, Pasadena, CA 91125 USA.	hes@astro.caltech.edu; eran@astro.caltech.edu	Zucker, Shay/D-5721-2019	Zucker, Shay/0000-0003-3173-3138	NASA through a grant from the Space Telescope Science Institute; ERC; Packard Foundation; Israeli Science Foundation; EU Seventh Framework Programme Marie Curie IRG fellowship; Benoziyo Center for Astrophysics; Peter and Patricia Gruber Awards; William Z. and Eda Bess Novick New Scientists Fund; Israel Science Foundation-Adler Foundation	NASA through a grant from the Space Telescope Science Institute(Space Telescope Science Institute); ERC(European Research Council (ERC)European Commission); Packard Foundation(The David & Lucile Packard Foundation); Israeli Science Foundation(Israel Science Foundation); EU Seventh Framework Programme Marie Curie IRG fellowship(European Commission); Benoziyo Center for Astrophysics; Peter and Patricia Gruber Awards; William Z. and Eda Bess Novick New Scientists Fund; Israel Science Foundation-Adler Foundation(Israel Science Foundation)	We thank H. K. Chang for comments that helped to improve this manuscript. Some of the numerical calculations presented here were performed on Caltech's Division of Geological and Planetary Sciences Dell cluster. Partial support for this research was provided by NASA through a grant from the Space Telescope Science Institute. R. S. acknowledges support from the ERC and the Packard Foundation. A. G.-Y. is supported by the Israeli Science Foundation, an EU Seventh Framework Programme Marie Curie IRG fellowship and the Benoziyo Center for Astrophysics, a research grant from the Peter and Patricia Gruber Awards, and the William Z. and Eda Bess Novick New Scientists Fund at the Weizmann Institute. S. Z. acknowledges support from the Israel Science Foundation-Adler Foundation for Space Research. E.O.O. is an Einstein Fellow.	AXELROD TS, 1992, ASTR SOC P, V34, P171; BAILEY ME, 1976, NATURE, V259, P290, DOI 10.1038/259290a0; Bernstein GM, 2004, ASTRON J, V128, P1364, DOI 10.1086/422919; Bianco FB, 2009, ASTRON J, V138, P568, DOI 10.1088/0004-6256/138/2/568; Bickerton SJ, 2008, ASTRON J, V135, P1039, DOI 10.1088/0004-6256/135/3/1039; Blocker AW, 2009, ASTROPHYS J, V701, P1742, DOI 10.1088/0004-637X/701/2/1742; Chang HK, 2007, MON NOT R ASTRON SOC, V378, P1287, DOI 10.1111/j.1365-2966.2007.11729.x; Chang HK, 2006, NATURE, V442, P660, DOI 10.1038/nature04941; Davis DR, 1997, ICARUS, V125, P50, DOI 10.1006/icar.1996.5595; DOHNANYI JS, 1969, J GEOPHYS RES, V74, P2531, DOI 10.1029/JB074i010p02531; DYSON FJ, 1992, Q J ROY ASTRON SOC, V33, P45; Elliot JL, 2005, ASTRON J, V129, P1117, DOI 10.1086/427395; Fraser WC, 2008, ICARUS, V195, P827, DOI 10.1016/j.icarus.2008.01.014; Fuentes CI, 2008, ASTRON J, V136, P83, DOI 10.1088/0004-6265/136/1/83; Fuentes CI, 2009, ASTROPHYS J, V696, P91, DOI 10.1088/0004-637X/696/1/91; Jones TA, 2008, ASTROPHYS J, V677, P1241, DOI 10.1086/533581; Kenyon SJ, 1999, ASTRON J, V118, P1101, DOI 10.1086/300969; Liu CY, 2008, MON NOT R ASTRON SOC, V388, pL44, DOI 10.1111/j.1745-3933.2008.00494.x; Monet DG, 2003, ASTRON J, V125, P984, DOI 10.1086/345888; Nihei TC, 2007, ASTRON J, V134, P1596, DOI 10.1086/521396; Pan M, 2005, ICARUS, V173, P342, DOI 10.1016/j.icarus.2004.09.004; Roques F, 2000, ICARUS, V147, P530, DOI 10.1006/icar.2000.6452; Roques F, 2006, ASTRON J, V132, P819, DOI 10.1086/505623; ROQUES F, 1987, ASTRON J, V93, P1549, DOI 10.1086/114438; ROQUES F, 2008, KUIPER BELT EXPLORED, P545; Skrutskie MF, 2006, ASTRON J, V131, P1163, DOI 10.1086/498708; Stern SA, 1997, ASTROPHYS J, V490, P879, DOI 10.1086/304912; Zhang ZW, 2008, ASTROPHYS J LETT, V685, pL157, DOI 10.1086/592741	28	65	65	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					895	897		10.1038/nature08608	http://dx.doi.org/10.1038/nature08608			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016596	Green Submitted			2022-12-28	WOS:000272795400037
J	Aronson, JK				Aronson, Jeffrey K.			Christmas 2009: Years Like This Patent medicines and secret remedies	BRITISH MEDICAL JOURNAL			English	Editorial Material									Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England	University of Oxford	Aronson, JK (corresponding author), Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England.	jeffrey.aronson@clinpharm.ox.ac.uk						Adair James Makittrick, 1790, ESSAYS FASHIONABLE D; Aronson J, 1997, BRIT MED J, V315, P165; ARONSON J, 2009, QJM             0722; ARONSON J, 2007, BRIT MED J, V334, P429; BARTRIP PWJ, 1990, MIRROR MED HIST BMJ, P181; BERRIDGE V, 1987, OPIUM PEOPLE OPIATE, P123; British Medical Association, 1912, MOR SECR REM WHAT TH; British Medical Association, 1909, SECR REM WHAT THEY C; CARSON G, 1961, ONE MAN 2 HORSE; Church Roy A., 2007, KNOWLEDGE TRUST PROF; HUNT JA, 2001, PHARM J, V266, P191; Loudon I., 1986, MED CARE GEN PRACTIT; Nahin Richard L, 2009, Natl Health Stat Report, P1; Proprietary Association, 1908, FACTS WORTH KNOW FAL; ROY P, 1989, HLTH SALE; Teschke R, 2009, J ETHNOPHARMACOL, V123, P378, DOI 10.1016/j.jep.2009.03.038; TURNER ES, 1952, SHOCKING HIST ADVERT, P142; 1906, BMJ, V2, P1645; 1906, BMJ, V2, P1223; 1904, BMJ, V2, P1585; 1906, BMJ, V2, P27	21	5	5	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 14	2009	339								b5415	10.1136/bmj.b5415	http://dx.doi.org/10.1136/bmj.b5415			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534XF	20008435				2022-12-28	WOS:000272930100005
J	Hayman, JA				Hayman, John A.			Christmas 2009: Diagnosis Darwin's illness revisited	BRITISH MEDICAL JOURNAL			English	Editorial Material							CYCLIC VOMITING SYNDROME		Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3800, Australia	Monash University	Hayman, JA (corresponding author), Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic 3800, Australia.	hayman@johnhayman.net		HAYMAN, John/0000-0002-4174-2639				[Anonymous], 2008, DARWINS ILLNESS; Boles RG, 2005, AM J MED GENET A, V133A, P71, DOI 10.1002/ajmg.a.30524; Darwin and Barlow, 1958, AUTOBIOGRAPHY C DARW; DARWIN C, 1849, COMMUNICATION, V4; DARWIN C, 1831, COMMUNICATION, V1; DARWIN C, 1848, COMMUNICATION, V4; DARWIN C, 2009, DARWINS BEAGLE DIARY; DARWIN CR, 1864, COMMUNICATION, V10; DARWIN E, 1864, COMMUNICATION, V12; Fleisher DR, 2005, BMC MED, V3, DOI 10.1186/1741-7015-3-20; FLEISHER DR, 1993, J PEDIATR GASTR NUTR, V17, P361, DOI 10.1097/00005176-199311000-00005; Gee S., 1882, ST BARTHOLOMEWS HOSP, V18, P1; Healey E, 2001, E DARWIN INSPIRATION; LEYDEN JJ, 1974, BRIT J DERMATOL, V90, P525, DOI 10.1111/j.1365-2133.1974.tb06447.x; Salpietro CD, 2003, EUR J PEDIATR, V162, P727, DOI 10.1007/s00431-003-1280-1; Sauer GC, 2000, INT J DERMATOL, V39, P474, DOI 10.1046/j.1365-4362.2000.00814.x; Wang QX, 2004, AM J MED GENET A, V131A, P50, DOI 10.1002/ajmg.a.30323; Wedgwood B, 1980, WEDGWOOD CIRCLE 1730; Winslow JH, 1971, DARWINS VICTORIAN MA; WOODRUFF AW, 1965, BRIT MED J, P1745	20	11	11	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 13	2009	339								b4968	10.1136/bmj.b4968	http://dx.doi.org/10.1136/bmj.b4968			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531VJ	20008377				2022-12-28	WOS:000272697900002
J	Nilsson, M; Beaglehole, R; Sauerborn, R				Nilsson, Maria; Beaglehole, Robert; Sauerborn, Rainer			Climate policy: lessons from tobacco control	LANCET			English	Editorial Material							HEALTH		[Nilsson, Maria; Sauerborn, Rainer] Umea Univ, Umea Ctr Global Hlth Res, SE-90187 Umea, Sweden; [Beaglehole, Robert] Univ Auckland, Auckland 1, New Zealand; [Sauerborn, Rainer] Heidelberg Univ, Inst Publ Hlth, Heidelberg, Germany	Umea University; University of Auckland; Ruprecht Karls University Heidelberg	Nilsson, M (corresponding author), Umea Univ, Umea Ctr Global Hlth Res, SE-90187 Umea, Sweden.	maria.nilsson@epiph.umu.se						*COP15, 2009, UN CLIM CHANG C DEC; Costello A, 2009, LANCET, V373, P1693, DOI [10.1016/S0140-6736(09)60935-1, 10.1016/S0140-6736(09)60929-6]; DOLL R, 1950, BRIT MED J, V2, P739, DOI 10.1136/bmj.2.4682.739; Frieden TR, 2007, LANCET, V369, P1758, DOI 10.1016/S0140-6736(07)60782-X; Friel S, 2008, LANCET, V372, P1677, DOI 10.1016/S0140-6736(08)61692-X; International Energy Agency, 2009, CO2 EM FUEL COMB 200; International Panel on Climate Change, 1996, IPCC 2 ASS CLIM CHAN; Michaels D, 2005, AM J PUBLIC HEALTH, V95, pS39, DOI 10.2105/AJPH.2004.043059; Office on Smoking and Health (US), 1986, HLTH CONS INV SMOK R; SAUERBORN R, 2009, GLOBAL HLTH ACTION; Solomon S., 2007, PHYS SCI BASIS WORKI; STERN N, 2007, STERN REV EC CLIMATE; *SURG GEN ADV COMM, 1964, SMOK HLTH; UNFCC, 1997, KYOT PROT; WHO, FRAM CONV TOB CONTR; World Health Organization, 2008, WHO REP GLOB TOB EP	16	8	8	2	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					1955	1956		10.1016/S0140-6736(09)61959-0	http://dx.doi.org/10.1016/S0140-6736(09)61959-0			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532EA	20006121				2022-12-28	WOS:000272727000009
J	Mathas, S; Misteli, T				Mathas, Stephan; Misteli, Tom			The Dangers of Transcription	CELL			English	Editorial Material							TRANSLOCATIONS	Transcription is obviously essential, but even a good thing can be dangerous at times. In this issue, Lin et al. (2009) provide evidence that binding of the transcription machinery may predispose genome regions to breakage and translocations that may lead to cancer.	[Mathas, Stephan] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany; [Mathas, Stephan] Charite, D-13353 Berlin, Germany; [Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mathas, S (corresponding author), Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.	stephan.mathas@charite.de; mistelit@mail.nih.gov	Mathas, Stephan/I-5589-2015		NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER; Intramural NIH HHS [Z01 BC010309-09] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Mani RS, 2009, SCIENCE, V326, P1230, DOI 10.1126/science.1178124; Mathas S, 2009, P NATL ACAD SCI USA, V106, P5831, DOI 10.1073/pnas.0900912106; Misteli T, 2009, NAT REV MOL CELL BIO, V10, P243, DOI 10.1038/nrm2651; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679	5	9	9	0	1	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 11	2009	139	6					1047	1049		10.1016/j.cell.2009.11.037	http://dx.doi.org/10.1016/j.cell.2009.11.037			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005797	Green Accepted, Bronze			2022-12-28	WOS:000272622800005
J	Walck, J; Dixon, K				Walck, Jeffrey; Dixon, Kingsley			Time to future-proof plants in storage	NATURE			English	Editorial Material									[Walck, Jeffrey] Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37132 USA; [Dixon, Kingsley] Kings Pk & Bot Gardens, Perth 6005, Australia; [Dixon, Kingsley] Univ Western Australia, Sch Plant Biol, Nedlands, WA 6009, Australia	Middle Tennessee State University; University of Western Australia	Walck, J (corresponding author), Middle Tennessee State Univ, Dept Biol, Murfreesboro, TN 37132 USA.	jwalck@mtsu.edu; kdixon@bgpa.wa.gov.au	Dixon, Kingsley W/A-8133-2016; Dixon, Kingsley W/B-1042-2011	Dixon, Kingsley W/0000-0001-5989-2929; 					0	11	11	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 10	2009	462	7274					721	721		10.1038/462721a	http://dx.doi.org/10.1038/462721a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	529ZZ	20010667	Bronze			2022-12-28	WOS:000272559900016
J	Crickmore, MA				Crickmore, Michael A.			GE PRIZE ESSAY The Molecular Basis of Size Differences	SCIENCE			English	Editorial Material							HOX CONTROL; DROSOPHILA; ULTRABITHORAX; MOBILITY; GENES		Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA	Rockefeller University	Crickmore, MA (corresponding author), Rockefeller Univ, Lab Neurogenet & Behav, New York, NY 10065 USA.	mcrickmore@rockefeller.edu						Crickmore MA, 2008, BIOESSAYS, V30, P843, DOI 10.1002/bies.20806; Crickmore MA, 2006, SCIENCE, V313, P63, DOI 10.1126/science.1128650; Crickmore MA, 2007, DEVELOPMENT, V134, P327, DOI 10.1242/dev.02737; Crickmore MA, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000633; LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0; Lin XH, 2004, DEVELOPMENT, V131, P6009, DOI 10.1242/dev.01522; SMOLIKUTLAUT SM, 1990, GENETICS, V124, P357; Weatherbee SD, 1998, GENE DEV, V12, P1474, DOI 10.1101/gad.12.10.1474	8	3	3	0	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 4	2009	326	5958					1360	1361		10.1126/science.1184444	http://dx.doi.org/10.1126/science.1184444			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	527EX	19965749				2022-12-28	WOS:000272351100030
J	Okada, Y; Yamagata, K; Hong, K; Wakayama, T; Zhang, Y				Okada, Yuki; Yamagata, Kazuo; Hong, Kwonho; Wakayama, Teruhiko; Zhang, Yi			A role for the elongator complex in zygotic paternal genome demethylation	NATURE			English	Article							DNA DEMETHYLATION; PREIMPLANTATION EMBRYOS; S-ADENOSYLMETHIONINE; MOUSE; GENE; METHYLATION; PROTEIN; GLYCOSYLASE; ARABIDOPSIS; SUBUNIT	The life cycle of mammals begins when a sperm enters an egg. Immediately after fertilization, both the maternal and paternal genomes undergo dramatic reprogramming to prepare for the transition from germ cell to somatic cell transcription programs(1). One of the molecular events that takes place during this transition is the demethylation of the paternal genome(2,3). Despite extensive efforts, the factors responsible for paternal DNA demethylation have not been identified(4). To search for such factors, we developed a live cell imaging system that allows us to monitor the paternal DNA methylation state in zygotes. Through short-interfering-RNA-mediated knockdown in mouse zygotes, we identified Elp3 (also called KAT9), a component of the elongator complex(5), to be important for paternal DNA demethylation. We demonstrate that knockdown of Elp3 impairs paternal DNA demethylation as indicated by reporter binding, immunostaining and bisulphite sequencing. Similar results were also obtained when other elongator components, Elp1 and Elp4, were knocked down. Importantly, injection of messenger RNA encoding the Elp3 radical SAM domain mutant, but not the HAT domain mutant, into MII oocytes before fertilization also impaired paternal DNA demethylation, indicating that the SAM radical domain is involved in the demethylation process. Our study not only establishes a critical role for the elongator complex in zygotic paternal genome demethylation, but also indicates that the demethylation process may be mediated through a reaction that requires an intact radical SAM domain.	[Okada, Yuki; Hong, Kwonho; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Okada, Yuki; Hong, Kwonho; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Yamagata, Kazuo; Wakayama, Teruhiko] RIKEN, Ctr Dev Biol, Lab Genom Reprogramming, Chuo Ku, Kobe, Hyogo 6500047, Japan	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; RIKEN	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu		Zhang, Yi/0000-0002-2789-0811; Hong, Kwonho/0000-0001-7479-4091	Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM068804-07, R01 GM068804] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jorgensen HF, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl527; Kim SH, 2004, BIOCHEM BIOPH RES CO, V324, P58, DOI 10.1016/j.bbrc.2004.09.023; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Opavsky R, 2007, PLOS GENET, V3, P1757, DOI 10.1371/journal.pgen.0030167; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Yamagata K, 2009, J REPROD DEVELOP, V55, P343, DOI 10.1262/jrd.20166	30	223	229	2	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					554	U177		10.1038/nature08732	http://dx.doi.org/10.1038/nature08732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20054296	Green Submitted, Green Accepted			2022-12-28	WOS:000273981100054
J	Mathur, D; Bost, A; Driver, I; Ohlstein, B				Mathur, Divya; Bost, Alyssa; Driver, Ian; Ohlstein, Benjamin			A Transient Niche Regulates the Specification of Drosophila Intestinal Stem Cells	SCIENCE			English	Article							SELF-RENEWAL; PROLIFERATION; ACTIVATION; MIDGUT; SPERMATOGENESIS; MELANOGASTER; MAINTENANCE; DIVISION; NOTCH; OVARY	Stem cell niches are locations where stem cells reside and self-renew. Although studies have shown how niches maintain stem cell fate during tissue homeostasis, less is known about their roles in establishing stem cells. The adult Drosophila midgut is maintained by intestinal stem cells (ISCs); however, how they are established is unknown. Here, we show that an ISC progenitor generates a niche cell via Notch signaling. This niche uses the bone morphogenetic protein 2/4 homolog, decapentaplegic, to allow progenitors to divide in an undifferentiated state and subsequently breaks down and dies, resulting in the specification of ISCs in the adult midgut. Our results demonstrate a paradigm for stem cell-niche biology, where progenitors generate transient niches that determine stem cell fate and may give insights into stem cell specification in other tissues.	[Mathur, Divya; Bost, Alyssa; Ohlstein, Benjamin] Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10032 USA; [Driver, Ian] Columbia Univ, Integrated Program Cellular Mol Struct & Genet St, Med Ctr, New York, NY 10032 USA	Columbia University; Columbia University	Ohlstein, B (corresponding author), Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10032 USA.	bo2160@columbia.edu		Driver, Ian/0000-0002-2674-5532	Searle Scholars Award; Charles Bohmfalk Research Award; NIH [R01 DK082456-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088] Funding Source: NIH RePORTER	Searle Scholars Award; Charles Bohmfalk Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Wolken and S. Selway for technical assistance with the Pswitch screen; members of the Drosophila community for sending fly stocks; Developmental Studies Hybridoma Bank for antibodies; E. Matunis, M. Buszczak, and J. Wilhelm for helpful discussions; and anonymous reviewers for comments. B. O. is the recipient of the 2009 Searle Scholars Award, the Charles Bohmfalk Research Award, and an NIH grant (R01 DK082456-01).	Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; ELSHATOURY HH, 1957, J EMBRYOL EXP MORPH, V5, P9; HARTENSTEIN V, 1992, ROUX ARCH DEV BIOL, V201, P194, DOI 10.1007/BF00188752; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Lee WC, 2009, DEVELOPMENT, V136, P2255, DOI 10.1242/dev.035196; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Nicholson L, 2008, GENETICS, V178, P215, DOI 10.1534/genetics.107.081968; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Robertson CW, 1936, J MORPHOL, V59, P351, DOI 10.1002/jmor.1050590207; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	27	130	134	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					210	213		10.1126/science.1181958	http://dx.doi.org/10.1126/science.1181958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056890	Green Accepted			2022-12-28	WOS:000273394000037
J	Miller, ME; Bonds, DE; Gerstein, HC; Seaquist, ER; Bergenstal, RM; Calles-Escandon, J; Childress, RD; Craven, TE; Cuddihy, RM; Dailey, G; Feinglos, MN; Ismail-Beigi, F; Largay, JF; O'Connor, PJ; Paul, T; Savage, PJ; Schubart, UK; Sood, A; Genuth, S				Miller, Michael E.; Bonds, Denise E.; Gerstein, Hertzel C.; Seaquist, Elizabeth R.; Bergenstal, Richard M.; Calles-Escandon, Jorge; Childress, R. Dale; Craven, Timothy E.; Cuddihy, Robert M.; Dailey, George; Feinglos, Mark N.; Ismail-Beigi, Farmarz; Largay, Joe F.; O'Connor, Patrick J.; Paul, Terri; Savage, Peter J.; Schubart, Ulrich K.; Sood, Ajay; Genuth, Saul		ACCORD Investigators	The effects of baseline characteristics, glycaemia treatment approach, and glycated haemoglobin concentration on the risk of severe hypoglycaemia: post hoc epidemiological analysis of the ACCORD study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							GLUCOSE CONTROL; FREQUENCY; ASSOCIATION; TYPE-1	Objectives To investigate potential determinants of severe hypoglycaemia, including baseline characteristics, in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial and the association of severe hypoglycaemia with levels of glycated haemoglobin (haemoglobin A(1C)) achieved during therapy. Design Post hoc epidemiological analysis of a double 2x2 factorial, randomised, controlled trial. Setting Diabetes clinics, research clinics, and primary care clinics. Participants 10 209 of the 10 251 participants enrolled in the ACCORD study with type 2 diabetes, a haemoglobin A(1C) concentration of 7.5% or more during screening, and aged 40-79 years with established cardiovascular disease or 55-79 years with evidence of significant atherosclerosis, albuminuria, left ventricular hypertrophy, or two or more additional risk factors for cardiovascular disease (dyslipidaemia, hypertension, current smoker, or obese). Interventions Intensive (haemoglobin A(1C) <6.0%) or standard (haemoglobin A(1C) 7.0-7.9%) glucose control. Main outcome measures Severe hypoglycaemia was defined as episodes of "low blood glucose" requiring the assistance of another person and documentation of either a plasma glucose less than 2.8 mmol/l (<50 mg/dl) or symptoms that promptly resolved with oral carbohydrate, intravenous glucose, or glucagon. Results The annual incidence of hypoglycaemia was 3.14% in the intensive treatment group and 1.03% in the standard glycaemia group. We found significantly increased risks for hypoglycaemia among women (P=0.0300), African-Americans (P<0.0001 compared with non-Hispanic whites), those with less than a high school education (P<0.0500 compared with college graduates), aged participants (P<0.0001 per 1 year increase), and those who used insulin at trial entry (P<0.0001). For every 1% unit decline in the haemoglobin A(1C) concentration from baseline to 4 month visit, there was a 28% (95% CI 19% to 37%) and 14% (4% to 23%) reduced risk of hypoglycaemia requiring medical assistance in the standard and intensive groups, respectively. In both treatment groups, the risk of hypoglycaemia requiring medical assistance increased with each 1% unit increment in the average updated haemoglobin A(1C) concentration (standard arm: hazard ratio 1.76, 95% CI 1.50 to 2.06; intensive arm: hazard ratio 1.15, 95% CI 1.02 to 1.21). Conclusions A greater drop in haemoglobin A(1C) concentration from baseline to the 4 month visit was not associated with an increased risk for hypoglycaemia. Patients with poorer glycaemic control had a greater risk of hypoglycaemia, irrespective of treatment group. Identification of baseline subgroups with increased risk for severe hypoglycaemia can provide guidance to clinicians attempting to modify patient therapy on the basis of individual risk.	[Miller, Michael E.; Craven, Timothy E.] Wake Forest Univ, Bowman Gray Sch Med, Div Publ Hlth Sci, Winston Salem, NC 27157 USA; [Bonds, Denise E.] NHLBI, NIH, Bethesda, MD 20892 USA; [Gerstein, Hertzel C.] McMaster Univ & Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8L 2X2, Canada; [Seaquist, Elizabeth R.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Bergenstal, Richard M.; Cuddihy, Robert M.] Int Diabet Ctr Pk Nicollet, Minneapolis, MN 55416 USA; [Calles-Escandon, Jorge] Wake Forest Univ, Bowman Gray Sch Med, Dept Internal Med, Sect Endocrinol & Metab, Winston Salem, NC 27157 USA; [Childress, R. Dale] Memphis Vet Affairs Med Ctr, Memphis, TN 38104 USA; [Dailey, George] Whittier Inst Diabet & Endocrinol, La Jolla, CA 92037 USA; [Feinglos, Mark N.] Duke Univ, Med Ctr, Div Metab Endocrinol & Nutr, Durham, NC 27710 USA; [Ismail-Beigi, Farmarz; Sood, Ajay; Genuth, Saul] Case Western Reserve Univ, Cleveland, OH 44106 USA; [Largay, Joe F.] Univ N Carolina, Dept Med, Div Endocrinol, Chapel Hill, NC 27514 USA; [O'Connor, Patrick J.] HealthPartners Res Fdn, Minneapolis, MN 55440 USA; [Paul, Terri] Univ Western Ontario, Dept Med, Schulich Sch Med & Dent, London, ON N6A 5C1, Canada; [Savage, Peter J.] NIDDKD, NIH, Bethesda, MD 20892 USA; [Schubart, Ulrich K.] Yeshiva Univ Albert Einstein Coll Med, Jacobi Med Ctr, Bronx, NY 10461 USA	Wake Forest University; Wake Forest Baptist Medical Center; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); McMaster University; Population Health Research Institute; University of Minnesota System; University of Minnesota Twin Cities; International Diabetes Center; Wake Forest University; Wake Forest Baptist Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Memphis VA Medical Center; Duke University; Case Western Reserve University; University of North Carolina; University of North Carolina Chapel Hill; HealthPartners Institute for Education & Research; Western University (University of Western Ontario); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); Jacobi Medical Center; Yeshiva University; Albert Einstein College of Medicine	Miller, ME (corresponding author), Wake Forest Univ, Bowman Gray Sch Med, Div Publ Hlth Sci, 300 S Hawthorne Rd, Winston Salem, NC 27157 USA.	mmiller@wfubmc.edu	Gerstein, Hertzel C/B-1235-2013; O'Connor, Patrick/HII-2987-2022; Gerstein, Hertzel/ABB-8781-2020	Gerstein, Hertzel C/0000-0001-8072-2836; Gerstein, Hertzel/0000-0001-8072-2836; O'Connor, Patrick/0000-0002-2324-6228	NHLBI NIH HHS [N01-HC-95180, N01-HC-95184, IAA-Y1-HC-1010, N01-HC-95182, IAA-Y1-HC-9035, N01-HC-95181, N01-HC-95179, N01-HC-95178, N01-HC-95183] Funding Source: Medline; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095183, N01HC095181, N01HC095180, N01HC095178, N01HC095179, N01HC095184, N01HC095182] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Amiel SA, 2008, DIABETIC MED, V25, P245, DOI 10.1111/j.1464-5491.2007.02341.x; Bonds DE, 2009, BMJ-BRIT MED J, V339, pb4909, DOI DOI 10.1136/BMJ.B4909; Bonds DE, 2007, AM J CARDIOL, V99, p80I, DOI 10.1016/j.amjcard.2007.03.026; Buse JB, 2007, AM J CARDIOL, V99, p21I, DOI 10.1016/j.amjcard.2007.03.003; Childs BP, 2005, DIABETES CARE, V28, P1245; Cryer PE, 2002, DIABETOLOGIA, V45, P937, DOI 10.1007/s00125-002-0822-9; Cryer PE, 2008, DIABETES, V57, P3169, DOI 10.2337/db08-1084; DCCT Res Grp, 1991, AM J MED, V90, P450, DOI 10.1016/0002-9343(91)80085-Z; Desouza C, 2003, DIABETES CARE, V26, P1485, DOI 10.2337/diacare.26.5.1485; Donnelly LA, 2005, DIABETIC MED, V22, P749, DOI 10.1111/j.1464-5491.2005.01501.x; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Gerstein HC, 2007, AM J CARDIOL, V99, p34I, DOI 10.1016/j.amjcard.2007.03.004; Gurlek A, 1999, EXP CLIN ENDOCR DIAB, V107, P220; Heller SR, 2007, DIABETOLOGIA, V50, P1140, DOI 10.1007/s00125-007-0599-y; Henderson JN, 2003, DIABETIC MED, V20, P1016, DOI 10.1046/j.1464-5491.2003.01072.x; Leese GP, 2003, DIABETES CARE, V26, P1176, DOI 10.2337/diacare.26.4.1176; Miller CD, 2001, ARCH INTERN MED, V161, P1653, DOI 10.1001/archinte.161.13.1653; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Skyler JS, 2009, J AM COLL CARDIOL, V53, P298, DOI [10.1016/j.jacc.2008.10.008, 10.2337/dc08-9026]; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Zammitt NN, 2005, DIABETES CARE, V28, P2948, DOI 10.2337/diacare.28.12.2948	23	222	225	0	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 8	2010	340								b5444	10.1136/bmj.b5444	http://dx.doi.org/10.1136/bmj.b5444			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542II	20061360	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000273486100002
J	Hood, E; Fellman, J; Spencer, RGM; Hernes, PJ; Edwards, R; D'Amore, D; Scott, D				Hood, Eran; Fellman, Jason; Spencer, Robert G. M.; Hernes, Peter J.; Edwards, Rick; D'Amore, David; Scott, Durelle			Glaciers as a source of ancient and labile organic matter to the marine environment	NATURE			English	Article							CARBON; ALASKA; EXPORT; FATE	Riverine organic matter supports of the order of one-fifth of estuarine metabolism(1). Coastal ecosystems are therefore sensitive to alteration of both the quantity and lability of terrigenous dissolved organic matter (DOM) delivered by rivers. The lability of DOM is thought to vary with age, with younger, relatively unaltered organic matter being more easily metabolized by aquatic heterotrophs than older, heavily modified material(2-4). This view is developed exclusively from work in watersheds where terrestrial plant and soil sources dominate streamwater DOM. Here we characterize streamwater DOM from 11 coastal watersheds on the Gulf of Alaska that vary widely in glacier coverage (0-64 per cent). In contrast to non-glacial rivers, we find that the bioavailability of DOM to marine microorganisms is significantly correlated with increasing C-14 age. Moreover, the most heavily glaciated watersheds are the source of the oldest (similar to 4 kyr C-14 age) and most labile (66 per cent bioavailable) DOM. These glacial watersheds have extreme runoff rates, in part because they are subject to some of the highest rates of glacier volume loss on Earth(5). We estimate the cumulative flux of dissolved organic carbon derived from glaciers contributing runoff to the Gulf of Alaska at 0.13 +/- 0.01 Tg yr(-1) (1 Tg = 10(12) g), of which similar to 0.10 Tg is highly labile. This indicates that glacial runoff is a quantitatively important source of labile reduced carbon to marine ecosystems. Moreover, because glaciers and ice sheets represent the second largest reservoir of water in the global hydrologic system, our findings indicate that climatically driven changes in glacier volume could alter the age, quantity and reactivity of DOM entering coastal oceans.	[Hood, Eran] Univ Alaska SE, Environm Sci & Geog Program, Juneau, AK 99801 USA; [Fellman, Jason] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Spencer, Robert G. M.; Hernes, Peter J.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Edwards, Rick; D'Amore, David] US Forest Serv, Pacific NW Res Stn, USDA, Juneau, AK 99801 USA; [Scott, Durelle] Virginia Tech, Blacksburg, VA 24061 USA	University of Alaska System; University of Alaska Southeastern; University of Alaska System; University of Alaska Fairbanks; University of California System; University of California Davis; United States Department of Agriculture (USDA); United States Forest Service; Virginia Polytechnic Institute & State University	Hood, E (corresponding author), Univ Alaska SE, Environm Sci & Geog Program, Juneau, AK 99801 USA.	eran.hood@uas.alaska.edu			US National Science Foundation [EAR-0838587]; University of Alaska Seed Grant; USDA Forest Service, Pacific Northwest Research Station; Division Of Earth Sciences [0838587, 0838497] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); University of Alaska Seed Grant; USDA Forest Service, Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	E. Neal and K. Smikrud contributed to the GOA glacier water flux estimates and K. Smikrud also provided Fig. 1. A. Arendt provided data on glacial wastage. We thank X. Xu at the KCCAMS facility for <SUP>14</SUP>C analyses, and R. Dyda and B. Holmes at UC Davis for assistance with lignin and <SUP>13</SUP>C-DOC analyses, respectively. Funding came from the US National Science Foundation (EAR-0838587), a University of Alaska Seed Grant ( to E. H.) and the USDA Forest Service, Pacific Northwest Research Station. The use of trade or firm names in this publication does not imply endorsement by the US Department of Agriculture.	Anesio AM, 2009, GLOBAL CHANGE BIOL, V15, P955, DOI 10.1111/j.1365-2486.2008.01758.x; Arendt AA, 2002, SCIENCE, V297, P382, DOI 10.1126/science.1072497; Bardgett RD, 2007, BIOLOGY LETT, V3, P487, DOI 10.1098/rsbl.2007.0242; Barker JD, 2006, ARCT ANTARCT ALP RES, V38, P163, DOI 10.1657/1523-0430(2006)38[163:AADODO]2.0.CO;2; CHINLEO G, 1992, MAR ECOL PROG SER, V87, P87, DOI 10.3354/meps087087; DEEVEY ES, 1957, SCIENCE, V125, P182, DOI 10.1126/science.125.3240.182; Druffel ERM, 2000, GEOPHYS RES LETT, V27, P1495, DOI 10.1029/1999GL002398; Fellman JB, 2008, BIOGEOCHEMISTRY, V88, P169, DOI 10.1007/s10533-008-9203-x; Hanna E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005641; Hernes PJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001421; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Holmes RM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032837; Hood E, 2008, NAT GEOSCI, V1, P583, DOI 10.1038/ngeo280; Hood E, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000971; Larsen CF, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000586; Ludwig W, 1996, GLOBAL BIOGEOCHEM CY, V10, P23, DOI 10.1029/95GB02925; Mayorga E, 2005, NATURE, V436, P538, DOI 10.1038/nature03880; MCKNIGHT DM, 1994, LIMNOL OCEANOGR, V39, P1972, DOI 10.4319/lo.1994.39.8.1972; McKnight DM., 2003, AQUATIC ECOSYSTEMS, P71, DOI 10.1016/B978-012256371-3/50004-4; Meier MF, 2007, SCIENCE, V317, P1064, DOI 10.1126/science.1143906; Neal EG, 2002, J HYDROL, V263, P188, DOI 10.1016/S0022-1694(02)00058-6; Opsahl S, 1999, LIMNOL OCEANOGR, V44, P2017, DOI 10.4319/lo.1999.44.8.2017; Opsahl S, 1997, NATURE, V386, P480, DOI 10.1038/386480a0; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; Raymond PA, 2001, NATURE, V409, P497, DOI 10.1038/35054034; Raymond PA, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002934; Royer TC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026767; Schiff SL, 1997, BIOGEOCHEMISTRY, V36, P43, DOI 10.1023/A:1005744131385; Simpson JJ, 2005, ARCTIC, V58, P137; SKIDMORE ML, 2000, APPL ENVIRON MICROB, V66, P3124; SMITH SV, 1993, REV GEOPHYS, V31, P75, DOI 10.1029/92RG02584; Sondergaard M, 2003, OPHELIA, V57, P161, DOI 10.1080/00785236.2003.10409512; Spencer RGM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036831; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x	34	366	379	9	236	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1044	U100		10.1038/nature08580	http://dx.doi.org/10.1038/nature08580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033045				2022-12-28	WOS:000272996000044
J	Petersen, CP; Reddien, PW				Petersen, Christian P.; Reddien, Peter W.			Wnt Signaling and the Polarity of the Primary Body Axis	CELL			English	Review							NUCLEAR BETA-CATENIN; SEA-URCHIN EMBRYO; C-ELEGANS EMBRYOS; ASYMMETRIC CELL DIVISIONS; PLANARIAN REGENERATION; SPEMANN ORGANIZER; WNT/BETA-CATENIN; MOUSE EMBRYO; DORSOVENTRAL AXIS; XENOPUS EMBRYOS	How animals establish and pattern the primary body axis is one of the most fundamental problems in biology. Data from diverse deuterostomes (frog, fish, mouse, and amphioxus) and from planarians (protostomes) suggest that Wnt signaling through beta-catenin controls posterior identity during body plan formation in most bilaterally symmetric animals. Wnt signaling also influences primary axis polarity of pre-bilaterian animals, indicating that an axial patterning role for Wnt signaling predates the evolution of bilaterally symmetric animals. The use of posterior Wnt signaling and anterior Wnt inhibition might be a unifying principle of body plan development in most animals.	[Petersen, Christian P.; Reddien, Peter W.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Reddien, Peter W.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Reddien, Peter W.] Howard Hughes Med Inst, Chevy Chase, MD USA	Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Howard Hughes Medical Institute	Reddien, PW (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	reddien@wi.mit.edu	Petersen, Christian P./GZG-4541-2022	Petersen, Christian P./0000-0001-7552-6865; /0000-0002-5569-333X	NIH [R01GM080639]; ACS [RSG-07-18001-DDC]; Keck Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ACS(American Cancer Society); Keck Foundation(W.M. Keck Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge support by NIH R01GM080639 and ACS RSG-07-18001-DDC, an American Cancer Society postdoctoral fellowship to C. P. P., and Rita Allen, Searle, Smith, and Keck Foundation support to P. W. R. P. W. R. is an HHMI Early Career Scientist. The authors thank T. DiCesare for illustration assistance, and E. Andersen, I. Cheeseman, C. Extavour, R. Harland, C. Lowe, H. Sive, and members of the Reddien laboratory for helpful comments and criticism.	Adamska M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001031; Adell T, 2009, DEVELOPMENT, V136, P905, DOI 10.1242/dev.033761; Adoutte A, 2000, P NATL ACAD SCI USA, V97, P4453, DOI 10.1073/pnas.97.9.4453; Agathon A, 2003, NATURE, V424, P448, DOI 10.1038/nature01822; Aulehla A, 2008, NAT CELL BIOL, V10, P186, DOI 10.1038/ncb1679; Bolognesi R, 2008, CURR BIOL, V18, P1624, DOI 10.1016/j.cub.2008.09.057; Bolognesi R, 2008, DEV GENES EVOL, V218, P193, DOI 10.1007/s00427-007-0170-3; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; De Robertis EM, 2008, CELL, V132, P185, DOI 10.1016/j.cell.2008.01.003; De Robertis EM, 2006, NAT REV MOL CELL BIO, V7, P296, DOI 10.1038/nrm1855; de Rosa R, 2005, EVOL DEV, V7, P574; DeRobertis EM, 1996, NATURE, V380, P37, DOI 10.1038/380037a0; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Dunty WC, 2008, DEVELOPMENT, V135, P85, DOI 10.1242/dev.009266; Erter CE, 2001, DEVELOPMENT, V128, P3571; Finnerty JR, 2004, SCIENCE, V304, P1335, DOI 10.1126/science.1091946; Fredieu JR, 1997, DEV BIOL, V186, P100, DOI 10.1006/dbio.1997.8566; Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; Goldstein B, 2006, DEV CELL, V10, P391, DOI 10.1016/j.devcel.2005.12.016; Guder C, 2006, DEVELOPMENT, V133, P901, DOI 10.1242/dev.02265; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; HEASMAN J, 1994, CELL, V79, P791, DOI 10.1016/0092-8674(94)90069-8; Henry JQ, 2008, DEV BIOL, V317, P368, DOI 10.1016/j.ydbio.2008.02.042; HERMAN MA, 1994, DEVELOPMENT, V120, P1035; HERMAN MA, 1995, CELL, V83, P101, DOI 10.1016/0092-8674(95)90238-4; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Holland LZ, 2005, DEV DYNAM, V233, P1430, DOI 10.1002/dvdy.20473; Holland LZ, 2002, DEV BIOL, V241, P209, DOI 10.1006/dbio.2001.0503; Huang SY, 2007, DEVELOPMENT, V134, P2685, DOI 10.1242/dev.008268; Huelsken J, 2000, J CELL BIOL, V148, P567, DOI 10.1083/jcb.148.3.567; Iglesias M, 2008, DEVELOPMENT, V135, P1215, DOI 10.1242/dev.020289; Imai K, 2000, DEVELOPMENT, V127, P3009; Ishikawa T, 2003, DEV BIOL, V253, P230, DOI 10.1016/S0012-1606(02)00020-9; KAO KR, 1988, DEV BIOL, V127, P64, DOI 10.1016/0012-1606(88)90189-3; KELLY GM, 1995, DEVELOPMENT, V121, P1787; Khokha MK, 2005, DEV CELL, V8, P401, DOI 10.1016/j.devcel.2005.01.013; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Kim CH, 2000, NATURE, V407, P913, DOI 10.1038/35038097; Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046; Kusserow A, 2005, NATURE, V433, P156, DOI 10.1038/nature03158; Larabell CA, 1997, J CELL BIOL, V136, P1123, DOI 10.1083/jcb.136.5.1123; Lee PN, 2006, SEMIN CELL DEV BIOL, V17, P157, DOI 10.1016/j.semcdb.2006.05.002; Lekven AC, 2001, DEV CELL, V1, P103, DOI 10.1016/S1534-5807(01)00007-7; Lengfeld T, 2009, DEV BIOL, V330, P186, DOI 10.1016/j.ydbio.2009.02.004; Leyns L, 1997, CELL, V88, P747, DOI 10.1016/S0092-8674(00)81921-2; Li Y, 2008, GENE DEV, V22, P3050, DOI 10.1101/gad.1687308; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Liu PT, 1999, NAT GENET, V22, P361, DOI 10.1038/11932; Logan CY, 1999, DEVELOPMENT, V126, P345; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Martin BL, 2009, CURR BIOL, V19, pR215, DOI 10.1016/j.cub.2009.01.052; Martindale MQ, 2009, DEV CELL, V17, P162, DOI 10.1016/j.devcel.2009.07.024; Martindale MQ, 2005, NAT REV GENET, V6, P917, DOI 10.1038/nrg1725; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; McGregor AP, 2008, CURR BIOL, V18, P1619, DOI 10.1016/j.cub.2008.08.045; McGrew LL, 1999, MECH DEVELOP, V87, P21, DOI 10.1016/S0925-4773(99)00136-7; MCGREW LL, 1995, DEV BIOL, V172, P337, DOI 10.1006/dbio.1995.0027; McGrew LL, 1997, MECH DEVELOP, V69, P105, DOI 10.1016/S0925-4773(97)00160-3; Mclin VA, 2007, DEVELOPMENT, V134, P2207, DOI 10.1242/dev.001230; Merrill BJ, 2004, DEVELOPMENT, V131, P263, DOI 10.1242/dev.00935; Miyawaki K, 2004, MECH DEVELOP, V121, P119, DOI 10.1016/j.mod.2004.01.002; Miyawaki K, 2003, DEV GROWTH DIFFER, V45, P121; Mohamed OA, 2004, DEV DYNAM, V231, P416, DOI 10.1002/dvdy.20135; Molina MD, 2007, DEV BIOL, V311, P79, DOI 10.1016/j.ydbio.2007.08.019; Momose T, 2008, DEVELOPMENT, V135, P2105, DOI 10.1242/dev.021543; Moussian B, 2005, CURR BIOL, V15, pR887, DOI 10.1016/j.cub.2005.10.026; Mukhopadhyay M, 2001, DEV CELL, V1, P423, DOI 10.1016/S1534-5807(01)00041-7; Nakamura K, 2005, GENE DEV, V19, P1749, DOI 10.1101/gad.1323705; Niehrs C, 2004, NAT REV GENET, V5, P425, DOI 10.1038/nrg1347; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Onai T, 2009, DEV BIOL, V332, P223, DOI 10.1016/j.ydbio.2009.05.571; Orii H, 2007, DEV GROWTH DIFFER, V49, P345, DOI 10.1111/j.1440-169x.2007.00931.x; Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010; Petersen CP, 2008, SCIENCE, V319, P327, DOI 10.1126/science.1149943; Petersen CP, 2009, P NATL ACAD SCI USA, V106, P17061, DOI 10.1073/pnas.0906823106; Popperl H, 1997, DEVELOPMENT, V124, P2997; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reddien PW, 2007, DEVELOPMENT, V134, P4043, DOI 10.1242/dev.007138; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P725, DOI 10.1146/annurev.cellbio.20.010403.095114; Rhinn M, 2005, DEVELOPMENT, V132, P1261, DOI 10.1242/dev.01685; Rocheleau CE, 1997, CELL, V90, P707, DOI 10.1016/S0092-8674(00)80531-0; Schneider S, 1996, MECH DEVELOP, V57, P191, DOI 10.1016/0925-4773(96)00546-1; Schneider SQ, 2007, DEV CELL, V13, P73, DOI 10.1016/j.devcel.2007.05.002; Schohl A, 2002, DEVELOPMENT, V129, P37; Schubert M, 2001, DEV BIOL, V240, P262, DOI 10.1006/dbio.2001.0460; Shimizu T, 2005, DEV BIOL, V279, P125, DOI 10.1016/j.ydbio.2004.12.007; Silhankova M, 2007, CURR OPIN GENET DEV, V17, P320, DOI 10.1016/j.gde.2007.05.007; SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0; TAKADA S, 1994, GENE DEV, V8, P174, DOI 10.1101/gad.8.2.174; Takeshita H, 2005, GENE DEV, V19, P1743, DOI 10.1101/gad.1322805; Tendeng C, 2006, GENE EXPR PATTERNS, V6, P761, DOI 10.1016/j.modgep.2006.01.006; Thorpe CJ, 1997, CELL, V90, P695, DOI 10.1016/S0092-8674(00)80530-9; Thorpe CJ, 2005, DEVELOPMENT, V132, P1763, DOI 10.1242/dev.01733; Wang SW, 1997, CELL, V88, P757, DOI 10.1016/S0092-8674(00)81922-4; Wikramanayake AH, 1998, P NATL ACAD SCI USA, V95, P9343, DOI 10.1073/pnas.95.16.9343; Wikramanayake AH, 2004, GENESIS, V39, P194, DOI 10.1002/gene.20045; Wikramanayake AH, 2003, NATURE, V426, P446, DOI 10.1038/nature02113; Yanze N, 2001, DEV BIOL, V236, P89, DOI 10.1006/dbio.2001.0299; Yu JK, 2007, NATURE, V445, P613, DOI 10.1038/nature05472; Zeng L, 1997, CELL, V90, P181, DOI 10.1016/S0092-8674(00)80324-4	104	348	364	3	65	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1056	1068		10.1016/j.cell.2009.11.035	http://dx.doi.org/10.1016/j.cell.2009.11.035			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005801	Bronze, Green Published			2022-12-28	WOS:000272622800009
J	Zakian, VA				Zakian, Virginia A.			The Ends Have Arrived	CELL			English	Editorial Material							TELOMERE TERMINAL TRANSFERASE; RIBOSOMAL-RNA; TETRAHYMENA; YEAST; DNA; SEQUENCE; GENE	The 2009 Nobel Prize in Physiology or Medicine has been awarded to Elizabeth Blackburn, Carol Greider, and Jack Szostak for their contributions to our understanding of how the ends of eukaryotic chromosomes, telomeres, are replicated by a specialized reverse transcriptase, telomerase. I present a personal view of the telomere field, putting the contributions of these three Nobel laureates into historical context.	Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Princeton University	Zakian, VA (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	vzakian@princeton.edu			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043265] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM043265-22, R01 GM043265] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		BLACKBURN EH, 1978, J MOL BIOL, V120, P33, DOI 10.1016/0022-2836(78)90294-2; Blasco MA, 1997, CELL, V91, P25, DOI 10.1016/S0092-8674(01)80006-4; GREIDER CW, 1989, NATURE, V337, P331, DOI 10.1038/337331a0; GREIDER CW, 1987, CELL, V51, P887, DOI 10.1016/0092-8674(87)90576-9; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; KLOBUTCHER LA, 1981, P NATL ACAD SCI-BIOL, V78, P3015, DOI 10.1073/pnas.78.5.3015; LUNDBLAD V, 1989, CELL, V57, P633, DOI 10.1016/0092-8674(89)90132-3; McClintock B, 1939, P NATL ACAD SCI USA, V25, P405, DOI 10.1073/pnas.25.8.405; Muller H, 1938, COLLECTING NET, V13, P181; PLUTA AF, 1984, P NATL ACAD SCI-BIOL, V81, P1475, DOI 10.1073/pnas.81.5.1475; SHAMPAY J, 1984, NATURE, V310, P154, DOI 10.1038/310154a0; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; VANDERPLOEG LHT, 1984, CELL, V36, P459, DOI 10.1016/0092-8674(84)90239-3; WATSON JD, 1972, NATURE-NEW BIOL, V239, P197, DOI 10.1038/newbio239197a0; YAO MC, 1977, CELL, V12, P121, DOI 10.1016/0092-8674(77)90190-8	15	10	10	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 11	2009	139	6					1038	1040		10.1016/j.cell.2009.11.033	http://dx.doi.org/10.1016/j.cell.2009.11.033			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005795	Green Accepted, Bronze			2022-12-28	WOS:000272622800003
J	Chappell, LC				Chappell, Lucy C.			Commentary: Complex medical conditions in pregnancy need appropriate multidisciplinary input	BRITISH MEDICAL JOURNAL			English	Editorial Material									Kings Coll London, Div Reprod & Endocrinol, London SE1 7EH, England	University of London; King's College London	Chappell, LC (corresponding author), Kings Coll London, Div Reprod & Endocrinol, London SE1 7EH, England.	lucy.chappell@kcl.ac.uk						Brent RL, 2009, AM J OBSTET GYNECOL, V200, P4, DOI 10.1016/j.ajog.2008.06.032; Buyon JP, 1998, J LEUKOCYTE BIOL, V63, P281, DOI 10.1002/jlb.63.3.281; *CTR MAT CHILD ENQ, SAV MOTH LIV; Reuss R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3862; Shah PS, 2009, BJOG-INT J OBSTET GY, V116, P1425, DOI 10.1111/j.1471-0528.2009.02278.x	5	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2009	339								b5179	10.1136/bmj.b5179	http://dx.doi.org/10.1136/bmj.b5179			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VH	20007659				2022-12-28	WOS:000272697600006
J	Brody, H				Brody, Howard			Medicine's Ethical Responsibility for Health Care Reform - The Top Five List	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Texas Med Branch, Inst Med Humanities, Galveston, TX 77555 USA	University of Texas System; University of Texas Medical Branch Galveston	Brody, H (corresponding author), Univ Texas Med Branch, Inst Med Humanities, Galveston, TX 77555 USA.		Brody, Howard/GQA-6310-2022					Dunnick N Reed, 2005, J Am Coll Radiol, V2, P401, DOI 10.1016/j.jacr.2004.12.008; Fisher ES, 2009, NEW ENGL J MED, V360, P849, DOI 10.1056/NEJMp0809794; Kirkley A, 2009, NEW ENGL J MED, V361, P2004; Kirkley A, 2008, NEW ENGL J MED, V359, P1097, DOI 10.1056/NEJMoa0708333; ROHACK JJ, 2009, COMMUNICATION   1107; Sirovich B, 2008, HEALTH AFFAIR, V27, P813, DOI 10.1377/hlthaff.27.3.813	6	224	225	1	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					283	285		10.1056/NEJMp0911423	http://dx.doi.org/10.1056/NEJMp0911423			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	548OT	20032315				2022-12-28	WOS:000273975000002
J	Gaston, KJ				Gaston, Kevin J.			Valuing Common Species	SCIENCE			English	Editorial Material							ECOSYSTEM FUNCTION; BIODIVERSITY; HEALTH		Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Gaston, KJ (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England.	k.j.gaston@sheffield.ac.uk						Bell JF, 2008, AM J PREV MED, V35, P547, DOI 10.1016/j.amepre.2008.07.006; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Gaston KJ, 2008, J BIOGEOGR, V35, P483, DOI 10.1111/j.1365-2699.2007.01772.x; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jablonski D, 2006, AM NAT, V168, P556, DOI 10.1086/507994; LEOPOLD LB, 1953, ROUND RIVER J A LEOP; Mitchell R, 2007, J EPIDEMIOL COMMUN H, V61, P681, DOI 10.1136/jech.2006.053553; Nielsen TS, 2007, HEALTH PLACE, V13, P839, DOI 10.1016/j.healthplace.2007.02.001; Sizling AL, 2009, AM NAT, V174, P82, DOI 10.1086/599305; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Taylor BW, 2006, SCIENCE, V313, P833, DOI 10.1126/science.1128223	16	236	242	6	121	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 8	2010	327	5962					154	155		10.1126/science.1182818	http://dx.doi.org/10.1126/science.1182818			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	541DQ	20056880				2022-12-28	WOS:000273394000022
J	Palmer, MA; Bernhardt, ES; Schlesinger, WH; Eshleman, KN; Foufoula-Georgiou, E; Hendryx, MS; Lemly, AD; Likens, GE; Loucks, OL; Power, ME; White, PS; Wilcock, PR				Palmer, M. A.; Bernhardt, E. S.; Schlesinger, W. H.; Eshleman, K. N.; Foufoula-Georgiou, E.; Hendryx, M. S.; Lemly, A. D.; Likens, G. E.; Loucks, O. L.; Power, M. E.; White, P. S.; Wilcock, P. R.			Mountaintop Mining Consequences	SCIENCE			English	Editorial Material							LAND-USE; COAL		[Palmer, M. A.; Eshleman, K. N.] Univ Maryland, Ctr Environm Sci, Cambridge, MD 21613 USA; [Palmer, M. A.] Univ Maryland, College Pk, MD 20742 USA; [Bernhardt, E. S.] Duke Univ, Durham, NC 27708 USA; [Schlesinger, W. H.; Likens, G. E.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Foufoula-Georgiou, E.] Univ Minnesota, Minneapolis, MN 55414 USA; [Hendryx, M. S.] W Virginia Univ, Morgantown, WV 26506 USA; [Lemly, A. D.] Wake Forest Univ, Winston Salem, NC 27109 USA; [Loucks, O. L.] Miami Univ, Oxford, OH 45056 USA; [Power, M. E.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [White, P. S.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Wilcock, P. R.] Johns Hopkins Univ, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland Center for Environmental Science; University System of Maryland; University of Maryland College Park; Duke University; Cary Institute of Ecosystem Studies; University of Minnesota System; University of Minnesota Twin Cities; West Virginia University; Wake Forest University; University System of Ohio; Miami University; University of California System; University of California Berkeley; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University	Palmer, MA (corresponding author), Univ Maryland, Ctr Environm Sci, Cambridge, MD 21613 USA.	mpalmer@umd.edu	Eshleman, Keith N/J-6531-2015; Bernhardt, Emily/B-4541-2010; Palmer, Margaret A/F-9648-2013; Bernhardt, Emily S/D-9940-2011	Eshleman, Keith N/0000-0002-8274-450X; Palmer, Margaret A/0000-0003-1468-7993; Bernhardt, Emily S/0000-0003-3031-621X; Hendryx, Michael/0000-0002-2764-387X; Foufoula-Georgiou, Efi/0000-0003-1078-231X				Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Amichev BY, 2008, FOREST ECOL MANAG, V256, P1949, DOI 10.1016/j.foreco.2008.07.020; CARACO NF, 1989, NATURE, V341, P316, DOI 10.1038/341316a0; Chikkatur AP, 2009, ENERGY, V34, P942, DOI 10.1016/j.energy.2008.12.014; Conley JM, 2009, ENVIRON SCI TECHNOL, V43, P7952, DOI 10.1021/es9016377; Emerson R, 2009, J ENVIRON QUAL, V38, P1821, DOI 10.2134/jeq2008.0479; *EPA, 2005, MOUNT MIN VF FIN PRO; *EPA, 2002, STREAM CHEM REP 2; Ferrari JR, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007109; Ghose MK, 2007, ENVIRON MONIT ASSESS, V130, P17, DOI 10.1007/s10661-006-9448-6; Hartman KJ, 2005, HYDROBIOLOGIA, V532, P91, DOI 10.1007/s10750-004-9019-1; Hendryx M, 2009, PUBLIC HEALTH REP, V124, P541, DOI 10.1177/003335490912400411; JOYE SB, 1995, SCIENCE, V270, P623, DOI 10.1126/science.270.5236.623; Lemly AD, 2002, SPR S ENV M; MCAULEY S, 2006, 5059 USGS; McCormick BC, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007594; Meyer JL, 2007, J AM WATER RESOUR AS, V43, P86, DOI 10.1111/j.1752-1688.2007.00008.x; Negley TL, 2006, HYDROL PROCESS, V20, P3467, DOI 10.1002/hyp.6148; Paybins KS, 2000, 1204 USGS; Pond GJ, 2008, J N AM BENTHOL SOC, V27, P717, DOI 10.1899/08-015.1; SAMS JI, 2000, 994208 USGS; Saylor KL, 2008, LAND COVER TRENDS CE; Simmons JA, 2008, ECOL APPL, V18, P104, DOI 10.1890/07-1117.1; Townsend PA, 2009, REMOTE SENS ENVIRON, V113, P62, DOI 10.1016/j.rse.2008.08.012; van der Welle MEW, 2008, SCI TOTAL ENVIRON, V406, P426, DOI 10.1016/j.scitotenv.2008.05.056; 2008, FED REG, V73, P10	26	395	405	5	244	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					148	149		10.1126/science.1180543	http://dx.doi.org/10.1126/science.1180543			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056876				2022-12-28	WOS:000273394000018
J	Sibanda, BL; Chirgadze, DY; Blundell, TL				Sibanda, Bancinyane L.; Chirgadze, Dimitri Y.; Blundell, Tom L.			Crystal structure of DNA-PKcs reveals a large open-ring cradle comprised of HEAT repeats	NATURE			English	Article							DEPENDENT PROTEIN-KINASE; CATALYTIC SUBUNIT; 3-DIMENSIONAL STRUCTURE; COMPLEX; DOMAIN; END; SUGGESTS; 3-KINASE; DAMAGE	Broken chromosomes arising from DNA double-strand breaks result from endogenous events such as the production of reactive oxygen species during cellular metabolism, as well as from exogenous sources such as ionizing radiation(1-3). Left unrepaired or incorrectly repaired they can lead to genomic changes that may result in cell death or cancer. DNA-dependent protein kinase (DNA-PK), a holoenzyme that comprises the DNA-PK catalytic subunit (DNA-PKcs) 4,5 and the heterodimer Ku70/Ku80, has a major role in non-homologous end joining-the main pathway in mammals used to repair double-strand breaks(6-8). DNA-PKcs is a serine/threonine protein kinase comprising a single polypeptide chain of 4,128 amino acids and belonging to the phosphatidylinositol-3-OH kinase (PI(3) K)-related protein family(9). DNA-PKcs is involved in the sensing and transmission of DNA damage signals to proteins such as p53, setting off events that lead to cell cycle arrest(10,11). It phosphorylates a wide range of substrates in vitro, including Ku70/Ku80, which is translocated along DNA(12). Here we present the crystal structure of human DNA-PKcs at 6.6 angstrom resolution, in which the overall fold is clearly visible, to our knowledge, for the first time. The many alpha-helical HEAT repeats (helix-turn-helix motifs) facilitate bending and allow the polypeptide chain to fold into a hollow circular structure. The carboxy-terminal kinase domain is located on top of this structure, and a small HEAT repeat domain that probably binds DNA is inside. The structure provides a flexible cradle to promote DNA double-strand-break repair.	[Sibanda, Bancinyane L.; Chirgadze, Dimitri Y.; Blundell, Tom L.] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England	University of Cambridge	Sibanda, BL (corresponding author), Univ Cambridge, Dept Biochem, Old Addenbrookes Site,80 Tennis Court Rd, Cambridge CB2 1GA, England.	lynn@cryst.bioc.cam.ac.uk; dima@cryst.bioc.cam.ac.uk		Chirgadze, Dimitri/0000-0001-9942-0993	Wellcome Trust; CR-UK	Wellcome Trust(Wellcome TrustEuropean Commission); CR-UK(Cancer Research UK)	We wish to thank G. Smith for providing pure DNA-PKcs that was used in the initial experiments as a marker and also for providing the DNA-PKcs and Ku70 antibodies, L. Pellegrini for help and advice at the beginning of the project, and S. Jackson for discussions. We are also grateful to R. Peat for preparing HeLa cells, L. Packman for help in identifying DNA-PKcs in polyacrylamide gels, N. Ban for providing Ta<INF>6</INF>Br<INF>12</INF><SUP>2+</SUP> and C. Muller-Dieckmann at the ESRF for support during the diffraction data collection experiments. This work was funded by the Wellcome Trust and CR-UK.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; ANDERSON CW, 1993, TRENDS BIOCHEM SCI, V18, P433, DOI 10.1016/0968-0004(93)90144-C; Ausubel F. M., 2002, SHORT PROTOCOLS MOL; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; BIEDERMANN KA, 1991, P NATL ACAD SCI USA, V88, P1394, DOI 10.1073/pnas.88.4.1394; Boskovic J, 2003, EMBO J, V22, P5875, DOI 10.1093/emboj/cdg555; Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; CARTER T, 1990, MOL CELL BIOL, V10, P6460, DOI 10.1128/MCB.10.12.6460; Chiu CY, 1998, J MOL BIOL, V284, P1075, DOI 10.1006/jmbi.1998.2212; Cingolani G, 1999, NATURE, V399, P221, DOI 10.1038/20367; Critchlow SE, 1998, TRENDS BIOCHEM SCI, V23, P394, DOI 10.1016/S0968-0004(98)01284-5; Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200; DVIR A, 1993, J BIOL CHEM, V268, P10440; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Gell D, 1999, NUCLEIC ACIDS RES, V27, P3494, DOI 10.1093/nar/27.17.3494; Goldenberg SJ, 2004, CELL, V119, P517, DOI 10.1016/j.cell.2004.10.019; GOTTLIEB TM, 1993, CELL, V72, P131, DOI 10.1016/0092-8674(93)90057-W; Groves MR, 1999, CELL, V96, P99, DOI 10.1016/S0092-8674(00)80963-0; Harris R, 2004, J MOL BIOL, V335, P573, DOI 10.1016/j.jmb.2003.10.047; HARTLEY KO, 1995, CELL, V82, P849, DOI 10.1016/0092-8674(95)90482-4; Hoekstra MF, 1997, CURR OPIN GENET DEV, V7, P170, DOI 10.1016/S0959-437X(97)80125-6; KEMP LM, 1984, MUTAT RES, V132, P189, DOI 10.1016/0167-8817(84)90037-3; Kleywegt GJ, 1996, ACTA CRYSTALLOGR D, V52, P842, DOI 10.1107/S0907444995016477; Leonard GA, 2009, J APPL CRYSTALLOGR, V42, P333, DOI 10.1107/S0021889809001721; Leslie A. G. W., 1992, JOINT CCP4 ESF EAMCB; Leuther KK, 1999, EMBO J, V18, P1114, DOI 10.1093/emboj/18.5.1114; Ma YM, 2002, CELL, V108, P781, DOI 10.1016/S0092-8674(02)00671-2; Meek K, 2007, MOL CELL BIOL, V27, P3881, DOI 10.1128/MCB.02366-06; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rivera-Calzada A, 2005, STRUCTURE, V13, P243, DOI 10.1016/j.str.2004.12.006; SCHNEIDER G, 1994, ACTA CRYSTALLOGR D, V50, P186, DOI 10.1107/S0907444993009679; Spagnolo L, 2006, MOL CELL, V22, P511, DOI 10.1016/j.molcel.2006.04.013; Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319; Williams DR, 2008, STRUCTURE, V16, P468, DOI 10.1016/j.str.2007.12.014; Yaneva M, 1997, EMBO J, V16, P5098, DOI 10.1093/emboj/16.16.5098; Yoo S, 1999, NUCLEIC ACIDS RES, V27, P4679, DOI 10.1093/nar/27.24.4679; ZDZIENICKA MZ, 1988, MUTAT RES, V194, P239; Zhang ZM, 2004, STRUCTURE, V12, P495, DOI 10.1016/j.str.2004.02.007	40	162	166	0	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					118	U132		10.1038/nature08648	http://dx.doi.org/10.1038/nature08648			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20023628	Green Accepted, Green Submitted			2022-12-28	WOS:000273344900042
J	Collins, FS				Collins, Francis S.			Opportunities for Research and NIH	SCIENCE			English	Editorial Material									NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA	Collins, FS (corresponding author), NIH, Bldg 10, Bethesda, MD 20892 USA.	collinsf@mail.nih.gov						Flockhart DA, 2009, CLIN PHARMACOL THER, V86, P109, DOI 10.1038/clpt.2009.39; Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512; Lieberman JA, 2005, NEW ENGL J MED, V353, P1209, DOI 10.1056/NEJMoa051688; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; *US COMM GLOB HLTH, 2009, US COMM GLOB HLTH RE; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	7	74	77	0	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					36	37		10.1126/science.1185055	http://dx.doi.org/10.1126/science.1185055			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	541DZ	20044560				2022-12-28	WOS:000273395400018
J	Whitmire, KH				Whitmire, Kenton H.			Molecular Donuts and Donut Holes	SCIENCE			English	Editorial Material							SUPRAMOLECULAR CHEMISTRY; IMOGOLITE		Rice Univ, Dept Chem, Houston, TX 77005 USA	Rice University	Whitmire, KH (corresponding author), Rice Univ, Dept Chem, POB 1892, Houston, TX 77005 USA.	whitmire@rice.edu	Whitmire, Kenton/C-2824-2014	Whitmire, Kenton/0000-0001-7362-535X				Bursill LA, 2000, PHILOS MAG A, V80, P105, DOI 10.1080/01418610008212043; CRADWICK PD, 1972, NATURE-PHYS SCI, V240, P187, DOI 10.1038/physci240187a0; CRAM DJ, 1992, NATURE, V356, P29, DOI 10.1038/356029a0; Creton B, 2008, J PHYS CHEM C, V112, P358, DOI 10.1021/jp0738412; LEHN JM, 1985, SCIENCE, V227, P849, DOI 10.1126/science.227.4689.849; MA P, 2009, SCIENCE, V324, P1697; Miras HN, 2010, SCIENCE, V327, P72, DOI [10.1126/science.11B1735, 10.1126/science.1181735]; Muller A, 2003, COORDIN CHEM REV, V245, P153, DOI 10.1016/S0010-8545(03)00110-3; Raymond KN, 2009, NATURE, V460, P585, DOI 10.1038/460585a; TAFT KL, 1990, J AM CHEM SOC, V112, P9629, DOI 10.1021/ja00182a027; WAGNER P, 2002, SUPRAMOL ORG MAT DES, V83, P83	11	2	2	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 1	2010	327	5961					38	39		10.1126/science.1184533	http://dx.doi.org/10.1126/science.1184533			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044561				2022-12-28	WOS:000273395400019
J	Clarke, R; Peden, JF; Hopewell, JC; Kyriakou, T; Goel, A; Heath, SC; Parish, S; Barlera, S; Franzosi, MG; Rust, S; Bennett, D; Silveira, A; Malarstig, A; Green, FR; Lathrop, M; Gigante, B; Leander, K; de Faire, U; Seedorf, U; Hamsten, A; Collins, R; Watkins, H; Farrall, M				Clarke, Robert; Peden, John F.; Hopewell, Jemma C.; Kyriakou, Theodosios; Goel, Anuj; Heath, Simon C.; Parish, Sarah; Barlera, Simona; Franzosi, Maria Grazia; Rust, Stephan; Bennett, Derrick; Silveira, Angela; Malarstig, Anders; Green, Fiona R.; Lathrop, Mark; Gigante, Bruna; Leander, Karin; de Faire, Ulf; Seedorf, Udo; Hamsten, Anders; Collins, Rory; Watkins, Hugh; Farrall, Martin		PROCARDIS Consortium	Genetic Variants Associated with Lp(a) Lipoprotein Level and Coronary Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							GENOME-WIDE ASSOCIATION; PENTANUCLEOTIDE REPEAT POLYMORPHISM; ARTERY-DISEASE; MYOCARDIAL-INFARCTION; APOLIPOPROTEIN(A) GENE; PLASMA LIPOPROTEIN(A); HEART-DISEASE; RISK; SUSCEPTIBILITY; LOCUS	BACKGROUND An increased level of Lp(a) lipoprotein has been identified as a risk factor for coronary artery disease that is highly heritable. The genetic determinants of the Lp(a) lipoprotein level and their relevance for the risk of coronary disease are incompletely understood. METHODS We used a novel gene chip containing 48,742 single-nucleotide polymorphisms (SNPs) in 2100 candidate genes to test for associations in 3145 case subjects with coronary disease and 3352 control subjects. Replication was tested in three independent populations involving 4846 additional case subjects with coronary disease and 4594 control subjects. RESULTS Three chromosomal regions (6q26-27, 9p21, and 1p13) were strongly associated with the risk of coronary disease. The LPA locus on 6q26-27 encoding Lp(a) lipoprotein had the strongest association. We identified a common variant (rs10455872) at the LPA locus with an odds ratio for coronary disease of 1.70 (95% confidence interval [CI], 1.49 to 1.95) and another independent variant (rs3798220) with an odds ratio of 1.92 (95% CI, 1.48 to 2.49). Both variants were strongly associated with an increased level of Lp(a) lipoprotein, a reduced copy number in LPA (which determines the number of kringle IV-type 2 repeats), and a small Lp(a) lipoprotein size. Replication studies confirmed the effects of both variants on the Lp(a) lipoprotein level and the risk of coronary disease. A meta-analysis showed that with a genotype score involving both LPA SNPs, the odds ratios for coronary disease were 1.51 (95% CI, 1.38 to 1.66) for one variant and 2.57 (95% CI, 1.80 to 3.67) for two or more variants. After adjustment for the Lp(a) lipoprotein level, the association between the LPA genotype score and the risk of coronary disease was abolished. CONCLUSIONS We identified two LPA variants that were strongly associated with both an increased level of Lp(a) lipoprotein and an increased risk of coronary disease. Our findings provide support for a causal role of Lp(a) lipoprotein in coronary disease.	[Farrall, Martin] Univ Oxford, Dept Cardiovasc Med, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Clarke, Robert; Hopewell, Jemma C.; Parish, Sarah; Bennett, Derrick; Collins, Rory] Univ Oxford, Clin Trial Serv Unit, Oxford OX3 7BN, England; [Clarke, Robert; Hopewell, Jemma C.; Parish, Sarah; Bennett, Derrick; Collins, Rory] Univ Oxford, Epidemiol Studies Unit, Oxford OX3 7BN, England; [Green, Fiona R.] Univ Surrey, Fac Hlth & Med Sci, Div Biochem Sci, Surrey, England; [Heath, Simon C.; Lathrop, Mark] CEA, Ctr Natl Genotypage, Inst Genom, Evry, France; [Barlera, Simona; Franzosi, Maria Grazia] Ist Ric Farmacol Mario Negri, Dept Cardiovasc Res, Milan, Italy; [Rust, Stephan; Seedorf, Udo] Univ Munster, Leibniz Inst Arterioskleroseforsch, Munster, Germany; [Silveira, Angela; Malarstig, Anders; Hamsten, Anders] Karolinska Inst, Dept Med, Atherosclerosis Res Unit, Stockholm, Sweden; [Gigante, Bruna; Leander, Karin; de Faire, Ulf] Karolinska Inst, Inst Environm Med, Div Cardiovasc Epidemiol, S-10401 Stockholm, Sweden	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Oxford; University of Surrey; CEA; UDICE-French Research Universities; Universite Paris Saclay; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; University of Munster; Karolinska Institutet; Karolinska Institutet	Farrall, M (corresponding author), Univ Oxford, Dept Cardiovasc Med, Wellcome Trust Ctr Human Genet, Roosevelt Dr, Oxford OX3 7BN, England.	hugh.watkins@cardiov.ox.ac.uk; martin.farrall@cardiov.ox.ac.uk	Bennett, Derrick/AFL-9254-2022; Nicolis, Enrico Bjørn/ABG-8467-2020; Gigante, Bruna/I-9252-2012; , Bennett/O-7998-2019; Leander, Karin/C-7261-2017; Colombo, Barbara Maria/AAH-7821-2019; Girelli, Domenico/B-1183-2008; Bennett, Derrick/AAH-1220-2022; Heath, Simon C/J-4138-2012; Collins, Rory/ABA-8487-2020	Bennett, Derrick/0000-0002-9170-8447; Nicolis, Enrico Bjørn/0000-0001-9246-2533; Leander, Karin/0000-0002-1404-9222; Colombo, Barbara Maria/0000-0002-2693-611X; Girelli, Domenico/0000-0001-9684-1899; Bennett, Derrick/0000-0002-9170-8447; Heath, Simon C/0000-0002-9550-0897; Gigante, Bruna/0000-0003-4508-7990; Goel, Anuj/0000-0003-2307-4021; Silveira, Angela/0000-0003-2063-4935; Hopewell, Jemma/0000-0002-3870-8018; Seedorf, Udo/0000-0003-4652-5358; Kyriakou, Theodosios/0000-0001-7794-8789; Watkins, Hugh/0000-0002-5287-9016	MRC [MC_U137686857] Funding Source: UKRI; British Heart Foundation Funding Source: Medline; Medical Research Council [MC_U137686857] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Barlera S, 2007, EUR J HUM GENET, V15, P221, DOI 10.1038/sj.ejhg.5201732; BERG K, 1979, CLIN GENET, V16, P347; Berglund L, 2004, ARTERIOSCL THROM VAS, V24, P2219, DOI 10.1161/01.ATV.0000144010.55563.63; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Caplice NM, 2001, BLOOD, V98, P2980, DOI 10.1182/blood.V98.10.2980; Chasman DI, 2009, ATHEROSCLEROSIS, V203, P371, DOI 10.1016/j.atherosclerosis.2008.07.019; Clarke R, 2006, PLOS GENET, V2, P990, DOI 10.1371/journal.pgen.0020107; Danik JS, 2006, JAMA-J AM MED ASSOC, V296, P1363, DOI 10.1001/jama.296.11.1363; Devlin B, 1999, BIOMETRICS, V55, P997, DOI 10.1111/j.0006-341X.1999.00997.x; Erqou S, 2009, JAMA-J AM MED ASSOC, V302, P412, DOI 10.1001/jama.2009.1063; Farrall M, 2006, PLOS GENET, V2, P755, DOI 10.1371/journal.pgen.0020072; GRAINGER DJ, 1994, NATURE, V370, P460, DOI 10.1038/370460a0; Hamsten A, 2008, J INTERN MED, V263, P538, DOI 10.1111/j.1365-2796.2008.01958.x; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Kamstrup PR, 2009, JAMA-J AM MED ASSOC, V301, P2331, DOI 10.1001/jama.2009.801; Kathiresan S, 2009, NAT GENET, V41, P56, DOI 10.1038/ng.291; Keating BJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003583; Kronenberg F, 1999, CIRCULATION, V100, P1154, DOI 10.1161/01.CIR.100.11.1154; Lanktree MB, 2009, J LIPID RES, V50, P768, DOI 10.1194/jlr.D800050-JLR200; Luke MM, 2007, ARTERIOSCL THROM VAS, V27, P2030, DOI 10.1161/ATVBAHA.107.141291; Marcovina SM, 1996, CLIN CHEM, V42, P436; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Ober C, 2009, J LIPID RES, V50, P798, DOI 10.1194/jlr.M800515-JLR200; Reuterwall C, 1999, J INTERN MED, V246, P161, DOI 10.1046/j.1365-2796.1999.00554.x; Rosby O, 2000, J INTERN MED, V247, P139, DOI 10.1046/j.1365-2796.2000.00628.x; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Samnegard A, 2005, J INTERN MED, V258, P411, DOI 10.1111/j.1365-2796.2005.01561.x; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Siekmeier R, 1996, LAB MED, V20, P294; Smolders B, 2007, STROKE, V38, P1959, DOI 10.1161/STROKEAHA.106.480657; Tregouet DA, 2009, NAT GENET, V41, P283, DOI 10.1038/ng.314; TROMMSDORFF M, 1995, J CLIN INVEST, V96, P150, DOI 10.1172/JCI118015; Tsimikas S, 2005, NEW ENGL J MED, V353, P46, DOI 10.1056/NEJMoa043175; Wang J, 2001, J LIPID RES, V42, P60; Watkins H, 2006, NAT REV GENET, V7, P163, DOI 10.1038/nrg1805; Watkins H, 2004, EUR J HUM GENET, V12, P770, DOI 10.1038/sj.ejhg.5201244; WHITE AL, 1994, J BIOL CHEM, V269, P9060; Willer CJ, 2008, NAT GENET, V40, P161, DOI 10.1038/ng.76; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	40	939	985	2	55	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					2518	2528		10.1056/NEJMoa0902604	http://dx.doi.org/10.1056/NEJMoa0902604			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535WX	20032323	Green Published			2022-12-28	WOS:000273003700007
J	Lesser, LI; Bazemore, AW				Lesser, Lenard I.; Bazemore, Andrew W.			Improving the Delivery of Preventive Services to Medicare Beneficiaries	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Lesser, Lenard I.] Univ Calif Los Angeles, Robert Wood Johnson Clin Scholars Program, Los Angeles, CA 90024 USA; [Bazemore, Andrew W.] Robert Graham Ctr Policy Studies Family Med & Pri, Washington, DC USA	University of California System; University of California Los Angeles	Lesser, LI (corresponding author), Univ Calif Los Angeles, Robert Wood Johnson Clin Scholars Program, 911 Broxton Ave,3rd Floor, Los Angeles, CA 90024 USA.	LLesser@mednet.ucla.edu		Bazemore, Andrew/0000-0002-6028-2279; Lesser, Lenard/0000-0002-0713-6707				*CTR MED MED SERV, PREV MED CLAIMS DAT; Ferrer RL, 2005, ANN INTERN MED, V142, P691, DOI 10.7326/0003-4819-142-8-200504190-00037; KAMEROW DB, 2008, MODERNIZING MEDICARE; Merenstein D, 2006, AM J PREV MED, V30, P521, DOI 10.1016/j.amepre.2006.02.003; Partnership for prevention, PREV CAR NAT PROF US; Patient-Centered Primary Care Collaborative, JOINT PRINC PAT CENT; Robert Graham Center Center for Policy Studies in Family Medicine and Primary Care, 2007, PAT CENT MED HOM HIS; Woolf SH, 2009, JAMA-J AM MED ASSOC, V301, P536, DOI 10.1001/jama.2009.51	8	7	7	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 23	2009	302	24					2699	2700		10.1001/jama.2009.1918	http://dx.doi.org/10.1001/jama.2009.1918			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535JU	20040560				2022-12-28	WOS:000272965300028
J	Day, G; Carter, N				Day, Giskin; Carter, Naiome			Christmas 2009: Professional matters Wards of the roses	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Day, Giskin; Carter, Naiome] Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England	Imperial College London	Day, G (corresponding author), Univ London Imperial Coll Sci Technol & Med, London SW7 2AZ, England.	giskin.day@imperial.ac.uk		Day, Giskin/0000-0002-9901-9267				*BRIT FLOR ASS, BFA TAK LEAD HOSP FL; GALE R, 1977, INT ARCH OCC ENV HEA, V40, P255, DOI 10.1007/BF00381413; GOULD D, 2004, J RES NURS, V9, P366; Gould D, 2005, BRIT J INFECT CONTRO, V6, P18; Haviland-Jones J., 2005, EVOL PSYCHOL-US, V3, P104, DOI [DOI 10.1177/147470490500300109,147470490500300109, 10.1177/147470490500300109, DOI 10.1177/147470490500300109]; Humphreys H, 2006, J HOSP INFECT, V64, P302, DOI 10.1016/j.jhin.2006.06.018; LaCharity Linda A, 2003, Crit Care Nurs Clin North Am, V15, P119, DOI 10.1016/S0899-5885(02)00037-0; Park SH, 2008, HORTTECHNOLOGY, V18, P563, DOI 10.21273/HORTTECH.18.4.563; Ruskin John, 1889, FRONDES AGRESTES REA; TAPLIN D, 1973, LANCET, V2, P1279; URQUHART F, 1996, SCOTSMAN        1012, P5	11	3	3	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 16	2009	339								b5257	10.1136/bmj.b5257	http://dx.doi.org/10.1136/bmj.b5257			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534XH	20015904	Green Submitted			2022-12-28	WOS:000272930300012
J	Friedrich, MJ				Friedrich, M. J.			Gene Therapy Repair of Donor Lungs Improves Outlook for Transplantation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	News Item																			0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	2009	302	23					2530	2530		10.1001/jama.302.23.2530	http://dx.doi.org/10.1001/jama.302.23.2530			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532HK	20009048				2022-12-28	WOS:000272737200003
J	Green, RC; Schneider, LS; Amato, DA; Beelen, AP; Wilcock, G; Swabb, EA; Zavitz, KH				Green, Robert C.; Schneider, Lon S.; Amato, David A.; Beelen, Andrew P.; Wilcock, Gordon; Swabb, Edward A.; Zavitz, Kenton H.		Tarenflurbil Phase 3 Study Grp	Effect of Tarenflurbil on Cognitive Decline and Activities of Daily Living in Patients With Mild Alzheimer Disease A Randomized Controlled Trial	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							CLINICAL-TRIALS; GAMMA-SECRETASE; R-FLURBIPROFEN; A-BETA-42; ENANTIOMERS; DEPOSITION; INVENTORY; SAFETY; NSAIDS; MODEL	Context Amyloid-beta peptide (A beta(42)) has been implicated in the pathogenesis of Alzheimer disease (AD). Tarenflurbil, a selective A beta(42)-lowering agent, demonstrated encouraging results on cognitive and functional outcomes among mildly affected patients in an earlier phase 2 trial. Objective To determine the efficacy, safety, and tolerability of tarenflurbil. Design, Setting, and Patients A multicenter, randomized, double-blind, placebo-controlled trial enrolling patients with mild AD was conducted at 133 trial sites in the United States between February 21, 2005, and April 30, 2008. Concomitant treatment with cholinesterase inhibitors or memantine was permitted. Intervention Tarenflurbil, 800 mg, or placebo, administered twice a day. Main Outcome Measures Co-primary efficacy end points were the change from baseline to month 18 in total score on the subscale of the Alzheimer Disease Assessment Scale-Cognitive Subscale (ADAS-Cog, 80-point version) and Alzheimer Disease Cooperative Studies-activities of daily living (ADCS-ADL) scale. Additional prespecified slope analyses explored the possibility of disease modification. Results Of the 1684 participants randomized, 1649 were included in the analysis, and 1046 completed the trial. Tarenflurbil had no beneficial effect on the co-primary outcomes (difference in change from baseline to month 18 vs placebo, based on least squares means: 0.1 for ADAS-Cog; 95% CI, -0.9 to 1.1; P=.86 and -0.5 for ADCS-ADL; 95% CI, -1.9 to 0.9; P=.48) using an intent-to-treat analysis. No significant differences occurred in the secondary outcomes. The ADAS-Cog score decreased by 7.1 points over 18 months. The tarenflurbil group had a small increase in frequency of dizziness, anemia, and infections. Conclusion Tarenflurbil did not slow cognitive decline or the loss of activities of daily living in patients with mild AD. Trial Registration clinicaltrials.gov Identifier: NCT00105547 JAMA. 2009;302(23):2557-2564	[Green, Robert C.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Green, Robert C.] Boston Univ, Sch Med, Dept Med Genet, Boston, MA 02118 USA; [Green, Robert C.] Boston Univ, Sch Med, Dept Epidemiol, Boston, MA 02118 USA; [Green, Robert C.] Boston Univ, Sch Publ Hlth, Dept Neurol, Boston, MA 02118 USA; [Green, Robert C.] Boston Univ, Sch Publ Hlth, Dept Med Genet, Boston, MA 02118 USA; [Green, Robert C.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA; [Schneider, Lon S.] Univ So Calif, Keck Sch Med, Dept Psychiat, Los Angeles, CA 90033 USA; [Schneider, Lon S.] Univ So Calif, Keck Sch Med, Dept Neurol, Los Angeles, CA 90033 USA; [Schneider, Lon S.] Univ So Calif, Keck Sch Med, Dept Gerontol, Los Angeles, CA 90033 USA; [Amato, David A.; Beelen, Andrew P.; Swabb, Edward A.; Zavitz, Kenton H.] Myriad Pharmaceut, Salt Lake City, UT USA; [Wilcock, Gordon] Univ Oxford, Nuffield Dept Med Clin Gerontol, Oxford, England	Boston University; Boston University; Boston University; Boston University; Boston University; Boston University; University of Southern California; University of Southern California; University of Southern California; University of Oxford	Green, RC (corresponding author), Boston Univ, Sch Med, Dept Neurol, 72 E Concord St,L-320, Boston, MA 02118 USA.	rcgreen@bu.edu		Adler, Lawrence/0000-0002-6619-2493; DeKosky, Steven/0000-0003-3743-2758	Myriad Pharmaceuticals; National Institutes of Health [RO1-HG02213, K24-AG027841, P30-AG13846, M01-RR00533]; UK Department of Health's National Institute for Health Research Biomedical Research Centres; NATIONAL CENTER FOR RESEARCH RESOURCES [M01RR000533] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG002213] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG013846, P50AG005142, K24AG027841, P30AG008051] Funding Source: NIH RePORTER	Myriad Pharmaceuticals; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UK Department of Health's National Institute for Health Research Biomedical Research Centres(National Institute for Health Research (NIHR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was primarily supported by Myriad Pharmaceuticals. Dr Green reported that he is supported by National Institutes of Health grants RO1-HG02213, K24-AG027841, P30-AG13846, and M01-RR00533. Dr Wilcock was partly supported by the Oxford Comprehensive Biomedical Research Centre with funding from the UK Department of Health's National Institute for Health Research Biomedical Research Centres funding scheme. The statistical analysis was conducted under the direction of Dr Amato, with assistance from Dr Alfred Balch and Mr Brent Evans, MS, both employees of Myriad Pharmaceuticals.; We thank Mary Jackson, RN, for overseeing the clinical operations of this study and Gary Mather, DVM, PhD, DABT, for the pharmacokinetic analyses, both are employees of Myriad Pharmaceuticals. We thank the members of the data and safety monitoring committee. Chris Clark, MD, and Jason Karlawish, MD (University of Pennsylvania), Gerald Faich, MD (Main Line Health Heart Center), and Weichung Shih, PhD (University of Medicine and Dentistry of New Jersey, School of Public Health).	Aisen PS, 2008, JAMA-J AM MED ASSOC, V300, P1774, DOI 10.1001/jama.300.15.1774; BRUNE K, 1992, J CLIN PHARMACOL, V32, P944, DOI 10.1002/j.1552-4604.1992.tb04643.x; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; Eriksen JL, 2003, J CLIN INVEST, V112, P440, DOI 10.1172/JCI200318162; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Galasko D, 1997, ALZ DIS ASSOC DIS, V11, pS33; Galasko DR, 2007, ALZ DIS ASSOC DIS, V21, P292, DOI 10.1097/WAD.0b013e31815d1048; GAUTHIER S, 2008, CLIN TRIALS ALZH DIS; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Jantzen PT, 2002, J NEUROSCI, V22, P2246, DOI 10.1523/JNEUROSCI.22-06-02246.2002; Kukar T, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-54; Kukar TL, 2008, NATURE, V453, P925, DOI 10.1038/nature07055; Lim GP, 2000, J NEUROSCI, V20, P5709, DOI 10.1523/JNEUROSCI.20-15-05709.2000; Logsdon R.G., 1999, J MENTAL HLTH AGING, V5, P21, DOI DOI 10.1037/T03352-000; McGowan E, 2005, NEURON, V47, P191, DOI 10.1016/j.neuron.2005.06.030; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; NOVAK M, 1989, GERONTOLOGIST, V29, P798, DOI 10.1093/geront/29.6.798; ROSEN WG, 1980, ANN NEUROL, V7, P486, DOI 10.1002/ana.410070516; ROSEN WG, 1984, AM J PSYCHIAT, V141, P1356; SANO M, 2008, ALZHEIMERS DEMENT S1, V4, pT200; Schneider LS, 2009, ALZHEIMERS DEMENT, V5, P388, DOI 10.1016/j.jalz.2009.07.038; Selkoe DJ, 2001, PHYSIOL REV, V81, P741, DOI 10.1152/physrev.2001.81.2.741; TRACY TS, 2005, BIOCHEM PHARMACOL, V49, P1269; Weggen S, 2001, NATURE, V414, P212, DOI 10.1038/35102591; Wilcock GK, 2008, LANCET NEUROL, V7, P483, DOI 10.1016/S1474-4422(08)70090-5; Yan Q, 2003, J NEUROSCI, V23, P7504; Yao YM, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-21; 2008, PHRMA WEB SYNOPSIS P	30	469	485	0	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	2009	302	23					2557	2564		10.1001/jama.2009.1866	http://dx.doi.org/10.1001/jama.2009.1866			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532HK	20009055	Green Accepted, Green Submitted, Bronze			2022-12-28	WOS:000272737200023
J	Cuschieri, K				Cuschieri, Kate			Should boys receive the human papillomavirus vaccine? No	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COST-EFFECTIVENESS ANALYSIS; CANCER		Royal Infirm Edinburgh NHS Trust, Scottish HPV Reference Lab, Edinburgh EH16 4SA, Midlothian, Scotland	Royal Infirmary of Edinburgh; University of Edinburgh	Cuschieri, K (corresponding author), Royal Infirm Edinburgh NHS Trust, Scottish HPV Reference Lab, Edinburgh EH16 4SA, Midlothian, Scotland.	KateCuschieri@luht.scot.nhs.uk						Backes DM, 2009, CANCER CAUSE CONTROL, V20, P449, DOI 10.1007/s10552-008-9276-9; de Kok IMCM, 2009, JNCI-J NATL CANCER I, V101, P1083, DOI 10.1093/jnci/djp183; FAIRLEY C, 2009, 25 INT PAP C MALM SW; Herrero R, 2003, JNCI-J NATL CANCER I, V95, P1772, DOI [10.1093/jnci/djg/107, 10.1093/jnci/djg107]; Hoots BE, 2009, INT J CANCER, V124, P2375, DOI 10.1002/ijc.24215; Hu D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.064; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kim JJ, 2007, BRIT J CANCER, V97, P1322, DOI 10.1038/sj.bjc.6604023; Kim JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3884; Marra F, 2009, PHARMACOECONOMICS, V27, P127, DOI 10.2165/00019053-200927020-00004; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Psyrri A, 2009, CURR OPIN ONCOL, V21, P201, DOI 10.1097/CCO.0b013e328329ab64; Smith MA, 2008, INT J CANCER, V123, P1854, DOI 10.1002/ijc.23633	13	7	7	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2009	339								b4921	10.1136/bmj.b4921	http://dx.doi.org/10.1136/bmj.b4921			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VD	19969601				2022-12-28	WOS:000272697200002
J	Hibbitts, S				Hibbitts, Sam			Should boys receive the human papillomavirus vaccine? Yes	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HPV VACCINE; CANCER; BURDEN; IMMUNOGENICITY; IMPACT		Cardiff Univ, Sch Med, Dept Obstet & Gynaecol, HPV Res Grp, Cardiff CF14 4XN, Wales	Cardiff University	Hibbitts, S (corresponding author), Cardiff Univ, Sch Med, Dept Obstet & Gynaecol, HPV Res Grp, Cardiff CF14 4XN, Wales.	hibbittssj@cf.ac.uk						Block SL, 2006, PEDIATRICS, V118, P2135, DOI 10.1542/peds.2006-0461; Castle PE, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4127; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; Garnett GP, 2006, VACCINE, V24, P178, DOI 10.1016/j.vaccine.2006.05.116; Hu D, 2008, AM J OBSTET GYNECOL, V198, DOI 10.1016/j.ajog.2008.03.064; Insinga RP, 2003, CLIN INFECT DIS, V36, P1397, DOI 10.1086/375074; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Kim JJ, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b3884; Munoz N, 2000, J CLIN VIROL, V19, P1, DOI 10.1016/S1386-6532(00)00125-6; Parkin DM, 2006, VACCINE, V24, P11, DOI 10.1016/j.vaccine.2006.05.111; Petaja T, 2009, J ADOLESCENT HEALTH, V44, P33, DOI 10.1016/j.jadohealth.2008.10.002; Powell N, 2009, INT J CANCER, V125, P2425, DOI 10.1002/ijc.24571; Robertson SE, 1997, B WORLD HEALTH ORGAN, V75, P69; Udesky L, 2007, LANCET, V369, P979, DOI 10.1016/S0140-6736(07)60475-9; Watson M, 2008, CANCER-AM CANCER SOC, V113, P2841, DOI 10.1002/cncr.23758	15	9	9	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 7	2009	339								b4928	10.1136/bmj.b4928	http://dx.doi.org/10.1136/bmj.b4928			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VD	19969602				2022-12-28	WOS:000272697200003
J	Wang, LM; Anderson, DJ				Wang, Liming; Anderson, David J.			Identification of an aggression-promoting pheromone and its receptor neurons in Drosophila	NATURE			English	Article							BEHAVIORAL-RESPONSES; SENSITIVE NEURONS; MELANOGASTER; ACETATE; PROTEIN; FLIES	Aggression is regulated by pheromones in many animal species(1-3). However, in no system have aggression pheromones, their cognate receptors and corresponding sensory neurons been identified. Here we show that 11-cis-vaccenyl acetate (cVA), a male-specific volatile pheromone, robustly promotes male-male aggression in the vinegar fly Drosophila melanogaster. The aggression-promoting effect of synthetic cVA requires olfactory sensory neurons (OSNs) expressing the receptor Or67d(4-6), as well as the receptor itself. Activation of Or67d-expressing OSNs, either by genetic manipulation of their excitability or by exposure to male pheromones in the absence of other classes of OSNs, is sufficient to promote aggression. High densities of male flies can promote aggression by the release of volatile cVA. In turn, cVA-promoted aggression can promote male fly dispersal from a food resource, in a manner dependent on Or67d-expressing OSNs. These data indicate that cVA may mediate negative-feedback control of male population density, through its effect on aggression. Identification of a pheromone-OSN pair controlling aggression in a genetic organism opens the way to unravelling the neurobiology of this evolutionarily conserved behaviour.	[Wang, Liming; Anderson, David J.] CALTECH, Div Biol 216 76, Pasadena, CA 91125 USA; [Anderson, David J.] CALTECH, Howard Hughes Med Inst, Pasadena, CA 91125 USA	California Institute of Technology; California Institute of Technology; Howard Hughes Medical Institute	Anderson, DJ (corresponding author), CALTECH, Div Biol 216 76, 1200 E Calif Blvd, Pasadena, CA 91125 USA.	lmwang@caltech.edu; wuwei@caltech.edu	Wang, Liming/C-8402-2011		NSF [EF-0623527, MCB-0418479]; Howard Hughes Medical Institute	NSF(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute)	We thank B. Dickson, M. Heisenberg and L. Vosshall for providing fly stocks, R. Axel, C. Bargmann, J. Levine and L. Vosshall for comments on the manuscript and L. Zipursky for discussions. This work was supported in part by NSF grants EF-0623527 and MCB-0418479. D. J. A. is an Investigator of the Howard Hughes Medical Institute.	Baier A, 2002, J EXP BIOL, V205, P1233; Baines RA, 2001, J NEUROSCI, V21, P1523, DOI 10.1523/JNEUROSCI.21-05-01523.2001; BARTELT RJ, 1985, J CHEM ECOL, V11, P1747, DOI 10.1007/BF01012124; Benton R, 2007, TRENDS NEUROSCI, V30, P512, DOI 10.1016/j.tins.2007.07.004; Certel SJ, 2007, P NATL ACAD SCI USA, V104, P4706, DOI 10.1073/pnas.0700328104; Chamero P, 2007, NATURE, V450, P899, DOI 10.1038/nature05997; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Dankert H, 2009, NAT METHODS, V6, P297, DOI [10.1038/NMETH.1310, 10.1038/nmeth.1310]; Datta SR, 2008, NATURE, V452, P473, DOI 10.1038/nature06808; Dierick HA, 2007, NAT GENET, V39, P678, DOI 10.1038/ng2029; Dierick HA, 2006, NAT GENET, V38, P1023, DOI 10.1038/ng1864; Ejima A, 2007, CURR BIOL, V17, P599, DOI 10.1016/j.cub.2007.01.053; Ha TS, 2006, J NEUROSCI, V26, P8727, DOI 10.1523/JNEUROSCI.0876-06.2006; HOFFMANN AA, 1987, ANIM BEHAV, V35, P807, DOI 10.1016/S0003-3472(87)80117-3; Hoyer SC, 2008, CURR BIOL, V18, P159, DOI 10.1016/j.cub.2007.12.052; Keverne EB, 2002, CURR BIOL, V12, pR807, DOI 10.1016/S0960-9822(02)01314-3; Kou R, 2006, NATURWISSENSCHAFTEN, V93, P286, DOI 10.1007/s00114-006-0095-0; Kurtovic A, 2007, NATURE, V446, P542, DOI 10.1038/nature05672; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Laughlin JD, 2008, CELL, V133, P1255, DOI 10.1016/j.cell.2008.04.046; Ono M, 2003, NATURE, V424, P637, DOI 10.1038/424637a; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Schlief ML, 2007, NAT NEUROSCI, V10, P623, DOI 10.1038/nn1881; SHOREY HH, 1973, ANNU REV ENTOMOL, V18, P349, DOI 10.1146/annurev.en.18.010173.002025; Sturtevant A. H., 1915, Journal of Animal Behavior Boston, V5, DOI 10.1037/h0074109; van Naters WVG, 2007, CURR BIOL, V17, P606, DOI 10.1016/j.cub.2007.02.043; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wang LM, 2008, P NATL ACAD SCI USA, V105, P5657, DOI 10.1073/pnas.0801327105; Xu PX, 2005, NEURON, V45, P193, DOI 10.1016/j.neuron.2004.12.031; Zhou C, 2008, NAT NEUROSCI, V11, P1059, DOI 10.1038/nn.2164	30	190	193	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					227	U114		10.1038/nature08678	http://dx.doi.org/10.1038/nature08678			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	19966787	Green Accepted			2022-12-28	WOS:000273582700035
J	Horie, M; Honda, T; Suzuki, Y; Kobayashi, Y; Daito, T; Oshida, T; Ikuta, K; Jern, P; Gojobori, T; Coffin, JM; Tomonaga, K				Horie, Masayuki; Honda, Tomoyuki; Suzuki, Yoshiyuki; Kobayashi, Yuki; Daito, Takuji; Oshida, Tatsuo; Ikuta, Kazuyoshi; Jern, Patric; Gojobori, Takashi; Coffin, John M.; Tomonaga, Keizo			Endogenous non-retroviral RNA virus elements in mammalian genomes	NATURE			English	Article							BORNA-DISEASE VIRUS; DNA; PROTEIN; SEQUENCES; BIOLOGY; CDNA	Retroviruses are the only group of viruses known to have left a fossil record, in the form of endogenous proviruses, and approximately 8% of the human genome is made up of these elements(1,2). Although many other viruses, including non-retroviral RNA viruses, are known to generate DNA forms of their own genomes during replication(3-5), none has been found as DNA in the germline of animals. Bornaviruses, a genus of non-segmented, negative-sense RNA virus, are unique among RNA viruses in that they establish persistent infection in the cell nucleus(6-8). Here we show that elements homologous to the nucleoprotein (N) gene of bornavirus exist in the genomes of several mammalian species, including humans, non-human primates, rodents and elephants. These sequences have been designated endogenous Borna-like N (EBLN) elements. Some of the primate EBLNs contain an intact open reading frame (ORF) and are expressed as mRNA. Phylogenetic analyses showed that EBLNs seem to have been generated by different insertional events in each specific animal family. Furthermore, the EBLN of a ground squirrel was formed by a recent integration event, whereas those in primates must have been formed more than 40 million years ago. We also show that the N mRNA of a current mammalian bornavirus, Borna disease virus (BDV), can form EBLN-like elements in the genomes of persistently infected cultured cells. Our results provide the first evidence for endogenization of non-retroviral virus-derived elements in mammalian genomes and give novel insights not only into generation of endogenous elements, but also into a role of bornavirus as a source of genetic novelty in its host.	[Horie, Masayuki; Honda, Tomoyuki; Daito, Takuji; Ikuta, Kazuyoshi; Tomonaga, Keizo] Osaka Univ, Dept Virol, Res Inst Microbial Dis BIKEN, Suita, Osaka 5650871, Japan; [Honda, Tomoyuki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028472, Japan; [Suzuki, Yoshiyuki; Kobayashi, Yuki; Gojobori, Takashi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 4118540, Japan; [Suzuki, Yoshiyuki; Kobayashi, Yuki; Gojobori, Takashi] Natl Inst Genet, DNA Data Bank Japan, Mishima, Shizuoka 4118540, Japan; [Oshida, Tatsuo] Obihiro Univ Agr & Vet Med, Dept Life Sci & Agr, Obihiro, Hokkaido 0808555, Japan; [Jern, Patric; Coffin, John M.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Tomonaga, Keizo] Japan Sci & Technol Agcy, PRESTO, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Japan Society for the Promotion of Science; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Obihiro University of Agriculture & Veterinary Medicine; Tufts University; Japan Science & Technology Agency (JST)	Tomonaga, K (corresponding author), Osaka Univ, Dept Virol, Res Inst Microbial Dis BIKEN, Suita, Osaka 5650871, Japan.	tomonaga@biken.osaka-u.ac.jp	Jern, Patric/AAR-2133-2021	Jern, Patric/0000-0003-3393-5825; Horie, Masayuki/0000-0003-4682-7698	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency; Ministry of Health, Labor and Welfare of Japan; National Cancer Institute [R37 CA 089441]; Wenner-Gren Foundation; George Kirby Foundation; NATIONAL CANCER INSTITUTE [R37CA089441] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wenner-Gren Foundation; George Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Kawahara for helping the capture of the wild shrews (Sorex unguiculatus and Sorex gracillimus) at Kiritappu wetland, Hokkaido, Japan. We thank I. Francischetti for provision of Gaboon viper (Bitis gabonica) venom gland tissue and a cDNA library, D. Vaughan for thirteen-lined ground squirrel (Spermophilus tridecemlineatus) brain and liver tissues, and K. Maeda, T. Miyazawa and N. Ohtaki for providing culture cell lines from several mammalian species. This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grants-in-aid for Scientific Research on Priority Areas (Infection and Host Responses; Matrix of Infection Phenomena) (K. T.), PRESTO (RNA and Biofunctions) from Japan Science and Technology Agency (JST) (K. T.), a Health Labour Sciences Research Grants for Research on Measures for Intractable Diseases (H20 nanchiippan 035) from the Ministry of Health, Labor and Welfare of Japan (K. T.), research grant R37 CA 089441 from the National Cancer Institute (J. M. C.) and a fellowship from the Wenner-Gren Foundation (P. J.). J. M. C. was a Research Professor of the American Cancer Society with support from the George Kirby Foundation.	Chase G, 2007, J VIROL, V81, P743, DOI 10.1128/JVI.01351-06; de la Torre JC, 2002, FRONT BIOSCI-LANDMRK, V7, pD569, DOI 10.2741/torre; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Francischetti IMB, 2004, GENE, V337, P55, DOI 10.1016/j.gene.2004.03.024; Geuking MB, 2009, SCIENCE, V323, P393, DOI 10.1126/science.1167375; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Hui EKW, 1998, CELL MOL LIFE SCI, V54, P1403, DOI 10.1007/s000180050262; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876; Korber B, 1998, SCIENCE, V280, P1868, DOI 10.1126/science.280.5371.1868; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LIPKIN WI, 2007, FIELDS VIROLOGY, P1829; Lovatt A, 1999, J VIROL METHODS, V82, P185, DOI 10.1016/S0166-0934(99)00111-1; Maestre J, 1995, EMBO J, V14, P6333, DOI 10.1002/j.1460-2075.1995.tb00324.x; Mercer JM, 2003, SCIENCE, V299, P1568, DOI 10.1126/science.1079705; MINAMI M, 1995, GENOMICS, V29, P403, DOI 10.1006/geno.1995.9004; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Ohtaki N, 2007, J VIROL, V81, P5940, DOI 10.1128/JVI.02137-06; Pavlicek A, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P57, DOI 10.1007/978-1-59745-039-3_4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomonaga K, 2002, MICROBES INFECT, V4, P491, DOI 10.1016/S1286-4579(02)01564-2; Wo YYP, 2006, ANAL BIOCHEM, V358, P149, DOI 10.1016/j.ab.2006.04.030; Zhang ZL, 2004, TRENDS GENET, V20, P62, DOI 10.1016/j.tig.2003.12.005; ZHDANOV VM, 1975, NATURE, V256, P471, DOI 10.1038/256471a0	29	306	325	1	78	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					84	U90		10.1038/nature08695	http://dx.doi.org/10.1038/nature08695			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054395	Green Accepted			2022-12-28	WOS:000273344900035
J	Schiller, D; Monfils, MH; Raio, CM; Johnson, DC; LeDoux, JE; Phelps, EA				Schiller, Daniela; Monfils, Marie-H.; Raio, Candace M.; Johnson, David C.; LeDoux, Joseph E.; Phelps, Elizabeth A.			Preventing the return of fear in humans using reconsolidation update mechanisms	NATURE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; MEMORY STABILIZATION; CONDITIONED FEAR; EXTINCTION; CONSOLIDATION; RETRIEVAL; AMYGDALA; CONTEXT; PROPRANOLOL; RECALL	Recent research on changing fears has examined targeting reconsolidation. During reconsolidation, stored information is rendered labile after being retrieved. Pharmacological manipulations at this stage result in an inability to retrieve the memories at later times, suggesting that they are erased or persistently inhibited. Unfortunately, the use of these pharmacological manipulations in humans can be problematic. Here we introduce a non-invasive technique to target the reconsolidation of fear memories in humans. We provide evidence that old fear memories can be updated with non-fearful information provided during the reconsolidation window. As a consequence, fear responses are no longer expressed, an effect that lasted at least a year and was selective only to reactivated memories without affecting others. These findings demonstrate the adaptive role of reconsolidation as a window of opportunity to rewrite emotional memories, and suggest a non-invasive technique that can be used safely in humans to prevent the return of fear.	[Schiller, Daniela; Monfils, Marie-H.; LeDoux, Joseph E.; Phelps, Elizabeth A.] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Schiller, Daniela; Raio, Candace M.; Johnson, David C.; Phelps, Elizabeth A.] NYU, Dept Psychol, New York, NY 10003 USA; [Monfils, Marie-H.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA	New York University; New York University; University of Texas System; University of Texas Austin	Phelps, EA (corresponding author), NYU, Ctr Neural Sci, New York, NY 10003 USA.	liz.phelps@nyu.edu	Raio, Candace/GON-5368-2022; Schiller, Daniela/Q-2431-2018; Monfils, Marie/F-1282-2013	Schiller, Daniela/0000-0002-0357-7724; Monfils, Marie-H./0000-0001-8971-6651	James S. McDonnell Foundation; National Institutes of Health (NIH) [R21 MH072279, R37 MH038774, P50 MH058911, RO1 MH046516, K05 MH067048]; NSERC; CIHR; AHFMR; Fulbright award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH046516, R01MH038774, R37MH038774, R21MH072279, P50MH058911, R01MH091147, K05MH067048] Funding Source: NIH RePORTER	James S. McDonnell Foundation; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC)); CIHR(Canadian Institutes of Health Research (CIHR)); AHFMR(Alberta Heritage Foundation for Medical Research); Fulbright award; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank K. Doelling for assistance with data collection and discussions on the revised version of the manuscript. We also thank Y. Niv and M. Milad for advice on the experimental protocols. This study was funded by the James S. McDonnell Foundation and National Institutes of Health (NIH) grant R21 MH072279 (E. A. P.), NIH grants R37 MH038774, P50 MH058911, RO1 MH046516 and K05 MH067048 (J.E.L.), Postdoctoral fellowships NSERC, CIHR and AHFMR (M.-H. M.), and a Fulbright award (D. S.).	Alberini CM, 2006, CELL MOL LIFE SCI, V63, P999, DOI 10.1007/s00018-006-6025-7; Alberini CM, 2005, TRENDS NEUROSCI, V28, P51, DOI 10.1016/j.tins.2004.11.001; Alvarez RP, 2007, LEARN MEMORY, V14, P247, DOI 10.1101/lm.493707; Bouton ME, 2002, BIOL PSYCHIAT, V52, P976, DOI 10.1016/S0006-3223(02)01546-9; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Doyere V, 2007, NAT NEUROSCI, V10, P414, DOI 10.1038/nn1871; Dudai Y, 2006, CURR OPIN NEUROBIOL, V16, P174, DOI 10.1016/j.conb.2006.03.010; Duvarci S, 2004, J NEUROSCI, V24, P9269, DOI 10.1523/JNEUROSCI.2971-04.2004; Foa EB, 2002, BIOL PSYCHIAT, V52, P987, DOI 10.1016/S0006-3223(02)01552-4; Forcato C, 2007, LEARN MEMORY, V14, P295, DOI 10.1101/lm.486107; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; Kalisch R, 2006, J NEUROSCI, V26, P9503, DOI 10.1523/JNEUROSCI.2021-06.2006; Kindt M, 2009, NAT NEUROSCI, V12, P256, DOI 10.1038/nn.2271; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milad MR, 2007, BIOL PSYCHIAT, V62, P446, DOI 10.1016/j.biopsych.2006.10.011; Miracle AD, 2006, NEUROBIOL LEARN MEM, V85, P213, DOI 10.1016/j.nlm.2005.10.005; MISANIN JR, 1968, SCIENCE, V160, P554, DOI 10.1126/science.160.3827.554; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Myers KM, 2006, LEARN MEMORY, V13, P216, DOI 10.1101/lm.119806; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Phelps EA, 2004, NEURON, V43, P897, DOI 10.1016/j.neuron.2004.08.042; Quirk GJ, 2008, NEUROPSYCHOPHARMACOL, V33, P56, DOI 10.1038/sj.npp.1301555; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Sara SJ, 2006, LEARN MEMORY, V13, P515, DOI 10.1101/lm.338406; Schiller D, 2008, LEARN MEMORY, V15, P394, DOI 10.1101/lm.909208; SQUIRE LR, 1981, ANNU REV PHARMACOL, V21, P323, DOI 10.1146/annurev.pa.21.040181.001543; SQUIRE LR, 2000, NEW COGNITIVE NEUROS, P765; Tollenaar MS, 2009, PSYCHOPHARMACOLOGY, V203, P793, DOI 10.1007/s00213-008-1427-x; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930	31	818	858	7	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					49	U51		10.1038/nature08637	http://dx.doi.org/10.1038/nature08637			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	540OV	20010606	Green Accepted			2022-12-28	WOS:000273344900027
J	Moellering, RC; Mattson-DiCecca, AA; Reynolds, EE				Moellering, Robert C.; Mattson-DiCecca, Anna A.; Reynolds, Eileen E.			Update: A 39-Year-Old Man With a Skin Infection	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RESISTANT STAPHYLOCOCCUS-AUREUS; COLONIZATION											Bloom HR, 2008, JAMA-J AM MED ASSOC, V299, P2511, DOI 10.1001/jama.299.21.2511-a; Gorwitz RJ, 2008, J INFECT DIS, V197, P1226, DOI 10.1086/533494; Miller LG, 2008, CLIN INFECT DIS, V46, P752, DOI 10.1086/526773; Moellering RC, 2008, JAMA-J AM MED ASSOC, V299, P79, DOI 10.1001/jama.298.21.jrr70002; Morgan M, 2008, J ANTIMICROB CHEMOTH, V62, P1181, DOI 10.1093/jac/dkn405	5	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2010	303	1					64	64		10.1001/jama.2009.1960	http://dx.doi.org/10.1001/jama.2009.1960			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539YS	20051570				2022-12-28	WOS:000273296900020
J	Vajo, Z; Tamas, F; Sinka, L; Jankovics, I				Vajo, Zoltan; Tamas, Ferenc; Sinka, Laszlo; Jankovics, Istvan			Safety and immunogenicity of a 2009 pandemic influenza A H1N1 vaccine when administered alone or simultaneously with the seasonal influenza vaccine for the 2009-10 influenza season: a multicentre, randomised controlled trial	LANCET			English	Article							CROSS-REACTIVE IMMUNITY; INACTIVATED WHOLE VIRUS; H5N1 VACCINE; CHILDREN; ANTIGEN; ADULTS	Background With the ongoing 2009 pandemic of influenza A H1N1, development of pandemic influenza vaccines has generated much interest. We investigated the safety and immunogenicity of a whole-virion, inactivated, adjuvanted pandemic H1N1 vaccine in adult and elderly volunteers, given without or simultaneously with the 2009-10 seasonal trivalent influenza vaccine. Methods This prospective, randomised study was undertaken in two centres in Hungary. 355 participants, including 203 adults (18-60 years) and 152 elderly people (>60 years), were assigned by stratified randomisation to either 0.5 mL of the pandemic vaccine (Fluval P, a monovalent vaccine with 6 mu g haemagglutinin per 0.5 mL content and aluminium phosphate gel adjuvant; n=178) or 0.5 mL of the pandemic vaccine and 0.5 mL of the seasonal trivalent vaccine (Fluval AB, a trivalent inactivated whole-virion influenza vaccine; n=177). All vaccinations were done by specific study personnel, who did not take part in the assessment of safety or immunogenicity. Co-primary objectives were safety and immunogenicity by haemagglutinin inhibition testing. All analyses were done according to it pre-established analysis plan. This study is registered with ClinicalTrials.gov, number NCT01010893. Findings Two participants receiving the pandemic vaccine only (group 1) and one receiving pandemic and seasonal vaccines (group 2) were lost to follow-up. Participants in both groups developed antibody responses against the pandemic influenza A H1N1 virus (group 1: seroconversion for adults 74.3%, 95% CI 64.6-82.4 and for elderly people 61.3%, 49.1-72.4; group 2: 76.8%, 67.2-84.7 and 81.8%, 71.4-89.7, respectively). Single doses of 6 mu g fulfilled European Union and US licensing criteria for interpandemic and pandemic influenza vaccines. Simultaneously, participants in group 2 developed the immune responses needed for licensing for all three seasonal strains in the seasonal vaccine for the 2009-10 season. All adverse events were rare, mild, and transient; the most frequent were pain at injection site (eight cases in group 1 vs 18 in group 2) and fatigue for 1-2 days after vaccination (three vs five cases). Interpretation The present pandemic vaccine is safe and immunogenic in healthy adult and elderly patients, and needs low doses and only one injection to trigger immune responses to comply with licensing criteria. It can be safely co-administered with the 2009-10 seasonal influenza vaccine. Funding Omninvest, Hungary.	[Jankovics, Istvan] Natl Ctr Epidemiol, Budapest, Hungary; [Vajo, Zoltan] Univ Debrecen, Med & Hlth Sci Ctr, H-4012 Debrecen, Hungary; [Tamas, Ferenc] State Primary Care Ctr, Pilosvorosvar, Hungary; [Sinka, Laszlo] State Primary Care Ctr, Veszprem, Hungary	University of Debrecen	Vajo, Z (corresponding author), Varosmajor U 49, H-1122 Budapest, Hungary.	zoltanvajo@gmail.com	Vajo, Zoltan/J-9016-2019	Vajo, Zoltan/0000-0003-1049-1694	Omninvest, Hungary	Omninvest, Hungary	This study was sponsored by Omninvest, Hungary. We thank Ryan Hampton for her help with preparation of the report.	Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Dennis C, 2006, NATURE, V440, P1099, DOI 10.1038/4401099a; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; *EUR CTR DIS PREV, 2007, TECHN REP EXP ADV GR; *EUR MED AG, 2009, EMEACHMPBWP133895200; European Committee for Proprietary Medial Products, 1997, CPMPBWP21496 EUR COM; European Directoriate for the Quality of Medicines and Health Care, 2007, EUR PHARM; Fazekas G, 2009, CLIN VACCINE IMMUNOL, V16, P437, DOI 10.1128/CVI.00327-08; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; KLIMOV A, 2003, SEROLOGIC DIAGNOSIS; Leroux-Roels I, 2007, LANCET, V370, P580, DOI 10.1016/S0140-6736(07)61297-5; Nolan TM, 2008, VACCINE, V26, P4160, DOI 10.1016/j.vaccine.2008.05.077; PROFETA ML, 1979, B I SIEROTER MILAN, V58, P457; *US FDA, 2007, GUID CLIN D IN PRESS; Vajo Z, 2008, INFLUENZA OTHER RESP, V2, P221, DOI 10.1111/j.1750-2659.2008.00055.x; Vajo Z, 2008, PEDIATR INFECT DIS J, V27, P1052, DOI 10.1097/INF.0b013e3181861dd7; Vajo Z, 2007, EMERG INFECT DIS, V13, P807, DOI 10.3201/eid1305.061248; Vajo Z, 2009, EXPERT REV VACCINES, V8, P619, DOI [10.1586/erv.09.25, 10.1586/ERV.09.25]; Voordouw ACG, 2004, JAMA-J AM MED ASSOC, V292, P2089, DOI 10.1001/jama.292.17.2089; *WHO, 2009, DG STAT FOLL M EM CO; WOOD JM, 1977, J BIOL STAND, V5, P237, DOI 10.1016/S0092-1157(77)80008-5; World Health Organization, PAND H1N1 2009 UPD 6 PAND H1N1 2009 UPD 6; World Health Organization, 2009, AV CAND REASS VACC V	25	129	133	1	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2010	375	9708					49	55		10.1016/S0140-6736(09)62039-0	http://dx.doi.org/10.1016/S0140-6736(09)62039-0			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539BZ	20018367				2022-12-28	WOS:000273229700031
J	Bolke, E; Matuschek, C				Boelke, Edwin; Matuschek, Christiane			Radiation Pneumonitis after Radiotherapy for Breast Cancer	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Boelke, Edwin; Matuschek, Christiane] Univ Dusseldorf, Dusseldorf, Germany	Heinrich Heine University Dusseldorf	Bolke, E (corresponding author), Univ Dusseldorf, Dusseldorf, Germany.	boelke@med.uni-duesseldorf.de	Boelke, Edwin/AAA-9630-2021; Matuschek, Christiane/ABI-6446-2020; Matuschek, Christiane/AHC-5887-2022	Boelke, Edwin/0000-0001-9112-1024; 					0	1	2	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					E65	E65		10.1056/NEJMicm0810650	http://dx.doi.org/10.1056/NEJMicm0810650			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042752				2022-12-28	WOS:000273181300014
J	Hunninghake, GM; Cho, MH; Tesfaigzi, Y; Soto-Quiros, ME; Avila, L; Lasky-Su, J; Stidley, C; Melen, E; Soderhall, C; Hallberg, J; Kull, I; Kere, J; Svartengren, M; Pershagen, G; Wickman, M; Lange, C; Demeo, DL; Hersh, CP; Klanderman, BJ; Raby, BA; Sparrow, D; Shapiro, SD; Silverman, EK; Litonjua, AA; Weiss, ST; Celedon, JC				Hunninghake, Gary M.; Cho, Michael H.; Tesfaigzi, Yohannes; Soto-Quiros, Manuel E.; Avila, Lydiana; Lasky-Su, Jessica; Stidley, Chris; Melen, Erik; Soderhall, Cilla; Hallberg, Jenny; Kull, Inger; Kere, Juha; Svartengren, Magnus; Pershagen, Goran; Wickman, Magnus; Lange, Christoph; Demeo, Dawn L.; Hersh, Craig P.; Klanderman, Barbara J.; Raby, Benjamin A.; Sparrow, David; Shapiro, Steven D.; Silverman, Edwin K.; Litonjua, Augusto A.; Weiss, Scott T.; Celedon, Juan C.			MMP12, Lung Function, and COPD in High-Risk Populations	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; AIR-FLOW OBSTRUCTION; CHILDHOOD ASTHMA; POLYMORPHISMS; GENE; DECLINE; EXPRESSION; VALUES	BACKGROUND Genetic variants influencing lung function in children and adults may ultimately lead to the development of chronic obstructive pulmonary disease ( COPD), particularly in high-risk groups. METHODS We tested for an association between single-nucleotide polymorphisms (SNPs) in the gene encoding matrix metalloproteinase 12 (MMP12) and a measure of lung function (prebronchodilator forced expiratory volume in 1 second [FEV1]) in more than 8300 subjects in seven cohorts that included children and adults. Within the Normative Aging Study (NAS), a cohort of initially healthy adult men, we tested for an association between SNPs that were associated with FEV1 and the time to the onset of COPD. We then examined the relationship between MMP12 SNPs and COPD in two cohorts of adults with COPD or at risk for COPD. RESULTS The minor allele ( G) of a functional variant in the promoter region of MMP12 (rs2276109 [-82A -> G]) was positively associated with FEV1 in a combined analysis of children with asthma and adult former and current smokers in all cohorts (P=2x10(-6)). This allele was also associated with a reduced risk of the onset of COPD in the NAS cohort (hazard ratio, 0.65; 95% confidence interval [CI], 0.46 to 0.92; P = 0.02) and with a reduced risk of COPD in a cohort of smokers ( odds ratio, 0.63; 95% CI, 0.45 to 0.88; P = 0.005) and among participants in a family-based study of early-onset COPD (P = 0.006). CONCLUSIONS The minor allele of a SNP in MMP12 (rs2276109) is associated with a positive effect on lung function in children with asthma and in adults who smoke. This allele is also associated with a reduced risk of COPD in adult smokers.	[Hunninghake, Gary M.; Cho, Michael H.; Lasky-Su, Jessica; Melen, Erik; Lange, Christoph; Demeo, Dawn L.; Hersh, Craig P.; Klanderman, Barbara J.; Raby, Benjamin A.; Silverman, Edwin K.; Litonjua, Augusto A.; Weiss, Scott T.; Celedon, Juan C.] Brigham & Womens Hosp, Channing Lab, Boston, MA 02115 USA; [Hunninghake, Gary M.; Cho, Michael H.; Lasky-Su, Jessica; Melen, Erik; Lange, Christoph; Demeo, Dawn L.; Hersh, Craig P.; Klanderman, Barbara J.; Raby, Benjamin A.; Silverman, Edwin K.; Litonjua, Augusto A.; Weiss, Scott T.; Celedon, Juan C.] Brigham & Womens Hosp, Ctr Genom Med, Boston, MA 02115 USA; [Hunninghake, Gary M.; Cho, Michael H.; Demeo, Dawn L.; Hersh, Craig P.; Raby, Benjamin A.; Silverman, Edwin K.; Litonjua, Augusto A.; Celedon, Juan C.] Brigham & Womens Hosp, Div Pulm & Crit Care Med, Boston, MA 02115 USA; [Hunninghake, Gary M.; Cho, Michael H.; Lasky-Su, Jessica; Melen, Erik; Demeo, Dawn L.; Hersh, Craig P.; Klanderman, Barbara J.; Raby, Benjamin A.; Silverman, Edwin K.; Litonjua, Augusto A.; Weiss, Scott T.; Celedon, Juan C.] Harvard Univ, Sch Med, Boston, MA USA; [Lange, Christoph] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [Sparrow, David] Boston Univ, Sch Med, VA Normat Aging Study, VA Healthcare Syst, Boston, MA 02118 USA; [Sparrow, David] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Tesfaigzi, Yohannes; Stidley, Chris] Lovelace Resp Res Inst, Albuquerque, NM USA; [Soto-Quiros, Manuel E.; Avila, Lydiana] Hosp Nacl Ninos Dr Carlos Saenz Herrera, Div Pediat Pulmonol, San Jose, Costa Rica; [Melen, Erik; Kull, Inger; Pershagen, Goran; Wickman, Magnus] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Soderhall, Cilla; Kere, Juha] Karolinska Inst, Novum, Dept Biosci, S-10401 Stockholm, Sweden; [Svartengren, Magnus] Karolinska Inst, Dept Publ Hlth Sci, S-10401 Stockholm, Sweden; [Wickman, Magnus] Karolinska Inst, Ctr Allergy Res, S-10401 Stockholm, Sweden; [Melen, Erik] Karolinska Univ Hosp, Astrid Lindgren Childrens Hosp, Stockholm, Sweden; [Hallberg, Jenny; Wickman, Magnus] Karolinska Inst, Sachs Childrens Hosp, Stockholm, Sweden; [Shapiro, Steven D.] Univ Pittsburgh, Dept Med, Pittsburgh, PA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health; Boston University; Boston University; Lovelace Respiratory Research Institute; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Celedon, JC (corresponding author), Brigham & Womens Hosp, Channing Lab, 181 Longwood Ave, Boston, MA 02115 USA.	juan.celedon@channing.harvard.edu	Kere, Juha/A-9179-2008; Avila, Lydiana/D-5638-2015; Kere, Juha/AAX-9117-2021; Svartengren, Magnus/AAM-7777-2021; Söderhäll, Cilla/E-3940-2012; Raby, Benjamin/AAK-3866-2021	Kere, Juha/0000-0003-1974-0271; Avila, Lydiana/0000-0002-9579-1591; Kere, Juha/0000-0003-1974-0271; Svartengren, Magnus/0000-0002-8165-7236; Söderhäll, Cilla/0000-0002-8397-3080; Pershagen, Goran/0000-0002-9701-1130; Kull, Inger/0000-0001-6096-3771; Litonjua, Augusto/0000-0003-0422-5875; Elkington, Paul/0000-0003-0390-0613; Tesfaigzi, Yohannes/0000-0002-3997-5839	National Heart, Lung, and Blood Institute (NHLBI) [K08 HL092222, K12 HL089990, K08 HL72918, K08 HL074193, R37 HL66289, K01 HL04370, U01 HL065899, U01 HL075419, P01 HL083069, R01 HL086601, R01 HL075478, N01HR76101, N01HR76102, N01HR76103, N01HR76104, N01HR76105, N01HR76106, N01HR76107, N01HR76108, N01HR76109, N01HR76110]; Swedish Research Council, Stockholm County Council, Center for Allergy Research, Karolinska Institutet; State of New Mexico; Cooperative Studies Program-Epidemiology Research and Information Center of the U. S. Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center, Boston; Medical Research Council [G0000934]; Wellcome Trust [068545/Z/02]; AstraZeneca; Merck; Johnson Johnson; Golden Helix; Novartis Pharmaceuticals; GlaxoSmithKline; Sandvik Hard Materials; Sepracor; Genentech; Phadia; Merck Sweden; DIVISION OF LUNG DISEASES [N01HR076118, N01HR076102, N01HR076106, N01HR076108, N01HR076114, N01HR076113, N01HR076119, N01HR076103, N01HR076101, N01HR076116, N01HR076104, N01HR076111, N01HR076109, N01HR076107, N01HR076112, N01HR076115, N01HR076110, N01HR076105] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K12HL089990, R37HL066289, T32HL076118, T32HL076116, P01HL083069, F32HL076108, K08HL074193, R01HL076113, K01HL004370, R01HL076101, U01HL075419, R01HL071393, R01HL084323, R01HL086601, R01HL075478, R01HL076114, K08HL072918, U01HL065899, K08HL092222] Funding Source: NIH RePORTER; MRC [G0000934] Funding Source: UKRI	National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Swedish Research Council, Stockholm County Council, Center for Allergy Research, Karolinska Institutet(Stockholm County CouncilSwedish Research Council); State of New Mexico; Cooperative Studies Program-Epidemiology Research and Information Center of the U. S. Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center, Boston; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); AstraZeneca(AstraZeneca); Merck(Merck & Company); Johnson Johnson(Johnson & JohnsonJohnson & Johnson USA); Golden Helix; Novartis Pharmaceuticals(Novartis); GlaxoSmithKline(GlaxoSmithKline); Sandvik Hard Materials; Sepracor; Genentech(Roche HoldingGenentech); Phadia(Phadia); Merck Sweden; DIVISION OF LUNG DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Supported by grants from the National Heart, Lung, and Blood Institute (NHLBI) (K08 HL092222, to Dr. Hunninghake; K12 HL089990, to Dr. Cho; K08 HL72918, to Dr. Demeo; and K08 HL074193, to Dr. Raby). The Genetics of Asthma in Costa Rica Study (GACRS) was supported by grants from the NHLBI (R37 HL66289 and K01 HL04370); the Childhood Asthma Management Program ( CAMP) Genetics Ancillary Study was supported by grants from the NHLBI (U01 HL065899, U01 HL075419, P01 HL083069, and R01 HL086601); the Children, Allergy, Milieu, Stockholm, Epidemiological Survey (BAMSE) was supported by the Swedish Research Council, Stockholm County Council, Center for Allergy Research, Karolinska Institutet, and Swedish Heart Lung Foundation; the Boston Early- Onset COPD (eoCOPD) study was supported by a grant from the NHLBI (R01 HL075478); the National Emphysema Treatment Trial ( NETT) was supported by contracts from the NHLBI (N01HR76101, N01HR76102, N01HR76103, N01HR76104, N01HR76105, N01HR76106, N01HR76107, N01HR76108, N01HR76109, N01HR76110, N01HR76111, N01HR76112, N01HR76113, N01HR76114, N01HR76115, N01HR76116, N01HR76118, and N01HR76119), Centers for Medicare and Medicaid Services, and Agency for Healthcare Research and Quality, and the NETT Genetics Ancillary Study was supported by grants from the NHLBI ( R01 HL71393 and R01 HL084323); the Lovelace Smokers Cohort was supported by funding from the State of New Mexico; and the Normative Aging Study (NAS) was supported by the Cooperative Studies Program-Epidemiology Research and Information Center of the U. S. Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center, Boston. The British 1958 Birth Cohort DNA collection, from which genotype data were used, was funded by grants from the Medical Research Council (G0000934) and the Wellcome Trust (068545/Z/02). Dr. Avila reports receiving lecture fees from AstraZeneca and Merck; Dr. Kere, grant support from Johnson & Johnson; Dr. Lange, consulting fees from Golden Helix; Dr. Raby, lecture fees from Novartis Pharmaceuticals; Dr. Silverman, consulting and lecture fees from AstraZeneca and consulting fees and grant support from GlaxoSmithKline; Dr. Soto-Quiros, lecture fees from AstraZeneca, GlaxoSmithKline, and Merck; Dr. Svartengren, lecture fees from Sandvik Hard Materials; Dr. Tesfaigzi, grant support from Sepracor; Dr. Weiss, consulting fees from Genentech; and Dr. Wickman, lecture fees from Phadia and Merck Sweden. No other potential conflict of interest relevant to this article was reported.	Adam E, 2006, J BIOL CHEM, V281, P6910, DOI 10.1074/jbc.M507140200; [Anonymous], 1995, AM J RESP CRIT CARE, V152, P1107, DOI 10.1164/ajrccm.152.3.7663792; BELL B, 1972, AGING HUM DEVELOP, V3, P5, DOI 10.2190/GGVP-XLB5-PC3N-EF0G; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; CRAPO RO, 1981, AM REV RESPIR DIS, V123, P659; Espada R, 1999, CHEST, V116, P1750; Fletcher CM, 1976, NATURAL HIST CHRONIC; Gilliland FD, 2002, AM J RESP CRIT CARE, V166, P710, DOI 10.1164/rccm.2112065; Grol MH, 1999, AM J RESP CRIT CARE, V160, P1830, DOI 10.1164/ajrccm.160.6.9812100; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hautamaki RD, 1997, SCIENCE, V277, P2002, DOI 10.1126/science.277.5334.2002; He JQ, 2002, AM J RESP CRIT CARE, V166, P323, DOI 10.1164/rccm.2111059; Hersh CP, 2005, AM J RESP CELL MOL, V33, P71, DOI 10.1165/rcmb.2005-0073OC; Houghton AM, 2006, J CLIN INVEST, V116, P753, DOI 10.1172/JCI25617; Hunninghake GM, 2008, J ALLERGY CLIN IMMUN, V122, P93, DOI 10.1016/j.jaci.2008.03.015; Hunninghake GM, 2007, J ALLERGY CLIN IMMUN, V119, P654, DOI 10.1016/j.jaci.2006.12.609; HUNNINGHAKE GW, 1981, SCIENCE, V212, P925, DOI 10.1126/science.7233186; Joos L, 2002, HUM MOL GENET, V11, P569, DOI 10.1093/hmg/11.5.569; Jormsjo S, 2000, CIRC RES, V86, P998, DOI 10.1161/01.RES.86.9.998; Juul K, 2006, AM J RESP CRIT CARE, V173, P858, DOI 10.1164/rccm.200509-1387OC; Kenchaiah S, 2002, NEW ENGL J MED, V347, P305, DOI 10.1056/NEJMoa020245; Lange C, 2004, AM J HUM GENET, V74, P367, DOI 10.1086/381563; Lange C., 2004, STAT APPL GENET MOL, V3, P17, DOI [DOI 10.2202/1544-6115.1067, 10.2202/1544-6115.1067]; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Meigs JB, 2008, NEW ENGL J MED, V359, P2208, DOI 10.1056/NEJMoa0804742; NIEWOEHNER DE, 1974, NEW ENGL J MED, V291, P755, DOI 10.1056/NEJM197410102911503; ORIE N G, 1961, Ned Tijdschr Geneeskd, V105, P2136; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Sadeghnejad A, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-21; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Silverman EK, 1998, AM J RESP CRIT CARE, V157, P1770, DOI 10.1164/ajrccm.157.6.9706014; Simpson A, 2005, AM J RESP CRIT CARE, V172, P55, DOI 10.1164/rccm.200412-1708OC; Sood A, 2008, COPD, V5, P274, DOI 10.1080/15412550802363345; *STGEORG U LOND, GEN INF BRIT 1958 BI; Van Eerdewegh P, 2002, NATURE, V418, P426, DOI 10.1038/nature00878; Wickman M, 2002, PEDIATR ALLERGY IMMU, V13, P11, DOI 10.1034/j.1399-3038.13.s.15.10.x; Woodruff PG, 2005, AM J RESP CRIT CARE, V172, P1383, DOI 10.1164/rccm.200505-686OC; Wu LH, 2003, GENES CELLS, V8, P225, DOI 10.1046/j.1365-2443.2003.00628.x; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P1009, DOI 10.1016/j.bbrc.2007.10.121; Zheng T, 2000, J CLIN INVEST, V106, P1081, DOI 10.1172/JCI10458	40	244	260	1	47	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2599	2608		10.1056/NEJMoa0904006	http://dx.doi.org/10.1056/NEJMoa0904006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20018959	Green Accepted			2022-12-28	WOS:000273181300007
J	Sheridan, RL; Goldstein, MA; Stoddard, FJ; Walker, TG				Sheridan, Robert L.; Goldstein, Mark A.; Stoddard, Frederick J., Jr.; Walker, T. Gregory			A Boy with Hypothermia and Frostbite Stage 3 hypothermia. Stage 3 frostbite with diffuse distal small-vessel thrombosis and impending limb loss	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ALCOHOL-USE; ACCIDENTAL HYPOTHERMIA; ADOLESCENTS; INJURY; BEHAVIORS; AGE; INVOLVEMENT; DISORDERS; DRINKING; ONSET		[Sheridan, Robert L.; Stoddard, Frederick J., Jr.] Massachusetts Gen Hosp, Dept Surg, Burns Serv, Boston, MA 02114 USA; [Goldstein, Mark A.] Massachusetts Gen Hosp, Div Adolescent & Young Adult Med, Dept Pediat, Boston, MA 02114 USA; [Stoddard, Frederick J., Jr.] Massachusetts Gen Hosp, Dept Psychiat, Boston, MA 02114 USA; [Walker, T. Gregory] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Sheridan, Robert L.] Harvard Univ, Sch Med, Dept Surg, Cambridge, MA 02138 USA; [Goldstein, Mark A.] Harvard Univ, Sch Med, Dept Pediat, Cambridge, MA 02138 USA; [Stoddard, Frederick J., Jr.] Harvard Univ, Sch Med, Dept Psychiat, Cambridge, MA 02138 USA; [Walker, T. Gregory] Harvard Univ, Sch Med, Dept Radiol, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Sheridan, RL (corresponding author), Massachusetts Gen Hosp, Dept Surg, Burns Serv, Boston, MA 02114 USA.							*AM MED ASS, 1997, GUID AD PREV SERV GA; [Anonymous], NIH PUBLICATION; Ary DV, 1999, BEHAV RES THER, V37, P217, DOI 10.1016/S0005-7967(98)00133-8; Biederman J, 2000, PEDIATRICS, V106, P792, DOI 10.1542/peds.106.4.792; Braaten JV, 1997, THROMB HAEMOSTASIS, V78, P1063; Bruen KJ, 2007, ARCH SURG-CHICAGO, V142, P546, DOI 10.1001/archsurg.142.6.546; Bruen KJ, 2009, J HAND SURG-AM, V34A, P553, DOI 10.1016/j.jhsa.2009.01.012; Cohen JA, 2017, TREATING TRAUMA TRAU, V2nd; Costello EJ, 2007, DRUG ALCOHOL DEPEN, V88, pS50, DOI 10.1016/j.drugalcdep.2006.12.009; de Mesones AR, 2002, HIGH ALT MED BIOL, V3, P395, DOI 10.1089/15270290260512873; de Souza D, 2007, J ELECTROCARDIOL, V40, P47, DOI 10.1016/j.jelectrocard.2006.08.094; DeWit DJ, 2000, AM J PSYCHIAT, V157, P745, DOI 10.1176/appi.ajp.157.5.745; DiClemente RJ, 2001, PEDIATRICS, V107, P1363, DOI 10.1542/peds.107.6.1363; Faden Vivian B, 2004, Alcohol Res Health, V28, P107; Grueskin J, 2007, WILD ENVIRON MED, V18, P133, DOI 10.1580/06-WEME-BR-034R1.1; Hanewinkel R, 2009, PEDIATRICS, V123, P989, DOI 10.1542/peds.2008-1465; Hingson R, 2001, PEDIATRICS, V108, P872, DOI 10.1542/peds.108.4.872; Hingson RW, 2000, JAMA-J AM MED ASSOC, V284, P1527, DOI 10.1001/jama.284.12.1527; Johnston L. D., 2008, NIH PUBLICATION, VI; Jurkovich GJ, 2007, SURG CLIN N AM, V87, P247, DOI 10.1016/j.suc.2006.10.003; Krantz MJ, 2005, NEW ENGL J MED, V352, P184, DOI 10.1056/NEJMicm030851; Nash SG, 2005, J ADOLESCENT HEALTH, V37, P19, DOI 10.1016/j.jadohealth.2004.06.004; O'keeffe K M, 1977, JACEP, V6, P491, DOI 10.1016/S0361-1124(77)80387-0; OSBORN JJ, 1953, AM J PHYSIOL, V175, P389, DOI 10.1152/ajplegacy.1953.175.3.389; Petrone P, 2003, EMERG MED CLIN N AM, V21, P1165, DOI 10.1016/S0733-8627(03)00074-9; RANKIN AC, 1984, BRIT MED J, V289, P874, DOI 10.1136/bmj.289.6449.874; Sieving RE, 2000, J ADOLESCENT HEALTH, V26, P27, DOI 10.1016/S1054-139X(99)00056-7; Silfvast T, 2003, RESUSCITATION, V59, P285, DOI 10.1016/S0300-9572(03)00237-5; Simantov E, 2000, ARCH PEDIAT ADOL MED, V154, P1025, DOI 10.1001/archpedi.154.10.1025; Stoddard FJ, 2002, J BURN CARE REHABIL, V23, P135, DOI 10.1097/00004630-200203000-00012; Stoddard FJ, 2001, J AM ACAD CHILD PSY, V40, P1128, DOI 10.1097/00004583-200110000-00007; TOWNE WD, 1972, NEW ENGL J MED, V287, P1135, DOI 10.1056/NEJM197211302872210; Twomey JA, 2005, J TRAUMA, V59, P1350, DOI 10.1097/01.ta.0000195517.50778.2e; WONG KC, 1983, WESTERN J MED, V138, P227	34	34	34	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2654	2662		10.1056/NEJMcpc0910088	http://dx.doi.org/10.1056/NEJMcpc0910088			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042758				2022-12-28	WOS:000273181300015
J	Rebeiz, M; Pool, JE; Kassner, VA; Aquadro, CF; Carroll, SB				Rebeiz, Mark; Pool, John E.; Kassner, Victoria A.; Aquadro, Charles F.; Carroll, Sean B.			Stepwise Modification of a Modular Enhancer Underlies Adaptation in a Drosophila Population	SCIENCE			English	Article							MORPHOLOGICAL EVOLUTION; LACTASE PERSISTENCE; REGULATORY CHANGES; PROTEIN; PIGMENTATION; EBONY; GAIN	The evolution of cis regulatory elements (enhancers) of developmentally regulated genes plays a large role in the evolution of animal morphology. However, the mutational path of enhancer evolution-the number, origin, effect, and order of mutations that alter enhancer function-has not been elucidated. Here, we localized a suite of substitutions in a modular enhancer of the ebony locus responsible for adaptive melanism in a Ugandan Drosophila population. We show that at least five mutations with varied effects arose recently from a combination of standing variation and new mutations and combined to create an allele of large phenotypic effect. We underscore how enhancers are distinct macromolecular entities, subject to fundamentally different, and generally more relaxed, functional constraints relative to protein sequences.	[Rebeiz, Mark; Carroll, Sean B.] Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA; [Rebeiz, Mark; Carroll, Sean B.] Univ Wisconsin, Mol Biol Lab, Madison, WI 53706 USA; [Pool, John E.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Pool, John E.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA; [Aquadro, Charles F.] Cornell Univ, Dept Mol Biol & Genet, Ithaca, NY 14850 USA	Howard Hughes Medical Institute; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of California System; University of California Berkeley; University of California System; University of California Davis; Cornell University	Carroll, SB (corresponding author), Univ Wisconsin, Howard Hughes Med Inst, Madison, WI 53706 USA.	sbcarrol@wisc.edu		Pool, John/0000-0003-2968-9545; Rebeiz, Mark/0000-0001-5731-5570	NIH [F32GM78972, F32HG004182, GM036431]; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [F32HG004182] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM078972, R01GM036431] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank H. Dufour and T. Williams for discussions and comments on the manuscript and K. Vaccaro for technical assistance. This work was supported by NIH postdoctoral fellowships F32GM78972 ( M. R.) and F32HG004182 (J.E.P.), NIH grant GM036431 ( C. F. A.), and the Howard Hughes Medical Institute ( S. B. C.).	Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Bloom JD, 2005, P NATL ACAD SCI USA, V102, P606, DOI 10.1073/pnas.0406744102; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; CARROLL SB, 2005, DNA DIVERSITY MOL GE; Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030; Cretekos CJ, 2008, GENE DEV, V22, P141, DOI 10.1101/gad.1620408; Davidson EH, 2006, REG GEN GEN REG; Gompel N, 2005, NATURE, V433, P481, DOI 10.1038/nature03235; Jeong S, 2008, CELL, V132, P783, DOI 10.1016/j.cell.2008.01.014; Jeong S, 2006, CELL, V125, P1387, DOI 10.1016/j.cell.2006.04.043; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Olds LC, 2003, HUM MOL GENET, V12, P2333, DOI 10.1093/hmg/ddg244; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Pool JE, 2007, MOL ECOL, V16, P2844, DOI 10.1111/j.1365-294X.2007.03324.x; Prabhakar S, 2008, SCIENCE, V321, P1346, DOI 10.1126/science.1159974; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; Richardt A, 2003, J BIOL CHEM, V278, P41160, DOI 10.1074/jbc.M304303200; Rockman MV, 2005, PLOS BIOL, V3, P2208, DOI 10.1371/journal.pbio.0030387; Stern DL, 2008, EVOLUTION, V62, P2155, DOI 10.1111/j.1558-5646.2008.00450.x; Tishkoff SA, 2007, NAT GENET, V39, P31, DOI 10.1038/ng1946; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Weinreich DM, 2006, SCIENCE, V312, P111, DOI 10.1126/science.1123539; Williams TM, 2008, CELL, V134, P610, DOI 10.1016/j.cell.2008.06.052; Wittkopp PJ, 2008, NAT GENET, V40, P346, DOI 10.1038/ng.77; Wittkopp PJ, 2002, DEVELOPMENT, V129, P1849; Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063	26	183	184	0	60	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1663	1667		10.1126/science.1178357	http://dx.doi.org/10.1126/science.1178357			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	20019281	Green Accepted			2022-12-28	WOS:000272839000045
J	Macilwain, C				Macilwain, Colin			World view: Out of service	NATURE			English	Editorial Material												cfmworldview@gmail.com							0	1	1	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					846	846		10.1038/462846a	http://dx.doi.org/10.1038/462846a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533AX	20016573	Bronze			2022-12-28	WOS:000272795400016
J	Morris, JR; Boutell, C; Keppler, M; Densham, R; Weekes, D; Alamshah, A; Butler, L; Galanty, Y; Pangon, L; Kiuchi, T; Ng, T; Solomon, E				Morris, Joanna R.; Boutell, Chris; Keppler, Melanie; Densham, Ruth; Weekes, Daniel; Alamshah, Amin; Butler, Laura; Galanty, Yaron; Pangon, Laurent; Kiuchi, Tai; Ng, Tony; Solomon, Ellen			The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress	NATURE			English	Article							UBIQUITIN STRUCTURES; LIGASE ACTIVITY; TARGETS BRCA1; DNA-REPAIR; ACTIVATION; BINDING; SUMOYLATION; COMPLEX; UBIQUITYLATION; BRCA1-BARD1	Mutations in BRCA1 are associated with a high risk of breast and ovarian cancer. BRCA1 participates in the DNA damage response and acts as a ubiquitin ligase. However, its regulation remains poorly understood. Here we report that BRCA1 is modified by small ubiquitin-like modifier ( SUMO) in response to genotoxic stress, and co-localizes at sites of DNA damage with SUMO1, SUMO2/3 and the SUMO-conjugating enzyme Ubc9. PIAS SUMO E3 ligases co-localize with and modulate SUMO modification of BRCA1, and are required for BRCA1 ubiquitin ligase activity in cells. In vitro SUMO modification of the BRCA1/BARD1 heterodimer greatly increases its ligase activity, identifying it as a SUMO-regulated ubiquitin ligase (SRUbL). Further, PIAS SUMO ligases are required for complete accumulation of double-stranded DNA (dsDNA) damage-repair proteins subsequent to RNF8 accrual, and for proficient double-strand break repair. These data demonstrate that the SUMOylation pathway plays a significant role in mammalian DNA damage response.	[Morris, Joanna R.; Densham, Ruth; Weekes, Daniel; Alamshah, Amin; Butler, Laura; Pangon, Laurent; Solomon, Ellen] Kings Coll London, Dept Med & Mol Genet, London SE1 9RT, England; [Boutell, Chris] MRC, Virol Unit, Glasgow G11 5JR, Lanark, Scotland; [Keppler, Melanie; Kiuchi, Tai; Ng, Tony] Kings Coll London, Richard Dimbleby Dept Canc Res, Randall Div Cell & Mol Biophys, London SE1 1UL, England; [Galanty, Yaron] Univ Cambridge, Wellcome Trust Canc Res UK Gurdon Inst, Cambridge CB2 1QN, England; [Galanty, Yaron] Univ Cambridge, Dept Zool, Cambridge CB2 1QN, England	University of London; King's College London; University of London; King's College London; University of Cambridge; University of Cambridge	Morris, JR (corresponding author), Kings Coll London, Dept Med & Mol Genet, Guys Med Sch Campus, London SE1 9RT, England.	jo.morris@genetics.kcl.ac.uk	Morris, Joanna/AAK-3388-2021; Densham, Ruth/AAO-1971-2020	Densham, Ruth/0000-0003-4490-2842; Ng, Tony/0000-0003-3894-5619; Boutell, Chris/0000-0002-2970-7785; Morris, Joanna/0000-0001-9762-8133; Weekes, Daniel/0000-0001-8083-7617; , Laura/0000-0001-7508-9650; Galanty, Yaron/0000-0001-7167-9004	Breast Cancer Campaign [SF06, 06NovPHD13Morris]; Cancer Research UK [C8820/A9494]; Medical Research Council [6900577]; Richard Dimbleby Cancer Fund; Breakthrough Breast Cancer; MRC Co-operative Group [G0100152, 56891]; UK Research Councils Basic Technology Research Programme [GR/R87901/01]; MRC [G9600577] Funding Source: UKRI; Engineering and Physical Sciences Research Council [GR/R87901/01] Funding Source: researchfish; Medical Research Council [G9600577] Funding Source: researchfish	Breast Cancer Campaign; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Richard Dimbleby Cancer Fund; Breakthrough Breast Cancer; MRC Co-operative Group(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); UK Research Councils Basic Technology Research Programme; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We are grateful to V. De Laurenzi for the PIAS1 expression constructs, to R. Hay for His-SUMO1 and His-SUMO2 cells, to D. Durocher for anti-RNF168 antibody, to G. Stewart for discussions and S. Jackson for sharing results before publication. The work was supported by grants from Breast Cancer Campaign ( to J.R.M.,A.A., # SF06, and L. B., # 06NovPHD13Morris), Cancer Research UK ( to R. D., # C8820/A9494), the Medical Research Council ( to E. S. and D. W., # 6900577, and C. B.), the Richard Dimbleby Cancer Fund to King's College London ( to M. K. and T. N.) and Breakthrough Breast Cancer ( to T. K). Multiphoton FLIM systems and acquisition/analysis software were built by S. Ameer-Beg, P. Barber and B. Vojnovic, with support from MRC Co-operative Group Grant G0100152 # 56891 and UK Research Councils Basic Technology Research Programme Grant GR/R87901/01.	Barber PR, 2005, PROC SPIE, V5700, P171, DOI 10.1117/12.590510; Bennardo N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000110; Bin W, 2007, P NATL ACAD SCI USA, V104, P20759, DOI 10.1073/pnas.0710061104; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Bossis G, 2006, MOL CELL, V21, P349, DOI 10.1016/j.molcel.2005.12.019; Boulton SJ, 2004, CURR BIOL, V14, P33, DOI 10.1016/j.cub.2003.11.029; Boutell C, 2003, J VIROL, V77, P8686, DOI 10.1128/JVI.77.16.8686-8694.2003; Boutell C, 2002, J VIROL, V76, P841, DOI 10.1128/JVI.76.2.841-850.2002; Brzovic PS, 2003, P NATL ACAD SCI USA, V100, P5646, DOI 10.1073/pnas.0836054100; Christensen DE, 2007, NAT STRUCT MOL BIOL, V14, P941, DOI 10.1038/nsmb1295; Dadke S, 2007, NAT CELL BIOL, V9, P80, DOI 10.1038/ncb1522; Doil C, 2009, CELL, V136, P435, DOI 10.1016/j.cell.2008.12.041; Ganesan S, 2006, P NATL ACAD SCI USA, V103, P4089, DOI 10.1073/pnas.0509922103; Hashizume R, 2001, J BIOL CHEM, V276, P14537, DOI 10.1074/jbc.C000881200; Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012; Huen MSY, 2007, CELL, V131, P901, DOI 10.1016/j.cell.2007.09.041; Ishiai M, 2004, MOL CELL BIOL, V24, P10733, DOI 10.1128/MCB.24.24.10733-10741.2004; Jaffray EG, 2006, METHODS, V38, P35, DOI 10.1016/j.ymeth.2005.07.020; Kim HT, 2008, MOL CELLS, V25, P457; Kim H, 2007, NAT STRUCT MOL BIOL, V14, P710, DOI 10.1038/nsmb1277; Kim H, 2007, SCIENCE, V316, P1202, DOI 10.1126/science.1139621; Kolas NK, 2007, SCIENCE, V318, P1637, DOI 10.1126/science.1150034; Liu ZX, 2007, NAT STRUCT MOL BIOL, V14, P716, DOI 10.1038/nsmb1279; Lorick KL, 1999, P NATL ACAD SCI USA, V96, P11364, DOI 10.1073/pnas.96.20.11364; Mabb AM, 2006, NAT CELL BIOL, V8, P986, DOI 10.1038/ncb1458; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Mallery DL, 2002, EMBO J, V21, P6755, DOI 10.1093/emboj/cdf691; Manke IA, 2003, SCIENCE, V302, P636, DOI 10.1126/science.1088877; Mo YY, 2004, CANCER RES, V64, P2793, DOI 10.1158/0008-5472.CAN-03-2410; Morris JR, 2006, HUM MOL GENET, V15, P599, DOI 10.1093/hmg/ddi476; Morris JR, 2004, HUM MOL GENET, V13, P807, DOI 10.1093/hmg/ddh095; Munarriz E, 2004, MOL CELL BIOL, V24, P10593, DOI 10.1128/MCB.24.24.10593-10610.2004; Ng T, 1999, SCIENCE, V283, P2085, DOI 10.1126/science.283.5410.2085; NISHIKAWA H, 2003, J BIOL CHEM; Park MA, 2008, NUCLEIC ACIDS RES, V36, P263, DOI 10.1093/nar/gkm969; Peter M, 2005, BIOPHYS J, V88, P1224, DOI 10.1529/biophysj.104.050153; Peter M, 2004, BIOL CELL, V96, P231, DOI 10.1016/j.biolcel.2003.12.006; Polanowska J, 2006, EMBO J, V25, P2178, DOI 10.1038/sj.emboj.7601102; Potts PR, 2005, MOL CELL BIOL, V25, P7021, DOI 10.1128/MCB.25.16.7021-7032.2005; Prag S, 2007, MOL BIOL CELL, V18, P2935, DOI 10.1091/mbc.E06-11-1031; Reid LJ, 2008, P NATL ACAD SCI USA, V105, P20876, DOI 10.1073/pnas.0811203106; Schmidt D, 2003, CELL MOL LIFE SCI, V60, P2561, DOI 10.1007/s00018-003-3129-1; Sobhian B, 2007, SCIENCE, V316, P1198, DOI 10.1126/science.1139516; Solomon E, 2009, CANCER GENET-SER, P75, DOI 10.1007/978-1-4419-0477-5_4; Stewart GS, 2009, CELL, V136, P420, DOI 10.1016/j.cell.2008.12.042; Wang B, 2007, SCIENCE, V316, P1194, DOI 10.1126/science.1139476; Wu-Baer F, 2003, J BIOL CHEM, V278, P34743, DOI 10.1074/jbc.C300249200; Yan J, 2007, CANCER RES, V67, P6647, DOI 10.1158/0008-5472.CAN-07-0924; Zhao GY, 2007, MOL CELL, V25, P663, DOI 10.1016/j.molcel.2007.01.029; Zhao XL, 2005, P NATL ACAD SCI USA, V102, P4777, DOI 10.1073/pnas.0500537102	50	314	335	1	53	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					886	U77		10.1038/nature08593	http://dx.doi.org/10.1038/nature08593			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016594				2022-12-28	WOS:000272795400035
J	Rehman, H; Seguin, A				Rehman, Habib; Seguin, Aimee			Frostbite.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Rehman, Habib; Seguin, Aimee] Regina QuAppelle Hlth Reg, Regina, SK, Canada		Rehman, H (corresponding author), Regina QuAppelle Hlth Reg, Regina, SK, Canada.								0	0	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2009	361	25					2461	2461		10.1056/NEJMicm0801077	http://dx.doi.org/10.1056/NEJMicm0801077			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	533CE	20018967				2022-12-28	WOS:000272798900010
J	Rogozov, V; Bermel, N				Rogozov, Vladislav; Bermel, Neil			Christmas 2009 Auto-appendectomy in the Antarctic: case report	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Rogozov, Vladislav] Sheffield Teaching Hosp, Dept Anaesthet, Sheffield S10 2JF, S Yorkshire, England; [Rogozov, Vladislav] Inst Clin & Expt Med, Cardiac Ctr, Dept Anaesthesiol & Resuscitat, Prague 14021, Czech Republic; [Bermel, Neil] Univ Sheffield, Dept Russian & Slavon Studies, Sheffield S3 7RA, S Yorkshire, England	University of Sheffield; Institute for Clinical & Experimental Medicine (IKEM); University of Sheffield	Rogozov, V (corresponding author), Sheffield Teaching Hosp, Dept Anaesthet, Sheffield S10 2JF, S Yorkshire, England.	v.rogozov@sheffield.ac.uk						Frost JG, 1936, J AMER MED ASSOC, V106, P1708, DOI 10.1001/jama.1936.02770200014005; GERBOVICH VI, 2007, FRAGMENT DIARIES 5 P, P63; RENNIE D, 1987, JAMA-J AM MED ASSOC, V257, P825, DOI 10.1001/jama.257.6.825; Rogozov, 2004, VESMIR, V1, P25; ROGOZOV LI, 1964, SOVIET ANTARCTIC EXP, V4, P223; ROGOZOV LI, 1962, BJULLETEN SOVIETSKOJ, V37, P42	6	8	8	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 15	2009	339								b4965	10.1136/bmj.b4965	http://dx.doi.org/10.1136/bmj.b4965			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534XG	20008968				2022-12-28	WOS:000272930200002
J	Bignami, GF				Bignami, Giovanni F.			Two Missions, One Microquasar	SCIENCE			English	Editorial Material									[Bignami, Giovanni F.] IUSS, I-27100 Pavia, Italy; [Bignami, Giovanni F.] Accademia Lincei, I-00165 Rome, Italy	IUSS PAVIA	Bignami, GF (corresponding author), IUSS, Lungoticino Sforza 56, I-27100 Pavia, Italy.	giovanni.bignami@gmail.com		Bignami, Giovanni/0000-0001-9582-2450				Abdo AA, 2009, SCIENCE, V326, P1512, DOI 10.1126/science.1182174; BIGNAMI GF, 1977, ASTRON ASTROPHYS, V55, P155; GIACCONI R, 1967, ASTROPHYS J, V148, pL119, DOI 10.1086/180028; TAVANI M, NATURE; VANKERKWIJK MH, 1992, NATURE, V355, P703, DOI 10.1038/355703a0; Vilhu O, 2003, ASTRON ASTROPHYS, V411, pL405, DOI 10.1051/0004-6361:20031257	6	1	1	0	1	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1490	1491		10.1126/science.1184534	http://dx.doi.org/10.1126/science.1184534			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007889				2022-12-28	WOS:000272623600043
J	Ren, Y; Yip, CK; Tripathi, A; Huie, D; Jeffrey, PD; Walz, T; Hughson, FM				Ren, Yi; Yip, Calvin K.; Tripathi, Arati; Huie, David; Jeffrey, Philip D.; Walz, Thomas; Hughson, Frederick M.			A Structure-Based Mechanism for Vesicle Capture by the Multisubunit Tethering Complex Dsl1	CELL			English	Article							ENDOPLASMIC RETICULUM RETRIEVAL; CRYSTAL-STRUCTURE; SNARE COMPLEX; TRANSPORT-VESICLE; PROTEIN-STRUCTURE; YEAST; EXOCYST; INTERACTS; COMPONENT; SUBUNIT	Vesicle trafficking requires membrane fusion, mediated by SNARE proteins, and upstream events that probably include "tethering,'' an initial long-range attachment between a vesicle and its target organelle. Among the factors proposed to mediate tethering are a set of multisubunit tethering complexes (MTCs). The Dsl1 complex, with only three subunits, is the simplest known MTC and is essential for the retrograde traffic of COPI-coated vesicles from the Golgi to the ER. To elucidate structural principles underlying MTC function, we have determined the structure of the Dsl1 complex, revealing a tower containing at its base the binding sites for two ER SNAREs and at its tip a flexible lasso for capturing vesicles. The Dsl1 complex binds to individual SNAREs via their N-terminal regulatory domains and also to assembled SNARE complexes; moreover, it is capable of accelerating SNARE complex assembly. Our results suggest that even the simplest MTC may be capable of orchestrating vesicle capture, uncoating, and fusion.	[Ren, Yi; Tripathi, Arati; Huie, David; Jeffrey, Philip D.; Hughson, Frederick M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA; [Yip, Calvin K.; Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Walz, Thomas] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Princeton University; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Hughson, FM (corresponding author), Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA.	hughson@princeton.edu		Walz, Thomas/0000-0003-2606-2835; Jeffrey, Philip/0000-0002-4351-5341; Yip, Calvin/0000-0003-1779-9501	National Institutes of Health [GM071574]; Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071574] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Jane Coffin Childs Memorial Fund for Medical Research; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge the staff of the National Synchrotron Light Source X29 beamline for assistance with x-ray data collection; Zong Lin and Hays Rye for assistance and discussion regarding fluorescence anisotropy experiments; Hans Dieter Schmitt for sharing results prior to publication; and Sean Munro, Mary Munson, Anne Spang, and Daniel Ungar for critical comments on the manuscript. This work was supported by a grant to F. M. H. from the National Institutes of Health (GM071574). C.K.Y. acknowledges a fellowship from the Jane Coffin Childs Memorial Fund for Medical Research. T. W. is an investigator of the Howard Hughes Medical Institute.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Andag U, 2003, J BIOL CHEM, V278, P51722, DOI 10.1074/jbc.M308740200; Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200; Aoki T, 2008, BIOCHEM J, V410, P93, DOI 10.1042/BJ20071304; Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694; Burri L, 2003, P NATL ACAD SCI USA, V100, P9873, DOI 10.1073/pnas.1734000100; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Cavanaugh LF, 2007, J BIOL CHEM, V282, P23418, DOI 10.1074/jbc.M703716200; Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DeLano W.L, PYMOL MOL GRAPHICS S; Dilcher M, 2003, EMBO J, V22, P3664, DOI 10.1093/emboj/cdg339; Dong G, 2005, NAT STRUCT MOL BIOL, V12, P1094, DOI 10.1038/nsmb1017; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030; Gillingham AK, 2003, BBA-MOL CELL RES, V1641, P71, DOI 10.1016/S0167-4889(03)00088-0; Hamburger ZA, 2006, J MOL BIOL, V356, P9, DOI 10.1016/j.jmb.2005.09.099; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Kamena F, 2004, SCIENCE, V304, P286, DOI 10.1126/science.1095049; Kim YG, 2006, CELL, V127, P817, DOI 10.1016/j.cell.2006.09.029; Koumandou VL, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-29; Kraynack BA, 2005, MOL BIOL CELL, V16, P3963, DOI 10.1091/mbc.E05-01-0056; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Moore BA, 2007, J MOL BIOL, V371, P410, DOI 10.1016/j.jmb.2007.05.018; Munson M, 2000, NAT STRUCT BIOL, V7, P894; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ohi Melanie, 2004, Biol Proced Online, V6, P23, DOI 10.1251/bpo70; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pfeffer SR, 1999, NAT CELL BIOL, V1, pE17, DOI 10.1038/8967; Reilly BA, 2001, MOL BIOL CELL, V12, P3783, DOI 10.1091/mbc.12.12.3783; Rice LM, 1999, MOL CELL, V4, P85, DOI 10.1016/S1097-2765(00)80190-2; Richardson BC, 2009, P NATL ACAD SCI USA, V106, P13329, DOI 10.1073/pnas.0901966106; Scheich C, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm067; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Sivaram MVS, 2005, BIOCHEMISTRY-US, V44, P6302, DOI 10.1021/bi048008z; Sivaram MVS, 2006, NAT STRUCT MOL BIOL, V13, P555, DOI 10.1038/nsmb1096; SWEET DJ, 1993, EMBO J, V12, P2831, DOI 10.1002/j.1460-2075.1993.tb05944.x; Sztul E, 2006, AM J PHYSIOL-CELL PH, V290, pC11, DOI 10.1152/ajpcell.00293.2005; Tochio H, 2001, SCIENCE, V293, P698, DOI 10.1126/science.1062950; Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548; Ungar D, 2003, ANNU REV CELL DEV BI, V19, P493, DOI 10.1146/annurev.cellbio.19.110701.155609; VanRheenen SM, 2001, TRAFFIC, V2, P212, DOI 10.1034/j.1600-0854.2001.020307.x; Whyte JRC, 2002, J CELL SCI, V115, P2627; Wu SY, 2005, NAT STRUCT MOL BIOL, V12, P879, DOI 10.1038/nsmb987; Zink S, 2009, DEV CELL, V17, P403, DOI 10.1016/j.devcel.2009.07.012	45	116	118	1	11	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 11	2009	139	6					1119	1129		10.1016/j.cell.2009.11.002	http://dx.doi.org/10.1016/j.cell.2009.11.002			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005805	Green Accepted, Bronze			2022-12-28	WOS:000272622800014
J	Gostissa, M; Yan, CT; Bianco, JM; Cogne, M; Pinaud, E; Alt, FW				Gostissa, Monica; Yan, Catherine T.; Bianco, Julia M.; Cogne, Michel; Pinaud, Eric; Alt, Frederick W.			Long-range oncogenic activation of Igh-c-myc translocations by the Igh 3 ' regulatory region	NATURE			English	Article							HEAVY-CHAIN LOCUS; CLASS-SWITCH RECOMBINATION; B-CELL DEVELOPMENT; CHROMOSOMAL TRANSLOCATIONS; V(D)J RECOMBINATION; GENE AMPLIFICATION; TRANSGENIC MICE; DNA BREAKS; END; MECHANISM	B-cell malignancies, such as human Burkitt's lymphoma, often contain translocations that link c-myc or other proto-oncogenes to the immunoglobulin heavy chain locus (IgH, encoded by Igh)(1). The nature of elements that activate oncogenes within such translocations has been a long-standing question. Translocations within Igh involve DNA double-strand breaks initiated either by the RAG1/2 endonuclease during variable, diversity and joining gene segment (V(D)J) recombination, or by activation-induced cytidine deaminase (AID, also known as AICDA) during class switch recombination (CSR)(2-4). V(D)J recombination in progenitor B (pro-B) cells assembles Igh variable region exons upstream of mu constant region (C mu) exons, which are the first of several sets of CH exons ('C-H genes') within a CH locus that span several hundred kilobases (kb)(5,6). In mature B cells, CSR deletes C mu and replaces it with a downstream C-H gene(6). An intronic enhancer (iE mu) between the variable region exons and C mu promotes V(D)J recombination in developing B cells(7). Furthermore, the Igh 3' regulatory region (Igh3' RR) lies downstream of the C-H locus and modulates CSR by long-range transcriptional enhancement of C-H genes(8-10). Transgenic mice bearing iE mu or Igh3' RR sequences fused to c-myc are predisposed to B lymphomas, demonstrating that such elements can confer oncogenic c-myc expression(11-16). However, in many B-cell lymphomas, Igh-c-myc translocations delete iE mu and place c-myc up to 200 kb upstream of the Igh3' RR1. Here we address the oncogenic role of the Igh3' RR by inactivating it in two distinct mouse models for B-cell lymphoma with Igh-c-myc translocations. We show that the Igh3' RR is dispensable for pro-B-cell lymphomas with V( D) J recombination-initiated translocations, but is required for peripheral B-cell lymphomas with CSR-associated translocations. As the Igh3' RR is not required for CSR-associated Igh breaks or Igh-c-myc translocations in peripheral B-cell lymphoma progenitors, we conclude that this regulatory region confers oncogenic activity by long-range and developmental stage-specific activation of translocated c-myc genes.	[Gostissa, Monica; Yan, Catherine T.; Bianco, Julia M.; Alt, Frederick W.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Gostissa, Monica; Yan, Catherine T.; Bianco, Julia M.; Alt, Frederick W.] Harvard Univ, Sch Med, Childrens Hosp, Boston, MA 02115 USA; [Gostissa, Monica; Yan, Catherine T.; Bianco, Julia M.; Alt, Frederick W.] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Gostissa, Monica; Yan, Catherine T.; Bianco, Julia M.; Alt, Frederick W.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Cogne, Michel; Pinaud, Eric] Univ Limoges, CNRS, Fac Med, UMR 6101, Limoges, France	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Harvard University; Harvard Medical School; Centre National de la Recherche Scientifique (CNRS); Universite de Limoges	Alt, FW (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA.	alt@enders.tch.harvard.edu	PINAUD, Eric/O-8443-2016; cogné, michel/D-7370-2015	PINAUD, Eric/0000-0001-7405-9273; cogné, michel/0000-0002-8519-4427	National Institutes of Health (NIH) [CA92625]; Leukemia and Lymphoma Society of America (LLS) SCORE; NCI; de Villiers International Achievement Award; Fondation pour la Recherche Medicale; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [P01CA092625] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society of America (LLS) SCORE(Leukemia and Lymphoma Society); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); de Villiers International Achievement Award; Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. G. Jiang for help with cloning translocation breakpoints. This work was supported by National Institutes of Health (NIH) grant CA92625 and the Leukemia and Lymphoma Society of America (LLS) SCORE grant to F. W. A. M. G. was a Special Fellow of the LLS and C.T.Y. was supported by an NCI training grant. M. G. and C. T. Y. were also supported by the de Villiers International Achievement Award of the LLS to F. W. A. E. P. was a Fellow of the Fondation pour la Recherche Medicale. F. W. A. is an Investigator of the Howard Hughes Medical Institute.	ADAMS JM, 1985, NATURE, V318, P533, DOI 10.1038/318533a0; Bassing CH, 2002, CELL, V109, pS45, DOI 10.1016/S0092-8674(02)00675-X; Chaudhuri Jayanta, 2007, Adv Immunol, V94, P157, DOI 10.1016/S0065-2776(06)94006-1; COGNE M, 1994, CELL, V77, P737, DOI 10.1016/0092-8674(94)90057-4; DARIAVACH P, 1991, EUR J IMMUNOL, V21, P1499, DOI 10.1002/eji.1830210625; Difilippantonio MJ, 2002, J EXP MED, V196, P469, DOI 10.1084/jem.20020851; Franco S, 2006, MOL CELL, V21, P201, DOI 10.1016/j.molcel.2006.01.005; Frank KM, 2000, MOL CELL, V5, P993, DOI 10.1016/S1097-2765(00)80264-6; Henderson A, 1998, ANNU REV IMMUNOL, V16, P163, DOI 10.1146/annurev.immunol.16.1.163; Janz S, 2006, DNA REPAIR, V5, P1213, DOI 10.1016/j.dnarep.2006.05.017; Khamlichi AA, 2000, ADV IMMUNOL, V75, P317, DOI 10.1016/S0065-2776(00)75008-5; Kuppers R, 2001, ONCOGENE, V20, P5580, DOI 10.1038/sj.onc.1204640; Lieber MR, 2008, J BIOL CHEM, V283, P1, DOI 10.1074/jbc.R700039200; Lieber MR, 2006, DNA REPAIR, V5, P1234, DOI 10.1016/j.dnarep.2006.05.013; LIEBERSON R, 1991, NUCLEIC ACIDS RES, V19, P933, DOI 10.1093/nar/19.4.933; MADISEN L, 1994, GENE DEV, V8, P2212, DOI 10.1101/gad.8.18.2212; Manis JP, 2002, TRENDS IMMUNOL, V23, P31, DOI 10.1016/S1471-4906(01)02111-1; NERI A, 1988, P NATL ACAD SCI USA, V85, P2748, DOI 10.1073/pnas.85.8.2748; Pinaud E, 2001, IMMUNITY, V15, P187, DOI 10.1016/S1074-7613(01)00181-9; Ramiro Almudena, 2007, Adv Immunol, V94, P75, DOI 10.1016/S0065-2776(06)94003-6; Ramiro AR, 2006, NATURE, V440, P105, DOI 10.1038/nature04495; Robbiani DF, 2008, CELL, V135, P1028, DOI 10.1016/j.cell.2008.09.062; SCHMIDT EV, 1988, P NATL ACAD SCI USA, V85, P6047, DOI 10.1073/pnas.85.16.6047; Truffinet V, 2007, J IMMUNOL, V179, P6033, DOI 10.4049/jimmunol.179.9.6033; Wang JH, 2005, J BIOL CHEM, V280, P12766, DOI 10.1074/jbc.M412446200; Wang JH, 2009, NATURE, V460, P231, DOI 10.1038/nature08159; Wang JH, 2008, J EXP MED, V205, P3079, DOI 10.1084/jem.20082271; Yan CT, 2007, NATURE, V449, P478, DOI 10.1038/nature06020; Yan Y, 2007, GENE CHROMOSOME CANC, V46, P950, DOI 10.1002/gcc.20480; Zhu CM, 2002, CELL, V109, P811, DOI 10.1016/S0092-8674(02)00770-5	30	65	69	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					803	U128		10.1038/nature08633	http://dx.doi.org/10.1038/nature08633			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010689	Green Accepted			2022-12-28	WOS:000272559900042
J	Haji-Akbari, A; Engel, M; Keys, AS; Zheng, XY; Petschek, RG; Palffy-Muhoray, P; Glotzer, SC				Haji-Akbari, Amir; Engel, Michael; Keys, Aaron S.; Zheng, Xiaoyu; Petschek, Rolfe G.; Palffy-Muhoray, Peter; Glotzer, Sharon C.			Disordered, quasicrystalline and crystalline phases of densely packed tetrahedra	NATURE			English	Article							PACKINGS	All hard, convex shapes are conjectured by Ulam to pack more densely than spheres(1), which have a maximum packing fraction of phi = pi/root 18 approximate to 0.7405. Simple lattice packings of many shapes easily surpass this packing fraction(2,3). For regular tetrahedra, this conjecture was shown to be true only very recently; an ordered arrangement was obtained via geometric construction with phi = 0.7786 (ref. 4), which was subsequently compressed numerically to phi = 0.7820 (ref. 5), while compressing with different initial conditions led to phi = 0.8230 ( ref. 6). Here we show that tetrahedra pack even more densely, and in a completely unexpected way. Following a conceptually different approach, using thermodynamic computer simulations that allow the system to evolve naturally towards high-density states, we observe that a fluid of hard tetrahedra undergoes a first-order phase transition to a dodecagonal quasicrystal(7-10), which can be compressed to a packing fraction of phi = 0.8324. By compressing a crystalline approximant of the quasicrystal, the highest packing fraction we obtain is phi = 0.8503. If quasicrystal formation is suppressed, the system remains disordered, jams and compresses to phi = 0.7858. Jamming and crystallization are both preceded by an entropy-driven transition from a simple fluid of independent tetrahedra to a complex fluid characterized by tetrahedra arranged in densely packed local motifs of pentagonal dipyramids that form a percolating network at the transition. The quasicrystal that we report represents the first example of a quasicrystal formed from hard or non-spherical particles. Our results demonstrate that particle shape and entropy can produce highly complex, ordered structures.	[Haji-Akbari, Amir; Engel, Michael; Keys, Aaron S.; Glotzer, Sharon C.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Glotzer, Sharon C.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Palffy-Muhoray, Peter] Kent State Univ, Inst Liquid Crystal, Kent, OH 44242 USA; [Zheng, Xiaoyu] Kent State Univ, Dept Math Sci, Kent, OH 44242 USA; [Petschek, Rolfe G.] Case Western Reserve Univ, Dept Phys, Cleveland, OH 44106 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; University System of Ohio; Kent State University; Kent State University Kent; Kent State University Salem; Case Western Reserve University	Glotzer, SC (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	sglotzer@umich.edu	Engel, Michael/G-1778-2010; Keys, Aaron/A-2572-2012; Haji-Akbari, Amir/G-7969-2011	Engel, Michael/0000-0002-7031-3825; Petschek, Rolfe/0000-0002-9334-3461; Haji-Akbari, Amir/0000-0002-2228-6957	The Air Force Office of Scientific Research; The National Science Foundation; Deutsche Forschungsgemeinschaft; Direct For Mathematical & Physical Scien [0807954] Funding Source: National Science Foundation	The Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); The National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	The Air Force Office of Scientific Research supported A. H.-A., P. P.-M. and S. C. G. The National Science Foundation supported A. S. K., A. H.-A. and S. C. G. in the shape-matching analyses that identified local motifs. M. E. was supported by a postdoctoral fellowship of the Deutsche Forschungsgemeinschaft.	Betke U, 2000, COMP GEOM-THEOR APPL, V16, P157, DOI 10.1016/S0925-7721(00)00007-9; Bolhuis P, 1997, J CHEM PHYS, V106, P666, DOI 10.1063/1.473404; Camp PJ, 1997, J CHEM PHYS, V106, P6681, DOI 10.1063/1.473665; Chen ER, 2008, DISCRETE COMPUT GEOM, V40, P214, DOI 10.1007/s00454-008-9101-y; Conrad M, 1998, ANGEW CHEM INT EDIT, V37, P1384, DOI 10.1002/(SICI)1521-3773(19980605)37:10<1383::AID-ANIE1383>3.0.CO;2-R; Conway JH, 2006, P NATL ACAD SCI USA, V103, P10612, DOI 10.1073/pnas.0601389103; Donev A, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.255506; Engel M, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.225505; FEL LG, 1995, PHYS REV E, V52, P702, DOI 10.1103/PhysRevE.52.702; FRANK FC, 1958, ACTA CRYSTALLOGR, V11, P184, DOI 10.1107/S0365110X58000487; Gardner M, 2001, COLOSSAL BOOK MATH C, P135; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Hales TC, 2006, DISCRETE COMPUT GEOM, V36, P5, DOI 10.1007/s00454-005-1210-2; Hales TC, 2005, ANN MATH, V162, P1065, DOI 10.4007/annals.2005.162.1065; Hayashida K, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.195502; John BS, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2819091; KALLUS Y, 2009, DENSE PERIODIC PACKI; Keys AS, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.235503; Kirkwood J. E., 1951, PHASE TRANSFORMATION, P67; KOLAFA J, 1995, MOL PHYS, V84, P421, DOI 10.1080/00268979500100281; Mikhael J, 2008, NATURE, V454, P501, DOI 10.1038/nature07074; ONSAGER L, 1949, ANN NY ACAD SCI, V51, P627, DOI 10.1111/j.1749-6632.1949.tb27296.x; Roth J, 2000, PHYS REV E, V61, P6845, DOI 10.1103/PhysRevE.61.6845; Steurer W, 2005, ACTA CRYSTALLOGR A, V61, P28, DOI 10.1107/S0108767304019269; Talapin DV, 2009, NATURE, V461, P964, DOI 10.1038/nature08439; Tang ZY, 2006, SCIENCE, V314, P274, DOI 10.1126/science.1128045; Torquato S, 2009, PHYS REV E, V80, DOI 10.1103/PhysRevE.80.041104; Torquato S, 2009, NATURE, V460, P876, DOI 10.1038/nature08239; VEERMAN JAC, 1992, PHYS REV A, V45, P5632, DOI 10.1103/PhysRevA.45.5632; Yamamoto A, 1996, ACTA CRYSTALLOGR A, V52, P509, DOI 10.1107/S0108767396000967; Zeng XB, 2004, NATURE, V428, P157, DOI 10.1038/nature02368	32	314	314	4	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					773	U91		10.1038/nature08641	http://dx.doi.org/10.1038/nature08641			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010683	Green Submitted			2022-12-28	WOS:000272559900035
J	Cui, HG; Pashuck, ET; Velichko, YS; Weigand, SJ; Cheetham, AG; Newcomb, CJ; Stupp, SI				Cui, Honggang; Pashuck, E. Thomas; Velichko, Yuri S.; Weigand, Steven J.; Cheetham, Andrew G.; Newcomb, Christina J.; Stupp, Samuel I.			Spontaneous and X-ray-Triggered Crystallization at Long Range in Self-Assembling Filament Networks	SCIENCE			English	Article							RADIATION-DAMAGE; LIPID-MEMBRANES; PROTEINS; MECHANOTRANSDUCTION; CONDENSATION; MESOPHASES; SCATTERING; CRYSTAL; ORDER	We report here crystallization at long range in networks of like-charge supramolecular peptide filaments mediated by repulsive forces. The crystallization is spontaneous beyond a given concentration of the molecules that form the filaments but can be triggered by x-rays at lower concentrations. The crystalline domains formed by x-ray irradiation, with interfilament separations of up to 320 angstroms, can be stable for hours after the beam is turned off, and ions that screen charges on the filaments suppress ordering. We hypothesize that the stability of crystalline domains emerges from a balance of repulsive tensions linked to native or x-ray-induced charges and the mechanical compressive entrapment of filaments within a network. Similar phenomena may occur naturally in the cytoskeleton of cells and, if induced externally in biological or artificial systems, lead to possible biomedical and lithographic functions.	[Cui, Honggang; Pashuck, E. Thomas; Velichko, Yuri S.; Newcomb, Christina J.; Stupp, Samuel I.] Northwestern Univ, Dept Mat Sci & Engn, Evanston, IL 60208 USA; [Weigand, Steven J.] Northwestern Univ, APS, Argonne Natl Lab, Synchrotron Res Ctr,DND CAT, Argonne, IL 60439 USA; [Cheetham, Andrew G.; Stupp, Samuel I.] Northwestern Univ, Inst BioNanotechnol Med, Chicago, IL 60611 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA; [Stupp, Samuel I.] Northwestern Univ, Dept Med, Evanston, IL 60208 USA	Northwestern University; Northwestern University; United States Department of Energy (DOE); Argonne National Laboratory; Northwestern University; Northwestern University; Northwestern University	Stupp, SI (corresponding author), Northwestern Univ, Dept Mat Sci & Engn, 2220 Campus Dr, Evanston, IL 60208 USA.	s-stupp@northwestern.edu	Velichko, Yuri/D-8596-2011; Cui, Honggang/C-6550-2008; Pashuck, E./AAG-1741-2021; Cui, Honggang/E-8012-2010; Weigand, Steven/G-6181-2015; Pashuck, Eugene/ABC-2634-2021; Stupp, Samuel/AGV-1942-2022; Stupp, Samuel/B-6737-2009	Weigand, Steven/0000-0003-3137-0672; Pashuck III, Eugene/0000-0003-2881-4965; Cheetham, Andrew/0000-0002-9933-9877; Velichko, Yury S/0000-0002-2287-5727	U.S. Department of Energy [DE-FG02-00ER45810]; E. I. DuPont de Nemours and Company; Dow Chemical Company; state of Illinois; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NIH National Institute of Dental and Craniofacial Research [5R01 DE015920]; NSF [DMR-0605427]; Direct For Mathematical & Physical Scien [1006713] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [U54CA119341] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE015920] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); E. I. DuPont de Nemours and Company; Dow Chemical Company; state of Illinois; U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NSF(National Science Foundation (NSF)); Direct For Mathematical & Physical Scien(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the U.S. Department of Energy (grant no. DE-FG02-00ER45810). The SAXS experiments were performed at the DND-CAT located at Sector 5 of the APS. DND-CAT is supported by E. I. DuPont de Nemours and Company, Dow Chemical Company, and the state of Illinois. Use of the APS was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract no. DE-AC02-06CH11357. Some additional support for this work was obtained from NIH National Institute of Dental and Craniofacial Research grant 5R01 DE015920 and NSF grant DMR-0605427. We thank the Biological Imaging Facility (BIF) at Northwestern for the use of TEM equipment.	Bathe M, 2008, BIOPHYS J, V94, P2955, DOI 10.1529/biophysj.107.119743; Bloomfield VA, 1997, BIOPOLYMERS, V44, P269, DOI 10.1002/(SICI)1097-0282(1997)44:3<269::AID-BIP6>3.0.CO;2-T; Cheng AC, 1996, BIOPHYS J, V70, P2212, DOI 10.1016/S0006-3495(96)79787-4; Cherezov V, 2002, J SYNCHROTRON RADIAT, V9, P333, DOI 10.1107/S0909049502014528; Chu B, 2001, CHEM REV, V101, P1727, DOI 10.1021/cr9900376; Collet E, 2003, SCIENCE, V300, P612, DOI 10.1126/science.1082001; Gardel ML, 2004, SCIENCE, V304, P1301, DOI 10.1126/science.1095087; GARRISON WM, 1987, CHEM REV, V87, P381, DOI 10.1021/cr00078a006; Hartgerink JD, 2001, SCIENCE, V294, P1684, DOI 10.1126/science.1063187; Ingber DE, 1997, ANNU REV PHYSIOL, V59, P575, DOI 10.1146/annurev.physiol.59.1.575; Lee SW, 2002, SCIENCE, V296, P892, DOI 10.1126/science.1068054; Lipfert J, 2007, ANNU REV BIOPH BIOM, V36, P307, DOI 10.1146/annurev.biophys.36.040306.132655; Nakata M, 2007, SCIENCE, V318, P1276, DOI 10.1126/science.1143826; NAVE C, 1995, RADIAT PHYS CHEM, V45, P483, DOI 10.1016/0969-806X(95)92800-E; Needleman DJ, 2004, P NATL ACAD SCI USA, V101, P16099, DOI 10.1073/pnas.0406076101; PARSEGIAN VA, 2005, VANDERWAALS; Pelletier O, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.148102; Pelta J, 1996, BIOPHYS J, V71, P48, DOI 10.1016/S0006-3495(96)79232-9; Pizzey CL, 2008, J CHEM PHYS, V129, DOI 10.1063/1.2955745; Ravelli RBG, 2000, STRUCTURE, V8, P315, DOI 10.1016/S0969-2126(00)00109-X; Song WH, 2003, SCIENCE, V302, P1363, DOI 10.1126/science.1089764; STARK G, 1991, BIOCHIM BIOPHYS ACTA, V1071, P103, DOI 10.1016/0304-4157(91)90020-W; Teng TY, 2000, J SYNCHROTRON RADIAT, V7, P313, DOI 10.1107/S0909049500008694; Velichko YS, 2008, J PHYS CHEM B, V112, P2326, DOI 10.1021/jp074420n; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; Weik M, 2000, P NATL ACAD SCI USA, V97, P623, DOI 10.1073/pnas.97.2.623	26	140	143	0	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					555	559		10.1126/science.1182340	http://dx.doi.org/10.1126/science.1182340			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	549CT	20019248	Green Accepted			2022-12-28	WOS:000274020500031
J	Boekholdt, SM; Kastelein, JJP				Boekholdt, S. Matthijs; Kastelein, John J. P.			C-reactive protein and cardiovascular risk: more fuel to the fire	LANCET			English	Editorial Material							INFLAMMATION; PREVENTION; PREDICTION; MARKERS		[Boekholdt, S. Matthijs] Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Netherlands; [Kastelein, John J. P.] Acad Med Ctr, Dept Vasc Med, NL-1100 DD Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	Boekholdt, SM (corresponding author), Acad Med Ctr, Dept Cardiol, NL-1100 DD Amsterdam, Netherlands.	S.M.Boekholdt@amc.uva.nl	Boekholdt, Matthijs S.M./G-7562-2014; Kastelein, John/AAF-7950-2020	Boekholdt, Matthijs/0000-0002-0861-0765				Bisoendial RJ, 2007, ATHEROSCLEROSIS, V195, pE10, DOI 10.1016/j.atherosclerosis.2007.04.053; Casas JP, 2006, INT J EPIDEMIOL, V35, P922, DOI 10.1093/ije/dyl041; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Cook NR, 2006, ANN INTERN MED, V145, P21, DOI 10.7326/0003-4819-145-1-200607040-00128; Danesh J, 2004, NEW ENGL J MED, V350, P1387, DOI 10.1056/NEJMoa032804; Elliott P, 2009, JAMA-J AM MED ASSOC, V302, P37, DOI 10.1001/jama.2009.954; Kaptoge S, 2010, LANCET, V375, P132, DOI 10.1016/S0140-6736(09)61717-7; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; LIUZZO G, 1994, NEW ENGL J MED, V331, P417, DOI 10.1056/NEJM199408183310701; Pearson TA, 2003, CIRCULATION, V107, P499, DOI 10.1161/01.CIR.0000052939.59093.45; Rana JS, 2009, HEART, V95, P1682, DOI 10.1136/hrt.2009.170134; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2009, LANCET, V373, P1175, DOI 10.1016/S0140-6736(09)60447-5; Ridker PM, 2001, NEW ENGL J MED, V344, P1959, DOI 10.1056/NEJM200106283442601	14	19	22	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2010	375	9709					95	96		10.1016/S0140-6736(09)62098-5	http://dx.doi.org/10.1016/S0140-6736(09)62098-5			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	544NM	20031200				2022-12-28	WOS:000273664500004
J	Ratnieks, FLW; Carreck, NL				Ratnieks, Francis L. W.; Carreck, Norman L.			Clarity on Honey Bee Collapse?	SCIENCE			English	Editorial Material							APIS-MELLIFERA; DISORDER		[Ratnieks, Francis L. W.; Carreck, Norman L.] Univ Sussex, Lab Apiculture & Social Insects, Dept Biol & Environm Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Ratnieks, FLW (corresponding author), Univ Sussex, Lab Apiculture & Social Insects, Dept Biol & Environm Sci, Brighton BN1 9QG, E Sussex, England.	f.ratnieks@sussex.ac.uk; norman.carreck@sussex.ac.uk	Carreck, Norman/AAN-6995-2021	Carreck, Norman/0000-0001-7779-9736				Ball B., 1997, Varroa! fight the mite., P11; Carreck N., 2005, P 39 INT AP C AUG 21, P32; Carreck N. L., 2002, APIACTA, V37, P44; CARRECK NL, 2009, P 41 INT AP C MONTP, P146; CCD Steering Committee, 2009, COL COLL DIS PROGR R; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Malone LA, 2001, APIDOLOGIE, V32, P287, DOI 10.1051/apido:2001130; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Maus Christian, 2003, Bulletin of Insectology, V56, P51; Mixon T, 2009, SCI BEE CULTURE, V1, P22; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Paxton RJ, 2010, J APICULT RES, V49, P80, DOI 10.3896/IBRA.1.49.1.11; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481	16	200	213	3	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 8	2010	327	5962					152	153		10.1126/science.1185563	http://dx.doi.org/10.1126/science.1185563			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056879				2022-12-28	WOS:000273394000021
J	Fournier, JC; DeRubeis, RJ; Hollon, SD; Dimidjian, S; Amsterdam, JD; Shelton, RC; Fawcett, J				Fournier, Jay C.; DeRubeis, Robert J.; Hollon, Steven D.; Dimidjian, Sona; Amsterdam, Jay D.; Shelton, Richard C.; Fawcett, Jan			Antidepressant Drug Effects and Depression Severity A Patient-Level Meta-analysis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Review							PLACEBO RUN-IN; RATING-SCALE; HAMILTON DEPRESSION; COGNITIVE THERAPY; RANDOMIZED-TRIAL; INITIAL SEVERITY; DYSTHYMIA; EFFICACY; MODERATE	Context Antidepressant medications represent the best established treatment for major depressive disorder, but there is little evidence that they have a specific pharmacological effect relative to pill placebo for patients with less severe depression. Objective To estimate the relative benefit of medication vs placebo across a wide range of initial symptom severity in patients diagnosed with depression. Data Sources PubMed, PsycINFO, and the Cochrane Library databases were searched from January 1980 through March 2009, along with references from meta-analyses and reviews. Study Selection Randomized placebo-controlled trials of antidepressants approved by the Food and Drug Administration in the treatment of major or minor depressive disorder were selected. Studies were included if their authors provided the requisite original data, they comprised adult outpatients, they included a medication vs placebo comparison for at least 6 weeks, they did not exclude patients on the basis of a placebo washout period, and they used the Hamilton Depression Rating Scale (HDRS). Data from 6 studies (718 patients) were included. Data Extraction Individual patient-level data were obtained from study authors. Results Medication vs placebo differences varied substantially as a function of baseline severity. Among patients with HDRS scores below 23, Cohen d effect sizes for the difference between medication and placebo were estimated to be less than 0.20 (a standard definition of a small effect). Estimates of the magnitude of the superiority of medication over placebo increased with increases in baseline depression severity and crossed the threshold defined by the National Institute for Clinical Excellence for a clinically significant difference at a baseline HDRS score of 25. Conclusions The magnitude of benefit of antidepressant medication compared with placebo increases with severity of depression symptoms and may be minimal or nonexistent, on average, in patients with mild or moderate symptoms. For patients with very severe depression, the benefit of medications over placebo is substantial. JAMA. 2010; 303(1): 47-53	[Fournier, Jay C.; DeRubeis, Robert J.] Univ Penn, Dept Psychol, Philadelphia, PA 19104 USA; [Amsterdam, Jay D.] Univ Penn, Dept Psychiat, Philadelphia, PA 19104 USA; [Hollon, Steven D.] Vanderbilt Univ, Dept Psychol, Nashville, TN 37240 USA; [Shelton, Richard C.] Vanderbilt Univ, Dept Psychiat, Nashville, TN USA; [Dimidjian, Sona] Univ Colorado, Dept Psychol, Boulder, CO 80309 USA; [Fawcett, Jan] Univ New Mexico, Sch Med, Dept Psychiat, Albuquerque, NM 87131 USA	University of Pennsylvania; University of Pennsylvania; Vanderbilt University; Vanderbilt University; University of Colorado System; University of Colorado Boulder; University of New Mexico	Fournier, JC (corresponding author), Univ Penn, Dept Psychol, 3720 Walnut St, Philadelphia, PA 19104 USA.	jcf@sas.upenn.edu	Fournier, Jay/AAG-8452-2019	Fournier, Jay/0000-0001-8967-1668; DeRubeis, Robert/0000-0003-3129-0277	National Institute of Mental Health, Bethesda, Maryland [MH50129 (R10), MH55875 (R10), MH01697 (K02), MH01741 (K24), MH060998 (R01)]; NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH001697, R10MH055877, R01MH060998, K24MH001741, R10MH055875] Funding Source: NIH RePORTER	National Institute of Mental Health, Bethesda, Maryland(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Funding/Support: This research was supported by grants MH50129 (R10), MH55875 (R10), MH01697 (K02), MH01741 (K24), and MH060998 (R01) from the National Institute of Mental Health, Bethesda, Maryland.	*AM PSYCH ASS TASK, 2000, HDB PSYCH MEAS; Bagby RM, 2004, AM J PSYCHIAT, V161, P2163, DOI 10.1176/appi.ajp.161.12.2163; BALDWIN D, 1995, CNS DRUGS, V4, P422, DOI 10.2165/00023210-199504060-00005; Barret JE, 2001, J FAM PRACTICE, V50, P405; BENJAMIN LS, 1963, PSYCHOSOM MED, V25, P556, DOI 10.1097/00006842-196311000-00005; Cohen J., 2013, STAT POWER ANAL BEHA, DOI DOI 10.4324/9780203771587; De Lima MS, 1999, PSYCHOL MED, V29, P1273, DOI 10.1017/S0033291799001324; DeRubeis RJ, 2005, ARCH GEN PSYCHIAT, V62, P409, DOI 10.1001/archpsyc.62.4.409; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Dunner DL, 2001, J CLIN PSYCHIAT, V62, P10; ELKIN I, 1989, ARCH GEN PSYCHIAT, V46, P971; FISHER S, 1965, PSYCHOPHARMACOLOGIA, V7, P57, DOI 10.1007/BF00404165; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hollon SD, 2002, PSYCHOL SCI, P39, DOI 10.1111/1529-1006.00008; Khan A, 2002, J CLIN PSYCHOPHARM, V22, P40, DOI 10.1097/00004714-200202000-00007; KHAN A, 1991, NEUROPSYCHOPHARMACOL, V4, P125; Kirsch I, 2008, PLOS MED, V5, P260, DOI 10.1371/journal.pmed.0050045; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; Landin R, 2000, BIOMETRICS, V56, P271, DOI 10.1111/j.0006-341X.2000.00271.x; Lee S, 2004, DEPRESS ANXIETY, V19, P10, DOI 10.1002/da.10134; National Institute for Clinical Excellence, 2004, DEPR MAN DEPR PRIM S; Philipp M, 1999, BRIT MED J, V319, P1534, DOI 10.1136/bmj.319.7224.1534; Steinberg KK, 1997, AM J EPIDEMIOL, V145, P917; TRIVEDI MH, 1994, NEUROPSYCHOPHARMACOL, V11, P33, DOI 10.1038/npp.1994.63; Turner Erick H, 2008, N Engl J Med, V358, P252, DOI 10.1056/NEJMsa065779; *US DEP HHS, 1999, AHCPR PUBL; *US DEP HHS, 1993, AHCPR PUBL; Wichers MC, 2009, NEUROPSYCHOPHARMACOL, V34, P923, DOI 10.1038/npp.2008.66; Zimmerman M, 2005, J CLIN PSYCHOPHARM, V25, P105, DOI 10.1097/01.jcp.0000155824.59585.46; Zimmerman M, 2002, J CLIN PSYCHOPHARM, V22, P610, DOI 10.1097/00004714-200212000-00011	30	1259	1288	6	327	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2010	303	1					47	53		10.1001/jama.2009.1943	http://dx.doi.org/10.1001/jama.2009.1943			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539YS	20051569	Green Accepted			2022-12-28	WOS:000273296900018
J	Ford, MK; Beattie, WS; Wijeysundera, DN				Ford, Meredith K.; Beattie, W. Scott; Wijeysundera, Duminda N.			Systematic Review: Prediction of Perioperative Cardiac Complications and Mortality by the Revised Cardiac Risk Index	ANNALS OF INTERNAL MEDICINE			English	Review							MAJOR NONCARDIAC SURGERY; RANDOMIZED CONTROLLED-TRIAL; ABDOMINAL AORTIC-ANEURYSMS; DIAGNOSTIC-TEST ACCURACY; BETA-BLOCKER THERAPY; VASCULAR-SURGERY; NATRIURETIC PEPTIDE; MYOCARDIAL-INFARCTION; ELDERLY-PATIENTS; TROPONIN-I	Background: The Revised Cardiac Risk Index (RCRI) is widely used to predict perioperative cardiac complications. Purpose: To evaluate the ability of the RCRI to predict cardiac complications and death after noncardiac surgery. Data Sources: MEDLINE, EMBASE, and ISI Web of Science (1966 to 31 December 2008). Study Selection: Cohort studies that reported the association of the RCRI with major cardiac complications (cardiac death, myocardial infarction, and nonfatal cardiac arrest) or death in the hospital or within 30 days of surgery. Data Extraction: Two reviewers independently extracted study characteristics, documented outcome data, and evaluated study quality. Data Synthesis: Of 24 studies (792 740 patients), 18 reported cardiac complications; 6 of the 18 studies were prospective and had uniform outcome surveillance and blinded outcome adjudication. The RCRI discriminated moderately well between patients at low versus high risk for cardiac events after mixed noncardiac surgery (area under the receiver-operating characteristic curve [AUC], 0.75 [95% CI, 0.72 to 0.79]); sensitivity, 0.65 [CI, 0.46 to 0.81]; specificity, 0.76 [CI, 0.58 to 0.88]; positive likelihood ratio, 2.78 [CI, 1.74 to 4.45]; negative likelihood ratio, 0.45 [CI, 0.31 to 0.67]). Prediction of cardiac events after vascular noncardiac surgery was less accurate (AUC, 0.64 [CI, 0.61 to 0.66]; sensitivity, 0.70 [CI, 0.53 to 0.82]; specificity, 0.55 [CI, 0.45 to 0.66]; positive likelihood ratio, 1.56 [CI, 1.42 to 1.73]; negative likelihood ratio, 0.55 [CI, 0.40 to 0.76]). Six studies reported death, with a median AUC of 0.62 (range, 0.54 to 0.78). A pooled AUC for predicting death could not be calculated because of very high heterogeneity (I-2 = 95%). Limitation: Studies generally were of low methodological quality, had varied definitions of cardiac events, and were statistically and clinically heterogeneous. Conclusion: The RCRI discriminated moderately well between patients at low versus high risk for cardiac events after mixed noncardiac surgery. It did not perform well at predicting cardiac events after vascular noncardiac surgery or at predicting death. High-quality research is needed in this area of perioperative medicine.	[Wijeysundera, Duminda N.] Toronto Gen Hosp, Dept Anesthesia, Toronto, ON M5G 2C4, Canada; Univ Toronto, Toronto, ON M5G 2C4, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto	Wijeysundera, DN (corresponding author), Toronto Gen Hosp, Dept Anesthesia, EN 3-450,200 Elizabeth St, Toronto, ON M5G 2C4, Canada.	d.wijeysundera@utoronto.ca	Beattie, William Scott/A-4352-2008; Wijeysundera, Duminda/L-3350-2018	Wijeysundera, Duminda/0000-0002-5897-8605	Abbott Laboratories; Canadian Anesthesiologists' Society; Canadian Institutes of Health; Department of Anesthesia at the University of Toronto	Abbott Laboratories(Abbott Laboratories); Canadian Anesthesiologists' Society; Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR)); Department of Anesthesia at the University of Toronto(University of Toronto)	In part by a Fellowship in Anesthesia from Abbott Laboratories and the Canadian Anesthesiologists' Society (Dr. Ford) and by a Clinician Scientist award from the Canadian Institutes of Health Research and a Merit Award from the Department of Anesthesia at the University of Toronto (Dr. Wijeysundera). Dr. Beattie is the R. Fraser Elliot Chair of Cardiac Anesthesia at the University Health Network.	Alexander S, 2008, J CARDIOVASC SURG, V49, P633; Ausset S, 2008, EUR J ANAESTH, V25, P158, DOI 10.1017/S0265021507001202; Austin PC, 2004, J CLIN EPIDEMIOL, V57, P1138, DOI 10.1016/j.jclinepi.2004.04.003; Boersma E, 2001, JAMA-J AM MED ASSOC, V285, P1865, DOI 10.1001/jama.285.14.1865; Boersma E, 2005, AM J MED, V118, P1134, DOI 10.1016/j.amjmed.2005.01.064; Bossuyt PM, 2003, ANN INTERN MED, V138, P40, DOI 10.7326/0003-4819-138-1-200301070-00010; Cuthbertson BH, 2007, BRIT J ANAESTH, V99, P170, DOI 10.1093/bja/aem158; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DETSKY AS, 1986, J GEN INTERN MED, V1, P211, DOI 10.1007/BF02596184; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Deville Walter L, 2002, BMC Med Res Methodol, V2, P9, DOI 10.1186/1471-2288-2-9; Filipovic M, 2003, J AM COLL CARDIOL, V42, P1767, DOI 10.1016/j.jacc.2003.05.008; Fisher BW, 2008, ANESTH ANALG, V107, P149, DOI 10.1213/ane.0b013e31817c6186; Fleischmann KE, 2003, AM J MED, V115, P515, DOI 10.1016/S0002-9343(03)00474-1; Fleisher LA, 2007, CIRCULATION, V116, pE418, DOI 10.1161/CIRCULATIONAHA.107.185699; GOLDMAN L, 1977, NEW ENGL J MED, V297, P845, DOI 10.1056/NEJM197710202971601; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Harbord RM, 2009, METAANALYSIS STATA U, P181; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; JAESCHKE R, 1994, JAMA-J AM MED ASSOC, V271, P703, DOI 10.1001/jama.271.9.703; Janes H, 2008, ANN INTERN MED, V149, P751, DOI 10.7326/0003-4819-149-10-200811180-00009; Justice AC, 1999, ANN INTERN MED, V130, P515, DOI 10.7326/0003-4819-130-6-199903160-00016; Karkos CD, 2002, J VASC SURG, V35, P943, DOI 10.1067/mva.2002.121982; Kertai MD, 2005, ARCH INTERN MED, V165, P898, DOI 10.1001/archinte.165.8.898; Kertai MD, 2004, AM J MED, V116, P8, DOI 10.1016/j.amjmed.2003.07.012; Kumar R, 2001, J GEN INTERN MED, V16, P507, DOI 10.1046/j.1525-1497.2001.016008507.x; Landesberg G, 2003, J AM COLL CARDIOL, V42, P1547, DOI 10.1016/j.jacc.2003.05.001; Laupacis A, 1997, JAMA-J AM MED ASSOC, V277, P488, DOI 10.1001/jama.277.6.488; Le Manach Y, 2005, ANESTHESIOLOGY, V102, P885, DOI 10.1097/00000542-200505000-00004; Lee TH, 1999, CIRCULATION, V100, P1043, DOI 10.1161/01.CIR.100.10.1043; Leeflang MMG, 2008, ANN INTERN MED, V149, P889, DOI 10.7326/0003-4819-149-12-200812160-00008; Leibowitz D, 2008, CARDIOLOGY, V110, P266, DOI 10.1159/000112411; Lindenauer PK, 2005, NEW ENGL J MED, V353, P349, DOI 10.1056/NEJMoa041895; Maia Paula C, 2008, Rev Port Cardiol, V27, P321; Moran PJ, 2008, ANAESTH INTENS CARE, V36, P167, DOI 10.1177/0310057X0803600205; Neary WD, 2007, BRIT J SURG, V94, P1300, DOI 10.1002/bjs.5809; Polanczyk CA, 2001, ANN INTERN MED, V134, P637, DOI 10.7326/0003-4819-134-8-200104170-00008; Press MJ, 2006, ARCH INTERN MED, V166, P914, DOI 10.1001/archinte.166.8.914; Rajagopalan S, 2008, J VASC SURG, V48, P912, DOI 10.1016/j.jvs.2008.05.015; Rathore SS, 2003, CIRCULATION, V107, P811, DOI 10.1161/01.CIR.0000049743.45748.02; Reilly DF, 1999, ARCH INTERN MED, V159, P2185, DOI 10.1001/archinte.159.18.2185; Rutter CM, 2001, STAT MED, V20, P2865, DOI 10.1002/sim.942; Schouten O, 2006, J VASC SURG, V44, P435, DOI 10.1016/j.jvs.2006.05.020; SCHWARZER G, 2009, R FDN STAT COMPUTING; Smetana GW, 2006, ANN INTERN MED, V144, P581, DOI 10.7326/0003-4819-144-8-200604180-00009; Stroup DF, 2000, JAMA-J AM MED ASSOC, V283, P2008, DOI 10.1001/jama.283.15.2008; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Team RC., 2022, LANG ENV STAT COMP; Klei WA, 2007, ANN SURG, V246, P165, DOI 10.1097/01.sla.0000261737.62514.63; VIECHTBAUER W, 2006, R FDN STAT COMPUTING; Visser JJ, 2006, J VASC SURG, V44, P1148, DOI 10.1016/j.jvs.2006.08.018; Weiser TG, 2008, LANCET, V372, P139, DOI 10.1016/S0140-6736(08)60878-8; Wijeysundera DN, 2006, ANESTHESIOLOGY, V104, P65, DOI 10.1097/00000542-200601000-00012; Yang H, 2006, AM HEART J, V152, P983, DOI 10.1016/j.ahj.2006.07.024; Yun KH, 2008, CIRC J, V72, P195, DOI 10.1253/circj.72.195; Zahid M, 2005, AM J CARDIOL, V96, P436, DOI 10.1016/j.amjcard.2005.03.095	56	289	303	0	20	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2010	152	1					26	W7		10.7326/0003-4819-152-1-201001050-00007	http://dx.doi.org/10.7326/0003-4819-152-1-201001050-00007			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543FJ	20048269				2022-12-28	WOS:000273556600004
J	Low, HH; Sachse, C; Amos, LA; Lowe, J				Low, Harry H.; Sachse, Carsten; Amos, Linda A.; Lowe, Jan			Structure of a Bacterial Dynamin-like Protein Lipid Tube Provides a Mechanism For Assembly and Membrane Curving	CELL			English	Article							CRYSTAL-STRUCTURE; MITOCHONDRIAL FUSION; BINDING PROTEINS; GTPASE DOMAIN; CONSTRICTION; RESOLUTION; MODEL; CONFORMATION; CYTOSKELETON; INSTABILITY	Proteins of the dynamin superfamily mediate membrane fission, fusion, and restructuring events by polymerizing upon lipid bilayers and forcing regions of high curvature. In this work, we show the electron cryomicroscopy reconstruction of a bacterial dynamin-like protein (BDLP) helical filament decorating a lipid tube at similar to 11 angstrom resolution. We fitted the BDLP crystal structure and produced a molecular model for the entire filament. The BDLP GTPase domain dimerizes and forms the tube surface, the GTPase effector domain (GED) mediates self-assembly, and the paddle region contacts the lipids and promotes curvature. Association of BDLP with GMPPNP and lipid induces radical, large-scale conformational changes affecting polymerization. Nucleotide hydrolysis seems therefore to be coupled to polymer disassembly and dissociation from lipid, rather than membrane restructuring. Observed structural similarities with rat dynamin 1 suggest that our results have broad implication for other dynamin family members.	[Low, Harry H.; Sachse, Carsten; Amos, Linda A.; Lowe, Jan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Low, HH (corresponding author), Univ London Birkbeck Coll, Sch Crystallog, Malet St, London WC1E 7HX, England.	h.low@mail.cryst.bbk.ac.uk; jyl@mrc-lmb.cam.ac.uk	Sachse, Carsten/AAY-9384-2020; Sachse, Carsten/H-2727-2012; Low, Harry/T-4482-2019; Löwe, Jan/X-6998-2019; Löwe, Jan/B-3882-2011	Sachse, Carsten/0000-0002-1168-5143; Sachse, Carsten/0000-0002-1168-5143; Lowe, Jan/0000-0002-5218-6615; Amos, Linda/0000-0001-8305-5346	Biotechnology and Biological Sciences Research Council [BBF0062841]; European Molecular Biology Organization long-term fellowship; Biotechnology and Biological Sciences Research Council [BB/F006284/1] Funding Source: researchfish; Medical Research Council [MC_U105184326, MC_U105184313] Funding Source: researchfish; BBSRC [BB/F006284/1] Funding Source: UKRI; MRC [MC_U105184326, MC_U105184313] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	H.L. was supported by Biotechnology and Biological Sciences Research Council grant BBF0062841. C.S. is supported by a European Molecular Biology Organization long-term fellowship. We would like to thank Christopher P. Mercogliano (MRC-LMB) for help with electron cryomicroscopy and Shaoxia Chen (MRC-LMB) for help and support with the electron microscopes.	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Fritz S, 2001, J CELL BIOL, V152, P683, DOI 10.1083/jcb.152.4.683; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Griffin EE, 2006, J BIOL CHEM, V281, P16599, DOI 10.1074/jbc.M601847200; Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Lowe J, 2004, ANNU REV BIOPH BIOM, V33, P177, DOI 10.1146/annurev.biophys.33.110502.132647; Lowe J, 2009, INT J BIOCHEM CELL B, V41, P323, DOI 10.1016/j.biocel.2008.08.010; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mozdy AD, 2003, NAT REV MOL CELL BIO, V4, P468, DOI 10.1038/nrm1125; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Narayanan R, 2005, J CELL BIOL, V169, P117, DOI 10.1083/jcb.200502042; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Okamoto PM, 1999, J BIOL CHEM, V274, P10277, DOI 10.1074/jbc.274.15.10277; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Wang WK, 2001, ACTA CRYSTALLOGR D, V57, P545, DOI 10.1107/S0907444901002529; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	42	125	127	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1342	1352		10.1016/j.cell.2009.11.003	http://dx.doi.org/10.1016/j.cell.2009.11.003			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064379	hybrid, Green Published			2022-12-28	WOS:000273048700021
J	Wu, DY; Hugenholtz, P; Mavromatis, K; Pukall, R; Dalin, E; Ivanova, NN; Kunin, V; Goodwin, L; Wu, M; Tindall, BJ; Hooper, SD; Pati, A; Lykidis, A; Spring, S; Anderson, IJ; D'haeseleer, P; Zemla, A; Singer, M; Lapidus, A; Nolan, M; Copeland, A; Han, C; Chen, F; Cheng, JF; Lucas, S; Kerfeld, C; Lang, E; Gronow, S; Chain, P; Bruce, D; Rubin, EM; Kyrpides, NC; Klenk, HP; Eisen, JA				Wu, Dongying; Hugenholtz, Philip; Mavromatis, Konstantinos; Pukall, Ruediger; Dalin, Eileen; Ivanova, Natalia N.; Kunin, Victor; Goodwin, Lynne; Wu, Martin; Tindall, Brian J.; Hooper, Sean D.; Pati, Amrita; Lykidis, Athanasios; Spring, Stefan; Anderson, Iain J.; D'haeseleer, Patrik; Zemla, Adam; Singer, Mitchell; Lapidus, Alla; Nolan, Matt; Copeland, Alex; Han, Cliff; Chen, Feng; Cheng, Jan-Fang; Lucas, Susan; Kerfeld, Cheryl; Lang, Elke; Gronow, Sabine; Chain, Patrick; Bruce, David; Rubin, Edward M.; Kyrpides, Nikos C.; Klenk, Hans-Peter; Eisen, Jonathan A.			A phylogeny-driven genomic encyclopaedia of Bacteria and Archaea	NATURE			English	Article							MICROBIAL DIVERSITY; PROTEIN FAMILIES; DATABASE GOLD; PROJECTS; SEQUENCE	Sequencing of bacterial and archaeal genomes has revolutionized our understanding of the many roles played by microorganisms(1). There are now nearly 1,000 completed bacterial and archaeal genomes available(2), most of which were chosen for sequencing on the basis of their physiology. As a result, the perspective provided by the currently available genomes is limited by a highly biased phylogenetic distribution(3-5). To explore the value added by choosing microbial genomes for sequencing on the basis of their evolutionary relationships, we have sequenced and analysed the genomes of 56 culturable species of Bacteria and Archaea selected to maximize phylogenetic coverage. Analysis of these genomes demonstrated pronounced benefits ( compared to an equivalent set of genomes randomly selected from the existing database) in diverse areas including the reconstruction of phylogenetic history, the discovery of new protein families and biological properties, and the prediction of functions for known genes from other organisms. Our results strongly support the need for systematic 'phylogenomic' efforts to compile a phylogeny-driven 'Genomic Encyclopedia of Bacteria and Archaea' in order to derive maximum knowledge from existing microbial genome data as well as from genome sequences to come.	[Wu, Dongying; Hugenholtz, Philip; Mavromatis, Konstantinos; Dalin, Eileen; Ivanova, Natalia N.; Kunin, Victor; Hooper, Sean D.; Pati, Amrita; Lykidis, Athanasios; Anderson, Iain J.; D'haeseleer, Patrik; Lapidus, Alla; Nolan, Matt; Copeland, Alex; Chen, Feng; Cheng, Jan-Fang; Lucas, Susan; Kerfeld, Cheryl; Chain, Patrick; Rubin, Edward M.; Kyrpides, Nikos C.; Eisen, Jonathan A.] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Wu, Dongying; Singer, Mitchell; Eisen, Jonathan A.] Univ Calif Davis, Davis, CA 95616 USA; [Pukall, Ruediger; Tindall, Brian J.; Spring, Stefan; Lang, Elke; Gronow, Sabine; Klenk, Hans-Peter] Deutsch Sammlung Mikroorganism Zellkultur GmbH, German Collect Microorganisms & Cell Cultures, D-38124 Braunschweig, Germany; [Goodwin, Lynne; Han, Cliff; Chain, Patrick; Bruce, David] Los Alamos Natl Lab, DOE Joint Genome Inst, Los Alamos, NM 87545 USA; [D'haeseleer, Patrik; Zemla, Adam] Univ Virginia, Charlottesville, VA 22904 USA; [Wu, Martin] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	United States Department of Energy (DOE); University of California System; University of California Davis; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); United States Department of Energy (DOE); Los Alamos National Laboratory; University of Virginia; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Eisen, JA (corresponding author), DOE Joint Genome Inst, Walnut Creek, CA 94598 USA.	jaeisen@ucdavis.edu	Chain, Patrick/O-4140-2019; Lapidus, Alla L/I-4348-2013; Kyrpides, Nikos C./A-6305-2014; Spring, Stefan/N-6933-2013; Hugenholtz, Philip/AAD-9138-2019; Eisen, Jonathan A./H-2706-2019; chain, patrick/B-9777-2013	Chain, Patrick/0000-0003-3949-3634; Lapidus, Alla L/0000-0003-0427-8731; Kyrpides, Nikos C./0000-0002-6131-0462; Spring, Stefan/0000-0001-6247-0938; Hugenholtz, Philip/0000-0001-5386-7925; Eisen, Jonathan A./0000-0002-0159-2197; Han, Cliff/0000-0003-1972-0692; Wu, Martin/0000-0003-3093-4077; Kunin, Victor/0000-0002-8741-7866; Ivanova, Natalia/0000-0002-5802-9485; Mavrommatis, Konstantinos/0000-0003-4549-385X; Cheng, Jan-Fang/0000-0001-7315-7613	US Department of Energy's Office of Science, Biological and Environmental Research Program; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; Gordon and Betty Moore Foundation [1660]; DFG INST [599/1-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067012, R01GM054592] Funding Source: NIH RePORTER	US Department of Energy's Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); DFG INST(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following people for assistance in aspects of the project including planning and discussions ( R. Stevens, G. Olsen, R. Edwards, J. Bristow, N. Ward, S. Baker, T. Lowe, J. Tiedje, G. Garrity, A. Darling, S. Giovannoni), analysis of genomes whose work could not be included in this report ( B. Henrissat, G. Xie, J. Kinney, I. Paulsen, N. Rawlings, M. Huntemann), project management ( M. Miller, M. Fenner, M. McGowen, A. Greiner), sequencing and finishing ( K. Ikeda, M. Chovatia, P. Richardson, T. Glavinadelrio, C. Detter), culture growth, DNA extraction, and metadata ( D. Gleim, E. Brambilla, S. Schneider, M. Schroder, M. Jando, G. Gehrich-Schroter, C. Wahrenburg, K. Steenblock, S. Welnitz, M. Kopitz, R. Fahnrich,H. Pomrenke, A. Schutze, M. Rohde, M. Goker), and manuscript editing ( M. Youle). This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract no. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract no. DE-AC02-06NA25396. Support for J. A. E., D. W. and M. W. was provided by the Gordon and Betty Moore Foundation Grant no. 1660 to J. A. E. Support for work at DSMZ was provided under DFG INST 599/1-1.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beiko RG, 2008, SYST BIOL, V57, P844, DOI 10.1080/10635150802559265; Bernal A, 2001, NUCLEIC ACIDS RES, V29, P126, DOI 10.1093/nar/29.1.126; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doolittle RF, 2002, BIOESSAYS, V24, P293, DOI 10.1002/bies.10079; Eisen JA, 2000, CURR OPIN MICROBIOL, V3, P475, DOI 10.1016/S1369-5274(00)00125-9; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Fraser CM, 2000, NATURE, V406, P799, DOI 10.1038/35021244; Hugenholtz P, 2002, GENOME BIOL, V3; Hugenholtz P, 2009, ENVIRON MICROBIOL, V11, P551, DOI 10.1111/j.1462-2920.2009.01888.x; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Lapage SP, 1992, INT CODE NOMENCLATUR; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; Matsuura Y, 2000, J MOL BIOL, V296, P579, DOI 10.1006/jmbi.1999.3467; Moulton V, 2007, J THEOR BIOL, V246, P186, DOI 10.1016/j.jtbi.2006.12.021; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pardi F, 2007, SYSTEMATIC BIOL, V56, P431, DOI 10.1080/10635150701411279; Sasse F, 1998, J NATL CANCER I, V90, P1559, DOI 10.1093/jnci/90.20.1559; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Waino M, 2003, EXTREMOPHILES, V7, P87, DOI 10.1007/s00792-002-0299-y; Ward N, 2001, NATURE, V414, P148, DOI 10.1038/35102737; Wu DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004207; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151	30	698	709	1	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1056	1060		10.1038/nature08656	http://dx.doi.org/10.1038/nature08656			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033048	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000272996000047
J	Opperman, JJ; Galloway, GE; Fargione, J; Mount, JF; Richter, BD; Secchi, S				Opperman, Jeffrey J.; Galloway, Gerald E.; Fargione, Joseph; Mount, Jeffrey F.; Richter, Brian D.; Secchi, Silvia			Sustainable Floodplains Through Large-Scale Reconnection to Rivers	SCIENCE			English	Editorial Material							ECOSYSTEM SERVICES; BIOMASS; FUTURE; TRENDS		[Opperman, Jeffrey J.; Fargione, Joseph; Richter, Brian D.] Nature Conservancy, Arlington, VA 22203 USA; [Opperman, Jeffrey J.; Mount, Jeffrey F.] Univ Calif Davis, Ctr Watershed Sci, Davis, CA 95616 USA; [Galloway, Gerald E.] Univ Maryland, Dept Civil & Environm Engn, College Pk, MD 20742 USA; [Galloway, Gerald E.] Univ Maryland, Sch Publ Policy, College Pk, MD 20742 USA; [Secchi, Silvia] So Illinois Univ, Dept Agribusiness Econ, Carbondale, IL 62901 USA	Nature Conservancy; University of California System; University of California Davis; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; Southern Illinois University System; Southern Illinois University	Opperman, JJ (corresponding author), Nature Conservancy, Arlington, VA 22203 USA.	jopperman@tnc.org	Secchi, Silvia/C-9124-2013	Secchi, Silvia/0000-0003-0095-0789				Akanbi A.A., 1999, 4 ILL STAT WAT SURV; Bates B.C., 2008, CLIMATE CHANGE WATER; BORMAN M, 2008, ALTON TELEGRAPH 0619; Costanza R, 1997, NATURE, V387, P253, DOI 10.1038/387253a0; Jercich SA, 1997, J WATER RES PL-ASCE, V123, P59, DOI 10.1061/(ASCE)0733-9496(1997)123:1(59); Kelley R., 1989, BATTLING INLAND SEA; Klijn F, 2004, AMBIO, V33, P141, DOI 10.1639/0044-7447(2004)033[0141:FMSFAU]2.0.CO;2; National Committee on Levee Safety, 2009, REC NAT LEV SAF PROG; *NOAA, COSTS AR NORM 2007 D; Pielke R.A., 2002, FLOOD DAMAGE US 1926; Pinter N, 2005, SCIENCE, V308, P207, DOI 10.1126/science.1108411; Sommer T, 2001, FISHERIES, V26, P6, DOI 10.1577/1548-8446(2001)026<0006:CYB>2.0.CO;2; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; *USA, 1999, POSTFL ASS SACR SAN; Volk TA, 2004, FRONT ECOL ENVIRON, V2, P411, DOI 10.1890/1540-9295(2004)002[0411:GFASAO]2.0.CO;2; Zedler JB, 2005, ANNU REV ENV RESOUR, V30, P39, DOI 10.1146/annurev.energy.30.050504.144248; 2007, SACRAMENTO BEE  0712, pB6; 1980, FED REG, V45, P64366	19	220	222	8	119	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 11	2009	326	5959					1487	1488		10.1126/science.1178256	http://dx.doi.org/10.1126/science.1178256			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007887				2022-12-28	WOS:000272623600041
J	Guo, M; Chong, YE; Shapiro, R; Beebe, K; Yang, XL; Schimmel, P				Guo, Min; Chong, Yeeting E.; Shapiro, Ryan; Beebe, Kirk; Yang, Xiang-Lei; Schimmel, Paul			Paradox of mistranslation of serine for alanine caused by AlaRS recognition dilemma	NATURE			English	Article							TRANSFER-RNA-SYNTHETASE; AMINO-ACID; STRUCTURAL BASIS; DISCRIMINATION; ISOLEUCINE; MECHANISM; SIEVE; MOTIF	Mistranslation arising from confusion of serine for alanine by alanyl-tRNA synthetases (AlaRSs) has profound functional consequences(1-3). Throughout evolution, two editing checkpoints prevent disease-causing mistranslation from confusing glycine or serine for alanine at the active site of AlaRS. In both bacteria and mice, Ser poses a bigger challenge than Gly(1,2). One checkpoint is the AlaRS editing centre, and the other is from widely distributed AlaXps-free-standing, genome-encoded editing proteins that clear Ser-tRNA(Ala). The paradox of misincorporating both a smaller (glycine) and a larger (serine) amino acid suggests a deep conflict for nature-designed AlaRS. Here we show the chemical basis for this conflict. Nine crystal structures, together with kinetic and mutational analysis, provided snapshots of adenylate formation for each amino acid. An inherent dilemma is posed by constraints of a structural design that pins down the alpha-amino group of the bound amino acid by using an acidic residue. This design, dating back more than 3 billion years, creates a serendipitous interaction with the serine OH that is difficult to avoid. Apparently because no better architecture for the recognition of alanine could be found, the serine misactivation problem was solved through free-standing AlaXps, which appeared contemporaneously with early AlaRSs. The results reveal unconventional problems and solutions arising from the historical design of the protein synthesis machinery.	[Guo, Min; Chong, Yeeting E.; Shapiro, Ryan; Beebe, Kirk; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Guo, Min; Chong, Yeeting E.; Shapiro, Ryan; Beebe, Kirk; Yang, Xiang-Lei; Schimmel, Paul] Scripps Res Inst, Dept Mol Biol, La Jolla, CA 92037 USA	Scripps Research Institute; Scripps Research Institute	Schimmel, P (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, BCC 379,10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	schimmel@scripps.edu	Chong, Yeeting/AAE-3792-2020; Yang, Xiang-Lei/AAR-7107-2020	Yang, Xiang-Lei/0000-0003-2554-084X	National Institutes of Health [GM 15539]; National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM015539, R37GM015539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Foundation for Cancer Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank R.J. Read for pointing out the errors in the previous AlaRS-ligand structures and for crystallographic discussions; and G. J. Kleywegt, Z. Otwinowski and A. Perrakis for technical assistance. X-ray diffraction data were collected at Stanford Synchrotron Radiation Laboratory (SSRL) beamlines 7-1, 9-1 and 11-1. This work was supported by grant GM 15539 from the National Institutes of Health and by a fellowship from the National Foundation for Cancer Research.	Ahel I, 2003, P NATL ACAD SCI USA, V100, P15422, DOI 10.1073/pnas.2136934100; Arnez JG, 1997, TRENDS BIOCHEM SCI, V22, P211, DOI 10.1016/S0968-0004(97)01052-9; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beebe K, 2003, EMBO J, V22, P668, DOI 10.1093/emboj/cdg065; Beebe K, 2008, NATURE, V451, P90, DOI 10.1038/nature06454; BELRHALI H, 1994, SCIENCE, V263, P1432, DOI 10.1126/science.8128224; Boniecki MT, 2008, P NATL ACAD SCI USA, V105, P19223, DOI 10.1073/pnas.0809336105; CARTER CW, 1993, ANNU REV BIOCHEM, V62, P715, DOI 10.1146/annurev.bi.62.070193.003435; Chong YE, 2008, J BIOL CHEM, V283, P30073, DOI 10.1074/jbc.M805943200; Cieslik M, 2009, ACTA CRYSTALLOGR D, V65, P500, DOI 10.1107/S0907444909009500; DAVIS MW, 1994, BIOCHEMISTRY-US, V33, P9904, DOI 10.1021/bi00199a012; ELDRED EW, 1972, J BIOL CHEM, V247, P2961; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fersht AR, 1998, SCIENCE, V280, P541, DOI 10.1126/science.280.5363.541; Fersht AR., 1977, ENZYME STRUCTURE MEC; First E.A., 2005, AMINOACYL TRNA SYNTH, P328; Fukai S, 2000, CELL, V103, P793, DOI 10.1016/S0092-8674(00)00182-3; Giege R, 2006, J BIOSCIENCES, V31, P477, DOI 10.1007/BF02705187; Guo M, 2009, SCIENCE, V325, P744, DOI 10.1126/science.1174343; Ho BK, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-49; Itoh Y, 2008, RNA BIOL, V5, P169, DOI 10.4161/rna.5.3.6876; Jakubowsky H., 2005, AMINOACYL TRNA SYNTH, P384; Lee JW, 2006, NATURE, V443, P50, DOI 10.1038/nature05096; Ling JQ, 2009, MOL CELL, V33, P654, DOI 10.1016/j.molcel.2009.01.031; Malde AK, 2009, J AM CHEM SOC, V131, P3848, DOI 10.1021/ja9002124; NORRIS AT, 1964, P NATL ACAD SCI USA, V52, P330, DOI 10.1073/pnas.52.2.330; Nureki O, 2001, COLD SPRING HARB SYM, V66, P167, DOI 10.1101/sqb.2001.66.167; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Sankaranarayanan R, 2000, NAT STRUCT BIOL, V7, P461; SHI JP, 1994, BIOCHEMISTRY-US, V33, P5312, DOI 10.1021/bi00183a039; Sokabe M, 2005, P NATL ACAD SCI USA, V102, P11669, DOI 10.1073/pnas.0502119102; Swairjo MA, 2005, P NATL ACAD SCI USA, V102, P988, DOI 10.1073/pnas.0409024102; TSUI WC, 1981, NUCLEIC ACIDS RES, V9, P4627, DOI 10.1093/nar/9.18.4627; Xin Y, 2000, J MOL BIOL, V303, P299, DOI 10.1006/jmbi.2000.4126	34	71	79	1	30	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					808	U134		10.1038/nature08612	http://dx.doi.org/10.1038/nature08612			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010690	Green Accepted			2022-12-28	WOS:000272559900043
J	Rubenstein, DR; Lovette, IJ				Rubenstein, Dustin R.; Lovette, Irby J.			Reproductive skew and selection on female ornamentation in social species	NATURE			English	Article							SEXUAL SELECTION; GENETIC VARIANCE; VARIABILITY; COMPETITION; EVOLUTION; DICHROMATISM; PHYLOGENY; BEHAVIOR; DRIVES	Male animals are typically more elaborately ornamented than females(1). Classic sexual selection theory notes that because sperm are cheaper to produce than eggs(2), and because males generally compete more intensely for reproductive opportunities and invest less in parental care than females(3), males can obtain greater fitness benefits from mating multiply(2,4). Therefore, sexual selection typically results in male-biased sex differences in secondary sexual characters(1,4). This generality has recently been questioned, because in cooperatively breeding vertebrates, the strength of selection on traits used in intra-sexual competition for access to mates (sexual selection(1,4)) or other resources linked to reproduction (social selection(5,6)) is similar in males and females(7,8). Because selection is acting with comparable intensity in both sexes in cooperatively breeding species, the degree of sexual dimorphism in traits used in intrasexual competition should be reduced in cooperative breeders(6). Here we use the socially diverse African starlings (Sturnidae) to demonstrate that the degree of sexual dimorphism in plumage and body size is reduced in cooperatively breeding species as a result of increased selection on females for traits that increase access to reproductive opportunities, other resources, or higher social status. In cooperative breeders such as these, where there is unequal sharing of reproduction (reproductive skew) among females, and where female dominance rank influences access to mates and other resources, intrasexual competition among females may be intense(7) and ultimately select for female trait elaboration(9). Selection is thereby acting with different intensities on males and females in cooperatively versus non-cooperatively breeding species, and female-female interactions in group-living vertebrates will have important consequences for the evolution of female morphological, physiological and behavioural traits.	[Rubenstein, Dustin R.] Columbia Univ, Dept Ecol Evolut & Environm Biol, New York, NY 10027 USA; [Rubenstein, Dustin R.] Univ Calif Berkeley, Dept Integrat Biol, Museum Vertebrate Zool, Berkeley, CA 94720 USA; [Rubenstein, Dustin R.; Lovette, Irby J.] Cornell Lab Ornithol, Fuller Evolutionary Biol Program, Ithaca, NY 14850 USA	Columbia University; University of California System; University of California Berkeley; Cornell University	Rubenstein, DR (corresponding author), Columbia Univ, Dept Ecol Evolut & Environm Biol, 10th Floor Schermerhorn Extens,1200 Amsterdam Ave, New York, NY 10027 USA.	dr2497@columbia.edu	Rubenstein, Dustin R./N-9302-2019; Rubenstein, Dustin R/A-3451-2015; Wang, Anna/F-6418-2014	Rubenstein, Dustin R./0000-0002-4999-3723; Rubenstein, Dustin R/0000-0002-4999-3723; 	NSF [DEB-0515981]; Miller Institute for Basic Research in Science at the University of California, Berkeley	NSF(National Science Foundation (NSF)); Miller Institute for Basic Research in Science at the University of California, Berkeley(University of California System)	This research was supported by grants from NSF to I. J. L. (DEB-0515981) and a postdoctoral fellowship from the Miller Institute for Basic Research in Science at the University of California, Berkeley to D. R. R. We thank E. Lacey, B. Lyon, B. McCleery, D. I. Rubenstein, R. Safran, A. L. Talaba and the Lacey laboratory for advice and assistance. P. Hohohnle helped conduct and interpret the MIPoD analyses. We acknowledge S. Edwards, J. Trimble ( Harvard Museum of Comparative Zoology), R. Prum, K. Zyskowski ( Yale Peabody Museum), J. Cracraft, P. Sweet ( American Museum of Natural History), N. Rice ( Academy of Natural Sciences, Philadelphia), M. Braun, D. James ( National Museum of Natural History) and R. Prys-Jones ( British Museum) for access to their collections.	Amundsen T, 2000, TRENDS ECOL EVOL, V15, P149, DOI 10.1016/S0169-5347(99)01800-5; Andersson Malte, 1994; ARNOLD SJ, 1994, AM NAT, V144, pS1, DOI 10.1086/285650; Badyaev AV, 2003, ANNU REV ECOL EVOL S, V34, P27, DOI 10.1146/annurev.ecolsys.34.011802.132441; BATEMAN AJ, 1948, HEREDITY, V2, P349, DOI 10.1038/hdy.1948.21; BULMER MG, 1971, AM NAT, V105, P201, DOI 10.1086/282718; Clutton-Brock T.H., 1983, P457; Clutton-Brock TH, 2006, NATURE, V444, P1065, DOI 10.1038/nature05386; Clutton-Brock T.H., 1988, P1; Clutton-Brock T, 2007, SCIENCE, V318, P1882, DOI 10.1126/science.1133311; Clutton-Brock T, 2009, ANIM BEHAV, V77, P3, DOI 10.1016/j.anbehav.2008.08.026; CRAIG AJFK, 1985, AUK, V102, P629, DOI 10.1093/auk/102.3.629; Darwin C., 1871, P475; Delhey K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001689; Dloniak SM, 2006, NATURE, V440, P1190, DOI 10.1038/nature04540; Hauber ME, 2005, INTEGR COMP BIOL, V45, P903, DOI 10.1093/icb/45.5.903; IRWIN RE, 1994, AM NAT, V144, P890, DOI 10.1086/285717; Kotiaho JS, 2001, NATURE, V410, P684, DOI 10.1038/35070557; LANDE R, 1979, EVOLUTION, V33, P402, DOI 10.2307/2407630; Lovette IJ, 2007, MOL PHYLOGENET EVOL, V44, P1031, DOI 10.1016/j.ympev.2007.03.017; Roughgarden J, 2006, SCIENCE, V311, P965, DOI 10.1126/science.1110105; Rowe L, 1996, P ROY SOC B-BIOL SCI, V263, P1415, DOI 10.1098/rspb.1996.0207; Rubenstein DR, 2007, CURR BIOL, V17, P1414, DOI 10.1016/j.cub.2007.07.032; Rubenstein DR, 2007, P R SOC B, V274, P1895, DOI 10.1098/rspb.2007.0424; Rubenstein DR, 2007, AM NAT, V170, P155, DOI 10.1086/518671; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; Van Homrigh A, 2007, CURR BIOL, V17, P528, DOI 10.1016/j.cub.2007.01.055; WESTEBERHARD MJ, 1979, P AM PHILOS SOC, V123, P222; WESTEBERHARD MJ, 1983, Q REV BIOL, V58, P155, DOI 10.1086/413215; WILKINSON R, 1982, ANIM BEHAV, V30, P1118, DOI 10.1016/S0003-3472(82)80202-9	30	113	113	0	99	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					786	U106		10.1038/nature08614	http://dx.doi.org/10.1038/nature08614			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010686				2022-12-28	WOS:000272559900038
J	Steele, IA; Mundell, CG; Smith, RJ; Kobayashi, S; Guidorzi, C				Steele, I. A.; Mundell, C. G.; Smith, R. J.; Kobayashi, S.; Guidorzi, C.			Ten per cent polarized optical emission from GRB 090102	NATURE			English	Article							GAMMA-RAY BURSTS; SPACE-TELESCOPE; AFTERGLOWS; GRB-021206; FIREBALL; MODEL; SHOCK	The nature of the jets and the role of magnetic fields in gamma-ray bursts (GRBs) remains unclear(1,2). In a baryon-dominated jet only weak, tangled fields generated in situ through shocks would be present(3). In an alternative model, jets are threaded with large-scale magnetic fields that originate at the central engine and that accelerate and collimate the material(4). To distinguish between the models the degree of polarization in early-time emission must be measured; however, previous claims of gamma-ray polarization have been controversial(5-8). Here we report that the early optical emission from GRB 090102 was polarized at 10 +/- 1 per cent, indicating the presence of large-scale fields originating in the expanding fireball. If the degree of polarization and its position angle were variable on timescales shorter than our 60-second exposure, then the peak polarization may have been larger than ten per cent.	[Steele, I. A.; Mundell, C. G.; Smith, R. J.; Kobayashi, S.] Liverpool John Moores Univ, Astrophys Res Inst, Liverpool CH41 1LD, Merseyside, England; [Guidorzi, C.] Univ Ferrara, Dept Phys, I-44122 Ferrara, Italy	Liverpool John Moores University; University of Ferrara	Steele, IA (corresponding author), Liverpool John Moores Univ, Astrophys Res Inst, Liverpool CH41 1LD, Merseyside, England.	ias@astro.livjm.ac.uk		Guidorzi, Cristiano/0000-0001-6869-0835	UK Science and Technology Facilities Council; Royal Society and Research Councils UK; Engineering and Physical Sciences Research Council [GR/T27969/01] Funding Source: researchfish; Science and Technology Facilities Council [PP/E001149/1, ST/G009465/1] Funding Source: researchfish; STFC [PP/E001149/1, ST/G009465/1] Funding Source: UKRI	UK Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); Royal Society and Research Councils UK; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Science and Technology Facilities Council(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC)); STFC(UK Research & Innovation (UKRI)Science & Technology Facilities Council (STFC))	The Liverpool Telescope is operated on the island of La Palma by Liverpool John Moores University in the Spanish Observatorio del Roque de los Muchachos of the Instituto de Astrofisica de Canarias with financial support from the UK Science and Technology Facilities Council. C. G. M. acknowledges financial support from the Royal Society and Research Councils UK. We thank J. Marchant for preparing Fig. 4 for us.	Clarke D, 2002, ASTRON ASTROPHYS, V383, P360, DOI 10.1051/0004-6361:20011717; Coburn W, 2003, NATURE, V423, P415, DOI 10.1038/nature01612; Covino S, 1999, ASTRON ASTROPHYS, V348, pL1; COVINO S, 2009, 8763 GCN; Fan YZ, 2009, MON NOT R ASTRON SOC, V397, P1539, DOI 10.1111/j.1365-2966.2009.15018.x; GENDRE B, MON NOT R ASTR UNPUB; GOMBOC A, 2008, ASTROPHYS J, V660, P489; Gotz D, 2009, ASTROPHYS J LETT, V695, pL208, DOI 10.1088/0004-637X/695/2/L208; Granot J, 2003, ASTROPHYS J, V596, pL17, DOI 10.1086/379110; Gruzinov A, 1999, ASTROPHYS J, V525, pL29, DOI 10.1086/312323; Gruzinov A, 1999, ASTROPHYS J, V511, P852, DOI 10.1086/306720; KLOTZ A, 2009, 8761 GCN; Lazzati D, 2004, MON NOT R ASTRON SOC, V347, pL1, DOI 10.1111/j.1365-2966.2004.07387.x; Lyutikov M, 2006, NEW J PHYS, V8, DOI 10.1088/1367-2630/8/7/119; Lyutikov M, 2009, MON NOT R ASTRON SOC, V396, P1545, DOI 10.1111/j.1365-2966.2009.14811.x; MANGANO V, 2009, 1921 GCN; McGlynn S, 2007, ASTRON ASTROPHYS, V466, P895, DOI 10.1051/0004-6361:20066179; Medvedev MV, 1999, ASTROPHYS J, V526, P697, DOI 10.1086/308038; Mimica P, 2009, ASTRON ASTROPHYS, V494, P879, DOI 10.1051/0004-6361:200810756; Mundell CG, 2007, SCIENCE, V315, P1822, DOI 10.1126/science.1138484; Piran T, 1999, PHYS REP, V314, P575, DOI 10.1016/S0370-1573(98)00127-6; Rutledge RE, 2004, MON NOT R ASTRON SOC, V350, P1288, DOI 10.1111/j.1365-2966.2004.07665.x; SCHMIDT GD, 1992, ASTRON J, V104, P1563, DOI 10.1086/116341; STEELE IA, 2006, P SOC PHOTO-OPT INS, V6269, pS179; Wijers RAMJ, 1999, ASTROPHYS J, V523, pL33, DOI 10.1086/312262; Willis DR, 2005, ASTRON ASTROPHYS, V439, P245, DOI 10.1051/0004-6361:20052693; Zhang B, 2004, INT J MOD PHYS A, V19, P2385, DOI 10.1142/S0217751X0401746X; Zhang B, 2005, ASTROPHYS J, V628, P315, DOI 10.1086/429787; Zhang B, 2003, ASTROPHYS J, V595, P950, DOI 10.1086/377363	30	111	112	0	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					767	769		10.1038/nature08590	http://dx.doi.org/10.1038/nature08590			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010682	Green Submitted			2022-12-28	WOS:000272559900033
J	Isselbacher, KJ				Isselbacher, Kurt J.			Paul C. Zamecnik (1912-2009) RETROSPECTIVE	SCIENCE			English	Biographical-Item									Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA	Harvard University; Massachusetts General Hospital	Isselbacher, KJ (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA.	kisselbacher@partners.org						ZAMECNIK PC, PUBLICATION LIST	1	1	1	0	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1359	1359		10.1126/science.1184725	http://dx.doi.org/10.1126/science.1184725			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965748				2022-12-28	WOS:000272351100029
J	Denk, T; Neukum, G; Roatsch, T; Porco, CC; Burns, JA; Galuba, GG; Schmedemann, N; Helfenstein, P; Thomas, PC; Wagner, RJ; West, RA				Denk, Tilmann; Neukum, Gerhard; Roatsch, Thomas; Porco, Carolyn C.; Burns, Joseph A.; Galuba, Goetz G.; Schmedemann, Nico; Helfenstein, Paul; Thomas, Peter C.; Wagner, Roland J.; West, Robert A.			Iapetus: Unique Surface Properties and a Global Color Dichotomy from Cassini Imaging	SCIENCE			English	Article							IRREGULAR SATELLITES; GALILEAN SATELLITES; SOLAR-SYSTEM; E-RING; PHOEBE; HYPERION; LAPETUS; SATURN; ENCELADUS; SCIENCE	Since 2004, Saturn's moon Iapetus has been observed repeatedly with the Imaging Science Subsystem of the Cassini spacecraft. The images show numerous impact craters down to the resolution limit of similar to 10 meters per pixel. Small, bright craters within the dark hemisphere indicate a dark blanket thickness on the order of meters or less. Dark, equator-facing and bright, poleward-facing crater walls suggest temperature-driven water-ice sublimation as the process responsible for local albedo patterns. Imaging data also reveal a global color dichotomy, wherein both dark and bright materials on the leading side have a substantially redder color than the respective trailing-side materials. This global pattern indicates an exogenic origin for the redder leading-side parts and suggests that the global color dichotomy initiated the thermal formation of the global albedo dichotomy.	[Denk, Tilmann; Neukum, Gerhard; Galuba, Goetz G.; Schmedemann, Nico] Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany; [Roatsch, Thomas; Wagner, Roland J.] Deutsch Zentrum Luft & Raumfahrt DLR, Inst Planetenforschung, D-12489 Berlin, Germany; [Porco, Carolyn C.] Space Sci Inst, Cassini Imaging Cent Lab Operat CICLOPS, Boulder, CO 80301 USA; [Burns, Joseph A.; Helfenstein, Paul; Thomas, Peter C.] Cornell Univ, Dept Astron, Ithaca, NY 14853 USA; [West, Robert A.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA	Free University of Berlin; Helmholtz Association; German Aerospace Centre (DLR); Cornell University; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL)	Denk, T (corresponding author), Free Univ Berlin, Inst Geol Wissensch, D-12249 Berlin, Germany.	Tilmann.Denk@fu-berlin.de		Denk, Tilmann/0000-0003-0764-3677	German Aerospace Center; NASA/JPL	German Aerospace Center(Helmholtz AssociationGerman Aerospace Centre (DLR)); NASA/JPL(National Aeronautics & Space Administration (NASA))	We acknowledge the individuals at CICLOPS (at the Space Science Institute in Boulder, CO) and JPL (Pasadena, CA), as well as the members and associates of the Imaging Team for the successful conduct of the ISS experiment onboard the Cassini spacecraft. This paper is dedicated to Steve Ostro, whose work helped considerably to explain the nature of Iapetus' dark terrain. This work has been funded by the German Aerospace Center (DLR) and NASA/JPL.	Black GJ, 2004, SCIENCE, V304, P553, DOI 10.1126/science.1096470; BURATTI BJ, 1991, ICARUS, V90, P1, DOI 10.1016/0019-1035(91)90064-Z; BURATTI BJ, 1990, ICARUS, V87, P339, DOI 10.1016/0019-1035(90)90138-Y; Buratti BJ, 2002, ICARUS, V155, P375, DOI 10.1006/icar.2001.6730; Burns JA, 1999, SCIENCE, V284, P1146, DOI 10.1126/science.284.5417.1146; BURNS JA, 1979, ICARUS, V40, P1, DOI 10.1016/0019-1035(79)90050-2; Burns JA, 1996, ASTR SOC P, V104, P179; CASSINI JD, 1677, J SCAVANS, P70; CHAPMAN CR, 1986, SATELLITES, P492; COOK AF, 1970, ICARUS, V13, P282, DOI 10.1016/0019-1035(70)90057-6; DAVIES ME, 1984, ICARUS, V59, P199, DOI 10.1016/0019-1035(84)90023-X; DENK T, 2002, LISB EUR JUP GAL CAS, P118; Giese B, 2008, ICARUS, V193, P359, DOI 10.1016/j.icarus.2007.06.005; HAMILTON DP, 1994, SCIENCE, V264, P550, DOI 10.1126/science.264.5158.550; Jarvis KS, 2000, ICARUS, V146, P125, DOI 10.1006/icar.2000.6311; JOHNSON TV, 1983, J GEOPHYS RES, V88, P5789, DOI 10.1029/JB088iB07p05789; Nesvorny D, 2003, ASTRON J, V126, P398, DOI 10.1086/375461; Neukum G., 1994, HAZARDS DUE COMETS A, P359; Ostro SJ, 2006, ICARUS, V183, P479, DOI 10.1016/j.icarus.2006.02.019; PANG KD, 1984, J GEOPHYS RES, V89, P9459, DOI 10.1029/JB089iB11p09459; Porco CC, 2004, SPACE SCI REV, V115, P363, DOI 10.1007/s11214-004-1456-7; Porco CC, 2005, SCIENCE, V307, P1237, DOI 10.1126/science.1107981; Roatsch T, 2009, PLANET SPACE SCI, V57, P83, DOI 10.1016/j.pss.2008.10.014; SOTER S, 1974, IAU C CORN U ITH NY, V28; Spencer JR, 2010, SCIENCE, V327, P432, DOI 10.1126/science.1177132; SPENCER JR, 1987, ICARUS, V69, P297, DOI 10.1016/0019-1035(87)90107-2; THOLEN DJ, 1983, ICARUS, V53, P341, DOI 10.1016/0019-1035(83)90154-9; THOMAS P, 1985, ICARUS, V64, P414, DOI 10.1016/0019-1035(85)90065-X; TOSI F, 2009, PREPRINT; Turrini D, 2008, MON NOT R ASTRON SOC, V391, P1029, DOI 10.1111/j.1365-2966.2008.13909.x; Verbiscer AJ, 2009, NATURE, V461, P1098, DOI 10.1038/nature08515; Wilson PD, 1996, ICARUS, V122, P92, DOI 10.1006/icar.1996.0111; Zahnle K, 2003, ICARUS, V163, P263, DOI 10.1016/S0019-1035(03)00048-4	33	29	29	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 22	2010	327	5964					435	439		10.1126/science.1177088	http://dx.doi.org/10.1126/science.1177088			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20007863				2022-12-28	WOS:000273783100029
J	Lin, S; Yang, S				Lin, Shin; Yang, Samuel			Molecular methods for pathogen detection in blood	LANCET			English	Editorial Material							STREAM INFECTIONS; PCR; DIAGNOSIS; SEPSIS		[Yang, Samuel] Johns Hopkins Sch Med, Dept Emergency Med, Baltimore, MD 21209 USA; [Lin, Shin] Stanford Univ, Dept Med, Sch Med, Stanford, CA 94305 USA	Johns Hopkins University; Johns Hopkins Medicine; Stanford University	Yang, S (corresponding author), Johns Hopkins Sch Med, Dept Emergency Med, Baltimore, MD 21209 USA.	syang10@jhmi.edu		Lin, Shin/0000-0003-0118-0413; Yang, Samuel/0000-0003-1123-9036				Garnacho-Montero J, 2008, J ANTIMICROB CHEMOTH, V61, P436, DOI 10.1093/jac/dkm460; Klouche M, 2008, CLIN CHEM LAB MED, V46, P888, DOI 10.1515/CCLM.2008.157; Kollef MH, 2000, CLIN INFECT DIS, V31, pS131, DOI 10.1086/314079; Tissari P, 2010, LANCET, V375, P224, DOI 10.1016/S0140-6736(09)61569-5; Wellinghausen N, 2009, J CLIN MICROBIOL, V47, P2759, DOI 10.1128/JCM.00567-09; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Yang S, 2004, LANCET INFECT DIS, V4, P337, DOI 10.1016/S1473-3099(04)01044-8; Zhao YA, 2009, J CLIN MICROBIOL, V47, P2067, DOI 10.1128/JCM.02230-08	8	4	5	0	8	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					178	179		10.1016/S0140-6736(09)61791-8	http://dx.doi.org/10.1016/S0140-6736(09)61791-8			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20004963				2022-12-28	WOS:000273853800007
J	Tissari, P; Zumla, A; Tarkka, E; Mero, S; Savolainen, L; Vaara, M; Aittakorpi, A; Laakso, S; Lindfors, M; Piiparinen, H; Maki, M; Carder, C; Huggett, J; Gant, V				Tissari, Paivi; Zumla, Alimuddin; Tarkka, Eveliina; Mero, Sointu; Savolainen, Laura; Vaara, Martti; Aittakorpi, Anne; Laakso, Sanna; Lindfors, Merja; Piiparinen, Heli; Maki, Minna; Carder, Caroline; Huggett, Jim; Gant, Vanya			Accurate and rapid identification of bacterial species from positive blood cultures with a DNA-based microarray platform: an observational study	LANCET			English	Article							REAL-TIME PCR; DIAGNOSIS; ASSAY; PATHOGENS	Background New DNA-based microarray platforms enable rapid detection and species identification of many pathogens, including bacteria. We assessed the sensitivity, specificity, and turnaround time of a new molecular sepsis assay. Methods 2107 positive blood-culture samples of 3318 blood samples from patients with clinically suspected sepsis were investigated for bacterial species by both conventional culture and Prove-it sepsis assay (Mobidiag, Helsinki, Finland) in two centres (UK and Finland). The assay is a novel PCR and microarray method that is based on amplification and detection of gyrB, parE, and mecA genes of 50 bacterial species. Operators of the test assay were not aware of culture results. We calculated sensitivity, specificity, and turnaround time according to Clinical and Laboratory Standards Institute recommendations. Findings 1807 of 2107 (86%) positive blood-culture samples included a pathogen covered by the assay. The assay had a clinical sensitivity of 94.7% (95% CI 93.6-95.7) and a specificity of 98.8% (98.1-99.2), and 100% for both measures for meticillin-resistant Staphylococcus aureus bacteraemia. The assay was a mean 18 h faster than was the conventional culture-based method, which takes an additional 1-2 working days. 34 of 3284 (1.0%) samples were excluded because of technical and operator errors. Interpretation Definitive identification of bacterial species with this microarray platform was highly sensitive, specific, and faster than was the gold-standard culture-based method. This assay could enable fast and earlier evidence-based management for clinical sepsis.	[Tissari, Paivi; Tarkka, Eveliina; Mero, Sointu; Savolainen, Laura; Vaara, Martti] Univ Helsinki, Hosp Lab, Div Clin Microbiol, Helsinki, Finland; [Zumla, Alimuddin; Carder, Caroline; Huggett, Jim; Gant, Vanya] UCL, Dept Clin Microbiol, Univ Coll London Hosp NHS Fdn Trust, Med Sch,Windeyer Inst Med Sci, London W1T 4JF, England; [Zumla, Alimuddin; Carder, Caroline; Huggett, Jim; Gant, Vanya] UCL, Ctr Infect Dis & Int Hlth, Sch Med, Windeyer Inst Med Sci, London W1T 4JF, England; [Aittakorpi, Anne; Laakso, Sanna; Lindfors, Merja; Piiparinen, Heli; Maki, Minna] Mobidiag, Helsinki, Finland	University of Helsinki; University College London Hospitals NHS Foundation Trust; University of London; University College London; University of London; University College London; UCL Medical School	Gant, V (corresponding author), UCL, Dept Clin Microbiol, Univ Coll London Hosp NHS Fdn Trust, Windeyer Inst, 46 Cleveland St, London W1T 4JF, England.	vanya.gant@uclh.nhs.uk	Vaara, Martti S/D-1698-2013; ZUMLA, Alimuddin/ABA-8208-2020; Huggett, Jim/N-9316-2013	ZUMLA, Alimuddin/0000-0002-5111-5735; Huggett, Jim/0000-0002-0945-1911; Savolainen, Laura/0000-0003-2527-4211	UK Comprehensive Biomedical Research Centre and National Institute for Health Research support through University College London Hospitals NHS Foundation Trust	UK Comprehensive Biomedical Research Centre and National Institute for Health Research support through University College London Hospitals NHS Foundation Trust	We thank Mobidiag for providing equipment and reagents for the Prove-it sepsis assay, and all UCLH and HUSLAB clinical and laboratory staff who helped with this study. VG and AZ receive UK Comprehensive Biomedical Research Centre and National Institute for Health Research support through University College London Hospitals NHS Foundation Trust. The study was done with normal clinical microbiology services of UCLH and HUSLAB. VG's personal discretionary funds were used.	Andrade SS, 2008, SHOCK, V30, P41, DOI 10.1097/SHK.0b013e3181819f6c; Angus DC, 2001, CRIT CARE MED, V29, pS109, DOI 10.1097/00003246-200107001-00035; Cenciarini-Borde C, 2009, FUTURE MICROBIOL, V4, P45, DOI 10.2217/17460913.4.1.45; *CLSI, 2003, M2A9 CLSI, V23; Davey PG, 2008, CLIN MICROBIOL INFEC, V14, P15, DOI 10.1111/j.1469-0691.2008.01959.x; Deborggraeve S, 2008, J INFECT DIS, V198, P1565, DOI 10.1086/592509; Eigner U, 2005, J CLIN MICROBIOL, V43, P5256, DOI 10.1128/JCM.43.10.5256-5262.2005; *EUR COMM STAND, 2002, 136122002 BS EN EUR; GERBERT S, 2008, J INFECTION, V57, P307; Howard D, 2001, CLIN INFECT DIS, V33, P1573, DOI 10.1086/323758; Kompalic-Cristo A, 2007, PARASITOL RES, V101, P619, DOI 10.1007/s00436-007-0524-9; Lehmann LE, 2008, MED MICROBIOL IMMUN, V197, P313, DOI 10.1007/s00430-007-0063-0; Mancini N, 2009, J CLIN MICROBIOL, V47, P1274, DOI 10.1128/JCM.00011-09; Mens P, 2007, TROP MED INT HEALTH, V12, P238, DOI 10.1111/j.1365-3165.2006.01779.x; National Clinical Committee Laboratory Standards NCCLS, 2006, PERFORMANCE STANDARD; Odds FC, 2007, J MED MICROBIOL, V56, P1066, DOI 10.1099/jmm.0.47239-0; Paule SM, 2007, J CLIN MICROBIOL, V45, P2993, DOI 10.1128/JCM.00670-07; Reier-Nilsen T, 2009, BMC PEDIATR, V9, DOI 10.1186/1471-2431-9-5; Roth SB, 2004, J CLIN MICROBIOL, V42, P4268, DOI 10.1128/JCM.42.9.4268-4274.2004; SALVADOR RB, 2008, ENFERM INFECC MIC S9, V26, P50; Vince A, 2008, J MED MICROBIOL, V57, P1306, DOI 10.1099/jmm.0.47797-0; WAYNE PA, 2002, EP12A CLSI; Westh H, 2009, CLIN MICROBIOL INFEC, V15, P544, DOI 10.1111/j.1469-0691.2009.02736.x; Zaidi AK, 2009, PEDIAT INFECT DIS S1, V28, P10	24	153	174	0	33	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					224	230		10.1016/S0140-6736(09)61569-5	http://dx.doi.org/10.1016/S0140-6736(09)61569-5			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20004964				2022-12-28	WOS:000273853800032
J	Jost, TS				Jost, Timothy S.			Implementation and Enforcement of Health Care Reform - Federal versus State Government	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA	Washington & Lee University	Jost, TS (corresponding author), Washington & Lee Univ, Sch Law, Lexington, VA 24450 USA.							CAUCHI R, 2009, STATE LEGISLATION OP; JOST TS, 2003, THREATS FACING OUR P, P172; Pollitz K, 2000, HEALTH AFFAIR, V19, P7, DOI 10.1377/hlthaff.19.4.7	3	6	6	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2								10.1056/NEJMp0911636	http://dx.doi.org/10.1056/NEJMp0911636			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	543FU	20042749				2022-12-28	WOS:000273558500004
J	Jain, S				Jain, Shaili			Googling Ourselves - What Physicians Can Learn from Online Rating Sites	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Aurora Behav Hlth Serv, Milwaukee, WI USA		Jain, S (corresponding author), Aurora Behav Hlth Serv, Milwaukee, WI USA.							GOLDSTEIN J, 2007, WALL STREET J   0822; GROOPMAN J, 2009, WALL STREET J   0408; HERRERA CR, 2006, GIVING DOCTORS CHECK; JAIN S, 2007, M WISCONSIN J S 1021; MILLER CC, 2007, FORBES MAGAZINE 0813	5	43	43	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2010	362	1					6	7		10.1056/NEJMp0903473	http://dx.doi.org/10.1056/NEJMp0903473			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	540PA	20054044				2022-12-28	WOS:000273345500003
J	Libster, R; Bugna, J; Coviello, S; Hijano, DR; Dunaiewsky, M; Reynoso, N; Cavalieri, ML; Guglielmo, MC; Areso, MS; Gilligan, T; Santucho, F; Cabral, G; Gregorio, GL; Moreno, R; Lutz, MI; Panigasi, AL; Saligari, L; Caballero, MT; Almeida, RME; Meyer, MEG; Neder, MD; Davenport, MC; Del Valle, MP; Santidrian, VS; Mosca, G; Dominguez, MG; Alvarez, L; Landa, P; Pota, A; Bolonati, N; Dalamon, R; Mercol, VIS; Espinoza, M; Peuchot, JC; Karolinski, A; Bruno, M; Borsa, A; Ferrero, F; Bonina, A; Ramonet, M; Albano, LC; Luedicke, N; Alterman, E; Savy, V; Baumeister, E; Chappell, JD; Edwards, KM; Melendi, GA; Polack, FP				Libster, Romina; Bugna, Jimena; Coviello, Silvina; Hijano, Diego R.; Dunaiewsky, Mariana; Reynoso, Natalia; Cavalieri, Maria L.; Guglielmo, Maria C.; Soledad Areso, M.; Gilligan, Tomas; Santucho, Fernanda; Cabral, Graciela; Gregorio, Gabriela L.; Moreno, Rina; Lutz, Maria I.; Panigasi, Alicia L.; Saligari, Liliana; Caballero, Mauricio T.; Eguees Almeida, Rodrigo M.; Gutierrez Meyer, Maria E.; Neder, Maria D.; Davenport, Maria C.; Del Valle, Maria P.; Santidrian, Valeria S.; Mosca, Guillermina; Garcia Dominguez, Mercedes; Alvarez, Liliana; Landa, Patricia; Pota, Ana; Bolonati, Norma; Dalamon, Ricardo; Sanchez Mercol, Victoria I.; Espinoza, Marco; Carlos Peuchot, Juan; Karolinski, Ariel; Bruno, Miriam; Borsa, Ana; Ferrero, Fernando; Bonina, Angel; Ramonet, Margarita; Albano, Lidia C.; Luedicke, Nora; Alterman, Elias; Savy, Vilma; Baumeister, Elsa; Chappell, James D.; Edwards, Kathryn M.; Melendi, Guillermina A.; Polack, Fernando P.			Pediatric Hospitalizations Associated with 2009 Pandemic Influenza A (H1N1) in Argentina	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							UNITED-STATES; CHILDREN; VIRUS; INFECTION; MORTALITY; ILLNESS; WAVE	BACKGROUND While the Northern Hemisphere experiences the effects of the 2009 pandemic influenza A (H1N1) virus, data from the recent influenza season in the Southern Hemisphere can provide important information on the burden of disease in children. METHODS We conducted a retrospective case series involving children with acute infection of the lower respiratory tract or fever in whom 2009 H1N1 influenza was diagnosed on reverse-transcriptase polymerase-chain-reaction assay and who were admitted to one of six pediatric hospitals serving a catchment area of 1.2 million children. We compared rates of admission and death with those among age-matched children who had been infected with seasonal influenza strains in previous years. RESULTS Between May and July 2009, a total of 251 children were hospitalized with 2009 H1N1 influenza. Rates of hospitalization were double those for seasonal influenza in 2008. Of the children who were hospitalized, 47 (19%) were admitted to an intensive care unit, 42 (17%) required mechanical ventilation, and 13 (5%) died. The overall rate of death was 1.1 per 100,000 children, as compared with 0.1 per 100,000 children for seasonal influenza in 2007. (No pediatric deaths associated with seasonal influenza were reported in 2008.) Most deaths were caused by refractory hypoxemia in infants under 1 year of age (death rate, 7.6 per 100,000). CONCLUSIONS Pandemic 2009 H1N1 influenza was associated with pediatric death rates that were 10 times the rates for seasonal influenza in previous years.	[Polack, Fernando P.] Vanderbilt Univ, Dept Pediat, Vanderbilt Vaccine Ctr, Nashville, TN 37232 USA; [Libster, Romina; Bugna, Jimena; Coviello, Silvina; Espinoza, Marco; Alterman, Elias; Melendi, Guillermina A.; Polack, Fernando P.] Fdn INFANT, Buenos Aires, DF, Argentina; [Hijano, Diego R.] Hosp Ninos Sor Ludovica La Plata, Inst Desarrollo & Invest Pediat, Buenos Aires, DF, Argentina; [Hijano, Diego R.; Dunaiewsky, Mariana; Reynoso, Natalia; Cavalieri, Maria L.; Guglielmo, Maria C.; Soledad Areso, M.; Caballero, Mauricio T.; Eguees Almeida, Rodrigo M.; Gutierrez Meyer, Maria E.; Mosca, Guillermina; Sanchez Mercol, Victoria I.] Minist Ciencia Tecn & Innovac Prod, Programa INFANT, Buenos Aires, DF, Argentina; [Dunaiewsky, Mariana; Guglielmo, Maria C.; Neder, Maria D.; Davenport, Maria C.; Del Valle, Maria P.; Santidrian, Valeria S.; Ferrero, Fernando; Bonina, Angel] Hosp Ninos Pedro de Elizalde, Buenos Aires, DF, Argentina; [Reynoso, Natalia; Mosca, Guillermina; Garcia Dominguez, Mercedes; Luedicke, Nora] Hosp Materno Infantil Dr Carlos Gianantonio, Buenos Aires, DF, Argentina; [Cavalieri, Maria L.; Soledad Areso, M.; Sanchez Mercol, Victoria I.; Carlos Peuchot, Juan] Hosp Eva Peron, Buenos Aires, DF, Argentina; [Gilligan, Tomas; Santucho, Fernanda; Saligari, Liliana; Landa, Patricia; Pota, Ana; Bolonati, Norma; Dalamon, Ricardo; Karolinski, Ariel; Bruno, Miriam] Hosp Durand, Buenos Aires, DF, Argentina; [Cabral, Graciela; Gregorio, Gabriela L.; Moreno, Rina; Lutz, Maria I.; Panigasi, Alicia L.; Saligari, Liliana; Ramonet, Margarita; Albano, Lidia C.] Hosp Posadas, Buenos Aires, DF, Argentina; [Caballero, Mauricio T.; Eguees Almeida, Rodrigo M.; Gutierrez Meyer, Maria E.; Borsa, Ana] Hosp Ninos Sor Maria Ludovica, Buenos Aires, DF, Argentina; [Savy, Vilma; Baumeister, Elsa] Dr Carlos G Malbran Inst, Buenos Aires, DF, Argentina; [Chappell, James D.] Vanderbilt Univ, Dept Pathol, Nashville, TN 37232 USA	Vanderbilt University; University of Buenos Aires; University of Buenos Aires; Vanderbilt University	Polack, FP (corresponding author), Vanderbilt Univ, Dept Pediat, Vanderbilt Vaccine Ctr, 1161 21st Ave,D-7235 MCN, Nashville, TN 37232 USA.	fernando.p.polack@vanderbilt.edu	Ferrero, Fernando/AAE-1886-2020; Hijano, Diego/N-2665-2018	Ferrero, Fernando/0000-0001-6335-0102; Hijano, Diego/0000-0002-2903-666X; Davenport, Maria Carolina/0000-0002-6675-8813	Fundacion INFANT 2008 Fundraising Campaign; National Institute of Environmental Health Sciences; Argentine National Ministry of Health; Thrasher Research Fund; Fogarty International Center Clinical Research Fellow Program at Vanderbilt University	Fundacion INFANT 2008 Fundraising Campaign; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Argentine National Ministry of Health; Thrasher Research Fund; Fogarty International Center Clinical Research Fellow Program at Vanderbilt University(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	Supported by the Fundacion INFANT 2008 Fundraising Campaign and the Director's Challenge Award from the National Institute of Environmental Health Sciences (to Dr. Polack); the Carrillo - Onativia Scholarship, Argentine National Ministry of Health (to Dr. Bugna); and an Early Career Thrasher Award from the Thrasher Research Fund and the Fogarty International Center Clinical Research Fellow Program at Vanderbilt University (to Dr. Melendi).	Andreasen V, 2008, J INFECT DIS, V197, P270, DOI 10.1086/524065; Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; Chowell G, 2009, NEW ENGL J MED, V361, P674, DOI 10.1056/NEJMoa0904023; Cordova-Villalobos Jose A, 2009, Health Res Policy Syst, V7, P21, DOI 10.1186/1478-4505-7-21; Freymuth F, 2006, J MED VIROL, V78, P1498, DOI 10.1002/jmv.20725; Hackett S, 2009, LANCET, V374, P605, DOI 10.1016/S0140-6736(09)61511-7; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Laham FR, 2004, J INFECT DIS, V189, P2047, DOI 10.1086/383350; Lister P, 2009, LANCET, V374, P605, DOI [10.1016/S0140-6736(09)61512-9, 10.1016/S0140-6736(09)61513-0]; Martinez FD, 2001, J ALLERGY CLIN IMMUN, V107, pS449, DOI 10.1067/mai.2001.114993; *MIN SAL, IN PAND INFL 2009; Neuzil KM, 2000, NEW ENGL J MED, V342, P225, DOI 10.1056/NEJM200001273420401; Olson DR, 2005, P NATL ACAD SCI USA, V102, P11059, DOI 10.1073/pnas.0408290102; Perez-Padilla R, 2009, NEW ENGL J MED, V361, P680, DOI 10.1056/NEJMoa0904252; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Rahman M, 2008, DIAGN MICR INFEC DIS, V62, P162, DOI 10.1016/j.diagmicrobio.2007.10.012; Simonsen L, 1998, J INFECT DIS, V178, P53, DOI 10.1086/515616; Simonsen L, 2005, THREAT PANDEMIC INFL, P89, DOI DOI 10.2105/AJPH.2007.119933; *SOC ARG PED, CAL VAC; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; RESULTADOS PROVINCIA; GEOGRAPHIC SPREAD IN; 2009, MMWR MORB MORTAL WKL, V58, P521; 2009, SITUACION INFLUENZA; 2009 H1N1 VACCINATIO; H1N1 FLU CLIN PUBLIC; CASES HUMAN INFECT P; SWINE INFLUENZA CASE	30	314	335	0	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2010	362	1					45	55		10.1056/NEJMoa0907673	http://dx.doi.org/10.1056/NEJMoa0907673			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	540PA	20032320				2022-12-28	WOS:000273345500008
J	Mahtani, KR; Rose, PW; van Someren, N				Mahtani, Kamal R.; Rose, Peter W.; van Someren, Niall			Case report Microscopic colitis in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IRRITABLE-BOWEL-SYNDROME; COLLAGENOUS COLITIS; LYMPHOCYTIC COLITIS; DISEASE; BUDESONIDE; DIARRHEA; RISK		[Rose, Peter W.] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; [van Someren, Niall] Chase Farm Hosp, Dept Med, Enfield EN2 8JL, Middx, England	University of Oxford; University of London; University College London; Royal Free London NHS Foundation Trust		kamal.mahtani@dphpc.ox.ac.uk			National Institute for Health Research [ACF-2008-13-014] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Chande N, 2005, SCAND J GASTROENTERO, V40, P343, DOI 10.1080/00365520510011623; Chande N, 2009, AM J GASTROENTEROL, V104, P235, DOI 10.1038/ajg.2008.16; Chiba M, 2009, WORLD J GASTROENTERO, V15, P2166, DOI 10.3748/wjg.15.2166; *DEP HLTH, 2000, GUID URG REF PAT SUP; Fernandez-Banares F, 1999, AM J GASTROENTEROL, V94, P418, DOI 10.1111/j.1572-0241.1999.00870.x; Fernandez-Banares F, 2007, AM J GASTROENTEROL, V102, P324, DOI 10.1111/j.1572-0241.2006.00902.x; Ford AC, 2008, JAMA-J AM MED ASSOC, V300, P1793, DOI 10.1001/jama.300.15.1793; Jones R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1877; Kao KT, 2009, WORLD J GASTROENTERO, V15, P3122, DOI 10.3748/wjg.15.3122; Limsui D, 2007, INFLAMM BOWEL DIS, V13, P175, DOI 10.1002/ibd.20059; McKeage K, 2002, DRUGS, V62, P2263, DOI 10.2165/00003495-200262150-00015; Miehlke S, 2009, GASTROENTEROLOGY, V136, P2092, DOI 10.1053/j.gastro.2009.02.078; Nielsen OH, 2004, LANCET, V364, P2055, DOI 10.1016/S0140-6736(04)17518-1; Olesen M, 2004, GUT, V53, P346, DOI 10.1136/gut.2003.014431; Pardi DS, 2007, GUT, V56, P504, DOI 10.1136/gut.2006.105890; RIDDELL RH, 1992, GUT, V33, P683, DOI 10.1136/gut.33.5.683; TALLEY NJ, 1992, AM J EPIDEMIOL, V136, P165, DOI 10.1093/oxfordjournals.aje.a116483; Thielman NM, 2004, NEW ENGL J MED, V350, P38, DOI 10.1056/NEJMcp031534; Thomas PD, 2003, GUT, V52, P1; Thomson RD, 2002, AM J GASTROENTEROL, V97, P2908; Williams JJ, 2008, CLIN GASTROENTEROL H, V6, P35, DOI 10.1016/j.cgh.2007.10.031	21	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2010	340								b5520	10.1136/bmj.b5520	http://dx.doi.org/10.1136/bmj.b5520			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542IE	20053827				2022-12-28	WOS:000273485500007
J	Skelhorn, J; Rowland, HM; Speed, MP; Ruxton, GD				Skelhorn, John; Rowland, Hannah M.; Speed, Michael P.; Ruxton, Graeme D.			Masquerade: Camouflage Without Crypsis	SCIENCE			English	Article							MIMICRY		[Skelhorn, John; Ruxton, Graeme D.] Univ Glasgow, Fac Biomed & Life Sci, Div Ecol & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland; [Rowland, Hannah M.; Speed, Michael P.] Univ Liverpool, Sch Biol Sci, Div Populat & Evolutionary Biol, Liverpool L69 7ZB, Merseyside, England	University of Glasgow; University of Liverpool	Ruxton, GD (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Div Ecol & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland.	G.Ruxton@bio.gla.ac.uk	Rowland, Hannah/D-8114-2012	Rowland, Hannah/0000-0002-1040-555X; Ruxton, Graeme/0000-0001-8943-6609	Natural Environment Research Council [NE/F002653/1] Funding Source: researchfish; NERC [NE/F002653/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ALLEN JA, 1985, J BIOL EDUC, V19, P268, DOI 10.1080/00219266.1985.9654747; ENDLER JA, 1981, BIOL J LINN SOC, V16, P25, DOI 10.1111/j.1095-8312.1981.tb01840.x; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; SPEED MP, 1993, ANIM BEHAV, V46, P1246, DOI 10.1006/anbe.1993.1321; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; [No title captured]	6	156	161	7	176	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					51	51		10.1126/science.1181931	http://dx.doi.org/10.1126/science.1181931			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044568				2022-12-28	WOS:000273395400026
J	Reavell, GT				Reavell, G. Thomas			Jobs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												tomreavell@msn.com							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	2009	302	23					2523	2524		10.1001/jama.2009.1809	http://dx.doi.org/10.1001/jama.2009.1809			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532HK	20009046				2022-12-28	WOS:000272737200001
J	Endersby, J				Endersby, Jim			Lumpers and Splitters: Darwin, Hooker, and the Search for Order	SCIENCE			English	Review							SYSTEMATICS	Classification was a key practice of the natural history sciences in the early 19th century, but leading taxonomists disagreed over basic matters, such as how many species the British flora contained. In this arena, the impact of Charles Darwin's ideas was surprisingly limited. For taxonomists like Darwin's friend, Joseph Dalton Hooker, the priority was to establish a reputation as a philosophical naturalist, and to do so Hooker embarked on a survey of global vegetation patterns. He believed that taxonomic "splitters" hindered his ambition to create natural laws for botany (and hence establish it as a prestigious science) by generating a multitude of redundant synonyms for every plant variety. Despite the fact that Darwin's ideas apparently promised a justification for splitting, they also offered a philosophical justification for Hooker's taxonomic practice, and so he enthusiastically championed his friend.	Univ Sussex, Dept Hist, Brighton BN1 9SH, E Sussex, England	University of Sussex	Endersby, J (corresponding author), Univ Sussex, Dept Hist, Brighton BN1 9SH, E Sussex, England.	j.j.endersby@sussex.ac.uk		Endersby, Jim/0000-0001-8219-4088				ALLEN DE, 2001, STUD HIST PHILOS S C, V32, P277; Bowler Peter, 2007, MONKEY TRIALS GORILL; BREWSTER D, 1833, EDINB REV, V57, P39; Brooke John Hedley, 1991, SCI RELIG SOME HIST, P309; Burkhardt F, 1990, CORRES C DARWIN, V6; Darwin C, 2009, ON THE ORIGIN OF SPECIES, P1, DOI 10.1017/CBO9780511694295.004; DEQUEIROZ K, 1988, PHILOS SCI, V55, P238, DOI 10.1086/289430; Dixon Thomas., 2008, SCI RELIG VERY SHORT; Hooker J.D, 1860, FLORA AUSTR ITS ORIG; Hooker J. D, 1853, INTRO ESSAY FLORA NO; HOOKER JD, 1851, FLORA NOVAE ZELANDIA, V2; Hooker JD, 1855, INTRO ESSAY FLORA IN; Hooker JD, 1861, T LINNEAN SOC LONDON, V23, P251; Hull, 2010, SCI PROCESS EVOLUTIO; Huxley L, 1918, LIFE LETT JD HOOKER, VI; PORTER DM, 1993, J HIST BIOL, V26, P1, DOI 10.1007/BF01060678; ROSS JC, 1847, VOYAGE DISCOVERY RES, V1, P64; *ROYAL BOT GARD, 1854, ARCH ROYAL BOT GARD, V174; Stamos David N., 2007, DARWIN NATURE SPECIE; STEVENS P. F., 1996, HIST REC AUSTR SCI, V11, P345; Stevens PF, 2000, TAXON, V49, P635, DOI 10.2307/1223969; Winsor MP, 2006, ANN MO BOT GARD, V93, P2, DOI 10.3417/0026-6493(2006)93[2:LBWNE]2.0.CO;2; 1863, NAT HIST REV Q J BIO, V10, P34	23	31	32	1	15	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1496	1499		10.1126/science.1165915	http://dx.doi.org/10.1126/science.1165915			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007893				2022-12-28	WOS:000272623600047
J	Jorgensen, C; Sherman, A; Chen, GI; Pasculescu, A; Poliakov, A; Hsiung, M; Larsen, B; Wilkinson, DG; Linding, R; Pawson, T				Jorgensen, Claus; Sherman, Andrew; Chen, Ginny I.; Pasculescu, Adrian; Poliakov, Alexei; Hsiung, Marilyn; Larsen, Brett; Wilkinson, David G.; Linding, Rune; Pawson, Tony			Cell-Specific Information Processing in Segregating Populations of Eph Receptor Ephrin-Expressing Cells	SCIENCE			English	Article							PHOSPHORYLATION NETWORKS; TYROSINE PHOSPHORYLATION; TRANSMEMBRANE LIGANDS; PROTEINS; FAMILY; ACTIVATION; ADHESION; KINASE; RESPONSES; PATHWAY	Cells have self-organizing properties that control their behavior in complex tissues. Contact between cells expressing either B-type Eph receptors or their transmembrane ephrin ligands initiates bidirectional signals that regulate cell positioning. However, simultaneously investigating how information is processed in two interacting cell types remains a challenge. We implemented a proteomic strategy to systematically determine cell-specific signaling networks underlying EphB2-and ephrin-B1-controlled cell sorting. Quantitative mass spectrometric analysis of mixed populations of EphB2-and ephrin-B1-expressing cells that were labeled with different isotopes revealed cell-specific tyrosine phosphorylation events. Functional associations between these phosphotyrosine signaling networks and cell sorting were established with small interfering RNA screening. Data-driven network modeling revealed that signaling between mixed EphB2-and ephrin-B1-expressing cells is asymmetric and that the distinct cell types use different tyrosine kinases and targets to process signals induced by cell-cell contact. We provide systems- and cell-specific network models of contact-initiated signaling between two distinct cell types.	[Linding, Rune] Inst Canc Res, Sect Cell & Mol Biol, Cellular & Mol Log Team, London SW3 6JB, England; [Jorgensen, Claus; Sherman, Andrew; Chen, Ginny I.; Pasculescu, Adrian; Hsiung, Marilyn; Larsen, Brett; Pawson, Tony] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Sherman, Andrew; Chen, Ginny I.; Pawson, Tony] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Poliakov, Alexei; Wilkinson, David G.] Natl Inst Med Res, Div Dev Neurobiol, MRC, London NW7 1AA, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; MRC National Institute for Medical Research	Linding, R (corresponding author), Inst Canc Res, Sect Cell & Mol Biol, Cellular & Mol Log Team, London SW3 6JB, England.	linding@icr.ac.uk; pawson@lunenfeld.ca	Pawson, Tony J/E-4578-2013; Poliakov, Alexei/C-6362-2008	Poliakov, Alexei/0000-0001-7428-4040; Wilkinson, David/0000-0001-6757-7080; Linding, Rune/0000-0003-0420-4839; Jorgensen, Claus/0000-0002-7841-943X	Canadian Cancer Society; Canadian Institutes for Health [MOP-6849]; Canada Foundation for Innovation; Human Frontiers Science Program; Lundbeck Foundation; Medical Research Council [MC_U117532048] Funding Source: researchfish; MRC [MC_U117532048] Funding Source: UKRI	Canadian Cancer Society(Canadian Cancer Society (CCS)); Canadian Institutes for Health(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Human Frontiers Science Program(Human Frontier Science Program); Lundbeck Foundation(Lundbeckfonden); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Bakal, J. Erler, C. Marshall, R. Marais (ICR), and K. Colwill (SLRI) for critical input on this manuscript. The authors are further indebted to O. Rocks, A. James, V. Nguyen, R. Bagshaw, A.-C. Gingras (SLRI), P. Huang (ICR), L. Foster (University of British Columbia), L. J Jensen (Center for Protein Research), S. Tate (Applied Biosystems/Sciex), and Thermo Scientific (in particular A. Sullivan) for technical assistance. This project was supported by Genome Canada through the Ontario Genomics Institute, a Terry Fox Programme grant from the Canadian Cancer Society, the Canadian Institutes for Health Research (grant MOP-6849), the Canada Foundation for Innovation, the Human Frontiers Science Program, and The Lundbeck Foundation. C.J. conceived and implemented the qBidS approach. R. L. conceived and performed the modeling work. C.J, A. S., and T. P. conceived and designed the siRNA screen. D. G. W. and A. P. (MRC NIMR) provided cell lines and advice on cell sorting. C.J., A. S., G. I. C., M. H., and B. L. conceived, designed, and performed the experiments. A. P., C.J., and R. L. conceived, designed, and performed the computational experiments. T. P. and R. L. oversaw the project. C.J., R. L., and T. P. wrote the paper. Mass spectrometric data has been submitted to the Proteomics Identifications (PRIDE) database under accession numbers 10295-10296.	Arvanitis D, 2008, GENE DEV, V22, P416, DOI 10.1101/gad.1630408; Bakal C, 2008, SCIENCE, V322, P453, DOI 10.1126/science.1158739; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Bruckner K, 1999, NEURON, V22, P511, DOI 10.1016/S0896-6273(00)80706-0; Bruckner K, 1997, SCIENCE, V275, P1640, DOI 10.1126/science.275.5306.1640; Cortina C, 2007, NAT GENET, V39, P1376, DOI 10.1038/ng.2007.11; Davy A, 1999, GENE DEV, V13, P3125, DOI 10.1101/gad.13.23.3125; Downward J, 2001, NATURE, V411, P759, DOI 10.1038/35081138; Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836; Gelfand MV, 2009, TRENDS CELL BIOL, V19, P99, DOI 10.1016/j.tcb.2009.01.001; Gordus A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.72; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Holland SJ, 1996, NATURE, V383, P722, DOI 10.1038/383722a0; Holland SJ, 1997, EMBO J, V16, P3877, DOI 10.1093/emboj/16.13.3877; Janes KA, 2005, SCIENCE, V310, P1646, DOI 10.1126/science.1116598; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Jorgensen Claus, 2008, Briefings in Functional Genomics & Proteomics, V7, P17, DOI 10.1093/bfgp/eln001; Kim L, 1998, J BIOL CHEM, V273, P23542, DOI 10.1074/jbc.273.36.23542; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Lin D, 1999, J BIOL CHEM, V274, P3726, DOI 10.1074/jbc.274.6.3726; Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052; MCGLADE J, 1993, EMBO J, V12, P3073, DOI 10.1002/j.1460-2075.1993.tb05976.x; Mellitzer G, 1999, NATURE, V400, P77, DOI 10.1038/21907; Miao H, 2000, NAT CELL BIOL, V2, P62, DOI 10.1038/35000008; Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433; Miller-Jensen K, 2007, NATURE, V448, P604, DOI 10.1038/nature06001; Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Poliakov A, 2008, J CELL BIOL, V183, P933, DOI 10.1083/jcb.200807151; ROZAKISADCOCK M, 1992, NATURE, V360, P689, DOI 10.1038/360689a0; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Shintani T, 2006, NAT NEUROSCI, V9, P761, DOI 10.1038/nn1697; Stein E, 1998, GENE DEV, V12, P667, DOI 10.1101/gad.12.5.667; Tan CSH, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000316; Tan CSH, 2009, SCIENCE, V325, P1686, DOI 10.1126/science.1174301; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	39	184	189	0	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1502	1509		10.1126/science.1176615	http://dx.doi.org/10.1126/science.1176615			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007894				2022-12-28	WOS:000272623600049
J	Aasebo, U; Kjaer, KG				Aasebo, Ulf; Kjaer, Kjell G.			CHRISTMAS: DIAGNOSIS Lead poisoning as possible cause of deaths at the Swedish House at Kapp Thordsen, Spitsbergen, winter 1872-3	BRITISH MEDICAL JOURNAL			English	Editorial Material								Objective To investigate cause of death in 17 sealers who died in the Swedish house in Kapp Thordsen, Spitsbergen, during the winter of 1872-3. Design Analysis of skeletal samples from one sealer's grave. Setting Field trip to Spitsbergen to exhume skeletal remains. Subjects One of 17 sailors who died in 1872-3. Results No objective signs of scurvy were found. The concentration of lead in the bone samples was 102.05 mu g/g. Conclusions The high concentrations of lead indicate that this man died from lead poisoning, probably from food tins. The absence of macroscopic signs of scurvy supports this theory.	[Aasebo, Ulf] Univ Tromso, Inst Clin Med, N-9001 Tromso, Norway; [Aasebo, Ulf] Univ Hosp N Norway, Dept Lung Med, Tromso, Norway	UiT The Arctic University of Tromso; UiT The Arctic University of Tromso; University Hospital of North Norway	Aasebo, U (corresponding author), Univ Tromso, Inst Clin Med, N-9001 Tromso, Norway.	ulf.aasebo@unn.no						ALBRIGTSEN K, 1973, COMMUNICATION   1014; Beattie O., 2004, FROZEN TIME FATE FRA; Busch J., 1981, HIST ARCHAEOL, V15, P95, DOI DOI 10.1007/BF03374016; CAKE KM, 1994, THESIS MCMASTERS U; ENVALL A, 1874, RAPPORT TILL KUNGL S, P87; Horowitz BZ, 2003, J TOXICOL-CLIN TOXIC, V41, P841, DOI 10.1081/CLT-120025349; HOUSTON CS, 1986, CAN MED ASSOC J, V135, P109; Keeleyside A., 1996, J ARCHAEOL SCI, V23, P461; Kjellman F.R., 1875, SVENSKA POLAR EXPEDI; KONOW T, 1816, 4085 NORSK TIDSSKR S; LAMB J, 2007, CAPTAIN COOK SCOURGE; MACK F, 1873, COMMUNICATION   0618; MAGRUDER WE, 1883, MED NEWS        0908, P261; McCORD C P, 1954, Ind Med Surg, V23, P120; NEARING JN, 1987, HLTH EFFECTS INORGAN; Rollin HB, 2009, J ENVIRON MONITOR, V11, P618, DOI 10.1039/b816236k; TELLEFSEN OB, 1873, HIS DIARY 1873 UNPUB; TLEBERG J, 1873, TROMSO STIFTSTI 0504; TLEBERG J, 1873, TROMSO STIFTSTIDENDE; WOODARD HELEN QUINCY, 1962, HEALTH PHYS, V8, P513, DOI 10.1097/00004032-196210000-00005	20	1	1	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 4	2009	339								b5038	10.1136/bmj.b5038	http://dx.doi.org/10.1136/bmj.b5038			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	528NU	19965937	Green Submitted, hybrid, Green Published			2022-12-28	WOS:000272453700002
J	Flora, A; Klisch, TJ; Schuster, G; Zoghbi, HY				Flora, Adriano; Klisch, Tiemo J.; Schuster, Gabriele; Zoghbi, Huda Y.			Deletion of Atoh1 Disrupts Sonic Hedgehog Signaling in the Developing Cerebellum and Prevents Medulloblastoma	SCIENCE			English	Article							MATH1; GENES; MOUSE; SUBTYPES; NEURONS; BINDING	Granule neuron precursors (GNPs) are the most actively proliferating cells in the postnatal nervous system, and mutations in pathways that control the GNP cell cycle can result in medulloblastoma. The transcription factor Atoh1 has been suspected to contribute to GNP proliferation, but its role in normal and neoplastic postnatal cerebellar development remains unexplored. We show that Atoh1 regulates the signal transduction pathway of Sonic Hedgehog, an extracellular factor that is essential for GNP proliferation, and demonstrate that deletion of Atoh1 prevents cerebellar neoplasia in a mouse model of medulloblastoma. Our data shed light on the function of Atoh1 in postnatal cerebellar development and identify a new mechanism that can be targeted to regulate medulloblastoma formation.	[Flora, Adriano; Klisch, Tiemo J.; Schuster, Gabriele; Zoghbi, Huda Y.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Klisch, Tiemo J.; Zoghbi, Huda Y.] Baylor Coll Med, Howard Hughes Med Inst, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Zoghbi, Huda Y.] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Howard Hughes Medical Institute; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Zoghbi, HY (corresponding author), Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA.	hzoghbi@bcm.edu		Klisch, Tiemo/0000-0001-8182-384X; Zoghbi, Huda/0000-0002-0700-3349	Intellectual and Developmental Disabilities Research Center at Baylor College of Medicine [5 P30 HD024064]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD024064] Funding Source: NIH RePORTER	Intellectual and Developmental Disabilities Research Center at Baylor College of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	We thank H.-T. Chao, X. Liu, and R. Atkinson for experimental support and V. Brandt for helping in editing the manuscript. We thank H. Bellen, G. Dotti, M. B. Bhattacharjee, E. Battaglioli, J. Neul, and members of the Zoghbi lab for critical reading of the manuscript. The confocal microscopy was supported by the Intellectual and Developmental Disabilities Research Center at Baylor College of Medicine ( 5 P30 HD024064). H. Y. Z. is an investigator and T. J. K. is a postdoctoral	Badea TC, 2003, J NEUROSCI, V23, P2314; Ben-Arie N, 2000, DEVELOPMENT, V127, P1039; BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Blaess S, 2006, DEVELOPMENT, V133, P1799, DOI 10.1242/dev.02339; Bossuyt W, 2009, PLOS BIOL, V7, P311, DOI 10.1371/journal.pbio.1000039; Briggs KJ, 2008, GENE DEV, V22, P770, DOI 10.1101/gad.1640908; Corrales JMD, 2004, DEVELOPMENT, V131, P5581, DOI 10.1242/dev.01438; Gilbertson RJ, 2008, ANNU REV PATHOL-MECH, V3, P341, DOI 10.1146/annurev.pathmechdis.3.121806.151518; Kessler JD, 2009, GENE DEV, V23, P157, DOI 10.1101/gad.1759909; Krizhanovsky V, 2006, J MOL NEUROSCI, V28, P211, DOI 10.1385/JMN:28:2:211; Lewis PM, 2004, DEV BIOL, V270, P393, DOI 10.1016/j.ydbio.2004.03.007; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Polkinghorn WR, 2007, NAT CLIN PRACT ONCOL, V4, P295, DOI 10.1038/ncponc0794; Robertson AG, 2008, GENOME RES, V18, P1906, DOI 10.1101/gr.078519.108; Rose MF, 2009, NEURON, V64, P341, DOI 10.1016/j.neuron.2009.10.023; Salsano E, 2004, NEUROSCI LETT, V370, P180, DOI 10.1016/j.neulet.2004.08.053; Sasaki H, 1999, DEVELOPMENT, V126, P3915; Schuller U, 2008, CANCER CELL, V14, P123, DOI 10.1016/j.ccr.2008.07.005; Shroyer NF, 2005, GENE DEV, V19, P2412, DOI 10.1101/gad.1353905; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Zhao H, 2008, GENE DEV, V22, P722, DOI 10.1101/gad.1636408	22	120	128	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1424	1427		10.1126/science.1181453	http://dx.doi.org/10.1126/science.1181453			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965762	Green Accepted			2022-12-28	WOS:000272351100049
J	Lloyd-Smith, JO; George, D; Pepin, KM; Pitzer, VE; Pulliam, JRC; Dobson, AP; Hudson, PJ; Grenfell, BT				Lloyd-Smith, James O.; George, Dylan; Pepin, Kim M.; Pitzer, Virginia E.; Pulliam, Juliet R. C.; Dobson, Andrew P.; Hudson, Peter J.; Grenfell, Bryan T.			Epidemic Dynamics at the Human-Animal Interface	SCIENCE			English	Review							ACUTE RESPIRATORY SYNDROME; TRANSMISSION DYNAMICS; SYNDROME CORONAVIRUS; RISK-FACTORS; HOST-RANGE; EMERGENCE; VIRUS; SPREAD; SARS; BSE	Few infectious diseases are entirely human-specific: Most human pathogens also circulate in animals or else originated in nonhuman hosts. Influenza, plague, and trypanosomiasis are classic examples of zoonotic infections that transmit from animals to humans. The multihost ecology of zoonoses leads to complex dynamics, and analytical tools, such as mathematical modeling, are vital to the development of effective control policies and research agendas. Much attention has focused on modeling pathogens with simpler life cycles and immediate global urgency, such as influenza and severe acute respiratory syndrome. Meanwhile, vector-transmitted, chronic, and protozoan infections have been neglected, as have crucial processes such as cross-species transmission. Progress in understanding and combating zoonoses requires a new generation of models that addresses a broader set of pathogen life histories and integrates across host species and scientific disciplines.	[Lloyd-Smith, James O.] Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA; [Lloyd-Smith, James O.; George, Dylan; Pitzer, Virginia E.; Pulliam, Juliet R. C.; Hudson, Peter J.; Grenfell, Bryan T.] NIH, Fogarty Int Ctr, Bethesda, MD 20892 USA; [George, Dylan] Colorado State Univ, Dept Biol, Ft Collins, CO 80523 USA; [Pepin, Kim M.; Pitzer, Virginia E.; Hudson, Peter J.; Grenfell, Bryan T.] Penn State Univ, Ctr Infect Dis Dynam, University Pk, PA 16802 USA; [Dobson, Andrew P.; Grenfell, Bryan T.] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA; [Dobson, Andrew P.; Grenfell, Bryan T.] Princeton Univ, Woodrow Wilson Sch, Princeton, NJ 08544 USA	University of California System; University of California Los Angeles; National Institutes of Health (NIH) - USA; NIH Fogarty International Center (FIC); Colorado State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Princeton University; Princeton University	Lloyd-Smith, JO (corresponding author), Univ Calif Los Angeles, Dept Ecol & Evolutionary Biol, Los Angeles, CA 90095 USA.	jlloydsmith@ucla.edu	Hudson, Peter/AAB-8080-2020; Pulliam, Juliet RC/A-6516-2008; Lloyd-Smith, James/AAG-4463-2021; /K-4080-2012	Hudson, Peter/0000-0003-0468-3403; Pulliam, Juliet RC/0000-0003-3314-8223; /0000-0001-7941-502X; Pitzer, Virginia/0000-0003-1015-2289	Science and Technology Directorate, U. S. Department of Homeland Security; Fogarty International Center, NIH; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R24HD047879] Funding Source: NIH RePORTER	Science and Technology Directorate, U. S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Fogarty International Center, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the Research and Policy for Infectious Disease Dynamics (RAPIDD) program of the Science and Technology Directorate, U. S. Department of Homeland Security, and the Fogarty International Center, NIH. We are grateful to O. Bjornstad, E. McKenzie, M. Poss, A. Read, and L. Simonsen for valuable comments and to B. Gee for assistance with figure preparation. J. L.-S. is grateful for the support of the De Logi Chair in Biological Sciences.	ANDERSON R M, 1991; Anderson RM, 1996, NATURE, V382, P779, DOI 10.1038/382779a0; Antia R, 2003, NATURE, V426, P658, DOI 10.1038/nature02104; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Childs JE, 2007, CURR TOP MICROBIOL, V315, P389; Childs JE, 2007, CURR TOP MICROBIOL, V315, P1; Cooper BS, 2006, PLOS MED, V3, P845, DOI 10.1371/journal.pmed.0030212; Daszak P, 2007, CURR TOP MICROBIOL, V315, P463; Dobson A, 2004, AM NAT, V164, pS64, DOI 10.1086/424681; Donnelly CA, 2003, LANCET, V361, P1761, DOI 10.1016/S0140-6736(03)13410-1; Ferguson NM, 2004, SCIENCE, V304, P968, DOI 10.1126/science.1096898; Ferguson NM, 1997, PHILOS T R SOC B, V352, P803, DOI 10.1098/rstb.1997.0063; Ferguson NM, 1998, P ROY SOC B-BIOL SCI, V265, P545, DOI 10.1098/rspb.1998.0329; FINE PEM, 1988, INT J EPIDEMIOL, V17, P643, DOI 10.1093/ije/17.3.643; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Graham AL, 2007, TRENDS PARASITOL, V23, P284, DOI 10.1016/j.pt.2007.04.005; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Gumel AB, 2004, P ROY SOC B-BIOL SCI, V271, P2223, DOI 10.1098/rspb.2004.2800; Halloran ME, 2008, P NATL ACAD SCI USA, V105, P4639, DOI 10.1073/pnas.0706849105; Hampson K, 2009, PLOS BIOL, V7, P462, DOI 10.1371/journal.pbio.1000053; Hassan R., 2005, ECOSYSTEMS HUMAN WEL; Hsieh YH, 2007, J THEOR BIOL, V244, P729, DOI 10.1016/j.jtbi.2006.09.015; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jordan D, 1999, PREV VET MED, V41, P55, DOI 10.1016/S0167-5877(99)00032-X; Keeling MJ., 2008, MODELING INFECT DIS, DOI DOI 10.1515/9781400841035; Kilpatrick AM, 2006, P ROY SOC B-BIOL SCI, V273, P2327, DOI 10.1098/rspb.2006.3575; King RJ, 2004, EMERG INFECT DIS, V10, P598, DOI 10.3201/eid1004.030241; Kuiken T, 2006, SCIENCE, V312, P394, DOI 10.1126/science.1122818; Laurenson MK, 2003, J ANIM ECOL, V72, P177, DOI 10.1046/j.1365-2656.2003.00688.x; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; Lloyd-Smith JO, 2003, P ROY SOC B-BIOL SCI, V270, P1979, DOI 10.1098/rspb.2003.2481; Lloyd-Smith JO, 2005, NATURE, V438, P355, DOI 10.1038/nature04153; Morens DM, 2008, LANCET INFECT DIS, V8, P710, DOI 10.1016/S1473-3099(08)70256-1; Ostfeld RS, 2006, PLOS BIOL, V4, P1058, DOI 10.1371/journal.pbio.0040145; Palmer SR, 1998, ZOONOSES BIOL CLIN P; Riley S, 2003, SCIENCE, V300, P1961, DOI 10.1126/science.1086478; Rimoin AW, 2007, EMERG INFECT DIS, V13, P934, DOI 10.3201/eid1306.061540; Russell CA, 2005, PLOS BIOL, V3, P382, DOI 10.1371/journal.pbio.0030088; RVACHEV LA, 1985, MATH BIOSCI, V75, P3, DOI 10.1016/0025-5564(85)90064-1; Sauvage F, 2007, EPIDEMIOL INFECT, V135, P46, DOI 10.1017/S0950268806006595; Sheahan T, 2008, J VIROL, V82, P2274, DOI 10.1128/JVI.02041-07; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; SMOLINKSY MS, 2003, MICROBIAL THREATS HL; Song HD, 2005, P NATL ACAD SCI USA, V102, P2430, DOI 10.1073/pnas.0409608102; Taylor LH, 2001, PHILOS T R SOC B, V356, P983, DOI 10.1098/rstb.2001.0888; Wallinga J, 2004, AM J EPIDEMIOL, V160, P509, DOI 10.1093/aje/kwh255; Weiss RA, 2004, NAT MED, V10, pS70, DOI 10.1038/nm1150; Wolfe ND, 2007, NATURE, V447, P279, DOI 10.1038/nature05775; Wolfe ND, 2005, EMERG INFECT DIS, V11, P1822, DOI 10.3201/eid1112.040789; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338; Woolhouse MEJ, 2005, EMERG INFECT DIS, V11, P1842, DOI 10.3201/eid1112.050997	51	415	422	5	196	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1362	1367		10.1126/science.1177345	http://dx.doi.org/10.1126/science.1177345			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965751	Green Accepted			2022-12-28	WOS:000272351100031
J	Myers, S; Bowden, R; Tumian, A; Bontrop, RE; Freeman, C; MacFie, TS; McVean, G; Donnelly, P				Myers, Simon; Bowden, Rory; Tumian, Afidalina; Bontrop, Ronald E.; Freeman, Colin; MacFie, Tammie S.; McVean, Gil; Donnelly, Peter			Drive Against Hotspot Motifs in Primates Implicates the PRDM9 Gene in Meiotic Recombination	SCIENCE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; HISTONE H3 METHYLTRANSFERASE; HUMAN GENOME; EVOLUTION; CONVERSION; INITIATION; HUMANS; MOUSE; CHIMPANZEES	Although present in both humans and chimpanzees, recombination hotspots, at which meiotic crossover events cluster, differ markedly in their genomic location between the species. We report that a 13-base pair sequence motif previously associated with the activity of 40% of human hotspots does not function in chimpanzees and is being removed by self-destructive drive in the human lineage. Multiple lines of evidence suggest that the rapidly evolving zinc-finger protein PRDM9 binds to this motif and that sequence changes in the protein may be responsible for hotspot differences between species. The involvement of PRDM9, which causes histone H3 lysine 4 trimethylation, implies that there is a common mechanism for recombination hotspots in eukaryotes but raises questions about what forces have driven such rapid change.	[Myers, Simon; Bowden, Rory; Tumian, Afidalina; McVean, Gil; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Myers, Simon; Bowden, Rory; Freeman, Colin; McVean, Gil; Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Bontrop, Ronald E.] Biomed Primate Res Ctr, Dept Comparat Genet & Refinement, NL-2288 GJ Rijswijk, Netherlands; [MacFie, Tammie S.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge	Myers, S (corresponding author), Univ Oxford, Dept Stat, 1 S Parks Rd, Oxford OX1 3TG, England.	myers@stats.ox.ac.uk	Bontrop, Ronald E/J-3628-2012; Myers, Simon R/A-6792-2015; Bontrop, Ronald E./D-4844-2011; Tumian, Afidalina/J-4404-2014	Bontrop, Ronald E/0000-0003-0874-6467; Myers, Simon R/0000-0002-2585-9626; Donnelly, Peter/0000-0001-9495-3408; Tumian, Afidalina/0000-0003-2763-6677	Leverhulme Trust; Royal Society; Wellcome Trust	Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust)	We thank N. Mundy for advice and provision of chimpanzee samples and C. Mitchell and E. Nerrienet for assisting in chimpanzee sample collection. We thank D. Falush and G. Coop for helpful conversations. Part of the work was completed while S. M. was a fellow at the Broad Institute. We would like to acknowledge funding from the Leverhulme Trust (to G. M.), the Royal Society (to P. D.), and the Wellcome Trust (to S. M., C. F., G. M., and P. D.). The chimpanzee genotype data for 22 hotspot candidate regions generated is available online with the SOM as Database S1.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Coop G, 2007, PLOS GENET, V3, P377, DOI 10.1371/journal.pgen.0030035; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; NAGYLAKI T, 1983, P NATL ACAD SCI-BIOL, V80, P6278, DOI 10.1073/pnas.80.20.6278; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Parvanov ED, 2009, PLOS BIOL, V7, P340, DOI 10.1371/journal.pbio.1000036; Persikov AV, 2009, BIOINFORMATICS, V25, P22, DOI 10.1093/bioinformatics/btn580; Presgraves DC, 2007, BIOESSAYS, V29, P386, DOI 10.1002/bies.20555; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Schimenti J, 2000, TRENDS GENET, V16, P240, DOI 10.1016/S0168-9525(00)02020-5; Webb AJ, 2008, P NATL ACAD SCI USA, V105, P10471, DOI 10.1073/pnas.0804933105; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070	26	432	438	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					876	879		10.1126/science.1182363	http://dx.doi.org/10.1126/science.1182363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20044541	Green Accepted			2022-12-28	WOS:000274408300065
J	Pellizzoni, A; Trois, A; Tavani, M; Pilia, M; Giuliani, A; Pucella, G; Esposito, P; Sabatini, S; Piano, G; Argan, A; Barbiellini, G; Bulgarelli, A; Burgay, M; Caraveo, P; Cattaneo, PW; Chen, AW; Cocco, V; Contessi, T; Costa, E; D'Ammando, F; Del Monte, E; De Paris, G; Di Cocco, G; Di Persio, G; Donnarumma, I; Evangelista, Y; Feroci, M; Ferrari, A; Fiorini, M; Fuschino, F; Galli, M; Gianotti, F; Hotan, A; Labanti, C; Lapshov, I; Lazzarotto, F; Lipari, P; Longo, F; Marisaldi, M; Mastropietro, M; Mereghetti, S; Moretti, E; Morselli, A; Pacciani, L; Palfreyman, J; Perotti, F; Picozza, P; Pittori, C; Possenti, A; Prest, M; Rapisarda, M; Rappoldi, A; Rossi, E; Rubini, A; Santolamazza, P; Scalise, E; Soffitta, P; Striani, E; Trifoglio, M; Vallazza, E; Vercellone, S; Verrecchia, F; Vittorini, V; Zambra, A; Zanello, D; Giommi, P; Colafrancesco, S; Antonelli, A; Salotti, L; D'Amico, N; Bignami, GF				Pellizzoni, A.; Trois, A.; Tavani, M.; Pilia, M.; Giuliani, A.; Pucella, G.; Esposito, P.; Sabatini, S.; Piano, G.; Argan, A.; Barbiellini, G.; Bulgarelli, A.; Burgay, M.; Caraveo, P.; Cattaneo, P. W.; Chen, A. W.; Cocco, V.; Contessi, T.; Costa, E.; D'Ammando, F.; Del Monte, E.; De Paris, G.; Di Cocco, G.; Di Persio, G.; Donnarumma, I.; Evangelista, Y.; Feroci, M.; Ferrari, A.; Fiorini, M.; Fuschino, F.; Galli, M.; Gianotti, F.; Hotan, A.; Labanti, C.; Lapshov, I.; Lazzarotto, F.; Lipari, P.; Longo, F.; Marisaldi, M.; Mastropietro, M.; Mereghetti, S.; Moretti, E.; Morselli, A.; Pacciani, L.; Palfreyman, J.; Perotti, F.; Picozza, P.; Pittori, C.; Possenti, A.; Prest, M.; Rapisarda, M.; Rappoldi, A.; Rossi, E.; Rubini, A.; Santolamazza, P.; Scalise, E.; Soffitta, P.; Striani, E.; Trifoglio, M.; Vallazza, E.; Vercellone, S.; Verrecchia, F.; Vittorini, V.; Zambra, A.; Zanello, D.; Giommi, P.; Colafrancesco, S.; Antonelli, A.; Salotti, L.; D'Amico, N.; Bignami, G. F.			Detection of Gamma-Ray Emission from the Vela Pulsar Wind Nebula with AGILE	SCIENCE			English	Article							SUPERNOVA REMNANT; TELESCOPE; HESS; DISCOVERY; EVOLUTION; CATALOG; REGION; RADIO	Pulsars are known to power winds of relativistic particles that can produce bright nebulae by interacting with the surrounding medium. These pulsar wind nebulae are observed by their radio, optical, and x-ray emissions, and in some cases also at TeV (teraelectron volt) energies, but the lack of information in the gamma-ray band precludes drawing a comprehensive multiwavelength picture of their phenomenology and emission mechanisms. Using data from the AGILE satellite, we detected the Vela pulsar wind nebula in the energy range from 100 MeV to 3 GeV. This result constrains the particle population responsible for the GeV emission and establishes a class of gamma-ray emitters that could account for a fraction of the unidentified galactic gamma-ray sources.	[Pellizzoni, A.; Pilia, M.; Burgay, M.; Possenti, A.; D'Amico, N.] INAF, Osservatorio Astron Cagliari, I-09012 Capoterra, CA, Italy; [Trois, A.; Tavani, M.; Sabatini, S.; Piano, G.; Argan, A.; Costa, E.; D'Ammando, F.; Del Monte, E.; De Paris, G.; Di Cocco, G.; Di Persio, G.; Donnarumma, I.; Evangelista, Y.; Feroci, M.; Lapshov, I.; Lazzarotto, F.; Mastropietro, M.; Pacciani, L.; Rubini, A.; Scalise, E.; Soffitta, P.] INAF IASF Roma, I-00133 Rome, Italy; [Tavani, M.; D'Ammando, F.; Picozza, P.; Striani, E.; Vittorini, V.] Univ Roma Tor Vergata, Dipartimento Fis, I-00133 Rome, Italy; [Tavani, M.; Sabatini, S.; Piano, G.; Picozza, P.; Striani, E.] INFN Roma Tor Vergata, I-00133 Rome, Italy; [Tavani, M.; Ferrari, A.] Consorzio Interuniv Fis Spaziale, I-10133 Turin, Italy; [Pilia, M.; Prest, M.] Univ Insubria, Dipartimento Fis, I-22100 Como, Italy; [Giuliani, A.; Esposito, P.; Caraveo, P.; Chen, A. W.; Contessi, T.; Fiorini, M.; Mereghetti, S.; Perotti, F.; Zambra, A.] INAF IASF Milano, I-20133 Milan, Italy; [Pucella, G.; Rapisarda, M.] ENEA Frascati, I-00044 Frascati, Roma, Italy; [Esposito, P.; Cattaneo, P. W.; Rappoldi, A.] INFN Pavia, I-27100 Pavia, Italy; [Barbiellini, G.; Longo, F.; Moretti, E.; Vallazza, E.] INFN Trieste, I-34012 Trieste, Italy; [Bulgarelli, A.; Fuschino, F.; Gianotti, F.; Labanti, C.; Marisaldi, M.; Trifoglio, M.] INAF IASF Bologna, I-40129 Bologna, Italy; [Galli, M.] ENEA Bologna, I-40128 Bologna, Italy; [Hotan, A.] Curtin Univ Technol, Perth, WA 6000, Australia; [Lipari, P.; Zanello, D.] INFN La Roma Sapienza, I-00185 Rome, Italy; [Palfreyman, J.] Univ Tasmania, Sch Math & Phys, Hobart, Tas 7001, Australia; [Santolamazza, P.; Verrecchia, F.; Giommi, P.; Colafrancesco, S.; Antonelli, A.] ESRIN, ASI Sci Data Ctr, I-00044 Frascati, Roma, Italy; [Vercellone, S.] INAF IASF Palermo, I-90146 Palermo, Italy; [Salotti, L.] ASI Agenzia Spaziale Italiana, I-00198 Rome, Italy; [D'Amico, N.] Univ Cagliari, Dipartimento Fis, I-09042 Monserrato, CA, Italy; [Bignami, G. F.] Ist Univ Super, I-27100 Pavia, Italy	Istituto Nazionale Astrofisica (INAF); Istituto Nazionale Astrofisica (INAF); University of Rome Tor Vergata; University of Rome Tor Vergata; University of Insubria; Istituto Nazionale Astrofisica (INAF); Italian National Agency New Technical Energy & Sustainable Economics Development; Istituto Nazionale di Fisica Nucleare (INFN); University of Pavia; Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale Astrofisica (INAF); Italian National Agency New Technical Energy & Sustainable Economics Development; Curtin University; University of Tasmania; Agenzia Spaziale Italiana (ASI); European Space Agency; Istituto Nazionale Astrofisica (INAF); Agenzia Spaziale Italiana (ASI); University of Cagliari	Pellizzoni, A (corresponding author), INAF, Osservatorio Astron Cagliari, Str 54, I-09012 Capoterra, CA, Italy.	apellizz@ca.astro.it	Vallazza, Erik Silvio/V-1732-2017; Morselli, Aldo/G-6769-2011; Pittori, Carlotta/C-7710-2016; Trifoglio, Massimo/F-5302-2015; Lazzarotto, Francesco/R-4124-2019; Esposito, Paolo/Q-2639-2019; Esposito, Paolo/ABE-6389-2020; Cattaneo, Paolo Walter/AAG-9097-2020; Chen, Andrew/AAC-3979-2020; Prest, Michela/V-1736-2017; Hotan, Aidan/AAH-4901-2021; ANTONELLI, ANTONELLA/C-6238-2011; Palfreyman, Jim/AAY-2239-2020; D'Amico, Nichi/A-5715-2009; Vercellone, Stefano/ABC-7250-2020; Lazzarotto, Francesco/J-4670-2012; Soffitta, Paolo/AAA-7514-2021; cattaneo, Paolo/AAC-4200-2021; Caraveo, Patrizia/AAL-5708-2020; giommi, paolo/L-1006-2018	Vallazza, Erik Silvio/0000-0002-7465-7430; Morselli, Aldo/0000-0002-7704-9553; Pittori, Carlotta/0000-0001-6661-9779; Trifoglio, Massimo/0000-0002-2505-3630; Esposito, Paolo/0000-0003-4849-5092; Esposito, Paolo/0000-0003-4849-5092; Cattaneo, Paolo Walter/0000-0001-6877-6882; Prest, Michela/0000-0003-3161-4454; Hotan, Aidan/0000-0001-7464-8801; Palfreyman, Jim/0000-0001-8691-8039; Vercellone, Stefano/0000-0003-1163-1396; Lazzarotto, Francesco/0000-0003-4871-4072; Soffitta, Paolo/0000-0002-7781-4104; Caraveo, Patrizia/0000-0003-2478-8018; Marisaldi, Martino/0000-0002-4000-3789; giommi, paolo/0000-0002-2265-5003; Evangelista, Yuri/0000-0001-6096-6710; Piano, Giovanni/0000-0002-9332-5319; Burgay, Marta/0000-0002-8265-4344; D'Ammando, Filippo/0000-0001-7618-7527; Scalise, Emanuele/0000-0002-3058-9720; Verrecchia, Francesco/0000-0003-3455-5082; Bulgarelli, Andrea/0000-0001-6347-0649; Bignami, Giovanni/0000-0001-9582-2450; Feroci, Marco/0000-0002-7617-3421; MEREGHETTI, SANDRO/0000-0003-3259-7801; Pacciani, Luigi/0000-0001-6897-5996; Moretti, Elena/0000-0001-5477-9097; Costa, Enrico/0000-0003-4925-8523; Picozza, Piergiorgio/0000-0002-7986-3321; Del Monte, Ettore/0000-0002-3013-6334; Sabatini, Sabina/0000-0003-2076-5767; Giuliani, Andrea/0000-0002-4315-1699; Gianotti, Fulvio/0000-0003-4666-119X; Argan, Andrea/0000-0002-6230-665X; Fiorini, Mauro/0000-0001-8297-1983; Fuschino, Fabio/0000-0003-2139-3299; Donnarumma, Immacolata/0000-0002-4700-4549; Tavani, Marco/0000-0003-2893-1459; Chen, Andrew/0000-0001-6425-5692; Antonelli, Lucio Angelo/0000-0002-5037-9034; Labanti, Claudio/0000-0002-5086-3619; Pellizzoni, Alberto Paolo/0000-0002-4590-0040; trois, alessio/0000-0002-3180-6002; Pilia, Maura/0000-0001-7397-8091; Rappoldi, Andrea/0000-0001-9702-7645; vittorini, valerio/0000-0002-1208-8818	Italian Space Agency; Italian Institute of Astrophysics; Italian Institute of Nuclear Physics	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); Italian Institute of Astrophysics; Italian Institute of Nuclear Physics	The AGILE mission is funded by the Italian Space Agency with scientific and programmatic participation by the Italian Institute of Astrophysics and the Italian Institute of Nuclear Physics.	Abdo AA, 2009, ASTROPHYS J SUPPL S, V183, P46, DOI 10.1088/0067-0049/183/1/46; Abdo AA, 2009, ASTROPHYS J, V696, P1084, DOI 10.1088/0004-637X/696/2/1084; Aharonian F, 2006, ASTRON ASTROPHYS, V448, pL43, DOI 10.1051/0004-6361:200600014; Aharonian FA, 2005, ASTRON ASTROPHYS, V437, pL7, DOI 10.1051/0004-6361:200500130; Alvarez H, 2001, ASTRON ASTROPHYS, V372, P636, DOI 10.1051/0004-6361:20010509; Aschenbach B, 1998, NATURE, V396, P141, DOI 10.1038/24103; Blondin JM, 2001, ASTROPHYS J, V563, P806, DOI 10.1086/324042; Caraveo PA, 2001, ASTROPHYS J, V561, P930, DOI 10.1086/323377; De Jager OC, 2007, ASTROPHYS J, V658, P1177, DOI 10.1086/511950; de Jager OC, 2008, ASTROPHYS J LETT, V689, pL125, DOI 10.1086/595959; DEJAGER OC, 1996, A AS, V120, P441; Dodson R, 2003, ASTROPHYS J, V596, P1137, DOI 10.1086/378089; DWARAKANATH KS, 1991, J ASTROPHYS ASTRON, V12, P199, DOI 10.1007/BF02702878; Enomoto R, 2006, ASTROPHYS J, V638, P397, DOI 10.1086/498858; Frail DA, 1997, ASTROPHYS J, V475, P224, DOI 10.1086/303537; Hales AS, 2004, ASTROPHYS J, V613, P977, DOI 10.1086/422598; Hartman RC, 1999, ASTROPHYS J SUPPL S, V123, P79, DOI 10.1086/313231; Helfand DJ, 2001, ASTROPHYS J, V556, P380, DOI 10.1086/321533; Horns D, 2006, ASTRON ASTROPHYS, V451, pL51, DOI 10.1051/0004-6361:20065116; KANBACH G, 1994, ASTRON ASTROPHYS, V289, P855; LaMassa SM, 2008, ASTROPHYS J LETT, V689, pL121, DOI 10.1086/595958; MARKWARDT CB, 1995, NATURE, V375, P40, DOI 10.1038/375040a0; MARKWARDT CB, 1997, ASTROPHYS J, V480, P13; Mattana F, 2009, ASTROPHYS J, V694, P12, DOI 10.1088/0004-637X/694/1/12; Pellizzoni A, 2005, AIP CONF PROC, V745, P371, DOI 10.1063/1.1878432; Pellizzoni A, 2009, ASTROPHYS J, V691, P1618, DOI 10.1088/0004-637X/691/2/1618; Pittori C, 2009, ASTRON ASTROPHYS, V506, P1563, DOI 10.1051/0004-6361/200911783; Rishbeth H., 1958, AUST J PHYS, V11, P550; Tavani M, 2009, ASTRON ASTROPHYS, V502, P995, DOI 10.1051/0004-6361/200810527; TAYLOR JH, 1993, ASTROPHYS J SUPPL S, V88, P529, DOI 10.1086/191832; THOMPSON DJ, 2005, COSMIC GAMMA RAY SOU, P149; WEILER KW, 1980, ASTRON ASTROPHYS, V90, P269	32	33	33	0	6	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 5	2010	327	5966					663	665		10.1126/science.1183844	http://dx.doi.org/10.1126/science.1183844			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20044540	Green Submitted			2022-12-28	WOS:000274251800030
J	Kirsch, DG; Santiago, PM; di Tomaso, E; Sullivan, JM; Hou, WS; Dayton, T; Jeffords, LB; Sodha, P; Mercer, KL; Cohen, R; Takeuchi, O; Korsmeyer, SJ; Bronson, RT; Kim, CF; Haigis, KM; Jain, RK; Jacks, T				Kirsch, David G.; Santiago, Philip M.; di Tomaso, Emmanuelle; Sullivan, Julie M.; Hou, Wu-Shiun; Dayton, Talya; Jeffords, Laura B.; Sodha, Pooja; Mercer, Kim L.; Cohen, Rhianna; Takeuchi, Osamu; Korsmeyer, Stanley J.; Bronson, Roderick T.; Kim, Carla F.; Haigis, Kevin M.; Jain, Rakesh K.; Jacks, Tyler			p53 Controls Radiation-Induced Gastrointestinal Syndrome in Mice Independent of Apoptosis	SCIENCE			English	Article							CELL-DEATH; ENDOTHELIAL APOPTOSIS; DNA-DAMAGE; PUMA; RADIOSENSITIVITY; PROLIFERATION; RADIOTHERAPY; SENSITIVITY; PROTECTS; MOUSE	Acute exposure to ionizing radiation can cause lethal damage to the gastrointestinal (GI) tract, a condition called the GI syndrome. Whether the target cells affected by radiation to cause the GI syndrome are derived from the epithelium or endothelium and whether the target cells die by apoptosis or other mechanisms are controversial issues. Studying mouse models, we found that selective deletion of the proapoptotic genes Bak1 and Bax from the GI epithelium or from endothelial cells did not protect mice from developing the GI syndrome after sub-total-body gamma irradiation. In contrast, selective deletion of p53 from the GI epithelium, but not from endothelial cells, sensitized irradiated mice to the GI syndrome. Transgenic mice overexpressing p53 in all tissues were protected from the GI syndrome after irradiation. These results suggest that the GI syndrome is caused by the death of GI epithelial cells and that these epithelial cells die by a mechanism that is regulated by p53 but independent of apoptosis.	[Kirsch, David G.; Santiago, Philip M.; Hou, Wu-Shiun; Dayton, Talya; Sodha, Pooja; Mercer, Kim L.; Cohen, Rhianna; Kim, Carla F.; Haigis, Kevin M.; Jacks, Tyler] MIT, David H Koch Inst Integrat Canc Res, Cambridge, MA 02139 USA; [Kirsch, David G.; di Tomaso, Emmanuelle; Jain, Rakesh K.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Kirsch, David G.; di Tomaso, Emmanuelle; Jain, Rakesh K.] Harvard Univ, Sch Med, Boston, MA 02114 USA; [Kirsch, David G.; Sullivan, Julie M.; Jeffords, Laura B.] Duke Univ, Med Ctr, Dept Radiat Oncol & Pharmacol, Durham, NC 27708 USA; [Kirsch, David G.; Sullivan, Julie M.; Jeffords, Laura B.] Duke Univ, Med Ctr, Dept Canc Biol, Durham, NC 27708 USA; [Takeuchi, Osamu; Korsmeyer, Stanley J.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Bronson, Roderick T.] Tufts Univ, Sch Med & Vet Med, North Grafton, MA 01536 USA; [Jacks, Tyler] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Duke University; Duke University; Harvard University; Dana-Farber Cancer Institute; Tufts University; Howard Hughes Medical Institute	Jacks, T (corresponding author), MIT, David H Koch Inst Integrat Canc Res, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	tjacks@mit.edu	Jain, Rakesh K/I-1384-2017; Takeuchi, Osamu/AAG-9359-2019; Takeuchi, Osamu/D-6007-2011	Jain, Rakesh K/0000-0001-7571-3548; Takeuchi, Osamu/0000-0002-1260-6232; Dayton, Talya/0000-0002-7994-7963	Howard Hughes Medical Institute; National Cancer Institute [P30-CA14051, KO8 CA 114176, P01 CA80124]; Dana Farber Cancer Center for Medical Countermeasures Against Radiation [U19-AI06775]; National Institute of Allergy and Infectious Diseases [RC1-AI078521]; American Society of Clinical Oncology; NATIONAL CANCER INSTITUTE [P30CA014051, K08CA114176, P01CA080124] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [RC1AI078521] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dana Farber Cancer Center for Medical Countermeasures Against Radiation; National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); American Society of Clinical Oncology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank M. Serrano for the super-p53 mice; A. Berns for the p53<SUP>FL</SUP> mice; P. Crawford and J. Gordon for advice; E. Travis for providing a model jig; J. Down, C. Pope, and K. Doppke for performing dosimetry measurements; and K. Held for critically reading the manuscript. This work is funded by the Howard Hughes Medical Institute (T. J.), partially funded by Cancer Center Support (core) grant P30-CA14051 from the National Cancer Institute (NCI) (T. J.), NCI grant KO8 CA 114176 (D. G. K.), the pilot project from the Dana Farber Cancer Center for Medical Countermeasures Against Radiation U19-AI06775 (D. G. K.), grant RC1-AI078521 from the National Institute of Allergy and Infectious Diseases (D. G. K.), an American Society of Clinical Oncology Young Investigator Award (D. G. K.), and NCI grant P01 CA80124 (R. K. J.). T. J. is the David H. Koch Professor of Biology and a Daniel K. Ludwig Scholar.	Branda CS, 2004, DEV CELL, V6, P7, DOI 10.1016/S1534-5807(03)00399-X; Brown M, 2008, INT J RADIAT ONCOL, V70, P799, DOI 10.1016/j.ijrobp.2007.12.001; Burdelya LG, 2008, SCIENCE, V320, P226, DOI 10.1126/science.1154986; Burdelya LG, 2006, CANCER RES, V66, P9356, DOI 10.1158/0008-5472.CAN-06-1223; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Coderre JA, 2006, RADIAT RES, V166, P495, DOI 10.1667/RR3597.1; Crawford PA, 2005, P NATL ACAD SCI USA, V102, P13254, DOI 10.1073/pnas.0504830102; El Marjou F, 2004, GENESIS, V39, P186, DOI 10.1002/gene.20042; Garcia-Barros M, 2003, SCIENCE, V300, P1155, DOI 10.1126/science.1082504; Garcia-Cao I, 2002, EMBO J, V21, P6225, DOI 10.1093/emboj/cdf595; HENDRY JH, 1982, INT J RADIAT BIOL, V42, P621, DOI 10.1080/09553008214551601; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Komarov PG, 1999, SCIENCE, V285, P1733, DOI 10.1126/science.285.5434.1733; Komarova EA, 2004, ONCOGENE, V23, P3265, DOI 10.1038/sj.onc.1207494; Koni PA, 2001, J EXP MED, V193, P741, DOI 10.1084/jem.193.6.741; Kroemer G, 2005, CELL DEATH DIFFER, V12, P1463, DOI 10.1038/sj.cdd.4401724; LESHER J, 1974, RADIAT RES, V57, P148, DOI 10.2307/3573763; Lindsten T, 2000, MOL CELL, V6, P1389, DOI 10.1016/S1097-2765(00)00136-2; MASON KA, 1989, RADIAT RES, V117, P480, DOI 10.2307/3577353; Merritt AJ, 1997, ONCOGENE, V14, P2759, DOI 10.1038/sj.onc.1201126; MERRITT AJ, 1994, CANCER RES, V54, P614; Mettler FA, 2002, NEW ENGL J MED, V346, P1554, DOI 10.1056/NEJMra000365; Paris F, 2001, SCIENCE, V293, P293, DOI 10.1126/science.1060191; POTTEN CS, 1977, NATURE, V269, P518, DOI 10.1038/269518a0; POTTEN CS, 1990, INT J RADIAT BIOL, V57, P185, DOI 10.1080/09553009014550431; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Rotolo JA, 2008, INT J RADIAT ONCOL, V70, P804, DOI 10.1016/j.ijrobp.2007.11.043; Salter AB, 2009, BLOOD, V113, P2104, DOI 10.1182/blood-2008-06-162941; Santana P, 1996, CELL, V86, P189, DOI 10.1016/S0092-8674(00)80091-4; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; TERRY NHA, 1989, INT J RADIAT ONCOL, V17, P569, DOI 10.1016/0360-3016(89)90108-9; VANBEKKUM DW, 1974, INT J RADIAT BIOL, V25, P361, DOI 10.1080/09553007414550431; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072	33	176	187	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					593	596		10.1126/science.1166202	http://dx.doi.org/10.1126/science.1166202			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20019247	Green Accepted, Green Submitted			2022-12-28	WOS:000274020500042
J	Kiessling, W; Simpson, C; Foote, M				Kiessling, Wolfgang; Simpson, Carl; Foote, Michael			Reefs as Cradles of Evolution and Sources of Biodiversity in the Phanerozoic	SCIENCE			English	Article							MARINE FOSSIL RECORD; LATITUDINAL GRADIENTS; HABITAT COMPLEXITY; DIVERSITY; DYNAMICS; CORALS; COMMUNITIES; PATTERNS; DIVERSIFICATION; ORIGINATION	Large-scale biodiversity gradients among environments and habitats are usually attributed to a complex array of ecological and evolutionary factors. We tested the evolutionary component of such gradients by compiling the environments of the geologically oldest occurrences of marine genera and using sampling standardization to assess if originations tended to be clustered in particular environments. Shallow, tropical environments and carbonate substrates all tend to have harbored high origination rates. Diversity within these environments tended to be preferentially generated in reefs, probably because of their habitat complexity. Reefs were also prolific at exporting diversity to other environments, which might be a consequence of low-diversity habitats being more susceptible to invasions.	[Kiessling, Wolfgang; Simpson, Carl] Humboldt Univ, Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde, D-10115 Berlin, Germany; [Foote, Michael] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Chicago	Kiessling, W (corresponding author), Humboldt Univ, Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde, D-10115 Berlin, Germany.	wolfgang.kiessling@mfn-berlin.de	Kiessling, Wolfgang/E-2259-2015; Simpson, Carl/E-7140-2010	Kiessling, Wolfgang/0000-0002-1088-2014; Simpson, Carl/0000-0003-0719-4437	Deutsche Forschungsgemeinschaft [KI 806/5-1]; VolkswagenStiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); VolkswagenStiftung(Volkswagen)	This work was supported by the Deutsche Forschungsgemeinschaft (grant KI 806/5-1) and the VolkswagenStiftung. We thank U. Merkel for contributing substantially to the reef occurrence data. This is Paleobiology Database publication # 105.	Alfaro ME, 2007, EVOLUTION, V61, P2104, DOI 10.1111/j.1558-5646.2007.00182.x; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Bellwood DR, 1996, CORAL REEFS, V15, P11, DOI 10.1007/BF01626074; Briggs JC, 2005, J BIOGEOGR, V32, P1517, DOI 10.1111/j.1365-2699.2005.01266.x; Glynn PW, 2004, ECOSYSTEMS, V7, P358, DOI 10.1007/s10021-004-0184-x; Gratwicke B, 2005, MAR ECOL PROG SER, V292, P301, DOI 10.3354/meps292301; Jablonski D, 2005, J EXP ZOOL PART B, V304B, P504, DOI 10.1002/jez.b.21075; JABLONSKI D, 1983, SCIENCE, V222, P1123, DOI 10.1126/science.222.4628.1123; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Kiessling W, 2005, NATURE, V433, P410, DOI 10.1038/nature03152; Kiessling W, 2007, PALEOBIOLOGY, V33, P414, DOI 10.1666/06069.1; KNOWLTON FG, 1994, SYST ZOOL, V9, P7; Kohn AJ, 1997, MARINE BIODIVERSITY-BOOK, P201, DOI 10.1017/CBO9780511752360.010; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; Lingo ME, 2006, ENVIRON BIOL FISH, V76, P71, DOI 10.1007/s10641-006-9009-4; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; PANDOLFI JM, 1992, J BIOGEOGR, V19, P593, DOI 10.2307/2845703; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; REAKAKUDLA ML, 1997, BIODIVERSITY, V2, P83; Rosen B. R., 1984, FOSSILS CLIMATE, P201; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; STEHLI FG, 1971, SYST ZOOL, V20, P115, DOI 10.2307/2412052; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Wagner PJ, 2007, P ROY SOC B-BIOL SCI, V274, P439, DOI 10.1098/rspb.2006.3742; Wallace CC, 2006, P ROY SOC B-BIOL SCI, V273, P975, DOI 10.1098/rspb.2005.3307; Williams ST, 2004, EVOLUTION, V58, P2227; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032	28	121	128	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 8	2010	327	5962					196	198		10.1126/science.1182241	http://dx.doi.org/10.1126/science.1182241			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056888	Green Submitted			2022-12-28	WOS:000273394000033
J	Patel, AS; Macleod, A				Patel, Anand Shantilal; Macleod, Alan			Picture Quiz The perils of a "FOOSH"	BRITISH MEDICAL JOURNAL			English	Editorial Material							PLASTER CASTS; FRACTURE		[Patel, Anand Shantilal; Macleod, Alan] Royal Berkshire Hosp Fdn Trust, Dept Trauma & Orthopaed, Reading RG1 5AN, Berks, England	Royal Berkshire Hospital	Patel, AS (corresponding author), Royal Berkshire Hosp Fdn Trust, Dept Trauma & Orthopaed, Reading RG1 5AN, Berks, England.	anandspatel@doctors.org.uk						Belthur MV, 2005, INJURY, V36, P1135, DOI 10.1016/j.injury.2004.11.005; Binfield PM, 1998, INJURY, V29, P93, DOI 10.1016/S0020-1383(97)00052-1; Boyd AS, 2009, AM FAM PHYSICIAN, V79, P16; Greenberg MS, 1994, HDB NEUROSURGERY, P411; Kaye A, 1991, ESSENTIAL NEUROSURGE, P333; Koval KJ, 2006, HDB FRACTURES; Nielsen DM, 2005, INJURY, V36, P588, DOI 10.1016/j.injury.2004.11.021; Salter R B, 1992, Instr Course Lect, V41, P351; SALTER RB, 1963, J BONE JOINT SURG AM, V45, P587, DOI 10.2106/00004623-196345030-00019; SANTORO V, 1988, CLIN ORTHOP RELAT R, P226; *WHEEL TXB ORTH, FRACT DIST RAD PHYS; YOUNGER ASE, 1990, INJURY, V21, P179, DOI 10.1016/0020-1383(90)90091-8	12	0	0	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 6	2010	340								b5438	10.1136/bmj.b5438	http://dx.doi.org/10.1136/bmj.b5438			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542IE	20053826				2022-12-28	WOS:000273485500011
J	Liang, XF; Wang, HQ; Wang, JZ; Fang, HH; Wu, J; Zhu, FC; Li, RC; Xia, SL; Zhao, YL; Li, FJ; Yan, SH; Yin, WD; An, K; Feng, DJ; Cui, XL; Qi, FC; Ju, CJ; Zhang, YH; Guo, ZJ; Chen, PY; Chen, Z; Yan, KM; Wang, Y				Liang, Xiao-Feng; Wang, Hua-Qing; Wang, Jun-Zhi; Fang, Han-Hua; Wu, Jiang; Zhu, Feng-Cai; Li, Rong-Cheng; Xia, Sheng-Li; Zhao, Yu-Liang; Li, Fang-Jun; Yan, Shao-Hong; Yin, Wei-Dong; An, Kang; Feng, Duo-Jia; Cui, Xuan-Lin; Qi, Feng-Chun; Ju, Chang-Jun; Zhang, Yu-Hui; Guo, Zhi-Jun; Chen, Ping-Yu; Chen, Ze; Yan, Kun-Ming; Wang, Yu			Safety and immunogenicity of 2009 pandemic influenza A H1N1 vaccines in China: a multicentre, double-blind, randomised, placebo-controlled trial	LANCET			English	Article							H5N1 VACCINE; VIRUS	Background The current influenza pandemic calls for a safe and effective vaccine. We assessed the safety and immunogenicity of eight formulations of 2009 pandemic influenza A H1N1 vaccine produced by ten Chinese manufacturers. Methods In this multicentre, double-blind, randomised trial, 12 691 people aged 3 years or older were recruited in ten centres in China. in each Centre, participants were stratified by age and randomly assigned by a random number table to receive one of several vaccine formulations or placebo. The study assessed eight formulations: split-virion formulation containing 7.5 mu g, 15 mu g, or 30 mu g haemagglutinin per dose, with or without aluminium hydroxide adjuvant, and whole-virion formulation containing 5 mu g or 10 mu g haemagglutinin per dose, with adjuvant. All formulations were produced from the reassortant strain X-179A (A/California/07/2009-A/PR/8/34). We analysed the safety (adverse events), immunogenicity (geometric mean titre [GMT] of haemagglutination inhibition antibody), and seroprotection (GMT >= 1:40) of the formulations. Analysis was by per protocol. Two sites registered their trial with ClinicalTrials.gov, numbers NCT00956111 and NCT00975572. The other eight studies were registered with the State Food and Drug Administration of China. Findings 12691 participants received the first dose on day 0, and 12348 participants received the second dose on day 21. The seroprotection rate 21 days after the first dose of vaccine ranged from 69.5% (95% CI 65.9-72.8)for the 7.5 mu g adjuvant split-virion formulation to 92.8% (91.9-93.6) for the 30 mu g non-adjuvant split-virion formulation. The seroprotection rate was 86.5% (796 of 920; 84.1-88.7) in recipients of one dose of the 7.5 mu g non-adjuvant split-virion vaccine compared with 9.8% (140 of 1432; 8.3-11.4) in recipients of placebo (p<0.0001). One dose of the 7.5 mu g non-adjuvant split-virion vaccine induced seroprotection in 178 of 232 children (aged 3 years to <12 years; 76.7%, 70.7-82.0), 211 of 218 adolescents (12 years to <18 years; 96.8%, 93.5-98.7), 289 of 323 adults (18-60 years; 89.5%, 85.6-92.6), and 118 of 147 adults older than 60 years (80.3%, 72.9-86.4), meeting the European Union's licensure criteria for seroprotection in all age-groups. In children, a second dose of the 7.5 mu g formulation increased the seroprotection rate to 97.7% (215 of 220, 94.8-99.3). Adverse reactions were mostly mild or moderate, and self-limited. Severe adverse effects occurred in 69 (0.6%, 0.5-0.8) recipients of vaccine compared with one recipient (0.1%, 0-0.2) of placebo. The most common severe adverse reaction was fever, which occurred in 25 (0.22%; 0.14-0.33) recipients of vaccine after the first dose and four (0.04%; 0.01-0.09) recipients of vaccine after the second dose compared with no recipients of placebo after either dose. Interpretation One dose of non-adjuvant split-virion vaccine containing 7.5 mu g haemagglutinin could be promoted as the formulation of choice against 2009 pandemic influenza A H1N1 for people aged 12 years or older. in children (aged <12 years), two 7.5 mu g doses might be needed. Funding Sinovac Biotech, Hualan Biological Bacterin, China National Biotec Group, Beijing Tiantan Biological Products, Changchun Institute of Biological Products, Changchun Changsheng Life Sciences, Jiangsu Yanshen Biological Technology Stock, Zhejiang Tianyuan Bio-Pharmaceutical, Lanzhou Institute of Biological Products, Shanghai Institute of Biological Products, and Dalian Aleph Biomedical.	[Liang, Xiao-Feng; Wang, Hua-Qing; Wang, Yu] Chinese Ctr Dis Control & Prevent, Beijing 100050, Peoples R China; [Wang, Jun-Zhi; Fang, Han-Hua] Natl Inst Control Pharmaceut & Biol Prod, Beijing, Peoples R China; [Wu, Jiang] Beijing Ctr Dis Control & Prevent, Beijing, Peoples R China; [Zhu, Feng-Cai] Jiangsu Prov Ctr Dis Control & Prevent, Nanjing, Jiangsu, Peoples R China; [Li, Rong-Cheng] Guangxi Autonomous Reg Ctr Dis Control & Prevent, Nanning, Guangxi, Peoples R China; [Xia, Sheng-Li] Henan Prov Ctr Dis Control & Prevent, Zhengzhou, Henan, Peoples R China; [Zhao, Yu-Liang] Hebei Prov Ctr Dis Control & Prevent, Shijiazhuang, Hebei, Peoples R China; [Li, Fang-Jun] Hunan Prov Ctr Dis Control & Prevent, Changsha, Hunan, Peoples R China; [Yan, Shao-Hong] Inner Mongolia Autonomous Reg Ctr Dis Control & P, Hohhot, Inner Mongolia, Peoples R China; [Yin, Wei-Dong] Sinovac Biotech, Beijing, Peoples R China; [An, Kang] Hualan Biol Bacterin, Xinxiang, Henan, Peoples R China; [Feng, Duo-Jia] China Natl Biotec Grp, Beijing, Peoples R China; [Cui, Xuan-Lin] Beijing Tiantan Biol Prod, Beijing, Peoples R China; [Qi, Feng-Chun] Changchun Inst Biol Prod, Changchun, Liaoning, Peoples R China; [Ju, Chang-Jun] Changchun Changsheng Life Sci, Changchun, Liaoning, Peoples R China; [Zhang, Yu-Hui] Jiangsu Yanshen Biol Technol Stock, Nanjing, Jiangsu, Peoples R China; [Guo, Zhi-Jun] Zhejiang Tianyuan Biopharmaceut, Hangzhou, Zhejiang, Peoples R China; [Chen, Ping-Yu] Lanzhou Inst Biol Prod, Lanzhou, Gansu, Peoples R China; [Chen, Ze] Shanghai Inst Biol Prod, Shanghai, Peoples R China; [Yan, Kun-Ming] Dalian Aleph Biomed, Dalian, Liaoning, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute of Food & Drug Control - China; Jiangsu Provincial Center for Disease Control & Prevention	Wang, Y (corresponding author), Chinese Ctr Dis Control & Prevent, 27 Nanwei Rd, Beijing 100050, Peoples R China.	wangyu@chinacdc.cn	fang, han/GSN-6404-2022	Zhang, Yuhui/0000-0002-6650-3423	Sinovac Biotech; Hualan Biological Bacterin; China National Biotec Group; Beijing Tiantan Biological Products; Changchun Institute of Biological Products; Changchun Changsheng Life Sciences; Jiangsu Yanshen Biological Technology Stock; Zhejiang Tianyuan Bio-Pharmaceutical; Lanzhou Institute of Biological Products; Shanghai Institute of Biological Products; Dalian Aleph Biomedical	Sinovac Biotech; Hualan Biological Bacterin; China National Biotec Group; Beijing Tiantan Biological Products; Changchun Institute of Biological Products; Changchun Changsheng Life Sciences; Jiangsu Yanshen Biological Technology Stock; Zhejiang Tianyuan Bio-Pharmaceutical; Lanzhou Institute of Biological Products; Shanghai Institute of Biological Products; Dalian Aleph Biomedical	The vaccine manufacturers funded the trials (Sinovac Biotech, Hualan Biological Bacterin, China National Biotec Group, Beijing Tiantan Biological Products, Changchun Institute of Biological Products, Changchun Changsheng Life Sciences, Jiangsu Yanshen Biological Technology Stock, Zhejiang Tianyuan Bio-Pharmaceutical, Lanzhou Institute of Biological Products, Shanghai Institute of Biological Products, and Dalian Aleph Biomedical). We thank the UK National Institute for Biological Standards and Control and the US Centers for Disease Control and Prevention for providing the virus strains and reference standards. We thank the volunteers for their participation in this study. We also thank the members of the Committee for the Pandernic (H1N1) 2009 Vaccine Clinical Trial for their critical suggestions on this study. We also acknowledge the contributions of Yuan-Zheng Qiu, Bao-Ping Zhu, Lisa Cairns, and Da-Peng Yin for assisting with manuscript preparation and revision; Guo-Min Zhang, Ling-Sheng Cao, Lei Cao, Wen-Di Wu, Wei Xia, Ke-Yu Jiang, Fu-Qiang Cui, and Shi-Cheng Yu for assisting with the data collection; and Jian-Sheng Wang, Yu-Qing Zhou, Jing-Shan Zheng, Da-Wei Liu, and Lan-Xiang Zhang for their advice on the trial.	Bresson JL, 2006, LANCET, V367, P1657, DOI 10.1016/S0140-6736(06)68656-X; *CDC, 2009, MMWR-MORBID MORTAL W, V58, P435; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Chen HL, 2009, EMERG INFECT DIS, V15, P1849, DOI 10.3201/eid1511.090868; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Ehrlich HJ, 2008, NEW ENGL J MED, V358, P2573, DOI 10.1056/NEJMoa073121; European Committee for Proprietary Medial Products, 1997, CPMPBWP21496 EUR COM; European Committee for Proprietary Medicinal Products, 2004, CPMPVEG471703 EUR CO; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Lin JT, 2006, LANCET, V368, P991, DOI 10.1016/S0140-6736(06)69294-5; *NIAID DIV MICR IN, PED TOX TABL; *NIAID DIV MICR IN, AD TOX TABL; *WHO, AV CAND REASS VACC V; *WHO, 2009, WKLY EPIDEMIOL REC, V84, P249; *WHO, SUMM AV CAND VACC VI; Wu J, 2009, CLIN INFECT DIS, V48, P1087, DOI 10.1086/597401; Zhu FC, 2009, NEW ENGL J MED, V361, P2414, DOI 10.1056/NEJMoa0908535	19	217	236	1	50	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2010	375	9708					56	66		10.1016/S0140-6736(09)62003-1	http://dx.doi.org/10.1016/S0140-6736(09)62003-1			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539BZ	20018364				2022-12-28	WOS:000273229700032
J	Iglehart, JK				Iglehart, John K.			Week 1 of the Senate Debate - Amending the Reform Bill	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		STRASSEL KA, 2009, WALL STREET J   1205, pA19	1	0	0	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26								10.1056/NEJMp0912010	http://dx.doi.org/10.1056/NEJMp0912010			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	535WX	20007552				2022-12-28	WOS:000273003700005
J	Opher, M; Bibi, FA; Toth, G; Richardson, JD; Izmodenov, VV; Gombosi, TI				Opher, M.; Bibi, F. Alouani; Toth, G.; Richardson, J. D.; Izmodenov, V. V.; Gombosi, T. I.			A strong, highly-tilted interstellar magnetic field near the Solar System	NATURE			English	Article							WIND; HELIOSPHERE; ASYMMETRIES; VOYAGER-1; DYNAMICS; PLASMA	Magnetic fields play an important (sometimes dominant) role in the evolution of gas clouds in the Galaxy, but the strength and orientation of the field in the interstellar medium near the heliosphere has been poorly constrained. Previous estimates of the field strength range from 1.8-2.5 mu G and the field was thought to be parallel to the Galactic plane(1) or inclined by 38-60 degrees (ref. 2) or 60-90 degrees (ref. 3) to this plane. These estimates relied either on indirect observational inferences or modelling in which the interstellar neutral hydrogen was not taken into account. Here we report measurements of the deflection of the solar wind plasma flows in the heliosheath(4) to determine the magnetic field strength and orientation in the interstellar medium. We find that the field strength in the local interstellar medium is 3.7-5.5 mu G. The field is tilted similar to 20-30 degrees from the interstellar medium flow direction (resulting from the peculiar motion of the Sun in the Galaxy) and is at an angle of about 30 degrees from the Galactic plane. We conclude that the interstellar medium field is turbulent or has a distortion in the solar vicinity.	[Opher, M.; Bibi, F. Alouani] George Mason Univ, Fairfax, VA 22030 USA; [Toth, G.; Gombosi, T. I.] Univ Michigan, Ctr Space Environm Modeling, Ann Arbor, MI 48109 USA; [Richardson, J. D.] MIT, Kavli Inst Astrophys & Space Res, Cambridge, MA 02139 USA; [Izmodenov, V. V.] Moscow MV Lomonosov State Univ, Space Res Inst IKI, Moscow 117997, Russia; [Izmodenov, V. V.] Russian Acad Sci, Inst Problems Mech, Moscow 117997, Russia	George Mason University; University of Michigan System; University of Michigan; Massachusetts Institute of Technology (MIT); Lomonosov Moscow State University; Russian Academy of Sciences; Space Research Institute of the Russian Academy of Sciences; Russian Academy of Sciences; Ishlinsky Institute for Problems in Mechanics RAS	Opher, M (corresponding author), George Mason Univ, 4400 Univ Dr, Fairfax, VA 22030 USA.	mopher@gmu.edu	Izmodenov, Vladislav V/K-6073-2012; Toth, Gabor/B-7977-2013; Gombosi, Tamas I/G-4238-2011	Izmodenov, Vladislav V/0000-0002-1748-0982; Toth, Gabor/0000-0002-5654-9823; Gombosi, Tamas I/0000-0001-9360-4951	NASA; National Science Foundation; Voyager project.; Russian Agency of Science; Dynastia Foundation	NASA(National Aeronautics & Space Administration (NASA)); National Science Foundation(National Science Foundation (NSF)); Voyager project.; Russian Agency of Science; Dynastia Foundation	We thank the staff at NASA Ames Research Center for the use of the Columbia supercomputer. M. O. and F. A. B. acknowledge the support of NASA and the National Science Foundation. J. R. is supported by the Voyager project. V. V. I. acknowledges the support of the Russian Agency of Science and the Dynastia Foundation. We thank E. C. Stone and R. Shelton for suggestions and comments.	Cox DP, 2003, ASTROPHYS J, V583, P205, DOI 10.1086/344926; Frisch PC, 2009, SPACE SCI REV, V146, P235, DOI 10.1007/s11214-009-9502-0; Frisch PC, 1996, SPACE SCI REV, V78, P213, DOI 10.1007/BF00170807; Izmodenov VV, 2008, ADV SPACE RES, V41, P318, DOI 10.1016/j.asr.2007.06.033; Izmodenov V, 2009, SPACE SCI REV, V143, P139, DOI 10.1007/s11214-008-9444-y; Jenkins EB, 2001, ASTROPHYS J SUPPL S, V137, P297, DOI 10.1086/323326; Jenkins E, 2009, SPACE SCI REV, V143, P205, DOI 10.1007/s11214-008-9352-1; Jokipii JR, 2005, SCIENCE, V307, P1424, DOI 10.1126/science.1109701; Lallement R, 2005, SCIENCE, V307, P1447, DOI 10.1126/science.1107953; Linsky J, 2009, ASTROPHYS SPACE SCI, V320, P85, DOI 10.1007/s10509-009-9992-y; Minter AH, 1996, ASTROPHYS J, V458, P194, DOI 10.1086/176803; Opher M, 2007, SCIENCE, V316, P875, DOI 10.1126/science.1139480; Opher M, 2006, ASTROPHYS J, V640, pL71, DOI 10.1086/503251; Opher M, 2009, SPACE SCI REV, V143, P43, DOI 10.1007/s11214-008-9453-x; Pogorelov NV, 2008, ASTROPHYS J LETT, V675, pL41, DOI 10.1086/529547; Pogorelov NV, 2007, ASTROPHYS J, V668, P611, DOI 10.1086/520952; Pogorelov NV, 2006, ASTROPHYS J, V636, pL161, DOI 10.1086/500087; Redfield S, 2008, ASTROPHYS J, V673, P283, DOI 10.1086/524002; Richardson JD, 2008, ADV SPACE RES, V41, P237, DOI 10.1016/j.asr.2007.03.069; Richardson JD, 2008, NATURE, V454, P63, DOI 10.1038/nature07024; Shelton R, 2009, SPACE SCI REV, V143, P303, DOI 10.1007/s11214-008-9359-7; Stone EC, 2005, SCIENCE, V309, P2017, DOI 10.1126/science.1117684; Stone EC, 2008, NATURE, V454, P71, DOI 10.1038/nature07022	23	113	114	1	13	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1036	1038		10.1038/nature08567	http://dx.doi.org/10.1038/nature08567			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033043				2022-12-28	WOS:000272996000042
J	Bennett, J				Bennett, Jean			Gene Therapy for Color Blindness.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Univ Penn, Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Bennett, J (corresponding author), Univ Penn, Sch Med, Scheie Eye Inst, FM Kirby Ctr Mol Ophthalmol, Philadelphia, PA 19104 USA.		Hassall, Mark M/J-4660-2018	Hassall, Mark M/0000-0002-6180-7954				*FED AV ADM, 2009, 2009 GUID AV MED EX, P140; Mancuso K, 2009, NATURE, V461, P784, DOI 10.1038/nature08401; WIESEL TN, 1963, J NEUROPHYSIOL, V26, P1003, DOI 10.1152/jn.1963.26.6.1003	3	10	12	1	17	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 17	2009	361	25					2483	2484		10.1056/NEJMcibr0908643	http://dx.doi.org/10.1056/NEJMcibr0908643			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	533CE	20018970				2022-12-28	WOS:000272798900016
J	Chen, DN; Pacal, M; Wenzel, P; Knoepfler, PS; Leone, G; Bremner, R				Chen, Danian; Pacal, Marek; Wenzel, Pamela; Knoepfler, Paul S.; Leone, Gustavo; Bremner, Rod			Division and apoptosis of E2f-deficient retinal progenitors	NATURE			English	Article							E2F FAMILY-MEMBERS; CELL-CYCLE; C-MYC; CHROMATIN IMMUNOPRECIPITATION; NEURONAL DIFFERENTIATION; TRANSCRIPTION FACTORS; TUMOR-SUPPRESSOR; TARGET GENE; PROLIFERATION; P53	The activating E2f transcription factors (E2f1, E2f2 and E2f3) induce transcription and are widely viewed as essential positive cell cycle regulators. Indeed, they drive cells out of quiescence, and the 'cancer cell cycle' in Rb1 null cells is E2f-dependent(1,2). Absence of activating E2fs in flies or mammalian fibroblasts causes cell cycle arrest(3,4), but this block is alleviated by removing repressive E2f or the tumour suppressor p53, respectively(5-7). Thus, whether activating E2fs are indispensable for normal division is an area of debate(1). Activating E2fs are also well known pro-apoptotic factors, providing a defence against oncogenesis(8), yet E2f1 can limit irradiation-induced apoptosis(9,10). In flies this occurs through repression of hid (also called Wrinkled; Smac/Diablo in mammals). However, in mammals the mechanism is unclear because Smac/Diablo is induced, not repressed, by E2f1(11), and in keratinocytes survival is promoted indirectly through induction of DNA repair targets(12). Thus, a direct pro-survival function for E2f1-3 and/or its relevance beyond irradiation has not been established. To address E2f1-3 function in normal cells in vivo we focused on the mouse retina, which is a relatively simple central nervous system component that can be manipulated genetically without compromising viability and has provided considerable insight into development and cancer(2,13). Here we show that unlike fibroblasts, E2f1-3 null retinal progenitor cells or activated Muller glia can divide. We attribute this effect to functional interchangeability with Mycn. However, loss of activating E2fs caused down-regulation of the p53 deacetylase Sirt1, p53 hyperacetylation and elevated apoptosis, establishing a novel E2f-Sirt1-p53 survival axis in vivo. Thus, activating E2fs are not universally required for normal mammalian cell division, but have an unexpected pro-survival role in development.	[Chen, Danian; Pacal, Marek; Bremner, Rod] Univ Toronto, Univ Hlth Network, Toronto Western Res Inst, Dept Ophthalmol & Visual Sci, Toronto, ON M5T 2S8, Canada; [Chen, Danian; Pacal, Marek; Bremner, Rod] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5T 2S8, Canada; [Wenzel, Pamela; Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA; [Wenzel, Pamela; Leone, Gustavo] Ohio State Univ, Ctr Comprehens Canc, Dept Mol Genet, Columbus, OH 43210 USA; [Knoepfler, Paul S.] Univ Calif Davis, Sch Med, Dept Cell Biol, Davis, CA 95616 USA; [Knoepfler, Paul S.] Univ Calif Davis, Sch Med, Dept Human Anat, Davis, CA 95616 USA	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University of California System; University of California Davis; University of California System; University of California Davis	Bremner, R (corresponding author), Univ Toronto, Univ Hlth Network, Toronto Western Res Inst, Dept Ophthalmol & Visual Sci, Toronto, ON M5T 2S8, Canada.	rbremner@uhnres.utoronto.ca	Wenzel, Pamela/A-2992-2010; Wenzel, Pamela/AAJ-1944-2021; Chen, Danian/GXV-7996-2022; Bremner, Rod/I-6490-2012	Wenzel, Pamela/0000-0002-4530-015X; Bremner, Rod/0000-0001-9184-7212; Knoepfler, Paul/0000-0001-5444-334X; Chen, Danian/0000-0002-6916-2978	Canadian Institutes for Health Research [MOP-74570]; NATIONAL CANCER INSTITUTE [R01CA121275] Funding Source: NIH RePORTER	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L. van Parijs and R. Weinberg for plasmids; R. Eisenman for mice; L. Penn for advice on Myc; and M. Cayouette and J. Wrana for comments. This work was supported by a grant from the Canadian Institutes for Health Research to R. B. (MOP-74570).	Alevizopoulos K, 1997, EMBO J, V16, P5322, DOI 10.1093/emboj/16.17.5322; Aslanian A, 2004, GENE DEV, V18, P1413, DOI 10.1101/gad.1196704; Berton TR, 2005, ONCOGENE, V24, P2449, DOI 10.1038/sj.onc.1208462; Bieda M, 2006, GENOME RES, V16, P595, DOI 10.1101/gr.4887606; Bode AM, 2004, NAT REV CANCER, V4, P793, DOI 10.1038/nrc1455; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Chen D, 2005, CELL DEATH DIFFER, V12, P358, DOI 10.1038/sj.cdd.4401536; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Chen D, 2007, PLOS BIOL, V5, P1504, DOI 10.1371/journal.pbio.0050179; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; Claassen GF, 2000, P NATL ACAD SCI USA, V97, P9498, DOI 10.1073/pnas.150006697; DeGregori J, 2006, CURR MOL MED, V6, P739; Dyer MA, 2000, NAT NEUROSCI, V3, P873, DOI 10.1038/78774; Fogal V, 2005, CELL DEATH DIFFER, V12, P369, DOI 10.1038/sj.cdd.4401562; Frolov MV, 2001, GENE DEV, V15, P2146, DOI 10.1101/gad.903901; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Knoepfler PS, 2002, GENE DEV, V16, P2699, DOI 10.1101/gad.1021202; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Livesey FJ, 2001, NAT REV NEUROSCI, V2, P109, DOI 10.1038/35053522; Livne-Bar I, 2006, P NATL ACAD SCI USA, V103, P4988, DOI 10.1073/pnas.0600083103; Lyons TE, 2006, AM J PHYSIOL-CELL PH, V290, pC189, DOI 10.1152/ajpcell.00630.2004; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Mao DYL, 2003, CURR BIOL, V13, P882, DOI 10.1016/S0960-9822(03)00297-5; Marquardt T, 2001, CELL, V105, P43, DOI 10.1016/S0092-8674(01)00295-1; Moon NS, 2005, DEV CELL, V9, P463, DOI 10.1016/j.devcel.2005.08.015; Ozono E, 2009, GENES CELLS, V14, P89, DOI 10.1111/j.1365-2443.2008.01248.x; Pacal M, 2006, CURR MOL MED, V6, P759; Rowland BD, 2006, CELL, V127, P871, DOI 10.1016/j.cell.2006.11.019; Santoni-Rugiu E, 2000, MOL CELL BIOL, V20, P3497, DOI 10.1128/MCB.20.10.3497-3509.2000; Sharma N, 2006, J BIOL CHEM, V281, P36124, DOI 10.1074/jbc.M604152200; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tang Y, 2008, CELL, V133, P612, DOI 10.1016/j.cell.2008.03.025; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Weinmann AS, 2002, GENE DEV, V16, P235, DOI 10.1101/gad.943102; Weinmann AS, 2001, MOL CELL BIOL, V21, P6820, DOI 10.1128/MCB.21.20.6820-6832.2001; Wikonkal NM, 2003, NAT CELL BIOL, V5, P655, DOI 10.1038/ncb1001; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Xie W, 2006, NUCLEIC ACIDS RES, V34, P2046, DOI 10.1093/nar/gkl150; Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507; Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69	46	116	122	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 17	2009	462	7275					925	U120		10.1038/nature08544	http://dx.doi.org/10.1038/nature08544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016601	Green Accepted			2022-12-28	WOS:000272795400044
J	Hyun, S; Lee, JH; Jin, H; Nam, J; Namkoong, B; Lee, G; Chung, J; Kim, VN				Hyun, Seogang; Lee, Jung Hyun; Jin, Hua; Nam, JinWu; Namkoong, Bumjin; Lee, Gina; Chung, Jongkyeong; Kim, V. Narry			Conserved MicroRNA miR-8/miR-200 and Its Target USH/FOG2 Control Growth by Regulating PI3K	CELL			English	Article							ZINC-FINGER PROTEINS; PROTHORACIC GLAND; DROSOPHILA; INSULIN; EXPRESSION; FRIEND; FOG-2; GENE; SIZE; FLIES	How body size is determined is a long-standing question in biology, yet its regulatory mechanisms remain largely unknown. Here, we find that a conserved microRNA miR-8 and its target, USH, regulate body size in Drosophila. miR-8 null flies are smaller in size and defective in insulin signaling in fat body that is the fly counterpart of liver and adipose tissue. Fat body-specific expression and clonal analyses reveal that miR-8 activates PI3K, thereby promoting fat cell growth cell-autonomously and enhancing organismal growth non-cell-autonomously. Comparative analyses identify USH and its human homolog, FOG2, as the targets of fly miR-8 and human miR-200, respectively. USH/FOG2 inhibits PI3K activity, suppressing cell growth in both flies and humans. FOG2 directly binds to p85 alpha, the regulatory subunit of PI3K, and interferes with the formation of a PI3K complex. Our study identifies two novel regulators of insulin signaling, miR-8/miR-200 and USH/FOG2, and suggests their roles in adolescent growth, aging, and cancer.	[Hyun, Seogang; Lee, Jung Hyun; Jin, Hua; Nam, JinWu; Namkoong, Bumjin; Kim, V. Narry] Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea; [Hyun, Seogang; Lee, Jung Hyun; Jin, Hua; Nam, JinWu; Namkoong, Bumjin; Kim, V. Narry] Seoul Natl Univ, Natl Creat Res Ctr, Seoul 151742, South Korea; [Lee, Gina; Chung, Jongkyeong] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Lee, Gina; Chung, Jongkyeong] Korea Adv Inst Sci & Technol, Natl Creat Res Ctr, Taejon 305701, South Korea	Seoul National University (SNU); Seoul National University (SNU); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Kim, VN (corresponding author), Seoul Natl Univ, Sch Biol Sci, Seoul 151742, South Korea.	narrykim@snu.ac.kr	Jin, Hua/AAS-9079-2020; Xie, Huangming/B-2260-2012	Jin, Hua/0000-0001-9829-0306; 	Creative Research Initiatives Programs [20090063603, R16-2001-002-01001-0]; National Research Foundation of Korea; Ministry of Education, Science and Technology of Korea; Seoul Science Fellowship	Creative Research Initiatives Programs; National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea); Seoul Science Fellowship	We are very grateful to Drs. Steve Cohen, Pascal Heitzler, Pat Simpson, K. VijayRaghavan, Bruce Edgar, YoungJoon Kim and Marc Haenlin for kindly sharing fly lines. We appreciate the help of Drs. Kweon Yu and Kyu-Sun Lee for immunostaining. We thank Dr. Elisa Izaurralde for the pAC5.1 luciferase vector and Dr. Seunghwan Hong for GST-p85 alpha. We are also grateful to Dr. Jeongbin Yim and his lab members for providing the equipment for fly work, Jisun Yoo for help with reporter cloning, and Dr. Walton Jones, Dr. Chirlmin Joo, Jinju Han, and David Jee for critical reading of the manuscript. This work was supported by the Creative Research Initiatives Programs (grant 20090063603 to V.N.K. and grant R16-2001-002-01001-0 to J.C.), the National Research Foundation of Korea, BK21 Research Fellowships from the Ministry of Education, Science and Technology of Korea (support to H.J.), and the Seoul Science Fellowship (support H.J.).	Arden KC, 2008, ONCOGENE, V27, P2345, DOI 10.1038/onc.2008.27; Asha H, 2003, GENETICS, V163, P203; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bielinska M, 2005, ENDOCRINOLOGY, V146, P3975, DOI 10.1210/en.2004-1643; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Caldwell PE, 2005, CURR BIOL, V15, P1785, DOI 10.1016/j.cub.2005.09.011; Choi PS, 2008, NEURON, V57, P41, DOI 10.1016/j.neuron.2007.11.018; Clugston RD, 2008, AM J PHYSIOL-LUNG C, V294, pL665, DOI 10.1152/ajplung.00027.2008; Colombani J, 2005, SCIENCE, V310, P667, DOI 10.1126/science.1119432; Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X; Cubadda Y, 1997, GENE DEV, V11, P3083, DOI 10.1101/gad.11.22.3083; Dykxhoorn DM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007181; Edgar BA, 2006, NAT REV GENET, V7, P907, DOI 10.1038/nrg1989; Flynt AS, 2009, J CELL BIOL, V185, P115, DOI 10.1083/jcb.200807026; Fossett N, 2001, TRENDS CARDIOVAS MED, V11, P185, DOI 10.1016/S1050-1738(01)00092-5; Fossett N, 2001, P NATL ACAD SCI USA, V98, P7342, DOI 10.1073/pnas.131215798; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Garriga-Canut M, 2004, J BIOL CHEM, V279, P23597, DOI 10.1074/jbc.M313987200; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; Holmes M, 1999, J BIOL CHEM, V274, P23491, DOI 10.1074/jbc.274.33.23491; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Karres JS, 2007, CELL, V131, P136, DOI 10.1016/j.cell.2007.09.020; Kaufman CK, 2003, GENE DEV, V17, P2108, DOI 10.1101/gad.1115203; Kennell JA, 2008, P NATL ACAD SCI USA, V105, P15417, DOI 10.1073/pnas.0807763105; Kim SK, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-411; Kiriakidou M, 2004, GENE DEV, V18, P1165, DOI 10.1101/gad.1184704; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003; Lee Y, 2005, NAT GENET, V37, P305, DOI 10.1038/ng1513; Leopold P, 2007, NATURE, V450, P186, DOI 10.1038/nature06286; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu JR, 1999, MOL CELL BIOL, V19, P4495; Mirth C, 2005, CURR BIOL, V15, P1796, DOI 10.1016/j.cub.2005.09.017; Mirth CK, 2007, BIOESSAYS, V29, P344, DOI 10.1002/bies.20552; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nanni S, 2006, MOL CANCER RES, V4, P79, DOI 10.1158/1541-7786.MCR-05-0098; Park SY, 2009, NAT STRUCT MOL BIOL, V16, P23, DOI 10.1038/nsmb.1533; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Puig O, 2005, GENE DEV, V19, P2435, DOI 10.1101/gad.1340505; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Smibert P, 2008, CELL CYCLE, V7, P2500, DOI 10.4161/cc.7.16.6454; Sorrentino RP, 2007, DEV BIOL, V311, P311, DOI 10.1016/j.ydbio.2007.08.011; Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060; Svensson EC, 1999, P NATL ACAD SCI USA, V96, P956, DOI 10.1073/pnas.96.3.956; Takata K, 2004, GENETICS, V168, P855, DOI 10.1534/genetics.103.025965; Tevosian SG, 1999, P NATL ACAD SCI USA, V96, P950, DOI 10.1073/pnas.96.3.950; Wachi S, 2005, BIOINFORMATICS, V21, P4205, DOI 10.1093/bioinformatics/bti688; Zinke I, 1999, DEVELOPMENT, V126, P5275	54	233	256	0	40	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1096	1108		10.1016/j.cell.2009.11.020	http://dx.doi.org/10.1016/j.cell.2009.11.020			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005803	Bronze			2022-12-28	WOS:000272622800012
J	Knowles, TPJ; Waudby, CA; Devlin, GL; Cohen, SIA; Aguzzi, A; Vendruscolo, M; Terentjev, EM; Welland, ME; Dobson, CM				Knowles, Tuomas P. J.; Waudby, Christopher A.; Devlin, Glyn L.; Cohen, Samuel I. A.; Aguzzi, Adriano; Vendruscolo, Michele; Terentjev, Eugene M.; Welland, Mark E.; Dobson, Christopher M.			An Analytical Solution to the Kinetics of Breakable Filament Assembly	SCIENCE			English	Article							AMYLOID FIBRIL FORMATION; MECHANISM; AGGREGATION; NUCLEATION; SCRAPIE; POLYMERIZATION; PATHWAY; DISEASE; GROWTH; TIME	We present an analytical treatment of a set of coupled kinetic equations that governs the self-assembly of filamentous molecular structures. Application to the case of protein aggregation demonstrates that the kinetics of amyloid growth can often be dominated by secondary rather than by primary nucleation events. Our results further reveal a range of general features of the growth kinetics of fragmenting filamentous structures, including the existence of generic scaling laws that provide mechanistic information in contexts ranging from in vitro amyloid growth to the in vivo development of mammalian prion diseases.	[Knowles, Tuomas P. J.; Welland, Mark E.] Univ Cambridge, Nanosci Ctr, Cambridge CB3 0FF, England; [Knowles, Tuomas P. J.; Terentjev, Eugene M.] Univ Cambridge, Cavendish Lab, Cambridge CB3 0HE, England; [Waudby, Christopher A.; Devlin, Glyn L.; Cohen, Samuel I. A.; Vendruscolo, Michele; Dobson, Christopher M.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England; [Aguzzi, Adriano] Univ Zurich Hosp, Inst Neuropathol, CH-8091 Zurich, Switzerland	University of Cambridge; University of Cambridge; University of Cambridge; University of Zurich; University Zurich Hospital	Welland, ME (corresponding author), Univ Cambridge, Nanosci Ctr, JJ Thomson Ave, Cambridge CB3 0FF, England.	mew10@cam.ac.uk; cmd44@cam.ac.uk	Terentjev, Eugene M/B-7623-2011; Vendruscolo, Michele/F-5901-2012; Aguzzi, Adriano/A-3351-2008; Waudby, Christopher/AAT-1736-2021; Knowles, Tuomas/C-6663-2009	Terentjev, Eugene M/0000-0003-3517-6578; Vendruscolo, Michele/0000-0002-3616-1610; Waudby, Christopher/0000-0001-7810-3753; Knowles, Tuomas/0000-0002-7879-0140; Aguzzi, Adriano/0000-0002-0344-6708	St John's College, Cambridge; Leverhulme; Wellcome Trusts; EPSRC [EP/F032773/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/F032773/1] Funding Source: researchfish	St John's College, Cambridge; Leverhulme; Wellcome Trusts(Wellcome Trust); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	T. P. J. K. acknowledges support from St John's College, Cambridge through a Research Fellowship. C. M. D. acknowledges support from the Leverhulme and Wellcome Trusts. We are grateful to A. Craig, A. Knowles, D. White, A. Buell, F. Chiti, A. Miranker, and J. Falsig for valuable discussions, and to M. Sandal for preparing a Web server, which is publicly available at www-vendruscolo. ch.cam.ac.uk/cgi-bin/nef/nefcgi.cgi, to enable the use of the equations presented in this work to fit experimental measurements and to predict aggregation kinetics.	Aguzzi A, 1997, NATURE, V389, P795, DOI 10.1038/39758; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Binger KJ, 2008, J MOL BIOL, V376, P1116, DOI 10.1016/j.jmb.2007.12.055; Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Collins SR, 2004, PLOS BIOL, V2, P1582, DOI 10.1371/journal.pbio.0020321; Fandrich M, 2007, J MOL BIOL, V365, P1266, DOI 10.1016/j.jmb.2006.11.009; Ferguson N, 2003, P NATL ACAD SCI USA, V100, P9814, DOI 10.1073/pnas.1333907100; Ferrone F, 1999, METHOD ENZYMOL, V309, P256; FERRONE FA, 1985, J MOL BIOL, V183, P611, DOI 10.1016/0022-2836(85)90175-5; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Fodera V, 2008, J PHYS CHEM B, V112, P3853, DOI 10.1021/jp710131u; Granas A., 2003, FIXED POINT THEORY; Hill EK, 2006, BIOMACROMOLECULES, V7, P10, DOI 10.1021/bm0505078; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kunes KC, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.051915; Oosawa F., 1975, THERMODYNAMICS POLYM; Pedersen JS, 2008, PROTEIN SCI, V17, P2, DOI 10.1110/ps.073127808; Poschel T, 2003, BIOPHYS J, V85, P3460, DOI 10.1016/S0006-3495(03)74767-5; PRUSINER SB, 1982, ANN NEUROL, V11, P353, DOI 10.1002/ana.410110406; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; Skotheim JM, 2005, SCIENCE, V308, P1308, DOI 10.1126/science.1107976; Tanaka M, 2006, NATURE, V442, P585, DOI 10.1038/nature04922; Thakur AK, 2009, NAT STRUCT MOL BIOL, V16, P380, DOI 10.1038/nsmb.1570; WHITESIDES GM, 1991, SCIENCE, V254, P1312, DOI 10.1126/science.1962191; Wright CF, 2005, NATURE, V438, P878, DOI 10.1038/nature04195; Xue WF, 2008, P NATL ACAD SCI USA, V105, P8926, DOI 10.1073/pnas.0711664105; Zhu L, 2003, J MOL BIOL, V328, P235, DOI 10.1016/S0022-2836(03)00249-3	28	774	776	7	281	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1533	1537		10.1126/science.1178250	http://dx.doi.org/10.1126/science.1178250			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007899				2022-12-28	WOS:000272623600057
J	Voytas, DF; Joung, JK				Voytas, Daniel F.; Joung, J. Keith			DNA Binding Made Easy	SCIENCE			English	Editorial Material							GENE; RICE		[Voytas, Daniel F.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA; [Voytas, Daniel F.] Univ Minnesota, Ctr Genome Engn, Minneapolis, MN 55455 USA; [Joung, J. Keith] Massachusetts Gen Hosp, Mol Pathol Unit, Charlestown, MA 02129 USA; [Joung, J. Keith] Massachusetts Gen Hosp, Ctr Canc Res, Charlestown, MA 02129 USA; [Joung, J. Keith] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Joung, J. Keith] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Voytas, DF (corresponding author), Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN 55455 USA.	voytas@umn.edu		Voytas, Daniel/0000-0002-4944-1224	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD006862] Funding Source: NIH RePORTER; NIH HHS [DP1 OD006862] Funding Source: Medline	OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Boch J, 2009, SCIENCE, V326, P1509, DOI 10.1126/science.1178811; Cathomen T, 2008, MOL THER, V16, P1200, DOI 10.1038/mt.2008.114; Gu KY, 2005, NATURE, V435, P1122, DOI 10.1038/nature03630; Gurlebeck D, 2005, PLANT J, V42, P175, DOI 10.1111/j.1365-313X.2005.02370.x; Moscou MJ, 2009, SCIENCE, V326, P1501, DOI 10.1126/science.1178817; Nissan G, 2006, MOL MICROBIOL, V61, P1118, DOI 10.1111/j.1365-2958.2006.05301.x; Paques F, 2007, CURR GENE THER, V7, P49, DOI 10.2174/156652307779940216; PAVLETICH NP, 1991, SCIENCE, V252, P809, DOI 10.1126/science.2028256; Pearson H, 2008, NATURE, V455, P160, DOI [10.1038/455160a, 10.1038/453150a]; Yang B, 2006, P NATL ACAD SCI USA, V103, P10503, DOI 10.1073/pnas.0604088103	10	24	50	0	9	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 11	2009	326	5959					1491	1492		10.1126/science.1183604	http://dx.doi.org/10.1126/science.1183604			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007890	Green Accepted			2022-12-28	WOS:000272623600044
J	Fuchs, VR				Fuchs, Victor R.			Eliminating "Waste" in Health Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Natl Bur Econ Res, Stanford, CA 94305 USA	National Bureau of Economic Research	Fuchs, VR (corresponding author), Natl Bur Econ Res, 30 Alta Rd, Stanford, CA 94305 USA.	vfuchs@stanford.edu						Bertrand OF, 2008, J INVASIVE CARDIOL, V20, P99; Canadian Institute for Health Information, MED IM CAN 2007; *CNN, OB SEEKS OUT SKEPT M; Emanuel EJ, 2008, JAMA-J AM MED ASSOC, V299, P2789, DOI 10.1001/jama.299.23.2789; Emanuel EJ, 2007, JAMA-J AM MED ASSOC, V298, P1323, DOI 10.1001/jama.298.11.1323; Yan BP, 2008, INT J CARDIOL, V130, P374, DOI 10.1016/j.ijcard.2008.06.046	6	24	24	0	1	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2481	2482		10.1001/jama.2009.1821	http://dx.doi.org/10.1001/jama.2009.1821			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529MD	19996406				2022-12-28	WOS:000272520500030
J	Bonifazi, P; Goldin, M; Picardo, MA; Jorquera, I; Cattani, A; Bianconi, G; Represa, A; Ben-Ari, Y; Cossart, R				Bonifazi, P.; Goldin, M.; Picardo, M. A.; Jorquera, I.; Cattani, A.; Bianconi, G.; Represa, A.; Ben-Ari, Y.; Cossart, R.			GABAergic Hub Neurons Orchestrate Synchrony in Developing Hippocampal Networks	SCIENCE			English	Article							SMALL-WORLD NETWORKS; PYRAMIDAL NEURONS; IN-VITRO; INTERNEURONS; OSCILLATIONS; GABA; CONNECTIVITY; POTENTIALS; DYNAMICS; GENERATION	Brain function operates through the coordinated activation of neuronal assemblies. Graph theory predicts that scale-free topologies, which include "hubs" (superconnected nodes), are an effective design to orchestrate synchronization. Whether hubs are present in neuronal assemblies and coordinate network activity remains unknown. Using network dynamics imaging, online reconstruction of functional connectivity, and targeted whole-cell recordings in rats and mice, we found that developing hippocampal networks follow a scale-free topology, and we demonstrated the existence of functional hubs. Perturbation of a single hub influenced the entire network dynamics. Morphophysiological analysis revealed that hub cells are a subpopulation of gamma-aminobutyric acid-releasing (GABAergic) interneurons possessing widespread axonal arborizations. These findings establish a central role for GABAergic interneurons in shaping developing networks and help provide a conceptual framework for studying neuronal synchrony.	[Bonifazi, P.; Goldin, M.; Picardo, M. A.; Jorquera, I.; Cattani, A.; Represa, A.; Ben-Ari, Y.; Cossart, R.] Univ Mediterranee, INSERM, U901, Inst Neurobiol Mediterradee, F-13273 Marseille 9, France; [Bianconi, G.] Northeastern Univ, Dept Phys, Boston, MA 02115 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Northeastern University	Cossart, R (corresponding author), Univ Mediterranee, INSERM, U901, Inst Neurobiol Mediterradee, Parc Sci Luminy,Boite Postale 13, F-13273 Marseille 9, France.	cossart@inmed.univ-mrs.fr	Bonifazi, Paolo/N-9737-2018; Cossart, Rosa/E-7674-2014; Bonifazi, Paolo/AAA-8035-2020; Cossart, Rosa/AAT-7934-2020; Bianconi, Ginestra/AAE-4114-2020; Bianconi, Ginestra/I-5742-2018; Represa, Alfonso/M-7383-2016	Bonifazi, Paolo/0000-0001-6374-8997; Cossart, Rosa/0000-0003-2111-6638; Bonifazi, Paolo/0000-0001-6374-8997; Cossart, Rosa/0000-0003-2111-6638; Bianconi, Ginestra/0000-0002-3380-887X; Bianconi, Ginestra/0000-0002-3380-887X; Represa, Alfonso/0000-0002-5096-8939; picardo, michel/0000-0003-1198-3930; Ben-Ari, Yehezkel/0000-0001-6208-8480; Goldin, Miri/0000-0002-4228-9944	INSERM; Ville de Marseille and Region Provence Alpes Cote d'Azur; Fondation pour la Recherche Medicale; Agence Nationale pour la Recherche; Fondation pour la Recherche sur le Cerveau; Fondation Bettencourt Schueller; CNRS; European Fellowships	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ville de Marseille and Region Provence Alpes Cote d'Azur(Region Provence-Alpes-Cote d'Azur); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Agence Nationale pour la Recherche(French National Research Agency (ANR)); Fondation pour la Recherche sur le Cerveau; Fondation Bettencourt Schueller; CNRS(Centre National de la Recherche Scientifique (CNRS)); European Fellowships	We thank D. Aronov, M. Colonnese, J. Epsztein, B. Fernandez, G. Fishell, C. Holmgren, B. Gutkin, M. Milh, and R. Khazipov for helpful suggestions and critical comments; C. Allene, K. Bennouar, and F. Michel for help with the experiments; and K. Obata and K. Vogt for kindly providing GAD67-EGFP Ki mice. This work was supported by grants from INSERM, the Ville de Marseille and Region Provence Alpes Cote d'Azur, the Fondation pour la Recherche Medicale, the Agence Nationale pour la Recherche, the Fondation pour la Recherche sur le Cerveau, and the Fondation Bettencourt Schueller. R. C. and A. R. were funded by the CNRS. M. Goldin and P. Bonifazi were funded by Framework Program 6 (FP6) and FP7-Intra-European Fellowships for career development.	Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Ben-Ari Y, 2001, TRENDS NEUROSCI, V24, P353, DOI 10.1016/S0166-2236(00)01813-0; Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bolea S, 2006, J NEUROPHYSIOL, V95, P552, DOI 10.1152/jn.00321.2005; Brecht M, 2004, NATURE, V427, P704, DOI 10.1038/nature02266; Buckner RL, 2009, J NEUROSCI, V29, P1860, DOI 10.1523/JNEUROSCI.5062-08.2009; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, TRENDS NEUROSCI, V27, P186, DOI 10.1016/j.tins.2004.02.007; Buzsaki G., 2006, RHYTHMS BRAIN; Canepari M, 2000, CELL CALCIUM, V27, P25, DOI 10.1054/ceca.1999.0086; Cattani AA, 2007, J NEUROPHYSIOL, V98, P2324, DOI 10.1152/jn.00378.2007; Crepel V, 2007, NEURON, V54, P105, DOI 10.1016/j.neuron.2007.03.007; de la Prida LM, 2006, NEURON, V49, P131, DOI 10.1016/j.neuron.2005.10.034; de la Prida LM, 1999, J NEUROPHYSIOL, V82, P202, DOI 10.1152/jn.1999.82.1.202; de la Prida LM, 1998, EUR J NEUROSCI, V10, P899, DOI 10.1046/j.1460-9568.1998.00097.x; Doischer D, 2008, J NEUROSCI, V28, P12956, DOI 10.1523/JNEUROSCI.2890-08.2008; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Eytan D, 2006, J NEUROSCI, V26, P8465, DOI 10.1523/JNEUROSCI.1627-06.2006; Freund TF, 1996, HIPPOCAMPUS, V6, P347, DOI 10.1002/(SICI)1098-1063(1996)6:4<347::AID-HIPO1>3.0.CO;2-I; Grinstein G, 2005, P NATL ACAD SCI USA, V102, P9948, DOI 10.1073/pnas.0504127102; Groc L, 2003, EUR J NEUROSCI, V17, P1873, DOI 10.1046/j.1460-9568.2003.02635.x; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Jeong HY, 2007, NEURAL COMPUT, V19, P706, DOI 10.1162/neco.2007.19.3.706; Jinno S, 2007, J NEUROSCI, V27, P8790, DOI 10.1523/JNEUROSCI.1847-07.2007; Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133; Li CYT, 2009, SCIENCE, V324, P643, DOI 10.1126/science.1169957; Lubenov EV, 2009, NATURE, V459, P534, DOI 10.1038/nature08010; Molnar G, 2008, PLOS BIOL, V6, P1842, DOI 10.1371/journal.pbio.0060222; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; PRICE DJD, 1965, SCIENCE, V149, P510; Rheims S, 2008, J NEUROPHYSIOL, V100, P609, DOI 10.1152/jn.90402.2008; Sipila ST, 2005, J NEUROSCI, V25, P5280, DOI 10.1523/JNEUROSCI.0378-05.2005; Song S, 2005, PLOS BIOL, V3, P507, DOI 10.1371/journal.pbio.0030068; Spitzer NC, 2006, NATURE, V444, P707, DOI 10.1038/nature05300; Sporns O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001049; Srinivas KV, 2007, EUR J NEUROSCI, V25, P3276, DOI 10.1111/j.1460-9568.2007.05559.x; Strata F, 1997, J NEUROSCI, V17, P1435; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Thomson AM, 2007, FRONT NEUROSCI-SWITZ, V1, P19, DOI 10.3389/neuro.01.1.1.002.2007; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wittner L, 2007, J PHYSIOL-LONDON, V584, P867, DOI 10.1113/jphysiol.2007.138131; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047	44	456	458	1	45	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 4	2009	326	5958					1419	1424		10.1126/science.1175509	http://dx.doi.org/10.1126/science.1175509			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965761	Green Published			2022-12-28	WOS:000272351100048
J	Le Goff, A; Artero, V; Jousselme, B; Tran, PD; Guillet, N; Metaye, R; Fihri, A; Palacin, S; Fontecave, M				Le Goff, Alan; Artero, Vincent; Jousselme, Bruno; Tran, Phong Dinh; Guillet, Nicolas; Metaye, Romain; Fihri, Aziz; Palacin, Serge; Fontecave, Marc			From Hydrogenases to Noble Metal-Free Catalytic Nanomaterials for H-2 Production and Uptake	SCIENCE			English	Article							CARBON NANOTUBES; DIAZONIUM SALTS; CRYSTAL-STRUCTURE; ONLY HYDROGENASE; REDUCTION; COMPLEXES; OXIDATION; MODELS	Interconversion of water and hydrogen in unitized regenerative fuel cells is a promising energy storage framework for smoothing out the temporal fluctuations of solar and wind power. However, replacement of presently available platinum catalysts by lower-cost and more abundant materials is a requisite for this technology to become economically viable. Here, we show that the covalent attachment of a nickel bisdiphosphine-based mimic of the active site of hydrogenase enzymes onto multiwalled carbon nanotubes results in a high-surface area cathode material with high catalytic activity under the strongly acidic conditions required in proton exchange membrane technology. Hydrogen evolves from aqueous sulfuric acid solution with very low overvoltages (20 millivolts), and the catalyst exhibits exceptional stability ( more than 100,000 turnovers). The same catalyst is also very efficient for hydrogen oxidation in this environment, exhibiting current densities similar to those observed for hydrogenase-based materials.	[Artero, Vincent; Tran, Phong Dinh; Fihri, Aziz; Fontecave, Marc] Univ Grenoble 1, Lab Chim & Biol Met, CEA, CNRS UMR 5249,Inst Rech Technol & Sci Vivant, F-38054 Grenoble 9, France; [Le Goff, Alan; Jousselme, Bruno; Metaye, Romain; Palacin, Serge] CEA, Inst Rayonnement Mat Saclay, Serv Phys & Chim Surfaces & Interfaces, Chem Surfaces & Interfaces Grp, F-91191 Gif Sur Yvette, France; [Guillet, Nicolas] CEA, Inst Laboratoire Innovat Technol Energies Nouvell, Dept Technol Hydrogene, Lab Composants Pile Combustible Electrolyse & Mod, F-38054 Grenoble 9, France; [Fontecave, Marc] Coll France, F-75005 Paris, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; CEA; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; PSL Research University Paris; College de France	Artero, V (corresponding author), Univ Grenoble 1, Lab Chim & Biol Met, CEA, CNRS UMR 5249,Inst Rech Technol & Sci Vivant, 17 Rue Martyrs, F-38054 Grenoble 9, France.	vincent.artero@cea.fr; serge.palacin@cea.fr	Artero, Vincent/C-6853-2008; TRAN, Phong/F-8470-2012; le goff, alan/B-9152-2008; Tran, Phong/GZA-8504-2022; TRAN, Phong/F-8483-2012; Jousselme, Bruno/N-4522-2013; PALACIN, Serge/H-1067-2012; Le Goff, Alan/AGZ-3449-2022	Artero, Vincent/0000-0002-6148-8471; PALACIN, Serge/0000-0003-0738-8557; Le Goff, Alan/0000-0002-6765-5859; Guillet, Nicolas/0000-0002-6880-967X; Jousselme, Bruno/0000-0002-4964-5120	CEA; CNRS; Agence Nationale de la Recherche [PAN-H 2008]	CEA(French Atomic Energy Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR))	This work was supported by the CEA (Nanosciences program, grant Grafthydro), the CNRS ("Materials" program, grant 961 "projets exploratoires: Interface Science des Materiaux/Vivant") and the Agence Nationale de la Recherche (PAN-H 2008, EnzHyd). The authors thank E. Mayousse and P.-A. Jacques for experimental contribution and V. Derycke for assistance in the SEM characterizations. The authors have filed a European patent application (EP-08 290 988.8) for the grafting procedure of catalysts presented here.	Abe T, 1998, POLYM ADVAN TECHNOL, V9, P559, DOI 10.1002/(SICI)1099-1581(199809)9:9<559::AID-PAT818>3.0.CO;2-1; Alonso-Lomillo MA, 2007, NANO LETT, V7, P1603, DOI 10.1021/nl070519u; Bahr JL, 2001, J AM CHEM SOC, V123, P6536, DOI 10.1021/ja010462s; Bashyam R, 2006, NATURE, V443, P63, DOI 10.1038/nature05118; Canaguier S, 2008, DALTON T, P315, DOI 10.1039/b713567j; COSNIER S, 1989, J CHEM SOC CHEM COMM, P1259, DOI 10.1039/c39890001259; Fontecilla-Camps JC, 2007, CHEM REV, V107, P5411, DOI 10.1021/cr078107t; Grivea S, 2007, ELECTROCHEM COMMUN, V9, P2768, DOI 10.1016/j.elecom.2007.09.004; Hambourger M, 2008, J AM CHEM SOC, V130, P2015, DOI 10.1021/ja077691k; Jousselme B, 2008, J ELECTROANAL CHEM, V621, P277, DOI 10.1016/j.jelechem.2008.01.026; Li ZL, 2005, J AM CHEM SOC, V127, P8950, DOI 10.1021/ja051590+; Mealli C, 2007, ANGEW CHEM INT EDIT, V46, P8942, DOI 10.1002/anie.200703413; Ogo S, 2007, SCIENCE, V316, P585, DOI 10.1126/science.1138751; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pinson J, 2005, CHEM SOC REV, V34, P429, DOI 10.1039/b406228k; Sgobba V, 2009, CHEM SOC REV, V38, P165, DOI 10.1039/b802652c; Silakov A, 2009, PHYS CHEM CHEM PHYS, V11, P6592, DOI 10.1039/b905841a; Singleton ML, 2008, ANGEW CHEM INT EDIT, V47, P9492, DOI 10.1002/anie.200803939; Tard C, 2005, NATURE, V433, P610, DOI 10.1038/nature03298; Tasis D, 2006, CHEM REV, V106, P1105, DOI 10.1021/cr050569o; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Wilson AD, 2007, P NATL ACAD SCI USA, V104, P6951, DOI 10.1073/pnas.0608928104; Wilson AD, 2006, J AM CHEM SOC, V128, P358, DOI 10.1021/ja056442y; Wu ZC, 2004, SCIENCE, V305, P1273, DOI 10.1126/science.1101243	25	737	745	7	528	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 4	2009	326	5958					1384	1387		10.1126/science.1179773	http://dx.doi.org/10.1126/science.1179773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965754	Green Published			2022-12-28	WOS:000272351100037
J	Nechaev, S; Fargo, DC; dos Santos, G; Liu, LW; Gao, Y; Adelman, K				Nechaev, Sergei; Fargo, David C.; dos Santos, Gilberto; Liu, Liwen; Gao, Yuan; Adelman, Karen			Global Analysis of Short RNAs Reveals Widespread Promoter-Proximal Stalling and Arrest of Pol II in Drosophila	SCIENCE			English	Article							CLEAVAGE FACTOR TFIIS; POLYMERASE-II; TRANSCRIPTION INITIATION; ELONGATION; MELANOGASTER; GENES; NELF; EXPRESSION; STABILITY; INVITRO	Emerging evidence indicates that gene expression in higher organisms is regulated by RNA polymerase II stalling during early transcription elongation. To probe the mechanisms responsible for this regulation, we developed methods to isolate and characterize short RNAs derived from stalled RNA polymerase II in Drosophila cells. Significant levels of these short RNAs were generated from more than one-third of all genes, indicating that promoter-proximal stalling is a general feature of early polymerase elongation. Nucleotide composition of the initially transcribed sequence played an important role in promoting transcriptional stalling by rendering polymerase elongation complexes highly susceptible to backtracking and arrest. These results indicate that the intrinsic efficiency of early elongation can greatly affect gene expression.	[Nechaev, Sergei; dos Santos, Gilberto; Adelman, Karen] NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA; [Fargo, David C.] NIEHS, Lib Serv, NIH, Res Triangle Pk, NC 27709 USA; [Fargo, David C.] NIEHS, Informat Serv, NIH, Res Triangle Pk, NC 27709 USA; [Liu, Liwen] NIEHS, Biostat Branch, NIH, Res Triangle Pk, NC 27709 USA; [Gao, Yuan] Virginia Commonwealth Univ, Dept Comp Sci, Richmond, VA 23284 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); Virginia Commonwealth University	Adelman, K (corresponding author), NIEHS, Mol Carcinogenesis Lab, NIH, Res Triangle Pk, NC 27709 USA.	adelmank@niehs.nih.gov	Gao, Yuan/E-1706-2011; Nechaev, Sergei/AAQ-3450-2021	Adelman, Karen/0000-0001-5364-334X	NIH, National Institute of Environmental Health Sciences [Z01 ES101987]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101987, ZICES102445, ZIAES101987] Funding Source: NIH RePORTER	NIH, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank P. Wade, T. Kunkel, and members of the Adelman laboratory for insightful discussions. We acknowledge S. Dai and J. Grovenstein for computational support. Sequence data are in the Gene Expression Omnibus (GEO) database under accession number GSE18643. This research was supported by the Intramural Research Program of the NIH, National Institute of Environmental Health Sciences (Z01 ES101987).	Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Ahsan B, 2009, NUCLEIC ACIDS RES, V37, pD49, DOI 10.1093/nar/gkn694; Aida M, 2006, MOL CELL BIOL, V26, P6094, DOI 10.1128/MCB.02366-05; COPPOLA JA, 1983, P NATL ACAD SCI-BIOL, V80, P1251, DOI 10.1073/pnas.80.5.1251; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Fejes-Toth K, 2009, NATURE, V457, P1028, DOI 10.1038/nature07759; Fish RN, 2002, BBA-GENE STRUCT EXPR, V1577, P287, DOI 10.1016/S0167-4781(02)00459-1; Gilchrist DA, 2008, GENE DEV, V22, P1921, DOI 10.1101/gad.1643208; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; JOVE R, 1984, J BIOL CHEM, V259, P8513; Juven-Gershon T, 2008, CURR OPIN CELL BIOL, V20, P253, DOI 10.1016/j.ceb.2008.03.003; KAINZ M, 1992, SCIENCE, V255, P838, DOI 10.1126/science.1536008; KEPHART DD, 1992, MOL CELL BIOL, V12, P2067, DOI 10.1128/MCB.12.5.2067; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; Komissarova N, 1997, J BIOL CHEM, V272, P15329, DOI 10.1074/jbc.272.24.15329; KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559; Lee CY, 2008, MOL CELL BIOL, V28, P3290, DOI 10.1128/MCB.02224-07; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Pal M, 2001, MOL CELL BIOL, V21, P5815, DOI 10.1128/MCB.21.17.5815-5825.2001; Palangat M, 2005, P NATL ACAD SCI USA, V102, P15036, DOI 10.1073/pnas.0409405102; Palangat M, 2001, J MOL BIOL, V311, P265, DOI 10.1006/jmbi.2001.4842; RASMUSSEN EB, 1995, J MOL BIOL, V252, P522, DOI 10.1006/jmbi.1995.0517; RASMUSSEN EB, 1993, P NATL ACAD SCI USA, V90, P7923, DOI 10.1073/pnas.90.17.7923; Reeder TC, 1996, CELL, V87, P767, DOI 10.1016/S0092-8674(00)81395-1; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; ROUGVIE AE, 1990, MOL CELL BIOL, V10, P6041, DOI 10.1128/MCB.10.11.6041; Tadigotla VR, 2006, P NATL ACAD SCI USA, V103, P4439, DOI 10.1073/pnas.0600508103; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	28	300	302	3	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					335	338		10.1126/science.1181421	http://dx.doi.org/10.1126/science.1181421			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20007866	Green Accepted			2022-12-28	WOS:000273629700044
J	Dennis, JW; Nabi, IR; Demetriou, M				Dennis, James W.; Nabi, Ivan R.; Demetriou, Michael			Metabolism, Cell Surface Organization, and Disease	CELL			English	Review							N-ACETYLGLUCOSAMINYLTRANSFERASE-V; LINKED OLIGOSACCHARIDES; CAENORHABDITIS-ELEGANS; PROTEIN GLYCOSYLATION; GLCNAC-TRANSFERASE; ACID BIOSYNTHESIS; GENE-EXPRESSION; GLYCAN; GROWTH; RECEPTOR		[Dennis, James W.] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Dennis, James W.] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Dennis, James W.] Univ Toronto, Dept Lab Med, Toronto, ON M5S 1A8, Canada; [Dennis, James W.] Univ Toronto, Dept Pathol, Toronto, ON M5S 1A8, Canada; [Nabi, Ivan R.] Univ British Columbia, Inst Life Sci, Dept Cellular & Physiol Sci, Vancouver, BC V6T 1Z3, Canada; [Demetriou, Michael] Univ Calif Irvine, Inst Immunol, Dept Neurol, Irvine, CA 92697 USA; [Demetriou, Michael] Univ Calif Irvine, Inst Immunol, Dept Microbiol & Mol Genet, Irvine, CA 92697 USA	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University of Toronto; University of British Columbia; University of California System; University of California Irvine; University of California System; University of California Irvine	Dennis, JW (corresponding author), Mt Sinai Hosp, Samuel Lunenfeld Res Inst, 600 Univ Ave R988, Toronto, ON M5G 1X5, Canada.	dennis@mshri.on.ca; mdemetri@uci.edu	Nabi, Ivan/GWZ-5144-2022; Dennis, James/E-7268-2013	Nabi, Ivan/0000-0002-0670-0513; Demetriou, Michael/0000-0002-2224-7798	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082266, R56AI082266, R01AI053331] Funding Source: NIH RePORTER; CIHR Funding Source: Medline; NIAID NIH HHS [R56 AI082266-01A1, R01 AI082266, R01 AI053331-05, R01 AI053331, R56 AI082266] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); CIHR(Canadian Institutes of Health Research (CIHR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ahmad N, 2004, J BIOL CHEM, V279, P10841, DOI 10.1074/jbc.M312834200; Alegre ML, 2001, NAT REV IMMUNOL, V1, P220, DOI 10.1038/35105024; Amano M, 2003, J BIOL CHEM, V278, P7469, DOI 10.1074/jbc.M209595200; Anjos S, 2002, J BIOL CHEM, V277, P46478, DOI 10.1074/jbc.M206894200; Aoki M, 1998, ANN NEUROL, V43, P645, DOI 10.1002/ana.410430514; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; Bailey JE, 1998, BIOTECHNOL PROGR, V14, P8, DOI 10.1021/bp9701269; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Boehmelt G, 2000, J BIOL CHEM, V275, P12821, DOI 10.1074/jbc.275.17.12821; Braccia A, 2003, J BIOL CHEM, V278, P15679, DOI 10.1074/jbc.M211228200; Brewer CF, 2002, CURR OPIN STRUC BIOL, V12, P616, DOI 10.1016/S0959-440X(02)00364-0; Broschat KO, 2002, J BIOL CHEM, V277, P14764, DOI 10.1074/jbc.M201056200; Buckhaults P, 1997, J BIOL CHEM, V272, P19575, DOI 10.1074/jbc.272.31.19575; Buse MG, 1996, J BIOL CHEM, V271, P23197, DOI 10.1074/jbc.271.38.23197; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Cha SK, 2009, MOL PHARMACOL, V76, P38, DOI 10.1124/mol.109.055780; Chen HL, 2009, J BIOL CHEM, V284, P32454, DOI 10.1074/jbc.M109.023630; Chen IJ, 2007, J BIOL CHEM, V282, P35361, DOI 10.1074/jbc.M706923200; Cheung P, 2007, GLYCOBIOLOGY, V17, P828, DOI 10.1093/glycob/cwm048; Chikuma Shunsuke, 2002, Mol Interv, V2, P205, DOI 10.1124/mi.2.4.205; Coffey MC, 1998, SCIENCE, V282, P1332, DOI 10.1126/science.282.5392.1332; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Coster ACF, 2004, TRAFFIC, V5, P763, DOI 10.1111/j.1600-0854.2004.00218.x; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Delacour D, 2007, TRAFFIC, V8, P379, DOI 10.1111/j.1600-0854.2007.00539.x; Demetriou M, 2001, NATURE, V409, P733, DOI 10.1038/35055582; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; Dennis JW, 2009, TRAFFIC, V10, P1569, DOI 10.1111/j.1600-0854.2009.00981.x; Dennis JW, 2002, BBA-GEN SUBJECTS, V1573, P414, DOI 10.1016/S0304-4165(02)00411-7; DENNIS JW, 1987, SCIENCE, V236, P582, DOI 10.1126/science.2953071; Dentin R, 2008, SCIENCE, V319, P1402, DOI 10.1126/science.1151363; DO KY, 1994, J BIOL CHEM, V269, P23456; Drickamer K, 2002, BIOCHEM SOC SYMP, V69, P59; Fernandes H, 2001, J BIOL CHEM, V276, P5375, DOI 10.1074/jbc.M005599200; Ferrell JE, 1996, TRENDS BIOCHEM SCI, V21, P460, DOI 10.1016/S0968-0004(96)20026-X; Frauwirth KA, 2002, IMMUNITY, V16, P769, DOI 10.1016/S1074-7613(02)00323-0; Freeze HH, 1998, J PEDIATR-US, V133, P593, DOI 10.1016/S0022-3476(98)70096-4; Galeano B, 2007, J CLIN INVEST, V117, P1585, DOI 10.1172/JCI30954; Gambetta MC, 2009, SCIENCE, V325, P93, DOI 10.1126/science.1169727; Gluckman PD, 2006, HORM RES, V65, P5, DOI 10.1159/000091500; Granovsky M, 1995, GLYCOBIOLOGY, V5, P797, DOI 10.1093/glycob/5.8.797; Grigorian A, 2007, J BIOL CHEM, V282, P20027, DOI 10.1074/jbc.M701890200; Grigorian A, 2009, IMMUNOL REV, V230, P232, DOI 10.1111/j.1600-065X.2009.00796.x; Gurdon JB, 2001, NATURE, V413, P797, DOI 10.1038/35101500; Gutternigg M, 2007, J BIOL CHEM, V282, P27825, DOI 10.1074/jbc.M704235200; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hinderlich S, 1997, J BIOL CHEM, V272, P24313, DOI 10.1074/jbc.272.39.24313; Hirabayashi J, 2002, BBA-GEN SUBJECTS, V1572, P232, DOI 10.1016/S0304-4165(02)00311-2; Housley MP, 2008, J BIOL CHEM, V283, P16283, DOI 10.1074/jbc.M802240200; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; IOFFE E, 1994, P NATL ACAD SCI USA, V91, P728, DOI 10.1073/pnas.91.2.728; Ishida H, 2005, FEBS LETT, V579, P71, DOI 10.1016/j.febslet.2004.11.037; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Jones J, 2005, BBA-GEN SUBJECTS, V1726, P121, DOI 10.1016/j.bbagen.2005.07.003; Klein P, 2004, P NATL ACAD SCI USA, V101, P929, DOI 10.1073/pnas.0307285101; Kolm-Litty V, 1998, J CLIN INVEST, V101, P160, DOI 10.1172/JCI119875; Konishi A, 2003, J BIOL CHEM, V278, P35049, DOI 10.1074/jbc.M304913200; Kreppel LK, 1999, J BIOL CHEM, V274, P32015, DOI 10.1074/jbc.274.45.32015; Kuball J, 2009, J EXP MED, V206, P463, DOI 10.1084/jem.20082487; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Lagana A, 2006, MOL CELL BIOL, V26, P3181, DOI 10.1128/MCB.26.8.3181-3193.2006; Lajoie P, 2007, J CELL BIOL, V179, P341, DOI 10.1083/jcb.200611106; Lanzetti L, 2004, NATURE, V429, P309, DOI 10.1038/nature02542; Lau KS, 2008, GLYCOBIOLOGY, V18, P750, DOI 10.1093/glycob/cwn071; Lau KS, 2007, CELL, V129, P123, DOI 10.1016/j.cell.2007.01.049; Lecca MR, 2004, FASEB J, V18, P240, DOI 10.1096/fj.04-2397fje; Lee H, 2002, AM J PATHOL, V161, P1357, DOI 10.1016/S0002-9440(10)64412-4; Lee RT, 2000, GLYCOCONJUGATE J, V17, P543, DOI 10.1023/A:1011070425430; Lee SU, 2007, J BIOL CHEM, V282, P33725, DOI 10.1074/jbc.M704839200; Leonard R, 2006, J BIOL CHEM, V281, P4867, DOI 10.1074/jbc.M511023200; Levy Y, 2001, J BIOL CHEM, V276, P31285, DOI 10.1074/jbc.M100340200; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marquardt T, 1999, BLOOD, V94, P3976, DOI 10.1182/blood.V94.12.3976.424k06_3976_3985; Matsuura I, 2004, NATURE, V430, P226, DOI 10.1038/nature02650; McClain DA, 2002, P NATL ACAD SCI USA, V99, P10695, DOI 10.1073/pnas.152346899; Mendelsohn R, 2007, CANCER RES, V67, P9771, DOI 10.1158/0008-5472.CAN-06-4580; METZLER M, 1994, EMBO J, V13, P2056, DOI 10.1002/j.1460-2075.1994.tb06480.x; Moro L, 2002, J BIOL CHEM, V277, P9405, DOI 10.1074/jbc.M109101200; Morrish F, 2009, ONCOGENE, V28, P2485, DOI 10.1038/onc.2009.112; Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521; Ohtsubo K, 2005, CELL, V123, P1307, DOI 10.1016/j.cell.2005.09.041; Okamoto T, 1998, J BIOL CHEM, V273, P5419, DOI 10.1074/jbc.273.10.5419; Partridge EA, 2004, SCIENCE, V306, P120, DOI 10.1126/science.1102109; Patnaik SK, 2006, GLYCOBIOLOGY, V16, P305, DOI 10.1093/glycob/cwj063; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Radman M, 2001, NATURE, V413, P115, DOI 10.1038/35093178; Reynolds AR, 2003, NAT CELL BIOL, V5, P447, DOI 10.1038/ncb981; Rudd PM, 1999, J MOL BIOL, V293, P351, DOI 10.1006/jmbi.1999.3104; Salvatore S, 2000, ALIMENT PHARM THER, V14, P1567, DOI 10.1046/j.1365-2036.2000.00883.x; Sarkar M, 2006, J BIOL CHEM, V281, P12776, DOI 10.1074/jbc.M512769200; Sasai K, 2002, GLYCOBIOLOGY, V12, P119, DOI 10.1093/glycob/12.2.119; SCHACHTER H, 1986, BIOCHEM CELL BIOL, V64, P163, DOI 10.1139/o86-026; Schneider H, 2006, SCIENCE, V313, P1972, DOI 10.1126/science.1131078; Seetharaman J, 1998, J BIOL CHEM, V273, P13047, DOI 10.1074/jbc.273.21.13047; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Shang J, 2007, J CELL BIOL, V176, P605, DOI 10.1083/jcb.200607007; Shi H, 2006, METHOD ENZYMOL, V417, P359, DOI 10.1016/S0076-6879(06)17022-6; Shiraha H, 2000, J BIOL CHEM, V275, P19343, DOI 10.1074/jbc.M000008200; Smith PL, 2002, J CELL BIOL, V158, P801, DOI 10.1083/jcb.200203125; Soleimani L, 2008, GENES BRAIN BEHAV, V7, P334, DOI 10.1111/j.1601-183X.2007.00358.x; Stillman BN, 2006, J IMMUNOL, V176, P778, DOI 10.4049/jimmunol.176.2.778; Stowell SR, 2008, J BIOL CHEM, V283, P10109, DOI 10.1074/jbc.M709545200; Stroop CJM, 2000, GLYCOBIOLOGY, V10, P901, DOI 10.1093/glycob/10.9.901; Takahashi M, 2008, BBA-GEN SUBJECTS, V1780, P520, DOI 10.1016/j.bbagen.2007.10.019; Takamatsu S, 1999, CANCER RES, V59, P3949; Takenaka Y, 2002, GLYCOCONJUGATE J, V19, P543, DOI 10.1023/B:GLYC.0000014084.01324.15; Tan J, 1996, AM J HUM GENET, V59, P810; Tanikawa R, 2008, J BONE MINER RES, V23, P278, DOI 10.1359/JBMR.071008; Taylor RP, 2008, J BIOL CHEM, V283, P6050, DOI 10.1074/jbc.M707328200; Togayachi A, 2007, P NATL ACAD SCI USA, V104, P15829, DOI 10.1073/pnas.0707426104; Toscano MA, 2007, NAT IMMUNOL, V8, P825, DOI 10.1038/ni1482; Trotti D, 2001, J BIOL CHEM, V276, P576, DOI 10.1074/jbc.M003779200; Tsuda T, 2000, J BIOL CHEM, V275, P21988, DOI 10.1074/jbc.M003400200; WALDMAN BC, 1990, BIOCHEMISTRY-US, V29, P44, DOI 10.1021/bi00453a006; Wang Y, 2001, GLYCOBIOLOGY, V11, P1051, DOI 10.1093/glycob/11.12.1051; WATERHOUSE P, 1995, SCIENCE, V270, P985, DOI 10.1126/science.270.5238.985; Wiley HS, 2001, TRAFFIC, V2, P12, DOI 10.1034/j.1600-0854.2001.020103.x; Winkler WC, 2004, NATURE, V428, P281, DOI 10.1038/nature02362; Wollscheid B, 2009, NAT BIOTECHNOL, V27, P378, DOI 10.1038/nbt.1532; Xu RH, 2005, NAT METHODS, V2, P185, DOI 10.1038/NMETH744; Zhang J, 2003, J CELL BIOCHEM, V88, P932, DOI 10.1002/jcb.10444; Zhu SX, 2004, BIOCHEM J, V382, P995, DOI 10.1042/BJ20040793	127	339	345	4	68	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1229	1241		10.1016/j.cell.2009.12.008	http://dx.doi.org/10.1016/j.cell.2009.12.008			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064370	Green Accepted, Bronze			2022-12-28	WOS:000273048700012
J	Moldovan, GL; D'Andrea, AD				Moldovan, George-Lucian; D'Andrea, Alan D.			FANCD2 Hurdles the DNA Interstrand Crosslink	CELL			English	Editorial Material							FANCONI-ANEMIA; REPAIR		[Moldovan, George-Lucian; D'Andrea, Alan D.] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Radiat Oncol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	D'Andrea, AD (corresponding author), Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Radiat Oncol, 44 Binney St, Boston, MA 02215 USA.	alan_dandrea@dfci.harvard.edu	Classen, Scott/AAY-8176-2020	George-Lucian, Moldovan/0000-0003-3825-149X	NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052725, R37HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA092584, P01 CA092584, P01 CA092584-09] Funding Source: Medline; NHLBI NIH HHS [R37 HL052725, R01 HL052725, R37 HL052725-16] Funding Source: Medline; NIAID NIH HHS [U19 AI067751-05, U19 AI067751] Funding Source: Medline; NIDDK NIH HHS [R01 DK043889, R01 DK043889-17] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ben-Yehoyada M, 2009, MOL CELL, V35, P704, DOI 10.1016/j.molcel.2009.08.014; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; KNIPSCHEER P, 2009, SCIENCE         1112, DOI DOI 10.1126/SCIENCE.1182372; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030	9	18	18	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1222	1224		10.1016/j.cell.2009.12.006	http://dx.doi.org/10.1016/j.cell.2009.12.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064367	Bronze, Green Accepted			2022-12-28	WOS:000273048700009
J	Lafuente-Lafuente, C; Mahe, I; Extramiana, F				Lafuente-Lafuente, Carmelo; Mahe, Isabelle; Extramiana, Fabrice			Management of atrial fibrillation	BMJ-BRITISH MEDICAL JOURNAL			English	Review							RHYTHM-CONTROL; ANTITHROMBOTIC THERAPY; STROKE PREVENTION; CATHETER ABLATION; SINUS RHYTHM; METAANALYSIS; WARFARIN; ASPIRIN; AGENTS; DRUGS		[Lafuente-Lafuente, Carmelo] Univ Paris 07, Hop Lariboisiere, AP HP, Clin Therapeut,Serv Med A, F-75010 Paris, France; [Mahe, Isabelle] Univ Paris 07, Hop Louis Mourier, Serv Med Interne 5, F-75010 Paris, France; [Extramiana, Fabrice] Univ Paris 07, Hop Lariboisiere, Serv Cardiol, F-75010 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Louis-Mourier - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite	Lafuente-Lafuente, C (corresponding author), Univ Paris 07, Hop Lariboisiere, AP HP, Clin Therapeut,Serv Med A, 2 Rue Ambroise Pare, F-75010 Paris, France.	c.lafuente@nodo3.net	Extramiana, Fabrice/ABH-3321-2020; Mahé, Isabelle/ABA-3641-2020	Mahé, Isabelle/0000-0003-1760-7880; Lafuente-Lafuente, Carmelo/0000-0002-2475-4670; Extramiana, Fabrice/0000-0001-8123-4842				Aguilar MI, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006186.pub2; Alboni P, 2004, NEW ENGL J MED, V351, P2384, DOI 10.1056/NEJMoa041233; Aspinall SL, 2005, J GEN INTERN MED, V20, P1008, DOI 10.1111/j.1525-1497.2005.0229.x; Connolly SJ, 2009, NEW ENGL J MED, V360, P2066, DOI 10.1056/NEJMoa0901301; Connolly SJ, 2009, NEW ENGL J MED, V361, P1139, DOI 10.1056/NEJMoa0905561; Cooper NJ, 2006, ARCH INTERN MED, V166, P1269, DOI 10.1001/archinte.166.12.1269; de Denus S, 2005, ARCH INTERN MED, V165, P258, DOI 10.1001/archinte.165.3.258; Doyle JF, 2009, MAYO CLIN PROC, V84, P234, DOI 10.1016/S0025-6196(11)61140-3; Ezekowitz M, 1998, ARCH INTERN MED, V158, P1316; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gage BF, 2001, JAMA-J AM MED ASSOC, V285, P2864, DOI 10.1001/jama.285.22.2864; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; Hart RG, 2007, ANN INTERN MED, V146, P857, DOI 10.7326/0003-4819-146-12-200706190-00007; Heeringa J, 2006, EUR HEART J, V27, P949, DOI 10.1093/eurheartj/ehi825; Hohnloser SH, 2009, NEW ENGL J MED, V360, P668, DOI 10.1056/NEJMoa0803778; Jais P, 2008, CIRCULATION, V118, P2498, DOI 10.1161/CIRCULATIONAHA.108.772582; Khan MN, 2008, NEW ENGL J MED, V359, P1778, DOI 10.1056/NEJMoa0708234; Lafuente-Lafuente C, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005049.pub2; Mant J, 2007, LANCET, V370, P493, DOI 10.1016/S0140-6736(07)61233-1; Miller MR, 2000, J FAM PRACTICE, V49, P1033; *NICE, 2006, CLIN GUID NICE, V36; Nichol G, 2002, HEART, V87, P535, DOI 10.1136/heart.87.6.535; Noheria A, 2008, ARCH INTERN MED, V168, P581, DOI 10.1001/archinte.168.6.581; Olshansky B, 2004, J AM COLL CARDIOL, V43, P1201, DOI 10.1016/j.jacc.2003.11.032; Roy D, 2008, NEW ENGL J MED, V358, P2667, DOI 10.1056/NEJMoa0708789; Segal JB, 2000, J FAM PRACTICE, V49, P47; Singer DE, 2008, CHEST, V133, p546S, DOI 10.1378/chest.08-0678; Testa L, 2005, EUR HEART J, V26, P2000, DOI 10.1093/eurheartj/ehi306; Wood MA, 2000, CIRCULATION, V101, P1138, DOI 10.1161/01.CIR.101.10.1138; Wyse DG, 2002, NEW ENGL J MED, V347, P1825, DOI 10.1056/nejmoa021328	30	16	16	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 23	2009	339								b5216	10.1136/bmj.b5216	http://dx.doi.org/10.1136/bmj.b5216			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	536ZL	20032065				2022-12-28	WOS:000273082400006
J	Alperson-Afil, N; Sharon, G; Kislev, M; Melamed, Y; Zohar, I; Ashkenazi, S; Rabinovich, R; Biton, R; Werker, E; Hartman, G; Feibel, C; Goren-Inbar, N				Alperson-Afil, Nira; Sharon, Gonen; Kislev, Mordechai; Melamed, Yoel; Zohar, Irit; Ashkenazi, Shosh; Rabinovich, Rivka; Biton, Rebecca; Werker, Ella; Hartman, Gideon; Feibel, Craig; Goren-Inbar, Naama			Spatial Organization of Hominin Activities at Gesher Benot Ya'aqov, Israel	SCIENCE			English	Article							ACHEULEAN SITE; WATER FISH	The spatial designation of discrete areas for different activities reflects formalized conceptualization of a living space. The results of spatial analyses of a Middle Pleistocene Acheulian archaeological horizon ( about 750,000 years ago) at Gesher Benot Ya'aqov, Israel, indicate that hominins differentiated their activities (stone knapping, tool use, floral and faunal processing and consumption) across space. These were organized in two main areas, including multiple activities around a hearth. The diversity of human activities and the distinctive patterning with which they are organized implies advanced organizational skills of the Gesher Benot Ya'aqov hominins.	[Alperson-Afil, Nira; Sharon, Gonen; Rabinovich, Rivka; Goren-Inbar, Naama] Hebrew Univ Jerusalem, Inst Archaeol, IL-91905 Jerusalem, Israel; [Kislev, Mordechai; Melamed, Yoel] Bar Ilan Univ, Fac Life Sci, IL-52900 Ramat Gan, Israel; [Zohar, Irit] Univ Haifa, Leon Recanati Inst Maritime Studies, IL-31905 Haifa, Israel; [Zohar, Irit] Tel Aviv Univ, George S Wise Fac Life Sci, Dept Zool, IL-69978 Tel Aviv, Israel; [Werker, Ella] Hebrew Univ Jerusalem, Dept Bot, IL-91904 Jerusalem, Israel; [Hartman, Gideon] Max Planck Inst Evolutionary Anthropol, Dept Human Evolut, D-04103 Leipzig, Germany; [Feibel, Craig] Rutgers State Univ, Dept Geol Sci, New Brunswick, NJ 08901 USA	Hebrew University of Jerusalem; Bar Ilan University; University of Haifa; Tel Aviv University; Hebrew University of Jerusalem; Max Planck Society; Rutgers State University New Brunswick	Alperson-Afil, N (corresponding author), Hebrew Univ Jerusalem, Inst Archaeol, IL-91905 Jerusalem, Israel.	alperson@mscc.huji.ac.il; goren@cc.huji.ac.il	Biton, Rebecca/G-6719-2012	Biton, Rebecca/0000-0003-4710-0538; Rabinovich, Rivka/0000-0002-1343-3134; Zohar, Irit/0000-0002-5943-2751; Sharon, Gonen/0000-0002-1226-2556	Israel Science Foundation [300/06, 886/02]; German-Israeli Foundation [I-896-208.4/2005]; Irene Levi Sala CARE Archaeological Foundation	Israel Science Foundation(Israel Science Foundation); German-Israeli Foundation(German-Israeli Foundation for Scientific Research and Development); Irene Levi Sala CARE Archaeological Foundation	Supported by Israel Science Foundation grant 300/06 to the Center of Excellence Project "The Effect of Climate Change on the Environment and Hominins of the Upper Jordan Valley between ca. 800 ka and 700 ka as a Basis for Prediction of Future Scenarios." The study of burned flint microartifacts was supported by grants from the German-Israeli Foundation ( GIF I-896-208.4/2005) and the Israel Science Foundation (886/02). The study of fish remains was supported by the Irene Levi Sala CARE Archaeological Foundation and carried out at the Department of Zoology and the I. Meier Segals Garden for Zoological Research at Tel Aviv University and at the Natural History Museum (NHM) in London and Brussels. We thank M. Goren for his help and support in the study and collection of freshwater fish; W. Van Neer (NHM Brussels), M. Richter, P. Campbell, and O. Crimmen (NHM UK) for providing access to labs and collections as well as helpful comments; A. Ben-Nun, head of the GIS center at the Hebrew University of Jerusalem, and I. Sharon and I. Gilead for greatly assisting in establishing the methodology for this study; M. Haber and S. Gorodetsky, who edited the manuscript with their usual professionalism; and two anonymous reviewers for their constructive and helpful comments.	Alperson-Afil N, 2008, QUATERNARY SCI REV, V27, P1733, DOI 10.1016/j.quascirev.2008.06.009; [Anonymous], 2005, EURASIAN PREHISTORY; Ashkenazi S, 2005, J ARCHAEOL SCI, V32, P675, DOI 10.1016/j.jas.2004.12.003; ASHKENAZI S, 2007, J ISR PREHIST SOC, V37, P135; Ashkenazi S, 2010, LETHAIA, V43, P116, DOI 10.1111/j.1502-3931.2009.00178.x; Binford LR., 1983, PURSUIT DECODING ARC; Dimentman C., 1992, LAKE HULA RECONSTRUC; ELDER RL, 1988, PALAEOGEOGR PALAEOCL, V62, P577, DOI 10.1016/0031-0182(88)90072-7; Farrand, 2001, SEDIMENTS ARCHAEOLOG, P127; Feibel C. S., 2004, HUMAN PALEOECOLOGY L, P21; Goren M, 1999, BIOL CONSERV, V89, P1, DOI 10.1016/S0006-3207(98)00127-X; Goren-Inbar N, 2002, P NATL ACAD SCI USA, V99, P2455, DOI 10.1073/pnas.032570499; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Goren-Inbar N., 1994, PALEORIENT, V20, P99, DOI DOI 10.3406/PALEO.1994.4604; Goren-Inbar N., 2002, ACHEULIAN SITE GESHE, VI; Madsen B., 2004, EURASIAN PREHISTORY, V2, P3; McBrearty S, 2000, J HUM EVOL, V39, P453, DOI 10.1006/jhev.2000.0435; Purdy B. A, 1975, LITHIC TECHNOLOGY MA, P133; Rabinovich R, 2008, J HUM EVOL, V54, P134, DOI 10.1016/j.jhevol.2007.07.007; Sergant J, 2006, J ARCHAEOL SCI, V33, P999, DOI 10.1016/j.jas.2005.11.011; SHARON G, 1999, J ISR PREHIST SOC, V28, P55; Speth J.D., 2007, MIDDLE UPPER PALAEOL, P165; Vaquero M, 2001, J ARCHAEOL SCI, V28, P1209, DOI 10.1006/jasc.2001.0656; Wadley L, 2001, CAMB ARCHAEOL J, V11, P201, DOI 10.1017/S0959774301000117; Yellen J.E., 1977, STUDIES ARCHEOLOGY; Zohar I, 2008, PALAEOGEOGR PALAEOCL, V258, P292, DOI 10.1016/j.palaeo.2007.11.004	26	105	108	2	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1677	1680		10.1126/science.1180695	http://dx.doi.org/10.1126/science.1180695			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533QJ	20019284				2022-12-28	WOS:000272839000048
J	Sorensen, R; Hansen, ML; Abildstrom, SZ; Hvelplund, A; Andersson, C; Jorgensen, C; Madsen, JK; Hansen, PR; Kober, L; Torp-Pedersen, C; Gislason, GH				Sorensen, Rikke; Hansen, Morten L.; Abildstrom, Steen Z.; Hvelplund, Anders; Andersson, Charlotte; Jorgensen, Casper; Madsen, Jan K.; Hansen, Peter R.; Kober, Lars; Torp-Pedersen, Christian; Gislason, Gunnar H.			Risk of bleeding in patients with acute myocardial infarction treated with different combinations of aspirin, clopidogrel, and vitamin K antagonists in Denmark: a retrospective analysis of nationwide registry data	LANCET			English	Article							ACUTE CORONARY SYNDROMES; TASK-FORCE; ANTITHROMBOTIC THERAPY; ANTIPLATELET THERAPY; ATRIAL-FIBRILLATION; EUROPEAN-SOCIETY; GLOBAL REGISTRY; WARFARIN; DIAGNOSIS; EVENTS	Background Combinations of aspirin, clopidogrel, and vitamin K antagonists are widely used in patients after myocardial infarction. However, data for the safety of combinations are sparse. We examined the risk of hospital admission for bleeding associated with different antithrombotic regimens. Methods By use of nationwide registers from Denmark, we identified 40 812 patients aged 30 years or older who had been admitted to hospital with first-time myocardial infarction between 2000 and 2005. Claimed prescriptions starting at hospital discharge were used to determine the regimen prescribed according to the following groups: monotherapy with aspirin, clopidogrel, or vitamin K antagonist; dual therapy with aspirin plus clopidogrel, aspirin plus vitamin K antagonist, or clopidogrel plus vitamin K antagonist; or triple therapy including all three drugs. Risk of hospital admission for bleeding, recurrent myocardial infarction, and death were assessed by Cox proportional hazards models with the drug exposure groups as time-varying covariates. Findings During a mean follow-up of 476.5 days (SD 142.0), 1891 (4.6%) patients were admitted to hospital with bleeding. The yearly incidence of bleeding was 2.6% for the aspirin group, 4.6% for clopidogrel, 4.3% for vitamin K antagonist, 3.7% for aspirin plus clopidogrel, 5.1% for aspirin plus vitamin K antagonist, 12.3% for clopidogrel plus vitamin K antagonist, and 12.0% for triple therapy. With aspirin as reference, adjusted hazard ratios for bleeding were 1.33 (95% CI 1.11-1.59) for clopidogrel, 1.23 (0.94-1.61) for vitamin K antagonist, 1.47 (1.28-1.69) for aspirin plus clopidogrel, 1.84 (1.51-2.23) for aspirin plus vitamin K antagonist, 3.52 (2.42-5.11) for clopidogrel plus vitamin K antagonist, and 4.05 (3.08-5.33) for triple therapy. Numbers needed to harm were 81.2 for aspirin plus clopidogrel, 45.4 for aspirin plus vitamin K antagonist, 15.2 for clopidogrel plus vitamin K antagonist, and 12.5 for triple therapy. 702 (37.9%) of 1852 patients with non-fatal bleeding had recurrent myocardial infarction or died during the study period compared with 7178 (18.4%) of 38 960 patients without non-fatal bleeding, (HR 3.00, 2.75-3.27, p<0.0001). Interpretation In patients with myocardial infarction, risk of hospital admission for bleeding increased with the number of antithrombotic drugs used. Treatment with triple therapy or dual therapy with clopidogrel plus vitamin K antagonist should be prescribed only after thorough individual risk assessment.	[Sorensen, Rikke; Hansen, Morten L.; Andersson, Charlotte; Jorgensen, Casper; Madsen, Jan K.; Hansen, Peter R.; Torp-Pedersen, Christian; Gislason, Gunnar H.] Univ Copenhagen, Gentofte Hosp, Dept Cardiol, DK-2900 Hellerup, Denmark; [Abildstrom, Steen Z.] Univ Copenhagen, Gentofte Hosp, Dept Internal Med, Cardiovasc Res Unit, DK-2900 Hellerup, Denmark; [Abildstrom, Steen Z.; Hvelplund, Anders] Univ So Denmark, Natl Inst Publ Hlth, Copenhagen, Denmark; [Kober, Lars] Rigshosp, Univ Copenhagen Hosp, Ctr Heart, Copenhagen, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; University of Copenhagen; Herlev & Gentofte Hospital; University of Southern Denmark; Rigshospitalet; University of Copenhagen	Sorensen, R (corresponding author), Univ Copenhagen, Gentofte Hosp, Dept Cardiol, Niels Andersens Vej 65,Post 4210, DK-2900 Hellerup, Denmark.	rs@heart.dk	Gislason, Gunnar/B-7561-2009; Hansen, Peter Riis/AAR-7659-2020; Torp-Pedersen, Christian/E-5931-2013; Andersson, Charlotte/P-4849-2014	Gislason, Gunnar/0000-0002-0548-402X; Kober, Lars/0000-0002-6635-1466; Hansen, Peter Riis/0000-0002-9056-535X; Sorensen, Rikke/0000-0001-9238-6681	Danish Heart Foundation [08-4-R64-A1885-B641-22470]; Danish Medical Research Council [271-06-0572]	Danish Heart Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by the Danish Heart Foundation (08-4-R64-A1885-B641-22470) and the Danish Medical Research Council (271-06-0572).	Anderson JL, 2007, CIRCULATION, V116, pE148, DOI 10.1161/CIRCULATIONAHA.107.181940; Bassand JP, 2007, EUR HEART J, V28, P1598, DOI 10.1093/eurheartj/ehm161; Buresly K, 2005, ARCH INTERN MED, V165, P784, DOI 10.1001/archinte.165.7.784; Chen ZM, 2005, LANCET, V366, P1607, DOI 10.1016/s0140-6736(05)67660-x; CHESEBRO JH, 1987, CIRCULATION, V76, P142, DOI 10.1161/01.CIR.76.1.142; Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Fuster V, 2006, CIRCULATION, V114, pE257, DOI 10.1161/CIRCULATIONAHA.106.177292; Gaist D, 1997, DAN MED BULL, V44, P445; Gent M, 1996, LANCET, V348, P1329, DOI 10.1016/s0140-6736(96)09457-3; Gislason GH, 2006, EUR HEART J, V27, P1153, DOI 10.1093/eurheartj/ehi705; Hallas J, 2006, BMJ-BRIT MED J, V333, P726, DOI 10.1136/bmj.38947.697558.AE; Hurlen M, 2002, NEW ENGL J MED, V347, P969, DOI 10.1056/NEJMoa020496; Jackevicius CA, 2008, NEW ENGL J MED, V359, P1802, DOI 10.1056/NEJMsa0803410; Karjalainen PP, 2007, EUR HEART J, V28, P726, DOI 10.1093/eurheartj/ehl488; Kumler T, 2008, EUR J HEART FAIL, V10, P658, DOI 10.1016/j.ejheart.2008.05.006; Madsen M, 2003, J CLIN EPIDEMIOL, V56, P124, DOI 10.1016/S0895-4356(02)00591-7; Manzano-Fernandez S, 2008, CHEST, V134, P559, DOI 10.1378/chest.08-0350; Mehta SR, 2001, LANCET, V358, P527, DOI 10.1016/S0140-6736(01)05701-4; Mortensen J, 2008, CARDIOLOGY, V111, P41, DOI 10.1159/000113426; Moscucci M, 2003, EUR HEART J, V24, P1815, DOI 10.1016/S0195-668X(03)00485-8; Nguyen MC, 2007, EUR HEART J, V28, P1717, DOI 10.1093/eurheartj/ehm186; Peters RJG, 2003, CIRCULATION, V108, P1682, DOI 10.1161/01.CIR.0000091201.39590.CB; Rao SV, 2005, AM J CARDIOL, V96, P1200, DOI 10.1016/j.amjcard.2005.06.056; Ruiz-Nodar JM, 2008, J AM COLL CARDIOL, V51, P818, DOI 10.1016/j.jacc.2007.11.035; Sabatine MS, 2005, NEW ENGL J MED, V352, P1179, DOI 10.1056/NEJMoa050522; Sackett D., 2000, EVIDENCE BASED MED P, DOI DOI 10.1136/BMJ.H3089; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; Tu JV, 2001, J AM COLL CARDIOL, V37, P992, DOI 10.1016/S0735-1097(01)01109-3; Van de Werf F, 2008, EUR HEART J, V29, P2909, DOI 10.1093/eurheartj/ehn416; van Es RF, 2002, LANCET, V360, P109, DOI 10.1016/S0140-6736(02)09409-6; Yusuf S, 2001, NEW ENGL J MED, V345, P494	31	440	459	0	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	DEC 12	2009	374	9706					1967	1974		10.1016/S0140-6736(09)61751-7	http://dx.doi.org/10.1016/S0140-6736(09)61751-7			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532EA	20006130				2022-12-28	WOS:000272727000020
J	Abdulla, MA; Ahmed, I; Assawamakin, A; Bhak, J; Brahmachari, SK; Calacal, GC; Chaurasia, A; Chen, CH; Chen, JM; Chen, YT; Chu, JY; Cutiongco-de la Paz, EMC; De Ungria, MCA; Delfin, FC; Edo, J; Fuchareon, S; Ghang, H; Gojobori, T; Han, JS; Ho, SF; Hoh, BP; Huang, W; Inoko, H; Jha, P; Jinam, TA; Jin, L; Jung, J; Kangwanpong, D; Kampuansai, J; Kennedy, GC; Khurana, P; Kim, HL; Kim, K; Kim, S; Kim, WY; Kimm, K; Kimura, R; Koike, T; Kulawonganunchai, S; Kumar, V; Lai, PS; Lee, JY; Lee, S; Liu, ET; Majumder, PP; Mandapati, KK; Marzuki, S; Mitchell, W; Mukerji, M; Naritomi, K; Ngamphiw, C; Niikawa, N; Nishida, N; Oh, B; Oh, S; Ohashi, J; Oka, A; Ong, R; Padilla, CD; Palittapongarnpim, P; Perdigon, HB; Phipps, ME; Png, E; Sakaki, Y; Salvador, JM; Sandraling, Y; Scaria, V; Seielstad, M; Sidek, MR; Sinha, A; Srikummool, M; Sudoyo, H; Sugano, S; Suryadi, H; Suzuki, Y; Tabbada, KA; Tan, A; Tokunaga, K; Tongsima, S; Villamor, LP; Wang, E; Wang, Y; Wang, HF; Wu, JY; Xiao, HS; Xu, SH; Yang, JO; Shugart, YY; Yoo, HS; Yuan, WT; Zhao, GP; Zilfalil, BA				Abdulla, Mahmood Ameen; Ahmed, Ikhlak; Assawamakin, Anunchai; Bhak, Jong; Brahmachari, Samir K.; Calacal, Gayvelline C.; Chaurasia, Amit; Chen, Chien-Hsiun; Chen, Jieming; Chen, Yuan-Tsong; Chu, Jiayou; Cutiongco-de la Paz, Eva Maria C.; De Ungria, Maria Corazon A.; Delfin, Frederick C.; Edo, Juli; Fuchareon, Suthat; Ghang, Ho; Gojobori, Takashi; Han, Junsong; Ho, Sheng-Feng; Hoh, Boon Peng; Huang, Wei; Inoko, Hidetoshi; Jha, Pankaj; Jinam, Timothy A.; Jin, Li; Jung, Jongsun; Kangwanpong, Daoroong; Kampuansai, Jatupol; Kennedy, Giulia C.; Khurana, Preeti; Kim, Hyung-Lae; Kim, Kwangjoong; Kim, Sangsoo; Kim, Woo-Yeon; Kimm, Kuchan; Kimura, Ryosuke; Koike, Tomohiro; Kulawonganunchai, Supasak; Kumar, Vikrant; Lai, Poh San; Lee, Jong-Young; Lee, Sunghoon; Liu, Edison T.; Majumder, Partha P.; Mandapati, Kiran Kumar; Marzuki, Sangkot; Mitchell, Wayne; Mukerji, Mitali; Naritomi, Kenji; Ngamphiw, Chumpol; Niikawa, Norio; Nishida, Nao; Oh, Bermseok; Oh, Sangho; Ohashi, Jun; Oka, Akira; Ong, Rick; Padilla, Carmencita D.; Palittapongarnpim, Prasit; Perdigon, Henry B.; Phipps, Maude Elvira; Png, Eileen; Sakaki, Yoshiyuki; Salvador, Jazelyn M.; Sandraling, Yuliana; Scaria, Vinod; Seielstad, Mark; Sidek, Mohd Ros; Sinha, Amit; Srikummool, Metawee; Sudoyo, Herawati; Sugano, Sumio; Suryadi, Helena; Suzuki, Yoshiyuki; Tabbada, Kristina A.; Tan, Adrian; Tokunaga, Katsushi; Tongsima, Sissades; Villamor, Lilian P.; Wang, Eric; Wang, Ying; Wang, Haifeng; Wu, Jer-Yuarn; Xiao, Huasheng; Xu, Shuhua; Yang, Jin Ok; Shugart, Yin Yao; Yoo, Hyang-Sook; Yuan, Wentao; Zhao, Guoping; Zilfalil, Bin Alwi		HUGO Pan Asian SNP Consortium; Indian Genome Variation Consortium	Mapping Human Genetic Diversity in Asia	SCIENCE			English	Article							POPULATION-STRUCTURE; WIDE ANALYSIS; ADMIXTURE; GEOGRAPHY; UYGHURS; HISTORY; EUROPE	Asia harbors substantial cultural and linguistic diversity, but the geographic structure of genetic variation across the continent remains enigmatic. Here we report a large-scale survey of autosomal variation from a broad geographic sample of Asian human populations. Our results show that genetic ancestry is strongly correlated with linguistic affiliations as well as geography. Most populations show relatedness within ethnic/linguistic groups, despite prevalent gene flow among populations. More than 90% of East Asian (EA) haplotypes could be found in either Southeast Asian (SEA) or Central-South Asian (CSA) populations and show clinal structure with haplotype diversity decreasing from south to north. Furthermore, 50% of EA haplotypes were found in SEA only and 5% were found in CSA only, indicating that SEA was a major geographic source of EA populations.	[Jin, Li] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Abdulla, Mahmood Ameen; Edo, Juli; Jinam, Timothy A.; Phipps, Maude Elvira] Univ Malaya, Fac Med, Dept Mol Med, Kuala Lumpur 50603, Malaysia; [Abdulla, Mahmood Ameen; Edo, Juli; Jinam, Timothy A.; Phipps, Maude Elvira] Univ Malaya, Fac Arts & Social Sci, Dept Anthropol, Kuala Lumpur 50603, Malaysia; [Ahmed, Ikhlak; Brahmachari, Samir K.; Chaurasia, Amit; Jha, Pankaj; Mukerji, Mitali; Scaria, Vinod; Sinha, Amit; Indian Genome Variation Consortium] CSIR, Inst Genom & Integrat Biol, Delhi 110007, India; [Assawamakin, Anunchai; Fuchareon, Suthat] Mahidol Univ, Puttamonthon 73170, Nakornpathom, Thailand; [Assawamakin, Anunchai; Kulawonganunchai, Supasak; Ngamphiw, Chumpol; Tongsima, Sissades] Natl Ctr Genet Engn & Biotechnol, Genome Inst, Biostat & Informat Lab, Pathum Thani 12120, Thailand; [Bhak, Jong; Ghang, Ho; Kim, Woo-Yeon; Lee, Sunghoon; Oh, Sangho; Yang, Jin Ok; Yoo, Hyang-Sook] KRIBB, KOBIC, Taejon 305806, South Korea; [Calacal, Gayvelline C.; De Ungria, Maria Corazon A.; Delfin, Frederick C.; Perdigon, Henry B.; Salvador, Jazelyn M.; Tabbada, Kristina A.; Villamor, Lilian P.] Univ Philippines, Nat Sci Res Inst, DNA Anal Lab, Quezon City 1101, Philippines; [Chen, Chien-Hsiun; Chen, Yuan-Tsong; Ho, Sheng-Feng; Wu, Jer-Yuarn] Acad Sinica, Inst Biomed Sci, Taipei 115, Taiwan; [Chen, Jieming; Kumar, Vikrant; Liu, Edison T.; Ong, Rick; Png, Eileen; Seielstad, Mark; Tan, Adrian] Genome Inst Singapore, Singapore 138672, Singapore; [Chu, Jiayou] Chinese Acad Med Sci, Inst Med Biol, Kunming, Peoples R China; [Cutiongco-de la Paz, Eva Maria C.; Padilla, Carmencita D.] Univ Philippines Manila, Natl Inst Hlth, Inst Human Genet, Ermita Manila 1000, Philippines; [Gojobori, Takashi; Koike, Tomohiro; Suzuki, Yoshiyuki] Res Org Informat & Syst, Ctr Informat Biol, Mishima, Shizuoka 4118540, Japan; [Gojobori, Takashi; Koike, Tomohiro; Suzuki, Yoshiyuki] Res Org Informat & Syst, DNA Data Bank Japan, Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Gojobori, Takashi] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Koto Ku, Tokyo 1350064, Japan; [Han, Junsong; Xiao, Huasheng] Natl Engn Ctr Biochip Shanghai, Shanghai 201203, Peoples R China; [Hoh, Boon Peng; Sidek, Mohd Ros; Zilfalil, Bin Alwi] Univ Sains Malaysia, Sch Med Sci, Ctr Human Genome, Kubang Kerian 16150, Kelantan, Malaysia; [Huang, Wei; Wang, Ying; Wang, Haifeng; Yuan, Wentao; Zhao, Guoping] Chinese Natl Human Genome Ctr Shanghai, MOST Shanghai Lab Dis & Hlth Genom, Shanghai 201203, Peoples R China; [Inoko, Hidetoshi; Oka, Akira] Tokai Univ, Sch Med, Dept Mol Life Sci, Div Mol Med Sci & Mol Med, Isehara, Kanagawa A2591193, Japan; [Jin, Li] Fudan Univ, Sch Life Sci, MOE Key Lab Contemporary Anthropol, Shanghai 200433, Peoples R China; [Jung, Jongsun; Kim, Hyung-Lae; Kim, Kwangjoong; Lee, Jong-Young; Oh, Bermseok] Korea Natl Inst Hlth, Seoul 122701, South Korea; [Kangwanpong, Daoroong; Kampuansai, Jatupol; Srikummool, Metawee] Chiang Mai Univ, Fac Sci, Dept Biol, Chiang Mai 50202, Thailand; [Kennedy, Giulia C.; Wang, Eric] Affymetrix, Genom Collaborat, Santa Clara, CA 95051 USA; [Kennedy, Giulia C.; Wang, Eric] Veracyte, San Francisco, CA 94080 USA; [Khurana, Preeti; Mandapati, Kiran Kumar] Ctr Genom Applicat, New Delhi 110020, India; [Kim, Sangsoo] Soongsil Univ, Seoul 156743, South Korea; [Kimm, Kuchan] Eulji Univ, Coll Med, Taejon 301832, South Korea; [Kimura, Ryosuke; Nishida, Nao; Ohashi, Jun; Tokunaga, Katsushi] Univ Tokyo, Grad Sch Med, Dept Human Genet, Bunkyo Ku, Tokyo 1130033, Japan; [Lai, Poh San] Natl Univ Singapore, Natl Univ Hosp, Yong Loo Lin Sch Med, Dept Paediat, Singapore 119074, Singapore; [Lai, Poh San] DSO Natl Labs, Def Med & Environm Res Inst, Populat Genet Lab, Singapore 117510, Singapore; [Majumder, Partha P.] Indian Stat Inst, Kolkata 700108, India; [Marzuki, Sangkot; Sandraling, Yuliana; Sudoyo, Herawati; Suryadi, Helena] Eijkman Inst Mol Biol, Jakarta 10430, Indonesia; [Mitchell, Wayne] Informat Expt Therapeut Ctr, Singapore 138669, Singapore; [Mitchell, Wayne] Nanyang Technol Univ, Sch Comp Engn, Div Informat Sci, Singapore 639798, Singapore; [Naritomi, Kenji] Univ Ryukyus, Fac Med, Dept Med Genet, Okinawa 9030215, Japan; [Palittapongarnpim, Prasit] Natl Sci & Technol Dev Agcy, Pathum Thani 12120, Thailand; [Phipps, Maude Elvira] Monash Univ, Bandar Sunway 46150, Selangor, Malaysia; [Sakaki, Yoshiyuki] RIKEN, Genom Sci Ctr, Tsurumi Ku, Yokohama, Kanagawa 2300045, Japan; Univ Hong Kong, Dept Biochem, Pokfulam, Hong Kong, Peoples R China; [Sugano, Sumio] Univ Tokyo, Grad Sch Frontier Sci, Dept Med Genome Sci, Lab Funct Genom,Shirokanedai Lab,Minato Ku, Tokyo 1088639, Japan; [Jin, Li; Xu, Shuhua] Chinese Acad Sci, Shanghai Inst Biol Sci, Max Planck Soc, Partner Inst Computat Biol, Shanghai 200031, Peoples R China; [Shugart, Yin Yao] NIMH, Genom Res Branch, NIH, Bethesda, MD 20892 USA; [Niikawa, Norio] Hlth Sci Univ Hokkaido, Res Inst Personalized Hlth Sci, Tobetsu 0610293, Japan	Fudan University; Universiti Malaya; Universiti Malaya; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Mahidol University; National Science & Technology Development Agency - Thailand; National Center Genetic Engineering & Biotechnology (BIOTEC); Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of the Philippines System; University of the Philippines Diliman; Academia Sinica - Taiwan; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medical Biology - CAMS; University of the Philippines System; University of the Philippines Manila; Research Organization of Information & Systems (ROIS); Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; National Institute of Advanced Industrial Science & Technology (AIST); Universiti Sains Malaysia; Tokai University; Fudan University; Korea Centers for Disease Control & Prevention (KCDC); Korea National Institute of Health (KNIH); Chiang Mai University; Affymetrix; Soongsil University; Eulji University; University of Tokyo; National University of Singapore; Indian Statistical Institute; Indian Statistical Institute Kolkata; Eijkman Institute; Agency for Science Technology & Research (A*STAR); A*STAR - Experimental Drug Development Centre (EDDC); Experimental Therapeutics Centre; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; University of the Ryukyus; National Science & Technology Development Agency - Thailand; Monash University; Monash University Sunway; RIKEN; University of Hong Kong; University of Tokyo; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Max Planck Society; National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Health Sciences University of Hokkaido	Jin, L (corresponding author), Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, 220 Handan Rd, Shanghai 200433, Peoples R China.	ljin007@gmail.com; liue@gis.a-star.edu.sg; seielstadm@gis.a-star.edu.sg; xushua@picb.ac.cn	Chen, Chien Hsiun/Q-3826-2018; Lee, Jong-Young/M-6319-2013; Kumar, Pankaj/AAV-4797-2020; Scaria, Vinod/AAS-3151-2021; Xu, Shuhua/AAH-7620-2020; XU, SHUHUA/D-5345-2009; Hoh, Boon-Peng/H-8682-2016; Anthropology, MOE KeyLab Fudan/A-9454-2010; Seielstad, Mark/T-7841-2019; Kimura, Ryosuke/B-3354-2015; Jin, Li/C-1468-2009; Villamor, Lilian/ABD-8677-2021; Tongsima, Sissades/F-4891-2011; Jin, Li/M-5063-2019; Liu, Edison/C-4141-2008; Wu, Jer-Yuarn/S-7010-2018; EDO, JULI A/L EDO/B-8721-2010; Mitchell, Wayne P/C-5219-2008; Phipps, Maude/F-7590-2012; Ahmed, Ikhlak/Q-2494-2019; Scaria, Vinod/B-2819-2008; De Ungria, Maria Corazon Abogado/T-9736-2019; Ngamphiw, Chumpol/ABB-6488-2021; Zilfalil, Bin Alwi/A-7069-2019	Lee, Jong-Young/0000-0002-0092-9958; Xu, Shuhua/0000-0002-1975-1002; XU, SHUHUA/0000-0002-1975-1002; Hoh, Boon-Peng/0000-0001-9249-4965; Jin, Li/0000-0002-4546-2415; Tongsima, Sissades/0000-0002-1491-1839; Phipps, Maude/0000-0001-8314-068X; De Ungria, Maria Corazon Abogado/0000-0001-7722-5193; Ngamphiw, Chumpol/0000-0002-8581-397X; Misra, Chaitali/0000-0001-8782-1589; Chaurasia, Amit/0000-0002-9719-1135; Ahmed, Ikhlak/0000-0002-5753-9627; Scaria, Vinod/0000-0001-7644-7181; Jinam, Timothy/0000-0003-4757-096X; Zhao, Guo-Ping/0000-0002-7621-6620; batra, Jyotsna/0000-0003-4646-6247; Mukerji, Mitali/0000-0003-0697-5055; MITRA, AMIT/0000-0003-4046-7070; Seielstad, Mark/0000-0001-5783-1401; Chen, Jieming/0000-0003-3767-9486; Lee, Sunghoon/0000-0002-8916-2035; Kumar, Pankaj/0000-0003-2584-937X; Zilfalil, Bin Alwi/0000-0001-5055-7892; KIM, KWANG JOONG/0000-0002-4844-6162; Wang, Haifeng/0000-0001-5022-0720; Palittapongarnpim, Prasit/0000-0001-5057-6719; Lee, Sunghoon/0000-0002-6682-119X; YAO, YIN/0000-0003-3053-8429				Brahmachari SK, 2008, J GENET, V87, P3; Cavalli-Sforza L., 1993, HIST GEOGRAPHY HUMAN; Cavalli-Sforza LL, 2003, NAT GENET, V33, P266, DOI 10.1038/ng1113; Chu JY, 1998, P NATL ACAD SCI USA, V95, P11763, DOI 10.1073/pnas.95.20.11763; Telles MPD, 2005, GENET MOL RES, V4, P742; Ding YC, 2000, P NATL ACAD SCI USA, V97, P14003, DOI 10.1073/pnas.240441297; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Hellenthal G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000078; Kayser M, 2008, AM J HUM GENET, V82, P194, DOI 10.1016/j.ajhg.2007.09.010; Lao O, 2008, CURR BIOL, V18, P1241, DOI 10.1016/j.cub.2008.07.049; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; Manica A, 2005, HUM GENET, V118, P366, DOI 10.1007/s00439-005-0039-3; Mountain JL, 1997, AM J HUM GENET, V61, P705, DOI 10.1086/515510; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Novembre J, 2008, NATURE, V456, P98, DOI 10.1038/nature07331; Patterson N, 2006, PLOS GENET, V2, P2074, DOI 10.1371/journal.pgen.0020190; Pritchard JK, 2000, GENETICS, V155, P945; REID L, 1994, LANGUAGE CONTACT CHA, P443; Rosenberg NA, 2005, PLOS GENET, V1, P660, DOI 10.1371/journal.pgen.0010070; Rosenberg NA, 2002, SCIENCE, V298, P2381, DOI 10.1126/science.1078311; Su B, 1999, AM J HUM GENET, V65, P1718, DOI 10.1086/302680; Tang H, 2005, GENET EPIDEMIOL, V28, P289, DOI 10.1002/gepi.20064; Tian C, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040004; Xu SH, 2008, AM J HUM GENET, V83, P322, DOI 10.1016/j.ajhg.2008.08.001; Xu SH, 2008, AM J HUM GENET, V82, P883, DOI 10.1016/j.ajhg.2008.01.017; Xu SH, 2009, MOL BIOL EVOL, V26, P2197, DOI 10.1093/molbev/msp130	26	408	430	7	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 11	2009	326	5959					1541	1545		10.1126/science.1177074	http://dx.doi.org/10.1126/science.1177074			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007900				2022-12-28	WOS:000272623600059
J	Karberg, S				Karberg, Sascha			Switching on Epigenetic Therapy	CELL			English	Editorial Material								Reversible epigenetic changes that alter gene expression are a characteristic of many cancers and other diseases. Biotech companies are taking note and are starting to develop new drugs to reverse such pathogenic "epimutations."											0	36	39	1	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 11	2009	139	6					1029	1031		10.1016/j.cell.2009.11.038	http://dx.doi.org/10.1016/j.cell.2009.11.038			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005793	Bronze			2022-12-28	WOS:000272622800001
J	Brass, SD; Dinkin, MJ; Williams, Z; Krishnamoorthy, KS; Copen, WA; Freeman, SH				Brass, Steven D.; Dinkin, Marc J.; Williams, Ziv; Krishnamoorthy, Kalpathy S.; Copen, William A.; Freeman, Stefanie H.			A 16-Year-Old Boy with Paroxysmal Headaches and Visual Changes Spinal arachnoid cyst.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							IDIOPATHIC INTRACRANIAL HYPERTENSION; CEREBRAL VENOUS THROMBOSIS; OPTIC DISK EDEMA; PSEUDOTUMOR CEREBRI; MAGNETIC-RESONANCE; PEDIATRIC-PATIENTS; MENINGEAL CYSTS; BIFIDA OCCULTA; CAUDA-EQUINA; BRAIN-TUMOR		[Brass, Steven D.; Krishnamoorthy, Kalpathy S.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Dinkin, Marc J.] Massachusetts Gen Hosp, Dept Neuroophthalmol, Boston, MA 02114 USA; [Williams, Ziv] Massachusetts Gen Hosp, Dept Neurosurg, Boston, MA 02114 USA; [Copen, William A.] Massachusetts Gen Hosp, Dept Radiol, Boston, MA 02114 USA; [Freeman, Stefanie H.] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA; [Brass, Steven D.; Dinkin, Marc J.; Krishnamoorthy, Kalpathy S.] Harvard Univ, Dept Neurol, Sch Med, Cambridge, MA 02138 USA; [Williams, Ziv] Harvard Univ, Dept Surg, Sch Med, Cambridge, MA 02138 USA; [Copen, William A.] Harvard Univ, Dept Radiol, Sch Med, Cambridge, MA 02138 USA; [Freeman, Stefanie H.] Harvard Univ, Dept Pathol, Sch Med, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard University; Harvard University; Harvard University	Brass, SD (corresponding author), Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA.			Dinkin, Marc/0000-0003-1277-1016				Adey G, 1992, Neurosurg Clin N Am, V3, P483; Agid R, 2006, NEURORADIOLOGY, V48, P521, DOI 10.1007/s00234-006-0095-y; Ahn UM, 2000, SPINE, V25, P1515, DOI 10.1097/00007632-200006150-00010; Alnaghmoosh N, 2006, CHILD NERV SYST, V22, P514, DOI 10.1007/s00381-005-0017-z; Amlashi SFA, 2004, NEW ENGL J MED, V350, pE18, DOI 10.1056/NEJMicm030102; Apel K, 2006, ACTA NEUROCHIR, V148, P221, DOI 10.1007/s00701-005-0697-x; Basaldella Luca, 2007, Neurosurg Focus, V22, pE4; Bianchi D, 1998, EUR NEUROL, V40, P179, DOI 10.1159/000007978; BOUSSER MG, 1997, CEREBRAL VENOUS THRO; BURGER PC, 2002, SURG PATHOLOGY NERVO, P535; Cinciripini GS, 1999, AM J OPHTHALMOL, V127, P178, DOI 10.1016/S0002-9394(98)00386-9; Costello F, 2002, J NEURO-OPHTHALMOL, V22, P199, DOI 10.1097/00041327-200209000-00002; de Oliveira RS, 2007, CHILD NERV SYST, V23, P1233, DOI 10.1007/s00381-007-0414-6; Digre KB, 2001, NEUROLOGIST, V7, P2, DOI 10.1097/00127893-200107010-00002; Doita M, 2003, SPINE, V28, pE229, DOI 10.1097/00007632-200306150-00024; Friedman DI, 2002, NEUROLOGY, V59, P1492, DOI 10.1212/01.WNL.0000029570.69134.1B; Ginsberg L., 2004, J NEUROL NEUROSUR S1, V75, P16, DOI DOI 10.1136/JNNP.2003.034272; GIUSEFFI V, 1991, NEUROLOGY, V41, P239, DOI 10.1212/WNL.41.2_Part_1.239; Guigou S, 2006, J FR OPHTALMOL, V29, P312, DOI 10.1016/S0181-5512(06)73789-5; HAMED LM, 1992, ARCH OPHTHALMOL-CHIC, V110, P636, DOI 10.1001/archopht.1992.01080170058024; Hanna L S, 1988, Metab Pediatr Syst Ophthalmol (1985), V11, P160; HAYREH MS, 1977, ARCH OPHTHALMOL-CHIC, V95, P1237, DOI 10.1001/archopht.1977.04450070135013; HEDGES TR, 1995, OPHTHALMOLOGY, V102, P1242, DOI 10.1016/S0161-6420(95)30883-4; KESLER A, 1994, BRIT J OPHTHALMOL, V78, P313, DOI 10.1136/bjo.78.4.313; Khosla A, 2002, AM J ROENTGENOL, V178, P201, DOI 10.2214/ajr.178.1.1780201; Lafitte F, 1997, CLIN RADIOL, V52, P672, DOI 10.1016/S0009-9260(97)80030-X; Lee HJ, 2001, PEDIATR NEUROSURG, V35, P181, DOI 10.1159/000050419; Liu James K, 2007, Neurosurg Focus, V22, pE6; MATZKIN DC, 1992, SURV OPHTHALMOL, V37, P130, DOI 10.1016/0039-6257(92)90076-6; Morandi X, 2006, MED HYPOTHESES, V67, P79, DOI 10.1016/j.mehy.2006.01.005; NABORS MW, 1988, J NEUROSURG, V68, P366, DOI 10.3171/jns.1988.68.3.0366; Porter A, 2006, CLIN NEUROL NEUROSUR, V108, P787, DOI 10.1016/j.clineuro.2005.10.007; Reese A B, 1930, Trans Am Ophthalmol Soc, V28, P341; Roos KL, 2000, SEMIN NEUROL, V20, P293, DOI 10.1055/s-2000-9393; Rothner A D, 2001, Semin Pediatr Neurol, V8, P34, DOI 10.1053/spen.2001.23330; SADUN AA, 1984, ANN NEUROL, V16, P489, DOI 10.1002/ana.410160410; Sato Kimiaki, 2002, Neurosurg Focus, V13, pecp1; Savini G, 2006, ARCH OPHTHALMOL-CHIC, V124, P1111, DOI 10.1001/archopht.124.8.1111; Schankin CJ, 2007, CEPHALALGIA, V27, P904, DOI 10.1111/j.1468-2982.2007.01368.x; Shams PN, 2005, J NEUROL, V252, P273, DOI 10.1007/s00415-005-0430-y; Skau M, 2006, CEPHALALGIA, V26, P384, DOI 10.1111/j.1468-2982.2005.01055.x; Steffen H, 1996, OPHTHALMOLOGY, V103, P1229, DOI 10.1016/S0161-6420(96)30518-6; SUWANWELA N, 1994, HEADACHE, V34, P435, DOI 10.1111/j.1526-4610.1994.hed3407435.x; TSO MOM, 1977, ARCH OPHTHALMOL-CHIC, V95, P1458, DOI 10.1001/archopht.1977.04450080168023; WAKAI S, 1984, DEV MED CHILD NEUROL, V26, P117; Zabek M, 2003, FOLIA NEUROPATHOL, V41, P231	46	2	2	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2009	361	24					2367	2378		10.1056/NEJMcpc0905547	http://dx.doi.org/10.1056/NEJMcpc0905547			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529VS	20007563				2022-12-28	WOS:000272547600012
J	Cohen, AB; Bianchi, MT				Cohen, Adam B.; Bianchi, Matt T.			Commentary: Neurological perspective	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Bianchi, Matt T.] Massachusetts Gen Hosp, Dept Neurol, SL Div, Boston, MA 02114 USA; [Cohen, Adam B.] Brigham & Womens Hosp, Dept Neurol, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Bianchi, MT (corresponding author), Massachusetts Gen Hosp, Dept Neurol, SL Div, Boston, MA 02114 USA.	mtbianchi@partners.org		Cohen, Adam/0000-0002-6163-0562				Brinar VV, 2008, CLIN NEUROL NEUROSUR, V110, P919, DOI 10.1016/j.clineuro.2008.07.002; Gurcan HM, 2009, INT IMMUNOPHARMACOL, V9, P10, DOI 10.1016/j.intimp.2008.10.004; Reuss R, 2009, BRIT MED J, V339, DOI 10.1136/bmj.b3862; Sawle GV, 1998, J NEUROL NEUROSUR PS, V64, P717, DOI 10.1136/jnnp.64.6.717; Wingerchuk DM, 2007, LANCET NEUROL, V6, P805, DOI 10.1016/S1474-4422(07)70216-8	5	0	0	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 10	2009	339								b5250	10.1136/bmj.b5250	http://dx.doi.org/10.1136/bmj.b5250			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VH	20007661				2022-12-28	WOS:000272697600009
J	Qiu, J				Qiu, Jane			Qian Xuesen (1911-2009) OBITUARY	NATURE			English	Biographical-Item									Nature, Beijing, Peoples R China		Qiu, J (corresponding author), Nature, Beijing, Peoples R China.	jane@janeqiu.com						XUESEN Q, PUBLICATION LIST	1	1	1	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 10	2009	462	7274					735	735		10.1038/462735a	http://dx.doi.org/10.1038/462735a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010679	Bronze			2022-12-28	WOS:000272559900027
J	Reuss, R; Bolz, M; Zettl, UK				Reuss, Reinhard; Bolz, Michael; Zettl, Uwe K.			Commentary: Managing clinicians' assessment	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Reuss, Reinhard; Zettl, Uwe K.] Univ Rostock, Dept Neurol, D-18147 Rostock, Germany; [Bolz, Michael] Univ Rostock, Dept Gynaecol, D-18147 Rostock, Germany	University of Rostock; University of Rostock	Reuss, R (corresponding author), Univ Rostock, Dept Neurol, D-18147 Rostock, Germany.	reinhard.reuss@neuro.med.uni-giessen.de						Klink DT, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/271363; NG CT, 2008, IR J MED SCI    1129; Ostensen M, 2008, RHEUMATOLOGY, V47, P28, DOI 10.1093/rheumatology/ken168; Roemer SF, 2007, BRAIN, V130, P1194, DOI 10.1093/brain/awl371; TEMPFER C, 2009, GYNAKOL GEBURTSH, P22; 2009, BMJ	6	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-8146			BRIT MED J	Br. Med. J.	DEC 10	2009	339								b5177	10.1136/bmj.b5177	http://dx.doi.org/10.1136/bmj.b5177			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	531VH	20007657				2022-12-28	WOS:000272697600004
J	Patkowski, K; Spirko, V; Szalewicz, K				Patkowski, Konrad; Spirko, Vladimir; Szalewicz, Krzysztof			On the Elusive Twelfth Vibrational State of Beryllium Dimer	SCIENCE			English	Article							GROUND ELECTRONIC-STATE; POTENTIAL-ENERGY CURVE; DIATOMIC-MOLECULES; BE-2	The beryllium dimer has puzzled chemists for roughly 80 years on account of its unexpectedly strong bonding interaction between two nominally closed-shell atoms. Recent spectroscopic measurements characterized the molecule's ground electronic state with sufficient resolution to distinguish 11 vibrational levels; the possibility that a twelfth level lay just below the dissociation threshold remained unresolved. Here we present a potential function, based on ab initio calculations at the full configuration interaction level, that definitively supports the presence of this twelfth vibrational state. "Morphed" versions of this potential, fitted to experimental data, closely reproduce the observed spectra to within 0.1 cm(-1), bolstering the strength of the assignment.	[Patkowski, Konrad; Szalewicz, Krzysztof] Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA; [Spirko, Vladimir] Acad Sci Czech Republic, Inst Organ Chem & Biochem, Dept Mol Modeling, CR-16610 Prague 6, Czech Republic	University of Delaware; Czech Academy of Sciences; Institute of Organic Chemistry & Biochemistry of the Czech Academy of Sciences	Patkowski, K (corresponding author), Univ Delaware, Dept Phys & Astron, Newark, DE 19716 USA.	patkowsk@udel.edu		Spirko, Vladimir/0000-0001-8928-4406; Patkowski, Konrad/0000-0002-4468-207X	NSF [CHE-0848589]; Academy of Sciences of the Czech Republic [IAA400550511, Z40550506]; Czech Ministry of Education, Youth and Sports [LC512, MSM6198959216]	NSF(National Science Foundation (NSF)); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Czech Ministry of Education, Youth and Sports(Ministry of Education, Youth & Sports - Czech Republic)	This work was supported by the NSF grant CHE-0848589, by the Academy of Sciences of the Czech Republic grant IAA400550511 ( project Z40550506), and by the Czech Ministry of Education, Youth and Sports grants LC512 and MSM6198959216.	BLUDSKY O, 1995, J MOL SPECTROSC, V169, P555, DOI 10.1006/jmsp.1995.1046; Blythe P, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.183002; BONDYBEY VE, 1984, CHEM PHYS LETT, V109, P436, DOI 10.1016/0009-2614(84)80339-5; BONDYBEY VE, 1985, SCIENCE, V227, P125, DOI 10.1126/science.227.4683.125; Gdanitz RJ, 1999, CHEM PHYS LETT, V312, P578, DOI 10.1016/S0009-2614(99)00985-9; JENC F, 1963, COLLECT CZECH CHEM C, V28, P1449, DOI 10.1135/cccc19631449; Leroy RJ, 1970, CHEM PHYS LETT, V5, P42, DOI 10.1016/0009-2614(70)80125-7; Martin JML, 1999, CHEM PHYS LETT, V303, P399, DOI 10.1016/S0009-2614(99)00214-6; Merritt JM, 2009, SCIENCE, V324, P1548, DOI 10.1126/science.1174326; Patkowski K, 2007, J PHYS CHEM A, V111, P12822, DOI 10.1021/jp076412c; Roeggen I, 1996, INT J QUANTUM CHEM, V60, P453, DOI 10.1002/(SICI)1097-461X(1996)60:1<453::AID-QUA44>3.0.CO;2-A; Roeggen I, 2005, INT J QUANTUM CHEM, V101, P201, DOI 10.1002/qua.20222; Spirko V, 2006, J MOL SPECTROSC, V235, P268, DOI 10.1016/j.jms.2005.11.012; Spirko V, 2005, COLLECT CZECH CHEM C, V70, P731, DOI 10.1135/cccc20050731; TANG KT, 1984, J CHEM PHYS, V80, P3726, DOI 10.1063/1.447150	15	80	81	0	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 4	2009	326	5958					1382	1384		10.1126/science.1181017	http://dx.doi.org/10.1126/science.1181017			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965753				2022-12-28	WOS:000272351100036
J	Lavee, J; Ashkenazi, T; Gurman, G; Steinberg, D				Lavee, Jacob; Ashkenazi, Tamar; Gurman, Gabriel; Steinberg, David			A new law for allocation of donor organs in Israel	LANCET			English	Editorial Material							DONATION; PROPOSAL		[Lavee, Jacob] Chaim Sheba Med Ctr, Heart Transplantat Unit, Dept Cardiac Surg, IL-52621 Tel Hashomer, Israel; [Lavee, Jacob; Ashkenazi, Tamar; Gurman, Gabriel] Minist Hlth, Israel Natl Transplant Ctr, Tel Aviv, Israel; [Steinberg, David] Lahey Clin Med Ctr, Sect Med Eth, Burlington, MA 01803 USA; [Steinberg, David] Harvard Univ, Sch Med, Boston, MA USA	Chaim Sheba Medical Center; Lahey Hospital & Medical Center; Harvard University; Harvard Medical School	Lavee, J (corresponding author), Chaim Sheba Med Ctr, Heart Transplantat Unit, IL-52621 Ramat Gan, Israel.	jaylavee@netvision.net.il		Lavee, Jacob/0000-0002-3641-1114				ASHKENAZI T, 2001, THESIS U TEL AVIV IS, P69; Bramstedt Katrina A, 2006, Prog Transplant, V16, P170; BURDICK JF, 1993, PREFERRED STATUS ORG; Eaton S, 1998, J MED ETHICS, V24, P166, DOI 10.1136/jme.24.3.166; Gubernatis G, 2000, TRANSPLANTATION, V70, P699, DOI 10.1097/00007890-200008270-00032; *ISR TRANSPL CTR, 2009, 2008 ANN REP ISR TRA; Israel Transplant Center, 2004, PUBL ATT ORG DON NAT; JARVIS R, 1995, J MED ETHICS, V21, P199, DOI 10.1136/jme.21.4.199; KITTUR DS, 1991, LANCET, V338, P1441, DOI 10.1016/0140-6736(91)92735-K; MUYSKENS J, 1992, TRANSPLANT P, V24, P2181; Peters David A, 1988, J Law Health, V3, P157; Siegal G, 2006, J LAW MED ETHICS, V34, P415, DOI 10.1111/j.1748-720X.2006.00048.x; Spital A, 2005, CLIN TRANSPLANT, V19, P269, DOI 10.1111/j.1399-0012.2005.00336.x; STEINBERGERWILC.R, 2004, P 6 EUR SOL OX FUEL, V1, P11; THUKRAL VK, 2000, ORGAN DONATION TRANS, P189; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; *UNOS, 2008, UNOS POL 3 5 5 2 ALL; VEATCH RM, 2000, TRANSPLANTATION ETHI, P1; Wilson DS, 2007, Q REV BIOL, V82, P327, DOI 10.1086/522809; ISRAELI DONORS DECLA	20	103	103	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	MAR-APR	2010	375	9720					1131	1133		10.1016/S0140-6736(09)61795-5	http://dx.doi.org/10.1016/S0140-6736(09)61795-5			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	578ZB	20022099				2022-12-28	WOS:000276334600037
J	Arguedas, A; Soley, C; Lindert, K				Arguedas, Adriano; Soley, Carolina; Lindert, Kelly			Responses to 2009 H1N1 Vaccine in Children 3 to 17 Years of Age	NEW ENGLAND JOURNAL OF MEDICINE			English	Letter							INFLUENZA		[Arguedas, Adriano; Soley, Carolina] Inst Atenc Pediat, San Jose, Costa Rica; [Lindert, Kelly] Novartis Vaccines & Diagnost, Cambridge, MA USA	Novartis	Arguedas, A (corresponding author), Inst Atenc Pediat, San Jose, Costa Rica.	kelly.lindert@novartis.com						Center for Biologics Evaluation and Research, 2007, GUID IND CLIN DAT NE; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Jain S, 2009, NEW ENGL J MED, V361, P1935, DOI 10.1056/NEJMoa0906695; 2009, MMWR MORB MORTAL WKL, V58, P521	5	52	57	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					370	372		10.1056/NEJMc0909988	http://dx.doi.org/10.1056/NEJMc0909988			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548OT	20042746				2022-12-28	WOS:000273975000029
J	Rieselbach, RE; Crouse, BJ; Frohna, JG				Rieselbach, Richard E.; Crouse, Byron J.; Frohna, John G.			Teaching Primary Care in Community Health Centers: Addressing the Workforce Crisis for the Underserved	ANNALS OF INTERNAL MEDICINE			English	Article							EXPANSION; REFORM; ACT	Universal coverage and multiple initiatives to improve health care delivery are crucial components of health care reform. However, the missing link has been a plan to rapidly address the primary care workforce crisis for the underserved. The authors propose a link between primary care graduate medical education and care for the underserved in community health centers, where expansion will be necessary for the anticipated increase in Medicaid and insured patients. This can be achieved by establishing primary care teaching health centers in expanded community health centers, which have established a patient-centered medical home practice environment. Residents would receive their final year of training in these centers, and then have the incentive of National Health Service Corps debt repayment if they subsequently practice in an underserved area. Primary care residents being trained in this setting would immediately increase the clinical capacity of community health centers and ultimately expand the primary care physician workforce. This proposal addresses the primary care physician workforce crisis and the associated key problems of limited access for the underserved and suboptimal primary care graduate medical education.	[Rieselbach, Richard E.] Univ Wisconsin, Sch Med & Publ Hlth, Madison, WI 53705 USA	University of Wisconsin System; University of Wisconsin Madison	Rieselbach, RE (corresponding author), Univ Wisconsin, Sch Med & Publ Hlth, 2136 HSLC,750 Highland Ave, Madison, WI 53705 USA.	rer@medicine.wisc.edu						Aaron HJ, 2008, NEW ENGL J MED, V359, P1865, DOI 10.1056/NEJMp0807204; *ACCR COUNC GRAD M, 2009, PROGR REQ RES ED INT; Accreditation Council for Graduate Medical Education, 2007, PROGR REQ RES ED PED; American Academy of Family Physicians American Academy of Pediatrics American College of Physicians & American Osteopathic Association, 2007, JOINT PRINC PAT CENT; [Anonymous], 2008, RES DAT 2008 MAIN RE; Bodenheimer T, 2006, NEW ENGL J MED, V355, P861, DOI 10.1056/NEJMp068155; Bodenheimer T, 2009, NEW ENGL J MED, V360, P2693, DOI 10.1056/NEJMp0902909; Collwill JM, 2008, HEALTH AFFAIR, V27, pW232, DOI 10.1377/hlthaff.27.3.w232; Fisher ES, 2008, NEW ENGL J MED, V359, P1202, DOI 10.1056/NEJMp0806233; *HLTH RES SERV ADM, 2009, SHORT DES HPSAS MUAS; Iglehart JK, 2008, NEW ENGL J MED, V358, P1321, DOI 10.1056/NEJMp0801332; Institute of Medicine, 2008, RET AG AM BUILD HLTH; Isaacs SL, 2007, HEALTH AFFAIR, V26, P871, DOI 10.1377/hlthaff.26.3.871; Keirns Carla C, 2008, Acad Med, V83, P498, DOI 10.1097/ACM.0b013e31816be3ab; Kronman AC, 2008, J GEN INTERN MED, V23, P1330, DOI 10.1007/s11606-008-0638-5; Lee TH, 2008, NEW ENGL J MED, V359, P2085, DOI 10.1056/NEJMp0805766; Leighton Ku, 2009, IS PRIMARY CARE SAFE; Morris CG, 2008, FAM MED, V40, P271; Mullan F, 1997, NEW ENGL J MED, V336, P1601, DOI 10.1056/NEJM199705293362212; *NAT ASS COMM HLTH, 2008, HLTH PROF TRAIN OPP; *NAT HLTH SERV COR, APPL INF B NAT HLTH; Paulus RA, 2008, HEALTH AFFAIR, V27, P1235, DOI 10.1377/hlthaff.27.5.1235; *R GRAH CTR, 2007, ACC DEN LOOK AM MED; RIESELBACH RE, 1986, NEW ENGL J MED, V314, P32, DOI 10.1056/NEJM198601023140106; Rosenblatt RA, 2006, JAMA-J AM MED ASSOC, V295, P1042, DOI 10.1001/jama.295.9.1042; Salsberg E, 2008, JAMA-J AM MED ASSOC, V300, P1174, DOI 10.1001/jama.300.10.1174; Steinbrook R, 2008, NEW ENGL J MED, V358, P2757, DOI 10.1056/NEJMp0804277; Steinbrook R, 2008, NEW ENGL J MED, V359, P2629, DOI 10.1056/NEJMp0808520; Steinbrook R, 2009, NEW ENGL J MED, V360, P1057, DOI 10.1056/NEJMp0900665; Wilson JF, 2009, ANN INTERN MED, V150, P149, DOI 10.7326/0003-4819-150-2-200901200-00024	30	39	39	1	8	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2					118	122		10.7326/0003-4819-152-2-201001190-00186	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-00186			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20008743				2022-12-28	WOS:000273953000007
J	Ekele, B; Morhason-Bello, I				Ekele, Bissallah; Morhason-Bello, Imran			Umbilical vein injection of oxytocin for retained placenta	LANCET			English	Editorial Material							RANDOMIZED CONTROLLED-TRIAL		[Ekele, Bissallah] Univ Abuja, Dept Obstet & Gynaecol, Coll Hlth Sci, Abuja, Nigeria; [Morhason-Bello, Imran] Univ Coll Hosp, Dept Obstet & Gynaecol, Ibadan, Nigeria	University of Ibadan; University College Hospital, Ibadan	Ekele, B (corresponding author), Univ Abuja, Dept Obstet & Gynaecol, Coll Hlth Sci, Abuja, Nigeria.	bissekele@yahoo.com		Morhason-Bello, Imran/0000-0002-7448-4824				[Anonymous], 2009, WHO GUID MAN POSTP H; Carroli G, 1998, BRIT J OBSTET GYNAEC, V105, P179, DOI 10.1111/j.1471-0528.1998.tb10049.x; Carroli G., 2001, COCHRANE DB SYST REV, V4; Ekele BA, 2007, ACTA OBSTET GYN SCAN, V86, P627, DOI 10.1080/00016340601134622; Galadanci HS, 2007, BJOG-INT J OBSTET GY, V114, P448, DOI 10.1111/j.1471-0528.2007.01229.x; Gazvani MR, 1998, OBSTET GYNECOL, V91, P203, DOI 10.1016/S0029-7844(97)00622-4; Habek D, 2007, INT J GYNECOL OBSTET, V99, P105, DOI 10.1016/j.ijgo.2007.05.007; HERMAN A, 1993, AM J OBSTET GYNECOL, V168, P1496, DOI 10.1016/S0002-9378(11)90788-1; Mwaniki P K, 2002, East Afr Med J, V79, P184; National Institute for Health and Clinical Excellence, 2007, INTR CAR CAR HLTH WO; Weeks AD, 2010, LANCET, V375, P141, DOI 10.1016/S0140-6736(09)61752-9	11	0	0	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 9	2010	375	9709					98	99		10.1016/S0140-6736(09)62095-X	http://dx.doi.org/10.1016/S0140-6736(09)62095-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544NM	20004012				2022-12-28	WOS:000273664500006
J	Abrams, DJ; Perkin, MA; Skinner, JR				Abrams, Dominic J.; Perkin, Malcolm A.; Skinner, Jonathan R.			Easily Missed? Long QT syndrome	BRITISH MEDICAL JOURNAL			English	Editorial Material							SYNCOPE		[Abrams, Dominic J.] St Bartholomews Hosp, Dept Cardiac Electrophysiol, London EC1A 7BE, England; [Abrams, Dominic J.] Great Ormond St Hosp Sick Children, London, England; [Skinner, Jonathan R.] Starship Childrens Hosp, Green Lane Paediat & Congenital Cardiac Serv, Auckland, New Zealand	University of London; Queen Mary University London; University of London; University College London; Great Ormond Street Hospital for Children NHS Foundation Trust; Starship Children's Hospital	Abrams, DJ (corresponding author), St Bartholomews Hosp, Dept Cardiac Electrophysiol, London EC1A 7BE, England.	d.abrams@qmul.ac.uk	Abrams, Dominic/AAD-8306-2021	Abrams, Dominic/0000-0001-5266-2805; Skinner, Jonathan Robert/0000-0002-3653-0412				Ganzeboom KS, 2003, AM J CARDIOL, V91, P1006, DOI 10.1016/S0002-9149(03)00127-9; Goldenberg I, 2008, CIRCULATION, V117, P2184, DOI 10.1161/CIRCULATIONAHA.107.701243; Hayashi K, 2009, CLIN SCI, V117, P415, DOI 10.1042/CS20080528; LEMPERT T, 1994, ANN NEUROL, V36, P233, DOI 10.1002/ana.410360217; MacCormick JM, 2009, ANN EMERG MED, V54, P26, DOI 10.1016/j.annemergmed.2009.01.031; Maron BJ, 2004, CIRCULATION, V109, P2807, DOI 10.1161/01.CIR.0000128363.85581.E1; Morita H, 2008, LANCET, V372, P750, DOI 10.1016/S0140-6736(08)61307-0; Postema PG, 2008, HEART RHYTHM, V5, P1015, DOI 10.1016/j.hrthm.2008.03.037; Sauer AJ, 2007, J AM COLL CARDIOL, V49, P329, DOI 10.1016/j.jacc.2006.08.057; Schwartz PJ, 2009, HEART RHYTHM, V6, P113, DOI 10.1016/j.hrthm.2008.10.017; Schwartz PJ, 2004, CIRCULATION, V109, P1826, DOI 10.1161/01.CIR.0000125523.14403.1E; Seth R, 2007, J AM COLL CARDIOL, V49, P1092, DOI 10.1016/j.jacc.2006.09.054; Swan H, 1999, J AM COLL CARDIOL, V34, P823, DOI 10.1016/S0735-1097(99)00255-7; Taggart NW, 2007, CIRCULATION, V115, P2613, DOI 10.1161/CIRCULATIONAHA.106.661082; Vincent GM, 2009, CIRCULATION, V119, P215, DOI 10.1161/CIRCULATIONAHA.108.772533	15	4	4	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 8	2010	340								b4815	10.1136/bmj.b4815	http://dx.doi.org/10.1136/bmj.b4815			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542II	20061357				2022-12-28	WOS:000273486100004
J	Darouiche, RO; Wall, MJ; Itani, KMF; Otterson, MF; Webb, AL; Carrick, MM; Miller, HJ; Awad, SS; Crosby, CT; Mosier, MC; AlSharif, A; Berger, DH				Darouiche, Rabih O.; Wall, Matthew J., Jr.; Itani, Kamal M. F.; Otterson, Mary F.; Webb, Alexandra L.; Carrick, Matthew M.; Miller, Harold J.; Awad, Samir S.; Crosby, Cynthia T.; Mosier, Michael C.; AlSharif, Atef; Berger, David H.			Chlorhexidine-Alcohol versus Povidone-Iodine for Surgical-Site Antisepsis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ELECTIVE COLORECTAL SURGERY; SUPPLEMENTAL PERIOPERATIVE OXYGEN; WOUND-INFECTION; ANTIMICROBIAL PROPHYLAXIS; PREVENTION; TRIAL; CEFOTETAN; HOSPITALIZATION; ANTIBIOTICS; MULTICENTER	BACKGROUND Since the patient's skin is a major source of pathogens that cause surgical-site infection, optimization of preoperative skin antisepsis may decrease postoperative infections. We hypothesized that preoperative skin cleansing with chlorhexidine-alcohol is more protective against infection than is povidone-iodine. METHODS We randomly assigned adults undergoing clean-contaminated surgery in six hospitals to preoperative skin preparation with either chlorhexidine-alcohol scrub or povidone-iodine scrub and paint. The primary outcome was any surgical-site infection within 30 days after surgery. Secondary outcomes included individual types of surgical-site infections. RESULTS A total of 849 subjects (409 in the chlorhexidine-alcohol group and 440 in the povidone-iodine group) qualified for the intention-to-treat analysis. The overall rate of surgical-site infection was significantly lower in the chlorhexidine-alcohol group than in the povidone-iodine group (9.5% vs. 16.1%; P = 0.004; relative risk, 0.59; 95% confidence interval, 0.41 to 0.85). Chlorhexidine-alcohol was significantly more protective than povidone-iodine against both superficial incisional infections (4.2% vs. 8.6%, P = 0.008) and deep incisional infections (1% vs. 3%, P = 0.05) but not against organ-space infections (4.4% vs. 4.5%). Similar results were observed in the per-protocol analysis of the 813 patients who remained in the study during the 30-day follow-up period. Adverse events were similar in the two study groups. CONCLUSIONS Preoperative cleansing of the patient's skin with chlorhexidine-alcohol is superior to cleansing with povidone-iodine for preventing surgical-site infection after clean-contaminated surgery. (ClinicalTrials.gov number, NCT00290290.)	[Darouiche, Rabih O.] Baylor Coll Med, Ctr Prostheses Infect, Houston, TX 77030 USA; [Darouiche, Rabih O.; Awad, Samir S.; AlSharif, Atef; Berger, David H.] Michael E DeBakey Vet Affairs Med Ctr, Houston, TX USA; [Wall, Matthew J., Jr.; Carrick, Matthew M.; Miller, Harold J.] Ben Taub Gen Hosp, Houston, TX 77030 USA; [Itani, Kamal M. F.] Vet Affairs Boston Healthcare Syst, Boston, MA USA; [Itani, Kamal M. F.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Otterson, Mary F.] Vet Affairs Med Ctr, Milwaukee, WI USA; [Otterson, Mary F.] Med Coll Wisconsin, Milwaukee, WI 53226 USA; [Webb, Alexandra L.] Vet Affairs Med Ctr, Atlanta, GA 30033 USA; [Crosby, Cynthia T.] Cardinal Hlth, Leawood, KS USA; [Mosier, Michael C.] Washburn Univ, Topeka, KS 66621 USA	Baylor College of Medicine; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Medical College of Wisconsin; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Cardinal Health Inc; Washburn University	Darouiche, RO (corresponding author), Baylor Coll Med, Ctr Prostheses Infect, 1333 Moursund Ave,Suite A221, Houston, TX 77030 USA.	rdarouiche@aol.com						ARNAUD JP, 1992, J HOSP INFECT, V22, P23, DOI 10.1016/S0195-6701(05)80004-0; Belda FJ, 2005, JAMA-J AM MED ASSOC, V294, P2035, DOI 10.1001/jama.294.16.2035; Belda FJ, 2005, JAMA-J AM MED ASSOC, V294, P2973; Bibbo C, 2005, CLIN ORTHOP RELAT R, P204, DOI 10.1097/blo.0000167832.47464.22; Chaiyakunapruk N, 2002, ANN INTERN MED, V136, P792, DOI 10.7326/0003-4819-136-11-200206040-00007; Culligan PJ, 2005, AM J OBSTET GYNECOL, V192, P422, DOI 10.1016/j.ajog.2004.08.010; Denton GW, 2001, DISINFECTION STERILI, P321; Fujita S, 2007, ARCH SURG-CHICAGO, V142, P657, DOI 10.1001/archsurg.142.7.657; Greif R, 2000, NEW ENGL J MED, V342, P161, DOI 10.1056/NEJM200001203420303; Hawn MT, 2008, J AM COLL SURGEONS, V206, P814, DOI 10.1016/j.jamcollsurg.2007.12.013; Ishizaka Kazuhiro, 2007, Journal of Infection and Chemotherapy, V13, P324, DOI 10.1007/s10156-007-0544-5; Itani KMF, 2006, NEW ENGL J MED, V355, P2640, DOI 10.1056/NEJMoa054408; Kirkland KB, 1999, INFECT CONT HOSP EP, V20, P725, DOI 10.1086/501572; Kurz A, 1996, NEW ENGL J MED, V334, P1209, DOI 10.1056/NEJM199605093341901; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Milsom JW, 1998, AM J SURG, V176, p46S, DOI 10.1016/S0002-9610(98)00220-7; Mohri Y, 2007, BRIT J SURG, V94, P683, DOI 10.1002/bjs.5837; Napolitano LM, 2006, SURG INFECT LARCH S3, V7, pS3; O'Grady NP, 2002, INFECT CONT HOSP EP, V23, P759, DOI 10.1086/502007; Ostrander RV, 2005, J BONE JOINT SURG AM, V87A, P980, DOI 10.2106/JBJS.D.01977; Smith RL, 2004, ANN SURG, V239, P599, DOI 10.1097/01.sla.0000124292.21605.99; TANNER J, 2006, COCHRANE DB SYST REV, V2; Uchiyama K, 2007, HEPATO-GASTROENTEROL, V54, P1487; WEBSTER J, 2007, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004985.PUB3; Wolf JS, 2008, J UROLOGY, V180, P2262; Wolf JS, 2008, J UROLOGY, V179, P1379, DOI [10.1016/j.juro.2008.01.068, 10.1016/S0022-5347(08)62119-9]; Yasunaga H, 2007, J HOSP INFECT, V65, P102, DOI 10.1016/j.jhin.2006.07.008	27	810	839	4	78	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2010	362	1					18	26		10.1056/NEJMoa0810988	http://dx.doi.org/10.1056/NEJMoa0810988			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	540PA	20054046	Bronze			2022-12-28	WOS:000273345500005
J	Ito, T; Woloszyn, M; Mazloff, M				Ito, T.; Woloszyn, M.; Mazloff, M.			Anthropogenic carbon dioxide transport in the Southern Ocean driven by Ekman flow	NATURE			English	Article							RECENT CLIMATE-CHANGE; CO2; CIRCULATION; MODEL; SINK	The Southern Ocean, with its large surface area and vigorous overturning circulation, is potentially a substantial sink of anthropogenic CO(2) (refs 1-4). Despite its importance, the mechanism and pathways of anthropogenic CO(2) uptake and transport are poorly understood. Regulation of the Southern Ocean carbon sink by the wind-driven Ekman flow, mesoscale eddies and their interaction is under debate(5-8). Here we use a high-resolution ocean circulation and carbon cycle model to address the mechanisms controlling the Southern Ocean sink of anthropogenic CO(2). The focus of our study is on the intra-annual variability in anthropogenic CO(2) over a two-year time period. We show that the pattern of carbon uptake is correlated with the oceanic vertical exchange. Zonally integrated carbon uptake peaks at the Antarctic polar front. The carbon is then advected away from the uptake regions by the circulation of the Southern Ocean, which is controlled by the interplay among Ekman flow, ocean eddies and subduction of water masses. Although lateral carbon fluxes are locally dominated by the imprint of mesoscale eddies, the Ekman transport is the primary mechanism for the zonally integrated, cross-frontal transport of anthropogenic CO(2). Intra-annual variability of the cross-frontal transport is dominated by the Ekman flow with little compensation from eddies. A budget analysis in the density coordinate highlights the importance of wind-driven transport across the polar front and subduction at the subtropical front. Our results suggest intimate connections between oceanic carbon uptake and climate variability through the temporal variability of Ekman transport.	[Ito, T.; Woloszyn, M.] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Mazloff, M.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Colorado State University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Ito, T (corresponding author), Colorado State Univ, Dept Atmospher Sci, 1371 Campus Delivery, Ft Collins, CO 80523 USA.	ito@atmos.colostate.edu	Woloszyn, Mary/T-2186-2019; Mazloff, Matthew/AAG-6463-2019; Ito, Takamitsu/F-3856-2010	Mazloff, Matthew/0000-0002-1650-5850; Ito, Takamitsu/0000-0001-9873-099X; Woloszyn, Molly/0000-0001-7080-757X	US National Aeronautics and Space Administration (NASA) [NNX08AL72G]; US National Oceanic and Atmospheric Administration [NA08OAR4320893]	US National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); US National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	T. I. and M. W. are supported by the US National Aeronautics and Space Administration (NASA) grant NNX08AL72G and the US National Oceanic and Atmospheric Administration grant NA08OAR4320893. The Southern Ocean State Estimate is supported by NASA and US National Oceanographic Partnership Program contracts to the Massachusetts Institute of Technology. The NASA Advanced Supercomputing division and the San Diego Supercomputer Center provided computing and data storage resources. J. L. Sarmiento and N. Lovenduski provided comments that improved the manuscript.	Boning CW, 2008, NAT GEOSCI, V1, P864, DOI 10.1038/ngeo362; Caldeira K, 2000, SCIENCE, V287, P620, DOI 10.1126/science.287.5453.620; Fletcher SEM, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002530; Garcia H.E., 2006, NOAA ATLAS NESDIS, V64, p396 pp; Gruber N, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003349; Ito T, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002103; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Lovenduski NS, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003139; Marinov I, 2006, NATURE, V441, P964, DOI 10.1038/nature04883; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5753, DOI 10.1029/96JC02775; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5733, DOI 10.1029/96JC02776; Marshall J, 2006, J PHYS OCEANOGR, V36, P1806, DOI 10.1175/JPO2949.1; Matsumoto K, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002397; MAZLOFF M, 2008, THESIS MIT; MAZLOFF MR, J PHYS OCEANOG UNPUB; Miller RL, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006323; Moore JK, 1999, J GEOPHYS RES-OCEANS, V104, P3059, DOI 10.1029/1998JC900032; Najjar RG, 1992, GLOBAL BIOGEOCHEM CY, V6, P45, DOI 10.1029/91GB02718; Orr JC, 2001, GLOBAL BIOGEOCHEM CY, V15, P43, DOI 10.1029/2000GB001273; Russell JL, 2006, J CLIMATE, V19, P6382, DOI 10.1175/JCLI3984.1; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; SARMIENTO JL, 1992, J GEOPHYS RES-OCEANS, V97, P3621, DOI 10.1029/91JC02849; Sokolov S, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004072; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; TOGGWEILER JR, 1995, DEEP-SEA RES PT I, V42, P477, DOI 10.1016/0967-0637(95)00012-U; WATSON AJ, 2003, CARBON DIOXIDE FLUXE, P123; Wunsch C, 2007, PHYSICA D, V230, P197, DOI 10.1016/j.physd.2006.09.040	30	105	110	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 7	2010	463	7277					80	U85		10.1038/nature08687	http://dx.doi.org/10.1038/nature08687			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054394				2022-12-28	WOS:000273344900034
J	Niedzwiedzki, G; Szrek, P; Narkiewicz, K; Narkiewicz, M; Ahlberg, PE				Niedzwiedzki, Grzegorz; Szrek, Piotr; Narkiewicz, Katarzyna; Narkiewicz, Marek; Ahlberg, Per E.			Tetrapod trackways from the early Middle Devonian period of Poland	NATURE			English	Article							NEAR-TETRAPOD; PECTORAL FIN; ORIGIN; PANDERICHTHYS; EVOLUTION; FOSSILS; FISH; JAWS	The fossil record of the earliest tetrapods (vertebrates with limbs rather than paired fins) consists of body fossils and trackways. The earliest body fossils of tetrapods date to the Late Devonian period (late Frasnian stage) and are preceded by transitional elpistostegids such as Panderichthys and Tiktaalik that still have paired fins. Claims of tetrapod trackways predating these body fossils have remained controversial with regard to both age and the identity of the track makers. Here we present well-preserved and securely dated tetrapod tracks from Polish marine tidal flat sediments of early Middle Devonian (Eifelian stage) age that are approximately 18 million years older than the earliest tetrapod body fossils and 10 million years earlier than the oldest elpistostegids. They force a radical reassessment of the timing, ecology and environmental setting of the fish-tetrapod transition, as well as the completeness of the body fossil record.	[Ahlberg, Per E.] Uppsala Univ, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, S-75236 Uppsala, Sweden; [Niedzwiedzki, Grzegorz] Warsaw Univ, Fac Biol, Dept Paleobiol & Evolut, PL-02097 Warsaw, Poland; [Szrek, Piotr] Warsaw Univ, Fac Geol, Dept Paleontol, PL-02089 Warsaw, Poland; [Szrek, Piotr; Narkiewicz, Katarzyna; Narkiewicz, Marek] Polish Geol Inst, PL-00975 Warsaw, Poland	Uppsala University; University of Warsaw; University of Warsaw; Polish Geological Institute - National Research Institute	Ahlberg, PE (corresponding author), Uppsala Univ, Dept Physiol & Dev Biol, Subdept Evolutionary Organismal Biol, Norbyvagen 18A, S-75236 Uppsala, Sweden.	per.ahlberg@ebc.uu.se	Ahlberg, Per/E-8086-2013	Ahlberg, Per/0000-0001-9054-2900; Niedzwiedzki, Grzegorz/0000-0002-4775-5254; Narkiewicz, Marek/0000-0003-1962-0253; Szrek, Piotr/0000-0001-9855-2003; Narkiewicz, Krzysztof/0000-0001-5949-5018; Narkiewicz, Katarzyna/0000-0003-1072-0987	Faculty of Biology, Warsaw University; Polish Geological Institute; Swedish Research Council	Faculty of Biology, Warsaw University; Polish Geological Institute; Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank G. Pienkowski, Z. Zlonkiewicz, S. Salwa (Polish Geological Institute, Warsaw and Kielce) and J. Dzik (Polish Academy of Sciences and Warsaw University) for their help in fieldwork. This research was supported, in part, by funding from the Faculty of Biology, Warsaw University and Polish Geological Institute. We thank J. O. Ebbestad (Museum of Evolution, Uppsala University) for help with preparing plaster casts of the trackways and P. Slipinski (Museum and Institute of Zoology, PAN) for help with scanning. I. Jackson (Uppsala University) corrected the English of the Supplementary Information text. P. E. A. acknowledges the support of the Swedish Research Council.	ADAMCZAK F, 1976, Senckenbergiana Lethaea, V57, P265; Ahlberg PE, 2005, NATURE, V437, P137, DOI 10.1038/nature03893; AHLBERG PE, 1991, NATURE, V354, P298, DOI 10.1038/354298a0; AHLBERG PE, 1995, NATURE, V373, P420, DOI 10.1038/373420a0; Ahlberg PE, 1998, T ROY SOC EDIN-EARTH, V89, P11, DOI 10.1017/S0263593300002340; Ahlberg PE, 1998, ZOOL J LINN SOC-LOND, V122, P99; AHLBERG PE, 1994, PHILOS T ROY SOC B, V343, P303, DOI 10.1098/rstb.1994.0027; Ahlberg PE, 1998, NATURE, V395, P792, DOI 10.1038/27421; Ahlberg PE, 2000, PALAEONTOLOGY, V43, P533, DOI 10.1111/j.0031-0239.2000.00138.x; Ahlberg PE, 2008, NATURE, V453, P1199, DOI 10.1038/nature06991; [Anonymous], [No title captured]; [Anonymous], 1992, FOSSIL FISHES LIVING; [Anonymous], 2004, ACTA U LATVIENSIS; Boisvert CA, 2005, NATURE, V438, P1145, DOI 10.1038/nature04119; Boisvert CA, 2008, NATURE, V456, P636, DOI 10.1038/nature07339; Brazeau MD, 2006, NATURE, V439, P318, DOI 10.1038/nature04196; Callier V, 2009, SCIENCE, V324, P364, DOI 10.1126/science.1167542; Clack JA, 2003, NATURE, V425, P65, DOI 10.1038/nature01904; Clack JA, 1997, PALAEOGEOGR PALAEOCL, V130, P227, DOI 10.1016/S0031-0182(96)00142-3; Clack JA., 2012, GAINING GROUND ORIGI; Clement G, 2004, NATURE, V427, P412, DOI 10.1038/427412a; Coates MI, 1996, T ROY SOC EDIN-EARTH, V87, P363, DOI 10.1017/S0263593300006787; COATES MI, 1990, NATURE, V347, P66, DOI 10.1038/347066a0; Daeschler EB, 2006, NATURE, V440, P757, DOI 10.1038/nature04639; Daeschler EB, 2000, J PALEONTOL, V74, P301, DOI 10.1666/0022-3360(2000)074<0301:ETJFTL>2.0.CO;2; DAESCHLER EB, 1994, SCIENCE, V265, P639, DOI 10.1126/science.265.5172.639; Downs JP, 2008, NATURE, V455, P925, DOI 10.1038/nature07189; Gouramanis C, 2003, AUST J EARTH SCI, V50, P811, DOI 10.1111/j.1440-0952.2003.01028.x; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; KURSS V, 1992, FOSSIL FISHES LIVING, P251; LEBEDEV OA, 1995, ZOOL J LINN SOC-LOND, V114, P307, DOI 10.1006/zjls.1995.0027; LEBEDEV OA, 1984, DOKL AKAD NAUK SSSR+, V278, P1470; Malec Jan, 1997, Bulletin of the Polish Academy of Sciences Earth Sciences, V45, P67; Markey MJ, 2007, P NATL ACAD SCI USA, V104, P7134, DOI 10.1073/pnas.0701706104; NARKIEWICZ K, N J GEOL PA IN PRESS; Pajchlowa M., 1957, Biuletyn Instytutu Geologicznego Warszawa, VNo. 122, P145; SCHULTZE HP, 1985, PALAEONTOLOGY, V28, P293; Scotese C.R., 2002, PALEOMAP; Shubin NH, 2004, SCIENCE, V304, P90, DOI 10.1126/science.1094295; Shubin NH, 2006, NATURE, V440, P764, DOI 10.1038/nature04637; STOSSEL I, 1995, J GEOL SOC LONDON, V152, P407, DOI 10.1144/gsjgs.152.2.0407; Szulczewski M., 1995, GEOL Q, V39, P471; TREWIN N H, 1986, Transactions of the Royal Society of Edinburgh Earth Sciences, V77, P21; Turnau E, 1999, REV PALAEOBOT PALYNO, V106, P237, DOI 10.1016/S0034-6667(99)00011-1; Vorobyeva E., 1991, P68; WARREN A, 1986, ALCHERINGA, V10, P183, DOI 10.1080/03115518608619153; WARREN JW, 1972, NATURE, V238, P469, DOI 10.1038/238469a0; Williams EA, 1997, J GEOL SOC LONDON, V154, P189, DOI 10.1144/gsjgs.154.2.0189; Zhu M, 2002, NATURE, V420, P760, DOI 10.1038/420760a; Zhu M, 2009, NATURE, V458, P469, DOI 10.1038/nature07855	50	174	177	1	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					43	48		10.1038/nature08623	http://dx.doi.org/10.1038/nature08623			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054388				2022-12-28	WOS:000273344900026
J	Cooke, GS; Main, J; Thursz, MR				Cooke, Graham S.; Main, Janice; Thursz, Mark R.			Treatment for hepatitis B	BMJ-BRITISH MEDICAL JOURNAL			English	Review							VIRUS INFECTION; LAMIVUDINE; CIRRHOSIS; THERAPY; TRANSMISSION; RISK; HIV		[Cooke, Graham S.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, London SW7 2AZ, England; [Cooke, Graham S.] Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Kwa Zulu, South Africa; [Main, Janice; Thursz, Mark R.] Univ London Imperial Coll Sci Technol & Med, Dept Hepatol, London SW7 2AZ, England	Imperial College London; University of Kwazulu Natal; Imperial College London	Cooke, GS (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis, St Marys Campus, London SW7 2AZ, England.	g.cooke@imperial.ac.uk		Cooke, Graham/0000-0001-6475-5056; Thursz, Mark/0000-0002-8218-192X				[Anonymous], 2008, MMWR; Bravo AA, 2001, NEW ENGL J MED, V344, P495, DOI 10.1056/NEJM200102153440706; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; DAVIS LG, 1989, LANCET, V1, P889; Dienstag JL, 2008, NEW ENGL J MED, V359, P1486, DOI 10.1056/NEJMra0801644; FONTANA RJ, 1996, HEPATOLOGY S5, V49, pS185; Fux CA, 2008, ANTIVIR THER, V13, P1077; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gay NJ, 1999, EPIDEMIOL INFECT, V122, P133, DOI 10.1017/S0950268898001745; Guha I, 2008, CLIN LIVER DIS, V12, P883, DOI 10.1016/j.cld.2008.07.010; Hadziyannis SJ, 2006, GASTROENTEROLOGY, V131, P1743, DOI 10.1053/j.gastro.2006.09.020; Iloeje UH, 2006, GASTROENTEROLOGY, V130, P678, DOI 10.1053/j.gastro.2005.11.016; Lai CL, 2008, NEW ENGL J MED, V359, P2488, DOI 10.1056/NEJMe0808185; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Lau GKK, 2005, NEW ENGL J MED, V352, P2682, DOI 10.1056/NEJMoa043470; Lessells RJ, 2008, LANCET INFECT DIS, V8, P210, DOI 10.1016/S1473-3099(08)70047-1; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; Marcellin P, 2009, J HEPATOL, V50, P227, DOI 10.1016/j.jhep.2008.10.001; *NIH CLIN GUID, 2008, ENT TREATM CHRON HEP; *NIH CLIN GUID, 2008, TEN TREATM CHRON HEP; *NIH CLIN GUID, 2008, TELB TREATM CHRON HE; Perrillo R, 2009, HEPATOLOGY, V49, pS103, DOI 10.1002/hep.22956; Perz JF, 2006, J HEPATOL, V45, P529, DOI 10.1016/j.jhep.2006.05.013; Pratt DS, 2000, NEW ENGL J MED, V342, P1266, DOI 10.1056/NEJM200004273421707; Reshef R, 2000, NEW ENGL J MED, V343, P1123, DOI 10.1056/NEJM200010123431513; Sung JJY, 2002, J VIRAL HEPATITIS, V9, P229, DOI 10.1046/j.1365-2893.2002.00352.x; THUN MJ, 2009, CARCINOGENESIS  1124; Thursz M, 2010, TROP MED INT HEALTH, V15, P2, DOI 10.1111/j.1365-3156.2009.02410.x; Wang JH, 2002, SCAND J GASTROENTERO, V37, P366, DOI 10.1080/003655202317284309; Xu WM, 2009, J VIRAL HEPATITIS, V16, P94, DOI 10.1111/j.1365-2893.2008.01056.x; Yao FY, 2001, HEPATOLOGY, V34, P411, DOI 10.1053/jhep.2001.26512; Yeo W, 2006, HEPATOLOGY, V43, P209, DOI 10.1002/hep.21051	34	15	19	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2010	340								b5429	10.1136/bmj.b5429	http://dx.doi.org/10.1136/bmj.b5429			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542IA	20051467				2022-12-28	WOS:000273485100006
J	Iglehart, JK				Iglehart, John K.			Rallying the Caucus - The Democrats' Struggle for Unity on Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		BALZ D, 2009, WASHINGTON POST 1216, pA6; Eggen D, 2009, WASH POST, pA04; Kane Paul, 2009, WASHINGTON POST 0707, pA3; *PETERSONPEW COMM, 2009, RED INK RIS CALL ACT	4	0	0	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27								10.1056/NEJMp0912352	http://dx.doi.org/10.1056/NEJMp0912352			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	538JV	20018957	Bronze			2022-12-28	WOS:000273181300006
J	Su, W; Yegappan, C; Carlisle, EJF; Clase, CM				Su, W.; Yegappan, C.; Carlisle, E. J. F.; Clase, C. M.			Lesson of the Week Reduced level of consciousness from baclofen in people with low kidney function	BRITISH MEDICAL JOURNAL			English	Review							CHRONIC-HEMODIALYSIS; INDUCED NEUROTOXICITY; INTRACTABLE HICCUPS; TOXICITY; PATIENT; DEPRESSION; CLEARANCE; DIALYSIS; CAPD		[Su, W.; Yegappan, C.; Carlisle, E. J. F.; Clase, C. M.] McMaster Univ, Dept Med, Hamilton, ON L8N 1Y2, Canada	McMaster University	Clase, CM (corresponding author), McMaster Univ, Dept Med, Hamilton, ON L8N 1Y2, Canada.	clase@mcmaster.ca		Clase, Catherine/0000-0002-4538-5958				*ALPH PHARM, 1999, ALPH BACL DAT SHEET; ANDERSON P, 1984, J TOXICOL-CLIN TOXIC, V22, P11, DOI 10.3109/00099308409035078; Aronoff GR, 2007, DRUG PRESCRIBING REN, V5th; Bassilios N, 2000, NEPHROL DIAL TRANSPL, V15, P715, DOI 10.1093/ndt/15.5.715; *BRIT MED ASS, 2009, ROYAL PHARM SOC GREA, P585; Brvar M, 2007, EUR J CLIN PHARMACOL, V63, P1143, DOI 10.1007/s00228-007-0371-8; Chen KS, 1997, ANN PHARMACOTHER, V31, P1315, DOI 10.1177/106002809703101108; Chen S, 2003, ACTA NEUROLOGICA TAI, V2, P89; Chen YC, 2003, RENAL FAILURE, V25, P297, DOI 10.1081/JDI-120018730; Choo YM, 2000, NEPHRON, V86, P546, DOI 10.1159/000045866; Chou CL, 2006, SOUTH MED J, V99, P1308, DOI 10.1097/01.smj.0000247632.84949.27; DAHLIN PA, 1984, DRUG INTEL CLIN PHAR, V18, P805, DOI 10.1177/106002808401801006; GUELAUD C, 1995, EUR RESPIR J, V8, P235, DOI 10.1183/09031936.95.08020235; Hadjiyannacos D, 2001, AM J NEPHROL, V21, P427, DOI 10.1159/000046290; HIMMELSBACH FA, 1992, DEUT MED WOCHENSCHR, V117, P733, DOI 10.1055/s-2008-1062370; Kroczak M, 2001, Przegl Lek, V58, P364; LEE TH, 1992, CLIN NEUROPHARMACOL, V15, P56, DOI 10.1097/00002826-199202000-00008; Lois F, 2006, EUR J EMERG MED, V13, P361, DOI 10.1097/01.mej.0000217992.32235.ff; Mery J P, 1987, Am J Kidney Dis, V10, P326; *NOV PHARM CAN, 2006, LIOR BACL PAT INF LE; PARMAR MS, 1991, ANN INTERN MED, V115, P499, DOI 10.7326/0003-4819-115-6-499_3; Peces R, 1998, NEPHROL DIAL TRANSPL, V13, P1896; REPCHINSKY C, 2009, COMPENDIUM PHARM SPE, P1287; Reynolds J.E.F., 1996, MARTINDALE EXTRA PHA, V31st; Sanjay S, 2003, J Assoc Physicians India, V51, P324; SEYFERT S, 1981, NERVENARZT, V52, P616; WHITE WB, 1985, ARCH INTERN MED, V145, P1717, DOI 10.1001/archinte.145.9.1717; Wu CC, 2002, PERITON DIALYSIS INT, V22, P279; WU V, 2000, NEPHROL DIAL TRANSPL, V20, P441; WUIS EW, 1989, EUR J CLIN PHARMACOL, V37, P181, DOI 10.1007/BF00558228	30	8	8	0	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 31	2009	339								b4559	10.1136/bmj.b4559	http://dx.doi.org/10.1136/bmj.b4559			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539JC	20044395				2022-12-28	WOS:000273249200002
J	Cameron, FL; Hansen, R; Abdelhadi, A				Cameron, F. L.; Hansen, R.; Abdelhadi, A.			Case report The vomiting baby	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HYPERTROPHIC PYLORIC-STENOSIS; GASTROESOPHAGEAL-REFLUX DISEASE; DIAGNOSIS; CHILDREN; MECHANISMS; INFANCY; US		[Hansen, R.] Univ Aberdeen, Aberdeen AB25 2ZG, Scotland; [Cameron, F. L.; Abdelhadi, A.] Aberdeen Matern Hosp, Aberdeen AB25 2ZL, Scotland	University of Aberdeen; University of Aberdeen	Hansen, R (corresponding author), Univ Aberdeen, Aberdeen AB25 2ZG, Scotland.	r.hansen@abdn.ac.uk	Hansen, Richard/G-3871-2011	Hansen, Richard/0000-0002-3944-6646				Badriul H, 1999, J GASTROEN HEPATOL, V14, P13, DOI 10.1046/j.1440-1746.1999.01811.x; BELDING HH, 1953, SURG GYNECOL OBSTET, V97, P322; Blumer Steven L, 2004, Ultrasound Q, V20, P79, DOI 10.1097/00013644-200409000-00002; Cohen H L, 2000, Radiology, V215 Suppl, P779; COHEN HL, 1987, RADIOLOGY, V164, P805, DOI 10.1148/radiology.164.3.3303123; Diamant NE, 1997, AM J MED, V103, p40S, DOI 10.1016/S0002-9343(97)00320-3; Gilet Anthony G, 2008, Ultrasound Q, V24, P93, DOI 10.1097/RUQ.0b013e31817c6113; HALLER JO, 1986, RADIOLOGY, V161, P335, DOI 10.1148/radiology.161.2.3532185; Hernanz-Schulman M, 2003, RADIOLOGY, V227, P319, DOI 10.1148/radiol.2272011329; Kawahara H, 1997, GASTROENTEROLOGY, V113, P399, DOI 10.1053/gast.1997.v113.pm9247456; NAIK DR, 1984, ARCH DIS CHILD, V59, P366, DOI 10.1136/adc.59.4.366; Nelson SP, 1997, ARCH PEDIAT ADOL MED, V151, P569, DOI 10.1001/archpedi.1997.02170430035007; Oue T, 1999, PEDIATR RES, V45, P853, DOI 10.1203/00006450-199906000-00012; SPITZ L, 1976, J PEDIATR SURG, V11, P33, DOI 10.1016/0022-3468(76)90166-4; Vandenplas Y, 2000, J GASTROEN HEPATOL, V15, P593, DOI 10.1046/j.1440-1746.2000.02169.x; VANDENPLAS Y, 1993, EUR J PEDIATR, V152, P704, DOI 10.1007/BF01953980; WESLEY JR, 1990, PEDIATR SURG INT, V5, P425	17	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2009	339								b4966	10.1136/bmj.b4966	http://dx.doi.org/10.1136/bmj.b4966			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539JB	20042484				2022-12-28	WOS:000273249100002
J	Green, E; Ali, Z				Green, Euan; Ali, Zubeir			Picture Quiz Flank pain and haematuria	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							MANAGEMENT		[Green, Euan; Ali, Zubeir] Royal Blackburn Hosp, Blackburn BB2 3HH, Lancs, England		Green, E (corresponding author), Royal Blackburn Hosp, Blackburn BB2 3HH, Lancs, England.	euan@doctors.org.uk						Altman AL, 2000, J UROLOGY, V164, P27, DOI 10.1016/S0022-5347(05)67441-1; DJAKOVIC N, 2005, EUR UROL, V47, P1; Hagiwara A, 2001, J TRAUMA, V51, P526, DOI 10.1097/00005373-200109000-00017; Santucci RA, 2005, J TRAUMA, V59, P491, DOI 10.1097/01.ta.0000179956.55078.c0; Santucci RA, 2004, BJU INT, V93, P937, DOI 10.1111/j.1464-4096.2004.04820.x; Shariat SF, 2008, BJU INT, V102, P728, DOI 10.1111/j.1464-410X.2008.07638.x	6	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 30	2009	339								b5443	10.1136/bmj.b5443	http://dx.doi.org/10.1136/bmj.b5443			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539JB	20042486				2022-12-28	WOS:000273249100004
J	Paulden, M; Palmer, S; Hewitt, C; Gilbody, S				Paulden, Mike; Palmer, Stephen; Hewitt, Catherine; Gilbody, Simon			Screening for postnatal depression in primary care: cost effectiveness analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							SPECIFICITY; IMPACT; METAANALYSIS; SENSITIVITY	Objective To evaluate the cost effectiveness of routine screening for postnatal depression in primary care. Design Cost effectiveness analysis with a decision model of alternative methods of screening for depression, including standardised postnatal depression and generic depression instruments. The performance of screening instruments was derived from a systematic review and bivariate meta-analysis at a range of instrument cut points; estimates of other relevant parameters were derived from literature sources and relevant databases. A decision tree considered the full treatment pathway from the possible onset of postnatal depression through identification, treatment, and possible relapse. Setting Primary care. Participants A hypothetical population of women assessed for postnatal depression either via routine care only or supplemented by use of formal identification methods six weeks postnatally, as recommended in recent guidelines. Main outcome measures Costs expressed in 2006-7 prices and impact on health outcomes expressed in terms of quality adjusted life years (QALYs). The time horizon of the analysis was one year. Results The routine application of either postnatal or general depression questionnaires did not seem to be cost effective compared with routine care only. The Edinburgh postnatal depression scale (at a cut point of 16) had an incremental cost effectiveness ratio (ICER) of 41 pound 103 ((sic)45 398, $67 130) per QALY compared with routine care only. The ICER for all other strategies ranged from 49 pound 928 to 272 pound 463 per QALY versus routine care only, while the probability that no formal identification strategy was cost effective was 88% (59%) at a cost effectiveness threshold of 20 pound 000 (30 pound 000) per QALY. While sensitivity analysis indicated that the cost of managing incorrectly identified depression (false positive result) was an important driver of the model, formal identification approaches did not seem to be cost effective at any feasible estimate of this cost. Conclusions Formal identification methods for postnatal depression do not seem to represent value for money for the NHS. The major determinant of cost effectiveness seems to be the potential additional costs of managing women incorrectly diagnosed as depressed. Formal identification methods for postnatal depression do not currently satisfy the National Screening Committee's criteria for the adoption of a screening strategy as part of national health policy.	[Gilbody, Simon] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	University of York - UK	Paulden, M (corresponding author), Univ Toronto, Toronto Hlth Econ & Technol Assessment THETA Coll, Leslie Dan Pharm Bldg,144 Coll St, Toronto, ON M5S 3M2, Canada.	mike.paulden@theta.utoronto.ca	Gilbody, Simon/E-6543-2010; Gilbody, Simon/AAY-3720-2021; Paulden, Michael/E-2061-2016	Gilbody, Simon/0000-0002-8236-6983; Paulden, Mike/0000-0002-0381-5980; Hewitt, Catherine Elizabeth/0000-0002-0415-3536	NIHR Health Technology Assessment (HTA) Programme [05/39/06]; National Institute for Health Research [05/39/06] Funding Source: researchfish	NIHR Health Technology Assessment (HTA) Programme; National Institute for Health Research(National Institute for Health Research (NIHR))	This study was funded by the NIHR Health Technology Assessment (HTA) Programme (HTA project grant 05/39/06). The funding source had no role in study design, conduct, data collection, data analysis, or data interpretation or in the decision to submit the manuscript for publication.	Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; [Anonymous], 2005, PERINATAL DEPRESSION; [Anonymous], 1996, GLOBAL BURDEN DIS CO; Arroll B, 2005, BRIT MED J, V331, P884, DOI 10.1136/bmj.38607.464537.7C; Briggs A, 2006, DECISION MODELLING H; Chisholm D, 1997, SOC PSYCH PSYCH EPID, V32, P68, DOI 10.1007/BF00788923; Chu HT, 2006, J CLIN EPIDEMIOL, V59, P1331, DOI 10.1016/j.jclinepi.2006.06.011; COGILL SR, 1986, BMJ-BRIT MED J, V292, P1165, DOI 10.1136/bmj.292.6529.1165; Cox J.L., 1998, J REPROD INFANT PSYC, V16, P199, DOI DOI 10.1080/02646839808404568; CURTIS K, 2007, UNIT COSTS HLTH SOCI; Hearn G, 1998, BRIT J GEN PRACT, V48, P1064; Hendrick V, 2003, BRIT MED J, V327, P1003, DOI 10.1136/bmj.327.7422.1003; Henshaw C., 2005, SCREENING PERINATAL; Hewitt CE, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13360; Higgins JPT, 2009, J R STAT SOC A STAT, V172, P137, DOI 10.1111/j.1467-985X.2008.00552.x; JOHANNESSON M, 1995, HEALTH POLICY, V31, P225, DOI 10.1016/0168-8510(95)98130-T; Kessler D, 2002, BRIT MED J, V325, P1016, DOI 10.1136/bmj.325.7371.1016; LOVESTONE S, 1993, BRIT J PSYCHIAT, V163, P210, DOI 10.1192/bjp.163.2.210; Murray L, 1999, J CHILD PSYCHOL PSYC, V40, P1259, DOI 10.1111/1469-7610.00542; Murray L, 1996, CHILD DEV, V67, P2512, DOI 10.2307/1131637; National Institute for Health and Clinical Excellence (NICE), 2008, GUID METH TECHN APPR; National Screening Committee, 2003, UK NAT SCREEN COMM C; NICE, 2007, ANT POSTN MENT HLTH; *PEARS, BECK DEPR INV 2 BDI; Reitsma JB, 2005, J CLIN EPIDEMIOL, V58, P982, DOI 10.1016/j.jclinepi.2005.02.022; Revicki DA, 1998, J AFFECT DISORDERS, V48, P25, DOI 10.1016/S0165-0327(97)00117-1; Shakespeare J., 2005, SCREENING PERINATAL, P21; *UK NAT SCREEN COM, 2009, CRIT APR VIAB EFF AP	28	88	88	0	22	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 22	2009	339								b5203	10.1136/bmj.b5203	http://dx.doi.org/10.1136/bmj.b5203			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	536ZJ	20028779	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000273082200006
J	Wu, B; Parquette, JR; RajanBabu, TV				Wu, Bin; Parquette, Jon R.; RajanBabu, T. V.			Regiodivergent Ring Opening of Chiral Aziridines	SCIENCE			English	Article							ASYMMETRIC CATALYSIS; KINETIC RESOLUTION; REAGENT		[Wu, Bin; Parquette, Jon R.; RajanBabu, T. V.] Ohio State Univ, Dept Chem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Parquette, JR (corresponding author), Ohio State Univ, Dept Chem, 100 W 18th Ave, Columbus, OH 43210 USA.	parquett@chemistry.ohio-state.edu; rajanbabu.1@osu.edu	RajanBabu, T/W-4932-2019		NSF [CHE-0526864, CHE-0610349]	NSF(National Science Foundation (NSF))	This work was supported by NSF programs CHE-0526864 ( Collaborative Research in Chemistry) and CHE-0610349.	Hwang S, 2008, BIOTECHNOL BIOPROC E, V13, P453, DOI 10.1007/s12257-008-0153-x; Jacobsen EN, 2000, ACCOUNTS CHEM RES, V33, P421, DOI 10.1021/ar960061v; Kagan HB, 2001, TETRAHEDRON, V57, P2449, DOI 10.1016/S0040-4020(01)00065-5; Tokunaga M, 1997, SCIENCE, V277, P936, DOI 10.1126/science.277.5328.936; Vedejs E, 2005, ANGEW CHEM INT EDIT, V44, P3974, DOI 10.1002/anie.200460842; Webster R, 2009, J AM CHEM SOC, V131, P444, DOI 10.1021/ja807942m; Wu B, 2009, ANGEW CHEM INT EDIT, V48, P1126, DOI 10.1002/anie.200804415	7	104	104	1	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1662	1662		10.1126/science.1180739	http://dx.doi.org/10.1126/science.1180739			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	533QJ	20019280				2022-12-28	WOS:000272839000044
J	Barwick, B; Flannigan, DJ; Zewail, AH				Barwick, Brett; Flannigan, David J.; Zewail, Ahmed H.			Photon-induced near-field electron microscopy	NATURE			English	Article							DIFFRACTION	In materials science and biology, optical near-field microscopies enable spatial resolutions beyond the diffraction limit(1,2), but they cannot provide the atomic-scale imaging capabilities of electron microscopy(3). Given the nature of interactions(4-8) between electrons and photons, and considering their connections(9,10) through nanostructures, it should be possible to achieve imaging of evanescent electromagnetic fields with electron pulses when such fields are resolved in both space (nanometre and below) and time (femtosecond) (11-13). Here we report the development of photon-induced near-field electron microscopy (PINEM), and the associated phenomena. We show that the precise spatiotemporal overlap of femtosecond single-electron packets with intense optical pulses at a nanostructure (individual carbon nanotube or silver nanowire in this instance) results in the direct absorption of integer multiples of photon quanta (nh omega) by the relativistic electrons accelerated to 200 keV. By energy-filtering only those electrons resulting from this absorption, it is possible to image directly in space the near-field electric field distribution, obtain the temporal behaviour of the field on the femtosecond timescale, and map its spatial polarization dependence. We believe that the observation of the photon-induced near-field effect in ultrafast electron microscopy demonstrates the potential for many applications, including those of direct space-time imaging of localized fields at interfaces and visualization of phenomena related to photonics, plasmonics and nanostructures.	[Barwick, Brett; Flannigan, David J.; Zewail, Ahmed H.] CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA	California Institute of Technology	Zewail, AH (corresponding author), CALTECH, Arthur Amos Noyes Lab Chem Phys, Phys Biol Ctr Ultrafast Sci & Technol, Pasadena, CA 91125 USA.	zewail@caltech.edu	Flannigan, David/E-4449-2014	Flannigan, David/0000-0002-1829-1868; gaber, sarah/0000-0002-5995-7291	National Science Foundation; Air Force Office of Scientific Research in the Gordon; Betty Moore Center for Physical Biology at the California Institute of Technology	National Science Foundation(National Science Foundation (NSF)); Air Force Office of Scientific Research in the Gordon(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Betty Moore Center for Physical Biology at the California Institute of Technology	This work was supported by the National Science Foundation and the Air Force Office of Scientific Research in the Gordon and Betty Moore Center for Physical Biology at the California Institute of Technology. We thank S. Skrabalak for synthesizing and providing the silver nanowires.	AGOSTINI P, 1979, PHYS REV LETT, V42, P1127, DOI 10.1103/PhysRevLett.42.1127; Barwick B, 2008, SCIENCE, V322, P1227, DOI 10.1126/science.1164000; Baum P, 2008, CHEM PHYS LETT, V462, P14, DOI 10.1016/j.cplett.2008.07.072; Baum P, 2007, P NATL ACAD SCI USA, V104, P18409, DOI 10.1073/pnas.0709019104; BETZIG E, 1992, SCIENCE, V257, P189, DOI 10.1126/science.257.5067.189; BOERSCH H, 1966, PHYS REV LETT, V17, P379, DOI 10.1103/PhysRevLett.17.379; BUCKSBAUM PH, 1988, PHYS REV LETT, V61, P1182, DOI 10.1103/PhysRevLett.61.1182; Burda C, 2005, CHEM REV, V105, P1025, DOI 10.1021/cr030063a; Carbone F, 2009, SCIENCE, V325, P181, DOI 10.1126/science.1175005; de Abajo FJG, 2008, NEW J PHYS, V10, DOI 10.1088/1367-2630/10/7/073035; DRAVID VP, 1993, SCIENCE, V259, P1601, DOI 10.1126/science.259.5101.1601; Freimund DL, 2001, NATURE, V413, P142, DOI 10.1038/35093065; HAMADA N, 1992, PHYS REV LETT, V68, P1579, DOI 10.1103/PhysRevLett.68.1579; Howie A, 1999, INST PHYS CONF SER, P311; HUMPHREYS CJ, 2002, UNDERSTANDING MAT; Ishikawa R, 2001, J APPL PHYS, V89, P4065, DOI 10.1063/1.1345851; Kapitza PL, 1933, P CAMB PHILOS SOC, V29, P297, DOI 10.1017/S0305004100011105; Kawata S, 2009, NAT PHOTONICS, V3, P388, DOI 10.1038/NPHOTON.2009.111; Kim S, 2008, NATURE, V453, P757, DOI 10.1038/nature07012; Korte KE, 2008, J MATER CHEM, V18, P437, DOI 10.1039/b714072j; Krausz F, 2009, REV MOD PHYS, V81, P163, DOI 10.1103/RevModPhys.81.163; Maier SA, 2005, J APPL PHYS, V98, DOI 10.1063/1.1951057; MIDGLEY PA, 1995, ULTRAMICROSCOPY, V59, P1, DOI 10.1016/0304-3991(95)00014-R; MULLER HG, 1986, J PHYS B-AT MOL OPT, V19, pL733, DOI 10.1088/0022-3700/19/21/003; Novotny L, 1997, PHYS REV LETT, V79, P645, DOI 10.1103/PhysRevLett.79.645; Park HS, 2007, NANO LETT, V7, P2545, DOI 10.1021/nl071369q; Saathoff G, 2008, PHYS REV A, V77, DOI 10.1103/PhysRevA.77.022903; Spence J.C.H., 2003, HIGH RESOLUTION ELEC, V3rd; Veisz L, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/12/451; Zewail A H, 2009, 4D ELECT MICROSCOPY	30	391	399	10	208	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 17	2009	462	7275					902	906		10.1038/nature08662	http://dx.doi.org/10.1038/nature08662			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016598	Green Accepted			2022-12-28	WOS:000272795400039
J	Giardini, D				Giardini, Domenico			Geothermal quake risks must be faced	NATURE			English	Editorial Material									ETH, Swiss Seismol Serv, CH-8092 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich	Giardini, D (corresponding author), ETH, Swiss Seismol Serv, Sonneggstr 5, CH-8092 Zurich, Switzerland.	giardini@sed.ethz.ch	Giardini, Domenico/F-5406-2011						0	168	173	4	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 17	2009	462	7275					848	849		10.1038/462848a	http://dx.doi.org/10.1038/462848a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533AX	20016577				2022-12-28	WOS:000272795400020
J	Sambunjak, D; Marusic, A				Sambunjak, Dario; Marusic, Ana			Mentoring What's in a Name?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ACADEMIC MEDICINE; WORK		[Marusic, Ana] Univ Split, Sch Med, Dept Res Methodol, Split 21000, Croatia; [Sambunjak, Dario] Univ Zagreb, Sch Med, Zagreb 41001, Croatia; [Sambunjak, Dario] Univ Split, Sch Med, Croatian Ctr Global Hlth, Split 21000, Croatia	University of Split; University of Zagreb; University of Split	Marusic, A (corresponding author), Univ Split, Sch Med, Dept Res Methodol, Soltanska 2, Split 21000, Croatia.	ana.marusic@mefst.hr	Marusic, Ana/E-7683-2013	Marusic, Ana/0000-0001-6272-0917; Sambunjak, Dario/0000-0002-9016-2198				Bray L, 2007, NURS EDUC TODAY, V27, P848, DOI 10.1016/j.nedt.2006.11.006; Detsky AS, 2007, JAMA-J AM MED ASSOC, V297, P2134, DOI 10.1001/jama.297.19.2134; Dougherty T.W., 2007, HDB MENTORING WORK T; Freeman R, 1997, BRIT J GEN PRACT, V47, P457; Higgins MC, 2001, ACAD MANAGE REV, V26, P264, DOI 10.5465/AMR.2001.4378023; Jackson VA, 2003, ACAD MED, V78, P328, DOI 10.1097/00001888-200303000-00020; Ragins BR, 2000, ACAD MANAGE J, V43, P1177, DOI 10.2307/1556344; Roberts A., 1999, HIST ED SOC B, V64, P313; Sambunjak D, 2006, JAMA-J AM MED ASSOC, V296, P1103, DOI 10.1001/jama.296.9.1103; Wanberg CR, 2003, RES PERS H, V22, P39	10	41	41	1	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	2009	302	23					2591	2592		10.1001/jama.2009.1858	http://dx.doi.org/10.1001/jama.2009.1858			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532HK	20009061				2022-12-28	WOS:000272737200029
J	Specchia, V; Piacentini, L; Tritto, P; Fanti, L; D'Alessandro, R; Palumbo, G; Pimpinelli, S; Bozzetti, MP				Specchia, Valeria; Piacentini, Lucia; Tritto, Patrizia; Fanti, Laura; D'Alessandro, Rosalba; Palumbo, Gioacchino; Pimpinelli, Sergio; Bozzetti, Maria P.			Hsp90 prevents phenotypic variation by suppressing the mutagenic activity of transposons	NATURE			English	Article							DROSOPHILA-MELANOGASTER; GENETIC-ANALYSIS; Y-CHROMOSOME; STELLATE; SPERMATOGENESIS; EVOLUTION; PROTEIN; HSP83; ORGANIZATION; CAPACITOR	The canalization concept(1) describes the resistance of a developmental process to phenotypic variation, regardless of genetic and environmental perturbations, owing to the existence of buffering mechanisms. Severe perturbations, which overcome such buffering mechanisms, produce altered phenotypes that can be heritable and can themselves be canalized by a genetic assimilation process. An important implication of this concept is that the buffering mechanism could be genetically controlled. Recent studies on Hsp90, a protein involved in several cellular processes and development pathways(2-5), indicate that it is a possible molecular mechanism for canalization and genetic assimilation. In both flies and plants, mutations in the Hsp90-encoding gene induce a wide range of phenotypic abnormalities, which have been interpreted as an increased sensitivity of different developmental pathways to hidden genetic variability(6,7.) Thus, Hsp90 chaperone machinery may be an evolutionarily conserved buffering mechanism of phenotypic variance, which provides the genetic material for natural selection. Here we offer an additional, perhaps alternative, explanation for proposals of a concrete mechanism underlying canalization. We show that, in Drosophila, functional alterations of Hsp90 affect the Piwi-interacting RNA (piRNA; a class of germ-line-specific small RNAs) silencing mechanism leading to transposon activation and the induction of morphological mutants. This indicates that Hsp90 mutations can generate new variation by transposon-mediated 'canonical' mutagenesis.	[Specchia, Valeria; Bozzetti, Maria P.] Univ Salento, DiSTeBA, I-73100 Lecce, Italy; [Piacentini, Lucia; Fanti, Laura; Pimpinelli, Sergio] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Piacentini, Lucia; Fanti, Laura; Pimpinelli, Sergio] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; [Tritto, Patrizia; D'Alessandro, Rosalba; Palumbo, Gioacchino] Univ Bari, DIGEMI, I-70126 Bari, Italy	University of Salento; Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Universita degli Studi di Bari Aldo Moro	Bozzetti, MP (corresponding author), Univ Salento, DiSTeBA, I-73100 Lecce, Italy.	maria.bozzetti@unisalento.it	D'Alessandro, Rosalba/J-2351-2018; Piacentini, Lucia/A-5391-2016; Bozzetti, Maria/C-4694-2013; Specchia, Valeria/AAS-8179-2020	Piacentini, Lucia/0000-0002-3656-5068; Specchia, Valeria/0000-0002-1051-6014; FANTI, Laura/0000-0003-4380-997X	Ministero dell'Universita e della Ricerca (MIUR)	Ministero dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by a grant from the Ministero dell'Universita e della Ricerca (MIUR) project: RNAi, heterochromatin and epigenetic control of gene expression and chromosome behaviour. V. S. was supported by a grant provided by MIUR for the same project.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; BOZZETTI MP, 1995, P NATL ACAD SCI USA, V92, P6067, DOI 10.1073/pnas.92.13.6067; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; CAIZZI R, 1993, GENETICS, V133, P335; CASTRILLON DH, 1993, GENETICS, V135, P489; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; DING D, 1993, MOL CELL BIOL, V13, P3773, DOI 10.1128/MCB.13.6.3773; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gvozdev VA, 2000, GENETICA, V109, P131, DOI 10.1023/A:1026596419250; HARDY RW, 1984, GENETICS, V107, P591; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; LIVAK KJ, 1990, GENETICS, V124, P303; LIVAK KJ, 1984, GENETICS, V107, P611; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; PALUMBO G, 1994, GENETICA, V94, P267, DOI 10.1007/BF01443440; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sambrook J., 2002, MOL CLONING LAB MANU; Schmidt A, 1999, GENETICS, V151, P749; Soriano S, 2002, J MOL EVOL, V55, P606, DOI 10.1007/s00239-002-2356-7; Stapleton W, 2001, CHROMOSOMA, V110, P228, DOI 10.1007/s004120100136; Tritto P, 2003, GENETICA, V117, P247, DOI 10.1023/A:1022960632306; vanderStraten A, 1997, EMBO J, V16, P1961, DOI 10.1093/emboj/16.8.1961; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Yue L, 1999, GENETICS, V151, P1065	30	195	197	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					662	U92		10.1038/nature08739	http://dx.doi.org/10.1038/nature08739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20062045				2022-12-28	WOS:000274193900036
J	Moro, K; Yamada, T; Tanabe, M; Takeuchi, T; Ikawa, T; Kawamoto, H; Furusawa, J; Ohtani, M; Fujii, H; Koyasu, S				Moro, Kazuyo; Yamada, Taketo; Tanabe, Masanobu; Takeuchi, Tsutomu; Ikawa, Tomokatsu; Kawamoto, Hiroshi; Furusawa, Jun-ichi; Ohtani, Masashi; Fujii, Hideki; Koyasu, Shigeo			Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells	NATURE			English	Article							NATURAL-KILLER-CELLS; ROR-GAMMA-T; INDUCER CELLS; MICE LACKING; IL-33; EXPRESSION; DIFFERENTIATION; LYMPHOCYTES; GENERATION; EXPULSION	Innate immune responses are important in combating various microbes during the early phases of infection. Natural killer (NK) cells are innate lymphocytes that, unlike T and B lymphocytes, do not express antigen receptors but rapidly exhibit cytotoxic activities against virus-infected cells and produce various cytokines(1,2). Here we report a new type of innate lymphocyte present in a novel lymphoid structure associated with adipose tissues in the peritoneal cavity. These cells do not express lineage (Lin) markers but do express c-Kit, Sca-1 (also known as Ly6a), IL7R and IL33R. Similar lymphoid clusters were found in both human and mouse mesentery and we term this tissue 'FALC' (fat-associated lymphoid cluster). FALC Lin(-)c-Kit(+)Sca-1(+) cells are distinct from lymphoid progenitors(3) and lymphoid tissue inducer cells(4). These cells proliferate in response to IL2 and produce large amounts of T(H)2 cytokines such as IL5, IL6 and IL13. IL5 and IL6 regulate B-cell antibody production and self-renewal of B1 cells(5-7). Indeed, FALC Lin(-)c-Kit(+)Sca-1(+) cells support the self-renewal of B1 cells and enhance IgA production. IL5 and IL13 mediate allergic inflammation and protection against helminth infection(8,9). After helminth infection and in response to IL33, FALC Lin(-)c-Kit(+)Sca-1(+) cells produce large amounts of IL13, which leads to goblet cell hyperplasia-a critical step for helminth expulsion. In mice devoid of FALC Lin(-)c-Kit(+)Sca-1(+) cells, such goblet cell hyperplasia was not induced. Thus, FALC Lin(-)c-Kit(+)Sca-1(+) cells are T(H)2-type innate lymphocytes, and we propose that these cells be called 'natural helper cells'.	[Moro, Kazuyo; Furusawa, Jun-ichi; Ohtani, Masashi; Fujii, Hideki; Koyasu, Shigeo] Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan; [Yamada, Taketo] Keio Univ, Sch Med, Dept Pathol, Shinjuku Ku, Tokyo 1608582, Japan; [Tanabe, Masanobu; Takeuchi, Tsutomu] Keio Univ, Sch Med, Dept Trop Med & Parasitol, Shinjuku Ku, Tokyo 1608582, Japan; [Moro, Kazuyo] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Ikawa, Tomokatsu; Kawamoto, Hiroshi] Riken Res Ctr Allergy & Immunol, Lab Lymphocyte Dev, Kanagawa 2300045, Japan; [Ohtani, Masashi] Kansai Med Univ, Inst Biomed Sci, Dept Cell Signalling, Osaka 5708506, Japan; [Koyasu, Shigeo] Japan Soc Promot Sci, Res Ctr Sci Syst, Chiyoda Ku, Tokyo 1028472, Japan	Keio University; Keio University; Keio University; Japan Science & Technology Agency (JST); RIKEN; Kansai Medical University; Japan Society for the Promotion of Science	Koyasu, S (corresponding author), Keio Univ, Sch Med, Dept Microbiol & Immunol, Shinjuku Ku, Tokyo 1608582, Japan.	koyasu@sc.itc.keio.ac.jp	Moro, Kazuyo/A-5987-2016; Koyasu, Shigeo/J-5583-2015	Koyasu, Shigeo/0000-0001-9585-3038; Moro, Kazuyo/0000-0002-7377-1303	Japan Society for the Promotion of Science [20790378, 14370116, 16390146, 18390155]; Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [22590437] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Y. Yokota and H. Kiyono for Id2<SUP>-/-</SUP> mice, D. Littman and S. Fagarasan for Rorc GFP/GFP mice, T. W. Mak for Il2/15rb<SUP>-/-</SUP> mice, K. Ikuta for Il7<SUP>-/-</SUP> mice, and K. Ishiwata for N. brasiliensis. Thanks are also owed to L. K. Clayton for critical reading of the manuscript and valuable suggestions, M. Fujiwara for help with microarray analysis, Y. Baba and A. Minowa for help with some experiments, and K. Takei and K. Hidaka for animal care. This work was supported by a Keio University Grant-in-Aid for Encouragement of Young Medical Scientists (to K. M.), a Grant-in Aid for Young Scientist (B) (20790378 to K. M.), Grants-in-Aid for Scientific Research (B) (14370116, 16390146, 18390155 to S. K.) from the Japan Society for the Promotion of Science, and a Scientific Frontier Research Grant from the Ministry of Education, Culture, Sports, Science and Technology, Japan. K. M. is a postdoctoral fellow of the Global COE program supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Andoniou CE, 2006, IMMUNOL REV, V214, P239, DOI 10.1111/j.1600-065X.2006.00465.x; Arend WP, 2008, IMMUNOL REV, V223, P20, DOI 10.1111/j.1600-065X.2008.00624.x; BEAGLEY KW, 1989, J EXP MED, V169, P2133, DOI 10.1084/jem.169.6.2133; CAO XQ, 1995, IMMUNITY, V2, P223, DOI 10.1016/1074-7613(95)90047-0; Eberl G, 2004, NAT IMMUNOL, V5, P64, DOI 10.1038/ni1022; Erickson LD, 2001, J IMMUNOL, V166, P1531, DOI 10.4049/jimmunol.166.3.1531; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Haraldsen G, 2009, TRENDS IMMUNOL, V30, P227, DOI 10.1016/j.it.2009.03.003; HAYASHI C, 1985, DEV BIOL, V109, P234, DOI 10.1016/0012-1606(85)90363-X; Humphreys NE, 2008, J IMMUNOL, V180, P2443, DOI 10.4049/jimmunol.180.4.2443; Ishiwata K, 2007, EXP PARASITOL, V117, P80, DOI 10.1016/j.exppara.2007.03.019; Kawamoto H, 2009, TRENDS IMMUNOL, V30, P193, DOI 10.1016/j.it.2009.03.001; Kennedy MK, 2000, J EXP MED, V191, P771, DOI 10.1084/jem.191.5.771; Knight PA, 2008, PARASITOLOGY, V135, P655, DOI 10.1017/S0031182008004319; Kroeger KM, 2009, J LEUKOCYTE BIOL, V86, P769, DOI 10.1189/jlb.0708452; Lodoen MB, 2006, CURR OPIN IMMUNOL, V18, P391, DOI 10.1016/j.coi.2006.05.002; Maki K, 1996, P NATL ACAD SCI USA, V93, P7172, DOI 10.1073/pnas.93.14.7172; MIYAWAKI S, 1994, EUR J IMMUNOL, V24, P429, DOI 10.1002/eji.1830240224; Nishikawa SI, 2003, IMMUNOL REV, V195, P72, DOI 10.1034/j.1600-065X.2003.00063.x; NOCKA K, 1990, EMBO J, V9, P1805, DOI 10.1002/j.1460-2075.1990.tb08305.x; Rangel-Moreno J, 2009, IMMUNITY, V30, P731, DOI 10.1016/j.immuni.2009.03.014; Sanos SL, 2009, NAT IMMUNOL, V10, P83, DOI 10.1038/ni.1684; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; SONODA E, 1989, J EXP MED, V170, P1415, DOI 10.1084/jem.170.4.1415; Suzuki H, 1997, J EXP MED, V185, P499, DOI 10.1084/jem.185.3.499; Tsuji M, 2008, IMMUNITY, V29, P261, DOI 10.1016/j.immuni.2008.05.014; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wang YH, 2007, J EXP MED, V204, P1837, DOI 10.1084/jem.20070406; WATANABE Y, 1992, CELL IMMUNOL, V142, P385, DOI 10.1016/0008-8749(92)90299-5; Wood IS, 2009, BIOCHEM BIOPH RES CO, V384, P105, DOI 10.1016/j.bbrc.2009.04.081; Yokota Y, 1999, NATURE, V397, P702, DOI 10.1038/17812; Yoshida H, 2001, J IMMUNOL, V167, P2511, DOI 10.4049/jimmunol.167.5.2511	33	1406	1459	1	98	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					540	U160		10.1038/nature08636	http://dx.doi.org/10.1038/nature08636			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20023630				2022-12-28	WOS:000273981100051
J	Pearce, SHS; Cheetham, TD				Pearce, Simon H. S.; Cheetham, Tim D.			Diagnosis and management of vitamin D deficiency	BRITISH MEDICAL JOURNAL			English	Review							25-HYDROXYVITAMIN-D LEVELS; SERUM 25-HYDROXYVITAMIN-D; D SUPPLEMENTATION; ALL-CAUSE; METAANALYSIS; MORTALITY; RICKETS; RISK; HEALTH; POPULATION		[Pearce, Simon H. S.; Cheetham, Tim D.] Univ Newcastle, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Pearce, Simon H. S.] Royal Victoria Infirm, Endocrine Unit, Newcastle Upon Tyne NE1 4LP, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Pearce, SHS (corresponding author), Univ Newcastle, Int Ctr Life, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England.	s.h.s.pearce@ncl.ac.uk	Pearce, Simon/AAB-3692-2019	Pearce, Simon/0000-0001-8384-8063				Autier P, 2007, ARCH INTERN MED, V167, P1730, DOI 10.1001/archinte.167.16.1730; Beck-Nielsen SS, 2009, EUR J PEDIATR, V168, P941, DOI 10.1007/s00431-008-0864-1; Bischoff-Ferrari HA, 2006, AM J CLIN NUTR, V84, P18, DOI 10.1093/ajcn/84.1.18; Chen P, 2009, BREAST CANC RES TREA; Department of Health, 2007, BIRTH 5; Department of Health, 1998, NUTR BON HLTH REP SU; Diamond TH, 2005, MED J AUSTRALIA, V182, P281, DOI 10.5694/j.1326-5377.2005.tb06701.x; Dobnig H, 2008, ARCH INTERN MED, V168, P1340, DOI 10.1001/archinte.168.12.1340; Ford L, 2006, ANN CLIN BIOCHEM, V43, P468, DOI 10.1258/000456306778904614; GINDE AA, 2009, ARCH INTERN MED, V626, P32; Ginde AA, 2009, J AM GERIATR SOC, V57, P1595, DOI 10.1111/j.1532-5415.2009.02359.x; Heaney RP, 2003, AM J CLIN NUTR, V77, P204, DOI 10.1093/ajcn/77.1.204; Hochberg Z, 2002, HORM RES, V58, P39, DOI 10.1159/000063214; Holick MF, 2008, NUTR REV, V66, pS182, DOI 10.1111/j.1753-4887.2008.00104.x; Hypponen E, 2007, AM J CLIN NUTR, V85, P860, DOI 10.1093/ajcn/85.3.860; Kimball S, 2008, ANN CLIN BIOCHEM, V45, P106, DOI 10.1258/acb.2007.007074; Lucas RM, 2008, INT J EPIDEMIOL, V37, P654, DOI 10.1093/ije/dyn017; Melamed ML, 2008, ARCH INTERN MED, V168, P1629, DOI 10.1001/archinte.168.15.1629; Misra M, 2008, PEDIATRICS, V122, P398, DOI 10.1542/peds.2007-1894; Munger KL, 2006, JAMA-J AM MED ASSOC, V296, P2832, DOI 10.1001/jama.296.23.2832; Pal BR, 2001, J PEDIATR-US, V139, P337, DOI 10.1067/mpd.2001.114877; Pittas AG, 2007, J CLIN ENDOCR METAB, V92, P2017, DOI 10.1210/jc.2007-0298; Robinson PD, 2006, ARCH DIS CHILD, V91, P564, DOI 10.1136/adc.2004.069575; Sievenpiper JL, 2008, BMJ-BRIT MED J, V336, P1371, DOI 10.1136/bmj.39555.820394.BE; Vieth R, 2007, AM J CLIN NUTR, V85, P649, DOI 10.1093/ajcn/85.3.649; Wagner CL, 2008, PEDIATRICS, V122, P1142, DOI 10.1542/peds.2008-1862; Wharton B, 2003, LANCET, V362, P1389, DOI 10.1016/S0140-6736(03)14636-3; Yin L, 2009, ALIMENT PHARM THER, V30, P113, DOI 10.1111/j.1365-2036.2009.04022.x; Zipitis CS, 2008, ARCH DIS CHILD, V93, P512, DOI 10.1136/adc.2007.128579; 2006, DTB, V44, P25	30	323	334	4	48	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 11	2010	340								b5664	10.1136/bmj.b5664	http://dx.doi.org/10.1136/bmj.b5664			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545CY	20064851				2022-12-28	WOS:000273711300001
J	Watts, G				Watts, Geoff			Xenotransplantation Bit of an animal	BRITISH MEDICAL JOURNAL			English	Editorial Material												geoff@scileg.freeserve.co.uk						*INT XEN ASS, WHAT IS XEN; *INT XEN ASS, INV XEN PRACT; Nuffield Council on Bioethics, 1996, AN TO HUM TRANSPL ET; PATIENCE C, 1997, NAT MED, V3, P2826; *WHO, 2004, 27 WORLD HLTH ASS AG	5	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 7	2010	340								b5595	10.1136/bmj.b5595	http://dx.doi.org/10.1136/bmj.b5595			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542IG	20056696				2022-12-28	WOS:000273485700002
J	Crossley, S; Faria, J; Shen, M; Resasco, DE				Crossley, Steven; Faria, Jimmy; Shen, Min; Resasco, Daniel E.			Solid Nanoparticles that Catalyze Biofuel Upgrade Reactions at the Water/Oil Interface	SCIENCE			English	Article							STABILIZED EMULSIONS; LIQUID ALKANES; BIO-OIL; BIOMASS; ADSORPTION; PARTICLES; PYROLYSIS	A recoverable catalyst that simultaneously stabilizes emulsions would be highly advantageous in streamlining processes such as biomass refining, in which the immiscibility and thermal instability of crude products greatly complicates purification procedures. Here, we report a family of solid catalysts that can stabilize water-oil emulsions and catalyze reactions at the liquid/liquid interface. By depositing palladium onto carbon nanotube-inorganic oxide hybrid nanoparticles, we demonstrate biphasic hydrodeoxygenation and condensation catalysis in three substrate classes of interest in biomass refining. Microscopic characterization of the emulsions supports localization of the hybrid particles at the interface.	[Crossley, Steven; Faria, Jimmy; Shen, Min; Resasco, Daniel E.] Univ Oklahoma, Sch Chem Biol & Mat Engn, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Resasco, DE (corresponding author), Univ Oklahoma, Sch Chem Biol & Mat Engn, Norman, OK 73019 USA.	resasco@ou.edu	Faria, J./J-3428-2017; Shen, Min/A-1394-2010; Resasco, Daniel E/AAS-6213-2021	Faria, J./0000-0002-8920-3538; Resasco, Daniel/0000-0001-5342-0621; Crossley, Steven/0000-0002-1017-9839	EPSCoR [0814361] Funding Source: National Science Foundation	EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))		Binks BP, 2005, LANGMUIR, V21, P3296, DOI 10.1021/la046915z; Binks BP, 2004, LANGMUIR, V20, P1130, DOI 10.1021/la0303557; Binks BP, 2000, LANGMUIR, V16, P8622, DOI 10.1021/la000189s; Binks BP, 2002, CURR OPIN COLLOID IN, V7, P21, DOI 10.1016/S1359-0294(02)00008-0; BRUCKNER R, 2002, ADV ORGANIC CHEM REA, P283; BRUNELLE JP, 1978, PURE APPL CHEM, V50, P1211, DOI 10.1351/pac197850091211; CHEN NY, 1979, J AM CHEM SOC, V101, P6783, DOI 10.1021/ja00516a065; Dai LL, 2005, LANGMUIR, V21, P2641, DOI 10.1021/la047256t; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; Elliott DC, 2007, ENERG FUEL, V21, P1792, DOI 10.1021/ef070044u; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; Huber GW, 2005, SCIENCE, V308, P1446, DOI 10.1126/science.1111166; Huber GW, 2006, CATAL TODAY, V111, P119, DOI 10.1016/j.cattod.2005.10.010; Iglesia E, 1997, APPL CATAL A-GEN, V161, P59, DOI 10.1016/S0926-860X(97)00186-5; Lambert S, 2009, J CATAL, V261, P23, DOI 10.1016/j.jcat.2008.10.014; Mohan D, 2006, ENERG FUEL, V20, P848, DOI 10.1021/ef0502397; Regalbuto JR, 1999, J CATAL, V184, P335, DOI 10.1006/jcat.1999.2471; Resasco DE, 2002, J NANOPART RES, V4, P131, DOI 10.1023/A:1020174126542; SAIZJIMENEZ C, 1986, ORG GEOCHEM, V10, P869, DOI 10.1016/S0146-6380(86)80024-9; Shen M, 2009, LANGMUIR, V25, P10843, DOI 10.1021/la901380b; Simonetti DA, 2008, CHEMSUSCHEM, V1, P725, DOI 10.1002/cssc.200800105; STARKS CM, 1971, J AM CHEM SOC, V93, P195, DOI 10.1021/ja00730a033; Wang RK, 2008, J AM CHEM SOC, V130, P14721, DOI 10.1021/ja804982b; West RM, 2008, CHEMSUSCHEM, V1, P417, DOI 10.1002/cssc.200800001; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Zhao C, 2009, ANGEW CHEM INT EDIT, V48, P3987, DOI 10.1002/anie.200900404	26	626	643	29	940	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					68	72		10.1126/science.1180769	http://dx.doi.org/10.1126/science.1180769			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044571				2022-12-28	WOS:000273395400031
J	Toussaint, S; Gerlach, H				Toussaint, Susanne; Gerlach, Herwig			Activated Protein C for Sepsis	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INTENSIVE-CARE UNITS; SEPTIC SHOCK; COST-EFFECTIVENESS; SURVIVING SEPSIS; ANTITHROMBIN-III; CLINICAL-TRIALS; ORGAN FAILURE; COAGULATION; INFLAMMATION; GUIDELINES	A 55-year-old man is brought to the emergency department with abdominal pain, fever (temperature, 102.9 degrees F), and dyspnea. His medical history includes an appendectomy 8 years earlier. Abdominal radiography shows free air as well as signs of small-bowel ileus. An emergency laparotomy is performed. Intraoperatively, a lower-small-bowel perforation is identified, with evidence of peritonitis. Partial ileal resection with end-to-end anastomosis is performed. Treatment with broad-spectrum antibiotics is initiated; blood cultures grow typical Enterobacteriaceae ( Escherichia coli and Proteus mirabilis) and Enterococcus faecium. Septic shock with hypotension requiring vasopressor support, hypoxemia requiring mechanical ventilation, and renal dysfunction develop, with an elevated serum lactate level. The patient's Acute Physiology and Chronic Health Evaluation (APACHE) II score ( see the Supplementary Appendix, available with the full text of this article at NEJM.org) is 27. Results of clotting studies are normal, and no clinical bleeding is detected. The surgeon and the intensivist decide that treatment with activated protein C is indicated.	[Gerlach, Herwig] Vivantes Klinikum Neukolln, Klin Anaesthesie Operat Intens Med & Schmerzthera, Dept Anesthesia Crit Care Med & Pain Management, D-12313 Berlin, Germany	VIivantes Klinikum Neukolln	Gerlach, H (corresponding author), Vivantes Klinikum Neukolln, Klin Anaesthesie Operat Intens Med & Schmerzthera, Dept Anesthesia Crit Care Med & Pain Management, Rudowerstr 48, D-12313 Berlin, Germany.	herwig.gerlach@vivantes.de						Abraham E, 2003, JAMA-J AM MED ASSOC, V290, P238, DOI 10.1001/jama.290.2.238; Abraham E, 2005, NEW ENGL J MED, V353, P1332, DOI 10.1056/NEJMoa050935; Adib-Conquy M, 2007, FEBS LETT, V581, P3723, DOI 10.1016/j.febslet.2007.03.074; Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2003, CRIT CARE MED, V31, P1, DOI 10.1097/00003246-200301000-00001; Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; Beale R, 2009, INFECTION, V37, P222, DOI 10.1007/s15010-008-8203-z; Bernard GR, 2001, CRIT CARE MED, V29, P2051, DOI 10.1097/00003246-200111000-00003; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bertolini G, 2007, INTENS CARE MED, V33, P426, DOI 10.1007/s00134-007-0554-x; Boldt J, 2000, CRIT CARE MED, V28, P445, DOI 10.1097/00003246-200002000-00026; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; BRUNBUISSON C, 1995, JAMA-J AM MED ASSOC, V274, P968, DOI 10.1001/jama.274.12.968; Carlet J, 2006, CRIT CARE MED, V34, P525, DOI 10.1097/01.CCM.0000198329.85851.8E; Choi G, 2007, CRIT CARE MED, V35, P1362, DOI 10.1097/01.CCM.0000261888.32654.6D; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; Cinel I, 2007, CURR OPIN INFECT DIS, V20, P345, DOI 10.1097/QCO.0b013e32818be70a; Davies A, 2005, ANAESTHESIA, V60, P155, DOI 10.1111/j.1365-2044.2004.04068.x; Dellinger RP, 2008, INTENS CARE MED, V34, P17, DOI 10.1007/s00134-007-0934-2; Dellinger RP, 2004, INTENS CARE MED, V30, P536, DOI 10.1007/s00134-004-2210-z; Dellinger RP, 2003, CLIN INFECT DIS, V36, P1259, DOI 10.1086/374835; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Eichacker PQ, 2006, NEW ENGL J MED, V355, P1640, DOI 10.1056/NEJMp068197; Ely EW, 2003, CRIT CARE MED, V31, P12, DOI 10.1097/00003246-200301000-00002; Engel C, 2007, INTENS CARE MED, V33, P606, DOI 10.1007/s00134-006-0517-7; Finfer S, 2004, INTENS CARE MED, V30, P589, DOI 10.1007/s00134-004-2157-0; Finfer S, 2008, INTENS CARE MED, V34, P1935, DOI 10.1007/s00134-008-1266-6; FOURRIER F, 1992, CHEST, V101, P816, DOI 10.1378/chest.101.3.816; Fumagalli R, 2007, CRIT CARE, V11, DOI 10.1186/cc6157; GERLACH H, 1989, J EXP MED, V170, P913, DOI 10.1084/jem.170.3.913; GERLACH H, 1990, ANNU REV MED, V41, P15; Griffin JH, 2007, J THROMB HAEMOST, V5, P73, DOI 10.1111/j.1538-7836.2007.02491.x; HEKMAN CM, 1987, SEMIN THROMB HEMOST, V13, P514, DOI 10.1055/s-2007-1003527; Kanji S, 2007, INTENS CARE MED, V33, P517, DOI 10.1007/s00134-007-0555-9; Karlsson S, 2009, CRIT CARE MED, V37, P1268, DOI 10.1097/CCM.0b013e31819c13ac; Kerschen EJ, 2007, J EXP MED, V204, P2439, DOI 10.1084/jem.20070404; Laterre PF, 2003, CRIT CARE, V7, P445, DOI 10.1186/cc2342; Laterre PF, 2007, CRIT CARE, V11, DOI 10.1186/cc6156; Levi M, 2003, J THROMB THROMBOLYS, V16, P43, DOI 10.1023/B:THRO.0000014592.27892.11; Levi M, 2007, CRIT CARE, V11, DOI 10.1186/cc6154; LORENTE JA, 1993, CHEST, V103, P1536, DOI 10.1378/chest.103.5.1536; Mackenzie AF, 2005, INTENS CARE MED, V31, P1624, DOI 10.1007/s00134-005-2829-4; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Moerer O, 2007, CRIT CARE, V11, DOI 10.1186/cc5952; Nadel S, 2007, LANCET, V369, P836, DOI 10.1016/S0140-6736(07)60411-5; NAWROTH PP, 1986, P NATL ACAD SCI USA, V83, P3460, DOI 10.1073/pnas.83.10.3460; Neilson AR, 2003, J CRIT CARE, V18, P217, DOI 10.1016/j.jcrc.2003.10.005; Padkin A, 2003, CRIT CARE MED, V31, P2332, DOI 10.1097/01.CCM.0000085141.75513.2B; Poole D, 2009, LANCET INFECT DIS, V9, P67, DOI 10.1016/S1473-3099(08)70306-2; POWARS D, 1993, CLIN INFECT DIS, V17, P254, DOI 10.1093/clinids/17.2.254; Reinhart K, 2006, Anaesthesist, V55 Suppl 1, P43; Rittirsch D, 2008, NAT REV IMMUNOL, V8, P776, DOI 10.1038/nri2402; Russell JA, 2006, NEW ENGL J MED, V355, P2267; Schouten M, 2008, J LEUKOCYTE BIOL, V83, P536, DOI 10.1189/jlb.0607373; Siegel JP, 2002, NEW ENGL J MED, V347, P1030, DOI 10.1056/NEJMsb021512; Sprung CL, 2008, NEW ENGL J MED, V358, P111, DOI 10.1056/NEJMoa071366; van Veen SQ, 2006, CRIT CARE MED, V34, P2799, DOI 10.1097/01.CCM.0000243795.04284.2A; Vincent JL, 2006, CRIT CARE, V10, DOI 10.1186/cc4909; Vincent JL, 1998, CRIT CARE MED, V26, P1793, DOI 10.1097/00003246-199811000-00016; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Warren BL, 2001, JAMA-J AM MED ASSOC, V286, P1869, DOI 10.1001/jama.286.15.1869; Warren HS, 2002, NEW ENGL J MED, V347, P1027, DOI 10.1056/NEJMsb020574	63	48	55	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2646	2652		10.1056/NEJMct0808063	http://dx.doi.org/10.1056/NEJMct0808063			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042756				2022-12-28	WOS:000273181300012
J	Ule, A; Schram, A; Riedl, A; Cason, TN				Ule, Aljaz; Schram, Arthur; Riedl, Arno; Cason, Timothy N.			Indirect Punishment and Generosity Toward Strangers	SCIENCE			English	Article							INDIRECT RECIPROCITY; ALTRUISTIC PUNISHMENT; COOPERATION; EVOLUTION; HUMANS; REPUTATION; BENEFITS; NORMS	Many people incur costs to reward strangers who have been kind to others. Theoretical and experimental evidence suggests that such "indirect rewarding" sustains cooperation between unrelated humans. Its emergence is surprising, because rewarders incur costs but receive no immediate benefits. It can prevail in the long run only if rewarders earn higher payoffs than "defectors" who ignore strangers' kindness. We provide experimental evidence regarding the payoffs received by individuals who employ these and other strategies, such as "indirect punishment" by imposing costs on unkind strangers. We find that if unkind strangers cannot be punished, defection earns most. If they can be punished, however, then indirect rewarding earns most. Indirect punishment plays this important role, even if it gives a low payoff and is rarely implemented.	[Ule, Aljaz; Schram, Arthur] Univ Amsterdam, Ctr Res Expt Econ & Polit Decis Making CREED, NL-1018 WB Amsterdam, Netherlands; [Ule, Aljaz] Univ Primorska, Fac Math Nat Sci & Informat Technol, Koper 6000, Slovenia; [Riedl, Arno] Maastricht Univ, Dept Econ AE1, NL-6200 MD Maastricht, Netherlands; [Cason, Timothy N.] Purdue Univ, Krannert Sch Management, Dept Econ, W Lafayette, IN 47907 USA	University of Amsterdam; University of Primorska; Maastricht University; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ule, A (corresponding author), Univ Amsterdam, Ctr Res Expt Econ & Polit Decis Making CREED, Roetersstr 11, NL-1018 WB Amsterdam, Netherlands.	a.ule@uva.nl	Schram, Arthur/G-5045-2011; Riedl, Arno/D-1007-2012	Schram, Arthur/0000-0002-1767-4998	Dutch Science Foundation Netherlands Organization for Scientific Research [451-07-031, 051-12-012]	Dutch Science Foundation Netherlands Organization for Scientific Research	We thank the Dutch Science Foundation Netherlands Organization for Scientific Research (NWO grants Veni 451-07-031 and Evolution and Behavior 051-12-012) for financial support and M. Egas, E. Fehr, S. G chter, M. Milinski, M. Sabelis, J. Ule, and M. van Veelen for helpful comments.	Alexander R., 1987, BIOL MORAL SYSTEMS; Bowles S, 2004, THEOR POPUL BIOL, V65, P17, DOI 10.1016/j.tpb.2003.07.001; Carpenter JP, 2004, J ECON BEHAV ORGAN, V55, P533, DOI 10.1016/j.jebo.2003.11.007; Dreber A, 2008, NATURE, V452, P348, DOI 10.1038/nature06723; Egas M, 2008, P ROY SOC B-BIOL SCI, V275, P871, DOI 10.1098/rspb.2007.1558; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Fehr E, 2003, NATURE, V425, P785, DOI 10.1038/nature02043; Gachter S, 2008, SCIENCE, V322, P1510, DOI 10.1126/science.1164744; Hagen EH, 2006, THEOR POPUL BIOL, V69, P339, DOI 10.1016/j.tpb.2005.09.005; Herrmann B, 2008, SCIENCE, V319, P1362, DOI 10.1126/science.1153808; Kurzban R, 2005, P NATL ACAD SCI USA, V102, P1803, DOI 10.1073/pnas.0408759102; Leimar O, 2001, P ROY SOC B-BIOL SCI, V268, P745, DOI 10.1098/rspb.2000.1573; Masclet D, 2003, AM ECON REV, V93, P366, DOI 10.1257/000282803321455359; Milinski M, 2002, NATURE, V415, P424, DOI 10.1038/415424a; Milinski M, 2001, P ROY SOC B-BIOL SCI, V268, P2495, DOI 10.1098/rspb.2001.1809; Nowak MA, 2005, NATURE, V437, P1291, DOI 10.1038/nature04131; Nowak MA, 1998, NATURE, V393, P573, DOI 10.1038/31225; Nowak MA, 2006, SCIENCE, V314, P1560, DOI 10.1126/science.1133755; Ohtsuki H, 2009, NATURE, V457, P79, DOI 10.1038/nature07601; Panchanathan K, 2004, NATURE, V432, P499, DOI 10.1038/nature02978; Seinen I, 2006, EUR ECON REV, V50, P581, DOI 10.1016/j.euroecorev.2004.10.005; Semmann D, 2004, BEHAV ECOL SOCIOBIOL, V56, P248, DOI 10.1007/s00265-004-0782-9; Sugden R, 1986, EC RIGHTS COOPERATIO; Wallace B, 2007, P NATL ACAD SCI USA, V104, P15631, DOI 10.1073/pnas.0706642104; Wedekind C, 2000, SCIENCE, V288, P850, DOI 10.1126/science.288.5467.850; Wedekind C, 2002, CURR BIOL, V12, P1012, DOI 10.1016/S0960-9822(02)00890-4	27	92	95	0	29	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 18	2009	326	5960					1701	1704		10.1126/science.1178883	http://dx.doi.org/10.1126/science.1178883			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533QJ	20019287	Green Published, Green Submitted			2022-12-28	WOS:000272839000055
J	Charlier, P; Poupon, J; Huynh-Charlier, I; Saliege, JF; Favier, D; Keyser, C; Ludes, B				Charlier, Philippe; Poupon, Joel; Huynh-Charlier, Isabelle; Saliege, Jean-Francois; Favier, Dominique; Keyser, Christine; Ludes, Bertrand			Christmas: Diagnosis A gold elixir of youth in the 16th century French court	BRITISH MEDICAL JOURNAL			English	Editorial Material							CHRYSOTHERAPY		[Charlier, Philippe] Hop Raymond Poincare, Garches, France; [Poupon, Joel] Hop Lariboisiere, F-75475 Paris, France; [Huynh-Charlier, Isabelle] Salpetriere Hosp, Paris, France; [Saliege, Jean-Francois] Inst Geophys, Paris, France; [Favier, Dominique] IFF France Int Flavors & Fragrances, Asnieres, France; [Keyser, Christine; Ludes, Bertrand] Inst Legal Med, Strasbourg, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Raymond-Poincare - APHP; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Lariboisiere-Fernand-Widal - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; UDICE-French Research Universities; Universite Paris Cite	Charlier, P (corresponding author), Hop Raymond Poincare, Garches, France.	ph_charlier@yahoo.fr	LUDES, Bertrand/AAB-6309-2022					Basset C, 2003, LIVER INT, V23, P89, DOI 10.1034/j.1600-0676.2003.00806.x; BEGUIN J, 1645, ELEMENTS CHYMIE, P273; Benazzi S, 2009, INT J LEGAL MED, V123, P333, DOI 10.1007/s00414-009-0339-6; BRANTOME, 1868, VIES DAMES ILLUSTRES; BUFFON, 1829, OEUVRES COMPLETES, V3, P262; Charlier P, 2008, VIRCHOWS ARCH, V453, P377, DOI 10.1007/s00428-008-0670-1; CHARLIER P, 2008, OSTEO ARCHEOLOGIE TE, P215; Charlier Philippe, 2006, Med Secoli, V18, P777; Charlier Philippe, 2006, Hist Sci Med, V40, P255; CHEVARD V, 1801, HIST CHARTRES ANCIEN, P389; de la Tourette Alexandre, 1575, BREF DISCOURS ADMIRA; DURADIER D, 1776, MEMOIRES HIST ANECDO, V4, P468; FERGUSON JE, 1992, NOBLE METALS BIOL SY, P91; GLASER C, 1668, TRAITE CHYMIE, P87; GLAUBER JR, 1659, TEINTURE VERITABLE P; GOTTLIEB NL, 1972, ARTHRITIS RHEUM-US, V15, P16, DOI 10.1002/art.1780150103; GOTTLIEB NL, 1974, ARTHRITIS RHEUM, V17, P56, DOI 10.1002/art.1780170109; MESSORI L, 2004, METAL IONS THEIR COM, P280; PLINY ELDER, NATURALIS HIST, V33, P25; ROUSSEL Pierre, 1875, HIST DESCRIPTION CHA; TETT SE, 1993, CLIN PHARMACOKINET, V25, P392, DOI 10.2165/00003088-199325050-00005; BETA ANAL LONDON MIA	22	3	3	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 16	2009	339								b5311	10.1136/bmj.b5311	http://dx.doi.org/10.1136/bmj.b5311			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	534XH	20015897				2022-12-28	WOS:000272930300016
J	Cohen, E; Paulsson, JF; Blinder, P; Burstyn-Cohen, T; Du, DG; Estepa, G; Adame, A; Pham, HM; Holzenberger, M; Kelly, JW; Masliah, E; Dillin, A				Cohen, Ehud; Paulsson, Johan F.; Blinder, Pablo; Burstyn-Cohen, Tal; Du, Deguo; Estepa, Gabriela; Adame, Anthony; Pham, Hang M.; Holzenberger, Martin; Kelly, Jeffery W.; Masliah, Eliezer; Dillin, Andrew			Reduced IGF-1 Signaling Delays Age-Associated Proteotoxicity in Mice	CELL			English	Article							BETA-AMYLOID PEPTIDE; FACTOR-I RECEPTOR; ALZHEIMERS-DISEASE; OXIDATIVE-STRESS; INSULIN-RECEPTOR; MOUSE MODEL; LIFE-SPAN; LONGEVITY; MUTANT; IMPAIRMENT	The insulin/insulin growth factor (IGF) signaling (IIS) pathway is a key regulator of aging of worms, flies, mice, and likely humans. Delayed aging by IIS reduction protects the nematode C. elegans from toxicity associated with the aggregation of the Alzheimer's disease-linked human peptide, A beta. We reduced IGF signaling in Alzheimer's model mice and discovered that these animals are protected from Alzheimer's-like disease symptoms, including reduced behavioral impairment, neuroinflammation, and neuronal loss. This protection is correlated with the hyperaggregation of A beta leading to tightly packed, ordered plaques, suggesting that one aspect of the protection conferred by reduced IGF signaling is the sequestration of soluble A beta oligomers into dense aggregates of lower toxicity. These findings indicate that the IGF signaling-regulated mechanism that protects from A beta toxicity is conserved from worms to mammals and point to the modulation of this signaling pathway as a promising strategy for the development of Alzheimer's disease therapy.	[Cohen, Ehud; Estepa, Gabriela; Dillin, Andrew] Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, La Jolla, CA 92037 USA; [Paulsson, Johan F.; Du, Deguo; Kelly, Jeffery W.] Scripps Res Inst, Dept Chem & Mol & Expt Med, La Jolla, CA 92037 USA; [Paulsson, Johan F.; Du, Deguo; Kelly, Jeffery W.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Blinder, Pablo] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Burstyn-Cohen, Tal] Salk Inst Biol Studies, Mol Neurobiol Lab, La Jolla, CA 92037 USA; [Adame, Anthony; Pham, Hang M.; Masliah, Eliezer] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Holzenberger, Martin] INSERM, F-75571 Paris 12, France; [Holzenberger, Martin] Univ Paris 06, Hop St Antoine, UMRS 938, F-75571 Paris 12, France	Howard Hughes Medical Institute; Salk Institute; Scripps Research Institute; Scripps Research Institute; University of California System; University of California San Diego; Salk Institute; University of California System; University of California San Diego; Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite	Dillin, A (corresponding author), Salk Inst Biol Studies, Howard Hughes Med Inst, Glenn Ctr Aging Res, Mol & Cell Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	dillin@salk.edu	Blinder, Pablo/AAX-7980-2020; Burstyn-Cohen, Tal/A-2848-2011; Burstyn-Cohen, Tal/K-8846-2012; Blinder, Pablo/GQI-2237-2022; Blinder, Pablo/D-2472-2009; Holzenberger, Martin/N-9732-2018	Blinder, Pablo/0000-0002-4042-214X; Burstyn-Cohen, Tal/0000-0002-2324-2921; Estepa, Gabriela/0000-0002-8380-1596; Cohen, Ehud/0000-0001-5552-7086; Holzenberger, Martin/0000-0003-4869-725X; Paulsson, Johan F/0000-0001-6601-8383	McKnight Foundation; NIA [P01 AG031097]; NATIONAL INSTITUTE ON AGING [P01AG031097] Funding Source: NIH RePORTER	McKnight Foundation; NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	.We thank Dr. Hyun-Eui Kim for expert assistance with size-exclusion chromatography and Dr. Gustavo Dziewczapolski for assistance with behavioral assay. We thank the McKnight Foundation (A.D.) and NIA P01 AG031097 (A.D., J.W.K., E.M.) for funding. E.C. and A.D. designed and initiated this study. E.C. crossed the mouse strains and performed the behavioral assays, quantitative PCR, ELISA, size exclusion, and WB experiments. T. B. C. performed IHC assays. Immunoelectron microscopy was carried out by J.F.P. D. D. executed in vitro kinetic aggregation assays. P. B. performed image processing of the EM data. A. A. assisted with IHC. G. E. assisted with mice genotyping and behavioral assays. H. M. P. assisted with WB. M. H. provided Igf1r<SUP>+/-</SUP> mice and expertise pertinent to Igf1r. E. C., A. D., J.W.K., and E. M. wrote the manuscript. A. D. and J.W.K. are founders of Proteostasis Therepeutics Inc. and disclose no conflict of interest in this study	AMADUCCI L, 1994, CURR OPIN NEUROL, V7, P283, DOI 10.1097/00019052-199408000-00001; Bar-On P, 2006, J NEUROCHEM, V98, P1032, DOI 10.1111/j.1471-4159.2006.04017.x; Behrends C, 2006, MOL CELL, V23, P887, DOI 10.1016/j.molcel.2006.08.017; Blanchard J, 2008, NEUROBIOL AGING, V29, P1011, DOI 10.1016/j.neurobiolaging.2007.02.010; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Carro E, 2002, NAT MED, V8, P1390, DOI 10.1038/nm793; Carro E, 2006, NEUROBIOL AGING, V27, P1618, DOI 10.1016/j.neurobiolaging.2005.09.039; Cheng IH, 2007, J BIOL CHEM, V282, P23818, DOI 10.1074/jbc.M701078200; Cohen E, 2008, NAT REV NEUROSCI, V9, P759, DOI 10.1038/nrn2474; Cohen E, 2006, SCIENCE, V313, P1604, DOI 10.1126/science.1124646; Craft S, 1998, NEUROLOGY, V50, P164, DOI 10.1212/WNL.50.1.164; Farzan M, 2000, P NATL ACAD SCI USA, V97, P9712, DOI 10.1073/pnas.160115697; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Fukui H, 2007, P NATL ACAD SCI USA, V104, P14163, DOI 10.1073/pnas.0705738104; Ghosh HS, 2008, CURR OPIN INVEST DR, V9, P1095; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Haass C, 2007, NAT REV MOL CELL BIO, V8, P101, DOI 10.1038/nrm2101; HAMOS JE, 1989, NEUROLOGY, V39, P355, DOI 10.1212/WNL.39.3.355; Holzenberger M, 2003, NATURE, V421, P182, DOI 10.1038/nature01298; Jankowsky JL, 2004, HUM MOL GENET, V13, P159, DOI 10.1093/hmg/ddh019; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Jensen MT, 2005, NEUROSCIENCE, V130, P667, DOI 10.1016/j.neuroscience.2004.09.055; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; King DL, 2002, PHYSIOL BEHAV, V75, P627, DOI 10.1016/S0031-9384(02)00639-X; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lesne S, 2006, NATURE, V440, P352, DOI 10.1038/nature04533; LINK CD, 1995, P NATL ACAD SCI USA, V92, P9368, DOI 10.1073/pnas.92.20.9368; MANCARDI GL, 1983, ACTA NEUROPATHOL, V61, P76, DOI 10.1007/BF00688390; Masliah E, 2000, J NEURAL TRANSM-SUPP, P175; Morley JF, 2002, P NATL ACAD SCI USA, V99, P10417, DOI 10.1073/pnas.152161099; Nadjar A, 2009, NEUROBIOL AGING, V30, P2021, DOI 10.1016/j.neurobiolaging.2008.02.009; Oberdoerffer P, 2008, CELL, V135, P907, DOI 10.1016/j.cell.2008.10.025; Partridge L, 2008, ONCOGENE, V27, P2351, DOI 10.1038/onc.2008.28; Reiserer RS, 2007, GENES BRAIN BEHAV, V6, P54, DOI 10.1111/j.1601-183X.2006.00221.x; SCHEFF SW, 1990, NEUROBIOL AGING, V11, P29, DOI 10.1016/0197-4580(90)90059-9; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Selkoe DJ, 2004, ANN INTERN MED, V140, P627, DOI 10.7326/0003-4819-140-8-200404200-00047; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shorter J, 2004, SCIENCE, V304, P1793, DOI 10.1126/science.1098007; Suh Y, 2008, P NATL ACAD SCI USA, V105, P3438, DOI 10.1073/pnas.0705467105; Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987; Westerheide SD, 2009, SCIENCE, V323, P1063, DOI 10.1126/science.1165946; Westerman MA, 2002, J NEUROSCI, V22, P1858, DOI 10.1523/JNEUROSCI.22-05-01858.2002; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Wirths O, 2010, NEUROBIOL AGING, V31, P747, DOI 10.1016/j.neurobiolaging.2008.06.011; Wolfe MS, 1999, NATURE, V398, P513, DOI 10.1038/19077	47	352	362	2	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1157	1169		10.1016/j.cell.2009.11.014	http://dx.doi.org/10.1016/j.cell.2009.11.014			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005808	Green Accepted, Bronze			2022-12-28	WOS:000272622800017
J	Uhlenhaut, NH; Jakob, S; Anlag, K; Eisenberger, T; Sekido, R; Kress, J; Treier, AC; Klugmann, C; Klasen, C; Holter, NI; Riethmacher, D; Schutz, G; Cooney, AJ; Lovell-Badge, R; Treier, M				Uhlenhaut, N. Henriette; Jakob, Susanne; Anlag, Katrin; Eisenberger, Tobias; Sekido, Ryohei; Kress, Jana; Treier, Anna-Corina; Klugmann, Claudia; Klasen, Christian; Holter, Nadine I.; Riethmacher, Dieter; Schuetz, Guenther; Cooney, Austin J.; Lovell-Badge, Robin; Treier, Mathias			Somatic Sex Reprogramming of Adult Ovaries to Testes by FOXL2 Ablation	CELL			English	Article							TRANSCRIPTION FACTOR FOXL2; GENE-TRANSCRIPTION; SERTOLI-CELLS; BETA-CATENIN; SRY ACTION; SOX9; REVERSAL; DIFFERENTIATION; FOLLICLE; MOUSE	In mammals, the transcription factor SRY, encoded by the Y chromosome, is normally responsible for triggering the indifferent gonads to develop as testes rather than ovaries. However, testis differentiation can occur in its absence. Here we demonstrate in the mouse that a single factor, the forkhead transcriptional regulator FOXL2, is required to prevent transdifferentiation of an adult ovary to a testis. Inducible deletion of Foxl2 in adult ovarian follicles leads to immediate upregulation of testis-specific genes including the critical SRY target gene Sox9. Concordantly, reprogramming of granulosa and theca cell lineages into Sertoli-like and Leydig-like cell lineages occurs with testosterone levels comparable to those of normal XY male littermates. Our results show that maintenance of the ovarian phenotype is an active process throughout life. They might also have important medical implications for the understanding and treatment of some disorders of sexual development in children and premature menopause in women. For a video summary of this article, see the PaperFlick file with the Supplemental Data available online.	[Uhlenhaut, N. Henriette; Anlag, Katrin; Eisenberger, Tobias; Kress, Jana; Treier, Anna-Corina; Klugmann, Claudia; Klasen, Christian; Holter, Nadine I.; Treier, Mathias] European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany; [Jakob, Susanne; Sekido, Ryohei; Lovell-Badge, Robin] Natl Inst Med Res, MRC, Div Dev Genet, London NW7 1AA, England; [Riethmacher, Dieter] Univ Southampton, Sch Med, Div Human Genet, Southampton SO16 6YD, Hants, England; [Schuetz, Guenther] German Canc Res Ctr, Div Mol Biol Cell 1, D-69120 Heidelberg, Germany; [Cooney, Austin J.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Treier, Mathias] Univ Cologne, Fac Med, D-50931 Cologne, Germany	European Molecular Biology Laboratory (EMBL); MRC National Institute for Medical Research; University of Southampton; Helmholtz Association; German Cancer Research Center (DKFZ); Baylor College of Medicine; University of Cologne	Treier, M (corresponding author), European Mol Biol Lab, Dev Biol Unit, D-69117 Heidelberg, Germany.	treier@embl.de	Riethmacher, Dieter/A-6242-2010; Riethmacher, Dieter/AAP-2227-2021; Uhlenhaut, Nina Henriette/C-6288-2014; Uhlenhaut, Henriette/AAP-5400-2020; Treier, Mathias/AAD-6388-2021; Riethmacher, Dieter/AAB-8690-2022; Uhlenhaut, Henriette/AFR-1141-2022	Riethmacher, Dieter/0000-0002-4206-5529; Uhlenhaut, Henriette/0000-0002-4220-4779; Sekido, Ryohei/0000-0003-2364-1882; Lovell-Badge, Robin/0000-0001-9364-4179	Deutsche Forschungsgemeinschaft [DFG-TR341]; MRC [U117512772]; Louis Jeantet Foundation; MRC [MC_U117562207] Funding Source: UKRI; Medical Research Council [MC_U117562207] Funding Source: researchfish	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Louis Jeantet Foundation; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the staff of the EMBL Laboratory Animal Resources for expert animal husbandry, and S. Fehsenfeld and T. Ivacevic for technical assistance. We thank A. F. Parlow at the National Hormone and Peptide Program; HUMC for help with serum testosterone measurements; and M. Wegner and D. Zarkower for SOX9 and DMRT1 antibodies. This work was supported in part by the Deutsche Forschungsgemeinschaft (DFG-TR341, M. T.) and by the MRC (U117512772) and Louis Jeantet Foundation (S.J., R. S., and R. L. B.).	Albrecht KH, 2001, DEV BIOL, V240, P92, DOI 10.1006/dbio.2001.0438; Arnold AP, 2009, HORM BEHAV, V55, P570, DOI 10.1016/j.yhbeh.2009.03.011; Barrionuevo F, 2006, BIOL REPROD, V74, P195, DOI 10.1095/biolreprod.105.045930; Barske LA, 2008, CURR OPIN GENET DEV, V18, P499, DOI 10.1016/j.gde.2008.11.004; Benayoun BA, 2008, HUM MOL GENET, V17, P3118, DOI 10.1093/hmg/ddn209; Bishop CE, 2000, NAT GENET, V26, P490, DOI 10.1038/82652; Bouma GJ, 2005, DEVELOPMENT, V132, P3045, DOI 10.1242/dev.01890; Brennan J, 2003, GENE DEV, V17, P800, DOI 10.1101/gad.1052503; BURGOYNE PS, 1988, DEVELOPMENT, V104, P683; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chaboissier MC, 2004, DEVELOPMENT, V131, P1891, DOI 10.1242/dev.01087; Chassot AA, 2008, SEX DEV, V2, P219, DOI 10.1159/000152038; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; Couse JF, 1999, SCIENCE, V286, P2328, DOI 10.1126/science.286.5448.2328; Coveney D, 2001, BIOL REPROD, V65, P613, DOI 10.1095/biolreprod65.2.613; Crisponi L, 2001, NAT GENET, V27, P159, DOI 10.1038/84781; DiNapoli L, 2008, MOL ENDOCRINOL, V22, P1, DOI 10.1210/me.2007-0250; Eppig JJ, 2001, REPRODUCTION, V122, P829, DOI 10.1530/rep.0.1220829; Guigon CJ, 2006, BIOL REPROD, V74, P450, DOI 10.1095/biolreprod.105.047134; GUIGUEN Y, 2009, GEN COMP ENDOCRINOL; Haider SG, 2004, INT REV CYTOL, V233, P181, DOI 10.1016/S0074-7696(04)33005-6; Hiramatsu R, 2009, DEVELOPMENT, V136, P129, DOI 10.1242/dev.029587; HOAGE TR, 1976, ANAT REC, V184, P699, DOI 10.1002/ar.1091840409; Huang B, 1999, AM J MED GENET, V87, P349, DOI 10.1002/(SICI)1096-8628(19991203)87:4<349::AID-AJMG13>3.0.CO;2-N; Jeays-Ward K, 2003, DEVELOPMENT, V130, P3663, DOI 10.1242/dev.00591; Kim Y, 2006, PLOS BIOL, V4, P1000, DOI 10.1371/journal.pbio.0040187; KOOPMAN P, 1991, NATURE, V351, P117, DOI 10.1038/351117a0; Maatouk DM, 2008, HUM MOL GENET, V17, P2949, DOI 10.1093/hmg/ddn193; Mandel H, 2008, AM J HUM GENET, V82, P39, DOI 10.1016/j.ajhg.2007.08.005; MCLAREN A, 1991, BIOESSAYS, V13, P151, DOI 10.1002/bies.950130402; Moniot B, 2009, DEVELOPMENT, V136, P1813, DOI 10.1242/dev.032631; Nakamura M, 2009, SEMIN CELL DEV BIOL, V20, P271, DOI 10.1016/j.semcdb.2008.10.003; Ottolenghi C, 2005, HUM MOL GENET, V14, P2053, DOI 10.1093/hmg/ddi210; Ottolenghi C, 2007, HUM MOL GENET, V16, P2795, DOI 10.1093/hmg/ddm235; Pailhoux E, 2001, NAT GENET, V29, P453, DOI 10.1038/ng769; Pannetier Maelle, 2004, Pediatr Endocrinol Rev, V1, P274; Pannetier M, 2006, J MOL ENDOCRINOL, V36, P399, DOI 10.1677/jme.1.01947; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Raymond CS, 2000, GENE DEV, V14, P2587, DOI 10.1101/gad.834100; Salmon NA, 2005, MOL REPROD DEV, V70, P271, DOI 10.1002/mrd.20208; Schmahl J, 2008, GENE DEV, V22, P3255, DOI 10.1101/gad.1723908; Schmidt D, 2004, DEVELOPMENT, V131, P933, DOI 10.1242/dev.00969; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Sekido R, 2008, NATURE, V453, P930, DOI 10.1038/nature06944; SHOEMAKER CM, 2009, CELL DEV BIOL, V20, P293; SINCLAIR AH, 1990, NATURE, V346, P240, DOI 10.1038/346240a0; Skinner MK, 2005, HUM REPROD UPDATE, V11, P461, DOI 10.1093/humupd/dmi020; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Stolt CC, 2003, GENE DEV, V17, P1677, DOI 10.1101/gad.259003; Swain A, 1998, NATURE, V391, P761, DOI 10.1038/35799; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Uda M, 2004, HUM MOL GENET, V13, P1171, DOI 10.1093/hmg/ddh124; Uhlenhaut NH, 2006, MOL GENET METAB, V88, P225, DOI 10.1016/j.ymgme.2006.03.005; Vainio S, 1999, NATURE, V397, P405, DOI 10.1038/17068; Vidal VPI, 2001, NAT GENET, V28, P216, DOI 10.1038/90046; Wilhelm D, 2007, J BIOL CHEM, V282, P10553, DOI 10.1074/jbc.M609578200; Wilhelm D, 2006, NAT REV GENET, V7, P620, DOI 10.1038/nrg1903; Yao HHC, 2002, GENE DEV, V16, P1433, DOI 10.1101/gad.981202; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015	59	626	658	5	119	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 11	2009	139	6					1130	1142		10.1016/j.cell.2009.11.021	http://dx.doi.org/10.1016/j.cell.2009.11.021			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	530WK	20005806	Bronze			2022-12-28	WOS:000272622800015
J	Baudat, F; Buard, J; Grey, C; Fledel-Alon, A; Ober, C; Przeworski, M; Coop, G; de Massy, B				Baudat, F.; Buard, J.; Grey, C.; Fledel-Alon, A.; Ober, C.; Przeworski, M.; Coop, G.; de Massy, B.			PRDM9 Is a Major Determinant of Meiotic Recombination Hotspots in Humans and Mice	SCIENCE			English	Article							HISTONE H3 METHYLTRANSFERASE; ZINC FINGERS; HUMAN GENOME; HOT-SPOTS; RATES; CHIMPANZEES; INITIATION; PATTERNS; MEIOSIS; SITES	Meiotic recombination events cluster into narrow segments of the genome, defined as hotspots. Here, we demonstrate that a major player for hotspot specification is the Prdm9 gene. First, two mouse strains that differ in hotspot usage are polymorphic for the zinc finger DNA binding array of PRDM9. Second, the human consensus PRDM9 allele is predicted to recognize the 13-mer motif enriched at human hotspots; this DNA binding specificity is verified by in vitro studies. Third, allelic variants of PRDM9 zinc fingers are significantly associated with variability in genome-wide hotspot usage among humans. Our results provide a molecular basis for the distribution of meiotic recombination in mammals, in which the binding of PRDM9 to specific DNA sequences targets the initiation of recombination at specific locations in the genome.	[Baudat, F.; Buard, J.; Grey, C.; de Massy, B.] CNRS, UPR1142, Inst Genet Humaine, Montpellier, France; [Fledel-Alon, A.; Ober, C.; Przeworski, M.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Przeworski, M.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Coop, G.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Coop, G.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of California System; University of California Davis; University of California System; University of California Davis	de Massy, B (corresponding author), CNRS, UPR1142, Inst Genet Humaine, Montpellier, France.	bernard.de-massy@igh.cnrs.fr		Ober, Carole/0000-0003-4626-9809; Coop, Graham/0000-0001-8431-0302; Baudat, Frederic/0000-0003-2415-8366	CNRS; Association pour la Recherche sur le Cancer [ARC 3939]; Fondation Jer me Lejeune; Agence Nationale de la Recherche [ANR-06-BLAN-0160-01, ANR-09-BLAN-0269-01]; Electricite de France; NIH [HD21244, HL085197, GM83098]; American Recovery and Reinvestment Act [03S1]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083098] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation Jer me Lejeune; Agence Nationale de la Recherche(French National Research Agency (ANR)); Electricite de France; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of our laboratories for discussions, J. Pritchard for comments on an earlier version of the manuscript, R. Hernandez and E. Leffler for their help with bioinformatics, E. Leffler for generating fig. S7, E. Brun for technical assistance on PRDM9 in vitro assays, and D. Haddou and F. Arnal for mouse facility service. This study was supported by a grant from CNRS; the Association pour la Recherche sur le Cancer (grant ARC 3939); the Fondation Jer me Lejeune and the Agence Nationale de la Recherche (grants ANR-06-BLAN-0160-01 and ANR-09-BLAN-0269-01) to B.d.M. C. G. was supported by a grant from Electricite de France. This research was further was supported by NIH grants HD21244 and HL085197 to C.O., a Sloan Foundation Fellowship to G. C., NIH grant GM83098, American Recovery and Reinvestment Act supplement 03S1, and a Howard Hughes Medical Institute Early Career Scientist Award to M. P. Sequences generated for this study are deposited in GenBank with the following accession numbers: GU216222, GU216223, GU216224, GU216225, GU216226, GU216227, GU216228, GU216229, and GU216230.	Arnheim N, 2007, ANNU REV GENET, V41, P369, DOI 10.1146/annurev.genet.41.110306.130301; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Buard J, 2007, TRENDS GENET, V23, P301, DOI 10.1016/j.tig.2007.03.014; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; de Massy B, 2003, TRENDS GENET, V19, P514, DOI 10.1016/S0168-9525(03)00201-4; Fu F, 2009, NUCLEIC ACIDS RES, V37, pD279, DOI 10.1093/nar/gkn606; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; HUNTER N, 2007, MOL GENETICS RECOMBI, P381; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Parvanov ED, 2009, PLOS BIOL, V7, P340, DOI 10.1371/journal.pbio.1000036; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3	30	639	651	1	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					836	840		10.1126/science.1183439	http://dx.doi.org/10.1126/science.1183439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20044539	Green Accepted			2022-12-28	WOS:000274408300053
J	Murray, TH				Murray, Thomas H.			American Values and Health Care Reform	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Hastings Ctr, Garrison, NY USA		Murray, TH (corresponding author), Hastings Ctr, Garrison, NY USA.							*HAST CTR, 2009, CONN AM VAL HLTH REF; Institute of Medicine, 2002, CAR COV TOO LITTL TO; NICHOLS LM, 2009, CONNECTING AM VALUES, P30; NIH-DOE Working Group on Ethical Legal and Social Implications of Human Genome Research, 1993, GEN INF HLTH INS REP	4	4	5	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					285	287		10.1056/NEJMp0911116	http://dx.doi.org/10.1056/NEJMp0911116			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	548OT	20032316				2022-12-28	WOS:000273975000003
J	Johnson, JA; Everett, BM; Katz, JT; Loscalzo, J				Johnson, Jennifer A.; Everett, Brendan M.; Katz, Joel T.; Loscalzo, Joseph			Painful Purple Toes	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							NONBACTERIAL THROMBOTIC ENDOCARDITIS; INFECTIVE ENDOCARDITIS; CARDIOEMBOLIC STROKE; INFARCTION; EMBOLI; CANCER		Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Katz, JT (corresponding author), 75 Francis St, Boston, MA 02115 USA.	jkatz@partners.org	Loscalzo, Joseph/ABD-8980-2021					ANGRIST A, 1954, AM J PATHOL, V30, P39; Asopa S, 2007, EUR J CARDIO-THORAC, V32, P696, DOI 10.1016/j.ejcts.2007.07.029; EISHI K, 1995, J THORAC CARDIOV SUR, V110, P1745, DOI 10.1016/S0022-5223(95)70038-2; Gillinov AM, 1996, ANN THORAC SURG, V61, P1125, DOI 10.1016/0003-4975(96)00014-8; KURAMOTO K, 1984, JPN CIRC J, V48, P1000, DOI 10.1253/jcj.48.1000; Lee AYY, 2003, NEW ENGL J MED, V349, P146, DOI 10.1056/NEJMoa025313; LOPEZ JA, 1987, AM HEART J, V113, P773, DOI 10.1016/0002-8703(87)90719-8; MARUYAMA M, 1989, STROKE, V20, P1305, DOI 10.1161/01.STR.20.10.1305; ROGERS LR, 1987, AM J MED, V83, P746, DOI 10.1016/0002-9343(87)90908-9; ROHNER RF, 1966, CANCER, V19, P1805, DOI 10.1002/1097-0142(196612)19:12<1805::AID-CNCR2820191207>3.0.CO;2-C; Ruttmann E, 2006, STROKE, V37, P2094, DOI 10.1161/01.STR.0000229894.28591.3f; Salem DN, 2004, CHEST, V126, p457S, DOI 10.1378/chest.126.3_suppl.457S; Smeglin A, 2008, J CLIN ONCOL, V26, P1383, DOI 10.1200/JCO.2007.12.9148	13	3	3	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2010	362	1					67	73		10.1056/NEJMcps0807291	http://dx.doi.org/10.1056/NEJMcps0807291			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	540PA	20054049				2022-12-28	WOS:000273345500012
J	Louie, JK; Acosta, M; Jamieson, DJ; Honein, MA				Louie, Janice K.; Acosta, Meileen; Jamieson, Denise J.; Honein, Margaret A.		Calif Pandemic H1N1 Working Grp	Severe 2009 H1N1 Influenza in Pregnant and Postpartum Women in California	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							A(H1N1) INFECTION; UNITED-STATES; IMMUNIZATION; ADMISSIONS; IMPACT; VIRUS; TESTS	BACKGROUND Like previous epidemic and pandemic diseases, 2009 pandemic influenza A (H1N1) may pose an increased risk of severe illness in pregnant women. METHODS Statewide surveillance for patients who were hospitalized with or died from 2009 H1N1 influenza was initiated by the California Department of Public Health. We reviewed demographic and clinical data reported from April 23 through August 11, 2009, for all H1N1-infected, reproductive-age women who were hospitalized or died -nonpregnant women, pregnant women, and postpartum women (those who had delivered <= 2 weeks previously). RESULTS Data were reported for 94 pregnant women, 8 postpartum women, and 137 nonpregnant women of reproductive age who were hospitalized with 2009 H1N1 influenza. Rapid antigen tests were falsely negative in 38% of the patients tested (58 of 153). Most pregnant patients (89 of 94 [95%]) were in the second or third trimester, and approximately one third (32 of 93 [34%]) had established risk factors for complications from influenza other than pregnancy. As compared with early antiviral treatment (administered <= 2 days after symptom onset) in pregnant women, later treatment was associated with admission to an intensive care unit (ICU) or death (relative risk, 4.3). In all, 18 pregnant women and 4 postpartum women (total, 22 of 102 [22%]) required intensive care, and 8 (8%) died. Six deliveries occurred in the ICU, including four emergency cesarean deliveries. The 2009 H1N1 influenza-specific maternal mortality ratio (the number of maternal deaths per 100,000 live births) was 4.3. CONCLUSIONS 2009 H1N1 influenza can cause severe illness and death in pregnant and postpartum women; regardless of the results of rapid antigen testing, prompt evaluation and antiviral treatment of influenza-like illness should be considered in such women. The high cause-specific maternal mortality rate suggests that 2009 H1N1 influenza may increase the 2009 maternal mortality ratio in the United States.	[Louie, Janice K.; Acosta, Meileen] Calif Dept Publ Hlth, Richmond, CA 94804 USA; [Jamieson, Denise J.] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA; [Honein, Margaret A.] Ctr Dis Control & Prevent, Natl Ctr Birth Defects & Dev Disabil, Atlanta, GA USA	California Department of Public Health; Centers for Disease Control & Prevention - USA; Centers for Disease Control & Prevention - USA	Louie, JK (corresponding author), Calif Dept Publ Hlth, 850 Marina Bay Pkwy, Richmond, CA 94804 USA.	janice.louie@cdph.ca.gov		Jamieson, Denise/0000-0003-2597-1201				[Anonymous], 2009, MMWR MORB MORTAL WKL, V58, P826; *CAL DEP PUBL HLTH, 2005, VIT STAT POP SUMM TA; *CDCP, CDC HLTH AL NETW HAN; Centers for Disease Control and Prevention, UPD INT REC OBST HLT; Centers for Disease Control and Prevention, 2009 H1N1 INFL VACC; Dodds L, 2007, CAN MED ASSOC J, V176, P463, DOI 10.1503/cmaj.061435; Fiore Anthony E., 2009, Morbidity and Mortality Weekly Report, V58, P1; FREEMAN DW, 1959, AM J OBSTET GYNECOL, V78, P1172, DOI 10.1016/0002-9378(59)90570-8; Harris JW, 1919, J AMER MED ASSOC, V72, P978, DOI 10.1001/jama.1919.02610140008002; Heron Melonie, 2009, Natl Vital Stat Rep, V57, P1; Jamieson DJ, 2006, EMERG INFECT DIS, V12, P1638, DOI 10.3201/eid1211.060152; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; Kumar A, 2009, JAMA-J AM MED ASSOC, V302, P1872, DOI 10.1001/jama.2009.1496; Louie JK, 2009, JAMA-J AM MED ASSOC, V302, P1896, DOI 10.1001/jama.2009.1583; Mahutte NG, 1999, OBSTET GYNECOL, V94, P263, DOI 10.1016/S0029-7844(99)00274-4; *NAT I ALL INF DIS, H1N1 VACC CLIN STUD; Neuzil KM, 1998, AM J EPIDEMIOL, V148, P1094, DOI 10.1093/oxfordjournals.aje.a009587; Rasmussen SA, 2008, EMERG INFECT DIS, V14, P95, DOI 10.3201/eid1401.070667; Saleeby E, 2009, OBSTET GYNECOL, V114, P885, DOI 10.1097/AOG.0b013e3181bb44bb; TAMMA PD, 2009, AM J OBSTET GYN 1020; Vasoo S, 2009, CLIN INFECT DIS, V49, P1090, DOI 10.1086/644743; Webb SAR, 2009, NEW ENGL J MED, V361, P1925, DOI 10.1056/NEJMoa0908481; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; 2009, MMWR MORB MORTAL WKL, V58, P497	24	473	509	1	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 7	2010	362	1					27	35		10.1056/NEJMoa0910444	http://dx.doi.org/10.1056/NEJMoa0910444			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	540PA	20032319				2022-12-28	WOS:000273345500006
J	Mazotti, LA				Mazotti, Lindsay A.			Integration	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												lindsay.mazotti@ucsf.edu		Mazotti, Lindsay/0000-0003-4462-378X					0	0	0	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2010	303	1					15	16		10.1001/jama.2009.1904	http://dx.doi.org/10.1001/jama.2009.1904			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539YS	20051560				2022-12-28	WOS:000273296900001
J	Lessler, J; Reich, NG; Cummings, DAT				Lessler, Justin; Reich, Nicholas G.; Cummings, Derek A. T.		New York City Dept Hlth; Mental Hyg Swine Influenza Invest	Outbreak of 2009 Pandemic Influenza A (H1N1) at a New York City School	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMMUNITY TRANSMISSION; INFECTIONS; HOUSEHOLD; DISTRIBUTIONS; CHILDREN; VIRUS	BACKGROUND In April 2009, an outbreak of novel swine-origin influenza A ( 2009 H1N1 influenza) occurred at a high school in Queens, New York. We describe the outbreak and characterize the clinical and epidemiologic aspects of this novel virus. METHODS The New York City Department of Health and Mental Hygiene characterized the outbreak through laboratory confirmation of the presence of the 2009 H1N1 virus in nasopharyngeal and oropharyngeal specimens and through information obtained from an online survey. Detailed information on exposure and the onset of symptoms was used to estimate the incubation period, generation time, and within-school reproductive number associated with 2009 H1N1 influenza, with the use of established techniques. RESULTS From April 24 through May 8, infection with the 2009 H1N1 virus was confirmed in 124 high-school students and employees. In responses to the online questionnaire, more than 800 students and employees (35% of student respondents and 10% of employee respondents) reported having an influenza-like illness during this period. No persons with confirmed 2009 H1N1 influenza or with influenza-like illness had severe symptoms. A linkage with travel to Mexico was identified. The estimated median incubation period for confirmed 2009 H1N1 influenza was 1.4 days (95% confidence interval [CI], 1.0 to 1.8), with symptoms developing in 95% of cases by 2.2 days (95% CI, 1.7 to 2.6). The estimated median generation time was 2.7 days (95% CI, 2.0 to 3.5). We estimate that the within-school reproductive number was 3.3. CONCLUSIONS The findings from this investigation suggest that 2009 H1N1 influenza in the high school was widespread but did not cause severe illness. The reasons for the rapid and extensive spread of influenza-like illnesses are unknown. The natural history and transmission of the 2009 H1N1 influenza virus appear to be similar to those of previously observed circulating pandemic and interpandemic influenza viruses.	[Lessler, Justin; Cummings, Derek A. T.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Reich, Nicholas G.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lessler, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St,E6545, Baltimore, MD 21205 USA.	jlessler@jhsph.edu	Reich, Nicholas/L-1168-2019; Tsoi, Benjamin/T-2766-2018	Reich, Nicholas/0000-0003-3503-9899; Lessler, Justin/0000-0002-9741-8109; Marx, Melissa/0000-0001-9735-6342; Tsoi, Benjamin/0000-0003-2927-6687; DiGrande, Laura/0000-0002-7742-0164	National Institutes of Health [1 R01 TW008246-01, 1U01-GM070708]; Bill and Melinda Gates Foundation; U. S. Department of Homeland Security [N00014-06-1-0991]; Burroughs Wellcome Fund; FOGARTY INTERNATIONAL CENTER [R01TW008246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); U. S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the National Institutes of Health (1 R01 TW008246-01, to Drs. Lessler and Cummings; and 1U01-GM070708, to Dr. Cummings), the Bill and Melinda Gates Foundation ( to Drs. Lessler and Cummings), and the U. S. Department of Homeland Security (N00014-06-1-0991, to Mr. Reich). Dr. Cummings is the recipient of a Career Award at the Scientific Interface from the Burroughs Wellcome Fund.	[Anonymous], MMWR MORB MORTAL WKL; BECKER NG, 1989, ANAL INFECT DIS DATA; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Klein J., 1992, SURVIVAL ANAL STATE; Lessler J, 2007, J R SOC INTERFACE, V4, P755, DOI 10.1098/rsif.2007.0228; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; LONGINI IM, 1982, BIOMETRICS, V38, P115, DOI 10.2307/2530294; MACKENZIE D, 2009, DEADLY NEW FLU VIRUS; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Nishiura H, 2009, EUROSURVEILLANCE, V14; Nishiura Hiroshi, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P1075; Reich NG, 2009, STAT MED, V28, P2769, DOI 10.1002/sim.3659; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; 2009, MMWR MORB MORTAL WKL, V58, P470	19	236	242	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2628	2636		10.1056/NEJMoa0906089	http://dx.doi.org/10.1056/NEJMoa0906089			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042754				2022-12-28	WOS:000273181300010
J	Tang, JWT; Settles, GS				Tang, Julian Wei-Tze; Settles, Gary S.			Coughing and Masks	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Tang, Julian Wei-Tze] Natl Univ Singapore Hosp, Singapore 117548, Singapore; [Settles, Gary S.] Penn State Univ, University Pk, PA 16802 USA	National University of Singapore; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Tang, JWT (corresponding author), Natl Univ Singapore Hosp, Singapore 117548, Singapore.		Settles, Gary S/D-5260-2009	Tang, Julian/0000-0002-4963-1028					0	16	17	0	4	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 24	2009	361	26					E62	E62		10.1056/NEJMicm0904279	http://dx.doi.org/10.1056/NEJMicm0904279			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	535WX	20032322				2022-12-28	WOS:000273003700013
J	Weisbuch, M; Pauker, K; Ambady, N				Weisbuch, Max; Pauker, Kristin; Ambady, Nalini			The Subtle Transmission of Race Bias via Televised Nonverbal Behavior	SCIENCE			English	Article							IMPLICIT ASSOCIATION TEST; RACIAL-ATTITUDES; EXTRAPERSONAL ASSOCIATIONS; PREJUDICE; DISCRIMINATION; BLACK	Compared with more explicit racial slurs and statements, biased facial expressions and body language may resist conscious identification and thus produce a hidden social influence. In four studies, we show that race biases can be subtly transmitted via televised nonverbal behavior. Characters on 11 popular television shows exhibited more negative nonverbal behavior toward black than toward status-matched white characters. Critically, exposure to prowhite (versus problack) nonverbal bias increased viewers' bias even though patterns of nonverbal behavior could not be consciously reported. These findings suggest that hidden patterns of televised nonverbal behavior influence bias among viewers.	[Weisbuch, Max; Pauker, Kristin; Ambady, Nalini] Tufts Univ, Dept Psychol, Medford, MA 02155 USA	Tufts University	Weisbuch, M (corresponding author), Tufts Univ, Dept Psychol, 490 Boston Ave, Medford, MA 02155 USA.	max.weisbuch@tufts.edu; nalini.ambady@tufts.edu	Pauker, Kristin/C-2453-2009	Pauker, Kristin/0000-0002-0848-5159	National Institute of Mental Health [F32MH078350]; National Institute of Health [R01 MH070833-02]; NATIONAL INSTITUTE OF MENTAL HEALTH [F32MH078350, R01MH070833] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank H. Fitzgerald and S. Malahy for their Herculean efforts in data collection. The project described here was supported by National Institute of Mental Health Award no. F32MH078350 (M. W.) and National Institute of Health Award no. R01 MH070833-02 to (N. A.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of Mental Health or the National Institutes of Health.	Amodio DM, 2006, J PERS SOC PSYCHOL, V91, P652, DOI 10.1037/0022-3514.91.4.652; Arkes HR, 2004, PSYCHOL INQ, V15, P257, DOI 10.1207/s15327965pli1504_01; Bertrand M, 2004, AM ECON REV, V94, P991, DOI 10.1257/0002828042002561; BRIGHAM JC, 1993, J APPL SOC PSYCHOL, V23, P1933, DOI 10.1111/j.1559-1816.1993.tb01074.x; CROSBY F, 1980, PSYCHOL BULL, V87, P546, DOI 10.1037/0033-2909.87.3.546; De Houwer J, 2001, PSYCHOL BULL, V127, P853, DOI 10.1037//0033-2909.127.6.853; DEPAULO BM, 1992, PSYCHOL BULL, V111, P203, DOI 10.1037/0033-2909.111.2.203; Dovidio JF, 2002, J PERS SOC PSYCHOL, V82, P62, DOI 10.1037//0022-3514.82.1.62; DOVIDIO JF, 1986, PREJUDICE DISCRIMINA, P61; FAZIO RH, 1995, J PERS SOC PSYCHOL, V69, P1013, DOI 10.1037/0022-3514.69.6.1013; FELDMAN RS, 1978, J EDUC PSYCHOL, V70, P979, DOI 10.1037/0022-0663.70.6.979; Greenwald AG, 1998, J PERS SOC PSYCHOL, V74, P1464, DOI 10.1037/0022-3514.74.6.1464; Greenwald AG, 2003, J PERS SOC PSYCHOL, V85, P197, DOI 10.1037/0022-3514.85.2.197; Han HA, 2006, J EXP SOC PSYCHOL, V42, P259, DOI 10.1016/j.jesp.2005.04.006; Hugenberg K, 2003, PSYCHOL SCI, V14, P640, DOI 10.1046/j.0956-7976.2003.psci_1478.x; Institute of Medicine Committee on Understanding and Eliminating Racial and Ethnic Disparities in Health Care, 2003, UNEQUAL TREATMENT CO, DOI DOI 10.17226/12875; Olson MA, 2006, PERS SOC PSYCHOL B, V32, P421, DOI 10.1177/0146167205284004; Olson MA, 2004, J PERS SOC PSYCHOL, V86, P653, DOI 10.1037/0022-3514.86.5.653; PARSONS CK, 1984, J APPL PSYCHOL, V69, P557, DOI 10.1037/0021-9010.69.4.557; Schreer GE, 2009, J APPL SOC PSYCHOL, V39, P1432, DOI 10.1111/j.1559-1816.2009.00489.x; Schuman Howard, 1997, RACIAL ATTITUDES AM; Shelton JN, 2005, PSYCHOL SCI, V16, P397, DOI 10.1111/j.0956-7976.2005.01547.x; Sinclair S, 2005, J PERS SOC PSYCHOL, V89, P583, DOI 10.1037/0022-3514.89.4.583; Walther E, 2002, J PERS SOC PSYCHOL, V82, P919, DOI 10.1037//0022-3514.82.6.919	24	121	122	0	25	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 18	2009	326	5960					1711	1714		10.1126/science.1178358	http://dx.doi.org/10.1126/science.1178358			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	533QJ	20019288	Green Accepted			2022-12-28	WOS:000272839000058
J	Kraft, P; Gadeholt, O; Wieser, MJ; Jennings, J; Classen, J				Kraft, Peter; Gadeholt, Ottar; Wieser, Matthias J.; Jennings, Jenifer; Classen, Joseph			CHRISTMAS 2009: YOUNG AND OLD Lying obliquely-a clinical sign of cognitive impairment: cross sectional observational study	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							QUALITY STANDARDS SUBCOMMITTEE; MINI-MENTAL-STATE; OBJECT ORIENTATION; PRACTICE PARAMETER; DEMENTIA; VERTICALITY; PREVALENCE; PERCEPTION; DIAGNOSIS	Objective To determine if failure to spontaneously orient the body along the longitudinal axis of a hospital bed when asked to lie down is associated with cognitive impairment in older patients. Design Cross sectional observational study. Setting Neurology department of a university hospital in Germany. Participants Convenience sample of 110 older (>= 60 years) inpatients with neurological conditions and 23 staff neurologists. Main outcome measures The main outcome measure was the association between the angle of the body axis and the results of three cognitive screening tests (mini-mental state examination, DemTect, and clock drawing test). Staff doctors were shown photographs of a model taken at a natural viewing able to determine their subjective perspective of what constitutes oblique. Results 110 neurological inpatients (mean age 70.9 (SD 6.8) years) were included after exclusions. Evidence of cognitive impairment was found in 34, with scores indicating dementia in eight, according to the mini-mental state examination, and in 11 according to the DemTect. Across all patients, the mean angular deviation of the body axis from the longitudinal axis of the bed (range 023) correlated linearly with the mini-mental state examination (r=-0.480), DemTect (r=-0.527), and the clock drawing test (r=-0.552) scores (P<0.001 for all), even after removing age as a covariate. Overall, 90% of staff neurologists considered a minimal body angle of 7 to be oblique. Angular deviation of at least 7 predicted cognitive impairment according to the three different tests, with specificities between 89% and 96% and sensitivities between 27% and 50%. Conclusion Clinicians might suspect cognitive impairment in mobile older inpatients with neurological disorders who spontaneously position themselves obliquely when asked to lie on a bed.	[Kraft, Peter; Gadeholt, Ottar; Jennings, Jenifer; Classen, Joseph] Univ Wurzburg, Dept Neurol, D-97070 Wurzburg, Germany; [Wieser, Matthias J.] Univ Wurzburg, Dept Psychol 1, D-97070 Wurzburg, Germany; [Classen, Joseph] Univ Leipzig, Dept Neurol, D-04103 Leipzig, Germany	University of Wurzburg; University of Wurzburg; Leipzig University	Classen, J (corresponding author), Univ Wurzburg, Dept Neurol, D-97070 Wurzburg, Germany.	joseph.classen@medizin.uni-leipzig.de	Wieser, Matthias J./AAV-7930-2020; Wieser, Matthias J/E-7614-2010; Gadeholt, Ottar/AAM-1030-2021	Wieser, Matthias J./0000-0002-0429-1541; Classen, Joseph/0000-0001-7182-6967	State of Bavaria	State of Bavaria	This study was part of OG's MD thesis. The study was supported by research funds from the State of Bavaria. The sponsor did not have any active role in the study. The researchers were independent of the funders.	Bickel H, 2006, DEMENT GERIATR COGN, V21, P242, DOI 10.1159/000091397; Caterini F, 2002, NEUROPSYCHOLOGY, V16, P146, DOI 10.1037//0894-4105.16.2.146; Cohen J., 1983, APPL MULTIPLE REGRES; Critchley M., 1953, PARIETAL LOBES; Cullen B, 2007, J NEUROL NEUROSUR PS, V78, P790, DOI 10.1136/jnnp.2006.095414; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Freedman M., 1994, CLOCK DRAWING NEUROP; Hickey A, 1997, INT J GERIATR PSYCH, V12, P27, DOI 10.1002/(SICI)1099-1166(199701)12:1<27::AID-GPS446>3.0.CO;2-F; Holsinger T, 2007, JAMA-J AM MED ASSOC, V297, P2391, DOI 10.1001/jama.297.21.2391; Kalbe E, 2004, INT J GERIATR PSYCH, V19, P136, DOI 10.1002/gps.1042; Karnath HO, 2007, J NEUROL, V254, P415, DOI 10.1007/s00415-006-0341-6; Knopman DS, 2001, NEUROLOGY, V56, P1143, DOI 10.1212/WNL.56.9.1143; KUKULL WA, 1994, J CLIN EPIDEMIOL, V47, P1061, DOI 10.1016/0895-4356(94)90122-8; Manckoundia P, 2007, CLIN NEUROPHYSIOL, V118, P786, DOI 10.1016/j.clinph.2006.11.274; OCONNOR DW, 1988, BMJ-BRIT MED J, V297, P1107, DOI 10.1136/bmj.297.6656.1107; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Petersen RC, 2001, NEUROLOGY, V56, P1133, DOI 10.1212/WNL.56.9.1133; Petersen RC, 2008, CNS SPECTRUMS, V13, P45, DOI 10.1017/S1092852900016151; Raymont V, 2004, LANCET, V364, P1421, DOI 10.1016/S0140-6736(04)17224-3; Royall DR, 1998, J NEUROL NEUROSUR PS, V64, P588, DOI 10.1136/jnnp.64.5.588; SHULMAN KI, 1993, INT J GERIATR PSYCH, V8, P487, DOI 10.1002/gps.930080606; Shulman KI, 2000, INT J GERIATR PSYCH, V15, P548, DOI 10.1002/1099-1166(200006)15:6<548::AID-GPS242>3.0.CO;2-U; SUNDERLAND T, 1989, J AM GERIATR SOC, V37, P725, DOI 10.1111/j.1532-5415.1989.tb02233.x; TOBIS JS, 1981, ARCH PHYS MED REHAB, V62, P619; Troyer Angela K, 2004, Evid Based Ment Health, V7, P70; Turnbull OH, 1997, NEUROPSYCHOLOGIA, V35, P153, DOI 10.1016/S0028-3932(96)00063-2	27	0	0	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 16	2009	339								b5273	10.1136/bmj.b5273	http://dx.doi.org/10.1136/bmj.b5273			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	534XH	20015907	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000272930300014
J	Calado, RT; Young, NS				Calado, Rodrigo T.; Young, Neal S.			Mechanisms of Disease: Telomere Diseases.	NEW ENGLAND JOURNAL OF MEDICINE			English	Review							IDIOPATHIC PULMONARY-FIBROSIS; DOMINANT DYSKERATOSIS-CONGENITA; BONE-MARROW-TRANSPLANTATION; HEMATOPOIETIC STEM-CELLS; GENOME-WIDE ASSOCIATION; CORONARY-ARTERY-DISEASE; ACUTE MYELOID-LEUKEMIA; APLASTIC-ANEMIA; MYELODYSPLASTIC SYNDROMES; CHROMOSOMAL INSTABILITY		[Calado, Rodrigo T.; Young, Neal S.] NHLBI, Hematol Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Calado, RT (corresponding author), 10 Ctr Dr,Bldg 10-CRC,Rm 3E-5140, Bethesda, MD 20892 USA.	calador@nhlbi.nih.gov	Calado, Rodrigo T./G-2619-2011	Calado, Rodrigo T./0000-0002-7966-6029	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL006089] Funding Source: NIH RePORTER; Intramural NIH HHS [Z99 HL999999] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alder JK, 2008, P NATL ACAD SCI USA, V105, P13051, DOI 10.1073/pnas.0804280105; Alter BP, 2007, BLOOD, V110, P1439, DOI 10.1182/blood-2007-02-075598; Alter BP, 2009, BLOOD, V113, P6549, DOI 10.1182/blood-2008-12-192880; ALTER BP, 2003, NATHAN OSKIS HEMATOL, P280; Armanios M, 2005, P NATL ACAD SCI USA, V102, P15960, DOI 10.1073/pnas.0508124102; Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157; Armstrong L, 2005, STEM CELLS, V23, P516, DOI 10.1634/stemcells.2004-0269; Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592; Ball SE, 1998, BLOOD, V91, P3582; Baykal C, 2003, J EUR ACAD DERMATOL, V17, P216, DOI 10.1046/j.1468-3083.2003.00585.x; Bayne S, 2005, MOL CELL ENDOCRINOL, V240, P11, DOI 10.1016/j.mce.2005.05.009; Beyne-Rauzy O, 2005, BLOOD, V106, P3200, DOI 10.1182/blood-2005-04-1386; Blackburn EH, 2006, NAT MED, V12, P1133, DOI 10.1038/nm1006-1133; Blasco MA, 2007, NAT CHEM BIOL, V3, P640, DOI 10.1038/nchembio.2007.38; Boveri T, 2008, ORIGIN MALIGNANT TUM; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Brummendorf TH, 2001, BLOOD, V97, P895, DOI 10.1182/blood.V97.4.895; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Calado RT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007926; Calado RT, 2009, BLOOD, V114, P2236, DOI 10.1182/blood-2008-09-178871; Calado RT, 2009, P NATL ACAD SCI USA, V106, P1187, DOI 10.1073/pnas.0807057106; Chakraborty S, 2009, J CLIN ONCOL, V27, P791, DOI 10.1200/JCO.2008.17.1033; Chen M, 2009, INT J CANCER, V125, P2342, DOI 10.1002/ijc.24642; Choi JK, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040010; COOPER JN, 2008, 50 ANN M AM SOC HEM; De Lange T, 2005, COLD SH Q B, V70, P197, DOI 10.1101/sqb.2005.70.032; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; Dokal I, 2000, BRIT J HAEMATOL, V110, P768, DOI 10.1046/j.1365-2141.2000.02109.x; Engelhardt M, 1998, LEUKEMIA, V12, P13, DOI 10.1038/sj.leu.2400889; Engelhardt M, 1997, BLOOD, V90, P182; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Finkel T, 2007, NATURE, V448, P767, DOI 10.1038/nature05985; Finley JC, 2006, CANCER EPIDEM BIOMAR, V15, P1451, DOI 10.1158/1055-9965.EPI-05-0837; Fitzpatrick AL, 2007, AM J EPIDEMIOL, V165, P14, DOI [10.1093/aje/kw346, 10.1093/aje/kwj346]; Fogarty PF, 2003, LANCET, V362, P1628, DOI 10.1016/S0140-6736(03)14797-6; Folini M, 2009, BBA-MOL BASIS DIS, V1792, P309, DOI 10.1016/j.bbadis.2009.01.014; Frenck RW, 1998, P NATL ACAD SCI USA, V95, P5607, DOI 10.1073/pnas.95.10.5607; Gebre-Medhin S, 2009, CYTOGENET GENOME RES, V124, P121, DOI 10.1159/000207516; Getliffe KM, 2005, ALIMENT PHARM THER, V21, P121, DOI 10.1111/j.1365-2036.2005.02311.x; Gonzalez-Huezo Maria S, 2006, Ann Hepatol, V5, P166; Graakjaer J, 2004, AGING CELL, V3, P97, DOI 10.1111/j.1474-9728.2004.00093.x; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hackett JA, 2002, ONCOGENE, V21, P619, DOI 10.1038/sj.onc.1205061; Hackett JA, 2001, CELL, V106, P275, DOI 10.1016/S0092-8674(01)00457-3; Hahn WC, 1999, NATURE, V400, P464, DOI 10.1038/22780; HASTIE ND, 1990, NATURE, V346, P866, DOI 10.1038/346866a0; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; HOSGOOD HD, 2009, LUNG CANC       0312; Huda N, 2007, AGING CELL, V6, P709, DOI 10.1111/j.1474-9726.2007.00330.x; Jang JS, 2008, CANCER SCI, V99, P1385, DOI 10.1111/j.1349-7006.2008.00831.x; Jiang H, 2008, P NATL ACAD SCI USA, V105, P11299, DOI 10.1073/pnas.0801457105; Knight S, 1998, BRIT J HAEMATOL, V103, P990, DOI 10.1046/j.1365-2141.1998.01103.x; Langston AA, 1996, BRIT J HAEMATOL, V92, P758, DOI 10.1046/j.1365-2141.1996.424984.x; Liu XN, 2009, CANCER SCI, V100, P1300, DOI 10.1111/j.1349-7006.2009.01169.x; Marrone A, 2004, BLOOD, V104, P3936, DOI 10.1182/blood-2004-05-1829; McKay JD, 2008, NAT GENET, V40, P1404, DOI 10.1038/ng.254; Mirabello L, 2009, AGING CELL, V8, P405, DOI 10.1111/j.1474-9726.2009.00485.x; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; MOYZIS RK, 1988, P NATL ACAD SCI USA, V85, P6622, DOI 10.1073/pnas.85.18.6622; Mushiroda T, 2008, J MED GENET, V45, P654, DOI 10.1136/jmg.2008.057356; Nanni S, 2002, J CLIN INVEST, V110, P219, DOI 10.1172/JCI200215552; Notaro R, 1997, P NATL ACAD SCI USA, V94, P13782, DOI 10.1073/pnas.94.25.13782; O'Donnell CJ, 2008, ARTERIOSCL THROM VAS, V28, P1165, DOI 10.1161/ATVBAHA.107.154849; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; OHYASHIKI JH, 1994, CANCER RES, V54, P3557; OLOVNIKO.AM, 1971, DOKL AKAD NAUK SSSR+, V201, P1496; PHILLIPS RJ, 1992, BRIT J DERMATOL, V127, P278, DOI 10.1111/j.1365-2133.1992.tb00128.x; Qazilbash MH, 1997, ACTA HAEMATOL-BASEL, V97, P164; Rafnar T, 2009, NAT GENET, V41, P221, DOI 10.1038/ng.296; Risques RA, 2007, CANCER EPIDEM BIOMAR, V16, P2649, DOI 10.1158/1055-9965.EPI-07-0624; Rocha V, 1998, BRIT J HAEMATOL, V103, P243, DOI 10.1046/j.1365-2141.1998.00949.x; Sarin KY, 2005, NATURE, V436, P1048, DOI 10.1038/nature03836; Satoh M, 2009, CLIN SCI, V116, P827, DOI 10.1042/CS20080404; Savage SA, 2007, BRIT J CANCER, V97, P832, DOI 10.1038/sj.bjc.6603934; Savage SA, 2008, AM J HUM GENET, V82, P501, DOI 10.1016/j.ajhg.2007.10.004; Savage Sharon A, 2009, Pediatr Blood Cancer, V53, P520, DOI 10.1002/pbc.22061; Sharpless NE, 2004, J CLIN INVEST, V113, P160, DOI 10.1172/JCI200420761; Shete S, 2009, NAT GENET, V41, P899, DOI 10.1038/ng.407; Sieglova Z, 2004, LEUKEMIA RES, V28, P1013, DOI 10.1016/j.leukres.2003.11.020; SLAGBOOM PE, 1994, AM J HUM GENET, V55, P876; Stacey SN, 2009, NAT GENET, V41, P909, DOI 10.1038/ng.412; Stewart SA, 2006, ANNU REV CELL DEV BI, V22, P531, DOI 10.1146/annurev.cellbio.22.010305.104518; Swiggers SJJ, 2006, GENE CHROMOSOME CANC, V45, P247, DOI 10.1002/gcc.20286; SZOSTAK JW, 1982, CELL, V29, P245, DOI 10.1016/0092-8674(82)90109-X; Talbot-Smith A, 2009, THORAX, V64, P440, DOI 10.1136/thx.2008.099796; Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104; Usselmann B, 2001, AM J GASTROENTEROL, V96, P1106; VAZIRI H, 1994, P NATL ACAD SCI USA, V91, P9857, DOI 10.1073/pnas.91.21.9857; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Vulliamy T, 2004, NAT GENET, V36, P447, DOI 10.1038/ng1346; Vulliamy TJ, 2001, BLOOD CELL MOL DIS, V27, P353, DOI 10.1006/bcmd.2001.0389; Vulliamy T, 2008, P NATL ACAD SCI USA, V105, P8073, DOI 10.1073/pnas.0800042105; Walne AJ, 2007, HUM MOL GENET, V16, P1619, DOI 10.1093/hmg/ddm111; Woo J, 2009, AGE AGEING, V38, P553, DOI 10.1093/ageing/afp098; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Wynn RF, 1998, LANCET, V351, P178, DOI 10.1016/S0140-6736(97)08256-1; Yamaguchi H, 2005, NEW ENGL J MED, V352, P1413, DOI 10.1056/NEJMoa042980; Yamaguchi H, 2003, BLOOD, V102, P916, DOI 10.1182/blood-2003-01-0335	101	568	591	1	53	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 10	2009	361	24					2353	2365		10.1056/NEJMra0903373	http://dx.doi.org/10.1056/NEJMra0903373			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529VS	20007561	Green Accepted			2022-12-28	WOS:000272547600009
J	Qi, Y; Spong, MC; Nam, K; Banerjee, A; Jiralerspong, S; Karplus, M; Verdine, GL				Qi, Yan; Spong, Marie C.; Nam, Kwangho; Banerjee, Anirban; Jiralerspong, Sao; Karplus, Martin; Verdine, Gregory L.			Encounter and extrusion of an intrahelical lesion by a DNA repair enzyme	NATURE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; EMPIRICAL FORCE-FIELD; ESCHERICHIA-COLI; FREE-ENERGY; STRUCTURAL BASIS; NUCLEIC-ACIDS; FPG PROTEIN; DAMAGED DNA; DUPLEX DNA; RECOGNITION	How living systems detect the presence of genotoxic damage embedded in a million-fold excess of undamaged DNA is an unresolved question in biology. Here we have captured and structurally elucidated a base-excision DNA repair enzyme, MutM, at the stage of initial encounter with a damaged nucleobase, 8-oxoguanine (oxoG), nested within a DNA duplex. Three structures of intrahelical oxoG-encounter complexes are compared with sequence-matched structures containing a normal G base in place of an oxoG lesion. Although the protein-DNA interfaces in the matched complexes differ by only two atoms-those that distinguish oxoG from G-their pronounced structural differences indicate that MutM can detect a lesion in DNA even at the earliest stages of encounter. All-atom computer simulations show the pathway by which encounter of the enzyme with the lesion causes extrusion from the DNA duplex, and they elucidate the critical free energy difference between oxoG and G along the extrusion pathway.	[Spong, Marie C.; Nam, Kwangho; Banerjee, Anirban; Jiralerspong, Sao; Karplus, Martin; Verdine, Gregory L.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Verdine, Gregory L.] Harvard Univ, Dept Stem Cell & Regenerat Biol, Cambridge, MA 02138 USA; [Qi, Yan; Verdine, Gregory L.] Harvard Univ, Sch Med, Grad Program Biophys, Boston, MA 02115 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Chem Biol Initiat, Boston, MA 02115 USA; [Verdine, Gregory L.] Dana Farber Canc Inst, Program Canc Chem Biol, Boston, MA 02115 USA; [Karplus, Martin] Univ Strasbourg, ISIS, F-67000 Strasbourg, France	Harvard University; Harvard University; Harvard University; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Karplus, M (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	marci@tammy.harvard.edu; gregory_verdine@harvard.edu	Banerjee, Anirban/AAC-4286-2020	banerjee, anirban/0000-0003-1494-6801; Jiralerspong, Sao/0000-0001-6032-3109; Banerjee, Anirban/0000-0002-9314-2862	NIH [GM044853, GM047467, CA100742, GM030804]; the National Science Foundation; Howard Hughes Medical Institute; National Cancer Center; NATIONAL CANCER INSTITUTE [R01CA100742] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM030804, R01GM030804, R01GM044853, P01GM047467] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); the National Science Foundation(National Science Foundation (NSF)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the NIH: GM044853, GM047467, CA100742 ( G. L. V.) and GM030804 ( M. K.). Y. Q. is supported by a predoctoral fellowship from the National Science Foundation; M. C. S. by a predoctoral fellowship from the Howard Hughes Medical Institute; K. N. by a postdoctoral fellowship from National Cancer Center. We thank the staff of the NSLS, APS and CHESS synchrotron facilities. These experiments made use of the computing facilities at NERSC and Harvard FAS. We are grateful to J. Jin for experimental assistance and J. Pu, V. Ovchinnikov and other members of the Karplus and Verdine groups for helpful advice.	Allen M. P., 1989, COMPUTER SIMULATION, DOI DOI 10.1093/OSO/9780198803195.001.0001; Banavali NK, 2002, J MOL BIOL, V319, P141, DOI 10.1016/S0022-2836(02)00194-8; Banerjee A, 2006, SCIENCE, V311, P1153, DOI 10.1126/science.1120288; Barnes DE, 2004, ANNU REV GENET, V38, P445, DOI 10.1146/annurev.genet.38.072902.092448; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Blainey PC, 2006, P NATL ACAD SCI USA, V103, P5752, DOI 10.1073/pnas.0509723103; Bowman BR, 2008, STRUCTURE, V16, P1166, DOI 10.1016/j.str.2008.04.012; BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211; Bruner SD, 2000, NATURE, V403, P859, DOI 10.1038/35002510; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cheng XL, 2005, J AM CHEM SOC, V127, P13906, DOI 10.1021/ja052542s; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fedorova OS, 2002, BIOCHEMISTRY-US, V41, P1520, DOI 10.1021/bi011524u; Foloppe N, 2000, J COMPUT CHEM, V21, P86, DOI 10.1002/(SICI)1096-987X(20000130)21:2<86::AID-JCC2>3.0.CO;2-G; Fromme JC, 2004, ADV PROTEIN CHEM, V69, P1; Fromme JC, 2003, J BIOL CHEM, V278, P51543, DOI 10.1074/jbc.M307768200; GROLLMAN AP, 1993, TRENDS GENET, V9, P246, DOI 10.1016/0168-9525(93)90089-Z; Hsu GW, 2004, NATURE, V431, P217, DOI 10.1038/nature02908; Hu J, 2006, J CHEM PHYS, V125, DOI 10.1063/1.2335640; Hu J, 2008, P NATL ACAD SCI USA, V105, P4615, DOI 10.1073/pnas.0708058105; Ishchenko AA, 2002, BIOCHEMISTRY-US, V41, P7540, DOI 10.1021/bi0121297; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; KUMAR S, 1992, J COMPUT CHEM, V13, P1011, DOI 10.1002/jcc.540130812; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; LIPSCOMB LA, 1995, P NATL ACAD SCI USA, V92, P719, DOI 10.1073/pnas.92.3.719; Loeb LA, 2001, CANCER RES, V61, P3230; Macke TJ, 1998, ACS SYM SER, V682, P379; MacKerell AD, 2000, J COMPUT CHEM, V21, P105, DOI 10.1002/(SICI)1096-987X(20000130)21:2<105::AID-JCC3>3.0.CO;2-P; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Minetti CASA, 2003, J MOL BIOL, V328, P1047, DOI 10.1016/S0022-2836(03)00365-6; ODA Y, 1991, NUCLEIC ACIDS RES, V19, P1407, DOI 10.1093/nar/19.7.1407; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paci E, 1999, J MOL BIOL, V288, P441, DOI 10.1006/jmbi.1999.2670; Painter J, 2006, ACTA CRYSTALLOGR D, V62, P439, DOI 10.1107/S0907444906005270; Parker JB, 2007, NATURE, V449, P433, DOI 10.1038/nature06131; Plum GE, 1995, BIOCHEMISTRY-US, V34, P16148, DOI 10.1021/bi00049a030; Priyakumar UD, 2006, J AM CHEM SOC, V128, P678, DOI 10.1021/ja056445a; Rajamani R, 2003, J COMPUT CHEM, V24, P1775, DOI 10.1002/jcc.10315; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; SCHLITTER J, 1993, MOL SIMULAT, V10, P291, DOI 10.1080/08927029308022170; SHIBUTANI S, 1991, NATURE, V349, P431, DOI 10.1038/349431a0; TORRIE GM, 1977, J COMPUT PHYS, V23, P187, DOI 10.1016/0021-9991(77)90121-8; van der Vaart A, 2005, J CHEM PHYS, V122, DOI 10.1063/1.1861885; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang W, 2006, DNA REPAIR, V5, P654, DOI 10.1016/j.dnarep.2006.02.004; Zharkov DO, 2008, CELL MOL LIFE SCI, V65, P1544, DOI 10.1007/s00018-008-7543-2	47	116	116	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 10	2009	462	7274					762	U79		10.1038/nature08561	http://dx.doi.org/10.1038/nature08561			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	529ZZ	20010681	Green Accepted			2022-12-28	WOS:000272559900032
J	Judge, DP				Judge, Daniel P.			Use of Genetics in the Clinical Evaluation of Cardiomyopathy	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ASSOCIATION TASK-FORCE; HYPERTROPHIC CARDIOMYOPATHY; DILATED CARDIOMYOPATHY; ALPHA-GALACTOSIDASE; AMERICAN-COLLEGE; SUDDEN-DEATH; DISEASE; DIAGNOSIS; SEQUENCE; GENOME	Inherited forms of cardiomyopathy are frequently responsible for heart failure that is otherwise unexplained. Evaluation of familial cardiomyopathy should include not only the individual patient, but also the pattern of inheritance within the family and assessment for the presence of syndromic features. The last 10 years have seen remarkable advances in genetics. Improvements in technology have lowered costs, such that clinical use of genetic testing is rapidly expanding. Genetic counseling about the potential risks and benefits of such testing is an important part of the care of individuals and families with inherited heart disease. Among inherited types of cardiomyopathy, the likelihood of finding a responsible gene mutation varies. Both hypertrophic and right ventricular forms of cardiomyopathy have a relatively high likelihood of finding a responsible gene mutation when testing is properly applied. Because of prominent genetic heterogeneity in familial dilated cardiomyopathy, recognition of pathogenic mutations is more challenging. With or without genetic testing, screening of family members who are at risk for an inherited form of cardiomyopathy leads to earlier identification, earlier treatment, and improved outcomes. JAMA. 2009; 302(22): 2471-2476	Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA	Johns Hopkins University	Judge, DP (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Ross Bldg 1049,720 Rutland Ave, Baltimore, MD 21205 USA.	djudge@jhmi.edu		Judge, Daniel/0000-0002-3407-0248				Arad M, 2005, NEW ENGL J MED, V352, P362, DOI 10.1056/NEJMoa033349; Becane HM, 2000, PACE, V23, P1661, DOI 10.1046/j.1460-9592.2000.01661.x; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; BLOOMFIELD SE, 1978, JAMA-J AM MED ASSOC, V240, P647, DOI 10.1001/jama.240.7.647; BONNE G, 1995, NAT GENET, V11, P438, DOI 10.1038/ng1295-438; Charron P, 2004, PRENATAL DIAG, V24, P701, DOI 10.1002/pd.969; Cheitlin MD, 2003, CIRCULATION, V108, P1146, DOI 10.1161/01.CIR.0000073597.57414.A9; CODD MB, 1989, CIRCULATION, V80, P564, DOI 10.1161/01.CIR.80.3.564; Desnick RJ, 2003, ANN INTERN MED, V138, P338, DOI 10.7326/0003-4819-138-4-200302180-00014; Duboc D, 2005, J AM COLL CARDIOL, V45, P855, DOI 10.1016/j.jacc.2004.09.078; Duboc D, 2007, AM HEART J, V154, P596, DOI 10.1016/j.ahj.2007.05.014; Eng CM, 2001, NEW ENGL J MED, V345, P9, DOI 10.1056/NEJM200107053450102; Falk RH, 2005, CIRCULATION, V112, P2047, DOI 10.1161/CIRCULATIONAHA.104.489187; Felker GM, 2000, NEW ENGL J MED, V342, P1077, DOI 10.1056/NEJM200004133421502; Goerss JB, 1995, EUR HEART J, V16, P2, DOI 10.1093/eurheartj/16.suppl_O.2; Grunig E, 1998, J AM COLL CARDIOL, V31, P186, DOI 10.1016/S0735-1097(97)00434-8; Hall MJ, 2009, CANCER, V115, P2804, DOI 10.1002/cncr.24332; Hall MJ, 2009, CANCER-AM CANCER SOC, V115, P2222, DOI 10.1002/cncr.24200; Hershberger RE, 2009, J CARD FAIL, V15, P83, DOI 10.1016/j.cardfail.2009.01.006; Jacobson DR, 1997, NEW ENGL J MED, V336, P466, DOI 10.1056/NEJM199702133360703; Judge DP, 2008, J CARDIOVASC TRANSL, V1, P144, DOI 10.1007/s12265-008-9025-1; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Margulies M, 2006, NATURE, V441, P120, DOI 10.1038/nature04726; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Maron BJ, 2009, JAMA-J AM MED ASSOC, V301, P1253, DOI 10.1001/jama.2009.371; Maron BJ, 2003, NEW ENGL J MED, V349, P1064, DOI 10.1056/NEJMra022783; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Mestroni L, 1999, EUR HEART J, V20, P93, DOI 10.1053/euhj.1998.1145; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Morita H, 2005, J CLIN INVEST, V115, P518, DOI 10.1172/JCI200524351; NICKLAS JM, 1992, NEW ENGL J MED, V327, P685; Offit K, 2004, JAMA-J AM MED ASSOC, V292, P1469, DOI 10.1001/jama.292.12.1469; Parks SB, 2008, AM HEART J, V156, P161, DOI 10.1016/j.ahj.2008.01.026; Pomfret EA, 1998, TRANSPLANTATION, V65, P918, DOI 10.1097/00007890-199804150-00010; ROMEO G, 1970, SCIENCE, V170, P180, DOI 10.1126/science.170.3954.180; Sermon K, 2004, LANCET, V363, P1633, DOI 10.1016/S0140-6736(04)16209-0; Southern EM, 1996, TRENDS GENET, V12, P110, DOI 10.1016/0168-9525(96)81422-3; SUTHERLAND GR, 1995, P NATL ACAD SCI USA, V92, P3636, DOI 10.1073/pnas.92.9.3636; Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6; van Tintelen JP, 2007, AM HEART J, V154, P1130, DOI 10.1016/j.ahj.2007.07.038; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884; WHITLEY CB, 1983, JAMA-J AM MED ASSOC, V249, P2177, DOI 10.1001/jama.1983.03330400029012; Zipes DP, 2006, CIRCULATION, V114, pE385, DOI 10.1161/CIRCULATIONAHA.106.178233; 2008, NATURE, V456, P1	46	37	37	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 9	2009	302	22					2471	2476		10.1001/jama.2009.1787	http://dx.doi.org/10.1001/jama.2009.1787			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	529MD	19996403				2022-12-28	WOS:000272520500027
J	Reich, PB				Reich, Peter B.			Elevated CO2 Reduces Losses of Plant Diversity Caused by Nitrogen Deposition	SCIENCE			English	Article							SPECIES RICHNESS; GRASSLAND RESPONSES; COMPETITION; ENRICHMENT; LIGHT; PHOTOSYNTHESIS; FERTILIZATION; PRODUCTIVITY; ECOSYSTEMS; MECHANISMS	The interactive effects of rising atmospheric carbon dioxide (CO2) concentrations and elevated nitrogen (N) deposition on plant diversity are not well understood. This is of concern because both factors are important components of global environmental change and because each might suppress diversity, with their combined effects possibly additive or synergistic. In a long-term open-air experiment, grassland assemblages planted with 16 species were grown under all combinations of ambient and elevated CO2 and ambient and elevated N. Over 10 years, elevated N reduced species richness by 16% at ambient CO2 but by just 8% at elevated CO2. This resulted from multiple effects of CO2 and N on plant traits and soil resources that altered competitive interactions among species. Elevated CO2 thus ameliorated the negative effects of N enrichment on species richness.	Univ Minnesota, Dept Forest Resources, St Paul, MN 55108 USA	University of Minnesota System; University of Minnesota Twin Cities	Reich, PB (corresponding author), Univ Minnesota, Dept Forest Resources, 1530 Cleveland Ave N, St Paul, MN 55108 USA.	preich@umn.edu		Reich, Peter/0000-0003-4424-662X	U. S. Department of Energy, National Institute for Climate Change Research; NSF, Long Term Ecological Research (LTER), Biocomplexity, and Long Term Research in Environmental Biology (LTREB) programs	U. S. Department of Energy, National Institute for Climate Change Research(United States Department of Energy (DOE)); NSF, Long Term Ecological Research (LTER), Biocomplexity, and Long Term Research in Environmental Biology (LTREB) programs	Funding was provided by the U. S. Department of Energy, National Institute for Climate Change Research; and the NSF, Long Term Ecological Research (LTER), Biocomplexity, and Long Term Research in Environmental Biology (LTREB) programs. Thanks to S. Hobbie, K. Worm, J. Trost, and D. Bahauddin in particular, and to many others for their contributions to the BioCON project; and to R. Dybzinski, K. Suding, I. Woodward, and B. Medlyn for critiquing an earlier version of the manuscript.	Ainsworth EA, 2005, NEW PHYTOL, V165, P351, DOI 10.1111/j.1469-8137.2004.01224.x; Belote RT, 2004, NEW PHYTOL, V161, P827, DOI 10.1111/j.1469-8137.2004.00977.x; Clark CM, 2008, NATURE, V451, P712, DOI 10.1038/nature06503; Crawley MJ, 2005, AM NAT, V165, P179, DOI 10.1086/427270; Davis MA, 1999, PLANT ECOL, V145, P341, DOI 10.1023/A:1009802211896; Dybzinski R, 2007, AM NAT, V170, P305, DOI 10.1086/519857; Gough L, 2000, OIKOS, V89, P428, DOI 10.1034/j.1600-0706.2000.890302.x; Harpole WS, 2007, NATURE, V446, P791, DOI 10.1038/nature05684; Hautier Y, 2009, SCIENCE, V324, P636, DOI 10.1126/science.1169640; IPCC (Intergovernmental Panel on Climate Change), 2007, CLIM CHANG 2007 PHYS; Niklaus PA, 2004, ECOL MONOGR, V74, P491, DOI 10.1890/03-4047; Novotny AM, 2007, OECOLOGIA, V151, P687, DOI 10.1007/s00442-006-0599-5; Oren R, 2001, NATURE, V411, P469, DOI 10.1038/35078064; Potvin C, 1997, ECOLOGY, V78, P666; Rajaniemi TK, 2003, J ECOL, V91, P407, DOI 10.1046/j.1365-2745.2003.00768.x; Reich PB, 2006, NATURE, V440, P922, DOI 10.1038/nature04486; Reich PB, 2001, NATURE, V410, P809, DOI 10.1038/35071062; Reich PB, 2006, ANNU REV ECOL EVOL S, V37, P611, DOI 10.1146/annurev.ecolsys.37.091305.110039; Shaw MR, 2002, SCIENCE, V298, P1987, DOI 10.1126/science.1075312; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Stevens CJ, 2006, GLOBAL CHANGE BIOL, V12, P1823, DOI 10.1111/j.1365-2486.2006.01217.x; Stevens CJ, 2004, SCIENCE, V303, P1876, DOI 10.1126/science.1094678; Suding KN, 2005, P NATL ACAD SCI USA, V102, P4387, DOI 10.1073/pnas.0408648102; WEDIN D, 1993, ECOL MONOGR, V63, P199, DOI 10.2307/2937180; Zavaleta ES, 2003, P NATL ACAD SCI USA, V100, P7650, DOI 10.1073/pnas.0932734100	25	109	124	3	182	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 4	2009	326	5958					1399	1402		10.1126/science.1178820	http://dx.doi.org/10.1126/science.1178820			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	527EX	19965757				2022-12-28	WOS:000272351100042
J	Konig, R; Stertz, S; Zhou, Y; Inoue, A; Hoffmann, HH; Bhattacharyya, S; Alamares, JG; Tscherne, DM; Ortigoza, MB; Liang, YH; Gao, QS; Andrews, SE; Bandyopadhyay, S; De Jesus, P; Tu, BP; Pache, L; Shih, C; Orth, A; Bonamy, G; Miraglia, L; Ideker, T; Garcia-Sastre, A; Young, JAT; Palese, P; Shaw, ML; Chanda, SK				Koenig, Renate; Stertz, Silke; Zhou, Yingyao; Inoue, Atsushi; Hoffmann, H. -Heinrich; Bhattacharyya, Suchita; Alamares, Judith G.; Tscherne, Donna M.; Ortigoza, Mila B.; Liang, Yuhong; Gao, Qinshan; Andrews, Shane E.; Bandyopadhyay, Sourav; De Jesus, Paul; Tu, Buu P.; Pache, Lars; Shih, Crystal; Orth, Anthony; Bonamy, Ghislain; Miraglia, Loren; Ideker, Trey; Garcia-Sastre, Adolfo; Young, John A. T.; Palese, Peter; Shaw, Megan L.; Chanda, Sumit K.			Human host factors required for influenza virus replication	NATURE			English	Article							FUNCTIONAL GENOMIC SCREEN; PROTEIN-KINASE-II; INFECTION; IDENTIFICATION; RNA	Influenza A virus is an RNA virus that encodes up to 11 proteins and this small coding capacity demands that the virus use the host cellular machinery for many aspects of its life cycle(1). Knowledge of these host cell requirements not only informs us of the molecular pathways exploited by the virus but also provides further targets that could be pursued for antiviral drug development. Here we use an integrative systems approach, based on genome-wide RNA interference screening, to identify 295 cellular cofactors required for early-stage influenza virus replication. Within this group, those involved in kinase-regulated signalling, ubiquitination and phosphatase activity are the most highly enriched, and 181 factors assemble into a highly significant host-pathogen interaction network. Moreover, 219 of the 295 factors were confirmed to be required for efficient wild-type influenza virus growth, and further analysis of a subset of genes showed 23 factors necessary for viral entry, including members of the vacuolar ATPase (vATPase) and COPI-protein families, fibroblast growth factor receptor (FGFR) proteins, and glycogen synthase kinase 3 (GSK3)-beta. Furthermore, 10 proteins were confirmed to be involved in post-entry steps of influenza virus replication. These include nuclear import components, proteases, and the calcium/calmodulin-dependent protein kinase (CaM kinase) II beta (CAMK2B). Notably, growth of swine-origin H1N1 influenza virus is also dependent on the identified host factors, and we show that small molecule inhibitors of several factors, including vATPase and CAMK2B, antagonize influenza virus replication.	[Koenig, Renate; Inoue, Atsushi; De Jesus, Paul; Pache, Lars; Shih, Crystal; Chanda, Sumit K.] Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, La Jolla, CA 92037 USA; [Bhattacharyya, Suchita; Young, John A. T.] Salk Inst Biol Studies, Nomis Ctr Immunobiol & Microbial Pathogenesis, La Jolla, CA 92037 USA; [Andrews, Shane E.] Salk Inst Biol Studies, Gene Express Lab, La Jolla, CA 92037 USA; [Stertz, Silke; Hoffmann, H. -Heinrich; Alamares, Judith G.; Tscherne, Donna M.; Ortigoza, Mila B.; Liang, Yuhong; Gao, Qinshan; Garcia-Sastre, Adolfo; Palese, Peter; Shaw, Megan L.] Mt Sinai Sch Med, Dept Microbiol, New York, NY 10029 USA; [Garcia-Sastre, Adolfo; Palese, Peter] Mt Sinai Sch Med, Dept Med, Div Infect Dis, New York, NY 10029 USA; [Garcia-Sastre, Adolfo] Mt Sinai Sch Med, Global Hlth & Emerging Pathogens Inst, New York, NY 10029 USA; [Zhou, Yingyao; Tu, Buu P.; Orth, Anthony; Bonamy, Ghislain; Miraglia, Loren] Genom Inst, San Diego, CA 92121 USA; [Zhou, Yingyao; Tu, Buu P.; Orth, Anthony; Bonamy, Ghislain; Miraglia, Loren] Novartis Res Fdn, San Diego, CA 92121 USA; [Bandyopadhyay, Sourav; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Bandyopadhyay, Sourav; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA	Sanford Burnham Prebys Medical Discovery Institute; Salk Institute; Salk Institute; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Novartis; University of California System; University of California San Diego; University of California System; University of California San Diego	Chanda, SK (corresponding author), Burnham Inst Med Res, Infect & Inflammatory Dis Ctr, 10901 N Torrey Pines Rd, La Jolla, CA 92037 USA.	megan.shaw@mssm.edu; schanda@burnham.org	Califano, Andrea/F-7239-2012; König, Renate/AAB-8918-2019; Stertz, Silke/D-5254-2015; Bhattacharyya, Suchita/V-5390-2019	König, Renate/0000-0003-4882-9179; Bhattacharyya, Suchita/0000-0002-6775-630X; Stertz, Silke/0000-0001-9491-2892; Palese, Peter/0000-0002-0337-5823; Shaw, Megan/0000-0002-1267-0891; Bonamy, Ghislain/0000-0002-2826-5225; Garcia-Sastre, Adolfo/0000-0002-6551-1827; Ortigoza, Mila/0000-0002-9428-1469; Young, John/0000-0003-1824-2561; Ideker, Trey/0000-0002-1708-8454; Brum Ortigoza, Mila/0000-0002-4522-0184	National Institutes of Health (NIH), (Northeast Biodefense Center) [U01 AI1074539, U54 AI057158]; National Institutes of Health (NIH) [HHSN272200900032C, HHSN266200700010C, 1 PO1 AI058113, 1R21AI083673, 1F32AI081428, 1 T32 AI07647, U54 AI057159, 1S10RR09145-01]; German Research Foundation; Mount Sinai Medical Scientist Training Program [T32 GM007280]; Japan Society for the Promotion of Science; NIH-NCI [5R24 CA095823-04]; NSF [DBI-9724504]; NATIONAL CANCER INSTITUTE [R24CA095823] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR009145] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057159, P01AI058113, F32AI081428, U01AI074539, R21AI083673, U54AI057158, T32AI007647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007280] Funding Source: NIH RePORTER	National Institutes of Health (NIH), (Northeast Biodefense Center)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); German Research Foundation(German Research Foundation (DFG)); Mount Sinai Medical Scientist Training Program; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); NIH-NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NSF(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health (NIH) grants U01 AI1074539, U54 AI057158 (Northeast Biodefense Center), HHSN272200900032C, HHSN266200700010C, 1 PO1 AI058113 and 1R21AI083673. S. S. is supported by a fellowship from the German Research Foundation and D. M. T. is supported by NIH fellowship 1F32AI081428. M.B.O. is supported by NIH training grant 1 T32 AI07647 and Mount Sinai Medical Scientist Training Program T32 GM007280. A. I. is supported by a Japan Society for the Promotion of Science Fellowship. The small molecule screen was performed at the National Screening Laboratory for the Regional Centers of Excellence in Biodefense (NSRB), Harvard Medical School, Boston and was supported by NIH grant U54 AI057159. Confocal laser scanning microscopy was performed at the MSSM-Microscopy Shared Resource Facility, supported with funding from NIH-NCI shared resources grant (5R24 CA095823-04), NSF Major Research Instrumentation grant (DBI-9724504) and NIH shared instrumentation grant (1S10RR09145-01). We thank R. Fouchier for providing influenza A/Netherlands/602/2009 (H1N1) virus.	Aniento F, 1996, J CELL BIOL, V133, P29, DOI 10.1083/jcb.133.1.29; Aza-Blanc P, 2003, MOL CELL, V12, P627, DOI 10.1016/S1097-2765(03)00348-4; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Beer C, 2005, J VIROL, V79, P10776, DOI 10.1128/JVI.79.16.10776-10787.2005; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Chanda SK, 2003, P NATL ACAD SCI USA, V100, P12153, DOI 10.1073/pnas.1934839100; Colbran RJ, 2004, BIOCHEM J, V378, P1, DOI 10.1042/BJ20031547; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Kutay U, 1997, CELL, V90, P1061, DOI 10.1016/S0092-8674(00)80372-4; Layne SP, 2009, SCIENCE, V323, P1560, DOI 10.1126/science.323.5921.1560; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Marsh GA, 2007, J VIROL, V81, P9727, DOI 10.1128/JVI.01144-07; MCCLURE MO, 1990, J GEN VIROL, V71, P767, DOI 10.1099/0022-1317-71-4-767; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sato S, 2000, P NATL ACAD SCI USA, V97, P10832, DOI 10.1073/pnas.170276797; Sessions OM, 2009, NATURE, V458, P1047, DOI 10.1038/nature07967; Sui BQ, 2009, VIROLOGY, V387, P473, DOI 10.1016/j.virol.2009.02.046; SUMI M, 1991, BIOCHEM BIOPH RES CO, V181, P968, DOI 10.1016/0006-291X(91)92031-E; Tai AW, 2009, CELL HOST MICROBE, V5, P298, DOI 10.1016/j.chom.2009.02.001; TSCHERNE DM, 2009, J VIROL METHODS 1029, DOI DOI 10.1016/J.JVIROMET; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wang TT, 2009, CELL, V137, P983, DOI 10.1016/j.cell.2009.05.032; WHITNEY JA, 1995, CELL, V83, P703; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	29	620	656	2	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					813	817		10.1038/nature08699	http://dx.doi.org/10.1038/nature08699			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20027183	Green Accepted, Green Submitted			2022-12-28	WOS:000274394300041
J	Kutner, JS				Kutner, Jean S.			An 86-Year-Old Woman With Cardiac Cachexia Contemplating the End of Her Life Review of Hospice Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							SERIOUSLY ILL PATIENTS; ADVANCED HEART-FAILURE; IMPLANTABLE DEFIBRILLATORS; PALLIATIVE CARE; DECISION-MAKING; MEDICARE PROGRAM; TERMINAL CARE; NEAR-DEATH; FAMILIES; PREFERENCES	Mrs H is an 86-year-old woman with progressive congestive heart failure and multiple chronic conditions who is experiencing worsening function and quality of life despite maximum medical therapies. She seeks advice regarding control over the circumstances of the end of her life, be it by suicide or under hospice care. Typical of US populations older than 65 years with multiple chronic health conditions and functional decline who are facing the end of life, Mrs H's concerns are particularly about quality of life, not being a burden on loved ones, and maintaining control. As she demonstrates, psychological, existential, and social factors, particularly fear of being a burden, are more common reasons for desiring hastened death than those related directly to physical symptoms. Hospice, which provides a multidisciplinary approach to care at the end of life, can assist Mrs H and her family in making decisions that are consistent with her goals. JAMA. 2010;303(4):349-356	Univ Colorado Denver, Sch Med, Dept Med, Div Gen Internal Med, Aurora, CO 80045 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus	Kutner, JS (corresponding author), Univ Colorado Denver, Sch Med, Dept Med, Div Gen Internal Med, Acad Off 1,Box B180,12631 E 17th Ave, Aurora, CO 80045 USA.	jean.kutner@ucdenver.edu			NIA NIH HHS [1K07 AG030337-01A2] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [K07AG030337] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alla F, 2000, AM HEART J, V139, P895, DOI 10.1016/S0002-8703(00)90023-1; American Heart Association, 2009, HEART DIS STROK STAT; [Anonymous], DARTMOUTH ATLAS HLTH; Braun TC, 1999, J PAIN SYMPTOM MANAG, V18, P126, DOI 10.1016/S0885-3924(99)00038-X; Campbell DE, 2004, ANN INTERN MED, V140, P269, DOI 10.7326/0003-4819-140-4-200402170-00009; Carlson MDA, 2008, J PAIN SYMPTOM MANAG, V36, P107, DOI 10.1016/j.jpainsymman.2007.09.014; Carlson MDA, 2007, HEALTH SERV RES, V42, P1672, DOI 10.1111/j.1475-6773.2006.00685.x; CARPENTER S, 2009, NY TIMES        0330; Casarett D, 2006, J AM GERIATR SOC, V54, P472, DOI 10.1111/j.1532-5415.2005.00628.x; Casarett D, 2005, J AM GERIATR SOC, V53, P249, DOI 10.1111/j.1532-5415.2005.53110.x; Casarett David J, 2003, Am J Hosp Palliat Care, V20, P205, DOI 10.1177/104990910302000309; Casarett DJ, 2004, J AM GERIATR SOC, V52, P1923, DOI 10.1111/j.1532-5415.2004.52520.x; Christakis NA, 2003, SOC SCI MED, V57, P465, DOI 10.1016/S0277-9536(02)00370-2; Christakis NA, 2000, BRIT MED J, V320, P469, DOI 10.1136/bmj.320.7233.469; Connor SR, 2004, J PAIN SYMPTOM MANAG, V28, P316, DOI 10.1016/j.jpainsymman.2004.07.003; Connor SR, 2007, J PAIN SYMPTOM MANAG, V33, P238, DOI 10.1016/j.jpainsymman.2006.10.010; Currow DC, 2007, J AM GERIATR SOC, V55, P590, DOI 10.1111/j.1532-5415.2007.01124.x; Dougherty CM, 2007, J CARDIOVASC NURS, V22, P480, DOI 10.1097/01.JCN.0000297384.36873.52; Downey L, 2009, J PAIN SYMPTOM MANAG, V37, P175, DOI 10.1016/j.jpainsymman.2008.02.012; Emanuel EJ, 2000, ANN INTERN MED, V132, P451, DOI 10.7326/0003-4819-132-6-200003210-00005; Ezekowitz JA, 2008, AM J CARDIOL, V102, P79, DOI 10.1016/j.amjcard.2008.02.102; Formiga F, 2004, QJM-INT J MED, V97, P803, DOI 10.1093/qjmed/hch135; Fox E, 1999, JAMA-J AM MED ASSOC, V282, P1638, DOI 10.1001/jama.282.17.1638; Fried TR, 2002, NEW ENGL J MED, V346, P1061, DOI 10.1056/NEJMsa012528; Fried TR, 1999, ANN INTERN MED, V131, P109, DOI 10.7326/0003-4819-131-2-199907200-00006; Ganzini L, 2003, NEW ENGL J MED, V349, P359, DOI 10.1056/NEJMsa035086; Ganzini L, 2000, NEW ENGL J MED, V342, P557, DOI 10.1056/NEJM200002243420806; Goldstein N, 2009, J AM COLL CARDIOL, V54, P371, DOI 10.1016/j.jacc.2009.04.030; Goldstein NE, 2008, J GEN INTERN MED, V23, P7, DOI 10.1007/s11606-007-0239-8; Goldstein NE, 2008, J GEN INTERN MED, V23, P2, DOI 10.1007/s11606-007-0237-x; Goldstein NE, 2004, ANN INTERN MED, V141, P835, DOI 10.7326/0003-4819-141-11-200412070-00006; Goodlin SJ, 2004, J CARD FAIL, V10, P200, DOI 10.1016/j.cardfail.2003.09.006; Hanchate A, 2009, ARCH INTERN MED, V169, P493, DOI 10.1001/archinternmed.2008.616; Heidenreich PA, 2006, J AM COLL CARDIOL, V47, P752, DOI 10.1016/j.jacc.2005.11.021; Hudson PL, 2006, PALLIATIVE MED, V20, P693, DOI 10.1177/0269216306071799; Huynh BC, 2008, J AM GERIATR SOC, V56, P1111, DOI 10.1111/j.1532-5415.2008.01756.x; Huynh BC, 2006, ARCH INTERN MED, V166, P1892, DOI 10.1001/archinte.166.17.1892; Jong P, 2002, ARCH INTERN MED, V162, P1689, DOI 10.1001/archinte.162.15.1689; Kellett J, 2008, EUR J INTERN MED, V19, P155, DOI 10.1016/j.ejim.2007.09.002; Kronman AC, 2008, J GEN INTERN MED, V23, P1330, DOI 10.1007/s11606-008-0638-5; Kung Hsiang-Ching, 2008, Natl Vital Stat Rep, V56, P1; Lee DS, 2003, JAMA-J AM MED ASSOC, V290, P2581, DOI 10.1001/jama.290.19.2581; Levenson JW, 2000, J AM GERIATR SOC, V48, pS101, DOI 10.1111/j.1532-5415.2000.tb03119.x; Levy WC, 2006, CIRCULATION, V113, P1424, DOI 10.1161/CIRCULATIONAHA.105.584102; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; Medicare Payment Advisory Commission, 2002, REP C MED BEN ACC HO; Morss S, 2008, J AM GERIATR SOC, V56, P124, DOI 10.1111/j.1532-5415.2007.01507.x; Mueller PS, 2008, PACE, V31, P560, DOI 10.1111/j.1540-8159.2008.01041.x; *NAT HOSP FDN, 2008, HOSP CAR CONS GUID S; *NAT HOSP PALL CAR, 2009, NHPCO FACTS FIG HOSP; National Consensus Project, 2009, CLIN PRACT GUID QUAL; *OR DEP HUM SERV, 2006, 8 ANN REP OR DEATH D; Quill TE, 2004, NEW ENGL J MED, V350, P2029, DOI 10.1056/NEJMp038216; Quill TE, 2000, ANN INTERN MED, V132, P408, DOI 10.7326/0003-4819-132-5-200003070-00012; Quill TE, 2000, JAMA-J AM MED ASSOC, V284, P2502, DOI 10.1001/jama.284.19.2502; Rhodes RL, 2008, J PAIN SYMPTOM MANAG, V35, P365, DOI 10.1016/j.jpainsymman.2007.12.004; Rosenfeld KE, 2000, J GEN INTERN MED, V15, P620, DOI 10.1046/j.1525-1497.2000.06289.x; Schockett ER, 2005, J PAIN SYMPTOM MANAG, V30, P400, DOI 10.1016/j.jpainsymman.2005.04.013; Singer PA, 1999, JAMA-J AM MED ASSOC, V281, P163, DOI 10.1001/jama.281.2.163; Smith MA, 2008, GERONTOLOGIST, V48, P25, DOI 10.1093/geront/48.1.25; Steinbrook R, 2008, NEW ENGL J MED, V359, P2513, DOI 10.1056/NEJMp0809394; Steinhauser KE, 2000, ANN INTERN MED, V132, P825, DOI 10.7326/0003-4819-132-10-200005160-00011; Stevenson J, 2004, BMJ-BRIT MED J, V329, P909, DOI 10.1136/bmj.329.7471.909; Taylor DH, 2007, SOC SCI MED, V65, P1466, DOI 10.1016/j.socscimed.2007.05.028; Teno J M, 2001, J Palliat Med, V4, P457, DOI 10.1089/109662101753381593; Teno JM, 2004, JAMA-J AM MED ASSOC, V291, P88, DOI 10.1001/jama.291.1.88; Teno JM, 2007, J PAIN SYMPTOM MANAG, V34, P120, DOI 10.1016/j.jpainsymman.2007.04.014; Teno JM, 2009, JAMA-J AM MED ASSOC, V301, P651, DOI 10.1001/jama.2009.109; Tsevat J, 1998, JAMA-J AM MED ASSOC, V279, P371, DOI 10.1001/jama.279.5.371; *US BUR CENS, US CENS DAT; US Department of Health and Human Services Centers for Medicare and Medicaid Services, 2008, FED REG, V73, P32087; Virnig BA, 2004, J AM GERIATR SOC, V52, P731, DOI 10.1111/j.1532-5415.2004.52213.x; Virnig BA, 2006, J PALLIAT MED, V9, P1292, DOI 10.1089/jpm.2006.9.1292; Weissman DE, 2004, JAMA-J AM MED ASSOC, V292, P1738, DOI 10.1001/jama.292.14.1738; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	75	11	11	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2010	303	4					349	356		10.1001/jama.2009.2015	http://dx.doi.org/10.1001/jama.2009.2015			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IC	20051558				2022-12-28	WOS:000273952800023
J	Blum, J; Winikoff, B; Raghavan, S; Dabash, R; Ramadan, MC; Dilbaz, B; Dao, B; Durocher, J; Yalvac, S; Diop, A; Dzuba, IG; Ngoc, NTN				Blum, Jennifer; Winikoff, Beverly; Raghavan, Sheila; Dabash, Rasha; Ramadan, Mohamed Cherine; Dilbaz, Berna; Dao, Blami; Durocher, Jill; Yalvac, Serdar; Diop, Ayisha; Dzuba, Ilana G.; Ngoc, Nguyen Thi Nhu			Treatment of post-partum haemorrhage with sublingual misoprostol versus oxytocin in women receiving prophylactic oxytocin: a double-blind, randomised, non-inferiority trial	LANCET			English	Article							RECTALLY ADMINISTERED MISOPROSTOL; INTRAUTERINE MISOPROSTOL; MANAGEMENT	Background Oxytocin, the gold-standard treatment for post-partum haemorrhage, needs refrigeration, intravenous infusion, and skilled providers for optimum use. Misoprostol, a potential alternative, is increasingly used ad hoc for treatment of post-partum haemorrhage; however, evidence is insufficient to lend support to recommendations for its use. This trial established whether sublingual misoprostol is non-inferior to intravenous oxytocin for treatment of post-partum haemorrhage in women receiving prophylactic oxytocin. Methods In this double-blind, non-inferiority trial, 31055 women exposed to prophylactic oxytocin had blood loss measured after vaginal delivery at five hospitals in Burkina Faso, Egypt, Turkey, and Vietnam (two secondary-level and three tertiary-level facilities). 809 (3%) women were diagnosed with post-partum haemorrhage and were randomly assigned to receive 800 mu g misoprostol (n=407) or 40 IU intravenous oxytocin (n=402). Providers and women were masked to treatment assignment. Primary endpoints were cessation of active bleeding within 20 min and additional blood loss of 300 mL or more after treatment. Clinical equivalence of misoprostol would be accepted if the upper bound of the 97.5% CI fell below the predefined non-inferiority margin of 6%. All outcomes were assessed from the time of initial treatment. This study is registered with ClinicalTrials.gov, number NCT00116350. Findings All randomly assigned participants were analysed. Active bleeding was controlled within 20 min after initial treatment for 363 (89%) women given misoprostol and 360 (90%) given oxytocin (relative risk [RR] 0.99, 95% CI 0.95-1.04; crude difference 0.4%, 95% CI -3.9 to 4.6). Additional blood loss of 300 mL or greater after treatment occurred for 139 (34%) women receiving misoprostol and 123 (31%) receiving oxytocin (RR 1.12, 95% CI 0.92-1.37). Shivering (152 [37%] vs 59 [15%]; RR 2.54, 95% CI 1.95-3.32) and fever (88 [22%] vs 59 [15%]; 1.47, 1.09-1.99) were significantly more common with misoprostol than with oxytocin. Six women had hysterectomies and two women died. Interpretation Misoprostol is clinically equivalent to oxytocin when used to stop excessive post-partum bleeding suspected to be due to uterine atony in women who have received oxytocin prophylactically during the third stage of labour.	[Blum, Jennifer; Winikoff, Beverly; Raghavan, Sheila; Dabash, Rasha; Durocher, Jill; Diop, Ayisha; Dzuba, Ilana G.] Gynu Hlth Projects, New York, NY 10010 USA; [Ramadan, Mohamed Cherine] El Gala Teaching Hosp, Dept Obstet & Gynecol, Cairo, Egypt; [Dilbaz, Berna; Yalvac, Serdar] MoH Etlik Zubeyde Hanim Womens Hlth Teaching & Re, Ankara, Turkey; [Dao, Blami] Ctr Hosp Souro Sanou, Dept Gynecol Obstet & Med Reprod, Bobo Dioulasso, Burkina Faso; [Ngoc, Nguyen Thi Nhu] Ctr Res & Consultancy Reprod Hlth, Ho Chi Minh City, Vietnam	Egyptian Knowledge Bank (EKB); General Organization of Teaching Hospitals & Institutes (GOTHI); Etlik Zubeyde Hanim Gynecology Education & Research Hospital	Blum, J (corresponding author), Gynu Hlth Projects, 15 E 26th St,Suite 801, New York, NY 10010 USA.	jblum@gynuity.org	YALVAC, SERDAR/B-9224-2016; DİLBAZ, BERNA/AAC-5818-2019; Dao, Blami/AAL-7704-2021	YALVAC, SERDAR/0000-0001-9941-4999; Dilbaz, Berna/0000-0003-1137-8650; Durocher, Jill/0000-0002-5572-8133	Bill & Melinda Gates Foundation	Bill & Melinda Gates Foundation(Bill & Melinda Gates Foundation)	We thank the women who participated in this trial and the providers who carefully collected the data; our colleagues at Family Care International; the members of our Post-Partum Haemorrhage Advisory Committee: Paul Blumenthal, Jose Guilherme Cecatti, Friday Okonofua, Swaraj Raibhandari, Nancy Sloan, Jeff Spieler, and Gijs Walraven; the Data Safety and Monitoring Board Members: Jose Guilherme Cecatti, Thomas Easterling, and Anne Paxton for their contributions to this trial; Nevine Hassanein, Abdel Aziz El Shobary, and Miral Breebaart in Egypt; Ngo Van Nhang at Hoc Mon Hospital and Tran Thanh Nhan at Cu Chi Hospital in Vietnam; Der Adolphe Some and Pascaline Zongo Tamini at Centre Hospitalier Souro Sanou in Burkina Faso; Ali Haberal, Salim Erkaya, Omer Kandemir, Dilek Torun, and Nurten Kaya at MoH Etlik Zubeyde Hanim Women's Health Teaching and Research Hospital in Turkey; and Melanie Pena at Gynuity Health Projects. This research was funded by a grant from the Bill & Melinda Gates Foundation.	Abdel-Aleem H, 2001, INT J GYNECOL OBSTET, V72, P75, DOI 10.1016/S0020-7292(00)00321-0; Adekanmi OA, 2001, BRIT J OBSTET GYNAEC, V108, P541, DOI 10.1111/j.1471-0528.2001.00110.x; Altman DG, 2001, ANN INTERN MED, V134, P663, DOI 10.7326/0003-4819-134-8-200104170-00012; [Anonymous], 2006, OBSTET GYNECOL, V108, P1039, DOI DOI 10.1097/00006250-200610000-00046; Blum J, 2007, INT J GYNECOL OBSTET, V99, pS202, DOI 10.1016/j.ijgo.2007.09.013; Derman RJ, 2006, LANCET, V368, P1248, DOI 10.1016/S0140-6736(06)69522-6; Hofmeyr G Justus, 2004, BMC Pregnancy Childbirth, V4, P16, DOI 10.1186/1471-2393-4-16; Hofmeyr GJ, 2008, BEST PRACT RES CL OB, V22, P1025, DOI 10.1016/j.bpobgyn.2008.08.005; Hofmeyr GJ, 2005, BJOG-INT J OBSTET GY, V112, P547, DOI 10.1111/j.1471-0528.2004.00512.x; Lokugamage AU, 2001, ACTA OBSTET GYN SCAN, V80, P835, DOI 10.1034/j.1600-0412.2001.080009835.x; Mousa HA, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003249.pub2; O'Brien P, 1998, OBSTET GYNECOL, V92, P212, DOI 10.1016/S0029-7844(98)00161-6; Oboro VO, 2003, INT J GYNECOL OBSTET, V80, P67, DOI 10.1016/S0020-7292(02)00301-6; Ozan H., 2000, Clinical and Experimental Obstetrics and Gynecology, V27, P221; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Prata N, 2005, INT J GYNECOL OBSTET, V90, P51, DOI 10.1016/j.ijgo.2005.03.007; Prendiville WJ, 2000, COCHRANE DB SYST REV, V3; Royal College of Obstetricians and Gynaecologists, 2009, RCOG GREEN TOP GUID, V52; Shojai R, 2004, Gynecol Obstet Fertil, V32, P703, DOI 10.1016/j.gyobfe.2004.05.015; Shojai R, 2001, J Gynecol Obstet Biol Reprod (Paris), V30, P572; Tang OS, 2007, INT J GYNECOL OBSTET, V99, pS160, DOI 10.1016/j.ijgo.2007.09.004; Tsu VD, 2004, INT J GYNECOL OBSTET, V85, pS83, DOI 10.1016/j.ijgo.2004.02.011; Walraven G, 2004, BJOG-INT J OBSTET GY, V111, P1014, DOI 10.1111/j.1471-0528.2004.00217.x; Winikoff B, 2010, LANCET, V375, P210, DOI 10.1016/S0140-6736(09)61924-3; World Health Organization, 2007, REC PREV POSTP HAEM; World Health Organization, 2000, MAN COMPL PREGN CHIL; Zuberi Nadeem F, 2008, BMC Pregnancy Childbirth, V8, P40, DOI 10.1186/1471-2393-8-40	27	92	95	1	17	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					217	223		10.1016/S0140-6736(09)61923-1	http://dx.doi.org/10.1016/S0140-6736(09)61923-1			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20060162				2022-12-28	WOS:000273853800031
J	Iglehart, JK				Iglehart, John K.			Senate's Reform Package Wrapped Up in Time for Christmas	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																		Zernike K., 2009, NY TIMES, p[A1, A16]	1	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2								10.1056/NEJMp0912667	http://dx.doi.org/10.1056/NEJMp0912667			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	543FU	20038784				2022-12-28	WOS:000273558500006
J	Pleasance, ED; Stephens, PJ; O'Meara, S; McBride, DJ; Meynert, A; Jones, D; Lin, ML; Beare, D; Lau, KW; Greenman, C; Varela, I; Nik-Zainal, S; Davies, HR; Ordonez, GR; Mudie, LJ; Latimer, C; Edkins, S; Stebbings, L; Chen, LN; Jia, MM; Leroy, C; Marshall, J; Menzies, A; Butler, A; Teague, JW; Mangion, J; Sun, YA; McLaughlin, SF; Peckham, HE; Tsung, EF; Costa, GL; Lee, CC; Minna, JD; Gazdar, A; Birney, E; Rhodes, MD; McKernan, KJ; Stratton, MR; Futreal, PA; Campbell, PJ				Pleasance, Erin D.; Stephens, Philip J.; O'Meara, Sarah; McBride, David J.; Meynert, Alison; Jones, David; Lin, Meng-Lay; Beare, David; Lau, King Wai; Greenman, Chris; Varela, Ignacio; Nik-Zainal, Serena; Davies, Helen R.; Ordonez, Gonzalo R.; Mudie, Laura J.; Latimer, Calli; Edkins, Sarah; Stebbings, Lucy; Chen, Lina; Jia, Mingming; Leroy, Catherine; Marshall, John; Menzies, Andrew; Butler, Adam; Teague, Jon W.; Mangion, Jonathon; Sun, Yongming A.; McLaughlin, Stephen F.; Peckham, Heather E.; Tsung, Eric F.; Costa, Gina L.; Lee, Clarence C.; Minna, John D.; Gazdar, Adi; Birney, Ewan; Rhodes, Michael D.; McKernan, Kevin J.; Stratton, Michael R.; Futreal, P. Andrew; Campbell, Peter J.			A small-cell lung cancer genome with complex signatures of tobacco exposure	NATURE			English	Article							ACUTE MYELOID-LEUKEMIA; HOLLIDAY JUNCTION RESOLVASE; SOMATIC MUTATIONS; CIGARETTE-SMOKING; P53 MUTATIONS; DNA-DAMAGE; GENE; BINDING; REPAIR; CARCINOGENESIS	Cancer is driven by mutation. Worldwide, tobacco smoking is the principal lifestyle exposure that causes cancer, exerting carcinogenicity through >60 chemicals that bind and mutate DNA. Using massively parallel sequencing technology, we sequenced a small-cell lung cancer cell line, NCI-H209, to explore the mutational burden associated with tobacco smoking. A total of 22,910 somatic substitutions were identified, including 134 in coding exons. Multiple mutation signatures testify to the cocktail of carcinogens in tobacco smoke and their proclivities for particular bases and surrounding sequence context. Effects of transcription-coupled repair and a second, more general, expression-linked repair pathway were evident. We identified a tandem duplication that duplicates exons 3-8 of CHD7 in frame, and another two lines carrying PVT1-CHD7 fusion genes, indicating that CHD7 may be recurrently rearranged in this disease. These findings illustrate the potential for next-generation sequencing to provide unprecedented insights into mutational processes, cellular repair pathways and gene networks associated with cancer.	[Pleasance, Erin D.; Stephens, Philip J.; O'Meara, Sarah; McBride, David J.; Jones, David; Lin, Meng-Lay; Beare, David; Lau, King Wai; Greenman, Chris; Varela, Ignacio; Nik-Zainal, Serena; Davies, Helen R.; Ordonez, Gonzalo R.; Mudie, Laura J.; Latimer, Calli; Edkins, Sarah; Stebbings, Lucy; Chen, Lina; Jia, Mingming; Leroy, Catherine; Marshall, John; Menzies, Andrew; Butler, Adam; Teague, Jon W.; Stratton, Michael R.; Futreal, P. Andrew; Campbell, Peter J.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England; [O'Meara, Sarah; Mangion, Jonathon] Life Technol, Warrington WA3 7QH, Cheshire, England; [Meynert, Alison; Birney, Ewan] European Bioinformat Inst, Hinxton CB10 1SD, England; [Sun, Yongming A.; Rhodes, Michael D.] Life Technol, Foster City, CA 94404 USA; [McLaughlin, Stephen F.; Peckham, Heather E.; Tsung, Eric F.; Costa, Gina L.; Lee, Clarence C.; McKernan, Kevin J.] Life Technol, Beverley, MA 01915 USA; [Minna, John D.; Gazdar, Adi] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Campbell, Peter J.] Univ Cambridge, Dept Haematol, Cambridge CB2 2XY, England	Wellcome Trust Sanger Institute; Thermo Fisher Scientific; European Molecular Biology Laboratory (EMBL); Thermo Fisher Scientific; Thermo Fisher Scientific; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of London; Institute of Cancer Research - UK; University of Cambridge	Campbell, PJ (corresponding author), Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England.	pc8@sanger.ac.uk	Varela, Ignacio/G-1699-2016; Wang, Weili/D-1546-2011; Nik-Zainal, Serena/ABD-4437-2020; Varela, Ignacio/AAA-7680-2021	Varela, Ignacio/0000-0002-0969-506X; Varela, Ignacio/0000-0002-0969-506X; Edkins, Sarah/0000-0003-0717-1972; Marshall, John/0000-0002-1216-5457; McKernan, Kevin/0000-0002-3908-1122; Nik-Zainal, Serena/0000-0001-5054-1727; Birney, Ewan/0000-0001-8314-8497	Wellcome Trust [077012/Z/05/Z]; Human Frontiers Science Programme; NCI [NCI P50CA70907]; NATIONAL CANCER INSTITUTE [P50CA070907] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Human Frontiers Science Programme(Human Frontier Science Program); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the Wellcome Trust (grant reference 077012/Z/05/Z). P.J.C. is a Kay Kendall Leukaemia Fund Intermediate Clinical Fellow. I. V. is supported by the Human Frontiers Science Programme. J. Minna. and A. G. are supported by an NCI grant (NCI P50CA70907).	Bagchi A, 2007, CELL, V128, P459, DOI 10.1016/j.cell.2006.11.052; Barbone F, 1997, CHEST, V112, P1474, DOI 10.1378/chest.112.6.1474; Campbell PJ, 2008, NAT GENET, V40, P722, DOI 10.1038/ng.128; CARNEY DN, 1985, CANCER RES, V45, P2913; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; DALGLIESH GL, NATURE IN PRESS, DOI DOI 10.1038/NATURE08672; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; DeMarini DM, 2004, MUTAT RES-REV MUTAT, V567, P447, DOI 10.1016/j.mrrev.2004.02.001; Denissenko MF, 1997, P NATL ACAD SCI USA, V94, P3893, DOI 10.1073/pnas.94.8.3893; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eckhardt F, 2006, NAT GENET, V38, P1378, DOI 10.1038/ng1909; Fekairi S, 2009, CELL, V138, P78, DOI 10.1016/j.cell.2009.06.029; Feng ZH, 2006, P NATL ACAD SCI USA, V103, P15404, DOI 10.1073/pnas.0607031103; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Hecht SS, 2008, CHEM RES TOXICOL, V21, P160, DOI 10.1021/tx7002068; HOROWITZ JM, 1990, P NATL ACAD SCI USA, V87, P2775, DOI 10.1073/pnas.87.7.2775; Jackson MA, 2006, TOXICOL SCI, V90, P400, DOI 10.1093/toxsci/kfj101; Jha P, 2009, NAT REV CANCER, V9, P655, DOI 10.1038/nrc2703; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; KAYE FJ, 1990, P NATL ACAD SCI USA, V87, P6922, DOI 10.1073/pnas.87.17.6922; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Ley TJ, 2008, NATURE, V456, P66, DOI 10.1038/nature07485; Liu YY, 2005, BIOCHEM J, V385, P519, DOI 10.1042/BJ20041151; Lubin JH, 2007, AM J EPIDEMIOL, V166, P479, DOI 10.1093/aje/kwm089; LUBIN JH, 1984, JNCI-J NATL CANCER I, V73, P383, DOI 10.1093/jnci/73.2.383; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; MORI N, 1990, ONCOGENE, V5, P1713; Pfeifer GP, 2002, ONCOGENE, V21, P7435, DOI 10.1038/sj.onc.1205803; Rodin SN, 2005, SEMIN CANCER BIOL, V15, P103, DOI 10.1016/j.semcancer.2004.08.005; Rozman M, 2004, GENE CHROMOSOME CANC, V40, P140, DOI 10.1002/gcc.20022; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Sher T, 2008, MAYO CLIN PROC, V83, P355, DOI 10.4065/83.3.355; Shuck SC, 2008, CELL RES, V18, P64, DOI 10.1038/cr.2008.2; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Svendsen JM, 2009, CELL, V138, P63, DOI 10.1016/j.cell.2009.06.030; Toh Chee-Keong, 2009, V472, P397, DOI 10.1007/978-1-60327-492-0_19; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Vlieghe D, 2006, NUCLEIC ACIDS RES, V34, pD95, DOI 10.1093/nar/gkj115; Wistuba II, 2001, SEMIN ONCOL, V28, P3, DOI 10.1053/sonc.2001.25738; Yokomizo A, 1998, ONCOGENE, V17, P475, DOI 10.1038/sj.onc.1201956; ZEIDLER R, 1994, GENE CHROMOSOME CANC, V9, P282, DOI 10.1002/gcc.2870090408	43	800	908	2	134	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					184	U66		10.1038/nature08629	http://dx.doi.org/10.1038/nature08629			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20016488	hybrid, Green Accepted, Green Submitted			2022-12-28	WOS:000273582700026
J	Fogarty, J; McCally, M				Fogarty, John; McCally, Michael			Health and Safety Risks of Carbon Capture and Storage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fogarty, John] Univ New Mexico, Dept Family Med, Albuquerque, NM 87131 USA; [McCally, Michael] Mt Sinai Sch Med, Dept Prevent Med, New York, NY USA	University of New Mexico; Icahn School of Medicine at Mount Sinai	McCally, M (corresponding author), 64 Lodge Trl, Santa Fe, NM 87506 USA.	michaelmccally@comcast.net						BAXTER PJ, 1989, BRIT MED J, V298, P1437, DOI 10.1136/bmj.298.6685.1437; *CTR HLTH GLOB ENV, HLTH SOL LOW CARB EC; Ford M, 2000, CLIN TOXICOLOGY; HAMILTON A, 1998, IND TOXICOLOGY; Haszeldine RS, 2009, SCIENCE, V325, P1647, DOI 10.1126/science.1172246; *INT EN AG, PROSP CO2 CAPT STOR; Schrag DP, 2007, SCIENCE, V315, P812, DOI 10.1126/science.1137632; Spreng D, 2007, ENERG POLICY, V35, P850, DOI 10.1016/j.enpol.2006.10.009; 2009, ECONOMIST       0305, P74; 2009, ECONOMIST       0305, P20	10	19	20	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2010	303	1					67	68		10.1001/jama.2009.1951	http://dx.doi.org/10.1001/jama.2009.1951			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539YS	20051572				2022-12-28	WOS:000273296900022
J	Ferner, RE; Hughes, DA; Aronson, JK				Ferner, Robin E.; Hughes, Dyfrig A.; Aronson, Jeffrey K.			NICE and new: appraising innovation	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hughes, Dyfrig A.] Bangor Univ, Inst Med & Social Care Res, Ctr Econ & Policy Hlth, Bangor LL57 1UT, Gwynedd, Wales; [Ferner, Robin E.] City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England; [Aronson, Jeffrey K.] Dept Primary Hlth Care, Oxford OX3 7LF, England	Bangor University; University of Birmingham	Hughes, DA (corresponding author), Bangor Univ, Inst Med & Social Care Res, Ctr Econ & Policy Hlth, Bangor LL57 1UT, Gwynedd, Wales.	d.a.hughes@bangor.ac.uk	Hughes, Dyfrig/H-5252-2012	Hughes, Dyfrig/0000-0001-8247-7459; Ferner, Robin/0000-0003-3769-1346				[Anonymous], 1988, BRIT MED J, V296, P320; Aronson JK, 2008, J AMBUL CARE MANAG, V31, P65, DOI 10.1097/01.JAC.0000304100.38120.b2; Baber NS, 2004, BRIT J CLIN PHARMACO, V58, P569, DOI 10.1111/j.1365-2125.2004.02341.x; Bailey CJ, 2007, BRIT MED J, V335, P1156, DOI 10.1136/bmj.39409.507662.94; *DEP INN U SKILLS, 2008, PROC INN INN PROC; Drummond M, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1204; Kennedy I., 2009, APPRAISING VALUE INN; McCabe C, 2008, PHARMACOECONOMICS, V26, P733, DOI 10.2165/00019053-200826090-00004; National Institute for Health and Clinical Excellence, 2008, GUID METH TECHN APPR; *NIH CLIN EXC, 2009, RESP SIR I KENN REP; Office for Life Sciences, 2009, LIF SCI BLUEPR; Po ALW, 1998, LANCET, V351, P1829, DOI 10.1016/S0140-6736(05)78800-0; Rawlins M, 2010, BRIT J CLIN PHARMACO, V70, P346, DOI 10.1111/j.1365-2125.2009.03589.x; Salomon JA, 2004, BMJ-BRIT MED J, V329, P733, DOI 10.1136/bmj.329.7468.733; VANDERKROEF C, 1979, LANCET, V2, P526; WALKER A, 2009, BASIC CLIN PHARM S1, V105, pO23	16	27	28	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 5	2010	340								b5493	10.1136/bmj.b5493	http://dx.doi.org/10.1136/bmj.b5493			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	542IA	20051468				2022-12-28	WOS:000273485100004
J	Ossowski, S; Schneeberger, K; Lucas-Lledo, JI; Warthmann, N; Clark, RM; Shaw, RG; Weigel, D; Lynch, M				Ossowski, Stephan; Schneeberger, Korbinian; Lucas-Lledo, Jose Ignacio; Warthmann, Norman; Clark, Richard M.; Shaw, Ruth G.; Weigel, Detlef; Lynch, Michael			The Rate and Molecular Spectrum of Spontaneous Mutations in Arabidopsis thaliana	SCIENCE			English	Article							GENOME-WIDE VIEW; SHORT READS; DIVERSITY; SEQUENCE	To take complete advantage of information on within-species polymorphism and divergence from close relatives, one needs to know the rate and the molecular spectrum of spontaneous mutations. To this end, we have searched for de novo spontaneous mutations in the complete nuclear genomes of five Arabidopsis thaliana mutation accumulation lines that had been maintained by single-seed descent for 30 generations. We identified and validated 99 base substitutions and 17 small and large insertions and deletions. Our results imply a spontaneous mutation rate of 7 x 10(-9) base substitutions per site per generation, the majority of which are G:C -> A:T transitions. We explain this very biased spectrum of base substitution mutations as a result of two main processes: deamination of methylated cytosines and ultraviolet light-induced mutagenesis.	[Lucas-Lledo, Jose Ignacio; Lynch, Michael] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Ossowski, Stephan; Schneeberger, Korbinian; Warthmann, Norman; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Clark, Richard M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Shaw, Ruth G.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Indiana University System; Indiana University Bloomington; Max Planck Society; Utah System of Higher Education; University of Utah; University of Minnesota System; University of Minnesota Twin Cities	Lucas-Lledo, JI (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	joslucas@indiana.edu; weigel@weigelworld.org	Ossowski, Stephan/E-2139-2011; Weigel, Detlef/AAR-3312-2021; Schneeberger, Korbinian/U-6329-2019; Lucas Lledó, José Ignacio/L-3112-2014; Weigel, Detlef/GSJ-0799-2022; Warthmann, Norman/E-1069-2011; Lledó, José Ignacio Lucas/AAA-5392-2019; Weigel, Detlef/C-1418-2008	Ossowski, Stephan/0000-0002-7416-9568; Schneeberger, Korbinian/0000-0002-5512-0443; Lucas Lledó, José Ignacio/0000-0001-6254-8942; Weigel, Detlef/0000-0002-2114-7963; Warthmann, Norman/0000-0002-1178-8409; Lledó, José Ignacio Lucas/0000-0001-6254-8942; Weigel, Detlef/0000-0002-2114-7963	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036827] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM036827, GM36827] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawabe A, 2008, GENETICS, V179, P985, DOI 10.1534/genetics.107.085282; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lynch M, 2008, MOL BIOL EVOL, V25, P2409, DOI 10.1093/molbev/msn185; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Marriage TN, 2009, HEREDITY, V103, P310, DOI 10.1038/hdy.2009.67; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Schultz ST, 1999, P NATL ACAD SCI USA, V96, P11393, DOI 10.1073/pnas.96.20.11393; Shaw FH, 2002, EVOLUTION, V56, P453, DOI 10.1111/j.0014-3820.2002.tb01358.x; Shaw RG, 2000, GENETICS, V155, P369; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wright SI, 2002, MOL BIOL EVOL, V19, P1407, DOI 10.1093/oxfordjournals.molbev.a004204	21	719	728	7	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					92	94		10.1126/science.1180677	http://dx.doi.org/10.1126/science.1180677			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044577	Green Accepted, Green Published			2022-12-28	WOS:000273395400038
J	Vargas-Parada, L				Vargas-Parada, Laura			H1N1: A Mexican Perspective	CELL			English	Editorial Material																			0	9	10	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 24	2009	139	7					1203	1205		10.1016/j.cell.2009.12.019	http://dx.doi.org/10.1016/j.cell.2009.12.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064360	Bronze			2022-12-28	WOS:000273048700001
J	Cassel, CK				Cassel, Christine K.			Policy for an Aging Society A Review of Systems	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARE		Amer Board Internal Med, Philadelphia, PA 19106 USA	American Board of Internal Medicine	Cassel, CK (corresponding author), Amer Board Internal Med, 510 Walnut St,Ste 1700, Philadelphia, PA 19106 USA.	ccassel@abim.org						*GER WORKF POL STU, ADGAP SURV GER MED F; *I MED COMM COMP E, IN NAT PRIOR COMP EF; Medicare Payment Advisory Commission, 2009, REP C IMPR INC MED P; *OR HLTH SCI U CTR, POLST PHYS ORD LIF S; Palmer RM, 2003, DIS MANAG HEALTH OUT, V11, P507, DOI 10.2165/00115677-200311080-00004; Reuben DB, 2009, JAMA-J AM MED ASSOC, V302, P2686, DOI 10.1001/jama.2009.1871; *US DEP HHS, FACT SHEET MED MED A; Yang Z, 2003, J GERONTOL B-PSYCHOL, V58, pS2, DOI 10.1093/geronb/58.1.S2	8	7	7	0	3	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 23	2009	302	24					2701	2702		10.1001/jama.2009.1901	http://dx.doi.org/10.1001/jama.2009.1901			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535JU	20040561				2022-12-28	WOS:000272965300029
J	Langelaan, JW; Roy, N				Langelaan, Jack W.; Roy, Nicholas			Enabling New Missions for Robotic Aircraft	SCIENCE			English	Editorial Material									[Langelaan, Jack W.] Penn State Univ, Dept Aerosp Engn, University Pk, PA 16802 USA; [Roy, Nicholas] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Massachusetts Institute of Technology (MIT)	Langelaan, JW (corresponding author), Penn State Univ, Dept Aerosp Engn, University Pk, PA 16802 USA.	jlangelaan@psu.edu; nickroy@mit.edu			Direct For Computer & Info Scie & Enginr [0746655] Funding Source: National Science Foundation	Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE))		Achtelik M., 2009, P SPIE, V7332; ALLEN MJ, 2007, AIAA AER SCI M EXH R; Chakrabarty A., 2009, AIAA GUID NAV CONTR; Deittert M, 2009, J GUID CONTROL DYNAM, V32, P1446, DOI 10.2514/1.43270; Griffiths S., 2007, ADV UNMANNED AERIAL, P213, DOI [10.1007/978-1-4020-6114-1_7, DOI 10.1007/978-1-4020-6114-1_7]; Lai K., 2009, P ROB SCI SYST; LEONARD JJ, 1992, INT J ROBOT RES, V11, P286, DOI 10.1177/027836499201100402; PATEL CK, 2008, ENERGY EXTRACTION AT; Rayleigh L., 1883, NATURE, V27, P534, DOI DOI 10.1038/027388A0; Sachs G, 2005, IBIS, V147, P1, DOI 10.1111/j.1474-919x.2004.00295.x; Thrun S, 1998, ARTIF INTELL, V99, P21, DOI 10.1016/S0004-3702(97)00078-7; Torralba A, 2003, NINTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOLS I AND II, PROCEEDINGS, P273; Wei Y, 2009, IEEE INT CONF ROBOT, P3761, DOI 10.1109/ROBOT.2009.5152775	13	29	32	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	DEC 18	2009	326	5960					1642	1644		10.1126/science.1182497	http://dx.doi.org/10.1126/science.1182497			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	533QJ	20019278				2022-12-28	WOS:000272839000041
J	de Souza, JA; Bines, J				de Souza, Jonas A.; Bines, Jose			The Global Breast Cancer Disparity Strategies for Bridging the Gap	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							ENDOCRINE THERAPY; LAPATINIB		[Bines, Jose] INCA, Inst Nacl Canc, BR-20560200 Rio De Janeiro, Brazil; [de Souza, Jonas A.] Univ Chicago, Med Ctr, Dept Med, Hematol Oncol Sect, Chicago, IL 60637 USA; [de Souza, Jonas A.] Univ Chicago, Global Hlth Initiat, Chicago, IL 60637 USA	National Cancer Institute (Inca); University of Chicago; University of Chicago Medical Center; University of Chicago	Bines, J (corresponding author), INCA, Inst Nacl Canc, Rua Visconde de Santa Isabel 274, BR-20560200 Rio De Janeiro, Brazil.	jose_bines@yahoo.com						Bines J, 2008, CANCER-AM CANCER SOC, V113, P2353, DOI 10.1002/cncr.23837; Ellis MJ, 2008, J NATL CANCER I, V100, P1380, DOI 10.1093/jnci/djn309; Ellis MJ, 2009, JAMA-J AM MED ASSOC, V302, P774, DOI 10.1001/jama.2009.1204; Eniu A, 2008, CANCER-AM CANCER SOC, V113, P2269, DOI 10.1002/cncr.23843; Gomez HL, 2008, J CLIN ONCOL, V26, P2999, DOI 10.1200/JCO.2007.14.0590; Gronwald J, 2009, J CLIN ONCOL, V27; OLOPADE OL, 2009, ASCO ED BOOK, P681; Phillips KA, 2009, CANCER-AM CANCER SOC, V115, P5166, DOI 10.1002/cncr.24574; Punglia RS, 2008, JNCI-J NATL CANCER I, V100, P642, DOI 10.1093/jnci/djn100; Ratain MJ, 2007, J CLIN ONCOL, V25, P3397, DOI 10.1200/JCO.2007.12.0758	10	3	3	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	2009	302	23					2589	2590		10.1001/jama.2009.1857	http://dx.doi.org/10.1001/jama.2009.1857			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532HK	20009060				2022-12-28	WOS:000272737200028
J	Grey, MR				Grey, Michael R.			Health Insurance Cooperatives Lessons From the Great Depression	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Univ Connecticut, Sch Med, Hosp Cent Connecticut, New Britain, CT 06050 USA	University of Connecticut	Grey, MR (corresponding author), Univ Connecticut, Sch Med, Hosp Cent Connecticut, 100 Grand St, New Britain, CT 06050 USA.	mgrey@thocc.org						DAVIS K, COOPERATIVE HLTH CAR; Grey Michael R., 1999, NEW DEAL MED RURAL H; GREY MR, 1994, AM J PUBLIC HEALTH, V84, P1678, DOI 10.2105/AJPH.84.10.1678; HACKER JS, UNCOOPERATIVE TROUBL; HAISLMAIER EF, HLTH INSURANCE COOPS; Sack Kevin, 2009, NY TIMES, pA1; Wicks EK, 2000, MILBANK Q, V78, P511, DOI 10.1111/1468-0009.00184	7	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 16	2009	302	23					2587	2588		10.1001/jama.2009.1856	http://dx.doi.org/10.1001/jama.2009.1856			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	532HK	20009059				2022-12-28	WOS:000272737200027
J	Grove, EL; Storey, RF				Grove, Erik L.; Storey, Robert F.			The right oral antithrombotics in acute coronary syndromes	LANCET			English	Editorial Material							ACUTE MYOCARDIAL-INFARCTION; ANTIPLATELET		[Grove, Erik L.] Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus, Denmark; [Storey, Robert F.] Univ Sheffield, Dept Cardiovasc Sci, Sheffield, S Yorkshire, England	Aarhus University; University of Sheffield	Grove, EL (corresponding author), Aarhus Univ Hosp, Dept Cardiol, DK-8200 Aarhus, Denmark.	erikgrove@dadlnet.dk	Storey, Robert/AAA-6853-2019	Storey, Robert/0000-0002-6677-6229; Grove, Erik/0000-0002-1466-0865				Eikelboom JW, 2006, CIRCULATION, V114, P774, DOI 10.1161/CIRCULATIONAHA.106.612812; Grove EL, 2009, FUTUR CARDIOL, V5, P247, DOI 10.2217/FCA.09.10; Grove EL, 2009, THROMB HAEMOSTASIS, V101, P151, DOI 10.1160/TH08-03-0186; Holmes DR, 2009, J AM COLL CARDIOL, V54, P95, DOI 10.1016/j.jacc.2009.03.044; Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001; Koch CG, 2008, NEW ENGL J MED, V358, P1229, DOI 10.1056/NEJMoa070403; Sorensen R, 2009, LANCET, V374, P1967, DOI 10.1016/S0140-6736(09)61751-7; Spencer FA, 2007, CIRCULATION, V116, P2793, DOI 10.1161/CIRCULATIONAHA.107.694273; Storey RF, 2009, LANCET, V373, P276, DOI 10.1016/S0140-6736(08)61846-2; Wang TY, 2008, CIRCULATION, V118, P2139, DOI 10.1161/CIRCULATIONAHA.108.787143; Wurtz M, 2010, HEART, V96, P368, DOI 10.1136/hrt.2009.181107; Yusuf S, 2006, NEW ENGL J MED, V354, P1464	12	7	7	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC 12	2009	374	9706					1947	1948		10.1016/S0140-6736(09)61961-9	http://dx.doi.org/10.1016/S0140-6736(09)61961-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	532EA	20006120				2022-12-28	WOS:000272727000004
J	Brown, RH				Brown, Robert H.			A Reinnervating MicroRNA	SCIENCE			English	Editorial Material							DISEASE; SITE		Univ Massachusetts, Sch Med, Program Neurosci, Worcester, MA 01655 USA	University of Massachusetts System; University of Massachusetts Worcester	Brown, RH (corresponding author), Univ Massachusetts, Sch Med, Program Neurosci, 55 Lake Ave N, Worcester, MA 01655 USA.	robert.brown@umassmed.edu						Ambros V, 2007, DEVELOPMENT, V134, P1635, DOI 10.1242/dev.002006; Clop A, 2006, NAT GENET, V38, P813, DOI 10.1038/ng1810; Eacker SM, 2009, NAT REV NEUROSCI, V10, P837, DOI 10.1038/nrn2726; Gao FB, 2008, TRENDS NEUROSCI, V31, P20, DOI 10.1016/j.tins.2007.10.004; Hebert SS, 2008, P NATL ACAD SCI USA, V105, P6415, DOI 10.1073/pnas.0710263105; Lee Y, 2008, NAT NEUROSCI, V11, P1137, DOI 10.1038/nn.2183; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Swoboda KJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005268; Wang G, 2008, AM J HUM GENET, V82, P283, DOI 10.1016/j.ajhg.2007.09.021; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046	12	17	17	1	5	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	DEC 11	2009	326	5959					1494	1495		10.1126/science.1183842	http://dx.doi.org/10.1126/science.1183842			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	530WS	20007892				2022-12-28	WOS:000272623600046
J	Doshi, P				Doshi, Peter			Neuraminidase inhibitors-the story behind the Cochrane review	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IMMUNIZATION PRACTICES ACIP; ADVISORY-COMMITTEE; ACUTE INFLUENZA; OSELTAMIVIR; RECOMMENDATIONS; PREVENTION; EFFICACY; SAFETY		MIT, Program Hist Anthropol Sci Technol & Soc, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Doshi, P (corresponding author), MIT, Program Hist Anthropol Sci Technol & Soc, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	pnd@mit.edu						Abraham J, 1996, SCI POLITICS PHARM I; Smith Nicole M., 2006, Morbidity and Mortality Weekly Report, V55, P1; [Anonymous], 2005, HHS PAND INFL PLAN; BROWNLEE S, 2009, ATLANTIC         NOV; Burch J, 2009, LANCET INFECT DIS, V9, P537, DOI 10.1016/S1473-3099(09)70199-9; Call SA, 2005, JAMA-J AM MED ASSOC, V293, P987, DOI 10.1001/jama.293.8.987; *CHUG PHARM CO, 2009, PROD INF; Fiore Anthony E., 2007, Morbidity and Mortality Weekly Report, V56, P1; *HOFFM LA ROCH, 2008, PROD LAB; HOFFMANLAROCHE, 2005, INVESTOR UPDATE TAMI; HUSEREAU DR, 2002, 7 CCOHTA; Jefferson TO, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001265.pub2; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; Kaiser L, 2003, ARCH INTERN MED, V163, P1667, DOI 10.1001/archinte.163.14.1667; KELLY HA, 2010, MED J AUSTRALIA, V192, P1; Murphy Trudy V., 2008, Morbidity and Mortality Weekly Report, V57, P1; Nicholson KG, 2000, LANCET, V355, P1845, DOI 10.1016/S0140-6736(00)02288-1; *ROCH LAB, IMP INFL; *ROCH PROD PTY LTD, 2009, PROD INF; *ROCH REG, 2009, PROD INF; Smith J, 2006, LANCET, V367, P1571, DOI 10.1016/S0140-6736(06)68683-2; STURCKE J, 2009, GUARDIAN        0816; Tappenden P, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13110; Toovey S, 2008, DRUG SAFETY, V31, P1097, DOI 10.2165/0002018-200831120-00006; Treanor JJ, 2000, JAMA-J AM MED ASSOC, V283, P1016, DOI 10.1001/jama.283.8.1016; Turner David, 2003, HEALTH TECHNOL ASSES, V7, P1, DOI DOI 10.3310/HTA7350	26	61	63	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 8	2009	339								b5164	10.1136/bmj.b5164	http://dx.doi.org/10.1136/bmj.b5164			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531VE	19995813	Green Submitted			2022-12-28	WOS:000272697300005
J	Cheer, K; Pearce, S				Cheer, Kelly; Pearce, Sushmita			Lesson of the Week Osteoarticular infection of the symphysis pubis and sacroiliac joints in active young sportsmen	BRITISH MEDICAL JOURNAL			English	Article							OSTEITIS PUBIS; OSTEOMYELITIS		[Cheer, Kelly; Pearce, Sushmita] Royal Albert Edward Infirm, Ctr Diabet, Wrightington Wigan & Leigh NHS Trust, Wigan WN1 2NN, England		Cheer, K (corresponding author), Royal Albert Edward Infirm, Ctr Diabet, Wrightington Wigan & Leigh NHS Trust, Wigan WN1 2NN, England.	kellycheer@doctors.net.uk						Bindal M, 2007, ARCH PHYS MED REHAB, V88, P1357, DOI 10.1016/j.apmr.2007.07.004; BOUZA E, 1978, Urology, V12, P663, DOI 10.1016/0090-4295(78)90428-4; Calza L, 2002, J MED MICROBIOL, V51, P620, DOI 10.1099/0022-1317-51-7-620; CHOI H, 2008, BR J SPORTS MED 0930; FRICKER PA, 1991, SPORTS MED, V12, P266, DOI 10.2165/00007256-199112040-00005; HAKEEM MJM, 2006, SCOT MED J, V51, P57; Meirovitz A, 2004, J BONE JOINT SURG AM, V86A, P1057, DOI 10.2106/00004623-200405000-00027; Pauli S, 2002, BRIT J SPORT MED, V36, P71, DOI 10.1136/bjsm.36.1.71; PHARM DV, 2007, PERMANENTE J, V11; SHANAHAN MDG, 1985, J BONE JOINT SURG BR, V67, P605, DOI 10.1302/0301-620X.67B4.4030859	10	5	5	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	DEC 7	2009	339								b5019	10.1136/bmj.b5019	http://dx.doi.org/10.1136/bmj.b5019			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	531VD	19969603				2022-12-28	WOS:000272697200004
